data_2kbn_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2kbn _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo . . . . . 0 N--CA 1.498 1.774 0 CA-C-O 121.534 0.556 . . . . 0.0 112.811 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 4.5 pt20 -79.6 89.05 5.1 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.272 -0.893 . . . . 0.0 109.505 -179.72 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 78.9 mt -75.03 143.57 43.46 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.499 -0.751 . . . . 0.0 109.768 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 98.9 m -131.24 136.36 48.15 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.622 -0.674 . . . . 0.0 109.939 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -78.43 153.51 31.43 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.567 -0.708 . . . . 0.0 109.926 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 96.1 mt -62.26 -43.09 97.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.388 -0.82 . . . . 0.0 109.42 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 11.8 p -62.71 -28.26 44.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.244 -0.91 . . . . 0.0 109.256 -179.666 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 55.1 t0 -67.59 -33.09 74.3 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.346 -0.846 . . . . 0.0 109.699 179.502 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 97.0 mt -68.8 120.55 16.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.29 -0.881 . . . . 0.0 110.182 -178.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 31.4 m -148.57 9.51 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 179.401 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 82.9 tt0 -134.45 139.61 45.64 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.418 -0.802 . . . . 0.0 109.586 179.611 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.505 ' ND2' ' OE2' ' A' ' 76' ' ' GLU . 31.0 p30 -82.5 151.66 26.39 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.587 -0.696 . . . . 0.0 110.56 -179.516 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 78.76 4.65 88.21 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 108.897 -1.681 . . . . 0.0 108.897 -179.737 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 44.1 tt0 -72.43 129.12 37.61 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.403 -1.057 . . . . 0.0 109.729 -179.627 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 85.2 m95 -99.99 137.52 38.33 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.618 -0.676 . . . . 0.0 109.942 -179.625 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 178.37 178.34 0.4 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.527 -0.733 . . . . 0.0 109.238 179.265 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 61.3 m-20 -102.43 145.32 29.71 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 51.9 tp -139.38 134.93 33.13 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.41 -0.806 . . . . 0.0 110.195 -179.538 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 34.0 ttpt -113.94 137.51 51.58 Favored 'General case' 0 N--CA 1.498 1.929 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 178.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -159.88 170.84 20.56 Favored 'General case' 0 N--CA 1.493 1.693 0 C-N-CA 119.064 -1.054 . . . . 0.0 110.55 -179.71 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 51.8 tttp -105.11 144.52 31.8 Favored 'General case' 0 N--CA 1.494 1.775 0 CA-C-O 121.345 0.593 . . . . 0.0 109.758 -179.784 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 62.5 t -83.31 120.02 33.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.324 -0.86 . . . . 0.0 109.971 -179.388 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.419 HG23 HD12 ' A' ' 25' ' ' ILE . 96.4 mt -96.89 -66.55 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.645 -0.659 . . . . 0.0 109.229 -180.0 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 66.3 mt-30 -146.05 142.92 29.04 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.353 -0.842 . . . . 0.0 109.984 -179.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -125.26 136.69 53.78 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 -179.781 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 92.1 m95 -111.53 133.0 54.11 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 179.576 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 . . . . . 0 N--CA 1.492 1.627 0 O-C-N 121.539 -0.726 . . . . 0.0 110.268 -179.266 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' SER . . . . . 0.513 ' OG ' ' N ' ' A' ' 35' ' ' ILE . 56.1 p . . . . . 0 N--CA 1.49 1.558 0 CA-C-O 121.506 0.669 . . . . 0.0 109.886 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.513 ' N ' ' OG ' ' A' ' 34' ' ' SER . 96.9 mt -74.14 135.3 27.77 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 O-C-N 121.464 -0.773 . . . . 0.0 110.082 -179.281 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 17.8 t -92.16 -62.34 1.43 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.624 -0.672 . . . . 0.0 109.601 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 85.5 mt-30 -136.85 155.53 49.66 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.405 -0.809 . . . . 0.0 109.97 -179.343 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 8.7 p -142.92 141.9 26.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 179.8 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -168.63 -160.0 15.55 Favored Glycine 0 N--CA 1.489 2.212 0 C-N-CA 119.202 -1.475 . . . . 0.0 110.384 -179.669 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -133.22 147.98 52.0 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.747 -0.855 . . . . 0.0 109.423 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 41.4 mt -117.25 133.33 56.12 Favored 'General case' 0 N--CA 1.499 1.983 0 CA-C-O 121.529 0.68 . . . . 0.0 109.92 -179.018 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -78.98 162.9 48.95 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 110.124 -1.19 . . . . 0.0 110.124 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.451 ' OD1' ' N ' ' A' ' 44' ' ' GLU . 55.1 t0 -173.83 153.43 2.18 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.586 -0.95 . . . . 0.0 109.36 179.553 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.451 ' N ' ' OD1' ' A' ' 43' ' ' ASP . 82.2 tt0 -63.03 -18.58 63.49 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.47 -0.768 . . . . 0.0 109.515 -179.877 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 72.4 p -92.2 -7.95 46.85 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.205 -0.935 . . . . 0.0 109.282 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 135.3 -150.67 20.29 Favored Glycine 0 N--CA 1.497 2.753 0 N-CA-C 109.998 -1.241 . . . . 0.0 109.998 179.268 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.415 HG21 HD11 ' A' ' 47' ' ' ILE . 96.7 mt -123.03 139.64 49.19 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 O-C-N 121.679 -0.895 . . . . 0.0 109.765 -179.423 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 9.3 tp -129.03 139.64 51.36 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 CA-C-O 121.662 0.744 . . . . 0.0 109.533 179.569 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 32.5 mtmm -85.52 148.41 25.97 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.665 -0.647 . . . . 0.0 109.871 -179.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 7.1 p90 -143.27 152.16 41.37 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.381 -0.825 . . . . 0.0 109.919 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 47.2 m -131.09 133.9 46.09 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 179.787 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 32.0 mm -97.08 124.22 49.82 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 O-C-N 121.203 -0.935 . . . . 0.0 110.184 -179.258 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 96.0 m95 -88.68 139.14 30.78 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 121.529 -0.732 . . . . 0.0 109.214 179.566 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 98.9 mttt . . . . . 0 N--CA 1.489 1.481 0 O-C-N 121.346 -0.846 . . . . 0.0 109.663 -179.735 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 61.1 mt . . . . . 0 N--CA 1.494 1.751 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -53.59 149.23 32.21 Favored 'Trans proline' 0 N--CA 1.501 1.923 0 C-N-CA 122.286 1.99 . . . . 0.0 112.941 179.205 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 62.0 mt -68.12 144.03 55.19 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.456 -0.777 . . . . 0.0 110.37 -179.253 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.443 ' CD1' ' N ' ' A' ' 61' ' ' LEU . 10.1 mp -78.31 144.65 35.89 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.724 -0.61 . . . . 0.0 109.447 -179.682 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 80.2 tt0 -98.38 145.03 27.13 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.39 -0.819 . . . . 0.0 110.514 -179.085 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 57.9 tt0 -78.48 139.31 38.7 Favored 'General case' 0 N--CA 1.489 1.518 0 CA-C-O 121.479 0.657 . . . . 0.0 111.061 -179.295 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 84.93 10.63 78.4 Favored Glycine 0 N--CA 1.492 2.414 0 N-CA-C 110.187 -1.165 . . . . 0.0 110.187 178.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -124.74 144.65 50.12 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.385 -1.067 . . . . 0.0 110.602 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 8.1 p -87.04 152.41 22.39 Favored 'General case' 0 N--CA 1.487 1.405 0 CA-C-O 121.466 0.65 . . . . 0.0 109.987 179.769 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 70.4 m-85 -144.64 150.99 38.32 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.454 -0.779 . . . . 0.0 109.96 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 18.1 tp -108.55 124.6 50.71 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 179.184 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 69.8 mt -104.48 132.47 50.69 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 179.769 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 88.8 mtm180 -127.75 144.67 51.07 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.621 -0.674 . . . . 0.0 110.054 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' SER . . . . . 0.424 ' O ' ' OG ' ' A' ' 71' ' ' SER . 5.2 t 58.43 59.8 2.84 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 122.064 -0.397 . . . . 0.0 110.374 179.748 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 3.4 m -117.59 162.25 15.76 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.165 0 O-C-N 121.486 -0.759 . . . . 0.0 108.989 179.281 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 7.1 p -122.91 136.98 57.95 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 CA-C-O 121.606 0.717 . . . . 0.0 110.149 -178.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 90.4 t -80.84 128.61 38.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.468 -0.77 . . . . 0.0 109.975 -179.484 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -98.16 166.1 22.04 Favored Glycine 0 N--CA 1.494 2.526 0 N-CA-C 110.158 -1.177 . . . . 0.0 110.158 -179.774 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . 0.505 ' OE2' ' ND2' ' A' ' 14' ' ' ASN . 96.7 mt-10 -90.68 124.99 35.53 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.803 -0.822 . . . . 0.0 109.378 179.896 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 79.4 t80 -134.45 108.56 8.2 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.494 -0.754 . . . . 0.0 109.744 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 11.2 m120 41.15 -123.55 0.51 Allowed 'General case' 0 N--CA 1.493 1.712 0 CA-C-O 121.439 0.637 . . . . 0.0 111.031 179.57 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 96.9 m-20 -91.91 -5.81 52.54 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.442 -0.786 . . . . 0.0 110.116 -179.054 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 79.5 mtp85 -115.57 -172.62 2.18 Favored 'General case' 0 N--CA 1.502 2.161 0 O-C-N 121.443 -0.785 . . . . 0.0 109.945 -179.774 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 90.2 m-85 -130.45 156.72 44.3 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.598 -0.689 . . . . 0.0 109.842 -179.486 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 15.8 pt20 -140.12 165.09 28.3 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.575 -0.703 . . . . 0.0 109.315 179.64 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 33.8 m -104.67 132.43 51.37 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 O-C-N 121.387 -0.821 . . . . 0.0 109.117 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -102.91 128.66 49.61 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.537 -0.727 . . . . 0.0 109.864 -178.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 21.1 t -94.61 130.67 43.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.582 -0.699 . . . . 0.0 109.532 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 18.9 p30 -132.83 176.94 8.03 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 179.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 22.7 pttm -58.83 -36.05 73.92 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.358 -0.839 . . . . 0.0 109.84 -179.47 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 77.5 m-20 -62.45 -38.26 89.09 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.283 -0.886 . . . . 0.0 109.327 179.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 93.3 p -69.68 161.93 28.73 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.093 -1.004 . . . . 0.0 109.801 -179.241 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 72.1 m -130.6 152.17 50.25 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.607 -0.683 . . . . 0.0 109.681 -179.638 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 96.6 mt -127.12 131.96 70.24 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 75.4 mm-40 -129.14 137.52 51.24 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.53 -0.732 . . . . 0.0 109.475 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -78.89 129.78 34.92 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.505 -0.747 . . . . 0.0 109.328 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 52.4 mt -103.14 136.41 42.99 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.499 -0.751 . . . . 0.0 109.568 -179.496 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 74.3 m -81.52 -5.39 57.93 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 179.797 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -112.94 117.94 45.36 Favored Pre-proline 0 N--CA 1.497 1.921 0 O-C-N 121.676 -0.64 . . . . 0.0 109.356 -179.695 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -75.24 163.44 34.82 Favored 'Trans proline' 0 N--CA 1.491 1.375 0 C-N-CA 121.971 1.78 . . . . 0.0 111.971 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.42 HD12 HG21 ' A' ' 98' ' ' ILE . 19.2 mm . . . . . 0 N--CA 1.493 1.724 0 O-C-N 121.197 -0.939 . . . . 0.0 109.335 -179.695 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo . . . . . 0 N--CA 1.491 1.372 0 CA-C-O 121.727 0.636 . . . . 0.0 112.277 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . 0.525 ' N ' ' OE1' ' A' ' 4' ' ' GLN . 1.0 OUTLIER -78.92 89.17 4.71 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.305 -0.872 . . . . 0.0 109.344 -179.728 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 80.3 mt -75.47 150.8 38.15 Favored 'General case' 0 N--CA 1.488 1.442 0 CA-C-O 121.754 0.787 . . . . 0.0 109.807 -179.783 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 4.9 t -144.55 156.67 44.26 Favored 'General case' 0 N--CA 1.487 1.404 0 CA-C-O 121.751 0.786 . . . . 0.0 109.539 179.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.58 159.14 15.1 Favored 'General case' 0 C--N 1.3 -1.579 0 CA-C-O 121.875 0.845 . . . . 0.0 110.352 -179.665 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 96.1 mt -62.96 -42.68 97.53 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 CA-C-O 121.539 0.685 . . . . 0.0 109.267 179.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 14.4 p -62.71 -28.36 44.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.377 -0.827 . . . . 0.0 109.259 179.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 -75.75 -17.93 59.72 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.23 -0.919 . . . . 0.0 109.123 179.66 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 96.1 mt -86.57 113.37 24.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.127 -0.983 . . . . 0.0 109.66 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 20.6 m -153.94 17.24 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 179.75 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -127.08 137.51 53.04 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.536 -0.728 . . . . 0.0 109.881 -179.63 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 11.8 m120 -77.95 138.71 39.0 Favored 'General case' 0 N--CA 1.485 1.306 0 CA-C-O 121.804 0.811 . . . . 0.0 110.92 -179.223 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 79.39 11.04 85.34 Favored Glycine 0 N--CA 1.492 2.425 0 N-CA-C 109.995 -1.242 . . . . 0.0 109.995 179.398 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 44.6 tt0 -70.68 130.68 42.41 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.037 -1.273 . . . . 0.0 109.994 -179.653 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 86.6 m95 -104.76 131.14 52.57 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.725 -0.609 . . . . 0.0 109.677 -179.533 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -178.71 177.13 0.91 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.486 -0.759 . . . . 0.0 109.851 179.586 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.685 ' ND2' ' H ' ' A' ' 71' ' ' SER . 3.0 m120 -105.06 145.18 30.85 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.626 -0.672 . . . . 0.0 109.568 -179.79 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 5.2 tt -141.89 134.74 28.68 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.293 -0.879 . . . . 0.0 110.263 179.743 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 19.4 ttpp -112.47 138.44 49.22 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 179.52 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -161.01 179.9 8.07 Favored 'General case' 0 N--CA 1.492 1.644 0 C-N-CA 119.364 -0.934 . . . . 0.0 110.116 -179.54 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 89.0 tttt -115.35 139.46 49.98 Favored 'General case' 0 N--CA 1.495 1.79 0 CA-C-O 121.717 0.77 . . . . 0.0 110.221 -179.453 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 75.8 t -78.24 129.2 37.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 CA-C-O 121.688 0.756 . . . . 0.0 110.534 -179.275 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.41 HG21 HD12 ' A' ' 25' ' ' ILE . 96.7 mt -102.32 -53.84 7.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 178.971 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 67.0 tp60 -147.14 148.86 32.0 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.249 -0.907 . . . . 0.0 109.668 -179.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.549 ' CD2' ' N ' ' A' ' 27' ' ' LEU . 1.2 pt? -141.44 135.62 30.49 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 179.529 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 3.6 m-90 -121.08 114.03 20.88 Favored 'General case' 0 N--CA 1.496 1.872 0 CA-C-O 121.545 0.688 . . . . 0.0 109.457 -179.569 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 17.3 pt-20 . . . . . 0 N--CA 1.49 1.555 0 O-C-N 121.584 -0.697 . . . . 0.0 109.789 179.917 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 71.2 p . . . . . 0 N--CA 1.498 1.945 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.401 HD12 HG22 ' A' ' 35' ' ' ILE . 83.7 mt -106.56 127.04 62.29 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 O-C-N 121.3 -0.875 . . . . 0.0 110.07 -179.817 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 44.8 m -73.15 -74.91 0.16 Allowed 'General case' 0 N--CA 1.49 1.554 0 CA-C-O 121.726 0.774 . . . . 0.0 109.797 179.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 15.3 pt20 -146.62 162.12 39.09 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.341 -0.849 . . . . 0.0 109.656 -179.357 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 34.0 m -132.05 158.65 43.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 CA-C-O 121.659 0.742 . . . . 0.0 109.708 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -178.72 -160.8 25.39 Favored Glycine 0 N--CA 1.486 2.03 0 N-CA-C 109.764 -1.334 . . . . 0.0 109.764 -179.557 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.548 ' CD2' ' N ' ' A' ' 40' ' ' LEU . 1.3 pt? -139.96 148.24 41.64 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.572 -0.958 . . . . 0.0 110.35 -179.728 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 40.3 mt -109.59 134.07 52.36 Favored 'General case' 0 N--CA 1.491 1.581 0 CA-C-O 121.541 0.686 . . . . 0.0 109.379 -179.46 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -82.85 162.59 41.16 Favored Glycine 0 N--CA 1.488 2.132 0 N-CA-C 110.228 -1.149 . . . . 0.0 110.228 -179.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.547 ' OD1' ' N ' ' A' ' 44' ' ' GLU . 67.5 t0 -172.98 143.56 1.18 Allowed 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.761 -0.846 . . . . 0.0 109.342 179.688 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.547 ' N ' ' OD1' ' A' ' 43' ' ' ASP . 96.7 mt-10 -54.76 -14.94 1.57 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.603 -0.686 . . . . 0.0 109.639 179.865 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 44.3 p -94.15 -11.0 31.36 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.129 -0.982 . . . . 0.0 109.566 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 140.32 -155.77 24.79 Favored Glycine 0 N--CA 1.497 2.709 0 N-CA-C 110.309 -1.116 . . . . 0.0 110.309 179.423 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 41.9 pt -126.68 150.8 32.73 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 O-C-N 121.707 -0.878 . . . . 0.0 109.892 -179.364 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 19.0 tt -143.94 141.83 24.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.555 -0.715 . . . . 0.0 109.625 179.319 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -85.31 155.83 21.18 Favored 'General case' 0 N--CA 1.491 1.592 0 CA-C-O 121.435 0.636 . . . . 0.0 110.362 -179.603 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 38.5 p90 -144.47 151.65 39.49 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.251 -0.906 . . . . 0.0 109.775 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 54.1 m -133.35 127.13 32.83 Favored 'General case' 0 N--CA 1.492 1.639 0 CA-C-O 121.546 0.688 . . . . 0.0 109.459 179.263 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 97.0 mt -95.1 124.39 47.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.54 -0.725 . . . . 0.0 109.81 179.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 90.2 m95 -82.67 105.99 14.16 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.422 -0.799 . . . . 0.0 109.065 179.334 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 73.8 tttt . . . . . 0 N--CA 1.491 1.605 0 CA-C-O 121.594 0.711 . . . . 0.0 109.723 -179.52 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 15.0 mt . . . . . 0 N--CA 1.491 1.598 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -66.19 151.8 82.69 Favored 'Trans proline' 0 C--N 1.31 -1.455 0 C-N-CA 122.5 2.133 . . . . 0.0 112.432 179.567 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 82.0 mt -68.84 137.51 53.98 Favored 'General case' 0 N--CA 1.488 1.444 0 CA-C-O 121.862 0.839 . . . . 0.0 110.514 -179.301 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.45 ' CD1' ' N ' ' A' ' 61' ' ' LEU . 10.3 mp -78.98 143.0 36.15 Favored 'General case' 0 N--CA 1.49 1.569 0 CA-C-O 121.656 0.741 . . . . 0.0 109.853 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 81.7 tt0 -85.78 138.69 31.9 Favored 'General case' 0 N--CA 1.49 1.546 0 CA-C-O 121.857 0.837 . . . . 0.0 110.182 -179.586 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 57.2 tt0 -74.61 136.78 41.99 Favored 'General case' 0 N--CA 1.489 1.489 0 CA-C-O 121.819 0.819 . . . . 0.0 111.329 -179.375 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 84.17 20.95 58.12 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 110.051 -1.219 . . . . 0.0 110.051 178.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -128.49 145.56 51.07 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.401 -1.058 . . . . 0.0 110.156 -179.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 11.5 m -83.22 144.8 29.53 Favored 'General case' 0 N--CA 1.488 1.439 0 CA-C-O 121.653 0.74 . . . . 0.0 110.192 -179.642 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 79.9 m-85 -138.24 149.18 45.5 Favored 'General case' 0 N--CA 1.491 1.597 0 CA-C-O 121.918 0.866 . . . . 0.0 109.908 179.757 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 35.0 tp -106.77 122.65 46.8 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 179.284 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 65.8 mt -101.11 130.24 47.13 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 179.836 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.436 ' CZ ' ' OE2' ' A' ' 92' ' ' GLU . 80.7 mtm180 -125.65 142.61 51.42 Favored 'General case' 0 N--CA 1.497 1.878 0 CA-C-O 121.865 0.841 . . . . 0.0 110.699 -178.848 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' SER . . . . . 0.685 ' H ' ' ND2' ' A' ' 19' ' ' ASN . 34.3 t 50.98 59.19 4.8 Favored 'General case' 0 N--CA 1.491 1.617 0 CA-C-N 115.683 -0.689 . . . . 0.0 111.032 179.118 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 6.4 m -111.49 160.68 10.64 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.989 0 O-C-N 121.406 -0.809 . . . . 0.0 109.633 178.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 7.4 p -118.41 134.24 62.65 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 CA-C-O 121.722 0.772 . . . . 0.0 109.604 -179.463 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 9.8 t -86.51 113.72 24.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 CA-C-O 121.824 0.821 . . . . 0.0 109.753 -179.499 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -90.65 143.87 17.02 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 110.112 -1.195 . . . . 0.0 110.112 -179.641 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -63.08 132.08 50.71 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.694 -0.886 . . . . 0.0 110.305 -179.816 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . 0.632 ' CD2' ' ND2' ' A' ' 78' ' ' ASN . 34.9 t80 -137.43 96.74 3.31 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.375 -0.828 . . . . 0.0 108.965 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . 0.632 ' ND2' ' CD2' ' A' ' 77' ' ' TYR . 21.1 p30 43.41 -141.93 0.15 Allowed 'General case' 0 N--CA 1.494 1.758 0 CA-C-O 121.631 0.729 . . . . 0.0 110.897 -179.897 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.515 ' N ' ' OD1' ' A' ' 78' ' ' ASN . 46.9 t0 -73.05 -2.49 21.46 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.43 -0.793 . . . . 0.0 109.098 -179.633 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . 0.492 ' N ' ' OD1' ' A' ' 78' ' ' ASN . 29.9 mmt180 -115.53 -171.98 2.07 Favored 'General case' 0 N--CA 1.495 1.805 0 CA-C-O 122.047 0.927 . . . . 0.0 110.228 -179.286 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -127.83 155.72 43.67 Favored 'General case' 0 N--CA 1.492 1.652 0 CA-C-O 121.558 0.694 . . . . 0.0 109.873 -179.207 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 52.1 tt0 -139.59 151.84 46.36 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.544 -0.722 . . . . 0.0 109.741 -179.599 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 3.8 m -108.98 132.23 57.6 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 179.235 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 87.9 mt-30 -105.93 127.08 52.9 Favored 'General case' 0 N--CA 1.495 1.795 0 CA-C-O 121.784 0.802 . . . . 0.0 110.178 -178.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 21.3 t -95.74 132.89 38.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 179.277 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 15.8 p30 -139.14 -178.14 5.22 Favored 'General case' 0 N--CA 1.492 1.668 0 CA-C-O 121.884 0.849 . . . . 0.0 110.362 -179.207 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 63.7 tttp -56.91 -40.25 75.97 Favored 'General case' 0 N--CA 1.492 1.647 0 CA-C-O 121.474 0.654 . . . . 0.0 110.064 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . 0.413 ' OD1' ' OG ' ' A' ' 71' ' ' SER . 23.2 t-20 -60.33 -37.94 82.18 Favored 'General case' 0 C--N 1.296 -1.725 0 O-C-N 121.306 -0.871 . . . . 0.0 109.89 -179.85 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 15.5 p -75.43 162.28 28.49 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.02 -1.05 . . . . 0.0 110.847 -179.133 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 67.4 m -131.62 149.83 52.36 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 179.701 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.402 HG22 HD13 ' A' ' 91' ' ' ILE . 97.0 mt -128.14 132.21 68.65 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 O-C-N 121.599 -0.688 . . . . 0.0 109.69 -179.664 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . 0.436 ' OE2' ' CZ ' ' A' ' 70' ' ' ARG . 86.0 mt-10 -124.99 131.8 53.36 Favored 'General case' 0 N--CA 1.5 2.069 0 CA-C-O 121.488 0.661 . . . . 0.0 109.513 -179.558 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 37.2 ttpt -82.36 118.38 23.13 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.424 -0.797 . . . . 0.0 109.653 -179.807 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.53 ' C ' ' H ' ' A' ' 96' ' ' GLU . 59.6 mt -111.63 130.66 55.69 Favored 'General case' 0 N--CA 1.495 1.812 0 CA-C-O 121.464 0.65 . . . . 0.0 109.459 -179.72 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 42.2 m -77.27 29.63 0.14 Allowed 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 179.358 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.53 ' H ' ' C ' ' A' ' 94' ' ' LEU . 72.5 tt0 -111.43 92.74 17.03 Favored Pre-proline 0 N--CA 1.493 1.72 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 -179.752 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -75.21 151.22 38.36 Favored 'Trans proline' 0 N--CA 1.491 1.358 0 C-N-CA 122.221 1.947 . . . . 0.0 112.219 -179.077 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 84.5 mt . . . . . 0 N--CA 1.493 1.699 0 CA-C-O 121.745 0.783 . . . . 0.0 109.511 -179.674 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo . . . . . 0 N--CA 1.495 1.588 0 CA-C-O 121.539 0.558 . . . . 0.0 112.555 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 84.9 mt-30 -76.41 91.89 3.34 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.152 -0.968 . . . . 0.0 108.723 179.45 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 82.6 mt -85.27 131.87 34.35 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.531 -0.731 . . . . 0.0 109.619 -179.071 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 99.9 m -123.64 131.01 53.51 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 179.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 71.5 mmtt -80.58 156.64 26.34 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-O 121.683 0.754 . . . . 0.0 110.362 -178.62 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.4 HG23 HD11 ' A' ' 8' ' ' ILE . 97.3 mt -62.89 -43.31 98.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.484 -0.76 . . . . 0.0 109.279 -179.798 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 14.5 p -66.28 -23.51 31.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.338 -0.851 . . . . 0.0 109.606 -179.743 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -78.49 -5.03 51.43 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.251 -0.905 . . . . 0.0 109.899 -179.778 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 96.7 mt -80.94 121.85 35.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 120.939 -1.101 . . . . 0.0 110.081 -179.579 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 31.2 m -146.55 10.25 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 179.172 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 48.2 tp10 -136.11 132.96 36.77 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.341 -0.849 . . . . 0.0 109.745 -179.782 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.488 ' ND2' ' CE1' ' A' ' 81' ' ' PHE . 11.4 m120 -82.38 142.04 32.31 Favored 'General case' 0 C--N 1.306 -1.311 0 O-C-N 121.347 -0.846 . . . . 0.0 110.431 -179.828 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 75.68 98.93 0.13 Allowed Glycine 0 N--CA 1.49 2.258 0 N-CA-C 110.032 -1.227 . . . . 0.0 110.032 179.232 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 14.1 pt20 -173.45 141.29 0.88 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.159 -1.201 . . . . 0.0 109.702 179.282 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 71.0 m95 -94.0 137.06 33.63 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.615 -0.678 . . . . 0.0 109.781 -179.549 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -175.58 177.68 1.72 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.139 -0.976 . . . . 0.0 109.639 179.745 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 81.4 m-20 -106.59 147.49 29.4 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.602 -0.686 . . . . 0.0 109.639 -179.703 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 40.2 tp -140.79 133.29 28.51 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.342 -0.849 . . . . 0.0 109.892 179.717 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 35.7 ttpt -117.29 137.78 52.18 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 178.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -161.81 174.91 12.52 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.869 -1.145 . . . . 0.0 110.194 -179.582 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 65.1 tttm -110.32 133.29 53.4 Favored 'General case' 0 N--CA 1.495 1.818 0 CA-C-O 121.517 0.675 . . . . 0.0 109.848 -179.753 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 67.1 t -77.77 126.94 38.5 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 O-C-N 121.369 -0.832 . . . . 0.0 109.745 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 23.2 pt -108.8 -34.0 2.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 179.368 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.68 ' NE2' ' HE1' ' A' ' 28' ' ' TRP . 50.3 tt0 -163.73 133.79 4.24 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.115 -0.991 . . . . 0.0 109.647 178.872 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -131.46 136.64 48.12 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 -179.83 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . 0.68 ' HE1' ' NE2' ' A' ' 26' ' ' GLN . 5.2 m0 -113.96 124.61 52.59 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.472 -0.768 . . . . 0.0 109.493 -179.595 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 2.9 pp20? . . . . . 0 N--CA 1.488 1.46 0 O-C-N 121.544 -0.722 . . . . 0.0 109.36 -179.921 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 5.1 p . . . . . 0 N--CA 1.499 1.988 0 N-CA-C 109.384 -0.599 . . . . 0.0 109.384 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 96.2 mt -109.9 118.06 56.06 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 CA-C-O 121.617 0.722 . . . . 0.0 109.83 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 44.1 t -77.79 -49.0 15.23 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.604 -0.685 . . . . 0.0 109.51 179.674 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 33.6 tt0 -147.34 153.48 39.75 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.222 -0.924 . . . . 0.0 110.016 -179.708 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 9.1 p -142.95 143.27 25.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.573 -0.704 . . . . 0.0 109.259 179.156 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -173.99 -154.27 10.61 Favored Glycine 0 N--CA 1.485 1.95 0 C-N-CA 119.534 -1.317 . . . . 0.0 109.941 -179.645 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -136.8 151.3 49.01 Favored 'General case' 0 N--CA 1.501 2.082 0 O-C-N 121.555 -0.968 . . . . 0.0 109.494 -179.019 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 66.3 mt -115.08 126.44 54.69 Favored 'General case' 0 N--CA 1.495 1.803 0 CA-C-O 121.597 0.713 . . . . 0.0 109.413 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -75.72 158.69 50.35 Favored Glycine 0 N--CA 1.488 2.157 0 N-CA-C 110.807 -0.917 . . . . 0.0 110.807 -179.443 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -170.97 151.65 3.35 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.519 -0.989 . . . . 0.0 109.07 179.253 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 17.6 pt-20 -59.41 -15.12 14.97 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.27 -0.894 . . . . 0.0 109.546 179.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 39.2 p -92.6 -13.14 30.04 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.093 -1.004 . . . . 0.0 109.279 -179.453 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 140.79 -151.47 22.44 Favored Glycine 0 N--CA 1.496 2.635 0 N-CA-C 109.987 -1.245 . . . . 0.0 109.987 179.353 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 96.7 mt -126.25 138.87 53.27 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 O-C-N 121.729 -0.865 . . . . 0.0 109.234 -179.815 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 9.6 tp -128.28 143.59 40.49 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 CA-C-O 121.789 0.804 . . . . 0.0 110.152 -179.727 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 19.1 mmmt -84.01 147.89 27.18 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.688 -0.633 . . . . 0.0 109.874 180.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 21.1 p90 -144.14 159.95 41.76 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.244 -0.91 . . . . 0.0 109.298 179.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 1.6 t -145.33 141.44 28.53 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.401 -0.812 . . . . 0.0 109.829 179.611 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.417 HG23 HD11 ' A' ' 52' ' ' ILE . 98.4 mt -107.43 118.7 55.67 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 O-C-N 121.573 -0.704 . . . . 0.0 109.316 179.596 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 59.3 m95 -86.34 139.42 30.99 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.158 -0.964 . . . . 0.0 110.139 -179.212 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 68.1 mttm . . . . . 0 N--CA 1.491 1.598 0 O-C-N 121.408 -0.807 . . . . 0.0 109.875 179.848 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 51.1 mt . . . . . 0 N--CA 1.496 1.84 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -68.26 162.05 42.03 Favored 'Trans proline' 0 N--CA 1.498 1.758 0 C-N-CA 122.707 2.271 . . . . 0.0 112.811 179.632 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 67.6 mt -64.77 149.79 48.62 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.317 -0.864 . . . . 0.0 110.682 -178.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.424 ' CD1' ' N ' ' A' ' 61' ' ' LEU . 10.7 mp -88.22 138.42 31.46 Favored 'General case' 0 N--CA 1.492 1.666 0 CA-C-O 121.572 0.701 . . . . 0.0 110.188 -179.239 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.467 ' N ' ' OH ' ' A' ' 67' ' ' TYR . 52.9 tp10 -66.43 137.01 56.55 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.407 -0.808 . . . . 0.0 110.054 -179.57 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 49.8 tt0 -73.18 135.66 44.65 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.564 -0.71 . . . . 0.0 110.68 -179.255 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 83.84 29.82 30.87 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 110.037 -1.225 . . . . 0.0 110.037 179.047 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -136.41 146.54 46.53 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.168 -1.195 . . . . 0.0 110.426 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 11.8 p -79.01 152.09 31.16 Favored 'General case' 0 N--CA 1.487 1.4 0 CA-C-O 121.542 0.686 . . . . 0.0 110.141 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . 0.467 ' OH ' ' N ' ' A' ' 62' ' ' GLU . 89.9 m-85 -144.47 147.59 33.48 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.412 -0.805 . . . . 0.0 109.662 179.698 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 15.7 tp -111.36 120.93 43.86 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 179.548 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 60.7 mt -97.32 134.85 40.05 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.534 -0.729 . . . . 0.0 109.313 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 79.1 mtp85 -128.19 138.96 52.7 Favored 'General case' 0 N--CA 1.497 1.897 0 CA-C-O 121.507 0.67 . . . . 0.0 110.388 -179.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 18.4 m 57.12 61.14 2.67 Favored 'General case' 0 N--CA 1.493 1.718 0 CA-C-O 121.005 0.431 . . . . 0.0 110.534 179.47 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 15.5 m -116.03 159.73 15.81 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.993 0 O-C-N 121.49 -0.756 . . . . 0.0 109.441 178.822 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 14.2 p -114.85 134.66 57.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 CA-C-O 121.474 0.654 . . . . 0.0 109.498 -179.361 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 11.7 t -88.29 113.56 25.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.298 -0.876 . . . . 0.0 109.744 -179.294 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -98.57 172.76 26.48 Favored Glycine 0 N--CA 1.493 2.484 0 N-CA-C 109.914 -1.275 . . . . 0.0 109.914 -179.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 81.3 tt0 -112.85 122.77 48.62 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.742 -0.858 . . . . 0.0 109.253 179.661 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 75.7 t80 -135.7 126.59 27.6 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.522 -0.736 . . . . 0.0 109.756 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 9.3 t-20 57.11 44.09 23.09 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.574 -0.704 . . . . 0.0 109.924 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 55.03 28.83 11.34 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.549 -0.72 . . . . 0.0 109.445 179.691 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 71.7 ttt180 -130.78 152.2 50.38 Favored 'General case' 0 N--CA 1.497 1.876 0 CA-C-O 121.516 0.674 . . . . 0.0 109.771 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . 0.488 ' CE1' ' ND2' ' A' ' 14' ' ' ASN . 91.6 m-85 -84.66 142.64 29.76 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.433 -0.792 . . . . 0.0 109.733 -179.835 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 7.1 pt20 -153.24 165.26 36.28 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.15 -0.969 . . . . 0.0 109.711 179.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 3.2 m -109.1 132.35 57.4 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.013 0 O-C-N 121.495 -0.753 . . . . 0.0 109.811 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 23.6 mt-30 -113.3 121.84 45.62 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 -179.777 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 27.8 t -91.18 129.5 41.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.298 -0.876 . . . . 0.0 109.9 -179.655 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 11.2 m-80 -140.88 -177.78 5.24 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.45 -0.781 . . . . 0.0 109.258 179.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.54 ' C ' ' H ' ' A' ' 89' ' ' SER . 63.0 pttt -44.3 164.79 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.575 -0.703 . . . . 0.0 111.02 -179.681 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 5.3 t30 72.15 -29.84 0.2 Allowed 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 -179.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' SER . . . . . 0.54 ' H ' ' C ' ' A' ' 87' ' ' LYS . 7.2 m -69.65 150.79 46.64 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.403 -0.81 . . . . 0.0 110.196 -179.522 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 46.9 t -132.56 146.55 51.99 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 96.8 mt -126.14 132.53 70.42 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 O-C-N 121.584 -0.698 . . . . 0.0 109.293 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -125.87 130.3 51.07 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.594 -0.691 . . . . 0.0 109.493 179.649 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 64.5 tttm -79.1 131.21 36.17 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.455 -0.778 . . . . 0.0 109.679 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 85.8 mt -110.22 137.49 47.88 Favored 'General case' 0 N--CA 1.498 1.927 0 CA-C-O 121.792 0.806 . . . . 0.0 110.174 -179.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 93.8 p -85.62 13.49 6.94 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.646 -0.658 . . . . 0.0 109.43 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 86.4 mt-10 -117.4 90.7 35.44 Favored Pre-proline 0 N--CA 1.499 2.002 0 O-C-N 121.674 -0.641 . . . . 0.0 109.491 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_exo -56.15 150.01 50.79 Favored 'Trans proline' 0 N--CA 1.499 1.818 0 C-N-CA 122.946 2.431 . . . . 0.0 112.758 179.518 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 48.1 mm . . . . . 0 N--CA 1.488 1.457 0 O-C-N 121.261 -0.899 . . . . 0.0 109.527 -179.533 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo . . . . . 0 N--CA 1.496 1.644 0 CA-C-O 121.551 0.563 . . . . 0.0 112.435 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 18.3 mm100 -76.6 92.62 3.5 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.082 -1.011 . . . . 0.0 109.58 -179.711 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 72.7 mt -76.34 138.05 40.22 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.501 -0.749 . . . . 0.0 109.638 -179.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 54.1 m -130.09 131.94 45.94 Favored 'General case' 0 N--CA 1.495 1.808 0 CA-C-O 121.427 0.632 . . . . 0.0 109.478 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 65.0 mttp -85.52 157.37 20.44 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.366 -0.834 . . . . 0.0 110.119 -179.51 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 96.2 mt -62.71 -43.48 98.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.352 -0.843 . . . . 0.0 109.393 -179.711 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 12.2 p -66.29 -22.93 30.89 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.206 -0.934 . . . . 0.0 109.667 -179.673 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.408 ' OD1' ' O ' ' A' ' 10' ' ' ASP . 57.7 t0 -73.75 -4.03 32.06 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.2 -0.937 . . . . 0.0 109.388 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 96.6 mt -74.96 125.92 35.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.141 -0.974 . . . . 0.0 109.767 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 4.1 m -129.15 -31.06 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 N-CA-C 109.241 -0.652 . . . . 0.0 109.241 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 -135.08 145.26 47.76 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.379 -0.825 . . . . 0.0 110.296 -179.515 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 64.2 m-80 -78.83 154.88 29.49 Favored 'General case' 0 C--N 1.306 -1.312 0 CA-C-O 121.514 0.673 . . . . 0.0 110.517 -179.595 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 88.69 8.21 70.44 Favored Glycine 0 N--CA 1.492 2.402 0 N-CA-C 109.136 -1.585 . . . . 0.0 109.136 179.638 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 18.4 tt0 -77.29 132.85 38.85 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.371 -1.076 . . . . 0.0 109.992 -179.649 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 89.5 m95 -99.56 134.25 42.7 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.39 -0.819 . . . . 0.0 110.006 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -179.9 -175.1 0.3 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.493 -0.754 . . . . 0.0 109.198 179.463 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.596 ' ND2' ' H ' ' A' ' 71' ' ' SER . 5.4 m120 -105.14 153.31 21.7 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.578 -0.701 . . . . 0.0 109.574 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 54.3 tp -139.58 137.85 35.72 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.536 -0.728 . . . . 0.0 109.303 179.492 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 35.9 ttpt -128.25 133.36 48.79 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.683 -0.635 . . . . 0.0 109.475 179.362 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -168.17 177.7 5.37 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.444 -0.785 . . . . 0.0 109.355 179.317 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.427 ' NZ ' ' O ' ' A' ' 98' ' ' ILE . 17.0 ptpt -107.21 146.28 31.6 Favored 'General case' 0 N--CA 1.496 1.861 0 CA-C-O 121.672 0.749 . . . . 0.0 110.179 -179.563 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 78.9 t -85.03 97.88 5.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.561 -0.712 . . . . 0.0 110.093 -179.282 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 37.2 mm -65.72 -44.8 93.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.484 -0.76 . . . . 0.0 109.089 179.703 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 68.1 tp60 -151.22 148.45 28.24 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.239 -0.913 . . . . 0.0 109.321 179.405 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.538 ' CD2' ' N ' ' A' ' 27' ' ' LEU . 1.3 pt? -128.5 145.22 51.18 Favored 'General case' 0 N--CA 1.494 1.754 0 CA-C-O 121.219 0.533 . . . . 0.0 109.976 -179.857 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 97.6 m95 -128.21 101.53 6.29 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 178.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.586 ' H ' ' CD ' ' A' ' 29' ' ' GLU . 1.6 pm0 . . . . . 0 N--CA 1.492 1.643 0 O-C-N 121.583 -0.698 . . . . 0.0 110.605 -178.82 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 20.8 t . . . . . 0 N--CA 1.495 1.824 0 CA-C-O 121.157 0.503 . . . . 0.0 110.435 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 31.7 mt -78.64 132.22 32.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.183 -0.948 . . . . 0.0 110.199 -178.264 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 8.7 t -98.91 -60.89 1.45 Allowed 'General case' 0 N--CA 1.494 1.727 0 CA-C-O 121.576 0.703 . . . . 0.0 109.283 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -150.36 150.3 31.24 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.257 -0.902 . . . . 0.0 109.565 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 28.7 m -135.57 160.15 39.87 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 O-C-N 121.5 -0.75 . . . . 0.0 109.762 179.724 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 178.6 -166.97 37.13 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -132.9 148.84 52.29 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.404 -1.056 . . . . 0.0 109.898 179.857 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 51.6 mt -111.73 130.72 55.7 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 -179.002 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -97.66 148.31 18.9 Favored Glycine 0 N--CA 1.493 2.493 0 N-CA-C 110.648 -0.981 . . . . 0.0 110.648 -179.362 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.434 ' OD1' ' O ' ' A' ' 46' ' ' GLY . 49.0 p30 -173.24 166.65 4.86 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.691 -0.888 . . . . 0.0 108.948 178.886 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 78.5 tt0 -61.56 -16.62 49.51 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.337 -0.852 . . . . 0.0 110.018 -179.347 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 82.7 p -85.48 0.25 52.89 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.952 -1.092 . . . . 0.0 109.212 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.434 ' O ' ' OD1' ' A' ' 43' ' ' ASP . . . 116.05 -147.94 18.9 Favored Glycine 0 N--CA 1.499 2.872 0 N-CA-C 110.241 -1.144 . . . . 0.0 110.241 178.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 96.9 mt -132.57 137.68 53.67 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 121.6 -0.941 . . . . 0.0 109.489 -179.419 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 19.7 tt -134.89 140.88 44.54 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 O-C-N 121.561 -0.712 . . . . 0.0 109.72 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 18.8 mtpp -83.46 155.02 23.63 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.491 -0.755 . . . . 0.0 109.669 -179.806 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 34.2 p90 -141.74 151.83 43.26 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.313 -0.867 . . . . 0.0 109.724 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.444 ' HG1' ' NE2' ' A' ' 82' ' ' GLN . 52.6 m -131.9 130.81 42.09 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 179.723 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 90.7 mt -102.62 124.05 56.35 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.381 -0.825 . . . . 0.0 110.253 -179.295 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 85.3 m95 -92.99 130.97 38.38 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.418 -0.801 . . . . 0.0 108.936 179.698 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 17.4 ptpt . . . . . 0 N--CA 1.49 1.528 0 O-C-N 121.23 -0.919 . . . . 0.0 109.632 -179.656 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 16.7 mt . . . . . 0 N--CA 1.491 1.616 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -71.46 155.49 59.7 Favored 'Trans proline' 0 N--CA 1.498 1.739 0 C-N-CA 122.656 2.238 . . . . 0.0 112.759 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 79.7 mt -76.43 141.56 41.35 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.398 -0.814 . . . . 0.0 109.95 -179.743 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.469 ' CD1' ' N ' ' A' ' 61' ' ' LEU . 10.0 mp -81.96 145.54 30.23 Favored 'General case' 0 N--CA 1.488 1.458 0 CA-C-O 121.491 0.662 . . . . 0.0 110.286 -179.169 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.545 ' OE1' ' N ' ' A' ' 62' ' ' GLU . 58.2 mp0 -93.14 144.95 24.78 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.404 -0.81 . . . . 0.0 109.922 -179.488 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 57.9 tt0 -76.55 142.25 40.88 Favored 'General case' 0 N--CA 1.489 1.515 0 CA-C-O 121.505 0.669 . . . . 0.0 111.205 -178.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 81.85 21.22 61.85 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 110.253 -1.139 . . . . 0.0 110.253 178.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -130.3 146.29 51.87 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.32 -1.106 . . . . 0.0 110.614 -179.68 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 11.6 p -80.37 151.81 29.22 Favored 'General case' 0 N--CA 1.488 1.473 0 CA-C-O 121.513 0.673 . . . . 0.0 110.002 -179.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . 0.415 ' OH ' ' OE1' ' A' ' 62' ' ' GLU . 97.2 m-85 -144.72 145.64 31.8 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.408 -0.808 . . . . 0.0 109.517 179.803 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 20.2 tp -110.24 122.51 47.81 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 179.398 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 69.6 mt -100.73 134.54 43.55 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 82.6 mtp180 -126.51 140.87 52.12 Favored 'General case' 0 N--CA 1.498 1.964 0 CA-C-O 121.729 0.776 . . . . 0.0 110.701 -179.268 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' SER . . . . . 0.596 ' H ' ' ND2' ' A' ' 19' ' ' ASN . 38.3 t 53.58 71.57 0.49 Allowed 'General case' 0 N--CA 1.491 1.583 0 CA-C-O 121.095 0.474 . . . . 0.0 110.514 179.524 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 18.0 m -128.93 164.19 31.9 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.023 0 O-C-N 121.578 -0.701 . . . . 0.0 109.336 178.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 9.7 p -120.45 135.83 59.42 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 CA-C-O 121.416 0.627 . . . . 0.0 109.418 -179.599 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 11.6 t -85.61 115.47 27.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.391 -0.818 . . . . 0.0 110.071 -178.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -94.17 -178.66 38.73 Favored Glycine 0 N--CA 1.492 2.419 0 N-CA-C 109.312 -1.515 . . . . 0.0 109.312 179.772 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -112.0 133.35 54.23 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.663 -0.904 . . . . 0.0 109.629 -179.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 91.3 t80 -136.49 108.1 6.98 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.418 -0.801 . . . . 0.0 109.147 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . 0.537 ' CG ' ' H ' ' A' ' 79' ' ' ASP . 66.7 t30 51.48 -134.38 1.63 Allowed 'General case' 0 N--CA 1.493 1.698 0 CA-C-O 121.603 0.716 . . . . 0.0 110.823 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.537 ' H ' ' CG ' ' A' ' 78' ' ' ASN . 36.5 t70 -87.1 -7.24 58.24 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.344 -0.848 . . . . 0.0 109.201 -179.389 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 85.2 mtp180 -108.56 173.98 6.08 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.711 -0.618 . . . . 0.0 109.763 -179.543 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 72.7 m-85 -104.74 155.85 18.52 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.605 -0.684 . . . . 0.0 109.944 -179.388 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . 0.444 ' NE2' ' HG1' ' A' ' 51' ' ' THR . 51.3 tt0 -138.35 153.19 48.97 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 -179.662 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 3.3 m -116.05 131.94 67.06 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 179.551 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 87.8 mt-30 -101.42 135.28 43.17 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.504 -0.748 . . . . 0.0 110.178 -178.74 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 71.4 t -107.09 130.55 58.97 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 179.274 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 79.2 m-20 -124.83 -179.57 4.58 Favored 'General case' 0 N--CA 1.496 1.854 0 CA-C-O 121.507 0.67 . . . . 0.0 109.911 -179.327 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 64.0 tttp -58.94 -41.0 86.35 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.592 -0.692 . . . . 0.0 110.043 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . 0.411 ' OD1' ' O ' ' A' ' 88' ' ' ASN . 41.9 t-20 -60.5 -35.67 76.51 Favored 'General case' 0 C--N 1.299 -1.602 0 O-C-N 121.109 -0.995 . . . . 0.0 109.112 -179.915 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 30.9 t -70.0 152.76 44.05 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.28 -0.887 . . . . 0.0 110.089 -179.519 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 35.3 t -128.74 148.91 50.88 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.601 -0.687 . . . . 0.0 109.495 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.421 HD12 HG22 ' A' ' 91' ' ' ILE . 96.2 mt -123.66 132.8 70.76 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 O-C-N 121.713 -0.617 . . . . 0.0 109.381 -179.782 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 82.5 tt0 -126.08 131.2 52.17 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 179.392 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 37.8 ttmt -79.81 131.37 35.88 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.487 -0.758 . . . . 0.0 109.923 -179.568 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 9.9 mp -101.08 137.31 39.62 Favored 'General case' 0 N--CA 1.493 1.685 0 CA-C-O 121.615 0.721 . . . . 0.0 109.644 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 70.3 m -90.4 6.33 43.7 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.649 -0.657 . . . . 0.0 109.501 -179.772 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.471 ' CD ' ' N ' ' A' ' 96' ' ' GLU . 1.3 pm0 -116.34 91.67 33.81 Favored Pre-proline 0 N--CA 1.499 1.975 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_exo -53.94 149.24 35.09 Favored 'Trans proline' 0 N--CA 1.495 1.611 0 C-N-CA 122.372 2.048 . . . . 0.0 112.249 -179.811 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.427 ' O ' ' NZ ' ' A' ' 23' ' ' LYS . 96.7 mt . . . . . 0 N--CA 1.493 1.722 0 CA-C-O 121.673 0.749 . . . . 0.0 110.644 -178.453 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo . . . . . 0 N--CA 1.496 1.635 0 CA-C-O 121.554 0.564 . . . . 0.0 112.715 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 58.9 tt0 -74.59 93.46 2.52 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.237 -0.915 . . . . 0.0 109.586 -179.775 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 86.6 mt -84.93 129.51 34.79 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.428 -0.795 . . . . 0.0 109.579 -179.694 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 98.7 m -127.76 131.21 49.67 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.621 -0.674 . . . . 0.0 110.042 -179.54 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -84.34 158.77 21.05 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.572 -0.705 . . . . 0.0 109.962 -179.79 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 97.3 mt -62.78 -43.7 98.95 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.289 -0.882 . . . . 0.0 109.553 -179.546 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 14.9 p -67.7 -21.94 27.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.188 -0.945 . . . . 0.0 109.404 -179.638 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -76.24 -4.15 40.35 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.373 -0.829 . . . . 0.0 109.184 179.634 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 96.7 mt -80.42 116.13 24.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.305 -0.872 . . . . 0.0 109.353 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 27.0 m -119.52 -19.92 5.15 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.875 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 179.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 22.1 pt-20 -139.34 141.62 37.65 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.42 -0.8 . . . . 0.0 109.955 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 23.3 p30 -86.15 167.0 15.32 Favored 'General case' 0 N--CA 1.491 1.59 0 CA-C-O 121.478 0.656 . . . . 0.0 110.378 -179.619 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 80.57 3.17 90.15 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.188 -1.565 . . . . 0.0 109.188 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 14.5 pt20 -84.58 145.68 27.92 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.321 -1.105 . . . . 0.0 110.106 -179.609 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' TRP . . . . . 0.439 ' CD1' ' N ' ' A' ' 17' ' ' TRP . 31.6 m95 -101.92 138.83 38.37 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.671 -0.643 . . . . 0.0 110.063 -179.593 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.426 ' C ' HD21 ' A' ' 19' ' ' ASN . . . -178.9 -170.08 0.18 Allowed 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 179.358 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.426 HD21 ' C ' ' A' ' 18' ' ' ALA . 3.3 m120 -108.32 149.54 28.52 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.544 -0.723 . . . . 0.0 109.567 -179.85 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -137.7 121.24 17.24 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 179.469 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 36.4 ttpt -110.48 139.75 45.4 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.666 -0.646 . . . . 0.0 109.771 179.577 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -167.78 -174.03 2.31 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.31 -0.868 . . . . 0.0 109.789 179.553 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 76.0 tttt -118.12 144.16 45.89 Favored 'General case' 0 N--CA 1.501 2.085 0 CA-C-O 121.545 0.688 . . . . 0.0 109.733 -179.663 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 4.7 t -78.77 120.88 30.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.429 -0.794 . . . . 0.0 111.059 -178.59 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.4 HG22 HD13 ' A' ' 25' ' ' ILE . 32.7 mm -94.57 -49.05 12.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 179.13 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 57.8 tt0 -153.92 149.68 27.55 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.406 -0.809 . . . . 0.0 109.482 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 95.0 mt -121.0 145.12 48.09 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.762 -0.586 . . . . 0.0 109.832 -179.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 2.1 t-105 -128.95 111.59 13.19 Favored 'General case' 0 N--CA 1.495 1.786 0 CA-C-O 121.55 0.691 . . . . 0.0 109.358 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 39.2 tp10 . . . . . 0 C--N 1.302 -1.498 0 O-C-N 121.494 -0.754 . . . . 0.0 109.776 -179.629 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.494 1.739 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 86.8 mt -108.99 128.91 64.48 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 O-C-N 121.477 -0.764 . . . . 0.0 109.605 -179.445 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 24.1 t -87.19 -68.46 0.75 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.616 -0.678 . . . . 0.0 109.901 -179.446 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 89.7 mt-30 -132.95 148.11 52.28 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.514 -0.742 . . . . 0.0 109.447 -179.374 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 44.6 t -128.99 134.46 64.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -158.7 -162.24 11.74 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -140.1 145.5 37.7 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.446 -1.032 . . . . 0.0 109.635 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 45.0 mt -115.04 133.07 56.35 Favored 'General case' 0 N--CA 1.496 1.829 0 CA-C-O 121.575 0.702 . . . . 0.0 109.583 -179.155 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -92.96 140.52 15.11 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 110.385 -1.086 . . . . 0.0 110.385 -179.588 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 39.7 t0 -148.41 159.12 44.34 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.52 -0.988 . . . . 0.0 108.682 179.343 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -66.6 -20.7 66.06 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.221 -0.925 . . . . 0.0 109.669 -179.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 58.4 p -79.66 -10.15 59.75 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.144 -0.973 . . . . 0.0 109.347 -179.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 139.21 -164.3 25.9 Favored Glycine 0 N--CA 1.496 2.677 0 N-CA-C 109.455 -1.458 . . . . 0.0 109.455 179.507 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 34.4 mm -114.58 132.05 64.87 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.0 0 O-C-N 121.631 -0.923 . . . . 0.0 108.81 -179.701 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 18.1 tt -133.5 141.41 44.44 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 O-C-N 121.577 -0.702 . . . . 0.0 110.003 -179.588 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -90.71 156.95 17.7 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.592 -0.692 . . . . 0.0 110.459 -179.349 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 8.6 p90 -146.08 160.51 41.8 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.241 -0.912 . . . . 0.0 109.622 179.501 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 1.6 t -141.25 141.41 34.0 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 179.335 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.419 HG21 HD12 ' A' ' 52' ' ' ILE . 87.5 mt -106.66 125.79 62.53 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 O-C-N 121.53 -0.731 . . . . 0.0 109.734 -179.581 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' TRP . . . . . 0.529 ' N ' ' CD1' ' A' ' 53' ' ' TRP . 13.5 m95 -99.98 147.59 25.42 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.528 -0.732 . . . . 0.0 109.733 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 54.0 mtmt . . . . . 0 N--CA 1.49 1.557 0 O-C-N 121.431 -0.793 . . . . 0.0 109.448 179.854 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 17.4 mt . . . . . 0 N--CA 1.497 1.892 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -54.97 149.25 43.58 Favored 'Trans proline' 0 N--CA 1.502 2.021 0 C-N-CA 122.292 1.995 . . . . 0.0 113.071 179.546 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 61.8 mt -65.72 140.07 58.42 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.432 -0.793 . . . . 0.0 110.33 -179.102 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.414 ' CD1' ' N ' ' A' ' 61' ' ' LEU . 10.8 mp -77.95 141.84 38.74 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.53 -0.731 . . . . 0.0 110.016 -179.551 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -90.19 150.86 21.81 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.468 -0.77 . . . . 0.0 109.974 -179.815 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 2.9 mm100 -81.96 145.19 30.41 Favored 'General case' 0 N--CA 1.493 1.709 0 CA-C-O 122.018 0.914 . . . . 0.0 112.006 -178.17 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 70.0 31.33 69.63 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 110.576 -1.01 . . . . 0.0 110.576 178.074 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 91.7 mt-10 -136.08 147.68 47.96 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.303 -1.116 . . . . 0.0 110.218 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 10.6 m -80.68 149.68 29.68 Favored 'General case' 0 N--CA 1.487 1.419 0 CA-C-O 121.324 0.583 . . . . 0.0 109.62 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 30.3 m-85 -144.04 142.48 30.68 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.398 -0.814 . . . . 0.0 109.107 179.531 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 14.5 tp -108.57 120.93 43.88 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 179.237 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 76.3 mt -100.51 132.81 45.7 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.512 -0.742 . . . . 0.0 109.297 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.473 ' C ' ' HG ' ' A' ' 71' ' ' SER . 89.8 mtm180 -127.02 131.87 50.88 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.797 -0.564 . . . . 0.0 110.059 -179.956 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' SER . . . . . 0.473 ' HG ' ' C ' ' A' ' 70' ' ' ARG . 1.1 m 75.88 54.9 0.06 Allowed 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 179.677 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 15.8 m -117.13 161.34 15.96 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.173 0 O-C-N 121.607 -0.683 . . . . 0.0 109.465 179.236 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 14.1 p -120.47 140.59 44.08 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 CA-C-O 121.499 0.666 . . . . 0.0 109.514 -179.325 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 99.6 t -84.56 120.35 35.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.445 -0.784 . . . . 0.0 110.139 -178.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -97.3 174.42 29.73 Favored Glycine 0 N--CA 1.493 2.48 0 N-CA-C 109.714 -1.354 . . . . 0.0 109.714 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . 0.547 ' N ' ' OE1' ' A' ' 76' ' ' GLU . 54.4 mp0 -112.72 119.48 38.22 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.766 -0.844 . . . . 0.0 109.027 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . 0.528 ' CE2' ' OD1' ' A' ' 78' ' ' ASN . 85.0 t80 -136.98 124.43 22.08 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.418 -0.801 . . . . 0.0 110.139 -179.846 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . 0.528 ' OD1' ' CE2' ' A' ' 77' ' ' TYR . 7.0 m120 55.53 38.37 30.13 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.76 -0.587 . . . . 0.0 109.901 179.356 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 25.7 t0 66.83 -4.08 0.83 Allowed 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.603 -0.686 . . . . 0.0 109.513 179.665 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . 0.47 ' H ' ' C ' ' A' ' 78' ' ' ASN . 80.1 mtp85 -93.72 -177.26 4.31 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.303 -0.873 . . . . 0.0 109.459 179.773 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -114.86 137.17 52.28 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.571 -0.706 . . . . 0.0 109.605 -179.67 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -143.25 159.63 41.98 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.385 -0.822 . . . . 0.0 109.645 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 22.5 m -104.08 131.72 52.21 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 179.662 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -102.25 114.67 29.03 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.356 -0.84 . . . . 0.0 109.422 -179.289 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 12.1 t -88.56 103.67 14.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.458 -0.776 . . . . 0.0 109.277 -179.81 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 2.0 p30 -151.14 -179.76 7.6 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.383 -0.823 . . . . 0.0 109.586 179.773 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.4 ' HG2' ' H ' ' A' ' 88' ' ' ASN . 49.2 tttm 67.43 -132.58 0.13 Allowed 'General case' 0 N--CA 1.495 1.807 0 CA-C-O 121.491 0.663 . . . . 0.0 110.822 179.436 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . 0.409 ' O ' ' C ' ' A' ' 89' ' ' SER . 10.2 m120 -95.47 13.19 26.8 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.244 -0.91 . . . . 0.0 109.047 -179.198 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' SER . . . . . 0.409 ' C ' ' O ' ' A' ' 88' ' ' ASN . 97.7 p -40.94 110.18 0.15 Allowed 'General case' 0 N--CA 1.495 1.817 0 CA-C-O 121.589 0.709 . . . . 0.0 109.646 -179.514 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 12.1 m -80.52 151.02 29.41 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.577 -0.702 . . . . 0.0 109.728 -179.051 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.41 HD12 HG21 ' A' ' 91' ' ' ILE . 96.7 mt -132.36 132.07 60.53 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 121.52 -0.738 . . . . 0.0 109.501 179.748 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 52.5 tp10 -128.28 134.61 48.97 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 179.697 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 38.7 ttpt -85.02 131.05 34.52 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.569 -0.707 . . . . 0.0 110.265 -179.457 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.456 ' CD2' ' N ' ' A' ' 94' ' ' LEU . 4.1 mm? -99.32 132.07 44.9 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.472 -0.768 . . . . 0.0 109.601 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 73.2 m -84.26 15.66 3.45 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 179.634 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 17.6 tp10 -118.05 89.83 35.71 Favored Pre-proline 0 N--CA 1.498 1.938 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 179.504 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -57.69 144.49 92.88 Favored 'Trans proline' 0 N--CA 1.498 1.745 0 C-N-CA 122.561 2.174 . . . . 0.0 112.208 179.659 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 90.5 mt . . . . . 0 N--CA 1.498 1.928 0 O-C-N 121.51 -0.744 . . . . 0.0 109.772 -179.828 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_exo . . . . . 0 N--CA 1.493 1.498 0 CA-C-O 121.672 0.613 . . . . 0.0 112.393 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 21.4 mp0 -88.17 75.69 8.59 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.143 -0.973 . . . . 0.0 108.936 179.675 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 84.3 mt -69.45 143.84 53.45 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.47 -0.769 . . . . 0.0 109.665 -179.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 93.9 m -125.15 128.83 49.02 Favored 'General case' 0 N--CA 1.497 1.881 0 CA-C-O 121.735 0.779 . . . . 0.0 109.63 -179.717 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 14.8 mptt -80.22 149.66 30.37 Favored 'General case' 0 C--N 1.302 -1.48 0 CA-C-O 121.86 0.838 . . . . 0.0 109.843 -179.451 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.451 ' CD1' ' H ' ' A' ' 8' ' ' ILE . 2.7 mp -63.15 -43.73 99.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 CA-C-O 121.566 0.698 . . . . 0.0 110.166 -179.451 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 10.0 p -69.76 -19.93 23.21 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.654 0 O-C-N 121.214 -0.929 . . . . 0.0 110.057 -179.253 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -82.05 -3.47 54.69 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.925 -1.109 . . . . 0.0 109.482 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 96.7 mt -79.65 121.02 32.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.056 -1.027 . . . . 0.0 110.012 -179.757 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 33.4 m -136.04 -4.33 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.488 -0.757 . . . . 0.0 109.06 179.445 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -138.11 140.86 40.15 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.026 -1.046 . . . . 0.0 109.845 -179.781 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 57.3 p30 -93.65 162.22 14.03 Favored 'General case' 0 N--CA 1.493 1.7 0 CA-C-O 121.677 0.751 . . . . 0.0 110.521 -179.739 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 79.94 6.03 89.29 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.376 -1.49 . . . . 0.0 109.376 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 -80.97 135.46 35.87 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.202 -1.176 . . . . 0.0 110.275 -179.46 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 85.3 m95 -99.93 136.56 39.65 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.542 -0.724 . . . . 0.0 109.29 179.294 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.441 ' C ' HD21 ' A' ' 19' ' ' ASN . . . -178.03 -172.98 0.35 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.22 -0.925 . . . . 0.0 109.697 -179.895 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.441 HD21 ' C ' ' A' ' 18' ' ' ALA . 3.5 m120 -109.26 149.07 29.97 Favored 'General case' 0 N--CA 1.495 1.819 0 CA-C-O 121.57 0.7 . . . . 0.0 109.648 -179.802 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 6.3 tt -136.93 133.36 35.6 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.357 -0.839 . . . . 0.0 110.128 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 37.6 ttmt -114.6 134.71 54.84 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 179.387 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -165.04 171.07 14.37 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 119.069 -1.052 . . . . 0.0 110.418 -179.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 64.9 tttm -106.26 142.25 36.26 Favored 'General case' 0 N--CA 1.496 1.842 0 CA-C-O 121.75 0.786 . . . . 0.0 110.028 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 92.5 t -79.84 121.98 34.18 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 O-C-N 121.382 -0.824 . . . . 0.0 110.378 -179.439 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.433 HD11 HG21 ' A' ' 25' ' ' ILE . 96.7 mt -100.72 -57.53 4.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 179.141 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 66.5 tp60 -147.79 139.45 23.89 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.058 -1.026 . . . . 0.0 110.08 -179.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.552 ' CD2' ' N ' ' A' ' 27' ' ' LEU . 1.2 pt? -142.96 138.21 29.94 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.741 -0.599 . . . . 0.0 109.618 179.228 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 4.9 m0 -113.03 142.45 45.7 Favored 'General case' 0 N--CA 1.497 1.92 0 CA-C-O 121.634 0.73 . . . . 0.0 109.795 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 3.0 pp20? . . . . . 0 N--CA 1.491 1.6 0 CA-C-O 121.601 0.715 . . . . 0.0 110.523 -179.355 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 42.2 t . . . . . 0 N--CA 1.49 1.56 0 CA-C-O 121.276 0.56 . . . . 0.0 110.096 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.412 HD12 HG22 ' A' ' 35' ' ' ILE . 97.5 mt -109.27 130.16 62.76 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 CA-C-O 121.968 0.889 . . . . 0.0 110.368 -179.334 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 19.3 t -74.8 -75.56 0.16 Allowed 'General case' 0 N--CA 1.491 1.617 0 CA-C-O 121.689 0.757 . . . . 0.0 109.642 179.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 -143.04 157.64 44.35 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.145 -0.972 . . . . 0.0 109.623 -179.566 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 13.9 m -132.74 135.01 58.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 CA-C-O 121.61 0.719 . . . . 0.0 109.426 179.771 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -160.34 -164.25 15.07 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 -179.551 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -133.7 148.96 51.51 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.5 -1.0 . . . . 0.0 110.137 -179.814 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 32.1 mt -120.11 136.91 54.43 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 -179.177 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -100.5 137.45 13.27 Favored Glycine 0 N--CA 1.494 2.52 0 N-CA-C 110.368 -1.093 . . . . 0.0 110.368 -179.296 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.552 ' C ' ' H ' ' A' ' 45' ' ' THR . 47.0 t0 -136.61 36.84 2.67 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.484 -1.009 . . . . 0.0 108.679 179.076 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.439 ' C ' ' H ' ' A' ' 46' ' ' GLY . 49.6 mt-10 63.98 -38.92 0.21 Allowed 'General case' 0 N--CA 1.503 2.199 0 CA-C-O 121.418 0.628 . . . . 0.0 110.412 -179.514 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.552 ' H ' ' C ' ' A' ' 43' ' ' ASP . 17.8 p -79.41 22.9 0.42 Allowed 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.051 -1.031 . . . . 0.0 109.707 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.439 ' H ' ' C ' ' A' ' 44' ' ' GLU . . . 114.45 -165.56 12.07 Favored Glycine 0 N--CA 1.498 2.78 0 N-CA-C 110.436 -1.066 . . . . 0.0 110.436 179.324 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 33.7 pt -129.19 145.17 36.17 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 O-C-N 121.673 -0.898 . . . . 0.0 109.457 -179.775 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 18.9 tt -137.95 143.2 33.97 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 O-C-N 121.48 -0.763 . . . . 0.0 109.875 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 32.6 mtmm -83.25 155.12 23.83 Favored 'General case' 0 N--CA 1.493 1.692 0 CA-C-O 121.56 0.695 . . . . 0.0 110.431 -179.485 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 42.8 p90 -144.75 153.37 41.61 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.261 -0.899 . . . . 0.0 109.591 179.833 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 93.7 m -131.24 129.99 42.31 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 179.582 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 96.7 mt -101.41 126.25 55.28 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 121.361 -0.837 . . . . 0.0 109.764 -179.537 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 30.9 m95 -104.18 143.5 32.85 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.489 -0.757 . . . . 0.0 109.011 179.305 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 98.5 mttt . . . . . 0 N--CA 1.49 1.568 0 O-C-N 121.231 -0.918 . . . . 0.0 108.984 179.702 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 36.6 mt . . . . . 0 N--CA 1.5 2.063 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_exo -49.98 157.81 2.57 Favored 'Trans proline' 0 N--CA 1.495 1.582 0 C-N-CA 122.685 2.257 . . . . 0.0 112.896 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 41.4 mt -65.48 141.79 58.37 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.306 -0.871 . . . . 0.0 110.219 -179.043 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.507 ' CD1' ' N ' ' A' ' 61' ' ' LEU . 9.3 mp -85.57 150.94 24.31 Favored 'General case' 0 N--CA 1.493 1.712 0 CA-C-O 121.816 0.817 . . . . 0.0 110.742 -179.295 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -74.61 150.68 39.55 Favored 'General case' 0 N--CA 1.491 1.591 0 CA-C-O 121.882 0.849 . . . . 0.0 110.722 -179.598 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 57.6 tt0 -86.2 138.77 31.63 Favored 'General case' 0 N--CA 1.49 1.526 0 CA-C-O 121.687 0.756 . . . . 0.0 111.185 -179.661 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 81.48 10.94 83.84 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 110.346 -1.102 . . . . 0.0 110.346 178.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -115.77 147.27 41.14 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.343 -1.093 . . . . 0.0 110.57 -179.622 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 15.4 t -80.58 143.55 33.1 Favored 'General case' 0 N--CA 1.49 1.532 0 CA-C-O 121.61 0.719 . . . . 0.0 110.122 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 46.0 m-85 -140.47 147.47 39.66 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.417 -0.802 . . . . 0.0 109.835 179.785 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 19.4 tp -111.11 123.97 51.26 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 179.216 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 13.6 mt -99.04 131.18 45.27 Favored 'General case' 0 N--CA 1.492 1.662 0 CA-C-O 121.388 0.613 . . . . 0.0 110.039 -179.452 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.485 ' O ' ' CB ' ' A' ' 71' ' ' SER . 82.9 mtp180 -129.64 125.98 37.33 Favored 'General case' 0 N--CA 1.494 1.742 0 CA-C-O 121.437 0.637 . . . . 0.0 109.994 179.757 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' SER . . . . . 0.485 ' CB ' ' O ' ' A' ' 70' ' ' ARG . 0.9 OUTLIER 82.85 49.91 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.863 0 CA-C-O 121.157 0.503 . . . . 0.0 110.265 179.398 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 15.9 m -113.49 162.06 11.92 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.079 0 O-C-N 121.21 -0.932 . . . . 0.0 109.687 179.387 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 2.7 p -125.44 137.72 56.74 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 CA-C-O 121.763 0.792 . . . . 0.0 109.656 -179.407 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 11.0 t -85.33 113.37 23.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 CA-C-O 121.653 0.739 . . . . 0.0 109.976 -179.499 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -95.22 174.68 32.7 Favored Glycine 0 N--CA 1.493 2.47 0 N-CA-C 109.787 -1.325 . . . . 0.0 109.787 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -109.84 123.19 49.14 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.547 -0.972 . . . . 0.0 109.242 179.72 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 84.7 t80 -132.71 115.99 16.05 Favored 'General case' 0 N--CA 1.493 1.676 0 CA-C-O 121.59 0.709 . . . . 0.0 109.965 -179.618 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 7.7 m120 56.06 38.21 29.67 Favored 'General case' 0 N--CA 1.492 1.672 0 CA-C-O 121.419 0.628 . . . . 0.0 110.088 179.533 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 70.23 -2.55 2.08 Favored 'General case' 0 N--CA 1.497 1.911 0 CA-C-O 121.425 0.631 . . . . 0.0 109.656 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 20.7 mmm180 -98.48 166.26 11.44 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.183 -0.948 . . . . 0.0 109.996 -179.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 60.4 m-85 -88.24 139.78 30.14 Favored 'General case' 0 N--CA 1.488 1.436 0 CA-C-O 121.881 0.848 . . . . 0.0 110.107 -179.104 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 52.9 tt0 -144.4 150.7 38.15 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.388 -0.82 . . . . 0.0 108.833 179.805 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 28.5 m -114.14 128.92 70.9 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 O-C-N 121.526 -0.734 . . . . 0.0 109.165 179.616 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 75.5 mt-30 -107.85 127.22 53.53 Favored 'General case' 0 N--CA 1.495 1.776 0 CA-C-O 121.653 0.739 . . . . 0.0 109.989 -179.215 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 18.8 t -96.64 107.88 20.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 CA-C-O 121.634 0.73 . . . . 0.0 109.229 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . 0.506 ' C ' HD21 ' A' ' 86' ' ' ASN . 0.4 OUTLIER -151.17 -170.05 3.55 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.395 -0.816 . . . . 0.0 109.914 -179.804 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 30.7 ttmt 59.27 37.13 23.74 Favored 'General case' 0 N--CA 1.493 1.724 0 CA-C-O 122.184 0.992 . . . . 0.0 109.879 179.758 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 10.2 t30 55.48 40.64 31.27 Favored 'General case' 0 N--CA 1.49 1.535 0 CA-C-O 121.637 0.732 . . . . 0.0 109.71 179.652 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 14.6 m -54.23 139.96 34.24 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.278 -0.889 . . . . 0.0 109.916 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 7.9 m -81.09 144.19 31.89 Favored 'General case' 0 N--CA 1.49 1.558 0 CA-C-O 121.795 0.807 . . . . 0.0 110.484 -179.092 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 96.6 mt -134.67 133.33 54.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.542 -0.723 . . . . 0.0 109.27 179.812 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -122.41 134.9 54.6 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.512 -0.742 . . . . 0.0 109.145 179.72 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -82.49 125.17 30.8 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.402 -0.811 . . . . 0.0 109.879 -179.649 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.479 ' CD2' ' N ' ' A' ' 94' ' ' LEU . 4.1 mm? -97.3 134.48 40.53 Favored 'General case' 0 N--CA 1.49 1.559 0 CA-C-O 121.911 0.862 . . . . 0.0 109.963 -179.653 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 67.6 m -84.3 -4.57 58.94 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 179.303 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 90.5 mt-10 -104.48 110.36 64.16 Favored Pre-proline 0 N--CA 1.498 1.936 0 O-C-N 121.277 -0.889 . . . . 0.0 109.574 -179.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -74.3 157.38 45.73 Favored 'Trans proline' 0 N--CA 1.493 1.459 0 C-N-CA 122.374 2.049 . . . . 0.0 112.548 -179.365 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 16.6 mm . . . . . 0 N--CA 1.491 1.583 0 O-C-N 121.191 -0.943 . . . . 0.0 109.813 -179.384 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo . . . . . 0 N--CA 1.496 1.635 0 CA-C-O 121.406 0.503 . . . . 0.0 112.498 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 3.0 tm0? -75.49 70.33 2.34 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.561 -0.712 . . . . 0.0 109.115 179.744 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 72.0 mt -70.63 144.39 51.15 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.329 -0.857 . . . . 0.0 109.788 -179.539 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 64.7 m -124.87 133.04 53.23 Favored 'General case' 0 N--CA 1.497 1.887 0 N-CA-C 108.936 -0.765 . . . . 0.0 108.936 179.822 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 56.2 mtpt -76.02 152.02 37.02 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.318 -0.864 . . . . 0.0 110.573 -178.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 97.2 mt -63.29 -43.42 98.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.519 -0.738 . . . . 0.0 109.377 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 10.0 p -63.68 -24.39 35.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.351 -0.843 . . . . 0.0 109.667 -179.778 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -79.73 -3.82 49.19 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.018 -1.051 . . . . 0.0 109.793 -179.815 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 97.6 mt -80.88 119.16 29.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 120.92 -1.112 . . . . 0.0 109.795 -179.709 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 16.1 m -151.46 12.69 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 N-CA-C 108.947 -0.761 . . . . 0.0 108.947 179.328 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 50.7 tp10 -139.21 139.94 37.62 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.254 -0.904 . . . . 0.0 109.622 -179.829 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 48.8 p-10 -86.89 154.9 20.5 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.347 -0.845 . . . . 0.0 109.881 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 74.43 3.76 67.28 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 179.601 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 39.0 tt0 -71.24 128.61 36.49 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.168 -1.195 . . . . 0.0 109.68 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 88.9 m95 -98.51 138.74 35.28 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.394 -0.816 . . . . 0.0 109.601 -179.655 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -177.55 -178.77 0.77 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.333 -0.854 . . . . 0.0 109.726 179.52 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 80.5 m-20 -109.42 146.11 35.02 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 6.2 tt -144.05 124.99 14.32 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.122 -0.986 . . . . 0.0 109.14 179.796 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 36.4 ttpt -111.31 133.66 53.46 Favored 'General case' 0 N--CA 1.497 1.908 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 179.247 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -164.04 174.32 11.49 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.102 -0.999 . . . . 0.0 109.632 -179.749 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 16.8 ptpt -109.06 148.29 31.04 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.392 -0.818 . . . . 0.0 109.571 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 91.2 t -84.48 128.97 38.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.576 -0.703 . . . . 0.0 110.231 -179.167 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 97.0 mt -95.93 -53.58 8.04 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 N-CA-C 108.401 -0.962 . . . . 0.0 108.401 178.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 69.6 tp60 -149.24 145.21 26.99 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.307 -0.871 . . . . 0.0 109.495 179.443 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.547 ' CD2' ' N ' ' A' ' 27' ' ' LEU . 1.2 pt? -143.33 140.47 30.56 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 179.41 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 39.2 t90 -115.51 125.38 52.96 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 179.748 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 . . . . . 0 N--CA 1.491 1.605 0 O-C-N 121.301 -0.875 . . . . 0.0 110.015 -179.703 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 43.2 t . . . . . 0 N--CA 1.497 1.879 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 86.3 mt -102.96 128.74 55.59 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 O-C-N 121.271 -0.893 . . . . 0.0 109.593 -179.537 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 41.6 t -86.93 -69.64 0.67 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.482 -0.761 . . . . 0.0 109.993 -179.405 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 97.7 mt-30 -133.43 154.27 50.92 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.298 -0.876 . . . . 0.0 109.656 -179.209 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 15.5 m -130.85 134.87 61.19 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 179.726 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -168.49 -163.72 22.96 Favored Glycine 0 N--CA 1.486 2.008 0 C-N-CA 119.08 -1.533 . . . . 0.0 110.273 -179.329 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.609 ' N ' ' CD1' ' A' ' 40' ' ' LEU . 0.0 OUTLIER -131.93 161.69 32.46 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.914 -0.757 . . . . 0.0 109.37 179.863 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 69.3 mt -120.25 133.46 55.47 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.584 -0.698 . . . . 0.0 109.329 -179.351 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -85.86 141.13 18.42 Favored Glycine 0 N--CA 1.492 2.427 0 N-CA-C 110.01 -1.236 . . . . 0.0 110.01 -179.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 44.0 t0 -151.26 163.73 38.23 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.443 -1.034 . . . . 0.0 109.922 179.826 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -64.21 -20.62 66.16 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.549 -0.719 . . . . 0.0 109.923 -179.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 44.7 p -92.32 -12.23 33.0 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 120.982 -1.074 . . . . 0.0 110.404 -179.283 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 144.81 -155.39 26.4 Favored Glycine 0 N--CA 1.497 2.75 0 C-N-CA 119.916 -1.135 . . . . 0.0 110.281 179.535 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 91.3 mt -125.59 137.18 58.51 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.975 0 O-C-N 121.802 -0.822 . . . . 0.0 108.811 -179.668 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 17.5 tt -129.4 150.05 34.24 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.232 0 O-C-N 121.452 -0.78 . . . . 0.0 110.342 -179.571 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.651 ' NZ ' HH22 ' A' ' 80' ' ' ARG . 14.7 mptt -83.81 151.97 24.88 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.654 -0.654 . . . . 0.0 109.812 -179.695 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 25.2 p90 -143.28 148.47 36.4 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.221 -0.924 . . . . 0.0 108.803 179.072 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 97.4 m -131.57 129.92 41.57 Favored 'General case' 0 N--CA 1.496 1.828 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 179.428 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 88.3 mt -98.07 127.8 50.13 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 O-C-N 121.311 -0.868 . . . . 0.0 110.158 -179.601 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 82.7 m95 -80.35 120.71 24.76 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 178.778 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 73.1 tttt . . . . . 0 C--N 1.3 -1.561 0 O-C-N 121.297 -0.877 . . . . 0.0 108.745 -179.139 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 63.9 mt . . . . . 0 N--CA 1.498 1.947 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -51.8 146.17 28.96 Favored 'Trans proline' 0 N--CA 1.501 1.937 0 C-N-CA 121.904 1.736 . . . . 0.0 112.766 179.415 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 77.4 mt -71.74 141.89 49.77 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.257 -0.902 . . . . 0.0 109.911 -179.837 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.441 ' CD1' ' N ' ' A' ' 61' ' ' LEU . 10.5 mp -79.19 146.38 33.13 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.472 -0.767 . . . . 0.0 109.976 -179.289 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 51.4 tp10 -88.17 147.62 24.79 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.268 -0.895 . . . . 0.0 109.538 -179.577 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . 0.531 ' OE1' ' N ' ' A' ' 64' ' ' GLY . 0.2 OUTLIER -81.71 126.26 31.58 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.276 -0.89 . . . . 0.0 110.093 -179.743 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . 0.531 ' N ' ' OE1' ' A' ' 63' ' ' GLN . . . 86.32 32.22 17.25 Favored Glycine 0 N--CA 1.495 2.628 0 N-CA-C 110.423 -1.071 . . . . 0.0 110.423 179.178 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -137.23 147.85 46.07 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.126 -1.22 . . . . 0.0 109.91 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 14.4 m -78.51 143.34 36.68 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.7 -0.625 . . . . 0.0 109.788 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 51.0 m-85 -139.71 141.37 36.93 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.492 -0.755 . . . . 0.0 109.501 179.27 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 15.1 tp -103.72 120.03 40.12 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 107.964 -1.124 . . . . 0.0 107.964 178.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 75.7 mt -105.85 129.38 54.03 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 -179.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -125.54 143.71 50.89 Favored 'General case' 0 N--CA 1.503 2.225 0 O-C-N 121.413 -0.804 . . . . 0.0 111.141 -179.181 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.6 m 61.82 46.1 7.16 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.916 -0.49 . . . . 0.0 110.714 179.124 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 8.0 m -99.3 162.05 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.978 0 O-C-N 121.016 -1.052 . . . . 0.0 109.139 179.133 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 7.5 p -122.52 139.5 49.22 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 -179.788 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 63.8 t -89.33 115.25 28.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.237 -0.914 . . . . 0.0 109.612 -179.444 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -99.56 151.4 19.31 Favored Glycine 0 N--CA 1.499 2.842 0 N-CA-C 109.79 -1.324 . . . . 0.0 109.79 -179.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -68.46 137.19 54.25 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.338 -1.095 . . . . 0.0 110.072 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . 0.51 ' O ' ' N ' ' A' ' 79' ' ' ASP . 42.1 t80 -131.06 126.25 35.34 Favored 'General case' 0 N--CA 1.497 1.917 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 179.385 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . 0.436 ' C ' ' O ' ' A' ' 77' ' ' TYR . 9.1 m120 -35.35 -30.29 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.047 0 CA-C-O 121.115 0.483 . . . . 0.0 110.469 -179.058 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.51 ' N ' ' O ' ' A' ' 77' ' ' TYR . 96.7 m-20 -113.37 67.9 0.67 Allowed 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.594 -0.691 . . . . 0.0 109.942 179.48 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . 0.651 HH22 ' NZ ' ' A' ' 49' ' ' LYS . 83.8 mtm180 85.62 -159.29 0.01 OUTLIER 'General case' 0 N--CA 1.508 2.473 0 CA-C-O 121.384 0.612 . . . . 0.0 110.514 178.262 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -103.52 151.89 22.33 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.526 -0.734 . . . . 0.0 109.519 -179.091 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -136.57 166.47 23.45 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.382 -0.824 . . . . 0.0 109.284 -179.63 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 18.8 m -105.89 130.49 57.32 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 179.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 87.5 mt-30 -106.45 131.18 53.94 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.429 -0.794 . . . . 0.0 110.49 -178.704 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 19.5 t -91.83 131.34 39.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 N-CA-C 109.006 -0.738 . . . . 0.0 109.006 179.449 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 99.9 m-20 -126.34 175.45 7.83 Favored 'General case' 0 N--CA 1.501 2.091 0 CA-C-O 121.79 0.805 . . . . 0.0 110.277 -179.459 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 63.8 tttm -56.64 -44.02 80.86 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.636 -0.665 . . . . 0.0 110.495 -179.57 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 10.4 m120 -63.77 -33.38 75.54 Favored 'General case' 0 C--N 1.297 -1.716 0 O-C-N 121.088 -1.007 . . . . 0.0 110.359 -179.207 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 59.8 m -60.66 147.44 41.98 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.987 -1.071 . . . . 0.0 110.786 -178.656 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 7.0 m -113.27 149.18 34.22 Favored 'General case' 0 N--CA 1.499 2.005 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 179.618 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.436 HG22 HD13 ' A' ' 91' ' ' ILE . 96.6 mt -131.35 131.47 63.18 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.041 0 O-C-N 121.44 -0.787 . . . . 0.0 109.597 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -133.01 133.46 43.15 Favored 'General case' 0 N--CA 1.501 2.095 0 O-C-N 121.386 -0.821 . . . . 0.0 108.921 178.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -82.58 124.75 30.43 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.34 -0.85 . . . . 0.0 109.185 -179.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.446 ' CD2' ' N ' ' A' ' 94' ' ' LEU . 4.1 mm? -96.87 137.01 36.6 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.273 -0.892 . . . . 0.0 109.93 -179.322 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 93.7 p -82.4 -5.3 58.56 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 179.697 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -103.13 109.91 62.55 Favored Pre-proline 0 N--CA 1.497 1.881 0 O-C-N 121.37 -0.831 . . . . 0.0 109.421 -179.389 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -74.9 159.45 41.66 Favored 'Trans proline' 0 N--CA 1.494 1.503 0 C-N-CA 121.835 1.69 . . . . 0.0 112.082 -179.307 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.406 HD13 HG21 ' A' ' 98' ' ' ILE . 96.8 mt . . . . . 0 N--CA 1.497 1.899 0 O-C-N 121.241 -0.912 . . . . 0.0 109.609 -179.741 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 21.5 Cg_exo . . . . . 0 N--CA 1.493 1.445 0 CA-C-O 121.585 0.577 . . . . 0.0 112.049 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 78.7 mt-30 -88.98 79.96 7.17 Favored 'General case' 0 N--CA 1.489 1.511 0 CA-C-O 121.915 0.864 . . . . 0.0 109.417 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -59.68 133.41 56.07 Favored 'General case' 0 N--CA 1.489 1.501 0 CA-C-O 121.829 0.823 . . . . 0.0 109.762 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 97.1 m -128.28 128.48 44.72 Favored 'General case' 0 N--CA 1.491 1.577 0 CA-C-O 121.852 0.834 . . . . 0.0 109.361 179.796 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -90.85 154.4 19.52 Favored 'General case' 0 C--N 1.301 -1.527 0 CA-C-O 121.768 0.794 . . . . 0.0 109.818 -179.592 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 66.3 mt -63.2 -43.84 99.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.699 -0.626 . . . . 0.0 109.708 -179.39 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 12.4 p -65.07 -22.4 31.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.47 -0.769 . . . . 0.0 109.807 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 96.5 m-20 -80.99 -2.63 48.67 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.385 -0.822 . . . . 0.0 109.611 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 97.6 mt -85.51 112.04 21.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.426 -0.796 . . . . 0.0 109.958 -179.743 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 22.3 m -135.73 -2.79 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 179.318 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -140.39 143.85 35.9 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.479 -0.763 . . . . 0.0 109.941 179.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 52.2 p30 -90.66 161.15 15.51 Favored 'General case' 0 N--CA 1.492 1.672 0 CA-C-O 121.872 0.844 . . . . 0.0 110.495 -179.704 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 79.63 15.89 78.69 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.289 -1.524 . . . . 0.0 109.289 -179.814 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 52.5 tt0 -81.54 132.5 35.31 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.477 -1.013 . . . . 0.0 110.195 -179.286 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 76.9 m95 -106.31 132.99 51.7 Favored 'General case' 0 N--CA 1.495 1.786 0 CA-C-O 121.451 0.643 . . . . 0.0 109.465 179.705 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 179.71 -172.64 0.19 Allowed 'General case' 0 N--CA 1.491 1.619 0 CA-C-O 121.745 0.783 . . . . 0.0 109.962 179.806 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.54 ' ND2' ' N ' ' A' ' 20' ' ' LEU . 0.4 OUTLIER -100.18 152.34 20.37 Favored 'General case' 0 N--CA 1.493 1.701 0 CA-C-O 121.544 0.688 . . . . 0.0 109.73 -179.956 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.54 ' N ' ' ND2' ' A' ' 19' ' ' ASN . 7.2 tp -135.84 129.73 32.84 Favored 'General case' 0 N--CA 1.49 1.573 0 CA-C-O 121.745 0.783 . . . . 0.0 110.057 -179.916 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 38.3 ttmt -119.53 132.83 55.84 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 179.602 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -165.09 178.25 7.15 Favored 'General case' 0 N--CA 1.495 1.789 0 C-N-CA 119.331 -0.947 . . . . 0.0 110.809 -179.542 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 65.1 tttm -112.11 143.45 43.13 Favored 'General case' 0 N--CA 1.496 1.873 0 CA-C-O 121.713 0.768 . . . . 0.0 110.059 -179.676 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 91.4 t -84.96 122.42 38.14 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 CA-C-O 121.884 0.849 . . . . 0.0 110.513 -179.046 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.467 ' C ' HE21 ' A' ' 63' ' ' GLN . 23.8 mm -100.66 -48.91 11.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 178.755 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 69.3 tp60 -149.3 144.15 26.28 Favored 'General case' 0 N--CA 1.488 1.454 0 CA-C-O 121.71 0.767 . . . . 0.0 109.816 179.461 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.6 ' CD2' ' N ' ' A' ' 27' ' ' LEU . 0.4 OUTLIER -141.71 136.42 30.79 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 179.866 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 3.7 m-90 -115.14 122.49 46.25 Favored 'General case' 0 N--CA 1.496 1.851 0 CA-C-O 121.838 0.828 . . . . 0.0 109.618 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 49.6 tp10 . . . . . 0 N--CA 1.491 1.602 0 CA-C-O 121.541 0.686 . . . . 0.0 110.047 -179.369 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 32.2 t . . . . . 0 N--CA 1.5 2.026 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 96.6 mt -125.09 123.6 65.75 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.129 0 O-C-N 121.27 -0.894 . . . . 0.0 109.538 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 5.8 t -68.81 -51.64 38.64 Favored 'General case' 0 N--CA 1.494 1.728 0 CA-C-O 121.523 0.677 . . . . 0.0 109.435 179.667 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 51.0 tt0 -157.53 153.3 26.77 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.515 -0.74 . . . . 0.0 109.69 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.7 p -142.99 145.7 22.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 179.653 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -175.17 -157.94 17.83 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.781 -1.327 . . . . 0.0 109.781 -179.589 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.9 pp -135.39 149.44 49.65 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.891 -0.77 . . . . 0.0 110.432 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 69.4 mt -117.24 132.13 56.69 Favored 'General case' 0 N--CA 1.498 1.933 0 CA-C-O 121.817 0.818 . . . . 0.0 109.647 -179.469 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -80.58 162.41 45.36 Favored Glycine 0 N--CA 1.488 2.147 0 N-CA-C 110.859 -0.896 . . . . 0.0 110.859 -179.577 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.531 ' OD1' ' N ' ' A' ' 44' ' ' GLU . 67.5 t0 -170.02 144.37 2.69 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.531 ' N ' ' OD1' ' A' ' 43' ' ' ASP . 19.1 pt-20 -59.84 -16.16 26.49 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.617 -0.677 . . . . 0.0 109.693 -179.788 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 36.2 p -91.25 -7.91 49.88 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 179.638 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 139.24 -153.61 22.98 Favored Glycine 0 N--CA 1.496 2.635 0 N-CA-C 109.81 -1.316 . . . . 0.0 109.81 179.414 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 36.1 pt -127.94 148.34 32.54 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.875 0 O-C-N 121.881 -0.776 . . . . 0.0 109.543 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 18.1 tt -141.69 138.58 31.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 CA-C-O 121.743 0.782 . . . . 0.0 110.034 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 68.9 mttm -83.75 156.86 22.34 Favored 'General case' 0 N--CA 1.49 1.545 0 CA-C-O 121.46 0.648 . . . . 0.0 109.981 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 28.2 p90 -148.62 150.44 33.27 Favored 'General case' 0 N--CA 1.491 1.599 0 CA-C-O 121.769 0.795 . . . . 0.0 109.991 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 97.8 m -130.24 129.81 43.81 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 179.575 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.409 HD12 HG22 ' A' ' 52' ' ' ILE . 92.8 mt -103.18 125.7 57.6 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 CA-C-O 121.904 0.859 . . . . 0.0 110.221 -179.423 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 96.6 m95 -86.71 142.13 28.41 Favored 'General case' 0 N--CA 1.49 1.556 0 CA-C-O 121.78 0.8 . . . . 0.0 109.881 -179.802 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 25.9 mtpp . . . . . 0 C--N 1.302 -1.47 0 O-C-N 121.655 -0.653 . . . . 0.0 109.434 -179.963 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 32.4 mt . . . . . 0 N--CA 1.491 1.611 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -55.89 147.75 60.69 Favored 'Trans proline' 0 N--CA 1.5 1.87 0 C-N-CA 123.067 2.511 . . . . 0.0 113.602 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 78.1 mt -70.74 144.27 50.99 Favored 'General case' 0 N--CA 1.492 1.631 0 CA-C-O 122.021 0.915 . . . . 0.0 110.479 -179.644 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.439 ' CD1' ' N ' ' A' ' 61' ' ' LEU . 10.0 mp -77.33 147.28 36.26 Favored 'General case' 0 N--CA 1.49 1.538 0 CA-C-O 121.733 0.778 . . . . 0.0 109.827 -179.899 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.555 ' H ' ' HH ' ' A' ' 67' ' ' TYR . 80.3 mm-40 -88.64 155.9 19.34 Favored 'General case' 0 N--CA 1.492 1.643 0 CA-C-O 121.968 0.89 . . . . 0.0 110.109 -179.755 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . 0.474 ' CD ' ' N ' ' A' ' 64' ' ' GLY . 6.8 tm0? -83.52 136.16 34.37 Favored 'General case' 0 C--N 1.301 -1.536 0 CA-C-O 121.889 0.852 . . . . 0.0 110.838 -179.2 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . 0.474 ' N ' ' CD ' ' A' ' 63' ' ' GLN . . . 82.18 0.99 90.25 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 110.003 -1.239 . . . . 0.0 110.003 179.145 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 -106.73 146.49 30.76 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.605 -0.938 . . . . 0.0 110.476 -179.513 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 6.1 m -86.25 148.38 25.66 Favored 'General case' 0 N--CA 1.489 1.496 0 CA-C-O 121.645 0.736 . . . . 0.0 109.98 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . 0.555 ' HH ' ' H ' ' A' ' 62' ' ' GLU . 65.1 m-85 -141.66 150.46 41.95 Favored 'General case' 0 N--CA 1.492 1.642 0 CA-C-O 122.016 0.912 . . . . 0.0 110.616 -179.709 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.517 ' CD1' HD22 ' A' ' 19' ' ' ASN . 31.5 tp -113.1 120.65 42.04 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.717 -0.845 . . . . 0.0 108.717 179.334 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 75.5 mt -102.04 126.87 49.08 Favored 'General case' 0 N--CA 1.491 1.612 0 CA-C-O 121.465 0.65 . . . . 0.0 109.376 -179.508 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.431 ' O ' ' CB ' ' A' ' 71' ' ' SER . 80.8 mtp180 -123.82 129.02 50.36 Favored 'General case' 0 N--CA 1.496 1.874 0 CA-C-O 121.714 0.768 . . . . 0.0 109.853 -179.697 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' SER . . . . . 0.431 ' CB ' ' O ' ' A' ' 70' ' ' ARG . 1.5 t 78.7 65.41 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.368 179.661 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 30.8 m -128.14 163.82 31.24 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 179.187 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 12.5 p -121.63 135.16 62.68 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 CA-C-O 121.72 0.771 . . . . 0.0 109.936 -179.524 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 12.5 t -89.94 114.83 28.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 CA-C-O 121.81 0.814 . . . . 0.0 109.482 -179.558 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -91.48 174.37 38.1 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 110.51 -1.036 . . . . 0.0 110.51 -179.292 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 82.8 tt0 -100.84 117.78 35.59 Favored 'General case' 0 N--CA 1.492 1.67 0 CA-C-O 121.997 0.903 . . . . 0.0 109.692 -179.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . 0.559 ' CD1' ' N ' ' A' ' 78' ' ' ASN . 27.2 t80 -101.53 162.75 12.67 Favored 'General case' 0 N--CA 1.493 1.71 0 CA-C-O 121.747 0.784 . . . . 0.0 109.854 -179.803 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . 0.559 ' N ' ' CD1' ' A' ' 77' ' ' TYR . 24.3 t-20 -53.19 104.37 0.09 Allowed 'General case' 0 N--CA 1.494 1.749 0 CA-C-O 122.323 1.059 . . . . 0.0 110.63 -179.182 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 43.1 t0 57.66 16.69 3.58 Favored 'General case' 0 N--CA 1.492 1.646 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.372 179.747 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 78.1 mtp85 -148.78 -167.51 2.84 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.182 -0.949 . . . . 0.0 110.087 179.587 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 80.4 m-85 -127.94 151.24 49.34 Favored 'General case' 0 N--CA 1.495 1.807 0 CA-C-O 121.654 0.74 . . . . 0.0 109.64 -179.713 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 49.0 tt0 -145.22 153.12 41.0 Favored 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 13.6 m -113.1 130.72 66.48 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 179.423 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 78.8 mt-30 -111.68 129.93 55.94 Favored 'General case' 0 N--CA 1.496 1.866 0 CA-C-O 121.658 0.742 . . . . 0.0 110.411 -178.678 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 3.0 t -103.34 119.01 51.24 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 CA-C-O 121.596 0.712 . . . . 0.0 109.727 179.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . 0.549 HD21 ' N ' ' A' ' 86' ' ' ASN . 0.0 OUTLIER -147.01 -166.9 2.63 Favored 'General case' 0 N--CA 1.493 1.722 0 CA-C-O 121.714 0.769 . . . . 0.0 109.872 -179.411 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 38.1 ttmt 59.34 -89.13 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.654 0 CA-C-O 121.432 0.634 . . . . 0.0 110.52 -179.772 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 26.5 t-20 -169.96 46.62 0.03 OUTLIER 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 108.731 -0.841 . . . . 0.0 108.731 -179.216 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 34.9 t -55.56 136.19 50.33 Favored 'General case' 0 N--CA 1.496 1.873 0 CA-C-O 121.767 0.794 . . . . 0.0 109.709 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 1.4 t -79.55 140.83 37.09 Favored 'General case' 0 N--CA 1.491 1.584 0 CA-C-O 121.614 0.721 . . . . 0.0 110.338 -179.316 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 97.4 mt -128.46 130.67 69.19 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 121.836 -0.54 . . . . 0.0 109.586 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 47.7 tp10 -127.73 130.76 49.35 Favored 'General case' 0 N--CA 1.495 1.817 0 CA-C-O 121.827 0.822 . . . . 0.0 109.235 179.752 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 65.7 tttm -81.43 132.36 35.32 Favored 'General case' 0 N--CA 1.49 1.552 0 CA-C-O 121.856 0.836 . . . . 0.0 110.416 -179.385 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 65.8 mt -103.26 131.07 50.61 Favored 'General case' 0 N--CA 1.492 1.663 0 CA-C-O 121.703 0.763 . . . . 0.0 109.545 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 10.1 t -83.52 6.58 19.93 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 179.775 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 33.5 mm-40 -118.04 90.61 37.74 Favored Pre-proline 0 N--CA 1.499 2.024 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 179.308 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_exo -56.22 147.57 65.35 Favored 'Trans proline' 0 N--CA 1.494 1.552 0 C-N-CA 122.886 2.39 . . . . 0.0 112.516 179.739 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 93.9 mt . . . . . 0 N--CA 1.494 1.766 0 CA-C-O 121.885 0.85 . . . . 0.0 110.06 -179.497 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo . . . . . 0 N--CA 1.494 1.518 0 CA-C-O 121.829 0.679 . . . . 0.0 112.8 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 27.6 mp0 -89.7 69.26 7.7 Favored 'General case' 0 N--CA 1.489 1.515 0 CA-C-O 121.844 0.83 . . . . 0.0 109.094 -179.827 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 71.9 mt -65.69 139.87 58.42 Favored 'General case' 0 N--CA 1.492 1.634 0 CA-C-O 121.63 0.728 . . . . 0.0 110.34 -179.422 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 92.3 m -128.83 132.15 47.77 Favored 'General case' 0 N--CA 1.493 1.693 0 CA-C-O 121.606 0.717 . . . . 0.0 109.576 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -75.35 146.86 40.55 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.461 -0.775 . . . . 0.0 109.998 -179.74 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 96.5 mt -63.84 -43.09 97.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.554 -0.716 . . . . 0.0 110.449 -179.563 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 13.2 p -62.06 -22.73 29.68 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.129 -0.982 . . . . 0.0 109.547 -179.783 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 51.7 t0 -76.17 -5.81 48.42 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.301 -0.874 . . . . 0.0 109.61 179.831 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 96.6 mt -82.4 119.32 31.71 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.038 -1.039 . . . . 0.0 110.23 -179.81 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 3.3 m -151.11 14.53 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 N-CA-C 108.582 -0.895 . . . . 0.0 108.582 179.65 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -138.04 145.24 41.58 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.419 -0.801 . . . . 0.0 110.019 -179.859 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 -82.78 144.39 30.19 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-O 121.682 0.753 . . . . 0.0 110.459 -179.796 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 65.99 110.9 0.01 OUTLIER Glycine 0 N--CA 1.491 2.331 0 N-CA-C 110.617 -0.993 . . . . 0.0 110.617 179.136 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 8.5 tt0 -169.47 130.26 1.08 Allowed 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.306 -1.114 . . . . 0.0 109.505 179.226 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 98.7 m95 -93.82 129.94 40.02 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.663 -0.648 . . . . 0.0 109.897 -179.668 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -175.59 171.53 2.76 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.535 -0.728 . . . . 0.0 109.695 179.749 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 67.0 m-20 -103.56 143.55 32.59 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.566 -0.709 . . . . 0.0 109.546 -179.679 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 5.0 mp -138.56 145.59 40.83 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.367 -0.833 . . . . 0.0 109.974 -179.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 33.9 ttmt -119.71 136.08 54.57 Favored 'General case' 0 N--CA 1.494 1.737 0 CA-C-O 121.481 0.658 . . . . 0.0 109.713 179.718 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -166.2 166.9 16.62 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 119.785 -0.766 . . . . 0.0 109.813 179.754 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 38.3 ttmt -105.5 142.01 36.0 Favored 'General case' 0 N--CA 1.492 1.641 0 CA-C-O 121.761 0.791 . . . . 0.0 109.987 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 58.8 t -81.19 127.04 39.88 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.362 0 CA-C-O 121.805 0.812 . . . . 0.0 110.292 -179.694 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 96.5 mt -97.42 -66.53 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 121.645 -0.659 . . . . 0.0 109.311 179.387 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.6 ' NE2' ' NE2' ' A' ' 63' ' ' GLN . 85.0 mm-40 -144.04 143.76 31.33 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.291 -0.881 . . . . 0.0 110.435 -179.766 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -143.17 139.68 30.44 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 -179.713 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 3.5 m-90 -114.92 149.92 36.48 Favored 'General case' 0 N--CA 1.494 1.739 0 CA-C-O 121.811 0.815 . . . . 0.0 109.889 179.803 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 . . . . . 0 C--N 1.306 -1.326 0 CA-C-O 121.428 0.633 . . . . 0.0 110.046 -179.971 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 14.2 t . . . . . 0 N--CA 1.493 1.697 0 CA-C-O 121.147 0.499 . . . . 0.0 110.226 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 96.7 mt -115.58 130.09 70.79 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 CA-C-O 121.823 0.82 . . . . 0.0 109.591 179.361 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 39.1 t -84.02 -68.91 0.68 Allowed 'General case' 0 C--N 1.302 -1.476 0 CA-C-O 121.518 0.675 . . . . 0.0 109.554 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 -137.43 160.98 37.55 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.406 -0.808 . . . . 0.0 109.997 -179.292 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 3.3 p -140.0 143.37 30.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -168.91 -152.61 7.84 Favored Glycine 0 N--CA 1.486 1.993 0 N-CA-C 110.02 -1.232 . . . . 0.0 110.02 -179.624 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -132.94 150.93 52.12 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.849 -0.794 . . . . 0.0 109.886 -179.707 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 65.7 mt -114.73 129.59 56.71 Favored 'General case' 0 N--CA 1.491 1.611 0 CA-C-O 121.814 0.816 . . . . 0.0 109.544 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -85.45 152.73 26.8 Favored Glycine 0 N--CA 1.488 2.145 0 N-CA-C 110.479 -1.048 . . . . 0.0 110.479 -179.536 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.527 ' OD1' ' N ' ' A' ' 44' ' ' GLU . 41.8 t0 -173.58 152.08 2.04 Favored 'General case' 0 C--N 1.306 -1.319 0 O-C-N 121.766 -0.844 . . . . 0.0 109.722 179.467 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.527 ' N ' ' OD1' ' A' ' 43' ' ' ASP . 82.7 tt0 -55.5 -16.71 4.12 Favored 'General case' 0 N--CA 1.492 1.657 0 CA-C-O 121.241 0.543 . . . . 0.0 110.65 -179.352 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 80.8 p -92.45 -0.94 57.3 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.813 -1.179 . . . . 0.0 109.373 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 126.02 -152.54 18.16 Favored Glycine 0 N--CA 1.499 2.848 0 N-CA-C 110.428 -1.069 . . . . 0.0 110.428 179.182 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 36.8 pt -126.24 151.99 33.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.807 -0.819 . . . . 0.0 109.202 -179.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 18.7 tt -147.95 151.0 13.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.217 -0.927 . . . . 0.0 110.067 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.599 ' HZ2' ' CZ ' ' A' ' 80' ' ' ARG . 0.0 OUTLIER -85.75 147.64 26.23 Favored 'General case' 0 N--CA 1.489 1.519 0 CA-C-O 121.538 0.685 . . . . 0.0 110.123 -179.997 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 13.3 p90 -143.92 159.71 42.09 Favored 'General case' 0 N--CA 1.486 1.34 0 O-C-N 121.418 -0.801 . . . . 0.0 109.461 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 1.8 t -141.94 142.37 33.01 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 179.468 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 92.8 mt -105.37 122.6 58.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 CA-C-O 121.77 0.795 . . . . 0.0 109.966 -179.798 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 43.1 m95 -91.36 136.89 32.79 Favored 'General case' 0 N--CA 1.487 1.378 0 CA-C-O 121.504 0.669 . . . . 0.0 109.384 179.845 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 56.3 mtpt . . . . . 0 N--CA 1.489 1.516 0 CA-C-O 121.708 0.766 . . . . 0.0 109.319 179.449 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 32.8 mt . . . . . 0 N--CA 1.495 1.803 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -72.4 162.4 41.6 Favored 'Trans proline' 0 N--CA 1.494 1.547 0 C-N-CA 123.047 2.498 . . . . 0.0 112.775 179.598 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 69.1 mt -67.45 143.64 56.14 Favored 'General case' 0 N--CA 1.49 1.528 0 CA-C-O 121.876 0.846 . . . . 0.0 110.512 -179.498 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.467 ' CD1' ' N ' ' A' ' 61' ' ' LEU . 10.1 mp -91.7 137.13 32.61 Favored 'General case' 0 N--CA 1.491 1.577 0 CA-C-O 121.684 0.754 . . . . 0.0 110.262 -179.304 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.45 ' OE1' ' OE2' ' A' ' 65' ' ' GLU . 95.9 mt-10 -81.81 147.94 29.12 Favored 'General case' 0 N--CA 1.49 1.533 0 CA-C-O 121.817 0.818 . . . . 0.0 110.195 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . 0.6 ' NE2' ' NE2' ' A' ' 26' ' ' GLN . 86.9 mt-30 -79.62 140.61 37.06 Favored 'General case' 0 N--CA 1.488 1.465 0 CA-C-O 121.789 0.804 . . . . 0.0 110.925 -179.324 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 79.39 35.21 30.16 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 110.3 -1.12 . . . . 0.0 110.3 179.304 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.45 ' OE2' ' OE1' ' A' ' 62' ' ' GLU . 91.5 mt-10 -140.95 143.76 34.73 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.206 -1.173 . . . . 0.0 110.134 179.647 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 89.5 p -81.63 143.46 31.91 Favored 'General case' 0 N--CA 1.486 1.365 0 CA-C-O 121.6 0.714 . . . . 0.0 110.217 -179.642 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . 0.403 ' HH ' ' H ' ' A' ' 62' ' ' GLU . 92.3 m-85 -138.41 142.12 39.56 Favored 'General case' 0 N--CA 1.489 1.479 0 CA-C-O 121.582 0.706 . . . . 0.0 110.025 -179.936 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 31.8 tp -108.56 113.3 26.19 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 108.563 -0.902 . . . . 0.0 108.563 179.197 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.8 mp -99.77 131.26 45.86 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 -179.708 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 85.7 mtp180 -126.51 148.67 49.67 Favored 'General case' 0 N--CA 1.491 1.576 0 CA-C-O 121.584 0.707 . . . . 0.0 110.432 -179.553 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' SER . . . . . 0.627 ' HG ' HD22 ' A' ' 88' ' ' ASN . 8.6 t 59.22 55.09 4.47 Favored 'General case' 0 N--CA 1.491 1.582 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.355 179.55 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 15.7 m -113.67 160.79 12.98 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 O-C-N 121.586 -0.696 . . . . 0.0 109.249 179.163 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 9.9 p -114.07 134.66 56.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 CA-C-O 121.809 0.814 . . . . 0.0 110.179 -178.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 16.8 t -82.43 119.62 32.3 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.343 0 CA-C-O 121.702 0.763 . . . . 0.0 109.898 -179.726 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -93.68 170.69 31.12 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 110.231 -1.148 . . . . 0.0 110.231 -179.618 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 22.4 pt-20 -102.88 133.43 47.98 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.651 -0.911 . . . . 0.0 110.195 -179.674 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . 0.633 ' CD2' ' ND2' ' A' ' 78' ' ' ASN . 42.6 t80 -136.86 96.66 3.35 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 179.624 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . 0.633 ' ND2' ' CD2' ' A' ' 77' ' ' TYR . 23.3 p30 42.2 -136.68 0.27 Allowed 'General case' 0 N--CA 1.495 1.799 0 CA-C-O 121.531 0.681 . . . . 0.0 111.417 -179.918 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.545 ' N ' ' OD1' ' A' ' 78' ' ' ASN . 97.6 m-20 -73.35 -6.28 45.13 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.433 -0.792 . . . . 0.0 109.689 -179.255 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . 0.599 ' CZ ' ' HZ2' ' A' ' 49' ' ' LYS . 88.6 mtm180 -110.34 -179.66 3.84 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.487 -0.758 . . . . 0.0 110.085 -179.661 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -129.84 154.55 47.16 Favored 'General case' 0 N--CA 1.493 1.707 0 CA-C-O 121.508 0.671 . . . . 0.0 109.597 -179.551 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 2.7 pt20 -139.73 162.28 35.49 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.526 -0.734 . . . . 0.0 109.808 -179.775 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 13.5 m -111.54 131.82 61.82 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 179.847 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 -106.43 118.56 36.96 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.469 -0.769 . . . . 0.0 109.978 -179.253 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 10.2 t -90.02 99.46 9.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 179.646 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 1.4 p30 -151.15 -177.06 5.81 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.511 -0.743 . . . . 0.0 109.762 -179.526 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.463 ' CG ' ' H ' ' A' ' 88' ' ' ASN . 14.8 tptm 66.57 -130.62 0.18 Allowed 'General case' 0 N--CA 1.489 1.484 0 CA-C-O 121.624 0.726 . . . . 0.0 111.386 179.137 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . 0.627 HD22 ' HG ' ' A' ' 71' ' ' SER . 0.6 OUTLIER -90.41 19.96 4.85 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.531 -0.731 . . . . 0.0 109.273 -179.317 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 19.5 m -57.09 144.09 35.96 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.405 -0.809 . . . . 0.0 109.899 -179.669 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 44.4 m -129.6 153.02 48.49 Favored 'General case' 0 N--CA 1.493 1.676 0 CA-C-O 121.398 0.618 . . . . 0.0 109.427 -179.709 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.431 HD11 HG23 ' A' ' 91' ' ' ILE . 96.8 mt -131.69 134.86 59.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.64 -0.663 . . . . 0.0 109.505 -179.938 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 73.8 mm-40 -128.74 136.23 50.28 Favored 'General case' 0 N--CA 1.494 1.747 0 CA-C-O 121.49 0.662 . . . . 0.0 109.31 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -82.01 124.99 30.28 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.525 -0.734 . . . . 0.0 109.937 -179.636 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 11.0 mp -103.67 131.35 50.9 Favored 'General case' 0 N--CA 1.493 1.695 0 CA-C-O 121.61 0.719 . . . . 0.0 109.47 179.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 39.1 t -80.48 -6.67 58.51 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.661 -0.65 . . . . 0.0 109.3 179.7 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -107.36 104.45 52.54 Favored Pre-proline 0 N--CA 1.495 1.811 0 O-C-N 121.422 -0.798 . . . . 0.0 109.457 -179.635 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -74.54 149.43 39.0 Favored 'Trans proline' 0 N--CA 1.491 1.372 0 C-N-CA 122.328 2.019 . . . . 0.0 112.833 -179.246 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 14.9 pt . . . . . 0 N--CA 1.49 1.535 0 CA-C-O 121.82 0.819 . . . . 0.0 110.757 -179.401 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_endo . . . . . 0 N--CA 1.495 1.587 0 CA-C-O 122.177 0.824 . . . . 0.0 112.752 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -86.6 88.89 7.75 Favored 'General case' 0 N--CA 1.488 1.463 0 CA-C-O 122.015 0.912 . . . . 0.0 109.487 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.401 ' N ' ' CD2' ' A' ' 5' ' ' LEU . 4.2 mm? -75.81 139.09 41.57 Favored 'General case' 0 N--CA 1.489 1.509 0 CA-C-O 121.608 0.718 . . . . 0.0 109.959 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 90.0 m -123.96 129.88 51.66 Favored 'General case' 0 N--CA 1.492 1.648 0 CA-C-O 121.643 0.735 . . . . 0.0 109.468 179.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 53.7 mtmt -80.08 153.91 28.44 Favored 'General case' 0 N--CA 1.489 1.485 0 CA-C-O 121.495 0.664 . . . . 0.0 110.374 -179.646 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.413 HG22 HD13 ' A' ' 8' ' ' ILE . 97.4 mt -62.71 -43.73 98.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 CA-C-O 121.627 0.727 . . . . 0.0 109.976 -179.837 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 13.0 p -65.45 -23.79 33.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.508 -0.745 . . . . 0.0 109.626 -179.676 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -78.81 -4.71 50.85 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.363 -0.836 . . . . 0.0 109.642 179.695 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 97.8 mt -82.23 118.8 30.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.174 -0.954 . . . . 0.0 109.672 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 3.1 m -146.89 6.88 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.565 -0.709 . . . . 0.0 109.275 -179.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 94.1 mt-10 -138.14 131.71 30.85 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.261 -0.9 . . . . 0.0 110.203 -179.457 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 51.5 p30 -83.78 153.15 24.26 Favored 'General case' 0 N--CA 1.488 1.438 0 CA-C-O 121.642 0.734 . . . . 0.0 110.442 -179.717 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 71.16 84.64 0.19 Allowed Glycine 0 N--CA 1.49 2.243 0 N-CA-C 110.084 -1.206 . . . . 0.0 110.084 179.577 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 27.3 tt0 -169.39 136.23 1.7 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.417 -1.049 . . . . 0.0 109.838 179.723 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 45.0 m95 -91.64 140.22 29.93 Favored 'General case' 0 N--CA 1.489 1.523 0 CA-C-O 121.567 0.698 . . . . 0.0 110.1 -179.83 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -168.51 170.39 9.73 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.559 -0.713 . . . . 0.0 109.561 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 62.8 m-80 -101.11 145.17 29.12 Favored 'General case' 0 N--CA 1.494 1.771 0 CA-C-O 121.624 0.726 . . . . 0.0 109.967 -179.458 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 51.9 tp -146.62 135.39 22.26 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.529 -0.732 . . . . 0.0 109.8 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 35.0 ttpt -120.3 137.12 54.43 Favored 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 179.312 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . 0.418 ' CB ' ' OD1' ' A' ' 43' ' ' ASP . . . -160.65 172.52 16.98 Favored 'General case' 0 N--CA 1.492 1.659 0 C-N-CA 119.201 -1.0 . . . . 0.0 110.792 -179.377 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 33.0 ttpt -113.15 141.19 47.22 Favored 'General case' 0 N--CA 1.493 1.723 0 CA-C-O 121.583 0.706 . . . . 0.0 109.563 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 87.1 t -77.94 132.02 33.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.648 -0.658 . . . . 0.0 110.561 -179.172 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 30.2 pt -124.46 -30.08 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 179.004 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 68.6 tp60 -150.17 125.98 10.42 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.194 -0.941 . . . . 0.0 109.54 179.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.545 ' CD2' ' N ' ' A' ' 27' ' ' LEU . 1.1 pt? -138.96 135.67 34.6 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.707 -0.621 . . . . 0.0 109.978 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . 0.415 ' CE3' ' O ' ' A' ' 29' ' ' GLU . 81.9 t90 -126.84 123.78 38.11 Favored 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.415 ' O ' ' CE3' ' A' ' 28' ' ' TRP . 82.0 tt0 . . . . . 0 N--CA 1.49 1.568 0 CA-C-O 121.515 0.674 . . . . 0.0 110.046 -179.597 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' SER . . . . . 0.407 ' N ' ' HZ3' ' A' ' 54' ' ' LYS . 0.9 OUTLIER . . . . . 0 N--CA 1.49 1.554 0 N-CA-C 109.573 -0.529 . . . . 0.0 109.573 . . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 90.5 mt -108.92 119.11 57.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 CA-C-O 121.601 0.715 . . . . 0.0 110.054 -179.775 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 3.8 t -76.11 -50.91 13.38 Favored 'General case' 0 N--CA 1.489 1.519 0 CA-C-O 121.822 0.82 . . . . 0.0 109.635 179.489 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 49.2 tt0 -150.42 155.37 39.44 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.291 -0.881 . . . . 0.0 110.22 -179.604 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 8.2 p -142.65 139.8 28.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.678 -0.639 . . . . 0.0 109.414 179.416 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -171.99 -163.36 25.76 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.893 -1.283 . . . . 0.0 109.893 -179.77 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -134.71 148.1 50.23 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.552 -0.969 . . . . 0.0 109.85 -179.394 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 67.6 mt -112.95 137.99 50.5 Favored 'General case' 0 N--CA 1.493 1.688 0 CA-C-O 121.742 0.782 . . . . 0.0 109.564 -179.456 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.421 ' O ' ' OD1' ' A' ' 43' ' ' ASP . . . -83.24 143.86 22.2 Favored Glycine 0 N--CA 1.486 2.029 0 N-CA-C 110.779 -0.929 . . . . 0.0 110.779 -179.542 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.421 ' OD1' ' O ' ' A' ' 42' ' ' GLY . 75.2 m-20 -149.47 160.22 43.64 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.877 -0.778 . . . . 0.0 109.38 179.534 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 79.8 tt0 -65.58 -21.39 66.59 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.686 -0.634 . . . . 0.0 109.61 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 67.4 p -89.97 -2.78 58.21 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.327 -0.858 . . . . 0.0 109.514 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 133.15 -147.26 18.92 Favored Glycine 0 N--CA 1.497 2.705 0 N-CA-C 110.341 -1.104 . . . . 0.0 110.341 179.215 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 40.9 pt -125.66 152.62 32.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.901 -0.764 . . . . 0.0 109.741 -179.626 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 8.4 tp -142.5 140.12 28.68 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 CA-C-O 121.741 0.781 . . . . 0.0 110.059 -179.822 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 54.9 mtmt -87.88 145.94 25.81 Favored 'General case' 0 N--CA 1.49 1.545 0 CA-C-O 121.509 0.671 . . . . 0.0 110.004 179.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 38.9 p90 -137.57 153.05 50.01 Favored 'General case' 0 N--CA 1.49 1.545 0 CA-C-O 121.659 0.742 . . . . 0.0 109.783 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 83.6 m -129.86 130.97 45.91 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.413 HD12 HG23 ' A' ' 52' ' ' ILE . 96.6 mt -103.75 129.1 56.35 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 CA-C-O 121.702 0.763 . . . . 0.0 109.983 -179.773 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 89.7 m95 -90.63 129.6 36.74 Favored 'General case' 0 N--CA 1.487 1.404 0 CA-C-O 121.698 0.761 . . . . 0.0 109.273 179.457 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.407 ' HZ3' ' N ' ' A' ' 34' ' ' SER . 3.1 ptpp? . . . . . 0 N--CA 1.489 1.477 0 CA-C-O 121.516 0.674 . . . . 0.0 109.939 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 45.9 mt . . . . . 0 N--CA 1.496 1.85 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -69.74 155.42 66.05 Favored 'Trans proline' 0 N--CA 1.497 1.716 0 C-N-CA 122.921 2.414 . . . . 0.0 113.283 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 75.2 mt -71.73 141.67 49.79 Favored 'General case' 0 N--CA 1.493 1.682 0 CA-C-O 121.852 0.834 . . . . 0.0 110.778 -179.27 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.447 ' CD1' ' N ' ' A' ' 61' ' ' LEU . 10.3 mp -80.29 143.76 33.38 Favored 'General case' 0 N--CA 1.491 1.586 0 CA-C-O 121.688 0.756 . . . . 0.0 110.065 -179.919 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -83.41 152.66 24.91 Favored 'General case' 0 N--CA 1.49 1.568 0 CA-C-O 121.941 0.876 . . . . 0.0 110.987 -179.478 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 58.5 tt0 -82.03 136.78 35.2 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-O 121.663 0.744 . . . . 0.0 110.754 -179.676 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 82.4 4.55 90.12 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 110.166 -1.174 . . . . 0.0 110.166 179.434 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -110.51 146.86 35.26 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.444 -1.033 . . . . 0.0 110.723 -179.581 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 19.1 p -84.97 152.44 23.47 Favored 'General case' 0 N--CA 1.487 1.42 0 CA-C-O 121.558 0.694 . . . . 0.0 110.2 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 74.4 m-85 -145.34 145.29 31.14 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.349 -0.845 . . . . 0.0 110.275 179.651 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 23.5 tp -108.01 121.14 44.2 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 108.96 -0.755 . . . . 0.0 108.96 179.395 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 68.4 mt -100.59 133.38 45.12 Favored 'General case' 0 N--CA 1.49 1.551 0 CA-C-O 121.256 0.55 . . . . 0.0 109.629 -179.614 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.454 ' O ' ' OG ' ' A' ' 71' ' ' SER . 80.5 mtp85 -129.28 142.05 50.94 Favored 'General case' 0 N--CA 1.493 1.698 0 CA-C-O 121.653 0.74 . . . . 0.0 110.161 -179.806 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' SER . . . . . 0.454 ' OG ' ' O ' ' A' ' 70' ' ' ARG . 3.3 p 53.44 60.96 3.36 Favored 'General case' 0 N--CA 1.493 1.697 0 CA-C-O 121.416 0.627 . . . . 0.0 110.405 -179.889 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 3.3 m -114.23 133.11 61.34 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 179.024 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 8.9 p -95.47 135.56 29.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 CA-C-O 121.582 0.706 . . . . 0.0 109.986 -179.258 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -93.23 124.99 45.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 CA-C-O 121.767 0.794 . . . . 0.0 109.695 -179.6 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -100.11 142.86 16.1 Favored Glycine 0 N--CA 1.493 2.446 0 N-CA-C 110.478 -1.049 . . . . 0.0 110.478 -179.618 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 17.5 pt-20 -59.14 138.7 57.46 Favored 'General case' 0 N--CA 1.49 1.566 0 CA-C-O 121.592 0.71 . . . . 0.0 110.082 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . 0.604 ' CG ' ' NE2' ' A' ' 82' ' ' GLN . 79.3 t80 -137.08 81.25 1.86 Allowed 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 179.446 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . 0.502 ' C ' ' O ' ' A' ' 77' ' ' TYR . 28.8 t-20 15.15 -79.81 0.0 OUTLIER 'General case' 0 N--CA 1.51 2.533 0 CA-C-O 121.581 0.705 . . . . 0.0 112.146 -179.859 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.533 ' N ' ' O ' ' A' ' 77' ' ' TYR . 52.0 t0 -47.8 -69.94 0.11 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.433 -0.792 . . . . 0.0 109.893 -179.75 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 88.5 mtm180 -133.64 -130.44 0.17 Allowed 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.618 -0.677 . . . . 0.0 109.998 -178.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 88.4 m-85 -129.47 154.43 46.99 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.578 -0.701 . . . . 0.0 110.046 -178.796 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . 0.604 ' NE2' ' CG ' ' A' ' 77' ' ' TYR . 87.0 mt-30 -132.78 161.93 32.8 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.761 -0.587 . . . . 0.0 109.897 -179.703 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 16.3 m -104.05 127.88 57.88 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 CA-C-O 121.61 0.719 . . . . 0.0 109.237 179.776 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 -106.39 126.45 52.26 Favored 'General case' 0 N--CA 1.494 1.74 0 CA-C-O 121.436 0.636 . . . . 0.0 109.793 -179.212 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 52.1 t -104.78 120.1 54.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 CA-C-O 121.581 0.705 . . . . 0.0 109.181 179.831 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . 0.404 ' O ' ' O ' ' A' ' 87' ' ' LYS . 0.4 OUTLIER -147.9 -175.98 5.09 Favored 'General case' 0 N--CA 1.489 1.52 0 CA-C-O 121.388 0.613 . . . . 0.0 110.039 -179.38 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.494 ' C ' ' H ' ' A' ' 89' ' ' SER . 85.4 tttt -37.83 157.32 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.737 0 CA-C-O 121.535 0.683 . . . . 0.0 111.016 -179.442 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . 0.481 ' CB ' ' O ' ' A' ' 87' ' ' LYS . 0.2 OUTLIER 77.92 -28.88 0.16 Allowed 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 -179.725 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' SER . . . . . 0.494 ' H ' ' C ' ' A' ' 87' ' ' LYS . 11.5 t -75.64 152.18 37.63 Favored 'General case' 0 N--CA 1.49 1.553 0 CA-C-O 121.557 0.694 . . . . 0.0 110.469 -179.696 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 32.1 t -132.54 141.68 48.84 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.553 -0.717 . . . . 0.0 109.702 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 96.4 mt -123.97 130.9 73.66 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 CA-C-O 121.273 0.559 . . . . 0.0 109.523 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -127.02 132.78 50.66 Favored 'General case' 0 N--CA 1.497 1.881 0 CA-C-O 121.621 0.724 . . . . 0.0 109.512 179.809 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -81.22 127.49 32.74 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-O 121.617 0.723 . . . . 0.0 110.078 -179.533 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 10.8 mp -103.51 131.85 50.27 Favored 'General case' 0 N--CA 1.495 1.784 0 CA-C-O 121.671 0.748 . . . . 0.0 110.09 -179.637 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 18.2 t -77.52 -6.05 52.22 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 179.284 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -102.25 110.36 62.46 Favored Pre-proline 0 N--CA 1.496 1.851 0 O-C-N 121.393 -0.817 . . . . 0.0 109.572 -179.75 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -75.78 152.02 36.74 Favored 'Trans proline' 0 N--CA 1.492 1.396 0 C-N-CA 122.795 2.33 . . . . 0.0 112.528 -178.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 56.3 mt . . . . . 0 N--CA 1.487 1.422 0 CA-C-O 121.951 0.882 . . . . 0.0 110.341 -179.589 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo . . . . . 0 N--CA 1.493 1.487 0 CA-C-O 121.774 0.656 . . . . 0.0 112.297 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . 0.525 ' H ' ' CD ' ' A' ' 4' ' ' GLN . 1.0 OUTLIER -76.44 90.78 3.27 Favored 'General case' 0 C--N 1.301 -1.527 0 CA-C-O 121.925 0.869 . . . . 0.0 109.463 -179.704 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 90.7 mt -81.78 139.83 34.58 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.663 -0.648 . . . . 0.0 109.574 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 99.2 m -127.1 131.05 50.93 Favored 'General case' 0 N--CA 1.494 1.753 0 CA-C-O 121.902 0.858 . . . . 0.0 109.86 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 70.2 mmtt -82.15 154.37 25.54 Favored 'General case' 0 C--N 1.301 -1.538 0 CA-C-O 121.648 0.737 . . . . 0.0 109.767 -179.401 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 96.2 mt -63.07 -43.52 99.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 CA-C-O 121.583 0.706 . . . . 0.0 109.568 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 13.6 p -65.24 -23.94 34.14 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 121.531 -0.731 . . . . 0.0 109.858 179.835 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 54.9 t0 -79.39 -2.48 41.9 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.382 -0.824 . . . . 0.0 109.67 -179.889 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 96.6 mt -78.7 117.94 25.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.108 -0.995 . . . . 0.0 109.908 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 3.3 m -136.02 -4.0 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 N-CA-C 108.979 -0.748 . . . . 0.0 108.979 179.533 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 79.4 mm-40 -139.76 137.8 35.37 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.248 -0.908 . . . . 0.0 110.21 -179.724 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 19.9 p-10 -91.85 159.93 15.55 Favored 'General case' 0 N--CA 1.491 1.588 0 CA-C-O 121.607 0.718 . . . . 0.0 110.162 179.821 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 78.69 2.14 84.88 Favored Glycine 0 N--CA 1.493 2.48 0 N-CA-C 109.559 -1.416 . . . . 0.0 109.559 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 33.1 tt0 -79.17 137.84 37.62 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.517 -0.99 . . . . 0.0 110.817 -179.239 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 68.9 m95 -93.45 132.35 37.79 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.781 -0.574 . . . . 0.0 109.692 179.629 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -174.29 176.78 2.38 Favored 'General case' 0 N--CA 1.493 1.722 0 C-N-CA 119.746 -0.782 . . . . 0.0 110.084 179.833 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 28.7 m-20 -104.48 142.68 34.19 Favored 'General case' 0 N--CA 1.495 1.781 0 CA-C-O 121.625 0.726 . . . . 0.0 110.095 -179.554 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 57.3 tp -133.71 138.92 46.09 Favored 'General case' 0 N--CA 1.493 1.705 0 CA-C-O 121.319 0.58 . . . . 0.0 109.485 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.534 ' HZ3' ' CG2' ' A' ' 98' ' ' ILE . 19.5 ttpp -119.55 135.18 54.9 Favored 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 179.175 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -160.98 171.75 18.13 Favored 'General case' 0 N--CA 1.493 1.681 0 C-N-CA 119.598 -0.841 . . . . 0.0 110.166 -179.82 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -114.5 142.61 46.17 Favored 'General case' 0 N--CA 1.496 1.858 0 CA-C-O 121.756 0.789 . . . . 0.0 110.182 -179.71 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 21.5 t -84.77 117.57 30.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 CA-C-O 121.536 0.684 . . . . 0.0 109.963 -179.588 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 25.3 pt -107.86 -30.24 2.53 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 179.277 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 12.7 tt0 -163.99 133.45 3.95 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-O 121.699 0.761 . . . . 0.0 109.927 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.551 ' CD2' ' N ' ' A' ' 27' ' ' LEU . 1.1 pt? -143.3 137.8 29.09 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.784 -0.572 . . . . 0.0 109.696 179.932 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 2.6 m-90 -116.36 133.01 56.51 Favored 'General case' 0 N--CA 1.495 1.82 0 CA-C-O 121.567 0.699 . . . . 0.0 109.628 179.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 . . . . . 0 C--N 1.301 -1.518 0 CA-C-O 121.269 0.557 . . . . 0.0 109.534 179.648 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' SER . . . . . 0.42 ' O ' ' CE3' ' A' ' 53' ' ' TRP . 40.0 m . . . . . 0 N--CA 1.493 1.709 0 CA-C-O 121.091 0.472 . . . . 0.0 110.213 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 94.7 mt -123.29 127.61 74.47 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.993 0 O-C-N 121.292 -0.88 . . . . 0.0 110.317 -179.054 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 45.9 t -75.83 -53.01 9.13 Favored 'General case' 0 N--CA 1.493 1.691 0 CA-C-O 121.904 0.859 . . . . 0.0 109.562 179.597 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . 0.483 ' OE1' ' N ' ' A' ' 38' ' ' VAL . 0.5 OUTLIER -147.04 147.67 30.89 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.195 -0.941 . . . . 0.0 109.941 -179.739 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.483 ' N ' ' OE1' ' A' ' 37' ' ' GLN . 8.6 p -134.01 138.49 50.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 CA-C-O 121.384 0.611 . . . . 0.0 109.464 179.872 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -160.64 -165.65 17.86 Favored Glycine 0 N--CA 1.488 2.163 0 C-N-CA 119.746 -1.216 . . . . 0.0 110.476 -179.591 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -132.49 143.83 50.04 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.898 -0.766 . . . . 0.0 109.512 -179.714 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 41.4 mt -116.28 136.12 53.28 Favored 'General case' 0 N--CA 1.494 1.749 0 CA-C-O 121.79 0.805 . . . . 0.0 109.707 -179.178 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -83.71 162.52 39.5 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 111.073 -0.811 . . . . 0.0 111.073 -179.438 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.552 ' OD1' ' N ' ' A' ' 44' ' ' GLU . 67.2 t0 -174.73 145.15 0.87 Allowed 'General case' 0 N--CA 1.49 1.557 0 CA-C-O 121.63 0.729 . . . . 0.0 109.129 179.705 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.552 ' N ' ' OD1' ' A' ' 43' ' ' ASP . 49.0 mt-10 -54.43 -14.88 1.38 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.654 -0.654 . . . . 0.0 110.072 179.927 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 39.5 p -93.55 -11.15 32.54 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.228 -0.92 . . . . 0.0 109.716 -179.894 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 138.86 -158.3 25.09 Favored Glycine 0 N--CA 1.498 2.806 0 C-N-CA 120.041 -1.076 . . . . 0.0 110.568 179.233 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.412 HG23 HD13 ' A' ' 47' ' ' ILE . 97.4 mt -124.44 134.2 67.34 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 O-C-N 121.906 -0.761 . . . . 0.0 109.443 -179.585 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 17.7 tt -128.82 141.93 45.31 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.998 0 CA-C-O 121.625 0.726 . . . . 0.0 109.935 -179.753 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 51.1 mtmt -86.46 152.0 23.04 Favored 'General case' 0 N--CA 1.491 1.609 0 CA-C-O 121.568 0.699 . . . . 0.0 110.108 -179.772 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 25.2 p90 -142.51 160.38 40.39 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.327 -0.858 . . . . 0.0 110.325 -179.688 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 1.9 t -138.58 137.52 37.08 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.436 HD13 HG21 ' A' ' 52' ' ' ILE . 90.6 mt -105.93 118.03 52.76 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 CA-C-O 121.534 0.683 . . . . 0.0 109.834 179.865 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' TRP . . . . . 0.42 ' CE3' ' O ' ' A' ' 34' ' ' SER . 72.7 m95 -85.77 142.56 28.87 Favored 'General case' 0 N--CA 1.488 1.463 0 CA-C-O 121.579 0.704 . . . . 0.0 109.524 179.874 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 98.6 mttt . . . . . 0 N--CA 1.491 1.625 0 O-C-N 121.564 -0.71 . . . . 0.0 110.335 -179.53 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.572 ' C ' ' H ' ' A' ' 60' ' ' LEU . 18.4 mt . . . . . 0 N--CA 1.488 1.473 0 N-CA-C 109.346 -0.612 . . . . 0.0 109.346 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.414 ' O ' ' O ' ' A' ' 60' ' ' LEU . 29.9 Cg_endo -67.97 22.97 0.13 Allowed 'Trans proline' 0 N--CA 1.493 1.489 0 C-N-CA 122.2 1.933 . . . . 0.0 111.801 179.564 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.572 ' H ' ' C ' ' A' ' 58' ' ' LEU . 72.0 mt 58.59 151.86 0.01 OUTLIER 'General case' 0 C--N 1.293 -1.866 0 CA-C-O 121.802 0.81 . . . . 0.0 110.18 179.661 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.508 ' CD1' ' N ' ' A' ' 61' ' ' LEU . 9.0 mp -85.46 143.55 28.5 Favored 'General case' 0 N--CA 1.491 1.625 0 CA-C-O 121.541 0.686 . . . . 0.0 109.747 -179.667 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -87.5 151.27 23.16 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-O 121.937 0.875 . . . . 0.0 110.558 -178.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 58.1 tt0 -76.15 132.08 39.78 Favored 'General case' 0 N--CA 1.491 1.583 0 CA-C-O 121.87 0.843 . . . . 0.0 111.542 -178.811 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 93.16 -4.95 74.94 Favored Glycine 0 N--CA 1.496 2.688 0 N-CA-C 110.745 -0.942 . . . . 0.0 110.745 178.57 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.531 ' N ' ' OE1' ' A' ' 65' ' ' GLU . 58.3 mp0 -103.36 149.17 25.02 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 121.119 -1.224 . . . . 0.0 110.725 -179.379 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 8.8 p -93.22 135.15 34.7 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 179.58 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -125.72 143.04 51.21 Favored 'General case' 0 N--CA 1.497 1.879 0 CA-C-O 122.079 0.943 . . . . 0.0 111.017 -179.101 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 11.9 tp -106.57 104.88 14.67 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 179.653 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 54.3 mt -79.62 141.06 36.87 Favored 'General case' 0 N--CA 1.491 1.6 0 CA-C-O 121.342 0.591 . . . . 0.0 109.543 -179.688 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 85.3 mtp180 -136.06 141.85 44.31 Favored 'General case' 0 N--CA 1.494 1.733 0 CA-C-O 121.862 0.839 . . . . 0.0 110.71 -179.37 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 2.0 m 53.04 43.34 31.83 Favored 'General case' 0 N--CA 1.492 1.656 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.963 178.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 7.5 m -99.22 162.36 2.95 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.982 0 O-C-N 121.513 -0.742 . . . . 0.0 109.586 179.162 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 7.8 p -108.5 135.81 46.11 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 CA-C-O 121.688 0.756 . . . . 0.0 110.182 -178.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 98.7 t -78.89 125.0 38.05 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 CA-C-O 121.818 0.818 . . . . 0.0 109.375 -179.626 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -83.22 163.89 41.66 Favored Glycine 0 N--CA 1.486 2.016 0 N-CA-C 110.093 -1.203 . . . . 0.0 110.093 -179.632 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -114.73 127.88 55.99 Favored 'General case' 0 N--CA 1.493 1.722 0 CA-C-O 121.734 0.778 . . . . 0.0 109.881 -179.843 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . 0.628 ' CD2' ' NE2' ' A' ' 82' ' ' GLN . 42.4 m-85 -132.84 81.25 1.93 Allowed 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 179.557 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 79.4 m-20 50.67 -112.67 0.63 Allowed 'General case' 0 N--CA 1.495 1.788 0 CA-C-O 121.355 0.598 . . . . 0.0 110.698 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 94.9 m-20 -90.56 -7.0 54.01 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.141 -0.974 . . . . 0.0 109.544 -179.727 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 94.1 mtt180 -102.66 166.33 10.57 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.382 -0.824 . . . . 0.0 110.557 -178.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -128.71 150.61 50.19 Favored 'General case' 0 N--CA 1.496 1.859 0 CA-C-O 121.481 0.658 . . . . 0.0 109.706 179.882 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . 0.628 ' NE2' ' CD2' ' A' ' 77' ' ' TYR . 74.4 mt-30 -144.65 177.29 8.79 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.625 -0.672 . . . . 0.0 109.428 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 2.6 m -118.49 133.14 66.27 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 179.543 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 84.4 mt-30 -113.58 122.34 46.93 Favored 'General case' 0 N--CA 1.494 1.756 0 CA-C-O 121.859 0.838 . . . . 0.0 109.618 -179.078 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 22.0 t -90.07 129.29 41.19 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 1.4 p30 -147.57 172.84 13.37 Favored 'General case' 0 N--CA 1.49 1.544 0 CA-C-O 121.86 0.838 . . . . 0.0 110.167 -179.278 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.475 ' O ' ' CB ' ' A' ' 88' ' ' ASN . 88.7 tttt -42.83 157.24 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 CA-C-O 121.768 0.794 . . . . 0.0 110.826 -179.761 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . 0.475 ' CB ' ' O ' ' A' ' 87' ' ' LYS . 2.1 t-20 79.31 -23.2 0.25 Allowed 'General case' 0 N--CA 1.494 1.753 0 CA-C-O 121.366 0.603 . . . . 0.0 109.814 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' SER . . . . . 0.407 ' H ' ' C ' ' A' ' 87' ' ' LYS . 11.1 m -74.81 148.1 40.61 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.287 -0.883 . . . . 0.0 110.199 -179.512 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 52.1 m -125.1 150.1 47.18 Favored 'General case' 0 N--CA 1.497 1.884 0 CA-C-O 121.58 0.705 . . . . 0.0 109.806 -179.797 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 98.0 mt -132.27 135.33 58.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 CA-C-O 121.365 0.602 . . . . 0.0 109.734 -179.42 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 81.1 tt0 -128.8 125.93 38.82 Favored 'General case' 0 N--CA 1.5 2.032 0 CA-C-O 121.61 0.719 . . . . 0.0 109.222 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 26.7 mtmm -74.34 135.25 42.51 Favored 'General case' 0 N--CA 1.49 1.529 0 CA-C-O 121.566 0.698 . . . . 0.0 110.296 -179.608 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 10.2 mp -105.45 134.53 48.42 Favored 'General case' 0 N--CA 1.494 1.766 0 CA-C-O 121.938 0.875 . . . . 0.0 109.82 179.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 93.3 p -83.19 -2.12 54.74 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 109.454 -0.572 . . . . 0.0 109.454 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -118.36 89.92 37.29 Favored Pre-proline 0 N--CA 1.5 2.027 0 O-C-N 121.539 -0.726 . . . . 0.0 109.195 179.873 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_exo -57.72 149.67 66.94 Favored 'Trans proline' 0 N--CA 1.492 1.406 0 C-N-CA 122.742 2.295 . . . . 0.0 112.6 179.538 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.534 ' CG2' ' HZ3' ' A' ' 21' ' ' LYS . 29.8 pt . . . . . 0 N--CA 1.489 1.483 0 CA-C-O 121.827 0.822 . . . . 0.0 110.353 -179.73 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo . . . . . 0 N--CA 1.496 1.646 0 CA-C-O 121.417 0.507 . . . . 0.0 112.625 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 59.2 tt0 -87.08 81.09 8.15 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 179.845 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 77.5 mt -76.16 146.83 38.91 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.582 -0.699 . . . . 0.0 110.201 -179.119 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 96.8 m -123.33 130.33 52.58 Favored 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 179.751 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -79.54 155.16 28.32 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.475 -0.766 . . . . 0.0 110.313 -179.079 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.407 ' H ' ' CD1' ' A' ' 8' ' ' ILE . 3.0 mp -63.45 -43.24 98.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.627 -0.67 . . . . 0.0 109.671 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 13.1 p -66.93 -20.6 27.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.287 -0.883 . . . . 0.0 109.517 -179.688 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -82.68 -1.37 51.03 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.335 -0.853 . . . . 0.0 109.455 179.606 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 96.4 mt -83.89 111.63 20.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.317 -0.864 . . . . 0.0 109.551 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 24.0 m -154.44 18.45 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 179.754 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -134.75 144.3 47.63 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.533 -0.729 . . . . 0.0 110.105 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.41 ' OD1' ' O ' ' A' ' 14' ' ' ASN . 46.6 p-10 -93.16 137.76 32.2 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.492 -0.755 . . . . 0.0 110.264 -179.578 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 80.7 18.98 69.17 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.279 -1.528 . . . . 0.0 109.279 179.876 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 51.8 tt0 -73.31 133.76 43.98 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.295 -1.121 . . . . 0.0 109.818 -179.528 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 90.0 m95 -106.76 130.87 54.4 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.553 -0.717 . . . . 0.0 109.657 179.78 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 178.32 -173.54 0.15 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.421 -0.799 . . . . 0.0 109.689 179.598 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 80.7 m-20 -99.29 152.69 19.64 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.545 -0.722 . . . . 0.0 109.407 -179.78 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -136.78 117.13 13.63 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.407 -0.808 . . . . 0.0 109.451 179.94 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 35.2 ttpt -115.61 135.29 54.22 Favored 'General case' 0 N--CA 1.497 1.892 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 178.755 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -167.15 175.66 7.32 Favored 'General case' 0 N--CA 1.492 1.647 0 C-N-CA 119.31 -0.956 . . . . 0.0 110.158 179.646 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -103.29 142.11 34.76 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.57 -0.706 . . . . 0.0 109.702 -179.6 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 93.7 t -82.49 128.16 38.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.322 -0.861 . . . . 0.0 110.444 -179.496 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.414 HG21 HD12 ' A' ' 25' ' ' ILE . 96.7 mt -98.58 -59.94 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 179.119 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.622 ' NE2' ' CZ2' ' A' ' 28' ' ' TRP . 60.0 tt0 -146.84 147.69 31.11 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.346 -0.846 . . . . 0.0 109.728 179.955 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -125.31 151.23 46.29 Favored 'General case' 0 N--CA 1.496 1.828 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 -179.706 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . 0.622 ' CZ2' ' NE2' ' A' ' 26' ' ' GLN . 96.2 m95 -124.3 105.34 9.39 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 179.478 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.401 ' OE1' ' N ' ' A' ' 29' ' ' GLU . 59.4 mp0 . . . . . 0 C--N 1.302 -1.476 0 CA-C-O 121.542 0.687 . . . . 0.0 110.04 -179.164 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 77.7 p . . . . . 0 N--CA 1.489 1.495 0 N-CA-C 110.176 -0.305 . . . . 0.0 110.176 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.41 HG23 HD13 ' A' ' 35' ' ' ILE . 96.8 mt -112.79 128.35 69.55 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.069 0 O-C-N 121.478 -0.764 . . . . 0.0 109.878 -179.743 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.465 ' OG ' ' CA ' ' A' ' 54' ' ' LYS . 1.3 m -85.01 -67.98 0.76 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.751 -0.593 . . . . 0.0 109.528 -179.781 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 51.2 tt0 -139.68 151.48 45.95 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.477 -0.764 . . . . 0.0 109.595 -179.638 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 8.3 p -135.71 139.38 46.38 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 179.677 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -164.35 -163.13 16.68 Favored Glycine 0 N--CA 1.49 2.297 0 C-N-CA 119.341 -1.409 . . . . 0.0 110.434 -179.509 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.521 ' N ' ' CD2' ' A' ' 40' ' ' LEU . 1.4 pt? -136.98 146.23 45.12 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.553 -0.969 . . . . 0.0 109.852 179.904 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 52.9 mt -109.79 132.32 54.25 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.524 -0.735 . . . . 0.0 109.865 -179.274 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -79.06 163.82 49.52 Favored Glycine 0 N--CA 1.487 2.074 0 N-CA-C 110.512 -1.035 . . . . 0.0 110.512 -179.81 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.487 ' OD1' ' N ' ' A' ' 44' ' ' GLU . 49.7 t0 -171.8 138.52 1.09 Allowed 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.68 -0.894 . . . . 0.0 109.105 179.346 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.487 ' N ' ' OD1' ' A' ' 43' ' ' ASP . 18.1 pt-20 -55.7 -13.39 1.66 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.415 -0.803 . . . . 0.0 109.222 -179.773 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 13.9 p -98.29 -9.34 25.63 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.441 -0.787 . . . . 0.0 109.376 -179.794 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 144.92 -157.64 27.37 Favored Glycine 0 N--CA 1.497 2.749 0 C-N-CA 120.078 -1.058 . . . . 0.0 110.487 179.281 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 40.1 pt -126.35 154.57 35.94 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 O-C-N 121.738 -0.86 . . . . 0.0 109.584 -179.864 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -141.39 142.15 29.49 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 121.308 -0.87 . . . . 0.0 109.459 179.426 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -91.24 143.97 26.1 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.658 -0.651 . . . . 0.0 109.348 179.455 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 33.4 p90 -137.61 152.51 49.45 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.168 -0.957 . . . . 0.0 109.674 -179.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 97.1 m -128.32 132.81 48.62 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 47.1 mm -99.99 121.33 50.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.405 -0.81 . . . . 0.0 109.875 -179.457 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' TRP . . . . . 0.482 ' CD1' ' OD1' ' A' ' 86' ' ' ASN . 89.2 m95 -82.16 124.19 29.66 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 108.72 -0.845 . . . . 0.0 108.72 179.368 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.465 ' CA ' ' OG ' ' A' ' 36' ' ' SER . 32.7 tttt . . . . . 0 C--N 1.301 -1.515 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 -179.219 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 37.3 mt . . . . . 0 N--CA 1.493 1.676 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -50.57 148.6 15.06 Favored 'Trans proline' 0 N--CA 1.496 1.637 0 C-N-CA 122.177 1.918 . . . . 0.0 112.797 179.133 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 84.0 mt -69.28 154.37 42.15 Favored 'General case' 0 N--CA 1.492 1.632 0 CA-C-O 121.836 0.827 . . . . 0.0 110.543 -179.195 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.556 ' N ' ' CD2' ' A' ' 61' ' ' LEU . 3.4 mm? -78.72 149.61 32.69 Favored 'General case' 0 C--N 1.304 -1.382 0 CA-C-O 121.421 0.629 . . . . 0.0 110.304 -178.663 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -106.26 146.49 30.27 Favored 'General case' 0 N--CA 1.495 1.823 0 CA-C-O 121.738 0.78 . . . . 0.0 110.057 -179.111 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 49.2 tt0 -81.34 134.21 35.54 Favored 'General case' 0 N--CA 1.488 1.468 0 CA-C-O 121.284 0.564 . . . . 0.0 110.81 -178.905 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 90.38 -6.65 82.3 Favored Glycine 0 N--CA 1.495 2.611 0 N-CA-C 110.355 -1.098 . . . . 0.0 110.355 178.717 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -104.6 150.47 24.63 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.37 -1.076 . . . . 0.0 110.749 -179.438 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 8.4 m -95.37 136.59 35.54 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.698 -0.626 . . . . 0.0 109.358 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 72.5 m-85 -121.87 145.1 48.41 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-O 121.748 0.785 . . . . 0.0 110.142 -179.848 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 14.0 tp -110.34 112.14 23.89 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 179.344 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 71.4 mt -95.86 131.99 41.6 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 -179.827 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 80.4 mtp85 -123.52 141.87 51.57 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.561 -0.712 . . . . 0.0 110.537 -179.334 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 9.2 t 57.81 65.04 1.4 Allowed 'General case' 0 N--CA 1.493 1.692 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.547 179.397 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 2.9 m -121.76 160.82 22.97 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 179.258 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 14.8 p -118.7 133.22 66.24 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 CA-C-O 121.63 0.728 . . . . 0.0 109.45 -179.258 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 14.0 t -85.6 121.37 37.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.654 -0.654 . . . . 0.0 109.68 -179.193 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -98.87 -172.35 31.6 Favored Glycine 0 N--CA 1.494 2.531 0 N-CA-C 109.784 -1.327 . . . . 0.0 109.784 -179.773 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -111.31 120.75 43.29 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.644 -0.916 . . . . 0.0 109.65 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . 0.496 ' O ' ' N ' ' A' ' 79' ' ' ASP . 86.7 t80 -108.67 80.77 1.37 Allowed 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 179.44 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . 0.455 ' C ' ' O ' ' A' ' 77' ' ' TYR . 94.3 m-20 31.07 -91.34 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.988 0 CA-C-O 121.482 0.658 . . . . 0.0 111.196 179.855 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.496 ' N ' ' O ' ' A' ' 77' ' ' TYR . 66.5 t0 -51.52 -68.69 0.15 Allowed 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.619 -0.676 . . . . 0.0 110.656 -179.453 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 85.2 mtp180 -120.96 -163.99 1.08 Allowed 'General case' 0 N--CA 1.501 2.123 0 O-C-N 121.528 -0.732 . . . . 0.0 110.336 -178.774 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 79.6 m-85 -99.08 162.93 12.79 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.56 -0.712 . . . . 0.0 109.793 -179.037 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 6.4 pt20 -141.95 162.01 36.55 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.377 -0.827 . . . . 0.0 109.834 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 2.7 m -107.96 131.18 59.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 179.81 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -106.7 131.72 53.51 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.676 -0.64 . . . . 0.0 110.041 -178.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 96.3 t -103.15 124.31 57.19 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . 0.482 ' OD1' ' CD1' ' A' ' 53' ' ' TRP . 80.3 m-20 -125.01 -176.52 3.58 Favored 'General case' 0 N--CA 1.496 1.834 0 CA-C-O 121.524 0.678 . . . . 0.0 109.739 -179.528 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 62.9 pttt -59.86 -33.43 71.78 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.741 -0.6 . . . . 0.0 109.862 -179.888 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 52.3 t-20 -63.45 -38.23 90.33 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.393 -0.817 . . . . 0.0 109.523 -179.558 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 27.7 t -76.57 164.78 25.6 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.34 -0.85 . . . . 0.0 110.325 -179.064 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 95.1 p -133.06 158.3 43.11 Favored 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 179.825 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.42 HD12 HG21 ' A' ' 91' ' ' ILE . 96.8 mt -125.54 132.63 70.71 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 O-C-N 121.668 -0.645 . . . . 0.0 110.02 -179.383 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 31.7 mm-40 -136.15 135.42 39.2 Favored 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 179.633 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -84.19 136.09 34.1 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.442 -0.786 . . . . 0.0 109.962 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 8.9 mp -108.25 133.66 52.18 Favored 'General case' 0 N--CA 1.499 1.986 0 CA-C-O 121.623 0.725 . . . . 0.0 109.384 179.503 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 89.7 p -76.09 1.95 14.2 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 179.637 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.416 ' OE2' ' O ' ' A' ' 97' ' ' PRO . 8.7 tm-20 -109.52 95.72 20.29 Favored Pre-proline 0 N--CA 1.497 1.883 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 -179.948 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . 0.416 ' O ' ' OE2' ' A' ' 96' ' ' GLU . 64.7 Cg_endo -76.78 158.89 35.13 Favored 'Trans proline' 0 N--CA 1.491 1.363 0 C-N-CA 122.241 1.961 . . . . 0.0 112.351 -179.149 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 86.8 mt . . . . . 0 N--CA 1.496 1.862 0 O-C-N 121.499 -0.751 . . . . 0.0 109.79 -179.574 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo . . . . . 0 N--CA 1.496 1.622 0 CA-C-O 121.753 0.647 . . . . 0.0 112.269 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . 0.496 ' H ' ' CD ' ' A' ' 4' ' ' GLN . 21.9 mp0 -72.72 92.61 1.57 Allowed 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.291 -0.88 . . . . 0.0 109.685 -179.719 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 86.6 mt -74.51 147.32 41.97 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.487 -0.758 . . . . 0.0 109.567 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.409 ' HG1' ' CB ' ' A' ' 18' ' ' ALA . 97.8 m -124.12 130.5 52.65 Favored 'General case' 0 N--CA 1.495 1.779 0 CA-C-O 121.736 0.779 . . . . 0.0 109.754 -179.897 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -98.87 159.12 15.18 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.597 -0.689 . . . . 0.0 110.048 -179.675 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 96.6 mt -63.84 -42.74 96.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.412 -0.805 . . . . 0.0 109.557 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 14.8 p -63.32 -23.58 33.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.24 -0.913 . . . . 0.0 109.441 -179.843 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 94.7 m-20 -78.9 -4.15 48.29 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.213 -0.929 . . . . 0.0 109.345 179.58 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 5.6 mm -69.12 98.95 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.079 -1.013 . . . . 0.0 109.639 -179.773 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 2.5 p -116.12 -40.11 2.7 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.36 0 O-C-N 121.625 -0.672 . . . . 0.0 109.3 179.871 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 79.4 tt0 -126.28 143.33 51.19 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.294 -0.879 . . . . 0.0 110.26 -178.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 55.8 p30 -87.14 163.16 17.12 Favored 'General case' 0 N--CA 1.492 1.627 0 CA-C-O 121.71 0.767 . . . . 0.0 110.447 -179.674 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 78.07 13.04 83.78 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 109.267 -1.533 . . . . 0.0 109.267 -179.494 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -83.58 129.94 34.98 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.187 -1.184 . . . . 0.0 110.082 -179.7 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 84.1 m95 -93.12 129.16 39.2 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.265 -0.897 . . . . 0.0 109.929 -179.734 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.409 ' CB ' ' HG1' ' A' ' 6' ' ' THR . . . -174.35 -173.33 0.76 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.6 -0.687 . . . . 0.0 109.303 179.581 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 73.5 m-20 -105.64 145.25 31.27 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.515 -0.741 . . . . 0.0 109.822 -179.463 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 40.5 tp -128.07 132.14 49.06 Favored 'General case' 0 N--CA 1.498 1.968 0 CA-C-O 121.69 0.757 . . . . 0.0 109.9 179.766 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 38.2 ttmt -116.09 130.18 56.69 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 179.359 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -166.65 179.01 5.65 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.84 -1.162 . . . . 0.0 110.775 -179.589 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.523 ' HZ2' ' C ' ' A' ' 64' ' ' GLY . 64.5 tttp -114.55 139.93 49.18 Favored 'General case' 0 N--CA 1.497 1.919 0 CA-C-O 121.619 0.723 . . . . 0.0 109.968 -179.682 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 87.6 t -81.02 115.73 24.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.413 -0.804 . . . . 0.0 109.943 -179.766 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.413 HD11 HG21 ' A' ' 25' ' ' ILE . 19.1 mm -93.92 -48.93 12.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.297 -0.877 . . . . 0.0 109.645 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 82.4 mt-30 -144.62 144.97 31.53 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.04 -1.038 . . . . 0.0 110.199 -179.347 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.552 ' CD2' ' N ' ' A' ' 27' ' ' LEU . 1.1 pt? -141.95 133.32 26.54 Favored 'General case' 0 N--CA 1.492 1.675 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 179.836 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 3.4 m0 -118.86 146.51 44.83 Favored 'General case' 0 N--CA 1.499 2.014 0 CA-C-O 121.741 0.781 . . . . 0.0 109.999 -179.347 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 50.0 tp10 . . . . . 0 N--CA 1.491 1.6 0 O-C-N 121.405 -0.81 . . . . 0.0 109.576 -179.808 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 40.1 t . . . . . 0 N--CA 1.495 1.806 0 CA-C-O 121.316 0.579 . . . . 0.0 110.555 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 96.9 mt -103.15 133.82 45.94 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 O-C-N 121.121 -0.987 . . . . 0.0 109.794 -179.523 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.459 ' CB ' ' HZ3' ' A' ' 54' ' ' LYS . 28.7 t -86.33 -70.61 0.59 Allowed 'General case' 0 N--CA 1.49 1.544 0 CA-C-O 121.664 0.745 . . . . 0.0 109.804 -179.946 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -141.19 153.93 45.57 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.088 -1.007 . . . . 0.0 110.375 -179.15 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 27.8 m -135.98 158.51 38.97 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 179.312 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -178.23 -150.91 8.99 Favored Glycine 0 N--CA 1.487 2.045 0 C-N-CA 119.467 -1.349 . . . . 0.0 110.033 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -135.25 148.11 49.48 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.655 -0.909 . . . . 0.0 109.374 -179.744 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 70.3 mt -111.54 128.4 56.01 Favored 'General case' 0 N--CA 1.495 1.787 0 CA-C-O 121.668 0.747 . . . . 0.0 109.31 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -80.44 158.03 41.1 Favored Glycine 0 N--CA 1.487 2.095 0 N-CA-C 110.012 -1.235 . . . . 0.0 110.012 -179.751 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.529 ' OD1' ' N ' ' A' ' 44' ' ' GLU . 67.2 t0 -172.58 143.14 1.3 Allowed 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.493 -1.004 . . . . 0.0 109.045 -179.923 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.529 ' N ' ' OD1' ' A' ' 43' ' ' ASP . 96.9 mt-10 -54.88 -14.45 1.45 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.427 -0.795 . . . . 0.0 109.793 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 37.4 p -93.33 -12.94 28.81 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.024 -1.047 . . . . 0.0 109.292 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 141.15 -157.32 25.99 Favored Glycine 0 N--CA 1.498 2.792 0 C-N-CA 119.876 -1.154 . . . . 0.0 110.245 179.378 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 41.5 pt -124.85 150.55 29.86 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 O-C-N 121.581 -0.953 . . . . 0.0 109.518 -179.451 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 20.8 tt -146.94 150.08 15.15 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 121.235 -0.916 . . . . 0.0 109.7 -179.741 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 72.5 mmtt -84.09 150.21 25.71 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.466 -0.771 . . . . 0.0 110.402 -179.23 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 17.3 p90 -143.65 151.76 40.51 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.321 -0.862 . . . . 0.0 109.19 179.52 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.545 ' OG1' ' NE2' ' A' ' 82' ' ' GLN . 35.0 m -132.99 137.18 46.44 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.629 -0.669 . . . . 0.0 109.469 179.807 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 29.7 mm -98.48 122.56 50.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.225 -0.922 . . . . 0.0 109.735 -179.676 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 97.3 m95 -98.17 140.97 31.68 Favored 'General case' 0 N--CA 1.49 1.543 0 CA-C-O 121.582 0.706 . . . . 0.0 109.639 179.841 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.459 ' HZ3' ' CB ' ' A' ' 36' ' ' SER . 29.0 mmtm . . . . . 0 N--CA 1.494 1.733 0 O-C-N 121.144 -0.973 . . . . 0.0 109.781 179.547 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 29.8 mt . . . . . 0 N--CA 1.497 1.91 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -69.76 159.42 53.46 Favored 'Trans proline' 0 N--CA 1.497 1.72 0 C-N-CA 122.837 2.358 . . . . 0.0 113.195 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 97.2 mt -71.52 141.61 50.12 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.274 -0.891 . . . . 0.0 109.98 -179.814 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.413 ' CD1' ' N ' ' A' ' 61' ' ' LEU . 9.6 mp -80.04 149.04 30.84 Favored 'General case' 0 N--CA 1.493 1.724 0 CA-C-O 121.727 0.775 . . . . 0.0 110.705 -179.084 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -104.91 126.63 52.18 Favored 'General case' 0 N--CA 1.497 1.914 0 CA-C-O 121.802 0.81 . . . . 0.0 109.758 -179.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 58.2 tt0 -64.49 147.89 51.79 Favored 'General case' 0 N--CA 1.496 1.855 0 CA-C-O 121.965 0.888 . . . . 0.0 111.835 -178.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . 0.523 ' C ' ' HZ2' ' A' ' 23' ' ' LYS . . . 81.05 22.94 60.15 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.937 -1.265 . . . . 0.0 109.937 178.825 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -139.26 145.46 39.21 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.248 -1.148 . . . . 0.0 110.094 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 11.1 p -84.42 149.73 25.79 Favored 'General case' 0 N--CA 1.486 1.333 0 CA-C-O 121.606 0.717 . . . . 0.0 109.856 179.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 66.6 m-85 -143.58 151.91 40.77 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.233 -0.917 . . . . 0.0 110.307 -179.867 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 21.9 tp -112.92 121.95 46.2 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 179.235 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 71.8 mt -100.84 130.74 46.9 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.393 -0.817 . . . . 0.0 109.849 -179.162 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 83.4 mtp180 -127.09 144.55 51.0 Favored 'General case' 0 N--CA 1.498 1.944 0 CA-C-O 121.878 0.847 . . . . 0.0 110.49 -179.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.8 m 58.34 57.43 3.91 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.798 -0.564 . . . . 0.0 110.49 179.385 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 17.9 m -118.81 164.67 14.85 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.98 0 O-C-N 121.598 -0.688 . . . . 0.0 109.656 179.33 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 11.8 p -120.47 136.11 58.56 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 CA-C-O 121.65 0.738 . . . . 0.0 109.379 -179.712 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 66.9 t -81.47 115.29 23.79 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 CA-C-O 121.831 0.824 . . . . 0.0 109.889 -178.863 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -84.92 167.32 41.89 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 110.024 -1.23 . . . . 0.0 110.024 -179.563 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -105.91 124.2 49.19 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.466 -1.02 . . . . 0.0 109.624 180.0 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 52.0 t80 -120.05 82.58 1.91 Allowed 'General case' 0 N--CA 1.492 1.637 0 CA-C-O 121.984 0.897 . . . . 0.0 108.807 179.719 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . 0.472 ' CG ' ' H ' ' A' ' 79' ' ' ASP . 50.1 t30 42.95 -117.63 0.46 Allowed 'General case' 0 N--CA 1.501 2.087 0 CA-C-O 121.729 0.776 . . . . 0.0 112.179 179.774 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.472 ' H ' ' CG ' ' A' ' 78' ' ' ASN . 42.4 t0 -70.22 -35.16 73.7 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.184 -0.947 . . . . 0.0 109.991 -178.806 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 84.4 mtt85 -101.22 -170.88 1.9 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.267 -0.896 . . . . 0.0 110.011 -179.377 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -127.9 150.53 49.83 Favored 'General case' 0 N--CA 1.494 1.756 0 CA-C-O 121.694 0.759 . . . . 0.0 110.075 -179.297 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . 0.545 ' NE2' ' OG1' ' A' ' 51' ' ' THR . 40.5 tt0 -133.13 126.44 31.73 Favored 'General case' 0 N--CA 1.49 1.528 0 CA-C-O 121.493 0.663 . . . . 0.0 109.351 -179.803 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 34.1 m -81.13 141.21 15.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.477 -0.764 . . . . 0.0 109.553 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 87.7 mt-30 -111.54 120.82 43.4 Favored 'General case' 0 N--CA 1.495 1.812 0 CA-C-O 121.799 0.809 . . . . 0.0 109.738 -179.449 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 4.5 t -93.24 99.3 9.45 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 179.655 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . 0.5 ' C ' HD21 ' A' ' 86' ' ' ASN . 0.1 OUTLIER -150.67 -176.7 5.61 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.495 -0.753 . . . . 0.0 109.313 -179.571 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.465 ' CG ' ' H ' ' A' ' 88' ' ' ASN . 14.4 tptm 66.27 -137.93 0.16 Allowed 'General case' 0 N--CA 1.491 1.621 0 CA-C-O 121.806 0.812 . . . . 0.0 110.826 179.588 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . 0.465 ' H ' ' CG ' ' A' ' 87' ' ' LYS . 15.0 m120 -86.14 22.62 1.71 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.474 -0.766 . . . . 0.0 109.227 -179.574 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 30.9 t -58.61 141.78 51.31 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.193 -0.942 . . . . 0.0 109.672 -179.759 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 64.0 m -127.16 152.32 47.5 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.546 -0.721 . . . . 0.0 109.318 -179.735 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.409 HD12 HG23 ' A' ' 91' ' ' ILE . 97.3 mt -128.07 131.73 69.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.692 -0.63 . . . . 0.0 109.351 -179.707 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -132.03 131.76 42.78 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.523 -0.736 . . . . 0.0 109.301 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.43 ' HZ1' ' CB ' ' A' ' 93' ' ' LYS . 4.8 ttpm? -79.61 136.69 36.9 Favored 'General case' 0 N--CA 1.489 1.487 0 CA-C-O 121.789 0.804 . . . . 0.0 110.31 -179.588 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 70.9 mt -98.15 132.85 43.32 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.42 -0.8 . . . . 0.0 109.744 -179.797 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 31.3 t -75.51 3.84 8.62 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.481 -0.762 . . . . 0.0 109.342 179.642 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -118.36 90.28 38.22 Favored Pre-proline 0 N--CA 1.495 1.812 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 179.593 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_exo -56.09 147.38 64.93 Favored 'Trans proline' 0 N--CA 1.495 1.606 0 C-N-CA 122.829 2.353 . . . . 0.0 112.394 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 90.6 mt . . . . . 0 N--CA 1.492 1.657 0 O-C-N 121.299 -0.876 . . . . 0.0 109.869 -179.205 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_exo . . . . . 0 N--CA 1.494 1.517 0 CA-C-O 121.624 0.593 . . . . 0.0 112.261 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 1.1 pt20 -74.88 72.35 2.07 Favored 'General case' 0 C--N 1.3 -1.55 0 CA-C-O 121.786 0.803 . . . . 0.0 109.905 -179.501 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 18.8 mt -65.74 137.3 57.18 Favored 'General case' 0 N--CA 1.489 1.479 0 CA-C-O 121.453 0.644 . . . . 0.0 109.734 179.882 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 91.8 m -128.54 135.5 49.48 Favored 'General case' 0 N--CA 1.494 1.728 0 CA-C-O 121.836 0.827 . . . . 0.0 109.811 -179.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 65.4 mttp -72.92 151.15 42.02 Favored 'General case' 0 N--CA 1.49 1.572 0 CA-C-O 121.704 0.764 . . . . 0.0 109.975 -179.458 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 92.4 mt -63.25 -43.13 98.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 CA-C-O 121.369 0.604 . . . . 0.0 109.379 -179.393 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 8.3 p -65.7 -24.07 33.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 -179.05 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -79.05 -6.47 56.48 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.639 -0.663 . . . . 0.0 109.327 -179.434 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 97.5 mt -85.89 113.79 24.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 CA-C-O 121.78 0.8 . . . . 0.0 109.543 179.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 31.7 m -150.12 12.21 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -124.97 137.51 54.25 Favored 'General case' 0 N--CA 1.501 2.123 0 CA-C-O 121.884 0.85 . . . . 0.0 110.268 -179.861 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 48.1 p-10 -84.08 140.8 31.58 Favored 'General case' 0 N--CA 1.489 1.518 0 CA-C-O 121.619 0.723 . . . . 0.0 109.881 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 75.99 19.0 79.16 Favored Glycine 0 N--CA 1.492 2.407 0 N-CA-C 109.647 -1.381 . . . . 0.0 109.647 179.626 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 57.0 tt0 -78.77 133.82 37.07 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.59 -0.947 . . . . 0.0 110.209 -179.623 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 84.3 m95 -106.78 130.64 54.45 Favored 'General case' 0 N--CA 1.494 1.748 0 CA-C-O 121.585 0.707 . . . . 0.0 110.148 -179.751 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -178.9 175.51 1.01 Allowed 'General case' 0 N--CA 1.493 1.689 0 CA-C-O 121.693 0.758 . . . . 0.0 110.391 179.248 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.422 ' OD1' ' O ' ' A' ' 69' ' ' LEU . 1.4 t30 -102.05 150.01 23.67 Favored 'General case' 0 N--CA 1.498 1.944 0 CA-C-O 121.902 0.858 . . . . 0.0 110.137 -179.432 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 7.2 tt -147.56 138.2 23.32 Favored 'General case' 0 C--N 1.305 -1.36 0 CA-C-O 121.779 0.8 . . . . 0.0 110.449 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 37.8 ttmt -109.83 133.22 53.4 Favored 'General case' 0 N--CA 1.496 1.863 0 CA-C-O 121.594 0.711 . . . . 0.0 109.561 179.477 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -163.18 170.5 17.68 Favored 'General case' 0 N--CA 1.494 1.746 0 CA-C-O 121.762 0.791 . . . . 0.0 110.589 179.718 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.57 ' HZ2' ' CA ' ' A' ' 65' ' ' GLU . 17.1 ttmm -113.83 142.31 46.24 Favored 'General case' 0 N--CA 1.498 1.957 0 CA-C-O 121.608 0.718 . . . . 0.0 109.934 -179.717 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 98.8 t -81.98 122.2 36.43 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 CA-C-O 121.528 0.68 . . . . 0.0 110.239 -179.515 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 26.0 mm -93.88 -44.98 13.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 CA-C-O 121.086 0.469 . . . . 0.0 110.031 -179.507 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 59.3 tt0 -158.14 147.62 19.66 Favored 'General case' 0 N--CA 1.492 1.642 0 CA-C-O 122.182 0.992 . . . . 0.0 110.334 -179.072 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.725 ' CD2' ' H ' ' A' ' 27' ' ' LEU . 0.0 OUTLIER -116.87 151.46 36.52 Favored 'General case' 0 N--CA 1.502 2.13 0 CA-C-O 121.632 0.729 . . . . 0.0 109.272 -179.205 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 23.9 t90 -138.15 111.18 7.8 Favored 'General case' 0 N--CA 1.493 1.675 0 CA-C-O 121.879 0.847 . . . . 0.0 109.678 179.148 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 . . . . . 0 N--CA 1.491 1.602 0 CA-C-O 121.675 0.75 . . . . 0.0 110.168 -179.618 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 16.4 m . . . . . 0 N--CA 1.492 1.649 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 85.6 mt -103.07 128.61 55.86 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 CA-C-O 121.912 0.863 . . . . 0.0 109.39 -179.56 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 28.1 t -74.92 -75.14 0.17 Allowed 'General case' 0 N--CA 1.489 1.52 0 CA-C-O 121.508 0.67 . . . . 0.0 109.852 -179.273 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 13.1 pt20 -139.78 156.51 46.72 Favored 'General case' 0 N--CA 1.494 1.736 0 CA-C-O 122.045 0.926 . . . . 0.0 110.488 -179.064 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 56.6 t -130.92 136.15 58.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 CA-C-O 121.639 0.733 . . . . 0.0 109.367 179.856 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -153.63 -151.26 5.69 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 110.11 -1.196 . . . . 0.0 110.11 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -134.48 152.09 51.56 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.739 -0.859 . . . . 0.0 109.772 -179.414 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 53.0 mt -116.85 126.46 53.05 Favored 'General case' 0 N--CA 1.494 1.753 0 CA-C-O 121.84 0.829 . . . . 0.0 109.77 -179.867 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -85.08 150.59 25.07 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 110.959 -0.856 . . . . 0.0 110.959 -179.573 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 44.3 t0 -168.55 164.37 12.46 Favored 'General case' 0 N--CA 1.489 1.494 0 CA-C-O 121.723 0.773 . . . . 0.0 109.583 179.335 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -66.06 -22.38 66.42 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.864 -0.523 . . . . 0.0 109.923 -179.181 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 65.5 p -88.48 -6.02 57.88 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.289 -0.882 . . . . 0.0 109.723 -179.433 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 134.45 -157.65 23.03 Favored Glycine 0 N--CA 1.5 2.956 0 C-N-CA 120.347 -0.93 . . . . 0.0 110.987 178.709 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 4.9 mp -126.02 133.68 68.34 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 CA-C-O 121.491 0.662 . . . . 0.0 109.539 -179.465 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 20.0 tt -127.67 151.83 34.99 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 CA-C-O 122.023 0.916 . . . . 0.0 110.439 -179.457 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 28.2 mmtp -83.94 153.24 24.04 Favored 'General case' 0 N--CA 1.489 1.507 0 CA-C-O 121.543 0.687 . . . . 0.0 109.709 -179.346 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 17.2 p90 -147.2 154.99 41.71 Favored 'General case' 0 N--CA 1.491 1.623 0 CA-C-O 122.03 0.919 . . . . 0.0 110.289 179.8 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 13.8 t -142.22 139.05 31.88 Favored 'General case' 0 N--CA 1.492 1.648 0 CA-C-O 121.684 0.755 . . . . 0.0 109.629 179.493 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 85.8 mt -103.83 116.37 47.49 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 CA-C-O 121.84 0.828 . . . . 0.0 109.803 -179.793 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 73.3 m95 -86.04 138.42 31.97 Favored 'General case' 0 N--CA 1.491 1.591 0 CA-C-O 121.537 0.684 . . . . 0.0 109.402 179.8 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 18.8 mmmt . . . . . 0 N--CA 1.491 1.587 0 CA-C-O 121.451 0.643 . . . . 0.0 109.453 -179.739 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 14.8 mt . . . . . 0 N--CA 1.488 1.473 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -71.54 156.37 58.05 Favored 'Trans proline' 0 C--N 1.31 -1.468 0 C-N-CA 122.561 2.174 . . . . 0.0 112.711 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 82.9 mt -72.41 144.98 47.96 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-O 121.894 0.855 . . . . 0.0 110.706 -179.439 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.454 ' CD1' ' N ' ' A' ' 61' ' ' LEU . 9.9 mp -86.86 137.62 32.25 Favored 'General case' 0 N--CA 1.488 1.427 0 CA-C-O 121.554 0.693 . . . . 0.0 109.625 -179.71 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.529 ' N ' ' OH ' ' A' ' 67' ' ' TYR . 97.8 mt-10 -80.74 144.9 31.83 Favored 'General case' 0 C--N 1.301 -1.516 0 CA-C-O 121.659 0.742 . . . . 0.0 110.27 -179.778 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . 0.417 ' C ' ' OE1' ' A' ' 65' ' ' GLU . 57.9 tt0 -80.85 125.78 30.52 Favored 'General case' 0 N--CA 1.488 1.465 0 CA-C-O 121.541 0.686 . . . . 0.0 110.437 -179.231 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 96.62 31.46 7.08 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.382 -1.487 . . . . 0.0 109.382 179.304 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.57 ' CA ' ' HZ2' ' A' ' 23' ' ' LYS . 59.9 mp0 -139.53 145.48 38.74 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.54 -0.977 . . . . 0.0 110.142 179.472 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 30.0 t -75.79 145.14 40.94 Favored 'General case' 0 N--CA 1.489 1.478 0 CA-C-O 121.481 0.658 . . . . 0.0 110.087 -179.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . 0.529 ' OH ' ' N ' ' A' ' 62' ' ' GLU . 94.0 m-85 -137.03 144.76 43.4 Favored 'General case' 0 N--CA 1.494 1.726 0 CA-C-O 121.9 0.857 . . . . 0.0 110.477 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -107.0 119.93 40.7 Favored 'General case' 0 N--CA 1.487 1.414 0 CA-C-O 121.551 0.691 . . . . 0.0 109.405 -179.541 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.422 ' O ' ' OD1' ' A' ' 19' ' ' ASN . 73.4 mt -93.83 110.44 22.09 Favored 'General case' 0 N--CA 1.491 1.591 0 CA-C-O 121.521 0.677 . . . . 0.0 109.335 179.909 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.532 ' NH2' ' OE1' ' A' ' 92' ' ' GLU . 94.6 mtt180 -102.36 135.39 44.05 Favored 'General case' 0 N--CA 1.492 1.656 0 CA-C-O 121.966 0.888 . . . . 0.0 110.438 -179.774 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' SER . . . . . 0.406 ' O ' ' OG ' ' A' ' 89' ' ' SER . 13.4 m 39.85 79.77 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.673 0 CA-C-N 115.03 -0.986 . . . . 0.0 110.806 179.86 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 22.3 m -120.98 163.34 18.76 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 CA-C-O 121.594 0.711 . . . . 0.0 109.921 179.082 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 8.4 p -120.96 135.98 59.41 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 CA-C-O 121.731 0.777 . . . . 0.0 109.953 -179.251 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 9.4 t -91.34 115.76 31.13 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 CA-C-O 121.809 0.814 . . . . 0.0 109.867 -179.534 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . 0.504 ' O ' ' NE2' ' A' ' 82' ' ' GLN . . . -99.43 177.37 29.6 Favored Glycine 0 N--CA 1.492 2.427 0 N-CA-C 110.083 -1.207 . . . . 0.0 110.083 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -103.14 115.88 31.43 Favored 'General case' 0 N--CA 1.494 1.742 0 CA-C-O 121.767 0.794 . . . . 0.0 109.718 179.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 82.0 t80 -124.88 120.55 31.97 Favored 'General case' 0 N--CA 1.494 1.771 0 CA-C-O 121.832 0.825 . . . . 0.0 109.893 179.833 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . 0.438 ' C ' ' H ' ' A' ' 80' ' ' ARG . 11.6 t-20 55.67 41.39 30.52 Favored 'General case' 0 N--CA 1.491 1.58 0 CA-C-N 116.14 -0.482 . . . . 0.0 109.808 179.448 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 13.7 t0 69.52 -1.85 2.11 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 179.354 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . 0.438 ' H ' ' C ' ' A' ' 78' ' ' ASN . 19.6 mmm180 -104.01 -170.16 1.73 Allowed 'General case' 0 N--CA 1.495 1.783 0 CA-C-O 121.406 0.622 . . . . 0.0 109.867 -179.886 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 78.9 m-85 -122.06 140.18 52.82 Favored 'General case' 0 N--CA 1.497 1.924 0 CA-C-O 121.949 0.88 . . . . 0.0 110.427 -179.128 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . 0.59 ' NE2' ' N ' ' A' ' 82' ' ' GLN . 0.0 OUTLIER -147.92 152.3 37.32 Favored 'General case' 0 N--CA 1.493 1.704 0 CA-C-O 121.623 0.725 . . . . 0.0 109.59 179.401 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 27.1 m -87.67 132.17 33.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 CA-C-O 121.808 0.813 . . . . 0.0 110.291 -179.658 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -109.18 122.64 47.75 Favored 'General case' 0 N--CA 1.496 1.831 0 CA-C-O 121.837 0.827 . . . . 0.0 110.106 -179.439 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 61.9 t -92.4 130.59 41.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 179.451 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 95.0 m-20 -128.92 -177.24 4.13 Favored 'General case' 0 N--CA 1.495 1.797 0 CA-C-O 121.874 0.845 . . . . 0.0 110.462 -179.449 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 63.7 tttp -56.1 -45.41 79.46 Favored 'General case' 0 N--CA 1.488 1.458 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.8 -179.318 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 98.8 m-20 -63.36 -35.54 80.72 Favored 'General case' 0 N--CA 1.488 1.475 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 -179.237 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' SER . . . . . 0.406 ' OG ' ' O ' ' A' ' 71' ' ' SER . 69.1 m -71.47 152.2 43.26 Favored 'General case' 0 N--CA 1.493 1.708 0 CA-C-O 121.717 0.77 . . . . 0.0 110.08 -179.752 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 43.7 t -131.93 146.15 51.93 Favored 'General case' 0 N--CA 1.497 1.875 0 CA-C-O 121.559 0.695 . . . . 0.0 109.615 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 96.5 mt -120.39 132.51 69.8 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 CA-C-O 121.697 0.76 . . . . 0.0 109.977 179.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . 0.532 ' OE1' ' NH2' ' A' ' 70' ' ' ARG . 77.1 tt0 -123.07 119.33 29.99 Favored 'General case' 0 N--CA 1.495 1.806 0 CA-C-O 121.81 0.814 . . . . 0.0 109.488 179.669 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 37.9 ttmt -75.79 131.85 40.04 Favored 'General case' 0 N--CA 1.488 1.44 0 CA-C-O 121.42 0.629 . . . . 0.0 109.629 179.736 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 85.4 mt -109.1 140.54 42.53 Favored 'General case' 0 N--CA 1.494 1.775 0 CA-C-O 121.888 0.851 . . . . 0.0 110.04 -179.813 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 90.9 p -79.87 -4.89 54.21 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 109.341 -0.615 . . . . 0.0 109.341 -179.261 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 81.2 mt-10 -97.7 113.67 63.88 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.827 -0.546 . . . . 0.0 109.59 -179.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_endo -75.29 155.37 41.59 Favored 'Trans proline' 0 C--N 1.313 -1.301 0 C-N-CA 122.53 2.153 . . . . 0.0 112.256 -179.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 89.9 mt . . . . . 0 N--CA 1.496 1.856 0 CA-C-O 121.899 0.857 . . . . 0.0 110.273 -179.542 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo . . . . . 0 N--CA 1.496 1.654 0 CA-C-O 121.541 0.559 . . . . 0.0 112.568 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 87.3 mt-30 -77.43 91.78 3.92 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.328 -0.857 . . . . 0.0 109.106 -179.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 79.5 mt -72.91 125.77 28.35 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.456 -0.777 . . . . 0.0 109.858 -179.229 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 98.8 m -127.12 132.49 50.58 Favored 'General case' 0 N--CA 1.498 1.927 0 CA-C-O 121.456 0.646 . . . . 0.0 109.327 179.878 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -74.76 153.31 38.85 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.555 -0.716 . . . . 0.0 110.415 -179.164 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 96.1 mt -62.52 -43.79 98.71 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.534 -0.729 . . . . 0.0 109.567 -179.691 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 11.7 p -64.05 -24.12 34.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.504 -0.747 . . . . 0.0 109.875 -179.341 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.434 ' OD1' ' O ' ' A' ' 10' ' ' ASP . 60.1 t0 -76.27 -5.88 48.97 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.202 -0.936 . . . . 0.0 109.644 -179.723 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 96.5 mt -84.01 120.39 34.83 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.078 -1.014 . . . . 0.0 109.886 -179.893 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 16.1 m -135.79 -0.04 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 179.352 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 49.9 tp10 -139.9 141.81 36.53 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.394 -0.816 . . . . 0.0 109.719 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 56.4 p30 -87.49 161.2 17.94 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.654 -0.654 . . . . 0.0 110.044 -179.859 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 81.93 14.72 76.79 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 108.816 -1.714 . . . . 0.0 108.816 -179.722 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 56.3 mt-30 -78.98 132.72 36.77 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.496 -1.002 . . . . 0.0 110.285 -179.752 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 92.2 m95 -105.32 106.57 17.13 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 179.407 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -156.82 -178.16 7.15 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.171 -0.955 . . . . 0.0 109.861 -179.727 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.468 HD22 ' CD1' ' A' ' 68' ' ' LEU . 0.6 OUTLIER -103.94 141.42 36.2 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.607 -0.683 . . . . 0.0 109.673 -179.743 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 92.2 mt -134.45 150.63 50.85 Favored 'General case' 0 N--CA 1.496 1.838 0 CA-C-O 121.652 0.739 . . . . 0.0 110.017 -179.816 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 35.7 ttpt -135.21 138.74 43.9 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 179.817 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -166.57 -171.44 1.88 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.157 -0.965 . . . . 0.0 110.396 -179.642 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 21.1 ptmt -121.85 144.73 48.66 Favored 'General case' 0 N--CA 1.496 1.858 0 CA-C-O 121.495 0.664 . . . . 0.0 109.584 -179.682 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 79.9 t -82.76 129.03 38.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.321 -0.862 . . . . 0.0 110.403 -179.284 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 96.7 mt -102.07 -51.52 9.14 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 179.501 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 52.5 tt0 -145.86 144.79 30.44 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.35 -0.844 . . . . 0.0 109.033 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -132.21 132.53 43.2 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.836 -0.54 . . . . 0.0 109.644 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 94.4 m95 -112.16 135.64 52.56 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.676 -0.64 . . . . 0.0 109.324 179.842 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 80.5 tt0 . . . . . 0 N--CA 1.494 1.725 0 O-C-N 121.439 -0.788 . . . . 0.0 110.146 -179.399 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' SER . . . . . 0.42 ' HG ' ' N ' ' A' ' 35' ' ' ILE . 96.5 p . . . . . 0 N--CA 1.49 1.574 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.42 ' N ' ' HG ' ' A' ' 34' ' ' SER . 96.8 mt -121.16 134.02 65.88 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.95 0 O-C-N 121.563 -0.71 . . . . 0.0 109.894 -179.907 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 33.2 t -85.08 -71.76 0.51 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.653 -0.654 . . . . 0.0 109.802 -179.807 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 46.6 mt-30 -134.01 156.64 47.82 Favored 'General case' 0 N--CA 1.498 1.931 0 CA-C-O 121.794 0.807 . . . . 0.0 110.451 -179.035 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.8 p -139.65 139.85 37.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 179.727 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -167.38 -147.75 5.39 Favored Glycine 0 N--CA 1.49 2.256 0 C-N-CA 119.395 -1.383 . . . . 0.0 110.187 -179.827 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -133.7 152.19 51.82 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.662 -0.904 . . . . 0.0 109.951 -179.545 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 73.6 mt -115.5 131.39 56.95 Favored 'General case' 0 N--CA 1.494 1.745 0 CA-C-O 121.534 0.683 . . . . 0.0 109.291 179.712 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -80.79 160.91 43.62 Favored Glycine 0 N--CA 1.486 2.03 0 N-CA-C 110.613 -0.995 . . . . 0.0 110.613 -179.346 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.418 ' OD2' ' OG1' ' A' ' 45' ' ' THR . 29.7 t70 -174.29 146.01 1.06 Allowed 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 179.508 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -57.36 -15.15 5.7 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.346 -0.846 . . . . 0.0 109.906 -179.603 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.418 ' OG1' ' OD2' ' A' ' 43' ' ' ASP . 42.1 p -94.69 -7.87 39.45 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.224 -0.923 . . . . 0.0 109.854 -179.709 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 138.77 -157.06 24.56 Favored Glycine 0 N--CA 1.5 2.936 0 N-CA-C 110.527 -1.029 . . . . 0.0 110.527 179.217 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 40.9 pt -124.87 153.83 32.23 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.005 0 O-C-N 121.856 -0.791 . . . . 0.0 109.517 -179.874 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 20.0 tt -147.31 149.5 15.53 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.253 -0.905 . . . . 0.0 109.937 179.667 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 18.9 mmmt -83.28 148.68 27.24 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.748 -0.595 . . . . 0.0 110.175 -179.605 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 16.1 p90 -143.88 153.63 42.53 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.441 -0.787 . . . . 0.0 109.435 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 87.9 m -134.14 135.57 43.24 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 179.711 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.405 HD13 HG21 ' A' ' 52' ' ' ILE . 91.9 mt -101.63 126.03 55.61 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.398 -0.814 . . . . 0.0 109.601 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 93.5 m95 -96.14 139.73 31.89 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.524 -0.735 . . . . 0.0 109.529 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 50.9 mtpt . . . . . 0 C--N 1.302 -1.488 0 O-C-N 121.529 -0.732 . . . . 0.0 109.124 -179.96 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 36.6 mt . . . . . 0 N--CA 1.496 1.844 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -69.98 162.03 43.73 Favored 'Trans proline' 0 N--CA 1.498 1.745 0 C-N-CA 122.911 2.408 . . . . 0.0 113.195 179.708 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 65.6 mt -69.0 143.55 54.34 Favored 'General case' 0 N--CA 1.493 1.69 0 CA-C-O 121.742 0.782 . . . . 0.0 110.388 -179.215 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.49 ' CD1' ' N ' ' A' ' 61' ' ' LEU . 9.7 mp -92.81 141.68 28.17 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.672 -0.643 . . . . 0.0 110.048 -179.186 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.685 ' H ' ' HH ' ' A' ' 67' ' ' TYR . 97.4 mt-10 -85.1 152.03 23.7 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.424 -0.797 . . . . 0.0 110.342 -179.644 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 55.4 tt0 -81.98 138.46 34.92 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.616 -0.678 . . . . 0.0 110.822 -179.336 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 79.88 23.6 61.55 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 110.105 -1.198 . . . . 0.0 110.105 178.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -126.94 146.59 50.26 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.441 -1.034 . . . . 0.0 110.307 -179.796 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 12.8 p -83.01 146.44 28.75 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 179.745 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . 0.685 ' HH ' ' H ' ' A' ' 62' ' ' GLU . 65.4 m-85 -140.36 145.07 36.65 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.438 -0.789 . . . . 0.0 110.007 179.775 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.468 ' CD1' HD22 ' A' ' 19' ' ' ASN . 17.8 tp -105.59 123.1 47.36 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 179.106 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.408 ' O ' ' OD1' ' A' ' 19' ' ' ASN . 67.5 mt -103.81 125.25 50.12 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 179.899 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 82.5 mtp180 -114.53 134.81 54.74 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.69 -0.631 . . . . 0.0 110.054 -179.755 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' SER . . . . . 0.403 ' O ' ' OG ' ' A' ' 89' ' ' SER . 31.2 t 60.46 73.72 0.47 Allowed 'General case' 0 N--CA 1.493 1.687 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.791 179.65 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 3.7 m -124.6 159.32 30.93 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.129 0 O-C-N 121.605 -0.684 . . . . 0.0 109.294 178.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 13.6 p -121.74 135.09 62.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 -179.807 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 13.4 t -84.74 118.89 32.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.483 -0.761 . . . . 0.0 110.306 -178.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -97.22 171.34 26.77 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 179.723 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -111.37 121.3 44.86 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.724 -0.868 . . . . 0.0 109.789 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . 0.509 ' CZ ' ' OD1' ' A' ' 78' ' ' ASN . 54.8 t80 -134.16 124.96 26.93 Favored 'General case' 0 N--CA 1.495 1.819 0 CA-C-O 121.393 0.616 . . . . 0.0 109.499 179.578 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . 0.54 ' C ' ' H ' ' A' ' 80' ' ' ARG . 6.4 m120 51.56 51.49 16.61 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.648 -0.657 . . . . 0.0 110.574 179.789 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 55.6 2.6 0.07 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.736 -0.602 . . . . 0.0 110.184 179.351 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . 0.54 ' H ' ' C ' ' A' ' 78' ' ' ASN . 18.7 mmm180 -103.88 163.0 12.65 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.378 -0.826 . . . . 0.0 109.704 -179.912 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 69.7 m-85 -95.71 143.51 26.9 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.449 -0.782 . . . . 0.0 109.748 -179.283 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -146.3 159.97 42.64 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.517 -0.739 . . . . 0.0 109.436 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 33.2 m -111.44 128.31 68.03 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 179.431 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 76.8 mt-30 -109.42 124.67 51.4 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.563 -0.711 . . . . 0.0 109.474 -179.345 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 10.7 t -97.18 106.78 18.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.385 -0.822 . . . . 0.0 109.611 -179.773 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -152.04 -177.43 6.16 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.466 -0.771 . . . . 0.0 109.985 179.934 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 72.5 tttt 66.76 -133.19 0.15 Allowed 'General case' 0 N--CA 1.492 1.667 0 CA-C-O 121.444 0.64 . . . . 0.0 110.932 179.306 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 12.7 m120 -88.52 20.65 3.27 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.432 -0.792 . . . . 0.0 109.246 -179.093 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' SER . . . . . 0.403 ' OG ' ' O ' ' A' ' 71' ' ' SER . 15.5 m -60.13 147.65 38.82 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.459 -0.776 . . . . 0.0 109.511 -179.73 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 25.5 m -128.78 152.35 48.55 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.618 -0.676 . . . . 0.0 109.747 -179.81 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 93.9 mt -129.1 133.5 65.77 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 179.785 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -126.42 134.28 51.04 Favored 'General case' 0 N--CA 1.497 1.912 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 179.548 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 63.7 tttp -79.79 129.26 34.33 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.41 -0.806 . . . . 0.0 109.837 -179.338 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.428 ' CD2' ' N ' ' A' ' 94' ' ' LEU . 4.1 mm? -100.54 133.18 45.37 Favored 'General case' 0 N--CA 1.493 1.702 0 CA-C-O 121.756 0.789 . . . . 0.0 109.802 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 23.1 t -85.29 10.43 12.56 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 -179.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 22.1 tt0 -118.47 90.24 38.58 Favored Pre-proline 0 N--CA 1.497 1.916 0 O-C-N 121.602 -0.686 . . . . 0.0 109.29 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_exo -56.14 146.84 68.51 Favored 'Trans proline' 0 N--CA 1.498 1.739 0 C-N-CA 122.785 2.323 . . . . 0.0 112.19 179.496 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 93.0 mt . . . . . 0 N--CA 1.495 1.801 0 O-C-N 121.474 -0.766 . . . . 0.0 109.997 -179.41 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo . . . . . 0 N--CA 1.49 1.304 0 CA-C-O 121.829 0.679 . . . . 0.0 112.714 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 7.8 pt20 -73.29 89.41 1.57 Allowed 'General case' 0 C--N 1.302 -1.487 0 CA-C-O 121.534 0.683 . . . . 0.0 110.223 -179.326 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 79.6 mt -79.33 139.78 37.71 Favored 'General case' 0 N--CA 1.488 1.474 0 CA-C-O 121.543 0.687 . . . . 0.0 109.734 179.7 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 69.5 m -127.16 130.91 50.66 Favored 'General case' 0 N--CA 1.496 1.854 0 CA-C-O 121.609 0.719 . . . . 0.0 109.666 179.667 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 63.7 mttp -84.23 156.95 21.77 Favored 'General case' 0 N--CA 1.49 1.568 0 CA-C-O 121.785 0.802 . . . . 0.0 109.688 179.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 95.6 mt -63.0 -42.58 97.23 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.557 0 CA-C-O 121.28 0.562 . . . . 0.0 109.518 -179.215 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 14.7 p -65.54 -24.04 33.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.605 -0.684 . . . . 0.0 109.559 -179.178 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 -77.03 -7.11 55.09 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.441 -0.787 . . . . 0.0 108.89 -179.455 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 98.6 mt -93.18 116.04 33.39 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 CA-C-O 121.662 0.744 . . . . 0.0 109.719 179.708 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 25.6 m -151.23 14.54 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 179.34 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -137.44 137.17 38.48 Favored 'General case' 0 N--CA 1.494 1.771 0 CA-C-O 121.762 0.792 . . . . 0.0 109.376 179.417 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 7.6 t-20 -74.32 147.59 42.13 Favored 'General case' 0 C--N 1.301 -1.529 0 CA-C-O 121.696 0.76 . . . . 0.0 109.99 -179.622 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 71.58 99.51 0.06 OUTLIER Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 179.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 27.5 tt0 -165.17 126.98 2.08 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.732 -0.863 . . . . 0.0 110.098 179.443 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 95.2 m95 -96.6 128.71 43.79 Favored 'General case' 0 N--CA 1.494 1.753 0 CA-C-O 121.477 0.656 . . . . 0.0 109.465 179.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -174.88 177.08 2.07 Favored 'General case' 0 N--CA 1.493 1.717 0 CA-C-O 121.878 0.846 . . . . 0.0 110.419 179.818 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.469 ' ND2' ' H ' ' A' ' 71' ' ' SER . 5.7 m120 -99.24 148.91 23.64 Favored 'General case' 0 N--CA 1.495 1.776 0 CA-C-O 121.728 0.775 . . . . 0.0 109.445 -179.712 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 54.5 tp -139.57 135.94 33.9 Favored 'General case' 0 N--CA 1.487 1.418 0 CA-C-O 121.962 0.887 . . . . 0.0 110.244 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 37.3 ttmt -122.36 132.65 54.49 Favored 'General case' 0 N--CA 1.49 1.566 0 CA-C-O 121.773 0.797 . . . . 0.0 109.121 179.148 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -160.95 178.04 9.78 Favored 'General case' 0 C--N 1.3 -1.555 0 CA-C-O 121.658 0.742 . . . . 0.0 109.808 -179.866 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 63.7 tttp -114.55 145.55 41.81 Favored 'General case' 0 N--CA 1.496 1.839 0 CA-C-O 121.775 0.797 . . . . 0.0 110.332 -178.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 89.5 t -83.54 108.14 15.77 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 CA-C-O 121.684 0.754 . . . . 0.0 110.34 -179.501 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 34.3 mm -94.24 -47.37 13.43 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 179.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 7.4 tt0 -148.41 140.55 24.06 Favored 'General case' 0 N--CA 1.494 1.774 0 CA-C-O 122.135 0.969 . . . . 0.0 109.968 -179.758 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -136.57 145.51 45.06 Favored 'General case' 0 N--CA 1.491 1.577 0 CA-C-O 121.956 0.884 . . . . 0.0 110.164 -179.335 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 5.7 m-90 -114.13 141.77 47.08 Favored 'General case' 0 N--CA 1.492 1.653 0 CA-C-O 121.648 0.737 . . . . 0.0 109.261 179.041 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 . . . . . 0 C--N 1.303 -1.42 0 CA-C-O 121.602 0.715 . . . . 0.0 109.795 -179.436 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 12.8 m . . . . . 0 N--CA 1.494 1.741 0 N-CA-C 109.009 -0.738 . . . . 0.0 109.009 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 96.7 mt -93.17 119.07 40.29 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 CA-C-O 121.839 0.828 . . . . 0.0 109.507 179.794 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 3.6 t -71.3 -56.01 6.88 Favored 'General case' 0 C--N 1.3 -1.546 0 CA-C-O 121.428 0.633 . . . . 0.0 109.525 179.761 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 83.7 mt-30 -147.63 147.6 30.19 Favored 'General case' 0 N--CA 1.49 1.539 0 CA-C-O 121.925 0.869 . . . . 0.0 110.456 -179.286 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.9 p -142.77 142.47 26.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 CA-C-O 121.613 0.72 . . . . 0.0 109.349 179.589 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -171.99 -155.26 10.82 Favored Glycine 0 N--CA 1.491 2.308 0 C-N-CA 119.952 -1.118 . . . . 0.0 110.562 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -132.9 147.52 52.29 Favored 'General case' 0 N--CA 1.494 1.745 0 CA-C-O 121.895 0.855 . . . . 0.0 110.269 -179.463 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 41.1 mt -116.88 130.72 56.89 Favored 'General case' 0 N--CA 1.496 1.83 0 CA-C-O 121.743 0.782 . . . . 0.0 109.407 -179.258 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -83.15 161.38 39.45 Favored Glycine 0 N--CA 1.495 2.609 0 N-CA-C 111.227 -0.749 . . . . 0.0 111.227 -179.146 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.557 ' OD1' ' N ' ' A' ' 44' ' ' GLU . 62.1 t0 -174.13 150.29 1.54 Allowed 'General case' 0 N--CA 1.493 1.722 0 CA-C-O 122.095 0.95 . . . . 0.0 110.031 179.643 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.557 ' N ' ' OD1' ' A' ' 43' ' ' ASP . 98.0 mt-10 -59.44 -17.67 32.93 Favored 'General case' 0 N--CA 1.491 1.601 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.139 179.979 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 41.6 p -92.25 -11.17 36.02 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 -179.688 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 139.95 -159.87 26.1 Favored Glycine 0 N--CA 1.498 2.77 0 C-N-CA 120.246 -0.978 . . . . 0.0 111.123 178.934 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 96.4 mt -125.21 132.86 70.64 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 CA-C-O 121.773 0.797 . . . . 0.0 109.993 -179.23 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 18.0 tt -131.17 148.43 32.91 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 CA-C-O 121.934 0.873 . . . . 0.0 110.421 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 54.7 mtpt -92.91 151.04 20.18 Favored 'General case' 0 N--CA 1.494 1.741 0 CA-C-O 121.713 0.768 . . . . 0.0 110.16 -179.841 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 5.8 p90 -142.84 152.99 42.75 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-O 122.003 0.906 . . . . 0.0 109.975 179.871 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 84.9 m -130.2 130.98 45.36 Favored 'General case' 0 N--CA 1.493 1.692 0 CA-C-O 121.864 0.84 . . . . 0.0 109.203 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 95.7 mt -100.26 121.93 51.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 CA-C-O 121.791 0.805 . . . . 0.0 110.049 -179.496 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 96.1 m95 -98.0 133.57 42.29 Favored 'General case' 0 N--CA 1.495 1.799 0 CA-C-O 121.551 0.691 . . . . 0.0 109.349 179.782 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 16.4 ptpt . . . . . 0 N--CA 1.496 1.841 0 O-C-N 121.759 -0.588 . . . . 0.0 109.83 179.949 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 11.4 mt . . . . . 0 N--CA 1.491 1.593 0 N-CA-C 108.633 -0.876 . . . . 0.0 108.633 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -68.86 153.46 72.76 Favored 'Trans proline' 0 C--N 1.312 -1.358 0 C-N-CA 122.403 2.069 . . . . 0.0 112.646 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 71.4 mt -72.75 142.95 48.14 Favored 'General case' 0 C--N 1.301 -1.525 0 CA-C-O 121.678 0.752 . . . . 0.0 109.968 -179.754 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 10.5 mp -87.84 135.49 33.37 Favored 'General case' 0 N--CA 1.49 1.554 0 CA-C-O 121.715 0.769 . . . . 0.0 109.707 -179.805 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.58 ' H ' ' HH ' ' A' ' 67' ' ' TYR . 46.1 tp10 -93.78 144.85 25.05 Favored 'General case' 0 N--CA 1.49 1.558 0 CA-C-O 121.89 0.852 . . . . 0.0 109.685 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 57.5 tt0 -79.15 143.74 35.16 Favored 'General case' 0 C--N 1.299 -1.597 0 CA-C-O 121.677 0.751 . . . . 0.0 110.318 -179.614 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 82.08 23.8 56.4 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 110.036 -1.226 . . . . 0.0 110.036 179.054 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.528 ' OE1' ' NZ ' ' A' ' 93' ' ' LYS . 95.8 mt-10 -136.55 144.91 44.48 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.384 -1.068 . . . . 0.0 110.109 179.672 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 12.2 p -89.23 145.69 25.24 Favored 'General case' 0 N--CA 1.489 1.496 0 CA-C-O 121.702 0.763 . . . . 0.0 110.223 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . 0.58 ' HH ' ' H ' ' A' ' 62' ' ' GLU . 98.2 m-85 -137.71 152.61 49.42 Favored 'General case' 0 N--CA 1.494 1.734 0 CA-C-O 122.122 0.963 . . . . 0.0 110.323 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 32.3 tp -111.1 121.55 45.62 Favored 'General case' 0 N--CA 1.494 1.733 0 CA-C-N 115.488 -0.778 . . . . 0.0 109.64 179.864 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 74.0 mt -102.15 133.1 47.55 Favored 'General case' 0 N--CA 1.494 1.728 0 CA-C-O 121.726 0.774 . . . . 0.0 109.373 179.538 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 86.8 mtm180 -129.61 147.35 51.4 Favored 'General case' 0 N--CA 1.495 1.819 0 CA-C-O 121.924 0.869 . . . . 0.0 110.51 -179.287 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' SER . . . . . 0.469 ' H ' ' ND2' ' A' ' 19' ' ' ASN . 1.7 m 56.46 55.34 6.61 Favored 'General case' 0 N--CA 1.494 1.729 0 CA-C-N 115.606 -0.725 . . . . 0.0 110.415 179.354 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 12.5 m -111.12 158.19 11.71 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 CA-C-O 121.626 0.727 . . . . 0.0 109.972 179.369 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 13.5 p -116.7 134.88 58.82 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 CA-C-O 121.828 0.823 . . . . 0.0 109.677 -179.631 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 11.7 t -86.27 115.48 27.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 CA-C-O 121.862 0.839 . . . . 0.0 109.88 -179.433 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -100.96 175.25 26.1 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 110.074 -1.21 . . . . 0.0 110.074 -179.776 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 48.0 tp10 -111.51 121.39 45.05 Favored 'General case' 0 N--CA 1.493 1.699 0 CA-C-O 121.829 0.824 . . . . 0.0 109.673 -179.906 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 87.3 t80 -136.58 125.37 24.01 Favored 'General case' 0 N--CA 1.492 1.655 0 CA-C-O 121.865 0.84 . . . . 0.0 110.14 179.834 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . 0.52 ' C ' ' H ' ' A' ' 80' ' ' ARG . 10.7 t-20 56.27 43.33 26.65 Favored 'General case' 0 N--CA 1.488 1.46 0 CA-C-N 116.081 -0.509 . . . . 0.0 109.781 179.193 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 48.2 t0 62.64 -1.36 0.45 Allowed 'General case' 0 N--CA 1.493 1.725 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 179.641 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . 0.52 ' H ' ' C ' ' A' ' 78' ' ' ASN . 83.2 mtp180 -100.09 178.23 4.85 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.606 -0.684 . . . . 0.0 109.986 179.868 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 78.3 m-85 -112.94 138.15 50.24 Favored 'General case' 0 N--CA 1.498 1.953 0 CA-C-O 122.086 0.946 . . . . 0.0 110.062 -179.303 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -147.09 163.0 37.68 Favored 'General case' 0 N--CA 1.489 1.52 0 CA-C-O 121.829 0.823 . . . . 0.0 110.292 179.936 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 2.5 m -106.24 131.65 55.38 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 -179.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 86.7 mt-30 -104.91 122.6 46.15 Favored 'General case' 0 N--CA 1.495 1.807 0 CA-C-O 122.107 0.956 . . . . 0.0 110.364 -179.172 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 18.2 t -93.93 129.73 43.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 CA-C-O 121.947 0.879 . . . . 0.0 109.765 -179.875 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 81.7 m-20 -134.82 -174.74 3.68 Favored 'General case' 0 N--CA 1.493 1.702 0 CA-C-O 121.452 0.644 . . . . 0.0 109.309 179.79 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 24.8 pttm -58.88 -34.75 72.0 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.858 -0.526 . . . . 0.0 109.924 -179.296 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 38.7 t30 -64.11 -38.07 89.74 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 10.0 m -72.76 156.33 39.04 Favored 'General case' 0 N--CA 1.492 1.675 0 CA-C-O 121.709 0.766 . . . . 0.0 110.73 -179.153 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 88.2 p -129.52 151.36 50.22 Favored 'General case' 0 N--CA 1.493 1.717 0 CA-C-O 121.692 0.758 . . . . 0.0 109.759 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 94.8 mt -124.65 132.79 70.85 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 CA-C-O 121.572 0.701 . . . . 0.0 109.572 -179.508 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 81.6 tt0 -130.13 134.37 47.29 Favored 'General case' 0 N--CA 1.497 1.881 0 CA-C-O 121.996 0.903 . . . . 0.0 109.838 179.621 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.528 ' NZ ' ' OE1' ' A' ' 65' ' ' GLU . 64.1 tttp -79.95 134.45 36.26 Favored 'General case' 0 N--CA 1.489 1.478 0 CA-C-O 121.748 0.785 . . . . 0.0 110.117 179.933 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 73.6 mt -100.88 133.76 44.87 Favored 'General case' 0 N--CA 1.492 1.67 0 CA-C-O 121.689 0.757 . . . . 0.0 109.726 179.626 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 88.8 p -78.74 -5.52 53.43 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 -179.604 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 21.5 tp10 -111.82 121.03 40.81 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.794 -0.567 . . . . 0.0 109.894 -179.751 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -74.29 154.25 46.03 Favored 'Trans proline' 0 N--CA 1.488 1.202 0 C-N-CA 122.511 2.141 . . . . 0.0 112.065 179.63 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 96.7 mt . . . . . 0 N--CA 1.499 1.988 0 CA-C-O 121.915 0.864 . . . . 0.0 110.364 -179.603 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo . . . . . 0 N--CA 1.497 1.703 0 CA-C-O 121.6 0.583 . . . . 0.0 112.312 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . 0.401 ' N ' ' CD ' ' A' ' 4' ' ' GLN . 28.2 mp0 -84.49 89.41 7.42 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.057 -1.027 . . . . 0.0 109.664 -179.581 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -73.73 142.02 46.33 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.456 -0.777 . . . . 0.0 109.351 179.616 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 98.4 m -122.77 129.2 51.46 Favored 'General case' 0 N--CA 1.498 1.962 0 CA-C-O 121.666 0.746 . . . . 0.0 109.812 -179.7 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -85.42 159.36 19.99 Favored 'General case' 0 N--CA 1.491 1.618 0 CA-C-O 121.609 0.719 . . . . 0.0 110.051 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 33.0 mm -63.85 -43.38 97.82 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 O-C-N 121.275 -0.89 . . . . 0.0 109.198 179.893 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 12.6 p -65.02 -22.53 31.6 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 O-C-N 121.47 -0.769 . . . . 0.0 109.529 -179.692 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -74.79 -7.03 52.15 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.092 -1.005 . . . . 0.0 109.257 179.45 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 96.7 mt -83.11 120.83 35.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.232 -0.917 . . . . 0.0 109.4 179.886 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 15.8 m -134.93 -28.04 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 O-C-N 121.346 -0.846 . . . . 0.0 109.721 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -135.05 152.39 51.65 Favored 'General case' 0 N--CA 1.501 2.113 0 O-C-N 121.188 -0.945 . . . . 0.0 110.372 -179.424 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 57.4 p30 -79.12 166.0 22.73 Favored 'General case' 0 N--CA 1.491 1.618 0 CA-C-O 121.6 0.714 . . . . 0.0 110.652 -179.201 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 71.02 92.91 0.08 OUTLIER Glycine 0 N--CA 1.491 2.303 0 N-CA-C 110.294 -1.122 . . . . 0.0 110.294 179.476 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 20.5 tt0 -168.89 130.9 1.25 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.408 -1.054 . . . . 0.0 109.183 179.279 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 91.9 m95 -95.65 133.56 39.58 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.404 -0.81 . . . . 0.0 109.774 -179.686 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -175.09 176.58 2.08 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.193 -0.942 . . . . 0.0 109.741 179.509 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 94.6 m-20 -103.91 145.01 30.75 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.438 -0.789 . . . . 0.0 109.072 179.888 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 5.6 tt -142.04 133.61 26.77 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.278 -0.889 . . . . 0.0 109.924 -179.818 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 3.5 ttmp? -117.01 141.85 47.72 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 179.558 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . 0.464 ' CB ' ' OD1' ' A' ' 43' ' ' ASP . . . -164.2 -177.18 4.83 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.887 -1.133 . . . . 0.0 110.352 -179.648 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -112.05 137.63 49.82 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.633 -0.667 . . . . 0.0 109.487 -179.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 71.2 t -83.54 96.64 4.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.295 -0.878 . . . . 0.0 110.197 -179.572 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.49 ' O ' ' NE2' ' A' ' 63' ' ' GLN . 96.7 mt -65.53 -45.32 92.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.418 -0.801 . . . . 0.0 109.433 179.744 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.525 ' NE2' ' CZ2' ' A' ' 28' ' ' TRP . 14.6 pt20 -170.61 148.4 3.03 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.397 -0.814 . . . . 0.0 109.737 -179.875 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -143.65 137.15 28.05 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.566 -0.709 . . . . 0.0 109.274 179.589 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . 0.525 ' CZ2' ' NE2' ' A' ' 26' ' ' GLN . 5.6 m0 -117.69 146.06 43.99 Favored 'General case' 0 N--CA 1.498 1.936 0 CA-C-O 121.717 0.77 . . . . 0.0 109.672 -179.709 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.6 ' H ' ' CD ' ' A' ' 29' ' ' GLU . 1.5 pm0 . . . . . 0 N--CA 1.491 1.579 0 CA-C-O 121.617 0.722 . . . . 0.0 110.568 -179.25 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 11.0 t . . . . . 0 N--CA 1.491 1.601 0 CA-C-O 121.012 0.434 . . . . 0.0 110.232 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.416 HG23 HD11 ' A' ' 35' ' ' ILE . 90.6 mt -98.6 133.69 40.09 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 O-C-N 121.299 -0.876 . . . . 0.0 110.173 -178.906 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 25.0 m -81.47 -70.8 0.51 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.578 -0.701 . . . . 0.0 110.112 -179.664 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 34.4 mt-30 -132.55 155.5 48.52 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.393 -0.817 . . . . 0.0 109.62 -179.02 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 9.4 p -137.1 141.03 41.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 -179.805 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -165.79 -158.5 10.85 Favored Glycine 0 N--CA 1.491 2.328 0 C-N-CA 119.422 -1.371 . . . . 0.0 110.177 -179.085 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -135.65 151.94 50.72 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.573 -0.957 . . . . 0.0 109.761 179.826 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 52.5 mt -114.88 139.76 49.52 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.453 -0.779 . . . . 0.0 109.235 -179.0 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -94.37 127.65 9.17 Favored Glycine 0 N--CA 1.493 2.498 0 N-CA-C 110.359 -1.097 . . . . 0.0 110.359 -179.63 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.464 ' OD1' ' CB ' ' A' ' 22' ' ' ALA . 73.0 m-20 -128.6 142.32 51.08 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.795 -0.827 . . . . 0.0 108.872 179.005 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -56.76 -14.99 3.83 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.411 -0.805 . . . . 0.0 109.52 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 16.5 p -99.3 -8.47 24.89 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.316 -0.865 . . . . 0.0 109.775 -179.763 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 153.95 -167.14 32.16 Favored Glycine 0 N--CA 1.498 2.821 0 C-N-CA 119.733 -1.222 . . . . 0.0 110.257 179.292 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 96.6 mt -125.61 134.7 66.05 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.081 0 O-C-N 121.586 -0.949 . . . . 0.0 108.656 179.895 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 20.6 tt -131.42 144.71 36.78 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.231 0 O-C-N 121.168 -0.958 . . . . 0.0 110.463 -179.566 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.541 ' NZ ' ' CE1' ' A' ' 77' ' ' TYR . 52.8 mtmt -84.34 157.19 21.56 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.727 -0.608 . . . . 0.0 110.42 -179.633 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 16.2 p90 -152.1 164.26 37.63 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.317 -0.864 . . . . 0.0 109.666 179.627 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 2.7 t -139.1 148.85 43.83 Favored 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 179.578 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 39.2 mm -106.41 126.36 62.12 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 O-C-N 121.472 -0.768 . . . . 0.0 109.562 -179.459 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 77.8 m95 -98.36 147.38 24.74 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.486 -0.759 . . . . 0.0 109.799 -179.72 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 64.7 mttp . . . . . 0 N--CA 1.49 1.54 0 O-C-N 121.449 -0.782 . . . . 0.0 109.255 179.755 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 14.2 mt . . . . . 0 N--CA 1.499 1.975 0 N-CA-C 109.749 -0.464 . . . . 0.0 109.749 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -70.13 165.28 31.91 Favored 'Trans proline' 0 N--CA 1.502 1.99 0 C-N-CA 123.095 2.53 . . . . 0.0 113.918 -179.102 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 66.6 mt -65.56 141.08 58.57 Favored 'General case' 0 N--CA 1.494 1.761 0 CA-C-O 121.905 0.86 . . . . 0.0 110.88 -178.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.506 ' CD1' ' N ' ' A' ' 61' ' ' LEU . 9.1 mp -87.39 145.9 26.11 Favored 'General case' 0 N--CA 1.492 1.654 0 CA-C-O 121.344 0.593 . . . . 0.0 110.037 -179.523 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.655 ' H ' ' HH ' ' A' ' 67' ' ' TYR . 83.7 tt0 -98.63 126.69 44.3 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.399 -0.813 . . . . 0.0 109.126 179.461 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . 0.49 ' NE2' ' O ' ' A' ' 25' ' ' ILE . 10.8 tm0? -69.19 140.34 54.61 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.508 -0.745 . . . . 0.0 111.231 -178.822 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . 0.447 ' N ' ' CD ' ' A' ' 63' ' ' GLN . . . 91.78 20.06 38.33 Favored Glycine 0 N--CA 1.495 2.581 0 N-CA-C 110.541 -1.024 . . . . 0.0 110.541 178.812 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.488 ' N ' ' OE1' ' A' ' 65' ' ' GLU . 58.8 mp0 -139.0 155.58 47.88 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.158 -1.201 . . . . 0.0 110.47 179.911 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 13.5 p -80.72 156.44 26.26 Favored 'General case' 0 N--CA 1.49 1.527 0 CA-C-O 121.552 0.691 . . . . 0.0 110.534 -179.418 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . 0.655 ' HH ' ' H ' ' A' ' 62' ' ' GLU . 88.4 m-85 -145.78 144.27 30.2 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.48 -0.763 . . . . 0.0 109.645 179.674 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 13.7 tp -111.86 117.93 34.13 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 179.219 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 4.6 mp -103.45 126.66 50.73 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.467 -0.771 . . . . 0.0 109.054 -179.553 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.41 ' O ' ' OG ' ' A' ' 71' ' ' SER . 90.3 mtm-85 -115.57 140.85 48.79 Favored 'General case' 0 N--CA 1.497 1.909 0 CA-C-O 121.645 0.736 . . . . 0.0 110.421 -178.982 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' SER . . . . . 0.41 ' OG ' ' O ' ' A' ' 70' ' ' ARG . 22.2 p 59.77 66.69 0.96 Allowed 'General case' 0 N--CA 1.494 1.744 0 CA-C-O 121.121 0.486 . . . . 0.0 110.703 179.67 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 16.5 m -116.26 160.79 15.45 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.134 0 O-C-N 121.537 -0.727 . . . . 0.0 109.252 178.841 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 7.4 p -117.72 133.16 65.37 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 CA-C-O 121.382 0.611 . . . . 0.0 109.423 -179.563 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 13.5 t -88.06 110.29 20.77 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.278 -0.889 . . . . 0.0 109.669 -179.427 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -88.29 172.15 41.14 Favored Glycine 0 N--CA 1.493 2.49 0 N-CA-C 109.887 -1.285 . . . . 0.0 109.887 -179.602 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -100.45 119.68 38.84 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.566 -0.961 . . . . 0.0 109.15 179.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . 0.541 ' CE1' ' NZ ' ' A' ' 49' ' ' LYS . 40.7 t80 -115.17 104.36 11.77 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.539 -0.726 . . . . 0.0 109.774 -179.68 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 41.45 -117.15 0.34 Allowed 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.582 -0.698 . . . . 0.0 111.204 179.471 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.418 ' N ' ' OD1' ' A' ' 79' ' ' ASP . 37.5 p-10 -94.53 -7.67 40.52 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.329 -0.857 . . . . 0.0 110.234 -178.794 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 95.4 mtt180 -112.18 177.46 4.63 Favored 'General case' 0 N--CA 1.501 2.091 0 O-C-N 121.417 -0.802 . . . . 0.0 110.015 -179.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 72.9 m-85 -109.54 148.64 30.9 Favored 'General case' 0 N--CA 1.497 1.905 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 -179.693 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 53.3 tt0 -137.88 154.01 49.5 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.306 -0.871 . . . . 0.0 109.751 -179.81 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 33.5 m -113.32 132.86 60.99 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 179.729 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 79.0 mt-30 -106.76 127.48 53.43 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.572 -0.705 . . . . 0.0 109.992 -178.883 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 16.8 t -94.8 98.14 7.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.474 -0.766 . . . . 0.0 109.093 179.753 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . 0.508 ' C ' HD21 ' A' ' 86' ' ' ASN . 0.1 OUTLIER -151.18 177.7 9.95 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.412 -0.805 . . . . 0.0 109.767 -179.759 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.539 ' C ' ' H ' ' A' ' 89' ' ' SER . 71.2 mmtt 61.19 -141.27 0.5 Allowed 'General case' 0 N--CA 1.493 1.712 0 CA-C-O 121.639 0.733 . . . . 0.0 110.772 179.169 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 32.3 t30 -66.46 9.52 0.16 Allowed 'General case' 0 C--N 1.304 -1.405 0 CA-C-O 121.334 0.588 . . . . 0.0 109.658 -179.446 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' SER . . . . . 0.539 ' H ' ' C ' ' A' ' 87' ' ' LYS . 13.3 p -58.18 143.61 43.54 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.249 -0.907 . . . . 0.0 109.671 -179.882 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 19.2 p -141.26 156.4 45.89 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.482 -0.761 . . . . 0.0 109.655 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 96.5 mt -132.58 134.53 58.68 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 121.556 -0.715 . . . . 0.0 109.445 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -126.48 136.83 53.12 Favored 'General case' 0 N--CA 1.499 2.013 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 179.516 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -80.13 128.91 34.07 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.397 -0.815 . . . . 0.0 109.678 -179.795 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 10.1 mp -105.23 134.59 48.08 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.451 -0.781 . . . . 0.0 109.636 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 96.6 p -88.6 8.51 28.0 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 108.774 -0.825 . . . . 0.0 108.774 179.521 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 67.0 mt-10 -117.55 90.38 35.1 Favored Pre-proline 0 N--CA 1.498 1.951 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 -179.775 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_exo -55.7 147.52 59.89 Favored 'Trans proline' 0 N--CA 1.497 1.705 0 C-N-CA 122.741 2.294 . . . . 0.0 112.658 179.618 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.425 ' O ' ' CG2' ' A' ' 98' ' ' ILE . 97.1 mt . . . . . 0 N--CA 1.491 1.587 0 CA-C-O 121.709 0.766 . . . . 0.0 109.67 -179.675 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo . . . . . 0 N--CA 1.493 1.5 0 CA-C-O 121.536 0.557 . . . . 0.0 111.765 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -87.89 87.95 7.51 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.806 -1.184 . . . . 0.0 109.201 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.451 ' N ' ' CD2' ' A' ' 5' ' ' LEU . 4.0 mm? -69.31 136.16 51.43 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.502 -0.748 . . . . 0.0 109.583 -179.913 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 96.7 m -124.58 128.59 49.14 Favored 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -84.28 156.94 21.71 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.513 -0.742 . . . . 0.0 110.135 -179.424 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 65.4 mt -62.53 -44.36 99.25 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 121.446 -0.784 . . . . 0.0 109.681 179.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 14.0 p -64.66 -23.53 33.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.28 -0.888 . . . . 0.0 109.527 -179.875 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -79.7 -4.04 50.05 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.127 -0.983 . . . . 0.0 109.513 179.693 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 97.1 mt -80.24 103.99 7.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.097 -1.002 . . . . 0.0 109.825 -179.609 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 28.0 m -122.15 -9.39 8.85 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 179.4 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 18.9 pt-20 -136.39 137.7 40.8 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.5 -0.75 . . . . 0.0 109.598 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 30.5 p30 -95.34 162.83 13.51 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.322 -0.861 . . . . 0.0 110.731 -179.238 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 79.5 2.8 88.34 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.738 -1.345 . . . . 0.0 109.738 179.764 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 21.1 pt20 -80.47 144.38 32.62 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.248 -1.148 . . . . 0.0 110.095 -179.671 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 87.9 m95 -97.94 137.27 37.02 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.515 -0.741 . . . . 0.0 109.526 179.796 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -177.0 -179.61 0.93 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.078 -1.014 . . . . 0.0 109.78 179.608 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -105.75 146.28 30.03 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 6.1 tt -143.64 134.3 25.04 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.141 -0.974 . . . . 0.0 109.719 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 34.3 ttpt -116.66 139.7 50.24 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.571 -0.706 . . . . 0.0 109.189 179.864 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -160.57 179.45 8.58 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.865 -1.147 . . . . 0.0 109.949 179.857 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 64.7 tttm -112.96 141.98 46.17 Favored 'General case' 0 N--CA 1.498 1.953 0 CA-C-O 121.37 0.605 . . . . 0.0 109.679 -179.656 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 97.2 t -82.4 125.01 39.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.283 -0.886 . . . . 0.0 110.438 -179.078 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.416 HD13 HG23 ' A' ' 25' ' ' ILE . 96.6 mt -102.05 -51.83 8.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 179.184 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 18.4 tt0 -148.02 145.05 28.35 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.446 -0.784 . . . . 0.0 109.193 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.542 ' CD2' ' N ' ' A' ' 27' ' ' LEU . 1.2 pt? -136.65 138.77 41.46 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 179.934 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 78.9 t90 -128.37 123.11 33.05 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.394 -0.816 . . . . 0.0 109.463 -179.543 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 . . . . . 0 N--CA 1.493 1.678 0 O-C-N 121.227 -0.921 . . . . 0.0 110.401 -179.52 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 38.4 t . . . . . 0 N--CA 1.487 1.39 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.403 HG22 HD11 ' A' ' 35' ' ' ILE . 86.4 mt -105.38 124.83 60.51 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.064 0 O-C-N 121.394 -0.816 . . . . 0.0 109.517 179.967 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 3.4 t -68.96 -57.21 5.79 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.466 -0.771 . . . . 0.0 110.256 -179.637 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -156.88 156.96 34.02 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.201 -0.937 . . . . 0.0 109.97 -179.543 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 30.6 m -132.49 135.8 57.14 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 179.521 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -160.07 -158.97 9.51 Favored Glycine 0 N--CA 1.492 2.423 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 -179.444 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 2.0 pp -135.7 147.39 48.48 Favored 'General case' 0 N--CA 1.503 2.182 0 O-C-N 121.291 -1.123 . . . . 0.0 110.498 -179.628 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 48.1 mt -111.98 139.26 47.64 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.608 -0.683 . . . . 0.0 109.29 -178.834 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -80.64 164.85 47.36 Favored Glycine 0 N--CA 1.491 2.333 0 C-N-CA 120.215 -0.993 . . . . 0.0 110.669 -179.522 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.53 ' OD1' ' N ' ' A' ' 44' ' ' GLU . 66.8 t0 -172.68 141.28 1.08 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.607 -0.937 . . . . 0.0 109.389 179.482 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.53 ' N ' ' OD1' ' A' ' 43' ' ' ASP . 97.2 mt-10 -54.81 -18.39 4.75 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.313 -0.867 . . . . 0.0 110.479 -179.593 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 33.3 p -94.76 -9.74 33.72 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.981 -1.074 . . . . 0.0 109.498 -179.903 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 146.04 -153.82 25.56 Favored Glycine 0 N--CA 1.497 2.729 0 N-CA-C 110.168 -1.173 . . . . 0.0 110.168 179.365 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 37.3 pt -125.93 154.78 35.27 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.969 0 O-C-N 121.714 -0.874 . . . . 0.0 109.14 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 10.9 tp -142.72 142.19 26.76 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 O-C-N 121.109 -0.994 . . . . 0.0 110.462 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 25.4 mtpp -83.3 153.02 24.85 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 179.661 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 30.9 p90 -147.55 160.82 42.2 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 120.972 -1.08 . . . . 0.0 110.103 -179.879 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.46 ' CG2' HE21 ' A' ' 82' ' ' GLN . 3.4 t -143.89 139.57 29.28 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 179.401 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.433 HG21 HD12 ' A' ' 52' ' ' ILE . 95.3 mt -104.5 119.86 54.01 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.983 0 O-C-N 121.301 -0.875 . . . . 0.0 109.695 -179.754 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 94.6 m95 -95.49 140.88 29.72 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.332 -0.855 . . . . 0.0 109.366 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 68.0 mttm . . . . . 0 N--CA 1.49 1.572 0 O-C-N 121.202 -0.936 . . . . 0.0 109.418 179.941 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 91.2 mt . . . . . 0 N--CA 1.496 1.85 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -52.57 154.37 12.13 Favored 'Trans proline' 0 N--CA 1.494 1.525 0 C-N-CA 122.15 1.9 . . . . 0.0 111.956 -179.759 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 62.4 mt -62.63 139.88 58.66 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.251 -0.905 . . . . 0.0 110.258 -178.638 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.506 ' CD1' ' N ' ' A' ' 61' ' ' LEU . 8.8 mp -80.95 149.52 29.34 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.681 -0.637 . . . . 0.0 110.034 -179.308 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 80.4 mm-40 -83.49 139.42 32.93 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.35 -0.844 . . . . 0.0 109.955 -179.712 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 56.8 tt0 -77.53 133.15 38.6 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.398 -0.814 . . . . 0.0 111.07 -179.121 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 95.13 -0.33 64.02 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 110.048 -1.221 . . . . 0.0 110.048 179.475 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.514 ' N ' ' OE1' ' A' ' 65' ' ' GLU . 58.4 mp0 -111.73 150.82 29.69 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 121.451 -1.029 . . . . 0.0 110.292 -179.572 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 7.7 m -86.88 152.0 22.83 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.705 -0.622 . . . . 0.0 109.925 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 74.0 m-85 -142.52 145.77 34.01 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.544 -0.722 . . . . 0.0 109.557 179.677 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 18.0 tp -106.01 124.11 49.06 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 179.445 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 61.3 mt -100.97 131.52 46.8 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 -179.621 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.453 ' CZ ' ' OE2' ' A' ' 92' ' ' GLU . 84.8 mtm180 -126.93 141.32 51.83 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.376 -0.827 . . . . 0.0 110.168 -179.364 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 8.3 m 56.95 57.22 4.78 Favored 'General case' 0 N--CA 1.493 1.721 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.382 179.405 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 15.5 m -113.74 161.81 12.33 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.12 0 O-C-N 121.378 -0.826 . . . . 0.0 108.929 178.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 7.6 p -117.94 134.08 62.69 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.02 0 CA-C-O 121.435 0.636 . . . . 0.0 109.534 -179.239 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 20.1 t -78.67 122.11 33.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.38 -0.825 . . . . 0.0 109.922 -179.173 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -95.28 171.77 29.87 Favored Glycine 0 N--CA 1.495 2.605 0 N-CA-C 109.368 -1.493 . . . . 0.0 109.368 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . 0.546 ' N ' ' OE1' ' A' ' 76' ' ' GLU . 57.5 mp0 -107.17 118.94 38.04 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.487 -1.008 . . . . 0.0 109.483 -179.691 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 55.5 t80 -118.75 107.41 13.62 Favored 'General case' 0 N--CA 1.496 1.836 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 179.508 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 97.7 m-20 44.57 -125.76 1.02 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.403 -0.811 . . . . 0.0 109.942 -179.369 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 66.1 m-20 -94.66 -5.42 45.65 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.363 -0.836 . . . . 0.0 108.994 179.867 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 88.3 mtm180 -100.2 166.18 11.12 Favored 'General case' 0 N--CA 1.493 1.69 0 CA-C-O 121.614 0.721 . . . . 0.0 109.704 -179.702 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 76.8 m-85 -101.84 151.01 22.58 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.425 -0.797 . . . . 0.0 109.579 -179.595 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . 0.46 HE21 ' CG2' ' A' ' 51' ' ' THR . 40.6 tt0 -138.54 157.1 46.8 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.389 -0.819 . . . . 0.0 109.643 -179.757 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 3.4 m -114.11 130.64 67.97 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 179.178 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 87.7 mt-30 -109.83 132.42 54.16 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.61 -0.682 . . . . 0.0 110.072 -178.316 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 3.9 t -104.55 126.93 59.29 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 179.505 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . 0.479 ' C ' HD21 ' A' ' 86' ' ' ASN . 0.1 OUTLIER -145.97 -176.44 5.15 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.208 -0.932 . . . . 0.0 109.531 -179.776 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.561 ' C ' ' H ' ' A' ' 89' ' ' SER . 21.7 ptmt -37.93 161.12 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.804 0 CA-C-O 121.544 0.688 . . . . 0.0 111.589 -178.942 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 5.1 t30 69.51 -23.71 0.15 Allowed 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 -179.678 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' SER . . . . . 0.561 ' H ' ' C ' ' A' ' 87' ' ' LYS . 10.6 t -78.31 155.94 29.89 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.197 -0.939 . . . . 0.0 109.86 -179.755 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 27.1 p -141.2 154.59 45.9 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.46 -0.775 . . . . 0.0 108.956 179.571 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 97.3 mt -129.98 132.49 65.5 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . 0.453 ' OE2' ' CZ ' ' A' ' 70' ' ' ARG . 80.3 mt-10 -120.95 140.95 51.16 Favored 'General case' 0 N--CA 1.502 2.126 0 O-C-N 121.436 -0.79 . . . . 0.0 109.264 -179.507 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 37.8 ttmt -84.18 122.95 29.56 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.185 -0.947 . . . . 0.0 109.266 -179.735 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.473 ' CD2' ' N ' ' A' ' 94' ' ' LEU . 3.9 mm? -96.79 136.85 36.75 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.367 -0.833 . . . . 0.0 109.804 -179.466 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 94.4 p -85.52 -1.23 56.87 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 179.349 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 37.6 mm-40 -108.48 98.81 29.81 Favored Pre-proline 0 N--CA 1.498 1.961 0 O-C-N 121.644 -0.66 . . . . 0.0 109.286 -179.81 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -74.3 155.28 46.41 Favored 'Trans proline' 0 N--CA 1.491 1.38 0 C-N-CA 121.982 1.788 . . . . 0.0 112.737 -178.796 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 90.6 mt . . . . . 0 N--CA 1.496 1.867 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 179.99 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo . . . . . 0 N--CA 1.486 1.066 0 CA-C-O 121.4 0.5 . . . . 0.0 112.144 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 55.9 tt0 -78.61 89.07 4.52 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.367 -0.833 . . . . 0.0 109.321 -179.68 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 81.7 mt -76.63 144.91 39.22 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.65 -0.656 . . . . 0.0 109.582 -179.744 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 86.6 m -123.46 130.41 52.65 Favored 'General case' 0 N--CA 1.496 1.834 0 CA-C-O 121.551 0.691 . . . . 0.0 109.515 -179.887 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 65.7 mttp -82.59 149.35 27.5 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.555 -0.715 . . . . 0.0 110.074 -179.32 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 95.6 mt -63.12 -43.29 98.83 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 O-C-N 121.618 -0.676 . . . . 0.0 109.677 179.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 11.1 p -63.83 -24.1 34.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.333 -0.854 . . . . 0.0 109.824 -179.663 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -75.0 -3.89 35.08 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.096 -1.003 . . . . 0.0 109.385 179.712 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 5.7 mm -70.95 92.63 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.313 -0.867 . . . . 0.0 109.52 -179.789 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 15.0 m -114.82 -20.6 5.89 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -139.09 140.56 38.04 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.268 -0.895 . . . . 0.0 109.938 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 55.4 p30 -89.74 167.93 12.5 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.499 -0.751 . . . . 0.0 110.263 -179.507 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 80.26 15.74 77.87 Favored Glycine 0 N--CA 1.488 2.144 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 -179.807 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 27.8 tt0 -96.28 132.35 41.84 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.335 -1.097 . . . . 0.0 109.709 -179.82 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 76.6 m95 -94.72 134.33 37.43 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.587 -0.695 . . . . 0.0 109.954 -179.536 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -173.29 -169.46 0.53 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.526 -0.734 . . . . 0.0 109.667 179.566 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 70.9 m-20 -107.34 152.03 24.7 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.6 -0.687 . . . . 0.0 109.159 -179.889 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -133.85 120.25 20.2 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.408 -0.807 . . . . 0.0 109.318 179.835 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 35.9 ttmt -112.51 126.56 55.46 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 179.131 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -168.57 -171.95 1.55 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.117 -0.989 . . . . 0.0 109.989 -179.706 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -119.28 138.8 52.77 Favored 'General case' 0 N--CA 1.497 1.887 0 CA-C-O 121.625 0.726 . . . . 0.0 109.976 -179.621 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 10.7 t -85.9 91.43 3.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.521 -0.737 . . . . 0.0 109.661 -179.476 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 62.6 mt -69.86 -42.65 79.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.481 -0.762 . . . . 0.0 109.612 179.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 98.8 mm-40 -127.64 125.94 41.07 Favored 'General case' 0 N--CA 1.498 1.932 0 CA-C-O 121.75 0.786 . . . . 0.0 110.117 -178.897 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 1.1 tt -121.92 130.55 53.43 Favored 'General case' 0 C--N 1.309 -1.193 0 N-CA-C 108.755 -0.832 . . . . 0.0 108.755 179.821 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 96.9 m95 -135.2 117.76 15.89 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.613 -0.68 . . . . 0.0 109.39 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 . . . . . 0 N--CA 1.493 1.68 0 O-C-N 121.485 -0.76 . . . . 0.0 110.025 -179.537 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 87.7 p . . . . . 0 N--CA 1.489 1.514 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 84.0 mt -131.41 130.57 62.89 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 O-C-N 121.479 -0.763 . . . . 0.0 109.238 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 37.2 t -75.28 -75.38 0.17 Allowed 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.568 -0.707 . . . . 0.0 109.46 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 16.0 pt20 -141.42 162.36 35.67 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.394 -0.816 . . . . 0.0 110.013 -179.58 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 27.6 m -131.96 154.76 40.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 179.425 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.424 ' C ' ' CE1' ' A' ' 50' ' ' PHE . . . -178.88 -169.79 39.98 Favored Glycine 0 N--CA 1.486 1.987 0 C-N-CA 119.268 -1.444 . . . . 0.0 109.827 -179.751 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 2.2 pp -136.44 150.57 48.8 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.646 -0.914 . . . . 0.0 109.638 -179.621 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 54.5 mt -107.55 161.36 14.92 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 -179.006 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -140.09 131.99 5.33 Favored Glycine 0 N--CA 1.493 2.475 0 N-CA-C 109.967 -1.253 . . . . 0.0 109.967 -179.714 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.429 ' OD2' ' OG1' ' A' ' 45' ' ' THR . 52.3 p30 -151.59 -167.07 2.68 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.618 -0.93 . . . . 0.0 109.16 179.796 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -76.96 -12.4 59.94 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.514 -0.741 . . . . 0.0 109.473 179.633 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.429 ' OG1' ' OD2' ' A' ' 43' ' ' ASP . 34.7 p -91.98 -5.65 52.67 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.293 -0.88 . . . . 0.0 109.605 -179.518 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 122.76 -148.67 16.88 Favored Glycine 0 N--CA 1.5 2.953 0 N-CA-C 110.195 -1.162 . . . . 0.0 110.195 179.304 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 43.7 pt -128.71 154.89 40.22 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 O-C-N 121.758 -0.848 . . . . 0.0 109.712 -179.541 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 17.1 tt -152.6 144.46 15.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.212 -0.93 . . . . 0.0 109.96 179.621 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 63.7 mttp -83.36 150.7 25.94 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.557 -0.714 . . . . 0.0 109.909 -179.494 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . 0.424 ' CE1' ' C ' ' A' ' 39' ' ' GLY . 35.5 p90 -142.36 152.12 42.56 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.291 -0.881 . . . . 0.0 109.622 -179.949 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 99.6 m -135.19 132.01 37.42 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 179.703 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.409 HD13 HG21 ' A' ' 52' ' ' ILE . 98.0 mt -106.05 129.06 59.85 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.601 -0.687 . . . . 0.0 109.844 -179.661 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 86.6 m95 -94.97 144.33 25.77 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.51 -0.744 . . . . 0.0 109.527 -179.924 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 98.3 mttt . . . . . 0 N--CA 1.489 1.478 0 O-C-N 121.413 -0.804 . . . . 0.0 109.409 179.814 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 23.3 mt . . . . . 0 N--CA 1.492 1.641 0 N-CA-C 109.503 -0.554 . . . . 0.0 109.503 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -68.85 159.55 53.35 Favored 'Trans proline' 0 N--CA 1.496 1.639 0 C-N-CA 122.832 2.355 . . . . 0.0 112.72 -179.817 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 69.2 mt -64.84 139.1 58.73 Favored 'General case' 0 N--CA 1.49 1.543 0 CA-C-O 121.624 0.726 . . . . 0.0 110.388 -179.163 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.483 ' CD1' ' N ' ' A' ' 61' ' ' LEU . 9.6 mp -76.94 149.85 35.98 Favored 'General case' 0 N--CA 1.49 1.545 0 CA-C-O 121.468 0.652 . . . . 0.0 110.175 -179.588 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 49.2 tp10 -81.2 118.86 22.93 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.45 -0.781 . . . . 0.0 109.297 -179.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 56.9 tt0 -64.21 134.63 55.16 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.55 -0.719 . . . . 0.0 110.902 -178.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 84.14 28.8 32.85 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 110.339 -1.105 . . . . 0.0 110.339 179.488 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -136.65 154.24 50.7 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.276 -1.132 . . . . 0.0 110.637 -179.634 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 6.7 m -81.16 142.07 33.6 Favored 'General case' 0 N--CA 1.488 1.444 0 CA-C-O 121.322 0.582 . . . . 0.0 109.707 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 29.3 m-85 -140.8 146.84 38.15 Favored 'General case' 0 N--CA 1.49 1.57 0 CA-C-O 121.782 0.801 . . . . 0.0 109.751 -179.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 23.3 tp -111.56 120.87 43.56 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 179.458 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 66.2 mt -102.87 133.17 48.39 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 -179.916 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.463 ' O ' ' OG ' ' A' ' 71' ' ' SER . 84.8 mtp180 -127.39 149.27 50.15 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.666 -0.646 . . . . 0.0 110.293 -179.517 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' SER . . . . . 0.463 ' OG ' ' O ' ' A' ' 70' ' ' ARG . 3.0 p 53.28 57.93 5.75 Favored 'General case' 0 N--CA 1.494 1.733 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.445 179.702 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 17.8 m -116.15 164.99 12.01 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.043 0 O-C-N 121.608 -0.682 . . . . 0.0 109.422 179.105 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 8.0 p -115.32 137.84 47.59 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 CA-C-O 121.485 0.659 . . . . 0.0 109.8 -179.065 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 89.0 t -85.28 108.43 17.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.559 -0.713 . . . . 0.0 109.65 -179.501 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -87.64 177.77 46.95 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 110.115 -1.194 . . . . 0.0 110.115 -179.43 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 -107.68 134.57 50.47 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.602 -0.94 . . . . 0.0 109.216 -179.867 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 55.7 t80 -108.83 145.14 35.74 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.477 -0.764 . . . . 0.0 109.756 -179.468 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . 0.442 ' O ' ' CB ' ' A' ' 79' ' ' ASP . 24.0 t-20 -69.43 62.99 0.16 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.588 -0.695 . . . . 0.0 109.96 -179.477 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.442 ' CB ' ' O ' ' A' ' 78' ' ' ASN . 0.7 OUTLIER 162.43 -25.57 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 179.701 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 25.1 ttm180 -166.88 -131.66 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.374 -0.829 . . . . 0.0 109.595 -179.778 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 89.6 m-85 -131.29 152.28 50.71 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.582 -0.699 . . . . 0.0 109.625 -179.573 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 6.0 pt20 -144.97 162.49 36.76 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.473 -0.767 . . . . 0.0 109.393 -179.836 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 3.3 m -109.36 132.66 56.89 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 179.804 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 87.0 mt-30 -107.14 132.48 52.98 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.632 -0.668 . . . . 0.0 110.18 -178.65 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 90.1 t -99.45 129.59 49.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 179.654 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 6.2 m-80 -144.38 176.36 9.42 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.475 -0.765 . . . . 0.0 109.524 -179.494 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.501 ' C ' ' H ' ' A' ' 89' ' ' SER . 61.3 tttp -40.94 159.75 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.723 0 CA-C-O 121.29 0.567 . . . . 0.0 110.459 -179.796 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . 0.447 ' CB ' ' O ' ' A' ' 87' ' ' LYS . 3.9 t30 77.26 -25.37 0.2 Allowed 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 -179.5 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' SER . . . . . 0.501 ' H ' ' C ' ' A' ' 87' ' ' LYS . 94.0 p -73.27 154.41 40.19 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 121.62 -0.675 . . . . 0.0 109.825 -179.809 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 75.7 m -132.26 150.52 52.14 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.625 -0.672 . . . . 0.0 109.472 -179.945 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 96.9 mt -130.11 130.6 65.98 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 179.864 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 53.0 tp10 -126.57 130.93 51.51 Favored 'General case' 0 N--CA 1.497 1.881 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 179.784 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 64.0 tttp -80.19 131.31 35.68 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.614 -0.679 . . . . 0.0 110.235 -179.274 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.478 ' CD2' ' N ' ' A' ' 94' ' ' LEU . 3.9 mm? -96.67 135.87 37.99 Favored 'General case' 0 N--CA 1.495 1.818 0 CA-C-O 121.777 0.799 . . . . 0.0 109.929 -179.809 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 68.1 m -84.65 -3.8 58.69 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.724 -0.61 . . . . 0.0 109.519 179.802 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 12.3 tp10 -117.47 91.17 37.07 Favored Pre-proline 0 N--CA 1.498 1.94 0 O-C-N 121.56 -0.712 . . . . 0.0 109.338 -179.854 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -55.77 147.66 59.86 Favored 'Trans proline' 0 N--CA 1.498 1.751 0 C-N-CA 122.727 2.284 . . . . 0.0 112.648 -179.869 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.409 HG23 HD13 ' A' ' 98' ' ' ILE . 95.9 mt . . . . . 0 N--CA 1.493 1.715 0 O-C-N 121.494 -0.754 . . . . 0.0 109.785 -179.434 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo . . . . . 0 N--CA 1.492 1.391 0 CA-C-O 121.561 0.567 . . . . 0.0 112.067 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . 0.513 ' N ' ' OE1' ' A' ' 4' ' ' GLN . 0.9 OUTLIER -76.24 90.12 3.14 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.352 -0.843 . . . . 0.0 109.878 -179.436 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 79.1 mt -76.61 145.74 38.7 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.706 -0.622 . . . . 0.0 109.435 179.897 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 92.0 m -125.26 132.24 52.96 Favored 'General case' 0 N--CA 1.493 1.723 0 CA-C-O 121.761 0.791 . . . . 0.0 109.704 -179.884 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -75.85 149.4 37.85 Favored 'General case' 0 C--N 1.3 -1.567 0 CA-C-O 121.785 0.802 . . . . 0.0 110.373 -179.578 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 97.2 mt -63.24 -43.22 98.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 CA-C-O 121.802 0.81 . . . . 0.0 109.563 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 7.6 p -65.06 -24.3 35.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.592 -0.693 . . . . 0.0 109.872 -179.67 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 50.3 t0 -79.4 -4.58 51.69 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.17 -0.956 . . . . 0.0 109.838 -179.639 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 97.1 mt -85.6 114.33 25.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 120.962 -1.086 . . . . 0.0 109.656 -179.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 34.6 m -149.84 15.04 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 179.741 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 79.3 mm-40 -127.87 133.54 49.34 Favored 'General case' 0 N--CA 1.497 1.907 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 -179.903 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 11.5 m120 -74.06 141.54 45.72 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-O 121.658 0.742 . . . . 0.0 110.079 -179.579 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 58.02 111.15 0.01 OUTLIER Glycine 0 N--CA 1.49 2.242 0 N-CA-C 110.465 -1.054 . . . . 0.0 110.465 179.504 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 29.1 tt0 -168.06 133.77 1.91 Allowed 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.424 -1.045 . . . . 0.0 109.174 179.501 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 60.4 m95 -88.63 136.82 32.8 Favored 'General case' 0 N--CA 1.49 1.558 0 CA-C-O 121.652 0.739 . . . . 0.0 109.938 -179.565 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -178.29 173.63 1.39 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.571 -0.705 . . . . 0.0 109.229 -179.717 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 73.0 m-20 -107.59 144.99 33.84 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.54 -0.725 . . . . 0.0 109.886 -179.434 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 60.4 tp -133.78 135.4 43.86 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.49 -0.756 . . . . 0.0 110.406 -179.59 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 38.5 ttmt -119.23 130.34 55.41 Favored 'General case' 0 N--CA 1.496 1.863 0 CA-C-O 121.321 0.581 . . . . 0.0 109.556 179.503 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -168.79 -172.91 1.72 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.345 -0.847 . . . . 0.0 109.93 179.414 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 21.3 ptmt -124.81 154.35 41.11 Favored 'General case' 0 N--CA 1.498 1.961 0 CA-C-O 121.46 0.648 . . . . 0.0 109.919 179.829 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 97.1 t -87.8 129.58 38.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 CA-C-O 121.613 0.721 . . . . 0.0 110.174 -179.539 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 96.4 mt -100.98 -55.81 5.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 N-CA-C 109.068 -0.715 . . . . 0.0 109.068 179.42 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.614 ' NE2' ' NE2' ' A' ' 63' ' ' GLN . 64.2 mm-40 -142.92 138.61 30.3 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.151 -0.968 . . . . 0.0 109.807 179.825 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.551 ' CD2' ' N ' ' A' ' 27' ' ' LEU . 1.2 pt? -143.22 139.41 30.25 Favored 'General case' 0 N--CA 1.492 1.631 0 CA-C-O 121.347 0.594 . . . . 0.0 109.988 -179.928 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 5.6 m-90 -111.86 140.31 46.61 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 179.595 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 . . . . . 0 N--CA 1.493 1.687 0 CA-C-O 121.645 0.736 . . . . 0.0 110.265 -179.563 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 14.7 m . . . . . 0 N--CA 1.492 1.657 0 N-CA-C 109.138 -0.689 . . . . 0.0 109.138 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 72.4 mt -107.34 126.39 63.54 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 O-C-N 121.131 -0.981 . . . . 0.0 109.576 -179.751 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.575 ' OG ' ' N ' ' A' ' 54' ' ' LYS . 1.0 OUTLIER -92.0 -69.47 0.74 Allowed 'General case' 0 N--CA 1.492 1.648 0 CA-C-O 121.837 0.827 . . . . 0.0 109.283 -179.905 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 99.3 mt-30 -138.71 154.01 48.54 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.303 -0.873 . . . . 0.0 109.792 -179.585 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.7 p -140.41 140.49 34.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.585 -0.697 . . . . 0.0 109.781 -179.806 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -170.56 -156.96 11.87 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 179.723 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -132.12 150.6 52.11 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.709 -0.877 . . . . 0.0 110.117 179.836 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 66.2 mt -109.71 134.33 52.11 Favored 'General case' 0 N--CA 1.492 1.674 0 CA-C-O 121.763 0.792 . . . . 0.0 109.591 -179.438 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -86.87 144.04 19.3 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 110.06 -1.216 . . . . 0.0 110.06 179.897 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 43.8 t0 -152.7 165.55 34.94 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 121.497 -1.002 . . . . 0.0 110.105 179.84 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -63.99 -17.89 63.75 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.82 -0.55 . . . . 0.0 110.826 -179.583 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 17.3 p -98.63 -5.91 30.85 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 120.809 -1.182 . . . . 0.0 109.99 -179.314 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 140.21 -129.82 4.38 Favored Glycine 0 N--CA 1.496 2.678 0 N-CA-C 110.219 -1.153 . . . . 0.0 110.219 179.491 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.544 ' N ' ' CD1' ' A' ' 47' ' ' ILE . 0.1 OUTLIER -145.09 158.89 13.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.583 -0.951 . . . . 0.0 109.819 -179.54 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 9.7 tp -148.73 147.72 16.54 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 179.172 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 69.1 mttm -85.07 153.52 22.66 Favored 'General case' 0 N--CA 1.49 1.533 0 CA-C-O 121.641 0.734 . . . . 0.0 110.403 -179.658 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 13.4 p90 -148.86 152.86 37.21 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.407 -0.808 . . . . 0.0 109.447 179.779 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 98.3 m -133.1 131.28 40.36 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 91.7 mt -100.55 125.43 54.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.4 -0.812 . . . . 0.0 110.098 -179.58 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 54.3 m95 -93.96 120.27 33.99 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 179.455 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.575 ' N ' ' OG ' ' A' ' 36' ' ' SER . 19.6 ptmt . . . . . 0 C--N 1.3 -1.565 0 CA-C-O 121.764 0.792 . . . . 0.0 108.928 179.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 40.4 mt . . . . . 0 N--CA 1.493 1.724 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -52.44 143.85 42.98 Favored 'Trans proline' 0 N--CA 1.497 1.694 0 C-N-CA 122.221 1.947 . . . . 0.0 112.752 179.929 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 79.2 mt -74.19 141.55 45.48 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.404 -0.81 . . . . 0.0 109.844 -179.852 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.485 ' CD1' ' N ' ' A' ' 61' ' ' LEU . 9.8 mp -86.26 149.07 25.33 Favored 'General case' 0 N--CA 1.489 1.508 0 CA-C-O 121.834 0.826 . . . . 0.0 110.078 -179.796 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -99.68 146.12 26.86 Favored 'General case' 0 N--CA 1.491 1.6 0 CA-C-O 121.761 0.791 . . . . 0.0 110.429 -179.275 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . 0.614 ' NE2' ' NE2' ' A' ' 26' ' ' GLN . 57.4 tt0 -75.17 135.54 41.07 Favored 'General case' 0 N--CA 1.489 1.48 0 CA-C-O 121.727 0.775 . . . . 0.0 110.413 -179.894 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 81.32 18.09 69.87 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 110.011 -1.236 . . . . 0.0 110.011 179.535 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 -125.27 147.22 49.19 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.393 -1.063 . . . . 0.0 110.646 -179.8 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.4 ' H ' ' HG ' ' A' ' 66' ' ' SER . 12.7 p -80.19 150.89 29.97 Favored 'General case' 0 N--CA 1.485 1.299 0 CA-C-O 121.721 0.772 . . . . 0.0 110.011 179.772 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 40.0 m-85 -145.42 144.37 30.6 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.497 -0.752 . . . . 0.0 109.547 179.915 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 25.0 tp -111.13 119.83 40.29 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 179.034 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 71.4 mt -105.22 128.37 53.38 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 -179.675 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 83.1 mtp180 -130.13 137.74 50.3 Favored 'General case' 0 N--CA 1.493 1.691 0 CA-C-O 121.502 0.668 . . . . 0.0 110.021 179.835 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.3 m 72.73 52.52 0.15 Allowed 'General case' 0 N--CA 1.495 1.78 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.198 179.677 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 20.4 m -113.68 160.7 13.03 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 O-C-N 121.377 -0.827 . . . . 0.0 110.196 179.626 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 11.1 p -114.37 140.46 35.04 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 CA-C-O 121.549 0.69 . . . . 0.0 109.19 -179.841 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 85.7 t -86.21 113.43 24.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 CA-C-O 121.996 0.903 . . . . 0.0 110.529 -179.062 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -87.27 177.09 47.28 Favored Glycine 0 N--CA 1.488 2.148 0 N-CA-C 109.882 -1.287 . . . . 0.0 109.882 179.875 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . 0.561 ' N ' ' OE1' ' A' ' 76' ' ' GLU . 52.8 mp0 -112.62 128.0 56.26 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.63 -0.923 . . . . 0.0 109.854 -179.341 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 80.7 t80 -130.7 86.11 2.35 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 179.662 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . 0.533 ' CG ' ' H ' ' A' ' 79' ' ' ASP . 64.4 t30 58.87 -139.71 0.74 Allowed 'General case' 0 N--CA 1.491 1.594 0 CA-C-O 121.508 0.671 . . . . 0.0 110.527 179.944 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.533 ' H ' ' CG ' ' A' ' 78' ' ' ASN . 93.0 m-20 -78.22 -5.95 53.41 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.412 -0.805 . . . . 0.0 109.244 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 16.5 tpp180 -107.74 145.98 32.76 Favored 'General case' 0 N--CA 1.497 1.88 0 CA-C-O 121.866 0.841 . . . . 0.0 110.029 -179.442 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 94.5 m-85 -85.85 153.49 22.21 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.532 -0.73 . . . . 0.0 110.167 -179.066 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 48.7 tt0 -140.76 154.07 46.13 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.438 -0.789 . . . . 0.0 109.659 -179.715 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 27.2 m -113.55 131.19 66.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 CA-C-O 121.591 0.71 . . . . 0.0 109.085 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 87.1 mt-30 -105.94 119.81 40.13 Favored 'General case' 0 N--CA 1.493 1.689 0 CA-C-O 121.606 0.717 . . . . 0.0 110.091 -178.777 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 11.2 t -93.67 103.44 14.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 179.158 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . 0.506 ' C ' HD21 ' A' ' 86' ' ' ASN . 0.4 OUTLIER -151.68 -178.77 6.91 Favored 'General case' 0 N--CA 1.489 1.49 0 CA-C-O 121.732 0.777 . . . . 0.0 110.474 -179.113 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.423 ' CG ' ' H ' ' A' ' 88' ' ' ASN . 30.6 ttmt 68.6 -131.76 0.1 Allowed 'General case' 0 N--CA 1.492 1.673 0 CA-C-O 121.642 0.734 . . . . 0.0 110.895 179.466 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . 0.423 ' H ' ' CG ' ' A' ' 87' ' ' LYS . 12.6 m120 -93.23 10.62 31.1 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.393 -0.817 . . . . 0.0 108.813 -179.51 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' SER . . . . . 0.41 ' C ' ' O ' ' A' ' 88' ' ' ASN . 40.6 t -39.07 111.72 0.2 Allowed 'General case' 0 N--CA 1.495 1.801 0 CA-C-O 121.863 0.84 . . . . 0.0 110.516 -179.439 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 6.1 m -77.41 145.56 37.12 Favored 'General case' 0 N--CA 1.489 1.52 0 CA-C-O 121.531 0.682 . . . . 0.0 109.947 -179.542 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 97.9 mt -135.98 132.05 50.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.441 -0.787 . . . . 0.0 109.604 179.849 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 83.1 tt0 -129.15 131.34 47.17 Favored 'General case' 0 N--CA 1.497 1.913 0 CA-C-O 121.673 0.749 . . . . 0.0 109.376 179.375 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 38.2 ttmt -80.77 125.74 30.44 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.622 -0.674 . . . . 0.0 109.613 -179.757 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 10.9 mp -100.94 131.15 46.95 Favored 'General case' 0 N--CA 1.496 1.836 0 CA-C-O 121.907 0.86 . . . . 0.0 110.079 -179.733 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 38.1 t -79.8 -3.6 48.43 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 108.566 -0.902 . . . . 0.0 108.566 179.179 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 60.3 mt-10 -102.41 106.09 47.01 Favored Pre-proline 0 N--CA 1.496 1.841 0 O-C-N 121.299 -0.875 . . . . 0.0 109.325 -179.767 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -76.17 154.4 37.05 Favored 'Trans proline' 0 C--N 1.316 -1.184 0 C-N-CA 122.202 1.934 . . . . 0.0 111.879 -179.44 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 90.6 mt . . . . . 0 N--CA 1.492 1.632 0 O-C-N 121.311 -0.868 . . . . 0.0 109.3 -179.846 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 78.7 mtm . . . . . 0 N--CA 1.49 1.555 0 CA-C-O 121.46 0.648 . . . . 0.0 109.802 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 48.68 57.17 18.32 Favored Pre-proline 0 N--CA 1.494 1.739 0 O-C-N 121.539 -0.726 . . . . 0.0 110.204 179.865 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -70.79 148.88 59.37 Favored 'Trans proline' 0 N--CA 1.498 1.774 0 C-N-CA 122.938 2.426 . . . . 0.0 112.811 179.766 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 4.5 pt20 -79.6 89.05 5.1 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.272 -0.893 . . . . 0.0 109.505 -179.72 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 78.9 mt -75.03 143.57 43.46 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.499 -0.751 . . . . 0.0 109.768 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 98.9 m -131.24 136.36 48.15 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.622 -0.674 . . . . 0.0 109.939 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -78.43 153.51 31.43 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.567 -0.708 . . . . 0.0 109.926 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 96.1 mt -62.26 -43.09 97.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.388 -0.82 . . . . 0.0 109.42 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 11.8 p -62.71 -28.26 44.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.244 -0.91 . . . . 0.0 109.256 -179.666 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 55.1 t0 -67.59 -33.09 74.3 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.346 -0.846 . . . . 0.0 109.699 179.502 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 97.0 mt -68.8 120.55 16.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.29 -0.881 . . . . 0.0 110.182 -178.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 31.4 m -148.57 9.51 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 179.401 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 82.9 tt0 -134.45 139.61 45.64 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.418 -0.802 . . . . 0.0 109.586 179.611 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.505 ' ND2' ' OE2' ' A' ' 76' ' ' GLU . 31.0 p30 -82.5 151.66 26.39 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.587 -0.696 . . . . 0.0 110.56 -179.516 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 78.76 4.65 88.21 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 108.897 -1.681 . . . . 0.0 108.897 -179.737 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 44.1 tt0 -72.43 129.12 37.61 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.403 -1.057 . . . . 0.0 109.729 -179.627 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 85.2 m95 -99.99 137.52 38.33 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.618 -0.676 . . . . 0.0 109.942 -179.625 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 178.37 178.34 0.4 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.527 -0.733 . . . . 0.0 109.238 179.265 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 61.3 m-20 -102.43 145.32 29.71 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 51.9 tp -139.38 134.93 33.13 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.41 -0.806 . . . . 0.0 110.195 -179.538 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 34.0 ttpt -113.94 137.51 51.58 Favored 'General case' 0 N--CA 1.498 1.929 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 178.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -159.88 170.84 20.56 Favored 'General case' 0 N--CA 1.493 1.693 0 C-N-CA 119.064 -1.054 . . . . 0.0 110.55 -179.71 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 51.8 tttp -105.11 144.52 31.8 Favored 'General case' 0 N--CA 1.494 1.775 0 CA-C-O 121.345 0.593 . . . . 0.0 109.758 -179.784 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 62.5 t -83.31 120.02 33.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.324 -0.86 . . . . 0.0 109.971 -179.388 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.419 HG23 HD12 ' A' ' 25' ' ' ILE . 96.4 mt -96.89 -66.55 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.645 -0.659 . . . . 0.0 109.229 -180.0 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 66.3 mt-30 -146.05 142.92 29.04 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.353 -0.842 . . . . 0.0 109.984 -179.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -125.26 136.69 53.78 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 -179.781 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 92.1 m95 -111.53 133.0 54.11 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 179.576 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -71.97 135.35 46.41 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.539 -0.726 . . . . 0.0 110.268 -179.266 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 48.7 t-20 -102.57 134.54 45.75 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.489 -0.757 . . . . 0.0 109.961 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 7.0 t -86.22 2.87 45.42 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 109.025 -0.731 . . . . 0.0 109.025 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . 0.686 ' HD1' ' H ' ' A' ' 34' ' ' SER . 7.3 t-80 -80.01 139.3 37.04 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.335 -0.853 . . . . 0.0 110.569 -179.406 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.553 ' N ' ' HD1' ' A' ' 32' ' ' HIS . 96.3 mt-10 -66.69 -39.36 88.07 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.427 -0.796 . . . . 0.0 109.647 179.663 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' SER . . . . . 0.686 ' H ' ' HD1' ' A' ' 32' ' ' HIS . 56.1 p -68.73 -66.31 0.59 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.252 -0.905 . . . . 0.0 109.886 -179.63 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.513 ' N ' ' OG ' ' A' ' 34' ' ' SER . 96.9 mt -74.14 135.3 27.77 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 O-C-N 121.464 -0.773 . . . . 0.0 110.082 -179.281 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 17.8 t -92.16 -62.34 1.43 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.624 -0.672 . . . . 0.0 109.601 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 85.5 mt-30 -136.85 155.53 49.66 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.405 -0.809 . . . . 0.0 109.97 -179.343 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 8.7 p -142.92 141.9 26.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 179.8 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -168.63 -160.0 15.55 Favored Glycine 0 N--CA 1.489 2.212 0 C-N-CA 119.202 -1.475 . . . . 0.0 110.384 -179.669 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -133.22 147.98 52.0 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.747 -0.855 . . . . 0.0 109.423 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 41.4 mt -117.25 133.33 56.12 Favored 'General case' 0 N--CA 1.499 1.983 0 CA-C-O 121.529 0.68 . . . . 0.0 109.92 -179.018 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -78.98 162.9 48.95 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 110.124 -1.19 . . . . 0.0 110.124 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.451 ' OD1' ' N ' ' A' ' 44' ' ' GLU . 55.1 t0 -173.83 153.43 2.18 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.586 -0.95 . . . . 0.0 109.36 179.553 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.451 ' N ' ' OD1' ' A' ' 43' ' ' ASP . 82.2 tt0 -63.03 -18.58 63.49 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.47 -0.768 . . . . 0.0 109.515 -179.877 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 72.4 p -92.2 -7.95 46.85 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.205 -0.935 . . . . 0.0 109.282 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 135.3 -150.67 20.29 Favored Glycine 0 N--CA 1.497 2.753 0 N-CA-C 109.998 -1.241 . . . . 0.0 109.998 179.268 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.415 HG21 HD11 ' A' ' 47' ' ' ILE . 96.7 mt -123.03 139.64 49.19 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 O-C-N 121.679 -0.895 . . . . 0.0 109.765 -179.423 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 9.3 tp -129.03 139.64 51.36 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 CA-C-O 121.662 0.744 . . . . 0.0 109.533 179.569 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 32.5 mtmm -85.52 148.41 25.97 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.665 -0.647 . . . . 0.0 109.871 -179.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 7.1 p90 -143.27 152.16 41.37 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.381 -0.825 . . . . 0.0 109.919 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 47.2 m -131.09 133.9 46.09 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 179.787 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 32.0 mm -97.08 124.22 49.82 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 O-C-N 121.203 -0.935 . . . . 0.0 110.184 -179.258 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 96.0 m95 -88.68 139.14 30.78 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 121.529 -0.732 . . . . 0.0 109.214 179.566 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -63.11 -35.29 79.79 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.346 -0.846 . . . . 0.0 109.663 -179.735 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . 0.505 ' OD1' ' N ' ' A' ' 56' ' ' ALA . 52.9 p-10 -55.95 -18.67 9.73 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.244 -0.91 . . . . 0.0 109.848 -179.191 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.505 ' N ' ' OD1' ' A' ' 55' ' ' ASN . . . -69.7 -38.38 76.93 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.209 -0.932 . . . . 0.0 109.77 179.492 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 54.7 44.11 29.06 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 -179.163 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 61.1 mt -107.99 153.08 41.91 Favored Pre-proline 0 N--CA 1.494 1.751 0 O-C-N 121.706 -0.621 . . . . 0.0 109.715 179.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -53.59 149.23 32.21 Favored 'Trans proline' 0 N--CA 1.501 1.923 0 C-N-CA 122.286 1.99 . . . . 0.0 112.941 179.205 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 62.0 mt -68.12 144.03 55.19 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.456 -0.777 . . . . 0.0 110.37 -179.253 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.443 ' CD1' ' N ' ' A' ' 61' ' ' LEU . 10.1 mp -78.31 144.65 35.89 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.724 -0.61 . . . . 0.0 109.447 -179.682 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 80.2 tt0 -98.38 145.03 27.13 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.39 -0.819 . . . . 0.0 110.514 -179.085 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 57.9 tt0 -78.48 139.31 38.7 Favored 'General case' 0 N--CA 1.489 1.518 0 CA-C-O 121.479 0.657 . . . . 0.0 111.061 -179.295 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 84.93 10.63 78.4 Favored Glycine 0 N--CA 1.492 2.414 0 N-CA-C 110.187 -1.165 . . . . 0.0 110.187 178.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -124.74 144.65 50.12 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.385 -1.067 . . . . 0.0 110.602 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 8.1 p -87.04 152.41 22.39 Favored 'General case' 0 N--CA 1.487 1.405 0 CA-C-O 121.466 0.65 . . . . 0.0 109.987 179.769 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 70.4 m-85 -144.64 150.99 38.32 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.454 -0.779 . . . . 0.0 109.96 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 18.1 tp -108.55 124.6 50.71 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 179.184 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 69.8 mt -104.48 132.47 50.69 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 179.769 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 88.8 mtm180 -127.75 144.67 51.07 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.621 -0.674 . . . . 0.0 110.054 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.424 ' O ' ' OG ' ' A' ' 71' ' ' SER . 5.2 t 58.43 59.8 2.84 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 122.064 -0.397 . . . . 0.0 110.374 179.748 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 3.4 m -117.59 162.25 15.76 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.165 0 O-C-N 121.486 -0.759 . . . . 0.0 108.989 179.281 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 7.1 p -122.91 136.98 57.95 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 CA-C-O 121.606 0.717 . . . . 0.0 110.149 -178.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 90.4 t -80.84 128.61 38.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.468 -0.77 . . . . 0.0 109.975 -179.484 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -98.16 166.1 22.04 Favored Glycine 0 N--CA 1.494 2.526 0 N-CA-C 110.158 -1.177 . . . . 0.0 110.158 -179.774 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.505 ' OE2' ' ND2' ' A' ' 14' ' ' ASN . 96.7 mt-10 -90.68 124.99 35.53 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.803 -0.822 . . . . 0.0 109.378 179.896 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 79.4 t80 -134.45 108.56 8.2 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.494 -0.754 . . . . 0.0 109.744 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 11.2 m120 41.15 -123.55 0.51 Allowed 'General case' 0 N--CA 1.493 1.712 0 CA-C-O 121.439 0.637 . . . . 0.0 111.031 179.57 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 96.9 m-20 -91.91 -5.81 52.54 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.442 -0.786 . . . . 0.0 110.116 -179.054 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 79.5 mtp85 -115.57 -172.62 2.18 Favored 'General case' 0 N--CA 1.502 2.161 0 O-C-N 121.443 -0.785 . . . . 0.0 109.945 -179.774 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 90.2 m-85 -130.45 156.72 44.3 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.598 -0.689 . . . . 0.0 109.842 -179.486 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 15.8 pt20 -140.12 165.09 28.3 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.575 -0.703 . . . . 0.0 109.315 179.64 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 33.8 m -104.67 132.43 51.37 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 O-C-N 121.387 -0.821 . . . . 0.0 109.117 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -102.91 128.66 49.61 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.537 -0.727 . . . . 0.0 109.864 -178.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 21.1 t -94.61 130.67 43.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.582 -0.699 . . . . 0.0 109.532 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 18.9 p30 -132.83 176.94 8.03 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 179.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 22.7 pttm -58.83 -36.05 73.92 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.358 -0.839 . . . . 0.0 109.84 -179.47 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 77.5 m-20 -62.45 -38.26 89.09 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.283 -0.886 . . . . 0.0 109.327 179.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 93.3 p -69.68 161.93 28.73 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.093 -1.004 . . . . 0.0 109.801 -179.241 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 72.1 m -130.6 152.17 50.25 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.607 -0.683 . . . . 0.0 109.681 -179.638 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 96.6 mt -127.12 131.96 70.24 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 75.4 mm-40 -129.14 137.52 51.24 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.53 -0.732 . . . . 0.0 109.475 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -78.89 129.78 34.92 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.505 -0.747 . . . . 0.0 109.328 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 52.4 mt -103.14 136.41 42.99 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.499 -0.751 . . . . 0.0 109.568 -179.496 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 74.3 m -81.52 -5.39 57.93 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 179.797 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -112.94 117.94 45.36 Favored Pre-proline 0 N--CA 1.497 1.921 0 O-C-N 121.676 -0.64 . . . . 0.0 109.356 -179.695 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -75.24 163.44 34.82 Favored 'Trans proline' 0 N--CA 1.491 1.375 0 C-N-CA 121.971 1.78 . . . . 0.0 111.971 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.42 HD12 HG21 ' A' ' 98' ' ' ILE . 19.2 mm -92.66 126.92 45.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.197 -0.939 . . . . 0.0 109.335 -179.695 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . 0.531 ' N ' ' OE1' ' A' ' 99' ' ' GLU . 57.5 mp0 -85.06 118.81 24.85 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.481 -0.762 . . . . 0.0 109.585 -179.591 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 35.7 m -107.8 -2.69 10.07 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 135.72 134.15 3.31 Favored Glycine 0 N--CA 1.497 2.706 0 N-CA-C 109.868 -1.293 . . . . 0.0 109.868 179.353 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.622 ' C ' ' H ' ' A' ' 104' ' ' HIS . 3.9 mm? -89.44 -0.49 57.53 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.458 -1.025 . . . . 0.0 108.996 179.689 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 77.6 tt0 63.28 -12.58 0.08 Allowed 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 -179.6 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . 0.622 ' H ' ' C ' ' A' ' 102' ' ' LEU . 36.8 p-80 -159.29 155.26 26.57 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 120.913 -1.117 . . . . 0.0 109.745 179.582 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 83.2 t60 -98.28 124.58 42.98 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.464 -0.772 . . . . 0.0 109.44 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 51.2 p-80 -108.0 155.39 20.4 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.458 -0.777 . . . . 0.0 110.075 -179.625 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 42.1 p-80 -152.76 160.76 43.13 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.407 -0.808 . . . . 0.0 109.672 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 96.9 m-70 -77.45 136.38 38.37 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.503 -0.748 . . . . 0.0 110.613 -179.28 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . 0.526 ' CG ' ' OXT' ' A' ' 109' ' ' HIS . 50.1 t-80 . . . . . 0 N--CA 1.49 1.543 0 CA-C-O 117.946 -1.026 . . . . 0.0 109.006 179.142 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 62.2 ttp . . . . . 0 N--CA 1.489 1.475 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 61.8 mt-10 -86.37 150.85 52.59 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.582 -0.699 . . . . 0.0 109.573 -179.165 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -66.26 148.59 84.91 Favored 'Trans proline' 0 C--N 1.312 -1.377 0 C-N-CA 122.342 2.028 . . . . 0.0 112.277 179.703 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . 0.525 ' N ' ' OE1' ' A' ' 4' ' ' GLN . 1.0 OUTLIER -78.92 89.17 4.71 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.305 -0.872 . . . . 0.0 109.344 -179.728 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 80.3 mt -75.47 150.8 38.15 Favored 'General case' 0 N--CA 1.488 1.442 0 CA-C-O 121.754 0.787 . . . . 0.0 109.807 -179.783 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 4.9 t -144.55 156.67 44.26 Favored 'General case' 0 N--CA 1.487 1.404 0 CA-C-O 121.751 0.786 . . . . 0.0 109.539 179.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.58 159.14 15.1 Favored 'General case' 0 C--N 1.3 -1.579 0 CA-C-O 121.875 0.845 . . . . 0.0 110.352 -179.665 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 96.1 mt -62.96 -42.68 97.53 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 CA-C-O 121.539 0.685 . . . . 0.0 109.267 179.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 14.4 p -62.71 -28.36 44.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.377 -0.827 . . . . 0.0 109.259 179.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 -75.75 -17.93 59.72 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.23 -0.919 . . . . 0.0 109.123 179.66 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 96.1 mt -86.57 113.37 24.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.127 -0.983 . . . . 0.0 109.66 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 20.6 m -153.94 17.24 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 179.75 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -127.08 137.51 53.04 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.536 -0.728 . . . . 0.0 109.881 -179.63 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 11.8 m120 -77.95 138.71 39.0 Favored 'General case' 0 N--CA 1.485 1.306 0 CA-C-O 121.804 0.811 . . . . 0.0 110.92 -179.223 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 79.39 11.04 85.34 Favored Glycine 0 N--CA 1.492 2.425 0 N-CA-C 109.995 -1.242 . . . . 0.0 109.995 179.398 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 44.6 tt0 -70.68 130.68 42.41 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.037 -1.273 . . . . 0.0 109.994 -179.653 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 86.6 m95 -104.76 131.14 52.57 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.725 -0.609 . . . . 0.0 109.677 -179.533 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -178.71 177.13 0.91 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.486 -0.759 . . . . 0.0 109.851 179.586 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.685 ' ND2' ' H ' ' A' ' 71' ' ' SER . 3.0 m120 -105.06 145.18 30.85 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.626 -0.672 . . . . 0.0 109.568 -179.79 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 5.2 tt -141.89 134.74 28.68 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.293 -0.879 . . . . 0.0 110.263 179.743 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 19.4 ttpp -112.47 138.44 49.22 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 179.52 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -161.01 179.9 8.07 Favored 'General case' 0 N--CA 1.492 1.644 0 C-N-CA 119.364 -0.934 . . . . 0.0 110.116 -179.54 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 89.0 tttt -115.35 139.46 49.98 Favored 'General case' 0 N--CA 1.495 1.79 0 CA-C-O 121.717 0.77 . . . . 0.0 110.221 -179.453 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 75.8 t -78.24 129.2 37.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 CA-C-O 121.688 0.756 . . . . 0.0 110.534 -179.275 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.41 HG21 HD12 ' A' ' 25' ' ' ILE . 96.7 mt -102.32 -53.84 7.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 178.971 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 67.0 tp60 -147.14 148.86 32.0 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.249 -0.907 . . . . 0.0 109.668 -179.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.549 ' CD2' ' N ' ' A' ' 27' ' ' LEU . 1.2 pt? -141.44 135.62 30.49 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 179.529 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 3.6 m-90 -121.08 114.03 20.88 Favored 'General case' 0 N--CA 1.496 1.872 0 CA-C-O 121.545 0.688 . . . . 0.0 109.457 -179.569 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 17.3 pt-20 -64.38 147.72 51.99 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.584 -0.697 . . . . 0.0 109.789 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . 0.534 ' ND2' ' O ' ' A' ' 36' ' ' SER . 0.4 OUTLIER -133.25 -41.06 0.89 Allowed 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 179.875 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.451 ' H ' ' ND2' ' A' ' 30' ' ' ASN . 1.3 p 39.42 48.75 1.77 Allowed 'General case' 0 N--CA 1.497 1.893 0 CA-C-O 122.014 0.911 . . . . 0.0 109.475 -179.276 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 78.1 t60 -62.72 -48.73 77.96 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.516 -0.74 . . . . 0.0 109.063 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.476 ' CG ' ' N ' ' A' ' 34' ' ' SER . 19.5 pt-20 -176.7 -47.07 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 179.92 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' SER . . . . . 0.476 ' N ' ' CG ' ' A' ' 33' ' ' GLU . 71.2 p -121.82 -7.14 9.03 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.535 -0.728 . . . . 0.0 109.218 -179.797 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.401 HD12 HG22 ' A' ' 35' ' ' ILE . 83.7 mt -106.56 127.04 62.29 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 O-C-N 121.3 -0.875 . . . . 0.0 110.07 -179.817 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.534 ' O ' ' ND2' ' A' ' 30' ' ' ASN . 44.8 m -73.15 -74.91 0.16 Allowed 'General case' 0 N--CA 1.49 1.554 0 CA-C-O 121.726 0.774 . . . . 0.0 109.797 179.876 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 15.3 pt20 -146.62 162.12 39.09 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.341 -0.849 . . . . 0.0 109.656 -179.357 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 34.0 m -132.05 158.65 43.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 CA-C-O 121.659 0.742 . . . . 0.0 109.708 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -178.72 -160.8 25.39 Favored Glycine 0 N--CA 1.486 2.03 0 N-CA-C 109.764 -1.334 . . . . 0.0 109.764 -179.557 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.548 ' CD2' ' N ' ' A' ' 40' ' ' LEU . 1.3 pt? -139.96 148.24 41.64 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.572 -0.958 . . . . 0.0 110.35 -179.728 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 40.3 mt -109.59 134.07 52.36 Favored 'General case' 0 N--CA 1.491 1.581 0 CA-C-O 121.541 0.686 . . . . 0.0 109.379 -179.46 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -82.85 162.59 41.16 Favored Glycine 0 N--CA 1.488 2.132 0 N-CA-C 110.228 -1.149 . . . . 0.0 110.228 -179.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.547 ' OD1' ' N ' ' A' ' 44' ' ' GLU . 67.5 t0 -172.98 143.56 1.18 Allowed 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.761 -0.846 . . . . 0.0 109.342 179.688 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.547 ' N ' ' OD1' ' A' ' 43' ' ' ASP . 96.7 mt-10 -54.76 -14.94 1.57 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.603 -0.686 . . . . 0.0 109.639 179.865 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 44.3 p -94.15 -11.0 31.36 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.129 -0.982 . . . . 0.0 109.566 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 140.32 -155.77 24.79 Favored Glycine 0 N--CA 1.497 2.709 0 N-CA-C 110.309 -1.116 . . . . 0.0 110.309 179.423 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 41.9 pt -126.68 150.8 32.73 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 O-C-N 121.707 -0.878 . . . . 0.0 109.892 -179.364 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 19.0 tt -143.94 141.83 24.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.555 -0.715 . . . . 0.0 109.625 179.319 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -85.31 155.83 21.18 Favored 'General case' 0 N--CA 1.491 1.592 0 CA-C-O 121.435 0.636 . . . . 0.0 110.362 -179.603 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 38.5 p90 -144.47 151.65 39.49 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.251 -0.906 . . . . 0.0 109.775 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 54.1 m -133.35 127.13 32.83 Favored 'General case' 0 N--CA 1.492 1.639 0 CA-C-O 121.546 0.688 . . . . 0.0 109.459 179.263 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 97.0 mt -95.1 124.39 47.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.54 -0.725 . . . . 0.0 109.81 179.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . 0.504 ' C ' ' H ' ' A' ' 55' ' ' ASN . 90.2 m95 -82.67 105.99 14.16 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.422 -0.799 . . . . 0.0 109.065 179.334 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 73.8 tttt -52.84 -9.18 0.11 Allowed 'General case' 0 N--CA 1.491 1.605 0 CA-C-O 121.594 0.711 . . . . 0.0 109.723 -179.52 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . 0.504 ' H ' ' C ' ' A' ' 53' ' ' TRP . 25.1 t-20 -63.11 -39.24 94.13 Favored 'General case' 0 C--N 1.298 -1.661 0 O-C-N 121.314 -0.866 . . . . 0.0 109.176 179.699 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -76.05 -11.88 60.02 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.283 -0.885 . . . . 0.0 109.237 179.634 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 73.0 mm-40 53.35 56.0 7.97 Favored 'General case' 0 N--CA 1.494 1.768 0 CA-C-O 121.933 0.873 . . . . 0.0 109.599 -179.817 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 15.0 mt -91.65 151.83 42.76 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.517 -0.739 . . . . 0.0 109.58 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -66.19 151.8 82.69 Favored 'Trans proline' 0 C--N 1.31 -1.455 0 C-N-CA 122.5 2.133 . . . . 0.0 112.432 179.567 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 82.0 mt -68.84 137.51 53.98 Favored 'General case' 0 N--CA 1.488 1.444 0 CA-C-O 121.862 0.839 . . . . 0.0 110.514 -179.301 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.45 ' CD1' ' N ' ' A' ' 61' ' ' LEU . 10.3 mp -78.98 143.0 36.15 Favored 'General case' 0 N--CA 1.49 1.569 0 CA-C-O 121.656 0.741 . . . . 0.0 109.853 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 81.7 tt0 -85.78 138.69 31.9 Favored 'General case' 0 N--CA 1.49 1.546 0 CA-C-O 121.857 0.837 . . . . 0.0 110.182 -179.586 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 57.2 tt0 -74.61 136.78 41.99 Favored 'General case' 0 N--CA 1.489 1.489 0 CA-C-O 121.819 0.819 . . . . 0.0 111.329 -179.375 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 84.17 20.95 58.12 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 110.051 -1.219 . . . . 0.0 110.051 178.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -128.49 145.56 51.07 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.401 -1.058 . . . . 0.0 110.156 -179.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 11.5 m -83.22 144.8 29.53 Favored 'General case' 0 N--CA 1.488 1.439 0 CA-C-O 121.653 0.74 . . . . 0.0 110.192 -179.642 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 79.9 m-85 -138.24 149.18 45.5 Favored 'General case' 0 N--CA 1.491 1.597 0 CA-C-O 121.918 0.866 . . . . 0.0 109.908 179.757 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 35.0 tp -106.77 122.65 46.8 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 179.284 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 65.8 mt -101.11 130.24 47.13 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 179.836 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.436 ' CZ ' ' OE2' ' A' ' 92' ' ' GLU . 80.7 mtm180 -125.65 142.61 51.42 Favored 'General case' 0 N--CA 1.497 1.878 0 CA-C-O 121.865 0.841 . . . . 0.0 110.699 -178.848 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.685 ' H ' ' ND2' ' A' ' 19' ' ' ASN . 34.3 t 50.98 59.19 4.8 Favored 'General case' 0 N--CA 1.491 1.617 0 CA-C-N 115.683 -0.689 . . . . 0.0 111.032 179.118 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 6.4 m -111.49 160.68 10.64 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.989 0 O-C-N 121.406 -0.809 . . . . 0.0 109.633 178.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 7.4 p -118.41 134.24 62.65 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 CA-C-O 121.722 0.772 . . . . 0.0 109.604 -179.463 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 9.8 t -86.51 113.72 24.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 CA-C-O 121.824 0.821 . . . . 0.0 109.753 -179.499 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -90.65 143.87 17.02 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 110.112 -1.195 . . . . 0.0 110.112 -179.641 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -63.08 132.08 50.71 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.694 -0.886 . . . . 0.0 110.305 -179.816 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . 0.632 ' CD2' ' ND2' ' A' ' 78' ' ' ASN . 34.9 t80 -137.43 96.74 3.31 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.375 -0.828 . . . . 0.0 108.965 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . 0.632 ' ND2' ' CD2' ' A' ' 77' ' ' TYR . 21.1 p30 43.41 -141.93 0.15 Allowed 'General case' 0 N--CA 1.494 1.758 0 CA-C-O 121.631 0.729 . . . . 0.0 110.897 -179.897 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.515 ' N ' ' OD1' ' A' ' 78' ' ' ASN . 46.9 t0 -73.05 -2.49 21.46 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.43 -0.793 . . . . 0.0 109.098 -179.633 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.492 ' N ' ' OD1' ' A' ' 78' ' ' ASN . 29.9 mmt180 -115.53 -171.98 2.07 Favored 'General case' 0 N--CA 1.495 1.805 0 CA-C-O 122.047 0.927 . . . . 0.0 110.228 -179.286 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -127.83 155.72 43.67 Favored 'General case' 0 N--CA 1.492 1.652 0 CA-C-O 121.558 0.694 . . . . 0.0 109.873 -179.207 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 52.1 tt0 -139.59 151.84 46.36 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.544 -0.722 . . . . 0.0 109.741 -179.599 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 3.8 m -108.98 132.23 57.6 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 179.235 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 87.9 mt-30 -105.93 127.08 52.9 Favored 'General case' 0 N--CA 1.495 1.795 0 CA-C-O 121.784 0.802 . . . . 0.0 110.178 -178.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 21.3 t -95.74 132.89 38.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 179.277 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 15.8 p30 -139.14 -178.14 5.22 Favored 'General case' 0 N--CA 1.492 1.668 0 CA-C-O 121.884 0.849 . . . . 0.0 110.362 -179.207 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 63.7 tttp -56.91 -40.25 75.97 Favored 'General case' 0 N--CA 1.492 1.647 0 CA-C-O 121.474 0.654 . . . . 0.0 110.064 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . 0.413 ' OD1' ' OG ' ' A' ' 71' ' ' SER . 23.2 t-20 -60.33 -37.94 82.18 Favored 'General case' 0 C--N 1.296 -1.725 0 O-C-N 121.306 -0.871 . . . . 0.0 109.89 -179.85 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 15.5 p -75.43 162.28 28.49 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.02 -1.05 . . . . 0.0 110.847 -179.133 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 67.4 m -131.62 149.83 52.36 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 179.701 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.402 HG22 HD13 ' A' ' 91' ' ' ILE . 97.0 mt -128.14 132.21 68.65 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 O-C-N 121.599 -0.688 . . . . 0.0 109.69 -179.664 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.436 ' OE2' ' CZ ' ' A' ' 70' ' ' ARG . 86.0 mt-10 -124.99 131.8 53.36 Favored 'General case' 0 N--CA 1.5 2.069 0 CA-C-O 121.488 0.661 . . . . 0.0 109.513 -179.558 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 37.2 ttpt -82.36 118.38 23.13 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.424 -0.797 . . . . 0.0 109.653 -179.807 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.53 ' C ' ' H ' ' A' ' 96' ' ' GLU . 59.6 mt -111.63 130.66 55.69 Favored 'General case' 0 N--CA 1.495 1.812 0 CA-C-O 121.464 0.65 . . . . 0.0 109.459 -179.72 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 42.2 m -77.27 29.63 0.14 Allowed 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 179.358 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.53 ' H ' ' C ' ' A' ' 94' ' ' LEU . 72.5 tt0 -111.43 92.74 17.03 Favored Pre-proline 0 N--CA 1.493 1.72 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 -179.752 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -75.21 151.22 38.36 Favored 'Trans proline' 0 N--CA 1.491 1.358 0 C-N-CA 122.221 1.947 . . . . 0.0 112.219 -179.077 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 84.5 mt -102.04 126.94 55.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 CA-C-O 121.745 0.783 . . . . 0.0 109.511 -179.674 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -87.84 115.56 25.38 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.62 -0.675 . . . . 0.0 109.965 -179.822 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 58.6 t -109.11 -41.76 5.1 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 CA-C-O 121.579 0.704 . . . . 0.0 109.195 179.762 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -69.64 -35.75 74.83 Favored Glycine 0 N--CA 1.498 2.805 0 N-CA-C 110.558 -1.017 . . . . 0.0 110.558 -179.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 31.9 mt -82.75 -0.39 47.47 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.176 -1.191 . . . . 0.0 108.95 -179.556 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 82.5 tt0 -56.71 129.8 42.73 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.252 -0.905 . . . . 0.0 110.102 -179.77 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 86.2 t60 -88.73 -82.64 0.24 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.499 -0.751 . . . . 0.0 109.89 179.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 81.8 t60 -148.29 148.02 29.97 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.111 -0.993 . . . . 0.0 110.145 -179.524 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 86.2 t60 -71.14 134.28 46.85 Favored 'General case' 0 N--CA 1.489 1.522 0 CA-C-O 121.808 0.813 . . . . 0.0 110.91 -179.411 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 65.7 t-80 -146.14 142.55 28.59 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.53 -0.731 . . . . 0.0 109.619 179.643 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 78.0 m80 -70.64 139.22 51.28 Favored 'General case' 0 N--CA 1.491 1.578 0 CA-C-O 121.65 0.738 . . . . 0.0 110.5 -179.503 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . 0.41 ' ND1' ' C ' ' A' ' 109' ' ' HIS . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.469 0 CA-C-O 118.172 -0.918 . . . . 0.0 109.025 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 51.7 ttp . . . . . 0 N--CA 1.489 1.478 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -163.17 153.44 13.57 Favored Pre-proline 0 C--N 1.303 -1.441 0 O-C-N 121.353 -0.842 . . . . 0.0 108.873 179.325 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -65.24 144.27 80.36 Favored 'Trans proline' 0 N--CA 1.495 1.588 0 C-N-CA 122.755 2.303 . . . . 0.0 112.555 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 84.9 mt-30 -76.41 91.89 3.34 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.152 -0.968 . . . . 0.0 108.723 179.45 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 82.6 mt -85.27 131.87 34.35 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.531 -0.731 . . . . 0.0 109.619 -179.071 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 99.9 m -123.64 131.01 53.51 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 179.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 71.5 mmtt -80.58 156.64 26.34 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-O 121.683 0.754 . . . . 0.0 110.362 -178.62 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.4 HG23 HD11 ' A' ' 8' ' ' ILE . 97.3 mt -62.89 -43.31 98.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.484 -0.76 . . . . 0.0 109.279 -179.798 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 14.5 p -66.28 -23.51 31.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.338 -0.851 . . . . 0.0 109.606 -179.743 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -78.49 -5.03 51.43 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.251 -0.905 . . . . 0.0 109.899 -179.778 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 96.7 mt -80.94 121.85 35.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 120.939 -1.101 . . . . 0.0 110.081 -179.579 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 31.2 m -146.55 10.25 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 179.172 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 48.2 tp10 -136.11 132.96 36.77 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.341 -0.849 . . . . 0.0 109.745 -179.782 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.488 ' ND2' ' CE1' ' A' ' 81' ' ' PHE . 11.4 m120 -82.38 142.04 32.31 Favored 'General case' 0 C--N 1.306 -1.311 0 O-C-N 121.347 -0.846 . . . . 0.0 110.431 -179.828 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 75.68 98.93 0.13 Allowed Glycine 0 N--CA 1.49 2.258 0 N-CA-C 110.032 -1.227 . . . . 0.0 110.032 179.232 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 14.1 pt20 -173.45 141.29 0.88 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.159 -1.201 . . . . 0.0 109.702 179.282 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 71.0 m95 -94.0 137.06 33.63 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.615 -0.678 . . . . 0.0 109.781 -179.549 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -175.58 177.68 1.72 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.139 -0.976 . . . . 0.0 109.639 179.745 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 81.4 m-20 -106.59 147.49 29.4 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.602 -0.686 . . . . 0.0 109.639 -179.703 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 40.2 tp -140.79 133.29 28.51 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.342 -0.849 . . . . 0.0 109.892 179.717 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 35.7 ttpt -117.29 137.78 52.18 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 178.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -161.81 174.91 12.52 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.869 -1.145 . . . . 0.0 110.194 -179.582 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 65.1 tttm -110.32 133.29 53.4 Favored 'General case' 0 N--CA 1.495 1.818 0 CA-C-O 121.517 0.675 . . . . 0.0 109.848 -179.753 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 67.1 t -77.77 126.94 38.5 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 O-C-N 121.369 -0.832 . . . . 0.0 109.745 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 23.2 pt -108.8 -34.0 2.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 179.368 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.68 ' NE2' ' HE1' ' A' ' 28' ' ' TRP . 50.3 tt0 -163.73 133.79 4.24 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.115 -0.991 . . . . 0.0 109.647 178.872 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -131.46 136.64 48.12 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 -179.83 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . 0.68 ' HE1' ' NE2' ' A' ' 26' ' ' GLN . 5.2 m0 -113.96 124.61 52.59 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.472 -0.768 . . . . 0.0 109.493 -179.595 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 2.9 pp20? -64.07 135.16 56.15 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.544 -0.722 . . . . 0.0 109.36 -179.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 55.8 t30 -106.4 134.93 48.76 Favored 'General case' 0 N--CA 1.493 1.689 0 CA-C-O 121.781 0.801 . . . . 0.0 110.371 -179.285 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.437 ' H ' ' HG1' ' A' ' 31' ' ' THR . 13.2 p -99.5 3.72 45.72 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 179.594 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 83.0 t60 -85.95 128.55 34.87 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.297 -0.877 . . . . 0.0 110.104 -179.531 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.516 ' O ' ' CB ' ' A' ' 34' ' ' SER . 22.3 pt-20 -53.97 157.0 2.64 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.484 -0.76 . . . . 0.0 110.723 -179.789 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' SER . . . . . 0.516 ' CB ' ' O ' ' A' ' 33' ' ' GLU . 5.1 p 84.6 -43.01 0.07 Allowed 'General case' 0 N--CA 1.499 1.988 0 N-CA-C 109.384 -0.599 . . . . 0.0 109.384 -179.861 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 96.2 mt -109.9 118.06 56.06 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 CA-C-O 121.617 0.722 . . . . 0.0 109.83 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 44.1 t -77.79 -49.0 15.23 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.604 -0.685 . . . . 0.0 109.51 179.674 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 33.6 tt0 -147.34 153.48 39.75 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.222 -0.924 . . . . 0.0 110.016 -179.708 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 9.1 p -142.95 143.27 25.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.573 -0.704 . . . . 0.0 109.259 179.156 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -173.99 -154.27 10.61 Favored Glycine 0 N--CA 1.485 1.95 0 C-N-CA 119.534 -1.317 . . . . 0.0 109.941 -179.645 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -136.8 151.3 49.01 Favored 'General case' 0 N--CA 1.501 2.082 0 O-C-N 121.555 -0.968 . . . . 0.0 109.494 -179.019 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 66.3 mt -115.08 126.44 54.69 Favored 'General case' 0 N--CA 1.495 1.803 0 CA-C-O 121.597 0.713 . . . . 0.0 109.413 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -75.72 158.69 50.35 Favored Glycine 0 N--CA 1.488 2.157 0 N-CA-C 110.807 -0.917 . . . . 0.0 110.807 -179.443 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -170.97 151.65 3.35 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.519 -0.989 . . . . 0.0 109.07 179.253 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 17.6 pt-20 -59.41 -15.12 14.97 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.27 -0.894 . . . . 0.0 109.546 179.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 39.2 p -92.6 -13.14 30.04 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.093 -1.004 . . . . 0.0 109.279 -179.453 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 140.79 -151.47 22.44 Favored Glycine 0 N--CA 1.496 2.635 0 N-CA-C 109.987 -1.245 . . . . 0.0 109.987 179.353 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 96.7 mt -126.25 138.87 53.27 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 O-C-N 121.729 -0.865 . . . . 0.0 109.234 -179.815 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 9.6 tp -128.28 143.59 40.49 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 CA-C-O 121.789 0.804 . . . . 0.0 110.152 -179.727 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 19.1 mmmt -84.01 147.89 27.18 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.688 -0.633 . . . . 0.0 109.874 180.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 21.1 p90 -144.14 159.95 41.76 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.244 -0.91 . . . . 0.0 109.298 179.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 1.6 t -145.33 141.44 28.53 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.401 -0.812 . . . . 0.0 109.829 179.611 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.417 HG23 HD11 ' A' ' 52' ' ' ILE . 98.4 mt -107.43 118.7 55.67 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 O-C-N 121.573 -0.704 . . . . 0.0 109.316 179.596 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 59.3 m95 -86.34 139.42 30.99 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.158 -0.964 . . . . 0.0 110.139 -179.212 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -49.3 -20.96 0.73 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.408 -0.807 . . . . 0.0 109.875 179.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 9.5 m120 -63.71 -38.04 89.61 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.12 -0.987 . . . . 0.0 109.688 -179.818 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -61.64 -34.63 76.02 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.257 -0.902 . . . . 0.0 109.097 -179.819 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 56.68 38.48 29.57 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.68 -0.638 . . . . 0.0 109.697 -179.722 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 51.1 mt -104.59 147.03 33.75 Favored Pre-proline 0 N--CA 1.496 1.84 0 O-C-N 121.496 -0.752 . . . . 0.0 109.618 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -68.26 162.05 42.03 Favored 'Trans proline' 0 N--CA 1.498 1.758 0 C-N-CA 122.707 2.271 . . . . 0.0 112.811 179.632 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 67.6 mt -64.77 149.79 48.62 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.317 -0.864 . . . . 0.0 110.682 -178.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.424 ' CD1' ' N ' ' A' ' 61' ' ' LEU . 10.7 mp -88.22 138.42 31.46 Favored 'General case' 0 N--CA 1.492 1.666 0 CA-C-O 121.572 0.701 . . . . 0.0 110.188 -179.239 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.467 ' N ' ' OH ' ' A' ' 67' ' ' TYR . 52.9 tp10 -66.43 137.01 56.55 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.407 -0.808 . . . . 0.0 110.054 -179.57 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 49.8 tt0 -73.18 135.66 44.65 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.564 -0.71 . . . . 0.0 110.68 -179.255 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 83.84 29.82 30.87 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 110.037 -1.225 . . . . 0.0 110.037 179.047 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -136.41 146.54 46.53 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.168 -1.195 . . . . 0.0 110.426 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 11.8 p -79.01 152.09 31.16 Favored 'General case' 0 N--CA 1.487 1.4 0 CA-C-O 121.542 0.686 . . . . 0.0 110.141 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.467 ' OH ' ' N ' ' A' ' 62' ' ' GLU . 89.9 m-85 -144.47 147.59 33.48 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.412 -0.805 . . . . 0.0 109.662 179.698 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 15.7 tp -111.36 120.93 43.86 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 179.548 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 60.7 mt -97.32 134.85 40.05 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.534 -0.729 . . . . 0.0 109.313 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 79.1 mtp85 -128.19 138.96 52.7 Favored 'General case' 0 N--CA 1.497 1.897 0 CA-C-O 121.507 0.67 . . . . 0.0 110.388 -179.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 18.4 m 57.12 61.14 2.67 Favored 'General case' 0 N--CA 1.493 1.718 0 CA-C-O 121.005 0.431 . . . . 0.0 110.534 179.47 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 15.5 m -116.03 159.73 15.81 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.993 0 O-C-N 121.49 -0.756 . . . . 0.0 109.441 178.822 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 14.2 p -114.85 134.66 57.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 CA-C-O 121.474 0.654 . . . . 0.0 109.498 -179.361 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 11.7 t -88.29 113.56 25.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.298 -0.876 . . . . 0.0 109.744 -179.294 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -98.57 172.76 26.48 Favored Glycine 0 N--CA 1.493 2.484 0 N-CA-C 109.914 -1.275 . . . . 0.0 109.914 -179.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 81.3 tt0 -112.85 122.77 48.62 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.742 -0.858 . . . . 0.0 109.253 179.661 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 75.7 t80 -135.7 126.59 27.6 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.522 -0.736 . . . . 0.0 109.756 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 9.3 t-20 57.11 44.09 23.09 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.574 -0.704 . . . . 0.0 109.924 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 55.03 28.83 11.34 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.549 -0.72 . . . . 0.0 109.445 179.691 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 71.7 ttt180 -130.78 152.2 50.38 Favored 'General case' 0 N--CA 1.497 1.876 0 CA-C-O 121.516 0.674 . . . . 0.0 109.771 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . 0.488 ' CE1' ' ND2' ' A' ' 14' ' ' ASN . 91.6 m-85 -84.66 142.64 29.76 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.433 -0.792 . . . . 0.0 109.733 -179.835 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 7.1 pt20 -153.24 165.26 36.28 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.15 -0.969 . . . . 0.0 109.711 179.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 3.2 m -109.1 132.35 57.4 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.013 0 O-C-N 121.495 -0.753 . . . . 0.0 109.811 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 23.6 mt-30 -113.3 121.84 45.62 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 -179.777 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 27.8 t -91.18 129.5 41.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.298 -0.876 . . . . 0.0 109.9 -179.655 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 11.2 m-80 -140.88 -177.78 5.24 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.45 -0.781 . . . . 0.0 109.258 179.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.54 ' C ' ' H ' ' A' ' 89' ' ' SER . 63.0 pttt -44.3 164.79 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.575 -0.703 . . . . 0.0 111.02 -179.681 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 5.3 t30 72.15 -29.84 0.2 Allowed 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 -179.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.54 ' H ' ' C ' ' A' ' 87' ' ' LYS . 7.2 m -69.65 150.79 46.64 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.403 -0.81 . . . . 0.0 110.196 -179.522 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 46.9 t -132.56 146.55 51.99 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 96.8 mt -126.14 132.53 70.42 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 O-C-N 121.584 -0.698 . . . . 0.0 109.293 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -125.87 130.3 51.07 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.594 -0.691 . . . . 0.0 109.493 179.649 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 64.5 tttm -79.1 131.21 36.17 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.455 -0.778 . . . . 0.0 109.679 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 85.8 mt -110.22 137.49 47.88 Favored 'General case' 0 N--CA 1.498 1.927 0 CA-C-O 121.792 0.806 . . . . 0.0 110.174 -179.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 93.8 p -85.62 13.49 6.94 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.646 -0.658 . . . . 0.0 109.43 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 86.4 mt-10 -117.4 90.7 35.44 Favored Pre-proline 0 N--CA 1.499 2.002 0 O-C-N 121.674 -0.641 . . . . 0.0 109.491 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_exo -56.15 150.01 50.79 Favored 'Trans proline' 0 N--CA 1.499 1.818 0 C-N-CA 122.946 2.431 . . . . 0.0 112.758 179.518 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.403 ' O ' ' C ' ' A' ' 99' ' ' GLU . 48.1 mm -75.22 0.02 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 121.261 -0.899 . . . . 0.0 109.527 -179.533 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . 0.403 ' C ' ' O ' ' A' ' 98' ' ' ILE . 40.6 tp10 42.33 62.03 1.81 Allowed 'General case' 0 C--N 1.292 -1.911 0 O-C-N 121.882 -0.511 . . . . 0.0 109.669 179.796 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 2.5 p -102.47 -17.21 7.09 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.261 0 O-C-N 121.251 -0.905 . . . . 0.0 109.052 -179.665 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -90.68 113.39 4.25 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.852 -1.299 . . . . 0.0 109.852 -179.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.419 ' N ' ' CD1' ' A' ' 102' ' ' LEU . 10.7 mp -86.3 -3.24 58.95 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.349 -1.089 . . . . 0.0 108.932 179.747 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -64.64 143.12 58.15 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.328 -0.857 . . . . 0.0 110.322 -179.739 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 77.8 m80 -85.71 -6.2 59.16 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.3 -0.875 . . . . 0.0 108.893 179.729 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 77.5 m80 53.34 -120.45 1.69 Allowed 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.454 -0.778 . . . . 0.0 110.294 179.781 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 86.0 t60 -159.36 141.68 13.72 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.081 -1.012 . . . . 0.0 109.029 -179.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 96.6 m-70 -108.76 138.18 45.51 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.48 -0.763 . . . . 0.0 109.843 -179.622 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 52.0 p-80 -77.38 141.97 39.54 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.513 -0.742 . . . . 0.0 110.518 -179.306 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 98.7 m-70 . . . . . 0 N--CA 1.489 1.516 0 CA-C-O 118.006 -0.997 . . . . 0.0 109.613 -179.935 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.0 ttt . . . . . 0 N--CA 1.49 1.547 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.447 ' N ' ' CD ' ' A' ' 3' ' ' PRO . 40.3 mm-40 58.51 52.86 4.85 Favored Pre-proline 0 N--CA 1.493 1.714 0 O-C-N 121.655 -0.653 . . . . 0.0 110.037 -179.657 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.447 ' CD ' ' N ' ' A' ' 2' ' ' GLU . 47.5 Cg_endo -67.04 145.93 75.28 Favored 'Trans proline' 0 N--CA 1.496 1.644 0 C-N-CA 122.717 2.278 . . . . 0.0 112.435 179.731 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 18.3 mm100 -76.6 92.62 3.5 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.082 -1.011 . . . . 0.0 109.58 -179.711 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 72.7 mt -76.34 138.05 40.22 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.501 -0.749 . . . . 0.0 109.638 -179.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 54.1 m -130.09 131.94 45.94 Favored 'General case' 0 N--CA 1.495 1.808 0 CA-C-O 121.427 0.632 . . . . 0.0 109.478 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 65.0 mttp -85.52 157.37 20.44 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.366 -0.834 . . . . 0.0 110.119 -179.51 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 96.2 mt -62.71 -43.48 98.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.352 -0.843 . . . . 0.0 109.393 -179.711 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 12.2 p -66.29 -22.93 30.89 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.206 -0.934 . . . . 0.0 109.667 -179.673 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.408 ' O ' ' OD1' ' A' ' 10' ' ' ASP . 57.7 t0 -73.75 -4.03 32.06 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.2 -0.937 . . . . 0.0 109.388 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 96.6 mt -74.96 125.92 35.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.141 -0.974 . . . . 0.0 109.767 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 4.1 m -129.15 -31.06 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 N-CA-C 109.241 -0.652 . . . . 0.0 109.241 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 -135.08 145.26 47.76 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.379 -0.825 . . . . 0.0 110.296 -179.515 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 64.2 m-80 -78.83 154.88 29.49 Favored 'General case' 0 C--N 1.306 -1.312 0 CA-C-O 121.514 0.673 . . . . 0.0 110.517 -179.595 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 88.69 8.21 70.44 Favored Glycine 0 N--CA 1.492 2.402 0 N-CA-C 109.136 -1.585 . . . . 0.0 109.136 179.638 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 18.4 tt0 -77.29 132.85 38.85 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.371 -1.076 . . . . 0.0 109.992 -179.649 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 89.5 m95 -99.56 134.25 42.7 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.39 -0.819 . . . . 0.0 110.006 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -179.9 -175.1 0.3 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.493 -0.754 . . . . 0.0 109.198 179.463 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.596 ' ND2' ' H ' ' A' ' 71' ' ' SER . 5.4 m120 -105.14 153.31 21.7 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.578 -0.701 . . . . 0.0 109.574 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 54.3 tp -139.58 137.85 35.72 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.536 -0.728 . . . . 0.0 109.303 179.492 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 35.9 ttpt -128.25 133.36 48.79 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.683 -0.635 . . . . 0.0 109.475 179.362 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -168.17 177.7 5.37 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.444 -0.785 . . . . 0.0 109.355 179.317 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.427 ' NZ ' ' O ' ' A' ' 98' ' ' ILE . 17.0 ptpt -107.21 146.28 31.6 Favored 'General case' 0 N--CA 1.496 1.861 0 CA-C-O 121.672 0.749 . . . . 0.0 110.179 -179.563 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 78.9 t -85.03 97.88 5.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.561 -0.712 . . . . 0.0 110.093 -179.282 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 37.2 mm -65.72 -44.8 93.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.484 -0.76 . . . . 0.0 109.089 179.703 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 68.1 tp60 -151.22 148.45 28.24 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.239 -0.913 . . . . 0.0 109.321 179.405 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.538 ' CD2' ' N ' ' A' ' 27' ' ' LEU . 1.3 pt? -128.5 145.22 51.18 Favored 'General case' 0 N--CA 1.494 1.754 0 CA-C-O 121.219 0.533 . . . . 0.0 109.976 -179.857 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 97.6 m95 -128.21 101.53 6.29 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 178.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.586 ' H ' ' CD ' ' A' ' 29' ' ' GLU . 1.6 pm0 -65.69 150.68 48.09 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.583 -0.698 . . . . 0.0 110.605 -178.82 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . 0.518 ' ND2' ' O ' ' A' ' 30' ' ' ASN . 0.7 OUTLIER -144.99 128.94 17.45 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.087 -1.008 . . . . 0.0 109.198 179.09 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 63.3 m -95.21 87.38 4.84 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.452 -0.78 . . . . 0.0 109.55 -178.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 80.8 m80 -131.62 160.61 34.87 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.495 -0.753 . . . . 0.0 109.178 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -66.45 -36.37 82.62 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.465 -0.772 . . . . 0.0 110.532 -179.339 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 20.8 t -100.84 -53.71 2.99 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.219 -0.926 . . . . 0.0 110.435 -179.161 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.486 ' C ' HD22 ' A' ' 30' ' ' ASN . 31.7 mt -78.64 132.22 32.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.183 -0.948 . . . . 0.0 110.199 -178.264 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 8.7 t -98.91 -60.89 1.45 Allowed 'General case' 0 N--CA 1.494 1.727 0 CA-C-O 121.576 0.703 . . . . 0.0 109.283 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -150.36 150.3 31.24 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.257 -0.902 . . . . 0.0 109.565 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 28.7 m -135.57 160.15 39.87 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 O-C-N 121.5 -0.75 . . . . 0.0 109.762 179.724 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 178.6 -166.97 37.13 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -132.9 148.84 52.29 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.404 -1.056 . . . . 0.0 109.898 179.857 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 51.6 mt -111.73 130.72 55.7 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 -179.002 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -97.66 148.31 18.9 Favored Glycine 0 N--CA 1.493 2.493 0 N-CA-C 110.648 -0.981 . . . . 0.0 110.648 -179.362 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.434 ' OD1' ' O ' ' A' ' 46' ' ' GLY . 49.0 p30 -173.24 166.65 4.86 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.691 -0.888 . . . . 0.0 108.948 178.886 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.438 ' OE2' ' NE2' ' A' ' 105' ' ' HIS . 78.5 tt0 -61.56 -16.62 49.51 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.337 -0.852 . . . . 0.0 110.018 -179.347 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 82.7 p -85.48 0.25 52.89 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.952 -1.092 . . . . 0.0 109.212 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.434 ' O ' ' OD1' ' A' ' 43' ' ' ASP . . . 116.05 -147.94 18.9 Favored Glycine 0 N--CA 1.499 2.872 0 N-CA-C 110.241 -1.144 . . . . 0.0 110.241 178.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 96.9 mt -132.57 137.68 53.67 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 121.6 -0.941 . . . . 0.0 109.489 -179.419 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 19.7 tt -134.89 140.88 44.54 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 O-C-N 121.561 -0.712 . . . . 0.0 109.72 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 18.8 mtpp -83.46 155.02 23.63 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.491 -0.755 . . . . 0.0 109.669 -179.806 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 34.2 p90 -141.74 151.83 43.26 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.313 -0.867 . . . . 0.0 109.724 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.444 ' HG1' ' NE2' ' A' ' 82' ' ' GLN . 52.6 m -131.9 130.81 42.09 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 179.723 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 90.7 mt -102.62 124.05 56.35 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.381 -0.825 . . . . 0.0 110.253 -179.295 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 85.3 m95 -92.99 130.97 38.38 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.418 -0.801 . . . . 0.0 108.936 179.698 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 17.4 ptpt -82.51 55.29 2.89 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.23 -0.919 . . . . 0.0 109.632 -179.656 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 90.8 m-20 -76.05 -3.04 33.67 Favored 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 179.503 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -151.03 -91.41 0.06 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.368 -0.832 . . . . 0.0 109.239 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 179.65 70.6 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 179.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 16.7 mt -87.83 146.27 38.53 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.201 -0.937 . . . . 0.0 109.983 -179.105 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -71.46 155.49 59.7 Favored 'Trans proline' 0 N--CA 1.498 1.739 0 C-N-CA 122.656 2.238 . . . . 0.0 112.759 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 79.7 mt -76.43 141.56 41.35 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.398 -0.814 . . . . 0.0 109.95 -179.743 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.469 ' CD1' ' N ' ' A' ' 61' ' ' LEU . 10.0 mp -81.96 145.54 30.23 Favored 'General case' 0 N--CA 1.488 1.458 0 CA-C-O 121.491 0.662 . . . . 0.0 110.286 -179.169 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.545 ' OE1' ' N ' ' A' ' 62' ' ' GLU . 58.2 mp0 -93.14 144.95 24.78 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.404 -0.81 . . . . 0.0 109.922 -179.488 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 57.9 tt0 -76.55 142.25 40.88 Favored 'General case' 0 N--CA 1.489 1.515 0 CA-C-O 121.505 0.669 . . . . 0.0 111.205 -178.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 81.85 21.22 61.85 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 110.253 -1.139 . . . . 0.0 110.253 178.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -130.3 146.29 51.87 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.32 -1.106 . . . . 0.0 110.614 -179.68 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 11.6 p -80.37 151.81 29.22 Favored 'General case' 0 N--CA 1.488 1.473 0 CA-C-O 121.513 0.673 . . . . 0.0 110.002 -179.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.415 ' OH ' ' OE1' ' A' ' 62' ' ' GLU . 97.2 m-85 -144.72 145.64 31.8 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.408 -0.808 . . . . 0.0 109.517 179.803 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 20.2 tp -110.24 122.51 47.81 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 179.398 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 69.6 mt -100.73 134.54 43.55 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 82.6 mtp180 -126.51 140.87 52.12 Favored 'General case' 0 N--CA 1.498 1.964 0 CA-C-O 121.729 0.776 . . . . 0.0 110.701 -179.268 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.596 ' H ' ' ND2' ' A' ' 19' ' ' ASN . 38.3 t 53.58 71.57 0.49 Allowed 'General case' 0 N--CA 1.491 1.583 0 CA-C-O 121.095 0.474 . . . . 0.0 110.514 179.524 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 18.0 m -128.93 164.19 31.9 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.023 0 O-C-N 121.578 -0.701 . . . . 0.0 109.336 178.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 9.7 p -120.45 135.83 59.42 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 CA-C-O 121.416 0.627 . . . . 0.0 109.418 -179.599 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 11.6 t -85.61 115.47 27.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.391 -0.818 . . . . 0.0 110.071 -178.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -94.17 -178.66 38.73 Favored Glycine 0 N--CA 1.492 2.419 0 N-CA-C 109.312 -1.515 . . . . 0.0 109.312 179.772 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -112.0 133.35 54.23 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.663 -0.904 . . . . 0.0 109.629 -179.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 91.3 t80 -136.49 108.1 6.98 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.418 -0.801 . . . . 0.0 109.147 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . 0.537 ' CG ' ' H ' ' A' ' 79' ' ' ASP . 66.7 t30 51.48 -134.38 1.63 Allowed 'General case' 0 N--CA 1.493 1.698 0 CA-C-O 121.603 0.716 . . . . 0.0 110.823 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.537 ' H ' ' CG ' ' A' ' 78' ' ' ASN . 36.5 t70 -87.1 -7.24 58.24 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.344 -0.848 . . . . 0.0 109.201 -179.389 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 85.2 mtp180 -108.56 173.98 6.08 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.711 -0.618 . . . . 0.0 109.763 -179.543 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 72.7 m-85 -104.74 155.85 18.52 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.605 -0.684 . . . . 0.0 109.944 -179.388 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . 0.444 ' NE2' ' HG1' ' A' ' 51' ' ' THR . 51.3 tt0 -138.35 153.19 48.97 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 -179.662 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 3.3 m -116.05 131.94 67.06 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 179.551 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 87.8 mt-30 -101.42 135.28 43.17 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.504 -0.748 . . . . 0.0 110.178 -178.74 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 71.4 t -107.09 130.55 58.97 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 179.274 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 79.2 m-20 -124.83 -179.57 4.58 Favored 'General case' 0 N--CA 1.496 1.854 0 CA-C-O 121.507 0.67 . . . . 0.0 109.911 -179.327 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 64.0 tttp -58.94 -41.0 86.35 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.592 -0.692 . . . . 0.0 110.043 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . 0.411 ' OD1' ' O ' ' A' ' 88' ' ' ASN . 41.9 t-20 -60.5 -35.67 76.51 Favored 'General case' 0 C--N 1.299 -1.602 0 O-C-N 121.109 -0.995 . . . . 0.0 109.112 -179.915 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 30.9 t -70.0 152.76 44.05 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.28 -0.887 . . . . 0.0 110.089 -179.519 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 35.3 t -128.74 148.91 50.88 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.601 -0.687 . . . . 0.0 109.495 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.421 HD12 HG22 ' A' ' 91' ' ' ILE . 96.2 mt -123.66 132.8 70.76 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 O-C-N 121.713 -0.617 . . . . 0.0 109.381 -179.782 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 82.5 tt0 -126.08 131.2 52.17 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 179.392 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 37.8 ttmt -79.81 131.37 35.88 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.487 -0.758 . . . . 0.0 109.923 -179.568 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 9.9 mp -101.08 137.31 39.62 Favored 'General case' 0 N--CA 1.493 1.685 0 CA-C-O 121.615 0.721 . . . . 0.0 109.644 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 70.3 m -90.4 6.33 43.7 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.649 -0.657 . . . . 0.0 109.501 -179.772 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.471 ' N ' ' CD ' ' A' ' 96' ' ' GLU . 1.3 pm0 -116.34 91.67 33.81 Favored Pre-proline 0 N--CA 1.499 1.975 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_exo -53.94 149.24 35.09 Favored 'Trans proline' 0 N--CA 1.495 1.611 0 C-N-CA 122.372 2.048 . . . . 0.0 112.249 -179.811 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.427 ' O ' ' NZ ' ' A' ' 23' ' ' LYS . 96.7 mt -100.62 128.62 52.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 CA-C-O 121.673 0.749 . . . . 0.0 110.644 -178.453 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . 0.535 ' N ' ' OE1' ' A' ' 99' ' ' GLU . 57.9 mp0 -87.59 127.81 35.27 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.577 -0.702 . . . . 0.0 109.383 -179.695 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 3.6 t -101.21 -15.57 7.58 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 O-C-N 121.499 -0.751 . . . . 0.0 109.363 -179.778 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -91.7 -2.71 69.42 Favored Glycine 0 N--CA 1.492 2.409 0 N-CA-C 109.117 -1.593 . . . . 0.0 109.117 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.466 ' O ' ' C ' ' A' ' 103' ' ' GLU . 10.8 tp -61.37 -61.28 2.65 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.286 -1.126 . . . . 0.0 109.89 -179.349 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . 0.466 ' C ' ' O ' ' A' ' 102' ' ' LEU . 10.7 pt-20 31.66 40.38 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.062 0 CA-C-O 121.423 0.63 . . . . 0.0 110.586 -179.641 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . 0.42 ' N ' ' O ' ' A' ' 102' ' ' LEU . 64.9 t60 -66.19 -44.51 83.76 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.451 -0.781 . . . . 0.0 109.254 -179.763 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . 0.438 ' NE2' ' OE2' ' A' ' 44' ' ' GLU . 99.0 m-70 41.13 90.53 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.705 0 CA-C-O 121.416 0.626 . . . . 0.0 110.543 -179.925 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 86.2 t60 -153.85 86.96 1.2 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.288 -0.882 . . . . 0.0 108.738 179.295 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . 0.504 ' C ' ' H ' ' A' ' 109' ' ' HIS . 44.8 p-80 -154.25 161.82 41.56 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.264 -0.898 . . . . 0.0 110.424 -179.83 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 54.5 t-80 50.06 11.01 0.06 Allowed 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.573 -0.704 . . . . 0.0 109.899 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . 0.504 ' H ' ' C ' ' A' ' 107' ' ' HIS . 85.6 t60 . . . . . 0 N--CA 1.491 1.623 0 CA-C-O 117.958 -1.02 . . . . 0.0 109.91 179.534 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.466 ' N ' ' SD ' ' A' ' 1' ' ' MET . 3.9 mpp? . . . . . 0 N--CA 1.489 1.51 0 CA-C-O 121.469 0.652 . . . . 0.0 109.657 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 41.33 57.76 9.04 Favored Pre-proline 0 N--CA 1.495 1.822 0 O-C-N 121.8 -0.563 . . . . 0.0 110.731 -179.82 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -72.97 151.4 50.3 Favored 'Trans proline' 0 N--CA 1.496 1.635 0 C-N-CA 122.605 2.204 . . . . 0.0 112.715 179.617 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 58.9 tt0 -74.59 93.46 2.52 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.237 -0.915 . . . . 0.0 109.586 -179.775 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 86.6 mt -84.93 129.51 34.79 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.428 -0.795 . . . . 0.0 109.579 -179.694 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 98.7 m -127.76 131.21 49.67 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.621 -0.674 . . . . 0.0 110.042 -179.54 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -84.34 158.77 21.05 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.572 -0.705 . . . . 0.0 109.962 -179.79 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 97.3 mt -62.78 -43.7 98.95 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.289 -0.882 . . . . 0.0 109.553 -179.546 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 14.9 p -67.7 -21.94 27.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.188 -0.945 . . . . 0.0 109.404 -179.638 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -76.24 -4.15 40.35 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.373 -0.829 . . . . 0.0 109.184 179.634 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 96.7 mt -80.42 116.13 24.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.305 -0.872 . . . . 0.0 109.353 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 27.0 m -119.52 -19.92 5.15 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.875 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 179.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 22.1 pt-20 -139.34 141.62 37.65 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.42 -0.8 . . . . 0.0 109.955 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 23.3 p30 -86.15 167.0 15.32 Favored 'General case' 0 N--CA 1.491 1.59 0 CA-C-O 121.478 0.656 . . . . 0.0 110.378 -179.619 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 80.57 3.17 90.15 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.188 -1.565 . . . . 0.0 109.188 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 14.5 pt20 -84.58 145.68 27.92 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.321 -1.105 . . . . 0.0 110.106 -179.609 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' TRP . . . . . 0.439 ' CD1' ' N ' ' A' ' 17' ' ' TRP . 31.6 m95 -101.92 138.83 38.37 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.671 -0.643 . . . . 0.0 110.063 -179.593 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.426 ' C ' HD21 ' A' ' 19' ' ' ASN . . . -178.9 -170.08 0.18 Allowed 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 179.358 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.426 HD21 ' C ' ' A' ' 18' ' ' ALA . 3.3 m120 -108.32 149.54 28.52 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.544 -0.723 . . . . 0.0 109.567 -179.85 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -137.7 121.24 17.24 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 179.469 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 36.4 ttpt -110.48 139.75 45.4 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.666 -0.646 . . . . 0.0 109.771 179.577 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -167.78 -174.03 2.31 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.31 -0.868 . . . . 0.0 109.789 179.553 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 76.0 tttt -118.12 144.16 45.89 Favored 'General case' 0 N--CA 1.501 2.085 0 CA-C-O 121.545 0.688 . . . . 0.0 109.733 -179.663 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 4.7 t -78.77 120.88 30.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.429 -0.794 . . . . 0.0 111.059 -178.59 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.4 HG22 HD13 ' A' ' 25' ' ' ILE . 32.7 mm -94.57 -49.05 12.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 179.13 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 57.8 tt0 -153.92 149.68 27.55 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.406 -0.809 . . . . 0.0 109.482 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 95.0 mt -121.0 145.12 48.09 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.762 -0.586 . . . . 0.0 109.832 -179.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 2.1 t-105 -128.95 111.59 13.19 Favored 'General case' 0 N--CA 1.495 1.786 0 CA-C-O 121.55 0.691 . . . . 0.0 109.358 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 39.2 tp10 -65.09 135.86 56.04 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.494 -0.754 . . . . 0.0 109.776 -179.629 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . 0.506 ' C ' ' H ' ' A' ' 32' ' ' HIS . 53.0 t-20 -103.45 -50.18 3.51 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.399 -0.813 . . . . 0.0 109.02 179.893 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 2.3 m 66.36 -4.06 0.75 Allowed 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 -179.7 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . 0.506 ' H ' ' C ' ' A' ' 30' ' ' ASN . 83.9 t60 -83.42 127.57 33.8 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.42 -0.8 . . . . 0.0 109.651 -179.639 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.48 ' O ' ' CB ' ' A' ' 34' ' ' SER . 98.2 mt-10 -40.06 154.99 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.698 -0.626 . . . . 0.0 110.938 -179.534 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' SER . . . . . 0.48 ' CB ' ' O ' ' A' ' 33' ' ' GLU . 0.9 OUTLIER 78.35 -50.0 0.47 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.764 -0.585 . . . . 0.0 109.716 179.964 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.468 ' CG2' HD21 ' A' ' 30' ' ' ASN . 86.8 mt -108.99 128.91 64.48 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 O-C-N 121.477 -0.764 . . . . 0.0 109.605 -179.445 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 24.1 t -87.19 -68.46 0.75 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.616 -0.678 . . . . 0.0 109.901 -179.446 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 89.7 mt-30 -132.95 148.11 52.28 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.514 -0.742 . . . . 0.0 109.447 -179.374 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 44.6 t -128.99 134.46 64.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -158.7 -162.24 11.74 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -140.1 145.5 37.7 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.446 -1.032 . . . . 0.0 109.635 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 45.0 mt -115.04 133.07 56.35 Favored 'General case' 0 N--CA 1.496 1.829 0 CA-C-O 121.575 0.702 . . . . 0.0 109.583 -179.155 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -92.96 140.52 15.11 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 110.385 -1.086 . . . . 0.0 110.385 -179.588 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 39.7 t0 -148.41 159.12 44.34 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.52 -0.988 . . . . 0.0 108.682 179.343 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -66.6 -20.7 66.06 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.221 -0.925 . . . . 0.0 109.669 -179.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 58.4 p -79.66 -10.15 59.75 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.144 -0.973 . . . . 0.0 109.347 -179.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 139.21 -164.3 25.9 Favored Glycine 0 N--CA 1.496 2.677 0 N-CA-C 109.455 -1.458 . . . . 0.0 109.455 179.507 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 34.4 mm -114.58 132.05 64.87 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.0 0 O-C-N 121.631 -0.923 . . . . 0.0 108.81 -179.701 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 18.1 tt -133.5 141.41 44.44 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 O-C-N 121.577 -0.702 . . . . 0.0 110.003 -179.588 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -90.71 156.95 17.7 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.592 -0.692 . . . . 0.0 110.459 -179.349 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 8.6 p90 -146.08 160.51 41.8 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.241 -0.912 . . . . 0.0 109.622 179.501 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 1.6 t -141.25 141.41 34.0 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 179.335 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.419 HG21 HD12 ' A' ' 52' ' ' ILE . 87.5 mt -106.66 125.79 62.53 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 O-C-N 121.53 -0.731 . . . . 0.0 109.734 -179.581 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . 0.529 ' CD1' ' N ' ' A' ' 53' ' ' TRP . 13.5 m95 -99.98 147.59 25.42 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.528 -0.732 . . . . 0.0 109.733 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.535 ' C ' ' H ' ' A' ' 56' ' ' ALA . 54.0 mtmt -67.16 -7.68 25.35 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.431 -0.793 . . . . 0.0 109.448 179.854 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 98.8 m-20 -72.1 26.91 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.199 -0.938 . . . . 0.0 109.844 -179.334 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.535 ' H ' ' C ' ' A' ' 54' ' ' LYS . . . -150.51 -39.33 0.13 Allowed 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 179.62 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 57.8 63.15 1.88 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.839 -0.538 . . . . 0.0 109.867 -179.84 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 17.4 mt -102.85 157.19 34.21 Favored Pre-proline 0 N--CA 1.497 1.892 0 O-C-N 121.567 -0.708 . . . . 0.0 109.599 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -54.97 149.25 43.58 Favored 'Trans proline' 0 N--CA 1.502 2.021 0 C-N-CA 122.292 1.995 . . . . 0.0 113.071 179.546 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 61.8 mt -65.72 140.07 58.42 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.432 -0.793 . . . . 0.0 110.33 -179.102 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.414 ' CD1' ' N ' ' A' ' 61' ' ' LEU . 10.8 mp -77.95 141.84 38.74 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.53 -0.731 . . . . 0.0 110.016 -179.551 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -90.19 150.86 21.81 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.468 -0.77 . . . . 0.0 109.974 -179.815 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 2.9 mm100 -81.96 145.19 30.41 Favored 'General case' 0 N--CA 1.493 1.709 0 CA-C-O 122.018 0.914 . . . . 0.0 112.006 -178.17 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 70.0 31.33 69.63 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 110.576 -1.01 . . . . 0.0 110.576 178.074 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 91.7 mt-10 -136.08 147.68 47.96 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.303 -1.116 . . . . 0.0 110.218 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 10.6 m -80.68 149.68 29.68 Favored 'General case' 0 N--CA 1.487 1.419 0 CA-C-O 121.324 0.583 . . . . 0.0 109.62 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 30.3 m-85 -144.04 142.48 30.68 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.398 -0.814 . . . . 0.0 109.107 179.531 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 14.5 tp -108.57 120.93 43.88 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 179.237 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 76.3 mt -100.51 132.81 45.7 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.512 -0.742 . . . . 0.0 109.297 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.473 ' C ' ' HG ' ' A' ' 71' ' ' SER . 89.8 mtm180 -127.02 131.87 50.88 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.797 -0.564 . . . . 0.0 110.059 -179.956 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.473 ' HG ' ' C ' ' A' ' 70' ' ' ARG . 1.1 m 75.88 54.9 0.06 Allowed 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 179.677 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 15.8 m -117.13 161.34 15.96 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.173 0 O-C-N 121.607 -0.683 . . . . 0.0 109.465 179.236 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 14.1 p -120.47 140.59 44.08 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 CA-C-O 121.499 0.666 . . . . 0.0 109.514 -179.325 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 99.6 t -84.56 120.35 35.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.445 -0.784 . . . . 0.0 110.139 -178.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -97.3 174.42 29.73 Favored Glycine 0 N--CA 1.493 2.48 0 N-CA-C 109.714 -1.354 . . . . 0.0 109.714 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.547 ' N ' ' OE1' ' A' ' 76' ' ' GLU . 54.4 mp0 -112.72 119.48 38.22 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.766 -0.844 . . . . 0.0 109.027 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . 0.528 ' CE2' ' OD1' ' A' ' 78' ' ' ASN . 85.0 t80 -136.98 124.43 22.08 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.418 -0.801 . . . . 0.0 110.139 -179.846 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . 0.528 ' OD1' ' CE2' ' A' ' 77' ' ' TYR . 7.0 m120 55.53 38.37 30.13 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.76 -0.587 . . . . 0.0 109.901 179.356 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 25.7 t0 66.83 -4.08 0.83 Allowed 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.603 -0.686 . . . . 0.0 109.513 179.665 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.47 ' H ' ' C ' ' A' ' 78' ' ' ASN . 80.1 mtp85 -93.72 -177.26 4.31 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.303 -0.873 . . . . 0.0 109.459 179.773 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -114.86 137.17 52.28 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.571 -0.706 . . . . 0.0 109.605 -179.67 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -143.25 159.63 41.98 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.385 -0.822 . . . . 0.0 109.645 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 22.5 m -104.08 131.72 52.21 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 179.662 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -102.25 114.67 29.03 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.356 -0.84 . . . . 0.0 109.422 -179.289 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 12.1 t -88.56 103.67 14.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.458 -0.776 . . . . 0.0 109.277 -179.81 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 2.0 p30 -151.14 -179.76 7.6 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.383 -0.823 . . . . 0.0 109.586 179.773 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.4 ' HG2' ' H ' ' A' ' 88' ' ' ASN . 49.2 tttm 67.43 -132.58 0.13 Allowed 'General case' 0 N--CA 1.495 1.807 0 CA-C-O 121.491 0.663 . . . . 0.0 110.822 179.436 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . 0.409 ' O ' ' C ' ' A' ' 89' ' ' SER . 10.2 m120 -95.47 13.19 26.8 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.244 -0.91 . . . . 0.0 109.047 -179.198 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.409 ' C ' ' O ' ' A' ' 88' ' ' ASN . 97.7 p -40.94 110.18 0.15 Allowed 'General case' 0 N--CA 1.495 1.817 0 CA-C-O 121.589 0.709 . . . . 0.0 109.646 -179.514 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 12.1 m -80.52 151.02 29.41 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.577 -0.702 . . . . 0.0 109.728 -179.051 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.41 HD12 HG21 ' A' ' 91' ' ' ILE . 96.7 mt -132.36 132.07 60.53 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 121.52 -0.738 . . . . 0.0 109.501 179.748 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 52.5 tp10 -128.28 134.61 48.97 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 179.697 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 38.7 ttpt -85.02 131.05 34.52 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.569 -0.707 . . . . 0.0 110.265 -179.457 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.456 ' CD2' ' N ' ' A' ' 94' ' ' LEU . 4.1 mm? -99.32 132.07 44.9 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.472 -0.768 . . . . 0.0 109.601 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 73.2 m -84.26 15.66 3.45 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 179.634 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 17.6 tp10 -118.05 89.83 35.71 Favored Pre-proline 0 N--CA 1.498 1.938 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 179.504 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -57.69 144.49 92.88 Favored 'Trans proline' 0 N--CA 1.498 1.745 0 C-N-CA 122.561 2.174 . . . . 0.0 112.208 179.659 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 90.5 mt -106.05 123.88 60.94 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 O-C-N 121.51 -0.744 . . . . 0.0 109.772 -179.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . 0.549 ' N ' ' OE1' ' A' ' 99' ' ' GLU . 58.7 mp0 -89.49 132.57 34.97 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.5 -0.75 . . . . 0.0 109.592 -179.508 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 7.3 t -88.52 58.12 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 O-C-N 121.38 -0.825 . . . . 0.0 109.254 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 75.53 13.41 82.96 Favored Glycine 0 N--CA 1.494 2.516 0 N-CA-C 109.972 -1.251 . . . . 0.0 109.972 179.521 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.495 ' CD2' ' N ' ' A' ' 102' ' ' LEU . 3.9 mm? -64.08 -42.13 97.08 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.112 -1.228 . . . . 0.0 109.489 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -92.42 108.9 20.31 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.262 -0.899 . . . . 0.0 109.935 -179.355 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . 0.607 ' NE2' ' CD2' ' A' ' 105' ' ' HIS . 11.1 p-80 -86.25 -16.14 38.58 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 179.639 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . 0.607 ' CD2' ' NE2' ' A' ' 104' ' ' HIS . 96.1 m-70 -95.16 14.51 21.87 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 179.719 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' HIS . . . . . 0.529 ' O ' ' N ' ' A' ' 108' ' ' HIS . 79.2 t60 -59.89 -45.65 91.85 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 121.564 -0.71 . . . . 0.0 109.233 179.818 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . 0.441 ' O ' ' N ' ' A' ' 109' ' ' HIS . 70.8 m80 47.81 11.7 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.4 -0.812 . . . . 0.0 109.706 -179.82 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . 0.529 ' N ' ' O ' ' A' ' 106' ' ' HIS . 55.1 p-80 36.68 32.94 0.02 OUTLIER 'General case' 0 N--CA 1.499 2.001 0 CA-C-O 121.444 0.64 . . . . 0.0 110.402 179.875 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . 0.441 ' N ' ' O ' ' A' ' 107' ' ' HIS . 63.4 t-80 . . . . . 0 N--CA 1.489 1.477 0 CA-C-O 118.025 -0.988 . . . . 0.0 109.637 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.456 ' H1 ' ' H ' ' A' ' 2' ' ' GLU . 6.4 ttt . . . . . 0 N--CA 1.491 1.624 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.64 ' N ' ' CD ' ' A' ' 3' ' ' PRO . 2.8 mm-40 -81.22 -38.95 0.99 Allowed Pre-proline 0 N--CA 1.493 1.709 0 O-C-N 121.68 -0.638 . . . . 0.0 109.815 179.457 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.64 ' CD ' ' N ' ' A' ' 2' ' ' GLU . 23.2 Cg_exo -61.37 147.01 96.62 Favored 'Trans proline' 0 N--CA 1.493 1.498 0 C-N-CA 122.484 2.123 . . . . 0.0 112.393 -179.175 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 21.4 mp0 -88.17 75.69 8.59 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.143 -0.973 . . . . 0.0 108.936 179.675 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 84.3 mt -69.45 143.84 53.45 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.47 -0.769 . . . . 0.0 109.665 -179.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 93.9 m -125.15 128.83 49.02 Favored 'General case' 0 N--CA 1.497 1.881 0 CA-C-O 121.735 0.779 . . . . 0.0 109.63 -179.717 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 14.8 mptt -80.22 149.66 30.37 Favored 'General case' 0 C--N 1.302 -1.48 0 CA-C-O 121.86 0.838 . . . . 0.0 109.843 -179.451 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.451 ' H ' ' CD1' ' A' ' 8' ' ' ILE . 2.7 mp -63.15 -43.73 99.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 CA-C-O 121.566 0.698 . . . . 0.0 110.166 -179.451 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 10.0 p -69.76 -19.93 23.21 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.654 0 O-C-N 121.214 -0.929 . . . . 0.0 110.057 -179.253 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -82.05 -3.47 54.69 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.925 -1.109 . . . . 0.0 109.482 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 96.7 mt -79.65 121.02 32.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.056 -1.027 . . . . 0.0 110.012 -179.757 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 33.4 m -136.04 -4.33 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.488 -0.757 . . . . 0.0 109.06 179.445 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -138.11 140.86 40.15 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.026 -1.046 . . . . 0.0 109.845 -179.781 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 57.3 p30 -93.65 162.22 14.03 Favored 'General case' 0 N--CA 1.493 1.7 0 CA-C-O 121.677 0.751 . . . . 0.0 110.521 -179.739 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 79.94 6.03 89.29 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.376 -1.49 . . . . 0.0 109.376 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 -80.97 135.46 35.87 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.202 -1.176 . . . . 0.0 110.275 -179.46 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 85.3 m95 -99.93 136.56 39.65 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.542 -0.724 . . . . 0.0 109.29 179.294 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.441 ' C ' HD21 ' A' ' 19' ' ' ASN . . . -178.03 -172.98 0.35 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.22 -0.925 . . . . 0.0 109.697 -179.895 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.441 HD21 ' C ' ' A' ' 18' ' ' ALA . 3.5 m120 -109.26 149.07 29.97 Favored 'General case' 0 N--CA 1.495 1.819 0 CA-C-O 121.57 0.7 . . . . 0.0 109.648 -179.802 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 6.3 tt -136.93 133.36 35.6 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.357 -0.839 . . . . 0.0 110.128 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 37.6 ttmt -114.6 134.71 54.84 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 179.387 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -165.04 171.07 14.37 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 119.069 -1.052 . . . . 0.0 110.418 -179.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 64.9 tttm -106.26 142.25 36.26 Favored 'General case' 0 N--CA 1.496 1.842 0 CA-C-O 121.75 0.786 . . . . 0.0 110.028 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 92.5 t -79.84 121.98 34.18 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 O-C-N 121.382 -0.824 . . . . 0.0 110.378 -179.439 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.433 HD11 HG21 ' A' ' 25' ' ' ILE . 96.7 mt -100.72 -57.53 4.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 179.141 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 66.5 tp60 -147.79 139.45 23.89 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.058 -1.026 . . . . 0.0 110.08 -179.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.552 ' CD2' ' N ' ' A' ' 27' ' ' LEU . 1.2 pt? -142.96 138.21 29.94 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.741 -0.599 . . . . 0.0 109.618 179.228 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 4.9 m0 -113.03 142.45 45.7 Favored 'General case' 0 N--CA 1.497 1.92 0 CA-C-O 121.634 0.73 . . . . 0.0 109.795 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 3.0 pp20? -80.42 140.52 35.96 Favored 'General case' 0 N--CA 1.491 1.6 0 CA-C-O 121.601 0.715 . . . . 0.0 110.523 -179.355 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 48.8 t30 -101.97 154.95 18.48 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.436 -0.79 . . . . 0.0 109.518 -179.818 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 63.0 m -97.02 -6.21 35.87 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.219 -0.925 . . . . 0.0 109.526 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 93.3 m-70 -80.74 135.06 35.93 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.93 -1.106 . . . . 0.0 110.372 -179.549 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 10.5 tm-20 -67.99 -36.99 80.95 Favored 'General case' 0 N--CA 1.495 1.785 0 CA-C-O 121.647 0.737 . . . . 0.0 109.949 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 42.2 t -61.55 -41.78 97.87 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.237 -0.915 . . . . 0.0 110.096 -179.36 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.412 HD12 HG22 ' A' ' 35' ' ' ILE . 97.5 mt -109.27 130.16 62.76 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 CA-C-O 121.968 0.889 . . . . 0.0 110.368 -179.334 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 19.3 t -74.8 -75.56 0.16 Allowed 'General case' 0 N--CA 1.491 1.617 0 CA-C-O 121.689 0.757 . . . . 0.0 109.642 179.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 -143.04 157.64 44.35 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.145 -0.972 . . . . 0.0 109.623 -179.566 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 13.9 m -132.74 135.01 58.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 CA-C-O 121.61 0.719 . . . . 0.0 109.426 179.771 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -160.34 -164.25 15.07 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 -179.551 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -133.7 148.96 51.51 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.5 -1.0 . . . . 0.0 110.137 -179.814 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 32.1 mt -120.11 136.91 54.43 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 -179.177 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -100.5 137.45 13.27 Favored Glycine 0 N--CA 1.494 2.52 0 N-CA-C 110.368 -1.093 . . . . 0.0 110.368 -179.296 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.552 ' C ' ' H ' ' A' ' 45' ' ' THR . 47.0 t0 -136.61 36.84 2.67 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.484 -1.009 . . . . 0.0 108.679 179.076 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.439 ' C ' ' H ' ' A' ' 46' ' ' GLY . 49.6 mt-10 63.98 -38.92 0.21 Allowed 'General case' 0 N--CA 1.503 2.199 0 CA-C-O 121.418 0.628 . . . . 0.0 110.412 -179.514 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.552 ' H ' ' C ' ' A' ' 43' ' ' ASP . 17.8 p -79.41 22.9 0.42 Allowed 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.051 -1.031 . . . . 0.0 109.707 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.439 ' H ' ' C ' ' A' ' 44' ' ' GLU . . . 114.45 -165.56 12.07 Favored Glycine 0 N--CA 1.498 2.78 0 N-CA-C 110.436 -1.066 . . . . 0.0 110.436 179.324 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 33.7 pt -129.19 145.17 36.17 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 O-C-N 121.673 -0.898 . . . . 0.0 109.457 -179.775 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 18.9 tt -137.95 143.2 33.97 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 O-C-N 121.48 -0.763 . . . . 0.0 109.875 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 32.6 mtmm -83.25 155.12 23.83 Favored 'General case' 0 N--CA 1.493 1.692 0 CA-C-O 121.56 0.695 . . . . 0.0 110.431 -179.485 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 42.8 p90 -144.75 153.37 41.61 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.261 -0.899 . . . . 0.0 109.591 179.833 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 93.7 m -131.24 129.99 42.31 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 179.582 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 96.7 mt -101.41 126.25 55.28 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 121.361 -0.837 . . . . 0.0 109.764 -179.537 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 30.9 m95 -104.18 143.5 32.85 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.489 -0.757 . . . . 0.0 109.011 179.305 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -87.45 44.92 1.22 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.231 -0.918 . . . . 0.0 108.984 179.702 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -61.39 -41.47 97.17 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.478 -0.764 . . . . 0.0 109.279 179.799 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -119.42 -80.69 0.62 Allowed 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.442 -0.786 . . . . 0.0 109.723 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -179.61 82.85 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.133 -0.979 . . . . 0.0 109.164 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 36.6 mt -114.09 96.96 43.9 Favored Pre-proline 0 N--CA 1.5 2.063 0 O-C-N 121.331 -0.856 . . . . 0.0 109.253 -179.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_exo -49.98 157.81 2.57 Favored 'Trans proline' 0 N--CA 1.495 1.582 0 C-N-CA 122.685 2.257 . . . . 0.0 112.896 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 41.4 mt -65.48 141.79 58.37 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.306 -0.871 . . . . 0.0 110.219 -179.043 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.507 ' CD1' ' N ' ' A' ' 61' ' ' LEU . 9.3 mp -85.57 150.94 24.31 Favored 'General case' 0 N--CA 1.493 1.712 0 CA-C-O 121.816 0.817 . . . . 0.0 110.742 -179.295 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -74.61 150.68 39.55 Favored 'General case' 0 N--CA 1.491 1.591 0 CA-C-O 121.882 0.849 . . . . 0.0 110.722 -179.598 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 57.6 tt0 -86.2 138.77 31.63 Favored 'General case' 0 N--CA 1.49 1.526 0 CA-C-O 121.687 0.756 . . . . 0.0 111.185 -179.661 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 81.48 10.94 83.84 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 110.346 -1.102 . . . . 0.0 110.346 178.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -115.77 147.27 41.14 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.343 -1.093 . . . . 0.0 110.57 -179.622 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 15.4 t -80.58 143.55 33.1 Favored 'General case' 0 N--CA 1.49 1.532 0 CA-C-O 121.61 0.719 . . . . 0.0 110.122 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 46.0 m-85 -140.47 147.47 39.66 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.417 -0.802 . . . . 0.0 109.835 179.785 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 19.4 tp -111.11 123.97 51.26 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 179.216 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 13.6 mt -99.04 131.18 45.27 Favored 'General case' 0 N--CA 1.492 1.662 0 CA-C-O 121.388 0.613 . . . . 0.0 110.039 -179.452 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.485 ' O ' ' CB ' ' A' ' 71' ' ' SER . 82.9 mtp180 -129.64 125.98 37.33 Favored 'General case' 0 N--CA 1.494 1.742 0 CA-C-O 121.437 0.637 . . . . 0.0 109.994 179.757 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.485 ' CB ' ' O ' ' A' ' 70' ' ' ARG . 0.9 OUTLIER 82.85 49.91 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.863 0 CA-C-O 121.157 0.503 . . . . 0.0 110.265 179.398 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 15.9 m -113.49 162.06 11.92 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.079 0 O-C-N 121.21 -0.932 . . . . 0.0 109.687 179.387 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 2.7 p -125.44 137.72 56.74 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 CA-C-O 121.763 0.792 . . . . 0.0 109.656 -179.407 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 11.0 t -85.33 113.37 23.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 CA-C-O 121.653 0.739 . . . . 0.0 109.976 -179.499 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -95.22 174.68 32.7 Favored Glycine 0 N--CA 1.493 2.47 0 N-CA-C 109.787 -1.325 . . . . 0.0 109.787 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -109.84 123.19 49.14 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.547 -0.972 . . . . 0.0 109.242 179.72 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 84.7 t80 -132.71 115.99 16.05 Favored 'General case' 0 N--CA 1.493 1.676 0 CA-C-O 121.59 0.709 . . . . 0.0 109.965 -179.618 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 7.7 m120 56.06 38.21 29.67 Favored 'General case' 0 N--CA 1.492 1.672 0 CA-C-O 121.419 0.628 . . . . 0.0 110.088 179.533 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 70.23 -2.55 2.08 Favored 'General case' 0 N--CA 1.497 1.911 0 CA-C-O 121.425 0.631 . . . . 0.0 109.656 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 20.7 mmm180 -98.48 166.26 11.44 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.183 -0.948 . . . . 0.0 109.996 -179.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 60.4 m-85 -88.24 139.78 30.14 Favored 'General case' 0 N--CA 1.488 1.436 0 CA-C-O 121.881 0.848 . . . . 0.0 110.107 -179.104 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 52.9 tt0 -144.4 150.7 38.15 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.388 -0.82 . . . . 0.0 108.833 179.805 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 28.5 m -114.14 128.92 70.9 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 O-C-N 121.526 -0.734 . . . . 0.0 109.165 179.616 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 75.5 mt-30 -107.85 127.22 53.53 Favored 'General case' 0 N--CA 1.495 1.776 0 CA-C-O 121.653 0.739 . . . . 0.0 109.989 -179.215 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 18.8 t -96.64 107.88 20.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 CA-C-O 121.634 0.73 . . . . 0.0 109.229 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.506 ' C ' HD21 ' A' ' 86' ' ' ASN . 0.4 OUTLIER -151.17 -170.05 3.55 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.395 -0.816 . . . . 0.0 109.914 -179.804 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 30.7 ttmt 59.27 37.13 23.74 Favored 'General case' 0 N--CA 1.493 1.724 0 CA-C-O 122.184 0.992 . . . . 0.0 109.879 179.758 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 10.2 t30 55.48 40.64 31.27 Favored 'General case' 0 N--CA 1.49 1.535 0 CA-C-O 121.637 0.732 . . . . 0.0 109.71 179.652 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 14.6 m -54.23 139.96 34.24 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.278 -0.889 . . . . 0.0 109.916 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 7.9 m -81.09 144.19 31.89 Favored 'General case' 0 N--CA 1.49 1.558 0 CA-C-O 121.795 0.807 . . . . 0.0 110.484 -179.092 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 96.6 mt -134.67 133.33 54.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.542 -0.723 . . . . 0.0 109.27 179.812 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -122.41 134.9 54.6 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.512 -0.742 . . . . 0.0 109.145 179.72 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -82.49 125.17 30.8 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.402 -0.811 . . . . 0.0 109.879 -179.649 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.479 ' CD2' ' N ' ' A' ' 94' ' ' LEU . 4.1 mm? -97.3 134.48 40.53 Favored 'General case' 0 N--CA 1.49 1.559 0 CA-C-O 121.911 0.862 . . . . 0.0 109.963 -179.653 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 67.6 m -84.3 -4.57 58.94 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 179.303 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 90.5 mt-10 -104.48 110.36 64.16 Favored Pre-proline 0 N--CA 1.498 1.936 0 O-C-N 121.277 -0.889 . . . . 0.0 109.574 -179.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -74.3 157.38 45.73 Favored 'Trans proline' 0 N--CA 1.493 1.459 0 C-N-CA 122.374 2.049 . . . . 0.0 112.548 -179.365 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 16.6 mm -97.19 126.19 50.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.191 -0.943 . . . . 0.0 109.813 -179.384 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -64.63 129.13 38.66 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.531 -0.731 . . . . 0.0 109.918 -179.673 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 27.3 m -112.1 -7.72 11.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 179.389 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 144.7 69.09 0.02 OUTLIER Glycine 0 N--CA 1.496 2.661 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 179.828 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.503 ' C ' ' H ' ' A' ' 104' ' ' HIS . 2.4 pp -85.19 0.75 50.77 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.24 -1.153 . . . . 0.0 109.115 179.682 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . 0.558 ' O ' ' N ' ' A' ' 105' ' ' HIS . 12.7 pt-20 -48.3 -13.79 0.05 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.176 -0.953 . . . . 0.0 109.428 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . 0.503 ' H ' ' C ' ' A' ' 102' ' ' LEU . 35.9 m80 33.98 -87.33 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.106 0 CA-C-O 121.389 0.614 . . . . 0.0 111.194 179.441 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . 0.558 ' N ' ' O ' ' A' ' 103' ' ' GLU . 85.0 t60 56.99 8.66 0.53 Allowed 'General case' 0 N--CA 1.492 1.662 0 CA-C-O 121.471 0.653 . . . . 0.0 109.379 -179.852 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' HIS . . . . . 0.534 ' O ' ' CG ' ' A' ' 107' ' ' HIS . 72.1 m80 -88.52 54.42 3.04 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.139 -0.975 . . . . 0.0 110.049 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . 0.534 ' CG ' ' O ' ' A' ' 106' ' ' HIS . 41.6 p-80 39.92 -163.16 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.953 0 CA-C-O 121.904 0.859 . . . . 0.0 111.485 179.167 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 45.9 p-80 -151.66 161.43 42.69 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.217 -0.927 . . . . 0.0 109.998 -179.718 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 84.2 t60 . . . . . 0 N--CA 1.491 1.583 0 CA-C-O 118.051 -0.976 . . . . 0.0 109.875 -179.952 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.2 ttt . . . . . 0 N--CA 1.491 1.622 0 CA-C-O 121.398 0.618 . . . . 0.0 109.424 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 5.6 mp0 -70.75 158.77 87.23 Favored Pre-proline 0 C--N 1.302 -1.481 0 O-C-N 121.236 -0.915 . . . . 0.0 109.323 -179.461 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -51.06 144.27 28.95 Favored 'Trans proline' 0 N--CA 1.496 1.635 0 C-N-CA 122.009 1.806 . . . . 0.0 112.498 179.378 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 3.0 tm0? -75.49 70.33 2.34 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.561 -0.712 . . . . 0.0 109.115 179.744 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 72.0 mt -70.63 144.39 51.15 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.329 -0.857 . . . . 0.0 109.788 -179.539 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 64.7 m -124.87 133.04 53.23 Favored 'General case' 0 N--CA 1.497 1.887 0 N-CA-C 108.936 -0.765 . . . . 0.0 108.936 179.822 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 56.2 mtpt -76.02 152.02 37.02 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.318 -0.864 . . . . 0.0 110.573 -178.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 97.2 mt -63.29 -43.42 98.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.519 -0.738 . . . . 0.0 109.377 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 10.0 p -63.68 -24.39 35.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.351 -0.843 . . . . 0.0 109.667 -179.778 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -79.73 -3.82 49.19 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.018 -1.051 . . . . 0.0 109.793 -179.815 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 97.6 mt -80.88 119.16 29.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 120.92 -1.112 . . . . 0.0 109.795 -179.709 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 16.1 m -151.46 12.69 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 N-CA-C 108.947 -0.761 . . . . 0.0 108.947 179.328 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 50.7 tp10 -139.21 139.94 37.62 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.254 -0.904 . . . . 0.0 109.622 -179.829 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 48.8 p-10 -86.89 154.9 20.5 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.347 -0.845 . . . . 0.0 109.881 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 74.43 3.76 67.28 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 179.601 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 39.0 tt0 -71.24 128.61 36.49 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.168 -1.195 . . . . 0.0 109.68 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 88.9 m95 -98.51 138.74 35.28 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.394 -0.816 . . . . 0.0 109.601 -179.655 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -177.55 -178.77 0.77 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.333 -0.854 . . . . 0.0 109.726 179.52 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 80.5 m-20 -109.42 146.11 35.02 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 6.2 tt -144.05 124.99 14.32 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.122 -0.986 . . . . 0.0 109.14 179.796 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 36.4 ttpt -111.31 133.66 53.46 Favored 'General case' 0 N--CA 1.497 1.908 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 179.247 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -164.04 174.32 11.49 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.102 -0.999 . . . . 0.0 109.632 -179.749 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 16.8 ptpt -109.06 148.29 31.04 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.392 -0.818 . . . . 0.0 109.571 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 91.2 t -84.48 128.97 38.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.576 -0.703 . . . . 0.0 110.231 -179.167 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 97.0 mt -95.93 -53.58 8.04 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 N-CA-C 108.401 -0.962 . . . . 0.0 108.401 178.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 69.6 tp60 -149.24 145.21 26.99 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.307 -0.871 . . . . 0.0 109.495 179.443 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.547 ' CD2' ' N ' ' A' ' 27' ' ' LEU . 1.2 pt? -143.33 140.47 30.56 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 179.41 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 39.2 t90 -115.51 125.38 52.96 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 179.748 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -68.51 142.49 55.26 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.301 -0.875 . . . . 0.0 110.015 -179.703 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 13.3 p-10 -156.69 114.78 3.26 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.18 -0.95 . . . . 0.0 109.339 179.606 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.438 ' O ' ' OG1' ' A' ' 31' ' ' THR . 0.0 OUTLIER -100.33 61.28 1.05 Allowed 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.328 -0.858 . . . . 0.0 108.869 -179.856 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 45.8 t-80 -61.57 -49.15 77.8 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.111 -0.993 . . . . 0.0 109.304 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 7.4 tm-20 -174.09 -74.08 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.469 -0.769 . . . . 0.0 109.064 179.602 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 43.2 t -106.59 6.1 29.66 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.457 -0.777 . . . . 0.0 109.448 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 86.3 mt -102.96 128.74 55.59 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 O-C-N 121.271 -0.893 . . . . 0.0 109.593 -179.537 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 41.6 t -86.93 -69.64 0.67 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.482 -0.761 . . . . 0.0 109.993 -179.405 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 97.7 mt-30 -133.43 154.27 50.92 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.298 -0.876 . . . . 0.0 109.656 -179.209 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 15.5 m -130.85 134.87 61.19 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 179.726 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -168.49 -163.72 22.96 Favored Glycine 0 N--CA 1.486 2.008 0 C-N-CA 119.08 -1.533 . . . . 0.0 110.273 -179.329 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.609 ' CD1' ' N ' ' A' ' 40' ' ' LEU . 0.0 OUTLIER -131.93 161.69 32.46 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.914 -0.757 . . . . 0.0 109.37 179.863 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 69.3 mt -120.25 133.46 55.47 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.584 -0.698 . . . . 0.0 109.329 -179.351 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -85.86 141.13 18.42 Favored Glycine 0 N--CA 1.492 2.427 0 N-CA-C 110.01 -1.236 . . . . 0.0 110.01 -179.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 44.0 t0 -151.26 163.73 38.23 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.443 -1.034 . . . . 0.0 109.922 179.826 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -64.21 -20.62 66.16 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.549 -0.719 . . . . 0.0 109.923 -179.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 44.7 p -92.32 -12.23 33.0 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 120.982 -1.074 . . . . 0.0 110.404 -179.283 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 144.81 -155.39 26.4 Favored Glycine 0 N--CA 1.497 2.75 0 C-N-CA 119.916 -1.135 . . . . 0.0 110.281 179.535 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 91.3 mt -125.59 137.18 58.51 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.975 0 O-C-N 121.802 -0.822 . . . . 0.0 108.811 -179.668 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 17.5 tt -129.4 150.05 34.24 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.232 0 O-C-N 121.452 -0.78 . . . . 0.0 110.342 -179.571 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.651 ' NZ ' HH22 ' A' ' 80' ' ' ARG . 14.7 mptt -83.81 151.97 24.88 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.654 -0.654 . . . . 0.0 109.812 -179.695 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 25.2 p90 -143.28 148.47 36.4 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.221 -0.924 . . . . 0.0 108.803 179.072 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 97.4 m -131.57 129.92 41.57 Favored 'General case' 0 N--CA 1.496 1.828 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 179.428 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 88.3 mt -98.07 127.8 50.13 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 O-C-N 121.311 -0.868 . . . . 0.0 110.158 -179.601 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 82.7 m95 -80.35 120.71 24.76 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 178.778 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.484 ' C ' ' H ' ' A' ' 56' ' ' ALA . 73.1 tttt -61.38 -34.34 75.18 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.297 -0.877 . . . . 0.0 108.745 -179.139 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 29.3 t-20 -55.85 -7.55 0.32 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.365 -0.834 . . . . 0.0 109.386 179.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.484 ' H ' ' C ' ' A' ' 54' ' ' LYS . . . -88.1 -25.14 23.17 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.062 -1.024 . . . . 0.0 108.716 179.147 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 51.75 49.6 20.46 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.389 -0.819 . . . . 0.0 110.068 179.578 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 63.9 mt -102.84 152.95 38.54 Favored Pre-proline 0 N--CA 1.498 1.947 0 O-C-N 121.244 -0.91 . . . . 0.0 109.323 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -51.8 146.17 28.96 Favored 'Trans proline' 0 N--CA 1.501 1.937 0 C-N-CA 121.904 1.736 . . . . 0.0 112.766 179.415 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 77.4 mt -71.74 141.89 49.77 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.257 -0.902 . . . . 0.0 109.911 -179.837 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.441 ' CD1' ' N ' ' A' ' 61' ' ' LEU . 10.5 mp -79.19 146.38 33.13 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.472 -0.767 . . . . 0.0 109.976 -179.289 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 51.4 tp10 -88.17 147.62 24.79 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.268 -0.895 . . . . 0.0 109.538 -179.577 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.531 ' OE1' ' N ' ' A' ' 64' ' ' GLY . 0.2 OUTLIER -81.71 126.26 31.58 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.276 -0.89 . . . . 0.0 110.093 -179.743 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.531 ' N ' ' OE1' ' A' ' 63' ' ' GLN . . . 86.32 32.22 17.25 Favored Glycine 0 N--CA 1.495 2.628 0 N-CA-C 110.423 -1.071 . . . . 0.0 110.423 179.178 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -137.23 147.85 46.07 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.126 -1.22 . . . . 0.0 109.91 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 14.4 m -78.51 143.34 36.68 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.7 -0.625 . . . . 0.0 109.788 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 51.0 m-85 -139.71 141.37 36.93 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.492 -0.755 . . . . 0.0 109.501 179.27 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 15.1 tp -103.72 120.03 40.12 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 107.964 -1.124 . . . . 0.0 107.964 178.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 75.7 mt -105.85 129.38 54.03 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 -179.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -125.54 143.71 50.89 Favored 'General case' 0 N--CA 1.503 2.225 0 O-C-N 121.413 -0.804 . . . . 0.0 111.141 -179.181 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.6 m 61.82 46.1 7.16 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.916 -0.49 . . . . 0.0 110.714 179.124 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 8.0 m -99.3 162.05 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.978 0 O-C-N 121.016 -1.052 . . . . 0.0 109.139 179.133 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 7.5 p -122.52 139.5 49.22 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 -179.788 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 63.8 t -89.33 115.25 28.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.237 -0.914 . . . . 0.0 109.612 -179.444 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -99.56 151.4 19.31 Favored Glycine 0 N--CA 1.499 2.842 0 N-CA-C 109.79 -1.324 . . . . 0.0 109.79 -179.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -68.46 137.19 54.25 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.338 -1.095 . . . . 0.0 110.072 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . 0.51 ' O ' ' N ' ' A' ' 79' ' ' ASP . 42.1 t80 -131.06 126.25 35.34 Favored 'General case' 0 N--CA 1.497 1.917 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 179.385 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . 0.436 ' C ' ' O ' ' A' ' 77' ' ' TYR . 9.1 m120 -35.35 -30.29 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.047 0 CA-C-O 121.115 0.483 . . . . 0.0 110.469 -179.058 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.51 ' N ' ' O ' ' A' ' 77' ' ' TYR . 96.7 m-20 -113.37 67.9 0.67 Allowed 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.594 -0.691 . . . . 0.0 109.942 179.48 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.651 HH22 ' NZ ' ' A' ' 49' ' ' LYS . 83.8 mtm180 85.62 -159.29 0.01 OUTLIER 'General case' 0 N--CA 1.508 2.473 0 CA-C-O 121.384 0.612 . . . . 0.0 110.514 178.262 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -103.52 151.89 22.33 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.526 -0.734 . . . . 0.0 109.519 -179.091 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -136.57 166.47 23.45 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.382 -0.824 . . . . 0.0 109.284 -179.63 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 18.8 m -105.89 130.49 57.32 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 179.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 87.5 mt-30 -106.45 131.18 53.94 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.429 -0.794 . . . . 0.0 110.49 -178.704 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 19.5 t -91.83 131.34 39.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 N-CA-C 109.006 -0.738 . . . . 0.0 109.006 179.449 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 99.9 m-20 -126.34 175.45 7.83 Favored 'General case' 0 N--CA 1.501 2.091 0 CA-C-O 121.79 0.805 . . . . 0.0 110.277 -179.459 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 63.8 tttm -56.64 -44.02 80.86 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.636 -0.665 . . . . 0.0 110.495 -179.57 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 10.4 m120 -63.77 -33.38 75.54 Favored 'General case' 0 C--N 1.297 -1.716 0 O-C-N 121.088 -1.007 . . . . 0.0 110.359 -179.207 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 59.8 m -60.66 147.44 41.98 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.987 -1.071 . . . . 0.0 110.786 -178.656 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 7.0 m -113.27 149.18 34.22 Favored 'General case' 0 N--CA 1.499 2.005 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 179.618 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.436 HG22 HD13 ' A' ' 91' ' ' ILE . 96.6 mt -131.35 131.47 63.18 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.041 0 O-C-N 121.44 -0.787 . . . . 0.0 109.597 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -133.01 133.46 43.15 Favored 'General case' 0 N--CA 1.501 2.095 0 O-C-N 121.386 -0.821 . . . . 0.0 108.921 178.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -82.58 124.75 30.43 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.34 -0.85 . . . . 0.0 109.185 -179.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.446 ' CD2' ' N ' ' A' ' 94' ' ' LEU . 4.1 mm? -96.87 137.01 36.6 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.273 -0.892 . . . . 0.0 109.93 -179.322 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 93.7 p -82.4 -5.3 58.56 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 179.697 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -103.13 109.91 62.55 Favored Pre-proline 0 N--CA 1.497 1.881 0 O-C-N 121.37 -0.831 . . . . 0.0 109.421 -179.389 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -74.9 159.45 41.66 Favored 'Trans proline' 0 N--CA 1.494 1.503 0 C-N-CA 121.835 1.69 . . . . 0.0 112.082 -179.307 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.406 HD13 HG21 ' A' ' 98' ' ' ILE . 96.8 mt -99.17 126.8 52.36 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 O-C-N 121.241 -0.912 . . . . 0.0 109.609 -179.741 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -78.22 122.15 25.31 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.506 -0.746 . . . . 0.0 109.886 -179.574 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 5.5 t -106.97 -12.73 10.1 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.994 0 O-C-N 121.5 -0.75 . . . . 0.0 109.205 179.818 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 144.32 60.01 0.02 OUTLIER Glycine 0 N--CA 1.496 2.645 0 N-CA-C 109.676 -1.37 . . . . 0.0 109.676 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 45.8 tp -62.89 -43.92 97.49 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.903 -1.351 . . . . 0.0 109.513 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . 0.465 ' O ' ' N ' ' A' ' 105' ' ' HIS . 80.9 tt0 -93.03 114.72 27.35 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.103 -0.998 . . . . 0.0 109.874 -179.832 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . 0.404 ' C ' ' O ' ' A' ' 103' ' ' GLU . 86.3 t60 40.8 -94.76 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.582 -0.699 . . . . 0.0 110.538 179.643 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . 0.465 ' N ' ' O ' ' A' ' 103' ' ' GLU . 84.0 m-70 -152.03 167.47 28.34 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.066 -1.021 . . . . 0.0 110.111 -179.911 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' HIS . . . . . 0.483 ' ND1' ' N ' ' A' ' 107' ' ' HIS . 63.6 t-80 -60.06 165.12 3.52 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.511 -0.743 . . . . 0.0 110.781 -179.133 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . 0.483 ' N ' ' ND1' ' A' ' 106' ' ' HIS . 85.3 t60 50.09 16.56 0.25 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.485 -0.759 . . . . 0.0 109.475 -179.833 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . 0.409 ' C ' ' O ' ' A' ' 107' ' ' HIS . 97.4 m-70 40.64 -124.49 0.47 Allowed 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.62 -0.675 . . . . 0.0 110.484 179.483 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 85.5 t60 . . . . . 0 N--CA 1.489 1.504 0 CA-C-O 118.085 -0.96 . . . . 0.0 109.166 -179.936 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 97.0 mmm . . . . . 0 N--CA 1.491 1.595 0 CA-C-O 121.593 0.711 . . . . 0.0 109.882 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -176.01 77.28 0.28 Allowed Pre-proline 0 N--CA 1.493 1.722 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 21.5 Cg_exo -62.54 148.4 93.39 Favored 'Trans proline' 0 N--CA 1.493 1.445 0 C-N-CA 122.936 2.424 . . . . 0.0 112.049 179.778 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 78.7 mt-30 -88.98 79.96 7.17 Favored 'General case' 0 N--CA 1.489 1.511 0 CA-C-O 121.915 0.864 . . . . 0.0 109.417 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -59.68 133.41 56.07 Favored 'General case' 0 N--CA 1.489 1.501 0 CA-C-O 121.829 0.823 . . . . 0.0 109.762 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 97.1 m -128.28 128.48 44.72 Favored 'General case' 0 N--CA 1.491 1.577 0 CA-C-O 121.852 0.834 . . . . 0.0 109.361 179.796 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -90.85 154.4 19.52 Favored 'General case' 0 C--N 1.301 -1.527 0 CA-C-O 121.768 0.794 . . . . 0.0 109.818 -179.592 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 66.3 mt -63.2 -43.84 99.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.699 -0.626 . . . . 0.0 109.708 -179.39 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 12.4 p -65.07 -22.4 31.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.47 -0.769 . . . . 0.0 109.807 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 96.5 m-20 -80.99 -2.63 48.67 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.385 -0.822 . . . . 0.0 109.611 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 97.6 mt -85.51 112.04 21.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.426 -0.796 . . . . 0.0 109.958 -179.743 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 22.3 m -135.73 -2.79 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 179.318 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -140.39 143.85 35.9 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.479 -0.763 . . . . 0.0 109.941 179.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 52.2 p30 -90.66 161.15 15.51 Favored 'General case' 0 N--CA 1.492 1.672 0 CA-C-O 121.872 0.844 . . . . 0.0 110.495 -179.704 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 79.63 15.89 78.69 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.289 -1.524 . . . . 0.0 109.289 -179.814 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 52.5 tt0 -81.54 132.5 35.31 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.477 -1.013 . . . . 0.0 110.195 -179.286 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 76.9 m95 -106.31 132.99 51.7 Favored 'General case' 0 N--CA 1.495 1.786 0 CA-C-O 121.451 0.643 . . . . 0.0 109.465 179.705 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 179.71 -172.64 0.19 Allowed 'General case' 0 N--CA 1.491 1.619 0 CA-C-O 121.745 0.783 . . . . 0.0 109.962 179.806 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.54 ' ND2' ' N ' ' A' ' 20' ' ' LEU . 0.4 OUTLIER -100.18 152.34 20.37 Favored 'General case' 0 N--CA 1.493 1.701 0 CA-C-O 121.544 0.688 . . . . 0.0 109.73 -179.956 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.54 ' N ' ' ND2' ' A' ' 19' ' ' ASN . 7.2 tp -135.84 129.73 32.84 Favored 'General case' 0 N--CA 1.49 1.573 0 CA-C-O 121.745 0.783 . . . . 0.0 110.057 -179.916 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 38.3 ttmt -119.53 132.83 55.84 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 179.602 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -165.09 178.25 7.15 Favored 'General case' 0 N--CA 1.495 1.789 0 C-N-CA 119.331 -0.947 . . . . 0.0 110.809 -179.542 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 65.1 tttm -112.11 143.45 43.13 Favored 'General case' 0 N--CA 1.496 1.873 0 CA-C-O 121.713 0.768 . . . . 0.0 110.059 -179.676 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 91.4 t -84.96 122.42 38.14 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 CA-C-O 121.884 0.849 . . . . 0.0 110.513 -179.046 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.467 ' C ' HE21 ' A' ' 63' ' ' GLN . 23.8 mm -100.66 -48.91 11.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 178.755 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 69.3 tp60 -149.3 144.15 26.28 Favored 'General case' 0 N--CA 1.488 1.454 0 CA-C-O 121.71 0.767 . . . . 0.0 109.816 179.461 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.6 ' CD2' ' N ' ' A' ' 27' ' ' LEU . 0.4 OUTLIER -141.71 136.42 30.79 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 179.866 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 3.7 m-90 -115.14 122.49 46.25 Favored 'General case' 0 N--CA 1.496 1.851 0 CA-C-O 121.838 0.828 . . . . 0.0 109.618 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 49.6 tp10 -62.3 140.47 58.5 Favored 'General case' 0 N--CA 1.491 1.602 0 CA-C-O 121.541 0.686 . . . . 0.0 110.047 -179.369 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . 0.683 HD22 ' CD2' ' A' ' 32' ' ' HIS . 7.2 t30 -132.54 124.57 28.7 Favored 'General case' 0 N--CA 1.494 1.765 0 CA-C-O 121.481 0.657 . . . . 0.0 109.625 179.863 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 17.2 p -121.86 51.51 1.33 Allowed 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 108.55 -0.908 . . . . 0.0 108.55 179.566 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . 0.683 ' CD2' HD22 ' A' ' 30' ' ' ASN . 13.0 m-70 -92.58 8.18 40.08 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 109.249 -0.648 . . . . 0.0 109.249 179.894 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 24.1 tp10 69.48 -13.25 0.39 Allowed 'General case' 0 N--CA 1.49 1.567 0 CA-C-O 121.325 0.583 . . . . 0.0 109.463 -179.827 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' SER . . . . . 0.539 ' H ' ' C ' ' A' ' 32' ' ' HIS . 32.2 t -106.6 -34.94 7.19 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.498 -0.751 . . . . 0.0 109.632 179.713 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 96.6 mt -125.09 123.6 65.75 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.129 0 O-C-N 121.27 -0.894 . . . . 0.0 109.538 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 5.8 t -68.81 -51.64 38.64 Favored 'General case' 0 N--CA 1.494 1.728 0 CA-C-O 121.523 0.677 . . . . 0.0 109.435 179.667 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 51.0 tt0 -157.53 153.3 26.77 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.515 -0.74 . . . . 0.0 109.69 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.7 p -142.99 145.7 22.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 179.653 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -175.17 -157.94 17.83 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.781 -1.327 . . . . 0.0 109.781 -179.589 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.9 pp -135.39 149.44 49.65 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.891 -0.77 . . . . 0.0 110.432 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 69.4 mt -117.24 132.13 56.69 Favored 'General case' 0 N--CA 1.498 1.933 0 CA-C-O 121.817 0.818 . . . . 0.0 109.647 -179.469 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -80.58 162.41 45.36 Favored Glycine 0 N--CA 1.488 2.147 0 N-CA-C 110.859 -0.896 . . . . 0.0 110.859 -179.577 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.531 ' OD1' ' N ' ' A' ' 44' ' ' GLU . 67.5 t0 -170.02 144.37 2.69 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.531 ' N ' ' OD1' ' A' ' 43' ' ' ASP . 19.1 pt-20 -59.84 -16.16 26.49 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.617 -0.677 . . . . 0.0 109.693 -179.788 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 36.2 p -91.25 -7.91 49.88 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 179.638 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 139.24 -153.61 22.98 Favored Glycine 0 N--CA 1.496 2.635 0 N-CA-C 109.81 -1.316 . . . . 0.0 109.81 179.414 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 36.1 pt -127.94 148.34 32.54 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.875 0 O-C-N 121.881 -0.776 . . . . 0.0 109.543 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 18.1 tt -141.69 138.58 31.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 CA-C-O 121.743 0.782 . . . . 0.0 110.034 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 68.9 mttm -83.75 156.86 22.34 Favored 'General case' 0 N--CA 1.49 1.545 0 CA-C-O 121.46 0.648 . . . . 0.0 109.981 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 28.2 p90 -148.62 150.44 33.27 Favored 'General case' 0 N--CA 1.491 1.599 0 CA-C-O 121.769 0.795 . . . . 0.0 109.991 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 97.8 m -130.24 129.81 43.81 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 179.575 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.409 HD12 HG22 ' A' ' 52' ' ' ILE . 92.8 mt -103.18 125.7 57.6 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 CA-C-O 121.904 0.859 . . . . 0.0 110.221 -179.423 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 96.6 m95 -86.71 142.13 28.41 Favored 'General case' 0 N--CA 1.49 1.556 0 CA-C-O 121.78 0.8 . . . . 0.0 109.881 -179.802 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 25.9 mtpp -66.49 -12.69 58.69 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.655 -0.653 . . . . 0.0 109.434 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 -64.35 -38.62 91.69 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.598 -0.689 . . . . 0.0 109.865 179.729 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -63.19 -37.03 85.63 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.402 -0.811 . . . . 0.0 109.661 -179.668 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 57.31 47.15 17.25 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 32.4 mt -108.91 153.66 42.31 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.829 -0.544 . . . . 0.0 109.677 -179.814 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -55.89 147.75 60.69 Favored 'Trans proline' 0 N--CA 1.5 1.87 0 C-N-CA 123.067 2.511 . . . . 0.0 113.602 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 78.1 mt -70.74 144.27 50.99 Favored 'General case' 0 N--CA 1.492 1.631 0 CA-C-O 122.021 0.915 . . . . 0.0 110.479 -179.644 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.439 ' CD1' ' N ' ' A' ' 61' ' ' LEU . 10.0 mp -77.33 147.28 36.26 Favored 'General case' 0 N--CA 1.49 1.538 0 CA-C-O 121.733 0.778 . . . . 0.0 109.827 -179.899 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.555 ' H ' ' HH ' ' A' ' 67' ' ' TYR . 80.3 mm-40 -88.64 155.9 19.34 Favored 'General case' 0 N--CA 1.492 1.643 0 CA-C-O 121.968 0.89 . . . . 0.0 110.109 -179.755 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.474 ' CD ' ' N ' ' A' ' 64' ' ' GLY . 6.8 tm0? -83.52 136.16 34.37 Favored 'General case' 0 C--N 1.301 -1.536 0 CA-C-O 121.889 0.852 . . . . 0.0 110.838 -179.2 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.474 ' N ' ' CD ' ' A' ' 63' ' ' GLN . . . 82.18 0.99 90.25 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 110.003 -1.239 . . . . 0.0 110.003 179.145 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 -106.73 146.49 30.76 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.605 -0.938 . . . . 0.0 110.476 -179.513 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 6.1 m -86.25 148.38 25.66 Favored 'General case' 0 N--CA 1.489 1.496 0 CA-C-O 121.645 0.736 . . . . 0.0 109.98 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.555 ' HH ' ' H ' ' A' ' 62' ' ' GLU . 65.1 m-85 -141.66 150.46 41.95 Favored 'General case' 0 N--CA 1.492 1.642 0 CA-C-O 122.016 0.912 . . . . 0.0 110.616 -179.709 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.517 ' CD1' HD22 ' A' ' 19' ' ' ASN . 31.5 tp -113.1 120.65 42.04 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.717 -0.845 . . . . 0.0 108.717 179.334 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 75.5 mt -102.04 126.87 49.08 Favored 'General case' 0 N--CA 1.491 1.612 0 CA-C-O 121.465 0.65 . . . . 0.0 109.376 -179.508 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.431 ' O ' ' CB ' ' A' ' 71' ' ' SER . 80.8 mtp180 -123.82 129.02 50.36 Favored 'General case' 0 N--CA 1.496 1.874 0 CA-C-O 121.714 0.768 . . . . 0.0 109.853 -179.697 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.431 ' CB ' ' O ' ' A' ' 70' ' ' ARG . 1.5 t 78.7 65.41 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.368 179.661 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 30.8 m -128.14 163.82 31.24 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 179.187 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 12.5 p -121.63 135.16 62.68 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 CA-C-O 121.72 0.771 . . . . 0.0 109.936 -179.524 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 12.5 t -89.94 114.83 28.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 CA-C-O 121.81 0.814 . . . . 0.0 109.482 -179.558 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -91.48 174.37 38.1 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 110.51 -1.036 . . . . 0.0 110.51 -179.292 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 82.8 tt0 -100.84 117.78 35.59 Favored 'General case' 0 N--CA 1.492 1.67 0 CA-C-O 121.997 0.903 . . . . 0.0 109.692 -179.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . 0.559 ' CD1' ' N ' ' A' ' 78' ' ' ASN . 27.2 t80 -101.53 162.75 12.67 Favored 'General case' 0 N--CA 1.493 1.71 0 CA-C-O 121.747 0.784 . . . . 0.0 109.854 -179.803 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . 0.559 ' N ' ' CD1' ' A' ' 77' ' ' TYR . 24.3 t-20 -53.19 104.37 0.09 Allowed 'General case' 0 N--CA 1.494 1.749 0 CA-C-O 122.323 1.059 . . . . 0.0 110.63 -179.182 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 43.1 t0 57.66 16.69 3.58 Favored 'General case' 0 N--CA 1.492 1.646 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.372 179.747 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 78.1 mtp85 -148.78 -167.51 2.84 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.182 -0.949 . . . . 0.0 110.087 179.587 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 80.4 m-85 -127.94 151.24 49.34 Favored 'General case' 0 N--CA 1.495 1.807 0 CA-C-O 121.654 0.74 . . . . 0.0 109.64 -179.713 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 49.0 tt0 -145.22 153.12 41.0 Favored 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 13.6 m -113.1 130.72 66.48 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 179.423 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 78.8 mt-30 -111.68 129.93 55.94 Favored 'General case' 0 N--CA 1.496 1.866 0 CA-C-O 121.658 0.742 . . . . 0.0 110.411 -178.678 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 3.0 t -103.34 119.01 51.24 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 CA-C-O 121.596 0.712 . . . . 0.0 109.727 179.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.549 ' N ' HD21 ' A' ' 86' ' ' ASN . 0.0 OUTLIER -147.01 -166.9 2.63 Favored 'General case' 0 N--CA 1.493 1.722 0 CA-C-O 121.714 0.769 . . . . 0.0 109.872 -179.411 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 38.1 ttmt 59.34 -89.13 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.654 0 CA-C-O 121.432 0.634 . . . . 0.0 110.52 -179.772 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 26.5 t-20 -169.96 46.62 0.03 OUTLIER 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 108.731 -0.841 . . . . 0.0 108.731 -179.216 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 34.9 t -55.56 136.19 50.33 Favored 'General case' 0 N--CA 1.496 1.873 0 CA-C-O 121.767 0.794 . . . . 0.0 109.709 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 1.4 t -79.55 140.83 37.09 Favored 'General case' 0 N--CA 1.491 1.584 0 CA-C-O 121.614 0.721 . . . . 0.0 110.338 -179.316 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 97.4 mt -128.46 130.67 69.19 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 121.836 -0.54 . . . . 0.0 109.586 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 47.7 tp10 -127.73 130.76 49.35 Favored 'General case' 0 N--CA 1.495 1.817 0 CA-C-O 121.827 0.822 . . . . 0.0 109.235 179.752 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 65.7 tttm -81.43 132.36 35.32 Favored 'General case' 0 N--CA 1.49 1.552 0 CA-C-O 121.856 0.836 . . . . 0.0 110.416 -179.385 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 65.8 mt -103.26 131.07 50.61 Favored 'General case' 0 N--CA 1.492 1.663 0 CA-C-O 121.703 0.763 . . . . 0.0 109.545 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 10.1 t -83.52 6.58 19.93 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 179.775 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 33.5 mm-40 -118.04 90.61 37.74 Favored Pre-proline 0 N--CA 1.499 2.024 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 179.308 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_exo -56.22 147.57 65.35 Favored 'Trans proline' 0 N--CA 1.494 1.552 0 C-N-CA 122.886 2.39 . . . . 0.0 112.516 179.739 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 93.9 mt -99.41 127.24 52.36 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 CA-C-O 121.885 0.85 . . . . 0.0 110.06 -179.497 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . 0.565 ' CD ' ' H ' ' A' ' 99' ' ' GLU . 0.9 OUTLIER -90.83 138.02 31.91 Favored 'General case' 0 C--N 1.301 -1.516 0 CA-C-O 121.496 0.665 . . . . 0.0 109.41 -179.935 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 25.2 m -105.55 -15.36 8.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 179.727 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -93.06 97.91 2.32 Favored Glycine 0 N--CA 1.497 2.726 0 N-CA-C 109.831 -1.308 . . . . 0.0 109.831 179.662 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.543 ' CD2' ' N ' ' A' ' 102' ' ' LEU . 3.7 mm? -89.11 -6.41 57.06 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.581 -0.952 . . . . 0.0 109.244 -179.907 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 52.7 38.87 27.34 Favored 'General case' 0 N--CA 1.489 1.485 0 CA-C-O 121.726 0.774 . . . . 0.0 109.175 179.577 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . 0.549 ' HD1' ' H ' ' A' ' 106' ' ' HIS . 30.6 t-80 -69.33 134.68 49.39 Favored 'General case' 0 N--CA 1.496 1.87 0 CA-C-O 121.873 0.844 . . . . 0.0 110.693 -179.153 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 86.4 t60 -66.39 -42.82 87.32 Favored 'General case' 0 N--CA 1.493 1.678 0 CA-C-O 121.393 0.616 . . . . 0.0 109.823 179.77 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' HIS . . . . . 0.549 ' H ' ' HD1' ' A' ' 104' ' ' HIS . 86.4 t60 -61.28 -44.22 97.58 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.528 -0.732 . . . . 0.0 109.835 -179.845 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 61.4 t-80 -126.37 128.54 47.21 Favored 'General case' 0 N--CA 1.497 1.896 0 CA-C-O 121.658 0.742 . . . . 0.0 109.798 -179.585 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . 0.412 ' C ' ' HD1' ' A' ' 108' ' ' HIS . 2.0 p80 -152.02 164.13 37.86 Favored 'General case' 0 N--CA 1.492 1.674 0 CA-C-O 121.491 0.662 . . . . 0.0 109.702 -179.882 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.492 1.636 0 CA-C-O 118.063 -0.97 . . . . 0.0 109.29 179.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 67.1 mtt . . . . . 0 N--CA 1.49 1.538 0 CA-C-O 121.662 0.744 . . . . 0.0 109.0 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.644 ' N ' ' CD ' ' A' ' 3' ' ' PRO . 1.7 mt-10 -74.03 -38.08 3.56 Favored Pre-proline 0 N--CA 1.495 1.809 0 O-C-N 121.564 -0.71 . . . . 0.0 110.126 179.811 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.644 ' CD ' ' N ' ' A' ' 2' ' ' GLU . 52.3 Cg_exo -58.06 145.46 91.85 Favored 'Trans proline' 0 N--CA 1.494 1.518 0 C-N-CA 122.616 2.211 . . . . 0.0 112.8 -179.19 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 27.6 mp0 -89.7 69.26 7.7 Favored 'General case' 0 N--CA 1.489 1.515 0 CA-C-O 121.844 0.83 . . . . 0.0 109.094 -179.827 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 71.9 mt -65.69 139.87 58.42 Favored 'General case' 0 N--CA 1.492 1.634 0 CA-C-O 121.63 0.728 . . . . 0.0 110.34 -179.422 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 92.3 m -128.83 132.15 47.77 Favored 'General case' 0 N--CA 1.493 1.693 0 CA-C-O 121.606 0.717 . . . . 0.0 109.576 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -75.35 146.86 40.55 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.461 -0.775 . . . . 0.0 109.998 -179.74 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 96.5 mt -63.84 -43.09 97.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.554 -0.716 . . . . 0.0 110.449 -179.563 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 13.2 p -62.06 -22.73 29.68 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.129 -0.982 . . . . 0.0 109.547 -179.783 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 51.7 t0 -76.17 -5.81 48.42 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.301 -0.874 . . . . 0.0 109.61 179.831 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 96.6 mt -82.4 119.32 31.71 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.038 -1.039 . . . . 0.0 110.23 -179.81 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 3.3 m -151.11 14.53 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 N-CA-C 108.582 -0.895 . . . . 0.0 108.582 179.65 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -138.04 145.24 41.58 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.419 -0.801 . . . . 0.0 110.019 -179.859 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 -82.78 144.39 30.19 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-O 121.682 0.753 . . . . 0.0 110.459 -179.796 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 65.99 110.9 0.01 OUTLIER Glycine 0 N--CA 1.491 2.331 0 N-CA-C 110.617 -0.993 . . . . 0.0 110.617 179.136 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 8.5 tt0 -169.47 130.26 1.08 Allowed 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.306 -1.114 . . . . 0.0 109.505 179.226 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 98.7 m95 -93.82 129.94 40.02 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.663 -0.648 . . . . 0.0 109.897 -179.668 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -175.59 171.53 2.76 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.535 -0.728 . . . . 0.0 109.695 179.749 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 67.0 m-20 -103.56 143.55 32.59 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.566 -0.709 . . . . 0.0 109.546 -179.679 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 5.0 mp -138.56 145.59 40.83 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.367 -0.833 . . . . 0.0 109.974 -179.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 33.9 ttmt -119.71 136.08 54.57 Favored 'General case' 0 N--CA 1.494 1.737 0 CA-C-O 121.481 0.658 . . . . 0.0 109.713 179.718 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -166.2 166.9 16.62 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 119.785 -0.766 . . . . 0.0 109.813 179.754 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 38.3 ttmt -105.5 142.01 36.0 Favored 'General case' 0 N--CA 1.492 1.641 0 CA-C-O 121.761 0.791 . . . . 0.0 109.987 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 58.8 t -81.19 127.04 39.88 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.362 0 CA-C-O 121.805 0.812 . . . . 0.0 110.292 -179.694 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 96.5 mt -97.42 -66.53 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 121.645 -0.659 . . . . 0.0 109.311 179.387 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.6 ' NE2' ' NE2' ' A' ' 63' ' ' GLN . 85.0 mm-40 -144.04 143.76 31.33 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.291 -0.881 . . . . 0.0 110.435 -179.766 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -143.17 139.68 30.44 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 -179.713 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 3.5 m-90 -114.92 149.92 36.48 Favored 'General case' 0 N--CA 1.494 1.739 0 CA-C-O 121.811 0.815 . . . . 0.0 109.889 179.803 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -63.66 138.06 58.34 Favored 'General case' 0 C--N 1.306 -1.326 0 CA-C-O 121.428 0.633 . . . . 0.0 110.046 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . 0.505 HD21 ' CG2' ' A' ' 35' ' ' ILE . 66.3 t30 -120.57 -67.83 0.95 Allowed 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 179.603 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 44.5 p 47.4 19.87 0.15 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.389 -0.82 . . . . 0.0 109.008 -179.725 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . 0.437 ' N ' ' C ' ' A' ' 30' ' ' ASN . 84.2 t60 -63.45 -51.14 66.95 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.567 -0.708 . . . . 0.0 109.837 179.847 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.547 ' C ' ' H ' ' A' ' 35' ' ' ILE . 44.4 tt0 -174.25 117.71 0.23 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.371 -0.831 . . . . 0.0 109.88 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 14.2 t 55.54 1.91 0.06 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.88 -0.512 . . . . 0.0 110.226 179.812 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.547 ' H ' ' C ' ' A' ' 33' ' ' GLU . 96.7 mt -115.58 130.09 70.79 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 CA-C-O 121.823 0.82 . . . . 0.0 109.591 179.361 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 39.1 t -84.02 -68.91 0.68 Allowed 'General case' 0 C--N 1.302 -1.476 0 CA-C-O 121.518 0.675 . . . . 0.0 109.554 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 -137.43 160.98 37.55 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.406 -0.808 . . . . 0.0 109.997 -179.292 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 3.3 p -140.0 143.37 30.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -168.91 -152.61 7.84 Favored Glycine 0 N--CA 1.486 1.993 0 N-CA-C 110.02 -1.232 . . . . 0.0 110.02 -179.624 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -132.94 150.93 52.12 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.849 -0.794 . . . . 0.0 109.886 -179.707 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 65.7 mt -114.73 129.59 56.71 Favored 'General case' 0 N--CA 1.491 1.611 0 CA-C-O 121.814 0.816 . . . . 0.0 109.544 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -85.45 152.73 26.8 Favored Glycine 0 N--CA 1.488 2.145 0 N-CA-C 110.479 -1.048 . . . . 0.0 110.479 -179.536 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.527 ' OD1' ' N ' ' A' ' 44' ' ' GLU . 41.8 t0 -173.58 152.08 2.04 Favored 'General case' 0 C--N 1.306 -1.319 0 O-C-N 121.766 -0.844 . . . . 0.0 109.722 179.467 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.527 ' N ' ' OD1' ' A' ' 43' ' ' ASP . 82.7 tt0 -55.5 -16.71 4.12 Favored 'General case' 0 N--CA 1.492 1.657 0 CA-C-O 121.241 0.543 . . . . 0.0 110.65 -179.352 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 80.8 p -92.45 -0.94 57.3 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.813 -1.179 . . . . 0.0 109.373 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 126.02 -152.54 18.16 Favored Glycine 0 N--CA 1.499 2.848 0 N-CA-C 110.428 -1.069 . . . . 0.0 110.428 179.182 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 36.8 pt -126.24 151.99 33.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.807 -0.819 . . . . 0.0 109.202 -179.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 18.7 tt -147.95 151.0 13.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.217 -0.927 . . . . 0.0 110.067 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.599 ' HZ2' ' CZ ' ' A' ' 80' ' ' ARG . 0.0 OUTLIER -85.75 147.64 26.23 Favored 'General case' 0 N--CA 1.489 1.519 0 CA-C-O 121.538 0.685 . . . . 0.0 110.123 -179.997 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 13.3 p90 -143.92 159.71 42.09 Favored 'General case' 0 N--CA 1.486 1.34 0 O-C-N 121.418 -0.801 . . . . 0.0 109.461 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 1.8 t -141.94 142.37 33.01 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 179.468 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 92.8 mt -105.37 122.6 58.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 CA-C-O 121.77 0.795 . . . . 0.0 109.966 -179.798 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 43.1 m95 -91.36 136.89 32.79 Favored 'General case' 0 N--CA 1.487 1.378 0 CA-C-O 121.504 0.669 . . . . 0.0 109.384 179.845 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 56.3 mtpt -70.29 -10.91 60.33 Favored 'General case' 0 N--CA 1.489 1.516 0 CA-C-O 121.708 0.766 . . . . 0.0 109.319 179.449 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 11.1 m120 -61.78 -40.94 96.95 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.563 -0.711 . . . . 0.0 109.769 -179.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -78.4 -11.36 59.94 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.231 -0.918 . . . . 0.0 109.284 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 55.06 63.77 2.01 Favored 'General case' 0 N--CA 1.494 1.727 0 CA-C-O 121.478 0.656 . . . . 0.0 109.749 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 32.8 mt -107.79 146.62 33.78 Favored Pre-proline 0 N--CA 1.495 1.803 0 O-C-N 121.718 -0.614 . . . . 0.0 109.837 -179.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -72.4 162.4 41.6 Favored 'Trans proline' 0 N--CA 1.494 1.547 0 C-N-CA 123.047 2.498 . . . . 0.0 112.775 179.598 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 69.1 mt -67.45 143.64 56.14 Favored 'General case' 0 N--CA 1.49 1.528 0 CA-C-O 121.876 0.846 . . . . 0.0 110.512 -179.498 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.467 ' CD1' ' N ' ' A' ' 61' ' ' LEU . 10.1 mp -91.7 137.13 32.61 Favored 'General case' 0 N--CA 1.491 1.577 0 CA-C-O 121.684 0.754 . . . . 0.0 110.262 -179.304 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.45 ' OE1' ' OE2' ' A' ' 65' ' ' GLU . 95.9 mt-10 -81.81 147.94 29.12 Favored 'General case' 0 N--CA 1.49 1.533 0 CA-C-O 121.817 0.818 . . . . 0.0 110.195 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.6 ' NE2' ' NE2' ' A' ' 26' ' ' GLN . 86.9 mt-30 -79.62 140.61 37.06 Favored 'General case' 0 N--CA 1.488 1.465 0 CA-C-O 121.789 0.804 . . . . 0.0 110.925 -179.324 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 79.39 35.21 30.16 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 110.3 -1.12 . . . . 0.0 110.3 179.304 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.45 ' OE2' ' OE1' ' A' ' 62' ' ' GLU . 91.5 mt-10 -140.95 143.76 34.73 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.206 -1.173 . . . . 0.0 110.134 179.647 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 89.5 p -81.63 143.46 31.91 Favored 'General case' 0 N--CA 1.486 1.365 0 CA-C-O 121.6 0.714 . . . . 0.0 110.217 -179.642 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.403 ' HH ' ' H ' ' A' ' 62' ' ' GLU . 92.3 m-85 -138.41 142.12 39.56 Favored 'General case' 0 N--CA 1.489 1.479 0 CA-C-O 121.582 0.706 . . . . 0.0 110.025 -179.936 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 31.8 tp -108.56 113.3 26.19 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 108.563 -0.902 . . . . 0.0 108.563 179.197 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.8 mp -99.77 131.26 45.86 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 -179.708 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 85.7 mtp180 -126.51 148.67 49.67 Favored 'General case' 0 N--CA 1.491 1.576 0 CA-C-O 121.584 0.707 . . . . 0.0 110.432 -179.553 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.627 ' HG ' HD22 ' A' ' 88' ' ' ASN . 8.6 t 59.22 55.09 4.47 Favored 'General case' 0 N--CA 1.491 1.582 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.355 179.55 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 15.7 m -113.67 160.79 12.98 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 O-C-N 121.586 -0.696 . . . . 0.0 109.249 179.163 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 9.9 p -114.07 134.66 56.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 CA-C-O 121.809 0.814 . . . . 0.0 110.179 -178.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 16.8 t -82.43 119.62 32.3 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.343 0 CA-C-O 121.702 0.763 . . . . 0.0 109.898 -179.726 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -93.68 170.69 31.12 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 110.231 -1.148 . . . . 0.0 110.231 -179.618 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 22.4 pt-20 -102.88 133.43 47.98 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.651 -0.911 . . . . 0.0 110.195 -179.674 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . 0.633 ' CD2' ' ND2' ' A' ' 78' ' ' ASN . 42.6 t80 -136.86 96.66 3.35 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 179.624 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . 0.633 ' ND2' ' CD2' ' A' ' 77' ' ' TYR . 23.3 p30 42.2 -136.68 0.27 Allowed 'General case' 0 N--CA 1.495 1.799 0 CA-C-O 121.531 0.681 . . . . 0.0 111.417 -179.918 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.545 ' N ' ' OD1' ' A' ' 78' ' ' ASN . 97.6 m-20 -73.35 -6.28 45.13 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.433 -0.792 . . . . 0.0 109.689 -179.255 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.599 ' CZ ' ' HZ2' ' A' ' 49' ' ' LYS . 88.6 mtm180 -110.34 -179.66 3.84 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.487 -0.758 . . . . 0.0 110.085 -179.661 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -129.84 154.55 47.16 Favored 'General case' 0 N--CA 1.493 1.707 0 CA-C-O 121.508 0.671 . . . . 0.0 109.597 -179.551 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 2.7 pt20 -139.73 162.28 35.49 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.526 -0.734 . . . . 0.0 109.808 -179.775 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 13.5 m -111.54 131.82 61.82 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 179.847 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 -106.43 118.56 36.96 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.469 -0.769 . . . . 0.0 109.978 -179.253 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 10.2 t -90.02 99.46 9.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 179.646 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 1.4 p30 -151.15 -177.06 5.81 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.511 -0.743 . . . . 0.0 109.762 -179.526 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.463 ' CG ' ' H ' ' A' ' 88' ' ' ASN . 14.8 tptm 66.57 -130.62 0.18 Allowed 'General case' 0 N--CA 1.489 1.484 0 CA-C-O 121.624 0.726 . . . . 0.0 111.386 179.137 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . 0.627 HD22 ' HG ' ' A' ' 71' ' ' SER . 0.6 OUTLIER -90.41 19.96 4.85 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.531 -0.731 . . . . 0.0 109.273 -179.317 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 19.5 m -57.09 144.09 35.96 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.405 -0.809 . . . . 0.0 109.899 -179.669 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 44.4 m -129.6 153.02 48.49 Favored 'General case' 0 N--CA 1.493 1.676 0 CA-C-O 121.398 0.618 . . . . 0.0 109.427 -179.709 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.431 HD11 HG23 ' A' ' 91' ' ' ILE . 96.8 mt -131.69 134.86 59.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.64 -0.663 . . . . 0.0 109.505 -179.938 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 73.8 mm-40 -128.74 136.23 50.28 Favored 'General case' 0 N--CA 1.494 1.747 0 CA-C-O 121.49 0.662 . . . . 0.0 109.31 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -82.01 124.99 30.28 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.525 -0.734 . . . . 0.0 109.937 -179.636 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 11.0 mp -103.67 131.35 50.9 Favored 'General case' 0 N--CA 1.493 1.695 0 CA-C-O 121.61 0.719 . . . . 0.0 109.47 179.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 39.1 t -80.48 -6.67 58.51 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.661 -0.65 . . . . 0.0 109.3 179.7 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -107.36 104.45 52.54 Favored Pre-proline 0 N--CA 1.495 1.811 0 O-C-N 121.422 -0.798 . . . . 0.0 109.457 -179.635 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -74.54 149.43 39.0 Favored 'Trans proline' 0 N--CA 1.491 1.372 0 C-N-CA 122.328 2.019 . . . . 0.0 112.833 -179.246 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 14.9 pt -82.37 135.02 25.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 CA-C-O 121.82 0.819 . . . . 0.0 110.757 -179.401 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 81.2 tt0 -66.95 122.0 16.76 Favored 'General case' 0 N--CA 1.487 1.403 0 CA-C-O 121.752 0.787 . . . . 0.0 109.304 -179.792 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 16.1 m -108.22 -1.56 9.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 97.7 104.1 2.3 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.753 -1.339 . . . . 0.0 109.753 179.439 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 83.3 mt -90.34 -5.66 55.96 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.799 -0.824 . . . . 0.0 108.783 179.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . 0.419 ' O ' ' O ' ' A' ' 104' ' ' HIS . 72.2 mm-40 -60.36 -178.37 0.09 Allowed 'General case' 0 N--CA 1.492 1.675 0 CA-C-O 122.003 0.906 . . . . 0.0 111.443 -178.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . 0.425 ' CE1' ' NE2' ' A' ' 106' ' ' HIS . 50.4 t-80 53.62 108.37 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 CA-C-O 121.767 0.794 . . . . 0.0 110.404 179.82 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 22.7 p-80 -146.54 166.01 27.76 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.594 -0.691 . . . . 0.0 109.432 179.739 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' HIS . . . . . 0.425 ' NE2' ' CE1' ' A' ' 104' ' ' HIS . 99.3 m-70 -130.71 160.41 34.4 Favored 'General case' 0 N--CA 1.495 1.795 0 CA-C-O 121.724 0.773 . . . . 0.0 109.97 -179.559 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . 0.539 ' O ' ' N ' ' A' ' 109' ' ' HIS . 4.7 p80 -148.3 165.63 30.44 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.752 -0.593 . . . . 0.0 109.518 -179.81 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 85.7 t60 54.71 -81.34 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.765 -0.584 . . . . 0.0 110.37 -179.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . 0.539 ' N ' ' O ' ' A' ' 107' ' ' HIS . 75.7 m80 . . . . . 0 N--CA 1.493 1.684 0 CA-C-O 118.215 -0.898 . . . . 0.0 110.367 -179.505 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 67.7 mtt . . . . . 0 N--CA 1.489 1.49 0 CA-C-O 121.732 0.777 . . . . 0.0 109.208 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.435 ' N ' ' CD ' ' A' ' 3' ' ' PRO . 7.4 mp0 47.04 54.47 15.38 Favored Pre-proline 0 N--CA 1.494 1.729 0 O-C-N 121.906 -0.496 . . . . 0.0 110.034 -179.697 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.435 ' CD ' ' N ' ' A' ' 2' ' ' GLU . 19.9 Cg_endo -62.28 144.0 94.75 Favored 'Trans proline' 0 N--CA 1.495 1.587 0 C-N-CA 122.825 2.35 . . . . 0.0 112.752 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -86.6 88.89 7.75 Favored 'General case' 0 N--CA 1.488 1.463 0 CA-C-O 122.015 0.912 . . . . 0.0 109.487 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.401 ' N ' ' CD2' ' A' ' 5' ' ' LEU . 4.2 mm? -75.81 139.09 41.57 Favored 'General case' 0 N--CA 1.489 1.509 0 CA-C-O 121.608 0.718 . . . . 0.0 109.959 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 90.0 m -123.96 129.88 51.66 Favored 'General case' 0 N--CA 1.492 1.648 0 CA-C-O 121.643 0.735 . . . . 0.0 109.468 179.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 53.7 mtmt -80.08 153.91 28.44 Favored 'General case' 0 N--CA 1.489 1.485 0 CA-C-O 121.495 0.664 . . . . 0.0 110.374 -179.646 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.413 HG22 HD13 ' A' ' 8' ' ' ILE . 97.4 mt -62.71 -43.73 98.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 CA-C-O 121.627 0.727 . . . . 0.0 109.976 -179.837 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 13.0 p -65.45 -23.79 33.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.508 -0.745 . . . . 0.0 109.626 -179.676 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -78.81 -4.71 50.85 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.363 -0.836 . . . . 0.0 109.642 179.695 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 97.8 mt -82.23 118.8 30.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.174 -0.954 . . . . 0.0 109.672 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 3.1 m -146.89 6.88 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.565 -0.709 . . . . 0.0 109.275 -179.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 94.1 mt-10 -138.14 131.71 30.85 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.261 -0.9 . . . . 0.0 110.203 -179.457 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 51.5 p30 -83.78 153.15 24.26 Favored 'General case' 0 N--CA 1.488 1.438 0 CA-C-O 121.642 0.734 . . . . 0.0 110.442 -179.717 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 71.16 84.64 0.19 Allowed Glycine 0 N--CA 1.49 2.243 0 N-CA-C 110.084 -1.206 . . . . 0.0 110.084 179.577 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 27.3 tt0 -169.39 136.23 1.7 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.417 -1.049 . . . . 0.0 109.838 179.723 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 45.0 m95 -91.64 140.22 29.93 Favored 'General case' 0 N--CA 1.489 1.523 0 CA-C-O 121.567 0.698 . . . . 0.0 110.1 -179.83 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -168.51 170.39 9.73 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.559 -0.713 . . . . 0.0 109.561 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 62.8 m-80 -101.11 145.17 29.12 Favored 'General case' 0 N--CA 1.494 1.771 0 CA-C-O 121.624 0.726 . . . . 0.0 109.967 -179.458 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 51.9 tp -146.62 135.39 22.26 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.529 -0.732 . . . . 0.0 109.8 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 35.0 ttpt -120.3 137.12 54.43 Favored 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 179.312 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.418 ' CB ' ' OD1' ' A' ' 43' ' ' ASP . . . -160.65 172.52 16.98 Favored 'General case' 0 N--CA 1.492 1.659 0 C-N-CA 119.201 -1.0 . . . . 0.0 110.792 -179.377 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 33.0 ttpt -113.15 141.19 47.22 Favored 'General case' 0 N--CA 1.493 1.723 0 CA-C-O 121.583 0.706 . . . . 0.0 109.563 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 87.1 t -77.94 132.02 33.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.648 -0.658 . . . . 0.0 110.561 -179.172 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 30.2 pt -124.46 -30.08 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 179.004 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 68.6 tp60 -150.17 125.98 10.42 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.194 -0.941 . . . . 0.0 109.54 179.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.545 ' CD2' ' N ' ' A' ' 27' ' ' LEU . 1.1 pt? -138.96 135.67 34.6 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.707 -0.621 . . . . 0.0 109.978 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . 0.415 ' CE3' ' O ' ' A' ' 29' ' ' GLU . 81.9 t90 -126.84 123.78 38.11 Favored 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.415 ' O ' ' CE3' ' A' ' 28' ' ' TRP . 82.0 tt0 -59.87 138.89 57.69 Favored 'General case' 0 N--CA 1.49 1.568 0 CA-C-O 121.515 0.674 . . . . 0.0 110.046 -179.597 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . 0.49 ' OD1' ' N ' ' A' ' 32' ' ' HIS . 19.0 t-20 -100.75 120.81 40.65 Favored 'General case' 0 N--CA 1.489 1.478 0 CA-C-O 121.566 0.698 . . . . 0.0 109.867 -179.914 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 60.3 p -94.77 0.87 55.3 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 179.722 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . 0.49 ' N ' ' OD1' ' A' ' 30' ' ' ASN . 99.6 m-70 -87.48 119.35 27.67 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.44 -0.787 . . . . 0.0 109.344 179.801 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.456 ' C ' ' H ' ' A' ' 35' ' ' ILE . 58.0 mp0 -42.94 166.2 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.502 0 CA-C-O 121.682 0.753 . . . . 0.0 111.029 -179.472 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' SER . . . . . 0.439 ' CB ' ' O ' ' A' ' 33' ' ' GLU . 0.9 OUTLIER 75.16 -39.97 0.42 Allowed 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 109.573 -0.529 . . . . 0.0 109.573 -179.899 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.456 ' H ' ' C ' ' A' ' 33' ' ' GLU . 90.5 mt -108.92 119.11 57.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 CA-C-O 121.601 0.715 . . . . 0.0 110.054 -179.775 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 3.8 t -76.11 -50.91 13.38 Favored 'General case' 0 N--CA 1.489 1.519 0 CA-C-O 121.822 0.82 . . . . 0.0 109.635 179.489 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 49.2 tt0 -150.42 155.37 39.44 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.291 -0.881 . . . . 0.0 110.22 -179.604 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 8.2 p -142.65 139.8 28.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.678 -0.639 . . . . 0.0 109.414 179.416 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -171.99 -163.36 25.76 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.893 -1.283 . . . . 0.0 109.893 -179.77 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -134.71 148.1 50.23 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.552 -0.969 . . . . 0.0 109.85 -179.394 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 67.6 mt -112.95 137.99 50.5 Favored 'General case' 0 N--CA 1.493 1.688 0 CA-C-O 121.742 0.782 . . . . 0.0 109.564 -179.456 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.421 ' O ' ' OD1' ' A' ' 43' ' ' ASP . . . -83.24 143.86 22.2 Favored Glycine 0 N--CA 1.486 2.029 0 N-CA-C 110.779 -0.929 . . . . 0.0 110.779 -179.542 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.421 ' OD1' ' O ' ' A' ' 42' ' ' GLY . 75.2 m-20 -149.47 160.22 43.64 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.877 -0.778 . . . . 0.0 109.38 179.534 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 79.8 tt0 -65.58 -21.39 66.59 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.686 -0.634 . . . . 0.0 109.61 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 67.4 p -89.97 -2.78 58.21 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.327 -0.858 . . . . 0.0 109.514 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 133.15 -147.26 18.92 Favored Glycine 0 N--CA 1.497 2.705 0 N-CA-C 110.341 -1.104 . . . . 0.0 110.341 179.215 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 40.9 pt -125.66 152.62 32.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.901 -0.764 . . . . 0.0 109.741 -179.626 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 8.4 tp -142.5 140.12 28.68 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 CA-C-O 121.741 0.781 . . . . 0.0 110.059 -179.822 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 54.9 mtmt -87.88 145.94 25.81 Favored 'General case' 0 N--CA 1.49 1.545 0 CA-C-O 121.509 0.671 . . . . 0.0 110.004 179.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 38.9 p90 -137.57 153.05 50.01 Favored 'General case' 0 N--CA 1.49 1.545 0 CA-C-O 121.659 0.742 . . . . 0.0 109.783 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 83.6 m -129.86 130.97 45.91 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.413 HD12 HG23 ' A' ' 52' ' ' ILE . 96.6 mt -103.75 129.1 56.35 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 CA-C-O 121.702 0.763 . . . . 0.0 109.983 -179.773 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 89.7 m95 -90.63 129.6 36.74 Favored 'General case' 0 N--CA 1.487 1.404 0 CA-C-O 121.698 0.761 . . . . 0.0 109.273 179.457 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.407 ' HZ3' ' N ' ' A' ' 34' ' ' SER . 3.1 ptpp? -67.11 -13.78 62.27 Favored 'General case' 0 N--CA 1.489 1.477 0 CA-C-O 121.516 0.674 . . . . 0.0 109.939 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . 0.574 ' OD1' ' N ' ' A' ' 56' ' ' ALA . 50.1 p-10 -63.7 -35.68 81.36 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.406 -0.809 . . . . 0.0 109.99 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.574 ' N ' ' OD1' ' A' ' 55' ' ' ASN . . . -77.74 -12.31 59.96 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.238 -0.914 . . . . 0.0 109.298 -179.896 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 52.49 56.61 7.42 Favored 'General case' 0 N--CA 1.494 1.73 0 CA-C-O 121.447 0.641 . . . . 0.0 110.15 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 45.9 mt -101.75 146.65 32.62 Favored Pre-proline 0 N--CA 1.496 1.85 0 O-C-N 121.495 -0.753 . . . . 0.0 109.328 179.517 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -69.74 155.42 66.05 Favored 'Trans proline' 0 N--CA 1.497 1.716 0 C-N-CA 122.921 2.414 . . . . 0.0 113.283 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 75.2 mt -71.73 141.67 49.79 Favored 'General case' 0 N--CA 1.493 1.682 0 CA-C-O 121.852 0.834 . . . . 0.0 110.778 -179.27 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.447 ' CD1' ' N ' ' A' ' 61' ' ' LEU . 10.3 mp -80.29 143.76 33.38 Favored 'General case' 0 N--CA 1.491 1.586 0 CA-C-O 121.688 0.756 . . . . 0.0 110.065 -179.919 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -83.41 152.66 24.91 Favored 'General case' 0 N--CA 1.49 1.568 0 CA-C-O 121.941 0.876 . . . . 0.0 110.987 -179.478 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 58.5 tt0 -82.03 136.78 35.2 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-O 121.663 0.744 . . . . 0.0 110.754 -179.676 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 82.4 4.55 90.12 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 110.166 -1.174 . . . . 0.0 110.166 179.434 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -110.51 146.86 35.26 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.444 -1.033 . . . . 0.0 110.723 -179.581 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 19.1 p -84.97 152.44 23.47 Favored 'General case' 0 N--CA 1.487 1.42 0 CA-C-O 121.558 0.694 . . . . 0.0 110.2 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 74.4 m-85 -145.34 145.29 31.14 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.349 -0.845 . . . . 0.0 110.275 179.651 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 23.5 tp -108.01 121.14 44.2 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 108.96 -0.755 . . . . 0.0 108.96 179.395 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 68.4 mt -100.59 133.38 45.12 Favored 'General case' 0 N--CA 1.49 1.551 0 CA-C-O 121.256 0.55 . . . . 0.0 109.629 -179.614 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.454 ' O ' ' OG ' ' A' ' 71' ' ' SER . 80.5 mtp85 -129.28 142.05 50.94 Favored 'General case' 0 N--CA 1.493 1.698 0 CA-C-O 121.653 0.74 . . . . 0.0 110.161 -179.806 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.454 ' OG ' ' O ' ' A' ' 70' ' ' ARG . 3.3 p 53.44 60.96 3.36 Favored 'General case' 0 N--CA 1.493 1.697 0 CA-C-O 121.416 0.627 . . . . 0.0 110.405 -179.889 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 3.3 m -114.23 133.11 61.34 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 179.024 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 8.9 p -95.47 135.56 29.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 CA-C-O 121.582 0.706 . . . . 0.0 109.986 -179.258 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -93.23 124.99 45.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 CA-C-O 121.767 0.794 . . . . 0.0 109.695 -179.6 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -100.11 142.86 16.1 Favored Glycine 0 N--CA 1.493 2.446 0 N-CA-C 110.478 -1.049 . . . . 0.0 110.478 -179.618 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 17.5 pt-20 -59.14 138.7 57.46 Favored 'General case' 0 N--CA 1.49 1.566 0 CA-C-O 121.592 0.71 . . . . 0.0 110.082 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . 0.604 ' CG ' ' NE2' ' A' ' 82' ' ' GLN . 79.3 t80 -137.08 81.25 1.86 Allowed 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 179.446 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . 0.502 ' C ' ' O ' ' A' ' 77' ' ' TYR . 28.8 t-20 15.15 -79.81 0.0 OUTLIER 'General case' 0 N--CA 1.51 2.533 0 CA-C-O 121.581 0.705 . . . . 0.0 112.146 -179.859 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.533 ' N ' ' O ' ' A' ' 77' ' ' TYR . 52.0 t0 -47.8 -69.94 0.11 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.433 -0.792 . . . . 0.0 109.893 -179.75 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 88.5 mtm180 -133.64 -130.44 0.17 Allowed 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.618 -0.677 . . . . 0.0 109.998 -178.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 88.4 m-85 -129.47 154.43 46.99 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.578 -0.701 . . . . 0.0 110.046 -178.796 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . 0.604 ' NE2' ' CG ' ' A' ' 77' ' ' TYR . 87.0 mt-30 -132.78 161.93 32.8 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.761 -0.587 . . . . 0.0 109.897 -179.703 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 16.3 m -104.05 127.88 57.88 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 CA-C-O 121.61 0.719 . . . . 0.0 109.237 179.776 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 -106.39 126.45 52.26 Favored 'General case' 0 N--CA 1.494 1.74 0 CA-C-O 121.436 0.636 . . . . 0.0 109.793 -179.212 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 52.1 t -104.78 120.1 54.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 CA-C-O 121.581 0.705 . . . . 0.0 109.181 179.831 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.404 ' O ' ' O ' ' A' ' 87' ' ' LYS . 0.4 OUTLIER -147.9 -175.98 5.09 Favored 'General case' 0 N--CA 1.489 1.52 0 CA-C-O 121.388 0.613 . . . . 0.0 110.039 -179.38 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.494 ' C ' ' H ' ' A' ' 89' ' ' SER . 85.4 tttt -37.83 157.32 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.737 0 CA-C-O 121.535 0.683 . . . . 0.0 111.016 -179.442 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . 0.481 ' CB ' ' O ' ' A' ' 87' ' ' LYS . 0.2 OUTLIER 77.92 -28.88 0.16 Allowed 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 -179.725 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.494 ' H ' ' C ' ' A' ' 87' ' ' LYS . 11.5 t -75.64 152.18 37.63 Favored 'General case' 0 N--CA 1.49 1.553 0 CA-C-O 121.557 0.694 . . . . 0.0 110.469 -179.696 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 32.1 t -132.54 141.68 48.84 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.553 -0.717 . . . . 0.0 109.702 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 96.4 mt -123.97 130.9 73.66 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 CA-C-O 121.273 0.559 . . . . 0.0 109.523 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -127.02 132.78 50.66 Favored 'General case' 0 N--CA 1.497 1.881 0 CA-C-O 121.621 0.724 . . . . 0.0 109.512 179.809 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -81.22 127.49 32.74 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-O 121.617 0.723 . . . . 0.0 110.078 -179.533 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 10.8 mp -103.51 131.85 50.27 Favored 'General case' 0 N--CA 1.495 1.784 0 CA-C-O 121.671 0.748 . . . . 0.0 110.09 -179.637 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 18.2 t -77.52 -6.05 52.22 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 179.284 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -102.25 110.36 62.46 Favored Pre-proline 0 N--CA 1.496 1.851 0 O-C-N 121.393 -0.817 . . . . 0.0 109.572 -179.75 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -75.78 152.02 36.74 Favored 'Trans proline' 0 N--CA 1.492 1.396 0 C-N-CA 122.795 2.33 . . . . 0.0 112.528 -178.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 56.3 mt -82.91 137.97 20.12 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 CA-C-O 121.951 0.882 . . . . 0.0 110.341 -179.589 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . 0.479 ' O ' ' C ' ' A' ' 100' ' ' VAL . 58.6 mp0 -47.99 -81.01 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 CA-C-N 116.078 -0.51 . . . . 0.0 109.715 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.479 ' C ' ' O ' ' A' ' 99' ' ' GLU . 8.6 m 32.12 43.28 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.005 0 CA-C-O 121.837 0.827 . . . . 0.0 110.369 -179.314 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 175.6 56.97 0.06 OUTLIER Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.476 -1.45 . . . . 0.0 109.476 -179.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 86.3 mt -86.99 -7.95 57.66 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.285 -1.126 . . . . 0.0 109.066 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 46.07 46.64 12.84 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.333 -0.854 . . . . 0.0 109.703 179.513 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . 0.423 ' CD2' ' H ' ' A' ' 104' ' ' HIS . 6.8 p80 -60.4 88.66 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 CA-C-O 121.85 0.833 . . . . 0.0 109.87 -179.849 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 45.1 p-80 -85.74 -15.29 42.65 Favored 'General case' 0 N--CA 1.489 1.514 0 CA-C-O 121.531 0.681 . . . . 0.0 109.448 179.662 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' HIS . . . . . 0.48 ' O ' ' CG ' ' A' ' 106' ' ' HIS . 51.2 p-80 -92.24 100.47 13.06 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.391 -0.818 . . . . 0.0 109.514 -179.923 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 73.0 m80 -67.7 -42.86 81.36 Favored 'General case' 0 N--CA 1.492 1.634 0 CA-C-O 121.572 0.701 . . . . 0.0 109.684 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 46.8 p-80 -163.44 25.22 0.08 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.452 -0.78 . . . . 0.0 109.239 -179.747 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 53.9 p-80 . . . . . 0 N--CA 1.492 1.661 0 CA-C-O 118.084 -0.96 . . . . 0.0 109.352 179.893 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 97.5 mtp . . . . . 0 N--CA 1.489 1.508 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 26.4 mm-40 -78.6 148.18 72.74 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.666 -0.646 . . . . 0.0 110.074 -179.402 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -70.06 149.91 65.67 Favored 'Trans proline' 0 N--CA 1.493 1.487 0 C-N-CA 122.702 2.268 . . . . 0.0 112.297 179.631 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . 0.525 ' H ' ' CD ' ' A' ' 4' ' ' GLN . 1.0 OUTLIER -76.44 90.78 3.27 Favored 'General case' 0 C--N 1.301 -1.527 0 CA-C-O 121.925 0.869 . . . . 0.0 109.463 -179.704 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 90.7 mt -81.78 139.83 34.58 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.663 -0.648 . . . . 0.0 109.574 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 99.2 m -127.1 131.05 50.93 Favored 'General case' 0 N--CA 1.494 1.753 0 CA-C-O 121.902 0.858 . . . . 0.0 109.86 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 70.2 mmtt -82.15 154.37 25.54 Favored 'General case' 0 C--N 1.301 -1.538 0 CA-C-O 121.648 0.737 . . . . 0.0 109.767 -179.401 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 96.2 mt -63.07 -43.52 99.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 CA-C-O 121.583 0.706 . . . . 0.0 109.568 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 13.6 p -65.24 -23.94 34.14 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 121.531 -0.731 . . . . 0.0 109.858 179.835 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 54.9 t0 -79.39 -2.48 41.9 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.382 -0.824 . . . . 0.0 109.67 -179.889 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 96.6 mt -78.7 117.94 25.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.108 -0.995 . . . . 0.0 109.908 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 3.3 m -136.02 -4.0 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 N-CA-C 108.979 -0.748 . . . . 0.0 108.979 179.533 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 79.4 mm-40 -139.76 137.8 35.37 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.248 -0.908 . . . . 0.0 110.21 -179.724 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 19.9 p-10 -91.85 159.93 15.55 Favored 'General case' 0 N--CA 1.491 1.588 0 CA-C-O 121.607 0.718 . . . . 0.0 110.162 179.821 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 78.69 2.14 84.88 Favored Glycine 0 N--CA 1.493 2.48 0 N-CA-C 109.559 -1.416 . . . . 0.0 109.559 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 33.1 tt0 -79.17 137.84 37.62 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.517 -0.99 . . . . 0.0 110.817 -179.239 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 68.9 m95 -93.45 132.35 37.79 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.781 -0.574 . . . . 0.0 109.692 179.629 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -174.29 176.78 2.38 Favored 'General case' 0 N--CA 1.493 1.722 0 C-N-CA 119.746 -0.782 . . . . 0.0 110.084 179.833 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 28.7 m-20 -104.48 142.68 34.19 Favored 'General case' 0 N--CA 1.495 1.781 0 CA-C-O 121.625 0.726 . . . . 0.0 110.095 -179.554 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 57.3 tp -133.71 138.92 46.09 Favored 'General case' 0 N--CA 1.493 1.705 0 CA-C-O 121.319 0.58 . . . . 0.0 109.485 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.534 ' HZ3' ' CG2' ' A' ' 98' ' ' ILE . 19.5 ttpp -119.55 135.18 54.9 Favored 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 179.175 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -160.98 171.75 18.13 Favored 'General case' 0 N--CA 1.493 1.681 0 C-N-CA 119.598 -0.841 . . . . 0.0 110.166 -179.82 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -114.5 142.61 46.17 Favored 'General case' 0 N--CA 1.496 1.858 0 CA-C-O 121.756 0.789 . . . . 0.0 110.182 -179.71 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 21.5 t -84.77 117.57 30.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 CA-C-O 121.536 0.684 . . . . 0.0 109.963 -179.588 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 25.3 pt -107.86 -30.24 2.53 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 179.277 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 12.7 tt0 -163.99 133.45 3.95 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-O 121.699 0.761 . . . . 0.0 109.927 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.551 ' CD2' ' N ' ' A' ' 27' ' ' LEU . 1.1 pt? -143.3 137.8 29.09 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.784 -0.572 . . . . 0.0 109.696 179.932 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 2.6 m-90 -116.36 133.01 56.51 Favored 'General case' 0 N--CA 1.495 1.82 0 CA-C-O 121.567 0.699 . . . . 0.0 109.628 179.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -66.38 139.97 58.04 Favored 'General case' 0 C--N 1.301 -1.518 0 CA-C-O 121.269 0.557 . . . . 0.0 109.534 179.648 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . 0.531 ' OD1' ' CG ' ' A' ' 32' ' ' HIS . 49.0 t-20 -102.87 -28.5 12.02 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 179.638 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.455 ' OG1' ' O ' ' A' ' 30' ' ' ASN . 44.2 p 52.58 12.48 0.25 Allowed 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 -179.771 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . 0.531 ' CG ' ' OD1' ' A' ' 30' ' ' ASN . 0.3 OUTLIER -78.03 146.24 35.45 Favored 'General case' 0 N--CA 1.491 1.588 0 CA-C-O 121.873 0.844 . . . . 0.0 110.218 -179.758 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -59.28 -49.21 78.7 Favored 'General case' 0 N--CA 1.493 1.705 0 CA-C-O 121.428 0.632 . . . . 0.0 110.238 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' SER . . . . . 0.42 ' O ' ' CE3' ' A' ' 53' ' ' TRP . 40.0 m -72.08 -35.01 69.13 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.32 -0.862 . . . . 0.0 110.213 -179.611 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 94.7 mt -123.29 127.61 74.47 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.993 0 O-C-N 121.292 -0.88 . . . . 0.0 110.317 -179.054 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 45.9 t -75.83 -53.01 9.13 Favored 'General case' 0 N--CA 1.493 1.691 0 CA-C-O 121.904 0.859 . . . . 0.0 109.562 179.597 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . 0.483 ' OE1' ' N ' ' A' ' 38' ' ' VAL . 0.5 OUTLIER -147.04 147.67 30.89 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.195 -0.941 . . . . 0.0 109.941 -179.739 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.483 ' N ' ' OE1' ' A' ' 37' ' ' GLN . 8.6 p -134.01 138.49 50.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 CA-C-O 121.384 0.611 . . . . 0.0 109.464 179.872 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -160.64 -165.65 17.86 Favored Glycine 0 N--CA 1.488 2.163 0 C-N-CA 119.746 -1.216 . . . . 0.0 110.476 -179.591 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -132.49 143.83 50.04 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.898 -0.766 . . . . 0.0 109.512 -179.714 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 41.4 mt -116.28 136.12 53.28 Favored 'General case' 0 N--CA 1.494 1.749 0 CA-C-O 121.79 0.805 . . . . 0.0 109.707 -179.178 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -83.71 162.52 39.5 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 111.073 -0.811 . . . . 0.0 111.073 -179.438 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.552 ' OD1' ' N ' ' A' ' 44' ' ' GLU . 67.2 t0 -174.73 145.15 0.87 Allowed 'General case' 0 N--CA 1.49 1.557 0 CA-C-O 121.63 0.729 . . . . 0.0 109.129 179.705 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.552 ' N ' ' OD1' ' A' ' 43' ' ' ASP . 49.0 mt-10 -54.43 -14.88 1.38 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.654 -0.654 . . . . 0.0 110.072 179.927 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 39.5 p -93.55 -11.15 32.54 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.228 -0.92 . . . . 0.0 109.716 -179.894 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 138.86 -158.3 25.09 Favored Glycine 0 N--CA 1.498 2.806 0 C-N-CA 120.041 -1.076 . . . . 0.0 110.568 179.233 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.412 HG23 HD13 ' A' ' 47' ' ' ILE . 97.4 mt -124.44 134.2 67.34 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 O-C-N 121.906 -0.761 . . . . 0.0 109.443 -179.585 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 17.7 tt -128.82 141.93 45.31 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.998 0 CA-C-O 121.625 0.726 . . . . 0.0 109.935 -179.753 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 51.1 mtmt -86.46 152.0 23.04 Favored 'General case' 0 N--CA 1.491 1.609 0 CA-C-O 121.568 0.699 . . . . 0.0 110.108 -179.772 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 25.2 p90 -142.51 160.38 40.39 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.327 -0.858 . . . . 0.0 110.325 -179.688 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 1.9 t -138.58 137.52 37.08 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.436 HD13 HG21 ' A' ' 52' ' ' ILE . 90.6 mt -105.93 118.03 52.76 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 CA-C-O 121.534 0.683 . . . . 0.0 109.834 179.865 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . 0.42 ' CE3' ' O ' ' A' ' 34' ' ' SER . 72.7 m95 -85.77 142.56 28.87 Favored 'General case' 0 N--CA 1.488 1.463 0 CA-C-O 121.579 0.704 . . . . 0.0 109.524 179.874 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -62.4 -8.8 6.64 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.564 -0.71 . . . . 0.0 110.335 -179.53 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . 0.414 ' O ' ' OE1' ' A' ' 57' ' ' GLU . 13.0 t-20 -75.75 -10.97 59.88 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.249 -0.907 . . . . 0.0 109.056 179.529 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.415 ' C ' ' OE1' ' A' ' 57' ' ' GLU . . . -94.19 -21.44 19.06 Favored 'General case' 0 N--CA 1.497 1.921 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 179.27 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.442 ' OE1' ' N ' ' A' ' 57' ' ' GLU . 56.0 mp0 40.39 51.53 2.84 Favored 'General case' 0 N--CA 1.495 1.805 0 CA-C-O 122.069 0.938 . . . . 0.0 109.979 -179.908 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.572 ' C ' ' H ' ' A' ' 60' ' ' LEU . 18.4 mt -94.92 150.06 37.23 Favored Pre-proline 0 N--CA 1.488 1.473 0 O-C-N 121.562 -0.711 . . . . 0.0 109.346 179.92 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.414 ' O ' ' O ' ' A' ' 60' ' ' LEU . 29.9 Cg_endo -67.97 22.97 0.13 Allowed 'Trans proline' 0 N--CA 1.493 1.489 0 C-N-CA 122.2 1.933 . . . . 0.0 111.801 179.564 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.572 ' H ' ' C ' ' A' ' 58' ' ' LEU . 72.0 mt 58.59 151.86 0.01 OUTLIER 'General case' 0 C--N 1.293 -1.866 0 CA-C-O 121.802 0.81 . . . . 0.0 110.18 179.661 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.508 ' CD1' ' N ' ' A' ' 61' ' ' LEU . 9.0 mp -85.46 143.55 28.5 Favored 'General case' 0 N--CA 1.491 1.625 0 CA-C-O 121.541 0.686 . . . . 0.0 109.747 -179.667 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -87.5 151.27 23.16 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-O 121.937 0.875 . . . . 0.0 110.558 -178.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 58.1 tt0 -76.15 132.08 39.78 Favored 'General case' 0 N--CA 1.491 1.583 0 CA-C-O 121.87 0.843 . . . . 0.0 111.542 -178.811 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 93.16 -4.95 74.94 Favored Glycine 0 N--CA 1.496 2.688 0 N-CA-C 110.745 -0.942 . . . . 0.0 110.745 178.57 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.531 ' OE1' ' N ' ' A' ' 65' ' ' GLU . 58.3 mp0 -103.36 149.17 25.02 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 121.119 -1.224 . . . . 0.0 110.725 -179.379 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 8.8 p -93.22 135.15 34.7 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 179.58 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -125.72 143.04 51.21 Favored 'General case' 0 N--CA 1.497 1.879 0 CA-C-O 122.079 0.943 . . . . 0.0 111.017 -179.101 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 11.9 tp -106.57 104.88 14.67 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 179.653 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 54.3 mt -79.62 141.06 36.87 Favored 'General case' 0 N--CA 1.491 1.6 0 CA-C-O 121.342 0.591 . . . . 0.0 109.543 -179.688 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 85.3 mtp180 -136.06 141.85 44.31 Favored 'General case' 0 N--CA 1.494 1.733 0 CA-C-O 121.862 0.839 . . . . 0.0 110.71 -179.37 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 2.0 m 53.04 43.34 31.83 Favored 'General case' 0 N--CA 1.492 1.656 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.963 178.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 7.5 m -99.22 162.36 2.95 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.982 0 O-C-N 121.513 -0.742 . . . . 0.0 109.586 179.162 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 7.8 p -108.5 135.81 46.11 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 CA-C-O 121.688 0.756 . . . . 0.0 110.182 -178.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 98.7 t -78.89 125.0 38.05 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 CA-C-O 121.818 0.818 . . . . 0.0 109.375 -179.626 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -83.22 163.89 41.66 Favored Glycine 0 N--CA 1.486 2.016 0 N-CA-C 110.093 -1.203 . . . . 0.0 110.093 -179.632 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -114.73 127.88 55.99 Favored 'General case' 0 N--CA 1.493 1.722 0 CA-C-O 121.734 0.778 . . . . 0.0 109.881 -179.843 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . 0.628 ' CD2' ' NE2' ' A' ' 82' ' ' GLN . 42.4 m-85 -132.84 81.25 1.93 Allowed 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 179.557 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 79.4 m-20 50.67 -112.67 0.63 Allowed 'General case' 0 N--CA 1.495 1.788 0 CA-C-O 121.355 0.598 . . . . 0.0 110.698 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 94.9 m-20 -90.56 -7.0 54.01 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.141 -0.974 . . . . 0.0 109.544 -179.727 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 94.1 mtt180 -102.66 166.33 10.57 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.382 -0.824 . . . . 0.0 110.557 -178.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -128.71 150.61 50.19 Favored 'General case' 0 N--CA 1.496 1.859 0 CA-C-O 121.481 0.658 . . . . 0.0 109.706 179.882 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . 0.628 ' NE2' ' CD2' ' A' ' 77' ' ' TYR . 74.4 mt-30 -144.65 177.29 8.79 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.625 -0.672 . . . . 0.0 109.428 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 2.6 m -118.49 133.14 66.27 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 179.543 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 84.4 mt-30 -113.58 122.34 46.93 Favored 'General case' 0 N--CA 1.494 1.756 0 CA-C-O 121.859 0.838 . . . . 0.0 109.618 -179.078 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 22.0 t -90.07 129.29 41.19 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 1.4 p30 -147.57 172.84 13.37 Favored 'General case' 0 N--CA 1.49 1.544 0 CA-C-O 121.86 0.838 . . . . 0.0 110.167 -179.278 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.475 ' O ' ' CB ' ' A' ' 88' ' ' ASN . 88.7 tttt -42.83 157.24 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 CA-C-O 121.768 0.794 . . . . 0.0 110.826 -179.761 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . 0.475 ' CB ' ' O ' ' A' ' 87' ' ' LYS . 2.1 t-20 79.31 -23.2 0.25 Allowed 'General case' 0 N--CA 1.494 1.753 0 CA-C-O 121.366 0.603 . . . . 0.0 109.814 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.407 ' H ' ' C ' ' A' ' 87' ' ' LYS . 11.1 m -74.81 148.1 40.61 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.287 -0.883 . . . . 0.0 110.199 -179.512 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 52.1 m -125.1 150.1 47.18 Favored 'General case' 0 N--CA 1.497 1.884 0 CA-C-O 121.58 0.705 . . . . 0.0 109.806 -179.797 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 98.0 mt -132.27 135.33 58.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 CA-C-O 121.365 0.602 . . . . 0.0 109.734 -179.42 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 81.1 tt0 -128.8 125.93 38.82 Favored 'General case' 0 N--CA 1.5 2.032 0 CA-C-O 121.61 0.719 . . . . 0.0 109.222 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 26.7 mtmm -74.34 135.25 42.51 Favored 'General case' 0 N--CA 1.49 1.529 0 CA-C-O 121.566 0.698 . . . . 0.0 110.296 -179.608 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 10.2 mp -105.45 134.53 48.42 Favored 'General case' 0 N--CA 1.494 1.766 0 CA-C-O 121.938 0.875 . . . . 0.0 109.82 179.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 93.3 p -83.19 -2.12 54.74 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 109.454 -0.572 . . . . 0.0 109.454 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -118.36 89.92 37.29 Favored Pre-proline 0 N--CA 1.5 2.027 0 O-C-N 121.539 -0.726 . . . . 0.0 109.195 179.873 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_exo -57.72 149.67 66.94 Favored 'Trans proline' 0 N--CA 1.492 1.406 0 C-N-CA 122.742 2.295 . . . . 0.0 112.6 179.538 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.534 ' CG2' ' HZ3' ' A' ' 21' ' ' LYS . 29.8 pt -74.68 143.98 12.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 CA-C-O 121.827 0.822 . . . . 0.0 110.353 -179.73 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -80.36 117.54 21.2 Favored 'General case' 0 N--CA 1.488 1.455 0 CA-C-O 121.503 0.668 . . . . 0.0 109.879 -179.686 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 35.3 m -109.64 -3.62 10.51 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 179.487 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -170.98 120.95 0.87 Allowed Glycine 0 N--CA 1.494 2.502 0 N-CA-C 109.707 -1.357 . . . . 0.0 109.707 179.651 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.454 ' N ' ' CD1' ' A' ' 102' ' ' LEU . 10.1 mp -86.83 1.66 51.63 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.606 -0.938 . . . . 0.0 108.553 179.645 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . 0.421 ' O ' ' O ' ' A' ' 102' ' ' LEU . 14.6 pt-20 -50.61 -176.23 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.684 0 CA-C-O 121.781 0.801 . . . . 0.0 110.487 -179.861 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 80.3 m80 -93.31 11.96 26.35 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 -179.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 59.8 t-80 -62.32 -44.37 96.67 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.466 -0.771 . . . . 0.0 109.373 179.601 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 92.2 m-70 -63.76 -41.06 98.06 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.532 -0.73 . . . . 0.0 109.358 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 52.8 t-80 -82.73 158.19 22.98 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.343 -0.848 . . . . 0.0 110.147 -179.757 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 77.9 m80 -141.15 147.7 38.86 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.624 -0.673 . . . . 0.0 110.035 -179.812 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 84.3 t60 . . . . . 0 N--CA 1.492 1.632 0 CA-C-O 118.071 -0.966 . . . . 0.0 109.105 179.912 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.455 ' O ' ' O ' ' A' ' 2' ' ' GLU . 82.4 mmm . . . . . 0 N--CA 1.489 1.482 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.455 ' O ' ' O ' ' A' ' 1' ' ' MET . 0.9 OUTLIER 57.32 149.4 0.06 OUTLIER Pre-proline 0 N--CA 1.494 1.738 0 CA-C-O 120.964 0.411 . . . . 0.0 110.355 179.902 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -70.06 150.98 67.16 Favored 'Trans proline' 0 N--CA 1.496 1.646 0 C-N-CA 122.691 2.261 . . . . 0.0 112.625 -179.844 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 59.2 tt0 -87.08 81.09 8.15 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 179.845 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 77.5 mt -76.16 146.83 38.91 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.582 -0.699 . . . . 0.0 110.201 -179.119 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 96.8 m -123.33 130.33 52.58 Favored 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 179.751 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -79.54 155.16 28.32 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.475 -0.766 . . . . 0.0 110.313 -179.079 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.407 ' H ' ' CD1' ' A' ' 8' ' ' ILE . 3.0 mp -63.45 -43.24 98.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.627 -0.67 . . . . 0.0 109.671 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 13.1 p -66.93 -20.6 27.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.287 -0.883 . . . . 0.0 109.517 -179.688 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -82.68 -1.37 51.03 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.335 -0.853 . . . . 0.0 109.455 179.606 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 96.4 mt -83.89 111.63 20.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.317 -0.864 . . . . 0.0 109.551 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 24.0 m -154.44 18.45 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 179.754 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -134.75 144.3 47.63 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.533 -0.729 . . . . 0.0 110.105 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.41 ' O ' ' OD1' ' A' ' 14' ' ' ASN . 46.6 p-10 -93.16 137.76 32.2 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.492 -0.755 . . . . 0.0 110.264 -179.578 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 80.7 18.98 69.17 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.279 -1.528 . . . . 0.0 109.279 179.876 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 51.8 tt0 -73.31 133.76 43.98 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.295 -1.121 . . . . 0.0 109.818 -179.528 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 90.0 m95 -106.76 130.87 54.4 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.553 -0.717 . . . . 0.0 109.657 179.78 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 178.32 -173.54 0.15 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.421 -0.799 . . . . 0.0 109.689 179.598 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 80.7 m-20 -99.29 152.69 19.64 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.545 -0.722 . . . . 0.0 109.407 -179.78 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -136.78 117.13 13.63 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.407 -0.808 . . . . 0.0 109.451 179.94 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 35.2 ttpt -115.61 135.29 54.22 Favored 'General case' 0 N--CA 1.497 1.892 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 178.755 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -167.15 175.66 7.32 Favored 'General case' 0 N--CA 1.492 1.647 0 C-N-CA 119.31 -0.956 . . . . 0.0 110.158 179.646 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -103.29 142.11 34.76 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.57 -0.706 . . . . 0.0 109.702 -179.6 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 93.7 t -82.49 128.16 38.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.322 -0.861 . . . . 0.0 110.444 -179.496 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.414 HG21 HD12 ' A' ' 25' ' ' ILE . 96.7 mt -98.58 -59.94 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 179.119 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.622 ' NE2' ' CZ2' ' A' ' 28' ' ' TRP . 60.0 tt0 -146.84 147.69 31.11 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.346 -0.846 . . . . 0.0 109.728 179.955 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -125.31 151.23 46.29 Favored 'General case' 0 N--CA 1.496 1.828 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 -179.706 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . 0.622 ' CZ2' ' NE2' ' A' ' 26' ' ' GLN . 96.2 m95 -124.3 105.34 9.39 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 179.478 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.401 ' OE1' ' N ' ' A' ' 29' ' ' GLU . 59.4 mp0 -59.49 139.51 57.05 Favored 'General case' 0 C--N 1.302 -1.476 0 CA-C-O 121.542 0.687 . . . . 0.0 110.04 -179.164 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 33.0 t30 -149.93 104.74 3.33 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.712 -0.848 . . . . 0.0 108.712 -179.846 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 5.7 m -89.1 49.91 1.86 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.543 -0.723 . . . . 0.0 109.205 -179.164 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . 0.553 ' O ' ' N ' ' A' ' 34' ' ' SER . 61.1 t60 -84.0 28.33 0.61 Allowed 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.437 -0.789 . . . . 0.0 109.609 -179.657 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 40.2 tp10 59.45 -71.48 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.733 -0.605 . . . . 0.0 110.227 179.525 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' SER . . . . . 0.553 ' N ' ' O ' ' A' ' 32' ' ' HIS . 77.7 p -61.37 -36.25 79.71 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.321 -0.862 . . . . 0.0 110.176 -179.246 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.41 HG23 HD13 ' A' ' 35' ' ' ILE . 96.8 mt -112.79 128.35 69.55 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.069 0 O-C-N 121.478 -0.764 . . . . 0.0 109.878 -179.743 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.465 ' OG ' ' CA ' ' A' ' 54' ' ' LYS . 1.3 m -85.01 -67.98 0.76 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.751 -0.593 . . . . 0.0 109.528 -179.781 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 51.2 tt0 -139.68 151.48 45.95 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.477 -0.764 . . . . 0.0 109.595 -179.638 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 8.3 p -135.71 139.38 46.38 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 179.677 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -164.35 -163.13 16.68 Favored Glycine 0 N--CA 1.49 2.297 0 C-N-CA 119.341 -1.409 . . . . 0.0 110.434 -179.509 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.521 ' CD2' ' N ' ' A' ' 40' ' ' LEU . 1.4 pt? -136.98 146.23 45.12 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.553 -0.969 . . . . 0.0 109.852 179.904 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 52.9 mt -109.79 132.32 54.25 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.524 -0.735 . . . . 0.0 109.865 -179.274 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -79.06 163.82 49.52 Favored Glycine 0 N--CA 1.487 2.074 0 N-CA-C 110.512 -1.035 . . . . 0.0 110.512 -179.81 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.487 ' OD1' ' N ' ' A' ' 44' ' ' GLU . 49.7 t0 -171.8 138.52 1.09 Allowed 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.68 -0.894 . . . . 0.0 109.105 179.346 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.487 ' N ' ' OD1' ' A' ' 43' ' ' ASP . 18.1 pt-20 -55.7 -13.39 1.66 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.415 -0.803 . . . . 0.0 109.222 -179.773 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 13.9 p -98.29 -9.34 25.63 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.441 -0.787 . . . . 0.0 109.376 -179.794 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 144.92 -157.64 27.37 Favored Glycine 0 N--CA 1.497 2.749 0 C-N-CA 120.078 -1.058 . . . . 0.0 110.487 179.281 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 40.1 pt -126.35 154.57 35.94 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 O-C-N 121.738 -0.86 . . . . 0.0 109.584 -179.864 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -141.39 142.15 29.49 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 121.308 -0.87 . . . . 0.0 109.459 179.426 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -91.24 143.97 26.1 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.658 -0.651 . . . . 0.0 109.348 179.455 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 33.4 p90 -137.61 152.51 49.45 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.168 -0.957 . . . . 0.0 109.674 -179.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 97.1 m -128.32 132.81 48.62 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 47.1 mm -99.99 121.33 50.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.405 -0.81 . . . . 0.0 109.875 -179.457 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . 0.482 ' CD1' ' OD1' ' A' ' 86' ' ' ASN . 89.2 m95 -82.16 124.19 29.66 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 108.72 -0.845 . . . . 0.0 108.72 179.368 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.465 ' CA ' ' OG ' ' A' ' 36' ' ' SER . 32.7 tttt -62.48 -15.17 48.53 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 -179.219 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 99.0 m-20 -63.33 -40.22 96.71 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.482 -0.761 . . . . 0.0 109.488 -179.706 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -64.59 -32.72 74.49 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.338 -0.851 . . . . 0.0 109.441 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 59.52 49.45 8.54 Favored 'General case' 0 N--CA 1.491 1.612 0 CA-C-O 121.282 0.563 . . . . 0.0 109.638 -179.458 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 37.3 mt -101.37 152.39 37.97 Favored Pre-proline 0 N--CA 1.493 1.676 0 O-C-N 121.624 -0.673 . . . . 0.0 109.5 179.868 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -50.57 148.6 15.06 Favored 'Trans proline' 0 N--CA 1.496 1.637 0 C-N-CA 122.177 1.918 . . . . 0.0 112.797 179.133 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 84.0 mt -69.28 154.37 42.15 Favored 'General case' 0 N--CA 1.492 1.632 0 CA-C-O 121.836 0.827 . . . . 0.0 110.543 -179.195 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.556 ' CD2' ' N ' ' A' ' 61' ' ' LEU . 3.4 mm? -78.72 149.61 32.69 Favored 'General case' 0 C--N 1.304 -1.382 0 CA-C-O 121.421 0.629 . . . . 0.0 110.304 -178.663 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -106.26 146.49 30.27 Favored 'General case' 0 N--CA 1.495 1.823 0 CA-C-O 121.738 0.78 . . . . 0.0 110.057 -179.111 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 49.2 tt0 -81.34 134.21 35.54 Favored 'General case' 0 N--CA 1.488 1.468 0 CA-C-O 121.284 0.564 . . . . 0.0 110.81 -178.905 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 90.38 -6.65 82.3 Favored Glycine 0 N--CA 1.495 2.611 0 N-CA-C 110.355 -1.098 . . . . 0.0 110.355 178.717 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -104.6 150.47 24.63 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.37 -1.076 . . . . 0.0 110.749 -179.438 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 8.4 m -95.37 136.59 35.54 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.698 -0.626 . . . . 0.0 109.358 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 72.5 m-85 -121.87 145.1 48.41 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-O 121.748 0.785 . . . . 0.0 110.142 -179.848 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 14.0 tp -110.34 112.14 23.89 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 179.344 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 71.4 mt -95.86 131.99 41.6 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 -179.827 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 80.4 mtp85 -123.52 141.87 51.57 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.561 -0.712 . . . . 0.0 110.537 -179.334 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 9.2 t 57.81 65.04 1.4 Allowed 'General case' 0 N--CA 1.493 1.692 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.547 179.397 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 2.9 m -121.76 160.82 22.97 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 179.258 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 14.8 p -118.7 133.22 66.24 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 CA-C-O 121.63 0.728 . . . . 0.0 109.45 -179.258 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 14.0 t -85.6 121.37 37.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.654 -0.654 . . . . 0.0 109.68 -179.193 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -98.87 -172.35 31.6 Favored Glycine 0 N--CA 1.494 2.531 0 N-CA-C 109.784 -1.327 . . . . 0.0 109.784 -179.773 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -111.31 120.75 43.29 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.644 -0.916 . . . . 0.0 109.65 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . 0.496 ' O ' ' N ' ' A' ' 79' ' ' ASP . 86.7 t80 -108.67 80.77 1.37 Allowed 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 179.44 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . 0.455 ' C ' ' O ' ' A' ' 77' ' ' TYR . 94.3 m-20 31.07 -91.34 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.988 0 CA-C-O 121.482 0.658 . . . . 0.0 111.196 179.855 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.496 ' N ' ' O ' ' A' ' 77' ' ' TYR . 66.5 t0 -51.52 -68.69 0.15 Allowed 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.619 -0.676 . . . . 0.0 110.656 -179.453 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 85.2 mtp180 -120.96 -163.99 1.08 Allowed 'General case' 0 N--CA 1.501 2.123 0 O-C-N 121.528 -0.732 . . . . 0.0 110.336 -178.774 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 79.6 m-85 -99.08 162.93 12.79 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.56 -0.712 . . . . 0.0 109.793 -179.037 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 6.4 pt20 -141.95 162.01 36.55 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.377 -0.827 . . . . 0.0 109.834 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 2.7 m -107.96 131.18 59.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 179.81 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -106.7 131.72 53.51 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.676 -0.64 . . . . 0.0 110.041 -178.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 96.3 t -103.15 124.31 57.19 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.482 ' OD1' ' CD1' ' A' ' 53' ' ' TRP . 80.3 m-20 -125.01 -176.52 3.58 Favored 'General case' 0 N--CA 1.496 1.834 0 CA-C-O 121.524 0.678 . . . . 0.0 109.739 -179.528 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 62.9 pttt -59.86 -33.43 71.78 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.741 -0.6 . . . . 0.0 109.862 -179.888 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 52.3 t-20 -63.45 -38.23 90.33 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.393 -0.817 . . . . 0.0 109.523 -179.558 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 27.7 t -76.57 164.78 25.6 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.34 -0.85 . . . . 0.0 110.325 -179.064 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 95.1 p -133.06 158.3 43.11 Favored 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 179.825 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.42 HD12 HG21 ' A' ' 91' ' ' ILE . 96.8 mt -125.54 132.63 70.71 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 O-C-N 121.668 -0.645 . . . . 0.0 110.02 -179.383 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 31.7 mm-40 -136.15 135.42 39.2 Favored 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 179.633 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -84.19 136.09 34.1 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.442 -0.786 . . . . 0.0 109.962 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 8.9 mp -108.25 133.66 52.18 Favored 'General case' 0 N--CA 1.499 1.986 0 CA-C-O 121.623 0.725 . . . . 0.0 109.384 179.503 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 89.7 p -76.09 1.95 14.2 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 179.637 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.416 ' OE2' ' O ' ' A' ' 97' ' ' PRO . 8.7 tm-20 -109.52 95.72 20.29 Favored Pre-proline 0 N--CA 1.497 1.883 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 -179.948 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . 0.416 ' O ' ' OE2' ' A' ' 96' ' ' GLU . 64.7 Cg_endo -76.78 158.89 35.13 Favored 'Trans proline' 0 N--CA 1.491 1.363 0 C-N-CA 122.241 1.961 . . . . 0.0 112.351 -179.149 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 86.8 mt -104.48 128.12 58.3 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 O-C-N 121.499 -0.751 . . . . 0.0 109.79 -179.574 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -67.37 138.05 56.44 Favored 'General case' 0 N--CA 1.489 1.492 0 CA-C-O 121.503 0.668 . . . . 0.0 110.197 -179.299 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 5.4 m -101.11 31.66 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 N-CA-C 108.979 -0.748 . . . . 0.0 108.979 179.705 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 103.16 127.62 6.14 Favored Glycine 0 N--CA 1.497 2.747 0 N-CA-C 110.314 -1.114 . . . . 0.0 110.314 179.395 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.41 ' N ' ' CD1' ' A' ' 102' ' ' LEU . 10.7 mp -88.62 -2.97 58.87 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.476 -1.014 . . . . 0.0 108.538 179.376 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -78.91 -4.71 51.12 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.565 -0.71 . . . . 0.0 109.315 179.881 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 76.6 t60 -65.14 -41.25 94.95 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.419 -0.801 . . . . 0.0 109.463 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 58.1 t-80 -75.53 129.69 37.64 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.446 -0.783 . . . . 0.0 110.405 -179.181 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 52.3 p-80 -151.95 15.26 0.64 Allowed 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 179.287 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 81.1 t60 -80.24 126.98 31.81 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.569 -0.707 . . . . 0.0 110.087 -179.314 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 8.1 p80 -154.08 163.45 40.07 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.447 -0.783 . . . . 0.0 109.674 179.524 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . 0.542 ' OXT' ' CG ' ' A' ' 109' ' ' HIS . 85.5 t60 . . . . . 0 N--CA 1.488 1.471 0 CA-C-O 117.829 -1.081 . . . . 0.0 108.835 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.47 ' N ' ' SD ' ' A' ' 1' ' ' MET . 0.9 OUTLIER . . . . . 0 N--CA 1.488 1.473 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 . . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.439 ' N ' ' CD ' ' A' ' 3' ' ' PRO . 27.7 tt0 -162.73 54.5 0.46 Allowed Pre-proline 0 C--N 1.303 -1.454 0 O-C-N 121.384 -0.823 . . . . 0.0 109.285 179.706 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.439 ' CD ' ' N ' ' A' ' 2' ' ' GLU . 30.7 Cg_endo -63.96 143.97 86.67 Favored 'Trans proline' 0 N--CA 1.496 1.622 0 C-N-CA 122.675 2.25 . . . . 0.0 112.269 -179.868 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . 0.496 ' H ' ' CD ' ' A' ' 4' ' ' GLN . 21.9 mp0 -72.72 92.61 1.57 Allowed 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.291 -0.88 . . . . 0.0 109.685 -179.719 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 86.6 mt -74.51 147.32 41.97 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.487 -0.758 . . . . 0.0 109.567 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.409 ' HG1' ' CB ' ' A' ' 18' ' ' ALA . 97.8 m -124.12 130.5 52.65 Favored 'General case' 0 N--CA 1.495 1.779 0 CA-C-O 121.736 0.779 . . . . 0.0 109.754 -179.897 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -98.87 159.12 15.18 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.597 -0.689 . . . . 0.0 110.048 -179.675 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 96.6 mt -63.84 -42.74 96.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.412 -0.805 . . . . 0.0 109.557 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 14.8 p -63.32 -23.58 33.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.24 -0.913 . . . . 0.0 109.441 -179.843 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 94.7 m-20 -78.9 -4.15 48.29 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.213 -0.929 . . . . 0.0 109.345 179.58 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 5.6 mm -69.12 98.95 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.079 -1.013 . . . . 0.0 109.639 -179.773 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 2.5 p -116.12 -40.11 2.7 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.36 0 O-C-N 121.625 -0.672 . . . . 0.0 109.3 179.871 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 79.4 tt0 -126.28 143.33 51.19 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.294 -0.879 . . . . 0.0 110.26 -178.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 55.8 p30 -87.14 163.16 17.12 Favored 'General case' 0 N--CA 1.492 1.627 0 CA-C-O 121.71 0.767 . . . . 0.0 110.447 -179.674 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 78.07 13.04 83.78 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 109.267 -1.533 . . . . 0.0 109.267 -179.494 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -83.58 129.94 34.98 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.187 -1.184 . . . . 0.0 110.082 -179.7 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 84.1 m95 -93.12 129.16 39.2 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.265 -0.897 . . . . 0.0 109.929 -179.734 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.409 ' CB ' ' HG1' ' A' ' 6' ' ' THR . . . -174.35 -173.33 0.76 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.6 -0.687 . . . . 0.0 109.303 179.581 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 73.5 m-20 -105.64 145.25 31.27 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.515 -0.741 . . . . 0.0 109.822 -179.463 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 40.5 tp -128.07 132.14 49.06 Favored 'General case' 0 N--CA 1.498 1.968 0 CA-C-O 121.69 0.757 . . . . 0.0 109.9 179.766 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 38.2 ttmt -116.09 130.18 56.69 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 179.359 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -166.65 179.01 5.65 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.84 -1.162 . . . . 0.0 110.775 -179.589 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.523 ' HZ2' ' C ' ' A' ' 64' ' ' GLY . 64.5 tttp -114.55 139.93 49.18 Favored 'General case' 0 N--CA 1.497 1.919 0 CA-C-O 121.619 0.723 . . . . 0.0 109.968 -179.682 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 87.6 t -81.02 115.73 24.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.413 -0.804 . . . . 0.0 109.943 -179.766 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.413 HD11 HG21 ' A' ' 25' ' ' ILE . 19.1 mm -93.92 -48.93 12.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.297 -0.877 . . . . 0.0 109.645 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 82.4 mt-30 -144.62 144.97 31.53 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.04 -1.038 . . . . 0.0 110.199 -179.347 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.552 ' CD2' ' N ' ' A' ' 27' ' ' LEU . 1.1 pt? -141.95 133.32 26.54 Favored 'General case' 0 N--CA 1.492 1.675 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 179.836 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 3.4 m0 -118.86 146.51 44.83 Favored 'General case' 0 N--CA 1.499 2.014 0 CA-C-O 121.741 0.781 . . . . 0.0 109.999 -179.347 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 50.0 tp10 -91.1 133.39 35.37 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.405 -0.81 . . . . 0.0 109.576 -179.808 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . 0.517 ' ND2' ' O ' ' A' ' 35' ' ' ILE . 14.1 p-10 -89.37 -168.88 2.3 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.342 -0.849 . . . . 0.0 110.143 -179.586 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 97.3 m -118.81 -14.5 9.48 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 179.508 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 99.3 m-70 -79.75 139.81 37.16 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.06 -1.025 . . . . 0.0 110.075 -179.871 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 71.8 mm-40 -69.29 -34.45 74.74 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.417 -0.802 . . . . 0.0 110.077 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 40.1 t -61.31 -42.4 98.6 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.146 -0.971 . . . . 0.0 110.555 -179.284 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.517 ' O ' ' ND2' ' A' ' 30' ' ' ASN . 96.9 mt -103.15 133.82 45.94 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 O-C-N 121.121 -0.987 . . . . 0.0 109.794 -179.523 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.459 ' CB ' ' HZ3' ' A' ' 54' ' ' LYS . 28.7 t -86.33 -70.61 0.59 Allowed 'General case' 0 N--CA 1.49 1.544 0 CA-C-O 121.664 0.745 . . . . 0.0 109.804 -179.946 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -141.19 153.93 45.57 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.088 -1.007 . . . . 0.0 110.375 -179.15 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 27.8 m -135.98 158.51 38.97 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 179.312 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -178.23 -150.91 8.99 Favored Glycine 0 N--CA 1.487 2.045 0 C-N-CA 119.467 -1.349 . . . . 0.0 110.033 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -135.25 148.11 49.48 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.655 -0.909 . . . . 0.0 109.374 -179.744 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 70.3 mt -111.54 128.4 56.01 Favored 'General case' 0 N--CA 1.495 1.787 0 CA-C-O 121.668 0.747 . . . . 0.0 109.31 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -80.44 158.03 41.1 Favored Glycine 0 N--CA 1.487 2.095 0 N-CA-C 110.012 -1.235 . . . . 0.0 110.012 -179.751 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.529 ' OD1' ' N ' ' A' ' 44' ' ' GLU . 67.2 t0 -172.58 143.14 1.3 Allowed 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.493 -1.004 . . . . 0.0 109.045 -179.923 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.529 ' N ' ' OD1' ' A' ' 43' ' ' ASP . 96.9 mt-10 -54.88 -14.45 1.45 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.427 -0.795 . . . . 0.0 109.793 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 37.4 p -93.33 -12.94 28.81 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.024 -1.047 . . . . 0.0 109.292 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 141.15 -157.32 25.99 Favored Glycine 0 N--CA 1.498 2.792 0 C-N-CA 119.876 -1.154 . . . . 0.0 110.245 179.378 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 41.5 pt -124.85 150.55 29.86 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 O-C-N 121.581 -0.953 . . . . 0.0 109.518 -179.451 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 20.8 tt -146.94 150.08 15.15 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 121.235 -0.916 . . . . 0.0 109.7 -179.741 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 72.5 mmtt -84.09 150.21 25.71 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.466 -0.771 . . . . 0.0 110.402 -179.23 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 17.3 p90 -143.65 151.76 40.51 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.321 -0.862 . . . . 0.0 109.19 179.52 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.545 ' OG1' ' NE2' ' A' ' 82' ' ' GLN . 35.0 m -132.99 137.18 46.44 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.629 -0.669 . . . . 0.0 109.469 179.807 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 29.7 mm -98.48 122.56 50.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.225 -0.922 . . . . 0.0 109.735 -179.676 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 97.3 m95 -98.17 140.97 31.68 Favored 'General case' 0 N--CA 1.49 1.543 0 CA-C-O 121.582 0.706 . . . . 0.0 109.639 179.841 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.459 ' HZ3' ' CB ' ' A' ' 36' ' ' SER . 29.0 mmtm -84.34 -10.41 57.62 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.144 -0.973 . . . . 0.0 109.781 179.547 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 89.7 m-20 -61.8 -41.01 97.2 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.174 -0.954 . . . . 0.0 109.477 -179.776 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -77.58 -8.59 58.08 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.226 -0.921 . . . . 0.0 108.937 179.654 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 58.18 58.11 3.66 Favored 'General case' 0 N--CA 1.495 1.797 0 CA-C-O 121.496 0.665 . . . . 0.0 109.604 -179.771 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 29.8 mt -105.65 147.52 34.82 Favored Pre-proline 0 N--CA 1.497 1.91 0 O-C-N 121.548 -0.72 . . . . 0.0 109.389 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -69.76 159.42 53.46 Favored 'Trans proline' 0 N--CA 1.497 1.72 0 C-N-CA 122.837 2.358 . . . . 0.0 113.195 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 97.2 mt -71.52 141.61 50.12 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.274 -0.891 . . . . 0.0 109.98 -179.814 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.413 ' CD1' ' N ' ' A' ' 61' ' ' LEU . 9.6 mp -80.04 149.04 30.84 Favored 'General case' 0 N--CA 1.493 1.724 0 CA-C-O 121.727 0.775 . . . . 0.0 110.705 -179.084 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -104.91 126.63 52.18 Favored 'General case' 0 N--CA 1.497 1.914 0 CA-C-O 121.802 0.81 . . . . 0.0 109.758 -179.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 58.2 tt0 -64.49 147.89 51.79 Favored 'General case' 0 N--CA 1.496 1.855 0 CA-C-O 121.965 0.888 . . . . 0.0 111.835 -178.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.523 ' C ' ' HZ2' ' A' ' 23' ' ' LYS . . . 81.05 22.94 60.15 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.937 -1.265 . . . . 0.0 109.937 178.825 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -139.26 145.46 39.21 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.248 -1.148 . . . . 0.0 110.094 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 11.1 p -84.42 149.73 25.79 Favored 'General case' 0 N--CA 1.486 1.333 0 CA-C-O 121.606 0.717 . . . . 0.0 109.856 179.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 66.6 m-85 -143.58 151.91 40.77 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.233 -0.917 . . . . 0.0 110.307 -179.867 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 21.9 tp -112.92 121.95 46.2 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 179.235 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 71.8 mt -100.84 130.74 46.9 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.393 -0.817 . . . . 0.0 109.849 -179.162 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 83.4 mtp180 -127.09 144.55 51.0 Favored 'General case' 0 N--CA 1.498 1.944 0 CA-C-O 121.878 0.847 . . . . 0.0 110.49 -179.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.8 m 58.34 57.43 3.91 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.798 -0.564 . . . . 0.0 110.49 179.385 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 17.9 m -118.81 164.67 14.85 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.98 0 O-C-N 121.598 -0.688 . . . . 0.0 109.656 179.33 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 11.8 p -120.47 136.11 58.56 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 CA-C-O 121.65 0.738 . . . . 0.0 109.379 -179.712 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 66.9 t -81.47 115.29 23.79 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 CA-C-O 121.831 0.824 . . . . 0.0 109.889 -178.863 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -84.92 167.32 41.89 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 110.024 -1.23 . . . . 0.0 110.024 -179.563 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -105.91 124.2 49.19 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.466 -1.02 . . . . 0.0 109.624 180.0 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 52.0 t80 -120.05 82.58 1.91 Allowed 'General case' 0 N--CA 1.492 1.637 0 CA-C-O 121.984 0.897 . . . . 0.0 108.807 179.719 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . 0.472 ' CG ' ' H ' ' A' ' 79' ' ' ASP . 50.1 t30 42.95 -117.63 0.46 Allowed 'General case' 0 N--CA 1.501 2.087 0 CA-C-O 121.729 0.776 . . . . 0.0 112.179 179.774 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.472 ' H ' ' CG ' ' A' ' 78' ' ' ASN . 42.4 t0 -70.22 -35.16 73.7 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.184 -0.947 . . . . 0.0 109.991 -178.806 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 84.4 mtt85 -101.22 -170.88 1.9 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.267 -0.896 . . . . 0.0 110.011 -179.377 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -127.9 150.53 49.83 Favored 'General case' 0 N--CA 1.494 1.756 0 CA-C-O 121.694 0.759 . . . . 0.0 110.075 -179.297 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . 0.545 ' NE2' ' OG1' ' A' ' 51' ' ' THR . 40.5 tt0 -133.13 126.44 31.73 Favored 'General case' 0 N--CA 1.49 1.528 0 CA-C-O 121.493 0.663 . . . . 0.0 109.351 -179.803 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 34.1 m -81.13 141.21 15.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.477 -0.764 . . . . 0.0 109.553 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 87.7 mt-30 -111.54 120.82 43.4 Favored 'General case' 0 N--CA 1.495 1.812 0 CA-C-O 121.799 0.809 . . . . 0.0 109.738 -179.449 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 4.5 t -93.24 99.3 9.45 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 179.655 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.5 ' C ' HD21 ' A' ' 86' ' ' ASN . 0.1 OUTLIER -150.67 -176.7 5.61 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.495 -0.753 . . . . 0.0 109.313 -179.571 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.465 ' CG ' ' H ' ' A' ' 88' ' ' ASN . 14.4 tptm 66.27 -137.93 0.16 Allowed 'General case' 0 N--CA 1.491 1.621 0 CA-C-O 121.806 0.812 . . . . 0.0 110.826 179.588 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . 0.465 ' H ' ' CG ' ' A' ' 87' ' ' LYS . 15.0 m120 -86.14 22.62 1.71 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.474 -0.766 . . . . 0.0 109.227 -179.574 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 30.9 t -58.61 141.78 51.31 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.193 -0.942 . . . . 0.0 109.672 -179.759 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 64.0 m -127.16 152.32 47.5 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.546 -0.721 . . . . 0.0 109.318 -179.735 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.409 HD12 HG23 ' A' ' 91' ' ' ILE . 97.3 mt -128.07 131.73 69.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.692 -0.63 . . . . 0.0 109.351 -179.707 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -132.03 131.76 42.78 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.523 -0.736 . . . . 0.0 109.301 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.43 ' CB ' ' HZ1' ' A' ' 93' ' ' LYS . 4.8 ttpm? -79.61 136.69 36.9 Favored 'General case' 0 N--CA 1.489 1.487 0 CA-C-O 121.789 0.804 . . . . 0.0 110.31 -179.588 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 70.9 mt -98.15 132.85 43.32 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.42 -0.8 . . . . 0.0 109.744 -179.797 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 31.3 t -75.51 3.84 8.62 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.481 -0.762 . . . . 0.0 109.342 179.642 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -118.36 90.28 38.22 Favored Pre-proline 0 N--CA 1.495 1.812 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 179.593 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_exo -56.09 147.38 64.93 Favored 'Trans proline' 0 N--CA 1.495 1.606 0 C-N-CA 122.829 2.353 . . . . 0.0 112.394 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 90.6 mt -97.43 125.82 50.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.299 -0.876 . . . . 0.0 109.869 -179.205 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 81.2 tt0 -90.49 124.05 34.67 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.557 -0.714 . . . . 0.0 109.989 -179.378 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 61.2 t -107.27 -14.3 9.55 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.918 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 179.496 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -75.1 55.46 2.71 Favored Glycine 0 N--CA 1.493 2.469 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 80.8 mt -88.32 -1.73 58.2 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.233 -1.157 . . . . 0.0 108.618 179.722 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -57.33 137.09 56.49 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.205 -0.934 . . . . 0.0 110.375 -179.524 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 61.0 t-80 -145.9 145.23 30.62 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.395 -0.816 . . . . 0.0 108.909 179.787 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 95.9 m-70 -114.04 -162.97 0.83 Allowed 'General case' 0 N--CA 1.498 1.947 0 CA-C-O 121.858 0.837 . . . . 0.0 110.71 -178.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 49.5 p-80 -69.72 139.71 53.41 Favored 'General case' 0 N--CA 1.49 1.533 0 CA-C-O 121.906 0.86 . . . . 0.0 110.957 -179.159 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 77.8 m80 -67.38 -41.99 84.12 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.476 -0.765 . . . . 0.0 109.367 179.637 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . 0.465 ' C ' ' HD1' ' A' ' 108' ' ' HIS . 2.1 p80 -155.23 165.18 37.47 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.187 -0.946 . . . . 0.0 109.921 -179.973 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 48.7 t-80 . . . . . 0 N--CA 1.492 1.663 0 CA-C-O 118.017 -0.992 . . . . 0.0 110.006 179.926 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 96.1 mtp . . . . . 0 N--CA 1.49 1.558 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.632 ' N ' ' CD ' ' A' ' 3' ' ' PRO . 4.1 tt0 -87.83 -41.28 0.5 Allowed Pre-proline 0 N--CA 1.496 1.831 0 O-C-N 121.705 -0.622 . . . . 0.0 109.734 179.467 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.632 ' CD ' ' N ' ' A' ' 2' ' ' GLU . 23.7 Cg_exo -61.6 146.24 97.04 Favored 'Trans proline' 0 N--CA 1.494 1.517 0 C-N-CA 122.532 2.155 . . . . 0.0 112.261 -179.225 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 1.1 pt20 -74.88 72.35 2.07 Favored 'General case' 0 C--N 1.3 -1.55 0 CA-C-O 121.786 0.803 . . . . 0.0 109.905 -179.501 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 18.8 mt -65.74 137.3 57.18 Favored 'General case' 0 N--CA 1.489 1.479 0 CA-C-O 121.453 0.644 . . . . 0.0 109.734 179.882 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 91.8 m -128.54 135.5 49.48 Favored 'General case' 0 N--CA 1.494 1.728 0 CA-C-O 121.836 0.827 . . . . 0.0 109.811 -179.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 65.4 mttp -72.92 151.15 42.02 Favored 'General case' 0 N--CA 1.49 1.572 0 CA-C-O 121.704 0.764 . . . . 0.0 109.975 -179.458 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 92.4 mt -63.25 -43.13 98.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 CA-C-O 121.369 0.604 . . . . 0.0 109.379 -179.393 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 8.3 p -65.7 -24.07 33.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 -179.05 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -79.05 -6.47 56.48 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.639 -0.663 . . . . 0.0 109.327 -179.434 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 97.5 mt -85.89 113.79 24.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 CA-C-O 121.78 0.8 . . . . 0.0 109.543 179.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 31.7 m -150.12 12.21 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -124.97 137.51 54.25 Favored 'General case' 0 N--CA 1.501 2.123 0 CA-C-O 121.884 0.85 . . . . 0.0 110.268 -179.861 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 48.1 p-10 -84.08 140.8 31.58 Favored 'General case' 0 N--CA 1.489 1.518 0 CA-C-O 121.619 0.723 . . . . 0.0 109.881 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 75.99 19.0 79.16 Favored Glycine 0 N--CA 1.492 2.407 0 N-CA-C 109.647 -1.381 . . . . 0.0 109.647 179.626 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 57.0 tt0 -78.77 133.82 37.07 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.59 -0.947 . . . . 0.0 110.209 -179.623 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 84.3 m95 -106.78 130.64 54.45 Favored 'General case' 0 N--CA 1.494 1.748 0 CA-C-O 121.585 0.707 . . . . 0.0 110.148 -179.751 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -178.9 175.51 1.01 Allowed 'General case' 0 N--CA 1.493 1.689 0 CA-C-O 121.693 0.758 . . . . 0.0 110.391 179.248 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.422 ' OD1' ' O ' ' A' ' 69' ' ' LEU . 1.4 t30 -102.05 150.01 23.67 Favored 'General case' 0 N--CA 1.498 1.944 0 CA-C-O 121.902 0.858 . . . . 0.0 110.137 -179.432 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 7.2 tt -147.56 138.2 23.32 Favored 'General case' 0 C--N 1.305 -1.36 0 CA-C-O 121.779 0.8 . . . . 0.0 110.449 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 37.8 ttmt -109.83 133.22 53.4 Favored 'General case' 0 N--CA 1.496 1.863 0 CA-C-O 121.594 0.711 . . . . 0.0 109.561 179.477 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -163.18 170.5 17.68 Favored 'General case' 0 N--CA 1.494 1.746 0 CA-C-O 121.762 0.791 . . . . 0.0 110.589 179.718 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.57 ' HZ2' ' CA ' ' A' ' 65' ' ' GLU . 17.1 ttmm -113.83 142.31 46.24 Favored 'General case' 0 N--CA 1.498 1.957 0 CA-C-O 121.608 0.718 . . . . 0.0 109.934 -179.717 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 98.8 t -81.98 122.2 36.43 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 CA-C-O 121.528 0.68 . . . . 0.0 110.239 -179.515 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 26.0 mm -93.88 -44.98 13.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 CA-C-O 121.086 0.469 . . . . 0.0 110.031 -179.507 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 59.3 tt0 -158.14 147.62 19.66 Favored 'General case' 0 N--CA 1.492 1.642 0 CA-C-O 122.182 0.992 . . . . 0.0 110.334 -179.072 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.725 ' CD2' ' H ' ' A' ' 27' ' ' LEU . 0.0 OUTLIER -116.87 151.46 36.52 Favored 'General case' 0 N--CA 1.502 2.13 0 CA-C-O 121.632 0.729 . . . . 0.0 109.272 -179.205 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 23.9 t90 -138.15 111.18 7.8 Favored 'General case' 0 N--CA 1.493 1.675 0 CA-C-O 121.879 0.847 . . . . 0.0 109.678 179.148 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -52.8 132.01 36.03 Favored 'General case' 0 N--CA 1.491 1.602 0 CA-C-O 121.675 0.75 . . . . 0.0 110.168 -179.618 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 59.9 t30 -88.74 172.05 9.52 Favored 'General case' 0 N--CA 1.491 1.614 0 CA-C-O 121.556 0.693 . . . . 0.0 110.112 -179.369 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 65.1 p -101.8 1.05 36.75 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.799 -0.563 . . . . 0.0 109.688 -179.126 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 65.3 m80 -105.04 139.11 40.21 Favored 'General case' 0 N--CA 1.501 2.079 0 CA-C-O 122.03 0.919 . . . . 0.0 110.531 -179.423 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -68.51 -37.23 79.86 Favored 'General case' 0 N--CA 1.491 1.607 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.853 -179.61 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 16.4 m -62.54 -36.31 82.21 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 -179.672 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 85.6 mt -103.07 128.61 55.86 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 CA-C-O 121.912 0.863 . . . . 0.0 109.39 -179.56 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 28.1 t -74.92 -75.14 0.17 Allowed 'General case' 0 N--CA 1.489 1.52 0 CA-C-O 121.508 0.67 . . . . 0.0 109.852 -179.273 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 13.1 pt20 -139.78 156.51 46.72 Favored 'General case' 0 N--CA 1.494 1.736 0 CA-C-O 122.045 0.926 . . . . 0.0 110.488 -179.064 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 56.6 t -130.92 136.15 58.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 CA-C-O 121.639 0.733 . . . . 0.0 109.367 179.856 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -153.63 -151.26 5.69 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 110.11 -1.196 . . . . 0.0 110.11 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -134.48 152.09 51.56 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.739 -0.859 . . . . 0.0 109.772 -179.414 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 53.0 mt -116.85 126.46 53.05 Favored 'General case' 0 N--CA 1.494 1.753 0 CA-C-O 121.84 0.829 . . . . 0.0 109.77 -179.867 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -85.08 150.59 25.07 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 110.959 -0.856 . . . . 0.0 110.959 -179.573 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 44.3 t0 -168.55 164.37 12.46 Favored 'General case' 0 N--CA 1.489 1.494 0 CA-C-O 121.723 0.773 . . . . 0.0 109.583 179.335 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -66.06 -22.38 66.42 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.864 -0.523 . . . . 0.0 109.923 -179.181 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 65.5 p -88.48 -6.02 57.88 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.289 -0.882 . . . . 0.0 109.723 -179.433 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 134.45 -157.65 23.03 Favored Glycine 0 N--CA 1.5 2.956 0 C-N-CA 120.347 -0.93 . . . . 0.0 110.987 178.709 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 4.9 mp -126.02 133.68 68.34 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 CA-C-O 121.491 0.662 . . . . 0.0 109.539 -179.465 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 20.0 tt -127.67 151.83 34.99 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 CA-C-O 122.023 0.916 . . . . 0.0 110.439 -179.457 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 28.2 mmtp -83.94 153.24 24.04 Favored 'General case' 0 N--CA 1.489 1.507 0 CA-C-O 121.543 0.687 . . . . 0.0 109.709 -179.346 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 17.2 p90 -147.2 154.99 41.71 Favored 'General case' 0 N--CA 1.491 1.623 0 CA-C-O 122.03 0.919 . . . . 0.0 110.289 179.8 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 13.8 t -142.22 139.05 31.88 Favored 'General case' 0 N--CA 1.492 1.648 0 CA-C-O 121.684 0.755 . . . . 0.0 109.629 179.493 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 85.8 mt -103.83 116.37 47.49 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 CA-C-O 121.84 0.828 . . . . 0.0 109.803 -179.793 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 73.3 m95 -86.04 138.42 31.97 Favored 'General case' 0 N--CA 1.491 1.591 0 CA-C-O 121.537 0.684 . . . . 0.0 109.402 179.8 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 18.8 mmmt -88.24 49.2 1.75 Allowed 'General case' 0 N--CA 1.491 1.587 0 CA-C-O 121.451 0.643 . . . . 0.0 109.453 -179.739 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 95.9 m-20 -69.69 -2.29 11.39 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -159.08 -88.61 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.541 -0.725 . . . . 0.0 109.564 179.538 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 179.15 71.56 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.87 0 CA-C-O 121.755 0.788 . . . . 0.0 109.485 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 14.8 mt -90.7 143.47 29.0 Favored Pre-proline 0 N--CA 1.488 1.473 0 O-C-N 121.519 -0.738 . . . . 0.0 109.333 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -71.54 156.37 58.05 Favored 'Trans proline' 0 C--N 1.31 -1.468 0 C-N-CA 122.561 2.174 . . . . 0.0 112.711 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 82.9 mt -72.41 144.98 47.96 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-O 121.894 0.855 . . . . 0.0 110.706 -179.439 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.454 ' CD1' ' N ' ' A' ' 61' ' ' LEU . 9.9 mp -86.86 137.62 32.25 Favored 'General case' 0 N--CA 1.488 1.427 0 CA-C-O 121.554 0.693 . . . . 0.0 109.625 -179.71 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.529 ' N ' ' OH ' ' A' ' 67' ' ' TYR . 97.8 mt-10 -80.74 144.9 31.83 Favored 'General case' 0 C--N 1.301 -1.516 0 CA-C-O 121.659 0.742 . . . . 0.0 110.27 -179.778 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.417 ' C ' ' OE1' ' A' ' 65' ' ' GLU . 57.9 tt0 -80.85 125.78 30.52 Favored 'General case' 0 N--CA 1.488 1.465 0 CA-C-O 121.541 0.686 . . . . 0.0 110.437 -179.231 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 96.62 31.46 7.08 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.382 -1.487 . . . . 0.0 109.382 179.304 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.57 ' CA ' ' HZ2' ' A' ' 23' ' ' LYS . 59.9 mp0 -139.53 145.48 38.74 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.54 -0.977 . . . . 0.0 110.142 179.472 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 30.0 t -75.79 145.14 40.94 Favored 'General case' 0 N--CA 1.489 1.478 0 CA-C-O 121.481 0.658 . . . . 0.0 110.087 -179.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.529 ' OH ' ' N ' ' A' ' 62' ' ' GLU . 94.0 m-85 -137.03 144.76 43.4 Favored 'General case' 0 N--CA 1.494 1.726 0 CA-C-O 121.9 0.857 . . . . 0.0 110.477 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -107.0 119.93 40.7 Favored 'General case' 0 N--CA 1.487 1.414 0 CA-C-O 121.551 0.691 . . . . 0.0 109.405 -179.541 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.422 ' O ' ' OD1' ' A' ' 19' ' ' ASN . 73.4 mt -93.83 110.44 22.09 Favored 'General case' 0 N--CA 1.491 1.591 0 CA-C-O 121.521 0.677 . . . . 0.0 109.335 179.909 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.532 ' NH2' ' OE1' ' A' ' 92' ' ' GLU . 94.6 mtt180 -102.36 135.39 44.05 Favored 'General case' 0 N--CA 1.492 1.656 0 CA-C-O 121.966 0.888 . . . . 0.0 110.438 -179.774 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.406 ' O ' ' OG ' ' A' ' 89' ' ' SER . 13.4 m 39.85 79.77 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.673 0 CA-C-N 115.03 -0.986 . . . . 0.0 110.806 179.86 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 22.3 m -120.98 163.34 18.76 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 CA-C-O 121.594 0.711 . . . . 0.0 109.921 179.082 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 8.4 p -120.96 135.98 59.41 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 CA-C-O 121.731 0.777 . . . . 0.0 109.953 -179.251 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 9.4 t -91.34 115.76 31.13 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 CA-C-O 121.809 0.814 . . . . 0.0 109.867 -179.534 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.504 ' O ' ' NE2' ' A' ' 82' ' ' GLN . . . -99.43 177.37 29.6 Favored Glycine 0 N--CA 1.492 2.427 0 N-CA-C 110.083 -1.207 . . . . 0.0 110.083 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -103.14 115.88 31.43 Favored 'General case' 0 N--CA 1.494 1.742 0 CA-C-O 121.767 0.794 . . . . 0.0 109.718 179.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 82.0 t80 -124.88 120.55 31.97 Favored 'General case' 0 N--CA 1.494 1.771 0 CA-C-O 121.832 0.825 . . . . 0.0 109.893 179.833 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . 0.438 ' C ' ' H ' ' A' ' 80' ' ' ARG . 11.6 t-20 55.67 41.39 30.52 Favored 'General case' 0 N--CA 1.491 1.58 0 CA-C-N 116.14 -0.482 . . . . 0.0 109.808 179.448 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 13.7 t0 69.52 -1.85 2.11 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 179.354 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.438 ' H ' ' C ' ' A' ' 78' ' ' ASN . 19.6 mmm180 -104.01 -170.16 1.73 Allowed 'General case' 0 N--CA 1.495 1.783 0 CA-C-O 121.406 0.622 . . . . 0.0 109.867 -179.886 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 78.9 m-85 -122.06 140.18 52.82 Favored 'General case' 0 N--CA 1.497 1.924 0 CA-C-O 121.949 0.88 . . . . 0.0 110.427 -179.128 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . 0.59 ' NE2' ' N ' ' A' ' 82' ' ' GLN . 0.0 OUTLIER -147.92 152.3 37.32 Favored 'General case' 0 N--CA 1.493 1.704 0 CA-C-O 121.623 0.725 . . . . 0.0 109.59 179.401 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 27.1 m -87.67 132.17 33.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 CA-C-O 121.808 0.813 . . . . 0.0 110.291 -179.658 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -109.18 122.64 47.75 Favored 'General case' 0 N--CA 1.496 1.831 0 CA-C-O 121.837 0.827 . . . . 0.0 110.106 -179.439 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 61.9 t -92.4 130.59 41.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 179.451 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 95.0 m-20 -128.92 -177.24 4.13 Favored 'General case' 0 N--CA 1.495 1.797 0 CA-C-O 121.874 0.845 . . . . 0.0 110.462 -179.449 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 63.7 tttp -56.1 -45.41 79.46 Favored 'General case' 0 N--CA 1.488 1.458 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.8 -179.318 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 98.8 m-20 -63.36 -35.54 80.72 Favored 'General case' 0 N--CA 1.488 1.475 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 -179.237 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.406 ' OG ' ' O ' ' A' ' 71' ' ' SER . 69.1 m -71.47 152.2 43.26 Favored 'General case' 0 N--CA 1.493 1.708 0 CA-C-O 121.717 0.77 . . . . 0.0 110.08 -179.752 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 43.7 t -131.93 146.15 51.93 Favored 'General case' 0 N--CA 1.497 1.875 0 CA-C-O 121.559 0.695 . . . . 0.0 109.615 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 96.5 mt -120.39 132.51 69.8 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 CA-C-O 121.697 0.76 . . . . 0.0 109.977 179.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.532 ' OE1' ' NH2' ' A' ' 70' ' ' ARG . 77.1 tt0 -123.07 119.33 29.99 Favored 'General case' 0 N--CA 1.495 1.806 0 CA-C-O 121.81 0.814 . . . . 0.0 109.488 179.669 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 37.9 ttmt -75.79 131.85 40.04 Favored 'General case' 0 N--CA 1.488 1.44 0 CA-C-O 121.42 0.629 . . . . 0.0 109.629 179.736 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 85.4 mt -109.1 140.54 42.53 Favored 'General case' 0 N--CA 1.494 1.775 0 CA-C-O 121.888 0.851 . . . . 0.0 110.04 -179.813 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 90.9 p -79.87 -4.89 54.21 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 109.341 -0.615 . . . . 0.0 109.341 -179.261 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 81.2 mt-10 -97.7 113.67 63.88 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.827 -0.546 . . . . 0.0 109.59 -179.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_endo -75.29 155.37 41.59 Favored 'Trans proline' 0 C--N 1.313 -1.301 0 C-N-CA 122.53 2.153 . . . . 0.0 112.256 -179.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 89.9 mt -107.44 129.68 60.92 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 CA-C-O 121.899 0.857 . . . . 0.0 110.273 -179.542 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . 0.512 ' N ' ' OE1' ' A' ' 99' ' ' GLU . 57.7 mp0 -81.39 122.03 26.97 Favored 'General case' 0 N--CA 1.489 1.477 0 CA-C-O 121.776 0.798 . . . . 0.0 110.004 -179.403 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 26.9 m -106.41 -3.86 9.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 179.708 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -162.77 118.04 0.8 Allowed Glycine 0 N--CA 1.493 2.492 0 N-CA-C 109.724 -1.351 . . . . 0.0 109.724 179.736 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.466 ' N ' ' CD1' ' A' ' 102' ' ' LEU . 9.7 mp -88.42 -2.45 58.61 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.744 -0.857 . . . . 0.0 109.202 -179.998 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 72.7 mm-40 -56.36 141.0 43.54 Favored 'General case' 0 N--CA 1.498 1.968 0 CA-C-O 121.647 0.736 . . . . 0.0 110.21 -179.666 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -73.12 -14.26 61.35 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 108.966 -0.754 . . . . 0.0 108.966 -179.442 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 28.8 t-80 -70.27 132.53 45.85 Favored 'General case' 0 N--CA 1.49 1.554 0 CA-C-O 121.498 0.666 . . . . 0.0 109.39 -179.515 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 80.6 m80 -112.32 148.48 34.12 Favored 'General case' 0 N--CA 1.496 1.852 0 CA-C-O 121.87 0.843 . . . . 0.0 109.909 -179.44 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 35.3 m170 -73.32 144.42 46.55 Favored 'General case' 0 N--CA 1.488 1.462 0 CA-C-O 121.797 0.808 . . . . 0.0 110.373 -179.096 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 47.9 p-80 -151.14 164.42 36.54 Favored 'General case' 0 N--CA 1.49 1.553 0 CA-C-O 121.667 0.746 . . . . 0.0 109.949 179.734 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . 0.491 ' OXT' ' CG ' ' A' ' 109' ' ' HIS . 53.9 t-80 . . . . . 0 N--CA 1.493 1.706 0 CA-C-O 118.108 -0.949 . . . . 0.0 109.512 -179.839 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.46 ' O ' ' O ' ' A' ' 2' ' ' GLU . 39.5 tpp . . . . . 0 N--CA 1.489 1.488 0 CA-C-O 121.361 0.601 . . . . 0.0 109.394 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.46 ' O ' ' O ' ' A' ' 1' ' ' MET . 19.0 mm-40 57.09 149.27 0.06 OUTLIER Pre-proline 0 N--CA 1.494 1.761 0 CA-C-O 121.092 0.472 . . . . 0.0 110.376 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -67.72 146.32 72.49 Favored 'Trans proline' 0 N--CA 1.496 1.654 0 C-N-CA 122.539 2.159 . . . . 0.0 112.568 -179.881 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 87.3 mt-30 -77.43 91.78 3.92 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.328 -0.857 . . . . 0.0 109.106 -179.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 79.5 mt -72.91 125.77 28.35 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.456 -0.777 . . . . 0.0 109.858 -179.229 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 98.8 m -127.12 132.49 50.58 Favored 'General case' 0 N--CA 1.498 1.927 0 CA-C-O 121.456 0.646 . . . . 0.0 109.327 179.878 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -74.76 153.31 38.85 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.555 -0.716 . . . . 0.0 110.415 -179.164 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 96.1 mt -62.52 -43.79 98.71 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.534 -0.729 . . . . 0.0 109.567 -179.691 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 11.7 p -64.05 -24.12 34.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.504 -0.747 . . . . 0.0 109.875 -179.341 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.434 ' OD1' ' O ' ' A' ' 10' ' ' ASP . 60.1 t0 -76.27 -5.88 48.97 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.202 -0.936 . . . . 0.0 109.644 -179.723 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 96.5 mt -84.01 120.39 34.83 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.078 -1.014 . . . . 0.0 109.886 -179.893 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 16.1 m -135.79 -0.04 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 179.352 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 49.9 tp10 -139.9 141.81 36.53 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.394 -0.816 . . . . 0.0 109.719 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 56.4 p30 -87.49 161.2 17.94 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.654 -0.654 . . . . 0.0 110.044 -179.859 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 81.93 14.72 76.79 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 108.816 -1.714 . . . . 0.0 108.816 -179.722 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 56.3 mt-30 -78.98 132.72 36.77 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.496 -1.002 . . . . 0.0 110.285 -179.752 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 92.2 m95 -105.32 106.57 17.13 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 179.407 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -156.82 -178.16 7.15 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.171 -0.955 . . . . 0.0 109.861 -179.727 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.468 HD22 ' CD1' ' A' ' 68' ' ' LEU . 0.6 OUTLIER -103.94 141.42 36.2 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.607 -0.683 . . . . 0.0 109.673 -179.743 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 92.2 mt -134.45 150.63 50.85 Favored 'General case' 0 N--CA 1.496 1.838 0 CA-C-O 121.652 0.739 . . . . 0.0 110.017 -179.816 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 35.7 ttpt -135.21 138.74 43.9 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 179.817 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -166.57 -171.44 1.88 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.157 -0.965 . . . . 0.0 110.396 -179.642 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.517 ' HZ3' ' CG2' ' A' ' 100' ' ' VAL . 21.1 ptmt -121.85 144.73 48.66 Favored 'General case' 0 N--CA 1.496 1.858 0 CA-C-O 121.495 0.664 . . . . 0.0 109.584 -179.682 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 79.9 t -82.76 129.03 38.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.321 -0.862 . . . . 0.0 110.403 -179.284 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 96.7 mt -102.07 -51.52 9.14 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 179.501 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 52.5 tt0 -145.86 144.79 30.44 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.35 -0.844 . . . . 0.0 109.033 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -132.21 132.53 43.2 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.836 -0.54 . . . . 0.0 109.644 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 94.4 m95 -112.16 135.64 52.56 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.676 -0.64 . . . . 0.0 109.324 179.842 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 80.5 tt0 -91.17 136.91 32.76 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.439 -0.788 . . . . 0.0 110.146 -179.399 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . 0.499 ' ND2' ' O ' ' A' ' 35' ' ' ILE . 20.6 p-10 -102.66 177.11 4.95 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.589 -0.694 . . . . 0.0 109.725 179.895 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 75.7 m -104.76 -10.99 17.05 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.614 -0.679 . . . . 0.0 109.394 179.873 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 99.5 m-70 -82.54 136.9 34.74 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.138 -0.977 . . . . 0.0 110.316 -179.31 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -70.65 -30.97 67.73 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.545 -0.722 . . . . 0.0 109.967 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' SER . . . . . 0.42 ' HG ' ' N ' ' A' ' 35' ' ' ILE . 96.5 p -58.12 -34.46 70.25 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.265 -0.897 . . . . 0.0 109.852 -179.033 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.499 ' O ' ' ND2' ' A' ' 30' ' ' ASN . 96.8 mt -121.16 134.02 65.88 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.95 0 O-C-N 121.563 -0.71 . . . . 0.0 109.894 -179.907 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.407 ' O ' ' OD1' ' A' ' 30' ' ' ASN . 33.2 t -85.08 -71.76 0.51 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.653 -0.654 . . . . 0.0 109.802 -179.807 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 46.6 mt-30 -134.01 156.64 47.82 Favored 'General case' 0 N--CA 1.498 1.931 0 CA-C-O 121.794 0.807 . . . . 0.0 110.451 -179.035 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.8 p -139.65 139.85 37.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 179.727 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -167.38 -147.75 5.39 Favored Glycine 0 N--CA 1.49 2.256 0 C-N-CA 119.395 -1.383 . . . . 0.0 110.187 -179.827 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -133.7 152.19 51.82 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.662 -0.904 . . . . 0.0 109.951 -179.545 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 73.6 mt -115.5 131.39 56.95 Favored 'General case' 0 N--CA 1.494 1.745 0 CA-C-O 121.534 0.683 . . . . 0.0 109.291 179.712 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -80.79 160.91 43.62 Favored Glycine 0 N--CA 1.486 2.03 0 N-CA-C 110.613 -0.995 . . . . 0.0 110.613 -179.346 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.418 ' OD2' ' OG1' ' A' ' 45' ' ' THR . 29.7 t70 -174.29 146.01 1.06 Allowed 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 179.508 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -57.36 -15.15 5.7 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.346 -0.846 . . . . 0.0 109.906 -179.603 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.418 ' OG1' ' OD2' ' A' ' 43' ' ' ASP . 42.1 p -94.69 -7.87 39.45 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.224 -0.923 . . . . 0.0 109.854 -179.709 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 138.77 -157.06 24.56 Favored Glycine 0 N--CA 1.5 2.936 0 N-CA-C 110.527 -1.029 . . . . 0.0 110.527 179.217 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 40.9 pt -124.87 153.83 32.23 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.005 0 O-C-N 121.856 -0.791 . . . . 0.0 109.517 -179.874 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 20.0 tt -147.31 149.5 15.53 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.253 -0.905 . . . . 0.0 109.937 179.667 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 18.9 mmmt -83.28 148.68 27.24 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.748 -0.595 . . . . 0.0 110.175 -179.605 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 16.1 p90 -143.88 153.63 42.53 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.441 -0.787 . . . . 0.0 109.435 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 87.9 m -134.14 135.57 43.24 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 179.711 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.405 HD13 HG21 ' A' ' 52' ' ' ILE . 91.9 mt -101.63 126.03 55.61 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.398 -0.814 . . . . 0.0 109.601 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 93.5 m95 -96.14 139.73 31.89 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.524 -0.735 . . . . 0.0 109.529 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 50.9 mtpt -79.33 -11.54 59.93 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.529 -0.732 . . . . 0.0 109.124 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 93.6 m-20 -61.46 -40.94 96.34 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.434 -0.791 . . . . 0.0 109.213 -179.732 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -75.66 -10.95 59.88 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 121.307 -0.871 . . . . 0.0 109.139 179.712 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 55.77 62.4 2.42 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.743 -0.598 . . . . 0.0 109.92 -179.858 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 36.6 mt -105.31 147.6 34.86 Favored Pre-proline 0 N--CA 1.496 1.844 0 O-C-N 121.649 -0.657 . . . . 0.0 109.617 179.797 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -69.98 162.03 43.73 Favored 'Trans proline' 0 N--CA 1.498 1.745 0 C-N-CA 122.911 2.408 . . . . 0.0 113.195 179.708 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 65.6 mt -69.0 143.55 54.34 Favored 'General case' 0 N--CA 1.493 1.69 0 CA-C-O 121.742 0.782 . . . . 0.0 110.388 -179.215 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.49 ' CD1' ' N ' ' A' ' 61' ' ' LEU . 9.7 mp -92.81 141.68 28.17 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.672 -0.643 . . . . 0.0 110.048 -179.186 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.685 ' H ' ' HH ' ' A' ' 67' ' ' TYR . 97.4 mt-10 -85.1 152.03 23.7 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.424 -0.797 . . . . 0.0 110.342 -179.644 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 55.4 tt0 -81.98 138.46 34.92 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.616 -0.678 . . . . 0.0 110.822 -179.336 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 79.88 23.6 61.55 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 110.105 -1.198 . . . . 0.0 110.105 178.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -126.94 146.59 50.26 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.441 -1.034 . . . . 0.0 110.307 -179.796 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 12.8 p -83.01 146.44 28.75 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 179.745 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.685 ' HH ' ' H ' ' A' ' 62' ' ' GLU . 65.4 m-85 -140.36 145.07 36.65 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.438 -0.789 . . . . 0.0 110.007 179.775 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.468 ' CD1' HD22 ' A' ' 19' ' ' ASN . 17.8 tp -105.59 123.1 47.36 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 179.106 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.408 ' O ' ' OD1' ' A' ' 19' ' ' ASN . 67.5 mt -103.81 125.25 50.12 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 179.899 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 82.5 mtp180 -114.53 134.81 54.74 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.69 -0.631 . . . . 0.0 110.054 -179.755 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.403 ' O ' ' OG ' ' A' ' 89' ' ' SER . 31.2 t 60.46 73.72 0.47 Allowed 'General case' 0 N--CA 1.493 1.687 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.791 179.65 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 3.7 m -124.6 159.32 30.93 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.129 0 O-C-N 121.605 -0.684 . . . . 0.0 109.294 178.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 13.6 p -121.74 135.09 62.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 -179.807 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 13.4 t -84.74 118.89 32.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.483 -0.761 . . . . 0.0 110.306 -178.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -97.22 171.34 26.77 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 179.723 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -111.37 121.3 44.86 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.724 -0.868 . . . . 0.0 109.789 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . 0.509 ' CZ ' ' OD1' ' A' ' 78' ' ' ASN . 54.8 t80 -134.16 124.96 26.93 Favored 'General case' 0 N--CA 1.495 1.819 0 CA-C-O 121.393 0.616 . . . . 0.0 109.499 179.578 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . 0.54 ' C ' ' H ' ' A' ' 80' ' ' ARG . 6.4 m120 51.56 51.49 16.61 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.648 -0.657 . . . . 0.0 110.574 179.789 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 55.6 2.6 0.07 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.736 -0.602 . . . . 0.0 110.184 179.351 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.54 ' H ' ' C ' ' A' ' 78' ' ' ASN . 18.7 mmm180 -103.88 163.0 12.65 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.378 -0.826 . . . . 0.0 109.704 -179.912 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 69.7 m-85 -95.71 143.51 26.9 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.449 -0.782 . . . . 0.0 109.748 -179.283 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -146.3 159.97 42.64 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.517 -0.739 . . . . 0.0 109.436 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 33.2 m -111.44 128.31 68.03 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 179.431 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 76.8 mt-30 -109.42 124.67 51.4 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.563 -0.711 . . . . 0.0 109.474 -179.345 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 10.7 t -97.18 106.78 18.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.385 -0.822 . . . . 0.0 109.611 -179.773 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -152.04 -177.43 6.16 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.466 -0.771 . . . . 0.0 109.985 179.934 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 72.5 tttt 66.76 -133.19 0.15 Allowed 'General case' 0 N--CA 1.492 1.667 0 CA-C-O 121.444 0.64 . . . . 0.0 110.932 179.306 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 12.7 m120 -88.52 20.65 3.27 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.432 -0.792 . . . . 0.0 109.246 -179.093 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.403 ' OG ' ' O ' ' A' ' 71' ' ' SER . 15.5 m -60.13 147.65 38.82 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.459 -0.776 . . . . 0.0 109.511 -179.73 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 25.5 m -128.78 152.35 48.55 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.618 -0.676 . . . . 0.0 109.747 -179.81 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 93.9 mt -129.1 133.5 65.77 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 179.785 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -126.42 134.28 51.04 Favored 'General case' 0 N--CA 1.497 1.912 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 179.548 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 63.7 tttp -79.79 129.26 34.33 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.41 -0.806 . . . . 0.0 109.837 -179.338 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.428 ' CD2' ' N ' ' A' ' 94' ' ' LEU . 4.1 mm? -100.54 133.18 45.37 Favored 'General case' 0 N--CA 1.493 1.702 0 CA-C-O 121.756 0.789 . . . . 0.0 109.802 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 23.1 t -85.29 10.43 12.56 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 -179.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 22.1 tt0 -118.47 90.24 38.58 Favored Pre-proline 0 N--CA 1.497 1.916 0 O-C-N 121.602 -0.686 . . . . 0.0 109.29 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_exo -56.14 146.84 68.51 Favored 'Trans proline' 0 N--CA 1.498 1.739 0 C-N-CA 122.785 2.323 . . . . 0.0 112.19 179.496 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 93.0 mt -100.43 127.97 52.93 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 O-C-N 121.474 -0.766 . . . . 0.0 109.997 -179.41 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -79.31 148.14 32.22 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.632 -0.667 . . . . 0.0 109.784 -179.865 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.517 ' CG2' ' HZ3' ' A' ' 23' ' ' LYS . 2.5 t -98.66 3.2 10.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 179.803 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 88.9 54.67 2.28 Favored Glycine 0 N--CA 1.493 2.491 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 -179.883 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 11.0 mp -63.36 -41.31 98.83 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.453 -1.028 . . . . 0.0 108.949 179.878 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 58.2 tt0 68.16 43.97 1.49 Allowed 'General case' 0 N--CA 1.494 1.747 0 CA-C-O 121.35 0.595 . . . . 0.0 109.697 179.859 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 33.0 p80 -83.42 -15.78 48.38 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.29 -0.881 . . . . 0.0 109.1 179.53 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 86.1 t60 -64.81 -40.67 95.6 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.381 -0.824 . . . . 0.0 109.436 179.746 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 59.2 t-80 -130.74 130.04 43.28 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.511 -0.743 . . . . 0.0 109.886 -179.779 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 86.3 t60 -156.36 72.03 0.73 Allowed 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 179.541 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 43.3 t-80 -151.96 139.54 19.67 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.369 -0.832 . . . . 0.0 109.494 -179.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 96.3 m-70 . . . . . 0 N--CA 1.491 1.624 0 CA-C-O 118.108 -0.948 . . . . 0.0 109.963 -179.608 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 97.7 mtp . . . . . 0 N--CA 1.49 1.541 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 24.4 mm-40 -57.41 150.82 41.87 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.855 -0.528 . . . . 0.0 110.208 -179.535 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -64.84 150.82 87.57 Favored 'Trans proline' 0 N--CA 1.49 1.304 0 C-N-CA 122.419 2.08 . . . . 0.0 112.714 -179.934 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 7.8 pt20 -73.29 89.41 1.57 Allowed 'General case' 0 C--N 1.302 -1.487 0 CA-C-O 121.534 0.683 . . . . 0.0 110.223 -179.326 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 79.6 mt -79.33 139.78 37.71 Favored 'General case' 0 N--CA 1.488 1.474 0 CA-C-O 121.543 0.687 . . . . 0.0 109.734 179.7 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 69.5 m -127.16 130.91 50.66 Favored 'General case' 0 N--CA 1.496 1.854 0 CA-C-O 121.609 0.719 . . . . 0.0 109.666 179.667 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 63.7 mttp -84.23 156.95 21.77 Favored 'General case' 0 N--CA 1.49 1.568 0 CA-C-O 121.785 0.802 . . . . 0.0 109.688 179.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 95.6 mt -63.0 -42.58 97.23 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.557 0 CA-C-O 121.28 0.562 . . . . 0.0 109.518 -179.215 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 14.7 p -65.54 -24.04 33.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.605 -0.684 . . . . 0.0 109.559 -179.178 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 -77.03 -7.11 55.09 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.441 -0.787 . . . . 0.0 108.89 -179.455 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 98.6 mt -93.18 116.04 33.39 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 CA-C-O 121.662 0.744 . . . . 0.0 109.719 179.708 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 25.6 m -151.23 14.54 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 179.34 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -137.44 137.17 38.48 Favored 'General case' 0 N--CA 1.494 1.771 0 CA-C-O 121.762 0.792 . . . . 0.0 109.376 179.417 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 7.6 t-20 -74.32 147.59 42.13 Favored 'General case' 0 C--N 1.301 -1.529 0 CA-C-O 121.696 0.76 . . . . 0.0 109.99 -179.622 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 71.58 99.51 0.06 OUTLIER Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 179.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 27.5 tt0 -165.17 126.98 2.08 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.732 -0.863 . . . . 0.0 110.098 179.443 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 95.2 m95 -96.6 128.71 43.79 Favored 'General case' 0 N--CA 1.494 1.753 0 CA-C-O 121.477 0.656 . . . . 0.0 109.465 179.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -174.88 177.08 2.07 Favored 'General case' 0 N--CA 1.493 1.717 0 CA-C-O 121.878 0.846 . . . . 0.0 110.419 179.818 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.469 ' ND2' ' H ' ' A' ' 71' ' ' SER . 5.7 m120 -99.24 148.91 23.64 Favored 'General case' 0 N--CA 1.495 1.776 0 CA-C-O 121.728 0.775 . . . . 0.0 109.445 -179.712 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 54.5 tp -139.57 135.94 33.9 Favored 'General case' 0 N--CA 1.487 1.418 0 CA-C-O 121.962 0.887 . . . . 0.0 110.244 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 37.3 ttmt -122.36 132.65 54.49 Favored 'General case' 0 N--CA 1.49 1.566 0 CA-C-O 121.773 0.797 . . . . 0.0 109.121 179.148 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -160.95 178.04 9.78 Favored 'General case' 0 C--N 1.3 -1.555 0 CA-C-O 121.658 0.742 . . . . 0.0 109.808 -179.866 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 63.7 tttp -114.55 145.55 41.81 Favored 'General case' 0 N--CA 1.496 1.839 0 CA-C-O 121.775 0.797 . . . . 0.0 110.332 -178.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 89.5 t -83.54 108.14 15.77 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 CA-C-O 121.684 0.754 . . . . 0.0 110.34 -179.501 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 34.3 mm -94.24 -47.37 13.43 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 179.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 7.4 tt0 -148.41 140.55 24.06 Favored 'General case' 0 N--CA 1.494 1.774 0 CA-C-O 122.135 0.969 . . . . 0.0 109.968 -179.758 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -136.57 145.51 45.06 Favored 'General case' 0 N--CA 1.491 1.577 0 CA-C-O 121.956 0.884 . . . . 0.0 110.164 -179.335 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 5.7 m-90 -114.13 141.77 47.08 Favored 'General case' 0 N--CA 1.492 1.653 0 CA-C-O 121.648 0.737 . . . . 0.0 109.261 179.041 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.456 ' O ' ' O ' ' A' ' 30' ' ' ASN . 80.9 tt0 -80.44 119.42 23.11 Favored 'General case' 0 C--N 1.303 -1.42 0 CA-C-O 121.602 0.715 . . . . 0.0 109.795 -179.436 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . 0.522 ' CG ' ' H ' ' A' ' 31' ' ' THR . 16.9 t-20 47.06 -178.5 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.512 0 CA-C-O 121.683 0.754 . . . . 0.0 110.305 179.594 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.522 ' H ' ' CG ' ' A' ' 30' ' ' ASN . 17.9 m -171.2 -41.95 0.02 OUTLIER 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 179.859 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 85.2 t60 -115.94 -83.09 0.63 Allowed 'General case' 0 N--CA 1.499 2.012 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 179.707 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 11.4 tm-20 -165.86 -56.54 0.03 OUTLIER 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.491 -0.755 . . . . 0.0 109.379 179.52 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 12.8 m -79.78 -6.44 57.3 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 109.009 -0.738 . . . . 0.0 109.009 -179.42 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.483 ' O ' ' ND2' ' A' ' 30' ' ' ASN . 96.7 mt -93.17 119.07 40.29 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 CA-C-O 121.839 0.828 . . . . 0.0 109.507 179.794 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 3.6 t -71.3 -56.01 6.88 Favored 'General case' 0 C--N 1.3 -1.546 0 CA-C-O 121.428 0.633 . . . . 0.0 109.525 179.761 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 83.7 mt-30 -147.63 147.6 30.19 Favored 'General case' 0 N--CA 1.49 1.539 0 CA-C-O 121.925 0.869 . . . . 0.0 110.456 -179.286 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.9 p -142.77 142.47 26.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 CA-C-O 121.613 0.72 . . . . 0.0 109.349 179.589 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -171.99 -155.26 10.82 Favored Glycine 0 N--CA 1.491 2.308 0 C-N-CA 119.952 -1.118 . . . . 0.0 110.562 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -132.9 147.52 52.29 Favored 'General case' 0 N--CA 1.494 1.745 0 CA-C-O 121.895 0.855 . . . . 0.0 110.269 -179.463 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 41.1 mt -116.88 130.72 56.89 Favored 'General case' 0 N--CA 1.496 1.83 0 CA-C-O 121.743 0.782 . . . . 0.0 109.407 -179.258 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -83.15 161.38 39.45 Favored Glycine 0 N--CA 1.495 2.609 0 N-CA-C 111.227 -0.749 . . . . 0.0 111.227 -179.146 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.557 ' OD1' ' N ' ' A' ' 44' ' ' GLU . 62.1 t0 -174.13 150.29 1.54 Allowed 'General case' 0 N--CA 1.493 1.722 0 CA-C-O 122.095 0.95 . . . . 0.0 110.031 179.643 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.557 ' N ' ' OD1' ' A' ' 43' ' ' ASP . 98.0 mt-10 -59.44 -17.67 32.93 Favored 'General case' 0 N--CA 1.491 1.601 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.139 179.979 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 41.6 p -92.25 -11.17 36.02 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 -179.688 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 139.95 -159.87 26.1 Favored Glycine 0 N--CA 1.498 2.77 0 C-N-CA 120.246 -0.978 . . . . 0.0 111.123 178.934 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 96.4 mt -125.21 132.86 70.64 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 CA-C-O 121.773 0.797 . . . . 0.0 109.993 -179.23 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 18.0 tt -131.17 148.43 32.91 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 CA-C-O 121.934 0.873 . . . . 0.0 110.421 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 54.7 mtpt -92.91 151.04 20.18 Favored 'General case' 0 N--CA 1.494 1.741 0 CA-C-O 121.713 0.768 . . . . 0.0 110.16 -179.841 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 5.8 p90 -142.84 152.99 42.75 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-O 122.003 0.906 . . . . 0.0 109.975 179.871 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 84.9 m -130.2 130.98 45.36 Favored 'General case' 0 N--CA 1.493 1.692 0 CA-C-O 121.864 0.84 . . . . 0.0 109.203 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 95.7 mt -100.26 121.93 51.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 CA-C-O 121.791 0.805 . . . . 0.0 110.049 -179.496 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 96.1 m95 -98.0 133.57 42.29 Favored 'General case' 0 N--CA 1.495 1.799 0 CA-C-O 121.551 0.691 . . . . 0.0 109.349 179.782 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 16.4 ptpt -89.25 53.35 2.62 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.759 -0.588 . . . . 0.0 109.83 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 99.3 m-20 -77.77 -1.89 33.62 Favored 'General case' 0 N--CA 1.496 1.856 0 CA-C-O 121.373 0.606 . . . . 0.0 109.401 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -154.63 -88.6 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.415 -0.803 . . . . 0.0 109.273 179.755 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 178.95 77.9 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.739 0 CA-C-O 121.582 0.706 . . . . 0.0 109.892 -179.798 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 11.4 mt -89.73 148.16 39.31 Favored Pre-proline 0 N--CA 1.491 1.593 0 N-CA-C 108.633 -0.876 . . . . 0.0 108.633 179.16 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -68.86 153.46 72.76 Favored 'Trans proline' 0 C--N 1.312 -1.358 0 C-N-CA 122.403 2.069 . . . . 0.0 112.646 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 71.4 mt -72.75 142.95 48.14 Favored 'General case' 0 C--N 1.301 -1.525 0 CA-C-O 121.678 0.752 . . . . 0.0 109.968 -179.754 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 10.5 mp -87.84 135.49 33.37 Favored 'General case' 0 N--CA 1.49 1.554 0 CA-C-O 121.715 0.769 . . . . 0.0 109.707 -179.805 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.58 ' H ' ' HH ' ' A' ' 67' ' ' TYR . 46.1 tp10 -93.78 144.85 25.05 Favored 'General case' 0 N--CA 1.49 1.558 0 CA-C-O 121.89 0.852 . . . . 0.0 109.685 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 57.5 tt0 -79.15 143.74 35.16 Favored 'General case' 0 C--N 1.299 -1.597 0 CA-C-O 121.677 0.751 . . . . 0.0 110.318 -179.614 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 82.08 23.8 56.4 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 110.036 -1.226 . . . . 0.0 110.036 179.054 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.528 ' OE1' ' NZ ' ' A' ' 93' ' ' LYS . 95.8 mt-10 -136.55 144.91 44.48 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.384 -1.068 . . . . 0.0 110.109 179.672 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 12.2 p -89.23 145.69 25.24 Favored 'General case' 0 N--CA 1.489 1.496 0 CA-C-O 121.702 0.763 . . . . 0.0 110.223 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.58 ' HH ' ' H ' ' A' ' 62' ' ' GLU . 98.2 m-85 -137.71 152.61 49.42 Favored 'General case' 0 N--CA 1.494 1.734 0 CA-C-O 122.122 0.963 . . . . 0.0 110.323 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 32.3 tp -111.1 121.55 45.62 Favored 'General case' 0 N--CA 1.494 1.733 0 CA-C-N 115.488 -0.778 . . . . 0.0 109.64 179.864 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 74.0 mt -102.15 133.1 47.55 Favored 'General case' 0 N--CA 1.494 1.728 0 CA-C-O 121.726 0.774 . . . . 0.0 109.373 179.538 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 86.8 mtm180 -129.61 147.35 51.4 Favored 'General case' 0 N--CA 1.495 1.819 0 CA-C-O 121.924 0.869 . . . . 0.0 110.51 -179.287 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.469 ' H ' ' ND2' ' A' ' 19' ' ' ASN . 1.7 m 56.46 55.34 6.61 Favored 'General case' 0 N--CA 1.494 1.729 0 CA-C-N 115.606 -0.725 . . . . 0.0 110.415 179.354 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 12.5 m -111.12 158.19 11.71 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 CA-C-O 121.626 0.727 . . . . 0.0 109.972 179.369 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 13.5 p -116.7 134.88 58.82 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 CA-C-O 121.828 0.823 . . . . 0.0 109.677 -179.631 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 11.7 t -86.27 115.48 27.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 CA-C-O 121.862 0.839 . . . . 0.0 109.88 -179.433 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -100.96 175.25 26.1 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 110.074 -1.21 . . . . 0.0 110.074 -179.776 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 48.0 tp10 -111.51 121.39 45.05 Favored 'General case' 0 N--CA 1.493 1.699 0 CA-C-O 121.829 0.824 . . . . 0.0 109.673 -179.906 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 87.3 t80 -136.58 125.37 24.01 Favored 'General case' 0 N--CA 1.492 1.655 0 CA-C-O 121.865 0.84 . . . . 0.0 110.14 179.834 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . 0.52 ' C ' ' H ' ' A' ' 80' ' ' ARG . 10.7 t-20 56.27 43.33 26.65 Favored 'General case' 0 N--CA 1.488 1.46 0 CA-C-N 116.081 -0.509 . . . . 0.0 109.781 179.193 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 48.2 t0 62.64 -1.36 0.45 Allowed 'General case' 0 N--CA 1.493 1.725 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 179.641 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.52 ' H ' ' C ' ' A' ' 78' ' ' ASN . 83.2 mtp180 -100.09 178.23 4.85 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.606 -0.684 . . . . 0.0 109.986 179.868 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 78.3 m-85 -112.94 138.15 50.24 Favored 'General case' 0 N--CA 1.498 1.953 0 CA-C-O 122.086 0.946 . . . . 0.0 110.062 -179.303 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -147.09 163.0 37.68 Favored 'General case' 0 N--CA 1.489 1.52 0 CA-C-O 121.829 0.823 . . . . 0.0 110.292 179.936 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 2.5 m -106.24 131.65 55.38 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 -179.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 86.7 mt-30 -104.91 122.6 46.15 Favored 'General case' 0 N--CA 1.495 1.807 0 CA-C-O 122.107 0.956 . . . . 0.0 110.364 -179.172 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 18.2 t -93.93 129.73 43.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 CA-C-O 121.947 0.879 . . . . 0.0 109.765 -179.875 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 81.7 m-20 -134.82 -174.74 3.68 Favored 'General case' 0 N--CA 1.493 1.702 0 CA-C-O 121.452 0.644 . . . . 0.0 109.309 179.79 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 24.8 pttm -58.88 -34.75 72.0 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.858 -0.526 . . . . 0.0 109.924 -179.296 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 38.7 t30 -64.11 -38.07 89.74 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 10.0 m -72.76 156.33 39.04 Favored 'General case' 0 N--CA 1.492 1.675 0 CA-C-O 121.709 0.766 . . . . 0.0 110.73 -179.153 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 88.2 p -129.52 151.36 50.22 Favored 'General case' 0 N--CA 1.493 1.717 0 CA-C-O 121.692 0.758 . . . . 0.0 109.759 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 94.8 mt -124.65 132.79 70.85 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 CA-C-O 121.572 0.701 . . . . 0.0 109.572 -179.508 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 81.6 tt0 -130.13 134.37 47.29 Favored 'General case' 0 N--CA 1.497 1.881 0 CA-C-O 121.996 0.903 . . . . 0.0 109.838 179.621 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.528 ' NZ ' ' OE1' ' A' ' 65' ' ' GLU . 64.1 tttp -79.95 134.45 36.26 Favored 'General case' 0 N--CA 1.489 1.478 0 CA-C-O 121.748 0.785 . . . . 0.0 110.117 179.933 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 73.6 mt -100.88 133.76 44.87 Favored 'General case' 0 N--CA 1.492 1.67 0 CA-C-O 121.689 0.757 . . . . 0.0 109.726 179.626 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 88.8 p -78.74 -5.52 53.43 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 -179.604 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 21.5 tp10 -111.82 121.03 40.81 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.794 -0.567 . . . . 0.0 109.894 -179.751 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -74.29 154.25 46.03 Favored 'Trans proline' 0 N--CA 1.488 1.202 0 C-N-CA 122.511 2.141 . . . . 0.0 112.065 179.63 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 96.7 mt -109.28 128.27 65.36 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 CA-C-O 121.915 0.864 . . . . 0.0 110.364 -179.603 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -86.26 136.12 33.29 Favored 'General case' 0 N--CA 1.495 1.82 0 CA-C-O 121.741 0.781 . . . . 0.0 110.388 -179.26 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 18.3 m -108.01 -4.66 10.44 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 N-CA-C 109.055 -0.721 . . . . 0.0 109.055 179.918 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 141.41 42.7 0.07 OUTLIER Glycine 0 N--CA 1.499 2.859 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 179.299 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.458 ' N ' ' CD1' ' A' ' 102' ' ' LEU . 10.2 mp -87.78 -6.7 58.04 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.647 -0.913 . . . . 0.0 108.657 179.684 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -66.62 176.94 1.73 Allowed 'General case' 0 N--CA 1.489 1.513 0 CA-C-O 121.709 0.766 . . . . 0.0 110.374 -179.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . 0.448 ' O ' ' CG ' ' A' ' 105' ' ' HIS . 33.8 p-80 -57.22 -42.9 82.21 Favored 'General case' 0 N--CA 1.49 1.574 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.736 -179.473 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . 0.448 ' CG ' ' O ' ' A' ' 104' ' ' HIS . 87.4 m-70 -156.8 117.62 3.67 Favored 'General case' 0 N--CA 1.493 1.699 0 CA-C-O 121.771 0.796 . . . . 0.0 110.001 179.605 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 86.6 t60 -92.08 -6.69 50.47 Favored 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 179.742 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 84.7 t60 -62.09 -42.38 99.16 Favored 'General case' 0 N--CA 1.492 1.652 0 CA-C-O 121.44 0.638 . . . . 0.0 109.573 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 58.0 t-80 -77.87 128.81 34.54 Favored 'General case' 0 C--N 1.303 -1.424 0 CA-C-O 121.7 0.762 . . . . 0.0 110.285 -179.177 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 56.0 p-80 . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 117.977 -1.011 . . . . 0.0 109.539 179.542 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 49.7 ttp . . . . . 0 N--CA 1.49 1.573 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.504 ' N ' ' CD ' ' A' ' 3' ' ' PRO . 28.3 tt0 -161.61 51.38 0.34 Allowed Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.355 -0.84 . . . . 0.0 109.169 179.446 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.504 ' CD ' ' N ' ' A' ' 2' ' ' GLU . 34.2 Cg_endo -62.83 143.52 91.86 Favored 'Trans proline' 0 N--CA 1.497 1.703 0 C-N-CA 122.891 2.394 . . . . 0.0 112.312 -179.938 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . 0.401 ' N ' ' CD ' ' A' ' 4' ' ' GLN . 28.2 mp0 -84.49 89.41 7.42 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.057 -1.027 . . . . 0.0 109.664 -179.581 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -73.73 142.02 46.33 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.456 -0.777 . . . . 0.0 109.351 179.616 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 98.4 m -122.77 129.2 51.46 Favored 'General case' 0 N--CA 1.498 1.962 0 CA-C-O 121.666 0.746 . . . . 0.0 109.812 -179.7 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -85.42 159.36 19.99 Favored 'General case' 0 N--CA 1.491 1.618 0 CA-C-O 121.609 0.719 . . . . 0.0 110.051 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 33.0 mm -63.85 -43.38 97.82 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 O-C-N 121.275 -0.89 . . . . 0.0 109.198 179.893 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 12.6 p -65.02 -22.53 31.6 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 O-C-N 121.47 -0.769 . . . . 0.0 109.529 -179.692 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -74.79 -7.03 52.15 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.092 -1.005 . . . . 0.0 109.257 179.45 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 96.7 mt -83.11 120.83 35.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.232 -0.917 . . . . 0.0 109.4 179.886 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 15.8 m -134.93 -28.04 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 O-C-N 121.346 -0.846 . . . . 0.0 109.721 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -135.05 152.39 51.65 Favored 'General case' 0 N--CA 1.501 2.113 0 O-C-N 121.188 -0.945 . . . . 0.0 110.372 -179.424 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 57.4 p30 -79.12 166.0 22.73 Favored 'General case' 0 N--CA 1.491 1.618 0 CA-C-O 121.6 0.714 . . . . 0.0 110.652 -179.201 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 71.02 92.91 0.08 OUTLIER Glycine 0 N--CA 1.491 2.303 0 N-CA-C 110.294 -1.122 . . . . 0.0 110.294 179.476 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 20.5 tt0 -168.89 130.9 1.25 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.408 -1.054 . . . . 0.0 109.183 179.279 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 91.9 m95 -95.65 133.56 39.58 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.404 -0.81 . . . . 0.0 109.774 -179.686 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -175.09 176.58 2.08 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.193 -0.942 . . . . 0.0 109.741 179.509 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 94.6 m-20 -103.91 145.01 30.75 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.438 -0.789 . . . . 0.0 109.072 179.888 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 5.6 tt -142.04 133.61 26.77 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.278 -0.889 . . . . 0.0 109.924 -179.818 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 3.5 ttmp? -117.01 141.85 47.72 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 179.558 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.464 ' CB ' ' OD1' ' A' ' 43' ' ' ASP . . . -164.2 -177.18 4.83 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.887 -1.133 . . . . 0.0 110.352 -179.648 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -112.05 137.63 49.82 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.633 -0.667 . . . . 0.0 109.487 -179.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 71.2 t -83.54 96.64 4.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.295 -0.878 . . . . 0.0 110.197 -179.572 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.49 ' O ' ' NE2' ' A' ' 63' ' ' GLN . 96.7 mt -65.53 -45.32 92.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.418 -0.801 . . . . 0.0 109.433 179.744 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.525 ' NE2' ' CZ2' ' A' ' 28' ' ' TRP . 14.6 pt20 -170.61 148.4 3.03 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.397 -0.814 . . . . 0.0 109.737 -179.875 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -143.65 137.15 28.05 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.566 -0.709 . . . . 0.0 109.274 179.589 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . 0.525 ' CZ2' ' NE2' ' A' ' 26' ' ' GLN . 5.6 m0 -117.69 146.06 43.99 Favored 'General case' 0 N--CA 1.498 1.936 0 CA-C-O 121.717 0.77 . . . . 0.0 109.672 -179.709 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.6 ' H ' ' CD ' ' A' ' 29' ' ' GLU . 1.5 pm0 -63.46 144.59 56.85 Favored 'General case' 0 N--CA 1.491 1.579 0 CA-C-O 121.617 0.722 . . . . 0.0 110.568 -179.25 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . 0.528 ' ND2' ' O ' ' A' ' 36' ' ' SER . 0.0 OUTLIER -90.45 178.03 6.22 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.42 -0.8 . . . . 0.0 110.058 -179.698 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 81.4 p -114.61 7.81 16.14 Favored 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 179.413 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 59.9 m80 -106.25 137.54 44.02 Favored 'General case' 0 N--CA 1.502 2.13 0 O-C-N 121.436 -0.79 . . . . 0.0 109.809 -179.81 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 50.1 tp10 -66.93 -38.34 85.99 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.427 -0.796 . . . . 0.0 109.792 -179.599 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 11.0 t -61.88 -41.69 98.17 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.307 -0.871 . . . . 0.0 110.232 -179.536 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.513 ' O ' ' ND2' ' A' ' 30' ' ' ASN . 90.6 mt -98.6 133.69 40.09 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 O-C-N 121.299 -0.876 . . . . 0.0 110.173 -178.906 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.528 ' O ' ' ND2' ' A' ' 30' ' ' ASN . 25.0 m -81.47 -70.8 0.51 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.578 -0.701 . . . . 0.0 110.112 -179.664 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 34.4 mt-30 -132.55 155.5 48.52 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.393 -0.817 . . . . 0.0 109.62 -179.02 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 9.4 p -137.1 141.03 41.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 -179.805 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -165.79 -158.5 10.85 Favored Glycine 0 N--CA 1.491 2.328 0 C-N-CA 119.422 -1.371 . . . . 0.0 110.177 -179.085 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -135.65 151.94 50.72 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.573 -0.957 . . . . 0.0 109.761 179.826 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 52.5 mt -114.88 139.76 49.52 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.453 -0.779 . . . . 0.0 109.235 -179.0 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -94.37 127.65 9.17 Favored Glycine 0 N--CA 1.493 2.498 0 N-CA-C 110.359 -1.097 . . . . 0.0 110.359 -179.63 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.464 ' OD1' ' CB ' ' A' ' 22' ' ' ALA . 73.0 m-20 -128.6 142.32 51.08 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.795 -0.827 . . . . 0.0 108.872 179.005 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -56.76 -14.99 3.83 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.411 -0.805 . . . . 0.0 109.52 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 16.5 p -99.3 -8.47 24.89 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.316 -0.865 . . . . 0.0 109.775 -179.763 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 153.95 -167.14 32.16 Favored Glycine 0 N--CA 1.498 2.821 0 C-N-CA 119.733 -1.222 . . . . 0.0 110.257 179.292 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 96.6 mt -125.61 134.7 66.05 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.081 0 O-C-N 121.586 -0.949 . . . . 0.0 108.656 179.895 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 20.6 tt -131.42 144.71 36.78 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.231 0 O-C-N 121.168 -0.958 . . . . 0.0 110.463 -179.566 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.541 ' NZ ' ' CE1' ' A' ' 77' ' ' TYR . 52.8 mtmt -84.34 157.19 21.56 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.727 -0.608 . . . . 0.0 110.42 -179.633 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 16.2 p90 -152.1 164.26 37.63 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.317 -0.864 . . . . 0.0 109.666 179.627 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 2.7 t -139.1 148.85 43.83 Favored 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 179.578 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 39.2 mm -106.41 126.36 62.12 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 O-C-N 121.472 -0.768 . . . . 0.0 109.562 -179.459 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 77.8 m95 -98.36 147.38 24.74 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.486 -0.759 . . . . 0.0 109.799 -179.72 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 64.7 mttp -78.83 -13.13 59.98 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.449 -0.782 . . . . 0.0 109.255 179.755 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 -61.51 -42.27 98.56 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.471 -0.768 . . . . 0.0 110.339 -179.22 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -76.01 -12.36 60.12 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.145 -0.972 . . . . 0.0 109.634 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 50.47 62.69 2.56 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.515 -0.741 . . . . 0.0 109.903 -179.882 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 14.2 mt -106.66 150.58 39.81 Favored Pre-proline 0 N--CA 1.499 1.975 0 O-C-N 121.59 -0.694 . . . . 0.0 109.749 -179.784 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -70.13 165.28 31.91 Favored 'Trans proline' 0 N--CA 1.502 1.99 0 C-N-CA 123.095 2.53 . . . . 0.0 113.918 -179.102 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 66.6 mt -65.56 141.08 58.57 Favored 'General case' 0 N--CA 1.494 1.761 0 CA-C-O 121.905 0.86 . . . . 0.0 110.88 -178.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.506 ' CD1' ' N ' ' A' ' 61' ' ' LEU . 9.1 mp -87.39 145.9 26.11 Favored 'General case' 0 N--CA 1.492 1.654 0 CA-C-O 121.344 0.593 . . . . 0.0 110.037 -179.523 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.655 ' H ' ' HH ' ' A' ' 67' ' ' TYR . 83.7 tt0 -98.63 126.69 44.3 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.399 -0.813 . . . . 0.0 109.126 179.461 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.49 ' NE2' ' O ' ' A' ' 25' ' ' ILE . 10.8 tm0? -69.19 140.34 54.61 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.508 -0.745 . . . . 0.0 111.231 -178.822 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.447 ' N ' ' CD ' ' A' ' 63' ' ' GLN . . . 91.78 20.06 38.33 Favored Glycine 0 N--CA 1.495 2.581 0 N-CA-C 110.541 -1.024 . . . . 0.0 110.541 178.812 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.488 ' OE1' ' N ' ' A' ' 65' ' ' GLU . 58.8 mp0 -139.0 155.58 47.88 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.158 -1.201 . . . . 0.0 110.47 179.911 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 13.5 p -80.72 156.44 26.26 Favored 'General case' 0 N--CA 1.49 1.527 0 CA-C-O 121.552 0.691 . . . . 0.0 110.534 -179.418 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.655 ' HH ' ' H ' ' A' ' 62' ' ' GLU . 88.4 m-85 -145.78 144.27 30.2 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.48 -0.763 . . . . 0.0 109.645 179.674 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 13.7 tp -111.86 117.93 34.13 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 179.219 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 4.6 mp -103.45 126.66 50.73 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.467 -0.771 . . . . 0.0 109.054 -179.553 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.41 ' O ' ' OG ' ' A' ' 71' ' ' SER . 90.3 mtm-85 -115.57 140.85 48.79 Favored 'General case' 0 N--CA 1.497 1.909 0 CA-C-O 121.645 0.736 . . . . 0.0 110.421 -178.982 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.41 ' OG ' ' O ' ' A' ' 70' ' ' ARG . 22.2 p 59.77 66.69 0.96 Allowed 'General case' 0 N--CA 1.494 1.744 0 CA-C-O 121.121 0.486 . . . . 0.0 110.703 179.67 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 16.5 m -116.26 160.79 15.45 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.134 0 O-C-N 121.537 -0.727 . . . . 0.0 109.252 178.841 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 7.4 p -117.72 133.16 65.37 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 CA-C-O 121.382 0.611 . . . . 0.0 109.423 -179.563 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 13.5 t -88.06 110.29 20.77 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.278 -0.889 . . . . 0.0 109.669 -179.427 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -88.29 172.15 41.14 Favored Glycine 0 N--CA 1.493 2.49 0 N-CA-C 109.887 -1.285 . . . . 0.0 109.887 -179.602 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -100.45 119.68 38.84 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.566 -0.961 . . . . 0.0 109.15 179.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . 0.541 ' CE1' ' NZ ' ' A' ' 49' ' ' LYS . 40.7 t80 -115.17 104.36 11.77 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.539 -0.726 . . . . 0.0 109.774 -179.68 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 41.45 -117.15 0.34 Allowed 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.582 -0.698 . . . . 0.0 111.204 179.471 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.418 ' N ' ' OD1' ' A' ' 79' ' ' ASP . 37.5 p-10 -94.53 -7.67 40.52 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.329 -0.857 . . . . 0.0 110.234 -178.794 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 95.4 mtt180 -112.18 177.46 4.63 Favored 'General case' 0 N--CA 1.501 2.091 0 O-C-N 121.417 -0.802 . . . . 0.0 110.015 -179.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 72.9 m-85 -109.54 148.64 30.9 Favored 'General case' 0 N--CA 1.497 1.905 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 -179.693 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 53.3 tt0 -137.88 154.01 49.5 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.306 -0.871 . . . . 0.0 109.751 -179.81 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 33.5 m -113.32 132.86 60.99 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 179.729 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 79.0 mt-30 -106.76 127.48 53.43 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.572 -0.705 . . . . 0.0 109.992 -178.883 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 16.8 t -94.8 98.14 7.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.474 -0.766 . . . . 0.0 109.093 179.753 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.508 ' C ' HD21 ' A' ' 86' ' ' ASN . 0.1 OUTLIER -151.18 177.7 9.95 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.412 -0.805 . . . . 0.0 109.767 -179.759 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.539 ' C ' ' H ' ' A' ' 89' ' ' SER . 71.2 mmtt 61.19 -141.27 0.5 Allowed 'General case' 0 N--CA 1.493 1.712 0 CA-C-O 121.639 0.733 . . . . 0.0 110.772 179.169 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 32.3 t30 -66.46 9.52 0.16 Allowed 'General case' 0 C--N 1.304 -1.405 0 CA-C-O 121.334 0.588 . . . . 0.0 109.658 -179.446 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.539 ' H ' ' C ' ' A' ' 87' ' ' LYS . 13.3 p -58.18 143.61 43.54 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.249 -0.907 . . . . 0.0 109.671 -179.882 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 19.2 p -141.26 156.4 45.89 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.482 -0.761 . . . . 0.0 109.655 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 96.5 mt -132.58 134.53 58.68 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 121.556 -0.715 . . . . 0.0 109.445 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -126.48 136.83 53.12 Favored 'General case' 0 N--CA 1.499 2.013 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 179.516 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -80.13 128.91 34.07 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.397 -0.815 . . . . 0.0 109.678 -179.795 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 10.1 mp -105.23 134.59 48.08 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.451 -0.781 . . . . 0.0 109.636 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 96.6 p -88.6 8.51 28.0 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 108.774 -0.825 . . . . 0.0 108.774 179.521 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 67.0 mt-10 -117.55 90.38 35.1 Favored Pre-proline 0 N--CA 1.498 1.951 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 -179.775 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_exo -55.7 147.52 59.89 Favored 'Trans proline' 0 N--CA 1.497 1.705 0 C-N-CA 122.741 2.294 . . . . 0.0 112.658 179.618 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.425 ' O ' ' CG2' ' A' ' 98' ' ' ILE . 97.1 mt -84.23 0.67 4.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 CA-C-O 121.709 0.766 . . . . 0.0 109.67 -179.675 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 45.06 87.47 0.02 OUTLIER 'General case' 0 C--N 1.293 -1.865 0 CA-C-O 121.401 0.619 . . . . 0.0 109.659 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 33.6 m -99.94 42.79 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 O-C-N 121.422 -0.799 . . . . 0.0 109.352 -179.84 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 155.87 -16.22 0.45 Allowed Glycine 0 N--CA 1.494 2.537 0 N-CA-C 109.055 -1.618 . . . . 0.0 109.055 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.4 ' N ' ' CD1' ' A' ' 102' ' ' LEU . 10.9 mp -83.28 1.84 38.97 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.395 -1.062 . . . . 0.0 108.755 179.779 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -72.91 -4.29 31.07 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.41 -0.806 . . . . 0.0 109.052 179.535 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 71.8 t60 -66.05 -41.29 91.01 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.472 -0.767 . . . . 0.0 109.984 -179.801 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 77.0 m80 -94.59 103.48 15.43 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.098 -1.001 . . . . 0.0 109.826 -179.585 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 45.4 p-80 -157.58 -2.52 0.1 Allowed 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 179.478 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 95.6 m-70 -67.19 -39.83 86.42 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.516 -0.74 . . . . 0.0 109.455 179.751 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 77.4 m80 -78.34 132.65 37.5 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.361 -0.837 . . . . 0.0 110.084 -179.336 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 39.3 p-80 . . . . . 0 N--CA 1.491 1.622 0 CA-C-O 118.082 -0.961 . . . . 0.0 109.205 179.748 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 67.0 mtt . . . . . 0 N--CA 1.491 1.595 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 52.5 mm-40 -138.27 60.41 21.74 Favored Pre-proline 0 N--CA 1.498 1.943 0 O-C-N 121.471 -0.768 . . . . 0.0 109.82 -179.578 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -68.88 136.59 35.8 Favored 'Trans proline' 0 C--N 1.308 -1.554 0 C-N-CA 122.056 1.838 . . . . 0.0 111.765 -179.742 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -87.89 87.95 7.51 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.806 -1.184 . . . . 0.0 109.201 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.451 ' N ' ' CD2' ' A' ' 5' ' ' LEU . 4.0 mm? -69.31 136.16 51.43 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.502 -0.748 . . . . 0.0 109.583 -179.913 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 96.7 m -124.58 128.59 49.14 Favored 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -84.28 156.94 21.71 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.513 -0.742 . . . . 0.0 110.135 -179.424 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 65.4 mt -62.53 -44.36 99.25 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 121.446 -0.784 . . . . 0.0 109.681 179.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 14.0 p -64.66 -23.53 33.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.28 -0.888 . . . . 0.0 109.527 -179.875 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -79.7 -4.04 50.05 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.127 -0.983 . . . . 0.0 109.513 179.693 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 97.1 mt -80.24 103.99 7.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.097 -1.002 . . . . 0.0 109.825 -179.609 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 28.0 m -122.15 -9.39 8.85 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 179.4 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 18.9 pt-20 -136.39 137.7 40.8 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.5 -0.75 . . . . 0.0 109.598 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 30.5 p30 -95.34 162.83 13.51 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.322 -0.861 . . . . 0.0 110.731 -179.238 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 79.5 2.8 88.34 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.738 -1.345 . . . . 0.0 109.738 179.764 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 21.1 pt20 -80.47 144.38 32.62 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.248 -1.148 . . . . 0.0 110.095 -179.671 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 87.9 m95 -97.94 137.27 37.02 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.515 -0.741 . . . . 0.0 109.526 179.796 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -177.0 -179.61 0.93 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.078 -1.014 . . . . 0.0 109.78 179.608 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -105.75 146.28 30.03 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 6.1 tt -143.64 134.3 25.04 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.141 -0.974 . . . . 0.0 109.719 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 34.3 ttpt -116.66 139.7 50.24 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.571 -0.706 . . . . 0.0 109.189 179.864 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -160.57 179.45 8.58 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.865 -1.147 . . . . 0.0 109.949 179.857 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 64.7 tttm -112.96 141.98 46.17 Favored 'General case' 0 N--CA 1.498 1.953 0 CA-C-O 121.37 0.605 . . . . 0.0 109.679 -179.656 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 97.2 t -82.4 125.01 39.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.283 -0.886 . . . . 0.0 110.438 -179.078 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.416 HD13 HG23 ' A' ' 25' ' ' ILE . 96.6 mt -102.05 -51.83 8.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 179.184 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 18.4 tt0 -148.02 145.05 28.35 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.446 -0.784 . . . . 0.0 109.193 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.542 ' CD2' ' N ' ' A' ' 27' ' ' LEU . 1.2 pt? -136.65 138.77 41.46 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 179.934 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 78.9 t90 -128.37 123.11 33.05 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.394 -0.816 . . . . 0.0 109.463 -179.543 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -64.27 138.83 58.64 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.227 -0.921 . . . . 0.0 110.401 -179.52 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 55.9 t30 -84.68 169.91 13.83 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.505 -0.747 . . . . 0.0 110.102 -179.538 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 81.8 p -101.95 3.23 38.81 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.454 -0.779 . . . . 0.0 109.068 179.629 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 96.1 m-70 -105.49 136.34 45.25 Favored 'General case' 0 N--CA 1.5 2.041 0 CA-C-O 121.615 0.721 . . . . 0.0 109.765 179.886 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 46.4 tp10 -67.35 -31.71 72.15 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.358 -0.839 . . . . 0.0 109.72 -179.834 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 38.4 t -60.52 -42.65 96.86 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.178 -0.951 . . . . 0.0 109.783 -179.671 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.403 HG22 HD11 ' A' ' 35' ' ' ILE . 86.4 mt -105.38 124.83 60.51 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.064 0 O-C-N 121.394 -0.816 . . . . 0.0 109.517 179.967 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 3.4 t -68.96 -57.21 5.79 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.466 -0.771 . . . . 0.0 110.256 -179.637 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -156.88 156.96 34.02 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.201 -0.937 . . . . 0.0 109.97 -179.543 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 30.6 m -132.49 135.8 57.14 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 179.521 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -160.07 -158.97 9.51 Favored Glycine 0 N--CA 1.492 2.423 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 -179.444 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 2.0 pp -135.7 147.39 48.48 Favored 'General case' 0 N--CA 1.503 2.182 0 O-C-N 121.291 -1.123 . . . . 0.0 110.498 -179.628 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 48.1 mt -111.98 139.26 47.64 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.608 -0.683 . . . . 0.0 109.29 -178.834 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -80.64 164.85 47.36 Favored Glycine 0 N--CA 1.491 2.333 0 C-N-CA 120.215 -0.993 . . . . 0.0 110.669 -179.522 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.53 ' OD1' ' N ' ' A' ' 44' ' ' GLU . 66.8 t0 -172.68 141.28 1.08 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.607 -0.937 . . . . 0.0 109.389 179.482 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.53 ' N ' ' OD1' ' A' ' 43' ' ' ASP . 97.2 mt-10 -54.81 -18.39 4.75 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.313 -0.867 . . . . 0.0 110.479 -179.593 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 33.3 p -94.76 -9.74 33.72 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.981 -1.074 . . . . 0.0 109.498 -179.903 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 146.04 -153.82 25.56 Favored Glycine 0 N--CA 1.497 2.729 0 N-CA-C 110.168 -1.173 . . . . 0.0 110.168 179.365 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 37.3 pt -125.93 154.78 35.27 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.969 0 O-C-N 121.714 -0.874 . . . . 0.0 109.14 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 10.9 tp -142.72 142.19 26.76 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 O-C-N 121.109 -0.994 . . . . 0.0 110.462 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 25.4 mtpp -83.3 153.02 24.85 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 179.661 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 30.9 p90 -147.55 160.82 42.2 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 120.972 -1.08 . . . . 0.0 110.103 -179.879 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.46 ' CG2' HE21 ' A' ' 82' ' ' GLN . 3.4 t -143.89 139.57 29.28 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 179.401 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.433 HG21 HD12 ' A' ' 52' ' ' ILE . 95.3 mt -104.5 119.86 54.01 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.983 0 O-C-N 121.301 -0.875 . . . . 0.0 109.695 -179.754 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 94.6 m95 -95.49 140.88 29.72 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.332 -0.855 . . . . 0.0 109.366 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -84.29 52.44 2.34 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.202 -0.936 . . . . 0.0 109.418 179.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . 0.42 ' ND2' ' O ' ' A' ' 55' ' ' ASN . 0.5 OUTLIER -74.28 -9.06 58.23 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.37 -0.831 . . . . 0.0 109.022 179.837 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -163.41 -78.68 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.347 -0.846 . . . . 0.0 109.143 179.889 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -171.8 114.53 0.35 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.181 -0.949 . . . . 0.0 109.701 179.893 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 91.2 mt -139.57 95.55 8.92 Favored Pre-proline 0 N--CA 1.496 1.85 0 O-C-N 121.33 -0.856 . . . . 0.0 108.834 179.543 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -52.57 154.37 12.13 Favored 'Trans proline' 0 N--CA 1.494 1.525 0 C-N-CA 122.15 1.9 . . . . 0.0 111.956 -179.759 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 62.4 mt -62.63 139.88 58.66 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.251 -0.905 . . . . 0.0 110.258 -178.638 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.506 ' CD1' ' N ' ' A' ' 61' ' ' LEU . 8.8 mp -80.95 149.52 29.34 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.681 -0.637 . . . . 0.0 110.034 -179.308 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 80.4 mm-40 -83.49 139.42 32.93 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.35 -0.844 . . . . 0.0 109.955 -179.712 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 56.8 tt0 -77.53 133.15 38.6 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.398 -0.814 . . . . 0.0 111.07 -179.121 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 95.13 -0.33 64.02 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 110.048 -1.221 . . . . 0.0 110.048 179.475 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.514 ' OE1' ' N ' ' A' ' 65' ' ' GLU . 58.4 mp0 -111.73 150.82 29.69 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 121.451 -1.029 . . . . 0.0 110.292 -179.572 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 7.7 m -86.88 152.0 22.83 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.705 -0.622 . . . . 0.0 109.925 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 74.0 m-85 -142.52 145.77 34.01 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.544 -0.722 . . . . 0.0 109.557 179.677 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 18.0 tp -106.01 124.11 49.06 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 179.445 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 61.3 mt -100.97 131.52 46.8 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 -179.621 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.453 ' CZ ' ' OE2' ' A' ' 92' ' ' GLU . 84.8 mtm180 -126.93 141.32 51.83 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.376 -0.827 . . . . 0.0 110.168 -179.364 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 8.3 m 56.95 57.22 4.78 Favored 'General case' 0 N--CA 1.493 1.721 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.382 179.405 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 15.5 m -113.74 161.81 12.33 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.12 0 O-C-N 121.378 -0.826 . . . . 0.0 108.929 178.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 7.6 p -117.94 134.08 62.69 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.02 0 CA-C-O 121.435 0.636 . . . . 0.0 109.534 -179.239 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 20.1 t -78.67 122.11 33.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.38 -0.825 . . . . 0.0 109.922 -179.173 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -95.28 171.77 29.87 Favored Glycine 0 N--CA 1.495 2.605 0 N-CA-C 109.368 -1.493 . . . . 0.0 109.368 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.546 ' N ' ' OE1' ' A' ' 76' ' ' GLU . 57.5 mp0 -107.17 118.94 38.04 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.487 -1.008 . . . . 0.0 109.483 -179.691 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 55.5 t80 -118.75 107.41 13.62 Favored 'General case' 0 N--CA 1.496 1.836 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 179.508 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 97.7 m-20 44.57 -125.76 1.02 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.403 -0.811 . . . . 0.0 109.942 -179.369 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 66.1 m-20 -94.66 -5.42 45.65 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.363 -0.836 . . . . 0.0 108.994 179.867 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 88.3 mtm180 -100.2 166.18 11.12 Favored 'General case' 0 N--CA 1.493 1.69 0 CA-C-O 121.614 0.721 . . . . 0.0 109.704 -179.702 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 76.8 m-85 -101.84 151.01 22.58 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.425 -0.797 . . . . 0.0 109.579 -179.595 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . 0.46 HE21 ' CG2' ' A' ' 51' ' ' THR . 40.6 tt0 -138.54 157.1 46.8 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.389 -0.819 . . . . 0.0 109.643 -179.757 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 3.4 m -114.11 130.64 67.97 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 179.178 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 87.7 mt-30 -109.83 132.42 54.16 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.61 -0.682 . . . . 0.0 110.072 -178.316 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 3.9 t -104.55 126.93 59.29 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 179.505 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.479 ' C ' HD21 ' A' ' 86' ' ' ASN . 0.1 OUTLIER -145.97 -176.44 5.15 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.208 -0.932 . . . . 0.0 109.531 -179.776 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.561 ' C ' ' H ' ' A' ' 89' ' ' SER . 21.7 ptmt -37.93 161.12 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.804 0 CA-C-O 121.544 0.688 . . . . 0.0 111.589 -178.942 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 5.1 t30 69.51 -23.71 0.15 Allowed 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 -179.678 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.561 ' H ' ' C ' ' A' ' 87' ' ' LYS . 10.6 t -78.31 155.94 29.89 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.197 -0.939 . . . . 0.0 109.86 -179.755 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 27.1 p -141.2 154.59 45.9 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.46 -0.775 . . . . 0.0 108.956 179.571 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 97.3 mt -129.98 132.49 65.5 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.453 ' OE2' ' CZ ' ' A' ' 70' ' ' ARG . 80.3 mt-10 -120.95 140.95 51.16 Favored 'General case' 0 N--CA 1.502 2.126 0 O-C-N 121.436 -0.79 . . . . 0.0 109.264 -179.507 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 37.8 ttmt -84.18 122.95 29.56 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.185 -0.947 . . . . 0.0 109.266 -179.735 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.473 ' CD2' ' N ' ' A' ' 94' ' ' LEU . 3.9 mm? -96.79 136.85 36.75 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.367 -0.833 . . . . 0.0 109.804 -179.466 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 94.4 p -85.52 -1.23 56.87 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 179.349 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 37.6 mm-40 -108.48 98.81 29.81 Favored Pre-proline 0 N--CA 1.498 1.961 0 O-C-N 121.644 -0.66 . . . . 0.0 109.286 -179.81 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -74.3 155.28 46.41 Favored 'Trans proline' 0 N--CA 1.491 1.38 0 C-N-CA 121.982 1.788 . . . . 0.0 112.737 -178.796 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 90.6 mt -102.7 123.82 56.3 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -87.26 125.34 34.14 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.408 -0.807 . . . . 0.0 110.425 -178.577 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 29.4 m -109.71 1.43 9.36 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.019 0 O-C-N 121.626 -0.672 . . . . 0.0 109.448 179.775 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -127.54 65.64 0.57 Allowed Glycine 0 N--CA 1.502 3.046 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 4.3 tp -86.9 -4.01 59.13 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.262 -1.14 . . . . 0.0 108.99 179.851 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -54.02 135.15 43.38 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.213 -0.93 . . . . 0.0 110.608 -179.089 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . 0.46 ' O ' ' CG ' ' A' ' 104' ' ' HIS . 45.6 p-80 -99.23 106.82 19.01 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.439 -0.788 . . . . 0.0 109.585 -179.942 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 52.2 t-80 -75.68 -87.92 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.361 -0.837 . . . . 0.0 109.737 -179.831 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 60.7 t-80 -156.54 -12.74 0.1 Allowed 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . 0.473 ' HD1' ' HD1' ' A' ' 108' ' ' HIS . 58.4 t-80 -62.09 -44.6 96.31 Favored 'General case' 0 N--CA 1.486 1.375 0 O-C-N 121.46 -0.775 . . . . 0.0 109.267 179.705 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . 0.473 ' HD1' ' HD1' ' A' ' 107' ' ' HIS . 47.5 p-80 -152.91 164.42 37.93 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.144 -0.972 . . . . 0.0 109.787 179.908 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . 0.45 ' O ' ' CG ' ' A' ' 109' ' ' HIS . 86.4 t60 . . . . . 0 N--CA 1.49 1.551 0 CA-C-O 117.916 -1.04 . . . . 0.0 109.223 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.5 tpt . . . . . 0 N--CA 1.49 1.536 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.509 ' N ' ' CD ' ' A' ' 3' ' ' PRO . 1.5 tt0 -68.35 -47.66 36.94 Favored Pre-proline 0 C--N 1.303 -1.434 0 O-C-N 121.576 -0.702 . . . . 0.0 109.752 179.763 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.509 ' CD ' ' N ' ' A' ' 2' ' ' GLU . 72.5 Cg_endo -79.76 150.11 21.1 Favored 'Trans proline' 0 C--N 1.312 -1.343 0 C-N-CA 122.167 1.911 . . . . 0.0 112.144 -179.116 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 55.9 tt0 -78.61 89.07 4.52 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.367 -0.833 . . . . 0.0 109.321 -179.68 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 81.7 mt -76.63 144.91 39.22 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.65 -0.656 . . . . 0.0 109.582 -179.744 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 86.6 m -123.46 130.41 52.65 Favored 'General case' 0 N--CA 1.496 1.834 0 CA-C-O 121.551 0.691 . . . . 0.0 109.515 -179.887 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 65.7 mttp -82.59 149.35 27.5 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.555 -0.715 . . . . 0.0 110.074 -179.32 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 95.6 mt -63.12 -43.29 98.83 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 O-C-N 121.618 -0.676 . . . . 0.0 109.677 179.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 11.1 p -63.83 -24.1 34.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.333 -0.854 . . . . 0.0 109.824 -179.663 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -75.0 -3.89 35.08 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.096 -1.003 . . . . 0.0 109.385 179.712 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 5.7 mm -70.95 92.63 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.313 -0.867 . . . . 0.0 109.52 -179.789 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 15.0 m -114.82 -20.6 5.89 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -139.09 140.56 38.04 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.268 -0.895 . . . . 0.0 109.938 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 55.4 p30 -89.74 167.93 12.5 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.499 -0.751 . . . . 0.0 110.263 -179.507 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 80.26 15.74 77.87 Favored Glycine 0 N--CA 1.488 2.144 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 -179.807 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 27.8 tt0 -96.28 132.35 41.84 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.335 -1.097 . . . . 0.0 109.709 -179.82 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 76.6 m95 -94.72 134.33 37.43 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.587 -0.695 . . . . 0.0 109.954 -179.536 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -173.29 -169.46 0.53 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.526 -0.734 . . . . 0.0 109.667 179.566 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 70.9 m-20 -107.34 152.03 24.7 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.6 -0.687 . . . . 0.0 109.159 -179.889 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -133.85 120.25 20.2 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.408 -0.807 . . . . 0.0 109.318 179.835 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 35.9 ttmt -112.51 126.56 55.46 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 179.131 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -168.57 -171.95 1.55 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.117 -0.989 . . . . 0.0 109.989 -179.706 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -119.28 138.8 52.77 Favored 'General case' 0 N--CA 1.497 1.887 0 CA-C-O 121.625 0.726 . . . . 0.0 109.976 -179.621 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 10.7 t -85.9 91.43 3.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.521 -0.737 . . . . 0.0 109.661 -179.476 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 62.6 mt -69.86 -42.65 79.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.481 -0.762 . . . . 0.0 109.612 179.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 98.8 mm-40 -127.64 125.94 41.07 Favored 'General case' 0 N--CA 1.498 1.932 0 CA-C-O 121.75 0.786 . . . . 0.0 110.117 -178.897 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 1.1 tt -121.92 130.55 53.43 Favored 'General case' 0 C--N 1.309 -1.193 0 N-CA-C 108.755 -0.832 . . . . 0.0 108.755 179.821 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 96.9 m95 -135.2 117.76 15.89 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.613 -0.68 . . . . 0.0 109.39 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -94.18 144.56 25.4 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.485 -0.76 . . . . 0.0 110.025 -179.537 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . 0.423 ' OD1' ' O ' ' A' ' 36' ' ' SER . 54.0 p30 -117.19 164.8 14.23 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.601 -0.687 . . . . 0.0 109.708 179.908 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 85.5 m -93.27 3.64 55.31 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 179.722 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 59.9 m80 -63.47 132.15 50.46 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.423 -0.798 . . . . 0.0 110.105 -179.336 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 80.5 tt0 -76.99 -23.07 52.27 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.545 -0.722 . . . . 0.0 109.857 -179.806 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 87.7 p -87.08 -17.28 33.23 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.181 -0.949 . . . . 0.0 109.495 -179.583 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.415 ' CG2' HD22 ' A' ' 30' ' ' ASN . 84.0 mt -131.41 130.57 62.89 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 O-C-N 121.479 -0.763 . . . . 0.0 109.238 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.423 ' O ' ' OD1' ' A' ' 30' ' ' ASN . 37.2 t -75.28 -75.38 0.17 Allowed 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.568 -0.707 . . . . 0.0 109.46 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 16.0 pt20 -141.42 162.36 35.67 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.394 -0.816 . . . . 0.0 110.013 -179.58 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 27.6 m -131.96 154.76 40.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 179.425 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.424 ' C ' ' CE1' ' A' ' 50' ' ' PHE . . . -178.88 -169.79 39.98 Favored Glycine 0 N--CA 1.486 1.987 0 C-N-CA 119.268 -1.444 . . . . 0.0 109.827 -179.751 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 2.2 pp -136.44 150.57 48.8 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.646 -0.914 . . . . 0.0 109.638 -179.621 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 54.5 mt -107.55 161.36 14.92 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 -179.006 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -140.09 131.99 5.33 Favored Glycine 0 N--CA 1.493 2.475 0 N-CA-C 109.967 -1.253 . . . . 0.0 109.967 -179.714 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.429 ' OD2' ' OG1' ' A' ' 45' ' ' THR . 52.3 p30 -151.59 -167.07 2.68 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.618 -0.93 . . . . 0.0 109.16 179.796 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -76.96 -12.4 59.94 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.514 -0.741 . . . . 0.0 109.473 179.633 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.429 ' OG1' ' OD2' ' A' ' 43' ' ' ASP . 34.7 p -91.98 -5.65 52.67 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.293 -0.88 . . . . 0.0 109.605 -179.518 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 122.76 -148.67 16.88 Favored Glycine 0 N--CA 1.5 2.953 0 N-CA-C 110.195 -1.162 . . . . 0.0 110.195 179.304 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 43.7 pt -128.71 154.89 40.22 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 O-C-N 121.758 -0.848 . . . . 0.0 109.712 -179.541 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 17.1 tt -152.6 144.46 15.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.212 -0.93 . . . . 0.0 109.96 179.621 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 63.7 mttp -83.36 150.7 25.94 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.557 -0.714 . . . . 0.0 109.909 -179.494 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.424 ' CE1' ' C ' ' A' ' 39' ' ' GLY . 35.5 p90 -142.36 152.12 42.56 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.291 -0.881 . . . . 0.0 109.622 -179.949 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 99.6 m -135.19 132.01 37.42 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 179.703 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.409 HD13 HG21 ' A' ' 52' ' ' ILE . 98.0 mt -106.05 129.06 59.85 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.601 -0.687 . . . . 0.0 109.844 -179.661 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 86.6 m95 -94.97 144.33 25.77 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.51 -0.744 . . . . 0.0 109.527 -179.924 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -66.92 -7.25 20.64 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.413 -0.804 . . . . 0.0 109.409 179.814 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 93.2 m-20 -61.95 -40.49 95.73 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.404 -0.81 . . . . 0.0 109.51 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -73.45 -11.77 60.57 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.357 -0.84 . . . . 0.0 109.089 179.776 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 46.07 46.7 12.85 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.72 -0.613 . . . . 0.0 109.67 179.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 23.3 mt -97.33 150.82 37.22 Favored Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 121.481 -0.762 . . . . 0.0 109.503 -179.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -68.85 159.55 53.35 Favored 'Trans proline' 0 N--CA 1.496 1.639 0 C-N-CA 122.832 2.355 . . . . 0.0 112.72 -179.817 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 69.2 mt -64.84 139.1 58.73 Favored 'General case' 0 N--CA 1.49 1.543 0 CA-C-O 121.624 0.726 . . . . 0.0 110.388 -179.163 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.483 ' CD1' ' N ' ' A' ' 61' ' ' LEU . 9.6 mp -76.94 149.85 35.98 Favored 'General case' 0 N--CA 1.49 1.545 0 CA-C-O 121.468 0.652 . . . . 0.0 110.175 -179.588 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 49.2 tp10 -81.2 118.86 22.93 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.45 -0.781 . . . . 0.0 109.297 -179.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 56.9 tt0 -64.21 134.63 55.16 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.55 -0.719 . . . . 0.0 110.902 -178.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 84.14 28.8 32.85 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 110.339 -1.105 . . . . 0.0 110.339 179.488 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -136.65 154.24 50.7 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.276 -1.132 . . . . 0.0 110.637 -179.634 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 6.7 m -81.16 142.07 33.6 Favored 'General case' 0 N--CA 1.488 1.444 0 CA-C-O 121.322 0.582 . . . . 0.0 109.707 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 29.3 m-85 -140.8 146.84 38.15 Favored 'General case' 0 N--CA 1.49 1.57 0 CA-C-O 121.782 0.801 . . . . 0.0 109.751 -179.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 23.3 tp -111.56 120.87 43.56 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 179.458 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 66.2 mt -102.87 133.17 48.39 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 -179.916 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.463 ' O ' ' OG ' ' A' ' 71' ' ' SER . 84.8 mtp180 -127.39 149.27 50.15 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.666 -0.646 . . . . 0.0 110.293 -179.517 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.463 ' OG ' ' O ' ' A' ' 70' ' ' ARG . 3.0 p 53.28 57.93 5.75 Favored 'General case' 0 N--CA 1.494 1.733 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.445 179.702 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 17.8 m -116.15 164.99 12.01 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.043 0 O-C-N 121.608 -0.682 . . . . 0.0 109.422 179.105 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 8.0 p -115.32 137.84 47.59 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 CA-C-O 121.485 0.659 . . . . 0.0 109.8 -179.065 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 89.0 t -85.28 108.43 17.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.559 -0.713 . . . . 0.0 109.65 -179.501 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -87.64 177.77 46.95 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 110.115 -1.194 . . . . 0.0 110.115 -179.43 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 -107.68 134.57 50.47 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.602 -0.94 . . . . 0.0 109.216 -179.867 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 55.7 t80 -108.83 145.14 35.74 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.477 -0.764 . . . . 0.0 109.756 -179.468 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . 0.442 ' O ' ' CB ' ' A' ' 79' ' ' ASP . 24.0 t-20 -69.43 62.99 0.16 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.588 -0.695 . . . . 0.0 109.96 -179.477 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.442 ' CB ' ' O ' ' A' ' 78' ' ' ASN . 0.7 OUTLIER 162.43 -25.57 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 179.701 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 25.1 ttm180 -166.88 -131.66 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.374 -0.829 . . . . 0.0 109.595 -179.778 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 89.6 m-85 -131.29 152.28 50.71 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.582 -0.699 . . . . 0.0 109.625 -179.573 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 6.0 pt20 -144.97 162.49 36.76 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.473 -0.767 . . . . 0.0 109.393 -179.836 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 3.3 m -109.36 132.66 56.89 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 179.804 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 87.0 mt-30 -107.14 132.48 52.98 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.632 -0.668 . . . . 0.0 110.18 -178.65 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 90.1 t -99.45 129.59 49.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 179.654 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 6.2 m-80 -144.38 176.36 9.42 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.475 -0.765 . . . . 0.0 109.524 -179.494 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.501 ' C ' ' H ' ' A' ' 89' ' ' SER . 61.3 tttp -40.94 159.75 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.723 0 CA-C-O 121.29 0.567 . . . . 0.0 110.459 -179.796 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . 0.447 ' CB ' ' O ' ' A' ' 87' ' ' LYS . 3.9 t30 77.26 -25.37 0.2 Allowed 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 -179.5 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.501 ' H ' ' C ' ' A' ' 87' ' ' LYS . 94.0 p -73.27 154.41 40.19 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 121.62 -0.675 . . . . 0.0 109.825 -179.809 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 75.7 m -132.26 150.52 52.14 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.625 -0.672 . . . . 0.0 109.472 -179.945 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 96.9 mt -130.11 130.6 65.98 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 179.864 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 53.0 tp10 -126.57 130.93 51.51 Favored 'General case' 0 N--CA 1.497 1.881 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 179.784 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 64.0 tttp -80.19 131.31 35.68 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.614 -0.679 . . . . 0.0 110.235 -179.274 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.478 ' CD2' ' N ' ' A' ' 94' ' ' LEU . 3.9 mm? -96.67 135.87 37.99 Favored 'General case' 0 N--CA 1.495 1.818 0 CA-C-O 121.777 0.799 . . . . 0.0 109.929 -179.809 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 68.1 m -84.65 -3.8 58.69 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.724 -0.61 . . . . 0.0 109.519 179.802 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 12.3 tp10 -117.47 91.17 37.07 Favored Pre-proline 0 N--CA 1.498 1.94 0 O-C-N 121.56 -0.712 . . . . 0.0 109.338 -179.854 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -55.77 147.66 59.86 Favored 'Trans proline' 0 N--CA 1.498 1.751 0 C-N-CA 122.727 2.284 . . . . 0.0 112.648 -179.869 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.409 HG23 HD13 ' A' ' 98' ' ' ILE . 95.9 mt -96.27 129.2 46.68 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.494 -0.754 . . . . 0.0 109.785 -179.434 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 74.8 mm-40 -90.15 125.36 35.43 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.582 -0.699 . . . . 0.0 109.643 -179.694 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 29.2 m -102.06 -2.48 9.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 N-CA-C 108.817 -0.808 . . . . 0.0 108.817 179.761 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 172.28 119.17 0.51 Allowed Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.811 -1.316 . . . . 0.0 109.811 179.74 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 83.1 mt -89.66 -5.17 57.34 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.458 -1.024 . . . . 0.0 109.118 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 76.1 mt-10 -81.87 107.63 14.74 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.406 -0.809 . . . . 0.0 109.994 -179.702 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 25.9 t-80 -170.25 71.51 0.06 Allowed 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 108.906 -0.775 . . . . 0.0 108.906 179.514 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 57.9 t-80 -157.96 134.85 9.91 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.327 -0.858 . . . . 0.0 109.78 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' HIS . . . . . 0.63 ' ND1' ' N ' ' A' ' 107' ' ' HIS . 55.3 t-80 42.44 -105.8 0.07 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.615 -0.678 . . . . 0.0 110.519 179.604 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . 0.63 ' N ' ' ND1' ' A' ' 106' ' ' HIS . 84.6 t60 46.03 80.34 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.579 -0.701 . . . . 0.0 109.718 -179.461 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . 0.444 ' CD2' ' O ' ' A' ' 109' ' ' HIS . 86.3 t60 -89.69 128.23 36.05 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.396 -0.815 . . . . 0.0 109.847 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . 0.444 ' O ' ' CD2' ' A' ' 108' ' ' HIS . 54.2 p-80 . . . . . 0 N--CA 1.49 1.552 0 CA-C-O 118.025 -0.988 . . . . 0.0 110.004 -179.869 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.6 ptt? . . . . . 0 N--CA 1.489 1.483 0 CA-C-O 121.792 0.806 . . . . 0.0 109.547 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 51.23 57.68 16.87 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.615 -0.678 . . . . 0.0 110.219 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -68.37 150.17 75.79 Favored 'Trans proline' 0 C--N 1.31 -1.463 0 C-N-CA 122.39 2.06 . . . . 0.0 112.067 179.685 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . 0.513 ' N ' ' OE1' ' A' ' 4' ' ' GLN . 0.9 OUTLIER -76.24 90.12 3.14 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.352 -0.843 . . . . 0.0 109.878 -179.436 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 79.1 mt -76.61 145.74 38.7 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.706 -0.622 . . . . 0.0 109.435 179.897 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 92.0 m -125.26 132.24 52.96 Favored 'General case' 0 N--CA 1.493 1.723 0 CA-C-O 121.761 0.791 . . . . 0.0 109.704 -179.884 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -75.85 149.4 37.85 Favored 'General case' 0 C--N 1.3 -1.567 0 CA-C-O 121.785 0.802 . . . . 0.0 110.373 -179.578 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 97.2 mt -63.24 -43.22 98.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 CA-C-O 121.802 0.81 . . . . 0.0 109.563 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 7.6 p -65.06 -24.3 35.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.592 -0.693 . . . . 0.0 109.872 -179.67 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 50.3 t0 -79.4 -4.58 51.69 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.17 -0.956 . . . . 0.0 109.838 -179.639 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 97.1 mt -85.6 114.33 25.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 120.962 -1.086 . . . . 0.0 109.656 -179.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 34.6 m -149.84 15.04 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 179.741 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 79.3 mm-40 -127.87 133.54 49.34 Favored 'General case' 0 N--CA 1.497 1.907 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 -179.903 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 11.5 m120 -74.06 141.54 45.72 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-O 121.658 0.742 . . . . 0.0 110.079 -179.579 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 58.02 111.15 0.01 OUTLIER Glycine 0 N--CA 1.49 2.242 0 N-CA-C 110.465 -1.054 . . . . 0.0 110.465 179.504 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 29.1 tt0 -168.06 133.77 1.91 Allowed 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.424 -1.045 . . . . 0.0 109.174 179.501 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 60.4 m95 -88.63 136.82 32.8 Favored 'General case' 0 N--CA 1.49 1.558 0 CA-C-O 121.652 0.739 . . . . 0.0 109.938 -179.565 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -178.29 173.63 1.39 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.571 -0.705 . . . . 0.0 109.229 -179.717 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 73.0 m-20 -107.59 144.99 33.84 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.54 -0.725 . . . . 0.0 109.886 -179.434 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 60.4 tp -133.78 135.4 43.86 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.49 -0.756 . . . . 0.0 110.406 -179.59 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 38.5 ttmt -119.23 130.34 55.41 Favored 'General case' 0 N--CA 1.496 1.863 0 CA-C-O 121.321 0.581 . . . . 0.0 109.556 179.503 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -168.79 -172.91 1.72 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.345 -0.847 . . . . 0.0 109.93 179.414 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 21.3 ptmt -124.81 154.35 41.11 Favored 'General case' 0 N--CA 1.498 1.961 0 CA-C-O 121.46 0.648 . . . . 0.0 109.919 179.829 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 97.1 t -87.8 129.58 38.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 CA-C-O 121.613 0.721 . . . . 0.0 110.174 -179.539 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 96.4 mt -100.98 -55.81 5.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 N-CA-C 109.068 -0.715 . . . . 0.0 109.068 179.42 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.614 ' NE2' ' NE2' ' A' ' 63' ' ' GLN . 64.2 mm-40 -142.92 138.61 30.3 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.151 -0.968 . . . . 0.0 109.807 179.825 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.551 ' CD2' ' N ' ' A' ' 27' ' ' LEU . 1.2 pt? -143.22 139.41 30.25 Favored 'General case' 0 N--CA 1.492 1.631 0 CA-C-O 121.347 0.594 . . . . 0.0 109.988 -179.928 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 5.6 m-90 -111.86 140.31 46.61 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 179.595 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -78.59 119.75 22.3 Favored 'General case' 0 N--CA 1.493 1.687 0 CA-C-O 121.645 0.736 . . . . 0.0 110.265 -179.563 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . 0.435 ' O ' ' C ' ' A' ' 31' ' ' THR . 55.7 t-20 -107.04 -43.91 4.52 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.543 -0.723 . . . . 0.0 109.243 179.756 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.435 ' C ' ' O ' ' A' ' 30' ' ' ASN . 1.2 p 38.22 53.75 1.71 Allowed 'General case' 0 N--CA 1.504 2.265 0 CA-C-O 122.023 0.916 . . . . 0.0 109.783 -179.539 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . 0.703 ' CD2' ' H ' ' A' ' 33' ' ' GLU . 29.4 t60 -83.72 -151.6 0.12 Allowed 'General case' 0 N--CA 1.494 1.758 0 CA-C-O 122.072 0.939 . . . . 0.0 110.738 -179.137 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.703 ' H ' ' CD2' ' A' ' 32' ' ' HIS . 97.2 mt-10 -70.08 -38.81 75.8 Favored 'General case' 0 N--CA 1.491 1.618 0 CA-C-O 121.661 0.743 . . . . 0.0 109.799 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 14.7 m -137.79 2.76 2.43 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.303 -0.873 . . . . 0.0 109.138 -179.609 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 72.4 mt -107.34 126.39 63.54 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 O-C-N 121.131 -0.981 . . . . 0.0 109.576 -179.751 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.575 ' OG ' ' N ' ' A' ' 54' ' ' LYS . 1.0 OUTLIER -92.0 -69.47 0.74 Allowed 'General case' 0 N--CA 1.492 1.648 0 CA-C-O 121.837 0.827 . . . . 0.0 109.283 -179.905 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 99.3 mt-30 -138.71 154.01 48.54 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.303 -0.873 . . . . 0.0 109.792 -179.585 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.7 p -140.41 140.49 34.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.585 -0.697 . . . . 0.0 109.781 -179.806 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -170.56 -156.96 11.87 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 179.723 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -132.12 150.6 52.11 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.709 -0.877 . . . . 0.0 110.117 179.836 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 66.2 mt -109.71 134.33 52.11 Favored 'General case' 0 N--CA 1.492 1.674 0 CA-C-O 121.763 0.792 . . . . 0.0 109.591 -179.438 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -86.87 144.04 19.3 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 110.06 -1.216 . . . . 0.0 110.06 179.897 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 43.8 t0 -152.7 165.55 34.94 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 121.497 -1.002 . . . . 0.0 110.105 179.84 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -63.99 -17.89 63.75 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.82 -0.55 . . . . 0.0 110.826 -179.583 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 17.3 p -98.63 -5.91 30.85 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 120.809 -1.182 . . . . 0.0 109.99 -179.314 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 140.21 -129.82 4.38 Favored Glycine 0 N--CA 1.496 2.678 0 N-CA-C 110.219 -1.153 . . . . 0.0 110.219 179.491 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.544 ' N ' ' CD1' ' A' ' 47' ' ' ILE . 0.1 OUTLIER -145.09 158.89 13.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.583 -0.951 . . . . 0.0 109.819 -179.54 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 9.7 tp -148.73 147.72 16.54 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 179.172 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 69.1 mttm -85.07 153.52 22.66 Favored 'General case' 0 N--CA 1.49 1.533 0 CA-C-O 121.641 0.734 . . . . 0.0 110.403 -179.658 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 13.4 p90 -148.86 152.86 37.21 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.407 -0.808 . . . . 0.0 109.447 179.779 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 98.3 m -133.1 131.28 40.36 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 91.7 mt -100.55 125.43 54.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.4 -0.812 . . . . 0.0 110.098 -179.58 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 54.3 m95 -93.96 120.27 33.99 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 179.455 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.575 ' N ' ' OG ' ' A' ' 36' ' ' SER . 19.6 ptmt -69.76 -5.05 22.71 Favored 'General case' 0 C--N 1.3 -1.565 0 CA-C-O 121.764 0.792 . . . . 0.0 108.928 179.947 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 8.7 m120 -61.84 -40.77 96.49 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.542 -0.724 . . . . 0.0 109.262 179.57 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -78.82 -12.92 60.05 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.224 -0.923 . . . . 0.0 109.166 179.592 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 55.43 62.22 2.55 Favored 'General case' 0 N--CA 1.494 1.761 0 CA-C-O 121.59 0.71 . . . . 0.0 109.99 179.914 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 40.4 mt -101.54 154.21 37.39 Favored Pre-proline 0 N--CA 1.493 1.724 0 O-C-N 121.651 -0.656 . . . . 0.0 109.237 179.836 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -52.44 143.85 42.98 Favored 'Trans proline' 0 N--CA 1.497 1.694 0 C-N-CA 122.221 1.947 . . . . 0.0 112.752 179.929 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 79.2 mt -74.19 141.55 45.48 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.404 -0.81 . . . . 0.0 109.844 -179.852 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.485 ' CD1' ' N ' ' A' ' 61' ' ' LEU . 9.8 mp -86.26 149.07 25.33 Favored 'General case' 0 N--CA 1.489 1.508 0 CA-C-O 121.834 0.826 . . . . 0.0 110.078 -179.796 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -99.68 146.12 26.86 Favored 'General case' 0 N--CA 1.491 1.6 0 CA-C-O 121.761 0.791 . . . . 0.0 110.429 -179.275 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.614 ' NE2' ' NE2' ' A' ' 26' ' ' GLN . 57.4 tt0 -75.17 135.54 41.07 Favored 'General case' 0 N--CA 1.489 1.48 0 CA-C-O 121.727 0.775 . . . . 0.0 110.413 -179.894 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 81.32 18.09 69.87 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 110.011 -1.236 . . . . 0.0 110.011 179.535 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 -125.27 147.22 49.19 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.393 -1.063 . . . . 0.0 110.646 -179.8 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.4 ' H ' ' HG ' ' A' ' 66' ' ' SER . 12.7 p -80.19 150.89 29.97 Favored 'General case' 0 N--CA 1.485 1.299 0 CA-C-O 121.721 0.772 . . . . 0.0 110.011 179.772 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 40.0 m-85 -145.42 144.37 30.6 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.497 -0.752 . . . . 0.0 109.547 179.915 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 25.0 tp -111.13 119.83 40.29 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 179.034 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 71.4 mt -105.22 128.37 53.38 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 -179.675 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 83.1 mtp180 -130.13 137.74 50.3 Favored 'General case' 0 N--CA 1.493 1.691 0 CA-C-O 121.502 0.668 . . . . 0.0 110.021 179.835 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.3 m 72.73 52.52 0.15 Allowed 'General case' 0 N--CA 1.495 1.78 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.198 179.677 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 20.4 m -113.68 160.7 13.03 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 O-C-N 121.377 -0.827 . . . . 0.0 110.196 179.626 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 11.1 p -114.37 140.46 35.04 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 CA-C-O 121.549 0.69 . . . . 0.0 109.19 -179.841 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 85.7 t -86.21 113.43 24.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 CA-C-O 121.996 0.903 . . . . 0.0 110.529 -179.062 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -87.27 177.09 47.28 Favored Glycine 0 N--CA 1.488 2.148 0 N-CA-C 109.882 -1.287 . . . . 0.0 109.882 179.875 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.561 ' N ' ' OE1' ' A' ' 76' ' ' GLU . 52.8 mp0 -112.62 128.0 56.26 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.63 -0.923 . . . . 0.0 109.854 -179.341 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 80.7 t80 -130.7 86.11 2.35 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 179.662 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . 0.533 ' CG ' ' H ' ' A' ' 79' ' ' ASP . 64.4 t30 58.87 -139.71 0.74 Allowed 'General case' 0 N--CA 1.491 1.594 0 CA-C-O 121.508 0.671 . . . . 0.0 110.527 179.944 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.533 ' H ' ' CG ' ' A' ' 78' ' ' ASN . 93.0 m-20 -78.22 -5.95 53.41 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.412 -0.805 . . . . 0.0 109.244 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 16.5 tpp180 -107.74 145.98 32.76 Favored 'General case' 0 N--CA 1.497 1.88 0 CA-C-O 121.866 0.841 . . . . 0.0 110.029 -179.442 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 94.5 m-85 -85.85 153.49 22.21 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.532 -0.73 . . . . 0.0 110.167 -179.066 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 48.7 tt0 -140.76 154.07 46.13 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.438 -0.789 . . . . 0.0 109.659 -179.715 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 27.2 m -113.55 131.19 66.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 CA-C-O 121.591 0.71 . . . . 0.0 109.085 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 87.1 mt-30 -105.94 119.81 40.13 Favored 'General case' 0 N--CA 1.493 1.689 0 CA-C-O 121.606 0.717 . . . . 0.0 110.091 -178.777 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 11.2 t -93.67 103.44 14.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 179.158 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.506 ' C ' HD21 ' A' ' 86' ' ' ASN . 0.4 OUTLIER -151.68 -178.77 6.91 Favored 'General case' 0 N--CA 1.489 1.49 0 CA-C-O 121.732 0.777 . . . . 0.0 110.474 -179.113 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.423 ' CG ' ' H ' ' A' ' 88' ' ' ASN . 30.6 ttmt 68.6 -131.76 0.1 Allowed 'General case' 0 N--CA 1.492 1.673 0 CA-C-O 121.642 0.734 . . . . 0.0 110.895 179.466 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . 0.423 ' H ' ' CG ' ' A' ' 87' ' ' LYS . 12.6 m120 -93.23 10.62 31.1 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.393 -0.817 . . . . 0.0 108.813 -179.51 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.41 ' C ' ' O ' ' A' ' 88' ' ' ASN . 40.6 t -39.07 111.72 0.2 Allowed 'General case' 0 N--CA 1.495 1.801 0 CA-C-O 121.863 0.84 . . . . 0.0 110.516 -179.439 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 6.1 m -77.41 145.56 37.12 Favored 'General case' 0 N--CA 1.489 1.52 0 CA-C-O 121.531 0.682 . . . . 0.0 109.947 -179.542 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 97.9 mt -135.98 132.05 50.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.441 -0.787 . . . . 0.0 109.604 179.849 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 83.1 tt0 -129.15 131.34 47.17 Favored 'General case' 0 N--CA 1.497 1.913 0 CA-C-O 121.673 0.749 . . . . 0.0 109.376 179.375 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 38.2 ttmt -80.77 125.74 30.44 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.622 -0.674 . . . . 0.0 109.613 -179.757 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 10.9 mp -100.94 131.15 46.95 Favored 'General case' 0 N--CA 1.496 1.836 0 CA-C-O 121.907 0.86 . . . . 0.0 110.079 -179.733 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 38.1 t -79.8 -3.6 48.43 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 108.566 -0.902 . . . . 0.0 108.566 179.179 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 60.3 mt-10 -102.41 106.09 47.01 Favored Pre-proline 0 N--CA 1.496 1.841 0 O-C-N 121.299 -0.875 . . . . 0.0 109.325 -179.767 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -76.17 154.4 37.05 Favored 'Trans proline' 0 C--N 1.316 -1.184 0 C-N-CA 122.202 1.934 . . . . 0.0 111.879 -179.44 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 90.6 mt -101.73 127.04 55.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.311 -0.868 . . . . 0.0 109.3 -179.846 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -88.71 121.75 31.42 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.602 -0.687 . . . . 0.0 109.529 -179.71 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 47.6 t -109.53 -13.57 10.69 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 179.62 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 107.88 78.82 1.13 Allowed Glycine 0 N--CA 1.501 2.972 0 N-CA-C 109.83 -1.308 . . . . 0.0 109.83 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 87.1 mt -89.15 -4.46 58.27 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.289 -1.124 . . . . 0.0 108.644 179.544 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . 0.422 ' OE1' ' O ' ' A' ' 104' ' ' HIS . 10.3 tm-20 -156.04 -70.21 0.11 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.32 -0.863 . . . . 0.0 109.216 179.443 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . 0.538 ' CD2' ' H ' ' A' ' 105' ' ' HIS . 85.5 t60 44.76 -108.81 0.15 Allowed 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.505 -0.747 . . . . 0.0 110.16 179.849 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . 0.538 ' H ' ' CD2' ' A' ' 104' ' ' HIS . 97.9 m-70 -150.9 146.13 26.1 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.16 -0.963 . . . . 0.0 109.4 -179.778 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 18.5 p80 -155.74 149.72 25.44 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.457 -0.777 . . . . 0.0 109.727 -179.859 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 97.9 m-70 -114.65 124.74 52.58 Favored 'General case' 0 N--CA 1.498 1.943 0 CA-C-O 121.518 0.675 . . . . 0.0 109.457 -179.892 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 86.2 t60 -95.38 129.33 42.57 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.423 -0.798 . . . . 0.0 109.89 -179.827 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . 0.465 ' ND1' ' OXT' ' A' ' 109' ' ' HIS . 11.3 p80 . . . . . 0 N--CA 1.488 1.462 0 CA-C-O 118.096 -0.954 . . . . 0.0 109.034 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 3' ' ' PRO . . . . . 0.4 ' HB2' HD22 ' A' ' 19' ' ' ASN . 60.0 Cg_endo . . . . . 0 N--CA 1.498 1.774 0 CA-C-O 121.534 0.556 . . . . 0.0 112.811 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 7.4 pt20 -79.6 89.05 5.1 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.272 -0.893 . . . . 0.0 109.505 -179.72 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 78.9 mt -75.03 143.57 43.46 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.499 -0.751 . . . . 0.0 109.768 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 98.9 m -131.24 136.36 48.15 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.622 -0.674 . . . . 0.0 109.939 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -78.43 153.51 31.43 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.567 -0.708 . . . . 0.0 109.926 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 96.1 mt -62.26 -43.09 97.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.388 -0.82 . . . . 0.0 109.42 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 11.8 p -62.71 -28.26 44.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.244 -0.91 . . . . 0.0 109.256 -179.666 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 55.1 t0 -67.59 -33.09 74.3 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.346 -0.846 . . . . 0.0 109.699 179.502 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 97.0 mt -68.8 120.55 16.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.29 -0.881 . . . . 0.0 110.182 -178.88 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 31.4 m -148.57 9.51 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 179.401 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 82.9 tt0 -134.45 139.61 45.64 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.418 -0.802 . . . . 0.0 109.586 179.611 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.505 ' ND2' ' OE2' ' A' ' 76' ' ' GLU . 31.0 p30 -82.5 151.66 26.39 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.587 -0.696 . . . . 0.0 110.56 -179.516 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 78.76 4.65 88.21 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 108.897 -1.681 . . . . 0.0 108.897 -179.737 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 44.1 tt0 -72.43 129.12 37.61 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.403 -1.057 . . . . 0.0 109.729 -179.627 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' TRP . . . . . 0.416 ' O ' ' HB2' ' A' ' 18' ' ' ALA . 85.2 m95 -99.99 137.52 38.33 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.618 -0.676 . . . . 0.0 109.942 -179.625 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.416 ' HB2' ' O ' ' A' ' 17' ' ' TRP . . . 178.37 178.34 0.4 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.527 -0.733 . . . . 0.0 109.238 179.265 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.4 HD22 ' HB2' ' A' ' 3' ' ' PRO . 61.3 m-20 -102.43 145.32 29.71 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 -179.906 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 51.9 tp -139.38 134.93 33.13 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.41 -0.806 . . . . 0.0 110.195 -179.538 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 34.0 ttpt -113.94 137.51 51.58 Favored 'General case' 0 N--CA 1.498 1.929 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 178.944 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -159.88 170.84 20.56 Favored 'General case' 0 N--CA 1.493 1.693 0 C-N-CA 119.064 -1.054 . . . . 0.0 110.55 -179.71 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 51.8 tttp -105.11 144.52 31.8 Favored 'General case' 0 N--CA 1.494 1.775 0 CA-C-O 121.345 0.593 . . . . 0.0 109.758 -179.784 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 62.5 t -83.31 120.02 33.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.324 -0.86 . . . . 0.0 109.971 -179.388 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 96.4 mt -96.89 -66.55 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.645 -0.659 . . . . 0.0 109.229 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 66.3 mt-30 -146.05 142.92 29.04 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.353 -0.842 . . . . 0.0 109.984 -179.893 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.433 ' N ' HD23 ' A' ' 27' ' ' LEU . 0.1 OUTLIER -125.26 136.69 53.78 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 -179.781 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 92.1 m95 -111.53 133.0 54.11 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 179.576 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 . . . . . 0 N--CA 1.492 1.627 0 O-C-N 121.539 -0.726 . . . . 0.0 110.268 -179.266 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 34' ' ' SER . . . . . 0.513 ' OG ' ' N ' ' A' ' 35' ' ' ILE . 56.1 p . . . . . 0 N--CA 1.49 1.558 0 CA-C-O 121.506 0.669 . . . . 0.0 109.886 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.513 ' N ' ' OG ' ' A' ' 34' ' ' SER . 96.9 mt -74.14 135.3 27.77 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 O-C-N 121.464 -0.773 . . . . 0.0 110.082 -179.281 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 17.8 t -92.16 -62.34 1.43 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.624 -0.672 . . . . 0.0 109.601 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 85.5 mt-30 -136.85 155.53 49.66 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.405 -0.809 . . . . 0.0 109.97 -179.343 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 8.7 p -142.92 141.9 26.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 179.8 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -168.63 -160.0 15.55 Favored Glycine 0 N--CA 1.489 2.212 0 C-N-CA 119.202 -1.475 . . . . 0.0 110.384 -179.669 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -133.22 147.98 52.0 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.747 -0.855 . . . . 0.0 109.423 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 41.4 mt -117.25 133.33 56.12 Favored 'General case' 0 N--CA 1.499 1.983 0 CA-C-O 121.529 0.68 . . . . 0.0 109.92 -179.018 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -78.98 162.9 48.95 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 110.124 -1.19 . . . . 0.0 110.124 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.451 ' OD1' ' N ' ' A' ' 44' ' ' GLU . 55.1 t0 -173.83 153.43 2.18 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.586 -0.95 . . . . 0.0 109.36 179.553 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.451 ' N ' ' OD1' ' A' ' 43' ' ' ASP . 82.2 tt0 -63.03 -18.58 63.49 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.47 -0.768 . . . . 0.0 109.515 -179.877 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 72.4 p -92.2 -7.95 46.85 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.205 -0.935 . . . . 0.0 109.282 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 135.3 -150.67 20.29 Favored Glycine 0 N--CA 1.497 2.753 0 N-CA-C 109.998 -1.241 . . . . 0.0 109.998 179.268 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 96.7 mt -123.03 139.64 49.19 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 O-C-N 121.679 -0.895 . . . . 0.0 109.765 -179.423 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 9.3 tp -129.03 139.64 51.36 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 CA-C-O 121.662 0.744 . . . . 0.0 109.533 179.569 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 32.5 mtmm -85.52 148.41 25.97 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.665 -0.647 . . . . 0.0 109.871 -179.896 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 7.1 p90 -143.27 152.16 41.37 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.381 -0.825 . . . . 0.0 109.919 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.432 ' CG2' HG23 ' A' ' 35' ' ' ILE . 47.2 m -131.09 133.9 46.09 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 179.787 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 32.0 mm -97.08 124.22 49.82 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 O-C-N 121.203 -0.935 . . . . 0.0 110.184 -179.258 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 96.0 m95 -88.68 139.14 30.78 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 121.529 -0.732 . . . . 0.0 109.214 179.566 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 98.9 mttt . . . . . 0 N--CA 1.489 1.481 0 O-C-N 121.346 -0.846 . . . . 0.0 109.663 -179.735 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 61.1 mt . . . . . 0 N--CA 1.494 1.751 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -53.59 149.23 32.21 Favored 'Trans proline' 0 N--CA 1.501 1.923 0 C-N-CA 122.286 1.99 . . . . 0.0 112.941 179.205 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 62.0 mt -68.12 144.03 55.19 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.456 -0.777 . . . . 0.0 110.37 -179.253 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.595 ' N ' HD12 ' A' ' 61' ' ' LEU . 10.1 mp -78.31 144.65 35.89 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.724 -0.61 . . . . 0.0 109.447 -179.682 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 80.2 tt0 -98.38 145.03 27.13 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.39 -0.819 . . . . 0.0 110.514 -179.085 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 57.9 tt0 -78.48 139.31 38.7 Favored 'General case' 0 N--CA 1.489 1.518 0 CA-C-O 121.479 0.657 . . . . 0.0 111.061 -179.295 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 84.93 10.63 78.4 Favored Glycine 0 N--CA 1.492 2.414 0 N-CA-C 110.187 -1.165 . . . . 0.0 110.187 178.795 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -124.74 144.65 50.12 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.385 -1.067 . . . . 0.0 110.602 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 8.1 p -87.04 152.41 22.39 Favored 'General case' 0 N--CA 1.487 1.405 0 CA-C-O 121.466 0.65 . . . . 0.0 109.987 179.769 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 70.4 m-85 -144.64 150.99 38.32 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.454 -0.779 . . . . 0.0 109.96 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 18.1 tp -108.55 124.6 50.71 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 179.184 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 69.8 mt -104.48 132.47 50.69 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 179.769 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 88.8 mtm180 -127.75 144.67 51.07 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.621 -0.674 . . . . 0.0 110.054 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.424 ' O ' ' OG ' ' A' ' 71' ' ' SER . 5.2 t 58.43 59.8 2.84 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 122.064 -0.397 . . . . 0.0 110.374 179.748 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 3.4 m -117.59 162.25 15.76 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.165 0 O-C-N 121.486 -0.759 . . . . 0.0 108.989 179.281 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 7.1 p -122.91 136.98 57.95 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 CA-C-O 121.606 0.717 . . . . 0.0 110.149 -178.914 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 90.4 t -80.84 128.61 38.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.468 -0.77 . . . . 0.0 109.975 -179.484 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -98.16 166.1 22.04 Favored Glycine 0 N--CA 1.494 2.526 0 N-CA-C 110.158 -1.177 . . . . 0.0 110.158 -179.774 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.505 ' OE2' ' ND2' ' A' ' 14' ' ' ASN . 96.7 mt-10 -90.68 124.99 35.53 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.803 -0.822 . . . . 0.0 109.378 179.896 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 79.4 t80 -134.45 108.56 8.2 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.494 -0.754 . . . . 0.0 109.744 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 87.8 m-20 41.15 -123.55 0.51 Allowed 'General case' 0 N--CA 1.493 1.712 0 CA-C-O 121.439 0.637 . . . . 0.0 111.031 179.57 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 96.9 m-20 -91.91 -5.81 52.54 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.442 -0.786 . . . . 0.0 110.116 -179.054 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 79.5 mtp85 -115.57 -172.62 2.18 Favored 'General case' 0 N--CA 1.502 2.161 0 O-C-N 121.443 -0.785 . . . . 0.0 109.945 -179.774 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 90.2 m-85 -130.45 156.72 44.3 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.598 -0.689 . . . . 0.0 109.842 -179.486 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 15.8 pt20 -140.12 165.09 28.3 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.575 -0.703 . . . . 0.0 109.315 179.64 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 33.8 m -104.67 132.43 51.37 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 O-C-N 121.387 -0.821 . . . . 0.0 109.117 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -102.91 128.66 49.61 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.537 -0.727 . . . . 0.0 109.864 -178.963 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 21.1 t -94.61 130.67 43.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.582 -0.699 . . . . 0.0 109.532 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 18.9 p30 -132.83 176.94 8.03 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 179.857 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 22.7 pttm -58.83 -36.05 73.92 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.358 -0.839 . . . . 0.0 109.84 -179.47 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 77.5 m-20 -62.45 -38.26 89.09 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.283 -0.886 . . . . 0.0 109.327 179.807 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 93.3 p -69.68 161.93 28.73 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.093 -1.004 . . . . 0.0 109.801 -179.241 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 72.1 m -130.6 152.17 50.25 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.607 -0.683 . . . . 0.0 109.681 -179.638 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 96.6 mt -127.12 131.96 70.24 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 75.4 mm-40 -129.14 137.52 51.24 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.53 -0.732 . . . . 0.0 109.475 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -78.89 129.78 34.92 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.505 -0.747 . . . . 0.0 109.328 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 52.4 mt -103.14 136.41 42.99 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.499 -0.751 . . . . 0.0 109.568 -179.496 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 74.3 m -81.52 -5.39 57.93 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 179.797 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -112.94 117.94 45.36 Favored Pre-proline 0 N--CA 1.497 1.921 0 O-C-N 121.676 -0.64 . . . . 0.0 109.356 -179.695 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -75.24 163.44 34.82 Favored 'Trans proline' 0 N--CA 1.491 1.375 0 C-N-CA 121.971 1.78 . . . . 0.0 111.971 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 19.2 mm . . . . . 0 N--CA 1.493 1.724 0 O-C-N 121.197 -0.939 . . . . 0.0 109.335 -179.695 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 3' ' ' PRO . . . . . 0.694 ' HB2' HD21 ' A' ' 19' ' ' ASN . 37.3 Cg_endo . . . . . 0 N--CA 1.491 1.372 0 CA-C-O 121.727 0.636 . . . . 0.0 112.277 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' GLN . . . . . 0.525 ' N ' ' OE1' ' A' ' 4' ' ' GLN . 1.0 OUTLIER -78.92 89.17 4.71 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.305 -0.872 . . . . 0.0 109.344 -179.728 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 80.3 mt -75.47 150.8 38.15 Favored 'General case' 0 N--CA 1.488 1.442 0 CA-C-O 121.754 0.787 . . . . 0.0 109.807 -179.783 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 4.9 t -144.55 156.67 44.26 Favored 'General case' 0 N--CA 1.487 1.404 0 CA-C-O 121.751 0.786 . . . . 0.0 109.539 179.876 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.58 159.14 15.1 Favored 'General case' 0 C--N 1.3 -1.579 0 CA-C-O 121.875 0.845 . . . . 0.0 110.352 -179.665 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 96.1 mt -62.96 -42.68 97.53 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 CA-C-O 121.539 0.685 . . . . 0.0 109.267 179.888 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 14.4 p -62.71 -28.36 44.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.377 -0.827 . . . . 0.0 109.259 179.876 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 -75.75 -17.93 59.72 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.23 -0.919 . . . . 0.0 109.123 179.66 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 96.1 mt -86.57 113.37 24.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.127 -0.983 . . . . 0.0 109.66 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 20.6 m -153.94 17.24 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 179.75 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -127.08 137.51 53.04 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.536 -0.728 . . . . 0.0 109.881 -179.63 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 82.2 m-20 -77.95 138.71 39.0 Favored 'General case' 0 N--CA 1.485 1.306 0 CA-C-O 121.804 0.811 . . . . 0.0 110.92 -179.223 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 79.39 11.04 85.34 Favored Glycine 0 N--CA 1.492 2.425 0 N-CA-C 109.995 -1.242 . . . . 0.0 109.995 179.398 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 44.6 tt0 -70.68 130.68 42.41 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.037 -1.273 . . . . 0.0 109.994 -179.653 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 86.6 m95 -104.76 131.14 52.57 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.725 -0.609 . . . . 0.0 109.677 -179.533 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -178.71 177.13 0.91 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.486 -0.759 . . . . 0.0 109.851 179.586 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.694 HD21 ' HB2' ' A' ' 3' ' ' PRO . 21.4 m-20 -105.06 145.18 30.85 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.626 -0.672 . . . . 0.0 109.568 -179.79 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 5.2 tt -141.89 134.74 28.68 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.293 -0.879 . . . . 0.0 110.263 179.743 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 19.4 ttpp -112.47 138.44 49.22 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 179.52 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -161.01 179.9 8.07 Favored 'General case' 0 N--CA 1.492 1.644 0 C-N-CA 119.364 -0.934 . . . . 0.0 110.116 -179.54 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 89.0 tttt -115.35 139.46 49.98 Favored 'General case' 0 N--CA 1.495 1.79 0 CA-C-O 121.717 0.77 . . . . 0.0 110.221 -179.453 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.429 HG22 ' CD2' ' A' ' 41' ' ' LEU . 75.8 t -78.24 129.2 37.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 CA-C-O 121.688 0.756 . . . . 0.0 110.534 -179.275 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.439 HD11 ' HA3' ' A' ' 42' ' ' GLY . 96.7 mt -102.32 -53.84 7.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 178.971 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 67.0 tp60 -147.14 148.86 32.0 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.249 -0.907 . . . . 0.0 109.668 -179.871 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.841 HD23 ' H ' ' A' ' 27' ' ' LEU . 1.2 pt? -141.44 135.62 30.49 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 179.529 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 3.6 m-90 -121.08 114.03 20.88 Favored 'General case' 0 N--CA 1.496 1.872 0 CA-C-O 121.545 0.688 . . . . 0.0 109.457 -179.569 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 17.3 pt-20 . . . . . 0 N--CA 1.49 1.555 0 O-C-N 121.584 -0.697 . . . . 0.0 109.789 179.917 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 71.2 p . . . . . 0 N--CA 1.498 1.945 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 83.7 mt -106.56 127.04 62.29 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 O-C-N 121.3 -0.875 . . . . 0.0 110.07 -179.817 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 44.8 m -73.15 -74.91 0.16 Allowed 'General case' 0 N--CA 1.49 1.554 0 CA-C-O 121.726 0.774 . . . . 0.0 109.797 179.876 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 15.3 pt20 -146.62 162.12 39.09 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.341 -0.849 . . . . 0.0 109.656 -179.357 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 34.0 m -132.05 158.65 43.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 CA-C-O 121.659 0.742 . . . . 0.0 109.708 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -178.72 -160.8 25.39 Favored Glycine 0 N--CA 1.486 2.03 0 N-CA-C 109.764 -1.334 . . . . 0.0 109.764 -179.557 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.884 HD23 ' H ' ' A' ' 40' ' ' LEU . 1.3 pt? -139.96 148.24 41.64 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.572 -0.958 . . . . 0.0 110.35 -179.728 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.429 ' CD2' HG22 ' A' ' 24' ' ' VAL . 40.3 mt -109.59 134.07 52.36 Favored 'General case' 0 N--CA 1.491 1.581 0 CA-C-O 121.541 0.686 . . . . 0.0 109.379 -179.46 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.439 ' HA3' HD11 ' A' ' 25' ' ' ILE . . . -82.85 162.59 41.16 Favored Glycine 0 N--CA 1.488 2.132 0 N-CA-C 110.228 -1.149 . . . . 0.0 110.228 -179.868 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.547 ' OD1' ' N ' ' A' ' 44' ' ' GLU . 67.5 t0 -172.98 143.56 1.18 Allowed 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.761 -0.846 . . . . 0.0 109.342 179.688 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.547 ' N ' ' OD1' ' A' ' 43' ' ' ASP . 96.7 mt-10 -54.76 -14.94 1.57 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.603 -0.686 . . . . 0.0 109.639 179.865 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 44.3 p -94.15 -11.0 31.36 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.129 -0.982 . . . . 0.0 109.566 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 140.32 -155.77 24.79 Favored Glycine 0 N--CA 1.497 2.709 0 N-CA-C 110.309 -1.116 . . . . 0.0 110.309 179.423 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 41.9 pt -126.68 150.8 32.73 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 O-C-N 121.707 -0.878 . . . . 0.0 109.892 -179.364 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 19.0 tt -143.94 141.83 24.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.555 -0.715 . . . . 0.0 109.625 179.319 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -85.31 155.83 21.18 Favored 'General case' 0 N--CA 1.491 1.592 0 CA-C-O 121.435 0.636 . . . . 0.0 110.362 -179.603 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 38.5 p90 -144.47 151.65 39.49 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.251 -0.906 . . . . 0.0 109.775 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 54.1 m -133.35 127.13 32.83 Favored 'General case' 0 N--CA 1.492 1.639 0 CA-C-O 121.546 0.688 . . . . 0.0 109.459 179.263 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 97.0 mt -95.1 124.39 47.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.54 -0.725 . . . . 0.0 109.81 179.906 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 90.2 m95 -82.67 105.99 14.16 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.422 -0.799 . . . . 0.0 109.065 179.334 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 73.8 tttt . . . . . 0 N--CA 1.491 1.605 0 CA-C-O 121.594 0.711 . . . . 0.0 109.723 -179.52 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 15.0 mt . . . . . 0 N--CA 1.491 1.598 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -66.19 151.8 82.69 Favored 'Trans proline' 0 C--N 1.31 -1.455 0 C-N-CA 122.5 2.133 . . . . 0.0 112.432 179.567 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 82.0 mt -68.84 137.51 53.98 Favored 'General case' 0 N--CA 1.488 1.444 0 CA-C-O 121.862 0.839 . . . . 0.0 110.514 -179.301 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.535 ' N ' HD12 ' A' ' 61' ' ' LEU . 10.3 mp -78.98 143.0 36.15 Favored 'General case' 0 N--CA 1.49 1.569 0 CA-C-O 121.656 0.741 . . . . 0.0 109.853 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 81.7 tt0 -85.78 138.69 31.9 Favored 'General case' 0 N--CA 1.49 1.546 0 CA-C-O 121.857 0.837 . . . . 0.0 110.182 -179.586 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 57.2 tt0 -74.61 136.78 41.99 Favored 'General case' 0 N--CA 1.489 1.489 0 CA-C-O 121.819 0.819 . . . . 0.0 111.329 -179.375 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 84.17 20.95 58.12 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 110.051 -1.219 . . . . 0.0 110.051 178.966 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -128.49 145.56 51.07 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.401 -1.058 . . . . 0.0 110.156 -179.871 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 11.5 m -83.22 144.8 29.53 Favored 'General case' 0 N--CA 1.488 1.439 0 CA-C-O 121.653 0.74 . . . . 0.0 110.192 -179.642 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 79.9 m-85 -138.24 149.18 45.5 Favored 'General case' 0 N--CA 1.491 1.597 0 CA-C-O 121.918 0.866 . . . . 0.0 109.908 179.757 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 35.0 tp -106.77 122.65 46.8 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 179.284 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 65.8 mt -101.11 130.24 47.13 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 179.836 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.436 ' CZ ' ' OE2' ' A' ' 92' ' ' GLU . 80.7 mtm180 -125.65 142.61 51.42 Favored 'General case' 0 N--CA 1.497 1.878 0 CA-C-O 121.865 0.841 . . . . 0.0 110.699 -178.848 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 34.3 t 50.98 59.19 4.8 Favored 'General case' 0 N--CA 1.491 1.617 0 CA-C-N 115.683 -0.689 . . . . 0.0 111.032 179.118 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 6.4 m -111.49 160.68 10.64 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.989 0 O-C-N 121.406 -0.809 . . . . 0.0 109.633 178.883 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 7.4 p -118.41 134.24 62.65 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 CA-C-O 121.722 0.772 . . . . 0.0 109.604 -179.463 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 9.8 t -86.51 113.72 24.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 CA-C-O 121.824 0.821 . . . . 0.0 109.753 -179.499 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -90.65 143.87 17.02 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 110.112 -1.195 . . . . 0.0 110.112 -179.641 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -63.08 132.08 50.71 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.694 -0.886 . . . . 0.0 110.305 -179.816 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' TYR . . . . . 0.632 ' CD2' ' ND2' ' A' ' 78' ' ' ASN . 34.9 t80 -137.43 96.74 3.31 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.375 -0.828 . . . . 0.0 108.965 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' ASN . . . . . 0.632 ' ND2' ' CD2' ' A' ' 77' ' ' TYR . 21.1 p30 43.41 -141.93 0.15 Allowed 'General case' 0 N--CA 1.494 1.758 0 CA-C-O 121.631 0.729 . . . . 0.0 110.897 -179.897 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.515 ' N ' ' OD1' ' A' ' 78' ' ' ASN . 46.9 t0 -73.05 -2.49 21.46 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.43 -0.793 . . . . 0.0 109.098 -179.633 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.492 ' N ' ' OD1' ' A' ' 78' ' ' ASN . 29.9 mmt180 -115.53 -171.98 2.07 Favored 'General case' 0 N--CA 1.495 1.805 0 CA-C-O 122.047 0.927 . . . . 0.0 110.228 -179.286 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -127.83 155.72 43.67 Favored 'General case' 0 N--CA 1.492 1.652 0 CA-C-O 121.558 0.694 . . . . 0.0 109.873 -179.207 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 52.1 tt0 -139.59 151.84 46.36 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.544 -0.722 . . . . 0.0 109.741 -179.599 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 3.8 m -108.98 132.23 57.6 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 179.235 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 87.9 mt-30 -105.93 127.08 52.9 Favored 'General case' 0 N--CA 1.495 1.795 0 CA-C-O 121.784 0.802 . . . . 0.0 110.178 -178.946 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.59 HG11 HD11 ' A' ' 91' ' ' ILE . 21.3 t -95.74 132.89 38.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 179.277 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 15.8 p30 -139.14 -178.14 5.22 Favored 'General case' 0 N--CA 1.492 1.668 0 CA-C-O 121.884 0.849 . . . . 0.0 110.362 -179.207 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 63.7 tttp -56.91 -40.25 75.97 Favored 'General case' 0 N--CA 1.492 1.647 0 CA-C-O 121.474 0.654 . . . . 0.0 110.064 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 23.2 t-20 -60.33 -37.94 82.18 Favored 'General case' 0 C--N 1.296 -1.725 0 O-C-N 121.306 -0.871 . . . . 0.0 109.89 -179.85 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 15.5 p -75.43 162.28 28.49 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.02 -1.05 . . . . 0.0 110.847 -179.133 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 67.4 m -131.62 149.83 52.36 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 179.701 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.59 HD11 HG11 ' A' ' 85' ' ' VAL . 97.0 mt -128.14 132.21 68.65 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 O-C-N 121.599 -0.688 . . . . 0.0 109.69 -179.664 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.436 ' OE2' ' CZ ' ' A' ' 70' ' ' ARG . 86.0 mt-10 -124.99 131.8 53.36 Favored 'General case' 0 N--CA 1.5 2.069 0 CA-C-O 121.488 0.661 . . . . 0.0 109.513 -179.558 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 37.2 ttpt -82.36 118.38 23.13 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.424 -0.797 . . . . 0.0 109.653 -179.807 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.495 ' C ' ' H ' ' A' ' 96' ' ' GLU . 59.6 mt -111.63 130.66 55.69 Favored 'General case' 0 N--CA 1.495 1.812 0 CA-C-O 121.464 0.65 . . . . 0.0 109.459 -179.72 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 42.2 m -77.27 29.63 0.14 Allowed 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 179.358 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.495 ' H ' ' C ' ' A' ' 94' ' ' LEU . 72.5 tt0 -111.43 92.74 17.03 Favored Pre-proline 0 N--CA 1.493 1.72 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 -179.752 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -75.21 151.22 38.36 Favored 'Trans proline' 0 N--CA 1.491 1.358 0 C-N-CA 122.221 1.947 . . . . 0.0 112.219 -179.077 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 84.5 mt . . . . . 0 N--CA 1.493 1.699 0 CA-C-O 121.745 0.783 . . . . 0.0 109.511 -179.674 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo . . . . . 0 N--CA 1.495 1.588 0 CA-C-O 121.539 0.558 . . . . 0.0 112.555 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 84.9 mt-30 -76.41 91.89 3.34 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.152 -0.968 . . . . 0.0 108.723 179.45 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 82.6 mt -85.27 131.87 34.35 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.531 -0.731 . . . . 0.0 109.619 -179.071 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 99.9 m -123.64 131.01 53.51 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 179.841 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 71.5 mmtt -80.58 156.64 26.34 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-O 121.683 0.754 . . . . 0.0 110.362 -178.62 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 97.3 mt -62.89 -43.31 98.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.484 -0.76 . . . . 0.0 109.279 -179.798 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 14.5 p -66.28 -23.51 31.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.338 -0.851 . . . . 0.0 109.606 -179.743 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -78.49 -5.03 51.43 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.251 -0.905 . . . . 0.0 109.899 -179.778 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 96.7 mt -80.94 121.85 35.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 120.939 -1.101 . . . . 0.0 110.081 -179.579 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 31.2 m -146.55 10.25 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 179.172 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 48.2 tp10 -136.11 132.96 36.77 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.341 -0.849 . . . . 0.0 109.745 -179.782 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 81.7 m-20 -82.38 142.04 32.31 Favored 'General case' 0 C--N 1.306 -1.311 0 O-C-N 121.347 -0.846 . . . . 0.0 110.431 -179.828 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 75.68 98.93 0.13 Allowed Glycine 0 N--CA 1.49 2.258 0 N-CA-C 110.032 -1.227 . . . . 0.0 110.032 179.232 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 14.1 pt20 -173.45 141.29 0.88 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.159 -1.201 . . . . 0.0 109.702 179.282 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 71.0 m95 -94.0 137.06 33.63 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.615 -0.678 . . . . 0.0 109.781 -179.549 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -175.58 177.68 1.72 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.139 -0.976 . . . . 0.0 109.639 179.745 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 81.4 m-20 -106.59 147.49 29.4 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.602 -0.686 . . . . 0.0 109.639 -179.703 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 40.2 tp -140.79 133.29 28.51 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.342 -0.849 . . . . 0.0 109.892 179.717 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 35.7 ttpt -117.29 137.78 52.18 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 178.9 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -161.81 174.91 12.52 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.869 -1.145 . . . . 0.0 110.194 -179.582 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 65.1 tttm -110.32 133.29 53.4 Favored 'General case' 0 N--CA 1.495 1.818 0 CA-C-O 121.517 0.675 . . . . 0.0 109.848 -179.753 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.482 HG22 ' CD2' ' A' ' 41' ' ' LEU . 67.1 t -77.77 126.94 38.5 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 O-C-N 121.369 -0.832 . . . . 0.0 109.745 -179.904 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 23.2 pt -108.8 -34.0 2.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 179.368 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 6.6 tt0 -163.73 133.79 4.24 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.115 -0.991 . . . . 0.0 109.647 178.872 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.506 HD12 ' O ' ' A' ' 27' ' ' LEU . 0.3 OUTLIER -131.46 136.64 48.12 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 -179.83 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 5.2 m0 -113.96 124.61 52.59 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.472 -0.768 . . . . 0.0 109.493 -179.595 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 2.9 pp20? . . . . . 0 N--CA 1.488 1.46 0 O-C-N 121.544 -0.722 . . . . 0.0 109.36 -179.921 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 5.1 p . . . . . 0 N--CA 1.499 1.988 0 N-CA-C 109.384 -0.599 . . . . 0.0 109.384 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 96.2 mt -109.9 118.06 56.06 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 CA-C-O 121.617 0.722 . . . . 0.0 109.83 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 44.1 t -77.79 -49.0 15.23 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.604 -0.685 . . . . 0.0 109.51 179.674 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 33.6 tt0 -147.34 153.48 39.75 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.222 -0.924 . . . . 0.0 110.016 -179.708 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 9.1 p -142.95 143.27 25.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.573 -0.704 . . . . 0.0 109.259 179.156 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -173.99 -154.27 10.61 Favored Glycine 0 N--CA 1.485 1.95 0 C-N-CA 119.534 -1.317 . . . . 0.0 109.941 -179.645 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.617 HD12 ' H ' ' A' ' 40' ' ' LEU . 0.1 OUTLIER -136.8 151.3 49.01 Favored 'General case' 0 N--CA 1.501 2.082 0 O-C-N 121.555 -0.968 . . . . 0.0 109.494 -179.019 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.482 ' CD2' HG22 ' A' ' 24' ' ' VAL . 66.3 mt -115.08 126.44 54.69 Favored 'General case' 0 N--CA 1.495 1.803 0 CA-C-O 121.597 0.713 . . . . 0.0 109.413 179.892 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -75.72 158.69 50.35 Favored Glycine 0 N--CA 1.488 2.157 0 N-CA-C 110.807 -0.917 . . . . 0.0 110.807 -179.443 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -170.97 151.65 3.35 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.519 -0.989 . . . . 0.0 109.07 179.253 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 17.6 pt-20 -59.41 -15.12 14.97 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.27 -0.894 . . . . 0.0 109.546 179.921 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 39.2 p -92.6 -13.14 30.04 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.093 -1.004 . . . . 0.0 109.279 -179.453 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 140.79 -151.47 22.44 Favored Glycine 0 N--CA 1.496 2.635 0 N-CA-C 109.987 -1.245 . . . . 0.0 109.987 179.353 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 96.7 mt -126.25 138.87 53.27 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 O-C-N 121.729 -0.865 . . . . 0.0 109.234 -179.815 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.556 HD11 ' O ' ' A' ' 81' ' ' PHE . 9.6 tp -128.28 143.59 40.49 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 CA-C-O 121.789 0.804 . . . . 0.0 110.152 -179.727 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 19.1 mmmt -84.01 147.89 27.18 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.688 -0.633 . . . . 0.0 109.874 180.0 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 21.1 p90 -144.14 159.95 41.76 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.244 -0.91 . . . . 0.0 109.298 179.843 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 1.6 t -145.33 141.44 28.53 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.401 -0.812 . . . . 0.0 109.829 179.611 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 98.4 mt -107.43 118.7 55.67 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 O-C-N 121.573 -0.704 . . . . 0.0 109.316 179.596 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 59.3 m95 -86.34 139.42 30.99 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.158 -0.964 . . . . 0.0 110.139 -179.212 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 68.1 mttm . . . . . 0 N--CA 1.491 1.598 0 O-C-N 121.408 -0.807 . . . . 0.0 109.875 179.848 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 51.1 mt . . . . . 0 N--CA 1.496 1.84 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -68.26 162.05 42.03 Favored 'Trans proline' 0 N--CA 1.498 1.758 0 C-N-CA 122.707 2.271 . . . . 0.0 112.811 179.632 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 67.6 mt -64.77 149.79 48.62 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.317 -0.864 . . . . 0.0 110.682 -178.948 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.558 ' N ' HD12 ' A' ' 61' ' ' LEU . 10.7 mp -88.22 138.42 31.46 Favored 'General case' 0 N--CA 1.492 1.666 0 CA-C-O 121.572 0.701 . . . . 0.0 110.188 -179.239 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.467 ' N ' ' OH ' ' A' ' 67' ' ' TYR . 52.9 tp10 -66.43 137.01 56.55 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.407 -0.808 . . . . 0.0 110.054 -179.57 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 17.1 tt0 -73.18 135.66 44.65 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.564 -0.71 . . . . 0.0 110.68 -179.255 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 83.84 29.82 30.87 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 110.037 -1.225 . . . . 0.0 110.037 179.047 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -136.41 146.54 46.53 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.168 -1.195 . . . . 0.0 110.426 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 11.8 p -79.01 152.09 31.16 Favored 'General case' 0 N--CA 1.487 1.4 0 CA-C-O 121.542 0.686 . . . . 0.0 110.141 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.467 ' OH ' ' N ' ' A' ' 62' ' ' GLU . 89.9 m-85 -144.47 147.59 33.48 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.412 -0.805 . . . . 0.0 109.662 179.698 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 15.7 tp -111.36 120.93 43.86 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 179.548 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 60.7 mt -97.32 134.85 40.05 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.534 -0.729 . . . . 0.0 109.313 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 79.1 mtp85 -128.19 138.96 52.7 Favored 'General case' 0 N--CA 1.497 1.897 0 CA-C-O 121.507 0.67 . . . . 0.0 110.388 -179.83 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 18.4 m 57.12 61.14 2.67 Favored 'General case' 0 N--CA 1.493 1.718 0 CA-C-O 121.005 0.431 . . . . 0.0 110.534 179.47 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 15.5 m -116.03 159.73 15.81 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.993 0 O-C-N 121.49 -0.756 . . . . 0.0 109.441 178.822 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 14.2 p -114.85 134.66 57.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 CA-C-O 121.474 0.654 . . . . 0.0 109.498 -179.361 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 11.7 t -88.29 113.56 25.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.298 -0.876 . . . . 0.0 109.744 -179.294 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -98.57 172.76 26.48 Favored Glycine 0 N--CA 1.493 2.484 0 N-CA-C 109.914 -1.275 . . . . 0.0 109.914 -179.797 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 81.3 tt0 -112.85 122.77 48.62 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.742 -0.858 . . . . 0.0 109.253 179.661 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 75.7 t80 -135.7 126.59 27.6 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.522 -0.736 . . . . 0.0 109.756 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 9.3 t-20 57.11 44.09 23.09 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.574 -0.704 . . . . 0.0 109.924 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 55.03 28.83 11.34 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.549 -0.72 . . . . 0.0 109.445 179.691 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 71.7 ttt180 -130.78 152.2 50.38 Favored 'General case' 0 N--CA 1.497 1.876 0 CA-C-O 121.516 0.674 . . . . 0.0 109.771 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' PHE . . . . . 0.556 ' O ' HD11 ' A' ' 48' ' ' ILE . 91.6 m-85 -84.66 142.64 29.76 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.433 -0.792 . . . . 0.0 109.733 -179.835 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -153.24 165.26 36.28 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.15 -0.969 . . . . 0.0 109.711 179.871 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 3.2 m -109.1 132.35 57.4 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.013 0 O-C-N 121.495 -0.753 . . . . 0.0 109.811 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 84.4 mt-30 -113.3 121.84 45.62 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 -179.777 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 27.8 t -91.18 129.5 41.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.298 -0.876 . . . . 0.0 109.9 -179.655 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 11.2 m-80 -140.88 -177.78 5.24 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.45 -0.781 . . . . 0.0 109.258 179.83 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.523 ' C ' ' H ' ' A' ' 89' ' ' SER . 63.0 pttt -44.3 164.79 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.575 -0.703 . . . . 0.0 111.02 -179.681 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 5.3 t30 72.15 -29.84 0.2 Allowed 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 -179.852 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.523 ' H ' ' C ' ' A' ' 87' ' ' LYS . 7.2 m -69.65 150.79 46.64 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.403 -0.81 . . . . 0.0 110.196 -179.522 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 46.9 t -132.56 146.55 51.99 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 96.8 mt -126.14 132.53 70.42 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 O-C-N 121.584 -0.698 . . . . 0.0 109.293 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -125.87 130.3 51.07 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.594 -0.691 . . . . 0.0 109.493 179.649 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 64.5 tttm -79.1 131.21 36.17 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.455 -0.778 . . . . 0.0 109.679 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 85.8 mt -110.22 137.49 47.88 Favored 'General case' 0 N--CA 1.498 1.927 0 CA-C-O 121.792 0.806 . . . . 0.0 110.174 -179.872 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 93.8 p -85.62 13.49 6.94 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.646 -0.658 . . . . 0.0 109.43 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 86.4 mt-10 -117.4 90.7 35.44 Favored Pre-proline 0 N--CA 1.499 2.002 0 O-C-N 121.674 -0.641 . . . . 0.0 109.491 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_exo -56.15 150.01 50.79 Favored 'Trans proline' 0 N--CA 1.499 1.818 0 C-N-CA 122.946 2.431 . . . . 0.0 112.758 179.518 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.536 ' O ' HG22 ' A' ' 98' ' ' ILE . 48.1 mm . . . . . 0 N--CA 1.488 1.457 0 O-C-N 121.261 -0.899 . . . . 0.0 109.527 -179.533 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 3' ' ' PRO . . . . . 0.672 ' HB2' HD21 ' A' ' 19' ' ' ASN . 47.5 Cg_endo . . . . . 0 N--CA 1.496 1.644 0 CA-C-O 121.551 0.563 . . . . 0.0 112.435 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 18.3 mm100 -76.6 92.62 3.5 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.082 -1.011 . . . . 0.0 109.58 -179.711 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 72.7 mt -76.34 138.05 40.22 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.501 -0.749 . . . . 0.0 109.638 -179.91 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 54.1 m -130.09 131.94 45.94 Favored 'General case' 0 N--CA 1.495 1.808 0 CA-C-O 121.427 0.632 . . . . 0.0 109.478 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 65.0 mttp -85.52 157.37 20.44 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.366 -0.834 . . . . 0.0 110.119 -179.51 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 96.2 mt -62.71 -43.48 98.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.352 -0.843 . . . . 0.0 109.393 -179.711 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 12.2 p -66.29 -22.93 30.89 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.206 -0.934 . . . . 0.0 109.667 -179.673 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.408 ' OD1' ' O ' ' A' ' 10' ' ' ASP . 57.7 t0 -73.75 -4.03 32.06 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.2 -0.937 . . . . 0.0 109.388 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 96.6 mt -74.96 125.92 35.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.141 -0.974 . . . . 0.0 109.767 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 4.1 m -129.15 -31.06 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 N-CA-C 109.241 -0.652 . . . . 0.0 109.241 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 -135.08 145.26 47.76 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.379 -0.825 . . . . 0.0 110.296 -179.515 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 64.2 m-80 -78.83 154.88 29.49 Favored 'General case' 0 C--N 1.306 -1.312 0 CA-C-O 121.514 0.673 . . . . 0.0 110.517 -179.595 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 88.69 8.21 70.44 Favored Glycine 0 N--CA 1.492 2.402 0 N-CA-C 109.136 -1.585 . . . . 0.0 109.136 179.638 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 18.4 tt0 -77.29 132.85 38.85 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.371 -1.076 . . . . 0.0 109.992 -179.649 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 89.5 m95 -99.56 134.25 42.7 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.39 -0.819 . . . . 0.0 110.006 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -179.9 -175.1 0.3 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.493 -0.754 . . . . 0.0 109.198 179.463 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.672 HD21 ' HB2' ' A' ' 3' ' ' PRO . 68.8 m-20 -105.14 153.31 21.7 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.578 -0.701 . . . . 0.0 109.574 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 54.3 tp -139.58 137.85 35.72 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.536 -0.728 . . . . 0.0 109.303 179.492 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 35.9 ttpt -128.25 133.36 48.79 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.683 -0.635 . . . . 0.0 109.475 179.362 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -168.17 177.7 5.37 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.444 -0.785 . . . . 0.0 109.355 179.317 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.427 ' NZ ' ' O ' ' A' ' 98' ' ' ILE . 17.0 ptpt -107.21 146.28 31.6 Favored 'General case' 0 N--CA 1.496 1.861 0 CA-C-O 121.672 0.749 . . . . 0.0 110.179 -179.563 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.465 HG22 ' CD2' ' A' ' 41' ' ' LEU . 78.9 t -85.03 97.88 5.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.561 -0.712 . . . . 0.0 110.093 -179.282 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 37.2 mm -65.72 -44.8 93.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.484 -0.76 . . . . 0.0 109.089 179.703 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 68.1 tp60 -151.22 148.45 28.24 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.239 -0.913 . . . . 0.0 109.321 179.405 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.963 ' H ' HD23 ' A' ' 27' ' ' LEU . 1.3 pt? -128.5 145.22 51.18 Favored 'General case' 0 N--CA 1.494 1.754 0 CA-C-O 121.219 0.533 . . . . 0.0 109.976 -179.857 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 97.6 m95 -128.21 101.53 6.29 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 178.991 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.674 ' H ' ' CD ' ' A' ' 29' ' ' GLU . 1.6 pm0 . . . . . 0 N--CA 1.492 1.643 0 O-C-N 121.583 -0.698 . . . . 0.0 110.605 -178.82 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 20.8 t . . . . . 0 N--CA 1.495 1.824 0 CA-C-O 121.157 0.503 . . . . 0.0 110.435 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 31.7 mt -78.64 132.22 32.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.183 -0.948 . . . . 0.0 110.199 -178.264 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 8.7 t -98.91 -60.89 1.45 Allowed 'General case' 0 N--CA 1.494 1.727 0 CA-C-O 121.576 0.703 . . . . 0.0 109.283 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -150.36 150.3 31.24 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.257 -0.902 . . . . 0.0 109.565 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 28.7 m -135.57 160.15 39.87 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 O-C-N 121.5 -0.75 . . . . 0.0 109.762 179.724 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 178.6 -166.97 37.13 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -132.9 148.84 52.29 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.404 -1.056 . . . . 0.0 109.898 179.857 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.465 ' CD2' HG22 ' A' ' 24' ' ' VAL . 51.6 mt -111.73 130.72 55.7 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 -179.002 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -97.66 148.31 18.9 Favored Glycine 0 N--CA 1.493 2.493 0 N-CA-C 110.648 -0.981 . . . . 0.0 110.648 -179.362 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.434 ' OD1' ' O ' ' A' ' 46' ' ' GLY . 49.0 p30 -173.24 166.65 4.86 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.691 -0.888 . . . . 0.0 108.948 178.886 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 78.5 tt0 -61.56 -16.62 49.51 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.337 -0.852 . . . . 0.0 110.018 -179.347 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 82.7 p -85.48 0.25 52.89 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.952 -1.092 . . . . 0.0 109.212 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.434 ' O ' ' OD1' ' A' ' 43' ' ' ASP . . . 116.05 -147.94 18.9 Favored Glycine 0 N--CA 1.499 2.872 0 N-CA-C 110.241 -1.144 . . . . 0.0 110.241 178.987 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 96.9 mt -132.57 137.68 53.67 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 121.6 -0.941 . . . . 0.0 109.489 -179.419 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 19.7 tt -134.89 140.88 44.54 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 O-C-N 121.561 -0.712 . . . . 0.0 109.72 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 18.8 mtpp -83.46 155.02 23.63 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.491 -0.755 . . . . 0.0 109.669 -179.806 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 34.2 p90 -141.74 151.83 43.26 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.313 -0.867 . . . . 0.0 109.724 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 52.6 m -131.9 130.81 42.09 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 179.723 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 90.7 mt -102.62 124.05 56.35 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.381 -0.825 . . . . 0.0 110.253 -179.295 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 85.3 m95 -92.99 130.97 38.38 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.418 -0.801 . . . . 0.0 108.936 179.698 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 17.4 ptpt . . . . . 0 N--CA 1.49 1.528 0 O-C-N 121.23 -0.919 . . . . 0.0 109.632 -179.656 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 16.7 mt . . . . . 0 N--CA 1.491 1.616 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -71.46 155.49 59.7 Favored 'Trans proline' 0 N--CA 1.498 1.739 0 C-N-CA 122.656 2.238 . . . . 0.0 112.759 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 79.7 mt -76.43 141.56 41.35 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.398 -0.814 . . . . 0.0 109.95 -179.743 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.625 ' N ' HD12 ' A' ' 61' ' ' LEU . 10.0 mp -81.96 145.54 30.23 Favored 'General case' 0 N--CA 1.488 1.458 0 CA-C-O 121.491 0.662 . . . . 0.0 110.286 -179.169 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.545 ' OE1' ' N ' ' A' ' 62' ' ' GLU . 58.2 mp0 -93.14 144.95 24.78 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.404 -0.81 . . . . 0.0 109.922 -179.488 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 57.9 tt0 -76.55 142.25 40.88 Favored 'General case' 0 N--CA 1.489 1.515 0 CA-C-O 121.505 0.669 . . . . 0.0 111.205 -178.994 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 81.85 21.22 61.85 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 110.253 -1.139 . . . . 0.0 110.253 178.817 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -130.3 146.29 51.87 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.32 -1.106 . . . . 0.0 110.614 -179.68 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 11.6 p -80.37 151.81 29.22 Favored 'General case' 0 N--CA 1.488 1.473 0 CA-C-O 121.513 0.673 . . . . 0.0 110.002 -179.894 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -144.72 145.64 31.8 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.408 -0.808 . . . . 0.0 109.517 179.803 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 20.2 tp -110.24 122.51 47.81 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 179.398 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 69.6 mt -100.73 134.54 43.55 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 82.6 mtp180 -126.51 140.87 52.12 Favored 'General case' 0 N--CA 1.498 1.964 0 CA-C-O 121.729 0.776 . . . . 0.0 110.701 -179.268 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 38.3 t 53.58 71.57 0.49 Allowed 'General case' 0 N--CA 1.491 1.583 0 CA-C-O 121.095 0.474 . . . . 0.0 110.514 179.524 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 18.0 m -128.93 164.19 31.9 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.023 0 O-C-N 121.578 -0.701 . . . . 0.0 109.336 178.957 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 9.7 p -120.45 135.83 59.42 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 CA-C-O 121.416 0.627 . . . . 0.0 109.418 -179.599 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 11.6 t -85.61 115.47 27.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.391 -0.818 . . . . 0.0 110.071 -178.965 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -94.17 -178.66 38.73 Favored Glycine 0 N--CA 1.492 2.419 0 N-CA-C 109.312 -1.515 . . . . 0.0 109.312 179.772 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -112.0 133.35 54.23 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.663 -0.904 . . . . 0.0 109.629 -179.885 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 91.3 t80 -136.49 108.1 6.98 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.418 -0.801 . . . . 0.0 109.147 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' ASN . . . . . 0.504 ' CG ' ' H ' ' A' ' 79' ' ' ASP . 66.7 t30 51.48 -134.38 1.63 Allowed 'General case' 0 N--CA 1.493 1.698 0 CA-C-O 121.603 0.716 . . . . 0.0 110.823 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.504 ' H ' ' CG ' ' A' ' 78' ' ' ASN . 36.5 t70 -87.1 -7.24 58.24 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.344 -0.848 . . . . 0.0 109.201 -179.389 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 85.2 mtp180 -108.56 173.98 6.08 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.711 -0.618 . . . . 0.0 109.763 -179.543 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 72.7 m-85 -104.74 155.85 18.52 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.605 -0.684 . . . . 0.0 109.944 -179.388 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 20.1 tt0 -138.35 153.19 48.97 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 -179.662 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 3.3 m -116.05 131.94 67.06 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 179.551 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 87.8 mt-30 -101.42 135.28 43.17 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.504 -0.748 . . . . 0.0 110.178 -178.74 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 71.4 t -107.09 130.55 58.97 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 179.274 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 79.2 m-20 -124.83 -179.57 4.58 Favored 'General case' 0 N--CA 1.496 1.854 0 CA-C-O 121.507 0.67 . . . . 0.0 109.911 -179.327 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 64.0 tttp -58.94 -41.0 86.35 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.592 -0.692 . . . . 0.0 110.043 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' ASN . . . . . 0.411 ' OD1' ' O ' ' A' ' 88' ' ' ASN . 41.9 t-20 -60.5 -35.67 76.51 Favored 'General case' 0 C--N 1.299 -1.602 0 O-C-N 121.109 -0.995 . . . . 0.0 109.112 -179.915 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 30.9 t -70.0 152.76 44.05 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.28 -0.887 . . . . 0.0 110.089 -179.519 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 35.3 t -128.74 148.91 50.88 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.601 -0.687 . . . . 0.0 109.495 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 96.2 mt -123.66 132.8 70.76 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 O-C-N 121.713 -0.617 . . . . 0.0 109.381 -179.782 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 82.5 tt0 -126.08 131.2 52.17 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 179.392 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.42 ' C ' HD12 ' A' ' 94' ' ' LEU . 37.8 ttmt -79.81 131.37 35.88 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.487 -0.758 . . . . 0.0 109.923 -179.568 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.438 HD12 ' N ' ' A' ' 94' ' ' LEU . 9.9 mp -101.08 137.31 39.62 Favored 'General case' 0 N--CA 1.493 1.685 0 CA-C-O 121.615 0.721 . . . . 0.0 109.644 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 70.3 m -90.4 6.33 43.7 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.649 -0.657 . . . . 0.0 109.501 -179.772 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.471 ' CD ' ' N ' ' A' ' 96' ' ' GLU . 1.3 pm0 -116.34 91.67 33.81 Favored Pre-proline 0 N--CA 1.499 1.975 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_exo -53.94 149.24 35.09 Favored 'Trans proline' 0 N--CA 1.495 1.611 0 C-N-CA 122.372 2.048 . . . . 0.0 112.249 -179.811 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.427 ' O ' ' NZ ' ' A' ' 23' ' ' LYS . 96.7 mt . . . . . 0 N--CA 1.493 1.722 0 CA-C-O 121.673 0.749 . . . . 0.0 110.644 -178.453 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 3' ' ' PRO . . . . . 0.447 ' HB2' HD21 ' A' ' 19' ' ' ASN . 74.4 Cg_endo . . . . . 0 N--CA 1.496 1.635 0 CA-C-O 121.554 0.564 . . . . 0.0 112.715 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 58.9 tt0 -74.59 93.46 2.52 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.237 -0.915 . . . . 0.0 109.586 -179.775 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 86.6 mt -84.93 129.51 34.79 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.428 -0.795 . . . . 0.0 109.579 -179.694 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 98.7 m -127.76 131.21 49.67 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.621 -0.674 . . . . 0.0 110.042 -179.54 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -84.34 158.77 21.05 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.572 -0.705 . . . . 0.0 109.962 -179.79 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 97.3 mt -62.78 -43.7 98.95 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.289 -0.882 . . . . 0.0 109.553 -179.546 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 14.9 p -67.7 -21.94 27.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.188 -0.945 . . . . 0.0 109.404 -179.638 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -76.24 -4.15 40.35 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.373 -0.829 . . . . 0.0 109.184 179.634 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 96.7 mt -80.42 116.13 24.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.305 -0.872 . . . . 0.0 109.353 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 27.0 m -119.52 -19.92 5.15 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.875 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 179.878 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 22.1 pt-20 -139.34 141.62 37.65 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.42 -0.8 . . . . 0.0 109.955 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 23.3 p30 -86.15 167.0 15.32 Favored 'General case' 0 N--CA 1.491 1.59 0 CA-C-O 121.478 0.656 . . . . 0.0 110.378 -179.619 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 80.57 3.17 90.15 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.188 -1.565 . . . . 0.0 109.188 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 14.5 pt20 -84.58 145.68 27.92 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.321 -1.105 . . . . 0.0 110.106 -179.609 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' TRP . . . . . 0.439 ' CD1' ' N ' ' A' ' 17' ' ' TRP . 31.6 m95 -101.92 138.83 38.37 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.671 -0.643 . . . . 0.0 110.063 -179.593 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -178.9 -170.08 0.18 Allowed 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 179.358 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.447 HD21 ' HB2' ' A' ' 3' ' ' PRO . 39.0 m-20 -108.32 149.54 28.52 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.544 -0.723 . . . . 0.0 109.567 -179.85 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.615 HD13 ' N ' ' A' ' 21' ' ' LYS . 0.3 OUTLIER -137.7 121.24 17.24 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 179.469 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.615 ' N ' HD13 ' A' ' 20' ' ' LEU . 36.4 ttpt -110.48 139.75 45.4 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.666 -0.646 . . . . 0.0 109.771 179.577 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -167.78 -174.03 2.31 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.31 -0.868 . . . . 0.0 109.789 179.553 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 76.0 tttt -118.12 144.16 45.89 Favored 'General case' 0 N--CA 1.501 2.085 0 CA-C-O 121.545 0.688 . . . . 0.0 109.733 -179.663 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.419 HG12 ' OE1' ' A' ' 63' ' ' GLN . 4.7 t -78.77 120.88 30.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.429 -0.794 . . . . 0.0 111.059 -178.59 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 32.7 mm -94.57 -49.05 12.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 179.13 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 57.8 tt0 -153.92 149.68 27.55 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.406 -0.809 . . . . 0.0 109.482 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 95.0 mt -121.0 145.12 48.09 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.762 -0.586 . . . . 0.0 109.832 -179.872 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 2.1 t-105 -128.95 111.59 13.19 Favored 'General case' 0 N--CA 1.495 1.786 0 CA-C-O 121.55 0.691 . . . . 0.0 109.358 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 39.2 tp10 . . . . . 0 C--N 1.302 -1.498 0 O-C-N 121.494 -0.754 . . . . 0.0 109.776 -179.629 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.494 1.739 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 86.8 mt -108.99 128.91 64.48 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 O-C-N 121.477 -0.764 . . . . 0.0 109.605 -179.445 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 24.1 t -87.19 -68.46 0.75 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.616 -0.678 . . . . 0.0 109.901 -179.446 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 89.7 mt-30 -132.95 148.11 52.28 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.514 -0.742 . . . . 0.0 109.447 -179.374 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 44.6 t -128.99 134.46 64.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -158.7 -162.24 11.74 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -140.1 145.5 37.7 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.446 -1.032 . . . . 0.0 109.635 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 45.0 mt -115.04 133.07 56.35 Favored 'General case' 0 N--CA 1.496 1.829 0 CA-C-O 121.575 0.702 . . . . 0.0 109.583 -179.155 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -92.96 140.52 15.11 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 110.385 -1.086 . . . . 0.0 110.385 -179.588 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 39.7 t0 -148.41 159.12 44.34 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.52 -0.988 . . . . 0.0 108.682 179.343 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -66.6 -20.7 66.06 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.221 -0.925 . . . . 0.0 109.669 -179.854 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 58.4 p -79.66 -10.15 59.75 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.144 -0.973 . . . . 0.0 109.347 -179.856 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 139.21 -164.3 25.9 Favored Glycine 0 N--CA 1.496 2.677 0 N-CA-C 109.455 -1.458 . . . . 0.0 109.455 179.507 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 34.4 mm -114.58 132.05 64.87 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.0 0 O-C-N 121.631 -0.923 . . . . 0.0 108.81 -179.701 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 18.1 tt -133.5 141.41 44.44 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 O-C-N 121.577 -0.702 . . . . 0.0 110.003 -179.588 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -90.71 156.95 17.7 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.592 -0.692 . . . . 0.0 110.459 -179.349 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 8.6 p90 -146.08 160.51 41.8 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.241 -0.912 . . . . 0.0 109.622 179.501 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.435 HG23 ' HE1' ' A' ' 53' ' ' TRP . 1.6 t -141.25 141.41 34.0 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 179.335 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 87.5 mt -106.66 125.79 62.53 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 O-C-N 121.53 -0.731 . . . . 0.0 109.734 -179.581 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' TRP . . . . . 0.529 ' N ' ' CD1' ' A' ' 53' ' ' TRP . 13.5 m95 -99.98 147.59 25.42 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.528 -0.732 . . . . 0.0 109.733 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 54.0 mtmt . . . . . 0 N--CA 1.49 1.557 0 O-C-N 121.431 -0.793 . . . . 0.0 109.448 179.854 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 17.4 mt . . . . . 0 N--CA 1.497 1.892 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -54.97 149.25 43.58 Favored 'Trans proline' 0 N--CA 1.502 2.021 0 C-N-CA 122.292 1.995 . . . . 0.0 113.071 179.546 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 61.8 mt -65.72 140.07 58.42 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.432 -0.793 . . . . 0.0 110.33 -179.102 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.535 ' N ' HD12 ' A' ' 61' ' ' LEU . 10.8 mp -77.95 141.84 38.74 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.53 -0.731 . . . . 0.0 110.016 -179.551 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -90.19 150.86 21.81 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.468 -0.77 . . . . 0.0 109.974 -179.815 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' GLN . . . . . 0.419 ' OE1' HG12 ' A' ' 24' ' ' VAL . 2.9 mm100 -81.96 145.19 30.41 Favored 'General case' 0 N--CA 1.493 1.709 0 CA-C-O 122.018 0.914 . . . . 0.0 112.006 -178.17 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 70.0 31.33 69.63 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 110.576 -1.01 . . . . 0.0 110.576 178.074 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 91.7 mt-10 -136.08 147.68 47.96 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.303 -1.116 . . . . 0.0 110.218 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 10.6 m -80.68 149.68 29.68 Favored 'General case' 0 N--CA 1.487 1.419 0 CA-C-O 121.324 0.583 . . . . 0.0 109.62 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 30.3 m-85 -144.04 142.48 30.68 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.398 -0.814 . . . . 0.0 109.107 179.531 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 14.5 tp -108.57 120.93 43.88 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 179.237 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 76.3 mt -100.51 132.81 45.7 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.512 -0.742 . . . . 0.0 109.297 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.408 ' O ' ' CB ' ' A' ' 71' ' ' SER . 89.8 mtm180 -127.02 131.87 50.88 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.797 -0.564 . . . . 0.0 110.059 -179.956 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.408 ' CB ' ' O ' ' A' ' 70' ' ' ARG . 1.1 m 75.88 54.9 0.06 Allowed 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 179.677 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 15.8 m -117.13 161.34 15.96 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.173 0 O-C-N 121.607 -0.683 . . . . 0.0 109.465 179.236 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 14.1 p -120.47 140.59 44.08 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 CA-C-O 121.499 0.666 . . . . 0.0 109.514 -179.325 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 99.6 t -84.56 120.35 35.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.445 -0.784 . . . . 0.0 110.139 -178.973 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -97.3 174.42 29.73 Favored Glycine 0 N--CA 1.493 2.48 0 N-CA-C 109.714 -1.354 . . . . 0.0 109.714 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.547 ' N ' ' OE1' ' A' ' 76' ' ' GLU . 54.4 mp0 -112.72 119.48 38.22 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.766 -0.844 . . . . 0.0 109.027 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' TYR . . . . . 0.528 ' CE2' ' OD1' ' A' ' 78' ' ' ASN . 85.0 t80 -136.98 124.43 22.08 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.418 -0.801 . . . . 0.0 110.139 -179.846 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' ASN . . . . . 0.528 ' OD1' ' CE2' ' A' ' 77' ' ' TYR . 7.0 m120 55.53 38.37 30.13 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.76 -0.587 . . . . 0.0 109.901 179.356 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 25.7 t0 66.83 -4.08 0.83 Allowed 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.603 -0.686 . . . . 0.0 109.513 179.665 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.417 ' H ' ' C ' ' A' ' 78' ' ' ASN . 80.1 mtp85 -93.72 -177.26 4.31 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.303 -0.873 . . . . 0.0 109.459 179.773 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -114.86 137.17 52.28 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.571 -0.706 . . . . 0.0 109.605 -179.67 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 -143.25 159.63 41.98 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.385 -0.822 . . . . 0.0 109.645 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.402 HG23 ' O ' ' A' ' 83' ' ' VAL . 22.5 m -104.08 131.72 52.21 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 179.662 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -102.25 114.67 29.03 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.356 -0.84 . . . . 0.0 109.422 -179.289 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 12.1 t -88.56 103.67 14.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.458 -0.776 . . . . 0.0 109.277 -179.81 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 2.0 p30 -151.14 -179.76 7.6 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.383 -0.823 . . . . 0.0 109.586 179.773 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 49.2 tttm 67.43 -132.58 0.13 Allowed 'General case' 0 N--CA 1.495 1.807 0 CA-C-O 121.491 0.663 . . . . 0.0 110.822 179.436 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' ASN . . . . . 0.409 ' O ' ' C ' ' A' ' 89' ' ' SER . 97.4 m-20 -95.47 13.19 26.8 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.244 -0.91 . . . . 0.0 109.047 -179.198 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.409 ' C ' ' O ' ' A' ' 88' ' ' ASN . 97.7 p -40.94 110.18 0.15 Allowed 'General case' 0 N--CA 1.495 1.817 0 CA-C-O 121.589 0.709 . . . . 0.0 109.646 -179.514 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 12.1 m -80.52 151.02 29.41 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.577 -0.702 . . . . 0.0 109.728 -179.051 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 96.7 mt -132.36 132.07 60.53 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 121.52 -0.738 . . . . 0.0 109.501 179.748 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 52.5 tp10 -128.28 134.61 48.97 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 179.697 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.426 ' C ' HD22 ' A' ' 94' ' ' LEU . 38.7 ttpt -85.02 131.05 34.52 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.569 -0.707 . . . . 0.0 110.265 -179.457 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.471 HD22 ' N ' ' A' ' 94' ' ' LEU . 4.1 mm? -99.32 132.07 44.9 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.472 -0.768 . . . . 0.0 109.601 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 73.2 m -84.26 15.66 3.45 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 179.634 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 17.6 tp10 -118.05 89.83 35.71 Favored Pre-proline 0 N--CA 1.498 1.938 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 179.504 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -57.69 144.49 92.88 Favored 'Trans proline' 0 N--CA 1.498 1.745 0 C-N-CA 122.561 2.174 . . . . 0.0 112.208 179.659 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 90.5 mt . . . . . 0 N--CA 1.498 1.928 0 O-C-N 121.51 -0.744 . . . . 0.0 109.772 -179.828 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_exo . . . . . 0 N--CA 1.493 1.498 0 CA-C-O 121.672 0.613 . . . . 0.0 112.393 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 21.4 mp0 -88.17 75.69 8.59 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.143 -0.973 . . . . 0.0 108.936 179.675 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 84.3 mt -69.45 143.84 53.45 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.47 -0.769 . . . . 0.0 109.665 -179.852 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 93.9 m -125.15 128.83 49.02 Favored 'General case' 0 N--CA 1.497 1.881 0 CA-C-O 121.735 0.779 . . . . 0.0 109.63 -179.717 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 14.8 mptt -80.22 149.66 30.37 Favored 'General case' 0 C--N 1.302 -1.48 0 CA-C-O 121.86 0.838 . . . . 0.0 109.843 -179.451 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.666 ' N ' HD12 ' A' ' 8' ' ' ILE . 2.7 mp -63.15 -43.73 99.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 CA-C-O 121.566 0.698 . . . . 0.0 110.166 -179.451 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 10.0 p -69.76 -19.93 23.21 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.654 0 O-C-N 121.214 -0.929 . . . . 0.0 110.057 -179.253 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -82.05 -3.47 54.69 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.925 -1.109 . . . . 0.0 109.482 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 96.7 mt -79.65 121.02 32.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.056 -1.027 . . . . 0.0 110.012 -179.757 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 33.4 m -136.04 -4.33 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.488 -0.757 . . . . 0.0 109.06 179.445 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -138.11 140.86 40.15 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.026 -1.046 . . . . 0.0 109.845 -179.781 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 57.3 p30 -93.65 162.22 14.03 Favored 'General case' 0 N--CA 1.493 1.7 0 CA-C-O 121.677 0.751 . . . . 0.0 110.521 -179.739 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 79.94 6.03 89.29 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.376 -1.49 . . . . 0.0 109.376 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 65.4 tt0 -80.97 135.46 35.87 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.202 -1.176 . . . . 0.0 110.275 -179.46 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 85.3 m95 -99.93 136.56 39.65 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.542 -0.724 . . . . 0.0 109.29 179.294 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -178.03 -172.98 0.35 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.22 -0.925 . . . . 0.0 109.697 -179.895 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 35.7 m-20 -109.26 149.07 29.97 Favored 'General case' 0 N--CA 1.495 1.819 0 CA-C-O 121.57 0.7 . . . . 0.0 109.648 -179.802 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 6.3 tt -136.93 133.36 35.6 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.357 -0.839 . . . . 0.0 110.128 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 37.6 ttmt -114.6 134.71 54.84 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 179.387 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -165.04 171.07 14.37 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 119.069 -1.052 . . . . 0.0 110.418 -179.904 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 64.9 tttm -106.26 142.25 36.26 Favored 'General case' 0 N--CA 1.496 1.842 0 CA-C-O 121.75 0.786 . . . . 0.0 110.028 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 92.5 t -79.84 121.98 34.18 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 O-C-N 121.382 -0.824 . . . . 0.0 110.378 -179.439 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 96.7 mt -100.72 -57.53 4.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 179.141 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 66.5 tp60 -147.79 139.45 23.89 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.058 -1.026 . . . . 0.0 110.08 -179.858 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.844 ' H ' HD23 ' A' ' 27' ' ' LEU . 1.2 pt? -142.96 138.21 29.94 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.741 -0.599 . . . . 0.0 109.618 179.228 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 4.9 m0 -113.03 142.45 45.7 Favored 'General case' 0 N--CA 1.497 1.92 0 CA-C-O 121.634 0.73 . . . . 0.0 109.795 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 3.0 pp20? . . . . . 0 N--CA 1.491 1.6 0 CA-C-O 121.601 0.715 . . . . 0.0 110.523 -179.355 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 42.2 t . . . . . 0 N--CA 1.49 1.56 0 CA-C-O 121.276 0.56 . . . . 0.0 110.096 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 97.5 mt -109.27 130.16 62.76 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 CA-C-O 121.968 0.889 . . . . 0.0 110.368 -179.334 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 19.3 t -74.8 -75.56 0.16 Allowed 'General case' 0 N--CA 1.491 1.617 0 CA-C-O 121.689 0.757 . . . . 0.0 109.642 179.888 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 -143.04 157.64 44.35 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.145 -0.972 . . . . 0.0 109.623 -179.566 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 13.9 m -132.74 135.01 58.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 CA-C-O 121.61 0.719 . . . . 0.0 109.426 179.771 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -160.34 -164.25 15.07 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 -179.551 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -133.7 148.96 51.51 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.5 -1.0 . . . . 0.0 110.137 -179.814 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 32.1 mt -120.11 136.91 54.43 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 -179.177 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -100.5 137.45 13.27 Favored Glycine 0 N--CA 1.494 2.52 0 N-CA-C 110.368 -1.093 . . . . 0.0 110.368 -179.296 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.488 ' O ' ' N ' ' A' ' 45' ' ' THR . 47.0 t0 -136.61 36.84 2.67 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.484 -1.009 . . . . 0.0 108.679 179.076 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 63.98 -38.92 0.21 Allowed 'General case' 0 N--CA 1.503 2.199 0 CA-C-O 121.418 0.628 . . . . 0.0 110.412 -179.514 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.488 ' N ' ' O ' ' A' ' 43' ' ' ASP . 17.8 p -79.41 22.9 0.42 Allowed 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.051 -1.031 . . . . 0.0 109.707 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 114.45 -165.56 12.07 Favored Glycine 0 N--CA 1.498 2.78 0 N-CA-C 110.436 -1.066 . . . . 0.0 110.436 179.324 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 33.7 pt -129.19 145.17 36.17 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 O-C-N 121.673 -0.898 . . . . 0.0 109.457 -179.775 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 18.9 tt -137.95 143.2 33.97 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 O-C-N 121.48 -0.763 . . . . 0.0 109.875 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 32.6 mtmm -83.25 155.12 23.83 Favored 'General case' 0 N--CA 1.493 1.692 0 CA-C-O 121.56 0.695 . . . . 0.0 110.431 -179.485 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 42.8 p90 -144.75 153.37 41.61 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.261 -0.899 . . . . 0.0 109.591 179.833 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 93.7 m -131.24 129.99 42.31 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 179.582 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 96.7 mt -101.41 126.25 55.28 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 121.361 -0.837 . . . . 0.0 109.764 -179.537 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 30.9 m95 -104.18 143.5 32.85 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.489 -0.757 . . . . 0.0 109.011 179.305 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 98.5 mttt . . . . . 0 N--CA 1.49 1.568 0 O-C-N 121.231 -0.918 . . . . 0.0 108.984 179.702 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 36.6 mt . . . . . 0 N--CA 1.5 2.063 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_exo -49.98 157.81 2.57 Favored 'Trans proline' 0 N--CA 1.495 1.582 0 C-N-CA 122.685 2.257 . . . . 0.0 112.896 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 41.4 mt -65.48 141.79 58.37 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.306 -0.871 . . . . 0.0 110.219 -179.043 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.599 ' N ' HD12 ' A' ' 61' ' ' LEU . 9.3 mp -85.57 150.94 24.31 Favored 'General case' 0 N--CA 1.493 1.712 0 CA-C-O 121.816 0.817 . . . . 0.0 110.742 -179.295 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -74.61 150.68 39.55 Favored 'General case' 0 N--CA 1.491 1.591 0 CA-C-O 121.882 0.849 . . . . 0.0 110.722 -179.598 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 57.6 tt0 -86.2 138.77 31.63 Favored 'General case' 0 N--CA 1.49 1.526 0 CA-C-O 121.687 0.756 . . . . 0.0 111.185 -179.661 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 81.48 10.94 83.84 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 110.346 -1.102 . . . . 0.0 110.346 178.959 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -115.77 147.27 41.14 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.343 -1.093 . . . . 0.0 110.57 -179.622 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 15.4 t -80.58 143.55 33.1 Favored 'General case' 0 N--CA 1.49 1.532 0 CA-C-O 121.61 0.719 . . . . 0.0 110.122 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 46.0 m-85 -140.47 147.47 39.66 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.417 -0.802 . . . . 0.0 109.835 179.785 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 19.4 tp -111.11 123.97 51.26 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 179.216 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 13.6 mt -99.04 131.18 45.27 Favored 'General case' 0 N--CA 1.492 1.662 0 CA-C-O 121.388 0.613 . . . . 0.0 110.039 -179.452 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.485 ' O ' ' CB ' ' A' ' 71' ' ' SER . 82.9 mtp180 -129.64 125.98 37.33 Favored 'General case' 0 N--CA 1.494 1.742 0 CA-C-O 121.437 0.637 . . . . 0.0 109.994 179.757 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.485 ' CB ' ' O ' ' A' ' 70' ' ' ARG . 0.9 OUTLIER 82.85 49.91 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.863 0 CA-C-O 121.157 0.503 . . . . 0.0 110.265 179.398 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 15.9 m -113.49 162.06 11.92 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.079 0 O-C-N 121.21 -0.932 . . . . 0.0 109.687 179.387 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 2.7 p -125.44 137.72 56.74 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 CA-C-O 121.763 0.792 . . . . 0.0 109.656 -179.407 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 11.0 t -85.33 113.37 23.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 CA-C-O 121.653 0.739 . . . . 0.0 109.976 -179.499 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -95.22 174.68 32.7 Favored Glycine 0 N--CA 1.493 2.47 0 N-CA-C 109.787 -1.325 . . . . 0.0 109.787 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -109.84 123.19 49.14 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.547 -0.972 . . . . 0.0 109.242 179.72 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 84.7 t80 -132.71 115.99 16.05 Favored 'General case' 0 N--CA 1.493 1.676 0 CA-C-O 121.59 0.709 . . . . 0.0 109.965 -179.618 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 7.7 m120 56.06 38.21 29.67 Favored 'General case' 0 N--CA 1.492 1.672 0 CA-C-O 121.419 0.628 . . . . 0.0 110.088 179.533 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 70.23 -2.55 2.08 Favored 'General case' 0 N--CA 1.497 1.911 0 CA-C-O 121.425 0.631 . . . . 0.0 109.656 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 20.7 mmm180 -98.48 166.26 11.44 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.183 -0.948 . . . . 0.0 109.996 -179.856 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 60.4 m-85 -88.24 139.78 30.14 Favored 'General case' 0 N--CA 1.488 1.436 0 CA-C-O 121.881 0.848 . . . . 0.0 110.107 -179.104 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 52.9 tt0 -144.4 150.7 38.15 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.388 -0.82 . . . . 0.0 108.833 179.805 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 28.5 m -114.14 128.92 70.9 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 O-C-N 121.526 -0.734 . . . . 0.0 109.165 179.616 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 75.5 mt-30 -107.85 127.22 53.53 Favored 'General case' 0 N--CA 1.495 1.776 0 CA-C-O 121.653 0.739 . . . . 0.0 109.989 -179.215 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 18.8 t -96.64 107.88 20.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 CA-C-O 121.634 0.73 . . . . 0.0 109.229 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 12.6 p30 -151.17 -170.05 3.55 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.395 -0.816 . . . . 0.0 109.914 -179.804 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 30.7 ttmt 59.27 37.13 23.74 Favored 'General case' 0 N--CA 1.493 1.724 0 CA-C-O 122.184 0.992 . . . . 0.0 109.879 179.758 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 10.2 t30 55.48 40.64 31.27 Favored 'General case' 0 N--CA 1.49 1.535 0 CA-C-O 121.637 0.732 . . . . 0.0 109.71 179.652 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 14.6 m -54.23 139.96 34.24 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.278 -0.889 . . . . 0.0 109.916 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 7.9 m -81.09 144.19 31.89 Favored 'General case' 0 N--CA 1.49 1.558 0 CA-C-O 121.795 0.807 . . . . 0.0 110.484 -179.092 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 96.6 mt -134.67 133.33 54.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.542 -0.723 . . . . 0.0 109.27 179.812 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -122.41 134.9 54.6 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.512 -0.742 . . . . 0.0 109.145 179.72 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.432 ' C ' HD22 ' A' ' 94' ' ' LEU . 88.5 tttt -82.49 125.17 30.8 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.402 -0.811 . . . . 0.0 109.879 -179.649 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.51 HD22 ' N ' ' A' ' 94' ' ' LEU . 4.1 mm? -97.3 134.48 40.53 Favored 'General case' 0 N--CA 1.49 1.559 0 CA-C-O 121.911 0.862 . . . . 0.0 109.963 -179.653 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 67.6 m -84.3 -4.57 58.94 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 179.303 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 90.5 mt-10 -104.48 110.36 64.16 Favored Pre-proline 0 N--CA 1.498 1.936 0 O-C-N 121.277 -0.889 . . . . 0.0 109.574 -179.831 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -74.3 157.38 45.73 Favored 'Trans proline' 0 N--CA 1.493 1.459 0 C-N-CA 122.374 2.049 . . . . 0.0 112.548 -179.365 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 16.6 mm . . . . . 0 N--CA 1.491 1.583 0 O-C-N 121.191 -0.943 . . . . 0.0 109.813 -179.384 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo . . . . . 0 N--CA 1.496 1.635 0 CA-C-O 121.406 0.503 . . . . 0.0 112.498 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 3.0 tm0? -75.49 70.33 2.34 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.561 -0.712 . . . . 0.0 109.115 179.744 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 72.0 mt -70.63 144.39 51.15 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.329 -0.857 . . . . 0.0 109.788 -179.539 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 64.7 m -124.87 133.04 53.23 Favored 'General case' 0 N--CA 1.497 1.887 0 N-CA-C 108.936 -0.765 . . . . 0.0 108.936 179.822 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 56.2 mtpt -76.02 152.02 37.02 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.318 -0.864 . . . . 0.0 110.573 -178.888 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 97.2 mt -63.29 -43.42 98.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.519 -0.738 . . . . 0.0 109.377 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 10.0 p -63.68 -24.39 35.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.351 -0.843 . . . . 0.0 109.667 -179.778 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -79.73 -3.82 49.19 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.018 -1.051 . . . . 0.0 109.793 -179.815 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 97.6 mt -80.88 119.16 29.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 120.92 -1.112 . . . . 0.0 109.795 -179.709 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 16.1 m -151.46 12.69 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 N-CA-C 108.947 -0.761 . . . . 0.0 108.947 179.328 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 50.7 tp10 -139.21 139.94 37.62 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.254 -0.904 . . . . 0.0 109.622 -179.829 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 48.8 p-10 -86.89 154.9 20.5 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.347 -0.845 . . . . 0.0 109.881 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 74.43 3.76 67.28 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 179.601 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 39.0 tt0 -71.24 128.61 36.49 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.168 -1.195 . . . . 0.0 109.68 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 88.9 m95 -98.51 138.74 35.28 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.394 -0.816 . . . . 0.0 109.601 -179.655 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -177.55 -178.77 0.77 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.333 -0.854 . . . . 0.0 109.726 179.52 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 80.5 m-20 -109.42 146.11 35.02 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.608 HD23 ' N ' ' A' ' 21' ' ' LYS . 6.2 tt -144.05 124.99 14.32 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.122 -0.986 . . . . 0.0 109.14 179.796 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.608 ' N ' HD23 ' A' ' 20' ' ' LEU . 36.4 ttpt -111.31 133.66 53.46 Favored 'General case' 0 N--CA 1.497 1.908 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 179.247 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -164.04 174.32 11.49 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.102 -0.999 . . . . 0.0 109.632 -179.749 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 16.8 ptpt -109.06 148.29 31.04 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.392 -0.818 . . . . 0.0 109.571 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.426 HG22 ' CD2' ' A' ' 41' ' ' LEU . 91.2 t -84.48 128.97 38.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.576 -0.703 . . . . 0.0 110.231 -179.167 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 97.0 mt -95.93 -53.58 8.04 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 N-CA-C 108.401 -0.962 . . . . 0.0 108.401 178.958 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 69.6 tp60 -149.24 145.21 26.99 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.307 -0.871 . . . . 0.0 109.495 179.443 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.832 HD23 ' H ' ' A' ' 27' ' ' LEU . 1.2 pt? -143.33 140.47 30.56 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 179.41 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 39.2 t90 -115.51 125.38 52.96 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 179.748 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 . . . . . 0 N--CA 1.491 1.605 0 O-C-N 121.301 -0.875 . . . . 0.0 110.015 -179.703 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 43.2 t . . . . . 0 N--CA 1.497 1.879 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 86.3 mt -102.96 128.74 55.59 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 O-C-N 121.271 -0.893 . . . . 0.0 109.593 -179.537 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 41.6 t -86.93 -69.64 0.67 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.482 -0.761 . . . . 0.0 109.993 -179.405 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 27.8 mt-30 -133.43 154.27 50.92 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.298 -0.876 . . . . 0.0 109.656 -179.209 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 15.5 m -130.85 134.87 61.19 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 179.726 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.526 ' C ' HD13 ' A' ' 40' ' ' LEU . . . -168.49 -163.72 22.96 Favored Glycine 0 N--CA 1.486 2.008 0 C-N-CA 119.08 -1.533 . . . . 0.0 110.273 -179.329 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.894 HD13 ' N ' ' A' ' 40' ' ' LEU . 0.0 OUTLIER -131.93 161.69 32.46 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.914 -0.757 . . . . 0.0 109.37 179.863 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.426 ' CD2' HG22 ' A' ' 24' ' ' VAL . 69.3 mt -120.25 133.46 55.47 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.584 -0.698 . . . . 0.0 109.329 -179.351 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -85.86 141.13 18.42 Favored Glycine 0 N--CA 1.492 2.427 0 N-CA-C 110.01 -1.236 . . . . 0.0 110.01 -179.886 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 44.0 t0 -151.26 163.73 38.23 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.443 -1.034 . . . . 0.0 109.922 179.826 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -64.21 -20.62 66.16 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.549 -0.719 . . . . 0.0 109.923 -179.841 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 44.7 p -92.32 -12.23 33.0 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 120.982 -1.074 . . . . 0.0 110.404 -179.283 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 144.81 -155.39 26.4 Favored Glycine 0 N--CA 1.497 2.75 0 C-N-CA 119.916 -1.135 . . . . 0.0 110.281 179.535 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 91.3 mt -125.59 137.18 58.51 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.975 0 O-C-N 121.802 -0.822 . . . . 0.0 108.811 -179.668 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 17.5 tt -129.4 150.05 34.24 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.232 0 O-C-N 121.452 -0.78 . . . . 0.0 110.342 -179.571 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.661 ' NZ ' HH22 ' A' ' 80' ' ' ARG . 14.7 mptt -83.81 151.97 24.88 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.654 -0.654 . . . . 0.0 109.812 -179.695 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 25.2 p90 -143.28 148.47 36.4 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.221 -0.924 . . . . 0.0 108.803 179.072 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 97.4 m -131.57 129.92 41.57 Favored 'General case' 0 N--CA 1.496 1.828 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 179.428 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 88.3 mt -98.07 127.8 50.13 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 O-C-N 121.311 -0.868 . . . . 0.0 110.158 -179.601 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 82.7 m95 -80.35 120.71 24.76 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 178.778 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 73.1 tttt . . . . . 0 C--N 1.3 -1.561 0 O-C-N 121.297 -0.877 . . . . 0.0 108.745 -179.139 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 63.9 mt . . . . . 0 N--CA 1.498 1.947 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -51.8 146.17 28.96 Favored 'Trans proline' 0 N--CA 1.501 1.937 0 C-N-CA 121.904 1.736 . . . . 0.0 112.766 179.415 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 77.4 mt -71.74 141.89 49.77 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.257 -0.902 . . . . 0.0 109.911 -179.837 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.565 ' N ' HD12 ' A' ' 61' ' ' LEU . 10.5 mp -79.19 146.38 33.13 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.472 -0.767 . . . . 0.0 109.976 -179.289 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 51.4 tp10 -88.17 147.62 24.79 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.268 -0.895 . . . . 0.0 109.538 -179.577 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' GLN . . . . . 0.531 ' OE1' ' N ' ' A' ' 64' ' ' GLY . 0.2 OUTLIER -81.71 126.26 31.58 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.276 -0.89 . . . . 0.0 110.093 -179.743 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.531 ' N ' ' OE1' ' A' ' 63' ' ' GLN . . . 86.32 32.22 17.25 Favored Glycine 0 N--CA 1.495 2.628 0 N-CA-C 110.423 -1.071 . . . . 0.0 110.423 179.178 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -137.23 147.85 46.07 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.126 -1.22 . . . . 0.0 109.91 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 14.4 m -78.51 143.34 36.68 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.7 -0.625 . . . . 0.0 109.788 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 51.0 m-85 -139.71 141.37 36.93 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.492 -0.755 . . . . 0.0 109.501 179.27 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.511 HD21 ' NE ' ' A' ' 70' ' ' ARG . 15.1 tp -103.72 120.03 40.12 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 107.964 -1.124 . . . . 0.0 107.964 178.989 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 75.7 mt -105.85 129.38 54.03 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 -179.844 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.511 ' NE ' HD21 ' A' ' 68' ' ' LEU . 99.6 mtt180 -125.54 143.71 50.89 Favored 'General case' 0 N--CA 1.503 2.225 0 O-C-N 121.413 -0.804 . . . . 0.0 111.141 -179.181 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.6 m 61.82 46.1 7.16 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.916 -0.49 . . . . 0.0 110.714 179.124 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 8.0 m -99.3 162.05 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.978 0 O-C-N 121.016 -1.052 . . . . 0.0 109.139 179.133 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 7.5 p -122.52 139.5 49.22 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 -179.788 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 63.8 t -89.33 115.25 28.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.237 -0.914 . . . . 0.0 109.612 -179.444 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -99.56 151.4 19.31 Favored Glycine 0 N--CA 1.499 2.842 0 N-CA-C 109.79 -1.324 . . . . 0.0 109.79 -179.834 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -68.46 137.19 54.25 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.338 -1.095 . . . . 0.0 110.072 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' TYR . . . . . 0.51 ' O ' ' N ' ' A' ' 79' ' ' ASP . 42.1 t80 -131.06 126.25 35.34 Favored 'General case' 0 N--CA 1.497 1.917 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 179.385 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' ASN . . . . . 0.436 ' C ' ' O ' ' A' ' 77' ' ' TYR . 96.5 m-20 -35.35 -30.29 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.047 0 CA-C-O 121.115 0.483 . . . . 0.0 110.469 -179.058 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.51 ' N ' ' O ' ' A' ' 77' ' ' TYR . 96.7 m-20 -113.37 67.9 0.67 Allowed 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.594 -0.691 . . . . 0.0 109.942 179.48 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.661 HH22 ' NZ ' ' A' ' 49' ' ' LYS . 83.8 mtm180 85.62 -159.29 0.01 OUTLIER 'General case' 0 N--CA 1.508 2.473 0 CA-C-O 121.384 0.612 . . . . 0.0 110.514 178.262 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -103.52 151.89 22.33 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.526 -0.734 . . . . 0.0 109.519 -179.091 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 19.0 pt20 -136.57 166.47 23.45 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.382 -0.824 . . . . 0.0 109.284 -179.63 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.446 HG23 ' O ' ' A' ' 83' ' ' VAL . 18.8 m -105.89 130.49 57.32 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 179.827 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 87.5 mt-30 -106.45 131.18 53.94 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.429 -0.794 . . . . 0.0 110.49 -178.704 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 19.5 t -91.83 131.34 39.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 N-CA-C 109.006 -0.738 . . . . 0.0 109.006 179.449 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 99.9 m-20 -126.34 175.45 7.83 Favored 'General case' 0 N--CA 1.501 2.091 0 CA-C-O 121.79 0.805 . . . . 0.0 110.277 -179.459 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 63.8 tttm -56.64 -44.02 80.86 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.636 -0.665 . . . . 0.0 110.495 -179.57 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 55.9 m-20 -63.77 -33.38 75.54 Favored 'General case' 0 C--N 1.297 -1.716 0 O-C-N 121.088 -1.007 . . . . 0.0 110.359 -179.207 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 59.8 m -60.66 147.44 41.98 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.987 -1.071 . . . . 0.0 110.786 -178.656 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 7.0 m -113.27 149.18 34.22 Favored 'General case' 0 N--CA 1.499 2.005 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 179.618 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 96.6 mt -131.35 131.47 63.18 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.041 0 O-C-N 121.44 -0.787 . . . . 0.0 109.597 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -133.01 133.46 43.15 Favored 'General case' 0 N--CA 1.501 2.095 0 O-C-N 121.386 -0.821 . . . . 0.0 108.921 178.988 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -82.58 124.75 30.43 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.34 -0.85 . . . . 0.0 109.185 -179.835 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.456 HD22 ' N ' ' A' ' 94' ' ' LEU . 4.1 mm? -96.87 137.01 36.6 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.273 -0.892 . . . . 0.0 109.93 -179.322 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 93.7 p -82.4 -5.3 58.56 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 179.697 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -103.13 109.91 62.55 Favored Pre-proline 0 N--CA 1.497 1.881 0 O-C-N 121.37 -0.831 . . . . 0.0 109.421 -179.389 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -74.9 159.45 41.66 Favored 'Trans proline' 0 N--CA 1.494 1.503 0 C-N-CA 121.835 1.69 . . . . 0.0 112.082 -179.307 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 96.8 mt . . . . . 0 N--CA 1.497 1.899 0 O-C-N 121.241 -0.912 . . . . 0.0 109.609 -179.741 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 21.5 Cg_exo . . . . . 0 N--CA 1.493 1.445 0 CA-C-O 121.585 0.577 . . . . 0.0 112.049 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 78.7 mt-30 -88.98 79.96 7.17 Favored 'General case' 0 N--CA 1.489 1.511 0 CA-C-O 121.915 0.864 . . . . 0.0 109.417 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -59.68 133.41 56.07 Favored 'General case' 0 N--CA 1.489 1.501 0 CA-C-O 121.829 0.823 . . . . 0.0 109.762 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 97.1 m -128.28 128.48 44.72 Favored 'General case' 0 N--CA 1.491 1.577 0 CA-C-O 121.852 0.834 . . . . 0.0 109.361 179.796 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -90.85 154.4 19.52 Favored 'General case' 0 C--N 1.301 -1.527 0 CA-C-O 121.768 0.794 . . . . 0.0 109.818 -179.592 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 66.3 mt -63.2 -43.84 99.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.699 -0.626 . . . . 0.0 109.708 -179.39 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 12.4 p -65.07 -22.4 31.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.47 -0.769 . . . . 0.0 109.807 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 96.5 m-20 -80.99 -2.63 48.67 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.385 -0.822 . . . . 0.0 109.611 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 97.6 mt -85.51 112.04 21.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.426 -0.796 . . . . 0.0 109.958 -179.743 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 22.3 m -135.73 -2.79 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 179.318 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -140.39 143.85 35.9 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.479 -0.763 . . . . 0.0 109.941 179.885 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 52.2 p30 -90.66 161.15 15.51 Favored 'General case' 0 N--CA 1.492 1.672 0 CA-C-O 121.872 0.844 . . . . 0.0 110.495 -179.704 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 79.63 15.89 78.69 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.289 -1.524 . . . . 0.0 109.289 -179.814 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 52.5 tt0 -81.54 132.5 35.31 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.477 -1.013 . . . . 0.0 110.195 -179.286 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 76.9 m95 -106.31 132.99 51.7 Favored 'General case' 0 N--CA 1.495 1.786 0 CA-C-O 121.451 0.643 . . . . 0.0 109.465 179.705 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 179.71 -172.64 0.19 Allowed 'General case' 0 N--CA 1.491 1.619 0 CA-C-O 121.745 0.783 . . . . 0.0 109.962 179.806 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.547 ' OD1' HD11 ' A' ' 68' ' ' LEU . 0.4 OUTLIER -100.18 152.34 20.37 Favored 'General case' 0 N--CA 1.493 1.701 0 CA-C-O 121.544 0.688 . . . . 0.0 109.73 -179.956 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.54 ' N ' ' ND2' ' A' ' 19' ' ' ASN . 7.2 tp -135.84 129.73 32.84 Favored 'General case' 0 N--CA 1.49 1.573 0 CA-C-O 121.745 0.783 . . . . 0.0 110.057 -179.916 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 38.3 ttmt -119.53 132.83 55.84 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 179.602 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -165.09 178.25 7.15 Favored 'General case' 0 N--CA 1.495 1.789 0 C-N-CA 119.331 -0.947 . . . . 0.0 110.809 -179.542 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 65.1 tttm -112.11 143.45 43.13 Favored 'General case' 0 N--CA 1.496 1.873 0 CA-C-O 121.713 0.768 . . . . 0.0 110.059 -179.676 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.542 ' CG1' HD22 ' A' ' 27' ' ' LEU . 91.4 t -84.96 122.42 38.14 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 CA-C-O 121.884 0.849 . . . . 0.0 110.513 -179.046 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 23.8 mm -100.66 -48.91 11.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 178.755 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 69.3 tp60 -149.3 144.15 26.28 Favored 'General case' 0 N--CA 1.488 1.454 0 CA-C-O 121.71 0.767 . . . . 0.0 109.816 179.461 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.879 ' N ' HD23 ' A' ' 27' ' ' LEU . 0.4 OUTLIER -141.71 136.42 30.79 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 179.866 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 3.7 m-90 -115.14 122.49 46.25 Favored 'General case' 0 N--CA 1.496 1.851 0 CA-C-O 121.838 0.828 . . . . 0.0 109.618 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 49.6 tp10 . . . . . 0 N--CA 1.491 1.602 0 CA-C-O 121.541 0.686 . . . . 0.0 110.047 -179.369 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 32.2 t . . . . . 0 N--CA 1.5 2.026 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 96.6 mt -125.09 123.6 65.75 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.129 0 O-C-N 121.27 -0.894 . . . . 0.0 109.538 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 5.8 t -68.81 -51.64 38.64 Favored 'General case' 0 N--CA 1.494 1.728 0 CA-C-O 121.523 0.677 . . . . 0.0 109.435 179.667 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 19.3 tt0 -157.53 153.3 26.77 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.515 -0.74 . . . . 0.0 109.69 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.7 p -142.99 145.7 22.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 179.653 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -175.17 -157.94 17.83 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.781 -1.327 . . . . 0.0 109.781 -179.589 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.9 pp -135.39 149.44 49.65 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.891 -0.77 . . . . 0.0 110.432 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 69.4 mt -117.24 132.13 56.69 Favored 'General case' 0 N--CA 1.498 1.933 0 CA-C-O 121.817 0.818 . . . . 0.0 109.647 -179.469 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -80.58 162.41 45.36 Favored Glycine 0 N--CA 1.488 2.147 0 N-CA-C 110.859 -0.896 . . . . 0.0 110.859 -179.577 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.531 ' OD1' ' N ' ' A' ' 44' ' ' GLU . 67.5 t0 -170.02 144.37 2.69 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.531 ' N ' ' OD1' ' A' ' 43' ' ' ASP . 19.1 pt-20 -59.84 -16.16 26.49 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.617 -0.677 . . . . 0.0 109.693 -179.788 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 36.2 p -91.25 -7.91 49.88 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 179.638 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 139.24 -153.61 22.98 Favored Glycine 0 N--CA 1.496 2.635 0 N-CA-C 109.81 -1.316 . . . . 0.0 109.81 179.414 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 36.1 pt -127.94 148.34 32.54 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.875 0 O-C-N 121.881 -0.776 . . . . 0.0 109.543 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 18.1 tt -141.69 138.58 31.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 CA-C-O 121.743 0.782 . . . . 0.0 110.034 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 68.9 mttm -83.75 156.86 22.34 Favored 'General case' 0 N--CA 1.49 1.545 0 CA-C-O 121.46 0.648 . . . . 0.0 109.981 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 28.2 p90 -148.62 150.44 33.27 Favored 'General case' 0 N--CA 1.491 1.599 0 CA-C-O 121.769 0.795 . . . . 0.0 109.991 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 97.8 m -130.24 129.81 43.81 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 179.575 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 92.8 mt -103.18 125.7 57.6 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 CA-C-O 121.904 0.859 . . . . 0.0 110.221 -179.423 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 96.6 m95 -86.71 142.13 28.41 Favored 'General case' 0 N--CA 1.49 1.556 0 CA-C-O 121.78 0.8 . . . . 0.0 109.881 -179.802 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 25.9 mtpp . . . . . 0 C--N 1.302 -1.47 0 O-C-N 121.655 -0.653 . . . . 0.0 109.434 -179.963 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 32.4 mt . . . . . 0 N--CA 1.491 1.611 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -55.89 147.75 60.69 Favored 'Trans proline' 0 N--CA 1.5 1.87 0 C-N-CA 123.067 2.511 . . . . 0.0 113.602 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 78.1 mt -70.74 144.27 50.99 Favored 'General case' 0 N--CA 1.492 1.631 0 CA-C-O 122.021 0.915 . . . . 0.0 110.479 -179.644 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.572 ' N ' HD12 ' A' ' 61' ' ' LEU . 10.0 mp -77.33 147.28 36.26 Favored 'General case' 0 N--CA 1.49 1.538 0 CA-C-O 121.733 0.778 . . . . 0.0 109.827 -179.899 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -88.64 155.9 19.34 Favored 'General case' 0 N--CA 1.492 1.643 0 CA-C-O 121.968 0.89 . . . . 0.0 110.109 -179.755 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' GLN . . . . . 0.488 ' NE2' ' C ' ' A' ' 63' ' ' GLN . 0.6 OUTLIER -83.52 136.16 34.37 Favored 'General case' 0 C--N 1.301 -1.536 0 CA-C-O 121.889 0.852 . . . . 0.0 110.838 -179.2 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.476 ' N ' ' NE2' ' A' ' 63' ' ' GLN . . . 82.18 0.99 90.25 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 110.003 -1.239 . . . . 0.0 110.003 179.145 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 -106.73 146.49 30.76 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.605 -0.938 . . . . 0.0 110.476 -179.513 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 6.1 m -86.25 148.38 25.66 Favored 'General case' 0 N--CA 1.489 1.496 0 CA-C-O 121.645 0.736 . . . . 0.0 109.98 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 65.1 m-85 -141.66 150.46 41.95 Favored 'General case' 0 N--CA 1.492 1.642 0 CA-C-O 122.016 0.912 . . . . 0.0 110.616 -179.709 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.547 HD11 ' OD1' ' A' ' 19' ' ' ASN . 31.5 tp -113.1 120.65 42.04 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.717 -0.845 . . . . 0.0 108.717 179.334 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 75.5 mt -102.04 126.87 49.08 Favored 'General case' 0 N--CA 1.491 1.612 0 CA-C-O 121.465 0.65 . . . . 0.0 109.376 -179.508 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.431 ' O ' ' CB ' ' A' ' 71' ' ' SER . 80.8 mtp180 -123.82 129.02 50.36 Favored 'General case' 0 N--CA 1.496 1.874 0 CA-C-O 121.714 0.768 . . . . 0.0 109.853 -179.697 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.431 ' CB ' ' O ' ' A' ' 70' ' ' ARG . 1.5 t 78.7 65.41 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.368 179.661 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 30.8 m -128.14 163.82 31.24 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 179.187 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 12.5 p -121.63 135.16 62.68 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 CA-C-O 121.72 0.771 . . . . 0.0 109.936 -179.524 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 12.5 t -89.94 114.83 28.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 CA-C-O 121.81 0.814 . . . . 0.0 109.482 -179.558 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -91.48 174.37 38.1 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 110.51 -1.036 . . . . 0.0 110.51 -179.292 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 82.8 tt0 -100.84 117.78 35.59 Favored 'General case' 0 N--CA 1.492 1.67 0 CA-C-O 121.997 0.903 . . . . 0.0 109.692 -179.725 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' TYR . . . . . 0.559 ' CD1' ' N ' ' A' ' 78' ' ' ASN . 27.2 t80 -101.53 162.75 12.67 Favored 'General case' 0 N--CA 1.493 1.71 0 CA-C-O 121.747 0.784 . . . . 0.0 109.854 -179.803 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' ASN . . . . . 0.559 ' N ' ' CD1' ' A' ' 77' ' ' TYR . 24.3 t-20 -53.19 104.37 0.09 Allowed 'General case' 0 N--CA 1.494 1.749 0 CA-C-O 122.323 1.059 . . . . 0.0 110.63 -179.182 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 43.1 t0 57.66 16.69 3.58 Favored 'General case' 0 N--CA 1.492 1.646 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.372 179.747 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 78.1 mtp85 -148.78 -167.51 2.84 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.182 -0.949 . . . . 0.0 110.087 179.587 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 80.4 m-85 -127.94 151.24 49.34 Favored 'General case' 0 N--CA 1.495 1.807 0 CA-C-O 121.654 0.74 . . . . 0.0 109.64 -179.713 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 49.0 tt0 -145.22 153.12 41.0 Favored 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 13.6 m -113.1 130.72 66.48 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 179.423 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 78.8 mt-30 -111.68 129.93 55.94 Favored 'General case' 0 N--CA 1.496 1.866 0 CA-C-O 121.658 0.742 . . . . 0.0 110.411 -178.678 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 3.0 t -103.34 119.01 51.24 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 CA-C-O 121.596 0.712 . . . . 0.0 109.727 179.861 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 8.7 p-10 -147.01 -166.9 2.63 Favored 'General case' 0 N--CA 1.493 1.722 0 CA-C-O 121.714 0.769 . . . . 0.0 109.872 -179.411 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 38.1 ttmt 59.34 -89.13 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.654 0 CA-C-O 121.432 0.634 . . . . 0.0 110.52 -179.772 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 26.5 t-20 -169.96 46.62 0.03 OUTLIER 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 108.731 -0.841 . . . . 0.0 108.731 -179.216 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 34.9 t -55.56 136.19 50.33 Favored 'General case' 0 N--CA 1.496 1.873 0 CA-C-O 121.767 0.794 . . . . 0.0 109.709 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 1.4 t -79.55 140.83 37.09 Favored 'General case' 0 N--CA 1.491 1.584 0 CA-C-O 121.614 0.721 . . . . 0.0 110.338 -179.316 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 97.4 mt -128.46 130.67 69.19 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 121.836 -0.54 . . . . 0.0 109.586 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 47.7 tp10 -127.73 130.76 49.35 Favored 'General case' 0 N--CA 1.495 1.817 0 CA-C-O 121.827 0.822 . . . . 0.0 109.235 179.752 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 65.7 tttm -81.43 132.36 35.32 Favored 'General case' 0 N--CA 1.49 1.552 0 CA-C-O 121.856 0.836 . . . . 0.0 110.416 -179.385 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 65.8 mt -103.26 131.07 50.61 Favored 'General case' 0 N--CA 1.492 1.663 0 CA-C-O 121.703 0.763 . . . . 0.0 109.545 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 10.1 t -83.52 6.58 19.93 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 179.775 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 33.5 mm-40 -118.04 90.61 37.74 Favored Pre-proline 0 N--CA 1.499 2.024 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 179.308 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_exo -56.22 147.57 65.35 Favored 'Trans proline' 0 N--CA 1.494 1.552 0 C-N-CA 122.886 2.39 . . . . 0.0 112.516 179.739 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 93.9 mt . . . . . 0 N--CA 1.494 1.766 0 CA-C-O 121.885 0.85 . . . . 0.0 110.06 -179.497 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo . . . . . 0 N--CA 1.494 1.518 0 CA-C-O 121.829 0.679 . . . . 0.0 112.8 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 27.6 mp0 -89.7 69.26 7.7 Favored 'General case' 0 N--CA 1.489 1.515 0 CA-C-O 121.844 0.83 . . . . 0.0 109.094 -179.827 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 71.9 mt -65.69 139.87 58.42 Favored 'General case' 0 N--CA 1.492 1.634 0 CA-C-O 121.63 0.728 . . . . 0.0 110.34 -179.422 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 92.3 m -128.83 132.15 47.77 Favored 'General case' 0 N--CA 1.493 1.693 0 CA-C-O 121.606 0.717 . . . . 0.0 109.576 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -75.35 146.86 40.55 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.461 -0.775 . . . . 0.0 109.998 -179.74 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 96.5 mt -63.84 -43.09 97.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.554 -0.716 . . . . 0.0 110.449 -179.563 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 13.2 p -62.06 -22.73 29.68 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.129 -0.982 . . . . 0.0 109.547 -179.783 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 51.7 t0 -76.17 -5.81 48.42 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.301 -0.874 . . . . 0.0 109.61 179.831 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 96.6 mt -82.4 119.32 31.71 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.038 -1.039 . . . . 0.0 110.23 -179.81 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 3.3 m -151.11 14.53 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 N-CA-C 108.582 -0.895 . . . . 0.0 108.582 179.65 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -138.04 145.24 41.58 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.419 -0.801 . . . . 0.0 110.019 -179.859 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 -82.78 144.39 30.19 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-O 121.682 0.753 . . . . 0.0 110.459 -179.796 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 65.99 110.9 0.01 OUTLIER Glycine 0 N--CA 1.491 2.331 0 N-CA-C 110.617 -0.993 . . . . 0.0 110.617 179.136 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 66.0 tt0 -169.47 130.26 1.08 Allowed 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.306 -1.114 . . . . 0.0 109.505 179.226 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 98.7 m95 -93.82 129.94 40.02 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.663 -0.648 . . . . 0.0 109.897 -179.668 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -175.59 171.53 2.76 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.535 -0.728 . . . . 0.0 109.695 179.749 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 67.0 m-20 -103.56 143.55 32.59 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.566 -0.709 . . . . 0.0 109.546 -179.679 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 5.0 mp -138.56 145.59 40.83 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.367 -0.833 . . . . 0.0 109.974 -179.856 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 33.9 ttmt -119.71 136.08 54.57 Favored 'General case' 0 N--CA 1.494 1.737 0 CA-C-O 121.481 0.658 . . . . 0.0 109.713 179.718 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -166.2 166.9 16.62 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 119.785 -0.766 . . . . 0.0 109.813 179.754 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 38.3 ttmt -105.5 142.01 36.0 Favored 'General case' 0 N--CA 1.492 1.641 0 CA-C-O 121.761 0.791 . . . . 0.0 109.987 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 58.8 t -81.19 127.04 39.88 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.362 0 CA-C-O 121.805 0.812 . . . . 0.0 110.292 -179.694 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 96.5 mt -97.42 -66.53 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 121.645 -0.659 . . . . 0.0 109.311 179.387 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 24.0 mm100 -144.04 143.76 31.33 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.291 -0.881 . . . . 0.0 110.435 -179.766 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.553 HD12 ' O ' ' A' ' 27' ' ' LEU . 0.3 OUTLIER -143.17 139.68 30.44 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 -179.713 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 3.5 m-90 -114.92 149.92 36.48 Favored 'General case' 0 N--CA 1.494 1.739 0 CA-C-O 121.811 0.815 . . . . 0.0 109.889 179.803 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 . . . . . 0 C--N 1.306 -1.326 0 CA-C-O 121.428 0.633 . . . . 0.0 110.046 -179.971 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 14.2 t . . . . . 0 N--CA 1.493 1.697 0 CA-C-O 121.147 0.499 . . . . 0.0 110.226 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 96.7 mt -115.58 130.09 70.79 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 CA-C-O 121.823 0.82 . . . . 0.0 109.591 179.361 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 39.1 t -84.02 -68.91 0.68 Allowed 'General case' 0 C--N 1.302 -1.476 0 CA-C-O 121.518 0.675 . . . . 0.0 109.554 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' GLN . . . . . 0.503 ' OE1' HD22 ' A' ' 60' ' ' LEU . 25.3 mt-30 -137.43 160.98 37.55 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.406 -0.808 . . . . 0.0 109.997 -179.292 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 3.3 p -140.0 143.37 30.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -168.91 -152.61 7.84 Favored Glycine 0 N--CA 1.486 1.993 0 N-CA-C 110.02 -1.232 . . . . 0.0 110.02 -179.624 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.412 ' N ' HD23 ' A' ' 40' ' ' LEU . 0.2 OUTLIER -132.94 150.93 52.12 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.849 -0.794 . . . . 0.0 109.886 -179.707 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 65.7 mt -114.73 129.59 56.71 Favored 'General case' 0 N--CA 1.491 1.611 0 CA-C-O 121.814 0.816 . . . . 0.0 109.544 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -85.45 152.73 26.8 Favored Glycine 0 N--CA 1.488 2.145 0 N-CA-C 110.479 -1.048 . . . . 0.0 110.479 -179.536 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.53 ' OD1' ' N ' ' A' ' 44' ' ' GLU . 41.8 t0 -173.58 152.08 2.04 Favored 'General case' 0 C--N 1.306 -1.319 0 O-C-N 121.766 -0.844 . . . . 0.0 109.722 179.467 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.53 ' N ' ' OD1' ' A' ' 43' ' ' ASP . 82.7 tt0 -55.5 -16.71 4.12 Favored 'General case' 0 N--CA 1.492 1.657 0 CA-C-O 121.241 0.543 . . . . 0.0 110.65 -179.352 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 80.8 p -92.45 -0.94 57.3 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.813 -1.179 . . . . 0.0 109.373 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 126.02 -152.54 18.16 Favored Glycine 0 N--CA 1.499 2.848 0 N-CA-C 110.428 -1.069 . . . . 0.0 110.428 179.182 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 36.8 pt -126.24 151.99 33.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.807 -0.819 . . . . 0.0 109.202 -179.815 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 18.7 tt -147.95 151.0 13.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.217 -0.927 . . . . 0.0 110.067 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.456 ' HZ1' ' HE2' ' A' ' 77' ' ' TYR . 0.0 OUTLIER -85.75 147.64 26.23 Favored 'General case' 0 N--CA 1.489 1.519 0 CA-C-O 121.538 0.685 . . . . 0.0 110.123 -179.997 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 13.3 p90 -143.92 159.71 42.09 Favored 'General case' 0 N--CA 1.486 1.34 0 O-C-N 121.418 -0.801 . . . . 0.0 109.461 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 1.8 t -141.94 142.37 33.01 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 179.468 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 92.8 mt -105.37 122.6 58.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 CA-C-O 121.77 0.795 . . . . 0.0 109.966 -179.798 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 43.1 m95 -91.36 136.89 32.79 Favored 'General case' 0 N--CA 1.487 1.378 0 CA-C-O 121.504 0.669 . . . . 0.0 109.384 179.845 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 56.3 mtpt . . . . . 0 N--CA 1.489 1.516 0 CA-C-O 121.708 0.766 . . . . 0.0 109.319 179.449 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 32.8 mt . . . . . 0 N--CA 1.495 1.803 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -72.4 162.4 41.6 Favored 'Trans proline' 0 N--CA 1.494 1.547 0 C-N-CA 123.047 2.498 . . . . 0.0 112.775 179.598 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.503 HD22 ' OE1' ' A' ' 37' ' ' GLN . 69.1 mt -67.45 143.64 56.14 Favored 'General case' 0 N--CA 1.49 1.528 0 CA-C-O 121.876 0.846 . . . . 0.0 110.512 -179.498 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.572 ' N ' HD12 ' A' ' 61' ' ' LEU . 10.1 mp -91.7 137.13 32.61 Favored 'General case' 0 N--CA 1.491 1.577 0 CA-C-O 121.684 0.754 . . . . 0.0 110.262 -179.304 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.45 ' OE1' ' OE2' ' A' ' 65' ' ' GLU . 95.9 mt-10 -81.81 147.94 29.12 Favored 'General case' 0 N--CA 1.49 1.533 0 CA-C-O 121.817 0.818 . . . . 0.0 110.195 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 32.7 mt-30 -79.62 140.61 37.06 Favored 'General case' 0 N--CA 1.488 1.465 0 CA-C-O 121.789 0.804 . . . . 0.0 110.925 -179.324 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 79.39 35.21 30.16 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 110.3 -1.12 . . . . 0.0 110.3 179.304 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.45 ' OE2' ' OE1' ' A' ' 62' ' ' GLU . 91.5 mt-10 -140.95 143.76 34.73 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.206 -1.173 . . . . 0.0 110.134 179.647 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 89.5 p -81.63 143.46 31.91 Favored 'General case' 0 N--CA 1.486 1.365 0 CA-C-O 121.6 0.714 . . . . 0.0 110.217 -179.642 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 92.3 m-85 -138.41 142.12 39.56 Favored 'General case' 0 N--CA 1.489 1.479 0 CA-C-O 121.582 0.706 . . . . 0.0 110.025 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 31.8 tp -108.56 113.3 26.19 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 108.563 -0.902 . . . . 0.0 108.563 179.197 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.8 mp -99.77 131.26 45.86 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 -179.708 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 85.7 mtp180 -126.51 148.67 49.67 Favored 'General case' 0 N--CA 1.491 1.576 0 CA-C-O 121.584 0.707 . . . . 0.0 110.432 -179.553 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 8.6 t 59.22 55.09 4.47 Favored 'General case' 0 N--CA 1.491 1.582 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.355 179.55 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 15.7 m -113.67 160.79 12.98 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 O-C-N 121.586 -0.696 . . . . 0.0 109.249 179.163 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 9.9 p -114.07 134.66 56.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 CA-C-O 121.809 0.814 . . . . 0.0 110.179 -178.955 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 16.8 t -82.43 119.62 32.3 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.343 0 CA-C-O 121.702 0.763 . . . . 0.0 109.898 -179.726 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -93.68 170.69 31.12 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 110.231 -1.148 . . . . 0.0 110.231 -179.618 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 22.4 pt-20 -102.88 133.43 47.98 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.651 -0.911 . . . . 0.0 110.195 -179.674 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' TYR . . . . . 0.633 ' CD2' ' ND2' ' A' ' 78' ' ' ASN . 42.6 t80 -136.86 96.66 3.35 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 179.624 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' ASN . . . . . 0.633 ' ND2' ' CD2' ' A' ' 77' ' ' TYR . 23.3 p30 42.2 -136.68 0.27 Allowed 'General case' 0 N--CA 1.495 1.799 0 CA-C-O 121.531 0.681 . . . . 0.0 111.417 -179.918 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.545 ' N ' ' OD1' ' A' ' 78' ' ' ASN . 97.6 m-20 -73.35 -6.28 45.13 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.433 -0.792 . . . . 0.0 109.689 -179.255 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.406 ' N ' ' OD1' ' A' ' 78' ' ' ASN . 88.6 mtm180 -110.34 -179.66 3.84 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.487 -0.758 . . . . 0.0 110.085 -179.661 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -129.84 154.55 47.16 Favored 'General case' 0 N--CA 1.493 1.707 0 CA-C-O 121.508 0.671 . . . . 0.0 109.597 -179.551 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 27.6 pt20 -139.73 162.28 35.49 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.526 -0.734 . . . . 0.0 109.808 -179.775 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.41 HG23 ' O ' ' A' ' 83' ' ' VAL . 13.5 m -111.54 131.82 61.82 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 179.847 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 -106.43 118.56 36.96 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.469 -0.769 . . . . 0.0 109.978 -179.253 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 10.2 t -90.02 99.46 9.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 179.646 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 9.2 p-10 -151.15 -177.06 5.81 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.511 -0.743 . . . . 0.0 109.762 -179.526 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.427 ' CG ' ' H ' ' A' ' 88' ' ' ASN . 14.8 tptm 66.57 -130.62 0.18 Allowed 'General case' 0 N--CA 1.489 1.484 0 CA-C-O 121.624 0.726 . . . . 0.0 111.386 179.137 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' ASN . . . . . 0.427 ' H ' ' CG ' ' A' ' 87' ' ' LYS . 13.3 p30 -90.41 19.96 4.85 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.531 -0.731 . . . . 0.0 109.273 -179.317 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 19.5 m -57.09 144.09 35.96 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.405 -0.809 . . . . 0.0 109.899 -179.669 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 44.4 m -129.6 153.02 48.49 Favored 'General case' 0 N--CA 1.493 1.676 0 CA-C-O 121.398 0.618 . . . . 0.0 109.427 -179.709 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 96.8 mt -131.69 134.86 59.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.64 -0.663 . . . . 0.0 109.505 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 73.8 mm-40 -128.74 136.23 50.28 Favored 'General case' 0 N--CA 1.494 1.747 0 CA-C-O 121.49 0.662 . . . . 0.0 109.31 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.412 ' C ' HD12 ' A' ' 94' ' ' LEU . 88.5 tttt -82.01 124.99 30.28 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.525 -0.734 . . . . 0.0 109.937 -179.636 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.417 HD12 ' N ' ' A' ' 94' ' ' LEU . 11.0 mp -103.67 131.35 50.9 Favored 'General case' 0 N--CA 1.493 1.695 0 CA-C-O 121.61 0.719 . . . . 0.0 109.47 179.84 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 39.1 t -80.48 -6.67 58.51 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.661 -0.65 . . . . 0.0 109.3 179.7 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -107.36 104.45 52.54 Favored Pre-proline 0 N--CA 1.495 1.811 0 O-C-N 121.422 -0.798 . . . . 0.0 109.457 -179.635 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -74.54 149.43 39.0 Favored 'Trans proline' 0 N--CA 1.491 1.372 0 C-N-CA 122.328 2.019 . . . . 0.0 112.833 -179.246 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.405 ' H ' HG12 ' A' ' 98' ' ' ILE . 14.9 pt . . . . . 0 N--CA 1.49 1.535 0 CA-C-O 121.82 0.819 . . . . 0.0 110.757 -179.401 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_endo . . . . . 0 N--CA 1.495 1.587 0 CA-C-O 122.177 0.824 . . . . 0.0 112.752 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -86.6 88.89 7.75 Favored 'General case' 0 N--CA 1.488 1.463 0 CA-C-O 122.015 0.912 . . . . 0.0 109.487 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.411 ' N ' HD22 ' A' ' 5' ' ' LEU . 4.2 mm? -75.81 139.09 41.57 Favored 'General case' 0 N--CA 1.489 1.509 0 CA-C-O 121.608 0.718 . . . . 0.0 109.959 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 90.0 m -123.96 129.88 51.66 Favored 'General case' 0 N--CA 1.492 1.648 0 CA-C-O 121.643 0.735 . . . . 0.0 109.468 179.85 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 53.7 mtmt -80.08 153.91 28.44 Favored 'General case' 0 N--CA 1.489 1.485 0 CA-C-O 121.495 0.664 . . . . 0.0 110.374 -179.646 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 97.4 mt -62.71 -43.73 98.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 CA-C-O 121.627 0.727 . . . . 0.0 109.976 -179.837 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 13.0 p -65.45 -23.79 33.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.508 -0.745 . . . . 0.0 109.626 -179.676 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -78.81 -4.71 50.85 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.363 -0.836 . . . . 0.0 109.642 179.695 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 97.8 mt -82.23 118.8 30.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.174 -0.954 . . . . 0.0 109.672 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 3.1 m -146.89 6.88 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.565 -0.709 . . . . 0.0 109.275 -179.887 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 94.1 mt-10 -138.14 131.71 30.85 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.261 -0.9 . . . . 0.0 110.203 -179.457 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 51.5 p30 -83.78 153.15 24.26 Favored 'General case' 0 N--CA 1.488 1.438 0 CA-C-O 121.642 0.734 . . . . 0.0 110.442 -179.717 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 71.16 84.64 0.19 Allowed Glycine 0 N--CA 1.49 2.243 0 N-CA-C 110.084 -1.206 . . . . 0.0 110.084 179.577 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 27.3 tt0 -169.39 136.23 1.7 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.417 -1.049 . . . . 0.0 109.838 179.723 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 45.0 m95 -91.64 140.22 29.93 Favored 'General case' 0 N--CA 1.489 1.523 0 CA-C-O 121.567 0.698 . . . . 0.0 110.1 -179.83 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -168.51 170.39 9.73 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.559 -0.713 . . . . 0.0 109.561 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 62.8 m-80 -101.11 145.17 29.12 Favored 'General case' 0 N--CA 1.494 1.771 0 CA-C-O 121.624 0.726 . . . . 0.0 109.967 -179.458 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 51.9 tp -146.62 135.39 22.26 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.529 -0.732 . . . . 0.0 109.8 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 35.0 ttpt -120.3 137.12 54.43 Favored 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 179.312 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.418 ' CB ' ' OD1' ' A' ' 43' ' ' ASP . . . -160.65 172.52 16.98 Favored 'General case' 0 N--CA 1.492 1.659 0 C-N-CA 119.201 -1.0 . . . . 0.0 110.792 -179.377 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 33.0 ttpt -113.15 141.19 47.22 Favored 'General case' 0 N--CA 1.493 1.723 0 CA-C-O 121.583 0.706 . . . . 0.0 109.563 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 87.1 t -77.94 132.02 33.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.648 -0.658 . . . . 0.0 110.561 -179.172 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 30.2 pt -124.46 -30.08 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 179.004 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 68.6 tp60 -150.17 125.98 10.42 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.194 -0.941 . . . . 0.0 109.54 179.859 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.88 HD23 ' H ' ' A' ' 27' ' ' LEU . 1.1 pt? -138.96 135.67 34.6 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.707 -0.621 . . . . 0.0 109.978 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' TRP . . . . . 0.415 ' CE3' ' O ' ' A' ' 29' ' ' GLU . 81.9 t90 -126.84 123.78 38.11 Favored 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.415 ' O ' ' CE3' ' A' ' 28' ' ' TRP . 82.0 tt0 . . . . . 0 N--CA 1.49 1.568 0 CA-C-O 121.515 0.674 . . . . 0.0 110.046 -179.597 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' SER . . . . . 0.638 ' N ' ' HZ3' ' A' ' 54' ' ' LYS . 0.9 OUTLIER . . . . . 0 N--CA 1.49 1.554 0 N-CA-C 109.573 -0.529 . . . . 0.0 109.573 . . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 90.5 mt -108.92 119.11 57.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 CA-C-O 121.601 0.715 . . . . 0.0 110.054 -179.775 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 3.8 t -76.11 -50.91 13.38 Favored 'General case' 0 N--CA 1.489 1.519 0 CA-C-O 121.822 0.82 . . . . 0.0 109.635 179.489 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 49.2 tt0 -150.42 155.37 39.44 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.291 -0.881 . . . . 0.0 110.22 -179.604 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 8.2 p -142.65 139.8 28.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.678 -0.639 . . . . 0.0 109.414 179.416 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -171.99 -163.36 25.76 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.893 -1.283 . . . . 0.0 109.893 -179.77 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -134.71 148.1 50.23 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.552 -0.969 . . . . 0.0 109.85 -179.394 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 67.6 mt -112.95 137.99 50.5 Favored 'General case' 0 N--CA 1.493 1.688 0 CA-C-O 121.742 0.782 . . . . 0.0 109.564 -179.456 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.421 ' O ' ' OD1' ' A' ' 43' ' ' ASP . . . -83.24 143.86 22.2 Favored Glycine 0 N--CA 1.486 2.029 0 N-CA-C 110.779 -0.929 . . . . 0.0 110.779 -179.542 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.421 ' OD1' ' O ' ' A' ' 42' ' ' GLY . 75.2 m-20 -149.47 160.22 43.64 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.877 -0.778 . . . . 0.0 109.38 179.534 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 79.8 tt0 -65.58 -21.39 66.59 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.686 -0.634 . . . . 0.0 109.61 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 67.4 p -89.97 -2.78 58.21 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.327 -0.858 . . . . 0.0 109.514 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 133.15 -147.26 18.92 Favored Glycine 0 N--CA 1.497 2.705 0 N-CA-C 110.341 -1.104 . . . . 0.0 110.341 179.215 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 40.9 pt -125.66 152.62 32.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.901 -0.764 . . . . 0.0 109.741 -179.626 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 8.4 tp -142.5 140.12 28.68 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 CA-C-O 121.741 0.781 . . . . 0.0 110.059 -179.822 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 54.9 mtmt -87.88 145.94 25.81 Favored 'General case' 0 N--CA 1.49 1.545 0 CA-C-O 121.509 0.671 . . . . 0.0 110.004 179.854 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 38.9 p90 -137.57 153.05 50.01 Favored 'General case' 0 N--CA 1.49 1.545 0 CA-C-O 121.659 0.742 . . . . 0.0 109.783 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 83.6 m -129.86 130.97 45.91 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 96.6 mt -103.75 129.1 56.35 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 CA-C-O 121.702 0.763 . . . . 0.0 109.983 -179.773 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 89.7 m95 -90.63 129.6 36.74 Favored 'General case' 0 N--CA 1.487 1.404 0 CA-C-O 121.698 0.761 . . . . 0.0 109.273 179.457 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.638 ' HZ3' ' N ' ' A' ' 34' ' ' SER . 3.1 ptpp? . . . . . 0 N--CA 1.489 1.477 0 CA-C-O 121.516 0.674 . . . . 0.0 109.939 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 45.9 mt . . . . . 0 N--CA 1.496 1.85 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -69.74 155.42 66.05 Favored 'Trans proline' 0 N--CA 1.497 1.716 0 C-N-CA 122.921 2.414 . . . . 0.0 113.283 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 75.2 mt -71.73 141.67 49.79 Favored 'General case' 0 N--CA 1.493 1.682 0 CA-C-O 121.852 0.834 . . . . 0.0 110.778 -179.27 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.572 ' N ' HD12 ' A' ' 61' ' ' LEU . 10.3 mp -80.29 143.76 33.38 Favored 'General case' 0 N--CA 1.491 1.586 0 CA-C-O 121.688 0.756 . . . . 0.0 110.065 -179.919 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -83.41 152.66 24.91 Favored 'General case' 0 N--CA 1.49 1.568 0 CA-C-O 121.941 0.876 . . . . 0.0 110.987 -179.478 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 58.5 tt0 -82.03 136.78 35.2 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-O 121.663 0.744 . . . . 0.0 110.754 -179.676 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 82.4 4.55 90.12 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 110.166 -1.174 . . . . 0.0 110.166 179.434 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -110.51 146.86 35.26 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.444 -1.033 . . . . 0.0 110.723 -179.581 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 19.1 p -84.97 152.44 23.47 Favored 'General case' 0 N--CA 1.487 1.42 0 CA-C-O 121.558 0.694 . . . . 0.0 110.2 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 74.4 m-85 -145.34 145.29 31.14 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.349 -0.845 . . . . 0.0 110.275 179.651 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 23.5 tp -108.01 121.14 44.2 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 108.96 -0.755 . . . . 0.0 108.96 179.395 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 68.4 mt -100.59 133.38 45.12 Favored 'General case' 0 N--CA 1.49 1.551 0 CA-C-O 121.256 0.55 . . . . 0.0 109.629 -179.614 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.453 ' O ' ' OG ' ' A' ' 71' ' ' SER . 80.5 mtp85 -129.28 142.05 50.94 Favored 'General case' 0 N--CA 1.493 1.698 0 CA-C-O 121.653 0.74 . . . . 0.0 110.161 -179.806 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.488 ' HG ' ' HA ' ' A' ' 89' ' ' SER . 3.3 p 53.44 60.96 3.36 Favored 'General case' 0 N--CA 1.493 1.697 0 CA-C-O 121.416 0.627 . . . . 0.0 110.405 -179.889 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 3.3 m -114.23 133.11 61.34 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 179.024 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 8.9 p -95.47 135.56 29.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 CA-C-O 121.582 0.706 . . . . 0.0 109.986 -179.258 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -93.23 124.99 45.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 CA-C-O 121.767 0.794 . . . . 0.0 109.695 -179.6 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -100.11 142.86 16.1 Favored Glycine 0 N--CA 1.493 2.446 0 N-CA-C 110.478 -1.049 . . . . 0.0 110.478 -179.618 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 17.5 pt-20 -59.14 138.7 57.46 Favored 'General case' 0 N--CA 1.49 1.566 0 CA-C-O 121.592 0.71 . . . . 0.0 110.082 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' TYR . . . . . 0.533 ' O ' ' N ' ' A' ' 79' ' ' ASP . 79.3 t80 -137.08 81.25 1.86 Allowed 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 179.446 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' ASN . . . . . 0.502 ' C ' ' O ' ' A' ' 77' ' ' TYR . 28.8 t-20 15.15 -79.81 0.0 OUTLIER 'General case' 0 N--CA 1.51 2.533 0 CA-C-O 121.581 0.705 . . . . 0.0 112.146 -179.859 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.533 ' N ' ' O ' ' A' ' 77' ' ' TYR . 52.0 t0 -47.8 -69.94 0.11 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.433 -0.792 . . . . 0.0 109.893 -179.75 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 88.5 mtm180 -133.64 -130.44 0.17 Allowed 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.618 -0.677 . . . . 0.0 109.998 -178.895 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 88.4 m-85 -129.47 154.43 46.99 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.578 -0.701 . . . . 0.0 110.046 -178.796 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' GLN . . . . . 0.457 ' OE1' ' CG ' ' A' ' 77' ' ' TYR . 27.3 mt-30 -132.78 161.93 32.8 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.761 -0.587 . . . . 0.0 109.897 -179.703 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.43 HG23 ' O ' ' A' ' 83' ' ' VAL . 16.3 m -104.05 127.88 57.88 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 CA-C-O 121.61 0.719 . . . . 0.0 109.237 179.776 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 -106.39 126.45 52.26 Favored 'General case' 0 N--CA 1.494 1.74 0 CA-C-O 121.436 0.636 . . . . 0.0 109.793 -179.212 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 52.1 t -104.78 120.1 54.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 CA-C-O 121.581 0.705 . . . . 0.0 109.181 179.831 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' ASN . . . . . 0.404 ' O ' ' O ' ' A' ' 87' ' ' LYS . 7.8 p-10 -147.9 -175.98 5.09 Favored 'General case' 0 N--CA 1.489 1.52 0 CA-C-O 121.388 0.613 . . . . 0.0 110.039 -179.38 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.481 ' O ' ' CB ' ' A' ' 88' ' ' ASN . 85.4 tttt -37.83 157.32 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.737 0 CA-C-O 121.535 0.683 . . . . 0.0 111.016 -179.442 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' ASN . . . . . 0.481 ' CB ' ' O ' ' A' ' 87' ' ' LYS . 11.4 t-20 77.92 -28.88 0.16 Allowed 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 -179.725 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.488 ' HA ' ' HG ' ' A' ' 71' ' ' SER . 11.5 t -75.64 152.18 37.63 Favored 'General case' 0 N--CA 1.49 1.553 0 CA-C-O 121.557 0.694 . . . . 0.0 110.469 -179.696 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 32.1 t -132.54 141.68 48.84 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.553 -0.717 . . . . 0.0 109.702 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 96.4 mt -123.97 130.9 73.66 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 CA-C-O 121.273 0.559 . . . . 0.0 109.523 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -127.02 132.78 50.66 Favored 'General case' 0 N--CA 1.497 1.881 0 CA-C-O 121.621 0.724 . . . . 0.0 109.512 179.809 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.463 ' C ' HD12 ' A' ' 94' ' ' LEU . 88.2 tttt -81.22 127.49 32.74 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-O 121.617 0.723 . . . . 0.0 110.078 -179.533 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.463 HD12 ' C ' ' A' ' 93' ' ' LYS . 10.8 mp -103.51 131.85 50.27 Favored 'General case' 0 N--CA 1.495 1.784 0 CA-C-O 121.671 0.748 . . . . 0.0 110.09 -179.637 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 18.2 t -77.52 -6.05 52.22 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 179.284 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -102.25 110.36 62.46 Favored Pre-proline 0 N--CA 1.496 1.851 0 O-C-N 121.393 -0.817 . . . . 0.0 109.572 -179.75 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -75.78 152.02 36.74 Favored 'Trans proline' 0 N--CA 1.492 1.396 0 C-N-CA 122.795 2.33 . . . . 0.0 112.528 -178.975 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 56.3 mt . . . . . 0 N--CA 1.487 1.422 0 CA-C-O 121.951 0.882 . . . . 0.0 110.341 -179.589 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo . . . . . 0 N--CA 1.493 1.487 0 CA-C-O 121.774 0.656 . . . . 0.0 112.297 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 4' ' ' GLN . . . . . 0.587 ' H ' ' CD ' ' A' ' 4' ' ' GLN . 1.0 OUTLIER -76.44 90.78 3.27 Favored 'General case' 0 C--N 1.301 -1.527 0 CA-C-O 121.925 0.869 . . . . 0.0 109.463 -179.704 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 90.7 mt -81.78 139.83 34.58 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.663 -0.648 . . . . 0.0 109.574 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 99.2 m -127.1 131.05 50.93 Favored 'General case' 0 N--CA 1.494 1.753 0 CA-C-O 121.902 0.858 . . . . 0.0 109.86 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 70.2 mmtt -82.15 154.37 25.54 Favored 'General case' 0 C--N 1.301 -1.538 0 CA-C-O 121.648 0.737 . . . . 0.0 109.767 -179.401 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 96.2 mt -63.07 -43.52 99.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 CA-C-O 121.583 0.706 . . . . 0.0 109.568 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 13.6 p -65.24 -23.94 34.14 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 121.531 -0.731 . . . . 0.0 109.858 179.835 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 54.9 t0 -79.39 -2.48 41.9 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.382 -0.824 . . . . 0.0 109.67 -179.889 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 96.6 mt -78.7 117.94 25.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.108 -0.995 . . . . 0.0 109.908 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 3.3 m -136.02 -4.0 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 N-CA-C 108.979 -0.748 . . . . 0.0 108.979 179.533 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 79.4 mm-40 -139.76 137.8 35.37 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.248 -0.908 . . . . 0.0 110.21 -179.724 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 19.9 p-10 -91.85 159.93 15.55 Favored 'General case' 0 N--CA 1.491 1.588 0 CA-C-O 121.607 0.718 . . . . 0.0 110.162 179.821 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 78.69 2.14 84.88 Favored Glycine 0 N--CA 1.493 2.48 0 N-CA-C 109.559 -1.416 . . . . 0.0 109.559 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 33.1 tt0 -79.17 137.84 37.62 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.517 -0.99 . . . . 0.0 110.817 -179.239 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 68.9 m95 -93.45 132.35 37.79 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.781 -0.574 . . . . 0.0 109.692 179.629 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -174.29 176.78 2.38 Favored 'General case' 0 N--CA 1.493 1.722 0 C-N-CA 119.746 -0.782 . . . . 0.0 110.084 179.833 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 28.7 m-20 -104.48 142.68 34.19 Favored 'General case' 0 N--CA 1.495 1.781 0 CA-C-O 121.625 0.726 . . . . 0.0 110.095 -179.554 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 57.3 tp -133.71 138.92 46.09 Favored 'General case' 0 N--CA 1.493 1.705 0 CA-C-O 121.319 0.58 . . . . 0.0 109.485 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 19.5 ttpp -119.55 135.18 54.9 Favored 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 179.175 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -160.98 171.75 18.13 Favored 'General case' 0 N--CA 1.493 1.681 0 C-N-CA 119.598 -0.841 . . . . 0.0 110.166 -179.82 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -114.5 142.61 46.17 Favored 'General case' 0 N--CA 1.496 1.858 0 CA-C-O 121.756 0.789 . . . . 0.0 110.182 -179.71 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 21.5 t -84.77 117.57 30.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 CA-C-O 121.536 0.684 . . . . 0.0 109.963 -179.588 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 25.3 pt -107.86 -30.24 2.53 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 179.277 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 12.7 tt0 -163.99 133.45 3.95 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-O 121.699 0.761 . . . . 0.0 109.927 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.838 HD23 ' H ' ' A' ' 27' ' ' LEU . 1.1 pt? -143.3 137.8 29.09 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.784 -0.572 . . . . 0.0 109.696 179.932 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 2.6 m-90 -116.36 133.01 56.51 Favored 'General case' 0 N--CA 1.495 1.82 0 CA-C-O 121.567 0.699 . . . . 0.0 109.628 179.883 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 . . . . . 0 C--N 1.301 -1.518 0 CA-C-O 121.269 0.557 . . . . 0.0 109.534 179.648 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 34' ' ' SER . . . . . 0.42 ' O ' ' CE3' ' A' ' 53' ' ' TRP . 40.0 m . . . . . 0 N--CA 1.493 1.709 0 CA-C-O 121.091 0.472 . . . . 0.0 110.213 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.41 HG23 ' OG1' ' A' ' 51' ' ' THR . 94.7 mt -123.29 127.61 74.47 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.993 0 O-C-N 121.292 -0.88 . . . . 0.0 110.317 -179.054 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 45.9 t -75.83 -53.01 9.13 Favored 'General case' 0 N--CA 1.493 1.691 0 CA-C-O 121.904 0.859 . . . . 0.0 109.562 179.597 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' GLN . . . . . 0.483 ' OE1' ' N ' ' A' ' 38' ' ' VAL . 0.5 OUTLIER -147.04 147.67 30.89 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.195 -0.941 . . . . 0.0 109.941 -179.739 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.483 ' N ' ' OE1' ' A' ' 37' ' ' GLN . 8.6 p -134.01 138.49 50.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 CA-C-O 121.384 0.611 . . . . 0.0 109.464 179.872 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -160.64 -165.65 17.86 Favored Glycine 0 N--CA 1.488 2.163 0 C-N-CA 119.746 -1.216 . . . . 0.0 110.476 -179.591 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -132.49 143.83 50.04 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.898 -0.766 . . . . 0.0 109.512 -179.714 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 41.4 mt -116.28 136.12 53.28 Favored 'General case' 0 N--CA 1.494 1.749 0 CA-C-O 121.79 0.805 . . . . 0.0 109.707 -179.178 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -83.71 162.52 39.5 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 111.073 -0.811 . . . . 0.0 111.073 -179.438 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.552 ' OD1' ' N ' ' A' ' 44' ' ' GLU . 67.2 t0 -174.73 145.15 0.87 Allowed 'General case' 0 N--CA 1.49 1.557 0 CA-C-O 121.63 0.729 . . . . 0.0 109.129 179.705 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.552 ' N ' ' OD1' ' A' ' 43' ' ' ASP . 49.0 mt-10 -54.43 -14.88 1.38 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.654 -0.654 . . . . 0.0 110.072 179.927 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 39.5 p -93.55 -11.15 32.54 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.228 -0.92 . . . . 0.0 109.716 -179.894 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 138.86 -158.3 25.09 Favored Glycine 0 N--CA 1.498 2.806 0 C-N-CA 120.041 -1.076 . . . . 0.0 110.568 179.233 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 97.4 mt -124.44 134.2 67.34 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 O-C-N 121.906 -0.761 . . . . 0.0 109.443 -179.585 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 17.7 tt -128.82 141.93 45.31 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.998 0 CA-C-O 121.625 0.726 . . . . 0.0 109.935 -179.753 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 51.1 mtmt -86.46 152.0 23.04 Favored 'General case' 0 N--CA 1.491 1.609 0 CA-C-O 121.568 0.699 . . . . 0.0 110.108 -179.772 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 25.2 p90 -142.51 160.38 40.39 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.327 -0.858 . . . . 0.0 110.325 -179.688 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.41 ' OG1' HG23 ' A' ' 35' ' ' ILE . 1.9 t -138.58 137.52 37.08 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 -179.945 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 90.6 mt -105.93 118.03 52.76 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 CA-C-O 121.534 0.683 . . . . 0.0 109.834 179.865 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' TRP . . . . . 0.42 ' CE3' ' O ' ' A' ' 34' ' ' SER . 72.7 m95 -85.77 142.56 28.87 Favored 'General case' 0 N--CA 1.488 1.463 0 CA-C-O 121.579 0.704 . . . . 0.0 109.524 179.874 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 98.6 mttt . . . . . 0 N--CA 1.491 1.625 0 O-C-N 121.564 -0.71 . . . . 0.0 110.335 -179.53 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.552 ' C ' ' H ' ' A' ' 60' ' ' LEU . 18.4 mt . . . . . 0 N--CA 1.488 1.473 0 N-CA-C 109.346 -0.612 . . . . 0.0 109.346 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.414 ' O ' ' O ' ' A' ' 60' ' ' LEU . 29.9 Cg_endo -67.97 22.97 0.13 Allowed 'Trans proline' 0 N--CA 1.493 1.489 0 C-N-CA 122.2 1.933 . . . . 0.0 111.801 179.564 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.552 ' H ' ' C ' ' A' ' 58' ' ' LEU . 72.0 mt 58.59 151.86 0.01 OUTLIER 'General case' 0 C--N 1.293 -1.866 0 CA-C-O 121.802 0.81 . . . . 0.0 110.18 179.661 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.644 ' N ' HD12 ' A' ' 61' ' ' LEU . 9.0 mp -85.46 143.55 28.5 Favored 'General case' 0 N--CA 1.491 1.625 0 CA-C-O 121.541 0.686 . . . . 0.0 109.747 -179.667 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -87.5 151.27 23.16 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-O 121.937 0.875 . . . . 0.0 110.558 -178.968 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 58.1 tt0 -76.15 132.08 39.78 Favored 'General case' 0 N--CA 1.491 1.583 0 CA-C-O 121.87 0.843 . . . . 0.0 111.542 -178.811 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 93.16 -4.95 74.94 Favored Glycine 0 N--CA 1.496 2.688 0 N-CA-C 110.745 -0.942 . . . . 0.0 110.745 178.57 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.531 ' OE1' ' N ' ' A' ' 65' ' ' GLU . 58.3 mp0 -103.36 149.17 25.02 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 121.119 -1.224 . . . . 0.0 110.725 -179.379 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 8.8 p -93.22 135.15 34.7 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 179.58 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -125.72 143.04 51.21 Favored 'General case' 0 N--CA 1.497 1.879 0 CA-C-O 122.079 0.943 . . . . 0.0 111.017 -179.101 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 11.9 tp -106.57 104.88 14.67 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 179.653 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 54.3 mt -79.62 141.06 36.87 Favored 'General case' 0 N--CA 1.491 1.6 0 CA-C-O 121.342 0.591 . . . . 0.0 109.543 -179.688 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 85.3 mtp180 -136.06 141.85 44.31 Favored 'General case' 0 N--CA 1.494 1.733 0 CA-C-O 121.862 0.839 . . . . 0.0 110.71 -179.37 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 2.0 m 53.04 43.34 31.83 Favored 'General case' 0 N--CA 1.492 1.656 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.963 178.951 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 7.5 m -99.22 162.36 2.95 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.982 0 O-C-N 121.513 -0.742 . . . . 0.0 109.586 179.162 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 7.8 p -108.5 135.81 46.11 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 CA-C-O 121.688 0.756 . . . . 0.0 110.182 -178.971 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 98.7 t -78.89 125.0 38.05 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 CA-C-O 121.818 0.818 . . . . 0.0 109.375 -179.626 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -83.22 163.89 41.66 Favored Glycine 0 N--CA 1.486 2.016 0 N-CA-C 110.093 -1.203 . . . . 0.0 110.093 -179.632 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -114.73 127.88 55.99 Favored 'General case' 0 N--CA 1.493 1.722 0 CA-C-O 121.734 0.778 . . . . 0.0 109.881 -179.843 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' TYR . . . . . 0.469 ' CG ' ' OE1' ' A' ' 82' ' ' GLN . 42.4 m-85 -132.84 81.25 1.93 Allowed 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 179.557 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 79.4 m-20 50.67 -112.67 0.63 Allowed 'General case' 0 N--CA 1.495 1.788 0 CA-C-O 121.355 0.598 . . . . 0.0 110.698 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 94.9 m-20 -90.56 -7.0 54.01 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.141 -0.974 . . . . 0.0 109.544 -179.727 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 94.1 mtt180 -102.66 166.33 10.57 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.382 -0.824 . . . . 0.0 110.557 -178.987 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -128.71 150.61 50.19 Favored 'General case' 0 N--CA 1.496 1.859 0 CA-C-O 121.481 0.658 . . . . 0.0 109.706 179.882 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' GLN . . . . . 0.469 ' OE1' ' CG ' ' A' ' 77' ' ' TYR . 30.0 mt-30 -144.65 177.29 8.79 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.625 -0.672 . . . . 0.0 109.428 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 2.6 m -118.49 133.14 66.27 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 179.543 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 84.4 mt-30 -113.58 122.34 46.93 Favored 'General case' 0 N--CA 1.494 1.756 0 CA-C-O 121.859 0.838 . . . . 0.0 109.618 -179.078 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 22.0 t -90.07 129.29 41.19 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 5.8 p-10 -147.57 172.84 13.37 Favored 'General case' 0 N--CA 1.49 1.544 0 CA-C-O 121.86 0.838 . . . . 0.0 110.167 -179.278 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.475 ' O ' ' CB ' ' A' ' 88' ' ' ASN . 88.7 tttt -42.83 157.24 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 CA-C-O 121.768 0.794 . . . . 0.0 110.826 -179.761 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 88' ' ' ASN . . . . . 0.475 ' CB ' ' O ' ' A' ' 87' ' ' LYS . 2.1 t-20 79.31 -23.2 0.25 Allowed 'General case' 0 N--CA 1.494 1.753 0 CA-C-O 121.366 0.603 . . . . 0.0 109.814 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 11.1 m -74.81 148.1 40.61 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.287 -0.883 . . . . 0.0 110.199 -179.512 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 52.1 m -125.1 150.1 47.18 Favored 'General case' 0 N--CA 1.497 1.884 0 CA-C-O 121.58 0.705 . . . . 0.0 109.806 -179.797 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 98.0 mt -132.27 135.33 58.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 CA-C-O 121.365 0.602 . . . . 0.0 109.734 -179.42 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 81.1 tt0 -128.8 125.93 38.82 Favored 'General case' 0 N--CA 1.5 2.032 0 CA-C-O 121.61 0.719 . . . . 0.0 109.222 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.429 ' C ' HD12 ' A' ' 94' ' ' LEU . 26.7 mtmm -74.34 135.25 42.51 Favored 'General case' 0 N--CA 1.49 1.529 0 CA-C-O 121.566 0.698 . . . . 0.0 110.296 -179.608 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.429 HD12 ' C ' ' A' ' 93' ' ' LYS . 10.2 mp -105.45 134.53 48.42 Favored 'General case' 0 N--CA 1.494 1.766 0 CA-C-O 121.938 0.875 . . . . 0.0 109.82 179.899 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 93.3 p -83.19 -2.12 54.74 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 109.454 -0.572 . . . . 0.0 109.454 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -118.36 89.92 37.29 Favored Pre-proline 0 N--CA 1.5 2.027 0 O-C-N 121.539 -0.726 . . . . 0.0 109.195 179.873 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_exo -57.72 149.67 66.94 Favored 'Trans proline' 0 N--CA 1.492 1.406 0 C-N-CA 122.742 2.295 . . . . 0.0 112.6 179.538 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 29.8 pt . . . . . 0 N--CA 1.489 1.483 0 CA-C-O 121.827 0.822 . . . . 0.0 110.353 -179.73 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo . . . . . 0 N--CA 1.496 1.646 0 CA-C-O 121.417 0.507 . . . . 0.0 112.625 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 59.2 tt0 -87.08 81.09 8.15 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 179.845 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 77.5 mt -76.16 146.83 38.91 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.582 -0.699 . . . . 0.0 110.201 -179.119 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 96.8 m -123.33 130.33 52.58 Favored 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 179.751 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -79.54 155.16 28.32 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.475 -0.766 . . . . 0.0 110.313 -179.079 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.628 ' N ' HD12 ' A' ' 8' ' ' ILE . 3.0 mp -63.45 -43.24 98.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.627 -0.67 . . . . 0.0 109.671 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 13.1 p -66.93 -20.6 27.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.287 -0.883 . . . . 0.0 109.517 -179.688 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -82.68 -1.37 51.03 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.335 -0.853 . . . . 0.0 109.455 179.606 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 96.4 mt -83.89 111.63 20.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.317 -0.864 . . . . 0.0 109.551 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 24.0 m -154.44 18.45 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 179.754 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -134.75 144.3 47.63 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.533 -0.729 . . . . 0.0 110.105 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.41 ' O ' ' OD1' ' A' ' 14' ' ' ASN . 46.6 p-10 -93.16 137.76 32.2 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.492 -0.755 . . . . 0.0 110.264 -179.578 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 80.7 18.98 69.17 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.279 -1.528 . . . . 0.0 109.279 179.876 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 51.8 tt0 -73.31 133.76 43.98 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.295 -1.121 . . . . 0.0 109.818 -179.528 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' TRP . . . . . 0.414 ' O ' ' HB2' ' A' ' 18' ' ' ALA . 90.0 m95 -106.76 130.87 54.4 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.553 -0.717 . . . . 0.0 109.657 179.78 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.414 ' HB2' ' O ' ' A' ' 17' ' ' TRP . . . 178.32 -173.54 0.15 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.421 -0.799 . . . . 0.0 109.689 179.598 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 80.7 m-20 -99.29 152.69 19.64 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.545 -0.722 . . . . 0.0 109.407 -179.78 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.57 HD13 ' N ' ' A' ' 21' ' ' LYS . 0.4 OUTLIER -136.78 117.13 13.63 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.407 -0.808 . . . . 0.0 109.451 179.94 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.57 ' N ' HD13 ' A' ' 20' ' ' LEU . 35.2 ttpt -115.61 135.29 54.22 Favored 'General case' 0 N--CA 1.497 1.892 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 178.755 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -167.15 175.66 7.32 Favored 'General case' 0 N--CA 1.492 1.647 0 C-N-CA 119.31 -0.956 . . . . 0.0 110.158 179.646 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -103.29 142.11 34.76 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.57 -0.706 . . . . 0.0 109.702 -179.6 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.438 HG22 ' CD2' ' A' ' 41' ' ' LEU . 93.7 t -82.49 128.16 38.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.322 -0.861 . . . . 0.0 110.444 -179.496 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 96.7 mt -98.58 -59.94 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 179.119 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.622 ' NE2' ' CZ2' ' A' ' 28' ' ' TRP . 60.0 tt0 -146.84 147.69 31.11 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.346 -0.846 . . . . 0.0 109.728 179.955 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.461 HD23 ' N ' ' A' ' 27' ' ' LEU . 0.1 OUTLIER -125.31 151.23 46.29 Favored 'General case' 0 N--CA 1.496 1.828 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 -179.706 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 28' ' ' TRP . . . . . 0.622 ' CZ2' ' NE2' ' A' ' 26' ' ' GLN . 96.2 m95 -124.3 105.34 9.39 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 179.478 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.401 ' OE1' ' N ' ' A' ' 29' ' ' GLU . 59.4 mp0 . . . . . 0 C--N 1.302 -1.476 0 CA-C-O 121.542 0.687 . . . . 0.0 110.04 -179.164 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 77.7 p . . . . . 0 N--CA 1.489 1.495 0 N-CA-C 110.176 -0.305 . . . . 0.0 110.176 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 96.8 mt -112.79 128.35 69.55 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.069 0 O-C-N 121.478 -0.764 . . . . 0.0 109.878 -179.743 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.465 ' OG ' ' CA ' ' A' ' 54' ' ' LYS . 1.3 m -85.01 -67.98 0.76 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.751 -0.593 . . . . 0.0 109.528 -179.781 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 20.4 tt0 -139.68 151.48 45.95 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.477 -0.764 . . . . 0.0 109.595 -179.638 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 8.3 p -135.71 139.38 46.38 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 179.677 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -164.35 -163.13 16.68 Favored Glycine 0 N--CA 1.49 2.297 0 C-N-CA 119.341 -1.409 . . . . 0.0 110.434 -179.509 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.893 HD23 ' H ' ' A' ' 40' ' ' LEU . 1.4 pt? -136.98 146.23 45.12 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.553 -0.969 . . . . 0.0 109.852 179.904 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.438 ' CD2' HG22 ' A' ' 24' ' ' VAL . 52.9 mt -109.79 132.32 54.25 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.524 -0.735 . . . . 0.0 109.865 -179.274 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -79.06 163.82 49.52 Favored Glycine 0 N--CA 1.487 2.074 0 N-CA-C 110.512 -1.035 . . . . 0.0 110.512 -179.81 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.487 ' OD1' ' N ' ' A' ' 44' ' ' GLU . 49.7 t0 -171.8 138.52 1.09 Allowed 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.68 -0.894 . . . . 0.0 109.105 179.346 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.487 ' N ' ' OD1' ' A' ' 43' ' ' ASP . 18.1 pt-20 -55.7 -13.39 1.66 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.415 -0.803 . . . . 0.0 109.222 -179.773 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 13.9 p -98.29 -9.34 25.63 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.441 -0.787 . . . . 0.0 109.376 -179.794 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 144.92 -157.64 27.37 Favored Glycine 0 N--CA 1.497 2.749 0 C-N-CA 120.078 -1.058 . . . . 0.0 110.487 179.281 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 40.1 pt -126.35 154.57 35.94 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 O-C-N 121.738 -0.86 . . . . 0.0 109.584 -179.864 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.714 HD13 ' H ' ' A' ' 49' ' ' LYS . 0.3 OUTLIER -141.39 142.15 29.49 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 121.308 -0.87 . . . . 0.0 109.459 179.426 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.714 ' H ' HD13 ' A' ' 48' ' ' ILE . 99.1 mttt -91.24 143.97 26.1 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.658 -0.651 . . . . 0.0 109.348 179.455 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 33.4 p90 -137.61 152.51 49.45 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.168 -0.957 . . . . 0.0 109.674 -179.87 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 97.1 m -128.32 132.81 48.62 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 47.1 mm -99.99 121.33 50.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.405 -0.81 . . . . 0.0 109.875 -179.457 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' TRP . . . . . 0.482 ' CD1' ' OD1' ' A' ' 86' ' ' ASN . 89.2 m95 -82.16 124.19 29.66 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 108.72 -0.845 . . . . 0.0 108.72 179.368 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.465 ' CA ' ' OG ' ' A' ' 36' ' ' SER . 32.7 tttt . . . . . 0 C--N 1.301 -1.515 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 -179.219 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 37.3 mt . . . . . 0 N--CA 1.493 1.676 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -50.57 148.6 15.06 Favored 'Trans proline' 0 N--CA 1.496 1.637 0 C-N-CA 122.177 1.918 . . . . 0.0 112.797 179.133 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 84.0 mt -69.28 154.37 42.15 Favored 'General case' 0 N--CA 1.492 1.632 0 CA-C-O 121.836 0.827 . . . . 0.0 110.543 -179.195 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.702 ' N ' HD22 ' A' ' 61' ' ' LEU . 3.4 mm? -78.72 149.61 32.69 Favored 'General case' 0 C--N 1.304 -1.382 0 CA-C-O 121.421 0.629 . . . . 0.0 110.304 -178.663 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -106.26 146.49 30.27 Favored 'General case' 0 N--CA 1.495 1.823 0 CA-C-O 121.738 0.78 . . . . 0.0 110.057 -179.111 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 49.2 tt0 -81.34 134.21 35.54 Favored 'General case' 0 N--CA 1.488 1.468 0 CA-C-O 121.284 0.564 . . . . 0.0 110.81 -178.905 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 90.38 -6.65 82.3 Favored Glycine 0 N--CA 1.495 2.611 0 N-CA-C 110.355 -1.098 . . . . 0.0 110.355 178.717 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -104.6 150.47 24.63 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.37 -1.076 . . . . 0.0 110.749 -179.438 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 8.4 m -95.37 136.59 35.54 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.698 -0.626 . . . . 0.0 109.358 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 72.5 m-85 -121.87 145.1 48.41 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-O 121.748 0.785 . . . . 0.0 110.142 -179.848 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 14.0 tp -110.34 112.14 23.89 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 179.344 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 71.4 mt -95.86 131.99 41.6 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 -179.827 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 80.4 mtp85 -123.52 141.87 51.57 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.561 -0.712 . . . . 0.0 110.537 -179.334 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 9.2 t 57.81 65.04 1.4 Allowed 'General case' 0 N--CA 1.493 1.692 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.547 179.397 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 2.9 m -121.76 160.82 22.97 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 179.258 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 14.8 p -118.7 133.22 66.24 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 CA-C-O 121.63 0.728 . . . . 0.0 109.45 -179.258 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 14.0 t -85.6 121.37 37.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.654 -0.654 . . . . 0.0 109.68 -179.193 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -98.87 -172.35 31.6 Favored Glycine 0 N--CA 1.494 2.531 0 N-CA-C 109.784 -1.327 . . . . 0.0 109.784 -179.773 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -111.31 120.75 43.29 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.644 -0.916 . . . . 0.0 109.65 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' TYR . . . . . 0.496 ' O ' ' N ' ' A' ' 79' ' ' ASP . 86.7 t80 -108.67 80.77 1.37 Allowed 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 179.44 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' ASN . . . . . 0.455 ' C ' ' O ' ' A' ' 77' ' ' TYR . 94.3 m-20 31.07 -91.34 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.988 0 CA-C-O 121.482 0.658 . . . . 0.0 111.196 179.855 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.496 ' N ' ' O ' ' A' ' 77' ' ' TYR . 66.5 t0 -51.52 -68.69 0.15 Allowed 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.619 -0.676 . . . . 0.0 110.656 -179.453 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 85.2 mtp180 -120.96 -163.99 1.08 Allowed 'General case' 0 N--CA 1.501 2.123 0 O-C-N 121.528 -0.732 . . . . 0.0 110.336 -178.774 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 79.6 m-85 -99.08 162.93 12.79 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.56 -0.712 . . . . 0.0 109.793 -179.037 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 27.8 pt20 -141.95 162.01 36.55 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.377 -0.827 . . . . 0.0 109.834 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 2.7 m -107.96 131.18 59.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 179.81 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -106.7 131.72 53.51 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.676 -0.64 . . . . 0.0 110.041 -178.996 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 96.3 t -103.15 124.31 57.19 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' ASN . . . . . 0.482 ' OD1' ' CD1' ' A' ' 53' ' ' TRP . 80.3 m-20 -125.01 -176.52 3.58 Favored 'General case' 0 N--CA 1.496 1.834 0 CA-C-O 121.524 0.678 . . . . 0.0 109.739 -179.528 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 62.9 pttt -59.86 -33.43 71.78 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.741 -0.6 . . . . 0.0 109.862 -179.888 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 52.3 t-20 -63.45 -38.23 90.33 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.393 -0.817 . . . . 0.0 109.523 -179.558 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 27.7 t -76.57 164.78 25.6 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.34 -0.85 . . . . 0.0 110.325 -179.064 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 95.1 p -133.06 158.3 43.11 Favored 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 179.825 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 96.8 mt -125.54 132.63 70.71 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 O-C-N 121.668 -0.645 . . . . 0.0 110.02 -179.383 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 31.7 mm-40 -136.15 135.42 39.2 Favored 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 179.633 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.451 ' C ' HD12 ' A' ' 94' ' ' LEU . 97.3 mttt -84.19 136.09 34.1 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.442 -0.786 . . . . 0.0 109.962 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.451 HD12 ' C ' ' A' ' 93' ' ' LYS . 8.9 mp -108.25 133.66 52.18 Favored 'General case' 0 N--CA 1.499 1.986 0 CA-C-O 121.623 0.725 . . . . 0.0 109.384 179.503 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 89.7 p -76.09 1.95 14.2 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 179.637 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.416 ' OE2' ' O ' ' A' ' 97' ' ' PRO . 8.7 tm-20 -109.52 95.72 20.29 Favored Pre-proline 0 N--CA 1.497 1.883 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 -179.948 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 97' ' ' PRO . . . . . 0.416 ' O ' ' OE2' ' A' ' 96' ' ' GLU . 64.7 Cg_endo -76.78 158.89 35.13 Favored 'Trans proline' 0 N--CA 1.491 1.363 0 C-N-CA 122.241 1.961 . . . . 0.0 112.351 -179.149 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 86.8 mt . . . . . 0 N--CA 1.496 1.862 0 O-C-N 121.499 -0.751 . . . . 0.0 109.79 -179.574 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo . . . . . 0 N--CA 1.496 1.622 0 CA-C-O 121.753 0.647 . . . . 0.0 112.269 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 4' ' ' GLN . . . . . 0.556 ' H ' ' CD ' ' A' ' 4' ' ' GLN . 21.9 mp0 -72.72 92.61 1.57 Allowed 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.291 -0.88 . . . . 0.0 109.685 -179.719 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 86.6 mt -74.51 147.32 41.97 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.487 -0.758 . . . . 0.0 109.567 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 97.8 m -124.12 130.5 52.65 Favored 'General case' 0 N--CA 1.495 1.779 0 CA-C-O 121.736 0.779 . . . . 0.0 109.754 -179.897 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -98.87 159.12 15.18 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.597 -0.689 . . . . 0.0 110.048 -179.675 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 96.6 mt -63.84 -42.74 96.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.412 -0.805 . . . . 0.0 109.557 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 14.8 p -63.32 -23.58 33.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.24 -0.913 . . . . 0.0 109.441 -179.843 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 94.7 m-20 -78.9 -4.15 48.29 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.213 -0.929 . . . . 0.0 109.345 179.58 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 5.6 mm -69.12 98.95 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.079 -1.013 . . . . 0.0 109.639 -179.773 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 2.5 p -116.12 -40.11 2.7 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.36 0 O-C-N 121.625 -0.672 . . . . 0.0 109.3 179.871 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 79.4 tt0 -126.28 143.33 51.19 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.294 -0.879 . . . . 0.0 110.26 -178.974 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 55.8 p30 -87.14 163.16 17.12 Favored 'General case' 0 N--CA 1.492 1.627 0 CA-C-O 121.71 0.767 . . . . 0.0 110.447 -179.674 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 78.07 13.04 83.78 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 109.267 -1.533 . . . . 0.0 109.267 -179.494 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 65.6 tt0 -83.58 129.94 34.98 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.187 -1.184 . . . . 0.0 110.082 -179.7 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 84.1 m95 -93.12 129.16 39.2 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.265 -0.897 . . . . 0.0 109.929 -179.734 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -174.35 -173.33 0.76 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.6 -0.687 . . . . 0.0 109.303 179.581 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 73.5 m-20 -105.64 145.25 31.27 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.515 -0.741 . . . . 0.0 109.822 -179.463 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 40.5 tp -128.07 132.14 49.06 Favored 'General case' 0 N--CA 1.498 1.968 0 CA-C-O 121.69 0.757 . . . . 0.0 109.9 179.766 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 38.2 ttmt -116.09 130.18 56.69 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 179.359 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -166.65 179.01 5.65 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.84 -1.162 . . . . 0.0 110.775 -179.589 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 64.5 tttp -114.55 139.93 49.18 Favored 'General case' 0 N--CA 1.497 1.919 0 CA-C-O 121.619 0.723 . . . . 0.0 109.968 -179.682 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 87.6 t -81.02 115.73 24.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.413 -0.804 . . . . 0.0 109.943 -179.766 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 19.1 mm -93.92 -48.93 12.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.297 -0.877 . . . . 0.0 109.645 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 82.4 mt-30 -144.62 144.97 31.53 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.04 -1.038 . . . . 0.0 110.199 -179.347 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.835 ' H ' HD23 ' A' ' 27' ' ' LEU . 1.1 pt? -141.95 133.32 26.54 Favored 'General case' 0 N--CA 1.492 1.675 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 179.836 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 3.4 m0 -118.86 146.51 44.83 Favored 'General case' 0 N--CA 1.499 2.014 0 CA-C-O 121.741 0.781 . . . . 0.0 109.999 -179.347 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 50.0 tp10 . . . . . 0 N--CA 1.491 1.6 0 O-C-N 121.405 -0.81 . . . . 0.0 109.576 -179.808 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 40.1 t . . . . . 0 N--CA 1.495 1.806 0 CA-C-O 121.316 0.579 . . . . 0.0 110.555 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 96.9 mt -103.15 133.82 45.94 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 O-C-N 121.121 -0.987 . . . . 0.0 109.794 -179.523 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 28.7 t -86.33 -70.61 0.59 Allowed 'General case' 0 N--CA 1.49 1.544 0 CA-C-O 121.664 0.745 . . . . 0.0 109.804 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -141.19 153.93 45.57 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.088 -1.007 . . . . 0.0 110.375 -179.15 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 27.8 m -135.98 158.51 38.97 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 179.312 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -178.23 -150.91 8.99 Favored Glycine 0 N--CA 1.487 2.045 0 C-N-CA 119.467 -1.349 . . . . 0.0 110.033 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.41 HD23 ' N ' ' A' ' 40' ' ' LEU . 0.2 OUTLIER -135.25 148.11 49.48 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.655 -0.909 . . . . 0.0 109.374 -179.744 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 70.3 mt -111.54 128.4 56.01 Favored 'General case' 0 N--CA 1.495 1.787 0 CA-C-O 121.668 0.747 . . . . 0.0 109.31 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -80.44 158.03 41.1 Favored Glycine 0 N--CA 1.487 2.095 0 N-CA-C 110.012 -1.235 . . . . 0.0 110.012 -179.751 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.529 ' OD1' ' N ' ' A' ' 44' ' ' GLU . 67.2 t0 -172.58 143.14 1.3 Allowed 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.493 -1.004 . . . . 0.0 109.045 -179.923 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.529 ' N ' ' OD1' ' A' ' 43' ' ' ASP . 96.9 mt-10 -54.88 -14.45 1.45 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.427 -0.795 . . . . 0.0 109.793 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 37.4 p -93.33 -12.94 28.81 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.024 -1.047 . . . . 0.0 109.292 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 141.15 -157.32 25.99 Favored Glycine 0 N--CA 1.498 2.792 0 C-N-CA 119.876 -1.154 . . . . 0.0 110.245 179.378 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 41.5 pt -124.85 150.55 29.86 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 O-C-N 121.581 -0.953 . . . . 0.0 109.518 -179.451 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 20.8 tt -146.94 150.08 15.15 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 121.235 -0.916 . . . . 0.0 109.7 -179.741 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 72.5 mmtt -84.09 150.21 25.71 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.466 -0.771 . . . . 0.0 110.402 -179.23 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 17.3 p90 -143.65 151.76 40.51 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.321 -0.862 . . . . 0.0 109.19 179.52 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 35.0 m -132.99 137.18 46.44 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.629 -0.669 . . . . 0.0 109.469 179.807 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 29.7 mm -98.48 122.56 50.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.225 -0.922 . . . . 0.0 109.735 -179.676 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 97.3 m95 -98.17 140.97 31.68 Favored 'General case' 0 N--CA 1.49 1.543 0 CA-C-O 121.582 0.706 . . . . 0.0 109.639 179.841 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 29.0 mmtm . . . . . 0 N--CA 1.494 1.733 0 O-C-N 121.144 -0.973 . . . . 0.0 109.781 179.547 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.487 ' CD1' HG12 ' A' ' 85' ' ' VAL . 29.8 mt . . . . . 0 N--CA 1.497 1.91 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -69.76 159.42 53.46 Favored 'Trans proline' 0 N--CA 1.497 1.72 0 C-N-CA 122.837 2.358 . . . . 0.0 113.195 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 97.2 mt -71.52 141.61 50.12 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.274 -0.891 . . . . 0.0 109.98 -179.814 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.596 ' N ' HD12 ' A' ' 61' ' ' LEU . 9.6 mp -80.04 149.04 30.84 Favored 'General case' 0 N--CA 1.493 1.724 0 CA-C-O 121.727 0.775 . . . . 0.0 110.705 -179.084 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -104.91 126.63 52.18 Favored 'General case' 0 N--CA 1.497 1.914 0 CA-C-O 121.802 0.81 . . . . 0.0 109.758 -179.911 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 58.2 tt0 -64.49 147.89 51.79 Favored 'General case' 0 N--CA 1.496 1.855 0 CA-C-O 121.965 0.888 . . . . 0.0 111.835 -178.933 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 81.05 22.94 60.15 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.937 -1.265 . . . . 0.0 109.937 178.825 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -139.26 145.46 39.21 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.248 -1.148 . . . . 0.0 110.094 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 11.1 p -84.42 149.73 25.79 Favored 'General case' 0 N--CA 1.486 1.333 0 CA-C-O 121.606 0.717 . . . . 0.0 109.856 179.915 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 66.6 m-85 -143.58 151.91 40.77 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.233 -0.917 . . . . 0.0 110.307 -179.867 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 21.9 tp -112.92 121.95 46.2 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 179.235 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 71.8 mt -100.84 130.74 46.9 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.393 -0.817 . . . . 0.0 109.849 -179.162 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 83.4 mtp180 -127.09 144.55 51.0 Favored 'General case' 0 N--CA 1.498 1.944 0 CA-C-O 121.878 0.847 . . . . 0.0 110.49 -179.876 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.8 m 58.34 57.43 3.91 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.798 -0.564 . . . . 0.0 110.49 179.385 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 17.9 m -118.81 164.67 14.85 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.98 0 O-C-N 121.598 -0.688 . . . . 0.0 109.656 179.33 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 11.8 p -120.47 136.11 58.56 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 CA-C-O 121.65 0.738 . . . . 0.0 109.379 -179.712 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 66.9 t -81.47 115.29 23.79 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 CA-C-O 121.831 0.824 . . . . 0.0 109.889 -178.863 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -84.92 167.32 41.89 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 110.024 -1.23 . . . . 0.0 110.024 -179.563 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -105.91 124.2 49.19 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.466 -1.02 . . . . 0.0 109.624 180.0 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 52.0 t80 -120.05 82.58 1.91 Allowed 'General case' 0 N--CA 1.492 1.637 0 CA-C-O 121.984 0.897 . . . . 0.0 108.807 179.719 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' ASN . . . . . 0.451 ' CG ' ' N ' ' A' ' 79' ' ' ASP . 50.1 t30 42.95 -117.63 0.46 Allowed 'General case' 0 N--CA 1.501 2.087 0 CA-C-O 121.729 0.776 . . . . 0.0 112.179 179.774 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.451 ' N ' ' CG ' ' A' ' 78' ' ' ASN . 42.4 t0 -70.22 -35.16 73.7 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.184 -0.947 . . . . 0.0 109.991 -178.806 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 84.4 mtt85 -101.22 -170.88 1.9 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.267 -0.896 . . . . 0.0 110.011 -179.377 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -127.9 150.53 49.83 Favored 'General case' 0 N--CA 1.494 1.756 0 CA-C-O 121.694 0.759 . . . . 0.0 110.075 -179.297 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 13.1 tt0 -133.13 126.44 31.73 Favored 'General case' 0 N--CA 1.49 1.528 0 CA-C-O 121.493 0.663 . . . . 0.0 109.351 -179.803 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 34.1 m -81.13 141.21 15.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.477 -0.764 . . . . 0.0 109.553 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 87.7 mt-30 -111.54 120.82 43.4 Favored 'General case' 0 N--CA 1.495 1.812 0 CA-C-O 121.799 0.809 . . . . 0.0 109.738 -179.449 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.487 HG12 ' CD1' ' A' ' 58' ' ' LEU . 4.5 t -93.24 99.3 9.45 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 179.655 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 22.5 p30 -150.67 -176.7 5.61 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.495 -0.753 . . . . 0.0 109.313 -179.571 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.445 ' CG ' ' H ' ' A' ' 88' ' ' ASN . 14.4 tptm 66.27 -137.93 0.16 Allowed 'General case' 0 N--CA 1.491 1.621 0 CA-C-O 121.806 0.812 . . . . 0.0 110.826 179.588 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 88' ' ' ASN . . . . . 0.445 ' H ' ' CG ' ' A' ' 87' ' ' LYS . 92.9 m-20 -86.14 22.62 1.71 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.474 -0.766 . . . . 0.0 109.227 -179.574 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 30.9 t -58.61 141.78 51.31 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.193 -0.942 . . . . 0.0 109.672 -179.759 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 64.0 m -127.16 152.32 47.5 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.546 -0.721 . . . . 0.0 109.318 -179.735 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 97.3 mt -128.07 131.73 69.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.692 -0.63 . . . . 0.0 109.351 -179.707 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -132.03 131.76 42.78 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.523 -0.736 . . . . 0.0 109.301 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 4.8 ttpm? -79.61 136.69 36.9 Favored 'General case' 0 N--CA 1.489 1.487 0 CA-C-O 121.789 0.804 . . . . 0.0 110.31 -179.588 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 70.9 mt -98.15 132.85 43.32 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.42 -0.8 . . . . 0.0 109.744 -179.797 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 31.3 t -75.51 3.84 8.62 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.481 -0.762 . . . . 0.0 109.342 179.642 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -118.36 90.28 38.22 Favored Pre-proline 0 N--CA 1.495 1.812 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 179.593 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_exo -56.09 147.38 64.93 Favored 'Trans proline' 0 N--CA 1.495 1.606 0 C-N-CA 122.829 2.353 . . . . 0.0 112.394 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 90.6 mt . . . . . 0 N--CA 1.492 1.657 0 O-C-N 121.299 -0.876 . . . . 0.0 109.869 -179.205 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_exo . . . . . 0 N--CA 1.494 1.517 0 CA-C-O 121.624 0.593 . . . . 0.0 112.261 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 4' ' ' GLN . . . . . 0.419 ' H ' ' HG2' ' A' ' 4' ' ' GLN . 11.9 pt20 -74.88 72.35 2.07 Favored 'General case' 0 C--N 1.3 -1.55 0 CA-C-O 121.786 0.803 . . . . 0.0 109.905 -179.501 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.431 HD23 HD22 ' A' ' 19' ' ' ASN . 18.8 mt -65.74 137.3 57.18 Favored 'General case' 0 N--CA 1.489 1.479 0 CA-C-O 121.453 0.644 . . . . 0.0 109.734 179.882 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 91.8 m -128.54 135.5 49.48 Favored 'General case' 0 N--CA 1.494 1.728 0 CA-C-O 121.836 0.827 . . . . 0.0 109.811 -179.909 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 65.4 mttp -72.92 151.15 42.02 Favored 'General case' 0 N--CA 1.49 1.572 0 CA-C-O 121.704 0.764 . . . . 0.0 109.975 -179.458 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 92.4 mt -63.25 -43.13 98.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 CA-C-O 121.369 0.604 . . . . 0.0 109.379 -179.393 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 8.3 p -65.7 -24.07 33.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 -179.05 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -79.05 -6.47 56.48 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.639 -0.663 . . . . 0.0 109.327 -179.434 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 97.5 mt -85.89 113.79 24.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 CA-C-O 121.78 0.8 . . . . 0.0 109.543 179.907 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 31.7 m -150.12 12.21 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -124.97 137.51 54.25 Favored 'General case' 0 N--CA 1.501 2.123 0 CA-C-O 121.884 0.85 . . . . 0.0 110.268 -179.861 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 48.1 p-10 -84.08 140.8 31.58 Favored 'General case' 0 N--CA 1.489 1.518 0 CA-C-O 121.619 0.723 . . . . 0.0 109.881 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 75.99 19.0 79.16 Favored Glycine 0 N--CA 1.492 2.407 0 N-CA-C 109.647 -1.381 . . . . 0.0 109.647 179.626 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 57.0 tt0 -78.77 133.82 37.07 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.59 -0.947 . . . . 0.0 110.209 -179.623 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 84.3 m95 -106.78 130.64 54.45 Favored 'General case' 0 N--CA 1.494 1.748 0 CA-C-O 121.585 0.707 . . . . 0.0 110.148 -179.751 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -178.9 175.51 1.01 Allowed 'General case' 0 N--CA 1.493 1.689 0 CA-C-O 121.693 0.758 . . . . 0.0 110.391 179.248 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.522 HD21 HD11 ' A' ' 68' ' ' LEU . 1.4 t30 -102.05 150.01 23.67 Favored 'General case' 0 N--CA 1.498 1.944 0 CA-C-O 121.902 0.858 . . . . 0.0 110.137 -179.432 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 7.2 tt -147.56 138.2 23.32 Favored 'General case' 0 C--N 1.305 -1.36 0 CA-C-O 121.779 0.8 . . . . 0.0 110.449 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 37.8 ttmt -109.83 133.22 53.4 Favored 'General case' 0 N--CA 1.496 1.863 0 CA-C-O 121.594 0.711 . . . . 0.0 109.561 179.477 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -163.18 170.5 17.68 Favored 'General case' 0 N--CA 1.494 1.746 0 CA-C-O 121.762 0.791 . . . . 0.0 110.589 179.718 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.417 ' HZ3' ' N ' ' A' ' 65' ' ' GLU . 17.1 ttmm -113.83 142.31 46.24 Favored 'General case' 0 N--CA 1.498 1.957 0 CA-C-O 121.608 0.718 . . . . 0.0 109.934 -179.717 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.402 HG22 ' CD2' ' A' ' 41' ' ' LEU . 98.8 t -81.98 122.2 36.43 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 CA-C-O 121.528 0.68 . . . . 0.0 110.239 -179.515 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 26.0 mm -93.88 -44.98 13.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 CA-C-O 121.086 0.469 . . . . 0.0 110.031 -179.507 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.825 ' C ' HD13 ' A' ' 27' ' ' LEU . 59.3 tt0 -158.14 147.62 19.66 Favored 'General case' 0 N--CA 1.492 1.642 0 CA-C-O 122.182 0.992 . . . . 0.0 110.334 -179.072 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 1.041 HD22 ' H ' ' A' ' 27' ' ' LEU . 0.0 OUTLIER -116.87 151.46 36.52 Favored 'General case' 0 N--CA 1.502 2.13 0 CA-C-O 121.632 0.729 . . . . 0.0 109.272 -179.205 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 23.9 t90 -138.15 111.18 7.8 Favored 'General case' 0 N--CA 1.493 1.675 0 CA-C-O 121.879 0.847 . . . . 0.0 109.678 179.148 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 . . . . . 0 N--CA 1.491 1.602 0 CA-C-O 121.675 0.75 . . . . 0.0 110.168 -179.618 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 16.4 m . . . . . 0 N--CA 1.492 1.649 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 85.6 mt -103.07 128.61 55.86 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 CA-C-O 121.912 0.863 . . . . 0.0 109.39 -179.56 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 28.1 t -74.92 -75.14 0.17 Allowed 'General case' 0 N--CA 1.489 1.52 0 CA-C-O 121.508 0.67 . . . . 0.0 109.852 -179.273 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 13.1 pt20 -139.78 156.51 46.72 Favored 'General case' 0 N--CA 1.494 1.736 0 CA-C-O 122.045 0.926 . . . . 0.0 110.488 -179.064 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 56.6 t -130.92 136.15 58.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 CA-C-O 121.639 0.733 . . . . 0.0 109.367 179.856 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -153.63 -151.26 5.69 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 110.11 -1.196 . . . . 0.0 110.11 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.4 HD23 ' N ' ' A' ' 40' ' ' LEU . 0.2 OUTLIER -134.48 152.09 51.56 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.739 -0.859 . . . . 0.0 109.772 -179.414 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.402 ' CD2' HG22 ' A' ' 24' ' ' VAL . 53.0 mt -116.85 126.46 53.05 Favored 'General case' 0 N--CA 1.494 1.753 0 CA-C-O 121.84 0.829 . . . . 0.0 109.77 -179.867 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -85.08 150.59 25.07 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 110.959 -0.856 . . . . 0.0 110.959 -179.573 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 44.3 t0 -168.55 164.37 12.46 Favored 'General case' 0 N--CA 1.489 1.494 0 CA-C-O 121.723 0.773 . . . . 0.0 109.583 179.335 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -66.06 -22.38 66.42 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.864 -0.523 . . . . 0.0 109.923 -179.181 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 65.5 p -88.48 -6.02 57.88 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.289 -0.882 . . . . 0.0 109.723 -179.433 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 134.45 -157.65 23.03 Favored Glycine 0 N--CA 1.5 2.956 0 C-N-CA 120.347 -0.93 . . . . 0.0 110.987 178.709 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 4.9 mp -126.02 133.68 68.34 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 CA-C-O 121.491 0.662 . . . . 0.0 109.539 -179.465 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 20.0 tt -127.67 151.83 34.99 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 CA-C-O 122.023 0.916 . . . . 0.0 110.439 -179.457 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 28.2 mmtp -83.94 153.24 24.04 Favored 'General case' 0 N--CA 1.489 1.507 0 CA-C-O 121.543 0.687 . . . . 0.0 109.709 -179.346 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 17.2 p90 -147.2 154.99 41.71 Favored 'General case' 0 N--CA 1.491 1.623 0 CA-C-O 122.03 0.919 . . . . 0.0 110.289 179.8 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 13.8 t -142.22 139.05 31.88 Favored 'General case' 0 N--CA 1.492 1.648 0 CA-C-O 121.684 0.755 . . . . 0.0 109.629 179.493 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 85.8 mt -103.83 116.37 47.49 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 CA-C-O 121.84 0.828 . . . . 0.0 109.803 -179.793 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 73.3 m95 -86.04 138.42 31.97 Favored 'General case' 0 N--CA 1.491 1.591 0 CA-C-O 121.537 0.684 . . . . 0.0 109.402 179.8 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 18.8 mmmt . . . . . 0 N--CA 1.491 1.587 0 CA-C-O 121.451 0.643 . . . . 0.0 109.453 -179.739 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 14.8 mt . . . . . 0 N--CA 1.488 1.473 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -71.54 156.37 58.05 Favored 'Trans proline' 0 C--N 1.31 -1.468 0 C-N-CA 122.561 2.174 . . . . 0.0 112.711 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 82.9 mt -72.41 144.98 47.96 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-O 121.894 0.855 . . . . 0.0 110.706 -179.439 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.568 ' N ' HD12 ' A' ' 61' ' ' LEU . 9.9 mp -86.86 137.62 32.25 Favored 'General case' 0 N--CA 1.488 1.427 0 CA-C-O 121.554 0.693 . . . . 0.0 109.625 -179.71 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.529 ' N ' ' OH ' ' A' ' 67' ' ' TYR . 97.8 mt-10 -80.74 144.9 31.83 Favored 'General case' 0 C--N 1.301 -1.516 0 CA-C-O 121.659 0.742 . . . . 0.0 110.27 -179.778 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' GLN . . . . . 0.417 ' C ' ' OE1' ' A' ' 65' ' ' GLU . 57.9 tt0 -80.85 125.78 30.52 Favored 'General case' 0 N--CA 1.488 1.465 0 CA-C-O 121.541 0.686 . . . . 0.0 110.437 -179.231 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 96.62 31.46 7.08 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.382 -1.487 . . . . 0.0 109.382 179.304 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.45 ' OE1' ' N ' ' A' ' 65' ' ' GLU . 59.9 mp0 -139.53 145.48 38.74 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.54 -0.977 . . . . 0.0 110.142 179.472 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 30.0 t -75.79 145.14 40.94 Favored 'General case' 0 N--CA 1.489 1.478 0 CA-C-O 121.481 0.658 . . . . 0.0 110.087 -179.908 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.529 ' OH ' ' N ' ' A' ' 62' ' ' GLU . 94.0 m-85 -137.03 144.76 43.4 Favored 'General case' 0 N--CA 1.494 1.726 0 CA-C-O 121.9 0.857 . . . . 0.0 110.477 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.567 HD13 ' N ' ' A' ' 69' ' ' LEU . 0.2 OUTLIER -107.0 119.93 40.7 Favored 'General case' 0 N--CA 1.487 1.414 0 CA-C-O 121.551 0.691 . . . . 0.0 109.405 -179.541 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.567 ' N ' HD13 ' A' ' 68' ' ' LEU . 73.4 mt -93.83 110.44 22.09 Favored 'General case' 0 N--CA 1.491 1.591 0 CA-C-O 121.521 0.677 . . . . 0.0 109.335 179.909 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.532 ' NH2' ' OE1' ' A' ' 92' ' ' GLU . 94.6 mtt180 -102.36 135.39 44.05 Favored 'General case' 0 N--CA 1.492 1.656 0 CA-C-O 121.966 0.888 . . . . 0.0 110.438 -179.774 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 13.4 m 39.85 79.77 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.673 0 CA-C-N 115.03 -0.986 . . . . 0.0 110.806 179.86 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 22.3 m -120.98 163.34 18.76 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 CA-C-O 121.594 0.711 . . . . 0.0 109.921 179.082 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 8.4 p -120.96 135.98 59.41 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 CA-C-O 121.731 0.777 . . . . 0.0 109.953 -179.251 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 9.4 t -91.34 115.76 31.13 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 CA-C-O 121.809 0.814 . . . . 0.0 109.867 -179.534 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.504 ' O ' ' NE2' ' A' ' 82' ' ' GLN . . . -99.43 177.37 29.6 Favored Glycine 0 N--CA 1.492 2.427 0 N-CA-C 110.083 -1.207 . . . . 0.0 110.083 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -103.14 115.88 31.43 Favored 'General case' 0 N--CA 1.494 1.742 0 CA-C-O 121.767 0.794 . . . . 0.0 109.718 179.938 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' TYR . . . . . 0.404 ' HB3' HE21 ' A' ' 82' ' ' GLN . 82.0 t80 -124.88 120.55 31.97 Favored 'General case' 0 N--CA 1.494 1.771 0 CA-C-O 121.832 0.825 . . . . 0.0 109.893 179.833 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 11.6 t-20 55.67 41.39 30.52 Favored 'General case' 0 N--CA 1.491 1.58 0 CA-C-N 116.14 -0.482 . . . . 0.0 109.808 179.448 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 13.7 t0 69.52 -1.85 2.11 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 179.354 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 19.6 mmm180 -104.01 -170.16 1.73 Allowed 'General case' 0 N--CA 1.495 1.783 0 CA-C-O 121.406 0.622 . . . . 0.0 109.867 -179.886 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 78.9 m-85 -122.06 140.18 52.82 Favored 'General case' 0 N--CA 1.497 1.924 0 CA-C-O 121.949 0.88 . . . . 0.0 110.427 -179.128 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' GLN . . . . . 0.59 ' NE2' ' N ' ' A' ' 82' ' ' GLN . 0.0 OUTLIER -147.92 152.3 37.32 Favored 'General case' 0 N--CA 1.493 1.704 0 CA-C-O 121.623 0.725 . . . . 0.0 109.59 179.401 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 27.1 m -87.67 132.17 33.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 CA-C-O 121.808 0.813 . . . . 0.0 110.291 -179.658 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -109.18 122.64 47.75 Favored 'General case' 0 N--CA 1.496 1.831 0 CA-C-O 121.837 0.827 . . . . 0.0 110.106 -179.439 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 61.9 t -92.4 130.59 41.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 179.451 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 95.0 m-20 -128.92 -177.24 4.13 Favored 'General case' 0 N--CA 1.495 1.797 0 CA-C-O 121.874 0.845 . . . . 0.0 110.462 -179.449 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 63.7 tttp -56.1 -45.41 79.46 Favored 'General case' 0 N--CA 1.488 1.458 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.8 -179.318 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 98.8 m-20 -63.36 -35.54 80.72 Favored 'General case' 0 N--CA 1.488 1.475 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 -179.237 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 69.1 m -71.47 152.2 43.26 Favored 'General case' 0 N--CA 1.493 1.708 0 CA-C-O 121.717 0.77 . . . . 0.0 110.08 -179.752 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 43.7 t -131.93 146.15 51.93 Favored 'General case' 0 N--CA 1.497 1.875 0 CA-C-O 121.559 0.695 . . . . 0.0 109.615 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 96.5 mt -120.39 132.51 69.8 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 CA-C-O 121.697 0.76 . . . . 0.0 109.977 179.88 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.532 ' OE1' ' NH2' ' A' ' 70' ' ' ARG . 77.1 tt0 -123.07 119.33 29.99 Favored 'General case' 0 N--CA 1.495 1.806 0 CA-C-O 121.81 0.814 . . . . 0.0 109.488 179.669 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 37.9 ttmt -75.79 131.85 40.04 Favored 'General case' 0 N--CA 1.488 1.44 0 CA-C-O 121.42 0.629 . . . . 0.0 109.629 179.736 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.431 HD11 HD23 ' A' ' 68' ' ' LEU . 85.4 mt -109.1 140.54 42.53 Favored 'General case' 0 N--CA 1.494 1.775 0 CA-C-O 121.888 0.851 . . . . 0.0 110.04 -179.813 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 90.9 p -79.87 -4.89 54.21 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 109.341 -0.615 . . . . 0.0 109.341 -179.261 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 81.2 mt-10 -97.7 113.67 63.88 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.827 -0.546 . . . . 0.0 109.59 -179.896 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_endo -75.29 155.37 41.59 Favored 'Trans proline' 0 C--N 1.313 -1.301 0 C-N-CA 122.53 2.153 . . . . 0.0 112.256 -179.907 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 89.9 mt . . . . . 0 N--CA 1.496 1.856 0 CA-C-O 121.899 0.857 . . . . 0.0 110.273 -179.542 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo . . . . . 0 N--CA 1.496 1.654 0 CA-C-O 121.541 0.559 . . . . 0.0 112.568 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 87.3 mt-30 -77.43 91.78 3.92 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.328 -0.857 . . . . 0.0 109.106 -179.935 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 79.5 mt -72.91 125.77 28.35 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.456 -0.777 . . . . 0.0 109.858 -179.229 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 98.8 m -127.12 132.49 50.58 Favored 'General case' 0 N--CA 1.498 1.927 0 CA-C-O 121.456 0.646 . . . . 0.0 109.327 179.878 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -74.76 153.31 38.85 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.555 -0.716 . . . . 0.0 110.415 -179.164 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 96.1 mt -62.52 -43.79 98.71 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.534 -0.729 . . . . 0.0 109.567 -179.691 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 11.7 p -64.05 -24.12 34.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.504 -0.747 . . . . 0.0 109.875 -179.341 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.434 ' OD1' ' O ' ' A' ' 10' ' ' ASP . 60.1 t0 -76.27 -5.88 48.97 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.202 -0.936 . . . . 0.0 109.644 -179.723 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 96.5 mt -84.01 120.39 34.83 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.078 -1.014 . . . . 0.0 109.886 -179.893 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 16.1 m -135.79 -0.04 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 179.352 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 49.9 tp10 -139.9 141.81 36.53 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.394 -0.816 . . . . 0.0 109.719 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 56.4 p30 -87.49 161.2 17.94 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.654 -0.654 . . . . 0.0 110.044 -179.859 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 81.93 14.72 76.79 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 108.816 -1.714 . . . . 0.0 108.816 -179.722 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 34.1 mt-30 -78.98 132.72 36.77 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.496 -1.002 . . . . 0.0 110.285 -179.752 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 92.2 m95 -105.32 106.57 17.13 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 179.407 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -156.82 -178.16 7.15 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.171 -0.955 . . . . 0.0 109.861 -179.727 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.504 HD21 ' CD1' ' A' ' 68' ' ' LEU . 0.6 OUTLIER -103.94 141.42 36.2 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.607 -0.683 . . . . 0.0 109.673 -179.743 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 92.2 mt -134.45 150.63 50.85 Favored 'General case' 0 N--CA 1.496 1.838 0 CA-C-O 121.652 0.739 . . . . 0.0 110.017 -179.816 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 35.7 ttpt -135.21 138.74 43.9 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 179.817 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -166.57 -171.44 1.88 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.157 -0.965 . . . . 0.0 110.396 -179.642 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 21.1 ptmt -121.85 144.73 48.66 Favored 'General case' 0 N--CA 1.496 1.858 0 CA-C-O 121.495 0.664 . . . . 0.0 109.584 -179.682 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 79.9 t -82.76 129.03 38.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.321 -0.862 . . . . 0.0 110.403 -179.284 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 96.7 mt -102.07 -51.52 9.14 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 179.501 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 52.5 tt0 -145.86 144.79 30.44 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.35 -0.844 . . . . 0.0 109.033 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -132.21 132.53 43.2 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.836 -0.54 . . . . 0.0 109.644 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 94.4 m95 -112.16 135.64 52.56 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.676 -0.64 . . . . 0.0 109.324 179.842 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 80.5 tt0 . . . . . 0 N--CA 1.494 1.725 0 O-C-N 121.439 -0.788 . . . . 0.0 110.146 -179.399 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 96.5 p . . . . . 0 N--CA 1.49 1.574 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 96.8 mt -121.16 134.02 65.88 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.95 0 O-C-N 121.563 -0.71 . . . . 0.0 109.894 -179.907 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 33.2 t -85.08 -71.76 0.51 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.653 -0.654 . . . . 0.0 109.802 -179.807 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 46.6 mt-30 -134.01 156.64 47.82 Favored 'General case' 0 N--CA 1.498 1.931 0 CA-C-O 121.794 0.807 . . . . 0.0 110.451 -179.035 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.8 p -139.65 139.85 37.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 179.727 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -167.38 -147.75 5.39 Favored Glycine 0 N--CA 1.49 2.256 0 C-N-CA 119.395 -1.383 . . . . 0.0 110.187 -179.827 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -133.7 152.19 51.82 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.662 -0.904 . . . . 0.0 109.951 -179.545 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 73.6 mt -115.5 131.39 56.95 Favored 'General case' 0 N--CA 1.494 1.745 0 CA-C-O 121.534 0.683 . . . . 0.0 109.291 179.712 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -80.79 160.91 43.62 Favored Glycine 0 N--CA 1.486 2.03 0 N-CA-C 110.613 -0.995 . . . . 0.0 110.613 -179.346 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -174.29 146.01 1.06 Allowed 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 179.508 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -57.36 -15.15 5.7 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.346 -0.846 . . . . 0.0 109.906 -179.603 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 42.1 p -94.69 -7.87 39.45 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.224 -0.923 . . . . 0.0 109.854 -179.709 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 138.77 -157.06 24.56 Favored Glycine 0 N--CA 1.5 2.936 0 N-CA-C 110.527 -1.029 . . . . 0.0 110.527 179.217 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 40.9 pt -124.87 153.83 32.23 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.005 0 O-C-N 121.856 -0.791 . . . . 0.0 109.517 -179.874 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 20.0 tt -147.31 149.5 15.53 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.253 -0.905 . . . . 0.0 109.937 179.667 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 18.9 mmmt -83.28 148.68 27.24 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.748 -0.595 . . . . 0.0 110.175 -179.605 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 16.1 p90 -143.88 153.63 42.53 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.441 -0.787 . . . . 0.0 109.435 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 87.9 m -134.14 135.57 43.24 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 179.711 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 91.9 mt -101.63 126.03 55.61 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.398 -0.814 . . . . 0.0 109.601 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 93.5 m95 -96.14 139.73 31.89 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.524 -0.735 . . . . 0.0 109.529 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 50.9 mtpt . . . . . 0 C--N 1.302 -1.488 0 O-C-N 121.529 -0.732 . . . . 0.0 109.124 -179.96 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 36.6 mt . . . . . 0 N--CA 1.496 1.844 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -69.98 162.03 43.73 Favored 'Trans proline' 0 N--CA 1.498 1.745 0 C-N-CA 122.911 2.408 . . . . 0.0 113.195 179.708 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 65.6 mt -69.0 143.55 54.34 Favored 'General case' 0 N--CA 1.493 1.69 0 CA-C-O 121.742 0.782 . . . . 0.0 110.388 -179.215 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.599 ' N ' HD12 ' A' ' 61' ' ' LEU . 9.7 mp -92.81 141.68 28.17 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.672 -0.643 . . . . 0.0 110.048 -179.186 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -85.1 152.03 23.7 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.424 -0.797 . . . . 0.0 110.342 -179.644 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 55.4 tt0 -81.98 138.46 34.92 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.616 -0.678 . . . . 0.0 110.822 -179.336 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 79.88 23.6 61.55 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 110.105 -1.198 . . . . 0.0 110.105 178.932 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -126.94 146.59 50.26 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.441 -1.034 . . . . 0.0 110.307 -179.796 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 12.8 p -83.01 146.44 28.75 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 179.745 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 65.4 m-85 -140.36 145.07 36.65 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.438 -0.789 . . . . 0.0 110.007 179.775 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.504 ' CD1' HD21 ' A' ' 19' ' ' ASN . 17.8 tp -105.59 123.1 47.36 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 179.106 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.408 ' O ' ' OD1' ' A' ' 19' ' ' ASN . 67.5 mt -103.81 125.25 50.12 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 179.899 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 82.5 mtp180 -114.53 134.81 54.74 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.69 -0.631 . . . . 0.0 110.054 -179.755 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 31.2 t 60.46 73.72 0.47 Allowed 'General case' 0 N--CA 1.493 1.687 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.791 179.65 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 3.7 m -124.6 159.32 30.93 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.129 0 O-C-N 121.605 -0.684 . . . . 0.0 109.294 178.993 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 13.6 p -121.74 135.09 62.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 -179.807 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 13.4 t -84.74 118.89 32.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.483 -0.761 . . . . 0.0 110.306 -178.966 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -97.22 171.34 26.77 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 179.723 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -111.37 121.3 44.86 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.724 -0.868 . . . . 0.0 109.789 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' TYR . . . . . 0.509 ' CZ ' ' OD1' ' A' ' 78' ' ' ASN . 54.8 t80 -134.16 124.96 26.93 Favored 'General case' 0 N--CA 1.495 1.819 0 CA-C-O 121.393 0.616 . . . . 0.0 109.499 179.578 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' ASN . . . . . 0.509 ' OD1' ' CZ ' ' A' ' 77' ' ' TYR . 6.4 m120 51.56 51.49 16.61 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.648 -0.657 . . . . 0.0 110.574 179.789 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 55.6 2.6 0.07 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.736 -0.602 . . . . 0.0 110.184 179.351 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.487 ' H ' ' C ' ' A' ' 78' ' ' ASN . 18.7 mmm180 -103.88 163.0 12.65 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.378 -0.826 . . . . 0.0 109.704 -179.912 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 69.7 m-85 -95.71 143.51 26.9 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.449 -0.782 . . . . 0.0 109.748 -179.283 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 15.3 pt20 -146.3 159.97 42.64 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.517 -0.739 . . . . 0.0 109.436 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.407 ' O ' HG23 ' A' ' 83' ' ' VAL . 33.2 m -111.44 128.31 68.03 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 179.431 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 33.3 mt-30 -109.42 124.67 51.4 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.563 -0.711 . . . . 0.0 109.474 -179.345 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 10.7 t -97.18 106.78 18.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.385 -0.822 . . . . 0.0 109.611 -179.773 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 13.9 p-10 -152.04 -177.43 6.16 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.466 -0.771 . . . . 0.0 109.985 179.934 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 72.5 tttt 66.76 -133.19 0.15 Allowed 'General case' 0 N--CA 1.492 1.667 0 CA-C-O 121.444 0.64 . . . . 0.0 110.932 179.306 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 90.0 m-20 -88.52 20.65 3.27 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.432 -0.792 . . . . 0.0 109.246 -179.093 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 15.5 m -60.13 147.65 38.82 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.459 -0.776 . . . . 0.0 109.511 -179.73 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 25.5 m -128.78 152.35 48.55 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.618 -0.676 . . . . 0.0 109.747 -179.81 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 93.9 mt -129.1 133.5 65.77 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 179.785 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -126.42 134.28 51.04 Favored 'General case' 0 N--CA 1.497 1.912 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 179.548 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.443 ' C ' HD22 ' A' ' 94' ' ' LEU . 63.7 tttp -79.79 129.26 34.33 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.41 -0.806 . . . . 0.0 109.837 -179.338 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.444 HD22 ' N ' ' A' ' 94' ' ' LEU . 4.1 mm? -100.54 133.18 45.37 Favored 'General case' 0 N--CA 1.493 1.702 0 CA-C-O 121.756 0.789 . . . . 0.0 109.802 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 23.1 t -85.29 10.43 12.56 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 -179.899 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 22.1 tt0 -118.47 90.24 38.58 Favored Pre-proline 0 N--CA 1.497 1.916 0 O-C-N 121.602 -0.686 . . . . 0.0 109.29 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_exo -56.14 146.84 68.51 Favored 'Trans proline' 0 N--CA 1.498 1.739 0 C-N-CA 122.785 2.323 . . . . 0.0 112.19 179.496 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 93.0 mt . . . . . 0 N--CA 1.495 1.801 0 O-C-N 121.474 -0.766 . . . . 0.0 109.997 -179.41 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 3' ' ' PRO . . . . . 0.571 ' HB2' HD21 ' A' ' 19' ' ' ASN . 28.9 Cg_endo . . . . . 0 N--CA 1.49 1.304 0 CA-C-O 121.829 0.679 . . . . 0.0 112.714 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 4' ' ' GLN . . . . . 0.42 ' HG2' ' H ' ' A' ' 4' ' ' GLN . 7.8 pt20 -73.29 89.41 1.57 Allowed 'General case' 0 C--N 1.302 -1.487 0 CA-C-O 121.534 0.683 . . . . 0.0 110.223 -179.326 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 79.6 mt -79.33 139.78 37.71 Favored 'General case' 0 N--CA 1.488 1.474 0 CA-C-O 121.543 0.687 . . . . 0.0 109.734 179.7 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 69.5 m -127.16 130.91 50.66 Favored 'General case' 0 N--CA 1.496 1.854 0 CA-C-O 121.609 0.719 . . . . 0.0 109.666 179.667 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 63.7 mttp -84.23 156.95 21.77 Favored 'General case' 0 N--CA 1.49 1.568 0 CA-C-O 121.785 0.802 . . . . 0.0 109.688 179.914 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 95.6 mt -63.0 -42.58 97.23 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.557 0 CA-C-O 121.28 0.562 . . . . 0.0 109.518 -179.215 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 14.7 p -65.54 -24.04 33.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.605 -0.684 . . . . 0.0 109.559 -179.178 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 -77.03 -7.11 55.09 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.441 -0.787 . . . . 0.0 108.89 -179.455 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 98.6 mt -93.18 116.04 33.39 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 CA-C-O 121.662 0.744 . . . . 0.0 109.719 179.708 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 25.6 m -151.23 14.54 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 179.34 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -137.44 137.17 38.48 Favored 'General case' 0 N--CA 1.494 1.771 0 CA-C-O 121.762 0.792 . . . . 0.0 109.376 179.417 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 45.6 t30 -74.32 147.59 42.13 Favored 'General case' 0 C--N 1.301 -1.529 0 CA-C-O 121.696 0.76 . . . . 0.0 109.99 -179.622 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 71.58 99.51 0.06 OUTLIER Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 179.92 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 27.5 tt0 -165.17 126.98 2.08 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.732 -0.863 . . . . 0.0 110.098 179.443 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 95.2 m95 -96.6 128.71 43.79 Favored 'General case' 0 N--CA 1.494 1.753 0 CA-C-O 121.477 0.656 . . . . 0.0 109.465 179.926 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.441 ' O ' HG22 ' A' ' 72' ' ' VAL . . . -174.88 177.08 2.07 Favored 'General case' 0 N--CA 1.493 1.717 0 CA-C-O 121.878 0.846 . . . . 0.0 110.419 179.818 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.571 HD21 ' HB2' ' A' ' 3' ' ' PRO . 68.7 m-20 -99.24 148.91 23.64 Favored 'General case' 0 N--CA 1.495 1.776 0 CA-C-O 121.728 0.775 . . . . 0.0 109.445 -179.712 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 54.5 tp -139.57 135.94 33.9 Favored 'General case' 0 N--CA 1.487 1.418 0 CA-C-O 121.962 0.887 . . . . 0.0 110.244 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 37.3 ttmt -122.36 132.65 54.49 Favored 'General case' 0 N--CA 1.49 1.566 0 CA-C-O 121.773 0.797 . . . . 0.0 109.121 179.148 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -160.95 178.04 9.78 Favored 'General case' 0 C--N 1.3 -1.555 0 CA-C-O 121.658 0.742 . . . . 0.0 109.808 -179.866 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 63.7 tttp -114.55 145.55 41.81 Favored 'General case' 0 N--CA 1.496 1.839 0 CA-C-O 121.775 0.797 . . . . 0.0 110.332 -178.958 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 89.5 t -83.54 108.14 15.77 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 CA-C-O 121.684 0.754 . . . . 0.0 110.34 -179.501 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.412 HG12 ' H ' ' A' ' 42' ' ' GLY . 34.3 mm -94.24 -47.37 13.43 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 179.915 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 60.3 tt0 -148.41 140.55 24.06 Favored 'General case' 0 N--CA 1.494 1.774 0 CA-C-O 122.135 0.969 . . . . 0.0 109.968 -179.758 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.483 ' N ' HD23 ' A' ' 27' ' ' LEU . 0.3 OUTLIER -136.57 145.51 45.06 Favored 'General case' 0 N--CA 1.491 1.577 0 CA-C-O 121.956 0.884 . . . . 0.0 110.164 -179.335 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 5.7 m-90 -114.13 141.77 47.08 Favored 'General case' 0 N--CA 1.492 1.653 0 CA-C-O 121.648 0.737 . . . . 0.0 109.261 179.041 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 . . . . . 0 C--N 1.303 -1.42 0 CA-C-O 121.602 0.715 . . . . 0.0 109.795 -179.436 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 12.8 m . . . . . 0 N--CA 1.494 1.741 0 N-CA-C 109.009 -0.738 . . . . 0.0 109.009 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 96.7 mt -93.17 119.07 40.29 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 CA-C-O 121.839 0.828 . . . . 0.0 109.507 179.794 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 3.6 t -71.3 -56.01 6.88 Favored 'General case' 0 C--N 1.3 -1.546 0 CA-C-O 121.428 0.633 . . . . 0.0 109.525 179.761 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 83.7 mt-30 -147.63 147.6 30.19 Favored 'General case' 0 N--CA 1.49 1.539 0 CA-C-O 121.925 0.869 . . . . 0.0 110.456 -179.286 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.9 p -142.77 142.47 26.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 CA-C-O 121.613 0.72 . . . . 0.0 109.349 179.589 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -171.99 -155.26 10.82 Favored Glycine 0 N--CA 1.491 2.308 0 C-N-CA 119.952 -1.118 . . . . 0.0 110.562 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -132.9 147.52 52.29 Favored 'General case' 0 N--CA 1.494 1.745 0 CA-C-O 121.895 0.855 . . . . 0.0 110.269 -179.463 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 41.1 mt -116.88 130.72 56.89 Favored 'General case' 0 N--CA 1.496 1.83 0 CA-C-O 121.743 0.782 . . . . 0.0 109.407 -179.258 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.412 ' H ' HG12 ' A' ' 25' ' ' ILE . . . -83.15 161.38 39.45 Favored Glycine 0 N--CA 1.495 2.609 0 N-CA-C 111.227 -0.749 . . . . 0.0 111.227 -179.146 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.557 ' OD1' ' N ' ' A' ' 44' ' ' GLU . 62.1 t0 -174.13 150.29 1.54 Allowed 'General case' 0 N--CA 1.493 1.722 0 CA-C-O 122.095 0.95 . . . . 0.0 110.031 179.643 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.557 ' N ' ' OD1' ' A' ' 43' ' ' ASP . 98.0 mt-10 -59.44 -17.67 32.93 Favored 'General case' 0 N--CA 1.491 1.601 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.139 179.979 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 41.6 p -92.25 -11.17 36.02 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 -179.688 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 139.95 -159.87 26.1 Favored Glycine 0 N--CA 1.498 2.77 0 C-N-CA 120.246 -0.978 . . . . 0.0 111.123 178.934 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 96.4 mt -125.21 132.86 70.64 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 CA-C-O 121.773 0.797 . . . . 0.0 109.993 -179.23 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 18.0 tt -131.17 148.43 32.91 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 CA-C-O 121.934 0.873 . . . . 0.0 110.421 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 54.7 mtpt -92.91 151.04 20.18 Favored 'General case' 0 N--CA 1.494 1.741 0 CA-C-O 121.713 0.768 . . . . 0.0 110.16 -179.841 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 5.8 p90 -142.84 152.99 42.75 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-O 122.003 0.906 . . . . 0.0 109.975 179.871 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 84.9 m -130.2 130.98 45.36 Favored 'General case' 0 N--CA 1.493 1.692 0 CA-C-O 121.864 0.84 . . . . 0.0 109.203 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 95.7 mt -100.26 121.93 51.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 CA-C-O 121.791 0.805 . . . . 0.0 110.049 -179.496 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 96.1 m95 -98.0 133.57 42.29 Favored 'General case' 0 N--CA 1.495 1.799 0 CA-C-O 121.551 0.691 . . . . 0.0 109.349 179.782 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 16.4 ptpt . . . . . 0 N--CA 1.496 1.841 0 O-C-N 121.759 -0.588 . . . . 0.0 109.83 179.949 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 11.4 mt . . . . . 0 N--CA 1.491 1.593 0 N-CA-C 108.633 -0.876 . . . . 0.0 108.633 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -68.86 153.46 72.76 Favored 'Trans proline' 0 C--N 1.312 -1.358 0 C-N-CA 122.403 2.069 . . . . 0.0 112.646 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 71.4 mt -72.75 142.95 48.14 Favored 'General case' 0 C--N 1.301 -1.525 0 CA-C-O 121.678 0.752 . . . . 0.0 109.968 -179.754 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.542 ' N ' HD12 ' A' ' 61' ' ' LEU . 10.5 mp -87.84 135.49 33.37 Favored 'General case' 0 N--CA 1.49 1.554 0 CA-C-O 121.715 0.769 . . . . 0.0 109.707 -179.805 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 46.1 tp10 -93.78 144.85 25.05 Favored 'General case' 0 N--CA 1.49 1.558 0 CA-C-O 121.89 0.852 . . . . 0.0 109.685 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 57.5 tt0 -79.15 143.74 35.16 Favored 'General case' 0 C--N 1.299 -1.597 0 CA-C-O 121.677 0.751 . . . . 0.0 110.318 -179.614 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 82.08 23.8 56.4 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 110.036 -1.226 . . . . 0.0 110.036 179.054 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.513 ' OE1' ' NZ ' ' A' ' 93' ' ' LYS . 95.8 mt-10 -136.55 144.91 44.48 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.384 -1.068 . . . . 0.0 110.109 179.672 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 12.2 p -89.23 145.69 25.24 Favored 'General case' 0 N--CA 1.489 1.496 0 CA-C-O 121.702 0.763 . . . . 0.0 110.223 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -137.71 152.61 49.42 Favored 'General case' 0 N--CA 1.494 1.734 0 CA-C-O 122.122 0.963 . . . . 0.0 110.323 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 32.3 tp -111.1 121.55 45.62 Favored 'General case' 0 N--CA 1.494 1.733 0 CA-C-N 115.488 -0.778 . . . . 0.0 109.64 179.864 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 74.0 mt -102.15 133.1 47.55 Favored 'General case' 0 N--CA 1.494 1.728 0 CA-C-O 121.726 0.774 . . . . 0.0 109.373 179.538 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 86.8 mtm180 -129.61 147.35 51.4 Favored 'General case' 0 N--CA 1.495 1.819 0 CA-C-O 121.924 0.869 . . . . 0.0 110.51 -179.287 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.7 m 56.46 55.34 6.61 Favored 'General case' 0 N--CA 1.494 1.729 0 CA-C-N 115.606 -0.725 . . . . 0.0 110.415 179.354 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.441 HG22 ' O ' ' A' ' 18' ' ' ALA . 12.5 m -111.12 158.19 11.71 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 CA-C-O 121.626 0.727 . . . . 0.0 109.972 179.369 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 13.5 p -116.7 134.88 58.82 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 CA-C-O 121.828 0.823 . . . . 0.0 109.677 -179.631 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 11.7 t -86.27 115.48 27.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 CA-C-O 121.862 0.839 . . . . 0.0 109.88 -179.433 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -100.96 175.25 26.1 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 110.074 -1.21 . . . . 0.0 110.074 -179.776 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 48.0 tp10 -111.51 121.39 45.05 Favored 'General case' 0 N--CA 1.493 1.699 0 CA-C-O 121.829 0.824 . . . . 0.0 109.673 -179.906 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 87.3 t80 -136.58 125.37 24.01 Favored 'General case' 0 N--CA 1.492 1.655 0 CA-C-O 121.865 0.84 . . . . 0.0 110.14 179.834 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' ASN . . . . . 0.488 ' C ' ' H ' ' A' ' 80' ' ' ARG . 10.7 t-20 56.27 43.33 26.65 Favored 'General case' 0 N--CA 1.488 1.46 0 CA-C-N 116.081 -0.509 . . . . 0.0 109.781 179.193 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 48.2 t0 62.64 -1.36 0.45 Allowed 'General case' 0 N--CA 1.493 1.725 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 179.641 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.488 ' H ' ' C ' ' A' ' 78' ' ' ASN . 83.2 mtp180 -100.09 178.23 4.85 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.606 -0.684 . . . . 0.0 109.986 179.868 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 78.3 m-85 -112.94 138.15 50.24 Favored 'General case' 0 N--CA 1.498 1.953 0 CA-C-O 122.086 0.946 . . . . 0.0 110.062 -179.303 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -147.09 163.0 37.68 Favored 'General case' 0 N--CA 1.489 1.52 0 CA-C-O 121.829 0.823 . . . . 0.0 110.292 179.936 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 2.5 m -106.24 131.65 55.38 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 -179.938 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 86.7 mt-30 -104.91 122.6 46.15 Favored 'General case' 0 N--CA 1.495 1.807 0 CA-C-O 122.107 0.956 . . . . 0.0 110.364 -179.172 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 18.2 t -93.93 129.73 43.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 CA-C-O 121.947 0.879 . . . . 0.0 109.765 -179.875 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 81.7 m-20 -134.82 -174.74 3.68 Favored 'General case' 0 N--CA 1.493 1.702 0 CA-C-O 121.452 0.644 . . . . 0.0 109.309 179.79 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 24.8 pttm -58.88 -34.75 72.0 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.858 -0.526 . . . . 0.0 109.924 -179.296 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 38.7 t30 -64.11 -38.07 89.74 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 10.0 m -72.76 156.33 39.04 Favored 'General case' 0 N--CA 1.492 1.675 0 CA-C-O 121.709 0.766 . . . . 0.0 110.73 -179.153 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 88.2 p -129.52 151.36 50.22 Favored 'General case' 0 N--CA 1.493 1.717 0 CA-C-O 121.692 0.758 . . . . 0.0 109.759 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 94.8 mt -124.65 132.79 70.85 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 CA-C-O 121.572 0.701 . . . . 0.0 109.572 -179.508 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 81.6 tt0 -130.13 134.37 47.29 Favored 'General case' 0 N--CA 1.497 1.881 0 CA-C-O 121.996 0.903 . . . . 0.0 109.838 179.621 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.513 ' NZ ' ' OE1' ' A' ' 65' ' ' GLU . 64.1 tttp -79.95 134.45 36.26 Favored 'General case' 0 N--CA 1.489 1.478 0 CA-C-O 121.748 0.785 . . . . 0.0 110.117 179.933 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 73.6 mt -100.88 133.76 44.87 Favored 'General case' 0 N--CA 1.492 1.67 0 CA-C-O 121.689 0.757 . . . . 0.0 109.726 179.626 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 88.8 p -78.74 -5.52 53.43 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 -179.604 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 21.5 tp10 -111.82 121.03 40.81 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.794 -0.567 . . . . 0.0 109.894 -179.751 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -74.29 154.25 46.03 Favored 'Trans proline' 0 N--CA 1.488 1.202 0 C-N-CA 122.511 2.141 . . . . 0.0 112.065 179.63 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 96.7 mt . . . . . 0 N--CA 1.499 1.988 0 CA-C-O 121.915 0.864 . . . . 0.0 110.364 -179.603 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo . . . . . 0 N--CA 1.497 1.703 0 CA-C-O 121.6 0.583 . . . . 0.0 112.312 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 4' ' ' GLN . . . . . 0.401 ' N ' ' CD ' ' A' ' 4' ' ' GLN . 28.2 mp0 -84.49 89.41 7.42 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.057 -1.027 . . . . 0.0 109.664 -179.581 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -73.73 142.02 46.33 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.456 -0.777 . . . . 0.0 109.351 179.616 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 98.4 m -122.77 129.2 51.46 Favored 'General case' 0 N--CA 1.498 1.962 0 CA-C-O 121.666 0.746 . . . . 0.0 109.812 -179.7 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -85.42 159.36 19.99 Favored 'General case' 0 N--CA 1.491 1.618 0 CA-C-O 121.609 0.719 . . . . 0.0 110.051 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 33.0 mm -63.85 -43.38 97.82 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 O-C-N 121.275 -0.89 . . . . 0.0 109.198 179.893 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 12.6 p -65.02 -22.53 31.6 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 O-C-N 121.47 -0.769 . . . . 0.0 109.529 -179.692 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -74.79 -7.03 52.15 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.092 -1.005 . . . . 0.0 109.257 179.45 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 96.7 mt -83.11 120.83 35.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.232 -0.917 . . . . 0.0 109.4 179.886 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 15.8 m -134.93 -28.04 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 O-C-N 121.346 -0.846 . . . . 0.0 109.721 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -135.05 152.39 51.65 Favored 'General case' 0 N--CA 1.501 2.113 0 O-C-N 121.188 -0.945 . . . . 0.0 110.372 -179.424 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 57.4 p30 -79.12 166.0 22.73 Favored 'General case' 0 N--CA 1.491 1.618 0 CA-C-O 121.6 0.714 . . . . 0.0 110.652 -179.201 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 71.02 92.91 0.08 OUTLIER Glycine 0 N--CA 1.491 2.303 0 N-CA-C 110.294 -1.122 . . . . 0.0 110.294 179.476 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 20.5 tt0 -168.89 130.9 1.25 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.408 -1.054 . . . . 0.0 109.183 179.279 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 91.9 m95 -95.65 133.56 39.58 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.404 -0.81 . . . . 0.0 109.774 -179.686 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.461 ' O ' HG22 ' A' ' 72' ' ' VAL . . . -175.09 176.58 2.08 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.193 -0.942 . . . . 0.0 109.741 179.509 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 94.6 m-20 -103.91 145.01 30.75 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.438 -0.789 . . . . 0.0 109.072 179.888 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 5.6 tt -142.04 133.61 26.77 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.278 -0.889 . . . . 0.0 109.924 -179.818 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 3.5 ttmp? -117.01 141.85 47.72 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 179.558 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.464 ' CB ' ' OD1' ' A' ' 43' ' ' ASP . . . -164.2 -177.18 4.83 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.887 -1.133 . . . . 0.0 110.352 -179.648 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -112.05 137.63 49.82 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.633 -0.667 . . . . 0.0 109.487 -179.913 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 71.2 t -83.54 96.64 4.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.295 -0.878 . . . . 0.0 110.197 -179.572 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 96.7 mt -65.53 -45.32 92.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.418 -0.801 . . . . 0.0 109.433 179.744 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.525 ' NE2' ' CZ2' ' A' ' 28' ' ' TRP . 14.6 pt20 -170.61 148.4 3.03 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.397 -0.814 . . . . 0.0 109.737 -179.875 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.546 ' O ' HD12 ' A' ' 27' ' ' LEU . 0.3 OUTLIER -143.65 137.15 28.05 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.566 -0.709 . . . . 0.0 109.274 179.589 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 28' ' ' TRP . . . . . 0.525 ' CZ2' ' NE2' ' A' ' 26' ' ' GLN . 5.6 m0 -117.69 146.06 43.99 Favored 'General case' 0 N--CA 1.498 1.936 0 CA-C-O 121.717 0.77 . . . . 0.0 109.672 -179.709 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.695 ' H ' ' CD ' ' A' ' 29' ' ' GLU . 1.5 pm0 . . . . . 0 N--CA 1.491 1.579 0 CA-C-O 121.617 0.722 . . . . 0.0 110.568 -179.25 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 11.0 t . . . . . 0 N--CA 1.491 1.601 0 CA-C-O 121.012 0.434 . . . . 0.0 110.232 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 90.6 mt -98.6 133.69 40.09 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 O-C-N 121.299 -0.876 . . . . 0.0 110.173 -178.906 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 25.0 m -81.47 -70.8 0.51 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.578 -0.701 . . . . 0.0 110.112 -179.664 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 34.4 mt-30 -132.55 155.5 48.52 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.393 -0.817 . . . . 0.0 109.62 -179.02 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 9.4 p -137.1 141.03 41.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 -179.805 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -165.79 -158.5 10.85 Favored Glycine 0 N--CA 1.491 2.328 0 C-N-CA 119.422 -1.371 . . . . 0.0 110.177 -179.085 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.732 ' O ' HD12 ' A' ' 40' ' ' LEU . 0.8 OUTLIER -135.65 151.94 50.72 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.573 -0.957 . . . . 0.0 109.761 179.826 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 52.5 mt -114.88 139.76 49.52 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.453 -0.779 . . . . 0.0 109.235 -179.0 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -94.37 127.65 9.17 Favored Glycine 0 N--CA 1.493 2.498 0 N-CA-C 110.359 -1.097 . . . . 0.0 110.359 -179.63 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.464 ' OD1' ' CB ' ' A' ' 22' ' ' ALA . 73.0 m-20 -128.6 142.32 51.08 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.795 -0.827 . . . . 0.0 108.872 179.005 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -56.76 -14.99 3.83 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.411 -0.805 . . . . 0.0 109.52 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 16.5 p -99.3 -8.47 24.89 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.316 -0.865 . . . . 0.0 109.775 -179.763 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 153.95 -167.14 32.16 Favored Glycine 0 N--CA 1.498 2.821 0 C-N-CA 119.733 -1.222 . . . . 0.0 110.257 179.292 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 96.6 mt -125.61 134.7 66.05 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.081 0 O-C-N 121.586 -0.949 . . . . 0.0 108.656 179.895 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 20.6 tt -131.42 144.71 36.78 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.231 0 O-C-N 121.168 -0.958 . . . . 0.0 110.463 -179.566 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 52.8 mtmt -84.34 157.19 21.56 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.727 -0.608 . . . . 0.0 110.42 -179.633 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 16.2 p90 -152.1 164.26 37.63 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.317 -0.864 . . . . 0.0 109.666 179.627 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.418 HG22 HE21 ' A' ' 82' ' ' GLN . 2.7 t -139.1 148.85 43.83 Favored 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 179.578 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 39.2 mm -106.41 126.36 62.12 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 O-C-N 121.472 -0.768 . . . . 0.0 109.562 -179.459 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 77.8 m95 -98.36 147.38 24.74 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.486 -0.759 . . . . 0.0 109.799 -179.72 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 64.7 mttp . . . . . 0 N--CA 1.49 1.54 0 O-C-N 121.449 -0.782 . . . . 0.0 109.255 179.755 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 14.2 mt . . . . . 0 N--CA 1.499 1.975 0 N-CA-C 109.749 -0.464 . . . . 0.0 109.749 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -70.13 165.28 31.91 Favored 'Trans proline' 0 N--CA 1.502 1.99 0 C-N-CA 123.095 2.53 . . . . 0.0 113.918 -179.102 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 66.6 mt -65.56 141.08 58.57 Favored 'General case' 0 N--CA 1.494 1.761 0 CA-C-O 121.905 0.86 . . . . 0.0 110.88 -178.995 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.597 ' N ' HD12 ' A' ' 61' ' ' LEU . 9.1 mp -87.39 145.9 26.11 Favored 'General case' 0 N--CA 1.492 1.654 0 CA-C-O 121.344 0.593 . . . . 0.0 110.037 -179.523 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.443 ' N ' ' OH ' ' A' ' 67' ' ' TYR . 83.7 tt0 -98.63 126.69 44.3 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.399 -0.813 . . . . 0.0 109.126 179.461 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' GLN . . . . . 0.447 ' CD ' ' N ' ' A' ' 64' ' ' GLY . 1.0 OUTLIER -69.19 140.34 54.61 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.508 -0.745 . . . . 0.0 111.231 -178.822 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.447 ' N ' ' CD ' ' A' ' 63' ' ' GLN . . . 91.78 20.06 38.33 Favored Glycine 0 N--CA 1.495 2.581 0 N-CA-C 110.541 -1.024 . . . . 0.0 110.541 178.812 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.488 ' OE1' ' N ' ' A' ' 65' ' ' GLU . 58.8 mp0 -139.0 155.58 47.88 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.158 -1.201 . . . . 0.0 110.47 179.911 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 13.5 p -80.72 156.44 26.26 Favored 'General case' 0 N--CA 1.49 1.527 0 CA-C-O 121.552 0.691 . . . . 0.0 110.534 -179.418 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.443 ' OH ' ' N ' ' A' ' 62' ' ' GLU . 88.4 m-85 -145.78 144.27 30.2 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.48 -0.763 . . . . 0.0 109.645 179.674 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 13.7 tp -111.86 117.93 34.13 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 179.219 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 4.6 mp -103.45 126.66 50.73 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.467 -0.771 . . . . 0.0 109.054 -179.553 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 90.3 mtm-85 -115.57 140.85 48.79 Favored 'General case' 0 N--CA 1.497 1.909 0 CA-C-O 121.645 0.736 . . . . 0.0 110.421 -178.982 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.4 ' OG ' ' O ' ' A' ' 71' ' ' SER . 22.2 p 59.77 66.69 0.96 Allowed 'General case' 0 N--CA 1.494 1.744 0 CA-C-O 121.121 0.486 . . . . 0.0 110.703 179.67 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.461 HG22 ' O ' ' A' ' 18' ' ' ALA . 16.5 m -116.26 160.79 15.45 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.134 0 O-C-N 121.537 -0.727 . . . . 0.0 109.252 178.841 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 7.4 p -117.72 133.16 65.37 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 CA-C-O 121.382 0.611 . . . . 0.0 109.423 -179.563 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 13.5 t -88.06 110.29 20.77 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.278 -0.889 . . . . 0.0 109.669 -179.427 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -88.29 172.15 41.14 Favored Glycine 0 N--CA 1.493 2.49 0 N-CA-C 109.887 -1.285 . . . . 0.0 109.887 -179.602 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -100.45 119.68 38.84 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.566 -0.961 . . . . 0.0 109.15 179.928 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 40.7 t80 -115.17 104.36 11.77 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.539 -0.726 . . . . 0.0 109.774 -179.68 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 41.45 -117.15 0.34 Allowed 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.582 -0.698 . . . . 0.0 111.204 179.471 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.418 ' N ' ' OD1' ' A' ' 79' ' ' ASP . 37.5 p-10 -94.53 -7.67 40.52 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.329 -0.857 . . . . 0.0 110.234 -178.794 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 95.4 mtt180 -112.18 177.46 4.63 Favored 'General case' 0 N--CA 1.501 2.091 0 O-C-N 121.417 -0.802 . . . . 0.0 110.015 -179.925 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 72.9 m-85 -109.54 148.64 30.9 Favored 'General case' 0 N--CA 1.497 1.905 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 -179.693 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' GLN . . . . . 0.418 HE21 HG22 ' A' ' 51' ' ' THR . 53.3 tt0 -137.88 154.01 49.5 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.306 -0.871 . . . . 0.0 109.751 -179.81 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 33.5 m -113.32 132.86 60.99 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 179.729 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 79.0 mt-30 -106.76 127.48 53.43 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.572 -0.705 . . . . 0.0 109.992 -178.883 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 16.8 t -94.8 98.14 7.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.474 -0.766 . . . . 0.0 109.093 179.753 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 31.4 p30 -151.18 177.7 9.95 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.412 -0.805 . . . . 0.0 109.767 -179.759 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.516 ' C ' ' H ' ' A' ' 89' ' ' SER . 71.2 mmtt 61.19 -141.27 0.5 Allowed 'General case' 0 N--CA 1.493 1.712 0 CA-C-O 121.639 0.733 . . . . 0.0 110.772 179.169 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 32.3 t30 -66.46 9.52 0.16 Allowed 'General case' 0 C--N 1.304 -1.405 0 CA-C-O 121.334 0.588 . . . . 0.0 109.658 -179.446 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.516 ' H ' ' C ' ' A' ' 87' ' ' LYS . 13.3 p -58.18 143.61 43.54 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.249 -0.907 . . . . 0.0 109.671 -179.882 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 19.2 p -141.26 156.4 45.89 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.482 -0.761 . . . . 0.0 109.655 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 96.5 mt -132.58 134.53 58.68 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 121.556 -0.715 . . . . 0.0 109.445 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -126.48 136.83 53.12 Favored 'General case' 0 N--CA 1.499 2.013 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 179.516 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.432 ' C ' HD12 ' A' ' 94' ' ' LEU . 88.4 tttt -80.13 128.91 34.07 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.397 -0.815 . . . . 0.0 109.678 -179.795 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.432 HD12 ' C ' ' A' ' 93' ' ' LYS . 10.1 mp -105.23 134.59 48.08 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.451 -0.781 . . . . 0.0 109.636 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 96.6 p -88.6 8.51 28.0 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 108.774 -0.825 . . . . 0.0 108.774 179.521 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 67.0 mt-10 -117.55 90.38 35.1 Favored Pre-proline 0 N--CA 1.498 1.951 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 -179.775 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_exo -55.7 147.52 59.89 Favored 'Trans proline' 0 N--CA 1.497 1.705 0 C-N-CA 122.741 2.294 . . . . 0.0 112.658 179.618 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.586 ' O ' HG22 ' A' ' 98' ' ' ILE . 97.1 mt . . . . . 0 N--CA 1.491 1.587 0 CA-C-O 121.709 0.766 . . . . 0.0 109.67 -179.675 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo . . . . . 0 N--CA 1.493 1.5 0 CA-C-O 121.536 0.557 . . . . 0.0 111.765 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -87.89 87.95 7.51 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.806 -1.184 . . . . 0.0 109.201 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.459 ' N ' HD22 ' A' ' 5' ' ' LEU . 4.0 mm? -69.31 136.16 51.43 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.502 -0.748 . . . . 0.0 109.583 -179.913 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 96.7 m -124.58 128.59 49.14 Favored 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -84.28 156.94 21.71 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.513 -0.742 . . . . 0.0 110.135 -179.424 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 65.4 mt -62.53 -44.36 99.25 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 121.446 -0.784 . . . . 0.0 109.681 179.907 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 14.0 p -64.66 -23.53 33.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.28 -0.888 . . . . 0.0 109.527 -179.875 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -79.7 -4.04 50.05 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.127 -0.983 . . . . 0.0 109.513 179.693 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 97.1 mt -80.24 103.99 7.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.097 -1.002 . . . . 0.0 109.825 -179.609 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 28.0 m -122.15 -9.39 8.85 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 179.4 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 18.9 pt-20 -136.39 137.7 40.8 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.5 -0.75 . . . . 0.0 109.598 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 30.5 p30 -95.34 162.83 13.51 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.322 -0.861 . . . . 0.0 110.731 -179.238 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 79.5 2.8 88.34 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.738 -1.345 . . . . 0.0 109.738 179.764 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 21.1 pt20 -80.47 144.38 32.62 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.248 -1.148 . . . . 0.0 110.095 -179.671 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 87.9 m95 -97.94 137.27 37.02 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.515 -0.741 . . . . 0.0 109.526 179.796 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -177.0 -179.61 0.93 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.078 -1.014 . . . . 0.0 109.78 179.608 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -105.75 146.28 30.03 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 6.1 tt -143.64 134.3 25.04 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.141 -0.974 . . . . 0.0 109.719 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 34.3 ttpt -116.66 139.7 50.24 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.571 -0.706 . . . . 0.0 109.189 179.864 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -160.57 179.45 8.58 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.865 -1.147 . . . . 0.0 109.949 179.857 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 64.7 tttm -112.96 141.98 46.17 Favored 'General case' 0 N--CA 1.498 1.953 0 CA-C-O 121.37 0.605 . . . . 0.0 109.679 -179.656 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 97.2 t -82.4 125.01 39.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.283 -0.886 . . . . 0.0 110.438 -179.078 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 96.6 mt -102.05 -51.83 8.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 179.184 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 18.4 tt0 -148.02 145.05 28.35 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.446 -0.784 . . . . 0.0 109.193 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.919 ' H ' HD23 ' A' ' 27' ' ' LEU . 1.2 pt? -136.65 138.77 41.46 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 179.934 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 78.9 t90 -128.37 123.11 33.05 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.394 -0.816 . . . . 0.0 109.463 -179.543 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 . . . . . 0 N--CA 1.493 1.678 0 O-C-N 121.227 -0.921 . . . . 0.0 110.401 -179.52 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 38.4 t . . . . . 0 N--CA 1.487 1.39 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 86.4 mt -105.38 124.83 60.51 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.064 0 O-C-N 121.394 -0.816 . . . . 0.0 109.517 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 3.4 t -68.96 -57.21 5.79 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.466 -0.771 . . . . 0.0 110.256 -179.637 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' GLN . . . . . 0.417 HE22 HD12 ' A' ' 27' ' ' LEU . 2.4 pt20 -156.88 156.96 34.02 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.201 -0.937 . . . . 0.0 109.97 -179.543 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 30.6 m -132.49 135.8 57.14 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 179.521 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -160.07 -158.97 9.51 Favored Glycine 0 N--CA 1.492 2.423 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 -179.444 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 2.0 pp -135.7 147.39 48.48 Favored 'General case' 0 N--CA 1.503 2.182 0 O-C-N 121.291 -1.123 . . . . 0.0 110.498 -179.628 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 48.1 mt -111.98 139.26 47.64 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.608 -0.683 . . . . 0.0 109.29 -178.834 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -80.64 164.85 47.36 Favored Glycine 0 N--CA 1.491 2.333 0 C-N-CA 120.215 -0.993 . . . . 0.0 110.669 -179.522 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.53 ' OD1' ' N ' ' A' ' 44' ' ' GLU . 66.8 t0 -172.68 141.28 1.08 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.607 -0.937 . . . . 0.0 109.389 179.482 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.53 ' N ' ' OD1' ' A' ' 43' ' ' ASP . 97.2 mt-10 -54.81 -18.39 4.75 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.313 -0.867 . . . . 0.0 110.479 -179.593 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 33.3 p -94.76 -9.74 33.72 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.981 -1.074 . . . . 0.0 109.498 -179.903 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 146.04 -153.82 25.56 Favored Glycine 0 N--CA 1.497 2.729 0 N-CA-C 110.168 -1.173 . . . . 0.0 110.168 179.365 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 37.3 pt -125.93 154.78 35.27 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.969 0 O-C-N 121.714 -0.874 . . . . 0.0 109.14 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.405 HD12 ' HA ' ' A' ' 48' ' ' ILE . 10.9 tp -142.72 142.19 26.76 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 O-C-N 121.109 -0.994 . . . . 0.0 110.462 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 25.4 mtpp -83.3 153.02 24.85 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 179.661 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 30.9 p90 -147.55 160.82 42.2 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 120.972 -1.08 . . . . 0.0 110.103 -179.879 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 3.4 t -143.89 139.57 29.28 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 179.401 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 95.3 mt -104.5 119.86 54.01 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.983 0 O-C-N 121.301 -0.875 . . . . 0.0 109.695 -179.754 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 94.6 m95 -95.49 140.88 29.72 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.332 -0.855 . . . . 0.0 109.366 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 68.0 mttm . . . . . 0 N--CA 1.49 1.572 0 O-C-N 121.202 -0.936 . . . . 0.0 109.418 179.941 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 91.2 mt . . . . . 0 N--CA 1.496 1.85 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -52.57 154.37 12.13 Favored 'Trans proline' 0 N--CA 1.494 1.525 0 C-N-CA 122.15 1.9 . . . . 0.0 111.956 -179.759 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 62.4 mt -62.63 139.88 58.66 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.251 -0.905 . . . . 0.0 110.258 -178.638 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.587 ' N ' HD12 ' A' ' 61' ' ' LEU . 8.8 mp -80.95 149.52 29.34 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.681 -0.637 . . . . 0.0 110.034 -179.308 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 80.4 mm-40 -83.49 139.42 32.93 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.35 -0.844 . . . . 0.0 109.955 -179.712 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 56.8 tt0 -77.53 133.15 38.6 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.398 -0.814 . . . . 0.0 111.07 -179.121 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 95.13 -0.33 64.02 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 110.048 -1.221 . . . . 0.0 110.048 179.475 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.514 ' N ' ' OE1' ' A' ' 65' ' ' GLU . 58.4 mp0 -111.73 150.82 29.69 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 121.451 -1.029 . . . . 0.0 110.292 -179.572 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 7.7 m -86.88 152.0 22.83 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.705 -0.622 . . . . 0.0 109.925 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 74.0 m-85 -142.52 145.77 34.01 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.544 -0.722 . . . . 0.0 109.557 179.677 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 18.0 tp -106.01 124.11 49.06 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 179.445 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 61.3 mt -100.97 131.52 46.8 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 -179.621 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.453 ' CZ ' ' OE2' ' A' ' 92' ' ' GLU . 84.8 mtm180 -126.93 141.32 51.83 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.376 -0.827 . . . . 0.0 110.168 -179.364 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 8.3 m 56.95 57.22 4.78 Favored 'General case' 0 N--CA 1.493 1.721 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.382 179.405 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 15.5 m -113.74 161.81 12.33 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.12 0 O-C-N 121.378 -0.826 . . . . 0.0 108.929 178.956 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 7.6 p -117.94 134.08 62.69 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.02 0 CA-C-O 121.435 0.636 . . . . 0.0 109.534 -179.239 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 20.1 t -78.67 122.11 33.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.38 -0.825 . . . . 0.0 109.922 -179.173 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -95.28 171.77 29.87 Favored Glycine 0 N--CA 1.495 2.605 0 N-CA-C 109.368 -1.493 . . . . 0.0 109.368 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.546 ' N ' ' OE1' ' A' ' 76' ' ' GLU . 57.5 mp0 -107.17 118.94 38.04 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.487 -1.008 . . . . 0.0 109.483 -179.691 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 55.5 t80 -118.75 107.41 13.62 Favored 'General case' 0 N--CA 1.496 1.836 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 179.508 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 97.7 m-20 44.57 -125.76 1.02 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.403 -0.811 . . . . 0.0 109.942 -179.369 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 66.1 m-20 -94.66 -5.42 45.65 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.363 -0.836 . . . . 0.0 108.994 179.867 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 88.3 mtm180 -100.2 166.18 11.12 Favored 'General case' 0 N--CA 1.493 1.69 0 CA-C-O 121.614 0.721 . . . . 0.0 109.704 -179.702 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 76.8 m-85 -101.84 151.01 22.58 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.425 -0.797 . . . . 0.0 109.579 -179.595 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 11.6 tt0 -138.54 157.1 46.8 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.389 -0.819 . . . . 0.0 109.643 -179.757 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 3.4 m -114.11 130.64 67.97 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 179.178 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 87.7 mt-30 -109.83 132.42 54.16 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.61 -0.682 . . . . 0.0 110.072 -178.316 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 3.9 t -104.55 126.93 59.29 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 179.505 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' ASN . . . . . 0.427 ' O ' ' O ' ' A' ' 87' ' ' LYS . 17.0 p30 -145.97 -176.44 5.15 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.208 -0.932 . . . . 0.0 109.531 -179.776 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.529 ' C ' ' H ' ' A' ' 89' ' ' SER . 21.7 ptmt -37.93 161.12 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.804 0 CA-C-O 121.544 0.688 . . . . 0.0 111.589 -178.942 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 5.1 t30 69.51 -23.71 0.15 Allowed 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 -179.678 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.529 ' H ' ' C ' ' A' ' 87' ' ' LYS . 10.6 t -78.31 155.94 29.89 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.197 -0.939 . . . . 0.0 109.86 -179.755 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 27.1 p -141.2 154.59 45.9 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.46 -0.775 . . . . 0.0 108.956 179.571 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 97.3 mt -129.98 132.49 65.5 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.453 ' OE2' ' CZ ' ' A' ' 70' ' ' ARG . 80.3 mt-10 -120.95 140.95 51.16 Favored 'General case' 0 N--CA 1.502 2.126 0 O-C-N 121.436 -0.79 . . . . 0.0 109.264 -179.507 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 37.8 ttmt -84.18 122.95 29.56 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.185 -0.947 . . . . 0.0 109.266 -179.735 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.487 HD22 ' N ' ' A' ' 94' ' ' LEU . 3.9 mm? -96.79 136.85 36.75 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.367 -0.833 . . . . 0.0 109.804 -179.466 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 94.4 p -85.52 -1.23 56.87 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 179.349 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 37.6 mm-40 -108.48 98.81 29.81 Favored Pre-proline 0 N--CA 1.498 1.961 0 O-C-N 121.644 -0.66 . . . . 0.0 109.286 -179.81 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -74.3 155.28 46.41 Favored 'Trans proline' 0 N--CA 1.491 1.38 0 C-N-CA 121.982 1.788 . . . . 0.0 112.737 -178.796 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 90.6 mt . . . . . 0 N--CA 1.496 1.867 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 179.99 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo . . . . . 0 N--CA 1.486 1.066 0 CA-C-O 121.4 0.5 . . . . 0.0 112.144 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 55.9 tt0 -78.61 89.07 4.52 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.367 -0.833 . . . . 0.0 109.321 -179.68 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 81.7 mt -76.63 144.91 39.22 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.65 -0.656 . . . . 0.0 109.582 -179.744 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 86.6 m -123.46 130.41 52.65 Favored 'General case' 0 N--CA 1.496 1.834 0 CA-C-O 121.551 0.691 . . . . 0.0 109.515 -179.887 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 65.7 mttp -82.59 149.35 27.5 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.555 -0.715 . . . . 0.0 110.074 -179.32 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 95.6 mt -63.12 -43.29 98.83 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 O-C-N 121.618 -0.676 . . . . 0.0 109.677 179.914 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 11.1 p -63.83 -24.1 34.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.333 -0.854 . . . . 0.0 109.824 -179.663 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -75.0 -3.89 35.08 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.096 -1.003 . . . . 0.0 109.385 179.712 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 5.7 mm -70.95 92.63 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.313 -0.867 . . . . 0.0 109.52 -179.789 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 15.0 m -114.82 -20.6 5.89 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -139.09 140.56 38.04 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.268 -0.895 . . . . 0.0 109.938 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.404 HD22 ' HB3' ' A' ' 76' ' ' GLU . 55.4 p30 -89.74 167.93 12.5 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.499 -0.751 . . . . 0.0 110.263 -179.507 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 80.26 15.74 77.87 Favored Glycine 0 N--CA 1.488 2.144 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 -179.807 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 27.8 tt0 -96.28 132.35 41.84 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.335 -1.097 . . . . 0.0 109.709 -179.82 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 76.6 m95 -94.72 134.33 37.43 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.587 -0.695 . . . . 0.0 109.954 -179.536 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -173.29 -169.46 0.53 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.526 -0.734 . . . . 0.0 109.667 179.566 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 70.9 m-20 -107.34 152.03 24.7 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.6 -0.687 . . . . 0.0 109.159 -179.889 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.616 HD13 ' N ' ' A' ' 21' ' ' LYS . 0.3 OUTLIER -133.85 120.25 20.2 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.408 -0.807 . . . . 0.0 109.318 179.835 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.616 ' N ' HD13 ' A' ' 20' ' ' LEU . 35.9 ttmt -112.51 126.56 55.46 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 179.131 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -168.57 -171.95 1.55 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.117 -0.989 . . . . 0.0 109.989 -179.706 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -119.28 138.8 52.77 Favored 'General case' 0 N--CA 1.497 1.887 0 CA-C-O 121.625 0.726 . . . . 0.0 109.976 -179.621 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 10.7 t -85.9 91.43 3.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.521 -0.737 . . . . 0.0 109.661 -179.476 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 62.6 mt -69.86 -42.65 79.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.481 -0.762 . . . . 0.0 109.612 179.915 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 98.8 mm-40 -127.64 125.94 41.07 Favored 'General case' 0 N--CA 1.498 1.932 0 CA-C-O 121.75 0.786 . . . . 0.0 110.117 -178.897 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 1.1 tt -121.92 130.55 53.43 Favored 'General case' 0 C--N 1.309 -1.193 0 N-CA-C 108.755 -0.832 . . . . 0.0 108.755 179.821 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 96.9 m95 -135.2 117.76 15.89 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.613 -0.68 . . . . 0.0 109.39 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 . . . . . 0 N--CA 1.493 1.68 0 O-C-N 121.485 -0.76 . . . . 0.0 110.025 -179.537 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 87.7 p . . . . . 0 N--CA 1.489 1.514 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 84.0 mt -131.41 130.57 62.89 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 O-C-N 121.479 -0.763 . . . . 0.0 109.238 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 37.2 t -75.28 -75.38 0.17 Allowed 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.568 -0.707 . . . . 0.0 109.46 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' GLN . . . . . 0.402 HE22 ' HA ' ' A' ' 60' ' ' LEU . 16.0 pt20 -141.42 162.36 35.67 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.394 -0.816 . . . . 0.0 110.013 -179.58 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 27.6 m -131.96 154.76 40.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 179.425 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.424 ' C ' ' CE1' ' A' ' 50' ' ' PHE . . . -178.88 -169.79 39.98 Favored Glycine 0 N--CA 1.486 1.987 0 C-N-CA 119.268 -1.444 . . . . 0.0 109.827 -179.751 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 2.2 pp -136.44 150.57 48.8 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.646 -0.914 . . . . 0.0 109.638 -179.621 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 54.5 mt -107.55 161.36 14.92 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 -179.006 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -140.09 131.99 5.33 Favored Glycine 0 N--CA 1.493 2.475 0 N-CA-C 109.967 -1.253 . . . . 0.0 109.967 -179.714 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.429 ' OD2' ' OG1' ' A' ' 45' ' ' THR . 52.3 p30 -151.59 -167.07 2.68 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.618 -0.93 . . . . 0.0 109.16 179.796 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -76.96 -12.4 59.94 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.514 -0.741 . . . . 0.0 109.473 179.633 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.429 ' OG1' ' OD2' ' A' ' 43' ' ' ASP . 34.7 p -91.98 -5.65 52.67 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.293 -0.88 . . . . 0.0 109.605 -179.518 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 122.76 -148.67 16.88 Favored Glycine 0 N--CA 1.5 2.953 0 N-CA-C 110.195 -1.162 . . . . 0.0 110.195 179.304 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 43.7 pt -128.71 154.89 40.22 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 O-C-N 121.758 -0.848 . . . . 0.0 109.712 -179.541 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 17.1 tt -152.6 144.46 15.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.212 -0.93 . . . . 0.0 109.96 179.621 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 63.7 mttp -83.36 150.7 25.94 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.557 -0.714 . . . . 0.0 109.909 -179.494 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.424 ' CE1' ' C ' ' A' ' 39' ' ' GLY . 35.5 p90 -142.36 152.12 42.56 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.291 -0.881 . . . . 0.0 109.622 -179.949 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 99.6 m -135.19 132.01 37.42 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 179.703 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 98.0 mt -106.05 129.06 59.85 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.601 -0.687 . . . . 0.0 109.844 -179.661 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 86.6 m95 -94.97 144.33 25.77 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.51 -0.744 . . . . 0.0 109.527 -179.924 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 98.3 mttt . . . . . 0 N--CA 1.489 1.478 0 O-C-N 121.413 -0.804 . . . . 0.0 109.409 179.814 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 23.3 mt . . . . . 0 N--CA 1.492 1.641 0 N-CA-C 109.503 -0.554 . . . . 0.0 109.503 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -68.85 159.55 53.35 Favored 'Trans proline' 0 N--CA 1.496 1.639 0 C-N-CA 122.832 2.355 . . . . 0.0 112.72 -179.817 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.402 ' HA ' HE22 ' A' ' 37' ' ' GLN . 69.2 mt -64.84 139.1 58.73 Favored 'General case' 0 N--CA 1.49 1.543 0 CA-C-O 121.624 0.726 . . . . 0.0 110.388 -179.163 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.591 ' N ' HD12 ' A' ' 61' ' ' LEU . 9.6 mp -76.94 149.85 35.98 Favored 'General case' 0 N--CA 1.49 1.545 0 CA-C-O 121.468 0.652 . . . . 0.0 110.175 -179.588 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 49.2 tp10 -81.2 118.86 22.93 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.45 -0.781 . . . . 0.0 109.297 -179.914 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 56.9 tt0 -64.21 134.63 55.16 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.55 -0.719 . . . . 0.0 110.902 -178.988 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 84.14 28.8 32.85 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 110.339 -1.105 . . . . 0.0 110.339 179.488 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -136.65 154.24 50.7 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.276 -1.132 . . . . 0.0 110.637 -179.634 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 6.7 m -81.16 142.07 33.6 Favored 'General case' 0 N--CA 1.488 1.444 0 CA-C-O 121.322 0.582 . . . . 0.0 109.707 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 29.3 m-85 -140.8 146.84 38.15 Favored 'General case' 0 N--CA 1.49 1.57 0 CA-C-O 121.782 0.801 . . . . 0.0 109.751 -179.942 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 23.3 tp -111.56 120.87 43.56 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 179.458 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 66.2 mt -102.87 133.17 48.39 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 -179.916 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.42 ' O ' ' OG ' ' A' ' 71' ' ' SER . 84.8 mtp180 -127.39 149.27 50.15 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.666 -0.646 . . . . 0.0 110.293 -179.517 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.496 ' HG ' ' HA ' ' A' ' 89' ' ' SER . 3.0 p 53.28 57.93 5.75 Favored 'General case' 0 N--CA 1.494 1.733 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.445 179.702 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 17.8 m -116.15 164.99 12.01 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.043 0 O-C-N 121.608 -0.682 . . . . 0.0 109.422 179.105 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 8.0 p -115.32 137.84 47.59 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 CA-C-O 121.485 0.659 . . . . 0.0 109.8 -179.065 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 89.0 t -85.28 108.43 17.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.559 -0.713 . . . . 0.0 109.65 -179.501 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -87.64 177.77 46.95 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 110.115 -1.194 . . . . 0.0 110.115 -179.43 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.404 ' HB3' HD22 ' A' ' 14' ' ' ASN . 17.2 pt-20 -107.68 134.57 50.47 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.602 -0.94 . . . . 0.0 109.216 -179.867 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 55.7 t80 -108.83 145.14 35.74 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.477 -0.764 . . . . 0.0 109.756 -179.468 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' ASN . . . . . 0.442 ' O ' ' CB ' ' A' ' 79' ' ' ASP . 24.0 t-20 -69.43 62.99 0.16 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.588 -0.695 . . . . 0.0 109.96 -179.477 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.442 ' CB ' ' O ' ' A' ' 78' ' ' ASN . 0.7 OUTLIER 162.43 -25.57 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 179.701 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 25.1 ttm180 -166.88 -131.66 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.374 -0.829 . . . . 0.0 109.595 -179.778 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 89.6 m-85 -131.29 152.28 50.71 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.582 -0.699 . . . . 0.0 109.625 -179.573 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 28.2 pt20 -144.97 162.49 36.76 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.473 -0.767 . . . . 0.0 109.393 -179.836 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 3.3 m -109.36 132.66 56.89 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 179.804 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 87.0 mt-30 -107.14 132.48 52.98 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.632 -0.668 . . . . 0.0 110.18 -178.65 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 90.1 t -99.45 129.59 49.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 179.654 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 6.2 m-80 -144.38 176.36 9.42 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.475 -0.765 . . . . 0.0 109.524 -179.494 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.473 ' C ' ' H ' ' A' ' 89' ' ' SER . 61.3 tttp -40.94 159.75 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.723 0 CA-C-O 121.29 0.567 . . . . 0.0 110.459 -179.796 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 88' ' ' ASN . . . . . 0.447 ' CB ' ' O ' ' A' ' 87' ' ' LYS . 3.9 t30 77.26 -25.37 0.2 Allowed 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 -179.5 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.496 ' HA ' ' HG ' ' A' ' 71' ' ' SER . 94.0 p -73.27 154.41 40.19 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 121.62 -0.675 . . . . 0.0 109.825 -179.809 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 75.7 m -132.26 150.52 52.14 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.625 -0.672 . . . . 0.0 109.472 -179.945 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 96.9 mt -130.11 130.6 65.98 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 179.864 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 53.0 tp10 -126.57 130.93 51.51 Favored 'General case' 0 N--CA 1.497 1.881 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 179.784 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.4 ' C ' HD22 ' A' ' 94' ' ' LEU . 64.0 tttp -80.19 131.31 35.68 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.614 -0.679 . . . . 0.0 110.235 -179.274 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.48 HD22 ' N ' ' A' ' 94' ' ' LEU . 3.9 mm? -96.67 135.87 37.99 Favored 'General case' 0 N--CA 1.495 1.818 0 CA-C-O 121.777 0.799 . . . . 0.0 109.929 -179.809 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 68.1 m -84.65 -3.8 58.69 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.724 -0.61 . . . . 0.0 109.519 179.802 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 12.3 tp10 -117.47 91.17 37.07 Favored Pre-proline 0 N--CA 1.498 1.94 0 O-C-N 121.56 -0.712 . . . . 0.0 109.338 -179.854 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -55.77 147.66 59.86 Favored 'Trans proline' 0 N--CA 1.498 1.751 0 C-N-CA 122.727 2.284 . . . . 0.0 112.648 -179.869 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 95.9 mt . . . . . 0 N--CA 1.493 1.715 0 O-C-N 121.494 -0.754 . . . . 0.0 109.785 -179.434 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo . . . . . 0 N--CA 1.492 1.391 0 CA-C-O 121.561 0.567 . . . . 0.0 112.067 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 4' ' ' GLN . . . . . 0.513 ' N ' ' OE1' ' A' ' 4' ' ' GLN . 0.9 OUTLIER -76.24 90.12 3.14 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.352 -0.843 . . . . 0.0 109.878 -179.436 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 79.1 mt -76.61 145.74 38.7 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.706 -0.622 . . . . 0.0 109.435 179.897 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 92.0 m -125.26 132.24 52.96 Favored 'General case' 0 N--CA 1.493 1.723 0 CA-C-O 121.761 0.791 . . . . 0.0 109.704 -179.884 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -75.85 149.4 37.85 Favored 'General case' 0 C--N 1.3 -1.567 0 CA-C-O 121.785 0.802 . . . . 0.0 110.373 -179.578 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 97.2 mt -63.24 -43.22 98.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 CA-C-O 121.802 0.81 . . . . 0.0 109.563 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 7.6 p -65.06 -24.3 35.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.592 -0.693 . . . . 0.0 109.872 -179.67 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 50.3 t0 -79.4 -4.58 51.69 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.17 -0.956 . . . . 0.0 109.838 -179.639 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 97.1 mt -85.6 114.33 25.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 120.962 -1.086 . . . . 0.0 109.656 -179.985 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 34.6 m -149.84 15.04 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 179.741 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 79.3 mm-40 -127.87 133.54 49.34 Favored 'General case' 0 N--CA 1.497 1.907 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 -179.903 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 93.2 m-20 -74.06 141.54 45.72 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-O 121.658 0.742 . . . . 0.0 110.079 -179.579 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 58.02 111.15 0.01 OUTLIER Glycine 0 N--CA 1.49 2.242 0 N-CA-C 110.465 -1.054 . . . . 0.0 110.465 179.504 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 29.1 tt0 -168.06 133.77 1.91 Allowed 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.424 -1.045 . . . . 0.0 109.174 179.501 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 60.4 m95 -88.63 136.82 32.8 Favored 'General case' 0 N--CA 1.49 1.558 0 CA-C-O 121.652 0.739 . . . . 0.0 109.938 -179.565 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -178.29 173.63 1.39 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.571 -0.705 . . . . 0.0 109.229 -179.717 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 73.0 m-20 -107.59 144.99 33.84 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.54 -0.725 . . . . 0.0 109.886 -179.434 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 60.4 tp -133.78 135.4 43.86 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.49 -0.756 . . . . 0.0 110.406 -179.59 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 38.5 ttmt -119.23 130.34 55.41 Favored 'General case' 0 N--CA 1.496 1.863 0 CA-C-O 121.321 0.581 . . . . 0.0 109.556 179.503 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -168.79 -172.91 1.72 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.345 -0.847 . . . . 0.0 109.93 179.414 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 21.3 ptmt -124.81 154.35 41.11 Favored 'General case' 0 N--CA 1.498 1.961 0 CA-C-O 121.46 0.648 . . . . 0.0 109.919 179.829 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 97.1 t -87.8 129.58 38.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 CA-C-O 121.613 0.721 . . . . 0.0 110.174 -179.539 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.402 HD11 ' HA3' ' A' ' 42' ' ' GLY . 96.4 mt -100.98 -55.81 5.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 N-CA-C 109.068 -0.715 . . . . 0.0 109.068 179.42 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 12.5 mm100 -142.92 138.61 30.3 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.151 -0.968 . . . . 0.0 109.807 179.825 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.833 ' H ' HD23 ' A' ' 27' ' ' LEU . 1.2 pt? -143.22 139.41 30.25 Favored 'General case' 0 N--CA 1.492 1.631 0 CA-C-O 121.347 0.594 . . . . 0.0 109.988 -179.928 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 5.6 m-90 -111.86 140.31 46.61 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 179.595 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 . . . . . 0 N--CA 1.493 1.687 0 CA-C-O 121.645 0.736 . . . . 0.0 110.265 -179.563 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 14.7 m . . . . . 0 N--CA 1.492 1.657 0 N-CA-C 109.138 -0.689 . . . . 0.0 109.138 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 72.4 mt -107.34 126.39 63.54 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 O-C-N 121.131 -0.981 . . . . 0.0 109.576 -179.751 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.575 ' OG ' ' N ' ' A' ' 54' ' ' LYS . 1.0 OUTLIER -92.0 -69.47 0.74 Allowed 'General case' 0 N--CA 1.492 1.648 0 CA-C-O 121.837 0.827 . . . . 0.0 109.283 -179.905 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 99.3 mt-30 -138.71 154.01 48.54 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.303 -0.873 . . . . 0.0 109.792 -179.585 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.7 p -140.41 140.49 34.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.585 -0.697 . . . . 0.0 109.781 -179.806 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -170.56 -156.96 11.87 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 179.723 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.688 HD23 ' H ' ' A' ' 40' ' ' LEU . 1.7 pt? -132.12 150.6 52.11 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.709 -0.877 . . . . 0.0 110.117 179.836 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 66.2 mt -109.71 134.33 52.11 Favored 'General case' 0 N--CA 1.492 1.674 0 CA-C-O 121.763 0.792 . . . . 0.0 109.591 -179.438 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.402 ' HA3' HD11 ' A' ' 25' ' ' ILE . . . -86.87 144.04 19.3 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 110.06 -1.216 . . . . 0.0 110.06 179.897 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 43.8 t0 -152.7 165.55 34.94 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 121.497 -1.002 . . . . 0.0 110.105 179.84 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -63.99 -17.89 63.75 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.82 -0.55 . . . . 0.0 110.826 -179.583 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 17.3 p -98.63 -5.91 30.85 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 120.809 -1.182 . . . . 0.0 109.99 -179.314 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 140.21 -129.82 4.38 Favored Glycine 0 N--CA 1.496 2.678 0 N-CA-C 110.219 -1.153 . . . . 0.0 110.219 179.491 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.823 HD13 ' H ' ' A' ' 47' ' ' ILE . 0.1 OUTLIER -145.09 158.89 13.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.583 -0.951 . . . . 0.0 109.819 -179.54 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.547 HD11 ' O ' ' A' ' 81' ' ' PHE . 9.7 tp -148.73 147.72 16.54 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 179.172 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 69.1 mttm -85.07 153.52 22.66 Favored 'General case' 0 N--CA 1.49 1.533 0 CA-C-O 121.641 0.734 . . . . 0.0 110.403 -179.658 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 13.4 p90 -148.86 152.86 37.21 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.407 -0.808 . . . . 0.0 109.447 179.779 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 98.3 m -133.1 131.28 40.36 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 91.7 mt -100.55 125.43 54.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.4 -0.812 . . . . 0.0 110.098 -179.58 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 54.3 m95 -93.96 120.27 33.99 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 179.455 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.575 ' N ' ' OG ' ' A' ' 36' ' ' SER . 19.6 ptmt . . . . . 0 C--N 1.3 -1.565 0 CA-C-O 121.764 0.792 . . . . 0.0 108.928 179.947 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 40.4 mt . . . . . 0 N--CA 1.493 1.724 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -52.44 143.85 42.98 Favored 'Trans proline' 0 N--CA 1.497 1.694 0 C-N-CA 122.221 1.947 . . . . 0.0 112.752 179.929 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 79.2 mt -74.19 141.55 45.48 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.404 -0.81 . . . . 0.0 109.844 -179.852 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.623 ' N ' HD12 ' A' ' 61' ' ' LEU . 9.8 mp -86.26 149.07 25.33 Favored 'General case' 0 N--CA 1.489 1.508 0 CA-C-O 121.834 0.826 . . . . 0.0 110.078 -179.796 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -99.68 146.12 26.86 Favored 'General case' 0 N--CA 1.491 1.6 0 CA-C-O 121.761 0.791 . . . . 0.0 110.429 -179.275 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 12.0 tt0 -75.17 135.54 41.07 Favored 'General case' 0 N--CA 1.489 1.48 0 CA-C-O 121.727 0.775 . . . . 0.0 110.413 -179.894 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 81.32 18.09 69.87 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 110.011 -1.236 . . . . 0.0 110.011 179.535 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 -125.27 147.22 49.19 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.393 -1.063 . . . . 0.0 110.646 -179.8 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 12.7 p -80.19 150.89 29.97 Favored 'General case' 0 N--CA 1.485 1.299 0 CA-C-O 121.721 0.772 . . . . 0.0 110.011 179.772 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 40.0 m-85 -145.42 144.37 30.6 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.497 -0.752 . . . . 0.0 109.547 179.915 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 25.0 tp -111.13 119.83 40.29 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 179.034 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 71.4 mt -105.22 128.37 53.38 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 -179.675 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 83.1 mtp180 -130.13 137.74 50.3 Favored 'General case' 0 N--CA 1.493 1.691 0 CA-C-O 121.502 0.668 . . . . 0.0 110.021 179.835 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.3 m 72.73 52.52 0.15 Allowed 'General case' 0 N--CA 1.495 1.78 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.198 179.677 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 20.4 m -113.68 160.7 13.03 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 O-C-N 121.377 -0.827 . . . . 0.0 110.196 179.626 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 11.1 p -114.37 140.46 35.04 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 CA-C-O 121.549 0.69 . . . . 0.0 109.19 -179.841 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 85.7 t -86.21 113.43 24.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 CA-C-O 121.996 0.903 . . . . 0.0 110.529 -179.062 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -87.27 177.09 47.28 Favored Glycine 0 N--CA 1.488 2.148 0 N-CA-C 109.882 -1.287 . . . . 0.0 109.882 179.875 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.561 ' N ' ' OE1' ' A' ' 76' ' ' GLU . 52.8 mp0 -112.62 128.0 56.26 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.63 -0.923 . . . . 0.0 109.854 -179.341 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 80.7 t80 -130.7 86.11 2.35 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 179.662 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' ASN . . . . . 0.494 ' CG ' ' H ' ' A' ' 79' ' ' ASP . 64.4 t30 58.87 -139.71 0.74 Allowed 'General case' 0 N--CA 1.491 1.594 0 CA-C-O 121.508 0.671 . . . . 0.0 110.527 179.944 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.494 ' H ' ' CG ' ' A' ' 78' ' ' ASN . 93.0 m-20 -78.22 -5.95 53.41 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.412 -0.805 . . . . 0.0 109.244 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 16.5 tpp180 -107.74 145.98 32.76 Favored 'General case' 0 N--CA 1.497 1.88 0 CA-C-O 121.866 0.841 . . . . 0.0 110.029 -179.442 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' PHE . . . . . 0.547 ' O ' HD11 ' A' ' 48' ' ' ILE . 94.5 m-85 -85.85 153.49 22.21 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.532 -0.73 . . . . 0.0 110.167 -179.066 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 48.7 tt0 -140.76 154.07 46.13 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.438 -0.789 . . . . 0.0 109.659 -179.715 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 27.2 m -113.55 131.19 66.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 CA-C-O 121.591 0.71 . . . . 0.0 109.085 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 87.1 mt-30 -105.94 119.81 40.13 Favored 'General case' 0 N--CA 1.493 1.689 0 CA-C-O 121.606 0.717 . . . . 0.0 110.091 -178.777 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 11.2 t -93.67 103.44 14.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 179.158 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 17.2 p30 -151.68 -178.77 6.91 Favored 'General case' 0 N--CA 1.489 1.49 0 CA-C-O 121.732 0.777 . . . . 0.0 110.474 -179.113 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 30.6 ttmt 68.6 -131.76 0.1 Allowed 'General case' 0 N--CA 1.492 1.673 0 CA-C-O 121.642 0.734 . . . . 0.0 110.895 179.466 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' ASN . . . . . 0.41 ' O ' ' C ' ' A' ' 89' ' ' SER . 91.5 m-20 -93.23 10.62 31.1 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.393 -0.817 . . . . 0.0 108.813 -179.51 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.41 ' C ' ' O ' ' A' ' 88' ' ' ASN . 40.6 t -39.07 111.72 0.2 Allowed 'General case' 0 N--CA 1.495 1.801 0 CA-C-O 121.863 0.84 . . . . 0.0 110.516 -179.439 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 6.1 m -77.41 145.56 37.12 Favored 'General case' 0 N--CA 1.489 1.52 0 CA-C-O 121.531 0.682 . . . . 0.0 109.947 -179.542 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 97.9 mt -135.98 132.05 50.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.441 -0.787 . . . . 0.0 109.604 179.849 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 83.1 tt0 -129.15 131.34 47.17 Favored 'General case' 0 N--CA 1.497 1.913 0 CA-C-O 121.673 0.749 . . . . 0.0 109.376 179.375 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.425 ' C ' HD12 ' A' ' 94' ' ' LEU . 38.2 ttmt -80.77 125.74 30.44 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.622 -0.674 . . . . 0.0 109.613 -179.757 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.469 HD12 ' N ' ' A' ' 94' ' ' LEU . 10.9 mp -100.94 131.15 46.95 Favored 'General case' 0 N--CA 1.496 1.836 0 CA-C-O 121.907 0.86 . . . . 0.0 110.079 -179.733 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 38.1 t -79.8 -3.6 48.43 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 108.566 -0.902 . . . . 0.0 108.566 179.179 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 60.3 mt-10 -102.41 106.09 47.01 Favored Pre-proline 0 N--CA 1.496 1.841 0 O-C-N 121.299 -0.875 . . . . 0.0 109.325 -179.767 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -76.17 154.4 37.05 Favored 'Trans proline' 0 C--N 1.316 -1.184 0 C-N-CA 122.202 1.934 . . . . 0.0 111.879 -179.44 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 90.6 mt . . . . . 0 N--CA 1.492 1.632 0 O-C-N 121.311 -0.868 . . . . 0.0 109.3 -179.846 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 78.7 mtm . . . . . 0 N--CA 1.49 1.555 0 CA-C-O 121.46 0.648 . . . . 0.0 109.802 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 48.68 57.17 18.32 Favored Pre-proline 0 N--CA 1.494 1.739 0 O-C-N 121.539 -0.726 . . . . 0.0 110.204 179.865 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.4 ' HB2' HD22 ' A' ' 19' ' ' ASN . 60.0 Cg_endo -70.79 148.88 59.37 Favored 'Trans proline' 0 N--CA 1.498 1.774 0 C-N-CA 122.938 2.426 . . . . 0.0 112.811 179.766 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 7.4 pt20 -79.6 89.05 5.1 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.272 -0.893 . . . . 0.0 109.505 -179.72 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 78.9 mt -75.03 143.57 43.46 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.499 -0.751 . . . . 0.0 109.768 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 98.9 m -131.24 136.36 48.15 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.622 -0.674 . . . . 0.0 109.939 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -78.43 153.51 31.43 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.567 -0.708 . . . . 0.0 109.926 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 96.1 mt -62.26 -43.09 97.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.388 -0.82 . . . . 0.0 109.42 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 11.8 p -62.71 -28.26 44.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.244 -0.91 . . . . 0.0 109.256 -179.666 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 55.1 t0 -67.59 -33.09 74.3 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.346 -0.846 . . . . 0.0 109.699 179.502 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 97.0 mt -68.8 120.55 16.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.29 -0.881 . . . . 0.0 110.182 -178.88 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 31.4 m -148.57 9.51 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 179.401 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 82.9 tt0 -134.45 139.61 45.64 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.418 -0.802 . . . . 0.0 109.586 179.611 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.505 ' ND2' ' OE2' ' A' ' 76' ' ' GLU . 31.0 p30 -82.5 151.66 26.39 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.587 -0.696 . . . . 0.0 110.56 -179.516 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 78.76 4.65 88.21 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 108.897 -1.681 . . . . 0.0 108.897 -179.737 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 44.1 tt0 -72.43 129.12 37.61 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.403 -1.057 . . . . 0.0 109.729 -179.627 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' TRP . . . . . 0.416 ' O ' ' HB2' ' A' ' 18' ' ' ALA . 85.2 m95 -99.99 137.52 38.33 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.618 -0.676 . . . . 0.0 109.942 -179.625 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.416 ' HB2' ' O ' ' A' ' 17' ' ' TRP . . . 178.37 178.34 0.4 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.527 -0.733 . . . . 0.0 109.238 179.265 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.4 HD22 ' HB2' ' A' ' 3' ' ' PRO . 61.3 m-20 -102.43 145.32 29.71 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 -179.906 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 51.9 tp -139.38 134.93 33.13 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.41 -0.806 . . . . 0.0 110.195 -179.538 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 34.0 ttpt -113.94 137.51 51.58 Favored 'General case' 0 N--CA 1.498 1.929 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 178.944 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -159.88 170.84 20.56 Favored 'General case' 0 N--CA 1.493 1.693 0 C-N-CA 119.064 -1.054 . . . . 0.0 110.55 -179.71 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 51.8 tttp -105.11 144.52 31.8 Favored 'General case' 0 N--CA 1.494 1.775 0 CA-C-O 121.345 0.593 . . . . 0.0 109.758 -179.784 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 62.5 t -83.31 120.02 33.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.324 -0.86 . . . . 0.0 109.971 -179.388 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 96.4 mt -96.89 -66.55 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.645 -0.659 . . . . 0.0 109.229 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 66.3 mt-30 -146.05 142.92 29.04 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.353 -0.842 . . . . 0.0 109.984 -179.893 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.433 HD23 ' N ' ' A' ' 27' ' ' LEU . 0.1 OUTLIER -125.26 136.69 53.78 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 -179.781 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 92.1 m95 -111.53 133.0 54.11 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 179.576 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -71.97 135.35 46.41 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.539 -0.726 . . . . 0.0 110.268 -179.266 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ASN . . . . . 0.432 HD22 HG21 ' A' ' 35' ' ' ILE . 48.7 t-20 -102.57 134.54 45.75 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.489 -0.757 . . . . 0.0 109.961 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 7.0 t -86.22 2.87 45.42 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 109.025 -0.731 . . . . 0.0 109.025 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 7.3 t-80 -80.01 139.3 37.04 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.335 -0.853 . . . . 0.0 110.569 -179.406 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -66.69 -39.36 88.07 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.427 -0.796 . . . . 0.0 109.647 179.663 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.513 ' OG ' ' N ' ' A' ' 35' ' ' ILE . 56.1 p -68.73 -66.31 0.59 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.252 -0.905 . . . . 0.0 109.886 -179.63 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.513 ' N ' ' OG ' ' A' ' 34' ' ' SER . 96.9 mt -74.14 135.3 27.77 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 O-C-N 121.464 -0.773 . . . . 0.0 110.082 -179.281 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 17.8 t -92.16 -62.34 1.43 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.624 -0.672 . . . . 0.0 109.601 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 85.5 mt-30 -136.85 155.53 49.66 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.405 -0.809 . . . . 0.0 109.97 -179.343 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 8.7 p -142.92 141.9 26.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 179.8 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -168.63 -160.0 15.55 Favored Glycine 0 N--CA 1.489 2.212 0 C-N-CA 119.202 -1.475 . . . . 0.0 110.384 -179.669 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -133.22 147.98 52.0 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.747 -0.855 . . . . 0.0 109.423 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 41.4 mt -117.25 133.33 56.12 Favored 'General case' 0 N--CA 1.499 1.983 0 CA-C-O 121.529 0.68 . . . . 0.0 109.92 -179.018 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -78.98 162.9 48.95 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 110.124 -1.19 . . . . 0.0 110.124 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.451 ' OD1' ' N ' ' A' ' 44' ' ' GLU . 55.1 t0 -173.83 153.43 2.18 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.586 -0.95 . . . . 0.0 109.36 179.553 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.451 ' N ' ' OD1' ' A' ' 43' ' ' ASP . 82.2 tt0 -63.03 -18.58 63.49 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.47 -0.768 . . . . 0.0 109.515 -179.877 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 72.4 p -92.2 -7.95 46.85 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.205 -0.935 . . . . 0.0 109.282 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 135.3 -150.67 20.29 Favored Glycine 0 N--CA 1.497 2.753 0 N-CA-C 109.998 -1.241 . . . . 0.0 109.998 179.268 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 96.7 mt -123.03 139.64 49.19 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 O-C-N 121.679 -0.895 . . . . 0.0 109.765 -179.423 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 9.3 tp -129.03 139.64 51.36 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 CA-C-O 121.662 0.744 . . . . 0.0 109.533 179.569 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 32.5 mtmm -85.52 148.41 25.97 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.665 -0.647 . . . . 0.0 109.871 -179.896 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 7.1 p90 -143.27 152.16 41.37 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.381 -0.825 . . . . 0.0 109.919 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.432 ' CG2' HG23 ' A' ' 35' ' ' ILE . 47.2 m -131.09 133.9 46.09 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 179.787 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 32.0 mm -97.08 124.22 49.82 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 O-C-N 121.203 -0.935 . . . . 0.0 110.184 -179.258 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 96.0 m95 -88.68 139.14 30.78 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 121.529 -0.732 . . . . 0.0 109.214 179.566 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -63.11 -35.29 79.79 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.346 -0.846 . . . . 0.0 109.663 -179.735 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ASN . . . . . 0.505 ' OD1' ' N ' ' A' ' 56' ' ' ALA . 52.9 p-10 -55.95 -18.67 9.73 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.244 -0.91 . . . . 0.0 109.848 -179.191 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.505 ' N ' ' OD1' ' A' ' 55' ' ' ASN . . . -69.7 -38.38 76.93 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.209 -0.932 . . . . 0.0 109.77 179.492 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 54.7 44.11 29.06 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 -179.163 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 61.1 mt -107.99 153.08 41.91 Favored Pre-proline 0 N--CA 1.494 1.751 0 O-C-N 121.706 -0.621 . . . . 0.0 109.715 179.902 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -53.59 149.23 32.21 Favored 'Trans proline' 0 N--CA 1.501 1.923 0 C-N-CA 122.286 1.99 . . . . 0.0 112.941 179.205 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 62.0 mt -68.12 144.03 55.19 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.456 -0.777 . . . . 0.0 110.37 -179.253 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.595 ' N ' HD12 ' A' ' 61' ' ' LEU . 10.1 mp -78.31 144.65 35.89 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.724 -0.61 . . . . 0.0 109.447 -179.682 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 80.2 tt0 -98.38 145.03 27.13 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.39 -0.819 . . . . 0.0 110.514 -179.085 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 57.9 tt0 -78.48 139.31 38.7 Favored 'General case' 0 N--CA 1.489 1.518 0 CA-C-O 121.479 0.657 . . . . 0.0 111.061 -179.295 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 84.93 10.63 78.4 Favored Glycine 0 N--CA 1.492 2.414 0 N-CA-C 110.187 -1.165 . . . . 0.0 110.187 178.795 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -124.74 144.65 50.12 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.385 -1.067 . . . . 0.0 110.602 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 8.1 p -87.04 152.41 22.39 Favored 'General case' 0 N--CA 1.487 1.405 0 CA-C-O 121.466 0.65 . . . . 0.0 109.987 179.769 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 70.4 m-85 -144.64 150.99 38.32 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.454 -0.779 . . . . 0.0 109.96 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 18.1 tp -108.55 124.6 50.71 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 179.184 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 69.8 mt -104.48 132.47 50.69 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 179.769 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 88.8 mtm180 -127.75 144.67 51.07 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.621 -0.674 . . . . 0.0 110.054 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.424 ' O ' ' OG ' ' A' ' 71' ' ' SER . 5.2 t 58.43 59.8 2.84 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 122.064 -0.397 . . . . 0.0 110.374 179.748 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 3.4 m -117.59 162.25 15.76 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.165 0 O-C-N 121.486 -0.759 . . . . 0.0 108.989 179.281 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 7.1 p -122.91 136.98 57.95 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 CA-C-O 121.606 0.717 . . . . 0.0 110.149 -178.914 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 90.4 t -80.84 128.61 38.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.468 -0.77 . . . . 0.0 109.975 -179.484 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -98.16 166.1 22.04 Favored Glycine 0 N--CA 1.494 2.526 0 N-CA-C 110.158 -1.177 . . . . 0.0 110.158 -179.774 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.505 ' OE2' ' ND2' ' A' ' 14' ' ' ASN . 96.7 mt-10 -90.68 124.99 35.53 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.803 -0.822 . . . . 0.0 109.378 179.896 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 79.4 t80 -134.45 108.56 8.2 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.494 -0.754 . . . . 0.0 109.744 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 87.8 m-20 41.15 -123.55 0.51 Allowed 'General case' 0 N--CA 1.493 1.712 0 CA-C-O 121.439 0.637 . . . . 0.0 111.031 179.57 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 96.9 m-20 -91.91 -5.81 52.54 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.442 -0.786 . . . . 0.0 110.116 -179.054 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 79.5 mtp85 -115.57 -172.62 2.18 Favored 'General case' 0 N--CA 1.502 2.161 0 O-C-N 121.443 -0.785 . . . . 0.0 109.945 -179.774 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 90.2 m-85 -130.45 156.72 44.3 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.598 -0.689 . . . . 0.0 109.842 -179.486 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 15.8 pt20 -140.12 165.09 28.3 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.575 -0.703 . . . . 0.0 109.315 179.64 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 33.8 m -104.67 132.43 51.37 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 O-C-N 121.387 -0.821 . . . . 0.0 109.117 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -102.91 128.66 49.61 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.537 -0.727 . . . . 0.0 109.864 -178.963 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 21.1 t -94.61 130.67 43.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.582 -0.699 . . . . 0.0 109.532 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 18.9 p30 -132.83 176.94 8.03 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 179.857 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 22.7 pttm -58.83 -36.05 73.92 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.358 -0.839 . . . . 0.0 109.84 -179.47 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 77.5 m-20 -62.45 -38.26 89.09 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.283 -0.886 . . . . 0.0 109.327 179.807 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 93.3 p -69.68 161.93 28.73 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.093 -1.004 . . . . 0.0 109.801 -179.241 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 72.1 m -130.6 152.17 50.25 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.607 -0.683 . . . . 0.0 109.681 -179.638 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 96.6 mt -127.12 131.96 70.24 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 75.4 mm-40 -129.14 137.52 51.24 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.53 -0.732 . . . . 0.0 109.475 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -78.89 129.78 34.92 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.505 -0.747 . . . . 0.0 109.328 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 52.4 mt -103.14 136.41 42.99 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.499 -0.751 . . . . 0.0 109.568 -179.496 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 74.3 m -81.52 -5.39 57.93 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 179.797 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -112.94 117.94 45.36 Favored Pre-proline 0 N--CA 1.497 1.921 0 O-C-N 121.676 -0.64 . . . . 0.0 109.356 -179.695 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -75.24 163.44 34.82 Favored 'Trans proline' 0 N--CA 1.491 1.375 0 C-N-CA 121.971 1.78 . . . . 0.0 111.971 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 19.2 mm -92.66 126.92 45.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.197 -0.939 . . . . 0.0 109.335 -179.695 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' GLU . . . . . 0.53 ' N ' ' OE1' ' A' ' 99' ' ' GLU . 57.5 mp0 -85.06 118.81 24.85 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.481 -0.762 . . . . 0.0 109.585 -179.591 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 35.7 m -107.8 -2.69 10.07 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 135.72 134.15 3.31 Favored Glycine 0 N--CA 1.497 2.706 0 N-CA-C 109.868 -1.293 . . . . 0.0 109.868 179.353 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.59 ' C ' ' H ' ' A' ' 104' ' ' HIS . 3.9 mm? -89.44 -0.49 57.53 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.458 -1.025 . . . . 0.0 108.996 179.689 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 77.6 tt0 63.28 -12.58 0.08 Allowed 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 -179.6 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' HIS . . . . . 0.59 ' H ' ' C ' ' A' ' 102' ' ' LEU . 36.8 p-80 -159.29 155.26 26.57 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 120.913 -1.117 . . . . 0.0 109.745 179.582 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 83.2 t60 -98.28 124.58 42.98 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.464 -0.772 . . . . 0.0 109.44 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 51.2 p-80 -108.0 155.39 20.4 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.458 -0.777 . . . . 0.0 110.075 -179.625 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 42.1 p-80 -152.76 160.76 43.13 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.407 -0.808 . . . . 0.0 109.672 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 96.9 m-70 -77.45 136.38 38.37 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.503 -0.748 . . . . 0.0 110.613 -179.28 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' HIS . . . . . 0.526 ' OXT' ' CG ' ' A' ' 109' ' ' HIS . 50.1 t-80 . . . . . 0 N--CA 1.49 1.543 0 CA-C-O 117.946 -1.026 . . . . 0.0 109.006 179.142 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 62.2 ttp . . . . . 0 N--CA 1.489 1.475 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 61.8 mt-10 -86.37 150.85 52.59 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.582 -0.699 . . . . 0.0 109.573 -179.165 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.694 ' HB2' HD21 ' A' ' 19' ' ' ASN . 37.3 Cg_endo -66.26 148.59 84.91 Favored 'Trans proline' 0 C--N 1.312 -1.377 0 C-N-CA 122.342 2.028 . . . . 0.0 112.277 179.703 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.525 ' N ' ' OE1' ' A' ' 4' ' ' GLN . 1.0 OUTLIER -78.92 89.17 4.71 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.305 -0.872 . . . . 0.0 109.344 -179.728 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 80.3 mt -75.47 150.8 38.15 Favored 'General case' 0 N--CA 1.488 1.442 0 CA-C-O 121.754 0.787 . . . . 0.0 109.807 -179.783 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 4.9 t -144.55 156.67 44.26 Favored 'General case' 0 N--CA 1.487 1.404 0 CA-C-O 121.751 0.786 . . . . 0.0 109.539 179.876 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.58 159.14 15.1 Favored 'General case' 0 C--N 1.3 -1.579 0 CA-C-O 121.875 0.845 . . . . 0.0 110.352 -179.665 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 96.1 mt -62.96 -42.68 97.53 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 CA-C-O 121.539 0.685 . . . . 0.0 109.267 179.888 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 14.4 p -62.71 -28.36 44.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.377 -0.827 . . . . 0.0 109.259 179.876 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 -75.75 -17.93 59.72 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.23 -0.919 . . . . 0.0 109.123 179.66 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 96.1 mt -86.57 113.37 24.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.127 -0.983 . . . . 0.0 109.66 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 20.6 m -153.94 17.24 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 179.75 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -127.08 137.51 53.04 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.536 -0.728 . . . . 0.0 109.881 -179.63 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 82.2 m-20 -77.95 138.71 39.0 Favored 'General case' 0 N--CA 1.485 1.306 0 CA-C-O 121.804 0.811 . . . . 0.0 110.92 -179.223 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 79.39 11.04 85.34 Favored Glycine 0 N--CA 1.492 2.425 0 N-CA-C 109.995 -1.242 . . . . 0.0 109.995 179.398 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 44.6 tt0 -70.68 130.68 42.41 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.037 -1.273 . . . . 0.0 109.994 -179.653 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 86.6 m95 -104.76 131.14 52.57 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.725 -0.609 . . . . 0.0 109.677 -179.533 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -178.71 177.13 0.91 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.486 -0.759 . . . . 0.0 109.851 179.586 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.694 HD21 ' HB2' ' A' ' 3' ' ' PRO . 21.4 m-20 -105.06 145.18 30.85 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.626 -0.672 . . . . 0.0 109.568 -179.79 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 5.2 tt -141.89 134.74 28.68 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.293 -0.879 . . . . 0.0 110.263 179.743 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 19.4 ttpp -112.47 138.44 49.22 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 179.52 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -161.01 179.9 8.07 Favored 'General case' 0 N--CA 1.492 1.644 0 C-N-CA 119.364 -0.934 . . . . 0.0 110.116 -179.54 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 89.0 tttt -115.35 139.46 49.98 Favored 'General case' 0 N--CA 1.495 1.79 0 CA-C-O 121.717 0.77 . . . . 0.0 110.221 -179.453 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.429 HG22 ' CD2' ' A' ' 41' ' ' LEU . 75.8 t -78.24 129.2 37.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 CA-C-O 121.688 0.756 . . . . 0.0 110.534 -179.275 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.439 HD11 ' HA3' ' A' ' 42' ' ' GLY . 96.7 mt -102.32 -53.84 7.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 178.971 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 67.0 tp60 -147.14 148.86 32.0 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.249 -0.907 . . . . 0.0 109.668 -179.871 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.841 HD23 ' H ' ' A' ' 27' ' ' LEU . 1.2 pt? -141.44 135.62 30.49 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 179.529 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 3.6 m-90 -121.08 114.03 20.88 Favored 'General case' 0 N--CA 1.496 1.872 0 CA-C-O 121.545 0.688 . . . . 0.0 109.457 -179.569 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 17.3 pt-20 -64.38 147.72 51.99 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.584 -0.697 . . . . 0.0 109.789 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ASN . . . . . 0.762 HD22 ' HB ' ' A' ' 35' ' ' ILE . 8.1 p-10 -133.25 -41.06 0.89 Allowed 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 179.875 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.431 ' C ' ' O ' ' A' ' 30' ' ' ASN . 1.3 p 39.42 48.75 1.77 Allowed 'General case' 0 N--CA 1.497 1.893 0 CA-C-O 122.014 0.911 . . . . 0.0 109.475 -179.276 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 78.1 t60 -62.72 -48.73 77.96 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.516 -0.74 . . . . 0.0 109.063 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.476 ' CG ' ' N ' ' A' ' 34' ' ' SER . 19.5 pt-20 -176.7 -47.07 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 179.92 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.476 ' N ' ' CG ' ' A' ' 33' ' ' GLU . 71.2 p -121.82 -7.14 9.03 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.535 -0.728 . . . . 0.0 109.218 -179.797 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.762 ' HB ' HD22 ' A' ' 30' ' ' ASN . 83.7 mt -106.56 127.04 62.29 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 O-C-N 121.3 -0.875 . . . . 0.0 110.07 -179.817 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 44.8 m -73.15 -74.91 0.16 Allowed 'General case' 0 N--CA 1.49 1.554 0 CA-C-O 121.726 0.774 . . . . 0.0 109.797 179.876 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 15.3 pt20 -146.62 162.12 39.09 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.341 -0.849 . . . . 0.0 109.656 -179.357 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 34.0 m -132.05 158.65 43.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 CA-C-O 121.659 0.742 . . . . 0.0 109.708 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -178.72 -160.8 25.39 Favored Glycine 0 N--CA 1.486 2.03 0 N-CA-C 109.764 -1.334 . . . . 0.0 109.764 -179.557 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.884 HD23 ' H ' ' A' ' 40' ' ' LEU . 1.3 pt? -139.96 148.24 41.64 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.572 -0.958 . . . . 0.0 110.35 -179.728 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.429 ' CD2' HG22 ' A' ' 24' ' ' VAL . 40.3 mt -109.59 134.07 52.36 Favored 'General case' 0 N--CA 1.491 1.581 0 CA-C-O 121.541 0.686 . . . . 0.0 109.379 -179.46 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.439 ' HA3' HD11 ' A' ' 25' ' ' ILE . . . -82.85 162.59 41.16 Favored Glycine 0 N--CA 1.488 2.132 0 N-CA-C 110.228 -1.149 . . . . 0.0 110.228 -179.868 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.547 ' OD1' ' N ' ' A' ' 44' ' ' GLU . 67.5 t0 -172.98 143.56 1.18 Allowed 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.761 -0.846 . . . . 0.0 109.342 179.688 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.547 ' N ' ' OD1' ' A' ' 43' ' ' ASP . 96.7 mt-10 -54.76 -14.94 1.57 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.603 -0.686 . . . . 0.0 109.639 179.865 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 44.3 p -94.15 -11.0 31.36 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.129 -0.982 . . . . 0.0 109.566 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 140.32 -155.77 24.79 Favored Glycine 0 N--CA 1.497 2.709 0 N-CA-C 110.309 -1.116 . . . . 0.0 110.309 179.423 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 41.9 pt -126.68 150.8 32.73 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 O-C-N 121.707 -0.878 . . . . 0.0 109.892 -179.364 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 19.0 tt -143.94 141.83 24.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.555 -0.715 . . . . 0.0 109.625 179.319 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -85.31 155.83 21.18 Favored 'General case' 0 N--CA 1.491 1.592 0 CA-C-O 121.435 0.636 . . . . 0.0 110.362 -179.603 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 38.5 p90 -144.47 151.65 39.49 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.251 -0.906 . . . . 0.0 109.775 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 54.1 m -133.35 127.13 32.83 Favored 'General case' 0 N--CA 1.492 1.639 0 CA-C-O 121.546 0.688 . . . . 0.0 109.459 179.263 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 97.0 mt -95.1 124.39 47.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.54 -0.725 . . . . 0.0 109.81 179.906 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' TRP . . . . . 0.45 ' C ' ' H ' ' A' ' 55' ' ' ASN . 90.2 m95 -82.67 105.99 14.16 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.422 -0.799 . . . . 0.0 109.065 179.334 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 73.8 tttt -52.84 -9.18 0.11 Allowed 'General case' 0 N--CA 1.491 1.605 0 CA-C-O 121.594 0.711 . . . . 0.0 109.723 -179.52 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ASN . . . . . 0.45 ' H ' ' C ' ' A' ' 53' ' ' TRP . 25.1 t-20 -63.11 -39.24 94.13 Favored 'General case' 0 C--N 1.298 -1.661 0 O-C-N 121.314 -0.866 . . . . 0.0 109.176 179.699 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -76.05 -11.88 60.02 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.283 -0.885 . . . . 0.0 109.237 179.634 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 73.0 mm-40 53.35 56.0 7.97 Favored 'General case' 0 N--CA 1.494 1.768 0 CA-C-O 121.933 0.873 . . . . 0.0 109.599 -179.817 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 15.0 mt -91.65 151.83 42.76 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.517 -0.739 . . . . 0.0 109.58 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -66.19 151.8 82.69 Favored 'Trans proline' 0 C--N 1.31 -1.455 0 C-N-CA 122.5 2.133 . . . . 0.0 112.432 179.567 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 82.0 mt -68.84 137.51 53.98 Favored 'General case' 0 N--CA 1.488 1.444 0 CA-C-O 121.862 0.839 . . . . 0.0 110.514 -179.301 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.535 ' N ' HD12 ' A' ' 61' ' ' LEU . 10.3 mp -78.98 143.0 36.15 Favored 'General case' 0 N--CA 1.49 1.569 0 CA-C-O 121.656 0.741 . . . . 0.0 109.853 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 81.7 tt0 -85.78 138.69 31.9 Favored 'General case' 0 N--CA 1.49 1.546 0 CA-C-O 121.857 0.837 . . . . 0.0 110.182 -179.586 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 57.2 tt0 -74.61 136.78 41.99 Favored 'General case' 0 N--CA 1.489 1.489 0 CA-C-O 121.819 0.819 . . . . 0.0 111.329 -179.375 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 84.17 20.95 58.12 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 110.051 -1.219 . . . . 0.0 110.051 178.966 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -128.49 145.56 51.07 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.401 -1.058 . . . . 0.0 110.156 -179.871 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 11.5 m -83.22 144.8 29.53 Favored 'General case' 0 N--CA 1.488 1.439 0 CA-C-O 121.653 0.74 . . . . 0.0 110.192 -179.642 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 79.9 m-85 -138.24 149.18 45.5 Favored 'General case' 0 N--CA 1.491 1.597 0 CA-C-O 121.918 0.866 . . . . 0.0 109.908 179.757 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 35.0 tp -106.77 122.65 46.8 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 179.284 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 65.8 mt -101.11 130.24 47.13 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 179.836 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.436 ' CZ ' ' OE2' ' A' ' 92' ' ' GLU . 80.7 mtm180 -125.65 142.61 51.42 Favored 'General case' 0 N--CA 1.497 1.878 0 CA-C-O 121.865 0.841 . . . . 0.0 110.699 -178.848 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 34.3 t 50.98 59.19 4.8 Favored 'General case' 0 N--CA 1.491 1.617 0 CA-C-N 115.683 -0.689 . . . . 0.0 111.032 179.118 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 6.4 m -111.49 160.68 10.64 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.989 0 O-C-N 121.406 -0.809 . . . . 0.0 109.633 178.883 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 7.4 p -118.41 134.24 62.65 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 CA-C-O 121.722 0.772 . . . . 0.0 109.604 -179.463 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 9.8 t -86.51 113.72 24.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 CA-C-O 121.824 0.821 . . . . 0.0 109.753 -179.499 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -90.65 143.87 17.02 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 110.112 -1.195 . . . . 0.0 110.112 -179.641 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -63.08 132.08 50.71 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.694 -0.886 . . . . 0.0 110.305 -179.816 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' TYR . . . . . 0.632 ' CD2' ' ND2' ' A' ' 78' ' ' ASN . 34.9 t80 -137.43 96.74 3.31 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.375 -0.828 . . . . 0.0 108.965 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ASN . . . . . 0.632 ' ND2' ' CD2' ' A' ' 77' ' ' TYR . 21.1 p30 43.41 -141.93 0.15 Allowed 'General case' 0 N--CA 1.494 1.758 0 CA-C-O 121.631 0.729 . . . . 0.0 110.897 -179.897 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.515 ' N ' ' OD1' ' A' ' 78' ' ' ASN . 46.9 t0 -73.05 -2.49 21.46 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.43 -0.793 . . . . 0.0 109.098 -179.633 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.492 ' N ' ' OD1' ' A' ' 78' ' ' ASN . 29.9 mmt180 -115.53 -171.98 2.07 Favored 'General case' 0 N--CA 1.495 1.805 0 CA-C-O 122.047 0.927 . . . . 0.0 110.228 -179.286 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -127.83 155.72 43.67 Favored 'General case' 0 N--CA 1.492 1.652 0 CA-C-O 121.558 0.694 . . . . 0.0 109.873 -179.207 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 52.1 tt0 -139.59 151.84 46.36 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.544 -0.722 . . . . 0.0 109.741 -179.599 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 3.8 m -108.98 132.23 57.6 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 179.235 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 87.9 mt-30 -105.93 127.08 52.9 Favored 'General case' 0 N--CA 1.495 1.795 0 CA-C-O 121.784 0.802 . . . . 0.0 110.178 -178.946 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.59 HG11 HD11 ' A' ' 91' ' ' ILE . 21.3 t -95.74 132.89 38.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 179.277 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 15.8 p30 -139.14 -178.14 5.22 Favored 'General case' 0 N--CA 1.492 1.668 0 CA-C-O 121.884 0.849 . . . . 0.0 110.362 -179.207 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 63.7 tttp -56.91 -40.25 75.97 Favored 'General case' 0 N--CA 1.492 1.647 0 CA-C-O 121.474 0.654 . . . . 0.0 110.064 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 23.2 t-20 -60.33 -37.94 82.18 Favored 'General case' 0 C--N 1.296 -1.725 0 O-C-N 121.306 -0.871 . . . . 0.0 109.89 -179.85 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 15.5 p -75.43 162.28 28.49 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.02 -1.05 . . . . 0.0 110.847 -179.133 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 67.4 m -131.62 149.83 52.36 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 179.701 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.59 HD11 HG11 ' A' ' 85' ' ' VAL . 97.0 mt -128.14 132.21 68.65 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 O-C-N 121.599 -0.688 . . . . 0.0 109.69 -179.664 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.436 ' OE2' ' CZ ' ' A' ' 70' ' ' ARG . 86.0 mt-10 -124.99 131.8 53.36 Favored 'General case' 0 N--CA 1.5 2.069 0 CA-C-O 121.488 0.661 . . . . 0.0 109.513 -179.558 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 37.2 ttpt -82.36 118.38 23.13 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.424 -0.797 . . . . 0.0 109.653 -179.807 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.495 ' C ' ' H ' ' A' ' 96' ' ' GLU . 59.6 mt -111.63 130.66 55.69 Favored 'General case' 0 N--CA 1.495 1.812 0 CA-C-O 121.464 0.65 . . . . 0.0 109.459 -179.72 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 42.2 m -77.27 29.63 0.14 Allowed 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 179.358 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.495 ' H ' ' C ' ' A' ' 94' ' ' LEU . 72.5 tt0 -111.43 92.74 17.03 Favored Pre-proline 0 N--CA 1.493 1.72 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 -179.752 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -75.21 151.22 38.36 Favored 'Trans proline' 0 N--CA 1.491 1.358 0 C-N-CA 122.221 1.947 . . . . 0.0 112.219 -179.077 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 84.5 mt -102.04 126.94 55.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 CA-C-O 121.745 0.783 . . . . 0.0 109.511 -179.674 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -87.84 115.56 25.38 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.62 -0.675 . . . . 0.0 109.965 -179.822 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 58.6 t -109.11 -41.76 5.1 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 CA-C-O 121.579 0.704 . . . . 0.0 109.195 179.762 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -69.64 -35.75 74.83 Favored Glycine 0 N--CA 1.498 2.805 0 N-CA-C 110.558 -1.017 . . . . 0.0 110.558 -179.829 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 31.9 mt -82.75 -0.39 47.47 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.176 -1.191 . . . . 0.0 108.95 -179.556 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 82.5 tt0 -56.71 129.8 42.73 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.252 -0.905 . . . . 0.0 110.102 -179.77 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 86.2 t60 -88.73 -82.64 0.24 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.499 -0.751 . . . . 0.0 109.89 179.834 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 81.8 t60 -148.29 148.02 29.97 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.111 -0.993 . . . . 0.0 110.145 -179.524 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 86.2 t60 -71.14 134.28 46.85 Favored 'General case' 0 N--CA 1.489 1.522 0 CA-C-O 121.808 0.813 . . . . 0.0 110.91 -179.411 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 65.7 t-80 -146.14 142.55 28.59 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.53 -0.731 . . . . 0.0 109.619 179.643 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 78.0 m80 -70.64 139.22 51.28 Favored 'General case' 0 N--CA 1.491 1.578 0 CA-C-O 121.65 0.738 . . . . 0.0 110.5 -179.503 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' HIS . . . . . 0.41 ' ND1' ' C ' ' A' ' 109' ' ' HIS . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.469 0 CA-C-O 118.172 -0.918 . . . . 0.0 109.025 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 51.7 ttp . . . . . 0 N--CA 1.489 1.478 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -163.17 153.44 13.57 Favored Pre-proline 0 C--N 1.303 -1.441 0 O-C-N 121.353 -0.842 . . . . 0.0 108.873 179.325 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -65.24 144.27 80.36 Favored 'Trans proline' 0 N--CA 1.495 1.588 0 C-N-CA 122.755 2.303 . . . . 0.0 112.555 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 84.9 mt-30 -76.41 91.89 3.34 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.152 -0.968 . . . . 0.0 108.723 179.45 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 82.6 mt -85.27 131.87 34.35 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.531 -0.731 . . . . 0.0 109.619 -179.071 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 99.9 m -123.64 131.01 53.51 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 179.841 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 71.5 mmtt -80.58 156.64 26.34 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-O 121.683 0.754 . . . . 0.0 110.362 -178.62 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 97.3 mt -62.89 -43.31 98.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.484 -0.76 . . . . 0.0 109.279 -179.798 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 14.5 p -66.28 -23.51 31.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.338 -0.851 . . . . 0.0 109.606 -179.743 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -78.49 -5.03 51.43 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.251 -0.905 . . . . 0.0 109.899 -179.778 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 96.7 mt -80.94 121.85 35.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 120.939 -1.101 . . . . 0.0 110.081 -179.579 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 31.2 m -146.55 10.25 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 179.172 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 48.2 tp10 -136.11 132.96 36.77 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.341 -0.849 . . . . 0.0 109.745 -179.782 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 81.7 m-20 -82.38 142.04 32.31 Favored 'General case' 0 C--N 1.306 -1.311 0 O-C-N 121.347 -0.846 . . . . 0.0 110.431 -179.828 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 75.68 98.93 0.13 Allowed Glycine 0 N--CA 1.49 2.258 0 N-CA-C 110.032 -1.227 . . . . 0.0 110.032 179.232 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 14.1 pt20 -173.45 141.29 0.88 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.159 -1.201 . . . . 0.0 109.702 179.282 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 71.0 m95 -94.0 137.06 33.63 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.615 -0.678 . . . . 0.0 109.781 -179.549 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -175.58 177.68 1.72 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.139 -0.976 . . . . 0.0 109.639 179.745 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 81.4 m-20 -106.59 147.49 29.4 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.602 -0.686 . . . . 0.0 109.639 -179.703 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 40.2 tp -140.79 133.29 28.51 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.342 -0.849 . . . . 0.0 109.892 179.717 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 35.7 ttpt -117.29 137.78 52.18 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 178.9 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -161.81 174.91 12.52 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.869 -1.145 . . . . 0.0 110.194 -179.582 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 65.1 tttm -110.32 133.29 53.4 Favored 'General case' 0 N--CA 1.495 1.818 0 CA-C-O 121.517 0.675 . . . . 0.0 109.848 -179.753 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.482 HG22 ' CD2' ' A' ' 41' ' ' LEU . 67.1 t -77.77 126.94 38.5 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 O-C-N 121.369 -0.832 . . . . 0.0 109.745 -179.904 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 23.2 pt -108.8 -34.0 2.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 179.368 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 6.6 tt0 -163.73 133.79 4.24 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.115 -0.991 . . . . 0.0 109.647 178.872 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.506 HD12 ' O ' ' A' ' 27' ' ' LEU . 0.3 OUTLIER -131.46 136.64 48.12 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 -179.83 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 5.2 m0 -113.96 124.61 52.59 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.472 -0.768 . . . . 0.0 109.493 -179.595 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 2.9 pp20? -64.07 135.16 56.15 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.544 -0.722 . . . . 0.0 109.36 -179.921 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ASN . . . . . 0.451 HD21 ' HA ' ' A' ' 30' ' ' ASN . 1.3 t-20 -106.4 134.93 48.76 Favored 'General case' 0 N--CA 1.493 1.689 0 CA-C-O 121.781 0.801 . . . . 0.0 110.371 -179.285 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 13.2 p -99.5 3.72 45.72 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 179.594 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 83.0 t60 -85.95 128.55 34.87 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.297 -0.877 . . . . 0.0 110.104 -179.531 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.516 ' O ' ' CB ' ' A' ' 34' ' ' SER . 22.3 pt-20 -53.97 157.0 2.64 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.484 -0.76 . . . . 0.0 110.723 -179.789 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.516 ' CB ' ' O ' ' A' ' 33' ' ' GLU . 5.1 p 84.6 -43.01 0.07 Allowed 'General case' 0 N--CA 1.499 1.988 0 N-CA-C 109.384 -0.599 . . . . 0.0 109.384 -179.861 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 96.2 mt -109.9 118.06 56.06 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 CA-C-O 121.617 0.722 . . . . 0.0 109.83 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 44.1 t -77.79 -49.0 15.23 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.604 -0.685 . . . . 0.0 109.51 179.674 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 33.6 tt0 -147.34 153.48 39.75 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.222 -0.924 . . . . 0.0 110.016 -179.708 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 9.1 p -142.95 143.27 25.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.573 -0.704 . . . . 0.0 109.259 179.156 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -173.99 -154.27 10.61 Favored Glycine 0 N--CA 1.485 1.95 0 C-N-CA 119.534 -1.317 . . . . 0.0 109.941 -179.645 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.617 HD12 ' H ' ' A' ' 40' ' ' LEU . 0.1 OUTLIER -136.8 151.3 49.01 Favored 'General case' 0 N--CA 1.501 2.082 0 O-C-N 121.555 -0.968 . . . . 0.0 109.494 -179.019 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.482 ' CD2' HG22 ' A' ' 24' ' ' VAL . 66.3 mt -115.08 126.44 54.69 Favored 'General case' 0 N--CA 1.495 1.803 0 CA-C-O 121.597 0.713 . . . . 0.0 109.413 179.892 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -75.72 158.69 50.35 Favored Glycine 0 N--CA 1.488 2.157 0 N-CA-C 110.807 -0.917 . . . . 0.0 110.807 -179.443 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -170.97 151.65 3.35 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.519 -0.989 . . . . 0.0 109.07 179.253 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 17.6 pt-20 -59.41 -15.12 14.97 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.27 -0.894 . . . . 0.0 109.546 179.921 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 39.2 p -92.6 -13.14 30.04 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.093 -1.004 . . . . 0.0 109.279 -179.453 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 140.79 -151.47 22.44 Favored Glycine 0 N--CA 1.496 2.635 0 N-CA-C 109.987 -1.245 . . . . 0.0 109.987 179.353 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 96.7 mt -126.25 138.87 53.27 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 O-C-N 121.729 -0.865 . . . . 0.0 109.234 -179.815 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.556 HD11 ' O ' ' A' ' 81' ' ' PHE . 9.6 tp -128.28 143.59 40.49 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 CA-C-O 121.789 0.804 . . . . 0.0 110.152 -179.727 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 19.1 mmmt -84.01 147.89 27.18 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.688 -0.633 . . . . 0.0 109.874 180.0 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 21.1 p90 -144.14 159.95 41.76 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.244 -0.91 . . . . 0.0 109.298 179.843 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 1.6 t -145.33 141.44 28.53 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.401 -0.812 . . . . 0.0 109.829 179.611 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 98.4 mt -107.43 118.7 55.67 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 O-C-N 121.573 -0.704 . . . . 0.0 109.316 179.596 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 59.3 m95 -86.34 139.42 30.99 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.158 -0.964 . . . . 0.0 110.139 -179.212 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -49.3 -20.96 0.73 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.408 -0.807 . . . . 0.0 109.875 179.848 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 68.1 m-20 -63.71 -38.04 89.61 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.12 -0.987 . . . . 0.0 109.688 -179.818 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -61.64 -34.63 76.02 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.257 -0.902 . . . . 0.0 109.097 -179.819 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 56.68 38.48 29.57 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.68 -0.638 . . . . 0.0 109.697 -179.722 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 51.1 mt -104.59 147.03 33.75 Favored Pre-proline 0 N--CA 1.496 1.84 0 O-C-N 121.496 -0.752 . . . . 0.0 109.618 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -68.26 162.05 42.03 Favored 'Trans proline' 0 N--CA 1.498 1.758 0 C-N-CA 122.707 2.271 . . . . 0.0 112.811 179.632 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 67.6 mt -64.77 149.79 48.62 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.317 -0.864 . . . . 0.0 110.682 -178.948 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.558 ' N ' HD12 ' A' ' 61' ' ' LEU . 10.7 mp -88.22 138.42 31.46 Favored 'General case' 0 N--CA 1.492 1.666 0 CA-C-O 121.572 0.701 . . . . 0.0 110.188 -179.239 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.467 ' N ' ' OH ' ' A' ' 67' ' ' TYR . 52.9 tp10 -66.43 137.01 56.55 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.407 -0.808 . . . . 0.0 110.054 -179.57 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 17.1 tt0 -73.18 135.66 44.65 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.564 -0.71 . . . . 0.0 110.68 -179.255 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 83.84 29.82 30.87 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 110.037 -1.225 . . . . 0.0 110.037 179.047 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -136.41 146.54 46.53 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.168 -1.195 . . . . 0.0 110.426 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 11.8 p -79.01 152.09 31.16 Favored 'General case' 0 N--CA 1.487 1.4 0 CA-C-O 121.542 0.686 . . . . 0.0 110.141 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.467 ' OH ' ' N ' ' A' ' 62' ' ' GLU . 89.9 m-85 -144.47 147.59 33.48 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.412 -0.805 . . . . 0.0 109.662 179.698 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 15.7 tp -111.36 120.93 43.86 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 179.548 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 60.7 mt -97.32 134.85 40.05 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.534 -0.729 . . . . 0.0 109.313 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 79.1 mtp85 -128.19 138.96 52.7 Favored 'General case' 0 N--CA 1.497 1.897 0 CA-C-O 121.507 0.67 . . . . 0.0 110.388 -179.83 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 18.4 m 57.12 61.14 2.67 Favored 'General case' 0 N--CA 1.493 1.718 0 CA-C-O 121.005 0.431 . . . . 0.0 110.534 179.47 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 15.5 m -116.03 159.73 15.81 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.993 0 O-C-N 121.49 -0.756 . . . . 0.0 109.441 178.822 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 14.2 p -114.85 134.66 57.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 CA-C-O 121.474 0.654 . . . . 0.0 109.498 -179.361 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 11.7 t -88.29 113.56 25.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.298 -0.876 . . . . 0.0 109.744 -179.294 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -98.57 172.76 26.48 Favored Glycine 0 N--CA 1.493 2.484 0 N-CA-C 109.914 -1.275 . . . . 0.0 109.914 -179.797 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 81.3 tt0 -112.85 122.77 48.62 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.742 -0.858 . . . . 0.0 109.253 179.661 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 75.7 t80 -135.7 126.59 27.6 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.522 -0.736 . . . . 0.0 109.756 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 9.3 t-20 57.11 44.09 23.09 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.574 -0.704 . . . . 0.0 109.924 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 55.03 28.83 11.34 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.549 -0.72 . . . . 0.0 109.445 179.691 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 71.7 ttt180 -130.78 152.2 50.38 Favored 'General case' 0 N--CA 1.497 1.876 0 CA-C-O 121.516 0.674 . . . . 0.0 109.771 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' PHE . . . . . 0.556 ' O ' HD11 ' A' ' 48' ' ' ILE . 91.6 m-85 -84.66 142.64 29.76 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.433 -0.792 . . . . 0.0 109.733 -179.835 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -153.24 165.26 36.28 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.15 -0.969 . . . . 0.0 109.711 179.871 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 3.2 m -109.1 132.35 57.4 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.013 0 O-C-N 121.495 -0.753 . . . . 0.0 109.811 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 84.4 mt-30 -113.3 121.84 45.62 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 -179.777 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 27.8 t -91.18 129.5 41.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.298 -0.876 . . . . 0.0 109.9 -179.655 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 11.2 m-80 -140.88 -177.78 5.24 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.45 -0.781 . . . . 0.0 109.258 179.83 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.523 ' C ' ' H ' ' A' ' 89' ' ' SER . 63.0 pttt -44.3 164.79 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.575 -0.703 . . . . 0.0 111.02 -179.681 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 5.3 t30 72.15 -29.84 0.2 Allowed 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 -179.852 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.523 ' H ' ' C ' ' A' ' 87' ' ' LYS . 7.2 m -69.65 150.79 46.64 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.403 -0.81 . . . . 0.0 110.196 -179.522 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 46.9 t -132.56 146.55 51.99 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 96.8 mt -126.14 132.53 70.42 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 O-C-N 121.584 -0.698 . . . . 0.0 109.293 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -125.87 130.3 51.07 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.594 -0.691 . . . . 0.0 109.493 179.649 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 64.5 tttm -79.1 131.21 36.17 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.455 -0.778 . . . . 0.0 109.679 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 85.8 mt -110.22 137.49 47.88 Favored 'General case' 0 N--CA 1.498 1.927 0 CA-C-O 121.792 0.806 . . . . 0.0 110.174 -179.872 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 93.8 p -85.62 13.49 6.94 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.646 -0.658 . . . . 0.0 109.43 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 86.4 mt-10 -117.4 90.7 35.44 Favored Pre-proline 0 N--CA 1.499 2.002 0 O-C-N 121.674 -0.641 . . . . 0.0 109.491 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_exo -56.15 150.01 50.79 Favored 'Trans proline' 0 N--CA 1.499 1.818 0 C-N-CA 122.946 2.431 . . . . 0.0 112.758 179.518 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.536 ' O ' HG22 ' A' ' 98' ' ' ILE . 48.1 mm -75.22 0.02 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 121.261 -0.899 . . . . 0.0 109.527 -179.533 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' GLU . . . . . 0.403 ' C ' ' O ' ' A' ' 98' ' ' ILE . 40.6 tp10 42.33 62.03 1.81 Allowed 'General case' 0 C--N 1.292 -1.911 0 O-C-N 121.882 -0.511 . . . . 0.0 109.669 179.796 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 2.5 p -102.47 -17.21 7.09 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.261 0 O-C-N 121.251 -0.905 . . . . 0.0 109.052 -179.665 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -90.68 113.39 4.25 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.852 -1.299 . . . . 0.0 109.852 -179.836 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.542 ' N ' HD12 ' A' ' 102' ' ' LEU . 10.7 mp -86.3 -3.24 58.95 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.349 -1.089 . . . . 0.0 108.932 179.747 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -64.64 143.12 58.15 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.328 -0.857 . . . . 0.0 110.322 -179.739 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 77.8 m80 -85.71 -6.2 59.16 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.3 -0.875 . . . . 0.0 108.893 179.729 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 77.5 m80 53.34 -120.45 1.69 Allowed 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.454 -0.778 . . . . 0.0 110.294 179.781 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 86.0 t60 -159.36 141.68 13.72 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.081 -1.012 . . . . 0.0 109.029 -179.844 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 96.6 m-70 -108.76 138.18 45.51 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.48 -0.763 . . . . 0.0 109.843 -179.622 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 52.0 p-80 -77.38 141.97 39.54 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.513 -0.742 . . . . 0.0 110.518 -179.306 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 98.7 m-70 . . . . . 0 N--CA 1.489 1.516 0 CA-C-O 118.006 -0.997 . . . . 0.0 109.613 -179.935 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.0 ttt . . . . . 0 N--CA 1.49 1.547 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.447 ' N ' ' CD ' ' A' ' 3' ' ' PRO . 40.3 mm-40 58.51 52.86 4.85 Favored Pre-proline 0 N--CA 1.493 1.714 0 O-C-N 121.655 -0.653 . . . . 0.0 110.037 -179.657 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.672 ' HB2' HD21 ' A' ' 19' ' ' ASN . 47.5 Cg_endo -67.04 145.93 75.28 Favored 'Trans proline' 0 N--CA 1.496 1.644 0 C-N-CA 122.717 2.278 . . . . 0.0 112.435 179.731 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 18.3 mm100 -76.6 92.62 3.5 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.082 -1.011 . . . . 0.0 109.58 -179.711 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 72.7 mt -76.34 138.05 40.22 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.501 -0.749 . . . . 0.0 109.638 -179.91 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 54.1 m -130.09 131.94 45.94 Favored 'General case' 0 N--CA 1.495 1.808 0 CA-C-O 121.427 0.632 . . . . 0.0 109.478 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 65.0 mttp -85.52 157.37 20.44 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.366 -0.834 . . . . 0.0 110.119 -179.51 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 96.2 mt -62.71 -43.48 98.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.352 -0.843 . . . . 0.0 109.393 -179.711 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 12.2 p -66.29 -22.93 30.89 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.206 -0.934 . . . . 0.0 109.667 -179.673 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.408 ' O ' ' OD1' ' A' ' 10' ' ' ASP . 57.7 t0 -73.75 -4.03 32.06 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.2 -0.937 . . . . 0.0 109.388 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 96.6 mt -74.96 125.92 35.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.141 -0.974 . . . . 0.0 109.767 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 4.1 m -129.15 -31.06 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 N-CA-C 109.241 -0.652 . . . . 0.0 109.241 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 -135.08 145.26 47.76 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.379 -0.825 . . . . 0.0 110.296 -179.515 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 64.2 m-80 -78.83 154.88 29.49 Favored 'General case' 0 C--N 1.306 -1.312 0 CA-C-O 121.514 0.673 . . . . 0.0 110.517 -179.595 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 88.69 8.21 70.44 Favored Glycine 0 N--CA 1.492 2.402 0 N-CA-C 109.136 -1.585 . . . . 0.0 109.136 179.638 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 18.4 tt0 -77.29 132.85 38.85 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.371 -1.076 . . . . 0.0 109.992 -179.649 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 89.5 m95 -99.56 134.25 42.7 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.39 -0.819 . . . . 0.0 110.006 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -179.9 -175.1 0.3 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.493 -0.754 . . . . 0.0 109.198 179.463 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.672 HD21 ' HB2' ' A' ' 3' ' ' PRO . 68.8 m-20 -105.14 153.31 21.7 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.578 -0.701 . . . . 0.0 109.574 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 54.3 tp -139.58 137.85 35.72 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.536 -0.728 . . . . 0.0 109.303 179.492 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 35.9 ttpt -128.25 133.36 48.79 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.683 -0.635 . . . . 0.0 109.475 179.362 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -168.17 177.7 5.37 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.444 -0.785 . . . . 0.0 109.355 179.317 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.427 ' NZ ' ' O ' ' A' ' 98' ' ' ILE . 17.0 ptpt -107.21 146.28 31.6 Favored 'General case' 0 N--CA 1.496 1.861 0 CA-C-O 121.672 0.749 . . . . 0.0 110.179 -179.563 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.465 HG22 ' CD2' ' A' ' 41' ' ' LEU . 78.9 t -85.03 97.88 5.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.561 -0.712 . . . . 0.0 110.093 -179.282 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 37.2 mm -65.72 -44.8 93.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.484 -0.76 . . . . 0.0 109.089 179.703 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 68.1 tp60 -151.22 148.45 28.24 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.239 -0.913 . . . . 0.0 109.321 179.405 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.963 HD23 ' H ' ' A' ' 27' ' ' LEU . 1.3 pt? -128.5 145.22 51.18 Favored 'General case' 0 N--CA 1.494 1.754 0 CA-C-O 121.219 0.533 . . . . 0.0 109.976 -179.857 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 97.6 m95 -128.21 101.53 6.29 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 178.991 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.674 ' H ' ' CD ' ' A' ' 29' ' ' GLU . 1.6 pm0 -65.69 150.68 48.09 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.583 -0.698 . . . . 0.0 110.605 -178.82 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 18.3 p30 -144.99 128.94 17.45 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.087 -1.008 . . . . 0.0 109.198 179.09 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 63.3 m -95.21 87.38 4.84 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.452 -0.78 . . . . 0.0 109.55 -178.946 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 80.8 m80 -131.62 160.61 34.87 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.495 -0.753 . . . . 0.0 109.178 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -66.45 -36.37 82.62 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.465 -0.772 . . . . 0.0 110.532 -179.339 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 20.8 t -100.84 -53.71 2.99 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.219 -0.926 . . . . 0.0 110.435 -179.161 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 31.7 mt -78.64 132.22 32.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.183 -0.948 . . . . 0.0 110.199 -178.264 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 8.7 t -98.91 -60.89 1.45 Allowed 'General case' 0 N--CA 1.494 1.727 0 CA-C-O 121.576 0.703 . . . . 0.0 109.283 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -150.36 150.3 31.24 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.257 -0.902 . . . . 0.0 109.565 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 28.7 m -135.57 160.15 39.87 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 O-C-N 121.5 -0.75 . . . . 0.0 109.762 179.724 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 178.6 -166.97 37.13 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -132.9 148.84 52.29 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.404 -1.056 . . . . 0.0 109.898 179.857 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.465 ' CD2' HG22 ' A' ' 24' ' ' VAL . 51.6 mt -111.73 130.72 55.7 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 -179.002 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -97.66 148.31 18.9 Favored Glycine 0 N--CA 1.493 2.493 0 N-CA-C 110.648 -0.981 . . . . 0.0 110.648 -179.362 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.434 ' OD1' ' O ' ' A' ' 46' ' ' GLY . 49.0 p30 -173.24 166.65 4.86 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.691 -0.888 . . . . 0.0 108.948 178.886 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.434 ' OE2' ' NE2' ' A' ' 105' ' ' HIS . 78.5 tt0 -61.56 -16.62 49.51 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.337 -0.852 . . . . 0.0 110.018 -179.347 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 82.7 p -85.48 0.25 52.89 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.952 -1.092 . . . . 0.0 109.212 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.434 ' O ' ' OD1' ' A' ' 43' ' ' ASP . . . 116.05 -147.94 18.9 Favored Glycine 0 N--CA 1.499 2.872 0 N-CA-C 110.241 -1.144 . . . . 0.0 110.241 178.987 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 96.9 mt -132.57 137.68 53.67 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 121.6 -0.941 . . . . 0.0 109.489 -179.419 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 19.7 tt -134.89 140.88 44.54 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 O-C-N 121.561 -0.712 . . . . 0.0 109.72 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 18.8 mtpp -83.46 155.02 23.63 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.491 -0.755 . . . . 0.0 109.669 -179.806 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 34.2 p90 -141.74 151.83 43.26 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.313 -0.867 . . . . 0.0 109.724 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 52.6 m -131.9 130.81 42.09 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 179.723 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 90.7 mt -102.62 124.05 56.35 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.381 -0.825 . . . . 0.0 110.253 -179.295 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 85.3 m95 -92.99 130.97 38.38 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.418 -0.801 . . . . 0.0 108.936 179.698 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 17.4 ptpt -82.51 55.29 2.89 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.23 -0.919 . . . . 0.0 109.632 -179.656 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 90.8 m-20 -76.05 -3.04 33.67 Favored 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 179.503 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -151.03 -91.41 0.06 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.368 -0.832 . . . . 0.0 109.239 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 179.65 70.6 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 179.846 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 16.7 mt -87.83 146.27 38.53 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.201 -0.937 . . . . 0.0 109.983 -179.105 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -71.46 155.49 59.7 Favored 'Trans proline' 0 N--CA 1.498 1.739 0 C-N-CA 122.656 2.238 . . . . 0.0 112.759 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 79.7 mt -76.43 141.56 41.35 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.398 -0.814 . . . . 0.0 109.95 -179.743 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.625 ' N ' HD12 ' A' ' 61' ' ' LEU . 10.0 mp -81.96 145.54 30.23 Favored 'General case' 0 N--CA 1.488 1.458 0 CA-C-O 121.491 0.662 . . . . 0.0 110.286 -179.169 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.545 ' OE1' ' N ' ' A' ' 62' ' ' GLU . 58.2 mp0 -93.14 144.95 24.78 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.404 -0.81 . . . . 0.0 109.922 -179.488 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 57.9 tt0 -76.55 142.25 40.88 Favored 'General case' 0 N--CA 1.489 1.515 0 CA-C-O 121.505 0.669 . . . . 0.0 111.205 -178.994 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 81.85 21.22 61.85 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 110.253 -1.139 . . . . 0.0 110.253 178.817 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -130.3 146.29 51.87 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.32 -1.106 . . . . 0.0 110.614 -179.68 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 11.6 p -80.37 151.81 29.22 Favored 'General case' 0 N--CA 1.488 1.473 0 CA-C-O 121.513 0.673 . . . . 0.0 110.002 -179.894 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -144.72 145.64 31.8 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.408 -0.808 . . . . 0.0 109.517 179.803 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 20.2 tp -110.24 122.51 47.81 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 179.398 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 69.6 mt -100.73 134.54 43.55 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 82.6 mtp180 -126.51 140.87 52.12 Favored 'General case' 0 N--CA 1.498 1.964 0 CA-C-O 121.729 0.776 . . . . 0.0 110.701 -179.268 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 38.3 t 53.58 71.57 0.49 Allowed 'General case' 0 N--CA 1.491 1.583 0 CA-C-O 121.095 0.474 . . . . 0.0 110.514 179.524 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 18.0 m -128.93 164.19 31.9 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.023 0 O-C-N 121.578 -0.701 . . . . 0.0 109.336 178.957 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 9.7 p -120.45 135.83 59.42 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 CA-C-O 121.416 0.627 . . . . 0.0 109.418 -179.599 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 11.6 t -85.61 115.47 27.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.391 -0.818 . . . . 0.0 110.071 -178.965 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -94.17 -178.66 38.73 Favored Glycine 0 N--CA 1.492 2.419 0 N-CA-C 109.312 -1.515 . . . . 0.0 109.312 179.772 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -112.0 133.35 54.23 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.663 -0.904 . . . . 0.0 109.629 -179.885 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 91.3 t80 -136.49 108.1 6.98 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.418 -0.801 . . . . 0.0 109.147 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ASN . . . . . 0.504 ' CG ' ' H ' ' A' ' 79' ' ' ASP . 66.7 t30 51.48 -134.38 1.63 Allowed 'General case' 0 N--CA 1.493 1.698 0 CA-C-O 121.603 0.716 . . . . 0.0 110.823 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.504 ' H ' ' CG ' ' A' ' 78' ' ' ASN . 36.5 t70 -87.1 -7.24 58.24 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.344 -0.848 . . . . 0.0 109.201 -179.389 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 85.2 mtp180 -108.56 173.98 6.08 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.711 -0.618 . . . . 0.0 109.763 -179.543 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 72.7 m-85 -104.74 155.85 18.52 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.605 -0.684 . . . . 0.0 109.944 -179.388 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 20.1 tt0 -138.35 153.19 48.97 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 -179.662 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 3.3 m -116.05 131.94 67.06 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 179.551 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 87.8 mt-30 -101.42 135.28 43.17 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.504 -0.748 . . . . 0.0 110.178 -178.74 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 71.4 t -107.09 130.55 58.97 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 179.274 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 79.2 m-20 -124.83 -179.57 4.58 Favored 'General case' 0 N--CA 1.496 1.854 0 CA-C-O 121.507 0.67 . . . . 0.0 109.911 -179.327 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 64.0 tttp -58.94 -41.0 86.35 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.592 -0.692 . . . . 0.0 110.043 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' ASN . . . . . 0.411 ' OD1' ' O ' ' A' ' 88' ' ' ASN . 41.9 t-20 -60.5 -35.67 76.51 Favored 'General case' 0 C--N 1.299 -1.602 0 O-C-N 121.109 -0.995 . . . . 0.0 109.112 -179.915 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 30.9 t -70.0 152.76 44.05 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.28 -0.887 . . . . 0.0 110.089 -179.519 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 35.3 t -128.74 148.91 50.88 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.601 -0.687 . . . . 0.0 109.495 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 96.2 mt -123.66 132.8 70.76 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 O-C-N 121.713 -0.617 . . . . 0.0 109.381 -179.782 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 82.5 tt0 -126.08 131.2 52.17 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 179.392 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.42 ' C ' HD12 ' A' ' 94' ' ' LEU . 37.8 ttmt -79.81 131.37 35.88 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.487 -0.758 . . . . 0.0 109.923 -179.568 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.438 ' N ' HD12 ' A' ' 94' ' ' LEU . 9.9 mp -101.08 137.31 39.62 Favored 'General case' 0 N--CA 1.493 1.685 0 CA-C-O 121.615 0.721 . . . . 0.0 109.644 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 70.3 m -90.4 6.33 43.7 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.649 -0.657 . . . . 0.0 109.501 -179.772 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.471 ' N ' ' CD ' ' A' ' 96' ' ' GLU . 1.3 pm0 -116.34 91.67 33.81 Favored Pre-proline 0 N--CA 1.499 1.975 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_exo -53.94 149.24 35.09 Favored 'Trans proline' 0 N--CA 1.495 1.611 0 C-N-CA 122.372 2.048 . . . . 0.0 112.249 -179.811 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.427 ' O ' ' NZ ' ' A' ' 23' ' ' LYS . 96.7 mt -100.62 128.62 52.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 CA-C-O 121.673 0.749 . . . . 0.0 110.644 -178.453 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' GLU . . . . . 0.535 ' N ' ' OE1' ' A' ' 99' ' ' GLU . 57.9 mp0 -87.59 127.81 35.27 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.577 -0.702 . . . . 0.0 109.383 -179.695 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 3.6 t -101.21 -15.57 7.58 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 O-C-N 121.499 -0.751 . . . . 0.0 109.363 -179.778 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -91.7 -2.71 69.42 Favored Glycine 0 N--CA 1.492 2.409 0 N-CA-C 109.117 -1.593 . . . . 0.0 109.117 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.466 ' O ' ' C ' ' A' ' 103' ' ' GLU . 10.8 tp -61.37 -61.28 2.65 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.286 -1.126 . . . . 0.0 109.89 -179.349 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' GLU . . . . . 0.466 ' C ' ' O ' ' A' ' 102' ' ' LEU . 10.7 pt-20 31.66 40.38 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.062 0 CA-C-O 121.423 0.63 . . . . 0.0 110.586 -179.641 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 104' ' ' HIS . . . . . 0.42 ' N ' ' O ' ' A' ' 102' ' ' LEU . 64.9 t60 -66.19 -44.51 83.76 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.451 -0.781 . . . . 0.0 109.254 -179.763 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' HIS . . . . . 0.434 ' NE2' ' OE2' ' A' ' 44' ' ' GLU . 99.0 m-70 41.13 90.53 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.705 0 CA-C-O 121.416 0.626 . . . . 0.0 110.543 -179.925 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 86.2 t60 -153.85 86.96 1.2 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.288 -0.882 . . . . 0.0 108.738 179.295 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' HIS . . . . . 0.462 ' C ' ' H ' ' A' ' 109' ' ' HIS . 44.8 p-80 -154.25 161.82 41.56 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.264 -0.898 . . . . 0.0 110.424 -179.83 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 54.5 t-80 50.06 11.01 0.06 Allowed 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.573 -0.704 . . . . 0.0 109.899 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' HIS . . . . . 0.462 ' H ' ' C ' ' A' ' 107' ' ' HIS . 85.6 t60 . . . . . 0 N--CA 1.491 1.623 0 CA-C-O 117.958 -1.02 . . . . 0.0 109.91 179.534 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.9 mpp? . . . . . 0 N--CA 1.489 1.51 0 CA-C-O 121.469 0.652 . . . . 0.0 109.657 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 41.33 57.76 9.04 Favored Pre-proline 0 N--CA 1.495 1.822 0 O-C-N 121.8 -0.563 . . . . 0.0 110.731 -179.82 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.447 ' HB2' HD21 ' A' ' 19' ' ' ASN . 74.4 Cg_endo -72.97 151.4 50.3 Favored 'Trans proline' 0 N--CA 1.496 1.635 0 C-N-CA 122.605 2.204 . . . . 0.0 112.715 179.617 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 58.9 tt0 -74.59 93.46 2.52 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.237 -0.915 . . . . 0.0 109.586 -179.775 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 86.6 mt -84.93 129.51 34.79 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.428 -0.795 . . . . 0.0 109.579 -179.694 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 98.7 m -127.76 131.21 49.67 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.621 -0.674 . . . . 0.0 110.042 -179.54 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -84.34 158.77 21.05 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.572 -0.705 . . . . 0.0 109.962 -179.79 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 97.3 mt -62.78 -43.7 98.95 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.289 -0.882 . . . . 0.0 109.553 -179.546 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 14.9 p -67.7 -21.94 27.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.188 -0.945 . . . . 0.0 109.404 -179.638 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -76.24 -4.15 40.35 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.373 -0.829 . . . . 0.0 109.184 179.634 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 96.7 mt -80.42 116.13 24.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.305 -0.872 . . . . 0.0 109.353 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 27.0 m -119.52 -19.92 5.15 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.875 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 179.878 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 22.1 pt-20 -139.34 141.62 37.65 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.42 -0.8 . . . . 0.0 109.955 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 23.3 p30 -86.15 167.0 15.32 Favored 'General case' 0 N--CA 1.491 1.59 0 CA-C-O 121.478 0.656 . . . . 0.0 110.378 -179.619 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 80.57 3.17 90.15 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.188 -1.565 . . . . 0.0 109.188 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 14.5 pt20 -84.58 145.68 27.92 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.321 -1.105 . . . . 0.0 110.106 -179.609 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' TRP . . . . . 0.439 ' CD1' ' N ' ' A' ' 17' ' ' TRP . 31.6 m95 -101.92 138.83 38.37 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.671 -0.643 . . . . 0.0 110.063 -179.593 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -178.9 -170.08 0.18 Allowed 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 179.358 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.447 HD21 ' HB2' ' A' ' 3' ' ' PRO . 39.0 m-20 -108.32 149.54 28.52 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.544 -0.723 . . . . 0.0 109.567 -179.85 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.615 HD13 ' N ' ' A' ' 21' ' ' LYS . 0.3 OUTLIER -137.7 121.24 17.24 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 179.469 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.615 ' N ' HD13 ' A' ' 20' ' ' LEU . 36.4 ttpt -110.48 139.75 45.4 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.666 -0.646 . . . . 0.0 109.771 179.577 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -167.78 -174.03 2.31 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.31 -0.868 . . . . 0.0 109.789 179.553 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 76.0 tttt -118.12 144.16 45.89 Favored 'General case' 0 N--CA 1.501 2.085 0 CA-C-O 121.545 0.688 . . . . 0.0 109.733 -179.663 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.419 HG12 ' OE1' ' A' ' 63' ' ' GLN . 4.7 t -78.77 120.88 30.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.429 -0.794 . . . . 0.0 111.059 -178.59 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 32.7 mm -94.57 -49.05 12.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 179.13 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 57.8 tt0 -153.92 149.68 27.55 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.406 -0.809 . . . . 0.0 109.482 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 95.0 mt -121.0 145.12 48.09 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.762 -0.586 . . . . 0.0 109.832 -179.872 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 2.1 t-105 -128.95 111.59 13.19 Favored 'General case' 0 N--CA 1.495 1.786 0 CA-C-O 121.55 0.691 . . . . 0.0 109.358 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 39.2 tp10 -65.09 135.86 56.04 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.494 -0.754 . . . . 0.0 109.776 -179.629 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ASN . . . . . 0.503 HD22 ' CG2' ' A' ' 35' ' ' ILE . 53.0 t-20 -103.45 -50.18 3.51 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.399 -0.813 . . . . 0.0 109.02 179.893 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 2.3 m 66.36 -4.06 0.75 Allowed 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 -179.7 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' HIS . . . . . 0.477 ' H ' ' C ' ' A' ' 30' ' ' ASN . 83.9 t60 -83.42 127.57 33.8 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.42 -0.8 . . . . 0.0 109.651 -179.639 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.48 ' O ' ' CB ' ' A' ' 34' ' ' SER . 98.2 mt-10 -40.06 154.99 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.698 -0.626 . . . . 0.0 110.938 -179.534 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.48 ' CB ' ' O ' ' A' ' 33' ' ' GLU . 0.9 OUTLIER 78.35 -50.0 0.47 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.764 -0.585 . . . . 0.0 109.716 179.964 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.503 ' CG2' HD22 ' A' ' 30' ' ' ASN . 86.8 mt -108.99 128.91 64.48 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 O-C-N 121.477 -0.764 . . . . 0.0 109.605 -179.445 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 24.1 t -87.19 -68.46 0.75 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.616 -0.678 . . . . 0.0 109.901 -179.446 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 89.7 mt-30 -132.95 148.11 52.28 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.514 -0.742 . . . . 0.0 109.447 -179.374 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 44.6 t -128.99 134.46 64.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -158.7 -162.24 11.74 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -140.1 145.5 37.7 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.446 -1.032 . . . . 0.0 109.635 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 45.0 mt -115.04 133.07 56.35 Favored 'General case' 0 N--CA 1.496 1.829 0 CA-C-O 121.575 0.702 . . . . 0.0 109.583 -179.155 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -92.96 140.52 15.11 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 110.385 -1.086 . . . . 0.0 110.385 -179.588 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 39.7 t0 -148.41 159.12 44.34 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.52 -0.988 . . . . 0.0 108.682 179.343 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -66.6 -20.7 66.06 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.221 -0.925 . . . . 0.0 109.669 -179.854 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 58.4 p -79.66 -10.15 59.75 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.144 -0.973 . . . . 0.0 109.347 -179.856 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 139.21 -164.3 25.9 Favored Glycine 0 N--CA 1.496 2.677 0 N-CA-C 109.455 -1.458 . . . . 0.0 109.455 179.507 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 34.4 mm -114.58 132.05 64.87 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.0 0 O-C-N 121.631 -0.923 . . . . 0.0 108.81 -179.701 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 18.1 tt -133.5 141.41 44.44 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 O-C-N 121.577 -0.702 . . . . 0.0 110.003 -179.588 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -90.71 156.95 17.7 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.592 -0.692 . . . . 0.0 110.459 -179.349 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 8.6 p90 -146.08 160.51 41.8 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.241 -0.912 . . . . 0.0 109.622 179.501 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.435 HG23 ' HE1' ' A' ' 53' ' ' TRP . 1.6 t -141.25 141.41 34.0 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 179.335 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 87.5 mt -106.66 125.79 62.53 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 O-C-N 121.53 -0.731 . . . . 0.0 109.734 -179.581 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' TRP . . . . . 0.529 ' CD1' ' N ' ' A' ' 53' ' ' TRP . 13.5 m95 -99.98 147.59 25.42 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.528 -0.732 . . . . 0.0 109.733 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.503 ' C ' ' H ' ' A' ' 56' ' ' ALA . 54.0 mtmt -67.16 -7.68 25.35 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.431 -0.793 . . . . 0.0 109.448 179.854 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 98.8 m-20 -72.1 26.91 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.199 -0.938 . . . . 0.0 109.844 -179.334 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.503 ' H ' ' C ' ' A' ' 54' ' ' LYS . . . -150.51 -39.33 0.13 Allowed 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 179.62 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 57.8 63.15 1.88 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.839 -0.538 . . . . 0.0 109.867 -179.84 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 17.4 mt -102.85 157.19 34.21 Favored Pre-proline 0 N--CA 1.497 1.892 0 O-C-N 121.567 -0.708 . . . . 0.0 109.599 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -54.97 149.25 43.58 Favored 'Trans proline' 0 N--CA 1.502 2.021 0 C-N-CA 122.292 1.995 . . . . 0.0 113.071 179.546 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 61.8 mt -65.72 140.07 58.42 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.432 -0.793 . . . . 0.0 110.33 -179.102 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.535 ' N ' HD12 ' A' ' 61' ' ' LEU . 10.8 mp -77.95 141.84 38.74 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.53 -0.731 . . . . 0.0 110.016 -179.551 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -90.19 150.86 21.81 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.468 -0.77 . . . . 0.0 109.974 -179.815 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.419 ' OE1' HG12 ' A' ' 24' ' ' VAL . 2.9 mm100 -81.96 145.19 30.41 Favored 'General case' 0 N--CA 1.493 1.709 0 CA-C-O 122.018 0.914 . . . . 0.0 112.006 -178.17 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 70.0 31.33 69.63 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 110.576 -1.01 . . . . 0.0 110.576 178.074 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 91.7 mt-10 -136.08 147.68 47.96 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.303 -1.116 . . . . 0.0 110.218 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 10.6 m -80.68 149.68 29.68 Favored 'General case' 0 N--CA 1.487 1.419 0 CA-C-O 121.324 0.583 . . . . 0.0 109.62 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 30.3 m-85 -144.04 142.48 30.68 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.398 -0.814 . . . . 0.0 109.107 179.531 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 14.5 tp -108.57 120.93 43.88 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 179.237 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 76.3 mt -100.51 132.81 45.7 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.512 -0.742 . . . . 0.0 109.297 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.408 ' O ' ' CB ' ' A' ' 71' ' ' SER . 89.8 mtm180 -127.02 131.87 50.88 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.797 -0.564 . . . . 0.0 110.059 -179.956 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.408 ' CB ' ' O ' ' A' ' 70' ' ' ARG . 1.1 m 75.88 54.9 0.06 Allowed 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 179.677 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 15.8 m -117.13 161.34 15.96 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.173 0 O-C-N 121.607 -0.683 . . . . 0.0 109.465 179.236 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 14.1 p -120.47 140.59 44.08 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 CA-C-O 121.499 0.666 . . . . 0.0 109.514 -179.325 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 99.6 t -84.56 120.35 35.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.445 -0.784 . . . . 0.0 110.139 -178.973 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -97.3 174.42 29.73 Favored Glycine 0 N--CA 1.493 2.48 0 N-CA-C 109.714 -1.354 . . . . 0.0 109.714 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.547 ' N ' ' OE1' ' A' ' 76' ' ' GLU . 54.4 mp0 -112.72 119.48 38.22 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.766 -0.844 . . . . 0.0 109.027 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' TYR . . . . . 0.528 ' CE2' ' OD1' ' A' ' 78' ' ' ASN . 85.0 t80 -136.98 124.43 22.08 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.418 -0.801 . . . . 0.0 110.139 -179.846 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ASN . . . . . 0.528 ' OD1' ' CE2' ' A' ' 77' ' ' TYR . 7.0 m120 55.53 38.37 30.13 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.76 -0.587 . . . . 0.0 109.901 179.356 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 25.7 t0 66.83 -4.08 0.83 Allowed 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.603 -0.686 . . . . 0.0 109.513 179.665 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.417 ' H ' ' C ' ' A' ' 78' ' ' ASN . 80.1 mtp85 -93.72 -177.26 4.31 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.303 -0.873 . . . . 0.0 109.459 179.773 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -114.86 137.17 52.28 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.571 -0.706 . . . . 0.0 109.605 -179.67 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 -143.25 159.63 41.98 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.385 -0.822 . . . . 0.0 109.645 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.402 HG23 ' O ' ' A' ' 83' ' ' VAL . 22.5 m -104.08 131.72 52.21 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 179.662 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -102.25 114.67 29.03 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.356 -0.84 . . . . 0.0 109.422 -179.289 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 12.1 t -88.56 103.67 14.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.458 -0.776 . . . . 0.0 109.277 -179.81 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 2.0 p30 -151.14 -179.76 7.6 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.383 -0.823 . . . . 0.0 109.586 179.773 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 49.2 tttm 67.43 -132.58 0.13 Allowed 'General case' 0 N--CA 1.495 1.807 0 CA-C-O 121.491 0.663 . . . . 0.0 110.822 179.436 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' ASN . . . . . 0.409 ' O ' ' C ' ' A' ' 89' ' ' SER . 97.4 m-20 -95.47 13.19 26.8 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.244 -0.91 . . . . 0.0 109.047 -179.198 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.409 ' C ' ' O ' ' A' ' 88' ' ' ASN . 97.7 p -40.94 110.18 0.15 Allowed 'General case' 0 N--CA 1.495 1.817 0 CA-C-O 121.589 0.709 . . . . 0.0 109.646 -179.514 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 12.1 m -80.52 151.02 29.41 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.577 -0.702 . . . . 0.0 109.728 -179.051 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 96.7 mt -132.36 132.07 60.53 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 121.52 -0.738 . . . . 0.0 109.501 179.748 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 52.5 tp10 -128.28 134.61 48.97 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 179.697 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.426 ' C ' HD22 ' A' ' 94' ' ' LEU . 38.7 ttpt -85.02 131.05 34.52 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.569 -0.707 . . . . 0.0 110.265 -179.457 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.471 HD22 ' N ' ' A' ' 94' ' ' LEU . 4.1 mm? -99.32 132.07 44.9 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.472 -0.768 . . . . 0.0 109.601 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 73.2 m -84.26 15.66 3.45 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 179.634 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 17.6 tp10 -118.05 89.83 35.71 Favored Pre-proline 0 N--CA 1.498 1.938 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 179.504 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -57.69 144.49 92.88 Favored 'Trans proline' 0 N--CA 1.498 1.745 0 C-N-CA 122.561 2.174 . . . . 0.0 112.208 179.659 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 90.5 mt -106.05 123.88 60.94 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 O-C-N 121.51 -0.744 . . . . 0.0 109.772 -179.828 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' GLU . . . . . 0.549 ' N ' ' OE1' ' A' ' 99' ' ' GLU . 58.7 mp0 -89.49 132.57 34.97 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.5 -0.75 . . . . 0.0 109.592 -179.508 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 7.3 t -88.52 58.12 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 O-C-N 121.38 -0.825 . . . . 0.0 109.254 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 75.53 13.41 82.96 Favored Glycine 0 N--CA 1.494 2.516 0 N-CA-C 109.972 -1.251 . . . . 0.0 109.972 179.521 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.526 HD22 ' N ' ' A' ' 102' ' ' LEU . 3.9 mm? -64.08 -42.13 97.08 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.112 -1.228 . . . . 0.0 109.489 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -92.42 108.9 20.31 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.262 -0.899 . . . . 0.0 109.935 -179.355 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' HIS . . . . . 0.607 ' NE2' ' CD2' ' A' ' 105' ' ' HIS . 11.1 p-80 -86.25 -16.14 38.58 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 179.639 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 105' ' ' HIS . . . . . 0.607 ' CD2' ' NE2' ' A' ' 104' ' ' HIS . 96.1 m-70 -95.16 14.51 21.87 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 179.719 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 106' ' ' HIS . . . . . 0.529 ' O ' ' N ' ' A' ' 108' ' ' HIS . 79.2 t60 -59.89 -45.65 91.85 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 121.564 -0.71 . . . . 0.0 109.233 179.818 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 107' ' ' HIS . . . . . 0.441 ' O ' ' N ' ' A' ' 109' ' ' HIS . 70.8 m80 47.81 11.7 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.4 -0.812 . . . . 0.0 109.706 -179.82 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 108' ' ' HIS . . . . . 0.529 ' N ' ' O ' ' A' ' 106' ' ' HIS . 55.1 p-80 36.68 32.94 0.02 OUTLIER 'General case' 0 N--CA 1.499 2.001 0 CA-C-O 121.444 0.64 . . . . 0.0 110.402 179.875 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 109' ' ' HIS . . . . . 0.441 ' N ' ' O ' ' A' ' 107' ' ' HIS . 63.4 t-80 . . . . . 0 N--CA 1.489 1.477 0 CA-C-O 118.025 -0.988 . . . . 0.0 109.637 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.452 ' H2 ' ' HD2' ' A' ' 3' ' ' PRO . 6.4 ttt . . . . . 0 N--CA 1.491 1.624 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.64 ' N ' ' CD ' ' A' ' 3' ' ' PRO . 2.8 mm-40 -81.22 -38.95 0.99 Allowed Pre-proline 0 N--CA 1.493 1.709 0 O-C-N 121.68 -0.638 . . . . 0.0 109.815 179.457 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.64 ' CD ' ' N ' ' A' ' 2' ' ' GLU . 23.2 Cg_exo -61.37 147.01 96.62 Favored 'Trans proline' 0 N--CA 1.493 1.498 0 C-N-CA 122.484 2.123 . . . . 0.0 112.393 -179.175 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 21.4 mp0 -88.17 75.69 8.59 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.143 -0.973 . . . . 0.0 108.936 179.675 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 84.3 mt -69.45 143.84 53.45 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.47 -0.769 . . . . 0.0 109.665 -179.852 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 93.9 m -125.15 128.83 49.02 Favored 'General case' 0 N--CA 1.497 1.881 0 CA-C-O 121.735 0.779 . . . . 0.0 109.63 -179.717 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 14.8 mptt -80.22 149.66 30.37 Favored 'General case' 0 C--N 1.302 -1.48 0 CA-C-O 121.86 0.838 . . . . 0.0 109.843 -179.451 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.666 ' N ' HD12 ' A' ' 8' ' ' ILE . 2.7 mp -63.15 -43.73 99.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 CA-C-O 121.566 0.698 . . . . 0.0 110.166 -179.451 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 10.0 p -69.76 -19.93 23.21 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.654 0 O-C-N 121.214 -0.929 . . . . 0.0 110.057 -179.253 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -82.05 -3.47 54.69 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.925 -1.109 . . . . 0.0 109.482 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 96.7 mt -79.65 121.02 32.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.056 -1.027 . . . . 0.0 110.012 -179.757 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 33.4 m -136.04 -4.33 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.488 -0.757 . . . . 0.0 109.06 179.445 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -138.11 140.86 40.15 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.026 -1.046 . . . . 0.0 109.845 -179.781 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 57.3 p30 -93.65 162.22 14.03 Favored 'General case' 0 N--CA 1.493 1.7 0 CA-C-O 121.677 0.751 . . . . 0.0 110.521 -179.739 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 79.94 6.03 89.29 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.376 -1.49 . . . . 0.0 109.376 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 65.4 tt0 -80.97 135.46 35.87 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.202 -1.176 . . . . 0.0 110.275 -179.46 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 85.3 m95 -99.93 136.56 39.65 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.542 -0.724 . . . . 0.0 109.29 179.294 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -178.03 -172.98 0.35 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.22 -0.925 . . . . 0.0 109.697 -179.895 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 35.7 m-20 -109.26 149.07 29.97 Favored 'General case' 0 N--CA 1.495 1.819 0 CA-C-O 121.57 0.7 . . . . 0.0 109.648 -179.802 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 6.3 tt -136.93 133.36 35.6 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.357 -0.839 . . . . 0.0 110.128 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 37.6 ttmt -114.6 134.71 54.84 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 179.387 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -165.04 171.07 14.37 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 119.069 -1.052 . . . . 0.0 110.418 -179.904 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 64.9 tttm -106.26 142.25 36.26 Favored 'General case' 0 N--CA 1.496 1.842 0 CA-C-O 121.75 0.786 . . . . 0.0 110.028 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 92.5 t -79.84 121.98 34.18 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 O-C-N 121.382 -0.824 . . . . 0.0 110.378 -179.439 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 96.7 mt -100.72 -57.53 4.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 179.141 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 66.5 tp60 -147.79 139.45 23.89 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.058 -1.026 . . . . 0.0 110.08 -179.858 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.844 HD23 ' H ' ' A' ' 27' ' ' LEU . 1.2 pt? -142.96 138.21 29.94 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.741 -0.599 . . . . 0.0 109.618 179.228 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 4.9 m0 -113.03 142.45 45.7 Favored 'General case' 0 N--CA 1.497 1.92 0 CA-C-O 121.634 0.73 . . . . 0.0 109.795 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 3.0 pp20? -80.42 140.52 35.96 Favored 'General case' 0 N--CA 1.491 1.6 0 CA-C-O 121.601 0.715 . . . . 0.0 110.523 -179.355 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ASN . . . . . 0.415 HD22 ' HB ' ' A' ' 35' ' ' ILE . 48.8 t30 -101.97 154.95 18.48 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.436 -0.79 . . . . 0.0 109.518 -179.818 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.486 ' O ' HG22 ' A' ' 31' ' ' THR . 63.0 m -97.02 -6.21 35.87 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.219 -0.925 . . . . 0.0 109.526 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 51.2 m80 -80.74 135.06 35.93 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.93 -1.106 . . . . 0.0 110.372 -179.549 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 10.5 tm-20 -67.99 -36.99 80.95 Favored 'General case' 0 N--CA 1.495 1.785 0 CA-C-O 121.647 0.737 . . . . 0.0 109.949 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 42.2 t -61.55 -41.78 97.87 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.237 -0.915 . . . . 0.0 110.096 -179.36 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.415 ' HB ' HD22 ' A' ' 30' ' ' ASN . 97.5 mt -109.27 130.16 62.76 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 CA-C-O 121.968 0.889 . . . . 0.0 110.368 -179.334 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 19.3 t -74.8 -75.56 0.16 Allowed 'General case' 0 N--CA 1.491 1.617 0 CA-C-O 121.689 0.757 . . . . 0.0 109.642 179.888 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 -143.04 157.64 44.35 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.145 -0.972 . . . . 0.0 109.623 -179.566 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 13.9 m -132.74 135.01 58.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 CA-C-O 121.61 0.719 . . . . 0.0 109.426 179.771 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -160.34 -164.25 15.07 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 -179.551 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -133.7 148.96 51.51 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.5 -1.0 . . . . 0.0 110.137 -179.814 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 32.1 mt -120.11 136.91 54.43 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 -179.177 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -100.5 137.45 13.27 Favored Glycine 0 N--CA 1.494 2.52 0 N-CA-C 110.368 -1.093 . . . . 0.0 110.368 -179.296 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.488 ' O ' ' N ' ' A' ' 45' ' ' THR . 47.0 t0 -136.61 36.84 2.67 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.484 -1.009 . . . . 0.0 108.679 179.076 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 63.98 -38.92 0.21 Allowed 'General case' 0 N--CA 1.503 2.199 0 CA-C-O 121.418 0.628 . . . . 0.0 110.412 -179.514 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.488 ' N ' ' O ' ' A' ' 43' ' ' ASP . 17.8 p -79.41 22.9 0.42 Allowed 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.051 -1.031 . . . . 0.0 109.707 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 114.45 -165.56 12.07 Favored Glycine 0 N--CA 1.498 2.78 0 N-CA-C 110.436 -1.066 . . . . 0.0 110.436 179.324 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 33.7 pt -129.19 145.17 36.17 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 O-C-N 121.673 -0.898 . . . . 0.0 109.457 -179.775 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 18.9 tt -137.95 143.2 33.97 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 O-C-N 121.48 -0.763 . . . . 0.0 109.875 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 32.6 mtmm -83.25 155.12 23.83 Favored 'General case' 0 N--CA 1.493 1.692 0 CA-C-O 121.56 0.695 . . . . 0.0 110.431 -179.485 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 42.8 p90 -144.75 153.37 41.61 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.261 -0.899 . . . . 0.0 109.591 179.833 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 93.7 m -131.24 129.99 42.31 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 179.582 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 96.7 mt -101.41 126.25 55.28 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 121.361 -0.837 . . . . 0.0 109.764 -179.537 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 30.9 m95 -104.18 143.5 32.85 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.489 -0.757 . . . . 0.0 109.011 179.305 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -87.45 44.92 1.22 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.231 -0.918 . . . . 0.0 108.984 179.702 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -61.39 -41.47 97.17 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.478 -0.764 . . . . 0.0 109.279 179.799 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -119.42 -80.69 0.62 Allowed 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.442 -0.786 . . . . 0.0 109.723 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -179.61 82.85 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.133 -0.979 . . . . 0.0 109.164 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 36.6 mt -114.09 96.96 43.9 Favored Pre-proline 0 N--CA 1.5 2.063 0 O-C-N 121.331 -0.856 . . . . 0.0 109.253 -179.893 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_exo -49.98 157.81 2.57 Favored 'Trans proline' 0 N--CA 1.495 1.582 0 C-N-CA 122.685 2.257 . . . . 0.0 112.896 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 41.4 mt -65.48 141.79 58.37 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.306 -0.871 . . . . 0.0 110.219 -179.043 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.599 ' N ' HD12 ' A' ' 61' ' ' LEU . 9.3 mp -85.57 150.94 24.31 Favored 'General case' 0 N--CA 1.493 1.712 0 CA-C-O 121.816 0.817 . . . . 0.0 110.742 -179.295 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -74.61 150.68 39.55 Favored 'General case' 0 N--CA 1.491 1.591 0 CA-C-O 121.882 0.849 . . . . 0.0 110.722 -179.598 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 57.6 tt0 -86.2 138.77 31.63 Favored 'General case' 0 N--CA 1.49 1.526 0 CA-C-O 121.687 0.756 . . . . 0.0 111.185 -179.661 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 81.48 10.94 83.84 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 110.346 -1.102 . . . . 0.0 110.346 178.959 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -115.77 147.27 41.14 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.343 -1.093 . . . . 0.0 110.57 -179.622 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 15.4 t -80.58 143.55 33.1 Favored 'General case' 0 N--CA 1.49 1.532 0 CA-C-O 121.61 0.719 . . . . 0.0 110.122 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 46.0 m-85 -140.47 147.47 39.66 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.417 -0.802 . . . . 0.0 109.835 179.785 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 19.4 tp -111.11 123.97 51.26 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 179.216 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 13.6 mt -99.04 131.18 45.27 Favored 'General case' 0 N--CA 1.492 1.662 0 CA-C-O 121.388 0.613 . . . . 0.0 110.039 -179.452 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.485 ' O ' ' CB ' ' A' ' 71' ' ' SER . 82.9 mtp180 -129.64 125.98 37.33 Favored 'General case' 0 N--CA 1.494 1.742 0 CA-C-O 121.437 0.637 . . . . 0.0 109.994 179.757 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.485 ' CB ' ' O ' ' A' ' 70' ' ' ARG . 0.9 OUTLIER 82.85 49.91 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.863 0 CA-C-O 121.157 0.503 . . . . 0.0 110.265 179.398 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 15.9 m -113.49 162.06 11.92 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.079 0 O-C-N 121.21 -0.932 . . . . 0.0 109.687 179.387 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 2.7 p -125.44 137.72 56.74 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 CA-C-O 121.763 0.792 . . . . 0.0 109.656 -179.407 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 11.0 t -85.33 113.37 23.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 CA-C-O 121.653 0.739 . . . . 0.0 109.976 -179.499 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -95.22 174.68 32.7 Favored Glycine 0 N--CA 1.493 2.47 0 N-CA-C 109.787 -1.325 . . . . 0.0 109.787 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -109.84 123.19 49.14 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.547 -0.972 . . . . 0.0 109.242 179.72 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 84.7 t80 -132.71 115.99 16.05 Favored 'General case' 0 N--CA 1.493 1.676 0 CA-C-O 121.59 0.709 . . . . 0.0 109.965 -179.618 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 7.7 m120 56.06 38.21 29.67 Favored 'General case' 0 N--CA 1.492 1.672 0 CA-C-O 121.419 0.628 . . . . 0.0 110.088 179.533 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 70.23 -2.55 2.08 Favored 'General case' 0 N--CA 1.497 1.911 0 CA-C-O 121.425 0.631 . . . . 0.0 109.656 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 20.7 mmm180 -98.48 166.26 11.44 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.183 -0.948 . . . . 0.0 109.996 -179.856 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 60.4 m-85 -88.24 139.78 30.14 Favored 'General case' 0 N--CA 1.488 1.436 0 CA-C-O 121.881 0.848 . . . . 0.0 110.107 -179.104 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 52.9 tt0 -144.4 150.7 38.15 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.388 -0.82 . . . . 0.0 108.833 179.805 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 28.5 m -114.14 128.92 70.9 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 O-C-N 121.526 -0.734 . . . . 0.0 109.165 179.616 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 75.5 mt-30 -107.85 127.22 53.53 Favored 'General case' 0 N--CA 1.495 1.776 0 CA-C-O 121.653 0.739 . . . . 0.0 109.989 -179.215 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 18.8 t -96.64 107.88 20.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 CA-C-O 121.634 0.73 . . . . 0.0 109.229 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 12.6 p30 -151.17 -170.05 3.55 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.395 -0.816 . . . . 0.0 109.914 -179.804 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 30.7 ttmt 59.27 37.13 23.74 Favored 'General case' 0 N--CA 1.493 1.724 0 CA-C-O 122.184 0.992 . . . . 0.0 109.879 179.758 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 10.2 t30 55.48 40.64 31.27 Favored 'General case' 0 N--CA 1.49 1.535 0 CA-C-O 121.637 0.732 . . . . 0.0 109.71 179.652 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 14.6 m -54.23 139.96 34.24 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.278 -0.889 . . . . 0.0 109.916 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 7.9 m -81.09 144.19 31.89 Favored 'General case' 0 N--CA 1.49 1.558 0 CA-C-O 121.795 0.807 . . . . 0.0 110.484 -179.092 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 96.6 mt -134.67 133.33 54.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.542 -0.723 . . . . 0.0 109.27 179.812 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -122.41 134.9 54.6 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.512 -0.742 . . . . 0.0 109.145 179.72 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.432 ' C ' HD22 ' A' ' 94' ' ' LEU . 88.5 tttt -82.49 125.17 30.8 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.402 -0.811 . . . . 0.0 109.879 -179.649 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.51 HD22 ' N ' ' A' ' 94' ' ' LEU . 4.1 mm? -97.3 134.48 40.53 Favored 'General case' 0 N--CA 1.49 1.559 0 CA-C-O 121.911 0.862 . . . . 0.0 109.963 -179.653 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 67.6 m -84.3 -4.57 58.94 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 179.303 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 90.5 mt-10 -104.48 110.36 64.16 Favored Pre-proline 0 N--CA 1.498 1.936 0 O-C-N 121.277 -0.889 . . . . 0.0 109.574 -179.831 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -74.3 157.38 45.73 Favored 'Trans proline' 0 N--CA 1.493 1.459 0 C-N-CA 122.374 2.049 . . . . 0.0 112.548 -179.365 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 16.6 mm -97.19 126.19 50.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.191 -0.943 . . . . 0.0 109.813 -179.384 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -64.63 129.13 38.66 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.531 -0.731 . . . . 0.0 109.918 -179.673 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 27.3 m -112.1 -7.72 11.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 179.389 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 144.7 69.09 0.02 OUTLIER Glycine 0 N--CA 1.496 2.661 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 179.828 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.501 ' O ' ' N ' ' A' ' 104' ' ' HIS . 2.4 pp -85.19 0.75 50.77 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.24 -1.153 . . . . 0.0 109.115 179.682 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' GLU . . . . . 0.558 ' O ' ' N ' ' A' ' 105' ' ' HIS . 12.7 pt-20 -48.3 -13.79 0.05 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.176 -0.953 . . . . 0.0 109.428 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' HIS . . . . . 0.501 ' N ' ' O ' ' A' ' 102' ' ' LEU . 35.9 m80 33.98 -87.33 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.106 0 CA-C-O 121.389 0.614 . . . . 0.0 111.194 179.441 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 105' ' ' HIS . . . . . 0.558 ' N ' ' O ' ' A' ' 103' ' ' GLU . 85.0 t60 56.99 8.66 0.53 Allowed 'General case' 0 N--CA 1.492 1.662 0 CA-C-O 121.471 0.653 . . . . 0.0 109.379 -179.852 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' HIS . . . . . 0.534 ' O ' ' CG ' ' A' ' 107' ' ' HIS . 72.1 m80 -88.52 54.42 3.04 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.139 -0.975 . . . . 0.0 110.049 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 107' ' ' HIS . . . . . 0.534 ' CG ' ' O ' ' A' ' 106' ' ' HIS . 41.6 p-80 39.92 -163.16 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.953 0 CA-C-O 121.904 0.859 . . . . 0.0 111.485 179.167 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 45.9 p-80 -151.66 161.43 42.69 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.217 -0.927 . . . . 0.0 109.998 -179.718 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 84.2 t60 . . . . . 0 N--CA 1.491 1.583 0 CA-C-O 118.051 -0.976 . . . . 0.0 109.875 -179.952 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.2 ttt . . . . . 0 N--CA 1.491 1.622 0 CA-C-O 121.398 0.618 . . . . 0.0 109.424 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 5.6 mp0 -70.75 158.77 87.23 Favored Pre-proline 0 C--N 1.302 -1.481 0 O-C-N 121.236 -0.915 . . . . 0.0 109.323 -179.461 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -51.06 144.27 28.95 Favored 'Trans proline' 0 N--CA 1.496 1.635 0 C-N-CA 122.009 1.806 . . . . 0.0 112.498 179.378 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 3.0 tm0? -75.49 70.33 2.34 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.561 -0.712 . . . . 0.0 109.115 179.744 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 72.0 mt -70.63 144.39 51.15 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.329 -0.857 . . . . 0.0 109.788 -179.539 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 64.7 m -124.87 133.04 53.23 Favored 'General case' 0 N--CA 1.497 1.887 0 N-CA-C 108.936 -0.765 . . . . 0.0 108.936 179.822 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 56.2 mtpt -76.02 152.02 37.02 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.318 -0.864 . . . . 0.0 110.573 -178.888 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 97.2 mt -63.29 -43.42 98.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.519 -0.738 . . . . 0.0 109.377 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 10.0 p -63.68 -24.39 35.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.351 -0.843 . . . . 0.0 109.667 -179.778 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -79.73 -3.82 49.19 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.018 -1.051 . . . . 0.0 109.793 -179.815 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 97.6 mt -80.88 119.16 29.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 120.92 -1.112 . . . . 0.0 109.795 -179.709 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 16.1 m -151.46 12.69 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 N-CA-C 108.947 -0.761 . . . . 0.0 108.947 179.328 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 50.7 tp10 -139.21 139.94 37.62 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.254 -0.904 . . . . 0.0 109.622 -179.829 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 48.8 p-10 -86.89 154.9 20.5 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.347 -0.845 . . . . 0.0 109.881 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 74.43 3.76 67.28 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 179.601 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 39.0 tt0 -71.24 128.61 36.49 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.168 -1.195 . . . . 0.0 109.68 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 88.9 m95 -98.51 138.74 35.28 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.394 -0.816 . . . . 0.0 109.601 -179.655 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -177.55 -178.77 0.77 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.333 -0.854 . . . . 0.0 109.726 179.52 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 80.5 m-20 -109.42 146.11 35.02 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.608 HD23 ' N ' ' A' ' 21' ' ' LYS . 6.2 tt -144.05 124.99 14.32 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.122 -0.986 . . . . 0.0 109.14 179.796 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.608 ' N ' HD23 ' A' ' 20' ' ' LEU . 36.4 ttpt -111.31 133.66 53.46 Favored 'General case' 0 N--CA 1.497 1.908 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 179.247 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -164.04 174.32 11.49 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.102 -0.999 . . . . 0.0 109.632 -179.749 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 16.8 ptpt -109.06 148.29 31.04 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.392 -0.818 . . . . 0.0 109.571 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.426 HG22 ' CD2' ' A' ' 41' ' ' LEU . 91.2 t -84.48 128.97 38.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.576 -0.703 . . . . 0.0 110.231 -179.167 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 97.0 mt -95.93 -53.58 8.04 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 N-CA-C 108.401 -0.962 . . . . 0.0 108.401 178.958 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 69.6 tp60 -149.24 145.21 26.99 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.307 -0.871 . . . . 0.0 109.495 179.443 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.832 HD23 ' H ' ' A' ' 27' ' ' LEU . 1.2 pt? -143.33 140.47 30.56 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 179.41 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 39.2 t90 -115.51 125.38 52.96 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 179.748 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -68.51 142.49 55.26 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.301 -0.875 . . . . 0.0 110.015 -179.703 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ASN . . . . . 0.442 HD21 HG21 ' A' ' 35' ' ' ILE . 13.3 p-10 -156.69 114.78 3.26 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.18 -0.95 . . . . 0.0 109.339 179.606 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.435 ' O ' ' OG1' ' A' ' 31' ' ' THR . 0.0 OUTLIER -100.33 61.28 1.05 Allowed 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.328 -0.858 . . . . 0.0 108.869 -179.856 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 45.8 t-80 -61.57 -49.15 77.8 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.111 -0.993 . . . . 0.0 109.304 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 7.4 tm-20 -174.09 -74.08 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.469 -0.769 . . . . 0.0 109.064 179.602 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 43.2 t -106.59 6.1 29.66 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.457 -0.777 . . . . 0.0 109.448 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.442 HG21 HD21 ' A' ' 30' ' ' ASN . 86.3 mt -102.96 128.74 55.59 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 O-C-N 121.271 -0.893 . . . . 0.0 109.593 -179.537 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 41.6 t -86.93 -69.64 0.67 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.482 -0.761 . . . . 0.0 109.993 -179.405 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 27.8 mt-30 -133.43 154.27 50.92 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.298 -0.876 . . . . 0.0 109.656 -179.209 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 15.5 m -130.85 134.87 61.19 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 179.726 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.526 ' C ' HD13 ' A' ' 40' ' ' LEU . . . -168.49 -163.72 22.96 Favored Glycine 0 N--CA 1.486 2.008 0 C-N-CA 119.08 -1.533 . . . . 0.0 110.273 -179.329 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.894 HD13 ' N ' ' A' ' 40' ' ' LEU . 0.0 OUTLIER -131.93 161.69 32.46 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.914 -0.757 . . . . 0.0 109.37 179.863 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.426 ' CD2' HG22 ' A' ' 24' ' ' VAL . 69.3 mt -120.25 133.46 55.47 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.584 -0.698 . . . . 0.0 109.329 -179.351 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -85.86 141.13 18.42 Favored Glycine 0 N--CA 1.492 2.427 0 N-CA-C 110.01 -1.236 . . . . 0.0 110.01 -179.886 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 44.0 t0 -151.26 163.73 38.23 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.443 -1.034 . . . . 0.0 109.922 179.826 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -64.21 -20.62 66.16 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.549 -0.719 . . . . 0.0 109.923 -179.841 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 44.7 p -92.32 -12.23 33.0 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 120.982 -1.074 . . . . 0.0 110.404 -179.283 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 144.81 -155.39 26.4 Favored Glycine 0 N--CA 1.497 2.75 0 C-N-CA 119.916 -1.135 . . . . 0.0 110.281 179.535 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 91.3 mt -125.59 137.18 58.51 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.975 0 O-C-N 121.802 -0.822 . . . . 0.0 108.811 -179.668 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 17.5 tt -129.4 150.05 34.24 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.232 0 O-C-N 121.452 -0.78 . . . . 0.0 110.342 -179.571 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.661 ' NZ ' HH22 ' A' ' 80' ' ' ARG . 14.7 mptt -83.81 151.97 24.88 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.654 -0.654 . . . . 0.0 109.812 -179.695 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 25.2 p90 -143.28 148.47 36.4 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.221 -0.924 . . . . 0.0 108.803 179.072 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 97.4 m -131.57 129.92 41.57 Favored 'General case' 0 N--CA 1.496 1.828 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 179.428 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 88.3 mt -98.07 127.8 50.13 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 O-C-N 121.311 -0.868 . . . . 0.0 110.158 -179.601 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 82.7 m95 -80.35 120.71 24.76 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 178.778 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.439 ' C ' ' H ' ' A' ' 56' ' ' ALA . 73.1 tttt -61.38 -34.34 75.18 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.297 -0.877 . . . . 0.0 108.745 -179.139 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 29.3 t-20 -55.85 -7.55 0.32 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.365 -0.834 . . . . 0.0 109.386 179.901 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.439 ' H ' ' C ' ' A' ' 54' ' ' LYS . . . -88.1 -25.14 23.17 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.062 -1.024 . . . . 0.0 108.716 179.147 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 51.75 49.6 20.46 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.389 -0.819 . . . . 0.0 110.068 179.578 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 63.9 mt -102.84 152.95 38.54 Favored Pre-proline 0 N--CA 1.498 1.947 0 O-C-N 121.244 -0.91 . . . . 0.0 109.323 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -51.8 146.17 28.96 Favored 'Trans proline' 0 N--CA 1.501 1.937 0 C-N-CA 121.904 1.736 . . . . 0.0 112.766 179.415 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 77.4 mt -71.74 141.89 49.77 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.257 -0.902 . . . . 0.0 109.911 -179.837 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.565 ' N ' HD12 ' A' ' 61' ' ' LEU . 10.5 mp -79.19 146.38 33.13 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.472 -0.767 . . . . 0.0 109.976 -179.289 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 51.4 tp10 -88.17 147.62 24.79 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.268 -0.895 . . . . 0.0 109.538 -179.577 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.531 ' OE1' ' N ' ' A' ' 64' ' ' GLY . 0.2 OUTLIER -81.71 126.26 31.58 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.276 -0.89 . . . . 0.0 110.093 -179.743 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.531 ' N ' ' OE1' ' A' ' 63' ' ' GLN . . . 86.32 32.22 17.25 Favored Glycine 0 N--CA 1.495 2.628 0 N-CA-C 110.423 -1.071 . . . . 0.0 110.423 179.178 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -137.23 147.85 46.07 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.126 -1.22 . . . . 0.0 109.91 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 14.4 m -78.51 143.34 36.68 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.7 -0.625 . . . . 0.0 109.788 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 51.0 m-85 -139.71 141.37 36.93 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.492 -0.755 . . . . 0.0 109.501 179.27 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.511 HD21 ' NE ' ' A' ' 70' ' ' ARG . 15.1 tp -103.72 120.03 40.12 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 107.964 -1.124 . . . . 0.0 107.964 178.989 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 75.7 mt -105.85 129.38 54.03 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 -179.844 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.511 ' NE ' HD21 ' A' ' 68' ' ' LEU . 99.6 mtt180 -125.54 143.71 50.89 Favored 'General case' 0 N--CA 1.503 2.225 0 O-C-N 121.413 -0.804 . . . . 0.0 111.141 -179.181 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.6 m 61.82 46.1 7.16 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.916 -0.49 . . . . 0.0 110.714 179.124 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 8.0 m -99.3 162.05 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.978 0 O-C-N 121.016 -1.052 . . . . 0.0 109.139 179.133 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 7.5 p -122.52 139.5 49.22 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 -179.788 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 63.8 t -89.33 115.25 28.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.237 -0.914 . . . . 0.0 109.612 -179.444 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -99.56 151.4 19.31 Favored Glycine 0 N--CA 1.499 2.842 0 N-CA-C 109.79 -1.324 . . . . 0.0 109.79 -179.834 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -68.46 137.19 54.25 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.338 -1.095 . . . . 0.0 110.072 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' TYR . . . . . 0.51 ' O ' ' N ' ' A' ' 79' ' ' ASP . 42.1 t80 -131.06 126.25 35.34 Favored 'General case' 0 N--CA 1.497 1.917 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 179.385 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ASN . . . . . 0.436 ' C ' ' O ' ' A' ' 77' ' ' TYR . 96.5 m-20 -35.35 -30.29 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.047 0 CA-C-O 121.115 0.483 . . . . 0.0 110.469 -179.058 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.51 ' N ' ' O ' ' A' ' 77' ' ' TYR . 96.7 m-20 -113.37 67.9 0.67 Allowed 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.594 -0.691 . . . . 0.0 109.942 179.48 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.661 HH22 ' NZ ' ' A' ' 49' ' ' LYS . 83.8 mtm180 85.62 -159.29 0.01 OUTLIER 'General case' 0 N--CA 1.508 2.473 0 CA-C-O 121.384 0.612 . . . . 0.0 110.514 178.262 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -103.52 151.89 22.33 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.526 -0.734 . . . . 0.0 109.519 -179.091 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 19.0 pt20 -136.57 166.47 23.45 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.382 -0.824 . . . . 0.0 109.284 -179.63 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.446 HG23 ' O ' ' A' ' 83' ' ' VAL . 18.8 m -105.89 130.49 57.32 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 179.827 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 87.5 mt-30 -106.45 131.18 53.94 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.429 -0.794 . . . . 0.0 110.49 -178.704 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 19.5 t -91.83 131.34 39.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 N-CA-C 109.006 -0.738 . . . . 0.0 109.006 179.449 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 99.9 m-20 -126.34 175.45 7.83 Favored 'General case' 0 N--CA 1.501 2.091 0 CA-C-O 121.79 0.805 . . . . 0.0 110.277 -179.459 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 63.8 tttm -56.64 -44.02 80.86 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.636 -0.665 . . . . 0.0 110.495 -179.57 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 55.9 m-20 -63.77 -33.38 75.54 Favored 'General case' 0 C--N 1.297 -1.716 0 O-C-N 121.088 -1.007 . . . . 0.0 110.359 -179.207 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 59.8 m -60.66 147.44 41.98 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.987 -1.071 . . . . 0.0 110.786 -178.656 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 7.0 m -113.27 149.18 34.22 Favored 'General case' 0 N--CA 1.499 2.005 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 179.618 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 96.6 mt -131.35 131.47 63.18 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.041 0 O-C-N 121.44 -0.787 . . . . 0.0 109.597 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -133.01 133.46 43.15 Favored 'General case' 0 N--CA 1.501 2.095 0 O-C-N 121.386 -0.821 . . . . 0.0 108.921 178.988 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -82.58 124.75 30.43 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.34 -0.85 . . . . 0.0 109.185 -179.835 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.456 HD22 ' N ' ' A' ' 94' ' ' LEU . 4.1 mm? -96.87 137.01 36.6 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.273 -0.892 . . . . 0.0 109.93 -179.322 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 93.7 p -82.4 -5.3 58.56 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 179.697 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -103.13 109.91 62.55 Favored Pre-proline 0 N--CA 1.497 1.881 0 O-C-N 121.37 -0.831 . . . . 0.0 109.421 -179.389 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -74.9 159.45 41.66 Favored 'Trans proline' 0 N--CA 1.494 1.503 0 C-N-CA 121.835 1.69 . . . . 0.0 112.082 -179.307 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 96.8 mt -99.17 126.8 52.36 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 O-C-N 121.241 -0.912 . . . . 0.0 109.609 -179.741 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -78.22 122.15 25.31 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.506 -0.746 . . . . 0.0 109.886 -179.574 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 5.5 t -106.97 -12.73 10.1 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.994 0 O-C-N 121.5 -0.75 . . . . 0.0 109.205 179.818 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 144.32 60.01 0.02 OUTLIER Glycine 0 N--CA 1.496 2.645 0 N-CA-C 109.676 -1.37 . . . . 0.0 109.676 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 45.8 tp -62.89 -43.92 97.49 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.903 -1.351 . . . . 0.0 109.513 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' GLU . . . . . 0.465 ' O ' ' N ' ' A' ' 105' ' ' HIS . 80.9 tt0 -93.03 114.72 27.35 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.103 -0.998 . . . . 0.0 109.874 -179.832 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' HIS . . . . . 0.404 ' C ' ' O ' ' A' ' 103' ' ' GLU . 86.3 t60 40.8 -94.76 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.582 -0.699 . . . . 0.0 110.538 179.643 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' HIS . . . . . 0.465 ' N ' ' O ' ' A' ' 103' ' ' GLU . 84.0 m-70 -152.03 167.47 28.34 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.066 -1.021 . . . . 0.0 110.111 -179.911 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 106' ' ' HIS . . . . . 0.483 ' ND1' ' N ' ' A' ' 107' ' ' HIS . 63.6 t-80 -60.06 165.12 3.52 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.511 -0.743 . . . . 0.0 110.781 -179.133 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 107' ' ' HIS . . . . . 0.483 ' N ' ' ND1' ' A' ' 106' ' ' HIS . 85.3 t60 50.09 16.56 0.25 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.485 -0.759 . . . . 0.0 109.475 -179.833 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 108' ' ' HIS . . . . . 0.409 ' C ' ' O ' ' A' ' 107' ' ' HIS . 97.4 m-70 40.64 -124.49 0.47 Allowed 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.62 -0.675 . . . . 0.0 110.484 179.483 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 85.5 t60 . . . . . 0 N--CA 1.489 1.504 0 CA-C-O 118.085 -0.96 . . . . 0.0 109.166 -179.936 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 97.0 mmm . . . . . 0 N--CA 1.491 1.595 0 CA-C-O 121.593 0.711 . . . . 0.0 109.882 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -176.01 77.28 0.28 Allowed Pre-proline 0 N--CA 1.493 1.722 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 21.5 Cg_exo -62.54 148.4 93.39 Favored 'Trans proline' 0 N--CA 1.493 1.445 0 C-N-CA 122.936 2.424 . . . . 0.0 112.049 179.778 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 78.7 mt-30 -88.98 79.96 7.17 Favored 'General case' 0 N--CA 1.489 1.511 0 CA-C-O 121.915 0.864 . . . . 0.0 109.417 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -59.68 133.41 56.07 Favored 'General case' 0 N--CA 1.489 1.501 0 CA-C-O 121.829 0.823 . . . . 0.0 109.762 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 97.1 m -128.28 128.48 44.72 Favored 'General case' 0 N--CA 1.491 1.577 0 CA-C-O 121.852 0.834 . . . . 0.0 109.361 179.796 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -90.85 154.4 19.52 Favored 'General case' 0 C--N 1.301 -1.527 0 CA-C-O 121.768 0.794 . . . . 0.0 109.818 -179.592 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 66.3 mt -63.2 -43.84 99.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.699 -0.626 . . . . 0.0 109.708 -179.39 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 12.4 p -65.07 -22.4 31.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.47 -0.769 . . . . 0.0 109.807 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 96.5 m-20 -80.99 -2.63 48.67 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.385 -0.822 . . . . 0.0 109.611 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 97.6 mt -85.51 112.04 21.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.426 -0.796 . . . . 0.0 109.958 -179.743 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 22.3 m -135.73 -2.79 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 179.318 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -140.39 143.85 35.9 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.479 -0.763 . . . . 0.0 109.941 179.885 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 52.2 p30 -90.66 161.15 15.51 Favored 'General case' 0 N--CA 1.492 1.672 0 CA-C-O 121.872 0.844 . . . . 0.0 110.495 -179.704 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 79.63 15.89 78.69 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.289 -1.524 . . . . 0.0 109.289 -179.814 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 52.5 tt0 -81.54 132.5 35.31 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.477 -1.013 . . . . 0.0 110.195 -179.286 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 76.9 m95 -106.31 132.99 51.7 Favored 'General case' 0 N--CA 1.495 1.786 0 CA-C-O 121.451 0.643 . . . . 0.0 109.465 179.705 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 179.71 -172.64 0.19 Allowed 'General case' 0 N--CA 1.491 1.619 0 CA-C-O 121.745 0.783 . . . . 0.0 109.962 179.806 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.547 ' OD1' HD11 ' A' ' 68' ' ' LEU . 0.4 OUTLIER -100.18 152.34 20.37 Favored 'General case' 0 N--CA 1.493 1.701 0 CA-C-O 121.544 0.688 . . . . 0.0 109.73 -179.956 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.54 ' N ' ' ND2' ' A' ' 19' ' ' ASN . 7.2 tp -135.84 129.73 32.84 Favored 'General case' 0 N--CA 1.49 1.573 0 CA-C-O 121.745 0.783 . . . . 0.0 110.057 -179.916 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 38.3 ttmt -119.53 132.83 55.84 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 179.602 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -165.09 178.25 7.15 Favored 'General case' 0 N--CA 1.495 1.789 0 C-N-CA 119.331 -0.947 . . . . 0.0 110.809 -179.542 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 65.1 tttm -112.11 143.45 43.13 Favored 'General case' 0 N--CA 1.496 1.873 0 CA-C-O 121.713 0.768 . . . . 0.0 110.059 -179.676 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.542 ' CG1' HD22 ' A' ' 27' ' ' LEU . 91.4 t -84.96 122.42 38.14 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 CA-C-O 121.884 0.849 . . . . 0.0 110.513 -179.046 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 23.8 mm -100.66 -48.91 11.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 178.755 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 69.3 tp60 -149.3 144.15 26.28 Favored 'General case' 0 N--CA 1.488 1.454 0 CA-C-O 121.71 0.767 . . . . 0.0 109.816 179.461 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.879 HD23 ' N ' ' A' ' 27' ' ' LEU . 0.4 OUTLIER -141.71 136.42 30.79 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 179.866 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 3.7 m-90 -115.14 122.49 46.25 Favored 'General case' 0 N--CA 1.496 1.851 0 CA-C-O 121.838 0.828 . . . . 0.0 109.618 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 49.6 tp10 -62.3 140.47 58.5 Favored 'General case' 0 N--CA 1.491 1.602 0 CA-C-O 121.541 0.686 . . . . 0.0 110.047 -179.369 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ASN . . . . . 0.518 HD22 ' CE1' ' A' ' 32' ' ' HIS . 7.5 t-20 -132.54 124.57 28.7 Favored 'General case' 0 N--CA 1.494 1.765 0 CA-C-O 121.481 0.657 . . . . 0.0 109.625 179.863 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 17.2 p -121.86 51.51 1.33 Allowed 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 108.55 -0.908 . . . . 0.0 108.55 179.566 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' HIS . . . . . 0.518 ' CE1' HD22 ' A' ' 30' ' ' ASN . 43.7 m170 -92.58 8.18 40.08 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 109.249 -0.648 . . . . 0.0 109.249 179.894 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 24.1 tp10 69.48 -13.25 0.39 Allowed 'General case' 0 N--CA 1.49 1.567 0 CA-C-O 121.325 0.583 . . . . 0.0 109.463 -179.827 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.498 ' H ' ' C ' ' A' ' 32' ' ' HIS . 32.2 t -106.6 -34.94 7.19 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.498 -0.751 . . . . 0.0 109.632 179.713 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 96.6 mt -125.09 123.6 65.75 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.129 0 O-C-N 121.27 -0.894 . . . . 0.0 109.538 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 5.8 t -68.81 -51.64 38.64 Favored 'General case' 0 N--CA 1.494 1.728 0 CA-C-O 121.523 0.677 . . . . 0.0 109.435 179.667 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 19.3 tt0 -157.53 153.3 26.77 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.515 -0.74 . . . . 0.0 109.69 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.7 p -142.99 145.7 22.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 179.653 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -175.17 -157.94 17.83 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.781 -1.327 . . . . 0.0 109.781 -179.589 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.9 pp -135.39 149.44 49.65 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.891 -0.77 . . . . 0.0 110.432 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 69.4 mt -117.24 132.13 56.69 Favored 'General case' 0 N--CA 1.498 1.933 0 CA-C-O 121.817 0.818 . . . . 0.0 109.647 -179.469 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -80.58 162.41 45.36 Favored Glycine 0 N--CA 1.488 2.147 0 N-CA-C 110.859 -0.896 . . . . 0.0 110.859 -179.577 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.531 ' OD1' ' N ' ' A' ' 44' ' ' GLU . 67.5 t0 -170.02 144.37 2.69 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.531 ' N ' ' OD1' ' A' ' 43' ' ' ASP . 19.1 pt-20 -59.84 -16.16 26.49 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.617 -0.677 . . . . 0.0 109.693 -179.788 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 36.2 p -91.25 -7.91 49.88 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 179.638 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 139.24 -153.61 22.98 Favored Glycine 0 N--CA 1.496 2.635 0 N-CA-C 109.81 -1.316 . . . . 0.0 109.81 179.414 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 36.1 pt -127.94 148.34 32.54 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.875 0 O-C-N 121.881 -0.776 . . . . 0.0 109.543 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 18.1 tt -141.69 138.58 31.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 CA-C-O 121.743 0.782 . . . . 0.0 110.034 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 68.9 mttm -83.75 156.86 22.34 Favored 'General case' 0 N--CA 1.49 1.545 0 CA-C-O 121.46 0.648 . . . . 0.0 109.981 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 28.2 p90 -148.62 150.44 33.27 Favored 'General case' 0 N--CA 1.491 1.599 0 CA-C-O 121.769 0.795 . . . . 0.0 109.991 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 97.8 m -130.24 129.81 43.81 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 179.575 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 92.8 mt -103.18 125.7 57.6 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 CA-C-O 121.904 0.859 . . . . 0.0 110.221 -179.423 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 96.6 m95 -86.71 142.13 28.41 Favored 'General case' 0 N--CA 1.49 1.556 0 CA-C-O 121.78 0.8 . . . . 0.0 109.881 -179.802 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 25.9 mtpp -66.49 -12.69 58.69 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.655 -0.653 . . . . 0.0 109.434 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 -64.35 -38.62 91.69 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.598 -0.689 . . . . 0.0 109.865 179.729 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -63.19 -37.03 85.63 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.402 -0.811 . . . . 0.0 109.661 -179.668 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 57.31 47.15 17.25 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 32.4 mt -108.91 153.66 42.31 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.829 -0.544 . . . . 0.0 109.677 -179.814 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -55.89 147.75 60.69 Favored 'Trans proline' 0 N--CA 1.5 1.87 0 C-N-CA 123.067 2.511 . . . . 0.0 113.602 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 78.1 mt -70.74 144.27 50.99 Favored 'General case' 0 N--CA 1.492 1.631 0 CA-C-O 122.021 0.915 . . . . 0.0 110.479 -179.644 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.572 ' N ' HD12 ' A' ' 61' ' ' LEU . 10.0 mp -77.33 147.28 36.26 Favored 'General case' 0 N--CA 1.49 1.538 0 CA-C-O 121.733 0.778 . . . . 0.0 109.827 -179.899 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -88.64 155.9 19.34 Favored 'General case' 0 N--CA 1.492 1.643 0 CA-C-O 121.968 0.89 . . . . 0.0 110.109 -179.755 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.488 ' NE2' ' C ' ' A' ' 63' ' ' GLN . 0.6 OUTLIER -83.52 136.16 34.37 Favored 'General case' 0 C--N 1.301 -1.536 0 CA-C-O 121.889 0.852 . . . . 0.0 110.838 -179.2 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.476 ' N ' ' NE2' ' A' ' 63' ' ' GLN . . . 82.18 0.99 90.25 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 110.003 -1.239 . . . . 0.0 110.003 179.145 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 -106.73 146.49 30.76 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.605 -0.938 . . . . 0.0 110.476 -179.513 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 6.1 m -86.25 148.38 25.66 Favored 'General case' 0 N--CA 1.489 1.496 0 CA-C-O 121.645 0.736 . . . . 0.0 109.98 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 65.1 m-85 -141.66 150.46 41.95 Favored 'General case' 0 N--CA 1.492 1.642 0 CA-C-O 122.016 0.912 . . . . 0.0 110.616 -179.709 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.547 HD11 ' OD1' ' A' ' 19' ' ' ASN . 31.5 tp -113.1 120.65 42.04 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.717 -0.845 . . . . 0.0 108.717 179.334 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 75.5 mt -102.04 126.87 49.08 Favored 'General case' 0 N--CA 1.491 1.612 0 CA-C-O 121.465 0.65 . . . . 0.0 109.376 -179.508 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.431 ' O ' ' CB ' ' A' ' 71' ' ' SER . 80.8 mtp180 -123.82 129.02 50.36 Favored 'General case' 0 N--CA 1.496 1.874 0 CA-C-O 121.714 0.768 . . . . 0.0 109.853 -179.697 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.431 ' CB ' ' O ' ' A' ' 70' ' ' ARG . 1.5 t 78.7 65.41 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.368 179.661 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 30.8 m -128.14 163.82 31.24 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 179.187 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 12.5 p -121.63 135.16 62.68 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 CA-C-O 121.72 0.771 . . . . 0.0 109.936 -179.524 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 12.5 t -89.94 114.83 28.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 CA-C-O 121.81 0.814 . . . . 0.0 109.482 -179.558 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -91.48 174.37 38.1 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 110.51 -1.036 . . . . 0.0 110.51 -179.292 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 82.8 tt0 -100.84 117.78 35.59 Favored 'General case' 0 N--CA 1.492 1.67 0 CA-C-O 121.997 0.903 . . . . 0.0 109.692 -179.725 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' TYR . . . . . 0.559 ' CD1' ' N ' ' A' ' 78' ' ' ASN . 27.2 t80 -101.53 162.75 12.67 Favored 'General case' 0 N--CA 1.493 1.71 0 CA-C-O 121.747 0.784 . . . . 0.0 109.854 -179.803 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ASN . . . . . 0.559 ' N ' ' CD1' ' A' ' 77' ' ' TYR . 24.3 t-20 -53.19 104.37 0.09 Allowed 'General case' 0 N--CA 1.494 1.749 0 CA-C-O 122.323 1.059 . . . . 0.0 110.63 -179.182 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 43.1 t0 57.66 16.69 3.58 Favored 'General case' 0 N--CA 1.492 1.646 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.372 179.747 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 78.1 mtp85 -148.78 -167.51 2.84 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.182 -0.949 . . . . 0.0 110.087 179.587 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 80.4 m-85 -127.94 151.24 49.34 Favored 'General case' 0 N--CA 1.495 1.807 0 CA-C-O 121.654 0.74 . . . . 0.0 109.64 -179.713 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 49.0 tt0 -145.22 153.12 41.0 Favored 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 13.6 m -113.1 130.72 66.48 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 179.423 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 78.8 mt-30 -111.68 129.93 55.94 Favored 'General case' 0 N--CA 1.496 1.866 0 CA-C-O 121.658 0.742 . . . . 0.0 110.411 -178.678 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 3.0 t -103.34 119.01 51.24 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 CA-C-O 121.596 0.712 . . . . 0.0 109.727 179.861 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 8.7 p-10 -147.01 -166.9 2.63 Favored 'General case' 0 N--CA 1.493 1.722 0 CA-C-O 121.714 0.769 . . . . 0.0 109.872 -179.411 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 38.1 ttmt 59.34 -89.13 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.654 0 CA-C-O 121.432 0.634 . . . . 0.0 110.52 -179.772 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 26.5 t-20 -169.96 46.62 0.03 OUTLIER 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 108.731 -0.841 . . . . 0.0 108.731 -179.216 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 34.9 t -55.56 136.19 50.33 Favored 'General case' 0 N--CA 1.496 1.873 0 CA-C-O 121.767 0.794 . . . . 0.0 109.709 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 1.4 t -79.55 140.83 37.09 Favored 'General case' 0 N--CA 1.491 1.584 0 CA-C-O 121.614 0.721 . . . . 0.0 110.338 -179.316 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 97.4 mt -128.46 130.67 69.19 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 121.836 -0.54 . . . . 0.0 109.586 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 47.7 tp10 -127.73 130.76 49.35 Favored 'General case' 0 N--CA 1.495 1.817 0 CA-C-O 121.827 0.822 . . . . 0.0 109.235 179.752 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 65.7 tttm -81.43 132.36 35.32 Favored 'General case' 0 N--CA 1.49 1.552 0 CA-C-O 121.856 0.836 . . . . 0.0 110.416 -179.385 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 65.8 mt -103.26 131.07 50.61 Favored 'General case' 0 N--CA 1.492 1.663 0 CA-C-O 121.703 0.763 . . . . 0.0 109.545 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 10.1 t -83.52 6.58 19.93 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 179.775 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 33.5 mm-40 -118.04 90.61 37.74 Favored Pre-proline 0 N--CA 1.499 2.024 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 179.308 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_exo -56.22 147.57 65.35 Favored 'Trans proline' 0 N--CA 1.494 1.552 0 C-N-CA 122.886 2.39 . . . . 0.0 112.516 179.739 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 93.9 mt -99.41 127.24 52.36 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 CA-C-O 121.885 0.85 . . . . 0.0 110.06 -179.497 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' GLU . . . . . 0.618 ' CD ' ' H ' ' A' ' 99' ' ' GLU . 0.9 OUTLIER -90.83 138.02 31.91 Favored 'General case' 0 C--N 1.301 -1.516 0 CA-C-O 121.496 0.665 . . . . 0.0 109.41 -179.935 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 25.2 m -105.55 -15.36 8.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 179.727 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -93.06 97.91 2.32 Favored Glycine 0 N--CA 1.497 2.726 0 N-CA-C 109.831 -1.308 . . . . 0.0 109.831 179.662 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.61 HD22 ' N ' ' A' ' 102' ' ' LEU . 3.7 mm? -89.11 -6.41 57.06 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.581 -0.952 . . . . 0.0 109.244 -179.907 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 52.7 38.87 27.34 Favored 'General case' 0 N--CA 1.489 1.485 0 CA-C-O 121.726 0.774 . . . . 0.0 109.175 179.577 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 30.6 t-80 -69.33 134.68 49.39 Favored 'General case' 0 N--CA 1.496 1.87 0 CA-C-O 121.873 0.844 . . . . 0.0 110.693 -179.153 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 86.4 t60 -66.39 -42.82 87.32 Favored 'General case' 0 N--CA 1.493 1.678 0 CA-C-O 121.393 0.616 . . . . 0.0 109.823 179.77 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 86.4 t60 -61.28 -44.22 97.58 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.528 -0.732 . . . . 0.0 109.835 -179.845 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 61.4 t-80 -126.37 128.54 47.21 Favored 'General case' 0 N--CA 1.497 1.896 0 CA-C-O 121.658 0.742 . . . . 0.0 109.798 -179.585 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' HIS . . . . . 0.434 ' C ' ' HD1' ' A' ' 108' ' ' HIS . 2.0 p80 -152.02 164.13 37.86 Favored 'General case' 0 N--CA 1.492 1.674 0 CA-C-O 121.491 0.662 . . . . 0.0 109.702 -179.882 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.636 0 CA-C-O 118.063 -0.97 . . . . 0.0 109.29 179.874 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 67.1 mtt . . . . . 0 N--CA 1.49 1.538 0 CA-C-O 121.662 0.744 . . . . 0.0 109.0 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.644 ' N ' ' CD ' ' A' ' 3' ' ' PRO . 1.7 mt-10 -74.03 -38.08 3.56 Favored Pre-proline 0 N--CA 1.495 1.809 0 O-C-N 121.564 -0.71 . . . . 0.0 110.126 179.811 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.644 ' CD ' ' N ' ' A' ' 2' ' ' GLU . 52.3 Cg_exo -58.06 145.46 91.85 Favored 'Trans proline' 0 N--CA 1.494 1.518 0 C-N-CA 122.616 2.211 . . . . 0.0 112.8 -179.19 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 27.6 mp0 -89.7 69.26 7.7 Favored 'General case' 0 N--CA 1.489 1.515 0 CA-C-O 121.844 0.83 . . . . 0.0 109.094 -179.827 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 71.9 mt -65.69 139.87 58.42 Favored 'General case' 0 N--CA 1.492 1.634 0 CA-C-O 121.63 0.728 . . . . 0.0 110.34 -179.422 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 92.3 m -128.83 132.15 47.77 Favored 'General case' 0 N--CA 1.493 1.693 0 CA-C-O 121.606 0.717 . . . . 0.0 109.576 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -75.35 146.86 40.55 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.461 -0.775 . . . . 0.0 109.998 -179.74 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 96.5 mt -63.84 -43.09 97.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.554 -0.716 . . . . 0.0 110.449 -179.563 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 13.2 p -62.06 -22.73 29.68 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.129 -0.982 . . . . 0.0 109.547 -179.783 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 51.7 t0 -76.17 -5.81 48.42 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.301 -0.874 . . . . 0.0 109.61 179.831 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 96.6 mt -82.4 119.32 31.71 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.038 -1.039 . . . . 0.0 110.23 -179.81 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 3.3 m -151.11 14.53 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 N-CA-C 108.582 -0.895 . . . . 0.0 108.582 179.65 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -138.04 145.24 41.58 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.419 -0.801 . . . . 0.0 110.019 -179.859 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 -82.78 144.39 30.19 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-O 121.682 0.753 . . . . 0.0 110.459 -179.796 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 65.99 110.9 0.01 OUTLIER Glycine 0 N--CA 1.491 2.331 0 N-CA-C 110.617 -0.993 . . . . 0.0 110.617 179.136 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 66.0 tt0 -169.47 130.26 1.08 Allowed 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.306 -1.114 . . . . 0.0 109.505 179.226 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 98.7 m95 -93.82 129.94 40.02 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.663 -0.648 . . . . 0.0 109.897 -179.668 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -175.59 171.53 2.76 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.535 -0.728 . . . . 0.0 109.695 179.749 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 67.0 m-20 -103.56 143.55 32.59 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.566 -0.709 . . . . 0.0 109.546 -179.679 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 5.0 mp -138.56 145.59 40.83 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.367 -0.833 . . . . 0.0 109.974 -179.856 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 33.9 ttmt -119.71 136.08 54.57 Favored 'General case' 0 N--CA 1.494 1.737 0 CA-C-O 121.481 0.658 . . . . 0.0 109.713 179.718 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -166.2 166.9 16.62 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 119.785 -0.766 . . . . 0.0 109.813 179.754 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 38.3 ttmt -105.5 142.01 36.0 Favored 'General case' 0 N--CA 1.492 1.641 0 CA-C-O 121.761 0.791 . . . . 0.0 109.987 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 58.8 t -81.19 127.04 39.88 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.362 0 CA-C-O 121.805 0.812 . . . . 0.0 110.292 -179.694 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 96.5 mt -97.42 -66.53 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 121.645 -0.659 . . . . 0.0 109.311 179.387 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 24.0 mm100 -144.04 143.76 31.33 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.291 -0.881 . . . . 0.0 110.435 -179.766 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.553 ' O ' HD12 ' A' ' 27' ' ' LEU . 0.3 OUTLIER -143.17 139.68 30.44 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 -179.713 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 3.5 m-90 -114.92 149.92 36.48 Favored 'General case' 0 N--CA 1.494 1.739 0 CA-C-O 121.811 0.815 . . . . 0.0 109.889 179.803 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -63.66 138.06 58.34 Favored 'General case' 0 C--N 1.306 -1.326 0 CA-C-O 121.428 0.633 . . . . 0.0 110.046 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ASN . . . . . 0.437 ' C ' ' N ' ' A' ' 32' ' ' HIS . 5.5 t-20 -120.57 -67.83 0.95 Allowed 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 179.603 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 44.5 p 47.4 19.87 0.15 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.389 -0.82 . . . . 0.0 109.008 -179.725 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' HIS . . . . . 0.437 ' N ' ' C ' ' A' ' 30' ' ' ASN . 84.2 t60 -63.45 -51.14 66.95 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.567 -0.708 . . . . 0.0 109.837 179.847 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.505 ' C ' ' H ' ' A' ' 35' ' ' ILE . 44.4 tt0 -174.25 117.71 0.23 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.371 -0.831 . . . . 0.0 109.88 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 14.2 t 55.54 1.91 0.06 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.88 -0.512 . . . . 0.0 110.226 179.812 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.505 ' H ' ' C ' ' A' ' 33' ' ' GLU . 96.7 mt -115.58 130.09 70.79 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 CA-C-O 121.823 0.82 . . . . 0.0 109.591 179.361 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 39.1 t -84.02 -68.91 0.68 Allowed 'General case' 0 C--N 1.302 -1.476 0 CA-C-O 121.518 0.675 . . . . 0.0 109.554 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' GLN . . . . . 0.503 ' OE1' HD22 ' A' ' 60' ' ' LEU . 25.3 mt-30 -137.43 160.98 37.55 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.406 -0.808 . . . . 0.0 109.997 -179.292 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 3.3 p -140.0 143.37 30.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -168.91 -152.61 7.84 Favored Glycine 0 N--CA 1.486 1.993 0 N-CA-C 110.02 -1.232 . . . . 0.0 110.02 -179.624 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.412 HD23 ' N ' ' A' ' 40' ' ' LEU . 0.2 OUTLIER -132.94 150.93 52.12 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.849 -0.794 . . . . 0.0 109.886 -179.707 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 65.7 mt -114.73 129.59 56.71 Favored 'General case' 0 N--CA 1.491 1.611 0 CA-C-O 121.814 0.816 . . . . 0.0 109.544 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -85.45 152.73 26.8 Favored Glycine 0 N--CA 1.488 2.145 0 N-CA-C 110.479 -1.048 . . . . 0.0 110.479 -179.536 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.53 ' OD1' ' N ' ' A' ' 44' ' ' GLU . 41.8 t0 -173.58 152.08 2.04 Favored 'General case' 0 C--N 1.306 -1.319 0 O-C-N 121.766 -0.844 . . . . 0.0 109.722 179.467 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.53 ' N ' ' OD1' ' A' ' 43' ' ' ASP . 82.7 tt0 -55.5 -16.71 4.12 Favored 'General case' 0 N--CA 1.492 1.657 0 CA-C-O 121.241 0.543 . . . . 0.0 110.65 -179.352 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 80.8 p -92.45 -0.94 57.3 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.813 -1.179 . . . . 0.0 109.373 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 126.02 -152.54 18.16 Favored Glycine 0 N--CA 1.499 2.848 0 N-CA-C 110.428 -1.069 . . . . 0.0 110.428 179.182 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 36.8 pt -126.24 151.99 33.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.807 -0.819 . . . . 0.0 109.202 -179.815 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 18.7 tt -147.95 151.0 13.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.217 -0.927 . . . . 0.0 110.067 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.456 ' HZ1' ' HE2' ' A' ' 77' ' ' TYR . 0.0 OUTLIER -85.75 147.64 26.23 Favored 'General case' 0 N--CA 1.489 1.519 0 CA-C-O 121.538 0.685 . . . . 0.0 110.123 -179.997 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 13.3 p90 -143.92 159.71 42.09 Favored 'General case' 0 N--CA 1.486 1.34 0 O-C-N 121.418 -0.801 . . . . 0.0 109.461 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 1.8 t -141.94 142.37 33.01 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 179.468 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 92.8 mt -105.37 122.6 58.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 CA-C-O 121.77 0.795 . . . . 0.0 109.966 -179.798 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 43.1 m95 -91.36 136.89 32.79 Favored 'General case' 0 N--CA 1.487 1.378 0 CA-C-O 121.504 0.669 . . . . 0.0 109.384 179.845 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 56.3 mtpt -70.29 -10.91 60.33 Favored 'General case' 0 N--CA 1.489 1.516 0 CA-C-O 121.708 0.766 . . . . 0.0 109.319 179.449 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 73.0 m-20 -61.78 -40.94 96.95 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.563 -0.711 . . . . 0.0 109.769 -179.909 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -78.4 -11.36 59.94 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.231 -0.918 . . . . 0.0 109.284 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 55.06 63.77 2.01 Favored 'General case' 0 N--CA 1.494 1.727 0 CA-C-O 121.478 0.656 . . . . 0.0 109.749 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 32.8 mt -107.79 146.62 33.78 Favored Pre-proline 0 N--CA 1.495 1.803 0 O-C-N 121.718 -0.614 . . . . 0.0 109.837 -179.899 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -72.4 162.4 41.6 Favored 'Trans proline' 0 N--CA 1.494 1.547 0 C-N-CA 123.047 2.498 . . . . 0.0 112.775 179.598 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.503 HD22 ' OE1' ' A' ' 37' ' ' GLN . 69.1 mt -67.45 143.64 56.14 Favored 'General case' 0 N--CA 1.49 1.528 0 CA-C-O 121.876 0.846 . . . . 0.0 110.512 -179.498 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.572 ' N ' HD12 ' A' ' 61' ' ' LEU . 10.1 mp -91.7 137.13 32.61 Favored 'General case' 0 N--CA 1.491 1.577 0 CA-C-O 121.684 0.754 . . . . 0.0 110.262 -179.304 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.45 ' OE1' ' OE2' ' A' ' 65' ' ' GLU . 95.9 mt-10 -81.81 147.94 29.12 Favored 'General case' 0 N--CA 1.49 1.533 0 CA-C-O 121.817 0.818 . . . . 0.0 110.195 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 32.7 mt-30 -79.62 140.61 37.06 Favored 'General case' 0 N--CA 1.488 1.465 0 CA-C-O 121.789 0.804 . . . . 0.0 110.925 -179.324 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 79.39 35.21 30.16 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 110.3 -1.12 . . . . 0.0 110.3 179.304 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.45 ' OE2' ' OE1' ' A' ' 62' ' ' GLU . 91.5 mt-10 -140.95 143.76 34.73 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.206 -1.173 . . . . 0.0 110.134 179.647 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 89.5 p -81.63 143.46 31.91 Favored 'General case' 0 N--CA 1.486 1.365 0 CA-C-O 121.6 0.714 . . . . 0.0 110.217 -179.642 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 92.3 m-85 -138.41 142.12 39.56 Favored 'General case' 0 N--CA 1.489 1.479 0 CA-C-O 121.582 0.706 . . . . 0.0 110.025 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 31.8 tp -108.56 113.3 26.19 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 108.563 -0.902 . . . . 0.0 108.563 179.197 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.8 mp -99.77 131.26 45.86 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 -179.708 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 85.7 mtp180 -126.51 148.67 49.67 Favored 'General case' 0 N--CA 1.491 1.576 0 CA-C-O 121.584 0.707 . . . . 0.0 110.432 -179.553 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 8.6 t 59.22 55.09 4.47 Favored 'General case' 0 N--CA 1.491 1.582 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.355 179.55 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 15.7 m -113.67 160.79 12.98 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 O-C-N 121.586 -0.696 . . . . 0.0 109.249 179.163 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 9.9 p -114.07 134.66 56.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 CA-C-O 121.809 0.814 . . . . 0.0 110.179 -178.955 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 16.8 t -82.43 119.62 32.3 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.343 0 CA-C-O 121.702 0.763 . . . . 0.0 109.898 -179.726 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -93.68 170.69 31.12 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 110.231 -1.148 . . . . 0.0 110.231 -179.618 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 22.4 pt-20 -102.88 133.43 47.98 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.651 -0.911 . . . . 0.0 110.195 -179.674 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' TYR . . . . . 0.633 ' CD2' ' ND2' ' A' ' 78' ' ' ASN . 42.6 t80 -136.86 96.66 3.35 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 179.624 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ASN . . . . . 0.633 ' ND2' ' CD2' ' A' ' 77' ' ' TYR . 23.3 p30 42.2 -136.68 0.27 Allowed 'General case' 0 N--CA 1.495 1.799 0 CA-C-O 121.531 0.681 . . . . 0.0 111.417 -179.918 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.545 ' N ' ' OD1' ' A' ' 78' ' ' ASN . 97.6 m-20 -73.35 -6.28 45.13 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.433 -0.792 . . . . 0.0 109.689 -179.255 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.406 ' N ' ' OD1' ' A' ' 78' ' ' ASN . 88.6 mtm180 -110.34 -179.66 3.84 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.487 -0.758 . . . . 0.0 110.085 -179.661 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -129.84 154.55 47.16 Favored 'General case' 0 N--CA 1.493 1.707 0 CA-C-O 121.508 0.671 . . . . 0.0 109.597 -179.551 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 27.6 pt20 -139.73 162.28 35.49 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.526 -0.734 . . . . 0.0 109.808 -179.775 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.41 HG23 ' O ' ' A' ' 83' ' ' VAL . 13.5 m -111.54 131.82 61.82 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 179.847 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 -106.43 118.56 36.96 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.469 -0.769 . . . . 0.0 109.978 -179.253 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 10.2 t -90.02 99.46 9.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 179.646 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 9.2 p-10 -151.15 -177.06 5.81 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.511 -0.743 . . . . 0.0 109.762 -179.526 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.427 ' CG ' ' H ' ' A' ' 88' ' ' ASN . 14.8 tptm 66.57 -130.62 0.18 Allowed 'General case' 0 N--CA 1.489 1.484 0 CA-C-O 121.624 0.726 . . . . 0.0 111.386 179.137 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' ASN . . . . . 0.427 ' H ' ' CG ' ' A' ' 87' ' ' LYS . 13.3 p30 -90.41 19.96 4.85 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.531 -0.731 . . . . 0.0 109.273 -179.317 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 19.5 m -57.09 144.09 35.96 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.405 -0.809 . . . . 0.0 109.899 -179.669 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 44.4 m -129.6 153.02 48.49 Favored 'General case' 0 N--CA 1.493 1.676 0 CA-C-O 121.398 0.618 . . . . 0.0 109.427 -179.709 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 96.8 mt -131.69 134.86 59.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.64 -0.663 . . . . 0.0 109.505 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 73.8 mm-40 -128.74 136.23 50.28 Favored 'General case' 0 N--CA 1.494 1.747 0 CA-C-O 121.49 0.662 . . . . 0.0 109.31 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.412 ' C ' HD12 ' A' ' 94' ' ' LEU . 88.5 tttt -82.01 124.99 30.28 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.525 -0.734 . . . . 0.0 109.937 -179.636 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.417 ' N ' HD12 ' A' ' 94' ' ' LEU . 11.0 mp -103.67 131.35 50.9 Favored 'General case' 0 N--CA 1.493 1.695 0 CA-C-O 121.61 0.719 . . . . 0.0 109.47 179.84 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 39.1 t -80.48 -6.67 58.51 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.661 -0.65 . . . . 0.0 109.3 179.7 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -107.36 104.45 52.54 Favored Pre-proline 0 N--CA 1.495 1.811 0 O-C-N 121.422 -0.798 . . . . 0.0 109.457 -179.635 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -74.54 149.43 39.0 Favored 'Trans proline' 0 N--CA 1.491 1.372 0 C-N-CA 122.328 2.019 . . . . 0.0 112.833 -179.246 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.405 ' H ' HG12 ' A' ' 98' ' ' ILE . 14.9 pt -82.37 135.02 25.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 CA-C-O 121.82 0.819 . . . . 0.0 110.757 -179.401 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 81.2 tt0 -66.95 122.0 16.76 Favored 'General case' 0 N--CA 1.487 1.403 0 CA-C-O 121.752 0.787 . . . . 0.0 109.304 -179.792 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 16.1 m -108.22 -1.56 9.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 97.7 104.1 2.3 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.753 -1.339 . . . . 0.0 109.753 179.439 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 83.3 mt -90.34 -5.66 55.96 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.799 -0.824 . . . . 0.0 108.783 179.889 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' GLU . . . . . 0.419 ' O ' ' O ' ' A' ' 104' ' ' HIS . 72.2 mm-40 -60.36 -178.37 0.09 Allowed 'General case' 0 N--CA 1.492 1.675 0 CA-C-O 122.003 0.906 . . . . 0.0 111.443 -178.999 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 104' ' ' HIS . . . . . 0.419 ' O ' ' O ' ' A' ' 103' ' ' GLU . 66.0 t60 53.62 108.37 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 CA-C-O 121.767 0.794 . . . . 0.0 110.404 179.82 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 22.7 p-80 -146.54 166.01 27.76 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.594 -0.691 . . . . 0.0 109.432 179.739 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 99.3 m-70 -130.71 160.41 34.4 Favored 'General case' 0 N--CA 1.495 1.795 0 CA-C-O 121.724 0.773 . . . . 0.0 109.97 -179.559 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' HIS . . . . . 0.539 ' O ' ' N ' ' A' ' 109' ' ' HIS . 18.4 p-80 -148.3 165.63 30.44 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.752 -0.593 . . . . 0.0 109.518 -179.81 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 85.7 t60 54.71 -81.34 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.765 -0.584 . . . . 0.0 110.37 -179.885 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' HIS . . . . . 0.539 ' N ' ' O ' ' A' ' 107' ' ' HIS . 75.7 m80 . . . . . 0 N--CA 1.493 1.684 0 CA-C-O 118.215 -0.898 . . . . 0.0 110.367 -179.505 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 67.7 mtt . . . . . 0 N--CA 1.489 1.49 0 CA-C-O 121.732 0.777 . . . . 0.0 109.208 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.435 ' N ' ' CD ' ' A' ' 3' ' ' PRO . 7.4 mp0 47.04 54.47 15.38 Favored Pre-proline 0 N--CA 1.494 1.729 0 O-C-N 121.906 -0.496 . . . . 0.0 110.034 -179.697 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.435 ' CD ' ' N ' ' A' ' 2' ' ' GLU . 19.9 Cg_endo -62.28 144.0 94.75 Favored 'Trans proline' 0 N--CA 1.495 1.587 0 C-N-CA 122.825 2.35 . . . . 0.0 112.752 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -86.6 88.89 7.75 Favored 'General case' 0 N--CA 1.488 1.463 0 CA-C-O 122.015 0.912 . . . . 0.0 109.487 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.411 ' N ' HD22 ' A' ' 5' ' ' LEU . 4.2 mm? -75.81 139.09 41.57 Favored 'General case' 0 N--CA 1.489 1.509 0 CA-C-O 121.608 0.718 . . . . 0.0 109.959 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 90.0 m -123.96 129.88 51.66 Favored 'General case' 0 N--CA 1.492 1.648 0 CA-C-O 121.643 0.735 . . . . 0.0 109.468 179.85 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 53.7 mtmt -80.08 153.91 28.44 Favored 'General case' 0 N--CA 1.489 1.485 0 CA-C-O 121.495 0.664 . . . . 0.0 110.374 -179.646 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 97.4 mt -62.71 -43.73 98.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 CA-C-O 121.627 0.727 . . . . 0.0 109.976 -179.837 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 13.0 p -65.45 -23.79 33.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.508 -0.745 . . . . 0.0 109.626 -179.676 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -78.81 -4.71 50.85 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.363 -0.836 . . . . 0.0 109.642 179.695 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 97.8 mt -82.23 118.8 30.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.174 -0.954 . . . . 0.0 109.672 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 3.1 m -146.89 6.88 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.565 -0.709 . . . . 0.0 109.275 -179.887 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 94.1 mt-10 -138.14 131.71 30.85 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.261 -0.9 . . . . 0.0 110.203 -179.457 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 51.5 p30 -83.78 153.15 24.26 Favored 'General case' 0 N--CA 1.488 1.438 0 CA-C-O 121.642 0.734 . . . . 0.0 110.442 -179.717 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 71.16 84.64 0.19 Allowed Glycine 0 N--CA 1.49 2.243 0 N-CA-C 110.084 -1.206 . . . . 0.0 110.084 179.577 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 27.3 tt0 -169.39 136.23 1.7 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.417 -1.049 . . . . 0.0 109.838 179.723 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 45.0 m95 -91.64 140.22 29.93 Favored 'General case' 0 N--CA 1.489 1.523 0 CA-C-O 121.567 0.698 . . . . 0.0 110.1 -179.83 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -168.51 170.39 9.73 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.559 -0.713 . . . . 0.0 109.561 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 62.8 m-80 -101.11 145.17 29.12 Favored 'General case' 0 N--CA 1.494 1.771 0 CA-C-O 121.624 0.726 . . . . 0.0 109.967 -179.458 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 51.9 tp -146.62 135.39 22.26 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.529 -0.732 . . . . 0.0 109.8 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 35.0 ttpt -120.3 137.12 54.43 Favored 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 179.312 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.418 ' CB ' ' OD1' ' A' ' 43' ' ' ASP . . . -160.65 172.52 16.98 Favored 'General case' 0 N--CA 1.492 1.659 0 C-N-CA 119.201 -1.0 . . . . 0.0 110.792 -179.377 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 33.0 ttpt -113.15 141.19 47.22 Favored 'General case' 0 N--CA 1.493 1.723 0 CA-C-O 121.583 0.706 . . . . 0.0 109.563 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 87.1 t -77.94 132.02 33.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.648 -0.658 . . . . 0.0 110.561 -179.172 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 30.2 pt -124.46 -30.08 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 179.004 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 68.6 tp60 -150.17 125.98 10.42 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.194 -0.941 . . . . 0.0 109.54 179.859 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.88 HD23 ' H ' ' A' ' 27' ' ' LEU . 1.1 pt? -138.96 135.67 34.6 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.707 -0.621 . . . . 0.0 109.978 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' TRP . . . . . 0.415 ' CE3' ' O ' ' A' ' 29' ' ' GLU . 81.9 t90 -126.84 123.78 38.11 Favored 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.415 ' O ' ' CE3' ' A' ' 28' ' ' TRP . 82.0 tt0 -59.87 138.89 57.69 Favored 'General case' 0 N--CA 1.49 1.568 0 CA-C-O 121.515 0.674 . . . . 0.0 110.046 -179.597 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ASN . . . . . 0.49 ' OD1' ' N ' ' A' ' 32' ' ' HIS . 19.0 t-20 -100.75 120.81 40.65 Favored 'General case' 0 N--CA 1.489 1.478 0 CA-C-O 121.566 0.698 . . . . 0.0 109.867 -179.914 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 60.3 p -94.77 0.87 55.3 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 179.722 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' HIS . . . . . 0.49 ' N ' ' OD1' ' A' ' 30' ' ' ASN . 99.6 m-70 -87.48 119.35 27.67 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.44 -0.787 . . . . 0.0 109.344 179.801 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.46 ' H ' ' CD ' ' A' ' 33' ' ' GLU . 58.0 mp0 -42.94 166.2 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.502 0 CA-C-O 121.682 0.753 . . . . 0.0 111.029 -179.472 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.439 ' CB ' ' O ' ' A' ' 33' ' ' GLU . 0.9 OUTLIER 75.16 -39.97 0.42 Allowed 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 109.573 -0.529 . . . . 0.0 109.573 -179.899 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.412 ' H ' ' C ' ' A' ' 33' ' ' GLU . 90.5 mt -108.92 119.11 57.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 CA-C-O 121.601 0.715 . . . . 0.0 110.054 -179.775 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 3.8 t -76.11 -50.91 13.38 Favored 'General case' 0 N--CA 1.489 1.519 0 CA-C-O 121.822 0.82 . . . . 0.0 109.635 179.489 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 49.2 tt0 -150.42 155.37 39.44 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.291 -0.881 . . . . 0.0 110.22 -179.604 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 8.2 p -142.65 139.8 28.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.678 -0.639 . . . . 0.0 109.414 179.416 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -171.99 -163.36 25.76 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.893 -1.283 . . . . 0.0 109.893 -179.77 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -134.71 148.1 50.23 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.552 -0.969 . . . . 0.0 109.85 -179.394 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 67.6 mt -112.95 137.99 50.5 Favored 'General case' 0 N--CA 1.493 1.688 0 CA-C-O 121.742 0.782 . . . . 0.0 109.564 -179.456 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.421 ' O ' ' OD1' ' A' ' 43' ' ' ASP . . . -83.24 143.86 22.2 Favored Glycine 0 N--CA 1.486 2.029 0 N-CA-C 110.779 -0.929 . . . . 0.0 110.779 -179.542 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.421 ' OD1' ' O ' ' A' ' 42' ' ' GLY . 75.2 m-20 -149.47 160.22 43.64 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.877 -0.778 . . . . 0.0 109.38 179.534 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 79.8 tt0 -65.58 -21.39 66.59 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.686 -0.634 . . . . 0.0 109.61 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 67.4 p -89.97 -2.78 58.21 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.327 -0.858 . . . . 0.0 109.514 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 133.15 -147.26 18.92 Favored Glycine 0 N--CA 1.497 2.705 0 N-CA-C 110.341 -1.104 . . . . 0.0 110.341 179.215 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 40.9 pt -125.66 152.62 32.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.901 -0.764 . . . . 0.0 109.741 -179.626 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 8.4 tp -142.5 140.12 28.68 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 CA-C-O 121.741 0.781 . . . . 0.0 110.059 -179.822 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 54.9 mtmt -87.88 145.94 25.81 Favored 'General case' 0 N--CA 1.49 1.545 0 CA-C-O 121.509 0.671 . . . . 0.0 110.004 179.854 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 38.9 p90 -137.57 153.05 50.01 Favored 'General case' 0 N--CA 1.49 1.545 0 CA-C-O 121.659 0.742 . . . . 0.0 109.783 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 83.6 m -129.86 130.97 45.91 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 96.6 mt -103.75 129.1 56.35 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 CA-C-O 121.702 0.763 . . . . 0.0 109.983 -179.773 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 89.7 m95 -90.63 129.6 36.74 Favored 'General case' 0 N--CA 1.487 1.404 0 CA-C-O 121.698 0.761 . . . . 0.0 109.273 179.457 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.41 ' HZ3' ' C ' ' A' ' 34' ' ' SER . 3.1 ptpp? -67.11 -13.78 62.27 Favored 'General case' 0 N--CA 1.489 1.477 0 CA-C-O 121.516 0.674 . . . . 0.0 109.939 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ASN . . . . . 0.574 ' OD1' ' N ' ' A' ' 56' ' ' ALA . 50.1 p-10 -63.7 -35.68 81.36 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.406 -0.809 . . . . 0.0 109.99 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.574 ' N ' ' OD1' ' A' ' 55' ' ' ASN . . . -77.74 -12.31 59.96 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.238 -0.914 . . . . 0.0 109.298 -179.896 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 52.49 56.61 7.42 Favored 'General case' 0 N--CA 1.494 1.73 0 CA-C-O 121.447 0.641 . . . . 0.0 110.15 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 45.9 mt -101.75 146.65 32.62 Favored Pre-proline 0 N--CA 1.496 1.85 0 O-C-N 121.495 -0.753 . . . . 0.0 109.328 179.517 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -69.74 155.42 66.05 Favored 'Trans proline' 0 N--CA 1.497 1.716 0 C-N-CA 122.921 2.414 . . . . 0.0 113.283 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 75.2 mt -71.73 141.67 49.79 Favored 'General case' 0 N--CA 1.493 1.682 0 CA-C-O 121.852 0.834 . . . . 0.0 110.778 -179.27 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.572 ' N ' HD12 ' A' ' 61' ' ' LEU . 10.3 mp -80.29 143.76 33.38 Favored 'General case' 0 N--CA 1.491 1.586 0 CA-C-O 121.688 0.756 . . . . 0.0 110.065 -179.919 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -83.41 152.66 24.91 Favored 'General case' 0 N--CA 1.49 1.568 0 CA-C-O 121.941 0.876 . . . . 0.0 110.987 -179.478 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 58.5 tt0 -82.03 136.78 35.2 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-O 121.663 0.744 . . . . 0.0 110.754 -179.676 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 82.4 4.55 90.12 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 110.166 -1.174 . . . . 0.0 110.166 179.434 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -110.51 146.86 35.26 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.444 -1.033 . . . . 0.0 110.723 -179.581 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 19.1 p -84.97 152.44 23.47 Favored 'General case' 0 N--CA 1.487 1.42 0 CA-C-O 121.558 0.694 . . . . 0.0 110.2 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 74.4 m-85 -145.34 145.29 31.14 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.349 -0.845 . . . . 0.0 110.275 179.651 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 23.5 tp -108.01 121.14 44.2 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 108.96 -0.755 . . . . 0.0 108.96 179.395 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 68.4 mt -100.59 133.38 45.12 Favored 'General case' 0 N--CA 1.49 1.551 0 CA-C-O 121.256 0.55 . . . . 0.0 109.629 -179.614 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.453 ' O ' ' OG ' ' A' ' 71' ' ' SER . 80.5 mtp85 -129.28 142.05 50.94 Favored 'General case' 0 N--CA 1.493 1.698 0 CA-C-O 121.653 0.74 . . . . 0.0 110.161 -179.806 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.488 ' HG ' ' HA ' ' A' ' 89' ' ' SER . 3.3 p 53.44 60.96 3.36 Favored 'General case' 0 N--CA 1.493 1.697 0 CA-C-O 121.416 0.627 . . . . 0.0 110.405 -179.889 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 3.3 m -114.23 133.11 61.34 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 179.024 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 8.9 p -95.47 135.56 29.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 CA-C-O 121.582 0.706 . . . . 0.0 109.986 -179.258 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -93.23 124.99 45.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 CA-C-O 121.767 0.794 . . . . 0.0 109.695 -179.6 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -100.11 142.86 16.1 Favored Glycine 0 N--CA 1.493 2.446 0 N-CA-C 110.478 -1.049 . . . . 0.0 110.478 -179.618 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 17.5 pt-20 -59.14 138.7 57.46 Favored 'General case' 0 N--CA 1.49 1.566 0 CA-C-O 121.592 0.71 . . . . 0.0 110.082 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' TYR . . . . . 0.533 ' O ' ' N ' ' A' ' 79' ' ' ASP . 79.3 t80 -137.08 81.25 1.86 Allowed 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 179.446 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ASN . . . . . 0.502 ' C ' ' O ' ' A' ' 77' ' ' TYR . 28.8 t-20 15.15 -79.81 0.0 OUTLIER 'General case' 0 N--CA 1.51 2.533 0 CA-C-O 121.581 0.705 . . . . 0.0 112.146 -179.859 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.533 ' N ' ' O ' ' A' ' 77' ' ' TYR . 52.0 t0 -47.8 -69.94 0.11 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.433 -0.792 . . . . 0.0 109.893 -179.75 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 88.5 mtm180 -133.64 -130.44 0.17 Allowed 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.618 -0.677 . . . . 0.0 109.998 -178.895 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 88.4 m-85 -129.47 154.43 46.99 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.578 -0.701 . . . . 0.0 110.046 -178.796 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' GLN . . . . . 0.457 ' OE1' ' CG ' ' A' ' 77' ' ' TYR . 27.3 mt-30 -132.78 161.93 32.8 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.761 -0.587 . . . . 0.0 109.897 -179.703 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.43 HG23 ' O ' ' A' ' 83' ' ' VAL . 16.3 m -104.05 127.88 57.88 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 CA-C-O 121.61 0.719 . . . . 0.0 109.237 179.776 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 -106.39 126.45 52.26 Favored 'General case' 0 N--CA 1.494 1.74 0 CA-C-O 121.436 0.636 . . . . 0.0 109.793 -179.212 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 52.1 t -104.78 120.1 54.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 CA-C-O 121.581 0.705 . . . . 0.0 109.181 179.831 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.404 ' O ' ' O ' ' A' ' 87' ' ' LYS . 7.8 p-10 -147.9 -175.98 5.09 Favored 'General case' 0 N--CA 1.489 1.52 0 CA-C-O 121.388 0.613 . . . . 0.0 110.039 -179.38 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.481 ' O ' ' CB ' ' A' ' 88' ' ' ASN . 85.4 tttt -37.83 157.32 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.737 0 CA-C-O 121.535 0.683 . . . . 0.0 111.016 -179.442 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' ASN . . . . . 0.481 ' CB ' ' O ' ' A' ' 87' ' ' LYS . 11.4 t-20 77.92 -28.88 0.16 Allowed 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 -179.725 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.488 ' HA ' ' HG ' ' A' ' 71' ' ' SER . 11.5 t -75.64 152.18 37.63 Favored 'General case' 0 N--CA 1.49 1.553 0 CA-C-O 121.557 0.694 . . . . 0.0 110.469 -179.696 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 32.1 t -132.54 141.68 48.84 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.553 -0.717 . . . . 0.0 109.702 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 96.4 mt -123.97 130.9 73.66 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 CA-C-O 121.273 0.559 . . . . 0.0 109.523 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -127.02 132.78 50.66 Favored 'General case' 0 N--CA 1.497 1.881 0 CA-C-O 121.621 0.724 . . . . 0.0 109.512 179.809 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.463 ' C ' HD12 ' A' ' 94' ' ' LEU . 88.2 tttt -81.22 127.49 32.74 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-O 121.617 0.723 . . . . 0.0 110.078 -179.533 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.463 HD12 ' C ' ' A' ' 93' ' ' LYS . 10.8 mp -103.51 131.85 50.27 Favored 'General case' 0 N--CA 1.495 1.784 0 CA-C-O 121.671 0.748 . . . . 0.0 110.09 -179.637 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 18.2 t -77.52 -6.05 52.22 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 179.284 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -102.25 110.36 62.46 Favored Pre-proline 0 N--CA 1.496 1.851 0 O-C-N 121.393 -0.817 . . . . 0.0 109.572 -179.75 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -75.78 152.02 36.74 Favored 'Trans proline' 0 N--CA 1.492 1.396 0 C-N-CA 122.795 2.33 . . . . 0.0 112.528 -178.975 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 56.3 mt -82.91 137.97 20.12 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 CA-C-O 121.951 0.882 . . . . 0.0 110.341 -179.589 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' GLU . . . . . 0.494 ' H ' ' CD ' ' A' ' 99' ' ' GLU . 58.6 mp0 -47.99 -81.01 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 CA-C-N 116.078 -0.51 . . . . 0.0 109.715 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.479 ' C ' ' O ' ' A' ' 99' ' ' GLU . 8.6 m 32.12 43.28 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.005 0 CA-C-O 121.837 0.827 . . . . 0.0 110.369 -179.314 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 175.6 56.97 0.06 OUTLIER Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.476 -1.45 . . . . 0.0 109.476 -179.855 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 86.3 mt -86.99 -7.95 57.66 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.285 -1.126 . . . . 0.0 109.066 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 46.07 46.64 12.84 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.333 -0.854 . . . . 0.0 109.703 179.513 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 19.0 p-80 -60.4 88.66 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 CA-C-O 121.85 0.833 . . . . 0.0 109.87 -179.849 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 45.1 p-80 -85.74 -15.29 42.65 Favored 'General case' 0 N--CA 1.489 1.514 0 CA-C-O 121.531 0.681 . . . . 0.0 109.448 179.662 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' HIS . . . . . 0.48 ' O ' ' CG ' ' A' ' 106' ' ' HIS . 51.2 p-80 -92.24 100.47 13.06 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.391 -0.818 . . . . 0.0 109.514 -179.923 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 73.0 m80 -67.7 -42.86 81.36 Favored 'General case' 0 N--CA 1.492 1.634 0 CA-C-O 121.572 0.701 . . . . 0.0 109.684 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 46.8 p-80 -163.44 25.22 0.08 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.452 -0.78 . . . . 0.0 109.239 -179.747 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 53.9 p-80 . . . . . 0 N--CA 1.492 1.661 0 CA-C-O 118.084 -0.96 . . . . 0.0 109.352 179.893 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 97.5 mtp . . . . . 0 N--CA 1.489 1.508 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 26.4 mm-40 -78.6 148.18 72.74 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.666 -0.646 . . . . 0.0 110.074 -179.402 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -70.06 149.91 65.67 Favored 'Trans proline' 0 N--CA 1.493 1.487 0 C-N-CA 122.702 2.268 . . . . 0.0 112.297 179.631 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.587 ' H ' ' CD ' ' A' ' 4' ' ' GLN . 1.0 OUTLIER -76.44 90.78 3.27 Favored 'General case' 0 C--N 1.301 -1.527 0 CA-C-O 121.925 0.869 . . . . 0.0 109.463 -179.704 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 90.7 mt -81.78 139.83 34.58 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.663 -0.648 . . . . 0.0 109.574 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 99.2 m -127.1 131.05 50.93 Favored 'General case' 0 N--CA 1.494 1.753 0 CA-C-O 121.902 0.858 . . . . 0.0 109.86 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 70.2 mmtt -82.15 154.37 25.54 Favored 'General case' 0 C--N 1.301 -1.538 0 CA-C-O 121.648 0.737 . . . . 0.0 109.767 -179.401 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 96.2 mt -63.07 -43.52 99.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 CA-C-O 121.583 0.706 . . . . 0.0 109.568 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 13.6 p -65.24 -23.94 34.14 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 121.531 -0.731 . . . . 0.0 109.858 179.835 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 54.9 t0 -79.39 -2.48 41.9 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.382 -0.824 . . . . 0.0 109.67 -179.889 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 96.6 mt -78.7 117.94 25.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.108 -0.995 . . . . 0.0 109.908 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 3.3 m -136.02 -4.0 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 N-CA-C 108.979 -0.748 . . . . 0.0 108.979 179.533 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 79.4 mm-40 -139.76 137.8 35.37 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.248 -0.908 . . . . 0.0 110.21 -179.724 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 19.9 p-10 -91.85 159.93 15.55 Favored 'General case' 0 N--CA 1.491 1.588 0 CA-C-O 121.607 0.718 . . . . 0.0 110.162 179.821 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 78.69 2.14 84.88 Favored Glycine 0 N--CA 1.493 2.48 0 N-CA-C 109.559 -1.416 . . . . 0.0 109.559 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 33.1 tt0 -79.17 137.84 37.62 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.517 -0.99 . . . . 0.0 110.817 -179.239 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 68.9 m95 -93.45 132.35 37.79 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.781 -0.574 . . . . 0.0 109.692 179.629 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -174.29 176.78 2.38 Favored 'General case' 0 N--CA 1.493 1.722 0 C-N-CA 119.746 -0.782 . . . . 0.0 110.084 179.833 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 28.7 m-20 -104.48 142.68 34.19 Favored 'General case' 0 N--CA 1.495 1.781 0 CA-C-O 121.625 0.726 . . . . 0.0 110.095 -179.554 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 57.3 tp -133.71 138.92 46.09 Favored 'General case' 0 N--CA 1.493 1.705 0 CA-C-O 121.319 0.58 . . . . 0.0 109.485 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 19.5 ttpp -119.55 135.18 54.9 Favored 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 179.175 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -160.98 171.75 18.13 Favored 'General case' 0 N--CA 1.493 1.681 0 C-N-CA 119.598 -0.841 . . . . 0.0 110.166 -179.82 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -114.5 142.61 46.17 Favored 'General case' 0 N--CA 1.496 1.858 0 CA-C-O 121.756 0.789 . . . . 0.0 110.182 -179.71 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 21.5 t -84.77 117.57 30.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 CA-C-O 121.536 0.684 . . . . 0.0 109.963 -179.588 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 25.3 pt -107.86 -30.24 2.53 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 179.277 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 12.7 tt0 -163.99 133.45 3.95 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-O 121.699 0.761 . . . . 0.0 109.927 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.838 HD23 ' H ' ' A' ' 27' ' ' LEU . 1.1 pt? -143.3 137.8 29.09 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.784 -0.572 . . . . 0.0 109.696 179.932 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 2.6 m-90 -116.36 133.01 56.51 Favored 'General case' 0 N--CA 1.495 1.82 0 CA-C-O 121.567 0.699 . . . . 0.0 109.628 179.883 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -66.38 139.97 58.04 Favored 'General case' 0 C--N 1.301 -1.518 0 CA-C-O 121.269 0.557 . . . . 0.0 109.534 179.648 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ASN . . . . . 0.531 ' OD1' ' CG ' ' A' ' 32' ' ' HIS . 49.0 t-20 -102.87 -28.5 12.02 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 179.638 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 44.2 p 52.58 12.48 0.25 Allowed 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 -179.771 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' HIS . . . . . 0.531 ' CG ' ' OD1' ' A' ' 30' ' ' ASN . 0.3 OUTLIER -78.03 146.24 35.45 Favored 'General case' 0 N--CA 1.491 1.588 0 CA-C-O 121.873 0.844 . . . . 0.0 110.218 -179.758 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -59.28 -49.21 78.7 Favored 'General case' 0 N--CA 1.493 1.705 0 CA-C-O 121.428 0.632 . . . . 0.0 110.238 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.42 ' O ' ' CE3' ' A' ' 53' ' ' TRP . 40.0 m -72.08 -35.01 69.13 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.32 -0.862 . . . . 0.0 110.213 -179.611 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.41 HG23 ' OG1' ' A' ' 51' ' ' THR . 94.7 mt -123.29 127.61 74.47 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.993 0 O-C-N 121.292 -0.88 . . . . 0.0 110.317 -179.054 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 45.9 t -75.83 -53.01 9.13 Favored 'General case' 0 N--CA 1.493 1.691 0 CA-C-O 121.904 0.859 . . . . 0.0 109.562 179.597 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' GLN . . . . . 0.483 ' OE1' ' N ' ' A' ' 38' ' ' VAL . 0.5 OUTLIER -147.04 147.67 30.89 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.195 -0.941 . . . . 0.0 109.941 -179.739 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.483 ' N ' ' OE1' ' A' ' 37' ' ' GLN . 8.6 p -134.01 138.49 50.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 CA-C-O 121.384 0.611 . . . . 0.0 109.464 179.872 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -160.64 -165.65 17.86 Favored Glycine 0 N--CA 1.488 2.163 0 C-N-CA 119.746 -1.216 . . . . 0.0 110.476 -179.591 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -132.49 143.83 50.04 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.898 -0.766 . . . . 0.0 109.512 -179.714 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 41.4 mt -116.28 136.12 53.28 Favored 'General case' 0 N--CA 1.494 1.749 0 CA-C-O 121.79 0.805 . . . . 0.0 109.707 -179.178 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -83.71 162.52 39.5 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 111.073 -0.811 . . . . 0.0 111.073 -179.438 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.552 ' OD1' ' N ' ' A' ' 44' ' ' GLU . 67.2 t0 -174.73 145.15 0.87 Allowed 'General case' 0 N--CA 1.49 1.557 0 CA-C-O 121.63 0.729 . . . . 0.0 109.129 179.705 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.552 ' N ' ' OD1' ' A' ' 43' ' ' ASP . 49.0 mt-10 -54.43 -14.88 1.38 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.654 -0.654 . . . . 0.0 110.072 179.927 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 39.5 p -93.55 -11.15 32.54 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.228 -0.92 . . . . 0.0 109.716 -179.894 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 138.86 -158.3 25.09 Favored Glycine 0 N--CA 1.498 2.806 0 C-N-CA 120.041 -1.076 . . . . 0.0 110.568 179.233 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 97.4 mt -124.44 134.2 67.34 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 O-C-N 121.906 -0.761 . . . . 0.0 109.443 -179.585 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 17.7 tt -128.82 141.93 45.31 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.998 0 CA-C-O 121.625 0.726 . . . . 0.0 109.935 -179.753 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 51.1 mtmt -86.46 152.0 23.04 Favored 'General case' 0 N--CA 1.491 1.609 0 CA-C-O 121.568 0.699 . . . . 0.0 110.108 -179.772 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 25.2 p90 -142.51 160.38 40.39 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.327 -0.858 . . . . 0.0 110.325 -179.688 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.41 ' OG1' HG23 ' A' ' 35' ' ' ILE . 1.9 t -138.58 137.52 37.08 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 -179.945 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 90.6 mt -105.93 118.03 52.76 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 CA-C-O 121.534 0.683 . . . . 0.0 109.834 179.865 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' TRP . . . . . 0.42 ' CE3' ' O ' ' A' ' 34' ' ' SER . 72.7 m95 -85.77 142.56 28.87 Favored 'General case' 0 N--CA 1.488 1.463 0 CA-C-O 121.579 0.704 . . . . 0.0 109.524 179.874 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -62.4 -8.8 6.64 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.564 -0.71 . . . . 0.0 110.335 -179.53 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' ASN . . . . . 0.414 ' O ' ' OE1' ' A' ' 57' ' ' GLU . 13.0 t-20 -75.75 -10.97 59.88 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.249 -0.907 . . . . 0.0 109.056 179.529 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.415 ' C ' ' OE1' ' A' ' 57' ' ' GLU . . . -94.19 -21.44 19.06 Favored 'General case' 0 N--CA 1.497 1.921 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 179.27 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.442 ' OE1' ' N ' ' A' ' 57' ' ' GLU . 56.0 mp0 40.39 51.53 2.84 Favored 'General case' 0 N--CA 1.495 1.805 0 CA-C-O 122.069 0.938 . . . . 0.0 109.979 -179.908 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.552 ' C ' ' H ' ' A' ' 60' ' ' LEU . 18.4 mt -94.92 150.06 37.23 Favored Pre-proline 0 N--CA 1.488 1.473 0 O-C-N 121.562 -0.711 . . . . 0.0 109.346 179.92 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.414 ' O ' ' O ' ' A' ' 60' ' ' LEU . 29.9 Cg_endo -67.97 22.97 0.13 Allowed 'Trans proline' 0 N--CA 1.493 1.489 0 C-N-CA 122.2 1.933 . . . . 0.0 111.801 179.564 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.552 ' H ' ' C ' ' A' ' 58' ' ' LEU . 72.0 mt 58.59 151.86 0.01 OUTLIER 'General case' 0 C--N 1.293 -1.866 0 CA-C-O 121.802 0.81 . . . . 0.0 110.18 179.661 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.644 ' N ' HD12 ' A' ' 61' ' ' LEU . 9.0 mp -85.46 143.55 28.5 Favored 'General case' 0 N--CA 1.491 1.625 0 CA-C-O 121.541 0.686 . . . . 0.0 109.747 -179.667 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -87.5 151.27 23.16 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-O 121.937 0.875 . . . . 0.0 110.558 -178.968 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 58.1 tt0 -76.15 132.08 39.78 Favored 'General case' 0 N--CA 1.491 1.583 0 CA-C-O 121.87 0.843 . . . . 0.0 111.542 -178.811 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 93.16 -4.95 74.94 Favored Glycine 0 N--CA 1.496 2.688 0 N-CA-C 110.745 -0.942 . . . . 0.0 110.745 178.57 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.531 ' OE1' ' N ' ' A' ' 65' ' ' GLU . 58.3 mp0 -103.36 149.17 25.02 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 121.119 -1.224 . . . . 0.0 110.725 -179.379 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 8.8 p -93.22 135.15 34.7 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 179.58 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -125.72 143.04 51.21 Favored 'General case' 0 N--CA 1.497 1.879 0 CA-C-O 122.079 0.943 . . . . 0.0 111.017 -179.101 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 11.9 tp -106.57 104.88 14.67 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 179.653 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 54.3 mt -79.62 141.06 36.87 Favored 'General case' 0 N--CA 1.491 1.6 0 CA-C-O 121.342 0.591 . . . . 0.0 109.543 -179.688 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 85.3 mtp180 -136.06 141.85 44.31 Favored 'General case' 0 N--CA 1.494 1.733 0 CA-C-O 121.862 0.839 . . . . 0.0 110.71 -179.37 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 2.0 m 53.04 43.34 31.83 Favored 'General case' 0 N--CA 1.492 1.656 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.963 178.951 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 7.5 m -99.22 162.36 2.95 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.982 0 O-C-N 121.513 -0.742 . . . . 0.0 109.586 179.162 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 7.8 p -108.5 135.81 46.11 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 CA-C-O 121.688 0.756 . . . . 0.0 110.182 -178.971 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 98.7 t -78.89 125.0 38.05 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 CA-C-O 121.818 0.818 . . . . 0.0 109.375 -179.626 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -83.22 163.89 41.66 Favored Glycine 0 N--CA 1.486 2.016 0 N-CA-C 110.093 -1.203 . . . . 0.0 110.093 -179.632 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -114.73 127.88 55.99 Favored 'General case' 0 N--CA 1.493 1.722 0 CA-C-O 121.734 0.778 . . . . 0.0 109.881 -179.843 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' TYR . . . . . 0.469 ' CG ' ' OE1' ' A' ' 82' ' ' GLN . 42.4 m-85 -132.84 81.25 1.93 Allowed 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 179.557 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 79.4 m-20 50.67 -112.67 0.63 Allowed 'General case' 0 N--CA 1.495 1.788 0 CA-C-O 121.355 0.598 . . . . 0.0 110.698 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 94.9 m-20 -90.56 -7.0 54.01 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.141 -0.974 . . . . 0.0 109.544 -179.727 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 94.1 mtt180 -102.66 166.33 10.57 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.382 -0.824 . . . . 0.0 110.557 -178.987 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -128.71 150.61 50.19 Favored 'General case' 0 N--CA 1.496 1.859 0 CA-C-O 121.481 0.658 . . . . 0.0 109.706 179.882 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' GLN . . . . . 0.469 ' OE1' ' CG ' ' A' ' 77' ' ' TYR . 30.0 mt-30 -144.65 177.29 8.79 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.625 -0.672 . . . . 0.0 109.428 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 2.6 m -118.49 133.14 66.27 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 179.543 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 84.4 mt-30 -113.58 122.34 46.93 Favored 'General case' 0 N--CA 1.494 1.756 0 CA-C-O 121.859 0.838 . . . . 0.0 109.618 -179.078 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 22.0 t -90.07 129.29 41.19 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 5.8 p-10 -147.57 172.84 13.37 Favored 'General case' 0 N--CA 1.49 1.544 0 CA-C-O 121.86 0.838 . . . . 0.0 110.167 -179.278 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.475 ' O ' ' CB ' ' A' ' 88' ' ' ASN . 88.7 tttt -42.83 157.24 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 CA-C-O 121.768 0.794 . . . . 0.0 110.826 -179.761 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' ASN . . . . . 0.475 ' CB ' ' O ' ' A' ' 87' ' ' LYS . 2.1 t-20 79.31 -23.2 0.25 Allowed 'General case' 0 N--CA 1.494 1.753 0 CA-C-O 121.366 0.603 . . . . 0.0 109.814 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 11.1 m -74.81 148.1 40.61 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.287 -0.883 . . . . 0.0 110.199 -179.512 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 52.1 m -125.1 150.1 47.18 Favored 'General case' 0 N--CA 1.497 1.884 0 CA-C-O 121.58 0.705 . . . . 0.0 109.806 -179.797 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 98.0 mt -132.27 135.33 58.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 CA-C-O 121.365 0.602 . . . . 0.0 109.734 -179.42 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 81.1 tt0 -128.8 125.93 38.82 Favored 'General case' 0 N--CA 1.5 2.032 0 CA-C-O 121.61 0.719 . . . . 0.0 109.222 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.429 ' C ' HD12 ' A' ' 94' ' ' LEU . 26.7 mtmm -74.34 135.25 42.51 Favored 'General case' 0 N--CA 1.49 1.529 0 CA-C-O 121.566 0.698 . . . . 0.0 110.296 -179.608 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.429 HD12 ' C ' ' A' ' 93' ' ' LYS . 10.2 mp -105.45 134.53 48.42 Favored 'General case' 0 N--CA 1.494 1.766 0 CA-C-O 121.938 0.875 . . . . 0.0 109.82 179.899 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 93.3 p -83.19 -2.12 54.74 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 109.454 -0.572 . . . . 0.0 109.454 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -118.36 89.92 37.29 Favored Pre-proline 0 N--CA 1.5 2.027 0 O-C-N 121.539 -0.726 . . . . 0.0 109.195 179.873 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_exo -57.72 149.67 66.94 Favored 'Trans proline' 0 N--CA 1.492 1.406 0 C-N-CA 122.742 2.295 . . . . 0.0 112.6 179.538 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 29.8 pt -74.68 143.98 12.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 CA-C-O 121.827 0.822 . . . . 0.0 110.353 -179.73 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -80.36 117.54 21.2 Favored 'General case' 0 N--CA 1.488 1.455 0 CA-C-O 121.503 0.668 . . . . 0.0 109.879 -179.686 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 35.3 m -109.64 -3.62 10.51 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 179.487 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -170.98 120.95 0.87 Allowed Glycine 0 N--CA 1.494 2.502 0 N-CA-C 109.707 -1.357 . . . . 0.0 109.707 179.651 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.563 ' N ' HD12 ' A' ' 102' ' ' LEU . 10.1 mp -86.83 1.66 51.63 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.606 -0.938 . . . . 0.0 108.553 179.645 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 103' ' ' GLU . . . . . 0.421 ' O ' ' O ' ' A' ' 102' ' ' LEU . 14.6 pt-20 -50.61 -176.23 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.684 0 CA-C-O 121.781 0.801 . . . . 0.0 110.487 -179.861 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 80.3 m80 -93.31 11.96 26.35 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 -179.888 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 59.8 t-80 -62.32 -44.37 96.67 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.466 -0.771 . . . . 0.0 109.373 179.601 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 92.2 m-70 -63.76 -41.06 98.06 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.532 -0.73 . . . . 0.0 109.358 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 52.8 t-80 -82.73 158.19 22.98 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.343 -0.848 . . . . 0.0 110.147 -179.757 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 77.9 m80 -141.15 147.7 38.86 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.624 -0.673 . . . . 0.0 110.035 -179.812 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 84.3 t60 . . . . . 0 N--CA 1.492 1.632 0 CA-C-O 118.071 -0.966 . . . . 0.0 109.105 179.912 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.455 ' O ' ' O ' ' A' ' 2' ' ' GLU . 82.4 mmm . . . . . 0 N--CA 1.489 1.482 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.455 ' O ' ' O ' ' A' ' 1' ' ' MET . 0.9 OUTLIER 57.32 149.4 0.06 OUTLIER Pre-proline 0 N--CA 1.494 1.738 0 CA-C-O 120.964 0.411 . . . . 0.0 110.355 179.902 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -70.06 150.98 67.16 Favored 'Trans proline' 0 N--CA 1.496 1.646 0 C-N-CA 122.691 2.261 . . . . 0.0 112.625 -179.844 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 59.2 tt0 -87.08 81.09 8.15 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 179.845 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 77.5 mt -76.16 146.83 38.91 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.582 -0.699 . . . . 0.0 110.201 -179.119 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 96.8 m -123.33 130.33 52.58 Favored 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 179.751 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -79.54 155.16 28.32 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.475 -0.766 . . . . 0.0 110.313 -179.079 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.628 ' N ' HD12 ' A' ' 8' ' ' ILE . 3.0 mp -63.45 -43.24 98.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.627 -0.67 . . . . 0.0 109.671 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 13.1 p -66.93 -20.6 27.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.287 -0.883 . . . . 0.0 109.517 -179.688 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -82.68 -1.37 51.03 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.335 -0.853 . . . . 0.0 109.455 179.606 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 96.4 mt -83.89 111.63 20.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.317 -0.864 . . . . 0.0 109.551 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 24.0 m -154.44 18.45 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 179.754 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -134.75 144.3 47.63 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.533 -0.729 . . . . 0.0 110.105 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.41 ' O ' ' OD1' ' A' ' 14' ' ' ASN . 46.6 p-10 -93.16 137.76 32.2 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.492 -0.755 . . . . 0.0 110.264 -179.578 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 80.7 18.98 69.17 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.279 -1.528 . . . . 0.0 109.279 179.876 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 51.8 tt0 -73.31 133.76 43.98 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.295 -1.121 . . . . 0.0 109.818 -179.528 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' TRP . . . . . 0.414 ' O ' ' HB2' ' A' ' 18' ' ' ALA . 90.0 m95 -106.76 130.87 54.4 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.553 -0.717 . . . . 0.0 109.657 179.78 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.414 ' HB2' ' O ' ' A' ' 17' ' ' TRP . . . 178.32 -173.54 0.15 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.421 -0.799 . . . . 0.0 109.689 179.598 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 80.7 m-20 -99.29 152.69 19.64 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.545 -0.722 . . . . 0.0 109.407 -179.78 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.57 HD13 ' N ' ' A' ' 21' ' ' LYS . 0.4 OUTLIER -136.78 117.13 13.63 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.407 -0.808 . . . . 0.0 109.451 179.94 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.57 ' N ' HD13 ' A' ' 20' ' ' LEU . 35.2 ttpt -115.61 135.29 54.22 Favored 'General case' 0 N--CA 1.497 1.892 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 178.755 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -167.15 175.66 7.32 Favored 'General case' 0 N--CA 1.492 1.647 0 C-N-CA 119.31 -0.956 . . . . 0.0 110.158 179.646 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -103.29 142.11 34.76 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.57 -0.706 . . . . 0.0 109.702 -179.6 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.438 HG22 ' CD2' ' A' ' 41' ' ' LEU . 93.7 t -82.49 128.16 38.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.322 -0.861 . . . . 0.0 110.444 -179.496 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 96.7 mt -98.58 -59.94 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 179.119 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.622 ' NE2' ' CZ2' ' A' ' 28' ' ' TRP . 60.0 tt0 -146.84 147.69 31.11 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.346 -0.846 . . . . 0.0 109.728 179.955 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.461 HD23 ' N ' ' A' ' 27' ' ' LEU . 0.1 OUTLIER -125.31 151.23 46.29 Favored 'General case' 0 N--CA 1.496 1.828 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 -179.706 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 28' ' ' TRP . . . . . 0.622 ' CZ2' ' NE2' ' A' ' 26' ' ' GLN . 96.2 m95 -124.3 105.34 9.39 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 179.478 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.401 ' OE1' ' N ' ' A' ' 29' ' ' GLU . 59.4 mp0 -59.49 139.51 57.05 Favored 'General case' 0 C--N 1.302 -1.476 0 CA-C-O 121.542 0.687 . . . . 0.0 110.04 -179.164 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 33.0 t30 -149.93 104.74 3.33 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.712 -0.848 . . . . 0.0 108.712 -179.846 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 5.7 m -89.1 49.91 1.86 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.543 -0.723 . . . . 0.0 109.205 -179.164 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' HIS . . . . . 0.553 ' O ' ' N ' ' A' ' 34' ' ' SER . 61.1 t60 -84.0 28.33 0.61 Allowed 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.437 -0.789 . . . . 0.0 109.609 -179.657 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 40.2 tp10 59.45 -71.48 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.733 -0.605 . . . . 0.0 110.227 179.525 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.553 ' N ' ' O ' ' A' ' 32' ' ' HIS . 77.7 p -61.37 -36.25 79.71 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.321 -0.862 . . . . 0.0 110.176 -179.246 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 96.8 mt -112.79 128.35 69.55 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.069 0 O-C-N 121.478 -0.764 . . . . 0.0 109.878 -179.743 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.465 ' OG ' ' CA ' ' A' ' 54' ' ' LYS . 1.3 m -85.01 -67.98 0.76 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.751 -0.593 . . . . 0.0 109.528 -179.781 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 20.4 tt0 -139.68 151.48 45.95 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.477 -0.764 . . . . 0.0 109.595 -179.638 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 8.3 p -135.71 139.38 46.38 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 179.677 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -164.35 -163.13 16.68 Favored Glycine 0 N--CA 1.49 2.297 0 C-N-CA 119.341 -1.409 . . . . 0.0 110.434 -179.509 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.893 HD23 ' H ' ' A' ' 40' ' ' LEU . 1.4 pt? -136.98 146.23 45.12 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.553 -0.969 . . . . 0.0 109.852 179.904 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.438 ' CD2' HG22 ' A' ' 24' ' ' VAL . 52.9 mt -109.79 132.32 54.25 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.524 -0.735 . . . . 0.0 109.865 -179.274 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -79.06 163.82 49.52 Favored Glycine 0 N--CA 1.487 2.074 0 N-CA-C 110.512 -1.035 . . . . 0.0 110.512 -179.81 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.487 ' OD1' ' N ' ' A' ' 44' ' ' GLU . 49.7 t0 -171.8 138.52 1.09 Allowed 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.68 -0.894 . . . . 0.0 109.105 179.346 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.487 ' N ' ' OD1' ' A' ' 43' ' ' ASP . 18.1 pt-20 -55.7 -13.39 1.66 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.415 -0.803 . . . . 0.0 109.222 -179.773 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 13.9 p -98.29 -9.34 25.63 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.441 -0.787 . . . . 0.0 109.376 -179.794 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 144.92 -157.64 27.37 Favored Glycine 0 N--CA 1.497 2.749 0 C-N-CA 120.078 -1.058 . . . . 0.0 110.487 179.281 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 40.1 pt -126.35 154.57 35.94 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 O-C-N 121.738 -0.86 . . . . 0.0 109.584 -179.864 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.714 HD13 ' H ' ' A' ' 49' ' ' LYS . 0.3 OUTLIER -141.39 142.15 29.49 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 121.308 -0.87 . . . . 0.0 109.459 179.426 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.714 ' H ' HD13 ' A' ' 48' ' ' ILE . 99.1 mttt -91.24 143.97 26.1 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.658 -0.651 . . . . 0.0 109.348 179.455 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 33.4 p90 -137.61 152.51 49.45 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.168 -0.957 . . . . 0.0 109.674 -179.87 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 97.1 m -128.32 132.81 48.62 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 47.1 mm -99.99 121.33 50.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.405 -0.81 . . . . 0.0 109.875 -179.457 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' TRP . . . . . 0.482 ' CD1' ' OD1' ' A' ' 86' ' ' ASN . 89.2 m95 -82.16 124.19 29.66 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 108.72 -0.845 . . . . 0.0 108.72 179.368 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.465 ' CA ' ' OG ' ' A' ' 36' ' ' SER . 32.7 tttt -62.48 -15.17 48.53 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 -179.219 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 99.0 m-20 -63.33 -40.22 96.71 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.482 -0.761 . . . . 0.0 109.488 -179.706 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -64.59 -32.72 74.49 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.338 -0.851 . . . . 0.0 109.441 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 59.52 49.45 8.54 Favored 'General case' 0 N--CA 1.491 1.612 0 CA-C-O 121.282 0.563 . . . . 0.0 109.638 -179.458 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 37.3 mt -101.37 152.39 37.97 Favored Pre-proline 0 N--CA 1.493 1.676 0 O-C-N 121.624 -0.673 . . . . 0.0 109.5 179.868 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -50.57 148.6 15.06 Favored 'Trans proline' 0 N--CA 1.496 1.637 0 C-N-CA 122.177 1.918 . . . . 0.0 112.797 179.133 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 84.0 mt -69.28 154.37 42.15 Favored 'General case' 0 N--CA 1.492 1.632 0 CA-C-O 121.836 0.827 . . . . 0.0 110.543 -179.195 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.702 ' N ' HD22 ' A' ' 61' ' ' LEU . 3.4 mm? -78.72 149.61 32.69 Favored 'General case' 0 C--N 1.304 -1.382 0 CA-C-O 121.421 0.629 . . . . 0.0 110.304 -178.663 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -106.26 146.49 30.27 Favored 'General case' 0 N--CA 1.495 1.823 0 CA-C-O 121.738 0.78 . . . . 0.0 110.057 -179.111 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 49.2 tt0 -81.34 134.21 35.54 Favored 'General case' 0 N--CA 1.488 1.468 0 CA-C-O 121.284 0.564 . . . . 0.0 110.81 -178.905 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 90.38 -6.65 82.3 Favored Glycine 0 N--CA 1.495 2.611 0 N-CA-C 110.355 -1.098 . . . . 0.0 110.355 178.717 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -104.6 150.47 24.63 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.37 -1.076 . . . . 0.0 110.749 -179.438 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 8.4 m -95.37 136.59 35.54 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.698 -0.626 . . . . 0.0 109.358 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 72.5 m-85 -121.87 145.1 48.41 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-O 121.748 0.785 . . . . 0.0 110.142 -179.848 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 14.0 tp -110.34 112.14 23.89 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 179.344 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 71.4 mt -95.86 131.99 41.6 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 -179.827 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 80.4 mtp85 -123.52 141.87 51.57 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.561 -0.712 . . . . 0.0 110.537 -179.334 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 9.2 t 57.81 65.04 1.4 Allowed 'General case' 0 N--CA 1.493 1.692 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.547 179.397 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 2.9 m -121.76 160.82 22.97 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 179.258 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 14.8 p -118.7 133.22 66.24 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 CA-C-O 121.63 0.728 . . . . 0.0 109.45 -179.258 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 14.0 t -85.6 121.37 37.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.654 -0.654 . . . . 0.0 109.68 -179.193 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -98.87 -172.35 31.6 Favored Glycine 0 N--CA 1.494 2.531 0 N-CA-C 109.784 -1.327 . . . . 0.0 109.784 -179.773 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -111.31 120.75 43.29 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.644 -0.916 . . . . 0.0 109.65 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' TYR . . . . . 0.496 ' O ' ' N ' ' A' ' 79' ' ' ASP . 86.7 t80 -108.67 80.77 1.37 Allowed 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 179.44 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' ASN . . . . . 0.455 ' C ' ' O ' ' A' ' 77' ' ' TYR . 94.3 m-20 31.07 -91.34 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.988 0 CA-C-O 121.482 0.658 . . . . 0.0 111.196 179.855 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.496 ' N ' ' O ' ' A' ' 77' ' ' TYR . 66.5 t0 -51.52 -68.69 0.15 Allowed 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.619 -0.676 . . . . 0.0 110.656 -179.453 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 85.2 mtp180 -120.96 -163.99 1.08 Allowed 'General case' 0 N--CA 1.501 2.123 0 O-C-N 121.528 -0.732 . . . . 0.0 110.336 -178.774 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 79.6 m-85 -99.08 162.93 12.79 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.56 -0.712 . . . . 0.0 109.793 -179.037 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 27.8 pt20 -141.95 162.01 36.55 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.377 -0.827 . . . . 0.0 109.834 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 2.7 m -107.96 131.18 59.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 179.81 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -106.7 131.72 53.51 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.676 -0.64 . . . . 0.0 110.041 -178.996 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 96.3 t -103.15 124.31 57.19 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.482 ' OD1' ' CD1' ' A' ' 53' ' ' TRP . 80.3 m-20 -125.01 -176.52 3.58 Favored 'General case' 0 N--CA 1.496 1.834 0 CA-C-O 121.524 0.678 . . . . 0.0 109.739 -179.528 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 62.9 pttt -59.86 -33.43 71.78 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.741 -0.6 . . . . 0.0 109.862 -179.888 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 52.3 t-20 -63.45 -38.23 90.33 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.393 -0.817 . . . . 0.0 109.523 -179.558 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 27.7 t -76.57 164.78 25.6 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.34 -0.85 . . . . 0.0 110.325 -179.064 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 95.1 p -133.06 158.3 43.11 Favored 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 179.825 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 96.8 mt -125.54 132.63 70.71 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 O-C-N 121.668 -0.645 . . . . 0.0 110.02 -179.383 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 31.7 mm-40 -136.15 135.42 39.2 Favored 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 179.633 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.451 ' C ' HD12 ' A' ' 94' ' ' LEU . 97.3 mttt -84.19 136.09 34.1 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.442 -0.786 . . . . 0.0 109.962 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.451 HD12 ' C ' ' A' ' 93' ' ' LYS . 8.9 mp -108.25 133.66 52.18 Favored 'General case' 0 N--CA 1.499 1.986 0 CA-C-O 121.623 0.725 . . . . 0.0 109.384 179.503 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 89.7 p -76.09 1.95 14.2 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 179.637 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.416 ' OE2' ' O ' ' A' ' 97' ' ' PRO . 8.7 tm-20 -109.52 95.72 20.29 Favored Pre-proline 0 N--CA 1.497 1.883 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 -179.948 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 97' ' ' PRO . . . . . 0.416 ' O ' ' OE2' ' A' ' 96' ' ' GLU . 64.7 Cg_endo -76.78 158.89 35.13 Favored 'Trans proline' 0 N--CA 1.491 1.363 0 C-N-CA 122.241 1.961 . . . . 0.0 112.351 -179.149 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 86.8 mt -104.48 128.12 58.3 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 O-C-N 121.499 -0.751 . . . . 0.0 109.79 -179.574 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -67.37 138.05 56.44 Favored 'General case' 0 N--CA 1.489 1.492 0 CA-C-O 121.503 0.668 . . . . 0.0 110.197 -179.299 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 5.4 m -101.11 31.66 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 N-CA-C 108.979 -0.748 . . . . 0.0 108.979 179.705 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 103.16 127.62 6.14 Favored Glycine 0 N--CA 1.497 2.747 0 N-CA-C 110.314 -1.114 . . . . 0.0 110.314 179.395 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.553 ' N ' HD12 ' A' ' 102' ' ' LEU . 10.7 mp -88.62 -2.97 58.87 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.476 -1.014 . . . . 0.0 108.538 179.376 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -78.91 -4.71 51.12 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.565 -0.71 . . . . 0.0 109.315 179.881 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 76.6 t60 -65.14 -41.25 94.95 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.419 -0.801 . . . . 0.0 109.463 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 58.1 t-80 -75.53 129.69 37.64 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.446 -0.783 . . . . 0.0 110.405 -179.181 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 52.3 p-80 -151.95 15.26 0.64 Allowed 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 179.287 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 81.1 t60 -80.24 126.98 31.81 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.569 -0.707 . . . . 0.0 110.087 -179.314 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 8.1 p80 -154.08 163.45 40.07 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.447 -0.783 . . . . 0.0 109.674 179.524 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' HIS . . . . . 0.542 ' OXT' ' CG ' ' A' ' 109' ' ' HIS . 85.5 t60 . . . . . 0 N--CA 1.488 1.471 0 CA-C-O 117.829 -1.081 . . . . 0.0 108.835 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.461 ' SD ' ' N ' ' A' ' 1' ' ' MET . 0.9 OUTLIER . . . . . 0 N--CA 1.488 1.473 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 . . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.439 ' N ' ' CD ' ' A' ' 3' ' ' PRO . 27.7 tt0 -162.73 54.5 0.46 Allowed Pre-proline 0 C--N 1.303 -1.454 0 O-C-N 121.384 -0.823 . . . . 0.0 109.285 179.706 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.439 ' CD ' ' N ' ' A' ' 2' ' ' GLU . 30.7 Cg_endo -63.96 143.97 86.67 Favored 'Trans proline' 0 N--CA 1.496 1.622 0 C-N-CA 122.675 2.25 . . . . 0.0 112.269 -179.868 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.556 ' H ' ' CD ' ' A' ' 4' ' ' GLN . 21.9 mp0 -72.72 92.61 1.57 Allowed 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.291 -0.88 . . . . 0.0 109.685 -179.719 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 86.6 mt -74.51 147.32 41.97 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.487 -0.758 . . . . 0.0 109.567 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 97.8 m -124.12 130.5 52.65 Favored 'General case' 0 N--CA 1.495 1.779 0 CA-C-O 121.736 0.779 . . . . 0.0 109.754 -179.897 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -98.87 159.12 15.18 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.597 -0.689 . . . . 0.0 110.048 -179.675 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 96.6 mt -63.84 -42.74 96.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.412 -0.805 . . . . 0.0 109.557 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 14.8 p -63.32 -23.58 33.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.24 -0.913 . . . . 0.0 109.441 -179.843 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 94.7 m-20 -78.9 -4.15 48.29 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.213 -0.929 . . . . 0.0 109.345 179.58 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 5.6 mm -69.12 98.95 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.079 -1.013 . . . . 0.0 109.639 -179.773 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 2.5 p -116.12 -40.11 2.7 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.36 0 O-C-N 121.625 -0.672 . . . . 0.0 109.3 179.871 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 79.4 tt0 -126.28 143.33 51.19 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.294 -0.879 . . . . 0.0 110.26 -178.974 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 55.8 p30 -87.14 163.16 17.12 Favored 'General case' 0 N--CA 1.492 1.627 0 CA-C-O 121.71 0.767 . . . . 0.0 110.447 -179.674 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 78.07 13.04 83.78 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 109.267 -1.533 . . . . 0.0 109.267 -179.494 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 65.6 tt0 -83.58 129.94 34.98 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.187 -1.184 . . . . 0.0 110.082 -179.7 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 84.1 m95 -93.12 129.16 39.2 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.265 -0.897 . . . . 0.0 109.929 -179.734 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -174.35 -173.33 0.76 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.6 -0.687 . . . . 0.0 109.303 179.581 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 73.5 m-20 -105.64 145.25 31.27 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.515 -0.741 . . . . 0.0 109.822 -179.463 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 40.5 tp -128.07 132.14 49.06 Favored 'General case' 0 N--CA 1.498 1.968 0 CA-C-O 121.69 0.757 . . . . 0.0 109.9 179.766 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 38.2 ttmt -116.09 130.18 56.69 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 179.359 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -166.65 179.01 5.65 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.84 -1.162 . . . . 0.0 110.775 -179.589 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 64.5 tttp -114.55 139.93 49.18 Favored 'General case' 0 N--CA 1.497 1.919 0 CA-C-O 121.619 0.723 . . . . 0.0 109.968 -179.682 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 87.6 t -81.02 115.73 24.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.413 -0.804 . . . . 0.0 109.943 -179.766 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 19.1 mm -93.92 -48.93 12.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.297 -0.877 . . . . 0.0 109.645 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 82.4 mt-30 -144.62 144.97 31.53 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.04 -1.038 . . . . 0.0 110.199 -179.347 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.835 ' H ' HD23 ' A' ' 27' ' ' LEU . 1.1 pt? -141.95 133.32 26.54 Favored 'General case' 0 N--CA 1.492 1.675 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 179.836 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 3.4 m0 -118.86 146.51 44.83 Favored 'General case' 0 N--CA 1.499 2.014 0 CA-C-O 121.741 0.781 . . . . 0.0 109.999 -179.347 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 50.0 tp10 -91.1 133.39 35.37 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.405 -0.81 . . . . 0.0 109.576 -179.808 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ASN . . . . . 0.517 ' ND2' ' O ' ' A' ' 35' ' ' ILE . 14.1 p-10 -89.37 -168.88 2.3 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.342 -0.849 . . . . 0.0 110.143 -179.586 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 97.3 m -118.81 -14.5 9.48 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 179.508 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 99.3 m-70 -79.75 139.81 37.16 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.06 -1.025 . . . . 0.0 110.075 -179.871 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 71.8 mm-40 -69.29 -34.45 74.74 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.417 -0.802 . . . . 0.0 110.077 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 40.1 t -61.31 -42.4 98.6 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.146 -0.971 . . . . 0.0 110.555 -179.284 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.517 ' O ' ' ND2' ' A' ' 30' ' ' ASN . 96.9 mt -103.15 133.82 45.94 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 O-C-N 121.121 -0.987 . . . . 0.0 109.794 -179.523 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 28.7 t -86.33 -70.61 0.59 Allowed 'General case' 0 N--CA 1.49 1.544 0 CA-C-O 121.664 0.745 . . . . 0.0 109.804 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -141.19 153.93 45.57 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.088 -1.007 . . . . 0.0 110.375 -179.15 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 27.8 m -135.98 158.51 38.97 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 179.312 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -178.23 -150.91 8.99 Favored Glycine 0 N--CA 1.487 2.045 0 C-N-CA 119.467 -1.349 . . . . 0.0 110.033 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.41 HD23 ' N ' ' A' ' 40' ' ' LEU . 0.2 OUTLIER -135.25 148.11 49.48 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.655 -0.909 . . . . 0.0 109.374 -179.744 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 70.3 mt -111.54 128.4 56.01 Favored 'General case' 0 N--CA 1.495 1.787 0 CA-C-O 121.668 0.747 . . . . 0.0 109.31 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -80.44 158.03 41.1 Favored Glycine 0 N--CA 1.487 2.095 0 N-CA-C 110.012 -1.235 . . . . 0.0 110.012 -179.751 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.529 ' OD1' ' N ' ' A' ' 44' ' ' GLU . 67.2 t0 -172.58 143.14 1.3 Allowed 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.493 -1.004 . . . . 0.0 109.045 -179.923 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.529 ' N ' ' OD1' ' A' ' 43' ' ' ASP . 96.9 mt-10 -54.88 -14.45 1.45 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.427 -0.795 . . . . 0.0 109.793 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 37.4 p -93.33 -12.94 28.81 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.024 -1.047 . . . . 0.0 109.292 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 141.15 -157.32 25.99 Favored Glycine 0 N--CA 1.498 2.792 0 C-N-CA 119.876 -1.154 . . . . 0.0 110.245 179.378 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 41.5 pt -124.85 150.55 29.86 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 O-C-N 121.581 -0.953 . . . . 0.0 109.518 -179.451 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 20.8 tt -146.94 150.08 15.15 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 121.235 -0.916 . . . . 0.0 109.7 -179.741 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 72.5 mmtt -84.09 150.21 25.71 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.466 -0.771 . . . . 0.0 110.402 -179.23 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 17.3 p90 -143.65 151.76 40.51 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.321 -0.862 . . . . 0.0 109.19 179.52 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 35.0 m -132.99 137.18 46.44 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.629 -0.669 . . . . 0.0 109.469 179.807 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 29.7 mm -98.48 122.56 50.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.225 -0.922 . . . . 0.0 109.735 -179.676 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 97.3 m95 -98.17 140.97 31.68 Favored 'General case' 0 N--CA 1.49 1.543 0 CA-C-O 121.582 0.706 . . . . 0.0 109.639 179.841 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 29.0 mmtm -84.34 -10.41 57.62 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.144 -0.973 . . . . 0.0 109.781 179.547 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 89.7 m-20 -61.8 -41.01 97.2 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.174 -0.954 . . . . 0.0 109.477 -179.776 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -77.58 -8.59 58.08 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.226 -0.921 . . . . 0.0 108.937 179.654 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 58.18 58.11 3.66 Favored 'General case' 0 N--CA 1.495 1.797 0 CA-C-O 121.496 0.665 . . . . 0.0 109.604 -179.771 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.487 ' CD1' HG12 ' A' ' 85' ' ' VAL . 29.8 mt -105.65 147.52 34.82 Favored Pre-proline 0 N--CA 1.497 1.91 0 O-C-N 121.548 -0.72 . . . . 0.0 109.389 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -69.76 159.42 53.46 Favored 'Trans proline' 0 N--CA 1.497 1.72 0 C-N-CA 122.837 2.358 . . . . 0.0 113.195 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 97.2 mt -71.52 141.61 50.12 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.274 -0.891 . . . . 0.0 109.98 -179.814 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.596 ' N ' HD12 ' A' ' 61' ' ' LEU . 9.6 mp -80.04 149.04 30.84 Favored 'General case' 0 N--CA 1.493 1.724 0 CA-C-O 121.727 0.775 . . . . 0.0 110.705 -179.084 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -104.91 126.63 52.18 Favored 'General case' 0 N--CA 1.497 1.914 0 CA-C-O 121.802 0.81 . . . . 0.0 109.758 -179.911 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 58.2 tt0 -64.49 147.89 51.79 Favored 'General case' 0 N--CA 1.496 1.855 0 CA-C-O 121.965 0.888 . . . . 0.0 111.835 -178.933 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 81.05 22.94 60.15 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.937 -1.265 . . . . 0.0 109.937 178.825 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -139.26 145.46 39.21 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.248 -1.148 . . . . 0.0 110.094 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 11.1 p -84.42 149.73 25.79 Favored 'General case' 0 N--CA 1.486 1.333 0 CA-C-O 121.606 0.717 . . . . 0.0 109.856 179.915 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 66.6 m-85 -143.58 151.91 40.77 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.233 -0.917 . . . . 0.0 110.307 -179.867 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 21.9 tp -112.92 121.95 46.2 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 179.235 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 71.8 mt -100.84 130.74 46.9 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.393 -0.817 . . . . 0.0 109.849 -179.162 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 83.4 mtp180 -127.09 144.55 51.0 Favored 'General case' 0 N--CA 1.498 1.944 0 CA-C-O 121.878 0.847 . . . . 0.0 110.49 -179.876 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.8 m 58.34 57.43 3.91 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.798 -0.564 . . . . 0.0 110.49 179.385 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 17.9 m -118.81 164.67 14.85 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.98 0 O-C-N 121.598 -0.688 . . . . 0.0 109.656 179.33 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 11.8 p -120.47 136.11 58.56 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 CA-C-O 121.65 0.738 . . . . 0.0 109.379 -179.712 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 66.9 t -81.47 115.29 23.79 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 CA-C-O 121.831 0.824 . . . . 0.0 109.889 -178.863 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -84.92 167.32 41.89 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 110.024 -1.23 . . . . 0.0 110.024 -179.563 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -105.91 124.2 49.19 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.466 -1.02 . . . . 0.0 109.624 180.0 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 52.0 t80 -120.05 82.58 1.91 Allowed 'General case' 0 N--CA 1.492 1.637 0 CA-C-O 121.984 0.897 . . . . 0.0 108.807 179.719 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' ASN . . . . . 0.451 ' CG ' ' N ' ' A' ' 79' ' ' ASP . 50.1 t30 42.95 -117.63 0.46 Allowed 'General case' 0 N--CA 1.501 2.087 0 CA-C-O 121.729 0.776 . . . . 0.0 112.179 179.774 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.451 ' N ' ' CG ' ' A' ' 78' ' ' ASN . 42.4 t0 -70.22 -35.16 73.7 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.184 -0.947 . . . . 0.0 109.991 -178.806 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 84.4 mtt85 -101.22 -170.88 1.9 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.267 -0.896 . . . . 0.0 110.011 -179.377 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -127.9 150.53 49.83 Favored 'General case' 0 N--CA 1.494 1.756 0 CA-C-O 121.694 0.759 . . . . 0.0 110.075 -179.297 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 13.1 tt0 -133.13 126.44 31.73 Favored 'General case' 0 N--CA 1.49 1.528 0 CA-C-O 121.493 0.663 . . . . 0.0 109.351 -179.803 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 34.1 m -81.13 141.21 15.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.477 -0.764 . . . . 0.0 109.553 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 87.7 mt-30 -111.54 120.82 43.4 Favored 'General case' 0 N--CA 1.495 1.812 0 CA-C-O 121.799 0.809 . . . . 0.0 109.738 -179.449 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.487 HG12 ' CD1' ' A' ' 58' ' ' LEU . 4.5 t -93.24 99.3 9.45 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 179.655 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 22.5 p30 -150.67 -176.7 5.61 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.495 -0.753 . . . . 0.0 109.313 -179.571 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.445 ' CG ' ' H ' ' A' ' 88' ' ' ASN . 14.4 tptm 66.27 -137.93 0.16 Allowed 'General case' 0 N--CA 1.491 1.621 0 CA-C-O 121.806 0.812 . . . . 0.0 110.826 179.588 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' ASN . . . . . 0.445 ' H ' ' CG ' ' A' ' 87' ' ' LYS . 92.9 m-20 -86.14 22.62 1.71 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.474 -0.766 . . . . 0.0 109.227 -179.574 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 30.9 t -58.61 141.78 51.31 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.193 -0.942 . . . . 0.0 109.672 -179.759 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 64.0 m -127.16 152.32 47.5 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.546 -0.721 . . . . 0.0 109.318 -179.735 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 97.3 mt -128.07 131.73 69.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.692 -0.63 . . . . 0.0 109.351 -179.707 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -132.03 131.76 42.78 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.523 -0.736 . . . . 0.0 109.301 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 4.8 ttpm? -79.61 136.69 36.9 Favored 'General case' 0 N--CA 1.489 1.487 0 CA-C-O 121.789 0.804 . . . . 0.0 110.31 -179.588 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 70.9 mt -98.15 132.85 43.32 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.42 -0.8 . . . . 0.0 109.744 -179.797 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 31.3 t -75.51 3.84 8.62 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.481 -0.762 . . . . 0.0 109.342 179.642 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -118.36 90.28 38.22 Favored Pre-proline 0 N--CA 1.495 1.812 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 179.593 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_exo -56.09 147.38 64.93 Favored 'Trans proline' 0 N--CA 1.495 1.606 0 C-N-CA 122.829 2.353 . . . . 0.0 112.394 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 90.6 mt -97.43 125.82 50.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.299 -0.876 . . . . 0.0 109.869 -179.205 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 81.2 tt0 -90.49 124.05 34.67 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.557 -0.714 . . . . 0.0 109.989 -179.378 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 61.2 t -107.27 -14.3 9.55 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.918 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 179.496 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -75.1 55.46 2.71 Favored Glycine 0 N--CA 1.493 2.469 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 80.8 mt -88.32 -1.73 58.2 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.233 -1.157 . . . . 0.0 108.618 179.722 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -57.33 137.09 56.49 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.205 -0.934 . . . . 0.0 110.375 -179.524 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 61.0 t-80 -145.9 145.23 30.62 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.395 -0.816 . . . . 0.0 108.909 179.787 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 95.9 m-70 -114.04 -162.97 0.83 Allowed 'General case' 0 N--CA 1.498 1.947 0 CA-C-O 121.858 0.837 . . . . 0.0 110.71 -178.925 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 49.5 p-80 -69.72 139.71 53.41 Favored 'General case' 0 N--CA 1.49 1.533 0 CA-C-O 121.906 0.86 . . . . 0.0 110.957 -179.159 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 77.8 m80 -67.38 -41.99 84.12 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.476 -0.765 . . . . 0.0 109.367 179.637 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' HIS . . . . . 0.434 ' ND1' ' C ' ' A' ' 108' ' ' HIS . 2.1 p80 -155.23 165.18 37.47 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.187 -0.946 . . . . 0.0 109.921 -179.973 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 48.7 t-80 . . . . . 0 N--CA 1.492 1.663 0 CA-C-O 118.017 -0.992 . . . . 0.0 110.006 179.926 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 96.1 mtp . . . . . 0 N--CA 1.49 1.558 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.632 ' N ' ' CD ' ' A' ' 3' ' ' PRO . 4.1 tt0 -87.83 -41.28 0.5 Allowed Pre-proline 0 N--CA 1.496 1.831 0 O-C-N 121.705 -0.622 . . . . 0.0 109.734 179.467 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.632 ' CD ' ' N ' ' A' ' 2' ' ' GLU . 23.7 Cg_exo -61.6 146.24 97.04 Favored 'Trans proline' 0 N--CA 1.494 1.517 0 C-N-CA 122.532 2.155 . . . . 0.0 112.261 -179.225 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.419 ' H ' ' HG2' ' A' ' 4' ' ' GLN . 11.9 pt20 -74.88 72.35 2.07 Favored 'General case' 0 C--N 1.3 -1.55 0 CA-C-O 121.786 0.803 . . . . 0.0 109.905 -179.501 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.431 HD23 HD22 ' A' ' 19' ' ' ASN . 18.8 mt -65.74 137.3 57.18 Favored 'General case' 0 N--CA 1.489 1.479 0 CA-C-O 121.453 0.644 . . . . 0.0 109.734 179.882 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 91.8 m -128.54 135.5 49.48 Favored 'General case' 0 N--CA 1.494 1.728 0 CA-C-O 121.836 0.827 . . . . 0.0 109.811 -179.909 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 65.4 mttp -72.92 151.15 42.02 Favored 'General case' 0 N--CA 1.49 1.572 0 CA-C-O 121.704 0.764 . . . . 0.0 109.975 -179.458 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 92.4 mt -63.25 -43.13 98.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 CA-C-O 121.369 0.604 . . . . 0.0 109.379 -179.393 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 8.3 p -65.7 -24.07 33.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 -179.05 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -79.05 -6.47 56.48 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.639 -0.663 . . . . 0.0 109.327 -179.434 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 97.5 mt -85.89 113.79 24.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 CA-C-O 121.78 0.8 . . . . 0.0 109.543 179.907 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 31.7 m -150.12 12.21 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -124.97 137.51 54.25 Favored 'General case' 0 N--CA 1.501 2.123 0 CA-C-O 121.884 0.85 . . . . 0.0 110.268 -179.861 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 48.1 p-10 -84.08 140.8 31.58 Favored 'General case' 0 N--CA 1.489 1.518 0 CA-C-O 121.619 0.723 . . . . 0.0 109.881 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 75.99 19.0 79.16 Favored Glycine 0 N--CA 1.492 2.407 0 N-CA-C 109.647 -1.381 . . . . 0.0 109.647 179.626 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 57.0 tt0 -78.77 133.82 37.07 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.59 -0.947 . . . . 0.0 110.209 -179.623 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 84.3 m95 -106.78 130.64 54.45 Favored 'General case' 0 N--CA 1.494 1.748 0 CA-C-O 121.585 0.707 . . . . 0.0 110.148 -179.751 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -178.9 175.51 1.01 Allowed 'General case' 0 N--CA 1.493 1.689 0 CA-C-O 121.693 0.758 . . . . 0.0 110.391 179.248 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.522 HD21 HD11 ' A' ' 68' ' ' LEU . 1.4 t30 -102.05 150.01 23.67 Favored 'General case' 0 N--CA 1.498 1.944 0 CA-C-O 121.902 0.858 . . . . 0.0 110.137 -179.432 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 7.2 tt -147.56 138.2 23.32 Favored 'General case' 0 C--N 1.305 -1.36 0 CA-C-O 121.779 0.8 . . . . 0.0 110.449 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 37.8 ttmt -109.83 133.22 53.4 Favored 'General case' 0 N--CA 1.496 1.863 0 CA-C-O 121.594 0.711 . . . . 0.0 109.561 179.477 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -163.18 170.5 17.68 Favored 'General case' 0 N--CA 1.494 1.746 0 CA-C-O 121.762 0.791 . . . . 0.0 110.589 179.718 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.417 ' HZ3' ' N ' ' A' ' 65' ' ' GLU . 17.1 ttmm -113.83 142.31 46.24 Favored 'General case' 0 N--CA 1.498 1.957 0 CA-C-O 121.608 0.718 . . . . 0.0 109.934 -179.717 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.402 HG22 ' CD2' ' A' ' 41' ' ' LEU . 98.8 t -81.98 122.2 36.43 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 CA-C-O 121.528 0.68 . . . . 0.0 110.239 -179.515 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 26.0 mm -93.88 -44.98 13.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 CA-C-O 121.086 0.469 . . . . 0.0 110.031 -179.507 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.825 ' C ' HD13 ' A' ' 27' ' ' LEU . 59.3 tt0 -158.14 147.62 19.66 Favored 'General case' 0 N--CA 1.492 1.642 0 CA-C-O 122.182 0.992 . . . . 0.0 110.334 -179.072 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 1.041 HD22 ' H ' ' A' ' 27' ' ' LEU . 0.0 OUTLIER -116.87 151.46 36.52 Favored 'General case' 0 N--CA 1.502 2.13 0 CA-C-O 121.632 0.729 . . . . 0.0 109.272 -179.205 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 23.9 t90 -138.15 111.18 7.8 Favored 'General case' 0 N--CA 1.493 1.675 0 CA-C-O 121.879 0.847 . . . . 0.0 109.678 179.148 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -52.8 132.01 36.03 Favored 'General case' 0 N--CA 1.491 1.602 0 CA-C-O 121.675 0.75 . . . . 0.0 110.168 -179.618 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 5.7 t-20 -88.74 172.05 9.52 Favored 'General case' 0 N--CA 1.491 1.614 0 CA-C-O 121.556 0.693 . . . . 0.0 110.112 -179.369 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 65.1 p -101.8 1.05 36.75 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.799 -0.563 . . . . 0.0 109.688 -179.126 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 65.3 m80 -105.04 139.11 40.21 Favored 'General case' 0 N--CA 1.501 2.079 0 CA-C-O 122.03 0.919 . . . . 0.0 110.531 -179.423 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -68.51 -37.23 79.86 Favored 'General case' 0 N--CA 1.491 1.607 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.853 -179.61 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 16.4 m -62.54 -36.31 82.21 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 -179.672 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 85.6 mt -103.07 128.61 55.86 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 CA-C-O 121.912 0.863 . . . . 0.0 109.39 -179.56 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 28.1 t -74.92 -75.14 0.17 Allowed 'General case' 0 N--CA 1.489 1.52 0 CA-C-O 121.508 0.67 . . . . 0.0 109.852 -179.273 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 13.1 pt20 -139.78 156.51 46.72 Favored 'General case' 0 N--CA 1.494 1.736 0 CA-C-O 122.045 0.926 . . . . 0.0 110.488 -179.064 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 56.6 t -130.92 136.15 58.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 CA-C-O 121.639 0.733 . . . . 0.0 109.367 179.856 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -153.63 -151.26 5.69 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 110.11 -1.196 . . . . 0.0 110.11 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.4 HD23 ' N ' ' A' ' 40' ' ' LEU . 0.2 OUTLIER -134.48 152.09 51.56 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.739 -0.859 . . . . 0.0 109.772 -179.414 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.402 ' CD2' HG22 ' A' ' 24' ' ' VAL . 53.0 mt -116.85 126.46 53.05 Favored 'General case' 0 N--CA 1.494 1.753 0 CA-C-O 121.84 0.829 . . . . 0.0 109.77 -179.867 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -85.08 150.59 25.07 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 110.959 -0.856 . . . . 0.0 110.959 -179.573 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 44.3 t0 -168.55 164.37 12.46 Favored 'General case' 0 N--CA 1.489 1.494 0 CA-C-O 121.723 0.773 . . . . 0.0 109.583 179.335 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -66.06 -22.38 66.42 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.864 -0.523 . . . . 0.0 109.923 -179.181 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 65.5 p -88.48 -6.02 57.88 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.289 -0.882 . . . . 0.0 109.723 -179.433 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 134.45 -157.65 23.03 Favored Glycine 0 N--CA 1.5 2.956 0 C-N-CA 120.347 -0.93 . . . . 0.0 110.987 178.709 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 4.9 mp -126.02 133.68 68.34 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 CA-C-O 121.491 0.662 . . . . 0.0 109.539 -179.465 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 20.0 tt -127.67 151.83 34.99 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 CA-C-O 122.023 0.916 . . . . 0.0 110.439 -179.457 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 28.2 mmtp -83.94 153.24 24.04 Favored 'General case' 0 N--CA 1.489 1.507 0 CA-C-O 121.543 0.687 . . . . 0.0 109.709 -179.346 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 17.2 p90 -147.2 154.99 41.71 Favored 'General case' 0 N--CA 1.491 1.623 0 CA-C-O 122.03 0.919 . . . . 0.0 110.289 179.8 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 13.8 t -142.22 139.05 31.88 Favored 'General case' 0 N--CA 1.492 1.648 0 CA-C-O 121.684 0.755 . . . . 0.0 109.629 179.493 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 85.8 mt -103.83 116.37 47.49 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 CA-C-O 121.84 0.828 . . . . 0.0 109.803 -179.793 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 73.3 m95 -86.04 138.42 31.97 Favored 'General case' 0 N--CA 1.491 1.591 0 CA-C-O 121.537 0.684 . . . . 0.0 109.402 179.8 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 18.8 mmmt -88.24 49.2 1.75 Allowed 'General case' 0 N--CA 1.491 1.587 0 CA-C-O 121.451 0.643 . . . . 0.0 109.453 -179.739 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 95.9 m-20 -69.69 -2.29 11.39 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -159.08 -88.61 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.541 -0.725 . . . . 0.0 109.564 179.538 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 179.15 71.56 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.87 0 CA-C-O 121.755 0.788 . . . . 0.0 109.485 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 14.8 mt -90.7 143.47 29.0 Favored Pre-proline 0 N--CA 1.488 1.473 0 O-C-N 121.519 -0.738 . . . . 0.0 109.333 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -71.54 156.37 58.05 Favored 'Trans proline' 0 C--N 1.31 -1.468 0 C-N-CA 122.561 2.174 . . . . 0.0 112.711 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 82.9 mt -72.41 144.98 47.96 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-O 121.894 0.855 . . . . 0.0 110.706 -179.439 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.568 ' N ' HD12 ' A' ' 61' ' ' LEU . 9.9 mp -86.86 137.62 32.25 Favored 'General case' 0 N--CA 1.488 1.427 0 CA-C-O 121.554 0.693 . . . . 0.0 109.625 -179.71 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.529 ' N ' ' OH ' ' A' ' 67' ' ' TYR . 97.8 mt-10 -80.74 144.9 31.83 Favored 'General case' 0 C--N 1.301 -1.516 0 CA-C-O 121.659 0.742 . . . . 0.0 110.27 -179.778 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.417 ' C ' ' OE1' ' A' ' 65' ' ' GLU . 57.9 tt0 -80.85 125.78 30.52 Favored 'General case' 0 N--CA 1.488 1.465 0 CA-C-O 121.541 0.686 . . . . 0.0 110.437 -179.231 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 96.62 31.46 7.08 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.382 -1.487 . . . . 0.0 109.382 179.304 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.45 ' OE1' ' N ' ' A' ' 65' ' ' GLU . 59.9 mp0 -139.53 145.48 38.74 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.54 -0.977 . . . . 0.0 110.142 179.472 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 30.0 t -75.79 145.14 40.94 Favored 'General case' 0 N--CA 1.489 1.478 0 CA-C-O 121.481 0.658 . . . . 0.0 110.087 -179.908 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.529 ' OH ' ' N ' ' A' ' 62' ' ' GLU . 94.0 m-85 -137.03 144.76 43.4 Favored 'General case' 0 N--CA 1.494 1.726 0 CA-C-O 121.9 0.857 . . . . 0.0 110.477 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.567 HD13 ' N ' ' A' ' 69' ' ' LEU . 0.2 OUTLIER -107.0 119.93 40.7 Favored 'General case' 0 N--CA 1.487 1.414 0 CA-C-O 121.551 0.691 . . . . 0.0 109.405 -179.541 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.567 ' N ' HD13 ' A' ' 68' ' ' LEU . 73.4 mt -93.83 110.44 22.09 Favored 'General case' 0 N--CA 1.491 1.591 0 CA-C-O 121.521 0.677 . . . . 0.0 109.335 179.909 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.532 ' NH2' ' OE1' ' A' ' 92' ' ' GLU . 94.6 mtt180 -102.36 135.39 44.05 Favored 'General case' 0 N--CA 1.492 1.656 0 CA-C-O 121.966 0.888 . . . . 0.0 110.438 -179.774 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 13.4 m 39.85 79.77 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.673 0 CA-C-N 115.03 -0.986 . . . . 0.0 110.806 179.86 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 22.3 m -120.98 163.34 18.76 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 CA-C-O 121.594 0.711 . . . . 0.0 109.921 179.082 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 8.4 p -120.96 135.98 59.41 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 CA-C-O 121.731 0.777 . . . . 0.0 109.953 -179.251 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 9.4 t -91.34 115.76 31.13 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 CA-C-O 121.809 0.814 . . . . 0.0 109.867 -179.534 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.504 ' O ' ' NE2' ' A' ' 82' ' ' GLN . . . -99.43 177.37 29.6 Favored Glycine 0 N--CA 1.492 2.427 0 N-CA-C 110.083 -1.207 . . . . 0.0 110.083 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -103.14 115.88 31.43 Favored 'General case' 0 N--CA 1.494 1.742 0 CA-C-O 121.767 0.794 . . . . 0.0 109.718 179.938 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' TYR . . . . . 0.404 ' HB3' HE21 ' A' ' 82' ' ' GLN . 82.0 t80 -124.88 120.55 31.97 Favored 'General case' 0 N--CA 1.494 1.771 0 CA-C-O 121.832 0.825 . . . . 0.0 109.893 179.833 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 11.6 t-20 55.67 41.39 30.52 Favored 'General case' 0 N--CA 1.491 1.58 0 CA-C-N 116.14 -0.482 . . . . 0.0 109.808 179.448 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 13.7 t0 69.52 -1.85 2.11 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 179.354 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 19.6 mmm180 -104.01 -170.16 1.73 Allowed 'General case' 0 N--CA 1.495 1.783 0 CA-C-O 121.406 0.622 . . . . 0.0 109.867 -179.886 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 78.9 m-85 -122.06 140.18 52.82 Favored 'General case' 0 N--CA 1.497 1.924 0 CA-C-O 121.949 0.88 . . . . 0.0 110.427 -179.128 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' GLN . . . . . 0.59 ' NE2' ' N ' ' A' ' 82' ' ' GLN . 0.0 OUTLIER -147.92 152.3 37.32 Favored 'General case' 0 N--CA 1.493 1.704 0 CA-C-O 121.623 0.725 . . . . 0.0 109.59 179.401 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 27.1 m -87.67 132.17 33.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 CA-C-O 121.808 0.813 . . . . 0.0 110.291 -179.658 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -109.18 122.64 47.75 Favored 'General case' 0 N--CA 1.496 1.831 0 CA-C-O 121.837 0.827 . . . . 0.0 110.106 -179.439 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 61.9 t -92.4 130.59 41.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 179.451 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 95.0 m-20 -128.92 -177.24 4.13 Favored 'General case' 0 N--CA 1.495 1.797 0 CA-C-O 121.874 0.845 . . . . 0.0 110.462 -179.449 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 63.7 tttp -56.1 -45.41 79.46 Favored 'General case' 0 N--CA 1.488 1.458 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.8 -179.318 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 98.8 m-20 -63.36 -35.54 80.72 Favored 'General case' 0 N--CA 1.488 1.475 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 -179.237 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 69.1 m -71.47 152.2 43.26 Favored 'General case' 0 N--CA 1.493 1.708 0 CA-C-O 121.717 0.77 . . . . 0.0 110.08 -179.752 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 43.7 t -131.93 146.15 51.93 Favored 'General case' 0 N--CA 1.497 1.875 0 CA-C-O 121.559 0.695 . . . . 0.0 109.615 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 96.5 mt -120.39 132.51 69.8 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 CA-C-O 121.697 0.76 . . . . 0.0 109.977 179.88 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.532 ' OE1' ' NH2' ' A' ' 70' ' ' ARG . 77.1 tt0 -123.07 119.33 29.99 Favored 'General case' 0 N--CA 1.495 1.806 0 CA-C-O 121.81 0.814 . . . . 0.0 109.488 179.669 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 37.9 ttmt -75.79 131.85 40.04 Favored 'General case' 0 N--CA 1.488 1.44 0 CA-C-O 121.42 0.629 . . . . 0.0 109.629 179.736 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.431 HD11 HD23 ' A' ' 68' ' ' LEU . 85.4 mt -109.1 140.54 42.53 Favored 'General case' 0 N--CA 1.494 1.775 0 CA-C-O 121.888 0.851 . . . . 0.0 110.04 -179.813 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 90.9 p -79.87 -4.89 54.21 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 109.341 -0.615 . . . . 0.0 109.341 -179.261 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 81.2 mt-10 -97.7 113.67 63.88 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.827 -0.546 . . . . 0.0 109.59 -179.896 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_endo -75.29 155.37 41.59 Favored 'Trans proline' 0 C--N 1.313 -1.301 0 C-N-CA 122.53 2.153 . . . . 0.0 112.256 -179.907 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 89.9 mt -107.44 129.68 60.92 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 CA-C-O 121.899 0.857 . . . . 0.0 110.273 -179.542 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' GLU . . . . . 0.512 ' N ' ' OE1' ' A' ' 99' ' ' GLU . 57.7 mp0 -81.39 122.03 26.97 Favored 'General case' 0 N--CA 1.489 1.477 0 CA-C-O 121.776 0.798 . . . . 0.0 110.004 -179.403 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 26.9 m -106.41 -3.86 9.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 179.708 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -162.77 118.04 0.8 Allowed Glycine 0 N--CA 1.493 2.492 0 N-CA-C 109.724 -1.351 . . . . 0.0 109.724 179.736 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.558 ' N ' HD12 ' A' ' 102' ' ' LEU . 9.7 mp -88.42 -2.45 58.61 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.744 -0.857 . . . . 0.0 109.202 -179.998 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 72.7 mm-40 -56.36 141.0 43.54 Favored 'General case' 0 N--CA 1.498 1.968 0 CA-C-O 121.647 0.736 . . . . 0.0 110.21 -179.666 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 4.0 p-80 -73.12 -14.26 61.35 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 108.966 -0.754 . . . . 0.0 108.966 -179.442 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 28.8 t-80 -70.27 132.53 45.85 Favored 'General case' 0 N--CA 1.49 1.554 0 CA-C-O 121.498 0.666 . . . . 0.0 109.39 -179.515 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 80.6 m80 -112.32 148.48 34.12 Favored 'General case' 0 N--CA 1.496 1.852 0 CA-C-O 121.87 0.843 . . . . 0.0 109.909 -179.44 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 35.3 m170 -73.32 144.42 46.55 Favored 'General case' 0 N--CA 1.488 1.462 0 CA-C-O 121.797 0.808 . . . . 0.0 110.373 -179.096 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 47.9 p-80 -151.14 164.42 36.54 Favored 'General case' 0 N--CA 1.49 1.553 0 CA-C-O 121.667 0.746 . . . . 0.0 109.949 179.734 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' HIS . . . . . 0.491 ' OXT' ' CG ' ' A' ' 109' ' ' HIS . 53.9 t-80 . . . . . 0 N--CA 1.493 1.706 0 CA-C-O 118.108 -0.949 . . . . 0.0 109.512 -179.839 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.46 ' O ' ' O ' ' A' ' 2' ' ' GLU . 39.5 tpp . . . . . 0 N--CA 1.489 1.488 0 CA-C-O 121.361 0.601 . . . . 0.0 109.394 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.46 ' O ' ' O ' ' A' ' 1' ' ' MET . 19.0 mm-40 57.09 149.27 0.06 OUTLIER Pre-proline 0 N--CA 1.494 1.761 0 CA-C-O 121.092 0.472 . . . . 0.0 110.376 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -67.72 146.32 72.49 Favored 'Trans proline' 0 N--CA 1.496 1.654 0 C-N-CA 122.539 2.159 . . . . 0.0 112.568 -179.881 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 87.3 mt-30 -77.43 91.78 3.92 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.328 -0.857 . . . . 0.0 109.106 -179.935 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 79.5 mt -72.91 125.77 28.35 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.456 -0.777 . . . . 0.0 109.858 -179.229 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 98.8 m -127.12 132.49 50.58 Favored 'General case' 0 N--CA 1.498 1.927 0 CA-C-O 121.456 0.646 . . . . 0.0 109.327 179.878 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -74.76 153.31 38.85 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.555 -0.716 . . . . 0.0 110.415 -179.164 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 96.1 mt -62.52 -43.79 98.71 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.534 -0.729 . . . . 0.0 109.567 -179.691 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 11.7 p -64.05 -24.12 34.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.504 -0.747 . . . . 0.0 109.875 -179.341 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.434 ' O ' ' OD1' ' A' ' 10' ' ' ASP . 60.1 t0 -76.27 -5.88 48.97 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.202 -0.936 . . . . 0.0 109.644 -179.723 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 96.5 mt -84.01 120.39 34.83 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.078 -1.014 . . . . 0.0 109.886 -179.893 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 16.1 m -135.79 -0.04 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 179.352 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 49.9 tp10 -139.9 141.81 36.53 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.394 -0.816 . . . . 0.0 109.719 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 56.4 p30 -87.49 161.2 17.94 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.654 -0.654 . . . . 0.0 110.044 -179.859 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 81.93 14.72 76.79 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 108.816 -1.714 . . . . 0.0 108.816 -179.722 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 34.1 mt-30 -78.98 132.72 36.77 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.496 -1.002 . . . . 0.0 110.285 -179.752 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 92.2 m95 -105.32 106.57 17.13 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 179.407 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -156.82 -178.16 7.15 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.171 -0.955 . . . . 0.0 109.861 -179.727 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.504 HD21 ' CD1' ' A' ' 68' ' ' LEU . 0.6 OUTLIER -103.94 141.42 36.2 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.607 -0.683 . . . . 0.0 109.673 -179.743 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 92.2 mt -134.45 150.63 50.85 Favored 'General case' 0 N--CA 1.496 1.838 0 CA-C-O 121.652 0.739 . . . . 0.0 110.017 -179.816 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 35.7 ttpt -135.21 138.74 43.9 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 179.817 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -166.57 -171.44 1.88 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.157 -0.965 . . . . 0.0 110.396 -179.642 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 21.1 ptmt -121.85 144.73 48.66 Favored 'General case' 0 N--CA 1.496 1.858 0 CA-C-O 121.495 0.664 . . . . 0.0 109.584 -179.682 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 79.9 t -82.76 129.03 38.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.321 -0.862 . . . . 0.0 110.403 -179.284 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 96.7 mt -102.07 -51.52 9.14 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 179.501 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 52.5 tt0 -145.86 144.79 30.44 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.35 -0.844 . . . . 0.0 109.033 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -132.21 132.53 43.2 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.836 -0.54 . . . . 0.0 109.644 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 94.4 m95 -112.16 135.64 52.56 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.676 -0.64 . . . . 0.0 109.324 179.842 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 80.5 tt0 -91.17 136.91 32.76 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.439 -0.788 . . . . 0.0 110.146 -179.399 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ASN . . . . . 0.499 ' ND2' ' O ' ' A' ' 35' ' ' ILE . 20.6 p-10 -102.66 177.11 4.95 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.589 -0.694 . . . . 0.0 109.725 179.895 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.427 ' O ' HG22 ' A' ' 31' ' ' THR . 75.7 m -104.76 -10.99 17.05 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.614 -0.679 . . . . 0.0 109.394 179.873 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 99.5 m-70 -82.54 136.9 34.74 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.138 -0.977 . . . . 0.0 110.316 -179.31 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -70.65 -30.97 67.73 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.545 -0.722 . . . . 0.0 109.967 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 96.5 p -58.12 -34.46 70.25 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.265 -0.897 . . . . 0.0 109.852 -179.033 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.499 ' O ' ' ND2' ' A' ' 30' ' ' ASN . 96.8 mt -121.16 134.02 65.88 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.95 0 O-C-N 121.563 -0.71 . . . . 0.0 109.894 -179.907 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.407 ' O ' ' OD1' ' A' ' 30' ' ' ASN . 33.2 t -85.08 -71.76 0.51 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.653 -0.654 . . . . 0.0 109.802 -179.807 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 46.6 mt-30 -134.01 156.64 47.82 Favored 'General case' 0 N--CA 1.498 1.931 0 CA-C-O 121.794 0.807 . . . . 0.0 110.451 -179.035 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.8 p -139.65 139.85 37.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 179.727 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -167.38 -147.75 5.39 Favored Glycine 0 N--CA 1.49 2.256 0 C-N-CA 119.395 -1.383 . . . . 0.0 110.187 -179.827 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -133.7 152.19 51.82 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.662 -0.904 . . . . 0.0 109.951 -179.545 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 73.6 mt -115.5 131.39 56.95 Favored 'General case' 0 N--CA 1.494 1.745 0 CA-C-O 121.534 0.683 . . . . 0.0 109.291 179.712 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -80.79 160.91 43.62 Favored Glycine 0 N--CA 1.486 2.03 0 N-CA-C 110.613 -0.995 . . . . 0.0 110.613 -179.346 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -174.29 146.01 1.06 Allowed 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 179.508 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -57.36 -15.15 5.7 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.346 -0.846 . . . . 0.0 109.906 -179.603 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 42.1 p -94.69 -7.87 39.45 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.224 -0.923 . . . . 0.0 109.854 -179.709 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 138.77 -157.06 24.56 Favored Glycine 0 N--CA 1.5 2.936 0 N-CA-C 110.527 -1.029 . . . . 0.0 110.527 179.217 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 40.9 pt -124.87 153.83 32.23 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.005 0 O-C-N 121.856 -0.791 . . . . 0.0 109.517 -179.874 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 20.0 tt -147.31 149.5 15.53 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.253 -0.905 . . . . 0.0 109.937 179.667 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 18.9 mmmt -83.28 148.68 27.24 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.748 -0.595 . . . . 0.0 110.175 -179.605 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 16.1 p90 -143.88 153.63 42.53 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.441 -0.787 . . . . 0.0 109.435 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 87.9 m -134.14 135.57 43.24 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 179.711 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 91.9 mt -101.63 126.03 55.61 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.398 -0.814 . . . . 0.0 109.601 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 93.5 m95 -96.14 139.73 31.89 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.524 -0.735 . . . . 0.0 109.529 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 50.9 mtpt -79.33 -11.54 59.93 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.529 -0.732 . . . . 0.0 109.124 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 93.6 m-20 -61.46 -40.94 96.34 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.434 -0.791 . . . . 0.0 109.213 -179.732 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -75.66 -10.95 59.88 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 121.307 -0.871 . . . . 0.0 109.139 179.712 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 55.77 62.4 2.42 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.743 -0.598 . . . . 0.0 109.92 -179.858 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 36.6 mt -105.31 147.6 34.86 Favored Pre-proline 0 N--CA 1.496 1.844 0 O-C-N 121.649 -0.657 . . . . 0.0 109.617 179.797 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -69.98 162.03 43.73 Favored 'Trans proline' 0 N--CA 1.498 1.745 0 C-N-CA 122.911 2.408 . . . . 0.0 113.195 179.708 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 65.6 mt -69.0 143.55 54.34 Favored 'General case' 0 N--CA 1.493 1.69 0 CA-C-O 121.742 0.782 . . . . 0.0 110.388 -179.215 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.599 ' N ' HD12 ' A' ' 61' ' ' LEU . 9.7 mp -92.81 141.68 28.17 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.672 -0.643 . . . . 0.0 110.048 -179.186 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -85.1 152.03 23.7 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.424 -0.797 . . . . 0.0 110.342 -179.644 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 55.4 tt0 -81.98 138.46 34.92 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.616 -0.678 . . . . 0.0 110.822 -179.336 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 79.88 23.6 61.55 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 110.105 -1.198 . . . . 0.0 110.105 178.932 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -126.94 146.59 50.26 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.441 -1.034 . . . . 0.0 110.307 -179.796 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 12.8 p -83.01 146.44 28.75 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 179.745 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 65.4 m-85 -140.36 145.07 36.65 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.438 -0.789 . . . . 0.0 110.007 179.775 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.504 ' CD1' HD21 ' A' ' 19' ' ' ASN . 17.8 tp -105.59 123.1 47.36 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 179.106 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.408 ' O ' ' OD1' ' A' ' 19' ' ' ASN . 67.5 mt -103.81 125.25 50.12 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 179.899 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 82.5 mtp180 -114.53 134.81 54.74 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.69 -0.631 . . . . 0.0 110.054 -179.755 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 31.2 t 60.46 73.72 0.47 Allowed 'General case' 0 N--CA 1.493 1.687 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.791 179.65 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 3.7 m -124.6 159.32 30.93 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.129 0 O-C-N 121.605 -0.684 . . . . 0.0 109.294 178.993 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 13.6 p -121.74 135.09 62.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 -179.807 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 13.4 t -84.74 118.89 32.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.483 -0.761 . . . . 0.0 110.306 -178.966 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -97.22 171.34 26.77 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 179.723 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -111.37 121.3 44.86 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.724 -0.868 . . . . 0.0 109.789 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' TYR . . . . . 0.509 ' CZ ' ' OD1' ' A' ' 78' ' ' ASN . 54.8 t80 -134.16 124.96 26.93 Favored 'General case' 0 N--CA 1.495 1.819 0 CA-C-O 121.393 0.616 . . . . 0.0 109.499 179.578 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' ASN . . . . . 0.509 ' OD1' ' CZ ' ' A' ' 77' ' ' TYR . 6.4 m120 51.56 51.49 16.61 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.648 -0.657 . . . . 0.0 110.574 179.789 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 55.6 2.6 0.07 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.736 -0.602 . . . . 0.0 110.184 179.351 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.487 ' H ' ' C ' ' A' ' 78' ' ' ASN . 18.7 mmm180 -103.88 163.0 12.65 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.378 -0.826 . . . . 0.0 109.704 -179.912 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 69.7 m-85 -95.71 143.51 26.9 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.449 -0.782 . . . . 0.0 109.748 -179.283 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 15.3 pt20 -146.3 159.97 42.64 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.517 -0.739 . . . . 0.0 109.436 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.407 ' O ' HG23 ' A' ' 83' ' ' VAL . 33.2 m -111.44 128.31 68.03 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 179.431 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 33.3 mt-30 -109.42 124.67 51.4 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.563 -0.711 . . . . 0.0 109.474 -179.345 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 10.7 t -97.18 106.78 18.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.385 -0.822 . . . . 0.0 109.611 -179.773 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 13.9 p-10 -152.04 -177.43 6.16 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.466 -0.771 . . . . 0.0 109.985 179.934 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 72.5 tttt 66.76 -133.19 0.15 Allowed 'General case' 0 N--CA 1.492 1.667 0 CA-C-O 121.444 0.64 . . . . 0.0 110.932 179.306 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 90.0 m-20 -88.52 20.65 3.27 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.432 -0.792 . . . . 0.0 109.246 -179.093 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 15.5 m -60.13 147.65 38.82 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.459 -0.776 . . . . 0.0 109.511 -179.73 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 25.5 m -128.78 152.35 48.55 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.618 -0.676 . . . . 0.0 109.747 -179.81 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 93.9 mt -129.1 133.5 65.77 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 179.785 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -126.42 134.28 51.04 Favored 'General case' 0 N--CA 1.497 1.912 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 179.548 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.443 ' C ' HD22 ' A' ' 94' ' ' LEU . 63.7 tttp -79.79 129.26 34.33 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.41 -0.806 . . . . 0.0 109.837 -179.338 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.444 HD22 ' N ' ' A' ' 94' ' ' LEU . 4.1 mm? -100.54 133.18 45.37 Favored 'General case' 0 N--CA 1.493 1.702 0 CA-C-O 121.756 0.789 . . . . 0.0 109.802 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 23.1 t -85.29 10.43 12.56 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 -179.899 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 22.1 tt0 -118.47 90.24 38.58 Favored Pre-proline 0 N--CA 1.497 1.916 0 O-C-N 121.602 -0.686 . . . . 0.0 109.29 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_exo -56.14 146.84 68.51 Favored 'Trans proline' 0 N--CA 1.498 1.739 0 C-N-CA 122.785 2.323 . . . . 0.0 112.19 179.496 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 93.0 mt -100.43 127.97 52.93 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 O-C-N 121.474 -0.766 . . . . 0.0 109.997 -179.41 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -79.31 148.14 32.22 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.632 -0.667 . . . . 0.0 109.784 -179.865 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 2.5 t -98.66 3.2 10.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 179.803 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 88.9 54.67 2.28 Favored Glycine 0 N--CA 1.493 2.491 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 -179.883 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.518 ' N ' HD12 ' A' ' 102' ' ' LEU . 11.0 mp -63.36 -41.31 98.83 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.453 -1.028 . . . . 0.0 108.949 179.878 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 58.2 tt0 68.16 43.97 1.49 Allowed 'General case' 0 N--CA 1.494 1.747 0 CA-C-O 121.35 0.595 . . . . 0.0 109.697 179.859 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 33.0 p80 -83.42 -15.78 48.38 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.29 -0.881 . . . . 0.0 109.1 179.53 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 86.1 t60 -64.81 -40.67 95.6 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.381 -0.824 . . . . 0.0 109.436 179.746 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 59.2 t-80 -130.74 130.04 43.28 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.511 -0.743 . . . . 0.0 109.886 -179.779 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 86.3 t60 -156.36 72.03 0.73 Allowed 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 179.541 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 43.3 t-80 -151.96 139.54 19.67 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.369 -0.832 . . . . 0.0 109.494 -179.909 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 96.3 m-70 . . . . . 0 N--CA 1.491 1.624 0 CA-C-O 118.108 -0.948 . . . . 0.0 109.963 -179.608 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 97.7 mtp . . . . . 0 N--CA 1.49 1.541 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 24.4 mm-40 -57.41 150.82 41.87 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.855 -0.528 . . . . 0.0 110.208 -179.535 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.571 ' HB2' HD21 ' A' ' 19' ' ' ASN . 28.9 Cg_endo -64.84 150.82 87.57 Favored 'Trans proline' 0 N--CA 1.49 1.304 0 C-N-CA 122.419 2.08 . . . . 0.0 112.714 -179.934 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.42 ' HG2' ' H ' ' A' ' 4' ' ' GLN . 7.8 pt20 -73.29 89.41 1.57 Allowed 'General case' 0 C--N 1.302 -1.487 0 CA-C-O 121.534 0.683 . . . . 0.0 110.223 -179.326 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 79.6 mt -79.33 139.78 37.71 Favored 'General case' 0 N--CA 1.488 1.474 0 CA-C-O 121.543 0.687 . . . . 0.0 109.734 179.7 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 69.5 m -127.16 130.91 50.66 Favored 'General case' 0 N--CA 1.496 1.854 0 CA-C-O 121.609 0.719 . . . . 0.0 109.666 179.667 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 63.7 mttp -84.23 156.95 21.77 Favored 'General case' 0 N--CA 1.49 1.568 0 CA-C-O 121.785 0.802 . . . . 0.0 109.688 179.914 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 95.6 mt -63.0 -42.58 97.23 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.557 0 CA-C-O 121.28 0.562 . . . . 0.0 109.518 -179.215 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 14.7 p -65.54 -24.04 33.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.605 -0.684 . . . . 0.0 109.559 -179.178 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 -77.03 -7.11 55.09 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.441 -0.787 . . . . 0.0 108.89 -179.455 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 98.6 mt -93.18 116.04 33.39 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 CA-C-O 121.662 0.744 . . . . 0.0 109.719 179.708 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 25.6 m -151.23 14.54 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 179.34 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -137.44 137.17 38.48 Favored 'General case' 0 N--CA 1.494 1.771 0 CA-C-O 121.762 0.792 . . . . 0.0 109.376 179.417 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 45.6 t30 -74.32 147.59 42.13 Favored 'General case' 0 C--N 1.301 -1.529 0 CA-C-O 121.696 0.76 . . . . 0.0 109.99 -179.622 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 71.58 99.51 0.06 OUTLIER Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 179.92 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 27.5 tt0 -165.17 126.98 2.08 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.732 -0.863 . . . . 0.0 110.098 179.443 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 95.2 m95 -96.6 128.71 43.79 Favored 'General case' 0 N--CA 1.494 1.753 0 CA-C-O 121.477 0.656 . . . . 0.0 109.465 179.926 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.441 ' O ' HG22 ' A' ' 72' ' ' VAL . . . -174.88 177.08 2.07 Favored 'General case' 0 N--CA 1.493 1.717 0 CA-C-O 121.878 0.846 . . . . 0.0 110.419 179.818 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.571 HD21 ' HB2' ' A' ' 3' ' ' PRO . 68.7 m-20 -99.24 148.91 23.64 Favored 'General case' 0 N--CA 1.495 1.776 0 CA-C-O 121.728 0.775 . . . . 0.0 109.445 -179.712 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 54.5 tp -139.57 135.94 33.9 Favored 'General case' 0 N--CA 1.487 1.418 0 CA-C-O 121.962 0.887 . . . . 0.0 110.244 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 37.3 ttmt -122.36 132.65 54.49 Favored 'General case' 0 N--CA 1.49 1.566 0 CA-C-O 121.773 0.797 . . . . 0.0 109.121 179.148 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -160.95 178.04 9.78 Favored 'General case' 0 C--N 1.3 -1.555 0 CA-C-O 121.658 0.742 . . . . 0.0 109.808 -179.866 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 63.7 tttp -114.55 145.55 41.81 Favored 'General case' 0 N--CA 1.496 1.839 0 CA-C-O 121.775 0.797 . . . . 0.0 110.332 -178.958 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 89.5 t -83.54 108.14 15.77 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 CA-C-O 121.684 0.754 . . . . 0.0 110.34 -179.501 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.412 HG12 ' H ' ' A' ' 42' ' ' GLY . 34.3 mm -94.24 -47.37 13.43 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 179.915 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 60.3 tt0 -148.41 140.55 24.06 Favored 'General case' 0 N--CA 1.494 1.774 0 CA-C-O 122.135 0.969 . . . . 0.0 109.968 -179.758 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.483 ' N ' HD23 ' A' ' 27' ' ' LEU . 0.3 OUTLIER -136.57 145.51 45.06 Favored 'General case' 0 N--CA 1.491 1.577 0 CA-C-O 121.956 0.884 . . . . 0.0 110.164 -179.335 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 5.7 m-90 -114.13 141.77 47.08 Favored 'General case' 0 N--CA 1.492 1.653 0 CA-C-O 121.648 0.737 . . . . 0.0 109.261 179.041 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.456 ' O ' ' O ' ' A' ' 30' ' ' ASN . 80.9 tt0 -80.44 119.42 23.11 Favored 'General case' 0 C--N 1.303 -1.42 0 CA-C-O 121.602 0.715 . . . . 0.0 109.795 -179.436 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' ASN . . . . . 0.483 ' ND2' ' O ' ' A' ' 35' ' ' ILE . 16.9 t-20 47.06 -178.5 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.512 0 CA-C-O 121.683 0.754 . . . . 0.0 110.305 179.594 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.481 ' H ' ' CG ' ' A' ' 30' ' ' ASN . 17.9 m -171.2 -41.95 0.02 OUTLIER 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 179.859 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 85.2 t60 -115.94 -83.09 0.63 Allowed 'General case' 0 N--CA 1.499 2.012 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 179.707 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 11.4 tm-20 -165.86 -56.54 0.03 OUTLIER 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.491 -0.755 . . . . 0.0 109.379 179.52 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 12.8 m -79.78 -6.44 57.3 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 109.009 -0.738 . . . . 0.0 109.009 -179.42 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.483 ' O ' ' ND2' ' A' ' 30' ' ' ASN . 96.7 mt -93.17 119.07 40.29 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 CA-C-O 121.839 0.828 . . . . 0.0 109.507 179.794 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 3.6 t -71.3 -56.01 6.88 Favored 'General case' 0 C--N 1.3 -1.546 0 CA-C-O 121.428 0.633 . . . . 0.0 109.525 179.761 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 83.7 mt-30 -147.63 147.6 30.19 Favored 'General case' 0 N--CA 1.49 1.539 0 CA-C-O 121.925 0.869 . . . . 0.0 110.456 -179.286 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.9 p -142.77 142.47 26.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 CA-C-O 121.613 0.72 . . . . 0.0 109.349 179.589 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -171.99 -155.26 10.82 Favored Glycine 0 N--CA 1.491 2.308 0 C-N-CA 119.952 -1.118 . . . . 0.0 110.562 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -132.9 147.52 52.29 Favored 'General case' 0 N--CA 1.494 1.745 0 CA-C-O 121.895 0.855 . . . . 0.0 110.269 -179.463 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 41.1 mt -116.88 130.72 56.89 Favored 'General case' 0 N--CA 1.496 1.83 0 CA-C-O 121.743 0.782 . . . . 0.0 109.407 -179.258 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.412 ' H ' HG12 ' A' ' 25' ' ' ILE . . . -83.15 161.38 39.45 Favored Glycine 0 N--CA 1.495 2.609 0 N-CA-C 111.227 -0.749 . . . . 0.0 111.227 -179.146 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.557 ' OD1' ' N ' ' A' ' 44' ' ' GLU . 62.1 t0 -174.13 150.29 1.54 Allowed 'General case' 0 N--CA 1.493 1.722 0 CA-C-O 122.095 0.95 . . . . 0.0 110.031 179.643 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.557 ' N ' ' OD1' ' A' ' 43' ' ' ASP . 98.0 mt-10 -59.44 -17.67 32.93 Favored 'General case' 0 N--CA 1.491 1.601 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.139 179.979 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 41.6 p -92.25 -11.17 36.02 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 -179.688 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 139.95 -159.87 26.1 Favored Glycine 0 N--CA 1.498 2.77 0 C-N-CA 120.246 -0.978 . . . . 0.0 111.123 178.934 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 96.4 mt -125.21 132.86 70.64 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 CA-C-O 121.773 0.797 . . . . 0.0 109.993 -179.23 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 18.0 tt -131.17 148.43 32.91 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 CA-C-O 121.934 0.873 . . . . 0.0 110.421 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 54.7 mtpt -92.91 151.04 20.18 Favored 'General case' 0 N--CA 1.494 1.741 0 CA-C-O 121.713 0.768 . . . . 0.0 110.16 -179.841 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 5.8 p90 -142.84 152.99 42.75 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-O 122.003 0.906 . . . . 0.0 109.975 179.871 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 84.9 m -130.2 130.98 45.36 Favored 'General case' 0 N--CA 1.493 1.692 0 CA-C-O 121.864 0.84 . . . . 0.0 109.203 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 95.7 mt -100.26 121.93 51.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 CA-C-O 121.791 0.805 . . . . 0.0 110.049 -179.496 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 96.1 m95 -98.0 133.57 42.29 Favored 'General case' 0 N--CA 1.495 1.799 0 CA-C-O 121.551 0.691 . . . . 0.0 109.349 179.782 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 16.4 ptpt -89.25 53.35 2.62 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.759 -0.588 . . . . 0.0 109.83 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 99.3 m-20 -77.77 -1.89 33.62 Favored 'General case' 0 N--CA 1.496 1.856 0 CA-C-O 121.373 0.606 . . . . 0.0 109.401 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -154.63 -88.6 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.415 -0.803 . . . . 0.0 109.273 179.755 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 178.95 77.9 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.739 0 CA-C-O 121.582 0.706 . . . . 0.0 109.892 -179.798 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 11.4 mt -89.73 148.16 39.31 Favored Pre-proline 0 N--CA 1.491 1.593 0 N-CA-C 108.633 -0.876 . . . . 0.0 108.633 179.16 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -68.86 153.46 72.76 Favored 'Trans proline' 0 C--N 1.312 -1.358 0 C-N-CA 122.403 2.069 . . . . 0.0 112.646 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 71.4 mt -72.75 142.95 48.14 Favored 'General case' 0 C--N 1.301 -1.525 0 CA-C-O 121.678 0.752 . . . . 0.0 109.968 -179.754 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.542 ' N ' HD12 ' A' ' 61' ' ' LEU . 10.5 mp -87.84 135.49 33.37 Favored 'General case' 0 N--CA 1.49 1.554 0 CA-C-O 121.715 0.769 . . . . 0.0 109.707 -179.805 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 46.1 tp10 -93.78 144.85 25.05 Favored 'General case' 0 N--CA 1.49 1.558 0 CA-C-O 121.89 0.852 . . . . 0.0 109.685 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 57.5 tt0 -79.15 143.74 35.16 Favored 'General case' 0 C--N 1.299 -1.597 0 CA-C-O 121.677 0.751 . . . . 0.0 110.318 -179.614 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 82.08 23.8 56.4 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 110.036 -1.226 . . . . 0.0 110.036 179.054 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.513 ' OE1' ' NZ ' ' A' ' 93' ' ' LYS . 95.8 mt-10 -136.55 144.91 44.48 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.384 -1.068 . . . . 0.0 110.109 179.672 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 12.2 p -89.23 145.69 25.24 Favored 'General case' 0 N--CA 1.489 1.496 0 CA-C-O 121.702 0.763 . . . . 0.0 110.223 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -137.71 152.61 49.42 Favored 'General case' 0 N--CA 1.494 1.734 0 CA-C-O 122.122 0.963 . . . . 0.0 110.323 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 32.3 tp -111.1 121.55 45.62 Favored 'General case' 0 N--CA 1.494 1.733 0 CA-C-N 115.488 -0.778 . . . . 0.0 109.64 179.864 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 74.0 mt -102.15 133.1 47.55 Favored 'General case' 0 N--CA 1.494 1.728 0 CA-C-O 121.726 0.774 . . . . 0.0 109.373 179.538 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 86.8 mtm180 -129.61 147.35 51.4 Favored 'General case' 0 N--CA 1.495 1.819 0 CA-C-O 121.924 0.869 . . . . 0.0 110.51 -179.287 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.7 m 56.46 55.34 6.61 Favored 'General case' 0 N--CA 1.494 1.729 0 CA-C-N 115.606 -0.725 . . . . 0.0 110.415 179.354 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.441 HG22 ' O ' ' A' ' 18' ' ' ALA . 12.5 m -111.12 158.19 11.71 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 CA-C-O 121.626 0.727 . . . . 0.0 109.972 179.369 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 13.5 p -116.7 134.88 58.82 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 CA-C-O 121.828 0.823 . . . . 0.0 109.677 -179.631 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 11.7 t -86.27 115.48 27.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 CA-C-O 121.862 0.839 . . . . 0.0 109.88 -179.433 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -100.96 175.25 26.1 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 110.074 -1.21 . . . . 0.0 110.074 -179.776 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 48.0 tp10 -111.51 121.39 45.05 Favored 'General case' 0 N--CA 1.493 1.699 0 CA-C-O 121.829 0.824 . . . . 0.0 109.673 -179.906 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 87.3 t80 -136.58 125.37 24.01 Favored 'General case' 0 N--CA 1.492 1.655 0 CA-C-O 121.865 0.84 . . . . 0.0 110.14 179.834 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' ASN . . . . . 0.488 ' C ' ' H ' ' A' ' 80' ' ' ARG . 10.7 t-20 56.27 43.33 26.65 Favored 'General case' 0 N--CA 1.488 1.46 0 CA-C-N 116.081 -0.509 . . . . 0.0 109.781 179.193 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 48.2 t0 62.64 -1.36 0.45 Allowed 'General case' 0 N--CA 1.493 1.725 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 179.641 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.488 ' H ' ' C ' ' A' ' 78' ' ' ASN . 83.2 mtp180 -100.09 178.23 4.85 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.606 -0.684 . . . . 0.0 109.986 179.868 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 78.3 m-85 -112.94 138.15 50.24 Favored 'General case' 0 N--CA 1.498 1.953 0 CA-C-O 122.086 0.946 . . . . 0.0 110.062 -179.303 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -147.09 163.0 37.68 Favored 'General case' 0 N--CA 1.489 1.52 0 CA-C-O 121.829 0.823 . . . . 0.0 110.292 179.936 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 2.5 m -106.24 131.65 55.38 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 -179.938 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 86.7 mt-30 -104.91 122.6 46.15 Favored 'General case' 0 N--CA 1.495 1.807 0 CA-C-O 122.107 0.956 . . . . 0.0 110.364 -179.172 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 18.2 t -93.93 129.73 43.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 CA-C-O 121.947 0.879 . . . . 0.0 109.765 -179.875 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 81.7 m-20 -134.82 -174.74 3.68 Favored 'General case' 0 N--CA 1.493 1.702 0 CA-C-O 121.452 0.644 . . . . 0.0 109.309 179.79 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 24.8 pttm -58.88 -34.75 72.0 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.858 -0.526 . . . . 0.0 109.924 -179.296 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 38.7 t30 -64.11 -38.07 89.74 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 10.0 m -72.76 156.33 39.04 Favored 'General case' 0 N--CA 1.492 1.675 0 CA-C-O 121.709 0.766 . . . . 0.0 110.73 -179.153 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 88.2 p -129.52 151.36 50.22 Favored 'General case' 0 N--CA 1.493 1.717 0 CA-C-O 121.692 0.758 . . . . 0.0 109.759 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 94.8 mt -124.65 132.79 70.85 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 CA-C-O 121.572 0.701 . . . . 0.0 109.572 -179.508 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 81.6 tt0 -130.13 134.37 47.29 Favored 'General case' 0 N--CA 1.497 1.881 0 CA-C-O 121.996 0.903 . . . . 0.0 109.838 179.621 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.513 ' NZ ' ' OE1' ' A' ' 65' ' ' GLU . 64.1 tttp -79.95 134.45 36.26 Favored 'General case' 0 N--CA 1.489 1.478 0 CA-C-O 121.748 0.785 . . . . 0.0 110.117 179.933 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 73.6 mt -100.88 133.76 44.87 Favored 'General case' 0 N--CA 1.492 1.67 0 CA-C-O 121.689 0.757 . . . . 0.0 109.726 179.626 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 88.8 p -78.74 -5.52 53.43 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 -179.604 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 21.5 tp10 -111.82 121.03 40.81 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.794 -0.567 . . . . 0.0 109.894 -179.751 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -74.29 154.25 46.03 Favored 'Trans proline' 0 N--CA 1.488 1.202 0 C-N-CA 122.511 2.141 . . . . 0.0 112.065 179.63 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 96.7 mt -109.28 128.27 65.36 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 CA-C-O 121.915 0.864 . . . . 0.0 110.364 -179.603 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -86.26 136.12 33.29 Favored 'General case' 0 N--CA 1.495 1.82 0 CA-C-O 121.741 0.781 . . . . 0.0 110.388 -179.26 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 18.3 m -108.01 -4.66 10.44 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 N-CA-C 109.055 -0.721 . . . . 0.0 109.055 179.918 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 141.41 42.7 0.07 OUTLIER Glycine 0 N--CA 1.499 2.859 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 179.299 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.578 ' N ' HD12 ' A' ' 102' ' ' LEU . 10.2 mp -87.78 -6.7 58.04 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.647 -0.913 . . . . 0.0 108.657 179.684 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -66.62 176.94 1.73 Allowed 'General case' 0 N--CA 1.489 1.513 0 CA-C-O 121.709 0.766 . . . . 0.0 110.374 -179.892 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' HIS . . . . . 0.448 ' O ' ' CG ' ' A' ' 105' ' ' HIS . 33.8 p-80 -57.22 -42.9 82.21 Favored 'General case' 0 N--CA 1.49 1.574 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.736 -179.473 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 105' ' ' HIS . . . . . 0.448 ' CG ' ' O ' ' A' ' 104' ' ' HIS . 55.9 m80 -156.8 117.62 3.67 Favored 'General case' 0 N--CA 1.493 1.699 0 CA-C-O 121.771 0.796 . . . . 0.0 110.001 179.605 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 86.6 t60 -92.08 -6.69 50.47 Favored 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 179.742 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 84.7 t60 -62.09 -42.38 99.16 Favored 'General case' 0 N--CA 1.492 1.652 0 CA-C-O 121.44 0.638 . . . . 0.0 109.573 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 58.0 t-80 -77.87 128.81 34.54 Favored 'General case' 0 C--N 1.303 -1.424 0 CA-C-O 121.7 0.762 . . . . 0.0 110.285 -179.177 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 56.0 p-80 . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 117.977 -1.011 . . . . 0.0 109.539 179.542 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 49.7 ttp . . . . . 0 N--CA 1.49 1.573 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.504 ' N ' ' CD ' ' A' ' 3' ' ' PRO . 28.3 tt0 -161.61 51.38 0.34 Allowed Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.355 -0.84 . . . . 0.0 109.169 179.446 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.504 ' CD ' ' N ' ' A' ' 2' ' ' GLU . 34.2 Cg_endo -62.83 143.52 91.86 Favored 'Trans proline' 0 N--CA 1.497 1.703 0 C-N-CA 122.891 2.394 . . . . 0.0 112.312 -179.938 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.401 ' N ' ' CD ' ' A' ' 4' ' ' GLN . 28.2 mp0 -84.49 89.41 7.42 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.057 -1.027 . . . . 0.0 109.664 -179.581 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -73.73 142.02 46.33 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.456 -0.777 . . . . 0.0 109.351 179.616 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 98.4 m -122.77 129.2 51.46 Favored 'General case' 0 N--CA 1.498 1.962 0 CA-C-O 121.666 0.746 . . . . 0.0 109.812 -179.7 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -85.42 159.36 19.99 Favored 'General case' 0 N--CA 1.491 1.618 0 CA-C-O 121.609 0.719 . . . . 0.0 110.051 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 33.0 mm -63.85 -43.38 97.82 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 O-C-N 121.275 -0.89 . . . . 0.0 109.198 179.893 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 12.6 p -65.02 -22.53 31.6 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 O-C-N 121.47 -0.769 . . . . 0.0 109.529 -179.692 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -74.79 -7.03 52.15 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.092 -1.005 . . . . 0.0 109.257 179.45 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 96.7 mt -83.11 120.83 35.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.232 -0.917 . . . . 0.0 109.4 179.886 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 15.8 m -134.93 -28.04 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 O-C-N 121.346 -0.846 . . . . 0.0 109.721 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -135.05 152.39 51.65 Favored 'General case' 0 N--CA 1.501 2.113 0 O-C-N 121.188 -0.945 . . . . 0.0 110.372 -179.424 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 57.4 p30 -79.12 166.0 22.73 Favored 'General case' 0 N--CA 1.491 1.618 0 CA-C-O 121.6 0.714 . . . . 0.0 110.652 -179.201 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 71.02 92.91 0.08 OUTLIER Glycine 0 N--CA 1.491 2.303 0 N-CA-C 110.294 -1.122 . . . . 0.0 110.294 179.476 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 20.5 tt0 -168.89 130.9 1.25 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.408 -1.054 . . . . 0.0 109.183 179.279 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 91.9 m95 -95.65 133.56 39.58 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.404 -0.81 . . . . 0.0 109.774 -179.686 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.461 ' O ' HG22 ' A' ' 72' ' ' VAL . . . -175.09 176.58 2.08 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.193 -0.942 . . . . 0.0 109.741 179.509 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 94.6 m-20 -103.91 145.01 30.75 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.438 -0.789 . . . . 0.0 109.072 179.888 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 5.6 tt -142.04 133.61 26.77 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.278 -0.889 . . . . 0.0 109.924 -179.818 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 3.5 ttmp? -117.01 141.85 47.72 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 179.558 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.464 ' CB ' ' OD1' ' A' ' 43' ' ' ASP . . . -164.2 -177.18 4.83 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.887 -1.133 . . . . 0.0 110.352 -179.648 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -112.05 137.63 49.82 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.633 -0.667 . . . . 0.0 109.487 -179.913 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 71.2 t -83.54 96.64 4.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.295 -0.878 . . . . 0.0 110.197 -179.572 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 96.7 mt -65.53 -45.32 92.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.418 -0.801 . . . . 0.0 109.433 179.744 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.525 ' NE2' ' CZ2' ' A' ' 28' ' ' TRP . 14.6 pt20 -170.61 148.4 3.03 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.397 -0.814 . . . . 0.0 109.737 -179.875 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.546 ' O ' HD12 ' A' ' 27' ' ' LEU . 0.3 OUTLIER -143.65 137.15 28.05 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.566 -0.709 . . . . 0.0 109.274 179.589 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 28' ' ' TRP . . . . . 0.525 ' CZ2' ' NE2' ' A' ' 26' ' ' GLN . 5.6 m0 -117.69 146.06 43.99 Favored 'General case' 0 N--CA 1.498 1.936 0 CA-C-O 121.717 0.77 . . . . 0.0 109.672 -179.709 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.695 ' H ' ' CD ' ' A' ' 29' ' ' GLU . 1.5 pm0 -63.46 144.59 56.85 Favored 'General case' 0 N--CA 1.491 1.579 0 CA-C-O 121.617 0.722 . . . . 0.0 110.568 -179.25 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' ASN . . . . . 0.528 ' ND2' ' O ' ' A' ' 36' ' ' SER . 0.0 OUTLIER -90.45 178.03 6.22 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.42 -0.8 . . . . 0.0 110.058 -179.698 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 81.4 p -114.61 7.81 16.14 Favored 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 179.413 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 59.9 m80 -106.25 137.54 44.02 Favored 'General case' 0 N--CA 1.502 2.13 0 O-C-N 121.436 -0.79 . . . . 0.0 109.809 -179.81 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 50.1 tp10 -66.93 -38.34 85.99 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.427 -0.796 . . . . 0.0 109.792 -179.599 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 11.0 t -61.88 -41.69 98.17 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.307 -0.871 . . . . 0.0 110.232 -179.536 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.513 ' O ' ' ND2' ' A' ' 30' ' ' ASN . 90.6 mt -98.6 133.69 40.09 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 O-C-N 121.299 -0.876 . . . . 0.0 110.173 -178.906 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.528 ' O ' ' ND2' ' A' ' 30' ' ' ASN . 25.0 m -81.47 -70.8 0.51 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.578 -0.701 . . . . 0.0 110.112 -179.664 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 34.4 mt-30 -132.55 155.5 48.52 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.393 -0.817 . . . . 0.0 109.62 -179.02 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 9.4 p -137.1 141.03 41.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 -179.805 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -165.79 -158.5 10.85 Favored Glycine 0 N--CA 1.491 2.328 0 C-N-CA 119.422 -1.371 . . . . 0.0 110.177 -179.085 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.732 ' O ' HD12 ' A' ' 40' ' ' LEU . 0.8 OUTLIER -135.65 151.94 50.72 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.573 -0.957 . . . . 0.0 109.761 179.826 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 52.5 mt -114.88 139.76 49.52 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.453 -0.779 . . . . 0.0 109.235 -179.0 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -94.37 127.65 9.17 Favored Glycine 0 N--CA 1.493 2.498 0 N-CA-C 110.359 -1.097 . . . . 0.0 110.359 -179.63 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.464 ' OD1' ' CB ' ' A' ' 22' ' ' ALA . 73.0 m-20 -128.6 142.32 51.08 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.795 -0.827 . . . . 0.0 108.872 179.005 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -56.76 -14.99 3.83 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.411 -0.805 . . . . 0.0 109.52 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 16.5 p -99.3 -8.47 24.89 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.316 -0.865 . . . . 0.0 109.775 -179.763 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 153.95 -167.14 32.16 Favored Glycine 0 N--CA 1.498 2.821 0 C-N-CA 119.733 -1.222 . . . . 0.0 110.257 179.292 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 96.6 mt -125.61 134.7 66.05 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.081 0 O-C-N 121.586 -0.949 . . . . 0.0 108.656 179.895 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 20.6 tt -131.42 144.71 36.78 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.231 0 O-C-N 121.168 -0.958 . . . . 0.0 110.463 -179.566 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 52.8 mtmt -84.34 157.19 21.56 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.727 -0.608 . . . . 0.0 110.42 -179.633 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 16.2 p90 -152.1 164.26 37.63 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.317 -0.864 . . . . 0.0 109.666 179.627 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.418 HG22 HE21 ' A' ' 82' ' ' GLN . 2.7 t -139.1 148.85 43.83 Favored 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 179.578 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 39.2 mm -106.41 126.36 62.12 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 O-C-N 121.472 -0.768 . . . . 0.0 109.562 -179.459 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 77.8 m95 -98.36 147.38 24.74 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.486 -0.759 . . . . 0.0 109.799 -179.72 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 64.7 mttp -78.83 -13.13 59.98 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.449 -0.782 . . . . 0.0 109.255 179.755 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 -61.51 -42.27 98.56 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.471 -0.768 . . . . 0.0 110.339 -179.22 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -76.01 -12.36 60.12 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.145 -0.972 . . . . 0.0 109.634 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 50.47 62.69 2.56 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.515 -0.741 . . . . 0.0 109.903 -179.882 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 14.2 mt -106.66 150.58 39.81 Favored Pre-proline 0 N--CA 1.499 1.975 0 O-C-N 121.59 -0.694 . . . . 0.0 109.749 -179.784 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -70.13 165.28 31.91 Favored 'Trans proline' 0 N--CA 1.502 1.99 0 C-N-CA 123.095 2.53 . . . . 0.0 113.918 -179.102 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 66.6 mt -65.56 141.08 58.57 Favored 'General case' 0 N--CA 1.494 1.761 0 CA-C-O 121.905 0.86 . . . . 0.0 110.88 -178.995 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.597 ' N ' HD12 ' A' ' 61' ' ' LEU . 9.1 mp -87.39 145.9 26.11 Favored 'General case' 0 N--CA 1.492 1.654 0 CA-C-O 121.344 0.593 . . . . 0.0 110.037 -179.523 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.443 ' N ' ' OH ' ' A' ' 67' ' ' TYR . 83.7 tt0 -98.63 126.69 44.3 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.399 -0.813 . . . . 0.0 109.126 179.461 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.447 ' CD ' ' N ' ' A' ' 64' ' ' GLY . 1.0 OUTLIER -69.19 140.34 54.61 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.508 -0.745 . . . . 0.0 111.231 -178.822 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.447 ' N ' ' CD ' ' A' ' 63' ' ' GLN . . . 91.78 20.06 38.33 Favored Glycine 0 N--CA 1.495 2.581 0 N-CA-C 110.541 -1.024 . . . . 0.0 110.541 178.812 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.488 ' OE1' ' N ' ' A' ' 65' ' ' GLU . 58.8 mp0 -139.0 155.58 47.88 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.158 -1.201 . . . . 0.0 110.47 179.911 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 13.5 p -80.72 156.44 26.26 Favored 'General case' 0 N--CA 1.49 1.527 0 CA-C-O 121.552 0.691 . . . . 0.0 110.534 -179.418 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.443 ' OH ' ' N ' ' A' ' 62' ' ' GLU . 88.4 m-85 -145.78 144.27 30.2 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.48 -0.763 . . . . 0.0 109.645 179.674 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 13.7 tp -111.86 117.93 34.13 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 179.219 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 4.6 mp -103.45 126.66 50.73 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.467 -0.771 . . . . 0.0 109.054 -179.553 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 90.3 mtm-85 -115.57 140.85 48.79 Favored 'General case' 0 N--CA 1.497 1.909 0 CA-C-O 121.645 0.736 . . . . 0.0 110.421 -178.982 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.4 ' OG ' ' O ' ' A' ' 71' ' ' SER . 22.2 p 59.77 66.69 0.96 Allowed 'General case' 0 N--CA 1.494 1.744 0 CA-C-O 121.121 0.486 . . . . 0.0 110.703 179.67 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.461 HG22 ' O ' ' A' ' 18' ' ' ALA . 16.5 m -116.26 160.79 15.45 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.134 0 O-C-N 121.537 -0.727 . . . . 0.0 109.252 178.841 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 7.4 p -117.72 133.16 65.37 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 CA-C-O 121.382 0.611 . . . . 0.0 109.423 -179.563 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 13.5 t -88.06 110.29 20.77 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.278 -0.889 . . . . 0.0 109.669 -179.427 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -88.29 172.15 41.14 Favored Glycine 0 N--CA 1.493 2.49 0 N-CA-C 109.887 -1.285 . . . . 0.0 109.887 -179.602 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -100.45 119.68 38.84 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.566 -0.961 . . . . 0.0 109.15 179.928 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 40.7 t80 -115.17 104.36 11.77 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.539 -0.726 . . . . 0.0 109.774 -179.68 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 41.45 -117.15 0.34 Allowed 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.582 -0.698 . . . . 0.0 111.204 179.471 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.418 ' N ' ' OD1' ' A' ' 79' ' ' ASP . 37.5 p-10 -94.53 -7.67 40.52 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.329 -0.857 . . . . 0.0 110.234 -178.794 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 95.4 mtt180 -112.18 177.46 4.63 Favored 'General case' 0 N--CA 1.501 2.091 0 O-C-N 121.417 -0.802 . . . . 0.0 110.015 -179.925 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 72.9 m-85 -109.54 148.64 30.9 Favored 'General case' 0 N--CA 1.497 1.905 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 -179.693 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' GLN . . . . . 0.418 HE21 HG22 ' A' ' 51' ' ' THR . 53.3 tt0 -137.88 154.01 49.5 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.306 -0.871 . . . . 0.0 109.751 -179.81 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 33.5 m -113.32 132.86 60.99 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 179.729 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 79.0 mt-30 -106.76 127.48 53.43 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.572 -0.705 . . . . 0.0 109.992 -178.883 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 16.8 t -94.8 98.14 7.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.474 -0.766 . . . . 0.0 109.093 179.753 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 31.4 p30 -151.18 177.7 9.95 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.412 -0.805 . . . . 0.0 109.767 -179.759 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.516 ' C ' ' H ' ' A' ' 89' ' ' SER . 71.2 mmtt 61.19 -141.27 0.5 Allowed 'General case' 0 N--CA 1.493 1.712 0 CA-C-O 121.639 0.733 . . . . 0.0 110.772 179.169 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 32.3 t30 -66.46 9.52 0.16 Allowed 'General case' 0 C--N 1.304 -1.405 0 CA-C-O 121.334 0.588 . . . . 0.0 109.658 -179.446 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.516 ' H ' ' C ' ' A' ' 87' ' ' LYS . 13.3 p -58.18 143.61 43.54 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.249 -0.907 . . . . 0.0 109.671 -179.882 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 19.2 p -141.26 156.4 45.89 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.482 -0.761 . . . . 0.0 109.655 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 96.5 mt -132.58 134.53 58.68 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 121.556 -0.715 . . . . 0.0 109.445 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -126.48 136.83 53.12 Favored 'General case' 0 N--CA 1.499 2.013 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 179.516 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.432 ' C ' HD12 ' A' ' 94' ' ' LEU . 88.4 tttt -80.13 128.91 34.07 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.397 -0.815 . . . . 0.0 109.678 -179.795 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.432 HD12 ' C ' ' A' ' 93' ' ' LYS . 10.1 mp -105.23 134.59 48.08 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.451 -0.781 . . . . 0.0 109.636 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 96.6 p -88.6 8.51 28.0 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 108.774 -0.825 . . . . 0.0 108.774 179.521 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 67.0 mt-10 -117.55 90.38 35.1 Favored Pre-proline 0 N--CA 1.498 1.951 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 -179.775 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_exo -55.7 147.52 59.89 Favored 'Trans proline' 0 N--CA 1.497 1.705 0 C-N-CA 122.741 2.294 . . . . 0.0 112.658 179.618 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.586 ' O ' HG22 ' A' ' 98' ' ' ILE . 97.1 mt -84.23 0.67 4.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 CA-C-O 121.709 0.766 . . . . 0.0 109.67 -179.675 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 45.06 87.47 0.02 OUTLIER 'General case' 0 C--N 1.293 -1.865 0 CA-C-O 121.401 0.619 . . . . 0.0 109.659 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 33.6 m -99.94 42.79 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 O-C-N 121.422 -0.799 . . . . 0.0 109.352 -179.84 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 155.87 -16.22 0.45 Allowed Glycine 0 N--CA 1.494 2.537 0 N-CA-C 109.055 -1.618 . . . . 0.0 109.055 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.531 ' N ' HD12 ' A' ' 102' ' ' LEU . 10.9 mp -83.28 1.84 38.97 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.395 -1.062 . . . . 0.0 108.755 179.779 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -72.91 -4.29 31.07 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.41 -0.806 . . . . 0.0 109.052 179.535 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 71.8 t60 -66.05 -41.29 91.01 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.472 -0.767 . . . . 0.0 109.984 -179.801 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 77.0 m80 -94.59 103.48 15.43 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.098 -1.001 . . . . 0.0 109.826 -179.585 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 45.4 p-80 -157.58 -2.52 0.1 Allowed 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 179.478 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 95.6 m-70 -67.19 -39.83 86.42 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.516 -0.74 . . . . 0.0 109.455 179.751 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 77.4 m80 -78.34 132.65 37.5 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.361 -0.837 . . . . 0.0 110.084 -179.336 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 39.3 p-80 . . . . . 0 N--CA 1.491 1.622 0 CA-C-O 118.082 -0.961 . . . . 0.0 109.205 179.748 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 67.0 mtt . . . . . 0 N--CA 1.491 1.595 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 52.5 mm-40 -138.27 60.41 21.74 Favored Pre-proline 0 N--CA 1.498 1.943 0 O-C-N 121.471 -0.768 . . . . 0.0 109.82 -179.578 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -68.88 136.59 35.8 Favored 'Trans proline' 0 C--N 1.308 -1.554 0 C-N-CA 122.056 1.838 . . . . 0.0 111.765 -179.742 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -87.89 87.95 7.51 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.806 -1.184 . . . . 0.0 109.201 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.459 ' N ' HD22 ' A' ' 5' ' ' LEU . 4.0 mm? -69.31 136.16 51.43 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.502 -0.748 . . . . 0.0 109.583 -179.913 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 96.7 m -124.58 128.59 49.14 Favored 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -84.28 156.94 21.71 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.513 -0.742 . . . . 0.0 110.135 -179.424 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 65.4 mt -62.53 -44.36 99.25 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 121.446 -0.784 . . . . 0.0 109.681 179.907 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 14.0 p -64.66 -23.53 33.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.28 -0.888 . . . . 0.0 109.527 -179.875 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -79.7 -4.04 50.05 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.127 -0.983 . . . . 0.0 109.513 179.693 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 97.1 mt -80.24 103.99 7.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.097 -1.002 . . . . 0.0 109.825 -179.609 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 28.0 m -122.15 -9.39 8.85 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 179.4 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 18.9 pt-20 -136.39 137.7 40.8 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.5 -0.75 . . . . 0.0 109.598 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 30.5 p30 -95.34 162.83 13.51 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.322 -0.861 . . . . 0.0 110.731 -179.238 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 79.5 2.8 88.34 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.738 -1.345 . . . . 0.0 109.738 179.764 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 21.1 pt20 -80.47 144.38 32.62 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.248 -1.148 . . . . 0.0 110.095 -179.671 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 87.9 m95 -97.94 137.27 37.02 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.515 -0.741 . . . . 0.0 109.526 179.796 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -177.0 -179.61 0.93 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.078 -1.014 . . . . 0.0 109.78 179.608 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -105.75 146.28 30.03 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 6.1 tt -143.64 134.3 25.04 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.141 -0.974 . . . . 0.0 109.719 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 34.3 ttpt -116.66 139.7 50.24 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.571 -0.706 . . . . 0.0 109.189 179.864 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -160.57 179.45 8.58 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.865 -1.147 . . . . 0.0 109.949 179.857 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 64.7 tttm -112.96 141.98 46.17 Favored 'General case' 0 N--CA 1.498 1.953 0 CA-C-O 121.37 0.605 . . . . 0.0 109.679 -179.656 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 97.2 t -82.4 125.01 39.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.283 -0.886 . . . . 0.0 110.438 -179.078 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 96.6 mt -102.05 -51.83 8.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 179.184 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 18.4 tt0 -148.02 145.05 28.35 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.446 -0.784 . . . . 0.0 109.193 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.919 HD23 ' H ' ' A' ' 27' ' ' LEU . 1.2 pt? -136.65 138.77 41.46 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 179.934 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 78.9 t90 -128.37 123.11 33.05 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.394 -0.816 . . . . 0.0 109.463 -179.543 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -64.27 138.83 58.64 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.227 -0.921 . . . . 0.0 110.401 -179.52 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' ASN . . . . . 0.404 HD22 ' HB ' ' A' ' 35' ' ' ILE . 55.9 t30 -84.68 169.91 13.83 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.505 -0.747 . . . . 0.0 110.102 -179.538 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 81.8 p -101.95 3.23 38.81 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.454 -0.779 . . . . 0.0 109.068 179.629 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 68.8 m80 -105.49 136.34 45.25 Favored 'General case' 0 N--CA 1.5 2.041 0 CA-C-O 121.615 0.721 . . . . 0.0 109.765 179.886 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 46.4 tp10 -67.35 -31.71 72.15 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.358 -0.839 . . . . 0.0 109.72 -179.834 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 38.4 t -60.52 -42.65 96.86 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.178 -0.951 . . . . 0.0 109.783 -179.671 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.404 ' HB ' HD22 ' A' ' 30' ' ' ASN . 86.4 mt -105.38 124.83 60.51 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.064 0 O-C-N 121.394 -0.816 . . . . 0.0 109.517 179.967 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 3.4 t -68.96 -57.21 5.79 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.466 -0.771 . . . . 0.0 110.256 -179.637 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' GLN . . . . . 0.417 HE22 HD12 ' A' ' 27' ' ' LEU . 2.4 pt20 -156.88 156.96 34.02 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.201 -0.937 . . . . 0.0 109.97 -179.543 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 30.6 m -132.49 135.8 57.14 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 179.521 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -160.07 -158.97 9.51 Favored Glycine 0 N--CA 1.492 2.423 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 -179.444 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 2.0 pp -135.7 147.39 48.48 Favored 'General case' 0 N--CA 1.503 2.182 0 O-C-N 121.291 -1.123 . . . . 0.0 110.498 -179.628 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 48.1 mt -111.98 139.26 47.64 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.608 -0.683 . . . . 0.0 109.29 -178.834 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -80.64 164.85 47.36 Favored Glycine 0 N--CA 1.491 2.333 0 C-N-CA 120.215 -0.993 . . . . 0.0 110.669 -179.522 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.53 ' OD1' ' N ' ' A' ' 44' ' ' GLU . 66.8 t0 -172.68 141.28 1.08 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.607 -0.937 . . . . 0.0 109.389 179.482 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.53 ' N ' ' OD1' ' A' ' 43' ' ' ASP . 97.2 mt-10 -54.81 -18.39 4.75 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.313 -0.867 . . . . 0.0 110.479 -179.593 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 33.3 p -94.76 -9.74 33.72 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.981 -1.074 . . . . 0.0 109.498 -179.903 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 146.04 -153.82 25.56 Favored Glycine 0 N--CA 1.497 2.729 0 N-CA-C 110.168 -1.173 . . . . 0.0 110.168 179.365 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 37.3 pt -125.93 154.78 35.27 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.969 0 O-C-N 121.714 -0.874 . . . . 0.0 109.14 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.405 HD12 ' HA ' ' A' ' 48' ' ' ILE . 10.9 tp -142.72 142.19 26.76 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 O-C-N 121.109 -0.994 . . . . 0.0 110.462 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 25.4 mtpp -83.3 153.02 24.85 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 179.661 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 30.9 p90 -147.55 160.82 42.2 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 120.972 -1.08 . . . . 0.0 110.103 -179.879 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 3.4 t -143.89 139.57 29.28 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 179.401 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 95.3 mt -104.5 119.86 54.01 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.983 0 O-C-N 121.301 -0.875 . . . . 0.0 109.695 -179.754 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 94.6 m95 -95.49 140.88 29.72 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.332 -0.855 . . . . 0.0 109.366 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -84.29 52.44 2.34 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.202 -0.936 . . . . 0.0 109.418 179.941 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' ASN . . . . . 0.42 ' ND2' ' O ' ' A' ' 55' ' ' ASN . 0.5 OUTLIER -74.28 -9.06 58.23 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.37 -0.831 . . . . 0.0 109.022 179.837 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -163.41 -78.68 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.347 -0.846 . . . . 0.0 109.143 179.889 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -171.8 114.53 0.35 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.181 -0.949 . . . . 0.0 109.701 179.893 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 91.2 mt -139.57 95.55 8.92 Favored Pre-proline 0 N--CA 1.496 1.85 0 O-C-N 121.33 -0.856 . . . . 0.0 108.834 179.543 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -52.57 154.37 12.13 Favored 'Trans proline' 0 N--CA 1.494 1.525 0 C-N-CA 122.15 1.9 . . . . 0.0 111.956 -179.759 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 62.4 mt -62.63 139.88 58.66 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.251 -0.905 . . . . 0.0 110.258 -178.638 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.587 ' N ' HD12 ' A' ' 61' ' ' LEU . 8.8 mp -80.95 149.52 29.34 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.681 -0.637 . . . . 0.0 110.034 -179.308 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 80.4 mm-40 -83.49 139.42 32.93 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.35 -0.844 . . . . 0.0 109.955 -179.712 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 56.8 tt0 -77.53 133.15 38.6 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.398 -0.814 . . . . 0.0 111.07 -179.121 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 95.13 -0.33 64.02 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 110.048 -1.221 . . . . 0.0 110.048 179.475 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.514 ' OE1' ' N ' ' A' ' 65' ' ' GLU . 58.4 mp0 -111.73 150.82 29.69 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 121.451 -1.029 . . . . 0.0 110.292 -179.572 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 7.7 m -86.88 152.0 22.83 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.705 -0.622 . . . . 0.0 109.925 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 74.0 m-85 -142.52 145.77 34.01 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.544 -0.722 . . . . 0.0 109.557 179.677 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 18.0 tp -106.01 124.11 49.06 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 179.445 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 61.3 mt -100.97 131.52 46.8 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 -179.621 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.453 ' CZ ' ' OE2' ' A' ' 92' ' ' GLU . 84.8 mtm180 -126.93 141.32 51.83 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.376 -0.827 . . . . 0.0 110.168 -179.364 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 8.3 m 56.95 57.22 4.78 Favored 'General case' 0 N--CA 1.493 1.721 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.382 179.405 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 15.5 m -113.74 161.81 12.33 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.12 0 O-C-N 121.378 -0.826 . . . . 0.0 108.929 178.956 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 7.6 p -117.94 134.08 62.69 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.02 0 CA-C-O 121.435 0.636 . . . . 0.0 109.534 -179.239 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 20.1 t -78.67 122.11 33.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.38 -0.825 . . . . 0.0 109.922 -179.173 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -95.28 171.77 29.87 Favored Glycine 0 N--CA 1.495 2.605 0 N-CA-C 109.368 -1.493 . . . . 0.0 109.368 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.546 ' N ' ' OE1' ' A' ' 76' ' ' GLU . 57.5 mp0 -107.17 118.94 38.04 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.487 -1.008 . . . . 0.0 109.483 -179.691 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 55.5 t80 -118.75 107.41 13.62 Favored 'General case' 0 N--CA 1.496 1.836 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 179.508 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 97.7 m-20 44.57 -125.76 1.02 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.403 -0.811 . . . . 0.0 109.942 -179.369 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 66.1 m-20 -94.66 -5.42 45.65 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.363 -0.836 . . . . 0.0 108.994 179.867 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 88.3 mtm180 -100.2 166.18 11.12 Favored 'General case' 0 N--CA 1.493 1.69 0 CA-C-O 121.614 0.721 . . . . 0.0 109.704 -179.702 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 76.8 m-85 -101.84 151.01 22.58 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.425 -0.797 . . . . 0.0 109.579 -179.595 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 11.6 tt0 -138.54 157.1 46.8 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.389 -0.819 . . . . 0.0 109.643 -179.757 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 3.4 m -114.11 130.64 67.97 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 179.178 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 87.7 mt-30 -109.83 132.42 54.16 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.61 -0.682 . . . . 0.0 110.072 -178.316 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 3.9 t -104.55 126.93 59.29 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 179.505 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.427 ' O ' ' O ' ' A' ' 87' ' ' LYS . 17.0 p30 -145.97 -176.44 5.15 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.208 -0.932 . . . . 0.0 109.531 -179.776 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.529 ' C ' ' H ' ' A' ' 89' ' ' SER . 21.7 ptmt -37.93 161.12 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.804 0 CA-C-O 121.544 0.688 . . . . 0.0 111.589 -178.942 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 5.1 t30 69.51 -23.71 0.15 Allowed 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 -179.678 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.529 ' H ' ' C ' ' A' ' 87' ' ' LYS . 10.6 t -78.31 155.94 29.89 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.197 -0.939 . . . . 0.0 109.86 -179.755 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 27.1 p -141.2 154.59 45.9 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.46 -0.775 . . . . 0.0 108.956 179.571 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 97.3 mt -129.98 132.49 65.5 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.453 ' OE2' ' CZ ' ' A' ' 70' ' ' ARG . 80.3 mt-10 -120.95 140.95 51.16 Favored 'General case' 0 N--CA 1.502 2.126 0 O-C-N 121.436 -0.79 . . . . 0.0 109.264 -179.507 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 37.8 ttmt -84.18 122.95 29.56 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.185 -0.947 . . . . 0.0 109.266 -179.735 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.487 HD22 ' N ' ' A' ' 94' ' ' LEU . 3.9 mm? -96.79 136.85 36.75 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.367 -0.833 . . . . 0.0 109.804 -179.466 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 94.4 p -85.52 -1.23 56.87 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 179.349 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 37.6 mm-40 -108.48 98.81 29.81 Favored Pre-proline 0 N--CA 1.498 1.961 0 O-C-N 121.644 -0.66 . . . . 0.0 109.286 -179.81 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -74.3 155.28 46.41 Favored 'Trans proline' 0 N--CA 1.491 1.38 0 C-N-CA 121.982 1.788 . . . . 0.0 112.737 -178.796 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 90.6 mt -102.7 123.82 56.3 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -87.26 125.34 34.14 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.408 -0.807 . . . . 0.0 110.425 -178.577 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 29.4 m -109.71 1.43 9.36 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.019 0 O-C-N 121.626 -0.672 . . . . 0.0 109.448 179.775 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -127.54 65.64 0.57 Allowed Glycine 0 N--CA 1.502 3.046 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 4.3 tp -86.9 -4.01 59.13 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.262 -1.14 . . . . 0.0 108.99 179.851 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -54.02 135.15 43.38 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.213 -0.93 . . . . 0.0 110.608 -179.089 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' HIS . . . . . 0.46 ' O ' ' CG ' ' A' ' 104' ' ' HIS . 45.6 p-80 -99.23 106.82 19.01 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.439 -0.788 . . . . 0.0 109.585 -179.942 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 52.2 t-80 -75.68 -87.92 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.361 -0.837 . . . . 0.0 109.737 -179.831 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 60.7 t-80 -156.54 -12.74 0.1 Allowed 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 58.4 t-80 -62.09 -44.6 96.31 Favored 'General case' 0 N--CA 1.486 1.375 0 O-C-N 121.46 -0.775 . . . . 0.0 109.267 179.705 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 47.5 p-80 -152.91 164.42 37.93 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.144 -0.972 . . . . 0.0 109.787 179.908 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' HIS . . . . . 0.45 ' O ' ' CG ' ' A' ' 109' ' ' HIS . 86.4 t60 . . . . . 0 N--CA 1.49 1.551 0 CA-C-O 117.916 -1.04 . . . . 0.0 109.223 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.5 tpt . . . . . 0 N--CA 1.49 1.536 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.509 ' N ' ' CD ' ' A' ' 3' ' ' PRO . 1.5 tt0 -68.35 -47.66 36.94 Favored Pre-proline 0 C--N 1.303 -1.434 0 O-C-N 121.576 -0.702 . . . . 0.0 109.752 179.763 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.509 ' CD ' ' N ' ' A' ' 2' ' ' GLU . 72.5 Cg_endo -79.76 150.11 21.1 Favored 'Trans proline' 0 C--N 1.312 -1.343 0 C-N-CA 122.167 1.911 . . . . 0.0 112.144 -179.116 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 55.9 tt0 -78.61 89.07 4.52 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.367 -0.833 . . . . 0.0 109.321 -179.68 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 81.7 mt -76.63 144.91 39.22 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.65 -0.656 . . . . 0.0 109.582 -179.744 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 86.6 m -123.46 130.41 52.65 Favored 'General case' 0 N--CA 1.496 1.834 0 CA-C-O 121.551 0.691 . . . . 0.0 109.515 -179.887 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 65.7 mttp -82.59 149.35 27.5 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.555 -0.715 . . . . 0.0 110.074 -179.32 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 95.6 mt -63.12 -43.29 98.83 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 O-C-N 121.618 -0.676 . . . . 0.0 109.677 179.914 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 11.1 p -63.83 -24.1 34.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.333 -0.854 . . . . 0.0 109.824 -179.663 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -75.0 -3.89 35.08 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.096 -1.003 . . . . 0.0 109.385 179.712 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 5.7 mm -70.95 92.63 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.313 -0.867 . . . . 0.0 109.52 -179.789 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 15.0 m -114.82 -20.6 5.89 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -139.09 140.56 38.04 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.268 -0.895 . . . . 0.0 109.938 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.404 HD22 ' HB3' ' A' ' 76' ' ' GLU . 55.4 p30 -89.74 167.93 12.5 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.499 -0.751 . . . . 0.0 110.263 -179.507 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 80.26 15.74 77.87 Favored Glycine 0 N--CA 1.488 2.144 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 -179.807 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 27.8 tt0 -96.28 132.35 41.84 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.335 -1.097 . . . . 0.0 109.709 -179.82 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 76.6 m95 -94.72 134.33 37.43 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.587 -0.695 . . . . 0.0 109.954 -179.536 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -173.29 -169.46 0.53 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.526 -0.734 . . . . 0.0 109.667 179.566 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 70.9 m-20 -107.34 152.03 24.7 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.6 -0.687 . . . . 0.0 109.159 -179.889 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.616 HD13 ' N ' ' A' ' 21' ' ' LYS . 0.3 OUTLIER -133.85 120.25 20.2 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.408 -0.807 . . . . 0.0 109.318 179.835 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.616 ' N ' HD13 ' A' ' 20' ' ' LEU . 35.9 ttmt -112.51 126.56 55.46 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 179.131 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -168.57 -171.95 1.55 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.117 -0.989 . . . . 0.0 109.989 -179.706 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -119.28 138.8 52.77 Favored 'General case' 0 N--CA 1.497 1.887 0 CA-C-O 121.625 0.726 . . . . 0.0 109.976 -179.621 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 10.7 t -85.9 91.43 3.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.521 -0.737 . . . . 0.0 109.661 -179.476 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 62.6 mt -69.86 -42.65 79.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.481 -0.762 . . . . 0.0 109.612 179.915 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 98.8 mm-40 -127.64 125.94 41.07 Favored 'General case' 0 N--CA 1.498 1.932 0 CA-C-O 121.75 0.786 . . . . 0.0 110.117 -178.897 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 1.1 tt -121.92 130.55 53.43 Favored 'General case' 0 C--N 1.309 -1.193 0 N-CA-C 108.755 -0.832 . . . . 0.0 108.755 179.821 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 96.9 m95 -135.2 117.76 15.89 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.613 -0.68 . . . . 0.0 109.39 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -94.18 144.56 25.4 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.485 -0.76 . . . . 0.0 110.025 -179.537 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' ASN . . . . . 0.765 ' C ' HD21 ' A' ' 30' ' ' ASN . 0.1 OUTLIER -117.19 164.8 14.23 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.601 -0.687 . . . . 0.0 109.708 179.908 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.529 ' O ' HG22 ' A' ' 31' ' ' THR . 85.5 m -93.27 3.64 55.31 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 179.722 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 59.9 m80 -63.47 132.15 50.46 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.423 -0.798 . . . . 0.0 110.105 -179.336 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 80.5 tt0 -76.99 -23.07 52.27 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.545 -0.722 . . . . 0.0 109.857 -179.806 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 87.7 p -87.08 -17.28 33.23 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.181 -0.949 . . . . 0.0 109.495 -179.583 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 84.0 mt -131.41 130.57 62.89 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 O-C-N 121.479 -0.763 . . . . 0.0 109.238 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.574 ' O ' ' ND2' ' A' ' 30' ' ' ASN . 37.2 t -75.28 -75.38 0.17 Allowed 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.568 -0.707 . . . . 0.0 109.46 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' GLN . . . . . 0.402 HE22 ' HA ' ' A' ' 60' ' ' LEU . 16.0 pt20 -141.42 162.36 35.67 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.394 -0.816 . . . . 0.0 110.013 -179.58 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 27.6 m -131.96 154.76 40.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 179.425 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.424 ' C ' ' CE1' ' A' ' 50' ' ' PHE . . . -178.88 -169.79 39.98 Favored Glycine 0 N--CA 1.486 1.987 0 C-N-CA 119.268 -1.444 . . . . 0.0 109.827 -179.751 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 2.2 pp -136.44 150.57 48.8 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.646 -0.914 . . . . 0.0 109.638 -179.621 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 54.5 mt -107.55 161.36 14.92 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 -179.006 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -140.09 131.99 5.33 Favored Glycine 0 N--CA 1.493 2.475 0 N-CA-C 109.967 -1.253 . . . . 0.0 109.967 -179.714 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.429 ' OD2' ' OG1' ' A' ' 45' ' ' THR . 52.3 p30 -151.59 -167.07 2.68 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.618 -0.93 . . . . 0.0 109.16 179.796 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -76.96 -12.4 59.94 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.514 -0.741 . . . . 0.0 109.473 179.633 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.429 ' OG1' ' OD2' ' A' ' 43' ' ' ASP . 34.7 p -91.98 -5.65 52.67 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.293 -0.88 . . . . 0.0 109.605 -179.518 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 122.76 -148.67 16.88 Favored Glycine 0 N--CA 1.5 2.953 0 N-CA-C 110.195 -1.162 . . . . 0.0 110.195 179.304 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 43.7 pt -128.71 154.89 40.22 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 O-C-N 121.758 -0.848 . . . . 0.0 109.712 -179.541 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 17.1 tt -152.6 144.46 15.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.212 -0.93 . . . . 0.0 109.96 179.621 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 63.7 mttp -83.36 150.7 25.94 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.557 -0.714 . . . . 0.0 109.909 -179.494 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.424 ' CE1' ' C ' ' A' ' 39' ' ' GLY . 35.5 p90 -142.36 152.12 42.56 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.291 -0.881 . . . . 0.0 109.622 -179.949 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 99.6 m -135.19 132.01 37.42 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 179.703 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 98.0 mt -106.05 129.06 59.85 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.601 -0.687 . . . . 0.0 109.844 -179.661 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 86.6 m95 -94.97 144.33 25.77 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.51 -0.744 . . . . 0.0 109.527 -179.924 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -66.92 -7.25 20.64 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.413 -0.804 . . . . 0.0 109.409 179.814 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 93.2 m-20 -61.95 -40.49 95.73 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.404 -0.81 . . . . 0.0 109.51 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -73.45 -11.77 60.57 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.357 -0.84 . . . . 0.0 109.089 179.776 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 46.07 46.7 12.85 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.72 -0.613 . . . . 0.0 109.67 179.908 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 23.3 mt -97.33 150.82 37.22 Favored Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 121.481 -0.762 . . . . 0.0 109.503 -179.926 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -68.85 159.55 53.35 Favored 'Trans proline' 0 N--CA 1.496 1.639 0 C-N-CA 122.832 2.355 . . . . 0.0 112.72 -179.817 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.402 ' HA ' HE22 ' A' ' 37' ' ' GLN . 69.2 mt -64.84 139.1 58.73 Favored 'General case' 0 N--CA 1.49 1.543 0 CA-C-O 121.624 0.726 . . . . 0.0 110.388 -179.163 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.591 ' N ' HD12 ' A' ' 61' ' ' LEU . 9.6 mp -76.94 149.85 35.98 Favored 'General case' 0 N--CA 1.49 1.545 0 CA-C-O 121.468 0.652 . . . . 0.0 110.175 -179.588 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 49.2 tp10 -81.2 118.86 22.93 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.45 -0.781 . . . . 0.0 109.297 -179.914 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 56.9 tt0 -64.21 134.63 55.16 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.55 -0.719 . . . . 0.0 110.902 -178.988 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 84.14 28.8 32.85 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 110.339 -1.105 . . . . 0.0 110.339 179.488 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -136.65 154.24 50.7 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.276 -1.132 . . . . 0.0 110.637 -179.634 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 6.7 m -81.16 142.07 33.6 Favored 'General case' 0 N--CA 1.488 1.444 0 CA-C-O 121.322 0.582 . . . . 0.0 109.707 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 29.3 m-85 -140.8 146.84 38.15 Favored 'General case' 0 N--CA 1.49 1.57 0 CA-C-O 121.782 0.801 . . . . 0.0 109.751 -179.942 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 23.3 tp -111.56 120.87 43.56 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 179.458 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 66.2 mt -102.87 133.17 48.39 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 -179.916 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.42 ' O ' ' OG ' ' A' ' 71' ' ' SER . 84.8 mtp180 -127.39 149.27 50.15 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.666 -0.646 . . . . 0.0 110.293 -179.517 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.496 ' HG ' ' HA ' ' A' ' 89' ' ' SER . 3.0 p 53.28 57.93 5.75 Favored 'General case' 0 N--CA 1.494 1.733 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.445 179.702 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 17.8 m -116.15 164.99 12.01 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.043 0 O-C-N 121.608 -0.682 . . . . 0.0 109.422 179.105 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 8.0 p -115.32 137.84 47.59 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 CA-C-O 121.485 0.659 . . . . 0.0 109.8 -179.065 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 89.0 t -85.28 108.43 17.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.559 -0.713 . . . . 0.0 109.65 -179.501 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -87.64 177.77 46.95 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 110.115 -1.194 . . . . 0.0 110.115 -179.43 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.404 ' HB3' HD22 ' A' ' 14' ' ' ASN . 17.2 pt-20 -107.68 134.57 50.47 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.602 -0.94 . . . . 0.0 109.216 -179.867 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 55.7 t80 -108.83 145.14 35.74 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.477 -0.764 . . . . 0.0 109.756 -179.468 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' ASN . . . . . 0.442 ' O ' ' CB ' ' A' ' 79' ' ' ASP . 24.0 t-20 -69.43 62.99 0.16 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.588 -0.695 . . . . 0.0 109.96 -179.477 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.442 ' CB ' ' O ' ' A' ' 78' ' ' ASN . 0.7 OUTLIER 162.43 -25.57 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 179.701 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 25.1 ttm180 -166.88 -131.66 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.374 -0.829 . . . . 0.0 109.595 -179.778 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 89.6 m-85 -131.29 152.28 50.71 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.582 -0.699 . . . . 0.0 109.625 -179.573 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 28.2 pt20 -144.97 162.49 36.76 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.473 -0.767 . . . . 0.0 109.393 -179.836 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 3.3 m -109.36 132.66 56.89 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 179.804 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 87.0 mt-30 -107.14 132.48 52.98 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.632 -0.668 . . . . 0.0 110.18 -178.65 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 90.1 t -99.45 129.59 49.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 179.654 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 6.2 m-80 -144.38 176.36 9.42 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.475 -0.765 . . . . 0.0 109.524 -179.494 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.473 ' C ' ' H ' ' A' ' 89' ' ' SER . 61.3 tttp -40.94 159.75 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.723 0 CA-C-O 121.29 0.567 . . . . 0.0 110.459 -179.796 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 88' ' ' ASN . . . . . 0.447 ' CB ' ' O ' ' A' ' 87' ' ' LYS . 3.9 t30 77.26 -25.37 0.2 Allowed 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 -179.5 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.496 ' HA ' ' HG ' ' A' ' 71' ' ' SER . 94.0 p -73.27 154.41 40.19 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 121.62 -0.675 . . . . 0.0 109.825 -179.809 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 75.7 m -132.26 150.52 52.14 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.625 -0.672 . . . . 0.0 109.472 -179.945 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 96.9 mt -130.11 130.6 65.98 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 179.864 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 53.0 tp10 -126.57 130.93 51.51 Favored 'General case' 0 N--CA 1.497 1.881 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 179.784 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.4 ' C ' HD22 ' A' ' 94' ' ' LEU . 64.0 tttp -80.19 131.31 35.68 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.614 -0.679 . . . . 0.0 110.235 -179.274 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.48 HD22 ' N ' ' A' ' 94' ' ' LEU . 3.9 mm? -96.67 135.87 37.99 Favored 'General case' 0 N--CA 1.495 1.818 0 CA-C-O 121.777 0.799 . . . . 0.0 109.929 -179.809 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 68.1 m -84.65 -3.8 58.69 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.724 -0.61 . . . . 0.0 109.519 179.802 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 12.3 tp10 -117.47 91.17 37.07 Favored Pre-proline 0 N--CA 1.498 1.94 0 O-C-N 121.56 -0.712 . . . . 0.0 109.338 -179.854 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -55.77 147.66 59.86 Favored 'Trans proline' 0 N--CA 1.498 1.751 0 C-N-CA 122.727 2.284 . . . . 0.0 112.648 -179.869 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 95.9 mt -96.27 129.2 46.68 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.494 -0.754 . . . . 0.0 109.785 -179.434 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 74.8 mm-40 -90.15 125.36 35.43 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.582 -0.699 . . . . 0.0 109.643 -179.694 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 29.2 m -102.06 -2.48 9.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 N-CA-C 108.817 -0.808 . . . . 0.0 108.817 179.761 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 172.28 119.17 0.51 Allowed Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.811 -1.316 . . . . 0.0 109.811 179.74 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 83.1 mt -89.66 -5.17 57.34 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.458 -1.024 . . . . 0.0 109.118 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 76.1 mt-10 -81.87 107.63 14.74 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.406 -0.809 . . . . 0.0 109.994 -179.702 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 25.9 t-80 -170.25 71.51 0.06 Allowed 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 108.906 -0.775 . . . . 0.0 108.906 179.514 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 57.9 t-80 -157.96 134.85 9.91 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.327 -0.858 . . . . 0.0 109.78 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' HIS . . . . . 0.63 ' ND1' ' N ' ' A' ' 107' ' ' HIS . 55.3 t-80 42.44 -105.8 0.07 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.615 -0.678 . . . . 0.0 110.519 179.604 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 107' ' ' HIS . . . . . 0.63 ' N ' ' ND1' ' A' ' 106' ' ' HIS . 84.6 t60 46.03 80.34 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.579 -0.701 . . . . 0.0 109.718 -179.461 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 49.1 t-80 -89.69 128.23 36.05 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.396 -0.815 . . . . 0.0 109.847 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 54.2 p-80 . . . . . 0 N--CA 1.49 1.552 0 CA-C-O 118.025 -0.988 . . . . 0.0 110.004 -179.869 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.6 ptt? . . . . . 0 N--CA 1.489 1.483 0 CA-C-O 121.792 0.806 . . . . 0.0 109.547 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 51.23 57.68 16.87 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.615 -0.678 . . . . 0.0 110.219 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -68.37 150.17 75.79 Favored 'Trans proline' 0 C--N 1.31 -1.463 0 C-N-CA 122.39 2.06 . . . . 0.0 112.067 179.685 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.513 ' N ' ' OE1' ' A' ' 4' ' ' GLN . 0.9 OUTLIER -76.24 90.12 3.14 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.352 -0.843 . . . . 0.0 109.878 -179.436 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 79.1 mt -76.61 145.74 38.7 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.706 -0.622 . . . . 0.0 109.435 179.897 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 92.0 m -125.26 132.24 52.96 Favored 'General case' 0 N--CA 1.493 1.723 0 CA-C-O 121.761 0.791 . . . . 0.0 109.704 -179.884 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -75.85 149.4 37.85 Favored 'General case' 0 C--N 1.3 -1.567 0 CA-C-O 121.785 0.802 . . . . 0.0 110.373 -179.578 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 97.2 mt -63.24 -43.22 98.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 CA-C-O 121.802 0.81 . . . . 0.0 109.563 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 7.6 p -65.06 -24.3 35.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.592 -0.693 . . . . 0.0 109.872 -179.67 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 50.3 t0 -79.4 -4.58 51.69 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.17 -0.956 . . . . 0.0 109.838 -179.639 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 97.1 mt -85.6 114.33 25.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 120.962 -1.086 . . . . 0.0 109.656 -179.985 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 34.6 m -149.84 15.04 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 179.741 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 79.3 mm-40 -127.87 133.54 49.34 Favored 'General case' 0 N--CA 1.497 1.907 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 -179.903 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 93.2 m-20 -74.06 141.54 45.72 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-O 121.658 0.742 . . . . 0.0 110.079 -179.579 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 58.02 111.15 0.01 OUTLIER Glycine 0 N--CA 1.49 2.242 0 N-CA-C 110.465 -1.054 . . . . 0.0 110.465 179.504 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 29.1 tt0 -168.06 133.77 1.91 Allowed 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.424 -1.045 . . . . 0.0 109.174 179.501 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 60.4 m95 -88.63 136.82 32.8 Favored 'General case' 0 N--CA 1.49 1.558 0 CA-C-O 121.652 0.739 . . . . 0.0 109.938 -179.565 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -178.29 173.63 1.39 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.571 -0.705 . . . . 0.0 109.229 -179.717 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 73.0 m-20 -107.59 144.99 33.84 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.54 -0.725 . . . . 0.0 109.886 -179.434 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 60.4 tp -133.78 135.4 43.86 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.49 -0.756 . . . . 0.0 110.406 -179.59 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 38.5 ttmt -119.23 130.34 55.41 Favored 'General case' 0 N--CA 1.496 1.863 0 CA-C-O 121.321 0.581 . . . . 0.0 109.556 179.503 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -168.79 -172.91 1.72 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.345 -0.847 . . . . 0.0 109.93 179.414 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 21.3 ptmt -124.81 154.35 41.11 Favored 'General case' 0 N--CA 1.498 1.961 0 CA-C-O 121.46 0.648 . . . . 0.0 109.919 179.829 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 97.1 t -87.8 129.58 38.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 CA-C-O 121.613 0.721 . . . . 0.0 110.174 -179.539 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.402 HD11 ' HA3' ' A' ' 42' ' ' GLY . 96.4 mt -100.98 -55.81 5.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 N-CA-C 109.068 -0.715 . . . . 0.0 109.068 179.42 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 12.5 mm100 -142.92 138.61 30.3 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.151 -0.968 . . . . 0.0 109.807 179.825 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.833 HD23 ' H ' ' A' ' 27' ' ' LEU . 1.2 pt? -143.22 139.41 30.25 Favored 'General case' 0 N--CA 1.492 1.631 0 CA-C-O 121.347 0.594 . . . . 0.0 109.988 -179.928 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 5.6 m-90 -111.86 140.31 46.61 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 179.595 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -78.59 119.75 22.3 Favored 'General case' 0 N--CA 1.493 1.687 0 CA-C-O 121.645 0.736 . . . . 0.0 110.265 -179.563 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' ASN . . . . . 0.442 HD22 HG21 ' A' ' 35' ' ' ILE . 55.7 t-20 -107.04 -43.91 4.52 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.543 -0.723 . . . . 0.0 109.243 179.756 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.435 ' C ' ' O ' ' A' ' 30' ' ' ASN . 1.2 p 38.22 53.75 1.71 Allowed 'General case' 0 N--CA 1.504 2.265 0 CA-C-O 122.023 0.916 . . . . 0.0 109.783 -179.539 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' HIS . . . . . 0.633 ' CG ' ' H ' ' A' ' 33' ' ' GLU . 8.3 t-80 -83.72 -151.6 0.12 Allowed 'General case' 0 N--CA 1.494 1.758 0 CA-C-O 122.072 0.939 . . . . 0.0 110.738 -179.137 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.633 ' H ' ' CG ' ' A' ' 32' ' ' HIS . 97.2 mt-10 -70.08 -38.81 75.8 Favored 'General case' 0 N--CA 1.491 1.618 0 CA-C-O 121.661 0.743 . . . . 0.0 109.799 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 14.7 m -137.79 2.76 2.43 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.303 -0.873 . . . . 0.0 109.138 -179.609 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.442 HG21 HD22 ' A' ' 30' ' ' ASN . 72.4 mt -107.34 126.39 63.54 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 O-C-N 121.131 -0.981 . . . . 0.0 109.576 -179.751 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.575 ' OG ' ' N ' ' A' ' 54' ' ' LYS . 1.0 OUTLIER -92.0 -69.47 0.74 Allowed 'General case' 0 N--CA 1.492 1.648 0 CA-C-O 121.837 0.827 . . . . 0.0 109.283 -179.905 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 99.3 mt-30 -138.71 154.01 48.54 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.303 -0.873 . . . . 0.0 109.792 -179.585 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.7 p -140.41 140.49 34.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.585 -0.697 . . . . 0.0 109.781 -179.806 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -170.56 -156.96 11.87 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 179.723 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.688 HD23 ' H ' ' A' ' 40' ' ' LEU . 1.7 pt? -132.12 150.6 52.11 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.709 -0.877 . . . . 0.0 110.117 179.836 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 66.2 mt -109.71 134.33 52.11 Favored 'General case' 0 N--CA 1.492 1.674 0 CA-C-O 121.763 0.792 . . . . 0.0 109.591 -179.438 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.402 ' HA3' HD11 ' A' ' 25' ' ' ILE . . . -86.87 144.04 19.3 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 110.06 -1.216 . . . . 0.0 110.06 179.897 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 43.8 t0 -152.7 165.55 34.94 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 121.497 -1.002 . . . . 0.0 110.105 179.84 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -63.99 -17.89 63.75 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.82 -0.55 . . . . 0.0 110.826 -179.583 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 17.3 p -98.63 -5.91 30.85 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 120.809 -1.182 . . . . 0.0 109.99 -179.314 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 140.21 -129.82 4.38 Favored Glycine 0 N--CA 1.496 2.678 0 N-CA-C 110.219 -1.153 . . . . 0.0 110.219 179.491 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.823 HD13 ' H ' ' A' ' 47' ' ' ILE . 0.1 OUTLIER -145.09 158.89 13.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.583 -0.951 . . . . 0.0 109.819 -179.54 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.547 HD11 ' O ' ' A' ' 81' ' ' PHE . 9.7 tp -148.73 147.72 16.54 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 179.172 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 69.1 mttm -85.07 153.52 22.66 Favored 'General case' 0 N--CA 1.49 1.533 0 CA-C-O 121.641 0.734 . . . . 0.0 110.403 -179.658 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 13.4 p90 -148.86 152.86 37.21 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.407 -0.808 . . . . 0.0 109.447 179.779 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 98.3 m -133.1 131.28 40.36 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 91.7 mt -100.55 125.43 54.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.4 -0.812 . . . . 0.0 110.098 -179.58 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 54.3 m95 -93.96 120.27 33.99 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 179.455 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.575 ' N ' ' OG ' ' A' ' 36' ' ' SER . 19.6 ptmt -69.76 -5.05 22.71 Favored 'General case' 0 C--N 1.3 -1.565 0 CA-C-O 121.764 0.792 . . . . 0.0 108.928 179.947 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 75.1 m-20 -61.84 -40.77 96.49 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.542 -0.724 . . . . 0.0 109.262 179.57 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -78.82 -12.92 60.05 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.224 -0.923 . . . . 0.0 109.166 179.592 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 55.43 62.22 2.55 Favored 'General case' 0 N--CA 1.494 1.761 0 CA-C-O 121.59 0.71 . . . . 0.0 109.99 179.914 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 40.4 mt -101.54 154.21 37.39 Favored Pre-proline 0 N--CA 1.493 1.724 0 O-C-N 121.651 -0.656 . . . . 0.0 109.237 179.836 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -52.44 143.85 42.98 Favored 'Trans proline' 0 N--CA 1.497 1.694 0 C-N-CA 122.221 1.947 . . . . 0.0 112.752 179.929 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 79.2 mt -74.19 141.55 45.48 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.404 -0.81 . . . . 0.0 109.844 -179.852 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.623 ' N ' HD12 ' A' ' 61' ' ' LEU . 9.8 mp -86.26 149.07 25.33 Favored 'General case' 0 N--CA 1.489 1.508 0 CA-C-O 121.834 0.826 . . . . 0.0 110.078 -179.796 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -99.68 146.12 26.86 Favored 'General case' 0 N--CA 1.491 1.6 0 CA-C-O 121.761 0.791 . . . . 0.0 110.429 -179.275 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 12.0 tt0 -75.17 135.54 41.07 Favored 'General case' 0 N--CA 1.489 1.48 0 CA-C-O 121.727 0.775 . . . . 0.0 110.413 -179.894 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 81.32 18.09 69.87 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 110.011 -1.236 . . . . 0.0 110.011 179.535 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 -125.27 147.22 49.19 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.393 -1.063 . . . . 0.0 110.646 -179.8 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 12.7 p -80.19 150.89 29.97 Favored 'General case' 0 N--CA 1.485 1.299 0 CA-C-O 121.721 0.772 . . . . 0.0 110.011 179.772 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 40.0 m-85 -145.42 144.37 30.6 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.497 -0.752 . . . . 0.0 109.547 179.915 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 25.0 tp -111.13 119.83 40.29 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 179.034 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 71.4 mt -105.22 128.37 53.38 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 -179.675 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 83.1 mtp180 -130.13 137.74 50.3 Favored 'General case' 0 N--CA 1.493 1.691 0 CA-C-O 121.502 0.668 . . . . 0.0 110.021 179.835 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.3 m 72.73 52.52 0.15 Allowed 'General case' 0 N--CA 1.495 1.78 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.198 179.677 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 20.4 m -113.68 160.7 13.03 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 O-C-N 121.377 -0.827 . . . . 0.0 110.196 179.626 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 11.1 p -114.37 140.46 35.04 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 CA-C-O 121.549 0.69 . . . . 0.0 109.19 -179.841 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 85.7 t -86.21 113.43 24.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 CA-C-O 121.996 0.903 . . . . 0.0 110.529 -179.062 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -87.27 177.09 47.28 Favored Glycine 0 N--CA 1.488 2.148 0 N-CA-C 109.882 -1.287 . . . . 0.0 109.882 179.875 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.561 ' N ' ' OE1' ' A' ' 76' ' ' GLU . 52.8 mp0 -112.62 128.0 56.26 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.63 -0.923 . . . . 0.0 109.854 -179.341 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 80.7 t80 -130.7 86.11 2.35 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 179.662 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' ASN . . . . . 0.494 ' CG ' ' H ' ' A' ' 79' ' ' ASP . 64.4 t30 58.87 -139.71 0.74 Allowed 'General case' 0 N--CA 1.491 1.594 0 CA-C-O 121.508 0.671 . . . . 0.0 110.527 179.944 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.494 ' H ' ' CG ' ' A' ' 78' ' ' ASN . 93.0 m-20 -78.22 -5.95 53.41 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.412 -0.805 . . . . 0.0 109.244 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 16.5 tpp180 -107.74 145.98 32.76 Favored 'General case' 0 N--CA 1.497 1.88 0 CA-C-O 121.866 0.841 . . . . 0.0 110.029 -179.442 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' PHE . . . . . 0.547 ' O ' HD11 ' A' ' 48' ' ' ILE . 94.5 m-85 -85.85 153.49 22.21 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.532 -0.73 . . . . 0.0 110.167 -179.066 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 48.7 tt0 -140.76 154.07 46.13 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.438 -0.789 . . . . 0.0 109.659 -179.715 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 27.2 m -113.55 131.19 66.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 CA-C-O 121.591 0.71 . . . . 0.0 109.085 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 87.1 mt-30 -105.94 119.81 40.13 Favored 'General case' 0 N--CA 1.493 1.689 0 CA-C-O 121.606 0.717 . . . . 0.0 110.091 -178.777 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 11.2 t -93.67 103.44 14.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 179.158 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 17.2 p30 -151.68 -178.77 6.91 Favored 'General case' 0 N--CA 1.489 1.49 0 CA-C-O 121.732 0.777 . . . . 0.0 110.474 -179.113 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 30.6 ttmt 68.6 -131.76 0.1 Allowed 'General case' 0 N--CA 1.492 1.673 0 CA-C-O 121.642 0.734 . . . . 0.0 110.895 179.466 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' ASN . . . . . 0.41 ' O ' ' C ' ' A' ' 89' ' ' SER . 91.5 m-20 -93.23 10.62 31.1 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.393 -0.817 . . . . 0.0 108.813 -179.51 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.41 ' C ' ' O ' ' A' ' 88' ' ' ASN . 40.6 t -39.07 111.72 0.2 Allowed 'General case' 0 N--CA 1.495 1.801 0 CA-C-O 121.863 0.84 . . . . 0.0 110.516 -179.439 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 6.1 m -77.41 145.56 37.12 Favored 'General case' 0 N--CA 1.489 1.52 0 CA-C-O 121.531 0.682 . . . . 0.0 109.947 -179.542 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 97.9 mt -135.98 132.05 50.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.441 -0.787 . . . . 0.0 109.604 179.849 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 83.1 tt0 -129.15 131.34 47.17 Favored 'General case' 0 N--CA 1.497 1.913 0 CA-C-O 121.673 0.749 . . . . 0.0 109.376 179.375 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.425 ' C ' HD12 ' A' ' 94' ' ' LEU . 38.2 ttmt -80.77 125.74 30.44 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.622 -0.674 . . . . 0.0 109.613 -179.757 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.469 ' N ' HD12 ' A' ' 94' ' ' LEU . 10.9 mp -100.94 131.15 46.95 Favored 'General case' 0 N--CA 1.496 1.836 0 CA-C-O 121.907 0.86 . . . . 0.0 110.079 -179.733 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 38.1 t -79.8 -3.6 48.43 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 108.566 -0.902 . . . . 0.0 108.566 179.179 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 60.3 mt-10 -102.41 106.09 47.01 Favored Pre-proline 0 N--CA 1.496 1.841 0 O-C-N 121.299 -0.875 . . . . 0.0 109.325 -179.767 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -76.17 154.4 37.05 Favored 'Trans proline' 0 C--N 1.316 -1.184 0 C-N-CA 122.202 1.934 . . . . 0.0 111.879 -179.44 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 90.6 mt -101.73 127.04 55.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.311 -0.868 . . . . 0.0 109.3 -179.846 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -88.71 121.75 31.42 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.602 -0.687 . . . . 0.0 109.529 -179.71 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 47.6 t -109.53 -13.57 10.69 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 179.62 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 107.88 78.82 1.13 Allowed Glycine 0 N--CA 1.501 2.972 0 N-CA-C 109.83 -1.308 . . . . 0.0 109.83 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 87.1 mt -89.15 -4.46 58.27 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.289 -1.124 . . . . 0.0 108.644 179.544 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' GLU . . . . . 0.422 ' OE1' ' O ' ' A' ' 104' ' ' HIS . 10.3 tm-20 -156.04 -70.21 0.11 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.32 -0.863 . . . . 0.0 109.216 179.443 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 104' ' ' HIS . . . . . 0.513 ' CG ' ' N ' ' A' ' 105' ' ' HIS . 49.9 t-80 44.76 -108.81 0.15 Allowed 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.505 -0.747 . . . . 0.0 110.16 179.849 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 105' ' ' HIS . . . . . 0.513 ' N ' ' CG ' ' A' ' 104' ' ' HIS . 97.9 m-70 -150.9 146.13 26.1 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.16 -0.963 . . . . 0.0 109.4 -179.778 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 18.5 p80 -155.74 149.72 25.44 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.457 -0.777 . . . . 0.0 109.727 -179.859 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 97.9 m-70 -114.65 124.74 52.58 Favored 'General case' 0 N--CA 1.498 1.943 0 CA-C-O 121.518 0.675 . . . . 0.0 109.457 -179.892 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 86.2 t60 -95.38 129.33 42.57 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.423 -0.798 . . . . 0.0 109.89 -179.827 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' HIS . . . . . 0.465 ' ND1' ' OXT' ' A' ' 109' ' ' HIS . 11.3 p80 . . . . . 0 N--CA 1.488 1.462 0 CA-C-O 118.096 -0.954 . . . . 0.0 109.034 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . 0.4 ' HB2' HD22 ' A' ' 19' ' ' ASN . 60.0 Cg_endo . . . . . 0 N--CA 1.498 1.774 0 CA-C-O 121.534 0.556 . . . . 0.0 112.811 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 4.5 pt20 -79.6 89.05 5.1 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.272 -0.893 . . . . 0.0 109.505 -179.72 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 78.9 mt -75.03 143.57 43.46 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.499 -0.751 . . . . 0.0 109.768 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 98.9 m -131.24 136.36 48.15 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.622 -0.674 . . . . 0.0 109.939 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -78.43 153.51 31.43 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.567 -0.708 . . . . 0.0 109.926 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 96.1 mt -62.26 -43.09 97.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.388 -0.82 . . . . 0.0 109.42 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 11.8 p -62.71 -28.26 44.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.244 -0.91 . . . . 0.0 109.256 -179.666 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 55.1 t0 -67.59 -33.09 74.3 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.346 -0.846 . . . . 0.0 109.699 179.502 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 97.0 mt -68.8 120.55 16.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.29 -0.881 . . . . 0.0 110.182 -178.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 31.4 m -148.57 9.51 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 179.401 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 82.9 tt0 -134.45 139.61 45.64 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.418 -0.802 . . . . 0.0 109.586 179.611 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.505 ' ND2' ' OE2' ' A' ' 76' ' ' GLU . 31.0 p30 -82.5 151.66 26.39 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.587 -0.696 . . . . 0.0 110.56 -179.516 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 78.76 4.65 88.21 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 108.897 -1.681 . . . . 0.0 108.897 -179.737 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 44.1 tt0 -72.43 129.12 37.61 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.403 -1.057 . . . . 0.0 109.729 -179.627 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' TRP . . . . . 0.416 ' O ' ' HB2' ' A' ' 18' ' ' ALA . 85.2 m95 -99.99 137.52 38.33 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.618 -0.676 . . . . 0.0 109.942 -179.625 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.416 ' HB2' ' O ' ' A' ' 17' ' ' TRP . . . 178.37 178.34 0.4 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.527 -0.733 . . . . 0.0 109.238 179.265 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.4 HD22 ' HB2' ' A' ' 3' ' ' PRO . 61.3 m-20 -102.43 145.32 29.71 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 -179.906 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 51.9 tp -139.38 134.93 33.13 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.41 -0.806 . . . . 0.0 110.195 -179.538 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 34.0 ttpt -113.94 137.51 51.58 Favored 'General case' 0 N--CA 1.498 1.929 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 178.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -159.88 170.84 20.56 Favored 'General case' 0 N--CA 1.493 1.693 0 C-N-CA 119.064 -1.054 . . . . 0.0 110.55 -179.71 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 51.8 tttp -105.11 144.52 31.8 Favored 'General case' 0 N--CA 1.494 1.775 0 CA-C-O 121.345 0.593 . . . . 0.0 109.758 -179.784 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 62.5 t -83.31 120.02 33.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.324 -0.86 . . . . 0.0 109.971 -179.388 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 96.4 mt -96.89 -66.55 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.645 -0.659 . . . . 0.0 109.229 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 66.3 mt-30 -146.05 142.92 29.04 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.353 -0.842 . . . . 0.0 109.984 -179.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.433 ' N ' HD23 ' A' ' 27' ' ' LEU . 0.1 OUTLIER -125.26 136.69 53.78 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 -179.781 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 92.1 m95 -111.53 133.0 54.11 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 179.576 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 . . . . . 0 N--CA 1.492 1.627 0 O-C-N 121.539 -0.726 . . . . 0.0 110.268 -179.266 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . 0.513 ' OG ' ' N ' ' A' ' 35' ' ' ILE . 56.1 p . . . . . 0 N--CA 1.49 1.558 0 CA-C-O 121.506 0.669 . . . . 0.0 109.886 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.513 ' N ' ' OG ' ' A' ' 34' ' ' SER . 96.9 mt -74.14 135.3 27.77 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 O-C-N 121.464 -0.773 . . . . 0.0 110.082 -179.281 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 17.8 t -92.16 -62.34 1.43 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.624 -0.672 . . . . 0.0 109.601 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 85.5 mt-30 -136.85 155.53 49.66 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.405 -0.809 . . . . 0.0 109.97 -179.343 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 8.7 p -142.92 141.9 26.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 179.8 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -168.63 -160.0 15.55 Favored Glycine 0 N--CA 1.489 2.212 0 C-N-CA 119.202 -1.475 . . . . 0.0 110.384 -179.669 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -133.22 147.98 52.0 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.747 -0.855 . . . . 0.0 109.423 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 41.4 mt -117.25 133.33 56.12 Favored 'General case' 0 N--CA 1.499 1.983 0 CA-C-O 121.529 0.68 . . . . 0.0 109.92 -179.018 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -78.98 162.9 48.95 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 110.124 -1.19 . . . . 0.0 110.124 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.451 ' OD1' ' N ' ' A' ' 44' ' ' GLU . 55.1 t0 -173.83 153.43 2.18 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.586 -0.95 . . . . 0.0 109.36 179.553 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.451 ' N ' ' OD1' ' A' ' 43' ' ' ASP . 82.2 tt0 -63.03 -18.58 63.49 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.47 -0.768 . . . . 0.0 109.515 -179.877 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 72.4 p -92.2 -7.95 46.85 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.205 -0.935 . . . . 0.0 109.282 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 135.3 -150.67 20.29 Favored Glycine 0 N--CA 1.497 2.753 0 N-CA-C 109.998 -1.241 . . . . 0.0 109.998 179.268 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 96.7 mt -123.03 139.64 49.19 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 O-C-N 121.679 -0.895 . . . . 0.0 109.765 -179.423 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 9.3 tp -129.03 139.64 51.36 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 CA-C-O 121.662 0.744 . . . . 0.0 109.533 179.569 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 32.5 mtmm -85.52 148.41 25.97 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.665 -0.647 . . . . 0.0 109.871 -179.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 7.1 p90 -143.27 152.16 41.37 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.381 -0.825 . . . . 0.0 109.919 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.432 ' CG2' HG23 ' A' ' 35' ' ' ILE . 47.2 m -131.09 133.9 46.09 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 179.787 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 32.0 mm -97.08 124.22 49.82 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 O-C-N 121.203 -0.935 . . . . 0.0 110.184 -179.258 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 96.0 m95 -88.68 139.14 30.78 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 121.529 -0.732 . . . . 0.0 109.214 179.566 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 98.9 mttt . . . . . 0 N--CA 1.489 1.481 0 O-C-N 121.346 -0.846 . . . . 0.0 109.663 -179.735 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 61.1 mt . . . . . 0 N--CA 1.494 1.751 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -53.59 149.23 32.21 Favored 'Trans proline' 0 N--CA 1.501 1.923 0 C-N-CA 122.286 1.99 . . . . 0.0 112.941 179.205 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 62.0 mt -68.12 144.03 55.19 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.456 -0.777 . . . . 0.0 110.37 -179.253 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.595 ' N ' HD12 ' A' ' 61' ' ' LEU . 10.1 mp -78.31 144.65 35.89 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.724 -0.61 . . . . 0.0 109.447 -179.682 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 80.2 tt0 -98.38 145.03 27.13 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.39 -0.819 . . . . 0.0 110.514 -179.085 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 57.9 tt0 -78.48 139.31 38.7 Favored 'General case' 0 N--CA 1.489 1.518 0 CA-C-O 121.479 0.657 . . . . 0.0 111.061 -179.295 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 84.93 10.63 78.4 Favored Glycine 0 N--CA 1.492 2.414 0 N-CA-C 110.187 -1.165 . . . . 0.0 110.187 178.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -124.74 144.65 50.12 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.385 -1.067 . . . . 0.0 110.602 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 8.1 p -87.04 152.41 22.39 Favored 'General case' 0 N--CA 1.487 1.405 0 CA-C-O 121.466 0.65 . . . . 0.0 109.987 179.769 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 70.4 m-85 -144.64 150.99 38.32 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.454 -0.779 . . . . 0.0 109.96 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 18.1 tp -108.55 124.6 50.71 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 179.184 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 69.8 mt -104.48 132.47 50.69 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 179.769 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 88.8 mtm180 -127.75 144.67 51.07 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.621 -0.674 . . . . 0.0 110.054 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.424 ' O ' ' OG ' ' A' ' 71' ' ' SER . 5.2 t 58.43 59.8 2.84 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 122.064 -0.397 . . . . 0.0 110.374 179.748 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 3.4 m -117.59 162.25 15.76 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.165 0 O-C-N 121.486 -0.759 . . . . 0.0 108.989 179.281 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 7.1 p -122.91 136.98 57.95 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 CA-C-O 121.606 0.717 . . . . 0.0 110.149 -178.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 90.4 t -80.84 128.61 38.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.468 -0.77 . . . . 0.0 109.975 -179.484 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -98.16 166.1 22.04 Favored Glycine 0 N--CA 1.494 2.526 0 N-CA-C 110.158 -1.177 . . . . 0.0 110.158 -179.774 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.505 ' OE2' ' ND2' ' A' ' 14' ' ' ASN . 96.7 mt-10 -90.68 124.99 35.53 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.803 -0.822 . . . . 0.0 109.378 179.896 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 79.4 t80 -134.45 108.56 8.2 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.494 -0.754 . . . . 0.0 109.744 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 11.2 m120 41.15 -123.55 0.51 Allowed 'General case' 0 N--CA 1.493 1.712 0 CA-C-O 121.439 0.637 . . . . 0.0 111.031 179.57 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 96.9 m-20 -91.91 -5.81 52.54 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.442 -0.786 . . . . 0.0 110.116 -179.054 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 79.5 mtp85 -115.57 -172.62 2.18 Favored 'General case' 0 N--CA 1.502 2.161 0 O-C-N 121.443 -0.785 . . . . 0.0 109.945 -179.774 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 90.2 m-85 -130.45 156.72 44.3 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.598 -0.689 . . . . 0.0 109.842 -179.486 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 15.8 pt20 -140.12 165.09 28.3 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.575 -0.703 . . . . 0.0 109.315 179.64 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 33.8 m -104.67 132.43 51.37 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 O-C-N 121.387 -0.821 . . . . 0.0 109.117 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -102.91 128.66 49.61 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.537 -0.727 . . . . 0.0 109.864 -178.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 21.1 t -94.61 130.67 43.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.582 -0.699 . . . . 0.0 109.532 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 18.9 p30 -132.83 176.94 8.03 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 179.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 22.7 pttm -58.83 -36.05 73.92 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.358 -0.839 . . . . 0.0 109.84 -179.47 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 77.5 m-20 -62.45 -38.26 89.09 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.283 -0.886 . . . . 0.0 109.327 179.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 93.3 p -69.68 161.93 28.73 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.093 -1.004 . . . . 0.0 109.801 -179.241 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 72.1 m -130.6 152.17 50.25 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.607 -0.683 . . . . 0.0 109.681 -179.638 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 96.6 mt -127.12 131.96 70.24 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 75.4 mm-40 -129.14 137.52 51.24 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.53 -0.732 . . . . 0.0 109.475 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -78.89 129.78 34.92 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.505 -0.747 . . . . 0.0 109.328 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 52.4 mt -103.14 136.41 42.99 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.499 -0.751 . . . . 0.0 109.568 -179.496 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 74.3 m -81.52 -5.39 57.93 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 179.797 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -112.94 117.94 45.36 Favored Pre-proline 0 N--CA 1.497 1.921 0 O-C-N 121.676 -0.64 . . . . 0.0 109.356 -179.695 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -75.24 163.44 34.82 Favored 'Trans proline' 0 N--CA 1.491 1.375 0 C-N-CA 121.971 1.78 . . . . 0.0 111.971 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 19.2 mm . . . . . 0 N--CA 1.493 1.724 0 O-C-N 121.197 -0.939 . . . . 0.0 109.335 -179.695 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo . . . . . 0 N--CA 1.491 1.372 0 CA-C-O 121.727 0.636 . . . . 0.0 112.277 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . 0.525 ' OE1' ' N ' ' A' ' 4' ' ' GLN . 1.0 OUTLIER -78.92 89.17 4.71 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.305 -0.872 . . . . 0.0 109.344 -179.728 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 80.3 mt -75.47 150.8 38.15 Favored 'General case' 0 N--CA 1.488 1.442 0 CA-C-O 121.754 0.787 . . . . 0.0 109.807 -179.783 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 4.9 t -144.55 156.67 44.26 Favored 'General case' 0 N--CA 1.487 1.404 0 CA-C-O 121.751 0.786 . . . . 0.0 109.539 179.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.58 159.14 15.1 Favored 'General case' 0 C--N 1.3 -1.579 0 CA-C-O 121.875 0.845 . . . . 0.0 110.352 -179.665 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 96.1 mt -62.96 -42.68 97.53 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 CA-C-O 121.539 0.685 . . . . 0.0 109.267 179.888 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 14.4 p -62.71 -28.36 44.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.377 -0.827 . . . . 0.0 109.259 179.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 -75.75 -17.93 59.72 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.23 -0.919 . . . . 0.0 109.123 179.66 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 96.1 mt -86.57 113.37 24.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.127 -0.983 . . . . 0.0 109.66 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 20.6 m -153.94 17.24 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 179.75 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -127.08 137.51 53.04 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.536 -0.728 . . . . 0.0 109.881 -179.63 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 11.8 m120 -77.95 138.71 39.0 Favored 'General case' 0 N--CA 1.485 1.306 0 CA-C-O 121.804 0.811 . . . . 0.0 110.92 -179.223 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 79.39 11.04 85.34 Favored Glycine 0 N--CA 1.492 2.425 0 N-CA-C 109.995 -1.242 . . . . 0.0 109.995 179.398 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 44.6 tt0 -70.68 130.68 42.41 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.037 -1.273 . . . . 0.0 109.994 -179.653 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 86.6 m95 -104.76 131.14 52.57 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.725 -0.609 . . . . 0.0 109.677 -179.533 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.407 ' C ' HD22 ' A' ' 19' ' ' ASN . . . -178.71 177.13 0.91 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.486 -0.759 . . . . 0.0 109.851 179.586 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.719 ' ND2' ' H ' ' A' ' 71' ' ' SER . 3.0 m120 -105.06 145.18 30.85 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.626 -0.672 . . . . 0.0 109.568 -179.79 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 5.2 tt -141.89 134.74 28.68 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.293 -0.879 . . . . 0.0 110.263 179.743 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 19.4 ttpp -112.47 138.44 49.22 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 179.52 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -161.01 179.9 8.07 Favored 'General case' 0 N--CA 1.492 1.644 0 C-N-CA 119.364 -0.934 . . . . 0.0 110.116 -179.54 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 89.0 tttt -115.35 139.46 49.98 Favored 'General case' 0 N--CA 1.495 1.79 0 CA-C-O 121.717 0.77 . . . . 0.0 110.221 -179.453 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.429 HG22 ' CD2' ' A' ' 41' ' ' LEU . 75.8 t -78.24 129.2 37.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 CA-C-O 121.688 0.756 . . . . 0.0 110.534 -179.275 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.439 HD11 ' HA3' ' A' ' 42' ' ' GLY . 96.7 mt -102.32 -53.84 7.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 178.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 67.0 tp60 -147.14 148.86 32.0 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.249 -0.907 . . . . 0.0 109.668 -179.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.841 ' H ' HD23 ' A' ' 27' ' ' LEU . 1.2 pt? -141.44 135.62 30.49 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 179.529 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 3.6 m-90 -121.08 114.03 20.88 Favored 'General case' 0 N--CA 1.496 1.872 0 CA-C-O 121.545 0.688 . . . . 0.0 109.457 -179.569 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 17.3 pt-20 . . . . . 0 N--CA 1.49 1.555 0 O-C-N 121.584 -0.697 . . . . 0.0 109.789 179.917 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 71.2 p . . . . . 0 N--CA 1.498 1.945 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 83.7 mt -106.56 127.04 62.29 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 O-C-N 121.3 -0.875 . . . . 0.0 110.07 -179.817 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 44.8 m -73.15 -74.91 0.16 Allowed 'General case' 0 N--CA 1.49 1.554 0 CA-C-O 121.726 0.774 . . . . 0.0 109.797 179.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 15.3 pt20 -146.62 162.12 39.09 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.341 -0.849 . . . . 0.0 109.656 -179.357 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 34.0 m -132.05 158.65 43.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 CA-C-O 121.659 0.742 . . . . 0.0 109.708 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -178.72 -160.8 25.39 Favored Glycine 0 N--CA 1.486 2.03 0 N-CA-C 109.764 -1.334 . . . . 0.0 109.764 -179.557 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.884 HD23 ' H ' ' A' ' 40' ' ' LEU . 1.3 pt? -139.96 148.24 41.64 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.572 -0.958 . . . . 0.0 110.35 -179.728 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.429 ' CD2' HG22 ' A' ' 24' ' ' VAL . 40.3 mt -109.59 134.07 52.36 Favored 'General case' 0 N--CA 1.491 1.581 0 CA-C-O 121.541 0.686 . . . . 0.0 109.379 -179.46 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.439 ' HA3' HD11 ' A' ' 25' ' ' ILE . . . -82.85 162.59 41.16 Favored Glycine 0 N--CA 1.488 2.132 0 N-CA-C 110.228 -1.149 . . . . 0.0 110.228 -179.868 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.547 ' OD1' ' N ' ' A' ' 44' ' ' GLU . 67.5 t0 -172.98 143.56 1.18 Allowed 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.761 -0.846 . . . . 0.0 109.342 179.688 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.547 ' N ' ' OD1' ' A' ' 43' ' ' ASP . 96.7 mt-10 -54.76 -14.94 1.57 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.603 -0.686 . . . . 0.0 109.639 179.865 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 44.3 p -94.15 -11.0 31.36 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.129 -0.982 . . . . 0.0 109.566 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 140.32 -155.77 24.79 Favored Glycine 0 N--CA 1.497 2.709 0 N-CA-C 110.309 -1.116 . . . . 0.0 110.309 179.423 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 41.9 pt -126.68 150.8 32.73 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 O-C-N 121.707 -0.878 . . . . 0.0 109.892 -179.364 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 19.0 tt -143.94 141.83 24.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.555 -0.715 . . . . 0.0 109.625 179.319 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -85.31 155.83 21.18 Favored 'General case' 0 N--CA 1.491 1.592 0 CA-C-O 121.435 0.636 . . . . 0.0 110.362 -179.603 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 38.5 p90 -144.47 151.65 39.49 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.251 -0.906 . . . . 0.0 109.775 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 54.1 m -133.35 127.13 32.83 Favored 'General case' 0 N--CA 1.492 1.639 0 CA-C-O 121.546 0.688 . . . . 0.0 109.459 179.263 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 97.0 mt -95.1 124.39 47.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.54 -0.725 . . . . 0.0 109.81 179.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 90.2 m95 -82.67 105.99 14.16 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.422 -0.799 . . . . 0.0 109.065 179.334 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 73.8 tttt . . . . . 0 N--CA 1.491 1.605 0 CA-C-O 121.594 0.711 . . . . 0.0 109.723 -179.52 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 15.0 mt . . . . . 0 N--CA 1.491 1.598 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -66.19 151.8 82.69 Favored 'Trans proline' 0 C--N 1.31 -1.455 0 C-N-CA 122.5 2.133 . . . . 0.0 112.432 179.567 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 82.0 mt -68.84 137.51 53.98 Favored 'General case' 0 N--CA 1.488 1.444 0 CA-C-O 121.862 0.839 . . . . 0.0 110.514 -179.301 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.535 ' N ' HD12 ' A' ' 61' ' ' LEU . 10.3 mp -78.98 143.0 36.15 Favored 'General case' 0 N--CA 1.49 1.569 0 CA-C-O 121.656 0.741 . . . . 0.0 109.853 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 81.7 tt0 -85.78 138.69 31.9 Favored 'General case' 0 N--CA 1.49 1.546 0 CA-C-O 121.857 0.837 . . . . 0.0 110.182 -179.586 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 57.2 tt0 -74.61 136.78 41.99 Favored 'General case' 0 N--CA 1.489 1.489 0 CA-C-O 121.819 0.819 . . . . 0.0 111.329 -179.375 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 84.17 20.95 58.12 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 110.051 -1.219 . . . . 0.0 110.051 178.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -128.49 145.56 51.07 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.401 -1.058 . . . . 0.0 110.156 -179.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 11.5 m -83.22 144.8 29.53 Favored 'General case' 0 N--CA 1.488 1.439 0 CA-C-O 121.653 0.74 . . . . 0.0 110.192 -179.642 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 79.9 m-85 -138.24 149.18 45.5 Favored 'General case' 0 N--CA 1.491 1.597 0 CA-C-O 121.918 0.866 . . . . 0.0 109.908 179.757 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 35.0 tp -106.77 122.65 46.8 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 179.284 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 65.8 mt -101.11 130.24 47.13 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 179.836 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.436 ' CZ ' ' OE2' ' A' ' 92' ' ' GLU . 80.7 mtm180 -125.65 142.61 51.42 Favored 'General case' 0 N--CA 1.497 1.878 0 CA-C-O 121.865 0.841 . . . . 0.0 110.699 -178.848 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.719 ' H ' ' ND2' ' A' ' 19' ' ' ASN . 34.3 t 50.98 59.19 4.8 Favored 'General case' 0 N--CA 1.491 1.617 0 CA-C-N 115.683 -0.689 . . . . 0.0 111.032 179.118 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 6.4 m -111.49 160.68 10.64 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.989 0 O-C-N 121.406 -0.809 . . . . 0.0 109.633 178.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 7.4 p -118.41 134.24 62.65 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 CA-C-O 121.722 0.772 . . . . 0.0 109.604 -179.463 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 9.8 t -86.51 113.72 24.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 CA-C-O 121.824 0.821 . . . . 0.0 109.753 -179.499 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -90.65 143.87 17.02 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 110.112 -1.195 . . . . 0.0 110.112 -179.641 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -63.08 132.08 50.71 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.694 -0.886 . . . . 0.0 110.305 -179.816 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . 0.632 ' CD2' ' ND2' ' A' ' 78' ' ' ASN . 34.9 t80 -137.43 96.74 3.31 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.375 -0.828 . . . . 0.0 108.965 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . 0.632 ' ND2' ' CD2' ' A' ' 77' ' ' TYR . 21.1 p30 43.41 -141.93 0.15 Allowed 'General case' 0 N--CA 1.494 1.758 0 CA-C-O 121.631 0.729 . . . . 0.0 110.897 -179.897 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.515 ' N ' ' OD1' ' A' ' 78' ' ' ASN . 46.9 t0 -73.05 -2.49 21.46 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.43 -0.793 . . . . 0.0 109.098 -179.633 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.492 ' N ' ' OD1' ' A' ' 78' ' ' ASN . 29.9 mmt180 -115.53 -171.98 2.07 Favored 'General case' 0 N--CA 1.495 1.805 0 CA-C-O 122.047 0.927 . . . . 0.0 110.228 -179.286 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -127.83 155.72 43.67 Favored 'General case' 0 N--CA 1.492 1.652 0 CA-C-O 121.558 0.694 . . . . 0.0 109.873 -179.207 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 52.1 tt0 -139.59 151.84 46.36 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.544 -0.722 . . . . 0.0 109.741 -179.599 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 3.8 m -108.98 132.23 57.6 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 179.235 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 87.9 mt-30 -105.93 127.08 52.9 Favored 'General case' 0 N--CA 1.495 1.795 0 CA-C-O 121.784 0.802 . . . . 0.0 110.178 -178.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.59 HG11 HD11 ' A' ' 91' ' ' ILE . 21.3 t -95.74 132.89 38.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 179.277 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 15.8 p30 -139.14 -178.14 5.22 Favored 'General case' 0 N--CA 1.492 1.668 0 CA-C-O 121.884 0.849 . . . . 0.0 110.362 -179.207 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 63.7 tttp -56.91 -40.25 75.97 Favored 'General case' 0 N--CA 1.492 1.647 0 CA-C-O 121.474 0.654 . . . . 0.0 110.064 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 23.2 t-20 -60.33 -37.94 82.18 Favored 'General case' 0 C--N 1.296 -1.725 0 O-C-N 121.306 -0.871 . . . . 0.0 109.89 -179.85 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 15.5 p -75.43 162.28 28.49 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.02 -1.05 . . . . 0.0 110.847 -179.133 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 67.4 m -131.62 149.83 52.36 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 179.701 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.59 HD11 HG11 ' A' ' 85' ' ' VAL . 97.0 mt -128.14 132.21 68.65 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 O-C-N 121.599 -0.688 . . . . 0.0 109.69 -179.664 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.436 ' OE2' ' CZ ' ' A' ' 70' ' ' ARG . 86.0 mt-10 -124.99 131.8 53.36 Favored 'General case' 0 N--CA 1.5 2.069 0 CA-C-O 121.488 0.661 . . . . 0.0 109.513 -179.558 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 37.2 ttpt -82.36 118.38 23.13 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.424 -0.797 . . . . 0.0 109.653 -179.807 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.495 ' C ' ' H ' ' A' ' 96' ' ' GLU . 59.6 mt -111.63 130.66 55.69 Favored 'General case' 0 N--CA 1.495 1.812 0 CA-C-O 121.464 0.65 . . . . 0.0 109.459 -179.72 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 42.2 m -77.27 29.63 0.14 Allowed 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 179.358 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.495 ' H ' ' C ' ' A' ' 94' ' ' LEU . 72.5 tt0 -111.43 92.74 17.03 Favored Pre-proline 0 N--CA 1.493 1.72 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 -179.752 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -75.21 151.22 38.36 Favored 'Trans proline' 0 N--CA 1.491 1.358 0 C-N-CA 122.221 1.947 . . . . 0.0 112.219 -179.077 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 84.5 mt . . . . . 0 N--CA 1.493 1.699 0 CA-C-O 121.745 0.783 . . . . 0.0 109.511 -179.674 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo . . . . . 0 N--CA 1.495 1.588 0 CA-C-O 121.539 0.558 . . . . 0.0 112.555 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 84.9 mt-30 -76.41 91.89 3.34 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.152 -0.968 . . . . 0.0 108.723 179.45 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 82.6 mt -85.27 131.87 34.35 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.531 -0.731 . . . . 0.0 109.619 -179.071 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 99.9 m -123.64 131.01 53.51 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 179.841 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 71.5 mmtt -80.58 156.64 26.34 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-O 121.683 0.754 . . . . 0.0 110.362 -178.62 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 97.3 mt -62.89 -43.31 98.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.484 -0.76 . . . . 0.0 109.279 -179.798 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 14.5 p -66.28 -23.51 31.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.338 -0.851 . . . . 0.0 109.606 -179.743 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -78.49 -5.03 51.43 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.251 -0.905 . . . . 0.0 109.899 -179.778 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 96.7 mt -80.94 121.85 35.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 120.939 -1.101 . . . . 0.0 110.081 -179.579 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 31.2 m -146.55 10.25 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 179.172 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 48.2 tp10 -136.11 132.96 36.77 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.341 -0.849 . . . . 0.0 109.745 -179.782 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.488 ' ND2' ' CE1' ' A' ' 81' ' ' PHE . 11.4 m120 -82.38 142.04 32.31 Favored 'General case' 0 C--N 1.306 -1.311 0 O-C-N 121.347 -0.846 . . . . 0.0 110.431 -179.828 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 75.68 98.93 0.13 Allowed Glycine 0 N--CA 1.49 2.258 0 N-CA-C 110.032 -1.227 . . . . 0.0 110.032 179.232 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 14.1 pt20 -173.45 141.29 0.88 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.159 -1.201 . . . . 0.0 109.702 179.282 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 71.0 m95 -94.0 137.06 33.63 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.615 -0.678 . . . . 0.0 109.781 -179.549 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -175.58 177.68 1.72 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.139 -0.976 . . . . 0.0 109.639 179.745 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 81.4 m-20 -106.59 147.49 29.4 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.602 -0.686 . . . . 0.0 109.639 -179.703 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 40.2 tp -140.79 133.29 28.51 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.342 -0.849 . . . . 0.0 109.892 179.717 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 35.7 ttpt -117.29 137.78 52.18 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 178.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -161.81 174.91 12.52 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.869 -1.145 . . . . 0.0 110.194 -179.582 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 65.1 tttm -110.32 133.29 53.4 Favored 'General case' 0 N--CA 1.495 1.818 0 CA-C-O 121.517 0.675 . . . . 0.0 109.848 -179.753 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.482 HG22 ' CD2' ' A' ' 41' ' ' LEU . 67.1 t -77.77 126.94 38.5 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 O-C-N 121.369 -0.832 . . . . 0.0 109.745 -179.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 23.2 pt -108.8 -34.0 2.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 179.368 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.72 ' NE2' ' HE1' ' A' ' 28' ' ' TRP . 50.3 tt0 -163.73 133.79 4.24 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.115 -0.991 . . . . 0.0 109.647 178.872 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.506 ' O ' HD12 ' A' ' 27' ' ' LEU . 0.3 OUTLIER -131.46 136.64 48.12 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 -179.83 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . 0.72 ' HE1' ' NE2' ' A' ' 26' ' ' GLN . 5.2 m0 -113.96 124.61 52.59 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.472 -0.768 . . . . 0.0 109.493 -179.595 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 2.9 pp20? . . . . . 0 N--CA 1.488 1.46 0 O-C-N 121.544 -0.722 . . . . 0.0 109.36 -179.921 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 5.1 p . . . . . 0 N--CA 1.499 1.988 0 N-CA-C 109.384 -0.599 . . . . 0.0 109.384 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 96.2 mt -109.9 118.06 56.06 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 CA-C-O 121.617 0.722 . . . . 0.0 109.83 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 44.1 t -77.79 -49.0 15.23 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.604 -0.685 . . . . 0.0 109.51 179.674 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 33.6 tt0 -147.34 153.48 39.75 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.222 -0.924 . . . . 0.0 110.016 -179.708 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 9.1 p -142.95 143.27 25.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.573 -0.704 . . . . 0.0 109.259 179.156 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -173.99 -154.27 10.61 Favored Glycine 0 N--CA 1.485 1.95 0 C-N-CA 119.534 -1.317 . . . . 0.0 109.941 -179.645 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.617 ' H ' HD12 ' A' ' 40' ' ' LEU . 0.1 OUTLIER -136.8 151.3 49.01 Favored 'General case' 0 N--CA 1.501 2.082 0 O-C-N 121.555 -0.968 . . . . 0.0 109.494 -179.019 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.482 ' CD2' HG22 ' A' ' 24' ' ' VAL . 66.3 mt -115.08 126.44 54.69 Favored 'General case' 0 N--CA 1.495 1.803 0 CA-C-O 121.597 0.713 . . . . 0.0 109.413 179.892 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -75.72 158.69 50.35 Favored Glycine 0 N--CA 1.488 2.157 0 N-CA-C 110.807 -0.917 . . . . 0.0 110.807 -179.443 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -170.97 151.65 3.35 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.519 -0.989 . . . . 0.0 109.07 179.253 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 17.6 pt-20 -59.41 -15.12 14.97 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.27 -0.894 . . . . 0.0 109.546 179.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 39.2 p -92.6 -13.14 30.04 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.093 -1.004 . . . . 0.0 109.279 -179.453 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 140.79 -151.47 22.44 Favored Glycine 0 N--CA 1.496 2.635 0 N-CA-C 109.987 -1.245 . . . . 0.0 109.987 179.353 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 96.7 mt -126.25 138.87 53.27 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 O-C-N 121.729 -0.865 . . . . 0.0 109.234 -179.815 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.556 HD11 ' O ' ' A' ' 81' ' ' PHE . 9.6 tp -128.28 143.59 40.49 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 CA-C-O 121.789 0.804 . . . . 0.0 110.152 -179.727 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 19.1 mmmt -84.01 147.89 27.18 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.688 -0.633 . . . . 0.0 109.874 180.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 21.1 p90 -144.14 159.95 41.76 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.244 -0.91 . . . . 0.0 109.298 179.843 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 1.6 t -145.33 141.44 28.53 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.401 -0.812 . . . . 0.0 109.829 179.611 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 98.4 mt -107.43 118.7 55.67 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 O-C-N 121.573 -0.704 . . . . 0.0 109.316 179.596 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 59.3 m95 -86.34 139.42 30.99 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.158 -0.964 . . . . 0.0 110.139 -179.212 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 68.1 mttm . . . . . 0 N--CA 1.491 1.598 0 O-C-N 121.408 -0.807 . . . . 0.0 109.875 179.848 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 51.1 mt . . . . . 0 N--CA 1.496 1.84 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -68.26 162.05 42.03 Favored 'Trans proline' 0 N--CA 1.498 1.758 0 C-N-CA 122.707 2.271 . . . . 0.0 112.811 179.632 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 67.6 mt -64.77 149.79 48.62 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.317 -0.864 . . . . 0.0 110.682 -178.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.558 ' N ' HD12 ' A' ' 61' ' ' LEU . 10.7 mp -88.22 138.42 31.46 Favored 'General case' 0 N--CA 1.492 1.666 0 CA-C-O 121.572 0.701 . . . . 0.0 110.188 -179.239 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.467 ' N ' ' OH ' ' A' ' 67' ' ' TYR . 52.9 tp10 -66.43 137.01 56.55 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.407 -0.808 . . . . 0.0 110.054 -179.57 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.442 HE21 ' HA ' ' A' ' 26' ' ' GLN . 49.8 tt0 -73.18 135.66 44.65 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.564 -0.71 . . . . 0.0 110.68 -179.255 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 83.84 29.82 30.87 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 110.037 -1.225 . . . . 0.0 110.037 179.047 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -136.41 146.54 46.53 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.168 -1.195 . . . . 0.0 110.426 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 11.8 p -79.01 152.09 31.16 Favored 'General case' 0 N--CA 1.487 1.4 0 CA-C-O 121.542 0.686 . . . . 0.0 110.141 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.467 ' OH ' ' N ' ' A' ' 62' ' ' GLU . 89.9 m-85 -144.47 147.59 33.48 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.412 -0.805 . . . . 0.0 109.662 179.698 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 15.7 tp -111.36 120.93 43.86 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 179.548 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 60.7 mt -97.32 134.85 40.05 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.534 -0.729 . . . . 0.0 109.313 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 79.1 mtp85 -128.19 138.96 52.7 Favored 'General case' 0 N--CA 1.497 1.897 0 CA-C-O 121.507 0.67 . . . . 0.0 110.388 -179.83 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 18.4 m 57.12 61.14 2.67 Favored 'General case' 0 N--CA 1.493 1.718 0 CA-C-O 121.005 0.431 . . . . 0.0 110.534 179.47 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 15.5 m -116.03 159.73 15.81 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.993 0 O-C-N 121.49 -0.756 . . . . 0.0 109.441 178.822 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 14.2 p -114.85 134.66 57.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 CA-C-O 121.474 0.654 . . . . 0.0 109.498 -179.361 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 11.7 t -88.29 113.56 25.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.298 -0.876 . . . . 0.0 109.744 -179.294 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -98.57 172.76 26.48 Favored Glycine 0 N--CA 1.493 2.484 0 N-CA-C 109.914 -1.275 . . . . 0.0 109.914 -179.797 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 81.3 tt0 -112.85 122.77 48.62 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.742 -0.858 . . . . 0.0 109.253 179.661 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 75.7 t80 -135.7 126.59 27.6 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.522 -0.736 . . . . 0.0 109.756 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 9.3 t-20 57.11 44.09 23.09 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.574 -0.704 . . . . 0.0 109.924 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 55.03 28.83 11.34 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.549 -0.72 . . . . 0.0 109.445 179.691 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 71.7 ttt180 -130.78 152.2 50.38 Favored 'General case' 0 N--CA 1.497 1.876 0 CA-C-O 121.516 0.674 . . . . 0.0 109.771 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . 0.556 ' O ' HD11 ' A' ' 48' ' ' ILE . 91.6 m-85 -84.66 142.64 29.76 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.433 -0.792 . . . . 0.0 109.733 -179.835 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 7.1 pt20 -153.24 165.26 36.28 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.15 -0.969 . . . . 0.0 109.711 179.871 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 3.2 m -109.1 132.35 57.4 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.013 0 O-C-N 121.495 -0.753 . . . . 0.0 109.811 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 23.6 mt-30 -113.3 121.84 45.62 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 -179.777 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 27.8 t -91.18 129.5 41.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.298 -0.876 . . . . 0.0 109.9 -179.655 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 11.2 m-80 -140.88 -177.78 5.24 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.45 -0.781 . . . . 0.0 109.258 179.83 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.523 ' C ' ' H ' ' A' ' 89' ' ' SER . 63.0 pttt -44.3 164.79 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.575 -0.703 . . . . 0.0 111.02 -179.681 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 5.3 t30 72.15 -29.84 0.2 Allowed 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 -179.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.523 ' H ' ' C ' ' A' ' 87' ' ' LYS . 7.2 m -69.65 150.79 46.64 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.403 -0.81 . . . . 0.0 110.196 -179.522 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 46.9 t -132.56 146.55 51.99 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 96.8 mt -126.14 132.53 70.42 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 O-C-N 121.584 -0.698 . . . . 0.0 109.293 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -125.87 130.3 51.07 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.594 -0.691 . . . . 0.0 109.493 179.649 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 64.5 tttm -79.1 131.21 36.17 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.455 -0.778 . . . . 0.0 109.679 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 85.8 mt -110.22 137.49 47.88 Favored 'General case' 0 N--CA 1.498 1.927 0 CA-C-O 121.792 0.806 . . . . 0.0 110.174 -179.872 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 93.8 p -85.62 13.49 6.94 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.646 -0.658 . . . . 0.0 109.43 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 86.4 mt-10 -117.4 90.7 35.44 Favored Pre-proline 0 N--CA 1.499 2.002 0 O-C-N 121.674 -0.641 . . . . 0.0 109.491 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_exo -56.15 150.01 50.79 Favored 'Trans proline' 0 N--CA 1.499 1.818 0 C-N-CA 122.946 2.431 . . . . 0.0 112.758 179.518 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.536 HG22 ' O ' ' A' ' 98' ' ' ILE . 48.1 mm . . . . . 0 N--CA 1.488 1.457 0 O-C-N 121.261 -0.899 . . . . 0.0 109.527 -179.533 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo . . . . . 0 N--CA 1.496 1.644 0 CA-C-O 121.551 0.563 . . . . 0.0 112.435 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 18.3 mm100 -76.6 92.62 3.5 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.082 -1.011 . . . . 0.0 109.58 -179.711 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 72.7 mt -76.34 138.05 40.22 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.501 -0.749 . . . . 0.0 109.638 -179.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 54.1 m -130.09 131.94 45.94 Favored 'General case' 0 N--CA 1.495 1.808 0 CA-C-O 121.427 0.632 . . . . 0.0 109.478 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 65.0 mttp -85.52 157.37 20.44 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.366 -0.834 . . . . 0.0 110.119 -179.51 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 96.2 mt -62.71 -43.48 98.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.352 -0.843 . . . . 0.0 109.393 -179.711 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 12.2 p -66.29 -22.93 30.89 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.206 -0.934 . . . . 0.0 109.667 -179.673 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.408 ' O ' ' OD1' ' A' ' 10' ' ' ASP . 57.7 t0 -73.75 -4.03 32.06 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.2 -0.937 . . . . 0.0 109.388 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 96.6 mt -74.96 125.92 35.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.141 -0.974 . . . . 0.0 109.767 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 4.1 m -129.15 -31.06 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 N-CA-C 109.241 -0.652 . . . . 0.0 109.241 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 -135.08 145.26 47.76 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.379 -0.825 . . . . 0.0 110.296 -179.515 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 64.2 m-80 -78.83 154.88 29.49 Favored 'General case' 0 C--N 1.306 -1.312 0 CA-C-O 121.514 0.673 . . . . 0.0 110.517 -179.595 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 88.69 8.21 70.44 Favored Glycine 0 N--CA 1.492 2.402 0 N-CA-C 109.136 -1.585 . . . . 0.0 109.136 179.638 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 18.4 tt0 -77.29 132.85 38.85 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.371 -1.076 . . . . 0.0 109.992 -179.649 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 89.5 m95 -99.56 134.25 42.7 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.39 -0.819 . . . . 0.0 110.006 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -179.9 -175.1 0.3 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.493 -0.754 . . . . 0.0 109.198 179.463 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.599 ' ND2' ' H ' ' A' ' 71' ' ' SER . 5.4 m120 -105.14 153.31 21.7 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.578 -0.701 . . . . 0.0 109.574 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 54.3 tp -139.58 137.85 35.72 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.536 -0.728 . . . . 0.0 109.303 179.492 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 35.9 ttpt -128.25 133.36 48.79 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.683 -0.635 . . . . 0.0 109.475 179.362 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -168.17 177.7 5.37 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.444 -0.785 . . . . 0.0 109.355 179.317 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.427 ' NZ ' ' O ' ' A' ' 98' ' ' ILE . 17.0 ptpt -107.21 146.28 31.6 Favored 'General case' 0 N--CA 1.496 1.861 0 CA-C-O 121.672 0.749 . . . . 0.0 110.179 -179.563 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.465 HG22 ' CD2' ' A' ' 41' ' ' LEU . 78.9 t -85.03 97.88 5.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.561 -0.712 . . . . 0.0 110.093 -179.282 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 37.2 mm -65.72 -44.8 93.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.484 -0.76 . . . . 0.0 109.089 179.703 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 68.1 tp60 -151.22 148.45 28.24 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.239 -0.913 . . . . 0.0 109.321 179.405 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.963 HD23 ' H ' ' A' ' 27' ' ' LEU . 1.3 pt? -128.5 145.22 51.18 Favored 'General case' 0 N--CA 1.494 1.754 0 CA-C-O 121.219 0.533 . . . . 0.0 109.976 -179.857 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 97.6 m95 -128.21 101.53 6.29 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 178.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.674 ' CD ' ' H ' ' A' ' 29' ' ' GLU . 1.6 pm0 . . . . . 0 N--CA 1.492 1.643 0 O-C-N 121.583 -0.698 . . . . 0.0 110.605 -178.82 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 20.8 t . . . . . 0 N--CA 1.495 1.824 0 CA-C-O 121.157 0.503 . . . . 0.0 110.435 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 31.7 mt -78.64 132.22 32.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.183 -0.948 . . . . 0.0 110.199 -178.264 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 8.7 t -98.91 -60.89 1.45 Allowed 'General case' 0 N--CA 1.494 1.727 0 CA-C-O 121.576 0.703 . . . . 0.0 109.283 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -150.36 150.3 31.24 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.257 -0.902 . . . . 0.0 109.565 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 28.7 m -135.57 160.15 39.87 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 O-C-N 121.5 -0.75 . . . . 0.0 109.762 179.724 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 178.6 -166.97 37.13 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -132.9 148.84 52.29 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.404 -1.056 . . . . 0.0 109.898 179.857 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.465 ' CD2' HG22 ' A' ' 24' ' ' VAL . 51.6 mt -111.73 130.72 55.7 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 -179.002 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -97.66 148.31 18.9 Favored Glycine 0 N--CA 1.493 2.493 0 N-CA-C 110.648 -0.981 . . . . 0.0 110.648 -179.362 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.434 ' OD1' ' O ' ' A' ' 46' ' ' GLY . 49.0 p30 -173.24 166.65 4.86 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.691 -0.888 . . . . 0.0 108.948 178.886 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 78.5 tt0 -61.56 -16.62 49.51 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.337 -0.852 . . . . 0.0 110.018 -179.347 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 82.7 p -85.48 0.25 52.89 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.952 -1.092 . . . . 0.0 109.212 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.434 ' O ' ' OD1' ' A' ' 43' ' ' ASP . . . 116.05 -147.94 18.9 Favored Glycine 0 N--CA 1.499 2.872 0 N-CA-C 110.241 -1.144 . . . . 0.0 110.241 178.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 96.9 mt -132.57 137.68 53.67 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 121.6 -0.941 . . . . 0.0 109.489 -179.419 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 19.7 tt -134.89 140.88 44.54 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 O-C-N 121.561 -0.712 . . . . 0.0 109.72 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 18.8 mtpp -83.46 155.02 23.63 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.491 -0.755 . . . . 0.0 109.669 -179.806 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 34.2 p90 -141.74 151.83 43.26 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.313 -0.867 . . . . 0.0 109.724 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 52.6 m -131.9 130.81 42.09 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 179.723 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 90.7 mt -102.62 124.05 56.35 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.381 -0.825 . . . . 0.0 110.253 -179.295 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 85.3 m95 -92.99 130.97 38.38 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.418 -0.801 . . . . 0.0 108.936 179.698 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 17.4 ptpt . . . . . 0 N--CA 1.49 1.528 0 O-C-N 121.23 -0.919 . . . . 0.0 109.632 -179.656 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 16.7 mt . . . . . 0 N--CA 1.491 1.616 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -71.46 155.49 59.7 Favored 'Trans proline' 0 N--CA 1.498 1.739 0 C-N-CA 122.656 2.238 . . . . 0.0 112.759 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 79.7 mt -76.43 141.56 41.35 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.398 -0.814 . . . . 0.0 109.95 -179.743 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.625 ' N ' HD12 ' A' ' 61' ' ' LEU . 10.0 mp -81.96 145.54 30.23 Favored 'General case' 0 N--CA 1.488 1.458 0 CA-C-O 121.491 0.662 . . . . 0.0 110.286 -179.169 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.545 ' N ' ' OE1' ' A' ' 62' ' ' GLU . 58.2 mp0 -93.14 144.95 24.78 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.404 -0.81 . . . . 0.0 109.922 -179.488 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 57.9 tt0 -76.55 142.25 40.88 Favored 'General case' 0 N--CA 1.489 1.515 0 CA-C-O 121.505 0.669 . . . . 0.0 111.205 -178.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 81.85 21.22 61.85 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 110.253 -1.139 . . . . 0.0 110.253 178.817 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -130.3 146.29 51.87 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.32 -1.106 . . . . 0.0 110.614 -179.68 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 11.6 p -80.37 151.81 29.22 Favored 'General case' 0 N--CA 1.488 1.473 0 CA-C-O 121.513 0.673 . . . . 0.0 110.002 -179.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -144.72 145.64 31.8 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.408 -0.808 . . . . 0.0 109.517 179.803 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 20.2 tp -110.24 122.51 47.81 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 179.398 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 69.6 mt -100.73 134.54 43.55 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 82.6 mtp180 -126.51 140.87 52.12 Favored 'General case' 0 N--CA 1.498 1.964 0 CA-C-O 121.729 0.776 . . . . 0.0 110.701 -179.268 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.599 ' H ' ' ND2' ' A' ' 19' ' ' ASN . 38.3 t 53.58 71.57 0.49 Allowed 'General case' 0 N--CA 1.491 1.583 0 CA-C-O 121.095 0.474 . . . . 0.0 110.514 179.524 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 18.0 m -128.93 164.19 31.9 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.023 0 O-C-N 121.578 -0.701 . . . . 0.0 109.336 178.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 9.7 p -120.45 135.83 59.42 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 CA-C-O 121.416 0.627 . . . . 0.0 109.418 -179.599 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 11.6 t -85.61 115.47 27.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.391 -0.818 . . . . 0.0 110.071 -178.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -94.17 -178.66 38.73 Favored Glycine 0 N--CA 1.492 2.419 0 N-CA-C 109.312 -1.515 . . . . 0.0 109.312 179.772 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -112.0 133.35 54.23 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.663 -0.904 . . . . 0.0 109.629 -179.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 91.3 t80 -136.49 108.1 6.98 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.418 -0.801 . . . . 0.0 109.147 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . 0.504 ' CG ' ' H ' ' A' ' 79' ' ' ASP . 66.7 t30 51.48 -134.38 1.63 Allowed 'General case' 0 N--CA 1.493 1.698 0 CA-C-O 121.603 0.716 . . . . 0.0 110.823 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.504 ' H ' ' CG ' ' A' ' 78' ' ' ASN . 36.5 t70 -87.1 -7.24 58.24 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.344 -0.848 . . . . 0.0 109.201 -179.389 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 85.2 mtp180 -108.56 173.98 6.08 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.711 -0.618 . . . . 0.0 109.763 -179.543 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 72.7 m-85 -104.74 155.85 18.52 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.605 -0.684 . . . . 0.0 109.944 -179.388 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 51.3 tt0 -138.35 153.19 48.97 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 -179.662 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 3.3 m -116.05 131.94 67.06 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 179.551 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 87.8 mt-30 -101.42 135.28 43.17 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.504 -0.748 . . . . 0.0 110.178 -178.74 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 71.4 t -107.09 130.55 58.97 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 179.274 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 79.2 m-20 -124.83 -179.57 4.58 Favored 'General case' 0 N--CA 1.496 1.854 0 CA-C-O 121.507 0.67 . . . . 0.0 109.911 -179.327 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 64.0 tttp -58.94 -41.0 86.35 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.592 -0.692 . . . . 0.0 110.043 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . 0.411 ' O ' ' OD1' ' A' ' 88' ' ' ASN . 41.9 t-20 -60.5 -35.67 76.51 Favored 'General case' 0 C--N 1.299 -1.602 0 O-C-N 121.109 -0.995 . . . . 0.0 109.112 -179.915 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 30.9 t -70.0 152.76 44.05 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.28 -0.887 . . . . 0.0 110.089 -179.519 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 35.3 t -128.74 148.91 50.88 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.601 -0.687 . . . . 0.0 109.495 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 96.2 mt -123.66 132.8 70.76 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 O-C-N 121.713 -0.617 . . . . 0.0 109.381 -179.782 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 82.5 tt0 -126.08 131.2 52.17 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 179.392 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.42 ' C ' HD12 ' A' ' 94' ' ' LEU . 37.8 ttmt -79.81 131.37 35.88 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.487 -0.758 . . . . 0.0 109.923 -179.568 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.438 ' N ' HD12 ' A' ' 94' ' ' LEU . 9.9 mp -101.08 137.31 39.62 Favored 'General case' 0 N--CA 1.493 1.685 0 CA-C-O 121.615 0.721 . . . . 0.0 109.644 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 70.3 m -90.4 6.33 43.7 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.649 -0.657 . . . . 0.0 109.501 -179.772 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.471 ' CD ' ' N ' ' A' ' 96' ' ' GLU . 1.3 pm0 -116.34 91.67 33.81 Favored Pre-proline 0 N--CA 1.499 1.975 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_exo -53.94 149.24 35.09 Favored 'Trans proline' 0 N--CA 1.495 1.611 0 C-N-CA 122.372 2.048 . . . . 0.0 112.249 -179.811 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.427 ' O ' ' NZ ' ' A' ' 23' ' ' LYS . 96.7 mt . . . . . 0 N--CA 1.493 1.722 0 CA-C-O 121.673 0.749 . . . . 0.0 110.644 -178.453 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo . . . . . 0 N--CA 1.496 1.635 0 CA-C-O 121.554 0.564 . . . . 0.0 112.715 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 58.9 tt0 -74.59 93.46 2.52 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.237 -0.915 . . . . 0.0 109.586 -179.775 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 86.6 mt -84.93 129.51 34.79 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.428 -0.795 . . . . 0.0 109.579 -179.694 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 98.7 m -127.76 131.21 49.67 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.621 -0.674 . . . . 0.0 110.042 -179.54 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -84.34 158.77 21.05 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.572 -0.705 . . . . 0.0 109.962 -179.79 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 97.3 mt -62.78 -43.7 98.95 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.289 -0.882 . . . . 0.0 109.553 -179.546 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 14.9 p -67.7 -21.94 27.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.188 -0.945 . . . . 0.0 109.404 -179.638 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -76.24 -4.15 40.35 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.373 -0.829 . . . . 0.0 109.184 179.634 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 96.7 mt -80.42 116.13 24.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.305 -0.872 . . . . 0.0 109.353 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 27.0 m -119.52 -19.92 5.15 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.875 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 179.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 22.1 pt-20 -139.34 141.62 37.65 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.42 -0.8 . . . . 0.0 109.955 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 23.3 p30 -86.15 167.0 15.32 Favored 'General case' 0 N--CA 1.491 1.59 0 CA-C-O 121.478 0.656 . . . . 0.0 110.378 -179.619 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 80.57 3.17 90.15 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.188 -1.565 . . . . 0.0 109.188 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 14.5 pt20 -84.58 145.68 27.92 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.321 -1.105 . . . . 0.0 110.106 -179.609 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' TRP . . . . . 0.439 ' CD1' ' N ' ' A' ' 17' ' ' TRP . 31.6 m95 -101.92 138.83 38.37 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.671 -0.643 . . . . 0.0 110.063 -179.593 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.456 ' C ' HD22 ' A' ' 19' ' ' ASN . . . -178.9 -170.08 0.18 Allowed 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 179.358 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.456 HD22 ' C ' ' A' ' 18' ' ' ALA . 3.3 m120 -108.32 149.54 28.52 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.544 -0.723 . . . . 0.0 109.567 -179.85 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.615 HD13 ' N ' ' A' ' 21' ' ' LYS . 0.3 OUTLIER -137.7 121.24 17.24 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 179.469 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.615 ' N ' HD13 ' A' ' 20' ' ' LEU . 36.4 ttpt -110.48 139.75 45.4 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.666 -0.646 . . . . 0.0 109.771 179.577 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -167.78 -174.03 2.31 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.31 -0.868 . . . . 0.0 109.789 179.553 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 76.0 tttt -118.12 144.16 45.89 Favored 'General case' 0 N--CA 1.501 2.085 0 CA-C-O 121.545 0.688 . . . . 0.0 109.733 -179.663 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.419 HG12 ' OE1' ' A' ' 63' ' ' GLN . 4.7 t -78.77 120.88 30.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.429 -0.794 . . . . 0.0 111.059 -178.59 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 32.7 mm -94.57 -49.05 12.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 179.13 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 57.8 tt0 -153.92 149.68 27.55 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.406 -0.809 . . . . 0.0 109.482 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 95.0 mt -121.0 145.12 48.09 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.762 -0.586 . . . . 0.0 109.832 -179.872 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 2.1 t-105 -128.95 111.59 13.19 Favored 'General case' 0 N--CA 1.495 1.786 0 CA-C-O 121.55 0.691 . . . . 0.0 109.358 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 39.2 tp10 . . . . . 0 C--N 1.302 -1.498 0 O-C-N 121.494 -0.754 . . . . 0.0 109.776 -179.629 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.494 1.739 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 86.8 mt -108.99 128.91 64.48 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 O-C-N 121.477 -0.764 . . . . 0.0 109.605 -179.445 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 24.1 t -87.19 -68.46 0.75 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.616 -0.678 . . . . 0.0 109.901 -179.446 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 89.7 mt-30 -132.95 148.11 52.28 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.514 -0.742 . . . . 0.0 109.447 -179.374 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 44.6 t -128.99 134.46 64.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -158.7 -162.24 11.74 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -140.1 145.5 37.7 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.446 -1.032 . . . . 0.0 109.635 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 45.0 mt -115.04 133.07 56.35 Favored 'General case' 0 N--CA 1.496 1.829 0 CA-C-O 121.575 0.702 . . . . 0.0 109.583 -179.155 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -92.96 140.52 15.11 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 110.385 -1.086 . . . . 0.0 110.385 -179.588 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 39.7 t0 -148.41 159.12 44.34 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.52 -0.988 . . . . 0.0 108.682 179.343 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -66.6 -20.7 66.06 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.221 -0.925 . . . . 0.0 109.669 -179.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 58.4 p -79.66 -10.15 59.75 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.144 -0.973 . . . . 0.0 109.347 -179.856 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 139.21 -164.3 25.9 Favored Glycine 0 N--CA 1.496 2.677 0 N-CA-C 109.455 -1.458 . . . . 0.0 109.455 179.507 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 34.4 mm -114.58 132.05 64.87 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.0 0 O-C-N 121.631 -0.923 . . . . 0.0 108.81 -179.701 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 18.1 tt -133.5 141.41 44.44 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 O-C-N 121.577 -0.702 . . . . 0.0 110.003 -179.588 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -90.71 156.95 17.7 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.592 -0.692 . . . . 0.0 110.459 -179.349 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 8.6 p90 -146.08 160.51 41.8 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.241 -0.912 . . . . 0.0 109.622 179.501 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.435 HG23 ' HE1' ' A' ' 53' ' ' TRP . 1.6 t -141.25 141.41 34.0 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 179.335 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 87.5 mt -106.66 125.79 62.53 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 O-C-N 121.53 -0.731 . . . . 0.0 109.734 -179.581 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' TRP . . . . . 0.529 ' N ' ' CD1' ' A' ' 53' ' ' TRP . 13.5 m95 -99.98 147.59 25.42 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.528 -0.732 . . . . 0.0 109.733 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 54.0 mtmt . . . . . 0 N--CA 1.49 1.557 0 O-C-N 121.431 -0.793 . . . . 0.0 109.448 179.854 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 17.4 mt . . . . . 0 N--CA 1.497 1.892 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -54.97 149.25 43.58 Favored 'Trans proline' 0 N--CA 1.502 2.021 0 C-N-CA 122.292 1.995 . . . . 0.0 113.071 179.546 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 61.8 mt -65.72 140.07 58.42 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.432 -0.793 . . . . 0.0 110.33 -179.102 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.535 ' N ' HD12 ' A' ' 61' ' ' LEU . 10.8 mp -77.95 141.84 38.74 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.53 -0.731 . . . . 0.0 110.016 -179.551 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -90.19 150.86 21.81 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.468 -0.77 . . . . 0.0 109.974 -179.815 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.419 ' OE1' HG12 ' A' ' 24' ' ' VAL . 2.9 mm100 -81.96 145.19 30.41 Favored 'General case' 0 N--CA 1.493 1.709 0 CA-C-O 122.018 0.914 . . . . 0.0 112.006 -178.17 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 70.0 31.33 69.63 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 110.576 -1.01 . . . . 0.0 110.576 178.074 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 91.7 mt-10 -136.08 147.68 47.96 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.303 -1.116 . . . . 0.0 110.218 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 10.6 m -80.68 149.68 29.68 Favored 'General case' 0 N--CA 1.487 1.419 0 CA-C-O 121.324 0.583 . . . . 0.0 109.62 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 30.3 m-85 -144.04 142.48 30.68 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.398 -0.814 . . . . 0.0 109.107 179.531 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 14.5 tp -108.57 120.93 43.88 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 179.237 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 76.3 mt -100.51 132.81 45.7 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.512 -0.742 . . . . 0.0 109.297 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.408 ' O ' ' CB ' ' A' ' 71' ' ' SER . 89.8 mtm180 -127.02 131.87 50.88 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.797 -0.564 . . . . 0.0 110.059 -179.956 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.408 ' CB ' ' O ' ' A' ' 70' ' ' ARG . 1.1 m 75.88 54.9 0.06 Allowed 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 179.677 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 15.8 m -117.13 161.34 15.96 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.173 0 O-C-N 121.607 -0.683 . . . . 0.0 109.465 179.236 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 14.1 p -120.47 140.59 44.08 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 CA-C-O 121.499 0.666 . . . . 0.0 109.514 -179.325 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 99.6 t -84.56 120.35 35.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.445 -0.784 . . . . 0.0 110.139 -178.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -97.3 174.42 29.73 Favored Glycine 0 N--CA 1.493 2.48 0 N-CA-C 109.714 -1.354 . . . . 0.0 109.714 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.547 ' N ' ' OE1' ' A' ' 76' ' ' GLU . 54.4 mp0 -112.72 119.48 38.22 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.766 -0.844 . . . . 0.0 109.027 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . 0.528 ' CE2' ' OD1' ' A' ' 78' ' ' ASN . 85.0 t80 -136.98 124.43 22.08 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.418 -0.801 . . . . 0.0 110.139 -179.846 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . 0.528 ' OD1' ' CE2' ' A' ' 77' ' ' TYR . 7.0 m120 55.53 38.37 30.13 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.76 -0.587 . . . . 0.0 109.901 179.356 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 25.7 t0 66.83 -4.08 0.83 Allowed 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.603 -0.686 . . . . 0.0 109.513 179.665 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.417 ' H ' ' C ' ' A' ' 78' ' ' ASN . 80.1 mtp85 -93.72 -177.26 4.31 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.303 -0.873 . . . . 0.0 109.459 179.773 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -114.86 137.17 52.28 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.571 -0.706 . . . . 0.0 109.605 -179.67 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -143.25 159.63 41.98 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.385 -0.822 . . . . 0.0 109.645 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.402 HG23 ' O ' ' A' ' 83' ' ' VAL . 22.5 m -104.08 131.72 52.21 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 179.662 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -102.25 114.67 29.03 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.356 -0.84 . . . . 0.0 109.422 -179.289 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 12.1 t -88.56 103.67 14.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.458 -0.776 . . . . 0.0 109.277 -179.81 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 2.0 p30 -151.14 -179.76 7.6 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.383 -0.823 . . . . 0.0 109.586 179.773 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 49.2 tttm 67.43 -132.58 0.13 Allowed 'General case' 0 N--CA 1.495 1.807 0 CA-C-O 121.491 0.663 . . . . 0.0 110.822 179.436 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . 0.409 ' O ' ' C ' ' A' ' 89' ' ' SER . 10.2 m120 -95.47 13.19 26.8 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.244 -0.91 . . . . 0.0 109.047 -179.198 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.409 ' C ' ' O ' ' A' ' 88' ' ' ASN . 97.7 p -40.94 110.18 0.15 Allowed 'General case' 0 N--CA 1.495 1.817 0 CA-C-O 121.589 0.709 . . . . 0.0 109.646 -179.514 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 12.1 m -80.52 151.02 29.41 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.577 -0.702 . . . . 0.0 109.728 -179.051 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 96.7 mt -132.36 132.07 60.53 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 121.52 -0.738 . . . . 0.0 109.501 179.748 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 52.5 tp10 -128.28 134.61 48.97 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 179.697 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.426 ' C ' HD22 ' A' ' 94' ' ' LEU . 38.7 ttpt -85.02 131.05 34.52 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.569 -0.707 . . . . 0.0 110.265 -179.457 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.471 HD22 ' N ' ' A' ' 94' ' ' LEU . 4.1 mm? -99.32 132.07 44.9 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.472 -0.768 . . . . 0.0 109.601 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 73.2 m -84.26 15.66 3.45 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 179.634 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 17.6 tp10 -118.05 89.83 35.71 Favored Pre-proline 0 N--CA 1.498 1.938 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 179.504 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -57.69 144.49 92.88 Favored 'Trans proline' 0 N--CA 1.498 1.745 0 C-N-CA 122.561 2.174 . . . . 0.0 112.208 179.659 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 90.5 mt . . . . . 0 N--CA 1.498 1.928 0 O-C-N 121.51 -0.744 . . . . 0.0 109.772 -179.828 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_exo . . . . . 0 N--CA 1.493 1.498 0 CA-C-O 121.672 0.613 . . . . 0.0 112.393 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 21.4 mp0 -88.17 75.69 8.59 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.143 -0.973 . . . . 0.0 108.936 179.675 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 84.3 mt -69.45 143.84 53.45 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.47 -0.769 . . . . 0.0 109.665 -179.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 93.9 m -125.15 128.83 49.02 Favored 'General case' 0 N--CA 1.497 1.881 0 CA-C-O 121.735 0.779 . . . . 0.0 109.63 -179.717 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 14.8 mptt -80.22 149.66 30.37 Favored 'General case' 0 C--N 1.302 -1.48 0 CA-C-O 121.86 0.838 . . . . 0.0 109.843 -179.451 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.666 ' N ' HD12 ' A' ' 8' ' ' ILE . 2.7 mp -63.15 -43.73 99.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 CA-C-O 121.566 0.698 . . . . 0.0 110.166 -179.451 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 10.0 p -69.76 -19.93 23.21 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.654 0 O-C-N 121.214 -0.929 . . . . 0.0 110.057 -179.253 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -82.05 -3.47 54.69 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.925 -1.109 . . . . 0.0 109.482 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 96.7 mt -79.65 121.02 32.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.056 -1.027 . . . . 0.0 110.012 -179.757 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 33.4 m -136.04 -4.33 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.488 -0.757 . . . . 0.0 109.06 179.445 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -138.11 140.86 40.15 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.026 -1.046 . . . . 0.0 109.845 -179.781 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 57.3 p30 -93.65 162.22 14.03 Favored 'General case' 0 N--CA 1.493 1.7 0 CA-C-O 121.677 0.751 . . . . 0.0 110.521 -179.739 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 79.94 6.03 89.29 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.376 -1.49 . . . . 0.0 109.376 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 -80.97 135.46 35.87 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.202 -1.176 . . . . 0.0 110.275 -179.46 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 85.3 m95 -99.93 136.56 39.65 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.542 -0.724 . . . . 0.0 109.29 179.294 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.466 ' C ' HD22 ' A' ' 19' ' ' ASN . . . -178.03 -172.98 0.35 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.22 -0.925 . . . . 0.0 109.697 -179.895 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.466 HD22 ' C ' ' A' ' 18' ' ' ALA . 3.5 m120 -109.26 149.07 29.97 Favored 'General case' 0 N--CA 1.495 1.819 0 CA-C-O 121.57 0.7 . . . . 0.0 109.648 -179.802 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 6.3 tt -136.93 133.36 35.6 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.357 -0.839 . . . . 0.0 110.128 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 37.6 ttmt -114.6 134.71 54.84 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 179.387 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -165.04 171.07 14.37 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 119.069 -1.052 . . . . 0.0 110.418 -179.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 64.9 tttm -106.26 142.25 36.26 Favored 'General case' 0 N--CA 1.496 1.842 0 CA-C-O 121.75 0.786 . . . . 0.0 110.028 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 92.5 t -79.84 121.98 34.18 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 O-C-N 121.382 -0.824 . . . . 0.0 110.378 -179.439 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 96.7 mt -100.72 -57.53 4.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 179.141 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 66.5 tp60 -147.79 139.45 23.89 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.058 -1.026 . . . . 0.0 110.08 -179.858 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.844 HD23 ' H ' ' A' ' 27' ' ' LEU . 1.2 pt? -142.96 138.21 29.94 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.741 -0.599 . . . . 0.0 109.618 179.228 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 4.9 m0 -113.03 142.45 45.7 Favored 'General case' 0 N--CA 1.497 1.92 0 CA-C-O 121.634 0.73 . . . . 0.0 109.795 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 3.0 pp20? . . . . . 0 N--CA 1.491 1.6 0 CA-C-O 121.601 0.715 . . . . 0.0 110.523 -179.355 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 42.2 t . . . . . 0 N--CA 1.49 1.56 0 CA-C-O 121.276 0.56 . . . . 0.0 110.096 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 97.5 mt -109.27 130.16 62.76 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 CA-C-O 121.968 0.889 . . . . 0.0 110.368 -179.334 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 19.3 t -74.8 -75.56 0.16 Allowed 'General case' 0 N--CA 1.491 1.617 0 CA-C-O 121.689 0.757 . . . . 0.0 109.642 179.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 -143.04 157.64 44.35 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.145 -0.972 . . . . 0.0 109.623 -179.566 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 13.9 m -132.74 135.01 58.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 CA-C-O 121.61 0.719 . . . . 0.0 109.426 179.771 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -160.34 -164.25 15.07 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 -179.551 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -133.7 148.96 51.51 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.5 -1.0 . . . . 0.0 110.137 -179.814 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 32.1 mt -120.11 136.91 54.43 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 -179.177 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -100.5 137.45 13.27 Favored Glycine 0 N--CA 1.494 2.52 0 N-CA-C 110.368 -1.093 . . . . 0.0 110.368 -179.296 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.488 ' O ' ' N ' ' A' ' 45' ' ' THR . 47.0 t0 -136.61 36.84 2.67 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.484 -1.009 . . . . 0.0 108.679 179.076 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 63.98 -38.92 0.21 Allowed 'General case' 0 N--CA 1.503 2.199 0 CA-C-O 121.418 0.628 . . . . 0.0 110.412 -179.514 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.488 ' N ' ' O ' ' A' ' 43' ' ' ASP . 17.8 p -79.41 22.9 0.42 Allowed 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.051 -1.031 . . . . 0.0 109.707 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 114.45 -165.56 12.07 Favored Glycine 0 N--CA 1.498 2.78 0 N-CA-C 110.436 -1.066 . . . . 0.0 110.436 179.324 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 33.7 pt -129.19 145.17 36.17 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 O-C-N 121.673 -0.898 . . . . 0.0 109.457 -179.775 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 18.9 tt -137.95 143.2 33.97 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 O-C-N 121.48 -0.763 . . . . 0.0 109.875 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 32.6 mtmm -83.25 155.12 23.83 Favored 'General case' 0 N--CA 1.493 1.692 0 CA-C-O 121.56 0.695 . . . . 0.0 110.431 -179.485 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 42.8 p90 -144.75 153.37 41.61 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.261 -0.899 . . . . 0.0 109.591 179.833 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 93.7 m -131.24 129.99 42.31 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 179.582 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 96.7 mt -101.41 126.25 55.28 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 121.361 -0.837 . . . . 0.0 109.764 -179.537 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 30.9 m95 -104.18 143.5 32.85 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.489 -0.757 . . . . 0.0 109.011 179.305 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 98.5 mttt . . . . . 0 N--CA 1.49 1.568 0 O-C-N 121.231 -0.918 . . . . 0.0 108.984 179.702 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 36.6 mt . . . . . 0 N--CA 1.5 2.063 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_exo -49.98 157.81 2.57 Favored 'Trans proline' 0 N--CA 1.495 1.582 0 C-N-CA 122.685 2.257 . . . . 0.0 112.896 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 41.4 mt -65.48 141.79 58.37 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.306 -0.871 . . . . 0.0 110.219 -179.043 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.599 ' N ' HD12 ' A' ' 61' ' ' LEU . 9.3 mp -85.57 150.94 24.31 Favored 'General case' 0 N--CA 1.493 1.712 0 CA-C-O 121.816 0.817 . . . . 0.0 110.742 -179.295 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -74.61 150.68 39.55 Favored 'General case' 0 N--CA 1.491 1.591 0 CA-C-O 121.882 0.849 . . . . 0.0 110.722 -179.598 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 57.6 tt0 -86.2 138.77 31.63 Favored 'General case' 0 N--CA 1.49 1.526 0 CA-C-O 121.687 0.756 . . . . 0.0 111.185 -179.661 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 81.48 10.94 83.84 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 110.346 -1.102 . . . . 0.0 110.346 178.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -115.77 147.27 41.14 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.343 -1.093 . . . . 0.0 110.57 -179.622 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 15.4 t -80.58 143.55 33.1 Favored 'General case' 0 N--CA 1.49 1.532 0 CA-C-O 121.61 0.719 . . . . 0.0 110.122 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 46.0 m-85 -140.47 147.47 39.66 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.417 -0.802 . . . . 0.0 109.835 179.785 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 19.4 tp -111.11 123.97 51.26 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 179.216 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 13.6 mt -99.04 131.18 45.27 Favored 'General case' 0 N--CA 1.492 1.662 0 CA-C-O 121.388 0.613 . . . . 0.0 110.039 -179.452 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.485 ' O ' ' CB ' ' A' ' 71' ' ' SER . 82.9 mtp180 -129.64 125.98 37.33 Favored 'General case' 0 N--CA 1.494 1.742 0 CA-C-O 121.437 0.637 . . . . 0.0 109.994 179.757 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.485 ' CB ' ' O ' ' A' ' 70' ' ' ARG . 0.9 OUTLIER 82.85 49.91 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.863 0 CA-C-O 121.157 0.503 . . . . 0.0 110.265 179.398 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 15.9 m -113.49 162.06 11.92 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.079 0 O-C-N 121.21 -0.932 . . . . 0.0 109.687 179.387 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 2.7 p -125.44 137.72 56.74 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 CA-C-O 121.763 0.792 . . . . 0.0 109.656 -179.407 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 11.0 t -85.33 113.37 23.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 CA-C-O 121.653 0.739 . . . . 0.0 109.976 -179.499 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -95.22 174.68 32.7 Favored Glycine 0 N--CA 1.493 2.47 0 N-CA-C 109.787 -1.325 . . . . 0.0 109.787 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -109.84 123.19 49.14 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.547 -0.972 . . . . 0.0 109.242 179.72 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 84.7 t80 -132.71 115.99 16.05 Favored 'General case' 0 N--CA 1.493 1.676 0 CA-C-O 121.59 0.709 . . . . 0.0 109.965 -179.618 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 7.7 m120 56.06 38.21 29.67 Favored 'General case' 0 N--CA 1.492 1.672 0 CA-C-O 121.419 0.628 . . . . 0.0 110.088 179.533 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 70.23 -2.55 2.08 Favored 'General case' 0 N--CA 1.497 1.911 0 CA-C-O 121.425 0.631 . . . . 0.0 109.656 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 20.7 mmm180 -98.48 166.26 11.44 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.183 -0.948 . . . . 0.0 109.996 -179.856 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 60.4 m-85 -88.24 139.78 30.14 Favored 'General case' 0 N--CA 1.488 1.436 0 CA-C-O 121.881 0.848 . . . . 0.0 110.107 -179.104 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 52.9 tt0 -144.4 150.7 38.15 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.388 -0.82 . . . . 0.0 108.833 179.805 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 28.5 m -114.14 128.92 70.9 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 O-C-N 121.526 -0.734 . . . . 0.0 109.165 179.616 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 75.5 mt-30 -107.85 127.22 53.53 Favored 'General case' 0 N--CA 1.495 1.776 0 CA-C-O 121.653 0.739 . . . . 0.0 109.989 -179.215 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 18.8 t -96.64 107.88 20.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 CA-C-O 121.634 0.73 . . . . 0.0 109.229 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . 0.536 HD22 ' C ' ' A' ' 86' ' ' ASN . 0.4 OUTLIER -151.17 -170.05 3.55 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.395 -0.816 . . . . 0.0 109.914 -179.804 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 30.7 ttmt 59.27 37.13 23.74 Favored 'General case' 0 N--CA 1.493 1.724 0 CA-C-O 122.184 0.992 . . . . 0.0 109.879 179.758 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 10.2 t30 55.48 40.64 31.27 Favored 'General case' 0 N--CA 1.49 1.535 0 CA-C-O 121.637 0.732 . . . . 0.0 109.71 179.652 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 14.6 m -54.23 139.96 34.24 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.278 -0.889 . . . . 0.0 109.916 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 7.9 m -81.09 144.19 31.89 Favored 'General case' 0 N--CA 1.49 1.558 0 CA-C-O 121.795 0.807 . . . . 0.0 110.484 -179.092 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 96.6 mt -134.67 133.33 54.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.542 -0.723 . . . . 0.0 109.27 179.812 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -122.41 134.9 54.6 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.512 -0.742 . . . . 0.0 109.145 179.72 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.432 ' C ' HD22 ' A' ' 94' ' ' LEU . 88.5 tttt -82.49 125.17 30.8 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.402 -0.811 . . . . 0.0 109.879 -179.649 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.51 HD22 ' N ' ' A' ' 94' ' ' LEU . 4.1 mm? -97.3 134.48 40.53 Favored 'General case' 0 N--CA 1.49 1.559 0 CA-C-O 121.911 0.862 . . . . 0.0 109.963 -179.653 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 67.6 m -84.3 -4.57 58.94 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 179.303 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 90.5 mt-10 -104.48 110.36 64.16 Favored Pre-proline 0 N--CA 1.498 1.936 0 O-C-N 121.277 -0.889 . . . . 0.0 109.574 -179.831 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -74.3 157.38 45.73 Favored 'Trans proline' 0 N--CA 1.493 1.459 0 C-N-CA 122.374 2.049 . . . . 0.0 112.548 -179.365 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 16.6 mm . . . . . 0 N--CA 1.491 1.583 0 O-C-N 121.191 -0.943 . . . . 0.0 109.813 -179.384 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo . . . . . 0 N--CA 1.496 1.635 0 CA-C-O 121.406 0.503 . . . . 0.0 112.498 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 3.0 tm0? -75.49 70.33 2.34 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.561 -0.712 . . . . 0.0 109.115 179.744 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 72.0 mt -70.63 144.39 51.15 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.329 -0.857 . . . . 0.0 109.788 -179.539 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 64.7 m -124.87 133.04 53.23 Favored 'General case' 0 N--CA 1.497 1.887 0 N-CA-C 108.936 -0.765 . . . . 0.0 108.936 179.822 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 56.2 mtpt -76.02 152.02 37.02 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.318 -0.864 . . . . 0.0 110.573 -178.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 97.2 mt -63.29 -43.42 98.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.519 -0.738 . . . . 0.0 109.377 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 10.0 p -63.68 -24.39 35.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.351 -0.843 . . . . 0.0 109.667 -179.778 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -79.73 -3.82 49.19 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.018 -1.051 . . . . 0.0 109.793 -179.815 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 97.6 mt -80.88 119.16 29.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 120.92 -1.112 . . . . 0.0 109.795 -179.709 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 16.1 m -151.46 12.69 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 N-CA-C 108.947 -0.761 . . . . 0.0 108.947 179.328 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 50.7 tp10 -139.21 139.94 37.62 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.254 -0.904 . . . . 0.0 109.622 -179.829 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 48.8 p-10 -86.89 154.9 20.5 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.347 -0.845 . . . . 0.0 109.881 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 74.43 3.76 67.28 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 179.601 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 39.0 tt0 -71.24 128.61 36.49 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.168 -1.195 . . . . 0.0 109.68 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 88.9 m95 -98.51 138.74 35.28 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.394 -0.816 . . . . 0.0 109.601 -179.655 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -177.55 -178.77 0.77 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.333 -0.854 . . . . 0.0 109.726 179.52 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 80.5 m-20 -109.42 146.11 35.02 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.608 HD23 ' N ' ' A' ' 21' ' ' LYS . 6.2 tt -144.05 124.99 14.32 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.122 -0.986 . . . . 0.0 109.14 179.796 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.608 ' N ' HD23 ' A' ' 20' ' ' LEU . 36.4 ttpt -111.31 133.66 53.46 Favored 'General case' 0 N--CA 1.497 1.908 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 179.247 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -164.04 174.32 11.49 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.102 -0.999 . . . . 0.0 109.632 -179.749 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 16.8 ptpt -109.06 148.29 31.04 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.392 -0.818 . . . . 0.0 109.571 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.426 HG22 ' CD2' ' A' ' 41' ' ' LEU . 91.2 t -84.48 128.97 38.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.576 -0.703 . . . . 0.0 110.231 -179.167 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 97.0 mt -95.93 -53.58 8.04 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 N-CA-C 108.401 -0.962 . . . . 0.0 108.401 178.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 69.6 tp60 -149.24 145.21 26.99 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.307 -0.871 . . . . 0.0 109.495 179.443 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.832 ' H ' HD23 ' A' ' 27' ' ' LEU . 1.2 pt? -143.33 140.47 30.56 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 179.41 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 39.2 t90 -115.51 125.38 52.96 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 179.748 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.411 ' HG2' HE21 ' A' ' 37' ' ' GLN . 97.2 mt-10 . . . . . 0 N--CA 1.491 1.605 0 O-C-N 121.301 -0.875 . . . . 0.0 110.015 -179.703 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 43.2 t . . . . . 0 N--CA 1.497 1.879 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 86.3 mt -102.96 128.74 55.59 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 O-C-N 121.271 -0.893 . . . . 0.0 109.593 -179.537 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 41.6 t -86.93 -69.64 0.67 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.482 -0.761 . . . . 0.0 109.993 -179.405 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . 0.411 HE21 ' HG2' ' A' ' 29' ' ' GLU . 97.7 mt-30 -133.43 154.27 50.92 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.298 -0.876 . . . . 0.0 109.656 -179.209 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 15.5 m -130.85 134.87 61.19 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 179.726 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.526 ' C ' HD13 ' A' ' 40' ' ' LEU . . . -168.49 -163.72 22.96 Favored Glycine 0 N--CA 1.486 2.008 0 C-N-CA 119.08 -1.533 . . . . 0.0 110.273 -179.329 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.894 ' N ' HD13 ' A' ' 40' ' ' LEU . 0.0 OUTLIER -131.93 161.69 32.46 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.914 -0.757 . . . . 0.0 109.37 179.863 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.426 ' CD2' HG22 ' A' ' 24' ' ' VAL . 69.3 mt -120.25 133.46 55.47 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.584 -0.698 . . . . 0.0 109.329 -179.351 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -85.86 141.13 18.42 Favored Glycine 0 N--CA 1.492 2.427 0 N-CA-C 110.01 -1.236 . . . . 0.0 110.01 -179.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 44.0 t0 -151.26 163.73 38.23 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.443 -1.034 . . . . 0.0 109.922 179.826 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -64.21 -20.62 66.16 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.549 -0.719 . . . . 0.0 109.923 -179.841 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 44.7 p -92.32 -12.23 33.0 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 120.982 -1.074 . . . . 0.0 110.404 -179.283 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 144.81 -155.39 26.4 Favored Glycine 0 N--CA 1.497 2.75 0 C-N-CA 119.916 -1.135 . . . . 0.0 110.281 179.535 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 91.3 mt -125.59 137.18 58.51 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.975 0 O-C-N 121.802 -0.822 . . . . 0.0 108.811 -179.668 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 17.5 tt -129.4 150.05 34.24 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.232 0 O-C-N 121.452 -0.78 . . . . 0.0 110.342 -179.571 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.661 ' NZ ' HH22 ' A' ' 80' ' ' ARG . 14.7 mptt -83.81 151.97 24.88 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.654 -0.654 . . . . 0.0 109.812 -179.695 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 25.2 p90 -143.28 148.47 36.4 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.221 -0.924 . . . . 0.0 108.803 179.072 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 97.4 m -131.57 129.92 41.57 Favored 'General case' 0 N--CA 1.496 1.828 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 179.428 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 88.3 mt -98.07 127.8 50.13 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 O-C-N 121.311 -0.868 . . . . 0.0 110.158 -179.601 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 82.7 m95 -80.35 120.71 24.76 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 178.778 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 73.1 tttt . . . . . 0 C--N 1.3 -1.561 0 O-C-N 121.297 -0.877 . . . . 0.0 108.745 -179.139 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 63.9 mt . . . . . 0 N--CA 1.498 1.947 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -51.8 146.17 28.96 Favored 'Trans proline' 0 N--CA 1.501 1.937 0 C-N-CA 121.904 1.736 . . . . 0.0 112.766 179.415 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 77.4 mt -71.74 141.89 49.77 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.257 -0.902 . . . . 0.0 109.911 -179.837 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.565 ' N ' HD12 ' A' ' 61' ' ' LEU . 10.5 mp -79.19 146.38 33.13 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.472 -0.767 . . . . 0.0 109.976 -179.289 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 51.4 tp10 -88.17 147.62 24.79 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.268 -0.895 . . . . 0.0 109.538 -179.577 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.531 ' OE1' ' N ' ' A' ' 64' ' ' GLY . 0.2 OUTLIER -81.71 126.26 31.58 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.276 -0.89 . . . . 0.0 110.093 -179.743 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.531 ' N ' ' OE1' ' A' ' 63' ' ' GLN . . . 86.32 32.22 17.25 Favored Glycine 0 N--CA 1.495 2.628 0 N-CA-C 110.423 -1.071 . . . . 0.0 110.423 179.178 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -137.23 147.85 46.07 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.126 -1.22 . . . . 0.0 109.91 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 14.4 m -78.51 143.34 36.68 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.7 -0.625 . . . . 0.0 109.788 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 51.0 m-85 -139.71 141.37 36.93 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.492 -0.755 . . . . 0.0 109.501 179.27 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.511 HD21 ' NE ' ' A' ' 70' ' ' ARG . 15.1 tp -103.72 120.03 40.12 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 107.964 -1.124 . . . . 0.0 107.964 178.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 75.7 mt -105.85 129.38 54.03 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 -179.844 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.511 ' NE ' HD21 ' A' ' 68' ' ' LEU . 99.6 mtt180 -125.54 143.71 50.89 Favored 'General case' 0 N--CA 1.503 2.225 0 O-C-N 121.413 -0.804 . . . . 0.0 111.141 -179.181 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.6 m 61.82 46.1 7.16 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.916 -0.49 . . . . 0.0 110.714 179.124 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 8.0 m -99.3 162.05 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.978 0 O-C-N 121.016 -1.052 . . . . 0.0 109.139 179.133 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 7.5 p -122.52 139.5 49.22 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 -179.788 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 63.8 t -89.33 115.25 28.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.237 -0.914 . . . . 0.0 109.612 -179.444 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -99.56 151.4 19.31 Favored Glycine 0 N--CA 1.499 2.842 0 N-CA-C 109.79 -1.324 . . . . 0.0 109.79 -179.834 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -68.46 137.19 54.25 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.338 -1.095 . . . . 0.0 110.072 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . 0.51 ' O ' ' N ' ' A' ' 79' ' ' ASP . 42.1 t80 -131.06 126.25 35.34 Favored 'General case' 0 N--CA 1.497 1.917 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 179.385 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . 0.436 ' C ' ' O ' ' A' ' 77' ' ' TYR . 9.1 m120 -35.35 -30.29 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.047 0 CA-C-O 121.115 0.483 . . . . 0.0 110.469 -179.058 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.51 ' N ' ' O ' ' A' ' 77' ' ' TYR . 96.7 m-20 -113.37 67.9 0.67 Allowed 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.594 -0.691 . . . . 0.0 109.942 179.48 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.661 HH22 ' NZ ' ' A' ' 49' ' ' LYS . 83.8 mtm180 85.62 -159.29 0.01 OUTLIER 'General case' 0 N--CA 1.508 2.473 0 CA-C-O 121.384 0.612 . . . . 0.0 110.514 178.262 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -103.52 151.89 22.33 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.526 -0.734 . . . . 0.0 109.519 -179.091 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -136.57 166.47 23.45 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.382 -0.824 . . . . 0.0 109.284 -179.63 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.446 ' O ' HG23 ' A' ' 83' ' ' VAL . 18.8 m -105.89 130.49 57.32 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 179.827 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 87.5 mt-30 -106.45 131.18 53.94 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.429 -0.794 . . . . 0.0 110.49 -178.704 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 19.5 t -91.83 131.34 39.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 N-CA-C 109.006 -0.738 . . . . 0.0 109.006 179.449 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 99.9 m-20 -126.34 175.45 7.83 Favored 'General case' 0 N--CA 1.501 2.091 0 CA-C-O 121.79 0.805 . . . . 0.0 110.277 -179.459 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 63.8 tttm -56.64 -44.02 80.86 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.636 -0.665 . . . . 0.0 110.495 -179.57 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 10.4 m120 -63.77 -33.38 75.54 Favored 'General case' 0 C--N 1.297 -1.716 0 O-C-N 121.088 -1.007 . . . . 0.0 110.359 -179.207 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 59.8 m -60.66 147.44 41.98 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.987 -1.071 . . . . 0.0 110.786 -178.656 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 7.0 m -113.27 149.18 34.22 Favored 'General case' 0 N--CA 1.499 2.005 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 179.618 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 96.6 mt -131.35 131.47 63.18 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.041 0 O-C-N 121.44 -0.787 . . . . 0.0 109.597 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -133.01 133.46 43.15 Favored 'General case' 0 N--CA 1.501 2.095 0 O-C-N 121.386 -0.821 . . . . 0.0 108.921 178.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -82.58 124.75 30.43 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.34 -0.85 . . . . 0.0 109.185 -179.835 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.456 ' N ' HD22 ' A' ' 94' ' ' LEU . 4.1 mm? -96.87 137.01 36.6 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.273 -0.892 . . . . 0.0 109.93 -179.322 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 93.7 p -82.4 -5.3 58.56 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 179.697 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -103.13 109.91 62.55 Favored Pre-proline 0 N--CA 1.497 1.881 0 O-C-N 121.37 -0.831 . . . . 0.0 109.421 -179.389 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -74.9 159.45 41.66 Favored 'Trans proline' 0 N--CA 1.494 1.503 0 C-N-CA 121.835 1.69 . . . . 0.0 112.082 -179.307 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 96.8 mt . . . . . 0 N--CA 1.497 1.899 0 O-C-N 121.241 -0.912 . . . . 0.0 109.609 -179.741 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 21.5 Cg_exo . . . . . 0 N--CA 1.493 1.445 0 CA-C-O 121.585 0.577 . . . . 0.0 112.049 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 78.7 mt-30 -88.98 79.96 7.17 Favored 'General case' 0 N--CA 1.489 1.511 0 CA-C-O 121.915 0.864 . . . . 0.0 109.417 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -59.68 133.41 56.07 Favored 'General case' 0 N--CA 1.489 1.501 0 CA-C-O 121.829 0.823 . . . . 0.0 109.762 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 97.1 m -128.28 128.48 44.72 Favored 'General case' 0 N--CA 1.491 1.577 0 CA-C-O 121.852 0.834 . . . . 0.0 109.361 179.796 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -90.85 154.4 19.52 Favored 'General case' 0 C--N 1.301 -1.527 0 CA-C-O 121.768 0.794 . . . . 0.0 109.818 -179.592 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 66.3 mt -63.2 -43.84 99.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.699 -0.626 . . . . 0.0 109.708 -179.39 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 12.4 p -65.07 -22.4 31.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.47 -0.769 . . . . 0.0 109.807 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 96.5 m-20 -80.99 -2.63 48.67 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.385 -0.822 . . . . 0.0 109.611 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 97.6 mt -85.51 112.04 21.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.426 -0.796 . . . . 0.0 109.958 -179.743 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 22.3 m -135.73 -2.79 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 179.318 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -140.39 143.85 35.9 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.479 -0.763 . . . . 0.0 109.941 179.885 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 52.2 p30 -90.66 161.15 15.51 Favored 'General case' 0 N--CA 1.492 1.672 0 CA-C-O 121.872 0.844 . . . . 0.0 110.495 -179.704 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 79.63 15.89 78.69 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.289 -1.524 . . . . 0.0 109.289 -179.814 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 52.5 tt0 -81.54 132.5 35.31 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.477 -1.013 . . . . 0.0 110.195 -179.286 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 76.9 m95 -106.31 132.99 51.7 Favored 'General case' 0 N--CA 1.495 1.786 0 CA-C-O 121.451 0.643 . . . . 0.0 109.465 179.705 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 179.71 -172.64 0.19 Allowed 'General case' 0 N--CA 1.491 1.619 0 CA-C-O 121.745 0.783 . . . . 0.0 109.962 179.806 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.547 ' OD1' HD11 ' A' ' 68' ' ' LEU . 0.4 OUTLIER -100.18 152.34 20.37 Favored 'General case' 0 N--CA 1.493 1.701 0 CA-C-O 121.544 0.688 . . . . 0.0 109.73 -179.956 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.54 ' N ' ' ND2' ' A' ' 19' ' ' ASN . 7.2 tp -135.84 129.73 32.84 Favored 'General case' 0 N--CA 1.49 1.573 0 CA-C-O 121.745 0.783 . . . . 0.0 110.057 -179.916 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 38.3 ttmt -119.53 132.83 55.84 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 179.602 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -165.09 178.25 7.15 Favored 'General case' 0 N--CA 1.495 1.789 0 C-N-CA 119.331 -0.947 . . . . 0.0 110.809 -179.542 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 65.1 tttm -112.11 143.45 43.13 Favored 'General case' 0 N--CA 1.496 1.873 0 CA-C-O 121.713 0.768 . . . . 0.0 110.059 -179.676 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.542 ' CG1' HD22 ' A' ' 27' ' ' LEU . 91.4 t -84.96 122.42 38.14 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 CA-C-O 121.884 0.849 . . . . 0.0 110.513 -179.046 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.506 ' C ' HE21 ' A' ' 63' ' ' GLN . 23.8 mm -100.66 -48.91 11.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 178.755 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 69.3 tp60 -149.3 144.15 26.28 Favored 'General case' 0 N--CA 1.488 1.454 0 CA-C-O 121.71 0.767 . . . . 0.0 109.816 179.461 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.879 ' N ' HD23 ' A' ' 27' ' ' LEU . 0.4 OUTLIER -141.71 136.42 30.79 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 179.866 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 3.7 m-90 -115.14 122.49 46.25 Favored 'General case' 0 N--CA 1.496 1.851 0 CA-C-O 121.838 0.828 . . . . 0.0 109.618 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 49.6 tp10 . . . . . 0 N--CA 1.491 1.602 0 CA-C-O 121.541 0.686 . . . . 0.0 110.047 -179.369 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 32.2 t . . . . . 0 N--CA 1.5 2.026 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 96.6 mt -125.09 123.6 65.75 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.129 0 O-C-N 121.27 -0.894 . . . . 0.0 109.538 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 5.8 t -68.81 -51.64 38.64 Favored 'General case' 0 N--CA 1.494 1.728 0 CA-C-O 121.523 0.677 . . . . 0.0 109.435 179.667 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . 0.446 HE22 HD12 ' A' ' 27' ' ' LEU . 51.0 tt0 -157.53 153.3 26.77 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.515 -0.74 . . . . 0.0 109.69 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.7 p -142.99 145.7 22.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 179.653 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -175.17 -157.94 17.83 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.781 -1.327 . . . . 0.0 109.781 -179.589 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.9 pp -135.39 149.44 49.65 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.891 -0.77 . . . . 0.0 110.432 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 69.4 mt -117.24 132.13 56.69 Favored 'General case' 0 N--CA 1.498 1.933 0 CA-C-O 121.817 0.818 . . . . 0.0 109.647 -179.469 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -80.58 162.41 45.36 Favored Glycine 0 N--CA 1.488 2.147 0 N-CA-C 110.859 -0.896 . . . . 0.0 110.859 -179.577 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.531 ' OD1' ' N ' ' A' ' 44' ' ' GLU . 67.5 t0 -170.02 144.37 2.69 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.531 ' N ' ' OD1' ' A' ' 43' ' ' ASP . 19.1 pt-20 -59.84 -16.16 26.49 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.617 -0.677 . . . . 0.0 109.693 -179.788 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 36.2 p -91.25 -7.91 49.88 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 179.638 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 139.24 -153.61 22.98 Favored Glycine 0 N--CA 1.496 2.635 0 N-CA-C 109.81 -1.316 . . . . 0.0 109.81 179.414 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 36.1 pt -127.94 148.34 32.54 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.875 0 O-C-N 121.881 -0.776 . . . . 0.0 109.543 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 18.1 tt -141.69 138.58 31.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 CA-C-O 121.743 0.782 . . . . 0.0 110.034 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 68.9 mttm -83.75 156.86 22.34 Favored 'General case' 0 N--CA 1.49 1.545 0 CA-C-O 121.46 0.648 . . . . 0.0 109.981 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 28.2 p90 -148.62 150.44 33.27 Favored 'General case' 0 N--CA 1.491 1.599 0 CA-C-O 121.769 0.795 . . . . 0.0 109.991 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 97.8 m -130.24 129.81 43.81 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 179.575 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 92.8 mt -103.18 125.7 57.6 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 CA-C-O 121.904 0.859 . . . . 0.0 110.221 -179.423 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 96.6 m95 -86.71 142.13 28.41 Favored 'General case' 0 N--CA 1.49 1.556 0 CA-C-O 121.78 0.8 . . . . 0.0 109.881 -179.802 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 25.9 mtpp . . . . . 0 C--N 1.302 -1.47 0 O-C-N 121.655 -0.653 . . . . 0.0 109.434 -179.963 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 32.4 mt . . . . . 0 N--CA 1.491 1.611 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -55.89 147.75 60.69 Favored 'Trans proline' 0 N--CA 1.5 1.87 0 C-N-CA 123.067 2.511 . . . . 0.0 113.602 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 78.1 mt -70.74 144.27 50.99 Favored 'General case' 0 N--CA 1.492 1.631 0 CA-C-O 122.021 0.915 . . . . 0.0 110.479 -179.644 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.572 ' N ' HD12 ' A' ' 61' ' ' LEU . 10.0 mp -77.33 147.28 36.26 Favored 'General case' 0 N--CA 1.49 1.538 0 CA-C-O 121.733 0.778 . . . . 0.0 109.827 -179.899 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -88.64 155.9 19.34 Favored 'General case' 0 N--CA 1.492 1.643 0 CA-C-O 121.968 0.89 . . . . 0.0 110.109 -179.755 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.506 HE21 ' C ' ' A' ' 25' ' ' ILE . 6.8 tm0? -83.52 136.16 34.37 Favored 'General case' 0 C--N 1.301 -1.536 0 CA-C-O 121.889 0.852 . . . . 0.0 110.838 -179.2 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.474 ' N ' ' CD ' ' A' ' 63' ' ' GLN . . . 82.18 0.99 90.25 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 110.003 -1.239 . . . . 0.0 110.003 179.145 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 -106.73 146.49 30.76 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.605 -0.938 . . . . 0.0 110.476 -179.513 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 6.1 m -86.25 148.38 25.66 Favored 'General case' 0 N--CA 1.489 1.496 0 CA-C-O 121.645 0.736 . . . . 0.0 109.98 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 65.1 m-85 -141.66 150.46 41.95 Favored 'General case' 0 N--CA 1.492 1.642 0 CA-C-O 122.016 0.912 . . . . 0.0 110.616 -179.709 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.547 HD11 ' OD1' ' A' ' 19' ' ' ASN . 31.5 tp -113.1 120.65 42.04 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.717 -0.845 . . . . 0.0 108.717 179.334 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 75.5 mt -102.04 126.87 49.08 Favored 'General case' 0 N--CA 1.491 1.612 0 CA-C-O 121.465 0.65 . . . . 0.0 109.376 -179.508 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.431 ' O ' ' CB ' ' A' ' 71' ' ' SER . 80.8 mtp180 -123.82 129.02 50.36 Favored 'General case' 0 N--CA 1.496 1.874 0 CA-C-O 121.714 0.768 . . . . 0.0 109.853 -179.697 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.431 ' CB ' ' O ' ' A' ' 70' ' ' ARG . 1.5 t 78.7 65.41 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.368 179.661 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 30.8 m -128.14 163.82 31.24 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 179.187 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 12.5 p -121.63 135.16 62.68 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 CA-C-O 121.72 0.771 . . . . 0.0 109.936 -179.524 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 12.5 t -89.94 114.83 28.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 CA-C-O 121.81 0.814 . . . . 0.0 109.482 -179.558 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -91.48 174.37 38.1 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 110.51 -1.036 . . . . 0.0 110.51 -179.292 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 82.8 tt0 -100.84 117.78 35.59 Favored 'General case' 0 N--CA 1.492 1.67 0 CA-C-O 121.997 0.903 . . . . 0.0 109.692 -179.725 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . 0.559 ' CD1' ' N ' ' A' ' 78' ' ' ASN . 27.2 t80 -101.53 162.75 12.67 Favored 'General case' 0 N--CA 1.493 1.71 0 CA-C-O 121.747 0.784 . . . . 0.0 109.854 -179.803 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . 0.559 ' N ' ' CD1' ' A' ' 77' ' ' TYR . 24.3 t-20 -53.19 104.37 0.09 Allowed 'General case' 0 N--CA 1.494 1.749 0 CA-C-O 122.323 1.059 . . . . 0.0 110.63 -179.182 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 43.1 t0 57.66 16.69 3.58 Favored 'General case' 0 N--CA 1.492 1.646 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.372 179.747 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 78.1 mtp85 -148.78 -167.51 2.84 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.182 -0.949 . . . . 0.0 110.087 179.587 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 80.4 m-85 -127.94 151.24 49.34 Favored 'General case' 0 N--CA 1.495 1.807 0 CA-C-O 121.654 0.74 . . . . 0.0 109.64 -179.713 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 49.0 tt0 -145.22 153.12 41.0 Favored 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 13.6 m -113.1 130.72 66.48 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 179.423 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 78.8 mt-30 -111.68 129.93 55.94 Favored 'General case' 0 N--CA 1.496 1.866 0 CA-C-O 121.658 0.742 . . . . 0.0 110.411 -178.678 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 3.0 t -103.34 119.01 51.24 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 CA-C-O 121.596 0.712 . . . . 0.0 109.727 179.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . 0.562 HD22 ' N ' ' A' ' 86' ' ' ASN . 0.0 OUTLIER -147.01 -166.9 2.63 Favored 'General case' 0 N--CA 1.493 1.722 0 CA-C-O 121.714 0.769 . . . . 0.0 109.872 -179.411 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 38.1 ttmt 59.34 -89.13 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.654 0 CA-C-O 121.432 0.634 . . . . 0.0 110.52 -179.772 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 26.5 t-20 -169.96 46.62 0.03 OUTLIER 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 108.731 -0.841 . . . . 0.0 108.731 -179.216 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 34.9 t -55.56 136.19 50.33 Favored 'General case' 0 N--CA 1.496 1.873 0 CA-C-O 121.767 0.794 . . . . 0.0 109.709 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 1.4 t -79.55 140.83 37.09 Favored 'General case' 0 N--CA 1.491 1.584 0 CA-C-O 121.614 0.721 . . . . 0.0 110.338 -179.316 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 97.4 mt -128.46 130.67 69.19 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 121.836 -0.54 . . . . 0.0 109.586 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 47.7 tp10 -127.73 130.76 49.35 Favored 'General case' 0 N--CA 1.495 1.817 0 CA-C-O 121.827 0.822 . . . . 0.0 109.235 179.752 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 65.7 tttm -81.43 132.36 35.32 Favored 'General case' 0 N--CA 1.49 1.552 0 CA-C-O 121.856 0.836 . . . . 0.0 110.416 -179.385 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 65.8 mt -103.26 131.07 50.61 Favored 'General case' 0 N--CA 1.492 1.663 0 CA-C-O 121.703 0.763 . . . . 0.0 109.545 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 10.1 t -83.52 6.58 19.93 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 179.775 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 33.5 mm-40 -118.04 90.61 37.74 Favored Pre-proline 0 N--CA 1.499 2.024 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 179.308 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_exo -56.22 147.57 65.35 Favored 'Trans proline' 0 N--CA 1.494 1.552 0 C-N-CA 122.886 2.39 . . . . 0.0 112.516 179.739 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 93.9 mt . . . . . 0 N--CA 1.494 1.766 0 CA-C-O 121.885 0.85 . . . . 0.0 110.06 -179.497 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo . . . . . 0 N--CA 1.494 1.518 0 CA-C-O 121.829 0.679 . . . . 0.0 112.8 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 27.6 mp0 -89.7 69.26 7.7 Favored 'General case' 0 N--CA 1.489 1.515 0 CA-C-O 121.844 0.83 . . . . 0.0 109.094 -179.827 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 71.9 mt -65.69 139.87 58.42 Favored 'General case' 0 N--CA 1.492 1.634 0 CA-C-O 121.63 0.728 . . . . 0.0 110.34 -179.422 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 92.3 m -128.83 132.15 47.77 Favored 'General case' 0 N--CA 1.493 1.693 0 CA-C-O 121.606 0.717 . . . . 0.0 109.576 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -75.35 146.86 40.55 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.461 -0.775 . . . . 0.0 109.998 -179.74 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 96.5 mt -63.84 -43.09 97.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.554 -0.716 . . . . 0.0 110.449 -179.563 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 13.2 p -62.06 -22.73 29.68 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.129 -0.982 . . . . 0.0 109.547 -179.783 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 51.7 t0 -76.17 -5.81 48.42 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.301 -0.874 . . . . 0.0 109.61 179.831 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 96.6 mt -82.4 119.32 31.71 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.038 -1.039 . . . . 0.0 110.23 -179.81 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 3.3 m -151.11 14.53 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 N-CA-C 108.582 -0.895 . . . . 0.0 108.582 179.65 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -138.04 145.24 41.58 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.419 -0.801 . . . . 0.0 110.019 -179.859 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 -82.78 144.39 30.19 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-O 121.682 0.753 . . . . 0.0 110.459 -179.796 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 65.99 110.9 0.01 OUTLIER Glycine 0 N--CA 1.491 2.331 0 N-CA-C 110.617 -0.993 . . . . 0.0 110.617 179.136 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 8.5 tt0 -169.47 130.26 1.08 Allowed 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.306 -1.114 . . . . 0.0 109.505 179.226 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 98.7 m95 -93.82 129.94 40.02 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.663 -0.648 . . . . 0.0 109.897 -179.668 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -175.59 171.53 2.76 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.535 -0.728 . . . . 0.0 109.695 179.749 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 67.0 m-20 -103.56 143.55 32.59 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.566 -0.709 . . . . 0.0 109.546 -179.679 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 5.0 mp -138.56 145.59 40.83 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.367 -0.833 . . . . 0.0 109.974 -179.856 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 33.9 ttmt -119.71 136.08 54.57 Favored 'General case' 0 N--CA 1.494 1.737 0 CA-C-O 121.481 0.658 . . . . 0.0 109.713 179.718 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -166.2 166.9 16.62 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 119.785 -0.766 . . . . 0.0 109.813 179.754 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 38.3 ttmt -105.5 142.01 36.0 Favored 'General case' 0 N--CA 1.492 1.641 0 CA-C-O 121.761 0.791 . . . . 0.0 109.987 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 58.8 t -81.19 127.04 39.88 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.362 0 CA-C-O 121.805 0.812 . . . . 0.0 110.292 -179.694 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 96.5 mt -97.42 -66.53 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 121.645 -0.659 . . . . 0.0 109.311 179.387 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.6 ' NE2' ' NE2' ' A' ' 63' ' ' GLN . 85.0 mm-40 -144.04 143.76 31.33 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.291 -0.881 . . . . 0.0 110.435 -179.766 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.553 ' O ' HD12 ' A' ' 27' ' ' LEU . 0.3 OUTLIER -143.17 139.68 30.44 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 -179.713 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 3.5 m-90 -114.92 149.92 36.48 Favored 'General case' 0 N--CA 1.494 1.739 0 CA-C-O 121.811 0.815 . . . . 0.0 109.889 179.803 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 . . . . . 0 C--N 1.306 -1.326 0 CA-C-O 121.428 0.633 . . . . 0.0 110.046 -179.971 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 14.2 t . . . . . 0 N--CA 1.493 1.697 0 CA-C-O 121.147 0.499 . . . . 0.0 110.226 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 96.7 mt -115.58 130.09 70.79 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 CA-C-O 121.823 0.82 . . . . 0.0 109.591 179.361 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 39.1 t -84.02 -68.91 0.68 Allowed 'General case' 0 C--N 1.302 -1.476 0 CA-C-O 121.518 0.675 . . . . 0.0 109.554 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . 0.503 ' OE1' HD22 ' A' ' 60' ' ' LEU . 25.3 mt-30 -137.43 160.98 37.55 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.406 -0.808 . . . . 0.0 109.997 -179.292 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 3.3 p -140.0 143.37 30.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -168.91 -152.61 7.84 Favored Glycine 0 N--CA 1.486 1.993 0 N-CA-C 110.02 -1.232 . . . . 0.0 110.02 -179.624 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.412 HD23 ' N ' ' A' ' 40' ' ' LEU . 0.2 OUTLIER -132.94 150.93 52.12 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.849 -0.794 . . . . 0.0 109.886 -179.707 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 65.7 mt -114.73 129.59 56.71 Favored 'General case' 0 N--CA 1.491 1.611 0 CA-C-O 121.814 0.816 . . . . 0.0 109.544 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -85.45 152.73 26.8 Favored Glycine 0 N--CA 1.488 2.145 0 N-CA-C 110.479 -1.048 . . . . 0.0 110.479 -179.536 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.53 ' OD1' ' N ' ' A' ' 44' ' ' GLU . 41.8 t0 -173.58 152.08 2.04 Favored 'General case' 0 C--N 1.306 -1.319 0 O-C-N 121.766 -0.844 . . . . 0.0 109.722 179.467 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.53 ' N ' ' OD1' ' A' ' 43' ' ' ASP . 82.7 tt0 -55.5 -16.71 4.12 Favored 'General case' 0 N--CA 1.492 1.657 0 CA-C-O 121.241 0.543 . . . . 0.0 110.65 -179.352 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 80.8 p -92.45 -0.94 57.3 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.813 -1.179 . . . . 0.0 109.373 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 126.02 -152.54 18.16 Favored Glycine 0 N--CA 1.499 2.848 0 N-CA-C 110.428 -1.069 . . . . 0.0 110.428 179.182 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 36.8 pt -126.24 151.99 33.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.807 -0.819 . . . . 0.0 109.202 -179.815 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 18.7 tt -147.95 151.0 13.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.217 -0.927 . . . . 0.0 110.067 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.456 ' HZ1' ' HE2' ' A' ' 77' ' ' TYR . 0.0 OUTLIER -85.75 147.64 26.23 Favored 'General case' 0 N--CA 1.489 1.519 0 CA-C-O 121.538 0.685 . . . . 0.0 110.123 -179.997 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 13.3 p90 -143.92 159.71 42.09 Favored 'General case' 0 N--CA 1.486 1.34 0 O-C-N 121.418 -0.801 . . . . 0.0 109.461 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 1.8 t -141.94 142.37 33.01 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 179.468 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 92.8 mt -105.37 122.6 58.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 CA-C-O 121.77 0.795 . . . . 0.0 109.966 -179.798 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 43.1 m95 -91.36 136.89 32.79 Favored 'General case' 0 N--CA 1.487 1.378 0 CA-C-O 121.504 0.669 . . . . 0.0 109.384 179.845 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 56.3 mtpt . . . . . 0 N--CA 1.489 1.516 0 CA-C-O 121.708 0.766 . . . . 0.0 109.319 179.449 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 32.8 mt . . . . . 0 N--CA 1.495 1.803 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -72.4 162.4 41.6 Favored 'Trans proline' 0 N--CA 1.494 1.547 0 C-N-CA 123.047 2.498 . . . . 0.0 112.775 179.598 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.503 HD22 ' OE1' ' A' ' 37' ' ' GLN . 69.1 mt -67.45 143.64 56.14 Favored 'General case' 0 N--CA 1.49 1.528 0 CA-C-O 121.876 0.846 . . . . 0.0 110.512 -179.498 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.572 ' N ' HD12 ' A' ' 61' ' ' LEU . 10.1 mp -91.7 137.13 32.61 Favored 'General case' 0 N--CA 1.491 1.577 0 CA-C-O 121.684 0.754 . . . . 0.0 110.262 -179.304 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.45 ' OE1' ' OE2' ' A' ' 65' ' ' GLU . 95.9 mt-10 -81.81 147.94 29.12 Favored 'General case' 0 N--CA 1.49 1.533 0 CA-C-O 121.817 0.818 . . . . 0.0 110.195 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.6 ' NE2' ' NE2' ' A' ' 26' ' ' GLN . 86.9 mt-30 -79.62 140.61 37.06 Favored 'General case' 0 N--CA 1.488 1.465 0 CA-C-O 121.789 0.804 . . . . 0.0 110.925 -179.324 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 79.39 35.21 30.16 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 110.3 -1.12 . . . . 0.0 110.3 179.304 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.45 ' OE2' ' OE1' ' A' ' 62' ' ' GLU . 91.5 mt-10 -140.95 143.76 34.73 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.206 -1.173 . . . . 0.0 110.134 179.647 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 89.5 p -81.63 143.46 31.91 Favored 'General case' 0 N--CA 1.486 1.365 0 CA-C-O 121.6 0.714 . . . . 0.0 110.217 -179.642 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 92.3 m-85 -138.41 142.12 39.56 Favored 'General case' 0 N--CA 1.489 1.479 0 CA-C-O 121.582 0.706 . . . . 0.0 110.025 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 31.8 tp -108.56 113.3 26.19 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 108.563 -0.902 . . . . 0.0 108.563 179.197 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.8 mp -99.77 131.26 45.86 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 -179.708 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 85.7 mtp180 -126.51 148.67 49.67 Favored 'General case' 0 N--CA 1.491 1.576 0 CA-C-O 121.584 0.707 . . . . 0.0 110.432 -179.553 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.592 ' CB ' HD21 ' A' ' 88' ' ' ASN . 8.6 t 59.22 55.09 4.47 Favored 'General case' 0 N--CA 1.491 1.582 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.355 179.55 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 15.7 m -113.67 160.79 12.98 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 O-C-N 121.586 -0.696 . . . . 0.0 109.249 179.163 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 9.9 p -114.07 134.66 56.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 CA-C-O 121.809 0.814 . . . . 0.0 110.179 -178.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 16.8 t -82.43 119.62 32.3 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.343 0 CA-C-O 121.702 0.763 . . . . 0.0 109.898 -179.726 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -93.68 170.69 31.12 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 110.231 -1.148 . . . . 0.0 110.231 -179.618 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 22.4 pt-20 -102.88 133.43 47.98 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.651 -0.911 . . . . 0.0 110.195 -179.674 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . 0.633 ' CD2' ' ND2' ' A' ' 78' ' ' ASN . 42.6 t80 -136.86 96.66 3.35 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 179.624 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . 0.633 ' ND2' ' CD2' ' A' ' 77' ' ' TYR . 23.3 p30 42.2 -136.68 0.27 Allowed 'General case' 0 N--CA 1.495 1.799 0 CA-C-O 121.531 0.681 . . . . 0.0 111.417 -179.918 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.545 ' N ' ' OD1' ' A' ' 78' ' ' ASN . 97.6 m-20 -73.35 -6.28 45.13 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.433 -0.792 . . . . 0.0 109.689 -179.255 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.406 ' N ' ' OD1' ' A' ' 78' ' ' ASN . 88.6 mtm180 -110.34 -179.66 3.84 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.487 -0.758 . . . . 0.0 110.085 -179.661 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -129.84 154.55 47.16 Favored 'General case' 0 N--CA 1.493 1.707 0 CA-C-O 121.508 0.671 . . . . 0.0 109.597 -179.551 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 2.7 pt20 -139.73 162.28 35.49 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.526 -0.734 . . . . 0.0 109.808 -179.775 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.41 HG23 ' O ' ' A' ' 83' ' ' VAL . 13.5 m -111.54 131.82 61.82 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 179.847 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 -106.43 118.56 36.96 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.469 -0.769 . . . . 0.0 109.978 -179.253 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 10.2 t -90.02 99.46 9.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 179.646 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 1.4 p30 -151.15 -177.06 5.81 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.511 -0.743 . . . . 0.0 109.762 -179.526 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.427 ' CG ' ' H ' ' A' ' 88' ' ' ASN . 14.8 tptm 66.57 -130.62 0.18 Allowed 'General case' 0 N--CA 1.489 1.484 0 CA-C-O 121.624 0.726 . . . . 0.0 111.386 179.137 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . 0.592 HD21 ' CB ' ' A' ' 71' ' ' SER . 0.6 OUTLIER -90.41 19.96 4.85 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.531 -0.731 . . . . 0.0 109.273 -179.317 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 19.5 m -57.09 144.09 35.96 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.405 -0.809 . . . . 0.0 109.899 -179.669 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 44.4 m -129.6 153.02 48.49 Favored 'General case' 0 N--CA 1.493 1.676 0 CA-C-O 121.398 0.618 . . . . 0.0 109.427 -179.709 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 96.8 mt -131.69 134.86 59.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.64 -0.663 . . . . 0.0 109.505 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 73.8 mm-40 -128.74 136.23 50.28 Favored 'General case' 0 N--CA 1.494 1.747 0 CA-C-O 121.49 0.662 . . . . 0.0 109.31 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.412 ' C ' HD12 ' A' ' 94' ' ' LEU . 88.5 tttt -82.01 124.99 30.28 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.525 -0.734 . . . . 0.0 109.937 -179.636 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.417 HD12 ' N ' ' A' ' 94' ' ' LEU . 11.0 mp -103.67 131.35 50.9 Favored 'General case' 0 N--CA 1.493 1.695 0 CA-C-O 121.61 0.719 . . . . 0.0 109.47 179.84 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 39.1 t -80.48 -6.67 58.51 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.661 -0.65 . . . . 0.0 109.3 179.7 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -107.36 104.45 52.54 Favored Pre-proline 0 N--CA 1.495 1.811 0 O-C-N 121.422 -0.798 . . . . 0.0 109.457 -179.635 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -74.54 149.43 39.0 Favored 'Trans proline' 0 N--CA 1.491 1.372 0 C-N-CA 122.328 2.019 . . . . 0.0 112.833 -179.246 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.405 ' H ' HG12 ' A' ' 98' ' ' ILE . 14.9 pt . . . . . 0 N--CA 1.49 1.535 0 CA-C-O 121.82 0.819 . . . . 0.0 110.757 -179.401 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_endo . . . . . 0 N--CA 1.495 1.587 0 CA-C-O 122.177 0.824 . . . . 0.0 112.752 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -86.6 88.89 7.75 Favored 'General case' 0 N--CA 1.488 1.463 0 CA-C-O 122.015 0.912 . . . . 0.0 109.487 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.411 HD22 ' N ' ' A' ' 5' ' ' LEU . 4.2 mm? -75.81 139.09 41.57 Favored 'General case' 0 N--CA 1.489 1.509 0 CA-C-O 121.608 0.718 . . . . 0.0 109.959 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 90.0 m -123.96 129.88 51.66 Favored 'General case' 0 N--CA 1.492 1.648 0 CA-C-O 121.643 0.735 . . . . 0.0 109.468 179.85 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 53.7 mtmt -80.08 153.91 28.44 Favored 'General case' 0 N--CA 1.489 1.485 0 CA-C-O 121.495 0.664 . . . . 0.0 110.374 -179.646 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 97.4 mt -62.71 -43.73 98.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 CA-C-O 121.627 0.727 . . . . 0.0 109.976 -179.837 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 13.0 p -65.45 -23.79 33.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.508 -0.745 . . . . 0.0 109.626 -179.676 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -78.81 -4.71 50.85 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.363 -0.836 . . . . 0.0 109.642 179.695 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 97.8 mt -82.23 118.8 30.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.174 -0.954 . . . . 0.0 109.672 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 3.1 m -146.89 6.88 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.565 -0.709 . . . . 0.0 109.275 -179.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 94.1 mt-10 -138.14 131.71 30.85 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.261 -0.9 . . . . 0.0 110.203 -179.457 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 51.5 p30 -83.78 153.15 24.26 Favored 'General case' 0 N--CA 1.488 1.438 0 CA-C-O 121.642 0.734 . . . . 0.0 110.442 -179.717 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 71.16 84.64 0.19 Allowed Glycine 0 N--CA 1.49 2.243 0 N-CA-C 110.084 -1.206 . . . . 0.0 110.084 179.577 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 27.3 tt0 -169.39 136.23 1.7 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.417 -1.049 . . . . 0.0 109.838 179.723 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 45.0 m95 -91.64 140.22 29.93 Favored 'General case' 0 N--CA 1.489 1.523 0 CA-C-O 121.567 0.698 . . . . 0.0 110.1 -179.83 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -168.51 170.39 9.73 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.559 -0.713 . . . . 0.0 109.561 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 62.8 m-80 -101.11 145.17 29.12 Favored 'General case' 0 N--CA 1.494 1.771 0 CA-C-O 121.624 0.726 . . . . 0.0 109.967 -179.458 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 51.9 tp -146.62 135.39 22.26 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.529 -0.732 . . . . 0.0 109.8 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 35.0 ttpt -120.3 137.12 54.43 Favored 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 179.312 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.418 ' CB ' ' OD1' ' A' ' 43' ' ' ASP . . . -160.65 172.52 16.98 Favored 'General case' 0 N--CA 1.492 1.659 0 C-N-CA 119.201 -1.0 . . . . 0.0 110.792 -179.377 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 33.0 ttpt -113.15 141.19 47.22 Favored 'General case' 0 N--CA 1.493 1.723 0 CA-C-O 121.583 0.706 . . . . 0.0 109.563 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 87.1 t -77.94 132.02 33.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.648 -0.658 . . . . 0.0 110.561 -179.172 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 30.2 pt -124.46 -30.08 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 179.004 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 68.6 tp60 -150.17 125.98 10.42 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.194 -0.941 . . . . 0.0 109.54 179.859 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.88 ' H ' HD23 ' A' ' 27' ' ' LEU . 1.1 pt? -138.96 135.67 34.6 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.707 -0.621 . . . . 0.0 109.978 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . 0.415 ' CE3' ' O ' ' A' ' 29' ' ' GLU . 81.9 t90 -126.84 123.78 38.11 Favored 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.415 ' O ' ' CE3' ' A' ' 28' ' ' TRP . 82.0 tt0 . . . . . 0 N--CA 1.49 1.568 0 CA-C-O 121.515 0.674 . . . . 0.0 110.046 -179.597 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . 0.638 ' N ' ' HZ3' ' A' ' 54' ' ' LYS . 0.9 OUTLIER . . . . . 0 N--CA 1.49 1.554 0 N-CA-C 109.573 -0.529 . . . . 0.0 109.573 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 90.5 mt -108.92 119.11 57.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 CA-C-O 121.601 0.715 . . . . 0.0 110.054 -179.775 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 3.8 t -76.11 -50.91 13.38 Favored 'General case' 0 N--CA 1.489 1.519 0 CA-C-O 121.822 0.82 . . . . 0.0 109.635 179.489 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 49.2 tt0 -150.42 155.37 39.44 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.291 -0.881 . . . . 0.0 110.22 -179.604 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 8.2 p -142.65 139.8 28.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.678 -0.639 . . . . 0.0 109.414 179.416 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -171.99 -163.36 25.76 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.893 -1.283 . . . . 0.0 109.893 -179.77 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -134.71 148.1 50.23 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.552 -0.969 . . . . 0.0 109.85 -179.394 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 67.6 mt -112.95 137.99 50.5 Favored 'General case' 0 N--CA 1.493 1.688 0 CA-C-O 121.742 0.782 . . . . 0.0 109.564 -179.456 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.421 ' O ' ' OD1' ' A' ' 43' ' ' ASP . . . -83.24 143.86 22.2 Favored Glycine 0 N--CA 1.486 2.029 0 N-CA-C 110.779 -0.929 . . . . 0.0 110.779 -179.542 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.421 ' OD1' ' O ' ' A' ' 42' ' ' GLY . 75.2 m-20 -149.47 160.22 43.64 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.877 -0.778 . . . . 0.0 109.38 179.534 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 79.8 tt0 -65.58 -21.39 66.59 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.686 -0.634 . . . . 0.0 109.61 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 67.4 p -89.97 -2.78 58.21 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.327 -0.858 . . . . 0.0 109.514 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 133.15 -147.26 18.92 Favored Glycine 0 N--CA 1.497 2.705 0 N-CA-C 110.341 -1.104 . . . . 0.0 110.341 179.215 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 40.9 pt -125.66 152.62 32.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.901 -0.764 . . . . 0.0 109.741 -179.626 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 8.4 tp -142.5 140.12 28.68 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 CA-C-O 121.741 0.781 . . . . 0.0 110.059 -179.822 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 54.9 mtmt -87.88 145.94 25.81 Favored 'General case' 0 N--CA 1.49 1.545 0 CA-C-O 121.509 0.671 . . . . 0.0 110.004 179.854 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 38.9 p90 -137.57 153.05 50.01 Favored 'General case' 0 N--CA 1.49 1.545 0 CA-C-O 121.659 0.742 . . . . 0.0 109.783 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 83.6 m -129.86 130.97 45.91 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 96.6 mt -103.75 129.1 56.35 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 CA-C-O 121.702 0.763 . . . . 0.0 109.983 -179.773 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 89.7 m95 -90.63 129.6 36.74 Favored 'General case' 0 N--CA 1.487 1.404 0 CA-C-O 121.698 0.761 . . . . 0.0 109.273 179.457 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.638 ' HZ3' ' N ' ' A' ' 34' ' ' SER . 3.1 ptpp? . . . . . 0 N--CA 1.489 1.477 0 CA-C-O 121.516 0.674 . . . . 0.0 109.939 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 45.9 mt . . . . . 0 N--CA 1.496 1.85 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -69.74 155.42 66.05 Favored 'Trans proline' 0 N--CA 1.497 1.716 0 C-N-CA 122.921 2.414 . . . . 0.0 113.283 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 75.2 mt -71.73 141.67 49.79 Favored 'General case' 0 N--CA 1.493 1.682 0 CA-C-O 121.852 0.834 . . . . 0.0 110.778 -179.27 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.572 ' N ' HD12 ' A' ' 61' ' ' LEU . 10.3 mp -80.29 143.76 33.38 Favored 'General case' 0 N--CA 1.491 1.586 0 CA-C-O 121.688 0.756 . . . . 0.0 110.065 -179.919 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -83.41 152.66 24.91 Favored 'General case' 0 N--CA 1.49 1.568 0 CA-C-O 121.941 0.876 . . . . 0.0 110.987 -179.478 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 58.5 tt0 -82.03 136.78 35.2 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-O 121.663 0.744 . . . . 0.0 110.754 -179.676 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 82.4 4.55 90.12 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 110.166 -1.174 . . . . 0.0 110.166 179.434 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -110.51 146.86 35.26 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.444 -1.033 . . . . 0.0 110.723 -179.581 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 19.1 p -84.97 152.44 23.47 Favored 'General case' 0 N--CA 1.487 1.42 0 CA-C-O 121.558 0.694 . . . . 0.0 110.2 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 74.4 m-85 -145.34 145.29 31.14 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.349 -0.845 . . . . 0.0 110.275 179.651 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 23.5 tp -108.01 121.14 44.2 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 108.96 -0.755 . . . . 0.0 108.96 179.395 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 68.4 mt -100.59 133.38 45.12 Favored 'General case' 0 N--CA 1.49 1.551 0 CA-C-O 121.256 0.55 . . . . 0.0 109.629 -179.614 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.453 ' O ' ' OG ' ' A' ' 71' ' ' SER . 80.5 mtp85 -129.28 142.05 50.94 Favored 'General case' 0 N--CA 1.493 1.698 0 CA-C-O 121.653 0.74 . . . . 0.0 110.161 -179.806 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.488 ' HG ' ' HA ' ' A' ' 89' ' ' SER . 3.3 p 53.44 60.96 3.36 Favored 'General case' 0 N--CA 1.493 1.697 0 CA-C-O 121.416 0.627 . . . . 0.0 110.405 -179.889 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 3.3 m -114.23 133.11 61.34 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 179.024 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 8.9 p -95.47 135.56 29.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 CA-C-O 121.582 0.706 . . . . 0.0 109.986 -179.258 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -93.23 124.99 45.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 CA-C-O 121.767 0.794 . . . . 0.0 109.695 -179.6 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -100.11 142.86 16.1 Favored Glycine 0 N--CA 1.493 2.446 0 N-CA-C 110.478 -1.049 . . . . 0.0 110.478 -179.618 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 17.5 pt-20 -59.14 138.7 57.46 Favored 'General case' 0 N--CA 1.49 1.566 0 CA-C-O 121.592 0.71 . . . . 0.0 110.082 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . 0.604 ' CG ' ' NE2' ' A' ' 82' ' ' GLN . 79.3 t80 -137.08 81.25 1.86 Allowed 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 179.446 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . 0.502 ' C ' ' O ' ' A' ' 77' ' ' TYR . 28.8 t-20 15.15 -79.81 0.0 OUTLIER 'General case' 0 N--CA 1.51 2.533 0 CA-C-O 121.581 0.705 . . . . 0.0 112.146 -179.859 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.533 ' N ' ' O ' ' A' ' 77' ' ' TYR . 52.0 t0 -47.8 -69.94 0.11 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.433 -0.792 . . . . 0.0 109.893 -179.75 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 88.5 mtm180 -133.64 -130.44 0.17 Allowed 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.618 -0.677 . . . . 0.0 109.998 -178.895 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 88.4 m-85 -129.47 154.43 46.99 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.578 -0.701 . . . . 0.0 110.046 -178.796 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . 0.604 ' NE2' ' CG ' ' A' ' 77' ' ' TYR . 87.0 mt-30 -132.78 161.93 32.8 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.761 -0.587 . . . . 0.0 109.897 -179.703 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.43 ' O ' HG23 ' A' ' 83' ' ' VAL . 16.3 m -104.05 127.88 57.88 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 CA-C-O 121.61 0.719 . . . . 0.0 109.237 179.776 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 -106.39 126.45 52.26 Favored 'General case' 0 N--CA 1.494 1.74 0 CA-C-O 121.436 0.636 . . . . 0.0 109.793 -179.212 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 52.1 t -104.78 120.1 54.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 CA-C-O 121.581 0.705 . . . . 0.0 109.181 179.831 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . 0.404 ' O ' ' O ' ' A' ' 87' ' ' LYS . 0.4 OUTLIER -147.9 -175.98 5.09 Favored 'General case' 0 N--CA 1.489 1.52 0 CA-C-O 121.388 0.613 . . . . 0.0 110.039 -179.38 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.481 ' O ' ' CB ' ' A' ' 88' ' ' ASN . 85.4 tttt -37.83 157.32 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.737 0 CA-C-O 121.535 0.683 . . . . 0.0 111.016 -179.442 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . 0.481 ' CB ' ' O ' ' A' ' 87' ' ' LYS . 0.2 OUTLIER 77.92 -28.88 0.16 Allowed 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 -179.725 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.488 ' HA ' ' HG ' ' A' ' 71' ' ' SER . 11.5 t -75.64 152.18 37.63 Favored 'General case' 0 N--CA 1.49 1.553 0 CA-C-O 121.557 0.694 . . . . 0.0 110.469 -179.696 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 32.1 t -132.54 141.68 48.84 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.553 -0.717 . . . . 0.0 109.702 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 96.4 mt -123.97 130.9 73.66 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 CA-C-O 121.273 0.559 . . . . 0.0 109.523 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -127.02 132.78 50.66 Favored 'General case' 0 N--CA 1.497 1.881 0 CA-C-O 121.621 0.724 . . . . 0.0 109.512 179.809 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.463 ' C ' HD12 ' A' ' 94' ' ' LEU . 88.2 tttt -81.22 127.49 32.74 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-O 121.617 0.723 . . . . 0.0 110.078 -179.533 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.463 HD12 ' C ' ' A' ' 93' ' ' LYS . 10.8 mp -103.51 131.85 50.27 Favored 'General case' 0 N--CA 1.495 1.784 0 CA-C-O 121.671 0.748 . . . . 0.0 110.09 -179.637 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 18.2 t -77.52 -6.05 52.22 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 179.284 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -102.25 110.36 62.46 Favored Pre-proline 0 N--CA 1.496 1.851 0 O-C-N 121.393 -0.817 . . . . 0.0 109.572 -179.75 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -75.78 152.02 36.74 Favored 'Trans proline' 0 N--CA 1.492 1.396 0 C-N-CA 122.795 2.33 . . . . 0.0 112.528 -178.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 56.3 mt . . . . . 0 N--CA 1.487 1.422 0 CA-C-O 121.951 0.882 . . . . 0.0 110.341 -179.589 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo . . . . . 0 N--CA 1.493 1.487 0 CA-C-O 121.774 0.656 . . . . 0.0 112.297 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . 0.587 ' CD ' ' H ' ' A' ' 4' ' ' GLN . 1.0 OUTLIER -76.44 90.78 3.27 Favored 'General case' 0 C--N 1.301 -1.527 0 CA-C-O 121.925 0.869 . . . . 0.0 109.463 -179.704 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 90.7 mt -81.78 139.83 34.58 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.663 -0.648 . . . . 0.0 109.574 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 99.2 m -127.1 131.05 50.93 Favored 'General case' 0 N--CA 1.494 1.753 0 CA-C-O 121.902 0.858 . . . . 0.0 109.86 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 70.2 mmtt -82.15 154.37 25.54 Favored 'General case' 0 C--N 1.301 -1.538 0 CA-C-O 121.648 0.737 . . . . 0.0 109.767 -179.401 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 96.2 mt -63.07 -43.52 99.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 CA-C-O 121.583 0.706 . . . . 0.0 109.568 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 13.6 p -65.24 -23.94 34.14 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 121.531 -0.731 . . . . 0.0 109.858 179.835 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 54.9 t0 -79.39 -2.48 41.9 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.382 -0.824 . . . . 0.0 109.67 -179.889 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 96.6 mt -78.7 117.94 25.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.108 -0.995 . . . . 0.0 109.908 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 3.3 m -136.02 -4.0 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 N-CA-C 108.979 -0.748 . . . . 0.0 108.979 179.533 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 79.4 mm-40 -139.76 137.8 35.37 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.248 -0.908 . . . . 0.0 110.21 -179.724 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 19.9 p-10 -91.85 159.93 15.55 Favored 'General case' 0 N--CA 1.491 1.588 0 CA-C-O 121.607 0.718 . . . . 0.0 110.162 179.821 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 78.69 2.14 84.88 Favored Glycine 0 N--CA 1.493 2.48 0 N-CA-C 109.559 -1.416 . . . . 0.0 109.559 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 33.1 tt0 -79.17 137.84 37.62 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.517 -0.99 . . . . 0.0 110.817 -179.239 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 68.9 m95 -93.45 132.35 37.79 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.781 -0.574 . . . . 0.0 109.692 179.629 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -174.29 176.78 2.38 Favored 'General case' 0 N--CA 1.493 1.722 0 C-N-CA 119.746 -0.782 . . . . 0.0 110.084 179.833 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 28.7 m-20 -104.48 142.68 34.19 Favored 'General case' 0 N--CA 1.495 1.781 0 CA-C-O 121.625 0.726 . . . . 0.0 110.095 -179.554 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 57.3 tp -133.71 138.92 46.09 Favored 'General case' 0 N--CA 1.493 1.705 0 CA-C-O 121.319 0.58 . . . . 0.0 109.485 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 19.5 ttpp -119.55 135.18 54.9 Favored 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 179.175 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -160.98 171.75 18.13 Favored 'General case' 0 N--CA 1.493 1.681 0 C-N-CA 119.598 -0.841 . . . . 0.0 110.166 -179.82 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -114.5 142.61 46.17 Favored 'General case' 0 N--CA 1.496 1.858 0 CA-C-O 121.756 0.789 . . . . 0.0 110.182 -179.71 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 21.5 t -84.77 117.57 30.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 CA-C-O 121.536 0.684 . . . . 0.0 109.963 -179.588 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 25.3 pt -107.86 -30.24 2.53 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 179.277 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 12.7 tt0 -163.99 133.45 3.95 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-O 121.699 0.761 . . . . 0.0 109.927 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.838 ' H ' HD23 ' A' ' 27' ' ' LEU . 1.1 pt? -143.3 137.8 29.09 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.784 -0.572 . . . . 0.0 109.696 179.932 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 2.6 m-90 -116.36 133.01 56.51 Favored 'General case' 0 N--CA 1.495 1.82 0 CA-C-O 121.567 0.699 . . . . 0.0 109.628 179.883 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 . . . . . 0 C--N 1.301 -1.518 0 CA-C-O 121.269 0.557 . . . . 0.0 109.534 179.648 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . 0.42 ' O ' ' CE3' ' A' ' 53' ' ' TRP . 40.0 m . . . . . 0 N--CA 1.493 1.709 0 CA-C-O 121.091 0.472 . . . . 0.0 110.213 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.41 HG23 ' OG1' ' A' ' 51' ' ' THR . 94.7 mt -123.29 127.61 74.47 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.993 0 O-C-N 121.292 -0.88 . . . . 0.0 110.317 -179.054 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 45.9 t -75.83 -53.01 9.13 Favored 'General case' 0 N--CA 1.493 1.691 0 CA-C-O 121.904 0.859 . . . . 0.0 109.562 179.597 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . 0.483 ' OE1' ' N ' ' A' ' 38' ' ' VAL . 0.5 OUTLIER -147.04 147.67 30.89 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.195 -0.941 . . . . 0.0 109.941 -179.739 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.483 ' N ' ' OE1' ' A' ' 37' ' ' GLN . 8.6 p -134.01 138.49 50.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 CA-C-O 121.384 0.611 . . . . 0.0 109.464 179.872 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -160.64 -165.65 17.86 Favored Glycine 0 N--CA 1.488 2.163 0 C-N-CA 119.746 -1.216 . . . . 0.0 110.476 -179.591 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -132.49 143.83 50.04 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.898 -0.766 . . . . 0.0 109.512 -179.714 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 41.4 mt -116.28 136.12 53.28 Favored 'General case' 0 N--CA 1.494 1.749 0 CA-C-O 121.79 0.805 . . . . 0.0 109.707 -179.178 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -83.71 162.52 39.5 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 111.073 -0.811 . . . . 0.0 111.073 -179.438 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.552 ' OD1' ' N ' ' A' ' 44' ' ' GLU . 67.2 t0 -174.73 145.15 0.87 Allowed 'General case' 0 N--CA 1.49 1.557 0 CA-C-O 121.63 0.729 . . . . 0.0 109.129 179.705 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.552 ' N ' ' OD1' ' A' ' 43' ' ' ASP . 49.0 mt-10 -54.43 -14.88 1.38 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.654 -0.654 . . . . 0.0 110.072 179.927 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 39.5 p -93.55 -11.15 32.54 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.228 -0.92 . . . . 0.0 109.716 -179.894 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 138.86 -158.3 25.09 Favored Glycine 0 N--CA 1.498 2.806 0 C-N-CA 120.041 -1.076 . . . . 0.0 110.568 179.233 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 97.4 mt -124.44 134.2 67.34 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 O-C-N 121.906 -0.761 . . . . 0.0 109.443 -179.585 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 17.7 tt -128.82 141.93 45.31 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.998 0 CA-C-O 121.625 0.726 . . . . 0.0 109.935 -179.753 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 51.1 mtmt -86.46 152.0 23.04 Favored 'General case' 0 N--CA 1.491 1.609 0 CA-C-O 121.568 0.699 . . . . 0.0 110.108 -179.772 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 25.2 p90 -142.51 160.38 40.39 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.327 -0.858 . . . . 0.0 110.325 -179.688 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.41 ' OG1' HG23 ' A' ' 35' ' ' ILE . 1.9 t -138.58 137.52 37.08 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 -179.945 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 90.6 mt -105.93 118.03 52.76 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 CA-C-O 121.534 0.683 . . . . 0.0 109.834 179.865 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' TRP . . . . . 0.42 ' CE3' ' O ' ' A' ' 34' ' ' SER . 72.7 m95 -85.77 142.56 28.87 Favored 'General case' 0 N--CA 1.488 1.463 0 CA-C-O 121.579 0.704 . . . . 0.0 109.524 179.874 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 98.6 mttt . . . . . 0 N--CA 1.491 1.625 0 O-C-N 121.564 -0.71 . . . . 0.0 110.335 -179.53 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.552 ' C ' ' H ' ' A' ' 60' ' ' LEU . 18.4 mt . . . . . 0 N--CA 1.488 1.473 0 N-CA-C 109.346 -0.612 . . . . 0.0 109.346 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.414 ' O ' ' O ' ' A' ' 60' ' ' LEU . 29.9 Cg_endo -67.97 22.97 0.13 Allowed 'Trans proline' 0 N--CA 1.493 1.489 0 C-N-CA 122.2 1.933 . . . . 0.0 111.801 179.564 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.552 ' H ' ' C ' ' A' ' 58' ' ' LEU . 72.0 mt 58.59 151.86 0.01 OUTLIER 'General case' 0 C--N 1.293 -1.866 0 CA-C-O 121.802 0.81 . . . . 0.0 110.18 179.661 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.644 ' N ' HD12 ' A' ' 61' ' ' LEU . 9.0 mp -85.46 143.55 28.5 Favored 'General case' 0 N--CA 1.491 1.625 0 CA-C-O 121.541 0.686 . . . . 0.0 109.747 -179.667 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -87.5 151.27 23.16 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-O 121.937 0.875 . . . . 0.0 110.558 -178.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 58.1 tt0 -76.15 132.08 39.78 Favored 'General case' 0 N--CA 1.491 1.583 0 CA-C-O 121.87 0.843 . . . . 0.0 111.542 -178.811 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 93.16 -4.95 74.94 Favored Glycine 0 N--CA 1.496 2.688 0 N-CA-C 110.745 -0.942 . . . . 0.0 110.745 178.57 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.531 ' OE1' ' N ' ' A' ' 65' ' ' GLU . 58.3 mp0 -103.36 149.17 25.02 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 121.119 -1.224 . . . . 0.0 110.725 -179.379 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 8.8 p -93.22 135.15 34.7 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 179.58 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -125.72 143.04 51.21 Favored 'General case' 0 N--CA 1.497 1.879 0 CA-C-O 122.079 0.943 . . . . 0.0 111.017 -179.101 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 11.9 tp -106.57 104.88 14.67 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 179.653 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 54.3 mt -79.62 141.06 36.87 Favored 'General case' 0 N--CA 1.491 1.6 0 CA-C-O 121.342 0.591 . . . . 0.0 109.543 -179.688 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 85.3 mtp180 -136.06 141.85 44.31 Favored 'General case' 0 N--CA 1.494 1.733 0 CA-C-O 121.862 0.839 . . . . 0.0 110.71 -179.37 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 2.0 m 53.04 43.34 31.83 Favored 'General case' 0 N--CA 1.492 1.656 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.963 178.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 7.5 m -99.22 162.36 2.95 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.982 0 O-C-N 121.513 -0.742 . . . . 0.0 109.586 179.162 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 7.8 p -108.5 135.81 46.11 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 CA-C-O 121.688 0.756 . . . . 0.0 110.182 -178.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 98.7 t -78.89 125.0 38.05 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 CA-C-O 121.818 0.818 . . . . 0.0 109.375 -179.626 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -83.22 163.89 41.66 Favored Glycine 0 N--CA 1.486 2.016 0 N-CA-C 110.093 -1.203 . . . . 0.0 110.093 -179.632 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -114.73 127.88 55.99 Favored 'General case' 0 N--CA 1.493 1.722 0 CA-C-O 121.734 0.778 . . . . 0.0 109.881 -179.843 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . 0.628 ' CD2' ' NE2' ' A' ' 82' ' ' GLN . 42.4 m-85 -132.84 81.25 1.93 Allowed 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 179.557 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 79.4 m-20 50.67 -112.67 0.63 Allowed 'General case' 0 N--CA 1.495 1.788 0 CA-C-O 121.355 0.598 . . . . 0.0 110.698 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 94.9 m-20 -90.56 -7.0 54.01 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.141 -0.974 . . . . 0.0 109.544 -179.727 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 94.1 mtt180 -102.66 166.33 10.57 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.382 -0.824 . . . . 0.0 110.557 -178.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -128.71 150.61 50.19 Favored 'General case' 0 N--CA 1.496 1.859 0 CA-C-O 121.481 0.658 . . . . 0.0 109.706 179.882 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . 0.628 ' NE2' ' CD2' ' A' ' 77' ' ' TYR . 74.4 mt-30 -144.65 177.29 8.79 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.625 -0.672 . . . . 0.0 109.428 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 2.6 m -118.49 133.14 66.27 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 179.543 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 84.4 mt-30 -113.58 122.34 46.93 Favored 'General case' 0 N--CA 1.494 1.756 0 CA-C-O 121.859 0.838 . . . . 0.0 109.618 -179.078 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 22.0 t -90.07 129.29 41.19 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 1.4 p30 -147.57 172.84 13.37 Favored 'General case' 0 N--CA 1.49 1.544 0 CA-C-O 121.86 0.838 . . . . 0.0 110.167 -179.278 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.475 ' O ' ' CB ' ' A' ' 88' ' ' ASN . 88.7 tttt -42.83 157.24 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 CA-C-O 121.768 0.794 . . . . 0.0 110.826 -179.761 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . 0.475 ' CB ' ' O ' ' A' ' 87' ' ' LYS . 2.1 t-20 79.31 -23.2 0.25 Allowed 'General case' 0 N--CA 1.494 1.753 0 CA-C-O 121.366 0.603 . . . . 0.0 109.814 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 11.1 m -74.81 148.1 40.61 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.287 -0.883 . . . . 0.0 110.199 -179.512 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 52.1 m -125.1 150.1 47.18 Favored 'General case' 0 N--CA 1.497 1.884 0 CA-C-O 121.58 0.705 . . . . 0.0 109.806 -179.797 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 98.0 mt -132.27 135.33 58.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 CA-C-O 121.365 0.602 . . . . 0.0 109.734 -179.42 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 81.1 tt0 -128.8 125.93 38.82 Favored 'General case' 0 N--CA 1.5 2.032 0 CA-C-O 121.61 0.719 . . . . 0.0 109.222 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.429 ' C ' HD12 ' A' ' 94' ' ' LEU . 26.7 mtmm -74.34 135.25 42.51 Favored 'General case' 0 N--CA 1.49 1.529 0 CA-C-O 121.566 0.698 . . . . 0.0 110.296 -179.608 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.429 HD12 ' C ' ' A' ' 93' ' ' LYS . 10.2 mp -105.45 134.53 48.42 Favored 'General case' 0 N--CA 1.494 1.766 0 CA-C-O 121.938 0.875 . . . . 0.0 109.82 179.899 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 93.3 p -83.19 -2.12 54.74 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 109.454 -0.572 . . . . 0.0 109.454 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -118.36 89.92 37.29 Favored Pre-proline 0 N--CA 1.5 2.027 0 O-C-N 121.539 -0.726 . . . . 0.0 109.195 179.873 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_exo -57.72 149.67 66.94 Favored 'Trans proline' 0 N--CA 1.492 1.406 0 C-N-CA 122.742 2.295 . . . . 0.0 112.6 179.538 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 29.8 pt . . . . . 0 N--CA 1.489 1.483 0 CA-C-O 121.827 0.822 . . . . 0.0 110.353 -179.73 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo . . . . . 0 N--CA 1.496 1.646 0 CA-C-O 121.417 0.507 . . . . 0.0 112.625 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 59.2 tt0 -87.08 81.09 8.15 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 179.845 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 77.5 mt -76.16 146.83 38.91 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.582 -0.699 . . . . 0.0 110.201 -179.119 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 96.8 m -123.33 130.33 52.58 Favored 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 179.751 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -79.54 155.16 28.32 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.475 -0.766 . . . . 0.0 110.313 -179.079 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.628 ' N ' HD12 ' A' ' 8' ' ' ILE . 3.0 mp -63.45 -43.24 98.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.627 -0.67 . . . . 0.0 109.671 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 13.1 p -66.93 -20.6 27.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.287 -0.883 . . . . 0.0 109.517 -179.688 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -82.68 -1.37 51.03 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.335 -0.853 . . . . 0.0 109.455 179.606 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 96.4 mt -83.89 111.63 20.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.317 -0.864 . . . . 0.0 109.551 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 24.0 m -154.44 18.45 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 179.754 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -134.75 144.3 47.63 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.533 -0.729 . . . . 0.0 110.105 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.41 ' O ' ' OD1' ' A' ' 14' ' ' ASN . 46.6 p-10 -93.16 137.76 32.2 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.492 -0.755 . . . . 0.0 110.264 -179.578 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 80.7 18.98 69.17 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.279 -1.528 . . . . 0.0 109.279 179.876 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 51.8 tt0 -73.31 133.76 43.98 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.295 -1.121 . . . . 0.0 109.818 -179.528 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' TRP . . . . . 0.414 ' O ' ' HB2' ' A' ' 18' ' ' ALA . 90.0 m95 -106.76 130.87 54.4 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.553 -0.717 . . . . 0.0 109.657 179.78 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.414 ' HB2' ' O ' ' A' ' 17' ' ' TRP . . . 178.32 -173.54 0.15 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.421 -0.799 . . . . 0.0 109.689 179.598 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 80.7 m-20 -99.29 152.69 19.64 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.545 -0.722 . . . . 0.0 109.407 -179.78 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.57 HD13 ' N ' ' A' ' 21' ' ' LYS . 0.4 OUTLIER -136.78 117.13 13.63 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.407 -0.808 . . . . 0.0 109.451 179.94 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.57 ' N ' HD13 ' A' ' 20' ' ' LEU . 35.2 ttpt -115.61 135.29 54.22 Favored 'General case' 0 N--CA 1.497 1.892 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 178.755 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -167.15 175.66 7.32 Favored 'General case' 0 N--CA 1.492 1.647 0 C-N-CA 119.31 -0.956 . . . . 0.0 110.158 179.646 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -103.29 142.11 34.76 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.57 -0.706 . . . . 0.0 109.702 -179.6 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.438 HG22 ' CD2' ' A' ' 41' ' ' LEU . 93.7 t -82.49 128.16 38.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.322 -0.861 . . . . 0.0 110.444 -179.496 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 96.7 mt -98.58 -59.94 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 179.119 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.622 ' NE2' ' CZ2' ' A' ' 28' ' ' TRP . 60.0 tt0 -146.84 147.69 31.11 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.346 -0.846 . . . . 0.0 109.728 179.955 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.461 ' N ' HD23 ' A' ' 27' ' ' LEU . 0.1 OUTLIER -125.31 151.23 46.29 Favored 'General case' 0 N--CA 1.496 1.828 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 -179.706 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . 0.622 ' CZ2' ' NE2' ' A' ' 26' ' ' GLN . 96.2 m95 -124.3 105.34 9.39 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 179.478 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.401 ' OE1' ' N ' ' A' ' 29' ' ' GLU . 59.4 mp0 . . . . . 0 C--N 1.302 -1.476 0 CA-C-O 121.542 0.687 . . . . 0.0 110.04 -179.164 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 77.7 p . . . . . 0 N--CA 1.489 1.495 0 N-CA-C 110.176 -0.305 . . . . 0.0 110.176 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 96.8 mt -112.79 128.35 69.55 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.069 0 O-C-N 121.478 -0.764 . . . . 0.0 109.878 -179.743 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.465 ' OG ' ' CA ' ' A' ' 54' ' ' LYS . 1.3 m -85.01 -67.98 0.76 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.751 -0.593 . . . . 0.0 109.528 -179.781 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 51.2 tt0 -139.68 151.48 45.95 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.477 -0.764 . . . . 0.0 109.595 -179.638 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 8.3 p -135.71 139.38 46.38 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 179.677 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -164.35 -163.13 16.68 Favored Glycine 0 N--CA 1.49 2.297 0 C-N-CA 119.341 -1.409 . . . . 0.0 110.434 -179.509 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.893 HD23 ' H ' ' A' ' 40' ' ' LEU . 1.4 pt? -136.98 146.23 45.12 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.553 -0.969 . . . . 0.0 109.852 179.904 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.438 ' CD2' HG22 ' A' ' 24' ' ' VAL . 52.9 mt -109.79 132.32 54.25 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.524 -0.735 . . . . 0.0 109.865 -179.274 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -79.06 163.82 49.52 Favored Glycine 0 N--CA 1.487 2.074 0 N-CA-C 110.512 -1.035 . . . . 0.0 110.512 -179.81 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.487 ' OD1' ' N ' ' A' ' 44' ' ' GLU . 49.7 t0 -171.8 138.52 1.09 Allowed 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.68 -0.894 . . . . 0.0 109.105 179.346 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.487 ' N ' ' OD1' ' A' ' 43' ' ' ASP . 18.1 pt-20 -55.7 -13.39 1.66 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.415 -0.803 . . . . 0.0 109.222 -179.773 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 13.9 p -98.29 -9.34 25.63 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.441 -0.787 . . . . 0.0 109.376 -179.794 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 144.92 -157.64 27.37 Favored Glycine 0 N--CA 1.497 2.749 0 C-N-CA 120.078 -1.058 . . . . 0.0 110.487 179.281 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 40.1 pt -126.35 154.57 35.94 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 O-C-N 121.738 -0.86 . . . . 0.0 109.584 -179.864 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.714 HD13 ' H ' ' A' ' 49' ' ' LYS . 0.3 OUTLIER -141.39 142.15 29.49 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 121.308 -0.87 . . . . 0.0 109.459 179.426 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.714 ' H ' HD13 ' A' ' 48' ' ' ILE . 99.1 mttt -91.24 143.97 26.1 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.658 -0.651 . . . . 0.0 109.348 179.455 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 33.4 p90 -137.61 152.51 49.45 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.168 -0.957 . . . . 0.0 109.674 -179.87 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 97.1 m -128.32 132.81 48.62 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 47.1 mm -99.99 121.33 50.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.405 -0.81 . . . . 0.0 109.875 -179.457 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' TRP . . . . . 0.482 ' CD1' ' OD1' ' A' ' 86' ' ' ASN . 89.2 m95 -82.16 124.19 29.66 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 108.72 -0.845 . . . . 0.0 108.72 179.368 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.465 ' CA ' ' OG ' ' A' ' 36' ' ' SER . 32.7 tttt . . . . . 0 C--N 1.301 -1.515 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 -179.219 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 37.3 mt . . . . . 0 N--CA 1.493 1.676 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -50.57 148.6 15.06 Favored 'Trans proline' 0 N--CA 1.496 1.637 0 C-N-CA 122.177 1.918 . . . . 0.0 112.797 179.133 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 84.0 mt -69.28 154.37 42.15 Favored 'General case' 0 N--CA 1.492 1.632 0 CA-C-O 121.836 0.827 . . . . 0.0 110.543 -179.195 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.702 HD22 ' N ' ' A' ' 61' ' ' LEU . 3.4 mm? -78.72 149.61 32.69 Favored 'General case' 0 C--N 1.304 -1.382 0 CA-C-O 121.421 0.629 . . . . 0.0 110.304 -178.663 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -106.26 146.49 30.27 Favored 'General case' 0 N--CA 1.495 1.823 0 CA-C-O 121.738 0.78 . . . . 0.0 110.057 -179.111 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 49.2 tt0 -81.34 134.21 35.54 Favored 'General case' 0 N--CA 1.488 1.468 0 CA-C-O 121.284 0.564 . . . . 0.0 110.81 -178.905 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 90.38 -6.65 82.3 Favored Glycine 0 N--CA 1.495 2.611 0 N-CA-C 110.355 -1.098 . . . . 0.0 110.355 178.717 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -104.6 150.47 24.63 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.37 -1.076 . . . . 0.0 110.749 -179.438 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 8.4 m -95.37 136.59 35.54 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.698 -0.626 . . . . 0.0 109.358 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 72.5 m-85 -121.87 145.1 48.41 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-O 121.748 0.785 . . . . 0.0 110.142 -179.848 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 14.0 tp -110.34 112.14 23.89 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 179.344 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 71.4 mt -95.86 131.99 41.6 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 -179.827 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 80.4 mtp85 -123.52 141.87 51.57 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.561 -0.712 . . . . 0.0 110.537 -179.334 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 9.2 t 57.81 65.04 1.4 Allowed 'General case' 0 N--CA 1.493 1.692 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.547 179.397 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 2.9 m -121.76 160.82 22.97 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 179.258 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 14.8 p -118.7 133.22 66.24 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 CA-C-O 121.63 0.728 . . . . 0.0 109.45 -179.258 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 14.0 t -85.6 121.37 37.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.654 -0.654 . . . . 0.0 109.68 -179.193 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -98.87 -172.35 31.6 Favored Glycine 0 N--CA 1.494 2.531 0 N-CA-C 109.784 -1.327 . . . . 0.0 109.784 -179.773 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -111.31 120.75 43.29 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.644 -0.916 . . . . 0.0 109.65 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . 0.496 ' O ' ' N ' ' A' ' 79' ' ' ASP . 86.7 t80 -108.67 80.77 1.37 Allowed 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 179.44 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . 0.455 ' C ' ' O ' ' A' ' 77' ' ' TYR . 94.3 m-20 31.07 -91.34 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.988 0 CA-C-O 121.482 0.658 . . . . 0.0 111.196 179.855 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.496 ' N ' ' O ' ' A' ' 77' ' ' TYR . 66.5 t0 -51.52 -68.69 0.15 Allowed 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.619 -0.676 . . . . 0.0 110.656 -179.453 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 85.2 mtp180 -120.96 -163.99 1.08 Allowed 'General case' 0 N--CA 1.501 2.123 0 O-C-N 121.528 -0.732 . . . . 0.0 110.336 -178.774 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 79.6 m-85 -99.08 162.93 12.79 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.56 -0.712 . . . . 0.0 109.793 -179.037 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 6.4 pt20 -141.95 162.01 36.55 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.377 -0.827 . . . . 0.0 109.834 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 2.7 m -107.96 131.18 59.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 179.81 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -106.7 131.72 53.51 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.676 -0.64 . . . . 0.0 110.041 -178.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 96.3 t -103.15 124.31 57.19 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . 0.482 ' OD1' ' CD1' ' A' ' 53' ' ' TRP . 80.3 m-20 -125.01 -176.52 3.58 Favored 'General case' 0 N--CA 1.496 1.834 0 CA-C-O 121.524 0.678 . . . . 0.0 109.739 -179.528 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 62.9 pttt -59.86 -33.43 71.78 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.741 -0.6 . . . . 0.0 109.862 -179.888 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 52.3 t-20 -63.45 -38.23 90.33 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.393 -0.817 . . . . 0.0 109.523 -179.558 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 27.7 t -76.57 164.78 25.6 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.34 -0.85 . . . . 0.0 110.325 -179.064 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 95.1 p -133.06 158.3 43.11 Favored 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 179.825 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 96.8 mt -125.54 132.63 70.71 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 O-C-N 121.668 -0.645 . . . . 0.0 110.02 -179.383 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 31.7 mm-40 -136.15 135.42 39.2 Favored 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 179.633 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.451 ' C ' HD12 ' A' ' 94' ' ' LEU . 97.3 mttt -84.19 136.09 34.1 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.442 -0.786 . . . . 0.0 109.962 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.451 HD12 ' C ' ' A' ' 93' ' ' LYS . 8.9 mp -108.25 133.66 52.18 Favored 'General case' 0 N--CA 1.499 1.986 0 CA-C-O 121.623 0.725 . . . . 0.0 109.384 179.503 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 89.7 p -76.09 1.95 14.2 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 179.637 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.416 ' OE2' ' O ' ' A' ' 97' ' ' PRO . 8.7 tm-20 -109.52 95.72 20.29 Favored Pre-proline 0 N--CA 1.497 1.883 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 -179.948 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . 0.416 ' O ' ' OE2' ' A' ' 96' ' ' GLU . 64.7 Cg_endo -76.78 158.89 35.13 Favored 'Trans proline' 0 N--CA 1.491 1.363 0 C-N-CA 122.241 1.961 . . . . 0.0 112.351 -179.149 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 86.8 mt . . . . . 0 N--CA 1.496 1.862 0 O-C-N 121.499 -0.751 . . . . 0.0 109.79 -179.574 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo . . . . . 0 N--CA 1.496 1.622 0 CA-C-O 121.753 0.647 . . . . 0.0 112.269 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . 0.556 ' H ' ' CD ' ' A' ' 4' ' ' GLN . 21.9 mp0 -72.72 92.61 1.57 Allowed 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.291 -0.88 . . . . 0.0 109.685 -179.719 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 86.6 mt -74.51 147.32 41.97 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.487 -0.758 . . . . 0.0 109.567 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 97.8 m -124.12 130.5 52.65 Favored 'General case' 0 N--CA 1.495 1.779 0 CA-C-O 121.736 0.779 . . . . 0.0 109.754 -179.897 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -98.87 159.12 15.18 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.597 -0.689 . . . . 0.0 110.048 -179.675 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 96.6 mt -63.84 -42.74 96.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.412 -0.805 . . . . 0.0 109.557 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 14.8 p -63.32 -23.58 33.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.24 -0.913 . . . . 0.0 109.441 -179.843 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 94.7 m-20 -78.9 -4.15 48.29 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.213 -0.929 . . . . 0.0 109.345 179.58 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 5.6 mm -69.12 98.95 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.079 -1.013 . . . . 0.0 109.639 -179.773 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 2.5 p -116.12 -40.11 2.7 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.36 0 O-C-N 121.625 -0.672 . . . . 0.0 109.3 179.871 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 79.4 tt0 -126.28 143.33 51.19 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.294 -0.879 . . . . 0.0 110.26 -178.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 55.8 p30 -87.14 163.16 17.12 Favored 'General case' 0 N--CA 1.492 1.627 0 CA-C-O 121.71 0.767 . . . . 0.0 110.447 -179.674 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 78.07 13.04 83.78 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 109.267 -1.533 . . . . 0.0 109.267 -179.494 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -83.58 129.94 34.98 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.187 -1.184 . . . . 0.0 110.082 -179.7 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 84.1 m95 -93.12 129.16 39.2 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.265 -0.897 . . . . 0.0 109.929 -179.734 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -174.35 -173.33 0.76 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.6 -0.687 . . . . 0.0 109.303 179.581 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 73.5 m-20 -105.64 145.25 31.27 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.515 -0.741 . . . . 0.0 109.822 -179.463 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 40.5 tp -128.07 132.14 49.06 Favored 'General case' 0 N--CA 1.498 1.968 0 CA-C-O 121.69 0.757 . . . . 0.0 109.9 179.766 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 38.2 ttmt -116.09 130.18 56.69 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 179.359 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -166.65 179.01 5.65 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.84 -1.162 . . . . 0.0 110.775 -179.589 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 64.5 tttp -114.55 139.93 49.18 Favored 'General case' 0 N--CA 1.497 1.919 0 CA-C-O 121.619 0.723 . . . . 0.0 109.968 -179.682 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 87.6 t -81.02 115.73 24.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.413 -0.804 . . . . 0.0 109.943 -179.766 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 19.1 mm -93.92 -48.93 12.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.297 -0.877 . . . . 0.0 109.645 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 82.4 mt-30 -144.62 144.97 31.53 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.04 -1.038 . . . . 0.0 110.199 -179.347 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.835 HD23 ' H ' ' A' ' 27' ' ' LEU . 1.1 pt? -141.95 133.32 26.54 Favored 'General case' 0 N--CA 1.492 1.675 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 179.836 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 3.4 m0 -118.86 146.51 44.83 Favored 'General case' 0 N--CA 1.499 2.014 0 CA-C-O 121.741 0.781 . . . . 0.0 109.999 -179.347 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 50.0 tp10 . . . . . 0 N--CA 1.491 1.6 0 O-C-N 121.405 -0.81 . . . . 0.0 109.576 -179.808 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 40.1 t . . . . . 0 N--CA 1.495 1.806 0 CA-C-O 121.316 0.579 . . . . 0.0 110.555 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 96.9 mt -103.15 133.82 45.94 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 O-C-N 121.121 -0.987 . . . . 0.0 109.794 -179.523 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 28.7 t -86.33 -70.61 0.59 Allowed 'General case' 0 N--CA 1.49 1.544 0 CA-C-O 121.664 0.745 . . . . 0.0 109.804 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -141.19 153.93 45.57 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.088 -1.007 . . . . 0.0 110.375 -179.15 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 27.8 m -135.98 158.51 38.97 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 179.312 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -178.23 -150.91 8.99 Favored Glycine 0 N--CA 1.487 2.045 0 C-N-CA 119.467 -1.349 . . . . 0.0 110.033 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.41 HD23 ' N ' ' A' ' 40' ' ' LEU . 0.2 OUTLIER -135.25 148.11 49.48 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.655 -0.909 . . . . 0.0 109.374 -179.744 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 70.3 mt -111.54 128.4 56.01 Favored 'General case' 0 N--CA 1.495 1.787 0 CA-C-O 121.668 0.747 . . . . 0.0 109.31 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -80.44 158.03 41.1 Favored Glycine 0 N--CA 1.487 2.095 0 N-CA-C 110.012 -1.235 . . . . 0.0 110.012 -179.751 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.529 ' OD1' ' N ' ' A' ' 44' ' ' GLU . 67.2 t0 -172.58 143.14 1.3 Allowed 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.493 -1.004 . . . . 0.0 109.045 -179.923 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.529 ' N ' ' OD1' ' A' ' 43' ' ' ASP . 96.9 mt-10 -54.88 -14.45 1.45 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.427 -0.795 . . . . 0.0 109.793 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 37.4 p -93.33 -12.94 28.81 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.024 -1.047 . . . . 0.0 109.292 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 141.15 -157.32 25.99 Favored Glycine 0 N--CA 1.498 2.792 0 C-N-CA 119.876 -1.154 . . . . 0.0 110.245 179.378 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 41.5 pt -124.85 150.55 29.86 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 O-C-N 121.581 -0.953 . . . . 0.0 109.518 -179.451 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 20.8 tt -146.94 150.08 15.15 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 121.235 -0.916 . . . . 0.0 109.7 -179.741 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 72.5 mmtt -84.09 150.21 25.71 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.466 -0.771 . . . . 0.0 110.402 -179.23 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 17.3 p90 -143.65 151.76 40.51 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.321 -0.862 . . . . 0.0 109.19 179.52 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.545 ' OG1' ' NE2' ' A' ' 82' ' ' GLN . 35.0 m -132.99 137.18 46.44 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.629 -0.669 . . . . 0.0 109.469 179.807 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 29.7 mm -98.48 122.56 50.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.225 -0.922 . . . . 0.0 109.735 -179.676 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 97.3 m95 -98.17 140.97 31.68 Favored 'General case' 0 N--CA 1.49 1.543 0 CA-C-O 121.582 0.706 . . . . 0.0 109.639 179.841 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 29.0 mmtm . . . . . 0 N--CA 1.494 1.733 0 O-C-N 121.144 -0.973 . . . . 0.0 109.781 179.547 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.487 ' CD1' HG12 ' A' ' 85' ' ' VAL . 29.8 mt . . . . . 0 N--CA 1.497 1.91 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -69.76 159.42 53.46 Favored 'Trans proline' 0 N--CA 1.497 1.72 0 C-N-CA 122.837 2.358 . . . . 0.0 113.195 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 97.2 mt -71.52 141.61 50.12 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.274 -0.891 . . . . 0.0 109.98 -179.814 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.596 ' N ' HD12 ' A' ' 61' ' ' LEU . 9.6 mp -80.04 149.04 30.84 Favored 'General case' 0 N--CA 1.493 1.724 0 CA-C-O 121.727 0.775 . . . . 0.0 110.705 -179.084 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -104.91 126.63 52.18 Favored 'General case' 0 N--CA 1.497 1.914 0 CA-C-O 121.802 0.81 . . . . 0.0 109.758 -179.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 58.2 tt0 -64.49 147.89 51.79 Favored 'General case' 0 N--CA 1.496 1.855 0 CA-C-O 121.965 0.888 . . . . 0.0 111.835 -178.933 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 81.05 22.94 60.15 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.937 -1.265 . . . . 0.0 109.937 178.825 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -139.26 145.46 39.21 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.248 -1.148 . . . . 0.0 110.094 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 11.1 p -84.42 149.73 25.79 Favored 'General case' 0 N--CA 1.486 1.333 0 CA-C-O 121.606 0.717 . . . . 0.0 109.856 179.915 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 66.6 m-85 -143.58 151.91 40.77 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.233 -0.917 . . . . 0.0 110.307 -179.867 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 21.9 tp -112.92 121.95 46.2 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 179.235 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 71.8 mt -100.84 130.74 46.9 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.393 -0.817 . . . . 0.0 109.849 -179.162 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 83.4 mtp180 -127.09 144.55 51.0 Favored 'General case' 0 N--CA 1.498 1.944 0 CA-C-O 121.878 0.847 . . . . 0.0 110.49 -179.876 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.8 m 58.34 57.43 3.91 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.798 -0.564 . . . . 0.0 110.49 179.385 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 17.9 m -118.81 164.67 14.85 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.98 0 O-C-N 121.598 -0.688 . . . . 0.0 109.656 179.33 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 11.8 p -120.47 136.11 58.56 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 CA-C-O 121.65 0.738 . . . . 0.0 109.379 -179.712 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 66.9 t -81.47 115.29 23.79 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 CA-C-O 121.831 0.824 . . . . 0.0 109.889 -178.863 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -84.92 167.32 41.89 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 110.024 -1.23 . . . . 0.0 110.024 -179.563 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -105.91 124.2 49.19 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.466 -1.02 . . . . 0.0 109.624 180.0 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 52.0 t80 -120.05 82.58 1.91 Allowed 'General case' 0 N--CA 1.492 1.637 0 CA-C-O 121.984 0.897 . . . . 0.0 108.807 179.719 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . 0.451 ' CG ' ' N ' ' A' ' 79' ' ' ASP . 50.1 t30 42.95 -117.63 0.46 Allowed 'General case' 0 N--CA 1.501 2.087 0 CA-C-O 121.729 0.776 . . . . 0.0 112.179 179.774 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.451 ' N ' ' CG ' ' A' ' 78' ' ' ASN . 42.4 t0 -70.22 -35.16 73.7 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.184 -0.947 . . . . 0.0 109.991 -178.806 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 84.4 mtt85 -101.22 -170.88 1.9 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.267 -0.896 . . . . 0.0 110.011 -179.377 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -127.9 150.53 49.83 Favored 'General case' 0 N--CA 1.494 1.756 0 CA-C-O 121.694 0.759 . . . . 0.0 110.075 -179.297 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . 0.545 ' NE2' ' OG1' ' A' ' 51' ' ' THR . 40.5 tt0 -133.13 126.44 31.73 Favored 'General case' 0 N--CA 1.49 1.528 0 CA-C-O 121.493 0.663 . . . . 0.0 109.351 -179.803 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 34.1 m -81.13 141.21 15.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.477 -0.764 . . . . 0.0 109.553 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 87.7 mt-30 -111.54 120.82 43.4 Favored 'General case' 0 N--CA 1.495 1.812 0 CA-C-O 121.799 0.809 . . . . 0.0 109.738 -179.449 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.487 HG12 ' CD1' ' A' ' 58' ' ' LEU . 4.5 t -93.24 99.3 9.45 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 179.655 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . 0.524 HD22 ' C ' ' A' ' 86' ' ' ASN . 0.1 OUTLIER -150.67 -176.7 5.61 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.495 -0.753 . . . . 0.0 109.313 -179.571 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.445 ' CG ' ' H ' ' A' ' 88' ' ' ASN . 14.4 tptm 66.27 -137.93 0.16 Allowed 'General case' 0 N--CA 1.491 1.621 0 CA-C-O 121.806 0.812 . . . . 0.0 110.826 179.588 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . 0.445 ' H ' ' CG ' ' A' ' 87' ' ' LYS . 15.0 m120 -86.14 22.62 1.71 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.474 -0.766 . . . . 0.0 109.227 -179.574 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 30.9 t -58.61 141.78 51.31 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.193 -0.942 . . . . 0.0 109.672 -179.759 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 64.0 m -127.16 152.32 47.5 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.546 -0.721 . . . . 0.0 109.318 -179.735 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 97.3 mt -128.07 131.73 69.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.692 -0.63 . . . . 0.0 109.351 -179.707 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -132.03 131.76 42.78 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.523 -0.736 . . . . 0.0 109.301 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 4.8 ttpm? -79.61 136.69 36.9 Favored 'General case' 0 N--CA 1.489 1.487 0 CA-C-O 121.789 0.804 . . . . 0.0 110.31 -179.588 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 70.9 mt -98.15 132.85 43.32 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.42 -0.8 . . . . 0.0 109.744 -179.797 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 31.3 t -75.51 3.84 8.62 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.481 -0.762 . . . . 0.0 109.342 179.642 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -118.36 90.28 38.22 Favored Pre-proline 0 N--CA 1.495 1.812 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 179.593 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_exo -56.09 147.38 64.93 Favored 'Trans proline' 0 N--CA 1.495 1.606 0 C-N-CA 122.829 2.353 . . . . 0.0 112.394 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 90.6 mt . . . . . 0 N--CA 1.492 1.657 0 O-C-N 121.299 -0.876 . . . . 0.0 109.869 -179.205 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_exo . . . . . 0 N--CA 1.494 1.517 0 CA-C-O 121.624 0.593 . . . . 0.0 112.261 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . 0.419 ' H ' ' HG2' ' A' ' 4' ' ' GLN . 1.1 pt20 -74.88 72.35 2.07 Favored 'General case' 0 C--N 1.3 -1.55 0 CA-C-O 121.786 0.803 . . . . 0.0 109.905 -179.501 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.431 HD23 HD22 ' A' ' 19' ' ' ASN . 18.8 mt -65.74 137.3 57.18 Favored 'General case' 0 N--CA 1.489 1.479 0 CA-C-O 121.453 0.644 . . . . 0.0 109.734 179.882 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 91.8 m -128.54 135.5 49.48 Favored 'General case' 0 N--CA 1.494 1.728 0 CA-C-O 121.836 0.827 . . . . 0.0 109.811 -179.909 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 65.4 mttp -72.92 151.15 42.02 Favored 'General case' 0 N--CA 1.49 1.572 0 CA-C-O 121.704 0.764 . . . . 0.0 109.975 -179.458 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 92.4 mt -63.25 -43.13 98.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 CA-C-O 121.369 0.604 . . . . 0.0 109.379 -179.393 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 8.3 p -65.7 -24.07 33.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 -179.05 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -79.05 -6.47 56.48 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.639 -0.663 . . . . 0.0 109.327 -179.434 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 97.5 mt -85.89 113.79 24.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 CA-C-O 121.78 0.8 . . . . 0.0 109.543 179.907 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 31.7 m -150.12 12.21 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -124.97 137.51 54.25 Favored 'General case' 0 N--CA 1.501 2.123 0 CA-C-O 121.884 0.85 . . . . 0.0 110.268 -179.861 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 48.1 p-10 -84.08 140.8 31.58 Favored 'General case' 0 N--CA 1.489 1.518 0 CA-C-O 121.619 0.723 . . . . 0.0 109.881 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 75.99 19.0 79.16 Favored Glycine 0 N--CA 1.492 2.407 0 N-CA-C 109.647 -1.381 . . . . 0.0 109.647 179.626 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 57.0 tt0 -78.77 133.82 37.07 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.59 -0.947 . . . . 0.0 110.209 -179.623 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 84.3 m95 -106.78 130.64 54.45 Favored 'General case' 0 N--CA 1.494 1.748 0 CA-C-O 121.585 0.707 . . . . 0.0 110.148 -179.751 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -178.9 175.51 1.01 Allowed 'General case' 0 N--CA 1.493 1.689 0 CA-C-O 121.693 0.758 . . . . 0.0 110.391 179.248 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.522 HD21 HD11 ' A' ' 68' ' ' LEU . 1.4 t30 -102.05 150.01 23.67 Favored 'General case' 0 N--CA 1.498 1.944 0 CA-C-O 121.902 0.858 . . . . 0.0 110.137 -179.432 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 7.2 tt -147.56 138.2 23.32 Favored 'General case' 0 C--N 1.305 -1.36 0 CA-C-O 121.779 0.8 . . . . 0.0 110.449 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 37.8 ttmt -109.83 133.22 53.4 Favored 'General case' 0 N--CA 1.496 1.863 0 CA-C-O 121.594 0.711 . . . . 0.0 109.561 179.477 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -163.18 170.5 17.68 Favored 'General case' 0 N--CA 1.494 1.746 0 CA-C-O 121.762 0.791 . . . . 0.0 110.589 179.718 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.417 ' HZ3' ' N ' ' A' ' 65' ' ' GLU . 17.1 ttmm -113.83 142.31 46.24 Favored 'General case' 0 N--CA 1.498 1.957 0 CA-C-O 121.608 0.718 . . . . 0.0 109.934 -179.717 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.402 HG22 ' CD2' ' A' ' 41' ' ' LEU . 98.8 t -81.98 122.2 36.43 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 CA-C-O 121.528 0.68 . . . . 0.0 110.239 -179.515 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 26.0 mm -93.88 -44.98 13.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 CA-C-O 121.086 0.469 . . . . 0.0 110.031 -179.507 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.825 ' C ' HD13 ' A' ' 27' ' ' LEU . 59.3 tt0 -158.14 147.62 19.66 Favored 'General case' 0 N--CA 1.492 1.642 0 CA-C-O 122.182 0.992 . . . . 0.0 110.334 -179.072 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 1.041 HD22 ' H ' ' A' ' 27' ' ' LEU . 0.0 OUTLIER -116.87 151.46 36.52 Favored 'General case' 0 N--CA 1.502 2.13 0 CA-C-O 121.632 0.729 . . . . 0.0 109.272 -179.205 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 23.9 t90 -138.15 111.18 7.8 Favored 'General case' 0 N--CA 1.493 1.675 0 CA-C-O 121.879 0.847 . . . . 0.0 109.678 179.148 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 . . . . . 0 N--CA 1.491 1.602 0 CA-C-O 121.675 0.75 . . . . 0.0 110.168 -179.618 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 16.4 m . . . . . 0 N--CA 1.492 1.649 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 85.6 mt -103.07 128.61 55.86 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 CA-C-O 121.912 0.863 . . . . 0.0 109.39 -179.56 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 28.1 t -74.92 -75.14 0.17 Allowed 'General case' 0 N--CA 1.489 1.52 0 CA-C-O 121.508 0.67 . . . . 0.0 109.852 -179.273 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 13.1 pt20 -139.78 156.51 46.72 Favored 'General case' 0 N--CA 1.494 1.736 0 CA-C-O 122.045 0.926 . . . . 0.0 110.488 -179.064 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 56.6 t -130.92 136.15 58.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 CA-C-O 121.639 0.733 . . . . 0.0 109.367 179.856 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -153.63 -151.26 5.69 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 110.11 -1.196 . . . . 0.0 110.11 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.4 HD23 ' N ' ' A' ' 40' ' ' LEU . 0.2 OUTLIER -134.48 152.09 51.56 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.739 -0.859 . . . . 0.0 109.772 -179.414 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.402 ' CD2' HG22 ' A' ' 24' ' ' VAL . 53.0 mt -116.85 126.46 53.05 Favored 'General case' 0 N--CA 1.494 1.753 0 CA-C-O 121.84 0.829 . . . . 0.0 109.77 -179.867 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -85.08 150.59 25.07 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 110.959 -0.856 . . . . 0.0 110.959 -179.573 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 44.3 t0 -168.55 164.37 12.46 Favored 'General case' 0 N--CA 1.489 1.494 0 CA-C-O 121.723 0.773 . . . . 0.0 109.583 179.335 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -66.06 -22.38 66.42 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.864 -0.523 . . . . 0.0 109.923 -179.181 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 65.5 p -88.48 -6.02 57.88 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.289 -0.882 . . . . 0.0 109.723 -179.433 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 134.45 -157.65 23.03 Favored Glycine 0 N--CA 1.5 2.956 0 C-N-CA 120.347 -0.93 . . . . 0.0 110.987 178.709 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 4.9 mp -126.02 133.68 68.34 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 CA-C-O 121.491 0.662 . . . . 0.0 109.539 -179.465 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 20.0 tt -127.67 151.83 34.99 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 CA-C-O 122.023 0.916 . . . . 0.0 110.439 -179.457 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 28.2 mmtp -83.94 153.24 24.04 Favored 'General case' 0 N--CA 1.489 1.507 0 CA-C-O 121.543 0.687 . . . . 0.0 109.709 -179.346 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 17.2 p90 -147.2 154.99 41.71 Favored 'General case' 0 N--CA 1.491 1.623 0 CA-C-O 122.03 0.919 . . . . 0.0 110.289 179.8 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 13.8 t -142.22 139.05 31.88 Favored 'General case' 0 N--CA 1.492 1.648 0 CA-C-O 121.684 0.755 . . . . 0.0 109.629 179.493 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 85.8 mt -103.83 116.37 47.49 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 CA-C-O 121.84 0.828 . . . . 0.0 109.803 -179.793 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 73.3 m95 -86.04 138.42 31.97 Favored 'General case' 0 N--CA 1.491 1.591 0 CA-C-O 121.537 0.684 . . . . 0.0 109.402 179.8 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 18.8 mmmt . . . . . 0 N--CA 1.491 1.587 0 CA-C-O 121.451 0.643 . . . . 0.0 109.453 -179.739 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 14.8 mt . . . . . 0 N--CA 1.488 1.473 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -71.54 156.37 58.05 Favored 'Trans proline' 0 C--N 1.31 -1.468 0 C-N-CA 122.561 2.174 . . . . 0.0 112.711 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 82.9 mt -72.41 144.98 47.96 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-O 121.894 0.855 . . . . 0.0 110.706 -179.439 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.568 ' N ' HD12 ' A' ' 61' ' ' LEU . 9.9 mp -86.86 137.62 32.25 Favored 'General case' 0 N--CA 1.488 1.427 0 CA-C-O 121.554 0.693 . . . . 0.0 109.625 -179.71 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.529 ' N ' ' OH ' ' A' ' 67' ' ' TYR . 97.8 mt-10 -80.74 144.9 31.83 Favored 'General case' 0 C--N 1.301 -1.516 0 CA-C-O 121.659 0.742 . . . . 0.0 110.27 -179.778 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.417 ' C ' ' OE1' ' A' ' 65' ' ' GLU . 57.9 tt0 -80.85 125.78 30.52 Favored 'General case' 0 N--CA 1.488 1.465 0 CA-C-O 121.541 0.686 . . . . 0.0 110.437 -179.231 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 96.62 31.46 7.08 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.382 -1.487 . . . . 0.0 109.382 179.304 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.45 ' OE1' ' N ' ' A' ' 65' ' ' GLU . 59.9 mp0 -139.53 145.48 38.74 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.54 -0.977 . . . . 0.0 110.142 179.472 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 30.0 t -75.79 145.14 40.94 Favored 'General case' 0 N--CA 1.489 1.478 0 CA-C-O 121.481 0.658 . . . . 0.0 110.087 -179.908 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.529 ' OH ' ' N ' ' A' ' 62' ' ' GLU . 94.0 m-85 -137.03 144.76 43.4 Favored 'General case' 0 N--CA 1.494 1.726 0 CA-C-O 121.9 0.857 . . . . 0.0 110.477 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.567 HD13 ' N ' ' A' ' 69' ' ' LEU . 0.2 OUTLIER -107.0 119.93 40.7 Favored 'General case' 0 N--CA 1.487 1.414 0 CA-C-O 121.551 0.691 . . . . 0.0 109.405 -179.541 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.567 ' N ' HD13 ' A' ' 68' ' ' LEU . 73.4 mt -93.83 110.44 22.09 Favored 'General case' 0 N--CA 1.491 1.591 0 CA-C-O 121.521 0.677 . . . . 0.0 109.335 179.909 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.532 ' NH2' ' OE1' ' A' ' 92' ' ' GLU . 94.6 mtt180 -102.36 135.39 44.05 Favored 'General case' 0 N--CA 1.492 1.656 0 CA-C-O 121.966 0.888 . . . . 0.0 110.438 -179.774 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 13.4 m 39.85 79.77 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.673 0 CA-C-N 115.03 -0.986 . . . . 0.0 110.806 179.86 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 22.3 m -120.98 163.34 18.76 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 CA-C-O 121.594 0.711 . . . . 0.0 109.921 179.082 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 8.4 p -120.96 135.98 59.41 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 CA-C-O 121.731 0.777 . . . . 0.0 109.953 -179.251 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 9.4 t -91.34 115.76 31.13 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 CA-C-O 121.809 0.814 . . . . 0.0 109.867 -179.534 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.504 ' O ' ' NE2' ' A' ' 82' ' ' GLN . . . -99.43 177.37 29.6 Favored Glycine 0 N--CA 1.492 2.427 0 N-CA-C 110.083 -1.207 . . . . 0.0 110.083 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -103.14 115.88 31.43 Favored 'General case' 0 N--CA 1.494 1.742 0 CA-C-O 121.767 0.794 . . . . 0.0 109.718 179.938 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . 0.404 ' HB3' HE21 ' A' ' 82' ' ' GLN . 82.0 t80 -124.88 120.55 31.97 Favored 'General case' 0 N--CA 1.494 1.771 0 CA-C-O 121.832 0.825 . . . . 0.0 109.893 179.833 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 11.6 t-20 55.67 41.39 30.52 Favored 'General case' 0 N--CA 1.491 1.58 0 CA-C-N 116.14 -0.482 . . . . 0.0 109.808 179.448 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 13.7 t0 69.52 -1.85 2.11 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 179.354 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 19.6 mmm180 -104.01 -170.16 1.73 Allowed 'General case' 0 N--CA 1.495 1.783 0 CA-C-O 121.406 0.622 . . . . 0.0 109.867 -179.886 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 78.9 m-85 -122.06 140.18 52.82 Favored 'General case' 0 N--CA 1.497 1.924 0 CA-C-O 121.949 0.88 . . . . 0.0 110.427 -179.128 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . 0.59 ' NE2' ' N ' ' A' ' 82' ' ' GLN . 0.0 OUTLIER -147.92 152.3 37.32 Favored 'General case' 0 N--CA 1.493 1.704 0 CA-C-O 121.623 0.725 . . . . 0.0 109.59 179.401 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 27.1 m -87.67 132.17 33.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 CA-C-O 121.808 0.813 . . . . 0.0 110.291 -179.658 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -109.18 122.64 47.75 Favored 'General case' 0 N--CA 1.496 1.831 0 CA-C-O 121.837 0.827 . . . . 0.0 110.106 -179.439 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 61.9 t -92.4 130.59 41.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 179.451 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 95.0 m-20 -128.92 -177.24 4.13 Favored 'General case' 0 N--CA 1.495 1.797 0 CA-C-O 121.874 0.845 . . . . 0.0 110.462 -179.449 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 63.7 tttp -56.1 -45.41 79.46 Favored 'General case' 0 N--CA 1.488 1.458 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.8 -179.318 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 98.8 m-20 -63.36 -35.54 80.72 Favored 'General case' 0 N--CA 1.488 1.475 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 -179.237 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 69.1 m -71.47 152.2 43.26 Favored 'General case' 0 N--CA 1.493 1.708 0 CA-C-O 121.717 0.77 . . . . 0.0 110.08 -179.752 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 43.7 t -131.93 146.15 51.93 Favored 'General case' 0 N--CA 1.497 1.875 0 CA-C-O 121.559 0.695 . . . . 0.0 109.615 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 96.5 mt -120.39 132.51 69.8 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 CA-C-O 121.697 0.76 . . . . 0.0 109.977 179.88 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.532 ' OE1' ' NH2' ' A' ' 70' ' ' ARG . 77.1 tt0 -123.07 119.33 29.99 Favored 'General case' 0 N--CA 1.495 1.806 0 CA-C-O 121.81 0.814 . . . . 0.0 109.488 179.669 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 37.9 ttmt -75.79 131.85 40.04 Favored 'General case' 0 N--CA 1.488 1.44 0 CA-C-O 121.42 0.629 . . . . 0.0 109.629 179.736 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.431 HD11 HD23 ' A' ' 68' ' ' LEU . 85.4 mt -109.1 140.54 42.53 Favored 'General case' 0 N--CA 1.494 1.775 0 CA-C-O 121.888 0.851 . . . . 0.0 110.04 -179.813 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 90.9 p -79.87 -4.89 54.21 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 109.341 -0.615 . . . . 0.0 109.341 -179.261 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 81.2 mt-10 -97.7 113.67 63.88 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.827 -0.546 . . . . 0.0 109.59 -179.896 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_endo -75.29 155.37 41.59 Favored 'Trans proline' 0 C--N 1.313 -1.301 0 C-N-CA 122.53 2.153 . . . . 0.0 112.256 -179.907 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 89.9 mt . . . . . 0 N--CA 1.496 1.856 0 CA-C-O 121.899 0.857 . . . . 0.0 110.273 -179.542 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo . . . . . 0 N--CA 1.496 1.654 0 CA-C-O 121.541 0.559 . . . . 0.0 112.568 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 87.3 mt-30 -77.43 91.78 3.92 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.328 -0.857 . . . . 0.0 109.106 -179.935 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 79.5 mt -72.91 125.77 28.35 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.456 -0.777 . . . . 0.0 109.858 -179.229 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 98.8 m -127.12 132.49 50.58 Favored 'General case' 0 N--CA 1.498 1.927 0 CA-C-O 121.456 0.646 . . . . 0.0 109.327 179.878 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -74.76 153.31 38.85 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.555 -0.716 . . . . 0.0 110.415 -179.164 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 96.1 mt -62.52 -43.79 98.71 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.534 -0.729 . . . . 0.0 109.567 -179.691 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 11.7 p -64.05 -24.12 34.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.504 -0.747 . . . . 0.0 109.875 -179.341 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.434 ' O ' ' OD1' ' A' ' 10' ' ' ASP . 60.1 t0 -76.27 -5.88 48.97 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.202 -0.936 . . . . 0.0 109.644 -179.723 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 96.5 mt -84.01 120.39 34.83 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.078 -1.014 . . . . 0.0 109.886 -179.893 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 16.1 m -135.79 -0.04 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 179.352 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 49.9 tp10 -139.9 141.81 36.53 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.394 -0.816 . . . . 0.0 109.719 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 56.4 p30 -87.49 161.2 17.94 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.654 -0.654 . . . . 0.0 110.044 -179.859 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 81.93 14.72 76.79 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 108.816 -1.714 . . . . 0.0 108.816 -179.722 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 56.3 mt-30 -78.98 132.72 36.77 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.496 -1.002 . . . . 0.0 110.285 -179.752 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 92.2 m95 -105.32 106.57 17.13 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 179.407 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -156.82 -178.16 7.15 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.171 -0.955 . . . . 0.0 109.861 -179.727 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.504 HD21 ' CD1' ' A' ' 68' ' ' LEU . 0.6 OUTLIER -103.94 141.42 36.2 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.607 -0.683 . . . . 0.0 109.673 -179.743 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 92.2 mt -134.45 150.63 50.85 Favored 'General case' 0 N--CA 1.496 1.838 0 CA-C-O 121.652 0.739 . . . . 0.0 110.017 -179.816 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 35.7 ttpt -135.21 138.74 43.9 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 179.817 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -166.57 -171.44 1.88 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.157 -0.965 . . . . 0.0 110.396 -179.642 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 21.1 ptmt -121.85 144.73 48.66 Favored 'General case' 0 N--CA 1.496 1.858 0 CA-C-O 121.495 0.664 . . . . 0.0 109.584 -179.682 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 79.9 t -82.76 129.03 38.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.321 -0.862 . . . . 0.0 110.403 -179.284 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 96.7 mt -102.07 -51.52 9.14 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 179.501 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 52.5 tt0 -145.86 144.79 30.44 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.35 -0.844 . . . . 0.0 109.033 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -132.21 132.53 43.2 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.836 -0.54 . . . . 0.0 109.644 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 94.4 m95 -112.16 135.64 52.56 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.676 -0.64 . . . . 0.0 109.324 179.842 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 80.5 tt0 . . . . . 0 N--CA 1.494 1.725 0 O-C-N 121.439 -0.788 . . . . 0.0 110.146 -179.399 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 96.5 p . . . . . 0 N--CA 1.49 1.574 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 96.8 mt -121.16 134.02 65.88 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.95 0 O-C-N 121.563 -0.71 . . . . 0.0 109.894 -179.907 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 33.2 t -85.08 -71.76 0.51 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.653 -0.654 . . . . 0.0 109.802 -179.807 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 46.6 mt-30 -134.01 156.64 47.82 Favored 'General case' 0 N--CA 1.498 1.931 0 CA-C-O 121.794 0.807 . . . . 0.0 110.451 -179.035 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.8 p -139.65 139.85 37.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 179.727 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -167.38 -147.75 5.39 Favored Glycine 0 N--CA 1.49 2.256 0 C-N-CA 119.395 -1.383 . . . . 0.0 110.187 -179.827 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -133.7 152.19 51.82 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.662 -0.904 . . . . 0.0 109.951 -179.545 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 73.6 mt -115.5 131.39 56.95 Favored 'General case' 0 N--CA 1.494 1.745 0 CA-C-O 121.534 0.683 . . . . 0.0 109.291 179.712 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -80.79 160.91 43.62 Favored Glycine 0 N--CA 1.486 2.03 0 N-CA-C 110.613 -0.995 . . . . 0.0 110.613 -179.346 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -174.29 146.01 1.06 Allowed 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 179.508 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -57.36 -15.15 5.7 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.346 -0.846 . . . . 0.0 109.906 -179.603 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 42.1 p -94.69 -7.87 39.45 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.224 -0.923 . . . . 0.0 109.854 -179.709 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 138.77 -157.06 24.56 Favored Glycine 0 N--CA 1.5 2.936 0 N-CA-C 110.527 -1.029 . . . . 0.0 110.527 179.217 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 40.9 pt -124.87 153.83 32.23 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.005 0 O-C-N 121.856 -0.791 . . . . 0.0 109.517 -179.874 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 20.0 tt -147.31 149.5 15.53 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.253 -0.905 . . . . 0.0 109.937 179.667 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 18.9 mmmt -83.28 148.68 27.24 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.748 -0.595 . . . . 0.0 110.175 -179.605 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 16.1 p90 -143.88 153.63 42.53 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.441 -0.787 . . . . 0.0 109.435 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 87.9 m -134.14 135.57 43.24 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 179.711 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 91.9 mt -101.63 126.03 55.61 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.398 -0.814 . . . . 0.0 109.601 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 93.5 m95 -96.14 139.73 31.89 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.524 -0.735 . . . . 0.0 109.529 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 50.9 mtpt . . . . . 0 C--N 1.302 -1.488 0 O-C-N 121.529 -0.732 . . . . 0.0 109.124 -179.96 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 36.6 mt . . . . . 0 N--CA 1.496 1.844 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -69.98 162.03 43.73 Favored 'Trans proline' 0 N--CA 1.498 1.745 0 C-N-CA 122.911 2.408 . . . . 0.0 113.195 179.708 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 65.6 mt -69.0 143.55 54.34 Favored 'General case' 0 N--CA 1.493 1.69 0 CA-C-O 121.742 0.782 . . . . 0.0 110.388 -179.215 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.599 ' N ' HD12 ' A' ' 61' ' ' LEU . 9.7 mp -92.81 141.68 28.17 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.672 -0.643 . . . . 0.0 110.048 -179.186 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -85.1 152.03 23.7 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.424 -0.797 . . . . 0.0 110.342 -179.644 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 55.4 tt0 -81.98 138.46 34.92 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.616 -0.678 . . . . 0.0 110.822 -179.336 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 79.88 23.6 61.55 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 110.105 -1.198 . . . . 0.0 110.105 178.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -126.94 146.59 50.26 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.441 -1.034 . . . . 0.0 110.307 -179.796 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 12.8 p -83.01 146.44 28.75 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 179.745 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 65.4 m-85 -140.36 145.07 36.65 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.438 -0.789 . . . . 0.0 110.007 179.775 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.504 ' CD1' HD21 ' A' ' 19' ' ' ASN . 17.8 tp -105.59 123.1 47.36 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 179.106 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.408 ' O ' ' OD1' ' A' ' 19' ' ' ASN . 67.5 mt -103.81 125.25 50.12 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 179.899 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 82.5 mtp180 -114.53 134.81 54.74 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.69 -0.631 . . . . 0.0 110.054 -179.755 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 31.2 t 60.46 73.72 0.47 Allowed 'General case' 0 N--CA 1.493 1.687 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.791 179.65 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 3.7 m -124.6 159.32 30.93 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.129 0 O-C-N 121.605 -0.684 . . . . 0.0 109.294 178.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 13.6 p -121.74 135.09 62.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 -179.807 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 13.4 t -84.74 118.89 32.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.483 -0.761 . . . . 0.0 110.306 -178.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -97.22 171.34 26.77 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 179.723 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -111.37 121.3 44.86 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.724 -0.868 . . . . 0.0 109.789 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . 0.509 ' CZ ' ' OD1' ' A' ' 78' ' ' ASN . 54.8 t80 -134.16 124.96 26.93 Favored 'General case' 0 N--CA 1.495 1.819 0 CA-C-O 121.393 0.616 . . . . 0.0 109.499 179.578 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . 0.509 ' OD1' ' CZ ' ' A' ' 77' ' ' TYR . 6.4 m120 51.56 51.49 16.61 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.648 -0.657 . . . . 0.0 110.574 179.789 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 55.6 2.6 0.07 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.736 -0.602 . . . . 0.0 110.184 179.351 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.487 ' H ' ' C ' ' A' ' 78' ' ' ASN . 18.7 mmm180 -103.88 163.0 12.65 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.378 -0.826 . . . . 0.0 109.704 -179.912 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 69.7 m-85 -95.71 143.51 26.9 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.449 -0.782 . . . . 0.0 109.748 -179.283 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -146.3 159.97 42.64 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.517 -0.739 . . . . 0.0 109.436 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.407 ' O ' HG23 ' A' ' 83' ' ' VAL . 33.2 m -111.44 128.31 68.03 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 179.431 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 76.8 mt-30 -109.42 124.67 51.4 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.563 -0.711 . . . . 0.0 109.474 -179.345 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 10.7 t -97.18 106.78 18.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.385 -0.822 . . . . 0.0 109.611 -179.773 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -152.04 -177.43 6.16 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.466 -0.771 . . . . 0.0 109.985 179.934 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 72.5 tttt 66.76 -133.19 0.15 Allowed 'General case' 0 N--CA 1.492 1.667 0 CA-C-O 121.444 0.64 . . . . 0.0 110.932 179.306 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 12.7 m120 -88.52 20.65 3.27 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.432 -0.792 . . . . 0.0 109.246 -179.093 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 15.5 m -60.13 147.65 38.82 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.459 -0.776 . . . . 0.0 109.511 -179.73 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 25.5 m -128.78 152.35 48.55 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.618 -0.676 . . . . 0.0 109.747 -179.81 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 93.9 mt -129.1 133.5 65.77 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 179.785 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -126.42 134.28 51.04 Favored 'General case' 0 N--CA 1.497 1.912 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 179.548 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.443 ' C ' HD22 ' A' ' 94' ' ' LEU . 63.7 tttp -79.79 129.26 34.33 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.41 -0.806 . . . . 0.0 109.837 -179.338 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.444 HD22 ' N ' ' A' ' 94' ' ' LEU . 4.1 mm? -100.54 133.18 45.37 Favored 'General case' 0 N--CA 1.493 1.702 0 CA-C-O 121.756 0.789 . . . . 0.0 109.802 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 23.1 t -85.29 10.43 12.56 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 -179.899 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 22.1 tt0 -118.47 90.24 38.58 Favored Pre-proline 0 N--CA 1.497 1.916 0 O-C-N 121.602 -0.686 . . . . 0.0 109.29 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_exo -56.14 146.84 68.51 Favored 'Trans proline' 0 N--CA 1.498 1.739 0 C-N-CA 122.785 2.323 . . . . 0.0 112.19 179.496 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 93.0 mt . . . . . 0 N--CA 1.495 1.801 0 O-C-N 121.474 -0.766 . . . . 0.0 109.997 -179.41 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo . . . . . 0 N--CA 1.49 1.304 0 CA-C-O 121.829 0.679 . . . . 0.0 112.714 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . 0.42 ' HG2' ' H ' ' A' ' 4' ' ' GLN . 7.8 pt20 -73.29 89.41 1.57 Allowed 'General case' 0 C--N 1.302 -1.487 0 CA-C-O 121.534 0.683 . . . . 0.0 110.223 -179.326 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 79.6 mt -79.33 139.78 37.71 Favored 'General case' 0 N--CA 1.488 1.474 0 CA-C-O 121.543 0.687 . . . . 0.0 109.734 179.7 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 69.5 m -127.16 130.91 50.66 Favored 'General case' 0 N--CA 1.496 1.854 0 CA-C-O 121.609 0.719 . . . . 0.0 109.666 179.667 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 63.7 mttp -84.23 156.95 21.77 Favored 'General case' 0 N--CA 1.49 1.568 0 CA-C-O 121.785 0.802 . . . . 0.0 109.688 179.914 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 95.6 mt -63.0 -42.58 97.23 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.557 0 CA-C-O 121.28 0.562 . . . . 0.0 109.518 -179.215 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 14.7 p -65.54 -24.04 33.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.605 -0.684 . . . . 0.0 109.559 -179.178 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 -77.03 -7.11 55.09 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.441 -0.787 . . . . 0.0 108.89 -179.455 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 98.6 mt -93.18 116.04 33.39 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 CA-C-O 121.662 0.744 . . . . 0.0 109.719 179.708 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 25.6 m -151.23 14.54 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 179.34 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -137.44 137.17 38.48 Favored 'General case' 0 N--CA 1.494 1.771 0 CA-C-O 121.762 0.792 . . . . 0.0 109.376 179.417 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 7.6 t-20 -74.32 147.59 42.13 Favored 'General case' 0 C--N 1.301 -1.529 0 CA-C-O 121.696 0.76 . . . . 0.0 109.99 -179.622 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 71.58 99.51 0.06 OUTLIER Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 179.92 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 27.5 tt0 -165.17 126.98 2.08 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.732 -0.863 . . . . 0.0 110.098 179.443 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 95.2 m95 -96.6 128.71 43.79 Favored 'General case' 0 N--CA 1.494 1.753 0 CA-C-O 121.477 0.656 . . . . 0.0 109.465 179.926 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.441 ' O ' HG22 ' A' ' 72' ' ' VAL . . . -174.88 177.08 2.07 Favored 'General case' 0 N--CA 1.493 1.717 0 CA-C-O 121.878 0.846 . . . . 0.0 110.419 179.818 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.481 ' ND2' ' H ' ' A' ' 71' ' ' SER . 5.7 m120 -99.24 148.91 23.64 Favored 'General case' 0 N--CA 1.495 1.776 0 CA-C-O 121.728 0.775 . . . . 0.0 109.445 -179.712 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 54.5 tp -139.57 135.94 33.9 Favored 'General case' 0 N--CA 1.487 1.418 0 CA-C-O 121.962 0.887 . . . . 0.0 110.244 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 37.3 ttmt -122.36 132.65 54.49 Favored 'General case' 0 N--CA 1.49 1.566 0 CA-C-O 121.773 0.797 . . . . 0.0 109.121 179.148 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -160.95 178.04 9.78 Favored 'General case' 0 C--N 1.3 -1.555 0 CA-C-O 121.658 0.742 . . . . 0.0 109.808 -179.866 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 63.7 tttp -114.55 145.55 41.81 Favored 'General case' 0 N--CA 1.496 1.839 0 CA-C-O 121.775 0.797 . . . . 0.0 110.332 -178.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 89.5 t -83.54 108.14 15.77 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 CA-C-O 121.684 0.754 . . . . 0.0 110.34 -179.501 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.412 HG12 ' H ' ' A' ' 42' ' ' GLY . 34.3 mm -94.24 -47.37 13.43 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 179.915 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 7.4 tt0 -148.41 140.55 24.06 Favored 'General case' 0 N--CA 1.494 1.774 0 CA-C-O 122.135 0.969 . . . . 0.0 109.968 -179.758 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.483 ' N ' HD23 ' A' ' 27' ' ' LEU . 0.3 OUTLIER -136.57 145.51 45.06 Favored 'General case' 0 N--CA 1.491 1.577 0 CA-C-O 121.956 0.884 . . . . 0.0 110.164 -179.335 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 5.7 m-90 -114.13 141.77 47.08 Favored 'General case' 0 N--CA 1.492 1.653 0 CA-C-O 121.648 0.737 . . . . 0.0 109.261 179.041 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 . . . . . 0 C--N 1.303 -1.42 0 CA-C-O 121.602 0.715 . . . . 0.0 109.795 -179.436 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 12.8 m . . . . . 0 N--CA 1.494 1.741 0 N-CA-C 109.009 -0.738 . . . . 0.0 109.009 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 96.7 mt -93.17 119.07 40.29 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 CA-C-O 121.839 0.828 . . . . 0.0 109.507 179.794 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 3.6 t -71.3 -56.01 6.88 Favored 'General case' 0 C--N 1.3 -1.546 0 CA-C-O 121.428 0.633 . . . . 0.0 109.525 179.761 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 83.7 mt-30 -147.63 147.6 30.19 Favored 'General case' 0 N--CA 1.49 1.539 0 CA-C-O 121.925 0.869 . . . . 0.0 110.456 -179.286 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.9 p -142.77 142.47 26.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 CA-C-O 121.613 0.72 . . . . 0.0 109.349 179.589 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -171.99 -155.26 10.82 Favored Glycine 0 N--CA 1.491 2.308 0 C-N-CA 119.952 -1.118 . . . . 0.0 110.562 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -132.9 147.52 52.29 Favored 'General case' 0 N--CA 1.494 1.745 0 CA-C-O 121.895 0.855 . . . . 0.0 110.269 -179.463 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 41.1 mt -116.88 130.72 56.89 Favored 'General case' 0 N--CA 1.496 1.83 0 CA-C-O 121.743 0.782 . . . . 0.0 109.407 -179.258 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.412 ' H ' HG12 ' A' ' 25' ' ' ILE . . . -83.15 161.38 39.45 Favored Glycine 0 N--CA 1.495 2.609 0 N-CA-C 111.227 -0.749 . . . . 0.0 111.227 -179.146 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.557 ' OD1' ' N ' ' A' ' 44' ' ' GLU . 62.1 t0 -174.13 150.29 1.54 Allowed 'General case' 0 N--CA 1.493 1.722 0 CA-C-O 122.095 0.95 . . . . 0.0 110.031 179.643 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.557 ' N ' ' OD1' ' A' ' 43' ' ' ASP . 98.0 mt-10 -59.44 -17.67 32.93 Favored 'General case' 0 N--CA 1.491 1.601 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.139 179.979 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 41.6 p -92.25 -11.17 36.02 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 -179.688 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 139.95 -159.87 26.1 Favored Glycine 0 N--CA 1.498 2.77 0 C-N-CA 120.246 -0.978 . . . . 0.0 111.123 178.934 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 96.4 mt -125.21 132.86 70.64 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 CA-C-O 121.773 0.797 . . . . 0.0 109.993 -179.23 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 18.0 tt -131.17 148.43 32.91 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 CA-C-O 121.934 0.873 . . . . 0.0 110.421 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 54.7 mtpt -92.91 151.04 20.18 Favored 'General case' 0 N--CA 1.494 1.741 0 CA-C-O 121.713 0.768 . . . . 0.0 110.16 -179.841 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 5.8 p90 -142.84 152.99 42.75 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-O 122.003 0.906 . . . . 0.0 109.975 179.871 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 84.9 m -130.2 130.98 45.36 Favored 'General case' 0 N--CA 1.493 1.692 0 CA-C-O 121.864 0.84 . . . . 0.0 109.203 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 95.7 mt -100.26 121.93 51.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 CA-C-O 121.791 0.805 . . . . 0.0 110.049 -179.496 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 96.1 m95 -98.0 133.57 42.29 Favored 'General case' 0 N--CA 1.495 1.799 0 CA-C-O 121.551 0.691 . . . . 0.0 109.349 179.782 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 16.4 ptpt . . . . . 0 N--CA 1.496 1.841 0 O-C-N 121.759 -0.588 . . . . 0.0 109.83 179.949 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 11.4 mt . . . . . 0 N--CA 1.491 1.593 0 N-CA-C 108.633 -0.876 . . . . 0.0 108.633 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -68.86 153.46 72.76 Favored 'Trans proline' 0 C--N 1.312 -1.358 0 C-N-CA 122.403 2.069 . . . . 0.0 112.646 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 71.4 mt -72.75 142.95 48.14 Favored 'General case' 0 C--N 1.301 -1.525 0 CA-C-O 121.678 0.752 . . . . 0.0 109.968 -179.754 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.542 ' N ' HD12 ' A' ' 61' ' ' LEU . 10.5 mp -87.84 135.49 33.37 Favored 'General case' 0 N--CA 1.49 1.554 0 CA-C-O 121.715 0.769 . . . . 0.0 109.707 -179.805 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 46.1 tp10 -93.78 144.85 25.05 Favored 'General case' 0 N--CA 1.49 1.558 0 CA-C-O 121.89 0.852 . . . . 0.0 109.685 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 57.5 tt0 -79.15 143.74 35.16 Favored 'General case' 0 C--N 1.299 -1.597 0 CA-C-O 121.677 0.751 . . . . 0.0 110.318 -179.614 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 82.08 23.8 56.4 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 110.036 -1.226 . . . . 0.0 110.036 179.054 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.513 ' OE1' ' NZ ' ' A' ' 93' ' ' LYS . 95.8 mt-10 -136.55 144.91 44.48 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.384 -1.068 . . . . 0.0 110.109 179.672 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 12.2 p -89.23 145.69 25.24 Favored 'General case' 0 N--CA 1.489 1.496 0 CA-C-O 121.702 0.763 . . . . 0.0 110.223 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -137.71 152.61 49.42 Favored 'General case' 0 N--CA 1.494 1.734 0 CA-C-O 122.122 0.963 . . . . 0.0 110.323 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 32.3 tp -111.1 121.55 45.62 Favored 'General case' 0 N--CA 1.494 1.733 0 CA-C-N 115.488 -0.778 . . . . 0.0 109.64 179.864 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 74.0 mt -102.15 133.1 47.55 Favored 'General case' 0 N--CA 1.494 1.728 0 CA-C-O 121.726 0.774 . . . . 0.0 109.373 179.538 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 86.8 mtm180 -129.61 147.35 51.4 Favored 'General case' 0 N--CA 1.495 1.819 0 CA-C-O 121.924 0.869 . . . . 0.0 110.51 -179.287 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.481 ' H ' ' ND2' ' A' ' 19' ' ' ASN . 1.7 m 56.46 55.34 6.61 Favored 'General case' 0 N--CA 1.494 1.729 0 CA-C-N 115.606 -0.725 . . . . 0.0 110.415 179.354 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.441 HG22 ' O ' ' A' ' 18' ' ' ALA . 12.5 m -111.12 158.19 11.71 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 CA-C-O 121.626 0.727 . . . . 0.0 109.972 179.369 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 13.5 p -116.7 134.88 58.82 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 CA-C-O 121.828 0.823 . . . . 0.0 109.677 -179.631 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 11.7 t -86.27 115.48 27.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 CA-C-O 121.862 0.839 . . . . 0.0 109.88 -179.433 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -100.96 175.25 26.1 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 110.074 -1.21 . . . . 0.0 110.074 -179.776 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 48.0 tp10 -111.51 121.39 45.05 Favored 'General case' 0 N--CA 1.493 1.699 0 CA-C-O 121.829 0.824 . . . . 0.0 109.673 -179.906 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 87.3 t80 -136.58 125.37 24.01 Favored 'General case' 0 N--CA 1.492 1.655 0 CA-C-O 121.865 0.84 . . . . 0.0 110.14 179.834 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . 0.488 ' C ' ' H ' ' A' ' 80' ' ' ARG . 10.7 t-20 56.27 43.33 26.65 Favored 'General case' 0 N--CA 1.488 1.46 0 CA-C-N 116.081 -0.509 . . . . 0.0 109.781 179.193 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 48.2 t0 62.64 -1.36 0.45 Allowed 'General case' 0 N--CA 1.493 1.725 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 179.641 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.488 ' H ' ' C ' ' A' ' 78' ' ' ASN . 83.2 mtp180 -100.09 178.23 4.85 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.606 -0.684 . . . . 0.0 109.986 179.868 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 78.3 m-85 -112.94 138.15 50.24 Favored 'General case' 0 N--CA 1.498 1.953 0 CA-C-O 122.086 0.946 . . . . 0.0 110.062 -179.303 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -147.09 163.0 37.68 Favored 'General case' 0 N--CA 1.489 1.52 0 CA-C-O 121.829 0.823 . . . . 0.0 110.292 179.936 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 2.5 m -106.24 131.65 55.38 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 -179.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 86.7 mt-30 -104.91 122.6 46.15 Favored 'General case' 0 N--CA 1.495 1.807 0 CA-C-O 122.107 0.956 . . . . 0.0 110.364 -179.172 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 18.2 t -93.93 129.73 43.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 CA-C-O 121.947 0.879 . . . . 0.0 109.765 -179.875 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 81.7 m-20 -134.82 -174.74 3.68 Favored 'General case' 0 N--CA 1.493 1.702 0 CA-C-O 121.452 0.644 . . . . 0.0 109.309 179.79 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 24.8 pttm -58.88 -34.75 72.0 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.858 -0.526 . . . . 0.0 109.924 -179.296 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 38.7 t30 -64.11 -38.07 89.74 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 10.0 m -72.76 156.33 39.04 Favored 'General case' 0 N--CA 1.492 1.675 0 CA-C-O 121.709 0.766 . . . . 0.0 110.73 -179.153 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 88.2 p -129.52 151.36 50.22 Favored 'General case' 0 N--CA 1.493 1.717 0 CA-C-O 121.692 0.758 . . . . 0.0 109.759 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 94.8 mt -124.65 132.79 70.85 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 CA-C-O 121.572 0.701 . . . . 0.0 109.572 -179.508 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 81.6 tt0 -130.13 134.37 47.29 Favored 'General case' 0 N--CA 1.497 1.881 0 CA-C-O 121.996 0.903 . . . . 0.0 109.838 179.621 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.513 ' NZ ' ' OE1' ' A' ' 65' ' ' GLU . 64.1 tttp -79.95 134.45 36.26 Favored 'General case' 0 N--CA 1.489 1.478 0 CA-C-O 121.748 0.785 . . . . 0.0 110.117 179.933 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 73.6 mt -100.88 133.76 44.87 Favored 'General case' 0 N--CA 1.492 1.67 0 CA-C-O 121.689 0.757 . . . . 0.0 109.726 179.626 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 88.8 p -78.74 -5.52 53.43 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 -179.604 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 21.5 tp10 -111.82 121.03 40.81 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.794 -0.567 . . . . 0.0 109.894 -179.751 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -74.29 154.25 46.03 Favored 'Trans proline' 0 N--CA 1.488 1.202 0 C-N-CA 122.511 2.141 . . . . 0.0 112.065 179.63 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 96.7 mt . . . . . 0 N--CA 1.499 1.988 0 CA-C-O 121.915 0.864 . . . . 0.0 110.364 -179.603 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo . . . . . 0 N--CA 1.497 1.703 0 CA-C-O 121.6 0.583 . . . . 0.0 112.312 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . 0.401 ' N ' ' CD ' ' A' ' 4' ' ' GLN . 28.2 mp0 -84.49 89.41 7.42 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.057 -1.027 . . . . 0.0 109.664 -179.581 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -73.73 142.02 46.33 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.456 -0.777 . . . . 0.0 109.351 179.616 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 98.4 m -122.77 129.2 51.46 Favored 'General case' 0 N--CA 1.498 1.962 0 CA-C-O 121.666 0.746 . . . . 0.0 109.812 -179.7 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -85.42 159.36 19.99 Favored 'General case' 0 N--CA 1.491 1.618 0 CA-C-O 121.609 0.719 . . . . 0.0 110.051 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 33.0 mm -63.85 -43.38 97.82 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 O-C-N 121.275 -0.89 . . . . 0.0 109.198 179.893 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 12.6 p -65.02 -22.53 31.6 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 O-C-N 121.47 -0.769 . . . . 0.0 109.529 -179.692 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -74.79 -7.03 52.15 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.092 -1.005 . . . . 0.0 109.257 179.45 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 96.7 mt -83.11 120.83 35.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.232 -0.917 . . . . 0.0 109.4 179.886 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 15.8 m -134.93 -28.04 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 O-C-N 121.346 -0.846 . . . . 0.0 109.721 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -135.05 152.39 51.65 Favored 'General case' 0 N--CA 1.501 2.113 0 O-C-N 121.188 -0.945 . . . . 0.0 110.372 -179.424 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 57.4 p30 -79.12 166.0 22.73 Favored 'General case' 0 N--CA 1.491 1.618 0 CA-C-O 121.6 0.714 . . . . 0.0 110.652 -179.201 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 71.02 92.91 0.08 OUTLIER Glycine 0 N--CA 1.491 2.303 0 N-CA-C 110.294 -1.122 . . . . 0.0 110.294 179.476 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 20.5 tt0 -168.89 130.9 1.25 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.408 -1.054 . . . . 0.0 109.183 179.279 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 91.9 m95 -95.65 133.56 39.58 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.404 -0.81 . . . . 0.0 109.774 -179.686 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.461 ' O ' HG22 ' A' ' 72' ' ' VAL . . . -175.09 176.58 2.08 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.193 -0.942 . . . . 0.0 109.741 179.509 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 94.6 m-20 -103.91 145.01 30.75 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.438 -0.789 . . . . 0.0 109.072 179.888 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 5.6 tt -142.04 133.61 26.77 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.278 -0.889 . . . . 0.0 109.924 -179.818 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 3.5 ttmp? -117.01 141.85 47.72 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 179.558 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.464 ' CB ' ' OD1' ' A' ' 43' ' ' ASP . . . -164.2 -177.18 4.83 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.887 -1.133 . . . . 0.0 110.352 -179.648 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -112.05 137.63 49.82 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.633 -0.667 . . . . 0.0 109.487 -179.913 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 71.2 t -83.54 96.64 4.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.295 -0.878 . . . . 0.0 110.197 -179.572 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.49 ' O ' ' NE2' ' A' ' 63' ' ' GLN . 96.7 mt -65.53 -45.32 92.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.418 -0.801 . . . . 0.0 109.433 179.744 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.525 ' NE2' ' CZ2' ' A' ' 28' ' ' TRP . 14.6 pt20 -170.61 148.4 3.03 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.397 -0.814 . . . . 0.0 109.737 -179.875 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.546 ' O ' HD12 ' A' ' 27' ' ' LEU . 0.3 OUTLIER -143.65 137.15 28.05 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.566 -0.709 . . . . 0.0 109.274 179.589 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . 0.525 ' CZ2' ' NE2' ' A' ' 26' ' ' GLN . 5.6 m0 -117.69 146.06 43.99 Favored 'General case' 0 N--CA 1.498 1.936 0 CA-C-O 121.717 0.77 . . . . 0.0 109.672 -179.709 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.695 ' CD ' ' H ' ' A' ' 29' ' ' GLU . 1.5 pm0 . . . . . 0 N--CA 1.491 1.579 0 CA-C-O 121.617 0.722 . . . . 0.0 110.568 -179.25 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 11.0 t . . . . . 0 N--CA 1.491 1.601 0 CA-C-O 121.012 0.434 . . . . 0.0 110.232 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 90.6 mt -98.6 133.69 40.09 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 O-C-N 121.299 -0.876 . . . . 0.0 110.173 -178.906 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 25.0 m -81.47 -70.8 0.51 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.578 -0.701 . . . . 0.0 110.112 -179.664 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 34.4 mt-30 -132.55 155.5 48.52 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.393 -0.817 . . . . 0.0 109.62 -179.02 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 9.4 p -137.1 141.03 41.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 -179.805 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -165.79 -158.5 10.85 Favored Glycine 0 N--CA 1.491 2.328 0 C-N-CA 119.422 -1.371 . . . . 0.0 110.177 -179.085 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.732 ' O ' HD12 ' A' ' 40' ' ' LEU . 0.8 OUTLIER -135.65 151.94 50.72 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.573 -0.957 . . . . 0.0 109.761 179.826 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 52.5 mt -114.88 139.76 49.52 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.453 -0.779 . . . . 0.0 109.235 -179.0 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -94.37 127.65 9.17 Favored Glycine 0 N--CA 1.493 2.498 0 N-CA-C 110.359 -1.097 . . . . 0.0 110.359 -179.63 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.464 ' OD1' ' CB ' ' A' ' 22' ' ' ALA . 73.0 m-20 -128.6 142.32 51.08 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.795 -0.827 . . . . 0.0 108.872 179.005 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -56.76 -14.99 3.83 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.411 -0.805 . . . . 0.0 109.52 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 16.5 p -99.3 -8.47 24.89 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.316 -0.865 . . . . 0.0 109.775 -179.763 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 153.95 -167.14 32.16 Favored Glycine 0 N--CA 1.498 2.821 0 C-N-CA 119.733 -1.222 . . . . 0.0 110.257 179.292 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 96.6 mt -125.61 134.7 66.05 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.081 0 O-C-N 121.586 -0.949 . . . . 0.0 108.656 179.895 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 20.6 tt -131.42 144.71 36.78 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.231 0 O-C-N 121.168 -0.958 . . . . 0.0 110.463 -179.566 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 52.8 mtmt -84.34 157.19 21.56 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.727 -0.608 . . . . 0.0 110.42 -179.633 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 16.2 p90 -152.1 164.26 37.63 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.317 -0.864 . . . . 0.0 109.666 179.627 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.418 HG22 HE21 ' A' ' 82' ' ' GLN . 2.7 t -139.1 148.85 43.83 Favored 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 179.578 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 39.2 mm -106.41 126.36 62.12 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 O-C-N 121.472 -0.768 . . . . 0.0 109.562 -179.459 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 77.8 m95 -98.36 147.38 24.74 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.486 -0.759 . . . . 0.0 109.799 -179.72 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 64.7 mttp . . . . . 0 N--CA 1.49 1.54 0 O-C-N 121.449 -0.782 . . . . 0.0 109.255 179.755 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 14.2 mt . . . . . 0 N--CA 1.499 1.975 0 N-CA-C 109.749 -0.464 . . . . 0.0 109.749 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -70.13 165.28 31.91 Favored 'Trans proline' 0 N--CA 1.502 1.99 0 C-N-CA 123.095 2.53 . . . . 0.0 113.918 -179.102 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 66.6 mt -65.56 141.08 58.57 Favored 'General case' 0 N--CA 1.494 1.761 0 CA-C-O 121.905 0.86 . . . . 0.0 110.88 -178.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.597 ' N ' HD12 ' A' ' 61' ' ' LEU . 9.1 mp -87.39 145.9 26.11 Favored 'General case' 0 N--CA 1.492 1.654 0 CA-C-O 121.344 0.593 . . . . 0.0 110.037 -179.523 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.443 ' N ' ' OH ' ' A' ' 67' ' ' TYR . 83.7 tt0 -98.63 126.69 44.3 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.399 -0.813 . . . . 0.0 109.126 179.461 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.49 ' NE2' ' O ' ' A' ' 25' ' ' ILE . 10.8 tm0? -69.19 140.34 54.61 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.508 -0.745 . . . . 0.0 111.231 -178.822 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.447 ' N ' ' CD ' ' A' ' 63' ' ' GLN . . . 91.78 20.06 38.33 Favored Glycine 0 N--CA 1.495 2.581 0 N-CA-C 110.541 -1.024 . . . . 0.0 110.541 178.812 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.488 ' OE1' ' N ' ' A' ' 65' ' ' GLU . 58.8 mp0 -139.0 155.58 47.88 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.158 -1.201 . . . . 0.0 110.47 179.911 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 13.5 p -80.72 156.44 26.26 Favored 'General case' 0 N--CA 1.49 1.527 0 CA-C-O 121.552 0.691 . . . . 0.0 110.534 -179.418 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.443 ' OH ' ' N ' ' A' ' 62' ' ' GLU . 88.4 m-85 -145.78 144.27 30.2 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.48 -0.763 . . . . 0.0 109.645 179.674 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 13.7 tp -111.86 117.93 34.13 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 179.219 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 4.6 mp -103.45 126.66 50.73 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.467 -0.771 . . . . 0.0 109.054 -179.553 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 90.3 mtm-85 -115.57 140.85 48.79 Favored 'General case' 0 N--CA 1.497 1.909 0 CA-C-O 121.645 0.736 . . . . 0.0 110.421 -178.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.4 ' OG ' ' O ' ' A' ' 71' ' ' SER . 22.2 p 59.77 66.69 0.96 Allowed 'General case' 0 N--CA 1.494 1.744 0 CA-C-O 121.121 0.486 . . . . 0.0 110.703 179.67 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.461 HG22 ' O ' ' A' ' 18' ' ' ALA . 16.5 m -116.26 160.79 15.45 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.134 0 O-C-N 121.537 -0.727 . . . . 0.0 109.252 178.841 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 7.4 p -117.72 133.16 65.37 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 CA-C-O 121.382 0.611 . . . . 0.0 109.423 -179.563 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 13.5 t -88.06 110.29 20.77 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.278 -0.889 . . . . 0.0 109.669 -179.427 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -88.29 172.15 41.14 Favored Glycine 0 N--CA 1.493 2.49 0 N-CA-C 109.887 -1.285 . . . . 0.0 109.887 -179.602 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -100.45 119.68 38.84 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.566 -0.961 . . . . 0.0 109.15 179.928 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 40.7 t80 -115.17 104.36 11.77 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.539 -0.726 . . . . 0.0 109.774 -179.68 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 41.45 -117.15 0.34 Allowed 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.582 -0.698 . . . . 0.0 111.204 179.471 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.418 ' N ' ' OD1' ' A' ' 79' ' ' ASP . 37.5 p-10 -94.53 -7.67 40.52 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.329 -0.857 . . . . 0.0 110.234 -178.794 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 95.4 mtt180 -112.18 177.46 4.63 Favored 'General case' 0 N--CA 1.501 2.091 0 O-C-N 121.417 -0.802 . . . . 0.0 110.015 -179.925 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 72.9 m-85 -109.54 148.64 30.9 Favored 'General case' 0 N--CA 1.497 1.905 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 -179.693 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . 0.418 HE21 HG22 ' A' ' 51' ' ' THR . 53.3 tt0 -137.88 154.01 49.5 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.306 -0.871 . . . . 0.0 109.751 -179.81 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 33.5 m -113.32 132.86 60.99 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 179.729 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 79.0 mt-30 -106.76 127.48 53.43 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.572 -0.705 . . . . 0.0 109.992 -178.883 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 16.8 t -94.8 98.14 7.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.474 -0.766 . . . . 0.0 109.093 179.753 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . 0.529 HD22 ' C ' ' A' ' 86' ' ' ASN . 0.1 OUTLIER -151.18 177.7 9.95 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.412 -0.805 . . . . 0.0 109.767 -179.759 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.516 ' C ' ' H ' ' A' ' 89' ' ' SER . 71.2 mmtt 61.19 -141.27 0.5 Allowed 'General case' 0 N--CA 1.493 1.712 0 CA-C-O 121.639 0.733 . . . . 0.0 110.772 179.169 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 32.3 t30 -66.46 9.52 0.16 Allowed 'General case' 0 C--N 1.304 -1.405 0 CA-C-O 121.334 0.588 . . . . 0.0 109.658 -179.446 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.516 ' H ' ' C ' ' A' ' 87' ' ' LYS . 13.3 p -58.18 143.61 43.54 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.249 -0.907 . . . . 0.0 109.671 -179.882 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 19.2 p -141.26 156.4 45.89 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.482 -0.761 . . . . 0.0 109.655 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 96.5 mt -132.58 134.53 58.68 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 121.556 -0.715 . . . . 0.0 109.445 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -126.48 136.83 53.12 Favored 'General case' 0 N--CA 1.499 2.013 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 179.516 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.432 ' C ' HD12 ' A' ' 94' ' ' LEU . 88.4 tttt -80.13 128.91 34.07 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.397 -0.815 . . . . 0.0 109.678 -179.795 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.432 HD12 ' C ' ' A' ' 93' ' ' LYS . 10.1 mp -105.23 134.59 48.08 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.451 -0.781 . . . . 0.0 109.636 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 96.6 p -88.6 8.51 28.0 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 108.774 -0.825 . . . . 0.0 108.774 179.521 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 67.0 mt-10 -117.55 90.38 35.1 Favored Pre-proline 0 N--CA 1.498 1.951 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 -179.775 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_exo -55.7 147.52 59.89 Favored 'Trans proline' 0 N--CA 1.497 1.705 0 C-N-CA 122.741 2.294 . . . . 0.0 112.658 179.618 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.586 HG22 ' O ' ' A' ' 98' ' ' ILE . 97.1 mt . . . . . 0 N--CA 1.491 1.587 0 CA-C-O 121.709 0.766 . . . . 0.0 109.67 -179.675 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo . . . . . 0 N--CA 1.493 1.5 0 CA-C-O 121.536 0.557 . . . . 0.0 111.765 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -87.89 87.95 7.51 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.806 -1.184 . . . . 0.0 109.201 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.459 HD22 ' N ' ' A' ' 5' ' ' LEU . 4.0 mm? -69.31 136.16 51.43 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.502 -0.748 . . . . 0.0 109.583 -179.913 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 96.7 m -124.58 128.59 49.14 Favored 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -84.28 156.94 21.71 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.513 -0.742 . . . . 0.0 110.135 -179.424 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 65.4 mt -62.53 -44.36 99.25 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 121.446 -0.784 . . . . 0.0 109.681 179.907 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 14.0 p -64.66 -23.53 33.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.28 -0.888 . . . . 0.0 109.527 -179.875 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -79.7 -4.04 50.05 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.127 -0.983 . . . . 0.0 109.513 179.693 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 97.1 mt -80.24 103.99 7.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.097 -1.002 . . . . 0.0 109.825 -179.609 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 28.0 m -122.15 -9.39 8.85 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 179.4 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 18.9 pt-20 -136.39 137.7 40.8 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.5 -0.75 . . . . 0.0 109.598 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 30.5 p30 -95.34 162.83 13.51 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.322 -0.861 . . . . 0.0 110.731 -179.238 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 79.5 2.8 88.34 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.738 -1.345 . . . . 0.0 109.738 179.764 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 21.1 pt20 -80.47 144.38 32.62 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.248 -1.148 . . . . 0.0 110.095 -179.671 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 87.9 m95 -97.94 137.27 37.02 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.515 -0.741 . . . . 0.0 109.526 179.796 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -177.0 -179.61 0.93 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.078 -1.014 . . . . 0.0 109.78 179.608 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -105.75 146.28 30.03 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 6.1 tt -143.64 134.3 25.04 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.141 -0.974 . . . . 0.0 109.719 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 34.3 ttpt -116.66 139.7 50.24 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.571 -0.706 . . . . 0.0 109.189 179.864 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -160.57 179.45 8.58 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.865 -1.147 . . . . 0.0 109.949 179.857 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 64.7 tttm -112.96 141.98 46.17 Favored 'General case' 0 N--CA 1.498 1.953 0 CA-C-O 121.37 0.605 . . . . 0.0 109.679 -179.656 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 97.2 t -82.4 125.01 39.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.283 -0.886 . . . . 0.0 110.438 -179.078 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 96.6 mt -102.05 -51.83 8.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 179.184 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 18.4 tt0 -148.02 145.05 28.35 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.446 -0.784 . . . . 0.0 109.193 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.919 ' H ' HD23 ' A' ' 27' ' ' LEU . 1.2 pt? -136.65 138.77 41.46 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 179.934 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 78.9 t90 -128.37 123.11 33.05 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.394 -0.816 . . . . 0.0 109.463 -179.543 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 . . . . . 0 N--CA 1.493 1.678 0 O-C-N 121.227 -0.921 . . . . 0.0 110.401 -179.52 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 38.4 t . . . . . 0 N--CA 1.487 1.39 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 86.4 mt -105.38 124.83 60.51 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.064 0 O-C-N 121.394 -0.816 . . . . 0.0 109.517 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 3.4 t -68.96 -57.21 5.79 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.466 -0.771 . . . . 0.0 110.256 -179.637 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . 0.417 HE22 HD12 ' A' ' 27' ' ' LEU . 2.4 pt20 -156.88 156.96 34.02 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.201 -0.937 . . . . 0.0 109.97 -179.543 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 30.6 m -132.49 135.8 57.14 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 179.521 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -160.07 -158.97 9.51 Favored Glycine 0 N--CA 1.492 2.423 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 -179.444 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 2.0 pp -135.7 147.39 48.48 Favored 'General case' 0 N--CA 1.503 2.182 0 O-C-N 121.291 -1.123 . . . . 0.0 110.498 -179.628 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 48.1 mt -111.98 139.26 47.64 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.608 -0.683 . . . . 0.0 109.29 -178.834 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -80.64 164.85 47.36 Favored Glycine 0 N--CA 1.491 2.333 0 C-N-CA 120.215 -0.993 . . . . 0.0 110.669 -179.522 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.53 ' OD1' ' N ' ' A' ' 44' ' ' GLU . 66.8 t0 -172.68 141.28 1.08 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.607 -0.937 . . . . 0.0 109.389 179.482 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.53 ' N ' ' OD1' ' A' ' 43' ' ' ASP . 97.2 mt-10 -54.81 -18.39 4.75 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.313 -0.867 . . . . 0.0 110.479 -179.593 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 33.3 p -94.76 -9.74 33.72 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.981 -1.074 . . . . 0.0 109.498 -179.903 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 146.04 -153.82 25.56 Favored Glycine 0 N--CA 1.497 2.729 0 N-CA-C 110.168 -1.173 . . . . 0.0 110.168 179.365 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 37.3 pt -125.93 154.78 35.27 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.969 0 O-C-N 121.714 -0.874 . . . . 0.0 109.14 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.405 HD12 ' HA ' ' A' ' 48' ' ' ILE . 10.9 tp -142.72 142.19 26.76 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 O-C-N 121.109 -0.994 . . . . 0.0 110.462 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 25.4 mtpp -83.3 153.02 24.85 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 179.661 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 30.9 p90 -147.55 160.82 42.2 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 120.972 -1.08 . . . . 0.0 110.103 -179.879 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.514 HG22 HE21 ' A' ' 82' ' ' GLN . 3.4 t -143.89 139.57 29.28 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 179.401 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 95.3 mt -104.5 119.86 54.01 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.983 0 O-C-N 121.301 -0.875 . . . . 0.0 109.695 -179.754 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 94.6 m95 -95.49 140.88 29.72 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.332 -0.855 . . . . 0.0 109.366 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 68.0 mttm . . . . . 0 N--CA 1.49 1.572 0 O-C-N 121.202 -0.936 . . . . 0.0 109.418 179.941 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 91.2 mt . . . . . 0 N--CA 1.496 1.85 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -52.57 154.37 12.13 Favored 'Trans proline' 0 N--CA 1.494 1.525 0 C-N-CA 122.15 1.9 . . . . 0.0 111.956 -179.759 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 62.4 mt -62.63 139.88 58.66 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.251 -0.905 . . . . 0.0 110.258 -178.638 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.587 ' N ' HD12 ' A' ' 61' ' ' LEU . 8.8 mp -80.95 149.52 29.34 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.681 -0.637 . . . . 0.0 110.034 -179.308 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 80.4 mm-40 -83.49 139.42 32.93 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.35 -0.844 . . . . 0.0 109.955 -179.712 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 56.8 tt0 -77.53 133.15 38.6 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.398 -0.814 . . . . 0.0 111.07 -179.121 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 95.13 -0.33 64.02 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 110.048 -1.221 . . . . 0.0 110.048 179.475 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.514 ' OE1' ' N ' ' A' ' 65' ' ' GLU . 58.4 mp0 -111.73 150.82 29.69 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 121.451 -1.029 . . . . 0.0 110.292 -179.572 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 7.7 m -86.88 152.0 22.83 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.705 -0.622 . . . . 0.0 109.925 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 74.0 m-85 -142.52 145.77 34.01 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.544 -0.722 . . . . 0.0 109.557 179.677 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 18.0 tp -106.01 124.11 49.06 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 179.445 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 61.3 mt -100.97 131.52 46.8 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 -179.621 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.453 ' CZ ' ' OE2' ' A' ' 92' ' ' GLU . 84.8 mtm180 -126.93 141.32 51.83 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.376 -0.827 . . . . 0.0 110.168 -179.364 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 8.3 m 56.95 57.22 4.78 Favored 'General case' 0 N--CA 1.493 1.721 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.382 179.405 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 15.5 m -113.74 161.81 12.33 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.12 0 O-C-N 121.378 -0.826 . . . . 0.0 108.929 178.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 7.6 p -117.94 134.08 62.69 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.02 0 CA-C-O 121.435 0.636 . . . . 0.0 109.534 -179.239 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 20.1 t -78.67 122.11 33.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.38 -0.825 . . . . 0.0 109.922 -179.173 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -95.28 171.77 29.87 Favored Glycine 0 N--CA 1.495 2.605 0 N-CA-C 109.368 -1.493 . . . . 0.0 109.368 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.546 ' N ' ' OE1' ' A' ' 76' ' ' GLU . 57.5 mp0 -107.17 118.94 38.04 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.487 -1.008 . . . . 0.0 109.483 -179.691 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 55.5 t80 -118.75 107.41 13.62 Favored 'General case' 0 N--CA 1.496 1.836 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 179.508 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 97.7 m-20 44.57 -125.76 1.02 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.403 -0.811 . . . . 0.0 109.942 -179.369 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 66.1 m-20 -94.66 -5.42 45.65 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.363 -0.836 . . . . 0.0 108.994 179.867 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 88.3 mtm180 -100.2 166.18 11.12 Favored 'General case' 0 N--CA 1.493 1.69 0 CA-C-O 121.614 0.721 . . . . 0.0 109.704 -179.702 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 76.8 m-85 -101.84 151.01 22.58 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.425 -0.797 . . . . 0.0 109.579 -179.595 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . 0.514 HE21 HG22 ' A' ' 51' ' ' THR . 40.6 tt0 -138.54 157.1 46.8 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.389 -0.819 . . . . 0.0 109.643 -179.757 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 3.4 m -114.11 130.64 67.97 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 179.178 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 87.7 mt-30 -109.83 132.42 54.16 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.61 -0.682 . . . . 0.0 110.072 -178.316 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 3.9 t -104.55 126.93 59.29 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 179.505 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . 0.499 HD22 ' C ' ' A' ' 86' ' ' ASN . 0.1 OUTLIER -145.97 -176.44 5.15 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.208 -0.932 . . . . 0.0 109.531 -179.776 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.529 ' C ' ' H ' ' A' ' 89' ' ' SER . 21.7 ptmt -37.93 161.12 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.804 0 CA-C-O 121.544 0.688 . . . . 0.0 111.589 -178.942 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 5.1 t30 69.51 -23.71 0.15 Allowed 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 -179.678 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.529 ' H ' ' C ' ' A' ' 87' ' ' LYS . 10.6 t -78.31 155.94 29.89 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.197 -0.939 . . . . 0.0 109.86 -179.755 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 27.1 p -141.2 154.59 45.9 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.46 -0.775 . . . . 0.0 108.956 179.571 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 97.3 mt -129.98 132.49 65.5 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.453 ' OE2' ' CZ ' ' A' ' 70' ' ' ARG . 80.3 mt-10 -120.95 140.95 51.16 Favored 'General case' 0 N--CA 1.502 2.126 0 O-C-N 121.436 -0.79 . . . . 0.0 109.264 -179.507 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 37.8 ttmt -84.18 122.95 29.56 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.185 -0.947 . . . . 0.0 109.266 -179.735 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.487 ' N ' HD22 ' A' ' 94' ' ' LEU . 3.9 mm? -96.79 136.85 36.75 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.367 -0.833 . . . . 0.0 109.804 -179.466 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 94.4 p -85.52 -1.23 56.87 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 179.349 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 37.6 mm-40 -108.48 98.81 29.81 Favored Pre-proline 0 N--CA 1.498 1.961 0 O-C-N 121.644 -0.66 . . . . 0.0 109.286 -179.81 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -74.3 155.28 46.41 Favored 'Trans proline' 0 N--CA 1.491 1.38 0 C-N-CA 121.982 1.788 . . . . 0.0 112.737 -178.796 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 90.6 mt . . . . . 0 N--CA 1.496 1.867 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 179.99 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo . . . . . 0 N--CA 1.486 1.066 0 CA-C-O 121.4 0.5 . . . . 0.0 112.144 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 55.9 tt0 -78.61 89.07 4.52 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.367 -0.833 . . . . 0.0 109.321 -179.68 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 81.7 mt -76.63 144.91 39.22 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.65 -0.656 . . . . 0.0 109.582 -179.744 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 86.6 m -123.46 130.41 52.65 Favored 'General case' 0 N--CA 1.496 1.834 0 CA-C-O 121.551 0.691 . . . . 0.0 109.515 -179.887 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 65.7 mttp -82.59 149.35 27.5 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.555 -0.715 . . . . 0.0 110.074 -179.32 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 95.6 mt -63.12 -43.29 98.83 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 O-C-N 121.618 -0.676 . . . . 0.0 109.677 179.914 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 11.1 p -63.83 -24.1 34.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.333 -0.854 . . . . 0.0 109.824 -179.663 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -75.0 -3.89 35.08 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.096 -1.003 . . . . 0.0 109.385 179.712 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 5.7 mm -70.95 92.63 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.313 -0.867 . . . . 0.0 109.52 -179.789 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 15.0 m -114.82 -20.6 5.89 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -139.09 140.56 38.04 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.268 -0.895 . . . . 0.0 109.938 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.404 HD22 ' HB3' ' A' ' 76' ' ' GLU . 55.4 p30 -89.74 167.93 12.5 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.499 -0.751 . . . . 0.0 110.263 -179.507 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 80.26 15.74 77.87 Favored Glycine 0 N--CA 1.488 2.144 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 -179.807 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 27.8 tt0 -96.28 132.35 41.84 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.335 -1.097 . . . . 0.0 109.709 -179.82 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 76.6 m95 -94.72 134.33 37.43 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.587 -0.695 . . . . 0.0 109.954 -179.536 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -173.29 -169.46 0.53 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.526 -0.734 . . . . 0.0 109.667 179.566 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 70.9 m-20 -107.34 152.03 24.7 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.6 -0.687 . . . . 0.0 109.159 -179.889 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.616 HD13 ' N ' ' A' ' 21' ' ' LYS . 0.3 OUTLIER -133.85 120.25 20.2 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.408 -0.807 . . . . 0.0 109.318 179.835 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.616 ' N ' HD13 ' A' ' 20' ' ' LEU . 35.9 ttmt -112.51 126.56 55.46 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 179.131 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -168.57 -171.95 1.55 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.117 -0.989 . . . . 0.0 109.989 -179.706 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -119.28 138.8 52.77 Favored 'General case' 0 N--CA 1.497 1.887 0 CA-C-O 121.625 0.726 . . . . 0.0 109.976 -179.621 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 10.7 t -85.9 91.43 3.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.521 -0.737 . . . . 0.0 109.661 -179.476 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 62.6 mt -69.86 -42.65 79.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.481 -0.762 . . . . 0.0 109.612 179.915 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 98.8 mm-40 -127.64 125.94 41.07 Favored 'General case' 0 N--CA 1.498 1.932 0 CA-C-O 121.75 0.786 . . . . 0.0 110.117 -178.897 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 1.1 tt -121.92 130.55 53.43 Favored 'General case' 0 C--N 1.309 -1.193 0 N-CA-C 108.755 -0.832 . . . . 0.0 108.755 179.821 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 96.9 m95 -135.2 117.76 15.89 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.613 -0.68 . . . . 0.0 109.39 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 . . . . . 0 N--CA 1.493 1.68 0 O-C-N 121.485 -0.76 . . . . 0.0 110.025 -179.537 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 87.7 p . . . . . 0 N--CA 1.489 1.514 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 84.0 mt -131.41 130.57 62.89 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 O-C-N 121.479 -0.763 . . . . 0.0 109.238 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 37.2 t -75.28 -75.38 0.17 Allowed 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.568 -0.707 . . . . 0.0 109.46 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . 0.402 HE22 ' HA ' ' A' ' 60' ' ' LEU . 16.0 pt20 -141.42 162.36 35.67 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.394 -0.816 . . . . 0.0 110.013 -179.58 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 27.6 m -131.96 154.76 40.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 179.425 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.424 ' C ' ' CE1' ' A' ' 50' ' ' PHE . . . -178.88 -169.79 39.98 Favored Glycine 0 N--CA 1.486 1.987 0 C-N-CA 119.268 -1.444 . . . . 0.0 109.827 -179.751 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 2.2 pp -136.44 150.57 48.8 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.646 -0.914 . . . . 0.0 109.638 -179.621 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 54.5 mt -107.55 161.36 14.92 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 -179.006 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -140.09 131.99 5.33 Favored Glycine 0 N--CA 1.493 2.475 0 N-CA-C 109.967 -1.253 . . . . 0.0 109.967 -179.714 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.429 ' OD2' ' OG1' ' A' ' 45' ' ' THR . 52.3 p30 -151.59 -167.07 2.68 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.618 -0.93 . . . . 0.0 109.16 179.796 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -76.96 -12.4 59.94 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.514 -0.741 . . . . 0.0 109.473 179.633 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.429 ' OG1' ' OD2' ' A' ' 43' ' ' ASP . 34.7 p -91.98 -5.65 52.67 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.293 -0.88 . . . . 0.0 109.605 -179.518 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 122.76 -148.67 16.88 Favored Glycine 0 N--CA 1.5 2.953 0 N-CA-C 110.195 -1.162 . . . . 0.0 110.195 179.304 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 43.7 pt -128.71 154.89 40.22 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 O-C-N 121.758 -0.848 . . . . 0.0 109.712 -179.541 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 17.1 tt -152.6 144.46 15.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.212 -0.93 . . . . 0.0 109.96 179.621 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 63.7 mttp -83.36 150.7 25.94 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.557 -0.714 . . . . 0.0 109.909 -179.494 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.424 ' CE1' ' C ' ' A' ' 39' ' ' GLY . 35.5 p90 -142.36 152.12 42.56 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.291 -0.881 . . . . 0.0 109.622 -179.949 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 99.6 m -135.19 132.01 37.42 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 179.703 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 98.0 mt -106.05 129.06 59.85 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.601 -0.687 . . . . 0.0 109.844 -179.661 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 86.6 m95 -94.97 144.33 25.77 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.51 -0.744 . . . . 0.0 109.527 -179.924 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 98.3 mttt . . . . . 0 N--CA 1.489 1.478 0 O-C-N 121.413 -0.804 . . . . 0.0 109.409 179.814 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 23.3 mt . . . . . 0 N--CA 1.492 1.641 0 N-CA-C 109.503 -0.554 . . . . 0.0 109.503 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -68.85 159.55 53.35 Favored 'Trans proline' 0 N--CA 1.496 1.639 0 C-N-CA 122.832 2.355 . . . . 0.0 112.72 -179.817 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.402 ' HA ' HE22 ' A' ' 37' ' ' GLN . 69.2 mt -64.84 139.1 58.73 Favored 'General case' 0 N--CA 1.49 1.543 0 CA-C-O 121.624 0.726 . . . . 0.0 110.388 -179.163 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.591 ' N ' HD12 ' A' ' 61' ' ' LEU . 9.6 mp -76.94 149.85 35.98 Favored 'General case' 0 N--CA 1.49 1.545 0 CA-C-O 121.468 0.652 . . . . 0.0 110.175 -179.588 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 49.2 tp10 -81.2 118.86 22.93 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.45 -0.781 . . . . 0.0 109.297 -179.914 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 56.9 tt0 -64.21 134.63 55.16 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.55 -0.719 . . . . 0.0 110.902 -178.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 84.14 28.8 32.85 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 110.339 -1.105 . . . . 0.0 110.339 179.488 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -136.65 154.24 50.7 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.276 -1.132 . . . . 0.0 110.637 -179.634 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 6.7 m -81.16 142.07 33.6 Favored 'General case' 0 N--CA 1.488 1.444 0 CA-C-O 121.322 0.582 . . . . 0.0 109.707 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 29.3 m-85 -140.8 146.84 38.15 Favored 'General case' 0 N--CA 1.49 1.57 0 CA-C-O 121.782 0.801 . . . . 0.0 109.751 -179.942 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 23.3 tp -111.56 120.87 43.56 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 179.458 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 66.2 mt -102.87 133.17 48.39 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 -179.916 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.42 ' O ' ' OG ' ' A' ' 71' ' ' SER . 84.8 mtp180 -127.39 149.27 50.15 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.666 -0.646 . . . . 0.0 110.293 -179.517 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.496 ' HG ' ' HA ' ' A' ' 89' ' ' SER . 3.0 p 53.28 57.93 5.75 Favored 'General case' 0 N--CA 1.494 1.733 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.445 179.702 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 17.8 m -116.15 164.99 12.01 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.043 0 O-C-N 121.608 -0.682 . . . . 0.0 109.422 179.105 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 8.0 p -115.32 137.84 47.59 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 CA-C-O 121.485 0.659 . . . . 0.0 109.8 -179.065 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 89.0 t -85.28 108.43 17.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.559 -0.713 . . . . 0.0 109.65 -179.501 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -87.64 177.77 46.95 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 110.115 -1.194 . . . . 0.0 110.115 -179.43 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.404 ' HB3' HD22 ' A' ' 14' ' ' ASN . 17.2 pt-20 -107.68 134.57 50.47 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.602 -0.94 . . . . 0.0 109.216 -179.867 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 55.7 t80 -108.83 145.14 35.74 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.477 -0.764 . . . . 0.0 109.756 -179.468 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . 0.442 ' O ' ' CB ' ' A' ' 79' ' ' ASP . 24.0 t-20 -69.43 62.99 0.16 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.588 -0.695 . . . . 0.0 109.96 -179.477 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.442 ' CB ' ' O ' ' A' ' 78' ' ' ASN . 0.7 OUTLIER 162.43 -25.57 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 179.701 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 25.1 ttm180 -166.88 -131.66 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.374 -0.829 . . . . 0.0 109.595 -179.778 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 89.6 m-85 -131.29 152.28 50.71 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.582 -0.699 . . . . 0.0 109.625 -179.573 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 6.0 pt20 -144.97 162.49 36.76 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.473 -0.767 . . . . 0.0 109.393 -179.836 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 3.3 m -109.36 132.66 56.89 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 179.804 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 87.0 mt-30 -107.14 132.48 52.98 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.632 -0.668 . . . . 0.0 110.18 -178.65 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 90.1 t -99.45 129.59 49.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 179.654 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 6.2 m-80 -144.38 176.36 9.42 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.475 -0.765 . . . . 0.0 109.524 -179.494 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.473 ' C ' ' H ' ' A' ' 89' ' ' SER . 61.3 tttp -40.94 159.75 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.723 0 CA-C-O 121.29 0.567 . . . . 0.0 110.459 -179.796 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . 0.447 ' CB ' ' O ' ' A' ' 87' ' ' LYS . 3.9 t30 77.26 -25.37 0.2 Allowed 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 -179.5 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.496 ' HA ' ' HG ' ' A' ' 71' ' ' SER . 94.0 p -73.27 154.41 40.19 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 121.62 -0.675 . . . . 0.0 109.825 -179.809 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 75.7 m -132.26 150.52 52.14 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.625 -0.672 . . . . 0.0 109.472 -179.945 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 96.9 mt -130.11 130.6 65.98 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 179.864 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 53.0 tp10 -126.57 130.93 51.51 Favored 'General case' 0 N--CA 1.497 1.881 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 179.784 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.4 ' C ' HD22 ' A' ' 94' ' ' LEU . 64.0 tttp -80.19 131.31 35.68 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.614 -0.679 . . . . 0.0 110.235 -179.274 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.48 HD22 ' N ' ' A' ' 94' ' ' LEU . 3.9 mm? -96.67 135.87 37.99 Favored 'General case' 0 N--CA 1.495 1.818 0 CA-C-O 121.777 0.799 . . . . 0.0 109.929 -179.809 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 68.1 m -84.65 -3.8 58.69 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.724 -0.61 . . . . 0.0 109.519 179.802 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 12.3 tp10 -117.47 91.17 37.07 Favored Pre-proline 0 N--CA 1.498 1.94 0 O-C-N 121.56 -0.712 . . . . 0.0 109.338 -179.854 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -55.77 147.66 59.86 Favored 'Trans proline' 0 N--CA 1.498 1.751 0 C-N-CA 122.727 2.284 . . . . 0.0 112.648 -179.869 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 95.9 mt . . . . . 0 N--CA 1.493 1.715 0 O-C-N 121.494 -0.754 . . . . 0.0 109.785 -179.434 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo . . . . . 0 N--CA 1.492 1.391 0 CA-C-O 121.561 0.567 . . . . 0.0 112.067 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . 0.513 ' OE1' ' N ' ' A' ' 4' ' ' GLN . 0.9 OUTLIER -76.24 90.12 3.14 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.352 -0.843 . . . . 0.0 109.878 -179.436 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 79.1 mt -76.61 145.74 38.7 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.706 -0.622 . . . . 0.0 109.435 179.897 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 92.0 m -125.26 132.24 52.96 Favored 'General case' 0 N--CA 1.493 1.723 0 CA-C-O 121.761 0.791 . . . . 0.0 109.704 -179.884 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -75.85 149.4 37.85 Favored 'General case' 0 C--N 1.3 -1.567 0 CA-C-O 121.785 0.802 . . . . 0.0 110.373 -179.578 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 97.2 mt -63.24 -43.22 98.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 CA-C-O 121.802 0.81 . . . . 0.0 109.563 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 7.6 p -65.06 -24.3 35.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.592 -0.693 . . . . 0.0 109.872 -179.67 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 50.3 t0 -79.4 -4.58 51.69 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.17 -0.956 . . . . 0.0 109.838 -179.639 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 97.1 mt -85.6 114.33 25.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 120.962 -1.086 . . . . 0.0 109.656 -179.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 34.6 m -149.84 15.04 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 179.741 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 79.3 mm-40 -127.87 133.54 49.34 Favored 'General case' 0 N--CA 1.497 1.907 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 -179.903 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 11.5 m120 -74.06 141.54 45.72 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-O 121.658 0.742 . . . . 0.0 110.079 -179.579 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 58.02 111.15 0.01 OUTLIER Glycine 0 N--CA 1.49 2.242 0 N-CA-C 110.465 -1.054 . . . . 0.0 110.465 179.504 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 29.1 tt0 -168.06 133.77 1.91 Allowed 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.424 -1.045 . . . . 0.0 109.174 179.501 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 60.4 m95 -88.63 136.82 32.8 Favored 'General case' 0 N--CA 1.49 1.558 0 CA-C-O 121.652 0.739 . . . . 0.0 109.938 -179.565 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -178.29 173.63 1.39 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.571 -0.705 . . . . 0.0 109.229 -179.717 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 73.0 m-20 -107.59 144.99 33.84 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.54 -0.725 . . . . 0.0 109.886 -179.434 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 60.4 tp -133.78 135.4 43.86 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.49 -0.756 . . . . 0.0 110.406 -179.59 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 38.5 ttmt -119.23 130.34 55.41 Favored 'General case' 0 N--CA 1.496 1.863 0 CA-C-O 121.321 0.581 . . . . 0.0 109.556 179.503 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -168.79 -172.91 1.72 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.345 -0.847 . . . . 0.0 109.93 179.414 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 21.3 ptmt -124.81 154.35 41.11 Favored 'General case' 0 N--CA 1.498 1.961 0 CA-C-O 121.46 0.648 . . . . 0.0 109.919 179.829 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 97.1 t -87.8 129.58 38.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 CA-C-O 121.613 0.721 . . . . 0.0 110.174 -179.539 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.402 HD11 ' HA3' ' A' ' 42' ' ' GLY . 96.4 mt -100.98 -55.81 5.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 N-CA-C 109.068 -0.715 . . . . 0.0 109.068 179.42 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.614 ' NE2' ' NE2' ' A' ' 63' ' ' GLN . 64.2 mm-40 -142.92 138.61 30.3 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.151 -0.968 . . . . 0.0 109.807 179.825 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.833 ' H ' HD23 ' A' ' 27' ' ' LEU . 1.2 pt? -143.22 139.41 30.25 Favored 'General case' 0 N--CA 1.492 1.631 0 CA-C-O 121.347 0.594 . . . . 0.0 109.988 -179.928 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 5.6 m-90 -111.86 140.31 46.61 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 179.595 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 . . . . . 0 N--CA 1.493 1.687 0 CA-C-O 121.645 0.736 . . . . 0.0 110.265 -179.563 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 14.7 m . . . . . 0 N--CA 1.492 1.657 0 N-CA-C 109.138 -0.689 . . . . 0.0 109.138 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 72.4 mt -107.34 126.39 63.54 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 O-C-N 121.131 -0.981 . . . . 0.0 109.576 -179.751 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.575 ' OG ' ' N ' ' A' ' 54' ' ' LYS . 1.0 OUTLIER -92.0 -69.47 0.74 Allowed 'General case' 0 N--CA 1.492 1.648 0 CA-C-O 121.837 0.827 . . . . 0.0 109.283 -179.905 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 99.3 mt-30 -138.71 154.01 48.54 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.303 -0.873 . . . . 0.0 109.792 -179.585 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.7 p -140.41 140.49 34.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.585 -0.697 . . . . 0.0 109.781 -179.806 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -170.56 -156.96 11.87 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 179.723 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.688 HD23 ' H ' ' A' ' 40' ' ' LEU . 1.7 pt? -132.12 150.6 52.11 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.709 -0.877 . . . . 0.0 110.117 179.836 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 66.2 mt -109.71 134.33 52.11 Favored 'General case' 0 N--CA 1.492 1.674 0 CA-C-O 121.763 0.792 . . . . 0.0 109.591 -179.438 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.402 ' HA3' HD11 ' A' ' 25' ' ' ILE . . . -86.87 144.04 19.3 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 110.06 -1.216 . . . . 0.0 110.06 179.897 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 43.8 t0 -152.7 165.55 34.94 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 121.497 -1.002 . . . . 0.0 110.105 179.84 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -63.99 -17.89 63.75 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.82 -0.55 . . . . 0.0 110.826 -179.583 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 17.3 p -98.63 -5.91 30.85 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 120.809 -1.182 . . . . 0.0 109.99 -179.314 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 140.21 -129.82 4.38 Favored Glycine 0 N--CA 1.496 2.678 0 N-CA-C 110.219 -1.153 . . . . 0.0 110.219 179.491 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.823 HD13 ' H ' ' A' ' 47' ' ' ILE . 0.1 OUTLIER -145.09 158.89 13.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.583 -0.951 . . . . 0.0 109.819 -179.54 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.547 HD11 ' O ' ' A' ' 81' ' ' PHE . 9.7 tp -148.73 147.72 16.54 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 179.172 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 69.1 mttm -85.07 153.52 22.66 Favored 'General case' 0 N--CA 1.49 1.533 0 CA-C-O 121.641 0.734 . . . . 0.0 110.403 -179.658 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 13.4 p90 -148.86 152.86 37.21 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.407 -0.808 . . . . 0.0 109.447 179.779 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 98.3 m -133.1 131.28 40.36 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 91.7 mt -100.55 125.43 54.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.4 -0.812 . . . . 0.0 110.098 -179.58 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 54.3 m95 -93.96 120.27 33.99 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 179.455 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.575 ' N ' ' OG ' ' A' ' 36' ' ' SER . 19.6 ptmt . . . . . 0 C--N 1.3 -1.565 0 CA-C-O 121.764 0.792 . . . . 0.0 108.928 179.947 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 40.4 mt . . . . . 0 N--CA 1.493 1.724 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -52.44 143.85 42.98 Favored 'Trans proline' 0 N--CA 1.497 1.694 0 C-N-CA 122.221 1.947 . . . . 0.0 112.752 179.929 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 79.2 mt -74.19 141.55 45.48 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.404 -0.81 . . . . 0.0 109.844 -179.852 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.623 ' N ' HD12 ' A' ' 61' ' ' LEU . 9.8 mp -86.26 149.07 25.33 Favored 'General case' 0 N--CA 1.489 1.508 0 CA-C-O 121.834 0.826 . . . . 0.0 110.078 -179.796 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -99.68 146.12 26.86 Favored 'General case' 0 N--CA 1.491 1.6 0 CA-C-O 121.761 0.791 . . . . 0.0 110.429 -179.275 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.614 ' NE2' ' NE2' ' A' ' 26' ' ' GLN . 57.4 tt0 -75.17 135.54 41.07 Favored 'General case' 0 N--CA 1.489 1.48 0 CA-C-O 121.727 0.775 . . . . 0.0 110.413 -179.894 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 81.32 18.09 69.87 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 110.011 -1.236 . . . . 0.0 110.011 179.535 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 -125.27 147.22 49.19 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.393 -1.063 . . . . 0.0 110.646 -179.8 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 12.7 p -80.19 150.89 29.97 Favored 'General case' 0 N--CA 1.485 1.299 0 CA-C-O 121.721 0.772 . . . . 0.0 110.011 179.772 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 40.0 m-85 -145.42 144.37 30.6 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.497 -0.752 . . . . 0.0 109.547 179.915 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 25.0 tp -111.13 119.83 40.29 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 179.034 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 71.4 mt -105.22 128.37 53.38 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 -179.675 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 83.1 mtp180 -130.13 137.74 50.3 Favored 'General case' 0 N--CA 1.493 1.691 0 CA-C-O 121.502 0.668 . . . . 0.0 110.021 179.835 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.3 m 72.73 52.52 0.15 Allowed 'General case' 0 N--CA 1.495 1.78 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.198 179.677 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 20.4 m -113.68 160.7 13.03 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 O-C-N 121.377 -0.827 . . . . 0.0 110.196 179.626 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 11.1 p -114.37 140.46 35.04 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 CA-C-O 121.549 0.69 . . . . 0.0 109.19 -179.841 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 85.7 t -86.21 113.43 24.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 CA-C-O 121.996 0.903 . . . . 0.0 110.529 -179.062 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -87.27 177.09 47.28 Favored Glycine 0 N--CA 1.488 2.148 0 N-CA-C 109.882 -1.287 . . . . 0.0 109.882 179.875 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.561 ' N ' ' OE1' ' A' ' 76' ' ' GLU . 52.8 mp0 -112.62 128.0 56.26 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.63 -0.923 . . . . 0.0 109.854 -179.341 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 80.7 t80 -130.7 86.11 2.35 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 179.662 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . 0.494 ' CG ' ' H ' ' A' ' 79' ' ' ASP . 64.4 t30 58.87 -139.71 0.74 Allowed 'General case' 0 N--CA 1.491 1.594 0 CA-C-O 121.508 0.671 . . . . 0.0 110.527 179.944 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.494 ' H ' ' CG ' ' A' ' 78' ' ' ASN . 93.0 m-20 -78.22 -5.95 53.41 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.412 -0.805 . . . . 0.0 109.244 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 16.5 tpp180 -107.74 145.98 32.76 Favored 'General case' 0 N--CA 1.497 1.88 0 CA-C-O 121.866 0.841 . . . . 0.0 110.029 -179.442 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . 0.547 ' O ' HD11 ' A' ' 48' ' ' ILE . 94.5 m-85 -85.85 153.49 22.21 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.532 -0.73 . . . . 0.0 110.167 -179.066 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 48.7 tt0 -140.76 154.07 46.13 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.438 -0.789 . . . . 0.0 109.659 -179.715 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 27.2 m -113.55 131.19 66.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 CA-C-O 121.591 0.71 . . . . 0.0 109.085 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 87.1 mt-30 -105.94 119.81 40.13 Favored 'General case' 0 N--CA 1.493 1.689 0 CA-C-O 121.606 0.717 . . . . 0.0 110.091 -178.777 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 11.2 t -93.67 103.44 14.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 179.158 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . 0.538 HD22 ' C ' ' A' ' 86' ' ' ASN . 0.4 OUTLIER -151.68 -178.77 6.91 Favored 'General case' 0 N--CA 1.489 1.49 0 CA-C-O 121.732 0.777 . . . . 0.0 110.474 -179.113 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 30.6 ttmt 68.6 -131.76 0.1 Allowed 'General case' 0 N--CA 1.492 1.673 0 CA-C-O 121.642 0.734 . . . . 0.0 110.895 179.466 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . 0.41 ' O ' ' C ' ' A' ' 89' ' ' SER . 12.6 m120 -93.23 10.62 31.1 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.393 -0.817 . . . . 0.0 108.813 -179.51 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.41 ' C ' ' O ' ' A' ' 88' ' ' ASN . 40.6 t -39.07 111.72 0.2 Allowed 'General case' 0 N--CA 1.495 1.801 0 CA-C-O 121.863 0.84 . . . . 0.0 110.516 -179.439 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 6.1 m -77.41 145.56 37.12 Favored 'General case' 0 N--CA 1.489 1.52 0 CA-C-O 121.531 0.682 . . . . 0.0 109.947 -179.542 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 97.9 mt -135.98 132.05 50.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.441 -0.787 . . . . 0.0 109.604 179.849 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 83.1 tt0 -129.15 131.34 47.17 Favored 'General case' 0 N--CA 1.497 1.913 0 CA-C-O 121.673 0.749 . . . . 0.0 109.376 179.375 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.425 ' C ' HD12 ' A' ' 94' ' ' LEU . 38.2 ttmt -80.77 125.74 30.44 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.622 -0.674 . . . . 0.0 109.613 -179.757 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.469 HD12 ' N ' ' A' ' 94' ' ' LEU . 10.9 mp -100.94 131.15 46.95 Favored 'General case' 0 N--CA 1.496 1.836 0 CA-C-O 121.907 0.86 . . . . 0.0 110.079 -179.733 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 38.1 t -79.8 -3.6 48.43 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 108.566 -0.902 . . . . 0.0 108.566 179.179 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 60.3 mt-10 -102.41 106.09 47.01 Favored Pre-proline 0 N--CA 1.496 1.841 0 O-C-N 121.299 -0.875 . . . . 0.0 109.325 -179.767 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -76.17 154.4 37.05 Favored 'Trans proline' 0 C--N 1.316 -1.184 0 C-N-CA 122.202 1.934 . . . . 0.0 111.879 -179.44 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 90.6 mt . . . . . 0 N--CA 1.492 1.632 0 O-C-N 121.311 -0.868 . . . . 0.0 109.3 -179.846 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 78.7 mtm . . . . . 0 N--CA 1.49 1.555 0 CA-C-O 121.46 0.648 . . . . 0.0 109.802 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 48.68 57.17 18.32 Favored Pre-proline 0 N--CA 1.494 1.739 0 O-C-N 121.539 -0.726 . . . . 0.0 110.204 179.865 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.4 ' HB2' HD22 ' A' ' 19' ' ' ASN . 60.0 Cg_endo -70.79 148.88 59.37 Favored 'Trans proline' 0 N--CA 1.498 1.774 0 C-N-CA 122.938 2.426 . . . . 0.0 112.811 179.766 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 4.5 pt20 -79.6 89.05 5.1 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.272 -0.893 . . . . 0.0 109.505 -179.72 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 78.9 mt -75.03 143.57 43.46 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.499 -0.751 . . . . 0.0 109.768 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 98.9 m -131.24 136.36 48.15 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.622 -0.674 . . . . 0.0 109.939 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -78.43 153.51 31.43 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.567 -0.708 . . . . 0.0 109.926 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 96.1 mt -62.26 -43.09 97.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.388 -0.82 . . . . 0.0 109.42 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 11.8 p -62.71 -28.26 44.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.244 -0.91 . . . . 0.0 109.256 -179.666 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 55.1 t0 -67.59 -33.09 74.3 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.346 -0.846 . . . . 0.0 109.699 179.502 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 97.0 mt -68.8 120.55 16.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.29 -0.881 . . . . 0.0 110.182 -178.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 31.4 m -148.57 9.51 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 179.401 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 82.9 tt0 -134.45 139.61 45.64 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.418 -0.802 . . . . 0.0 109.586 179.611 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.505 ' ND2' ' OE2' ' A' ' 76' ' ' GLU . 31.0 p30 -82.5 151.66 26.39 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.587 -0.696 . . . . 0.0 110.56 -179.516 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 78.76 4.65 88.21 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 108.897 -1.681 . . . . 0.0 108.897 -179.737 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 44.1 tt0 -72.43 129.12 37.61 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.403 -1.057 . . . . 0.0 109.729 -179.627 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' TRP . . . . . 0.416 ' O ' ' HB2' ' A' ' 18' ' ' ALA . 85.2 m95 -99.99 137.52 38.33 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.618 -0.676 . . . . 0.0 109.942 -179.625 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.416 ' HB2' ' O ' ' A' ' 17' ' ' TRP . . . 178.37 178.34 0.4 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.527 -0.733 . . . . 0.0 109.238 179.265 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.4 HD22 ' HB2' ' A' ' 3' ' ' PRO . 61.3 m-20 -102.43 145.32 29.71 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 -179.906 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 51.9 tp -139.38 134.93 33.13 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.41 -0.806 . . . . 0.0 110.195 -179.538 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 34.0 ttpt -113.94 137.51 51.58 Favored 'General case' 0 N--CA 1.498 1.929 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 178.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -159.88 170.84 20.56 Favored 'General case' 0 N--CA 1.493 1.693 0 C-N-CA 119.064 -1.054 . . . . 0.0 110.55 -179.71 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 51.8 tttp -105.11 144.52 31.8 Favored 'General case' 0 N--CA 1.494 1.775 0 CA-C-O 121.345 0.593 . . . . 0.0 109.758 -179.784 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 62.5 t -83.31 120.02 33.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.324 -0.86 . . . . 0.0 109.971 -179.388 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 96.4 mt -96.89 -66.55 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.645 -0.659 . . . . 0.0 109.229 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 66.3 mt-30 -146.05 142.92 29.04 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.353 -0.842 . . . . 0.0 109.984 -179.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.433 ' N ' HD23 ' A' ' 27' ' ' LEU . 0.1 OUTLIER -125.26 136.69 53.78 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 -179.781 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 92.1 m95 -111.53 133.0 54.11 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 179.576 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -71.97 135.35 46.41 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.539 -0.726 . . . . 0.0 110.268 -179.266 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.432 HD22 HG21 ' A' ' 35' ' ' ILE . 48.7 t-20 -102.57 134.54 45.75 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.489 -0.757 . . . . 0.0 109.961 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 7.0 t -86.22 2.87 45.42 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 109.025 -0.731 . . . . 0.0 109.025 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 7.3 t-80 -80.01 139.3 37.04 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.335 -0.853 . . . . 0.0 110.569 -179.406 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -66.69 -39.36 88.07 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.427 -0.796 . . . . 0.0 109.647 179.663 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.513 ' OG ' ' N ' ' A' ' 35' ' ' ILE . 56.1 p -68.73 -66.31 0.59 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.252 -0.905 . . . . 0.0 109.886 -179.63 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.513 ' N ' ' OG ' ' A' ' 34' ' ' SER . 96.9 mt -74.14 135.3 27.77 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 O-C-N 121.464 -0.773 . . . . 0.0 110.082 -179.281 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 17.8 t -92.16 -62.34 1.43 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.624 -0.672 . . . . 0.0 109.601 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 85.5 mt-30 -136.85 155.53 49.66 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.405 -0.809 . . . . 0.0 109.97 -179.343 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 8.7 p -142.92 141.9 26.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 179.8 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -168.63 -160.0 15.55 Favored Glycine 0 N--CA 1.489 2.212 0 C-N-CA 119.202 -1.475 . . . . 0.0 110.384 -179.669 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -133.22 147.98 52.0 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.747 -0.855 . . . . 0.0 109.423 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 41.4 mt -117.25 133.33 56.12 Favored 'General case' 0 N--CA 1.499 1.983 0 CA-C-O 121.529 0.68 . . . . 0.0 109.92 -179.018 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -78.98 162.9 48.95 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 110.124 -1.19 . . . . 0.0 110.124 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.451 ' OD1' ' N ' ' A' ' 44' ' ' GLU . 55.1 t0 -173.83 153.43 2.18 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.586 -0.95 . . . . 0.0 109.36 179.553 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.451 ' N ' ' OD1' ' A' ' 43' ' ' ASP . 82.2 tt0 -63.03 -18.58 63.49 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.47 -0.768 . . . . 0.0 109.515 -179.877 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 72.4 p -92.2 -7.95 46.85 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.205 -0.935 . . . . 0.0 109.282 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 135.3 -150.67 20.29 Favored Glycine 0 N--CA 1.497 2.753 0 N-CA-C 109.998 -1.241 . . . . 0.0 109.998 179.268 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 96.7 mt -123.03 139.64 49.19 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 O-C-N 121.679 -0.895 . . . . 0.0 109.765 -179.423 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 9.3 tp -129.03 139.64 51.36 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 CA-C-O 121.662 0.744 . . . . 0.0 109.533 179.569 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 32.5 mtmm -85.52 148.41 25.97 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.665 -0.647 . . . . 0.0 109.871 -179.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 7.1 p90 -143.27 152.16 41.37 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.381 -0.825 . . . . 0.0 109.919 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.432 ' CG2' HG23 ' A' ' 35' ' ' ILE . 47.2 m -131.09 133.9 46.09 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 179.787 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 32.0 mm -97.08 124.22 49.82 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 O-C-N 121.203 -0.935 . . . . 0.0 110.184 -179.258 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 96.0 m95 -88.68 139.14 30.78 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 121.529 -0.732 . . . . 0.0 109.214 179.566 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -63.11 -35.29 79.79 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.346 -0.846 . . . . 0.0 109.663 -179.735 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.505 ' OD1' ' N ' ' A' ' 56' ' ' ALA . 52.9 p-10 -55.95 -18.67 9.73 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.244 -0.91 . . . . 0.0 109.848 -179.191 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.505 ' N ' ' OD1' ' A' ' 55' ' ' ASN . . . -69.7 -38.38 76.93 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.209 -0.932 . . . . 0.0 109.77 179.492 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 54.7 44.11 29.06 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 -179.163 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 61.1 mt -107.99 153.08 41.91 Favored Pre-proline 0 N--CA 1.494 1.751 0 O-C-N 121.706 -0.621 . . . . 0.0 109.715 179.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -53.59 149.23 32.21 Favored 'Trans proline' 0 N--CA 1.501 1.923 0 C-N-CA 122.286 1.99 . . . . 0.0 112.941 179.205 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 62.0 mt -68.12 144.03 55.19 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.456 -0.777 . . . . 0.0 110.37 -179.253 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.595 ' N ' HD12 ' A' ' 61' ' ' LEU . 10.1 mp -78.31 144.65 35.89 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.724 -0.61 . . . . 0.0 109.447 -179.682 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 80.2 tt0 -98.38 145.03 27.13 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.39 -0.819 . . . . 0.0 110.514 -179.085 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 57.9 tt0 -78.48 139.31 38.7 Favored 'General case' 0 N--CA 1.489 1.518 0 CA-C-O 121.479 0.657 . . . . 0.0 111.061 -179.295 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 84.93 10.63 78.4 Favored Glycine 0 N--CA 1.492 2.414 0 N-CA-C 110.187 -1.165 . . . . 0.0 110.187 178.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -124.74 144.65 50.12 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.385 -1.067 . . . . 0.0 110.602 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 8.1 p -87.04 152.41 22.39 Favored 'General case' 0 N--CA 1.487 1.405 0 CA-C-O 121.466 0.65 . . . . 0.0 109.987 179.769 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 70.4 m-85 -144.64 150.99 38.32 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.454 -0.779 . . . . 0.0 109.96 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 18.1 tp -108.55 124.6 50.71 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 179.184 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 69.8 mt -104.48 132.47 50.69 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 179.769 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 88.8 mtm180 -127.75 144.67 51.07 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.621 -0.674 . . . . 0.0 110.054 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.424 ' O ' ' OG ' ' A' ' 71' ' ' SER . 5.2 t 58.43 59.8 2.84 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 122.064 -0.397 . . . . 0.0 110.374 179.748 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 3.4 m -117.59 162.25 15.76 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.165 0 O-C-N 121.486 -0.759 . . . . 0.0 108.989 179.281 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 7.1 p -122.91 136.98 57.95 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 CA-C-O 121.606 0.717 . . . . 0.0 110.149 -178.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 90.4 t -80.84 128.61 38.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.468 -0.77 . . . . 0.0 109.975 -179.484 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -98.16 166.1 22.04 Favored Glycine 0 N--CA 1.494 2.526 0 N-CA-C 110.158 -1.177 . . . . 0.0 110.158 -179.774 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.505 ' OE2' ' ND2' ' A' ' 14' ' ' ASN . 96.7 mt-10 -90.68 124.99 35.53 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.803 -0.822 . . . . 0.0 109.378 179.896 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 79.4 t80 -134.45 108.56 8.2 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.494 -0.754 . . . . 0.0 109.744 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 11.2 m120 41.15 -123.55 0.51 Allowed 'General case' 0 N--CA 1.493 1.712 0 CA-C-O 121.439 0.637 . . . . 0.0 111.031 179.57 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 96.9 m-20 -91.91 -5.81 52.54 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.442 -0.786 . . . . 0.0 110.116 -179.054 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 79.5 mtp85 -115.57 -172.62 2.18 Favored 'General case' 0 N--CA 1.502 2.161 0 O-C-N 121.443 -0.785 . . . . 0.0 109.945 -179.774 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 90.2 m-85 -130.45 156.72 44.3 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.598 -0.689 . . . . 0.0 109.842 -179.486 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 15.8 pt20 -140.12 165.09 28.3 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.575 -0.703 . . . . 0.0 109.315 179.64 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 33.8 m -104.67 132.43 51.37 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 O-C-N 121.387 -0.821 . . . . 0.0 109.117 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -102.91 128.66 49.61 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.537 -0.727 . . . . 0.0 109.864 -178.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 21.1 t -94.61 130.67 43.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.582 -0.699 . . . . 0.0 109.532 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 18.9 p30 -132.83 176.94 8.03 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 179.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 22.7 pttm -58.83 -36.05 73.92 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.358 -0.839 . . . . 0.0 109.84 -179.47 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 77.5 m-20 -62.45 -38.26 89.09 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.283 -0.886 . . . . 0.0 109.327 179.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 93.3 p -69.68 161.93 28.73 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.093 -1.004 . . . . 0.0 109.801 -179.241 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 72.1 m -130.6 152.17 50.25 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.607 -0.683 . . . . 0.0 109.681 -179.638 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 96.6 mt -127.12 131.96 70.24 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 75.4 mm-40 -129.14 137.52 51.24 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.53 -0.732 . . . . 0.0 109.475 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -78.89 129.78 34.92 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.505 -0.747 . . . . 0.0 109.328 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 52.4 mt -103.14 136.41 42.99 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.499 -0.751 . . . . 0.0 109.568 -179.496 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 74.3 m -81.52 -5.39 57.93 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 179.797 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -112.94 117.94 45.36 Favored Pre-proline 0 N--CA 1.497 1.921 0 O-C-N 121.676 -0.64 . . . . 0.0 109.356 -179.695 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -75.24 163.44 34.82 Favored 'Trans proline' 0 N--CA 1.491 1.375 0 C-N-CA 121.971 1.78 . . . . 0.0 111.971 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 19.2 mm -92.66 126.92 45.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.197 -0.939 . . . . 0.0 109.335 -179.695 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . 0.53 ' OE1' ' N ' ' A' ' 99' ' ' GLU . 57.5 mp0 -85.06 118.81 24.85 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.481 -0.762 . . . . 0.0 109.585 -179.591 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 35.7 m -107.8 -2.69 10.07 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 135.72 134.15 3.31 Favored Glycine 0 N--CA 1.497 2.706 0 N-CA-C 109.868 -1.293 . . . . 0.0 109.868 179.353 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.59 ' C ' ' H ' ' A' ' 104' ' ' HIS . 3.9 mm? -89.44 -0.49 57.53 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.458 -1.025 . . . . 0.0 108.996 179.689 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 77.6 tt0 63.28 -12.58 0.08 Allowed 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 -179.6 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . 0.59 ' H ' ' C ' ' A' ' 102' ' ' LEU . 36.8 p-80 -159.29 155.26 26.57 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 120.913 -1.117 . . . . 0.0 109.745 179.582 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 83.2 t60 -98.28 124.58 42.98 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.464 -0.772 . . . . 0.0 109.44 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 51.2 p-80 -108.0 155.39 20.4 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.458 -0.777 . . . . 0.0 110.075 -179.625 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 42.1 p-80 -152.76 160.76 43.13 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.407 -0.808 . . . . 0.0 109.672 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 96.9 m-70 -77.45 136.38 38.37 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.503 -0.748 . . . . 0.0 110.613 -179.28 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . 0.526 ' OXT' ' CG ' ' A' ' 109' ' ' HIS . 50.1 t-80 . . . . . 0 N--CA 1.49 1.543 0 CA-C-O 117.946 -1.026 . . . . 0.0 109.006 179.142 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 62.2 ttp . . . . . 0 N--CA 1.489 1.475 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 61.8 mt-10 -86.37 150.85 52.59 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.582 -0.699 . . . . 0.0 109.573 -179.165 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -66.26 148.59 84.91 Favored 'Trans proline' 0 C--N 1.312 -1.377 0 C-N-CA 122.342 2.028 . . . . 0.0 112.277 179.703 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.525 ' OE1' ' N ' ' A' ' 4' ' ' GLN . 1.0 OUTLIER -78.92 89.17 4.71 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.305 -0.872 . . . . 0.0 109.344 -179.728 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 80.3 mt -75.47 150.8 38.15 Favored 'General case' 0 N--CA 1.488 1.442 0 CA-C-O 121.754 0.787 . . . . 0.0 109.807 -179.783 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 4.9 t -144.55 156.67 44.26 Favored 'General case' 0 N--CA 1.487 1.404 0 CA-C-O 121.751 0.786 . . . . 0.0 109.539 179.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.58 159.14 15.1 Favored 'General case' 0 C--N 1.3 -1.579 0 CA-C-O 121.875 0.845 . . . . 0.0 110.352 -179.665 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 96.1 mt -62.96 -42.68 97.53 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 CA-C-O 121.539 0.685 . . . . 0.0 109.267 179.888 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 14.4 p -62.71 -28.36 44.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.377 -0.827 . . . . 0.0 109.259 179.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 -75.75 -17.93 59.72 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.23 -0.919 . . . . 0.0 109.123 179.66 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 96.1 mt -86.57 113.37 24.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.127 -0.983 . . . . 0.0 109.66 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 20.6 m -153.94 17.24 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 179.75 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -127.08 137.51 53.04 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.536 -0.728 . . . . 0.0 109.881 -179.63 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 11.8 m120 -77.95 138.71 39.0 Favored 'General case' 0 N--CA 1.485 1.306 0 CA-C-O 121.804 0.811 . . . . 0.0 110.92 -179.223 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 79.39 11.04 85.34 Favored Glycine 0 N--CA 1.492 2.425 0 N-CA-C 109.995 -1.242 . . . . 0.0 109.995 179.398 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 44.6 tt0 -70.68 130.68 42.41 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.037 -1.273 . . . . 0.0 109.994 -179.653 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 86.6 m95 -104.76 131.14 52.57 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.725 -0.609 . . . . 0.0 109.677 -179.533 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.407 ' C ' HD22 ' A' ' 19' ' ' ASN . . . -178.71 177.13 0.91 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.486 -0.759 . . . . 0.0 109.851 179.586 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.719 ' ND2' ' H ' ' A' ' 71' ' ' SER . 3.0 m120 -105.06 145.18 30.85 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.626 -0.672 . . . . 0.0 109.568 -179.79 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 5.2 tt -141.89 134.74 28.68 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.293 -0.879 . . . . 0.0 110.263 179.743 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 19.4 ttpp -112.47 138.44 49.22 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 179.52 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -161.01 179.9 8.07 Favored 'General case' 0 N--CA 1.492 1.644 0 C-N-CA 119.364 -0.934 . . . . 0.0 110.116 -179.54 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 89.0 tttt -115.35 139.46 49.98 Favored 'General case' 0 N--CA 1.495 1.79 0 CA-C-O 121.717 0.77 . . . . 0.0 110.221 -179.453 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.429 HG22 ' CD2' ' A' ' 41' ' ' LEU . 75.8 t -78.24 129.2 37.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 CA-C-O 121.688 0.756 . . . . 0.0 110.534 -179.275 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.439 HD11 ' HA3' ' A' ' 42' ' ' GLY . 96.7 mt -102.32 -53.84 7.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 178.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 67.0 tp60 -147.14 148.86 32.0 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.249 -0.907 . . . . 0.0 109.668 -179.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.841 ' H ' HD23 ' A' ' 27' ' ' LEU . 1.2 pt? -141.44 135.62 30.49 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 179.529 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 3.6 m-90 -121.08 114.03 20.88 Favored 'General case' 0 N--CA 1.496 1.872 0 CA-C-O 121.545 0.688 . . . . 0.0 109.457 -179.569 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 17.3 pt-20 -64.38 147.72 51.99 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.584 -0.697 . . . . 0.0 109.789 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.534 ' ND2' ' O ' ' A' ' 36' ' ' SER . 0.4 OUTLIER -133.25 -41.06 0.89 Allowed 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 179.875 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.431 ' C ' ' O ' ' A' ' 30' ' ' ASN . 1.3 p 39.42 48.75 1.77 Allowed 'General case' 0 N--CA 1.497 1.893 0 CA-C-O 122.014 0.911 . . . . 0.0 109.475 -179.276 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 78.1 t60 -62.72 -48.73 77.96 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.516 -0.74 . . . . 0.0 109.063 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.476 ' CG ' ' N ' ' A' ' 34' ' ' SER . 19.5 pt-20 -176.7 -47.07 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 179.92 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.476 ' N ' ' CG ' ' A' ' 33' ' ' GLU . 71.2 p -121.82 -7.14 9.03 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.535 -0.728 . . . . 0.0 109.218 -179.797 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 83.7 mt -106.56 127.04 62.29 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 O-C-N 121.3 -0.875 . . . . 0.0 110.07 -179.817 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.534 ' O ' ' ND2' ' A' ' 30' ' ' ASN . 44.8 m -73.15 -74.91 0.16 Allowed 'General case' 0 N--CA 1.49 1.554 0 CA-C-O 121.726 0.774 . . . . 0.0 109.797 179.876 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . 0.422 ' HA ' HD22 ' A' ' 30' ' ' ASN . 15.3 pt20 -146.62 162.12 39.09 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.341 -0.849 . . . . 0.0 109.656 -179.357 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 34.0 m -132.05 158.65 43.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 CA-C-O 121.659 0.742 . . . . 0.0 109.708 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -178.72 -160.8 25.39 Favored Glycine 0 N--CA 1.486 2.03 0 N-CA-C 109.764 -1.334 . . . . 0.0 109.764 -179.557 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.884 HD23 ' H ' ' A' ' 40' ' ' LEU . 1.3 pt? -139.96 148.24 41.64 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.572 -0.958 . . . . 0.0 110.35 -179.728 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.429 ' CD2' HG22 ' A' ' 24' ' ' VAL . 40.3 mt -109.59 134.07 52.36 Favored 'General case' 0 N--CA 1.491 1.581 0 CA-C-O 121.541 0.686 . . . . 0.0 109.379 -179.46 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.439 ' HA3' HD11 ' A' ' 25' ' ' ILE . . . -82.85 162.59 41.16 Favored Glycine 0 N--CA 1.488 2.132 0 N-CA-C 110.228 -1.149 . . . . 0.0 110.228 -179.868 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.547 ' OD1' ' N ' ' A' ' 44' ' ' GLU . 67.5 t0 -172.98 143.56 1.18 Allowed 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.761 -0.846 . . . . 0.0 109.342 179.688 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.547 ' N ' ' OD1' ' A' ' 43' ' ' ASP . 96.7 mt-10 -54.76 -14.94 1.57 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.603 -0.686 . . . . 0.0 109.639 179.865 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 44.3 p -94.15 -11.0 31.36 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.129 -0.982 . . . . 0.0 109.566 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 140.32 -155.77 24.79 Favored Glycine 0 N--CA 1.497 2.709 0 N-CA-C 110.309 -1.116 . . . . 0.0 110.309 179.423 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 41.9 pt -126.68 150.8 32.73 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 O-C-N 121.707 -0.878 . . . . 0.0 109.892 -179.364 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 19.0 tt -143.94 141.83 24.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.555 -0.715 . . . . 0.0 109.625 179.319 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -85.31 155.83 21.18 Favored 'General case' 0 N--CA 1.491 1.592 0 CA-C-O 121.435 0.636 . . . . 0.0 110.362 -179.603 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 38.5 p90 -144.47 151.65 39.49 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.251 -0.906 . . . . 0.0 109.775 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 54.1 m -133.35 127.13 32.83 Favored 'General case' 0 N--CA 1.492 1.639 0 CA-C-O 121.546 0.688 . . . . 0.0 109.459 179.263 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 97.0 mt -95.1 124.39 47.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.54 -0.725 . . . . 0.0 109.81 179.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . 0.45 ' C ' ' H ' ' A' ' 55' ' ' ASN . 90.2 m95 -82.67 105.99 14.16 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.422 -0.799 . . . . 0.0 109.065 179.334 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 73.8 tttt -52.84 -9.18 0.11 Allowed 'General case' 0 N--CA 1.491 1.605 0 CA-C-O 121.594 0.711 . . . . 0.0 109.723 -179.52 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.45 ' H ' ' C ' ' A' ' 53' ' ' TRP . 25.1 t-20 -63.11 -39.24 94.13 Favored 'General case' 0 C--N 1.298 -1.661 0 O-C-N 121.314 -0.866 . . . . 0.0 109.176 179.699 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -76.05 -11.88 60.02 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.283 -0.885 . . . . 0.0 109.237 179.634 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 73.0 mm-40 53.35 56.0 7.97 Favored 'General case' 0 N--CA 1.494 1.768 0 CA-C-O 121.933 0.873 . . . . 0.0 109.599 -179.817 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 15.0 mt -91.65 151.83 42.76 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.517 -0.739 . . . . 0.0 109.58 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -66.19 151.8 82.69 Favored 'Trans proline' 0 C--N 1.31 -1.455 0 C-N-CA 122.5 2.133 . . . . 0.0 112.432 179.567 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 82.0 mt -68.84 137.51 53.98 Favored 'General case' 0 N--CA 1.488 1.444 0 CA-C-O 121.862 0.839 . . . . 0.0 110.514 -179.301 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.535 ' N ' HD12 ' A' ' 61' ' ' LEU . 10.3 mp -78.98 143.0 36.15 Favored 'General case' 0 N--CA 1.49 1.569 0 CA-C-O 121.656 0.741 . . . . 0.0 109.853 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 81.7 tt0 -85.78 138.69 31.9 Favored 'General case' 0 N--CA 1.49 1.546 0 CA-C-O 121.857 0.837 . . . . 0.0 110.182 -179.586 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 57.2 tt0 -74.61 136.78 41.99 Favored 'General case' 0 N--CA 1.489 1.489 0 CA-C-O 121.819 0.819 . . . . 0.0 111.329 -179.375 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 84.17 20.95 58.12 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 110.051 -1.219 . . . . 0.0 110.051 178.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -128.49 145.56 51.07 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.401 -1.058 . . . . 0.0 110.156 -179.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 11.5 m -83.22 144.8 29.53 Favored 'General case' 0 N--CA 1.488 1.439 0 CA-C-O 121.653 0.74 . . . . 0.0 110.192 -179.642 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 79.9 m-85 -138.24 149.18 45.5 Favored 'General case' 0 N--CA 1.491 1.597 0 CA-C-O 121.918 0.866 . . . . 0.0 109.908 179.757 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 35.0 tp -106.77 122.65 46.8 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 179.284 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 65.8 mt -101.11 130.24 47.13 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 179.836 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.436 ' CZ ' ' OE2' ' A' ' 92' ' ' GLU . 80.7 mtm180 -125.65 142.61 51.42 Favored 'General case' 0 N--CA 1.497 1.878 0 CA-C-O 121.865 0.841 . . . . 0.0 110.699 -178.848 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.719 ' H ' ' ND2' ' A' ' 19' ' ' ASN . 34.3 t 50.98 59.19 4.8 Favored 'General case' 0 N--CA 1.491 1.617 0 CA-C-N 115.683 -0.689 . . . . 0.0 111.032 179.118 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 6.4 m -111.49 160.68 10.64 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.989 0 O-C-N 121.406 -0.809 . . . . 0.0 109.633 178.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 7.4 p -118.41 134.24 62.65 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 CA-C-O 121.722 0.772 . . . . 0.0 109.604 -179.463 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 9.8 t -86.51 113.72 24.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 CA-C-O 121.824 0.821 . . . . 0.0 109.753 -179.499 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -90.65 143.87 17.02 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 110.112 -1.195 . . . . 0.0 110.112 -179.641 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -63.08 132.08 50.71 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.694 -0.886 . . . . 0.0 110.305 -179.816 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . 0.632 ' CD2' ' ND2' ' A' ' 78' ' ' ASN . 34.9 t80 -137.43 96.74 3.31 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.375 -0.828 . . . . 0.0 108.965 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.632 ' ND2' ' CD2' ' A' ' 77' ' ' TYR . 21.1 p30 43.41 -141.93 0.15 Allowed 'General case' 0 N--CA 1.494 1.758 0 CA-C-O 121.631 0.729 . . . . 0.0 110.897 -179.897 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.515 ' N ' ' OD1' ' A' ' 78' ' ' ASN . 46.9 t0 -73.05 -2.49 21.46 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.43 -0.793 . . . . 0.0 109.098 -179.633 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.492 ' N ' ' OD1' ' A' ' 78' ' ' ASN . 29.9 mmt180 -115.53 -171.98 2.07 Favored 'General case' 0 N--CA 1.495 1.805 0 CA-C-O 122.047 0.927 . . . . 0.0 110.228 -179.286 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -127.83 155.72 43.67 Favored 'General case' 0 N--CA 1.492 1.652 0 CA-C-O 121.558 0.694 . . . . 0.0 109.873 -179.207 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 52.1 tt0 -139.59 151.84 46.36 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.544 -0.722 . . . . 0.0 109.741 -179.599 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 3.8 m -108.98 132.23 57.6 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 179.235 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 87.9 mt-30 -105.93 127.08 52.9 Favored 'General case' 0 N--CA 1.495 1.795 0 CA-C-O 121.784 0.802 . . . . 0.0 110.178 -178.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.59 HG11 HD11 ' A' ' 91' ' ' ILE . 21.3 t -95.74 132.89 38.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 179.277 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 15.8 p30 -139.14 -178.14 5.22 Favored 'General case' 0 N--CA 1.492 1.668 0 CA-C-O 121.884 0.849 . . . . 0.0 110.362 -179.207 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 63.7 tttp -56.91 -40.25 75.97 Favored 'General case' 0 N--CA 1.492 1.647 0 CA-C-O 121.474 0.654 . . . . 0.0 110.064 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 23.2 t-20 -60.33 -37.94 82.18 Favored 'General case' 0 C--N 1.296 -1.725 0 O-C-N 121.306 -0.871 . . . . 0.0 109.89 -179.85 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 15.5 p -75.43 162.28 28.49 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.02 -1.05 . . . . 0.0 110.847 -179.133 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 67.4 m -131.62 149.83 52.36 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 179.701 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.59 HD11 HG11 ' A' ' 85' ' ' VAL . 97.0 mt -128.14 132.21 68.65 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 O-C-N 121.599 -0.688 . . . . 0.0 109.69 -179.664 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.436 ' OE2' ' CZ ' ' A' ' 70' ' ' ARG . 86.0 mt-10 -124.99 131.8 53.36 Favored 'General case' 0 N--CA 1.5 2.069 0 CA-C-O 121.488 0.661 . . . . 0.0 109.513 -179.558 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 37.2 ttpt -82.36 118.38 23.13 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.424 -0.797 . . . . 0.0 109.653 -179.807 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.495 ' C ' ' H ' ' A' ' 96' ' ' GLU . 59.6 mt -111.63 130.66 55.69 Favored 'General case' 0 N--CA 1.495 1.812 0 CA-C-O 121.464 0.65 . . . . 0.0 109.459 -179.72 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 42.2 m -77.27 29.63 0.14 Allowed 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 179.358 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.495 ' H ' ' C ' ' A' ' 94' ' ' LEU . 72.5 tt0 -111.43 92.74 17.03 Favored Pre-proline 0 N--CA 1.493 1.72 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 -179.752 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -75.21 151.22 38.36 Favored 'Trans proline' 0 N--CA 1.491 1.358 0 C-N-CA 122.221 1.947 . . . . 0.0 112.219 -179.077 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 84.5 mt -102.04 126.94 55.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 CA-C-O 121.745 0.783 . . . . 0.0 109.511 -179.674 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -87.84 115.56 25.38 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.62 -0.675 . . . . 0.0 109.965 -179.822 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 58.6 t -109.11 -41.76 5.1 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 CA-C-O 121.579 0.704 . . . . 0.0 109.195 179.762 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -69.64 -35.75 74.83 Favored Glycine 0 N--CA 1.498 2.805 0 N-CA-C 110.558 -1.017 . . . . 0.0 110.558 -179.829 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 31.9 mt -82.75 -0.39 47.47 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.176 -1.191 . . . . 0.0 108.95 -179.556 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 82.5 tt0 -56.71 129.8 42.73 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.252 -0.905 . . . . 0.0 110.102 -179.77 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 86.2 t60 -88.73 -82.64 0.24 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.499 -0.751 . . . . 0.0 109.89 179.834 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 81.8 t60 -148.29 148.02 29.97 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.111 -0.993 . . . . 0.0 110.145 -179.524 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 86.2 t60 -71.14 134.28 46.85 Favored 'General case' 0 N--CA 1.489 1.522 0 CA-C-O 121.808 0.813 . . . . 0.0 110.91 -179.411 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 65.7 t-80 -146.14 142.55 28.59 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.53 -0.731 . . . . 0.0 109.619 179.643 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 78.0 m80 -70.64 139.22 51.28 Favored 'General case' 0 N--CA 1.491 1.578 0 CA-C-O 121.65 0.738 . . . . 0.0 110.5 -179.503 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . 0.41 ' ND1' ' C ' ' A' ' 109' ' ' HIS . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.469 0 CA-C-O 118.172 -0.918 . . . . 0.0 109.025 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 51.7 ttp . . . . . 0 N--CA 1.489 1.478 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -163.17 153.44 13.57 Favored Pre-proline 0 C--N 1.303 -1.441 0 O-C-N 121.353 -0.842 . . . . 0.0 108.873 179.325 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -65.24 144.27 80.36 Favored 'Trans proline' 0 N--CA 1.495 1.588 0 C-N-CA 122.755 2.303 . . . . 0.0 112.555 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 84.9 mt-30 -76.41 91.89 3.34 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.152 -0.968 . . . . 0.0 108.723 179.45 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 82.6 mt -85.27 131.87 34.35 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.531 -0.731 . . . . 0.0 109.619 -179.071 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 99.9 m -123.64 131.01 53.51 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 179.841 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 71.5 mmtt -80.58 156.64 26.34 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-O 121.683 0.754 . . . . 0.0 110.362 -178.62 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 97.3 mt -62.89 -43.31 98.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.484 -0.76 . . . . 0.0 109.279 -179.798 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 14.5 p -66.28 -23.51 31.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.338 -0.851 . . . . 0.0 109.606 -179.743 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -78.49 -5.03 51.43 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.251 -0.905 . . . . 0.0 109.899 -179.778 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 96.7 mt -80.94 121.85 35.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 120.939 -1.101 . . . . 0.0 110.081 -179.579 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 31.2 m -146.55 10.25 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 179.172 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 48.2 tp10 -136.11 132.96 36.77 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.341 -0.849 . . . . 0.0 109.745 -179.782 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.488 ' ND2' ' CE1' ' A' ' 81' ' ' PHE . 11.4 m120 -82.38 142.04 32.31 Favored 'General case' 0 C--N 1.306 -1.311 0 O-C-N 121.347 -0.846 . . . . 0.0 110.431 -179.828 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 75.68 98.93 0.13 Allowed Glycine 0 N--CA 1.49 2.258 0 N-CA-C 110.032 -1.227 . . . . 0.0 110.032 179.232 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 14.1 pt20 -173.45 141.29 0.88 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.159 -1.201 . . . . 0.0 109.702 179.282 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 71.0 m95 -94.0 137.06 33.63 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.615 -0.678 . . . . 0.0 109.781 -179.549 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -175.58 177.68 1.72 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.139 -0.976 . . . . 0.0 109.639 179.745 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 81.4 m-20 -106.59 147.49 29.4 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.602 -0.686 . . . . 0.0 109.639 -179.703 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 40.2 tp -140.79 133.29 28.51 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.342 -0.849 . . . . 0.0 109.892 179.717 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 35.7 ttpt -117.29 137.78 52.18 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 178.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -161.81 174.91 12.52 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.869 -1.145 . . . . 0.0 110.194 -179.582 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 65.1 tttm -110.32 133.29 53.4 Favored 'General case' 0 N--CA 1.495 1.818 0 CA-C-O 121.517 0.675 . . . . 0.0 109.848 -179.753 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.482 HG22 ' CD2' ' A' ' 41' ' ' LEU . 67.1 t -77.77 126.94 38.5 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 O-C-N 121.369 -0.832 . . . . 0.0 109.745 -179.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 23.2 pt -108.8 -34.0 2.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 179.368 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.72 ' NE2' ' HE1' ' A' ' 28' ' ' TRP . 50.3 tt0 -163.73 133.79 4.24 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.115 -0.991 . . . . 0.0 109.647 178.872 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.506 ' O ' HD12 ' A' ' 27' ' ' LEU . 0.3 OUTLIER -131.46 136.64 48.12 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 -179.83 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . 0.72 ' HE1' ' NE2' ' A' ' 26' ' ' GLN . 5.2 m0 -113.96 124.61 52.59 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.472 -0.768 . . . . 0.0 109.493 -179.595 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 2.9 pp20? -64.07 135.16 56.15 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.544 -0.722 . . . . 0.0 109.36 -179.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.436 HD22 ' CG2' ' A' ' 35' ' ' ILE . 55.8 t30 -106.4 134.93 48.76 Favored 'General case' 0 N--CA 1.493 1.689 0 CA-C-O 121.781 0.801 . . . . 0.0 110.371 -179.285 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 13.2 p -99.5 3.72 45.72 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 179.594 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 83.0 t60 -85.95 128.55 34.87 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.297 -0.877 . . . . 0.0 110.104 -179.531 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.516 ' O ' ' CB ' ' A' ' 34' ' ' SER . 22.3 pt-20 -53.97 157.0 2.64 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.484 -0.76 . . . . 0.0 110.723 -179.789 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.516 ' CB ' ' O ' ' A' ' 33' ' ' GLU . 5.1 p 84.6 -43.01 0.07 Allowed 'General case' 0 N--CA 1.499 1.988 0 N-CA-C 109.384 -0.599 . . . . 0.0 109.384 -179.861 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.436 ' CG2' HD22 ' A' ' 30' ' ' ASN . 96.2 mt -109.9 118.06 56.06 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 CA-C-O 121.617 0.722 . . . . 0.0 109.83 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 44.1 t -77.79 -49.0 15.23 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.604 -0.685 . . . . 0.0 109.51 179.674 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 33.6 tt0 -147.34 153.48 39.75 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.222 -0.924 . . . . 0.0 110.016 -179.708 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 9.1 p -142.95 143.27 25.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.573 -0.704 . . . . 0.0 109.259 179.156 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -173.99 -154.27 10.61 Favored Glycine 0 N--CA 1.485 1.95 0 C-N-CA 119.534 -1.317 . . . . 0.0 109.941 -179.645 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.617 ' H ' HD12 ' A' ' 40' ' ' LEU . 0.1 OUTLIER -136.8 151.3 49.01 Favored 'General case' 0 N--CA 1.501 2.082 0 O-C-N 121.555 -0.968 . . . . 0.0 109.494 -179.019 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.482 ' CD2' HG22 ' A' ' 24' ' ' VAL . 66.3 mt -115.08 126.44 54.69 Favored 'General case' 0 N--CA 1.495 1.803 0 CA-C-O 121.597 0.713 . . . . 0.0 109.413 179.892 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -75.72 158.69 50.35 Favored Glycine 0 N--CA 1.488 2.157 0 N-CA-C 110.807 -0.917 . . . . 0.0 110.807 -179.443 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -170.97 151.65 3.35 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.519 -0.989 . . . . 0.0 109.07 179.253 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 17.6 pt-20 -59.41 -15.12 14.97 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.27 -0.894 . . . . 0.0 109.546 179.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 39.2 p -92.6 -13.14 30.04 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.093 -1.004 . . . . 0.0 109.279 -179.453 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 140.79 -151.47 22.44 Favored Glycine 0 N--CA 1.496 2.635 0 N-CA-C 109.987 -1.245 . . . . 0.0 109.987 179.353 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 96.7 mt -126.25 138.87 53.27 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 O-C-N 121.729 -0.865 . . . . 0.0 109.234 -179.815 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.556 HD11 ' O ' ' A' ' 81' ' ' PHE . 9.6 tp -128.28 143.59 40.49 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 CA-C-O 121.789 0.804 . . . . 0.0 110.152 -179.727 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 19.1 mmmt -84.01 147.89 27.18 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.688 -0.633 . . . . 0.0 109.874 180.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 21.1 p90 -144.14 159.95 41.76 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.244 -0.91 . . . . 0.0 109.298 179.843 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 1.6 t -145.33 141.44 28.53 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.401 -0.812 . . . . 0.0 109.829 179.611 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 98.4 mt -107.43 118.7 55.67 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 O-C-N 121.573 -0.704 . . . . 0.0 109.316 179.596 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 59.3 m95 -86.34 139.42 30.99 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.158 -0.964 . . . . 0.0 110.139 -179.212 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -49.3 -20.96 0.73 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.408 -0.807 . . . . 0.0 109.875 179.848 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 9.5 m120 -63.71 -38.04 89.61 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.12 -0.987 . . . . 0.0 109.688 -179.818 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -61.64 -34.63 76.02 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.257 -0.902 . . . . 0.0 109.097 -179.819 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 56.68 38.48 29.57 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.68 -0.638 . . . . 0.0 109.697 -179.722 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 51.1 mt -104.59 147.03 33.75 Favored Pre-proline 0 N--CA 1.496 1.84 0 O-C-N 121.496 -0.752 . . . . 0.0 109.618 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -68.26 162.05 42.03 Favored 'Trans proline' 0 N--CA 1.498 1.758 0 C-N-CA 122.707 2.271 . . . . 0.0 112.811 179.632 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 67.6 mt -64.77 149.79 48.62 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.317 -0.864 . . . . 0.0 110.682 -178.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.558 ' N ' HD12 ' A' ' 61' ' ' LEU . 10.7 mp -88.22 138.42 31.46 Favored 'General case' 0 N--CA 1.492 1.666 0 CA-C-O 121.572 0.701 . . . . 0.0 110.188 -179.239 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.467 ' N ' ' OH ' ' A' ' 67' ' ' TYR . 52.9 tp10 -66.43 137.01 56.55 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.407 -0.808 . . . . 0.0 110.054 -179.57 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.442 HE21 ' HA ' ' A' ' 26' ' ' GLN . 49.8 tt0 -73.18 135.66 44.65 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.564 -0.71 . . . . 0.0 110.68 -179.255 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 83.84 29.82 30.87 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 110.037 -1.225 . . . . 0.0 110.037 179.047 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -136.41 146.54 46.53 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.168 -1.195 . . . . 0.0 110.426 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 11.8 p -79.01 152.09 31.16 Favored 'General case' 0 N--CA 1.487 1.4 0 CA-C-O 121.542 0.686 . . . . 0.0 110.141 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.467 ' OH ' ' N ' ' A' ' 62' ' ' GLU . 89.9 m-85 -144.47 147.59 33.48 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.412 -0.805 . . . . 0.0 109.662 179.698 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 15.7 tp -111.36 120.93 43.86 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 179.548 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 60.7 mt -97.32 134.85 40.05 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.534 -0.729 . . . . 0.0 109.313 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 79.1 mtp85 -128.19 138.96 52.7 Favored 'General case' 0 N--CA 1.497 1.897 0 CA-C-O 121.507 0.67 . . . . 0.0 110.388 -179.83 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 18.4 m 57.12 61.14 2.67 Favored 'General case' 0 N--CA 1.493 1.718 0 CA-C-O 121.005 0.431 . . . . 0.0 110.534 179.47 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 15.5 m -116.03 159.73 15.81 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.993 0 O-C-N 121.49 -0.756 . . . . 0.0 109.441 178.822 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 14.2 p -114.85 134.66 57.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 CA-C-O 121.474 0.654 . . . . 0.0 109.498 -179.361 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 11.7 t -88.29 113.56 25.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.298 -0.876 . . . . 0.0 109.744 -179.294 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -98.57 172.76 26.48 Favored Glycine 0 N--CA 1.493 2.484 0 N-CA-C 109.914 -1.275 . . . . 0.0 109.914 -179.797 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 81.3 tt0 -112.85 122.77 48.62 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.742 -0.858 . . . . 0.0 109.253 179.661 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 75.7 t80 -135.7 126.59 27.6 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.522 -0.736 . . . . 0.0 109.756 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 9.3 t-20 57.11 44.09 23.09 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.574 -0.704 . . . . 0.0 109.924 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 55.03 28.83 11.34 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.549 -0.72 . . . . 0.0 109.445 179.691 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 71.7 ttt180 -130.78 152.2 50.38 Favored 'General case' 0 N--CA 1.497 1.876 0 CA-C-O 121.516 0.674 . . . . 0.0 109.771 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . 0.556 ' O ' HD11 ' A' ' 48' ' ' ILE . 91.6 m-85 -84.66 142.64 29.76 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.433 -0.792 . . . . 0.0 109.733 -179.835 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 7.1 pt20 -153.24 165.26 36.28 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.15 -0.969 . . . . 0.0 109.711 179.871 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 3.2 m -109.1 132.35 57.4 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.013 0 O-C-N 121.495 -0.753 . . . . 0.0 109.811 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 23.6 mt-30 -113.3 121.84 45.62 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 -179.777 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 27.8 t -91.18 129.5 41.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.298 -0.876 . . . . 0.0 109.9 -179.655 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 11.2 m-80 -140.88 -177.78 5.24 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.45 -0.781 . . . . 0.0 109.258 179.83 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.523 ' C ' ' H ' ' A' ' 89' ' ' SER . 63.0 pttt -44.3 164.79 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.575 -0.703 . . . . 0.0 111.02 -179.681 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 5.3 t30 72.15 -29.84 0.2 Allowed 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 -179.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.523 ' H ' ' C ' ' A' ' 87' ' ' LYS . 7.2 m -69.65 150.79 46.64 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.403 -0.81 . . . . 0.0 110.196 -179.522 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 46.9 t -132.56 146.55 51.99 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 96.8 mt -126.14 132.53 70.42 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 O-C-N 121.584 -0.698 . . . . 0.0 109.293 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -125.87 130.3 51.07 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.594 -0.691 . . . . 0.0 109.493 179.649 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 64.5 tttm -79.1 131.21 36.17 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.455 -0.778 . . . . 0.0 109.679 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 85.8 mt -110.22 137.49 47.88 Favored 'General case' 0 N--CA 1.498 1.927 0 CA-C-O 121.792 0.806 . . . . 0.0 110.174 -179.872 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 93.8 p -85.62 13.49 6.94 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.646 -0.658 . . . . 0.0 109.43 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 86.4 mt-10 -117.4 90.7 35.44 Favored Pre-proline 0 N--CA 1.499 2.002 0 O-C-N 121.674 -0.641 . . . . 0.0 109.491 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_exo -56.15 150.01 50.79 Favored 'Trans proline' 0 N--CA 1.499 1.818 0 C-N-CA 122.946 2.431 . . . . 0.0 112.758 179.518 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.536 HG22 ' O ' ' A' ' 98' ' ' ILE . 48.1 mm -75.22 0.02 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 121.261 -0.899 . . . . 0.0 109.527 -179.533 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . 0.403 ' C ' ' O ' ' A' ' 98' ' ' ILE . 40.6 tp10 42.33 62.03 1.81 Allowed 'General case' 0 C--N 1.292 -1.911 0 O-C-N 121.882 -0.511 . . . . 0.0 109.669 179.796 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 2.5 p -102.47 -17.21 7.09 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.261 0 O-C-N 121.251 -0.905 . . . . 0.0 109.052 -179.665 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -90.68 113.39 4.25 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.852 -1.299 . . . . 0.0 109.852 -179.836 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.542 HD12 ' N ' ' A' ' 102' ' ' LEU . 10.7 mp -86.3 -3.24 58.95 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.349 -1.089 . . . . 0.0 108.932 179.747 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -64.64 143.12 58.15 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.328 -0.857 . . . . 0.0 110.322 -179.739 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 77.8 m80 -85.71 -6.2 59.16 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.3 -0.875 . . . . 0.0 108.893 179.729 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 77.5 m80 53.34 -120.45 1.69 Allowed 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.454 -0.778 . . . . 0.0 110.294 179.781 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 86.0 t60 -159.36 141.68 13.72 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.081 -1.012 . . . . 0.0 109.029 -179.844 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 96.6 m-70 -108.76 138.18 45.51 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.48 -0.763 . . . . 0.0 109.843 -179.622 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 52.0 p-80 -77.38 141.97 39.54 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.513 -0.742 . . . . 0.0 110.518 -179.306 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 98.7 m-70 . . . . . 0 N--CA 1.489 1.516 0 CA-C-O 118.006 -0.997 . . . . 0.0 109.613 -179.935 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.0 ttt . . . . . 0 N--CA 1.49 1.547 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.447 ' N ' ' CD ' ' A' ' 3' ' ' PRO . 40.3 mm-40 58.51 52.86 4.85 Favored Pre-proline 0 N--CA 1.493 1.714 0 O-C-N 121.655 -0.653 . . . . 0.0 110.037 -179.657 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.447 ' CD ' ' N ' ' A' ' 2' ' ' GLU . 47.5 Cg_endo -67.04 145.93 75.28 Favored 'Trans proline' 0 N--CA 1.496 1.644 0 C-N-CA 122.717 2.278 . . . . 0.0 112.435 179.731 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 18.3 mm100 -76.6 92.62 3.5 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.082 -1.011 . . . . 0.0 109.58 -179.711 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 72.7 mt -76.34 138.05 40.22 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.501 -0.749 . . . . 0.0 109.638 -179.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 54.1 m -130.09 131.94 45.94 Favored 'General case' 0 N--CA 1.495 1.808 0 CA-C-O 121.427 0.632 . . . . 0.0 109.478 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 65.0 mttp -85.52 157.37 20.44 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.366 -0.834 . . . . 0.0 110.119 -179.51 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 96.2 mt -62.71 -43.48 98.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.352 -0.843 . . . . 0.0 109.393 -179.711 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 12.2 p -66.29 -22.93 30.89 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.206 -0.934 . . . . 0.0 109.667 -179.673 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.408 ' OD1' ' O ' ' A' ' 10' ' ' ASP . 57.7 t0 -73.75 -4.03 32.06 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.2 -0.937 . . . . 0.0 109.388 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 96.6 mt -74.96 125.92 35.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.141 -0.974 . . . . 0.0 109.767 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 4.1 m -129.15 -31.06 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 N-CA-C 109.241 -0.652 . . . . 0.0 109.241 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 -135.08 145.26 47.76 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.379 -0.825 . . . . 0.0 110.296 -179.515 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 64.2 m-80 -78.83 154.88 29.49 Favored 'General case' 0 C--N 1.306 -1.312 0 CA-C-O 121.514 0.673 . . . . 0.0 110.517 -179.595 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 88.69 8.21 70.44 Favored Glycine 0 N--CA 1.492 2.402 0 N-CA-C 109.136 -1.585 . . . . 0.0 109.136 179.638 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 18.4 tt0 -77.29 132.85 38.85 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.371 -1.076 . . . . 0.0 109.992 -179.649 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 89.5 m95 -99.56 134.25 42.7 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.39 -0.819 . . . . 0.0 110.006 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -179.9 -175.1 0.3 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.493 -0.754 . . . . 0.0 109.198 179.463 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.599 ' ND2' ' H ' ' A' ' 71' ' ' SER . 5.4 m120 -105.14 153.31 21.7 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.578 -0.701 . . . . 0.0 109.574 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 54.3 tp -139.58 137.85 35.72 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.536 -0.728 . . . . 0.0 109.303 179.492 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 35.9 ttpt -128.25 133.36 48.79 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.683 -0.635 . . . . 0.0 109.475 179.362 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -168.17 177.7 5.37 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.444 -0.785 . . . . 0.0 109.355 179.317 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.427 ' NZ ' ' O ' ' A' ' 98' ' ' ILE . 17.0 ptpt -107.21 146.28 31.6 Favored 'General case' 0 N--CA 1.496 1.861 0 CA-C-O 121.672 0.749 . . . . 0.0 110.179 -179.563 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.465 HG22 ' CD2' ' A' ' 41' ' ' LEU . 78.9 t -85.03 97.88 5.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.561 -0.712 . . . . 0.0 110.093 -179.282 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 37.2 mm -65.72 -44.8 93.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.484 -0.76 . . . . 0.0 109.089 179.703 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 68.1 tp60 -151.22 148.45 28.24 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.239 -0.913 . . . . 0.0 109.321 179.405 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.963 ' H ' HD23 ' A' ' 27' ' ' LEU . 1.3 pt? -128.5 145.22 51.18 Favored 'General case' 0 N--CA 1.494 1.754 0 CA-C-O 121.219 0.533 . . . . 0.0 109.976 -179.857 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 97.6 m95 -128.21 101.53 6.29 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 178.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.674 ' CD ' ' H ' ' A' ' 29' ' ' GLU . 1.6 pm0 -65.69 150.68 48.09 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.583 -0.698 . . . . 0.0 110.605 -178.82 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.518 ' ND2' ' O ' ' A' ' 30' ' ' ASN . 0.7 OUTLIER -144.99 128.94 17.45 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.087 -1.008 . . . . 0.0 109.198 179.09 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 63.3 m -95.21 87.38 4.84 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.452 -0.78 . . . . 0.0 109.55 -178.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 80.8 m80 -131.62 160.61 34.87 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.495 -0.753 . . . . 0.0 109.178 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -66.45 -36.37 82.62 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.465 -0.772 . . . . 0.0 110.532 -179.339 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 20.8 t -100.84 -53.71 2.99 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.219 -0.926 . . . . 0.0 110.435 -179.161 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.513 ' C ' HD21 ' A' ' 30' ' ' ASN . 31.7 mt -78.64 132.22 32.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.183 -0.948 . . . . 0.0 110.199 -178.264 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 8.7 t -98.91 -60.89 1.45 Allowed 'General case' 0 N--CA 1.494 1.727 0 CA-C-O 121.576 0.703 . . . . 0.0 109.283 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -150.36 150.3 31.24 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.257 -0.902 . . . . 0.0 109.565 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 28.7 m -135.57 160.15 39.87 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 O-C-N 121.5 -0.75 . . . . 0.0 109.762 179.724 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 178.6 -166.97 37.13 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -132.9 148.84 52.29 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.404 -1.056 . . . . 0.0 109.898 179.857 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.465 ' CD2' HG22 ' A' ' 24' ' ' VAL . 51.6 mt -111.73 130.72 55.7 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 -179.002 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -97.66 148.31 18.9 Favored Glycine 0 N--CA 1.493 2.493 0 N-CA-C 110.648 -0.981 . . . . 0.0 110.648 -179.362 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.434 ' OD1' ' O ' ' A' ' 46' ' ' GLY . 49.0 p30 -173.24 166.65 4.86 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.691 -0.888 . . . . 0.0 108.948 178.886 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.434 ' OE2' ' NE2' ' A' ' 105' ' ' HIS . 78.5 tt0 -61.56 -16.62 49.51 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.337 -0.852 . . . . 0.0 110.018 -179.347 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 82.7 p -85.48 0.25 52.89 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.952 -1.092 . . . . 0.0 109.212 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.434 ' O ' ' OD1' ' A' ' 43' ' ' ASP . . . 116.05 -147.94 18.9 Favored Glycine 0 N--CA 1.499 2.872 0 N-CA-C 110.241 -1.144 . . . . 0.0 110.241 178.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 96.9 mt -132.57 137.68 53.67 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 121.6 -0.941 . . . . 0.0 109.489 -179.419 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 19.7 tt -134.89 140.88 44.54 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 O-C-N 121.561 -0.712 . . . . 0.0 109.72 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 18.8 mtpp -83.46 155.02 23.63 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.491 -0.755 . . . . 0.0 109.669 -179.806 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 34.2 p90 -141.74 151.83 43.26 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.313 -0.867 . . . . 0.0 109.724 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 52.6 m -131.9 130.81 42.09 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 179.723 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 90.7 mt -102.62 124.05 56.35 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.381 -0.825 . . . . 0.0 110.253 -179.295 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 85.3 m95 -92.99 130.97 38.38 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.418 -0.801 . . . . 0.0 108.936 179.698 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 17.4 ptpt -82.51 55.29 2.89 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.23 -0.919 . . . . 0.0 109.632 -179.656 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 90.8 m-20 -76.05 -3.04 33.67 Favored 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 179.503 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -151.03 -91.41 0.06 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.368 -0.832 . . . . 0.0 109.239 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 179.65 70.6 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 179.846 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 16.7 mt -87.83 146.27 38.53 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.201 -0.937 . . . . 0.0 109.983 -179.105 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -71.46 155.49 59.7 Favored 'Trans proline' 0 N--CA 1.498 1.739 0 C-N-CA 122.656 2.238 . . . . 0.0 112.759 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 79.7 mt -76.43 141.56 41.35 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.398 -0.814 . . . . 0.0 109.95 -179.743 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.625 ' N ' HD12 ' A' ' 61' ' ' LEU . 10.0 mp -81.96 145.54 30.23 Favored 'General case' 0 N--CA 1.488 1.458 0 CA-C-O 121.491 0.662 . . . . 0.0 110.286 -179.169 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.545 ' OE1' ' N ' ' A' ' 62' ' ' GLU . 58.2 mp0 -93.14 144.95 24.78 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.404 -0.81 . . . . 0.0 109.922 -179.488 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 57.9 tt0 -76.55 142.25 40.88 Favored 'General case' 0 N--CA 1.489 1.515 0 CA-C-O 121.505 0.669 . . . . 0.0 111.205 -178.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 81.85 21.22 61.85 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 110.253 -1.139 . . . . 0.0 110.253 178.817 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -130.3 146.29 51.87 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.32 -1.106 . . . . 0.0 110.614 -179.68 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 11.6 p -80.37 151.81 29.22 Favored 'General case' 0 N--CA 1.488 1.473 0 CA-C-O 121.513 0.673 . . . . 0.0 110.002 -179.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -144.72 145.64 31.8 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.408 -0.808 . . . . 0.0 109.517 179.803 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 20.2 tp -110.24 122.51 47.81 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 179.398 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 69.6 mt -100.73 134.54 43.55 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 82.6 mtp180 -126.51 140.87 52.12 Favored 'General case' 0 N--CA 1.498 1.964 0 CA-C-O 121.729 0.776 . . . . 0.0 110.701 -179.268 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.599 ' H ' ' ND2' ' A' ' 19' ' ' ASN . 38.3 t 53.58 71.57 0.49 Allowed 'General case' 0 N--CA 1.491 1.583 0 CA-C-O 121.095 0.474 . . . . 0.0 110.514 179.524 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 18.0 m -128.93 164.19 31.9 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.023 0 O-C-N 121.578 -0.701 . . . . 0.0 109.336 178.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 9.7 p -120.45 135.83 59.42 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 CA-C-O 121.416 0.627 . . . . 0.0 109.418 -179.599 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 11.6 t -85.61 115.47 27.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.391 -0.818 . . . . 0.0 110.071 -178.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -94.17 -178.66 38.73 Favored Glycine 0 N--CA 1.492 2.419 0 N-CA-C 109.312 -1.515 . . . . 0.0 109.312 179.772 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -112.0 133.35 54.23 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.663 -0.904 . . . . 0.0 109.629 -179.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 91.3 t80 -136.49 108.1 6.98 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.418 -0.801 . . . . 0.0 109.147 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.504 ' CG ' ' H ' ' A' ' 79' ' ' ASP . 66.7 t30 51.48 -134.38 1.63 Allowed 'General case' 0 N--CA 1.493 1.698 0 CA-C-O 121.603 0.716 . . . . 0.0 110.823 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.504 ' H ' ' CG ' ' A' ' 78' ' ' ASN . 36.5 t70 -87.1 -7.24 58.24 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.344 -0.848 . . . . 0.0 109.201 -179.389 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 85.2 mtp180 -108.56 173.98 6.08 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.711 -0.618 . . . . 0.0 109.763 -179.543 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 72.7 m-85 -104.74 155.85 18.52 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.605 -0.684 . . . . 0.0 109.944 -179.388 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 51.3 tt0 -138.35 153.19 48.97 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 -179.662 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 3.3 m -116.05 131.94 67.06 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 179.551 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 87.8 mt-30 -101.42 135.28 43.17 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.504 -0.748 . . . . 0.0 110.178 -178.74 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 71.4 t -107.09 130.55 58.97 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 179.274 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 79.2 m-20 -124.83 -179.57 4.58 Favored 'General case' 0 N--CA 1.496 1.854 0 CA-C-O 121.507 0.67 . . . . 0.0 109.911 -179.327 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 64.0 tttp -58.94 -41.0 86.35 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.592 -0.692 . . . . 0.0 110.043 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . 0.411 ' OD1' ' O ' ' A' ' 88' ' ' ASN . 41.9 t-20 -60.5 -35.67 76.51 Favored 'General case' 0 C--N 1.299 -1.602 0 O-C-N 121.109 -0.995 . . . . 0.0 109.112 -179.915 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 30.9 t -70.0 152.76 44.05 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.28 -0.887 . . . . 0.0 110.089 -179.519 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 35.3 t -128.74 148.91 50.88 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.601 -0.687 . . . . 0.0 109.495 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 96.2 mt -123.66 132.8 70.76 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 O-C-N 121.713 -0.617 . . . . 0.0 109.381 -179.782 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 82.5 tt0 -126.08 131.2 52.17 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 179.392 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.42 ' C ' HD12 ' A' ' 94' ' ' LEU . 37.8 ttmt -79.81 131.37 35.88 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.487 -0.758 . . . . 0.0 109.923 -179.568 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.438 HD12 ' N ' ' A' ' 94' ' ' LEU . 9.9 mp -101.08 137.31 39.62 Favored 'General case' 0 N--CA 1.493 1.685 0 CA-C-O 121.615 0.721 . . . . 0.0 109.644 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 70.3 m -90.4 6.33 43.7 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.649 -0.657 . . . . 0.0 109.501 -179.772 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.471 ' CD ' ' N ' ' A' ' 96' ' ' GLU . 1.3 pm0 -116.34 91.67 33.81 Favored Pre-proline 0 N--CA 1.499 1.975 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_exo -53.94 149.24 35.09 Favored 'Trans proline' 0 N--CA 1.495 1.611 0 C-N-CA 122.372 2.048 . . . . 0.0 112.249 -179.811 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.427 ' O ' ' NZ ' ' A' ' 23' ' ' LYS . 96.7 mt -100.62 128.62 52.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 CA-C-O 121.673 0.749 . . . . 0.0 110.644 -178.453 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . 0.535 ' OE1' ' N ' ' A' ' 99' ' ' GLU . 57.9 mp0 -87.59 127.81 35.27 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.577 -0.702 . . . . 0.0 109.383 -179.695 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 3.6 t -101.21 -15.57 7.58 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 O-C-N 121.499 -0.751 . . . . 0.0 109.363 -179.778 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -91.7 -2.71 69.42 Favored Glycine 0 N--CA 1.492 2.409 0 N-CA-C 109.117 -1.593 . . . . 0.0 109.117 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.466 ' O ' ' C ' ' A' ' 103' ' ' GLU . 10.8 tp -61.37 -61.28 2.65 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.286 -1.126 . . . . 0.0 109.89 -179.349 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . 0.466 ' C ' ' O ' ' A' ' 102' ' ' LEU . 10.7 pt-20 31.66 40.38 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.062 0 CA-C-O 121.423 0.63 . . . . 0.0 110.586 -179.641 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . 0.42 ' N ' ' O ' ' A' ' 102' ' ' LEU . 64.9 t60 -66.19 -44.51 83.76 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.451 -0.781 . . . . 0.0 109.254 -179.763 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . 0.434 ' NE2' ' OE2' ' A' ' 44' ' ' GLU . 99.0 m-70 41.13 90.53 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.705 0 CA-C-O 121.416 0.626 . . . . 0.0 110.543 -179.925 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 86.2 t60 -153.85 86.96 1.2 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.288 -0.882 . . . . 0.0 108.738 179.295 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . 0.462 ' C ' ' H ' ' A' ' 109' ' ' HIS . 44.8 p-80 -154.25 161.82 41.56 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.264 -0.898 . . . . 0.0 110.424 -179.83 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 54.5 t-80 50.06 11.01 0.06 Allowed 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.573 -0.704 . . . . 0.0 109.899 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . 0.462 ' H ' ' C ' ' A' ' 107' ' ' HIS . 85.6 t60 . . . . . 0 N--CA 1.491 1.623 0 CA-C-O 117.958 -1.02 . . . . 0.0 109.91 179.534 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.9 mpp? . . . . . 0 N--CA 1.489 1.51 0 CA-C-O 121.469 0.652 . . . . 0.0 109.657 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 41.33 57.76 9.04 Favored Pre-proline 0 N--CA 1.495 1.822 0 O-C-N 121.8 -0.563 . . . . 0.0 110.731 -179.82 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -72.97 151.4 50.3 Favored 'Trans proline' 0 N--CA 1.496 1.635 0 C-N-CA 122.605 2.204 . . . . 0.0 112.715 179.617 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 58.9 tt0 -74.59 93.46 2.52 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.237 -0.915 . . . . 0.0 109.586 -179.775 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 86.6 mt -84.93 129.51 34.79 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.428 -0.795 . . . . 0.0 109.579 -179.694 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 98.7 m -127.76 131.21 49.67 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.621 -0.674 . . . . 0.0 110.042 -179.54 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -84.34 158.77 21.05 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.572 -0.705 . . . . 0.0 109.962 -179.79 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 97.3 mt -62.78 -43.7 98.95 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.289 -0.882 . . . . 0.0 109.553 -179.546 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 14.9 p -67.7 -21.94 27.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.188 -0.945 . . . . 0.0 109.404 -179.638 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -76.24 -4.15 40.35 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.373 -0.829 . . . . 0.0 109.184 179.634 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 96.7 mt -80.42 116.13 24.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.305 -0.872 . . . . 0.0 109.353 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 27.0 m -119.52 -19.92 5.15 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.875 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 179.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 22.1 pt-20 -139.34 141.62 37.65 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.42 -0.8 . . . . 0.0 109.955 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 23.3 p30 -86.15 167.0 15.32 Favored 'General case' 0 N--CA 1.491 1.59 0 CA-C-O 121.478 0.656 . . . . 0.0 110.378 -179.619 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 80.57 3.17 90.15 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.188 -1.565 . . . . 0.0 109.188 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 14.5 pt20 -84.58 145.68 27.92 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.321 -1.105 . . . . 0.0 110.106 -179.609 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' TRP . . . . . 0.439 ' CD1' ' N ' ' A' ' 17' ' ' TRP . 31.6 m95 -101.92 138.83 38.37 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.671 -0.643 . . . . 0.0 110.063 -179.593 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.456 ' C ' HD22 ' A' ' 19' ' ' ASN . . . -178.9 -170.08 0.18 Allowed 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 179.358 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.456 HD22 ' C ' ' A' ' 18' ' ' ALA . 3.3 m120 -108.32 149.54 28.52 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.544 -0.723 . . . . 0.0 109.567 -179.85 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.615 HD13 ' N ' ' A' ' 21' ' ' LYS . 0.3 OUTLIER -137.7 121.24 17.24 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 179.469 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.615 ' N ' HD13 ' A' ' 20' ' ' LEU . 36.4 ttpt -110.48 139.75 45.4 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.666 -0.646 . . . . 0.0 109.771 179.577 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -167.78 -174.03 2.31 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.31 -0.868 . . . . 0.0 109.789 179.553 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 76.0 tttt -118.12 144.16 45.89 Favored 'General case' 0 N--CA 1.501 2.085 0 CA-C-O 121.545 0.688 . . . . 0.0 109.733 -179.663 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.419 HG12 ' OE1' ' A' ' 63' ' ' GLN . 4.7 t -78.77 120.88 30.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.429 -0.794 . . . . 0.0 111.059 -178.59 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 32.7 mm -94.57 -49.05 12.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 179.13 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 57.8 tt0 -153.92 149.68 27.55 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.406 -0.809 . . . . 0.0 109.482 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 95.0 mt -121.0 145.12 48.09 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.762 -0.586 . . . . 0.0 109.832 -179.872 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 2.1 t-105 -128.95 111.59 13.19 Favored 'General case' 0 N--CA 1.495 1.786 0 CA-C-O 121.55 0.691 . . . . 0.0 109.358 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 39.2 tp10 -65.09 135.86 56.04 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.494 -0.754 . . . . 0.0 109.776 -179.629 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.503 HD22 ' CG2' ' A' ' 35' ' ' ILE . 53.0 t-20 -103.45 -50.18 3.51 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.399 -0.813 . . . . 0.0 109.02 179.893 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 2.3 m 66.36 -4.06 0.75 Allowed 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 -179.7 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . 0.477 ' H ' ' C ' ' A' ' 30' ' ' ASN . 83.9 t60 -83.42 127.57 33.8 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.42 -0.8 . . . . 0.0 109.651 -179.639 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.48 ' O ' ' CB ' ' A' ' 34' ' ' SER . 98.2 mt-10 -40.06 154.99 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.698 -0.626 . . . . 0.0 110.938 -179.534 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.48 ' CB ' ' O ' ' A' ' 33' ' ' GLU . 0.9 OUTLIER 78.35 -50.0 0.47 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.764 -0.585 . . . . 0.0 109.716 179.964 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.503 ' CG2' HD22 ' A' ' 30' ' ' ASN . 86.8 mt -108.99 128.91 64.48 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 O-C-N 121.477 -0.764 . . . . 0.0 109.605 -179.445 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 24.1 t -87.19 -68.46 0.75 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.616 -0.678 . . . . 0.0 109.901 -179.446 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 89.7 mt-30 -132.95 148.11 52.28 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.514 -0.742 . . . . 0.0 109.447 -179.374 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 44.6 t -128.99 134.46 64.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -158.7 -162.24 11.74 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -140.1 145.5 37.7 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.446 -1.032 . . . . 0.0 109.635 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 45.0 mt -115.04 133.07 56.35 Favored 'General case' 0 N--CA 1.496 1.829 0 CA-C-O 121.575 0.702 . . . . 0.0 109.583 -179.155 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -92.96 140.52 15.11 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 110.385 -1.086 . . . . 0.0 110.385 -179.588 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 39.7 t0 -148.41 159.12 44.34 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.52 -0.988 . . . . 0.0 108.682 179.343 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -66.6 -20.7 66.06 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.221 -0.925 . . . . 0.0 109.669 -179.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 58.4 p -79.66 -10.15 59.75 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.144 -0.973 . . . . 0.0 109.347 -179.856 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 139.21 -164.3 25.9 Favored Glycine 0 N--CA 1.496 2.677 0 N-CA-C 109.455 -1.458 . . . . 0.0 109.455 179.507 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 34.4 mm -114.58 132.05 64.87 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.0 0 O-C-N 121.631 -0.923 . . . . 0.0 108.81 -179.701 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 18.1 tt -133.5 141.41 44.44 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 O-C-N 121.577 -0.702 . . . . 0.0 110.003 -179.588 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -90.71 156.95 17.7 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.592 -0.692 . . . . 0.0 110.459 -179.349 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 8.6 p90 -146.08 160.51 41.8 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.241 -0.912 . . . . 0.0 109.622 179.501 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.435 HG23 ' HE1' ' A' ' 53' ' ' TRP . 1.6 t -141.25 141.41 34.0 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 179.335 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 87.5 mt -106.66 125.79 62.53 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 O-C-N 121.53 -0.731 . . . . 0.0 109.734 -179.581 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . 0.529 ' CD1' ' N ' ' A' ' 53' ' ' TRP . 13.5 m95 -99.98 147.59 25.42 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.528 -0.732 . . . . 0.0 109.733 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.503 ' C ' ' H ' ' A' ' 56' ' ' ALA . 54.0 mtmt -67.16 -7.68 25.35 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.431 -0.793 . . . . 0.0 109.448 179.854 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 98.8 m-20 -72.1 26.91 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.199 -0.938 . . . . 0.0 109.844 -179.334 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.503 ' H ' ' C ' ' A' ' 54' ' ' LYS . . . -150.51 -39.33 0.13 Allowed 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 179.62 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 57.8 63.15 1.88 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.839 -0.538 . . . . 0.0 109.867 -179.84 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 17.4 mt -102.85 157.19 34.21 Favored Pre-proline 0 N--CA 1.497 1.892 0 O-C-N 121.567 -0.708 . . . . 0.0 109.599 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -54.97 149.25 43.58 Favored 'Trans proline' 0 N--CA 1.502 2.021 0 C-N-CA 122.292 1.995 . . . . 0.0 113.071 179.546 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 61.8 mt -65.72 140.07 58.42 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.432 -0.793 . . . . 0.0 110.33 -179.102 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.535 ' N ' HD12 ' A' ' 61' ' ' LEU . 10.8 mp -77.95 141.84 38.74 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.53 -0.731 . . . . 0.0 110.016 -179.551 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -90.19 150.86 21.81 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.468 -0.77 . . . . 0.0 109.974 -179.815 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.419 ' OE1' HG12 ' A' ' 24' ' ' VAL . 2.9 mm100 -81.96 145.19 30.41 Favored 'General case' 0 N--CA 1.493 1.709 0 CA-C-O 122.018 0.914 . . . . 0.0 112.006 -178.17 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 70.0 31.33 69.63 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 110.576 -1.01 . . . . 0.0 110.576 178.074 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 91.7 mt-10 -136.08 147.68 47.96 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.303 -1.116 . . . . 0.0 110.218 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 10.6 m -80.68 149.68 29.68 Favored 'General case' 0 N--CA 1.487 1.419 0 CA-C-O 121.324 0.583 . . . . 0.0 109.62 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 30.3 m-85 -144.04 142.48 30.68 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.398 -0.814 . . . . 0.0 109.107 179.531 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 14.5 tp -108.57 120.93 43.88 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 179.237 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 76.3 mt -100.51 132.81 45.7 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.512 -0.742 . . . . 0.0 109.297 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.408 ' O ' ' CB ' ' A' ' 71' ' ' SER . 89.8 mtm180 -127.02 131.87 50.88 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.797 -0.564 . . . . 0.0 110.059 -179.956 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.408 ' CB ' ' O ' ' A' ' 70' ' ' ARG . 1.1 m 75.88 54.9 0.06 Allowed 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 179.677 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 15.8 m -117.13 161.34 15.96 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.173 0 O-C-N 121.607 -0.683 . . . . 0.0 109.465 179.236 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 14.1 p -120.47 140.59 44.08 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 CA-C-O 121.499 0.666 . . . . 0.0 109.514 -179.325 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 99.6 t -84.56 120.35 35.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.445 -0.784 . . . . 0.0 110.139 -178.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -97.3 174.42 29.73 Favored Glycine 0 N--CA 1.493 2.48 0 N-CA-C 109.714 -1.354 . . . . 0.0 109.714 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.547 ' N ' ' OE1' ' A' ' 76' ' ' GLU . 54.4 mp0 -112.72 119.48 38.22 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.766 -0.844 . . . . 0.0 109.027 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . 0.528 ' CE2' ' OD1' ' A' ' 78' ' ' ASN . 85.0 t80 -136.98 124.43 22.08 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.418 -0.801 . . . . 0.0 110.139 -179.846 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.528 ' OD1' ' CE2' ' A' ' 77' ' ' TYR . 7.0 m120 55.53 38.37 30.13 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.76 -0.587 . . . . 0.0 109.901 179.356 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 25.7 t0 66.83 -4.08 0.83 Allowed 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.603 -0.686 . . . . 0.0 109.513 179.665 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.417 ' H ' ' C ' ' A' ' 78' ' ' ASN . 80.1 mtp85 -93.72 -177.26 4.31 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.303 -0.873 . . . . 0.0 109.459 179.773 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -114.86 137.17 52.28 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.571 -0.706 . . . . 0.0 109.605 -179.67 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -143.25 159.63 41.98 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.385 -0.822 . . . . 0.0 109.645 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.402 HG23 ' O ' ' A' ' 83' ' ' VAL . 22.5 m -104.08 131.72 52.21 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 179.662 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -102.25 114.67 29.03 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.356 -0.84 . . . . 0.0 109.422 -179.289 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 12.1 t -88.56 103.67 14.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.458 -0.776 . . . . 0.0 109.277 -179.81 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 2.0 p30 -151.14 -179.76 7.6 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.383 -0.823 . . . . 0.0 109.586 179.773 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 49.2 tttm 67.43 -132.58 0.13 Allowed 'General case' 0 N--CA 1.495 1.807 0 CA-C-O 121.491 0.663 . . . . 0.0 110.822 179.436 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . 0.409 ' O ' ' C ' ' A' ' 89' ' ' SER . 10.2 m120 -95.47 13.19 26.8 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.244 -0.91 . . . . 0.0 109.047 -179.198 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.409 ' C ' ' O ' ' A' ' 88' ' ' ASN . 97.7 p -40.94 110.18 0.15 Allowed 'General case' 0 N--CA 1.495 1.817 0 CA-C-O 121.589 0.709 . . . . 0.0 109.646 -179.514 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 12.1 m -80.52 151.02 29.41 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.577 -0.702 . . . . 0.0 109.728 -179.051 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 96.7 mt -132.36 132.07 60.53 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 121.52 -0.738 . . . . 0.0 109.501 179.748 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 52.5 tp10 -128.28 134.61 48.97 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 179.697 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.426 ' C ' HD22 ' A' ' 94' ' ' LEU . 38.7 ttpt -85.02 131.05 34.52 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.569 -0.707 . . . . 0.0 110.265 -179.457 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.471 ' N ' HD22 ' A' ' 94' ' ' LEU . 4.1 mm? -99.32 132.07 44.9 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.472 -0.768 . . . . 0.0 109.601 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 73.2 m -84.26 15.66 3.45 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 179.634 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 17.6 tp10 -118.05 89.83 35.71 Favored Pre-proline 0 N--CA 1.498 1.938 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 179.504 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -57.69 144.49 92.88 Favored 'Trans proline' 0 N--CA 1.498 1.745 0 C-N-CA 122.561 2.174 . . . . 0.0 112.208 179.659 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 90.5 mt -106.05 123.88 60.94 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 O-C-N 121.51 -0.744 . . . . 0.0 109.772 -179.828 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . 0.549 ' OE1' ' N ' ' A' ' 99' ' ' GLU . 58.7 mp0 -89.49 132.57 34.97 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.5 -0.75 . . . . 0.0 109.592 -179.508 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 7.3 t -88.52 58.12 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 O-C-N 121.38 -0.825 . . . . 0.0 109.254 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 75.53 13.41 82.96 Favored Glycine 0 N--CA 1.494 2.516 0 N-CA-C 109.972 -1.251 . . . . 0.0 109.972 179.521 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.526 HD22 ' N ' ' A' ' 102' ' ' LEU . 3.9 mm? -64.08 -42.13 97.08 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.112 -1.228 . . . . 0.0 109.489 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -92.42 108.9 20.31 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.262 -0.899 . . . . 0.0 109.935 -179.355 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . 0.607 ' NE2' ' CD2' ' A' ' 105' ' ' HIS . 11.1 p-80 -86.25 -16.14 38.58 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 179.639 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . 0.607 ' CD2' ' NE2' ' A' ' 104' ' ' HIS . 96.1 m-70 -95.16 14.51 21.87 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 179.719 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' HIS . . . . . 0.529 ' O ' ' N ' ' A' ' 108' ' ' HIS . 79.2 t60 -59.89 -45.65 91.85 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 121.564 -0.71 . . . . 0.0 109.233 179.818 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . 0.441 ' O ' ' N ' ' A' ' 109' ' ' HIS . 70.8 m80 47.81 11.7 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.4 -0.812 . . . . 0.0 109.706 -179.82 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . 0.529 ' N ' ' O ' ' A' ' 106' ' ' HIS . 55.1 p-80 36.68 32.94 0.02 OUTLIER 'General case' 0 N--CA 1.499 2.001 0 CA-C-O 121.444 0.64 . . . . 0.0 110.402 179.875 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . 0.441 ' N ' ' O ' ' A' ' 107' ' ' HIS . 63.4 t-80 . . . . . 0 N--CA 1.489 1.477 0 CA-C-O 118.025 -0.988 . . . . 0.0 109.637 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.452 ' H2 ' ' HD2' ' A' ' 3' ' ' PRO . 6.4 ttt . . . . . 0 N--CA 1.491 1.624 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.64 ' N ' ' CD ' ' A' ' 3' ' ' PRO . 2.8 mm-40 -81.22 -38.95 0.99 Allowed Pre-proline 0 N--CA 1.493 1.709 0 O-C-N 121.68 -0.638 . . . . 0.0 109.815 179.457 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.64 ' CD ' ' N ' ' A' ' 2' ' ' GLU . 23.2 Cg_exo -61.37 147.01 96.62 Favored 'Trans proline' 0 N--CA 1.493 1.498 0 C-N-CA 122.484 2.123 . . . . 0.0 112.393 -179.175 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 21.4 mp0 -88.17 75.69 8.59 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.143 -0.973 . . . . 0.0 108.936 179.675 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 84.3 mt -69.45 143.84 53.45 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.47 -0.769 . . . . 0.0 109.665 -179.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 93.9 m -125.15 128.83 49.02 Favored 'General case' 0 N--CA 1.497 1.881 0 CA-C-O 121.735 0.779 . . . . 0.0 109.63 -179.717 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 14.8 mptt -80.22 149.66 30.37 Favored 'General case' 0 C--N 1.302 -1.48 0 CA-C-O 121.86 0.838 . . . . 0.0 109.843 -179.451 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.666 ' N ' HD12 ' A' ' 8' ' ' ILE . 2.7 mp -63.15 -43.73 99.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 CA-C-O 121.566 0.698 . . . . 0.0 110.166 -179.451 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 10.0 p -69.76 -19.93 23.21 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.654 0 O-C-N 121.214 -0.929 . . . . 0.0 110.057 -179.253 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -82.05 -3.47 54.69 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.925 -1.109 . . . . 0.0 109.482 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 96.7 mt -79.65 121.02 32.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.056 -1.027 . . . . 0.0 110.012 -179.757 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 33.4 m -136.04 -4.33 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.488 -0.757 . . . . 0.0 109.06 179.445 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -138.11 140.86 40.15 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.026 -1.046 . . . . 0.0 109.845 -179.781 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 57.3 p30 -93.65 162.22 14.03 Favored 'General case' 0 N--CA 1.493 1.7 0 CA-C-O 121.677 0.751 . . . . 0.0 110.521 -179.739 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 79.94 6.03 89.29 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.376 -1.49 . . . . 0.0 109.376 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 -80.97 135.46 35.87 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.202 -1.176 . . . . 0.0 110.275 -179.46 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 85.3 m95 -99.93 136.56 39.65 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.542 -0.724 . . . . 0.0 109.29 179.294 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.466 ' C ' HD22 ' A' ' 19' ' ' ASN . . . -178.03 -172.98 0.35 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.22 -0.925 . . . . 0.0 109.697 -179.895 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.466 HD22 ' C ' ' A' ' 18' ' ' ALA . 3.5 m120 -109.26 149.07 29.97 Favored 'General case' 0 N--CA 1.495 1.819 0 CA-C-O 121.57 0.7 . . . . 0.0 109.648 -179.802 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 6.3 tt -136.93 133.36 35.6 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.357 -0.839 . . . . 0.0 110.128 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 37.6 ttmt -114.6 134.71 54.84 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 179.387 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -165.04 171.07 14.37 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 119.069 -1.052 . . . . 0.0 110.418 -179.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 64.9 tttm -106.26 142.25 36.26 Favored 'General case' 0 N--CA 1.496 1.842 0 CA-C-O 121.75 0.786 . . . . 0.0 110.028 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 92.5 t -79.84 121.98 34.18 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 O-C-N 121.382 -0.824 . . . . 0.0 110.378 -179.439 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 96.7 mt -100.72 -57.53 4.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 179.141 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 66.5 tp60 -147.79 139.45 23.89 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.058 -1.026 . . . . 0.0 110.08 -179.858 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.844 ' H ' HD23 ' A' ' 27' ' ' LEU . 1.2 pt? -142.96 138.21 29.94 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.741 -0.599 . . . . 0.0 109.618 179.228 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 4.9 m0 -113.03 142.45 45.7 Favored 'General case' 0 N--CA 1.497 1.92 0 CA-C-O 121.634 0.73 . . . . 0.0 109.795 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 3.0 pp20? -80.42 140.52 35.96 Favored 'General case' 0 N--CA 1.491 1.6 0 CA-C-O 121.601 0.715 . . . . 0.0 110.523 -179.355 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.415 HD22 ' HB ' ' A' ' 35' ' ' ILE . 48.8 t30 -101.97 154.95 18.48 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.436 -0.79 . . . . 0.0 109.518 -179.818 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.486 HG22 ' O ' ' A' ' 31' ' ' THR . 63.0 m -97.02 -6.21 35.87 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.219 -0.925 . . . . 0.0 109.526 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 93.3 m-70 -80.74 135.06 35.93 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.93 -1.106 . . . . 0.0 110.372 -179.549 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 10.5 tm-20 -67.99 -36.99 80.95 Favored 'General case' 0 N--CA 1.495 1.785 0 CA-C-O 121.647 0.737 . . . . 0.0 109.949 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 42.2 t -61.55 -41.78 97.87 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.237 -0.915 . . . . 0.0 110.096 -179.36 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.415 ' HB ' HD22 ' A' ' 30' ' ' ASN . 97.5 mt -109.27 130.16 62.76 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 CA-C-O 121.968 0.889 . . . . 0.0 110.368 -179.334 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 19.3 t -74.8 -75.56 0.16 Allowed 'General case' 0 N--CA 1.491 1.617 0 CA-C-O 121.689 0.757 . . . . 0.0 109.642 179.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 -143.04 157.64 44.35 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.145 -0.972 . . . . 0.0 109.623 -179.566 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 13.9 m -132.74 135.01 58.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 CA-C-O 121.61 0.719 . . . . 0.0 109.426 179.771 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -160.34 -164.25 15.07 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 -179.551 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -133.7 148.96 51.51 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.5 -1.0 . . . . 0.0 110.137 -179.814 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 32.1 mt -120.11 136.91 54.43 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 -179.177 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -100.5 137.45 13.27 Favored Glycine 0 N--CA 1.494 2.52 0 N-CA-C 110.368 -1.093 . . . . 0.0 110.368 -179.296 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.488 ' O ' ' N ' ' A' ' 45' ' ' THR . 47.0 t0 -136.61 36.84 2.67 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.484 -1.009 . . . . 0.0 108.679 179.076 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 63.98 -38.92 0.21 Allowed 'General case' 0 N--CA 1.503 2.199 0 CA-C-O 121.418 0.628 . . . . 0.0 110.412 -179.514 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.488 ' N ' ' O ' ' A' ' 43' ' ' ASP . 17.8 p -79.41 22.9 0.42 Allowed 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.051 -1.031 . . . . 0.0 109.707 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 114.45 -165.56 12.07 Favored Glycine 0 N--CA 1.498 2.78 0 N-CA-C 110.436 -1.066 . . . . 0.0 110.436 179.324 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 33.7 pt -129.19 145.17 36.17 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 O-C-N 121.673 -0.898 . . . . 0.0 109.457 -179.775 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 18.9 tt -137.95 143.2 33.97 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 O-C-N 121.48 -0.763 . . . . 0.0 109.875 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 32.6 mtmm -83.25 155.12 23.83 Favored 'General case' 0 N--CA 1.493 1.692 0 CA-C-O 121.56 0.695 . . . . 0.0 110.431 -179.485 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 42.8 p90 -144.75 153.37 41.61 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.261 -0.899 . . . . 0.0 109.591 179.833 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 93.7 m -131.24 129.99 42.31 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 179.582 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 96.7 mt -101.41 126.25 55.28 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 121.361 -0.837 . . . . 0.0 109.764 -179.537 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 30.9 m95 -104.18 143.5 32.85 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.489 -0.757 . . . . 0.0 109.011 179.305 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -87.45 44.92 1.22 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.231 -0.918 . . . . 0.0 108.984 179.702 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -61.39 -41.47 97.17 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.478 -0.764 . . . . 0.0 109.279 179.799 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -119.42 -80.69 0.62 Allowed 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.442 -0.786 . . . . 0.0 109.723 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -179.61 82.85 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.133 -0.979 . . . . 0.0 109.164 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 36.6 mt -114.09 96.96 43.9 Favored Pre-proline 0 N--CA 1.5 2.063 0 O-C-N 121.331 -0.856 . . . . 0.0 109.253 -179.893 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_exo -49.98 157.81 2.57 Favored 'Trans proline' 0 N--CA 1.495 1.582 0 C-N-CA 122.685 2.257 . . . . 0.0 112.896 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 41.4 mt -65.48 141.79 58.37 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.306 -0.871 . . . . 0.0 110.219 -179.043 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.599 ' N ' HD12 ' A' ' 61' ' ' LEU . 9.3 mp -85.57 150.94 24.31 Favored 'General case' 0 N--CA 1.493 1.712 0 CA-C-O 121.816 0.817 . . . . 0.0 110.742 -179.295 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -74.61 150.68 39.55 Favored 'General case' 0 N--CA 1.491 1.591 0 CA-C-O 121.882 0.849 . . . . 0.0 110.722 -179.598 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 57.6 tt0 -86.2 138.77 31.63 Favored 'General case' 0 N--CA 1.49 1.526 0 CA-C-O 121.687 0.756 . . . . 0.0 111.185 -179.661 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 81.48 10.94 83.84 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 110.346 -1.102 . . . . 0.0 110.346 178.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -115.77 147.27 41.14 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.343 -1.093 . . . . 0.0 110.57 -179.622 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 15.4 t -80.58 143.55 33.1 Favored 'General case' 0 N--CA 1.49 1.532 0 CA-C-O 121.61 0.719 . . . . 0.0 110.122 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 46.0 m-85 -140.47 147.47 39.66 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.417 -0.802 . . . . 0.0 109.835 179.785 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 19.4 tp -111.11 123.97 51.26 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 179.216 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 13.6 mt -99.04 131.18 45.27 Favored 'General case' 0 N--CA 1.492 1.662 0 CA-C-O 121.388 0.613 . . . . 0.0 110.039 -179.452 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.485 ' O ' ' CB ' ' A' ' 71' ' ' SER . 82.9 mtp180 -129.64 125.98 37.33 Favored 'General case' 0 N--CA 1.494 1.742 0 CA-C-O 121.437 0.637 . . . . 0.0 109.994 179.757 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.485 ' CB ' ' O ' ' A' ' 70' ' ' ARG . 0.9 OUTLIER 82.85 49.91 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.863 0 CA-C-O 121.157 0.503 . . . . 0.0 110.265 179.398 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 15.9 m -113.49 162.06 11.92 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.079 0 O-C-N 121.21 -0.932 . . . . 0.0 109.687 179.387 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 2.7 p -125.44 137.72 56.74 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 CA-C-O 121.763 0.792 . . . . 0.0 109.656 -179.407 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 11.0 t -85.33 113.37 23.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 CA-C-O 121.653 0.739 . . . . 0.0 109.976 -179.499 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -95.22 174.68 32.7 Favored Glycine 0 N--CA 1.493 2.47 0 N-CA-C 109.787 -1.325 . . . . 0.0 109.787 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -109.84 123.19 49.14 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.547 -0.972 . . . . 0.0 109.242 179.72 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 84.7 t80 -132.71 115.99 16.05 Favored 'General case' 0 N--CA 1.493 1.676 0 CA-C-O 121.59 0.709 . . . . 0.0 109.965 -179.618 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 7.7 m120 56.06 38.21 29.67 Favored 'General case' 0 N--CA 1.492 1.672 0 CA-C-O 121.419 0.628 . . . . 0.0 110.088 179.533 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 70.23 -2.55 2.08 Favored 'General case' 0 N--CA 1.497 1.911 0 CA-C-O 121.425 0.631 . . . . 0.0 109.656 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 20.7 mmm180 -98.48 166.26 11.44 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.183 -0.948 . . . . 0.0 109.996 -179.856 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 60.4 m-85 -88.24 139.78 30.14 Favored 'General case' 0 N--CA 1.488 1.436 0 CA-C-O 121.881 0.848 . . . . 0.0 110.107 -179.104 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 52.9 tt0 -144.4 150.7 38.15 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.388 -0.82 . . . . 0.0 108.833 179.805 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 28.5 m -114.14 128.92 70.9 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 O-C-N 121.526 -0.734 . . . . 0.0 109.165 179.616 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 75.5 mt-30 -107.85 127.22 53.53 Favored 'General case' 0 N--CA 1.495 1.776 0 CA-C-O 121.653 0.739 . . . . 0.0 109.989 -179.215 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 18.8 t -96.64 107.88 20.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 CA-C-O 121.634 0.73 . . . . 0.0 109.229 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.536 HD22 ' C ' ' A' ' 86' ' ' ASN . 0.4 OUTLIER -151.17 -170.05 3.55 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.395 -0.816 . . . . 0.0 109.914 -179.804 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 30.7 ttmt 59.27 37.13 23.74 Favored 'General case' 0 N--CA 1.493 1.724 0 CA-C-O 122.184 0.992 . . . . 0.0 109.879 179.758 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 10.2 t30 55.48 40.64 31.27 Favored 'General case' 0 N--CA 1.49 1.535 0 CA-C-O 121.637 0.732 . . . . 0.0 109.71 179.652 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 14.6 m -54.23 139.96 34.24 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.278 -0.889 . . . . 0.0 109.916 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 7.9 m -81.09 144.19 31.89 Favored 'General case' 0 N--CA 1.49 1.558 0 CA-C-O 121.795 0.807 . . . . 0.0 110.484 -179.092 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 96.6 mt -134.67 133.33 54.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.542 -0.723 . . . . 0.0 109.27 179.812 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -122.41 134.9 54.6 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.512 -0.742 . . . . 0.0 109.145 179.72 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.432 ' C ' HD22 ' A' ' 94' ' ' LEU . 88.5 tttt -82.49 125.17 30.8 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.402 -0.811 . . . . 0.0 109.879 -179.649 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.51 ' N ' HD22 ' A' ' 94' ' ' LEU . 4.1 mm? -97.3 134.48 40.53 Favored 'General case' 0 N--CA 1.49 1.559 0 CA-C-O 121.911 0.862 . . . . 0.0 109.963 -179.653 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 67.6 m -84.3 -4.57 58.94 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 179.303 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 90.5 mt-10 -104.48 110.36 64.16 Favored Pre-proline 0 N--CA 1.498 1.936 0 O-C-N 121.277 -0.889 . . . . 0.0 109.574 -179.831 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -74.3 157.38 45.73 Favored 'Trans proline' 0 N--CA 1.493 1.459 0 C-N-CA 122.374 2.049 . . . . 0.0 112.548 -179.365 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 16.6 mm -97.19 126.19 50.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.191 -0.943 . . . . 0.0 109.813 -179.384 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -64.63 129.13 38.66 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.531 -0.731 . . . . 0.0 109.918 -179.673 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 27.3 m -112.1 -7.72 11.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 179.389 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 144.7 69.09 0.02 OUTLIER Glycine 0 N--CA 1.496 2.661 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 179.828 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.501 ' O ' ' N ' ' A' ' 104' ' ' HIS . 2.4 pp -85.19 0.75 50.77 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.24 -1.153 . . . . 0.0 109.115 179.682 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . 0.558 ' O ' ' N ' ' A' ' 105' ' ' HIS . 12.7 pt-20 -48.3 -13.79 0.05 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.176 -0.953 . . . . 0.0 109.428 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . 0.501 ' N ' ' O ' ' A' ' 102' ' ' LEU . 35.9 m80 33.98 -87.33 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.106 0 CA-C-O 121.389 0.614 . . . . 0.0 111.194 179.441 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . 0.558 ' N ' ' O ' ' A' ' 103' ' ' GLU . 85.0 t60 56.99 8.66 0.53 Allowed 'General case' 0 N--CA 1.492 1.662 0 CA-C-O 121.471 0.653 . . . . 0.0 109.379 -179.852 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' HIS . . . . . 0.534 ' O ' ' CG ' ' A' ' 107' ' ' HIS . 72.1 m80 -88.52 54.42 3.04 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.139 -0.975 . . . . 0.0 110.049 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . 0.534 ' CG ' ' O ' ' A' ' 106' ' ' HIS . 41.6 p-80 39.92 -163.16 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.953 0 CA-C-O 121.904 0.859 . . . . 0.0 111.485 179.167 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 45.9 p-80 -151.66 161.43 42.69 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.217 -0.927 . . . . 0.0 109.998 -179.718 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 84.2 t60 . . . . . 0 N--CA 1.491 1.583 0 CA-C-O 118.051 -0.976 . . . . 0.0 109.875 -179.952 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.2 ttt . . . . . 0 N--CA 1.491 1.622 0 CA-C-O 121.398 0.618 . . . . 0.0 109.424 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 5.6 mp0 -70.75 158.77 87.23 Favored Pre-proline 0 C--N 1.302 -1.481 0 O-C-N 121.236 -0.915 . . . . 0.0 109.323 -179.461 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -51.06 144.27 28.95 Favored 'Trans proline' 0 N--CA 1.496 1.635 0 C-N-CA 122.009 1.806 . . . . 0.0 112.498 179.378 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 3.0 tm0? -75.49 70.33 2.34 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.561 -0.712 . . . . 0.0 109.115 179.744 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 72.0 mt -70.63 144.39 51.15 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.329 -0.857 . . . . 0.0 109.788 -179.539 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 64.7 m -124.87 133.04 53.23 Favored 'General case' 0 N--CA 1.497 1.887 0 N-CA-C 108.936 -0.765 . . . . 0.0 108.936 179.822 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 56.2 mtpt -76.02 152.02 37.02 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.318 -0.864 . . . . 0.0 110.573 -178.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 97.2 mt -63.29 -43.42 98.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.519 -0.738 . . . . 0.0 109.377 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 10.0 p -63.68 -24.39 35.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.351 -0.843 . . . . 0.0 109.667 -179.778 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -79.73 -3.82 49.19 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.018 -1.051 . . . . 0.0 109.793 -179.815 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 97.6 mt -80.88 119.16 29.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 120.92 -1.112 . . . . 0.0 109.795 -179.709 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 16.1 m -151.46 12.69 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 N-CA-C 108.947 -0.761 . . . . 0.0 108.947 179.328 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 50.7 tp10 -139.21 139.94 37.62 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.254 -0.904 . . . . 0.0 109.622 -179.829 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 48.8 p-10 -86.89 154.9 20.5 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.347 -0.845 . . . . 0.0 109.881 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 74.43 3.76 67.28 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 179.601 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 39.0 tt0 -71.24 128.61 36.49 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.168 -1.195 . . . . 0.0 109.68 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 88.9 m95 -98.51 138.74 35.28 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.394 -0.816 . . . . 0.0 109.601 -179.655 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -177.55 -178.77 0.77 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.333 -0.854 . . . . 0.0 109.726 179.52 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 80.5 m-20 -109.42 146.11 35.02 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.608 HD23 ' N ' ' A' ' 21' ' ' LYS . 6.2 tt -144.05 124.99 14.32 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.122 -0.986 . . . . 0.0 109.14 179.796 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.608 ' N ' HD23 ' A' ' 20' ' ' LEU . 36.4 ttpt -111.31 133.66 53.46 Favored 'General case' 0 N--CA 1.497 1.908 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 179.247 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -164.04 174.32 11.49 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.102 -0.999 . . . . 0.0 109.632 -179.749 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 16.8 ptpt -109.06 148.29 31.04 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.392 -0.818 . . . . 0.0 109.571 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.426 HG22 ' CD2' ' A' ' 41' ' ' LEU . 91.2 t -84.48 128.97 38.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.576 -0.703 . . . . 0.0 110.231 -179.167 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 97.0 mt -95.93 -53.58 8.04 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 N-CA-C 108.401 -0.962 . . . . 0.0 108.401 178.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 69.6 tp60 -149.24 145.21 26.99 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.307 -0.871 . . . . 0.0 109.495 179.443 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.832 ' H ' HD23 ' A' ' 27' ' ' LEU . 1.2 pt? -143.33 140.47 30.56 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 179.41 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 39.2 t90 -115.51 125.38 52.96 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 179.748 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.411 ' HG2' HE21 ' A' ' 37' ' ' GLN . 97.2 mt-10 -68.51 142.49 55.26 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.301 -0.875 . . . . 0.0 110.015 -179.703 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.442 HD21 HG21 ' A' ' 35' ' ' ILE . 13.3 p-10 -156.69 114.78 3.26 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.18 -0.95 . . . . 0.0 109.339 179.606 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.435 ' O ' ' OG1' ' A' ' 31' ' ' THR . 0.0 OUTLIER -100.33 61.28 1.05 Allowed 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.328 -0.858 . . . . 0.0 108.869 -179.856 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 45.8 t-80 -61.57 -49.15 77.8 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.111 -0.993 . . . . 0.0 109.304 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 7.4 tm-20 -174.09 -74.08 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.469 -0.769 . . . . 0.0 109.064 179.602 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 43.2 t -106.59 6.1 29.66 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.457 -0.777 . . . . 0.0 109.448 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.442 HG21 HD21 ' A' ' 30' ' ' ASN . 86.3 mt -102.96 128.74 55.59 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 O-C-N 121.271 -0.893 . . . . 0.0 109.593 -179.537 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 41.6 t -86.93 -69.64 0.67 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.482 -0.761 . . . . 0.0 109.993 -179.405 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . 0.411 HE21 ' HG2' ' A' ' 29' ' ' GLU . 97.7 mt-30 -133.43 154.27 50.92 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.298 -0.876 . . . . 0.0 109.656 -179.209 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 15.5 m -130.85 134.87 61.19 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 179.726 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.526 ' C ' HD13 ' A' ' 40' ' ' LEU . . . -168.49 -163.72 22.96 Favored Glycine 0 N--CA 1.486 2.008 0 C-N-CA 119.08 -1.533 . . . . 0.0 110.273 -179.329 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.894 ' N ' HD13 ' A' ' 40' ' ' LEU . 0.0 OUTLIER -131.93 161.69 32.46 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.914 -0.757 . . . . 0.0 109.37 179.863 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.426 ' CD2' HG22 ' A' ' 24' ' ' VAL . 69.3 mt -120.25 133.46 55.47 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.584 -0.698 . . . . 0.0 109.329 -179.351 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -85.86 141.13 18.42 Favored Glycine 0 N--CA 1.492 2.427 0 N-CA-C 110.01 -1.236 . . . . 0.0 110.01 -179.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 44.0 t0 -151.26 163.73 38.23 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.443 -1.034 . . . . 0.0 109.922 179.826 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -64.21 -20.62 66.16 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.549 -0.719 . . . . 0.0 109.923 -179.841 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 44.7 p -92.32 -12.23 33.0 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 120.982 -1.074 . . . . 0.0 110.404 -179.283 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 144.81 -155.39 26.4 Favored Glycine 0 N--CA 1.497 2.75 0 C-N-CA 119.916 -1.135 . . . . 0.0 110.281 179.535 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 91.3 mt -125.59 137.18 58.51 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.975 0 O-C-N 121.802 -0.822 . . . . 0.0 108.811 -179.668 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 17.5 tt -129.4 150.05 34.24 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.232 0 O-C-N 121.452 -0.78 . . . . 0.0 110.342 -179.571 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.661 ' NZ ' HH22 ' A' ' 80' ' ' ARG . 14.7 mptt -83.81 151.97 24.88 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.654 -0.654 . . . . 0.0 109.812 -179.695 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 25.2 p90 -143.28 148.47 36.4 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.221 -0.924 . . . . 0.0 108.803 179.072 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 97.4 m -131.57 129.92 41.57 Favored 'General case' 0 N--CA 1.496 1.828 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 179.428 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 88.3 mt -98.07 127.8 50.13 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 O-C-N 121.311 -0.868 . . . . 0.0 110.158 -179.601 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 82.7 m95 -80.35 120.71 24.76 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 178.778 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.439 ' C ' ' H ' ' A' ' 56' ' ' ALA . 73.1 tttt -61.38 -34.34 75.18 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.297 -0.877 . . . . 0.0 108.745 -179.139 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 29.3 t-20 -55.85 -7.55 0.32 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.365 -0.834 . . . . 0.0 109.386 179.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.439 ' H ' ' C ' ' A' ' 54' ' ' LYS . . . -88.1 -25.14 23.17 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.062 -1.024 . . . . 0.0 108.716 179.147 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 51.75 49.6 20.46 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.389 -0.819 . . . . 0.0 110.068 179.578 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 63.9 mt -102.84 152.95 38.54 Favored Pre-proline 0 N--CA 1.498 1.947 0 O-C-N 121.244 -0.91 . . . . 0.0 109.323 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -51.8 146.17 28.96 Favored 'Trans proline' 0 N--CA 1.501 1.937 0 C-N-CA 121.904 1.736 . . . . 0.0 112.766 179.415 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 77.4 mt -71.74 141.89 49.77 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.257 -0.902 . . . . 0.0 109.911 -179.837 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.565 ' N ' HD12 ' A' ' 61' ' ' LEU . 10.5 mp -79.19 146.38 33.13 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.472 -0.767 . . . . 0.0 109.976 -179.289 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 51.4 tp10 -88.17 147.62 24.79 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.268 -0.895 . . . . 0.0 109.538 -179.577 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.531 ' OE1' ' N ' ' A' ' 64' ' ' GLY . 0.2 OUTLIER -81.71 126.26 31.58 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.276 -0.89 . . . . 0.0 110.093 -179.743 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.531 ' N ' ' OE1' ' A' ' 63' ' ' GLN . . . 86.32 32.22 17.25 Favored Glycine 0 N--CA 1.495 2.628 0 N-CA-C 110.423 -1.071 . . . . 0.0 110.423 179.178 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -137.23 147.85 46.07 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.126 -1.22 . . . . 0.0 109.91 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 14.4 m -78.51 143.34 36.68 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.7 -0.625 . . . . 0.0 109.788 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 51.0 m-85 -139.71 141.37 36.93 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.492 -0.755 . . . . 0.0 109.501 179.27 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.511 HD21 ' NE ' ' A' ' 70' ' ' ARG . 15.1 tp -103.72 120.03 40.12 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 107.964 -1.124 . . . . 0.0 107.964 178.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 75.7 mt -105.85 129.38 54.03 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 -179.844 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.511 ' NE ' HD21 ' A' ' 68' ' ' LEU . 99.6 mtt180 -125.54 143.71 50.89 Favored 'General case' 0 N--CA 1.503 2.225 0 O-C-N 121.413 -0.804 . . . . 0.0 111.141 -179.181 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.6 m 61.82 46.1 7.16 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.916 -0.49 . . . . 0.0 110.714 179.124 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 8.0 m -99.3 162.05 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.978 0 O-C-N 121.016 -1.052 . . . . 0.0 109.139 179.133 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 7.5 p -122.52 139.5 49.22 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 -179.788 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 63.8 t -89.33 115.25 28.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.237 -0.914 . . . . 0.0 109.612 -179.444 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -99.56 151.4 19.31 Favored Glycine 0 N--CA 1.499 2.842 0 N-CA-C 109.79 -1.324 . . . . 0.0 109.79 -179.834 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -68.46 137.19 54.25 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.338 -1.095 . . . . 0.0 110.072 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . 0.51 ' O ' ' N ' ' A' ' 79' ' ' ASP . 42.1 t80 -131.06 126.25 35.34 Favored 'General case' 0 N--CA 1.497 1.917 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 179.385 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.436 ' C ' ' O ' ' A' ' 77' ' ' TYR . 9.1 m120 -35.35 -30.29 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.047 0 CA-C-O 121.115 0.483 . . . . 0.0 110.469 -179.058 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.51 ' N ' ' O ' ' A' ' 77' ' ' TYR . 96.7 m-20 -113.37 67.9 0.67 Allowed 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.594 -0.691 . . . . 0.0 109.942 179.48 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.661 HH22 ' NZ ' ' A' ' 49' ' ' LYS . 83.8 mtm180 85.62 -159.29 0.01 OUTLIER 'General case' 0 N--CA 1.508 2.473 0 CA-C-O 121.384 0.612 . . . . 0.0 110.514 178.262 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -103.52 151.89 22.33 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.526 -0.734 . . . . 0.0 109.519 -179.091 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -136.57 166.47 23.45 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.382 -0.824 . . . . 0.0 109.284 -179.63 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.446 ' O ' HG23 ' A' ' 83' ' ' VAL . 18.8 m -105.89 130.49 57.32 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 179.827 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 87.5 mt-30 -106.45 131.18 53.94 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.429 -0.794 . . . . 0.0 110.49 -178.704 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 19.5 t -91.83 131.34 39.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 N-CA-C 109.006 -0.738 . . . . 0.0 109.006 179.449 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 99.9 m-20 -126.34 175.45 7.83 Favored 'General case' 0 N--CA 1.501 2.091 0 CA-C-O 121.79 0.805 . . . . 0.0 110.277 -179.459 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 63.8 tttm -56.64 -44.02 80.86 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.636 -0.665 . . . . 0.0 110.495 -179.57 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 10.4 m120 -63.77 -33.38 75.54 Favored 'General case' 0 C--N 1.297 -1.716 0 O-C-N 121.088 -1.007 . . . . 0.0 110.359 -179.207 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 59.8 m -60.66 147.44 41.98 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.987 -1.071 . . . . 0.0 110.786 -178.656 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 7.0 m -113.27 149.18 34.22 Favored 'General case' 0 N--CA 1.499 2.005 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 179.618 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 96.6 mt -131.35 131.47 63.18 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.041 0 O-C-N 121.44 -0.787 . . . . 0.0 109.597 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -133.01 133.46 43.15 Favored 'General case' 0 N--CA 1.501 2.095 0 O-C-N 121.386 -0.821 . . . . 0.0 108.921 178.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -82.58 124.75 30.43 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.34 -0.85 . . . . 0.0 109.185 -179.835 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.456 ' N ' HD22 ' A' ' 94' ' ' LEU . 4.1 mm? -96.87 137.01 36.6 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.273 -0.892 . . . . 0.0 109.93 -179.322 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 93.7 p -82.4 -5.3 58.56 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 179.697 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -103.13 109.91 62.55 Favored Pre-proline 0 N--CA 1.497 1.881 0 O-C-N 121.37 -0.831 . . . . 0.0 109.421 -179.389 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -74.9 159.45 41.66 Favored 'Trans proline' 0 N--CA 1.494 1.503 0 C-N-CA 121.835 1.69 . . . . 0.0 112.082 -179.307 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 96.8 mt -99.17 126.8 52.36 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 O-C-N 121.241 -0.912 . . . . 0.0 109.609 -179.741 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -78.22 122.15 25.31 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.506 -0.746 . . . . 0.0 109.886 -179.574 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 5.5 t -106.97 -12.73 10.1 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.994 0 O-C-N 121.5 -0.75 . . . . 0.0 109.205 179.818 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 144.32 60.01 0.02 OUTLIER Glycine 0 N--CA 1.496 2.645 0 N-CA-C 109.676 -1.37 . . . . 0.0 109.676 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 45.8 tp -62.89 -43.92 97.49 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.903 -1.351 . . . . 0.0 109.513 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . 0.465 ' O ' ' N ' ' A' ' 105' ' ' HIS . 80.9 tt0 -93.03 114.72 27.35 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.103 -0.998 . . . . 0.0 109.874 -179.832 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . 0.404 ' C ' ' O ' ' A' ' 103' ' ' GLU . 86.3 t60 40.8 -94.76 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.582 -0.699 . . . . 0.0 110.538 179.643 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . 0.465 ' N ' ' O ' ' A' ' 103' ' ' GLU . 84.0 m-70 -152.03 167.47 28.34 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.066 -1.021 . . . . 0.0 110.111 -179.911 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' HIS . . . . . 0.483 ' ND1' ' N ' ' A' ' 107' ' ' HIS . 63.6 t-80 -60.06 165.12 3.52 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.511 -0.743 . . . . 0.0 110.781 -179.133 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . 0.483 ' N ' ' ND1' ' A' ' 106' ' ' HIS . 85.3 t60 50.09 16.56 0.25 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.485 -0.759 . . . . 0.0 109.475 -179.833 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . 0.409 ' C ' ' O ' ' A' ' 107' ' ' HIS . 97.4 m-70 40.64 -124.49 0.47 Allowed 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.62 -0.675 . . . . 0.0 110.484 179.483 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 85.5 t60 . . . . . 0 N--CA 1.489 1.504 0 CA-C-O 118.085 -0.96 . . . . 0.0 109.166 -179.936 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 97.0 mmm . . . . . 0 N--CA 1.491 1.595 0 CA-C-O 121.593 0.711 . . . . 0.0 109.882 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -176.01 77.28 0.28 Allowed Pre-proline 0 N--CA 1.493 1.722 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 21.5 Cg_exo -62.54 148.4 93.39 Favored 'Trans proline' 0 N--CA 1.493 1.445 0 C-N-CA 122.936 2.424 . . . . 0.0 112.049 179.778 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 78.7 mt-30 -88.98 79.96 7.17 Favored 'General case' 0 N--CA 1.489 1.511 0 CA-C-O 121.915 0.864 . . . . 0.0 109.417 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -59.68 133.41 56.07 Favored 'General case' 0 N--CA 1.489 1.501 0 CA-C-O 121.829 0.823 . . . . 0.0 109.762 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 97.1 m -128.28 128.48 44.72 Favored 'General case' 0 N--CA 1.491 1.577 0 CA-C-O 121.852 0.834 . . . . 0.0 109.361 179.796 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -90.85 154.4 19.52 Favored 'General case' 0 C--N 1.301 -1.527 0 CA-C-O 121.768 0.794 . . . . 0.0 109.818 -179.592 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 66.3 mt -63.2 -43.84 99.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.699 -0.626 . . . . 0.0 109.708 -179.39 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 12.4 p -65.07 -22.4 31.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.47 -0.769 . . . . 0.0 109.807 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 96.5 m-20 -80.99 -2.63 48.67 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.385 -0.822 . . . . 0.0 109.611 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 97.6 mt -85.51 112.04 21.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.426 -0.796 . . . . 0.0 109.958 -179.743 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 22.3 m -135.73 -2.79 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 179.318 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -140.39 143.85 35.9 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.479 -0.763 . . . . 0.0 109.941 179.885 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 52.2 p30 -90.66 161.15 15.51 Favored 'General case' 0 N--CA 1.492 1.672 0 CA-C-O 121.872 0.844 . . . . 0.0 110.495 -179.704 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 79.63 15.89 78.69 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.289 -1.524 . . . . 0.0 109.289 -179.814 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 52.5 tt0 -81.54 132.5 35.31 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.477 -1.013 . . . . 0.0 110.195 -179.286 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 76.9 m95 -106.31 132.99 51.7 Favored 'General case' 0 N--CA 1.495 1.786 0 CA-C-O 121.451 0.643 . . . . 0.0 109.465 179.705 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 179.71 -172.64 0.19 Allowed 'General case' 0 N--CA 1.491 1.619 0 CA-C-O 121.745 0.783 . . . . 0.0 109.962 179.806 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.547 ' OD1' HD11 ' A' ' 68' ' ' LEU . 0.4 OUTLIER -100.18 152.34 20.37 Favored 'General case' 0 N--CA 1.493 1.701 0 CA-C-O 121.544 0.688 . . . . 0.0 109.73 -179.956 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.54 ' N ' ' ND2' ' A' ' 19' ' ' ASN . 7.2 tp -135.84 129.73 32.84 Favored 'General case' 0 N--CA 1.49 1.573 0 CA-C-O 121.745 0.783 . . . . 0.0 110.057 -179.916 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 38.3 ttmt -119.53 132.83 55.84 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 179.602 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -165.09 178.25 7.15 Favored 'General case' 0 N--CA 1.495 1.789 0 C-N-CA 119.331 -0.947 . . . . 0.0 110.809 -179.542 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 65.1 tttm -112.11 143.45 43.13 Favored 'General case' 0 N--CA 1.496 1.873 0 CA-C-O 121.713 0.768 . . . . 0.0 110.059 -179.676 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.542 ' CG1' HD22 ' A' ' 27' ' ' LEU . 91.4 t -84.96 122.42 38.14 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 CA-C-O 121.884 0.849 . . . . 0.0 110.513 -179.046 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.506 ' C ' HE21 ' A' ' 63' ' ' GLN . 23.8 mm -100.66 -48.91 11.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 178.755 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 69.3 tp60 -149.3 144.15 26.28 Favored 'General case' 0 N--CA 1.488 1.454 0 CA-C-O 121.71 0.767 . . . . 0.0 109.816 179.461 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.879 ' N ' HD23 ' A' ' 27' ' ' LEU . 0.4 OUTLIER -141.71 136.42 30.79 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 179.866 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 3.7 m-90 -115.14 122.49 46.25 Favored 'General case' 0 N--CA 1.496 1.851 0 CA-C-O 121.838 0.828 . . . . 0.0 109.618 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 49.6 tp10 -62.3 140.47 58.5 Favored 'General case' 0 N--CA 1.491 1.602 0 CA-C-O 121.541 0.686 . . . . 0.0 110.047 -179.369 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.716 HD21 ' CD2' ' A' ' 32' ' ' HIS . 7.2 t30 -132.54 124.57 28.7 Favored 'General case' 0 N--CA 1.494 1.765 0 CA-C-O 121.481 0.657 . . . . 0.0 109.625 179.863 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 17.2 p -121.86 51.51 1.33 Allowed 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 108.55 -0.908 . . . . 0.0 108.55 179.566 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . 0.716 ' CD2' HD21 ' A' ' 30' ' ' ASN . 13.0 m-70 -92.58 8.18 40.08 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 109.249 -0.648 . . . . 0.0 109.249 179.894 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 24.1 tp10 69.48 -13.25 0.39 Allowed 'General case' 0 N--CA 1.49 1.567 0 CA-C-O 121.325 0.583 . . . . 0.0 109.463 -179.827 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.498 ' H ' ' C ' ' A' ' 32' ' ' HIS . 32.2 t -106.6 -34.94 7.19 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.498 -0.751 . . . . 0.0 109.632 179.713 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 96.6 mt -125.09 123.6 65.75 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.129 0 O-C-N 121.27 -0.894 . . . . 0.0 109.538 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 5.8 t -68.81 -51.64 38.64 Favored 'General case' 0 N--CA 1.494 1.728 0 CA-C-O 121.523 0.677 . . . . 0.0 109.435 179.667 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . 0.446 HE22 HD12 ' A' ' 27' ' ' LEU . 51.0 tt0 -157.53 153.3 26.77 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.515 -0.74 . . . . 0.0 109.69 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.7 p -142.99 145.7 22.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 179.653 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -175.17 -157.94 17.83 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.781 -1.327 . . . . 0.0 109.781 -179.589 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.9 pp -135.39 149.44 49.65 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.891 -0.77 . . . . 0.0 110.432 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 69.4 mt -117.24 132.13 56.69 Favored 'General case' 0 N--CA 1.498 1.933 0 CA-C-O 121.817 0.818 . . . . 0.0 109.647 -179.469 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -80.58 162.41 45.36 Favored Glycine 0 N--CA 1.488 2.147 0 N-CA-C 110.859 -0.896 . . . . 0.0 110.859 -179.577 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.531 ' OD1' ' N ' ' A' ' 44' ' ' GLU . 67.5 t0 -170.02 144.37 2.69 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.531 ' N ' ' OD1' ' A' ' 43' ' ' ASP . 19.1 pt-20 -59.84 -16.16 26.49 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.617 -0.677 . . . . 0.0 109.693 -179.788 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 36.2 p -91.25 -7.91 49.88 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 179.638 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 139.24 -153.61 22.98 Favored Glycine 0 N--CA 1.496 2.635 0 N-CA-C 109.81 -1.316 . . . . 0.0 109.81 179.414 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 36.1 pt -127.94 148.34 32.54 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.875 0 O-C-N 121.881 -0.776 . . . . 0.0 109.543 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 18.1 tt -141.69 138.58 31.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 CA-C-O 121.743 0.782 . . . . 0.0 110.034 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 68.9 mttm -83.75 156.86 22.34 Favored 'General case' 0 N--CA 1.49 1.545 0 CA-C-O 121.46 0.648 . . . . 0.0 109.981 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 28.2 p90 -148.62 150.44 33.27 Favored 'General case' 0 N--CA 1.491 1.599 0 CA-C-O 121.769 0.795 . . . . 0.0 109.991 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 97.8 m -130.24 129.81 43.81 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 179.575 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 92.8 mt -103.18 125.7 57.6 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 CA-C-O 121.904 0.859 . . . . 0.0 110.221 -179.423 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 96.6 m95 -86.71 142.13 28.41 Favored 'General case' 0 N--CA 1.49 1.556 0 CA-C-O 121.78 0.8 . . . . 0.0 109.881 -179.802 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 25.9 mtpp -66.49 -12.69 58.69 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.655 -0.653 . . . . 0.0 109.434 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 -64.35 -38.62 91.69 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.598 -0.689 . . . . 0.0 109.865 179.729 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -63.19 -37.03 85.63 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.402 -0.811 . . . . 0.0 109.661 -179.668 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 57.31 47.15 17.25 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 32.4 mt -108.91 153.66 42.31 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.829 -0.544 . . . . 0.0 109.677 -179.814 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -55.89 147.75 60.69 Favored 'Trans proline' 0 N--CA 1.5 1.87 0 C-N-CA 123.067 2.511 . . . . 0.0 113.602 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 78.1 mt -70.74 144.27 50.99 Favored 'General case' 0 N--CA 1.492 1.631 0 CA-C-O 122.021 0.915 . . . . 0.0 110.479 -179.644 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.572 ' N ' HD12 ' A' ' 61' ' ' LEU . 10.0 mp -77.33 147.28 36.26 Favored 'General case' 0 N--CA 1.49 1.538 0 CA-C-O 121.733 0.778 . . . . 0.0 109.827 -179.899 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -88.64 155.9 19.34 Favored 'General case' 0 N--CA 1.492 1.643 0 CA-C-O 121.968 0.89 . . . . 0.0 110.109 -179.755 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.506 HE21 ' C ' ' A' ' 25' ' ' ILE . 6.8 tm0? -83.52 136.16 34.37 Favored 'General case' 0 C--N 1.301 -1.536 0 CA-C-O 121.889 0.852 . . . . 0.0 110.838 -179.2 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.474 ' N ' ' CD ' ' A' ' 63' ' ' GLN . . . 82.18 0.99 90.25 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 110.003 -1.239 . . . . 0.0 110.003 179.145 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 -106.73 146.49 30.76 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.605 -0.938 . . . . 0.0 110.476 -179.513 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 6.1 m -86.25 148.38 25.66 Favored 'General case' 0 N--CA 1.489 1.496 0 CA-C-O 121.645 0.736 . . . . 0.0 109.98 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 65.1 m-85 -141.66 150.46 41.95 Favored 'General case' 0 N--CA 1.492 1.642 0 CA-C-O 122.016 0.912 . . . . 0.0 110.616 -179.709 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.547 HD11 ' OD1' ' A' ' 19' ' ' ASN . 31.5 tp -113.1 120.65 42.04 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.717 -0.845 . . . . 0.0 108.717 179.334 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 75.5 mt -102.04 126.87 49.08 Favored 'General case' 0 N--CA 1.491 1.612 0 CA-C-O 121.465 0.65 . . . . 0.0 109.376 -179.508 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.431 ' O ' ' CB ' ' A' ' 71' ' ' SER . 80.8 mtp180 -123.82 129.02 50.36 Favored 'General case' 0 N--CA 1.496 1.874 0 CA-C-O 121.714 0.768 . . . . 0.0 109.853 -179.697 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.431 ' CB ' ' O ' ' A' ' 70' ' ' ARG . 1.5 t 78.7 65.41 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.368 179.661 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 30.8 m -128.14 163.82 31.24 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 179.187 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 12.5 p -121.63 135.16 62.68 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 CA-C-O 121.72 0.771 . . . . 0.0 109.936 -179.524 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 12.5 t -89.94 114.83 28.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 CA-C-O 121.81 0.814 . . . . 0.0 109.482 -179.558 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -91.48 174.37 38.1 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 110.51 -1.036 . . . . 0.0 110.51 -179.292 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 82.8 tt0 -100.84 117.78 35.59 Favored 'General case' 0 N--CA 1.492 1.67 0 CA-C-O 121.997 0.903 . . . . 0.0 109.692 -179.725 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . 0.559 ' CD1' ' N ' ' A' ' 78' ' ' ASN . 27.2 t80 -101.53 162.75 12.67 Favored 'General case' 0 N--CA 1.493 1.71 0 CA-C-O 121.747 0.784 . . . . 0.0 109.854 -179.803 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.559 ' N ' ' CD1' ' A' ' 77' ' ' TYR . 24.3 t-20 -53.19 104.37 0.09 Allowed 'General case' 0 N--CA 1.494 1.749 0 CA-C-O 122.323 1.059 . . . . 0.0 110.63 -179.182 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 43.1 t0 57.66 16.69 3.58 Favored 'General case' 0 N--CA 1.492 1.646 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.372 179.747 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 78.1 mtp85 -148.78 -167.51 2.84 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.182 -0.949 . . . . 0.0 110.087 179.587 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 80.4 m-85 -127.94 151.24 49.34 Favored 'General case' 0 N--CA 1.495 1.807 0 CA-C-O 121.654 0.74 . . . . 0.0 109.64 -179.713 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 49.0 tt0 -145.22 153.12 41.0 Favored 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 13.6 m -113.1 130.72 66.48 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 179.423 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 78.8 mt-30 -111.68 129.93 55.94 Favored 'General case' 0 N--CA 1.496 1.866 0 CA-C-O 121.658 0.742 . . . . 0.0 110.411 -178.678 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 3.0 t -103.34 119.01 51.24 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 CA-C-O 121.596 0.712 . . . . 0.0 109.727 179.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.562 HD22 ' N ' ' A' ' 86' ' ' ASN . 0.0 OUTLIER -147.01 -166.9 2.63 Favored 'General case' 0 N--CA 1.493 1.722 0 CA-C-O 121.714 0.769 . . . . 0.0 109.872 -179.411 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 38.1 ttmt 59.34 -89.13 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.654 0 CA-C-O 121.432 0.634 . . . . 0.0 110.52 -179.772 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 26.5 t-20 -169.96 46.62 0.03 OUTLIER 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 108.731 -0.841 . . . . 0.0 108.731 -179.216 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 34.9 t -55.56 136.19 50.33 Favored 'General case' 0 N--CA 1.496 1.873 0 CA-C-O 121.767 0.794 . . . . 0.0 109.709 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 1.4 t -79.55 140.83 37.09 Favored 'General case' 0 N--CA 1.491 1.584 0 CA-C-O 121.614 0.721 . . . . 0.0 110.338 -179.316 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 97.4 mt -128.46 130.67 69.19 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 121.836 -0.54 . . . . 0.0 109.586 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 47.7 tp10 -127.73 130.76 49.35 Favored 'General case' 0 N--CA 1.495 1.817 0 CA-C-O 121.827 0.822 . . . . 0.0 109.235 179.752 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 65.7 tttm -81.43 132.36 35.32 Favored 'General case' 0 N--CA 1.49 1.552 0 CA-C-O 121.856 0.836 . . . . 0.0 110.416 -179.385 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 65.8 mt -103.26 131.07 50.61 Favored 'General case' 0 N--CA 1.492 1.663 0 CA-C-O 121.703 0.763 . . . . 0.0 109.545 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 10.1 t -83.52 6.58 19.93 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 179.775 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 33.5 mm-40 -118.04 90.61 37.74 Favored Pre-proline 0 N--CA 1.499 2.024 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 179.308 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_exo -56.22 147.57 65.35 Favored 'Trans proline' 0 N--CA 1.494 1.552 0 C-N-CA 122.886 2.39 . . . . 0.0 112.516 179.739 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 93.9 mt -99.41 127.24 52.36 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 CA-C-O 121.885 0.85 . . . . 0.0 110.06 -179.497 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . 0.618 ' CD ' ' H ' ' A' ' 99' ' ' GLU . 0.9 OUTLIER -90.83 138.02 31.91 Favored 'General case' 0 C--N 1.301 -1.516 0 CA-C-O 121.496 0.665 . . . . 0.0 109.41 -179.935 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 25.2 m -105.55 -15.36 8.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 179.727 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -93.06 97.91 2.32 Favored Glycine 0 N--CA 1.497 2.726 0 N-CA-C 109.831 -1.308 . . . . 0.0 109.831 179.662 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.61 HD22 ' N ' ' A' ' 102' ' ' LEU . 3.7 mm? -89.11 -6.41 57.06 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.581 -0.952 . . . . 0.0 109.244 -179.907 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 52.7 38.87 27.34 Favored 'General case' 0 N--CA 1.489 1.485 0 CA-C-O 121.726 0.774 . . . . 0.0 109.175 179.577 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 30.6 t-80 -69.33 134.68 49.39 Favored 'General case' 0 N--CA 1.496 1.87 0 CA-C-O 121.873 0.844 . . . . 0.0 110.693 -179.153 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 86.4 t60 -66.39 -42.82 87.32 Favored 'General case' 0 N--CA 1.493 1.678 0 CA-C-O 121.393 0.616 . . . . 0.0 109.823 179.77 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 86.4 t60 -61.28 -44.22 97.58 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.528 -0.732 . . . . 0.0 109.835 -179.845 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 61.4 t-80 -126.37 128.54 47.21 Favored 'General case' 0 N--CA 1.497 1.896 0 CA-C-O 121.658 0.742 . . . . 0.0 109.798 -179.585 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . 0.434 ' C ' ' HD1' ' A' ' 108' ' ' HIS . 2.0 p80 -152.02 164.13 37.86 Favored 'General case' 0 N--CA 1.492 1.674 0 CA-C-O 121.491 0.662 . . . . 0.0 109.702 -179.882 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.492 1.636 0 CA-C-O 118.063 -0.97 . . . . 0.0 109.29 179.874 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 67.1 mtt . . . . . 0 N--CA 1.49 1.538 0 CA-C-O 121.662 0.744 . . . . 0.0 109.0 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.644 ' N ' ' CD ' ' A' ' 3' ' ' PRO . 1.7 mt-10 -74.03 -38.08 3.56 Favored Pre-proline 0 N--CA 1.495 1.809 0 O-C-N 121.564 -0.71 . . . . 0.0 110.126 179.811 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.644 ' CD ' ' N ' ' A' ' 2' ' ' GLU . 52.3 Cg_exo -58.06 145.46 91.85 Favored 'Trans proline' 0 N--CA 1.494 1.518 0 C-N-CA 122.616 2.211 . . . . 0.0 112.8 -179.19 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 27.6 mp0 -89.7 69.26 7.7 Favored 'General case' 0 N--CA 1.489 1.515 0 CA-C-O 121.844 0.83 . . . . 0.0 109.094 -179.827 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 71.9 mt -65.69 139.87 58.42 Favored 'General case' 0 N--CA 1.492 1.634 0 CA-C-O 121.63 0.728 . . . . 0.0 110.34 -179.422 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 92.3 m -128.83 132.15 47.77 Favored 'General case' 0 N--CA 1.493 1.693 0 CA-C-O 121.606 0.717 . . . . 0.0 109.576 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -75.35 146.86 40.55 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.461 -0.775 . . . . 0.0 109.998 -179.74 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 96.5 mt -63.84 -43.09 97.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.554 -0.716 . . . . 0.0 110.449 -179.563 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 13.2 p -62.06 -22.73 29.68 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.129 -0.982 . . . . 0.0 109.547 -179.783 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 51.7 t0 -76.17 -5.81 48.42 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.301 -0.874 . . . . 0.0 109.61 179.831 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 96.6 mt -82.4 119.32 31.71 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.038 -1.039 . . . . 0.0 110.23 -179.81 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 3.3 m -151.11 14.53 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 N-CA-C 108.582 -0.895 . . . . 0.0 108.582 179.65 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -138.04 145.24 41.58 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.419 -0.801 . . . . 0.0 110.019 -179.859 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 -82.78 144.39 30.19 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-O 121.682 0.753 . . . . 0.0 110.459 -179.796 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 65.99 110.9 0.01 OUTLIER Glycine 0 N--CA 1.491 2.331 0 N-CA-C 110.617 -0.993 . . . . 0.0 110.617 179.136 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 8.5 tt0 -169.47 130.26 1.08 Allowed 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.306 -1.114 . . . . 0.0 109.505 179.226 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 98.7 m95 -93.82 129.94 40.02 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.663 -0.648 . . . . 0.0 109.897 -179.668 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -175.59 171.53 2.76 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.535 -0.728 . . . . 0.0 109.695 179.749 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 67.0 m-20 -103.56 143.55 32.59 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.566 -0.709 . . . . 0.0 109.546 -179.679 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 5.0 mp -138.56 145.59 40.83 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.367 -0.833 . . . . 0.0 109.974 -179.856 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 33.9 ttmt -119.71 136.08 54.57 Favored 'General case' 0 N--CA 1.494 1.737 0 CA-C-O 121.481 0.658 . . . . 0.0 109.713 179.718 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -166.2 166.9 16.62 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 119.785 -0.766 . . . . 0.0 109.813 179.754 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 38.3 ttmt -105.5 142.01 36.0 Favored 'General case' 0 N--CA 1.492 1.641 0 CA-C-O 121.761 0.791 . . . . 0.0 109.987 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 58.8 t -81.19 127.04 39.88 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.362 0 CA-C-O 121.805 0.812 . . . . 0.0 110.292 -179.694 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 96.5 mt -97.42 -66.53 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 121.645 -0.659 . . . . 0.0 109.311 179.387 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.6 ' NE2' ' NE2' ' A' ' 63' ' ' GLN . 85.0 mm-40 -144.04 143.76 31.33 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.291 -0.881 . . . . 0.0 110.435 -179.766 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.553 ' O ' HD12 ' A' ' 27' ' ' LEU . 0.3 OUTLIER -143.17 139.68 30.44 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 -179.713 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 3.5 m-90 -114.92 149.92 36.48 Favored 'General case' 0 N--CA 1.494 1.739 0 CA-C-O 121.811 0.815 . . . . 0.0 109.889 179.803 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -63.66 138.06 58.34 Favored 'General case' 0 C--N 1.306 -1.326 0 CA-C-O 121.428 0.633 . . . . 0.0 110.046 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.542 HD22 ' CG2' ' A' ' 35' ' ' ILE . 66.3 t30 -120.57 -67.83 0.95 Allowed 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 179.603 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 44.5 p 47.4 19.87 0.15 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.389 -0.82 . . . . 0.0 109.008 -179.725 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . 0.437 ' N ' ' C ' ' A' ' 30' ' ' ASN . 84.2 t60 -63.45 -51.14 66.95 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.567 -0.708 . . . . 0.0 109.837 179.847 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.505 ' C ' ' H ' ' A' ' 35' ' ' ILE . 44.4 tt0 -174.25 117.71 0.23 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.371 -0.831 . . . . 0.0 109.88 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 14.2 t 55.54 1.91 0.06 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.88 -0.512 . . . . 0.0 110.226 179.812 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.542 ' CG2' HD22 ' A' ' 30' ' ' ASN . 96.7 mt -115.58 130.09 70.79 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 CA-C-O 121.823 0.82 . . . . 0.0 109.591 179.361 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 39.1 t -84.02 -68.91 0.68 Allowed 'General case' 0 C--N 1.302 -1.476 0 CA-C-O 121.518 0.675 . . . . 0.0 109.554 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . 0.503 ' OE1' HD22 ' A' ' 60' ' ' LEU . 25.3 mt-30 -137.43 160.98 37.55 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.406 -0.808 . . . . 0.0 109.997 -179.292 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 3.3 p -140.0 143.37 30.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -168.91 -152.61 7.84 Favored Glycine 0 N--CA 1.486 1.993 0 N-CA-C 110.02 -1.232 . . . . 0.0 110.02 -179.624 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.412 HD23 ' N ' ' A' ' 40' ' ' LEU . 0.2 OUTLIER -132.94 150.93 52.12 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.849 -0.794 . . . . 0.0 109.886 -179.707 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 65.7 mt -114.73 129.59 56.71 Favored 'General case' 0 N--CA 1.491 1.611 0 CA-C-O 121.814 0.816 . . . . 0.0 109.544 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -85.45 152.73 26.8 Favored Glycine 0 N--CA 1.488 2.145 0 N-CA-C 110.479 -1.048 . . . . 0.0 110.479 -179.536 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.53 ' OD1' ' N ' ' A' ' 44' ' ' GLU . 41.8 t0 -173.58 152.08 2.04 Favored 'General case' 0 C--N 1.306 -1.319 0 O-C-N 121.766 -0.844 . . . . 0.0 109.722 179.467 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.53 ' N ' ' OD1' ' A' ' 43' ' ' ASP . 82.7 tt0 -55.5 -16.71 4.12 Favored 'General case' 0 N--CA 1.492 1.657 0 CA-C-O 121.241 0.543 . . . . 0.0 110.65 -179.352 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 80.8 p -92.45 -0.94 57.3 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.813 -1.179 . . . . 0.0 109.373 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 126.02 -152.54 18.16 Favored Glycine 0 N--CA 1.499 2.848 0 N-CA-C 110.428 -1.069 . . . . 0.0 110.428 179.182 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 36.8 pt -126.24 151.99 33.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.807 -0.819 . . . . 0.0 109.202 -179.815 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 18.7 tt -147.95 151.0 13.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.217 -0.927 . . . . 0.0 110.067 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.456 ' HZ1' ' HE2' ' A' ' 77' ' ' TYR . 0.0 OUTLIER -85.75 147.64 26.23 Favored 'General case' 0 N--CA 1.489 1.519 0 CA-C-O 121.538 0.685 . . . . 0.0 110.123 -179.997 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 13.3 p90 -143.92 159.71 42.09 Favored 'General case' 0 N--CA 1.486 1.34 0 O-C-N 121.418 -0.801 . . . . 0.0 109.461 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 1.8 t -141.94 142.37 33.01 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 179.468 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 92.8 mt -105.37 122.6 58.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 CA-C-O 121.77 0.795 . . . . 0.0 109.966 -179.798 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 43.1 m95 -91.36 136.89 32.79 Favored 'General case' 0 N--CA 1.487 1.378 0 CA-C-O 121.504 0.669 . . . . 0.0 109.384 179.845 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 56.3 mtpt -70.29 -10.91 60.33 Favored 'General case' 0 N--CA 1.489 1.516 0 CA-C-O 121.708 0.766 . . . . 0.0 109.319 179.449 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 11.1 m120 -61.78 -40.94 96.95 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.563 -0.711 . . . . 0.0 109.769 -179.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -78.4 -11.36 59.94 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.231 -0.918 . . . . 0.0 109.284 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 55.06 63.77 2.01 Favored 'General case' 0 N--CA 1.494 1.727 0 CA-C-O 121.478 0.656 . . . . 0.0 109.749 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 32.8 mt -107.79 146.62 33.78 Favored Pre-proline 0 N--CA 1.495 1.803 0 O-C-N 121.718 -0.614 . . . . 0.0 109.837 -179.899 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -72.4 162.4 41.6 Favored 'Trans proline' 0 N--CA 1.494 1.547 0 C-N-CA 123.047 2.498 . . . . 0.0 112.775 179.598 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.503 HD22 ' OE1' ' A' ' 37' ' ' GLN . 69.1 mt -67.45 143.64 56.14 Favored 'General case' 0 N--CA 1.49 1.528 0 CA-C-O 121.876 0.846 . . . . 0.0 110.512 -179.498 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.572 ' N ' HD12 ' A' ' 61' ' ' LEU . 10.1 mp -91.7 137.13 32.61 Favored 'General case' 0 N--CA 1.491 1.577 0 CA-C-O 121.684 0.754 . . . . 0.0 110.262 -179.304 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.45 ' OE1' ' OE2' ' A' ' 65' ' ' GLU . 95.9 mt-10 -81.81 147.94 29.12 Favored 'General case' 0 N--CA 1.49 1.533 0 CA-C-O 121.817 0.818 . . . . 0.0 110.195 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.6 ' NE2' ' NE2' ' A' ' 26' ' ' GLN . 86.9 mt-30 -79.62 140.61 37.06 Favored 'General case' 0 N--CA 1.488 1.465 0 CA-C-O 121.789 0.804 . . . . 0.0 110.925 -179.324 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 79.39 35.21 30.16 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 110.3 -1.12 . . . . 0.0 110.3 179.304 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.45 ' OE2' ' OE1' ' A' ' 62' ' ' GLU . 91.5 mt-10 -140.95 143.76 34.73 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.206 -1.173 . . . . 0.0 110.134 179.647 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 89.5 p -81.63 143.46 31.91 Favored 'General case' 0 N--CA 1.486 1.365 0 CA-C-O 121.6 0.714 . . . . 0.0 110.217 -179.642 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 92.3 m-85 -138.41 142.12 39.56 Favored 'General case' 0 N--CA 1.489 1.479 0 CA-C-O 121.582 0.706 . . . . 0.0 110.025 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 31.8 tp -108.56 113.3 26.19 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 108.563 -0.902 . . . . 0.0 108.563 179.197 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.8 mp -99.77 131.26 45.86 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 -179.708 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 85.7 mtp180 -126.51 148.67 49.67 Favored 'General case' 0 N--CA 1.491 1.576 0 CA-C-O 121.584 0.707 . . . . 0.0 110.432 -179.553 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.592 ' CB ' HD21 ' A' ' 88' ' ' ASN . 8.6 t 59.22 55.09 4.47 Favored 'General case' 0 N--CA 1.491 1.582 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.355 179.55 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 15.7 m -113.67 160.79 12.98 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 O-C-N 121.586 -0.696 . . . . 0.0 109.249 179.163 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 9.9 p -114.07 134.66 56.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 CA-C-O 121.809 0.814 . . . . 0.0 110.179 -178.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 16.8 t -82.43 119.62 32.3 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.343 0 CA-C-O 121.702 0.763 . . . . 0.0 109.898 -179.726 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -93.68 170.69 31.12 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 110.231 -1.148 . . . . 0.0 110.231 -179.618 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 22.4 pt-20 -102.88 133.43 47.98 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.651 -0.911 . . . . 0.0 110.195 -179.674 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . 0.633 ' CD2' ' ND2' ' A' ' 78' ' ' ASN . 42.6 t80 -136.86 96.66 3.35 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 179.624 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.633 ' ND2' ' CD2' ' A' ' 77' ' ' TYR . 23.3 p30 42.2 -136.68 0.27 Allowed 'General case' 0 N--CA 1.495 1.799 0 CA-C-O 121.531 0.681 . . . . 0.0 111.417 -179.918 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.545 ' N ' ' OD1' ' A' ' 78' ' ' ASN . 97.6 m-20 -73.35 -6.28 45.13 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.433 -0.792 . . . . 0.0 109.689 -179.255 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.406 ' N ' ' OD1' ' A' ' 78' ' ' ASN . 88.6 mtm180 -110.34 -179.66 3.84 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.487 -0.758 . . . . 0.0 110.085 -179.661 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -129.84 154.55 47.16 Favored 'General case' 0 N--CA 1.493 1.707 0 CA-C-O 121.508 0.671 . . . . 0.0 109.597 -179.551 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 2.7 pt20 -139.73 162.28 35.49 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.526 -0.734 . . . . 0.0 109.808 -179.775 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.41 HG23 ' O ' ' A' ' 83' ' ' VAL . 13.5 m -111.54 131.82 61.82 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 179.847 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 -106.43 118.56 36.96 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.469 -0.769 . . . . 0.0 109.978 -179.253 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 10.2 t -90.02 99.46 9.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 179.646 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 1.4 p30 -151.15 -177.06 5.81 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.511 -0.743 . . . . 0.0 109.762 -179.526 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.427 ' CG ' ' H ' ' A' ' 88' ' ' ASN . 14.8 tptm 66.57 -130.62 0.18 Allowed 'General case' 0 N--CA 1.489 1.484 0 CA-C-O 121.624 0.726 . . . . 0.0 111.386 179.137 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . 0.592 HD21 ' CB ' ' A' ' 71' ' ' SER . 0.6 OUTLIER -90.41 19.96 4.85 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.531 -0.731 . . . . 0.0 109.273 -179.317 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 19.5 m -57.09 144.09 35.96 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.405 -0.809 . . . . 0.0 109.899 -179.669 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 44.4 m -129.6 153.02 48.49 Favored 'General case' 0 N--CA 1.493 1.676 0 CA-C-O 121.398 0.618 . . . . 0.0 109.427 -179.709 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 96.8 mt -131.69 134.86 59.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.64 -0.663 . . . . 0.0 109.505 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 73.8 mm-40 -128.74 136.23 50.28 Favored 'General case' 0 N--CA 1.494 1.747 0 CA-C-O 121.49 0.662 . . . . 0.0 109.31 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.412 ' C ' HD12 ' A' ' 94' ' ' LEU . 88.5 tttt -82.01 124.99 30.28 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.525 -0.734 . . . . 0.0 109.937 -179.636 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.417 HD12 ' N ' ' A' ' 94' ' ' LEU . 11.0 mp -103.67 131.35 50.9 Favored 'General case' 0 N--CA 1.493 1.695 0 CA-C-O 121.61 0.719 . . . . 0.0 109.47 179.84 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 39.1 t -80.48 -6.67 58.51 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.661 -0.65 . . . . 0.0 109.3 179.7 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -107.36 104.45 52.54 Favored Pre-proline 0 N--CA 1.495 1.811 0 O-C-N 121.422 -0.798 . . . . 0.0 109.457 -179.635 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -74.54 149.43 39.0 Favored 'Trans proline' 0 N--CA 1.491 1.372 0 C-N-CA 122.328 2.019 . . . . 0.0 112.833 -179.246 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.405 ' H ' HG12 ' A' ' 98' ' ' ILE . 14.9 pt -82.37 135.02 25.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 CA-C-O 121.82 0.819 . . . . 0.0 110.757 -179.401 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 81.2 tt0 -66.95 122.0 16.76 Favored 'General case' 0 N--CA 1.487 1.403 0 CA-C-O 121.752 0.787 . . . . 0.0 109.304 -179.792 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 16.1 m -108.22 -1.56 9.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 97.7 104.1 2.3 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.753 -1.339 . . . . 0.0 109.753 179.439 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 83.3 mt -90.34 -5.66 55.96 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.799 -0.824 . . . . 0.0 108.783 179.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . 0.419 ' O ' ' O ' ' A' ' 104' ' ' HIS . 72.2 mm-40 -60.36 -178.37 0.09 Allowed 'General case' 0 N--CA 1.492 1.675 0 CA-C-O 122.003 0.906 . . . . 0.0 111.443 -178.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . 0.425 ' CE1' ' NE2' ' A' ' 106' ' ' HIS . 50.4 t-80 53.62 108.37 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 CA-C-O 121.767 0.794 . . . . 0.0 110.404 179.82 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 22.7 p-80 -146.54 166.01 27.76 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.594 -0.691 . . . . 0.0 109.432 179.739 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' HIS . . . . . 0.425 ' NE2' ' CE1' ' A' ' 104' ' ' HIS . 99.3 m-70 -130.71 160.41 34.4 Favored 'General case' 0 N--CA 1.495 1.795 0 CA-C-O 121.724 0.773 . . . . 0.0 109.97 -179.559 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . 0.539 ' O ' ' N ' ' A' ' 109' ' ' HIS . 4.7 p80 -148.3 165.63 30.44 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.752 -0.593 . . . . 0.0 109.518 -179.81 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 85.7 t60 54.71 -81.34 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.765 -0.584 . . . . 0.0 110.37 -179.885 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . 0.539 ' N ' ' O ' ' A' ' 107' ' ' HIS . 75.7 m80 . . . . . 0 N--CA 1.493 1.684 0 CA-C-O 118.215 -0.898 . . . . 0.0 110.367 -179.505 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 67.7 mtt . . . . . 0 N--CA 1.489 1.49 0 CA-C-O 121.732 0.777 . . . . 0.0 109.208 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.435 ' N ' ' CD ' ' A' ' 3' ' ' PRO . 7.4 mp0 47.04 54.47 15.38 Favored Pre-proline 0 N--CA 1.494 1.729 0 O-C-N 121.906 -0.496 . . . . 0.0 110.034 -179.697 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.435 ' CD ' ' N ' ' A' ' 2' ' ' GLU . 19.9 Cg_endo -62.28 144.0 94.75 Favored 'Trans proline' 0 N--CA 1.495 1.587 0 C-N-CA 122.825 2.35 . . . . 0.0 112.752 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -86.6 88.89 7.75 Favored 'General case' 0 N--CA 1.488 1.463 0 CA-C-O 122.015 0.912 . . . . 0.0 109.487 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.411 HD22 ' N ' ' A' ' 5' ' ' LEU . 4.2 mm? -75.81 139.09 41.57 Favored 'General case' 0 N--CA 1.489 1.509 0 CA-C-O 121.608 0.718 . . . . 0.0 109.959 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 90.0 m -123.96 129.88 51.66 Favored 'General case' 0 N--CA 1.492 1.648 0 CA-C-O 121.643 0.735 . . . . 0.0 109.468 179.85 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 53.7 mtmt -80.08 153.91 28.44 Favored 'General case' 0 N--CA 1.489 1.485 0 CA-C-O 121.495 0.664 . . . . 0.0 110.374 -179.646 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 97.4 mt -62.71 -43.73 98.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 CA-C-O 121.627 0.727 . . . . 0.0 109.976 -179.837 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 13.0 p -65.45 -23.79 33.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.508 -0.745 . . . . 0.0 109.626 -179.676 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -78.81 -4.71 50.85 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.363 -0.836 . . . . 0.0 109.642 179.695 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 97.8 mt -82.23 118.8 30.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.174 -0.954 . . . . 0.0 109.672 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 3.1 m -146.89 6.88 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.565 -0.709 . . . . 0.0 109.275 -179.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 94.1 mt-10 -138.14 131.71 30.85 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.261 -0.9 . . . . 0.0 110.203 -179.457 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 51.5 p30 -83.78 153.15 24.26 Favored 'General case' 0 N--CA 1.488 1.438 0 CA-C-O 121.642 0.734 . . . . 0.0 110.442 -179.717 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 71.16 84.64 0.19 Allowed Glycine 0 N--CA 1.49 2.243 0 N-CA-C 110.084 -1.206 . . . . 0.0 110.084 179.577 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 27.3 tt0 -169.39 136.23 1.7 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.417 -1.049 . . . . 0.0 109.838 179.723 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 45.0 m95 -91.64 140.22 29.93 Favored 'General case' 0 N--CA 1.489 1.523 0 CA-C-O 121.567 0.698 . . . . 0.0 110.1 -179.83 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -168.51 170.39 9.73 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.559 -0.713 . . . . 0.0 109.561 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 62.8 m-80 -101.11 145.17 29.12 Favored 'General case' 0 N--CA 1.494 1.771 0 CA-C-O 121.624 0.726 . . . . 0.0 109.967 -179.458 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 51.9 tp -146.62 135.39 22.26 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.529 -0.732 . . . . 0.0 109.8 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 35.0 ttpt -120.3 137.12 54.43 Favored 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 179.312 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.418 ' CB ' ' OD1' ' A' ' 43' ' ' ASP . . . -160.65 172.52 16.98 Favored 'General case' 0 N--CA 1.492 1.659 0 C-N-CA 119.201 -1.0 . . . . 0.0 110.792 -179.377 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 33.0 ttpt -113.15 141.19 47.22 Favored 'General case' 0 N--CA 1.493 1.723 0 CA-C-O 121.583 0.706 . . . . 0.0 109.563 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 87.1 t -77.94 132.02 33.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.648 -0.658 . . . . 0.0 110.561 -179.172 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 30.2 pt -124.46 -30.08 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 179.004 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 68.6 tp60 -150.17 125.98 10.42 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.194 -0.941 . . . . 0.0 109.54 179.859 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.88 ' H ' HD23 ' A' ' 27' ' ' LEU . 1.1 pt? -138.96 135.67 34.6 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.707 -0.621 . . . . 0.0 109.978 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . 0.415 ' CE3' ' O ' ' A' ' 29' ' ' GLU . 81.9 t90 -126.84 123.78 38.11 Favored 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.415 ' O ' ' CE3' ' A' ' 28' ' ' TRP . 82.0 tt0 -59.87 138.89 57.69 Favored 'General case' 0 N--CA 1.49 1.568 0 CA-C-O 121.515 0.674 . . . . 0.0 110.046 -179.597 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.49 ' OD1' ' N ' ' A' ' 32' ' ' HIS . 19.0 t-20 -100.75 120.81 40.65 Favored 'General case' 0 N--CA 1.489 1.478 0 CA-C-O 121.566 0.698 . . . . 0.0 109.867 -179.914 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 60.3 p -94.77 0.87 55.3 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 179.722 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . 0.49 ' N ' ' OD1' ' A' ' 30' ' ' ASN . 99.6 m-70 -87.48 119.35 27.67 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.44 -0.787 . . . . 0.0 109.344 179.801 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.46 ' H ' ' CD ' ' A' ' 33' ' ' GLU . 58.0 mp0 -42.94 166.2 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.502 0 CA-C-O 121.682 0.753 . . . . 0.0 111.029 -179.472 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.439 ' CB ' ' O ' ' A' ' 33' ' ' GLU . 0.9 OUTLIER 75.16 -39.97 0.42 Allowed 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 109.573 -0.529 . . . . 0.0 109.573 -179.899 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.412 ' H ' ' C ' ' A' ' 33' ' ' GLU . 90.5 mt -108.92 119.11 57.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 CA-C-O 121.601 0.715 . . . . 0.0 110.054 -179.775 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 3.8 t -76.11 -50.91 13.38 Favored 'General case' 0 N--CA 1.489 1.519 0 CA-C-O 121.822 0.82 . . . . 0.0 109.635 179.489 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 49.2 tt0 -150.42 155.37 39.44 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.291 -0.881 . . . . 0.0 110.22 -179.604 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 8.2 p -142.65 139.8 28.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.678 -0.639 . . . . 0.0 109.414 179.416 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -171.99 -163.36 25.76 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.893 -1.283 . . . . 0.0 109.893 -179.77 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -134.71 148.1 50.23 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.552 -0.969 . . . . 0.0 109.85 -179.394 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 67.6 mt -112.95 137.99 50.5 Favored 'General case' 0 N--CA 1.493 1.688 0 CA-C-O 121.742 0.782 . . . . 0.0 109.564 -179.456 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.421 ' O ' ' OD1' ' A' ' 43' ' ' ASP . . . -83.24 143.86 22.2 Favored Glycine 0 N--CA 1.486 2.029 0 N-CA-C 110.779 -0.929 . . . . 0.0 110.779 -179.542 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.421 ' OD1' ' O ' ' A' ' 42' ' ' GLY . 75.2 m-20 -149.47 160.22 43.64 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.877 -0.778 . . . . 0.0 109.38 179.534 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 79.8 tt0 -65.58 -21.39 66.59 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.686 -0.634 . . . . 0.0 109.61 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 67.4 p -89.97 -2.78 58.21 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.327 -0.858 . . . . 0.0 109.514 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 133.15 -147.26 18.92 Favored Glycine 0 N--CA 1.497 2.705 0 N-CA-C 110.341 -1.104 . . . . 0.0 110.341 179.215 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 40.9 pt -125.66 152.62 32.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.901 -0.764 . . . . 0.0 109.741 -179.626 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 8.4 tp -142.5 140.12 28.68 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 CA-C-O 121.741 0.781 . . . . 0.0 110.059 -179.822 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 54.9 mtmt -87.88 145.94 25.81 Favored 'General case' 0 N--CA 1.49 1.545 0 CA-C-O 121.509 0.671 . . . . 0.0 110.004 179.854 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 38.9 p90 -137.57 153.05 50.01 Favored 'General case' 0 N--CA 1.49 1.545 0 CA-C-O 121.659 0.742 . . . . 0.0 109.783 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 83.6 m -129.86 130.97 45.91 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 96.6 mt -103.75 129.1 56.35 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 CA-C-O 121.702 0.763 . . . . 0.0 109.983 -179.773 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 89.7 m95 -90.63 129.6 36.74 Favored 'General case' 0 N--CA 1.487 1.404 0 CA-C-O 121.698 0.761 . . . . 0.0 109.273 179.457 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.41 ' HZ3' ' C ' ' A' ' 34' ' ' SER . 3.1 ptpp? -67.11 -13.78 62.27 Favored 'General case' 0 N--CA 1.489 1.477 0 CA-C-O 121.516 0.674 . . . . 0.0 109.939 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.574 ' OD1' ' N ' ' A' ' 56' ' ' ALA . 50.1 p-10 -63.7 -35.68 81.36 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.406 -0.809 . . . . 0.0 109.99 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.574 ' N ' ' OD1' ' A' ' 55' ' ' ASN . . . -77.74 -12.31 59.96 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.238 -0.914 . . . . 0.0 109.298 -179.896 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 52.49 56.61 7.42 Favored 'General case' 0 N--CA 1.494 1.73 0 CA-C-O 121.447 0.641 . . . . 0.0 110.15 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 45.9 mt -101.75 146.65 32.62 Favored Pre-proline 0 N--CA 1.496 1.85 0 O-C-N 121.495 -0.753 . . . . 0.0 109.328 179.517 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -69.74 155.42 66.05 Favored 'Trans proline' 0 N--CA 1.497 1.716 0 C-N-CA 122.921 2.414 . . . . 0.0 113.283 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 75.2 mt -71.73 141.67 49.79 Favored 'General case' 0 N--CA 1.493 1.682 0 CA-C-O 121.852 0.834 . . . . 0.0 110.778 -179.27 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.572 ' N ' HD12 ' A' ' 61' ' ' LEU . 10.3 mp -80.29 143.76 33.38 Favored 'General case' 0 N--CA 1.491 1.586 0 CA-C-O 121.688 0.756 . . . . 0.0 110.065 -179.919 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -83.41 152.66 24.91 Favored 'General case' 0 N--CA 1.49 1.568 0 CA-C-O 121.941 0.876 . . . . 0.0 110.987 -179.478 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 58.5 tt0 -82.03 136.78 35.2 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-O 121.663 0.744 . . . . 0.0 110.754 -179.676 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 82.4 4.55 90.12 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 110.166 -1.174 . . . . 0.0 110.166 179.434 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -110.51 146.86 35.26 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.444 -1.033 . . . . 0.0 110.723 -179.581 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 19.1 p -84.97 152.44 23.47 Favored 'General case' 0 N--CA 1.487 1.42 0 CA-C-O 121.558 0.694 . . . . 0.0 110.2 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 74.4 m-85 -145.34 145.29 31.14 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.349 -0.845 . . . . 0.0 110.275 179.651 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 23.5 tp -108.01 121.14 44.2 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 108.96 -0.755 . . . . 0.0 108.96 179.395 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 68.4 mt -100.59 133.38 45.12 Favored 'General case' 0 N--CA 1.49 1.551 0 CA-C-O 121.256 0.55 . . . . 0.0 109.629 -179.614 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.453 ' O ' ' OG ' ' A' ' 71' ' ' SER . 80.5 mtp85 -129.28 142.05 50.94 Favored 'General case' 0 N--CA 1.493 1.698 0 CA-C-O 121.653 0.74 . . . . 0.0 110.161 -179.806 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.488 ' HG ' ' HA ' ' A' ' 89' ' ' SER . 3.3 p 53.44 60.96 3.36 Favored 'General case' 0 N--CA 1.493 1.697 0 CA-C-O 121.416 0.627 . . . . 0.0 110.405 -179.889 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 3.3 m -114.23 133.11 61.34 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 179.024 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 8.9 p -95.47 135.56 29.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 CA-C-O 121.582 0.706 . . . . 0.0 109.986 -179.258 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -93.23 124.99 45.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 CA-C-O 121.767 0.794 . . . . 0.0 109.695 -179.6 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -100.11 142.86 16.1 Favored Glycine 0 N--CA 1.493 2.446 0 N-CA-C 110.478 -1.049 . . . . 0.0 110.478 -179.618 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 17.5 pt-20 -59.14 138.7 57.46 Favored 'General case' 0 N--CA 1.49 1.566 0 CA-C-O 121.592 0.71 . . . . 0.0 110.082 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . 0.604 ' CG ' ' NE2' ' A' ' 82' ' ' GLN . 79.3 t80 -137.08 81.25 1.86 Allowed 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 179.446 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.502 ' C ' ' O ' ' A' ' 77' ' ' TYR . 28.8 t-20 15.15 -79.81 0.0 OUTLIER 'General case' 0 N--CA 1.51 2.533 0 CA-C-O 121.581 0.705 . . . . 0.0 112.146 -179.859 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.533 ' N ' ' O ' ' A' ' 77' ' ' TYR . 52.0 t0 -47.8 -69.94 0.11 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.433 -0.792 . . . . 0.0 109.893 -179.75 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 88.5 mtm180 -133.64 -130.44 0.17 Allowed 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.618 -0.677 . . . . 0.0 109.998 -178.895 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 88.4 m-85 -129.47 154.43 46.99 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.578 -0.701 . . . . 0.0 110.046 -178.796 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . 0.604 ' NE2' ' CG ' ' A' ' 77' ' ' TYR . 87.0 mt-30 -132.78 161.93 32.8 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.761 -0.587 . . . . 0.0 109.897 -179.703 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.43 ' O ' HG23 ' A' ' 83' ' ' VAL . 16.3 m -104.05 127.88 57.88 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 CA-C-O 121.61 0.719 . . . . 0.0 109.237 179.776 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 -106.39 126.45 52.26 Favored 'General case' 0 N--CA 1.494 1.74 0 CA-C-O 121.436 0.636 . . . . 0.0 109.793 -179.212 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 52.1 t -104.78 120.1 54.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 CA-C-O 121.581 0.705 . . . . 0.0 109.181 179.831 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.404 ' O ' ' O ' ' A' ' 87' ' ' LYS . 0.4 OUTLIER -147.9 -175.98 5.09 Favored 'General case' 0 N--CA 1.489 1.52 0 CA-C-O 121.388 0.613 . . . . 0.0 110.039 -179.38 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.481 ' O ' ' CB ' ' A' ' 88' ' ' ASN . 85.4 tttt -37.83 157.32 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.737 0 CA-C-O 121.535 0.683 . . . . 0.0 111.016 -179.442 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . 0.481 ' CB ' ' O ' ' A' ' 87' ' ' LYS . 0.2 OUTLIER 77.92 -28.88 0.16 Allowed 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 -179.725 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.488 ' HA ' ' HG ' ' A' ' 71' ' ' SER . 11.5 t -75.64 152.18 37.63 Favored 'General case' 0 N--CA 1.49 1.553 0 CA-C-O 121.557 0.694 . . . . 0.0 110.469 -179.696 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 32.1 t -132.54 141.68 48.84 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.553 -0.717 . . . . 0.0 109.702 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 96.4 mt -123.97 130.9 73.66 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 CA-C-O 121.273 0.559 . . . . 0.0 109.523 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -127.02 132.78 50.66 Favored 'General case' 0 N--CA 1.497 1.881 0 CA-C-O 121.621 0.724 . . . . 0.0 109.512 179.809 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.463 ' C ' HD12 ' A' ' 94' ' ' LEU . 88.2 tttt -81.22 127.49 32.74 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-O 121.617 0.723 . . . . 0.0 110.078 -179.533 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.463 HD12 ' C ' ' A' ' 93' ' ' LYS . 10.8 mp -103.51 131.85 50.27 Favored 'General case' 0 N--CA 1.495 1.784 0 CA-C-O 121.671 0.748 . . . . 0.0 110.09 -179.637 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 18.2 t -77.52 -6.05 52.22 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 179.284 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -102.25 110.36 62.46 Favored Pre-proline 0 N--CA 1.496 1.851 0 O-C-N 121.393 -0.817 . . . . 0.0 109.572 -179.75 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -75.78 152.02 36.74 Favored 'Trans proline' 0 N--CA 1.492 1.396 0 C-N-CA 122.795 2.33 . . . . 0.0 112.528 -178.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 56.3 mt -82.91 137.97 20.12 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 CA-C-O 121.951 0.882 . . . . 0.0 110.341 -179.589 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . 0.494 ' H ' ' CD ' ' A' ' 99' ' ' GLU . 58.6 mp0 -47.99 -81.01 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 CA-C-N 116.078 -0.51 . . . . 0.0 109.715 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.479 ' C ' ' O ' ' A' ' 99' ' ' GLU . 8.6 m 32.12 43.28 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.005 0 CA-C-O 121.837 0.827 . . . . 0.0 110.369 -179.314 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 175.6 56.97 0.06 OUTLIER Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.476 -1.45 . . . . 0.0 109.476 -179.855 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 86.3 mt -86.99 -7.95 57.66 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.285 -1.126 . . . . 0.0 109.066 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 46.07 46.64 12.84 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.333 -0.854 . . . . 0.0 109.703 179.513 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . 0.494 ' H ' ' CD2' ' A' ' 104' ' ' HIS . 6.8 p80 -60.4 88.66 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 CA-C-O 121.85 0.833 . . . . 0.0 109.87 -179.849 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 45.1 p-80 -85.74 -15.29 42.65 Favored 'General case' 0 N--CA 1.489 1.514 0 CA-C-O 121.531 0.681 . . . . 0.0 109.448 179.662 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' HIS . . . . . 0.48 ' CG ' ' O ' ' A' ' 106' ' ' HIS . 51.2 p-80 -92.24 100.47 13.06 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.391 -0.818 . . . . 0.0 109.514 -179.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 73.0 m80 -67.7 -42.86 81.36 Favored 'General case' 0 N--CA 1.492 1.634 0 CA-C-O 121.572 0.701 . . . . 0.0 109.684 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 46.8 p-80 -163.44 25.22 0.08 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.452 -0.78 . . . . 0.0 109.239 -179.747 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 53.9 p-80 . . . . . 0 N--CA 1.492 1.661 0 CA-C-O 118.084 -0.96 . . . . 0.0 109.352 179.893 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 97.5 mtp . . . . . 0 N--CA 1.489 1.508 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 26.4 mm-40 -78.6 148.18 72.74 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.666 -0.646 . . . . 0.0 110.074 -179.402 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -70.06 149.91 65.67 Favored 'Trans proline' 0 N--CA 1.493 1.487 0 C-N-CA 122.702 2.268 . . . . 0.0 112.297 179.631 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.587 ' CD ' ' H ' ' A' ' 4' ' ' GLN . 1.0 OUTLIER -76.44 90.78 3.27 Favored 'General case' 0 C--N 1.301 -1.527 0 CA-C-O 121.925 0.869 . . . . 0.0 109.463 -179.704 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 90.7 mt -81.78 139.83 34.58 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.663 -0.648 . . . . 0.0 109.574 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 99.2 m -127.1 131.05 50.93 Favored 'General case' 0 N--CA 1.494 1.753 0 CA-C-O 121.902 0.858 . . . . 0.0 109.86 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 70.2 mmtt -82.15 154.37 25.54 Favored 'General case' 0 C--N 1.301 -1.538 0 CA-C-O 121.648 0.737 . . . . 0.0 109.767 -179.401 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 96.2 mt -63.07 -43.52 99.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 CA-C-O 121.583 0.706 . . . . 0.0 109.568 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 13.6 p -65.24 -23.94 34.14 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 121.531 -0.731 . . . . 0.0 109.858 179.835 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 54.9 t0 -79.39 -2.48 41.9 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.382 -0.824 . . . . 0.0 109.67 -179.889 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 96.6 mt -78.7 117.94 25.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.108 -0.995 . . . . 0.0 109.908 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 3.3 m -136.02 -4.0 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 N-CA-C 108.979 -0.748 . . . . 0.0 108.979 179.533 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 79.4 mm-40 -139.76 137.8 35.37 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.248 -0.908 . . . . 0.0 110.21 -179.724 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 19.9 p-10 -91.85 159.93 15.55 Favored 'General case' 0 N--CA 1.491 1.588 0 CA-C-O 121.607 0.718 . . . . 0.0 110.162 179.821 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 78.69 2.14 84.88 Favored Glycine 0 N--CA 1.493 2.48 0 N-CA-C 109.559 -1.416 . . . . 0.0 109.559 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 33.1 tt0 -79.17 137.84 37.62 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.517 -0.99 . . . . 0.0 110.817 -179.239 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 68.9 m95 -93.45 132.35 37.79 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.781 -0.574 . . . . 0.0 109.692 179.629 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -174.29 176.78 2.38 Favored 'General case' 0 N--CA 1.493 1.722 0 C-N-CA 119.746 -0.782 . . . . 0.0 110.084 179.833 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 28.7 m-20 -104.48 142.68 34.19 Favored 'General case' 0 N--CA 1.495 1.781 0 CA-C-O 121.625 0.726 . . . . 0.0 110.095 -179.554 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 57.3 tp -133.71 138.92 46.09 Favored 'General case' 0 N--CA 1.493 1.705 0 CA-C-O 121.319 0.58 . . . . 0.0 109.485 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 19.5 ttpp -119.55 135.18 54.9 Favored 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 179.175 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -160.98 171.75 18.13 Favored 'General case' 0 N--CA 1.493 1.681 0 C-N-CA 119.598 -0.841 . . . . 0.0 110.166 -179.82 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -114.5 142.61 46.17 Favored 'General case' 0 N--CA 1.496 1.858 0 CA-C-O 121.756 0.789 . . . . 0.0 110.182 -179.71 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 21.5 t -84.77 117.57 30.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 CA-C-O 121.536 0.684 . . . . 0.0 109.963 -179.588 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 25.3 pt -107.86 -30.24 2.53 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 179.277 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 12.7 tt0 -163.99 133.45 3.95 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-O 121.699 0.761 . . . . 0.0 109.927 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.838 ' H ' HD23 ' A' ' 27' ' ' LEU . 1.1 pt? -143.3 137.8 29.09 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.784 -0.572 . . . . 0.0 109.696 179.932 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 2.6 m-90 -116.36 133.01 56.51 Favored 'General case' 0 N--CA 1.495 1.82 0 CA-C-O 121.567 0.699 . . . . 0.0 109.628 179.883 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -66.38 139.97 58.04 Favored 'General case' 0 C--N 1.301 -1.518 0 CA-C-O 121.269 0.557 . . . . 0.0 109.534 179.648 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.531 ' OD1' ' CG ' ' A' ' 32' ' ' HIS . 49.0 t-20 -102.87 -28.5 12.02 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 179.638 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 44.2 p 52.58 12.48 0.25 Allowed 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 -179.771 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . 0.531 ' CG ' ' OD1' ' A' ' 30' ' ' ASN . 0.3 OUTLIER -78.03 146.24 35.45 Favored 'General case' 0 N--CA 1.491 1.588 0 CA-C-O 121.873 0.844 . . . . 0.0 110.218 -179.758 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -59.28 -49.21 78.7 Favored 'General case' 0 N--CA 1.493 1.705 0 CA-C-O 121.428 0.632 . . . . 0.0 110.238 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.42 ' O ' ' CE3' ' A' ' 53' ' ' TRP . 40.0 m -72.08 -35.01 69.13 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.32 -0.862 . . . . 0.0 110.213 -179.611 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.41 HG23 ' OG1' ' A' ' 51' ' ' THR . 94.7 mt -123.29 127.61 74.47 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.993 0 O-C-N 121.292 -0.88 . . . . 0.0 110.317 -179.054 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 45.9 t -75.83 -53.01 9.13 Favored 'General case' 0 N--CA 1.493 1.691 0 CA-C-O 121.904 0.859 . . . . 0.0 109.562 179.597 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . 0.483 ' OE1' ' N ' ' A' ' 38' ' ' VAL . 0.5 OUTLIER -147.04 147.67 30.89 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.195 -0.941 . . . . 0.0 109.941 -179.739 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.483 ' N ' ' OE1' ' A' ' 37' ' ' GLN . 8.6 p -134.01 138.49 50.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 CA-C-O 121.384 0.611 . . . . 0.0 109.464 179.872 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -160.64 -165.65 17.86 Favored Glycine 0 N--CA 1.488 2.163 0 C-N-CA 119.746 -1.216 . . . . 0.0 110.476 -179.591 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -132.49 143.83 50.04 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.898 -0.766 . . . . 0.0 109.512 -179.714 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 41.4 mt -116.28 136.12 53.28 Favored 'General case' 0 N--CA 1.494 1.749 0 CA-C-O 121.79 0.805 . . . . 0.0 109.707 -179.178 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -83.71 162.52 39.5 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 111.073 -0.811 . . . . 0.0 111.073 -179.438 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.552 ' OD1' ' N ' ' A' ' 44' ' ' GLU . 67.2 t0 -174.73 145.15 0.87 Allowed 'General case' 0 N--CA 1.49 1.557 0 CA-C-O 121.63 0.729 . . . . 0.0 109.129 179.705 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.552 ' N ' ' OD1' ' A' ' 43' ' ' ASP . 49.0 mt-10 -54.43 -14.88 1.38 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.654 -0.654 . . . . 0.0 110.072 179.927 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 39.5 p -93.55 -11.15 32.54 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.228 -0.92 . . . . 0.0 109.716 -179.894 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 138.86 -158.3 25.09 Favored Glycine 0 N--CA 1.498 2.806 0 C-N-CA 120.041 -1.076 . . . . 0.0 110.568 179.233 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 97.4 mt -124.44 134.2 67.34 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 O-C-N 121.906 -0.761 . . . . 0.0 109.443 -179.585 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 17.7 tt -128.82 141.93 45.31 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.998 0 CA-C-O 121.625 0.726 . . . . 0.0 109.935 -179.753 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 51.1 mtmt -86.46 152.0 23.04 Favored 'General case' 0 N--CA 1.491 1.609 0 CA-C-O 121.568 0.699 . . . . 0.0 110.108 -179.772 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 25.2 p90 -142.51 160.38 40.39 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.327 -0.858 . . . . 0.0 110.325 -179.688 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.41 ' OG1' HG23 ' A' ' 35' ' ' ILE . 1.9 t -138.58 137.52 37.08 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 -179.945 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 90.6 mt -105.93 118.03 52.76 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 CA-C-O 121.534 0.683 . . . . 0.0 109.834 179.865 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . 0.42 ' CE3' ' O ' ' A' ' 34' ' ' SER . 72.7 m95 -85.77 142.56 28.87 Favored 'General case' 0 N--CA 1.488 1.463 0 CA-C-O 121.579 0.704 . . . . 0.0 109.524 179.874 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -62.4 -8.8 6.64 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.564 -0.71 . . . . 0.0 110.335 -179.53 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.414 ' O ' ' OE1' ' A' ' 57' ' ' GLU . 13.0 t-20 -75.75 -10.97 59.88 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.249 -0.907 . . . . 0.0 109.056 179.529 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.415 ' C ' ' OE1' ' A' ' 57' ' ' GLU . . . -94.19 -21.44 19.06 Favored 'General case' 0 N--CA 1.497 1.921 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 179.27 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.442 ' N ' ' OE1' ' A' ' 57' ' ' GLU . 56.0 mp0 40.39 51.53 2.84 Favored 'General case' 0 N--CA 1.495 1.805 0 CA-C-O 122.069 0.938 . . . . 0.0 109.979 -179.908 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.552 ' C ' ' H ' ' A' ' 60' ' ' LEU . 18.4 mt -94.92 150.06 37.23 Favored Pre-proline 0 N--CA 1.488 1.473 0 O-C-N 121.562 -0.711 . . . . 0.0 109.346 179.92 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.414 ' O ' ' O ' ' A' ' 60' ' ' LEU . 29.9 Cg_endo -67.97 22.97 0.13 Allowed 'Trans proline' 0 N--CA 1.493 1.489 0 C-N-CA 122.2 1.933 . . . . 0.0 111.801 179.564 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.552 ' H ' ' C ' ' A' ' 58' ' ' LEU . 72.0 mt 58.59 151.86 0.01 OUTLIER 'General case' 0 C--N 1.293 -1.866 0 CA-C-O 121.802 0.81 . . . . 0.0 110.18 179.661 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.644 ' N ' HD12 ' A' ' 61' ' ' LEU . 9.0 mp -85.46 143.55 28.5 Favored 'General case' 0 N--CA 1.491 1.625 0 CA-C-O 121.541 0.686 . . . . 0.0 109.747 -179.667 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -87.5 151.27 23.16 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-O 121.937 0.875 . . . . 0.0 110.558 -178.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 58.1 tt0 -76.15 132.08 39.78 Favored 'General case' 0 N--CA 1.491 1.583 0 CA-C-O 121.87 0.843 . . . . 0.0 111.542 -178.811 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 93.16 -4.95 74.94 Favored Glycine 0 N--CA 1.496 2.688 0 N-CA-C 110.745 -0.942 . . . . 0.0 110.745 178.57 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.531 ' OE1' ' N ' ' A' ' 65' ' ' GLU . 58.3 mp0 -103.36 149.17 25.02 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 121.119 -1.224 . . . . 0.0 110.725 -179.379 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 8.8 p -93.22 135.15 34.7 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 179.58 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -125.72 143.04 51.21 Favored 'General case' 0 N--CA 1.497 1.879 0 CA-C-O 122.079 0.943 . . . . 0.0 111.017 -179.101 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 11.9 tp -106.57 104.88 14.67 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 179.653 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 54.3 mt -79.62 141.06 36.87 Favored 'General case' 0 N--CA 1.491 1.6 0 CA-C-O 121.342 0.591 . . . . 0.0 109.543 -179.688 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 85.3 mtp180 -136.06 141.85 44.31 Favored 'General case' 0 N--CA 1.494 1.733 0 CA-C-O 121.862 0.839 . . . . 0.0 110.71 -179.37 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 2.0 m 53.04 43.34 31.83 Favored 'General case' 0 N--CA 1.492 1.656 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.963 178.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 7.5 m -99.22 162.36 2.95 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.982 0 O-C-N 121.513 -0.742 . . . . 0.0 109.586 179.162 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 7.8 p -108.5 135.81 46.11 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 CA-C-O 121.688 0.756 . . . . 0.0 110.182 -178.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 98.7 t -78.89 125.0 38.05 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 CA-C-O 121.818 0.818 . . . . 0.0 109.375 -179.626 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -83.22 163.89 41.66 Favored Glycine 0 N--CA 1.486 2.016 0 N-CA-C 110.093 -1.203 . . . . 0.0 110.093 -179.632 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -114.73 127.88 55.99 Favored 'General case' 0 N--CA 1.493 1.722 0 CA-C-O 121.734 0.778 . . . . 0.0 109.881 -179.843 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . 0.628 ' CD2' ' NE2' ' A' ' 82' ' ' GLN . 42.4 m-85 -132.84 81.25 1.93 Allowed 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 179.557 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 79.4 m-20 50.67 -112.67 0.63 Allowed 'General case' 0 N--CA 1.495 1.788 0 CA-C-O 121.355 0.598 . . . . 0.0 110.698 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 94.9 m-20 -90.56 -7.0 54.01 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.141 -0.974 . . . . 0.0 109.544 -179.727 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 94.1 mtt180 -102.66 166.33 10.57 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.382 -0.824 . . . . 0.0 110.557 -178.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -128.71 150.61 50.19 Favored 'General case' 0 N--CA 1.496 1.859 0 CA-C-O 121.481 0.658 . . . . 0.0 109.706 179.882 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . 0.628 ' NE2' ' CD2' ' A' ' 77' ' ' TYR . 74.4 mt-30 -144.65 177.29 8.79 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.625 -0.672 . . . . 0.0 109.428 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 2.6 m -118.49 133.14 66.27 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 179.543 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 84.4 mt-30 -113.58 122.34 46.93 Favored 'General case' 0 N--CA 1.494 1.756 0 CA-C-O 121.859 0.838 . . . . 0.0 109.618 -179.078 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 22.0 t -90.07 129.29 41.19 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 1.4 p30 -147.57 172.84 13.37 Favored 'General case' 0 N--CA 1.49 1.544 0 CA-C-O 121.86 0.838 . . . . 0.0 110.167 -179.278 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.475 ' O ' ' CB ' ' A' ' 88' ' ' ASN . 88.7 tttt -42.83 157.24 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 CA-C-O 121.768 0.794 . . . . 0.0 110.826 -179.761 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . 0.475 ' CB ' ' O ' ' A' ' 87' ' ' LYS . 2.1 t-20 79.31 -23.2 0.25 Allowed 'General case' 0 N--CA 1.494 1.753 0 CA-C-O 121.366 0.603 . . . . 0.0 109.814 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 11.1 m -74.81 148.1 40.61 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.287 -0.883 . . . . 0.0 110.199 -179.512 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 52.1 m -125.1 150.1 47.18 Favored 'General case' 0 N--CA 1.497 1.884 0 CA-C-O 121.58 0.705 . . . . 0.0 109.806 -179.797 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 98.0 mt -132.27 135.33 58.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 CA-C-O 121.365 0.602 . . . . 0.0 109.734 -179.42 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 81.1 tt0 -128.8 125.93 38.82 Favored 'General case' 0 N--CA 1.5 2.032 0 CA-C-O 121.61 0.719 . . . . 0.0 109.222 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.429 ' C ' HD12 ' A' ' 94' ' ' LEU . 26.7 mtmm -74.34 135.25 42.51 Favored 'General case' 0 N--CA 1.49 1.529 0 CA-C-O 121.566 0.698 . . . . 0.0 110.296 -179.608 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.429 HD12 ' C ' ' A' ' 93' ' ' LYS . 10.2 mp -105.45 134.53 48.42 Favored 'General case' 0 N--CA 1.494 1.766 0 CA-C-O 121.938 0.875 . . . . 0.0 109.82 179.899 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 93.3 p -83.19 -2.12 54.74 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 109.454 -0.572 . . . . 0.0 109.454 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -118.36 89.92 37.29 Favored Pre-proline 0 N--CA 1.5 2.027 0 O-C-N 121.539 -0.726 . . . . 0.0 109.195 179.873 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_exo -57.72 149.67 66.94 Favored 'Trans proline' 0 N--CA 1.492 1.406 0 C-N-CA 122.742 2.295 . . . . 0.0 112.6 179.538 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 29.8 pt -74.68 143.98 12.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 CA-C-O 121.827 0.822 . . . . 0.0 110.353 -179.73 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -80.36 117.54 21.2 Favored 'General case' 0 N--CA 1.488 1.455 0 CA-C-O 121.503 0.668 . . . . 0.0 109.879 -179.686 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 35.3 m -109.64 -3.62 10.51 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 179.487 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -170.98 120.95 0.87 Allowed Glycine 0 N--CA 1.494 2.502 0 N-CA-C 109.707 -1.357 . . . . 0.0 109.707 179.651 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.563 HD12 ' N ' ' A' ' 102' ' ' LEU . 10.1 mp -86.83 1.66 51.63 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.606 -0.938 . . . . 0.0 108.553 179.645 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . 0.421 ' O ' ' O ' ' A' ' 102' ' ' LEU . 14.6 pt-20 -50.61 -176.23 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.684 0 CA-C-O 121.781 0.801 . . . . 0.0 110.487 -179.861 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 80.3 m80 -93.31 11.96 26.35 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 -179.888 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 59.8 t-80 -62.32 -44.37 96.67 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.466 -0.771 . . . . 0.0 109.373 179.601 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 92.2 m-70 -63.76 -41.06 98.06 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.532 -0.73 . . . . 0.0 109.358 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 52.8 t-80 -82.73 158.19 22.98 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.343 -0.848 . . . . 0.0 110.147 -179.757 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 77.9 m80 -141.15 147.7 38.86 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.624 -0.673 . . . . 0.0 110.035 -179.812 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 84.3 t60 . . . . . 0 N--CA 1.492 1.632 0 CA-C-O 118.071 -0.966 . . . . 0.0 109.105 179.912 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.455 ' O ' ' O ' ' A' ' 2' ' ' GLU . 82.4 mmm . . . . . 0 N--CA 1.489 1.482 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.455 ' O ' ' O ' ' A' ' 1' ' ' MET . 0.9 OUTLIER 57.32 149.4 0.06 OUTLIER Pre-proline 0 N--CA 1.494 1.738 0 CA-C-O 120.964 0.411 . . . . 0.0 110.355 179.902 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -70.06 150.98 67.16 Favored 'Trans proline' 0 N--CA 1.496 1.646 0 C-N-CA 122.691 2.261 . . . . 0.0 112.625 -179.844 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 59.2 tt0 -87.08 81.09 8.15 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 179.845 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 77.5 mt -76.16 146.83 38.91 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.582 -0.699 . . . . 0.0 110.201 -179.119 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 96.8 m -123.33 130.33 52.58 Favored 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 179.751 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -79.54 155.16 28.32 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.475 -0.766 . . . . 0.0 110.313 -179.079 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.628 ' N ' HD12 ' A' ' 8' ' ' ILE . 3.0 mp -63.45 -43.24 98.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.627 -0.67 . . . . 0.0 109.671 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 13.1 p -66.93 -20.6 27.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.287 -0.883 . . . . 0.0 109.517 -179.688 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -82.68 -1.37 51.03 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.335 -0.853 . . . . 0.0 109.455 179.606 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 96.4 mt -83.89 111.63 20.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.317 -0.864 . . . . 0.0 109.551 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 24.0 m -154.44 18.45 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 179.754 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -134.75 144.3 47.63 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.533 -0.729 . . . . 0.0 110.105 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.41 ' O ' ' OD1' ' A' ' 14' ' ' ASN . 46.6 p-10 -93.16 137.76 32.2 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.492 -0.755 . . . . 0.0 110.264 -179.578 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 80.7 18.98 69.17 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.279 -1.528 . . . . 0.0 109.279 179.876 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 51.8 tt0 -73.31 133.76 43.98 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.295 -1.121 . . . . 0.0 109.818 -179.528 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' TRP . . . . . 0.414 ' O ' ' HB2' ' A' ' 18' ' ' ALA . 90.0 m95 -106.76 130.87 54.4 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.553 -0.717 . . . . 0.0 109.657 179.78 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.414 ' HB2' ' O ' ' A' ' 17' ' ' TRP . . . 178.32 -173.54 0.15 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.421 -0.799 . . . . 0.0 109.689 179.598 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 80.7 m-20 -99.29 152.69 19.64 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.545 -0.722 . . . . 0.0 109.407 -179.78 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.57 HD13 ' N ' ' A' ' 21' ' ' LYS . 0.4 OUTLIER -136.78 117.13 13.63 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.407 -0.808 . . . . 0.0 109.451 179.94 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.57 ' N ' HD13 ' A' ' 20' ' ' LEU . 35.2 ttpt -115.61 135.29 54.22 Favored 'General case' 0 N--CA 1.497 1.892 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 178.755 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -167.15 175.66 7.32 Favored 'General case' 0 N--CA 1.492 1.647 0 C-N-CA 119.31 -0.956 . . . . 0.0 110.158 179.646 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -103.29 142.11 34.76 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.57 -0.706 . . . . 0.0 109.702 -179.6 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.438 HG22 ' CD2' ' A' ' 41' ' ' LEU . 93.7 t -82.49 128.16 38.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.322 -0.861 . . . . 0.0 110.444 -179.496 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 96.7 mt -98.58 -59.94 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 179.119 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.622 ' NE2' ' CZ2' ' A' ' 28' ' ' TRP . 60.0 tt0 -146.84 147.69 31.11 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.346 -0.846 . . . . 0.0 109.728 179.955 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.461 ' N ' HD23 ' A' ' 27' ' ' LEU . 0.1 OUTLIER -125.31 151.23 46.29 Favored 'General case' 0 N--CA 1.496 1.828 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 -179.706 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . 0.622 ' CZ2' ' NE2' ' A' ' 26' ' ' GLN . 96.2 m95 -124.3 105.34 9.39 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 179.478 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.401 ' OE1' ' N ' ' A' ' 29' ' ' GLU . 59.4 mp0 -59.49 139.51 57.05 Favored 'General case' 0 C--N 1.302 -1.476 0 CA-C-O 121.542 0.687 . . . . 0.0 110.04 -179.164 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 33.0 t30 -149.93 104.74 3.33 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.712 -0.848 . . . . 0.0 108.712 -179.846 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 5.7 m -89.1 49.91 1.86 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.543 -0.723 . . . . 0.0 109.205 -179.164 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . 0.553 ' O ' ' N ' ' A' ' 34' ' ' SER . 61.1 t60 -84.0 28.33 0.61 Allowed 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.437 -0.789 . . . . 0.0 109.609 -179.657 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 40.2 tp10 59.45 -71.48 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.733 -0.605 . . . . 0.0 110.227 179.525 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.553 ' N ' ' O ' ' A' ' 32' ' ' HIS . 77.7 p -61.37 -36.25 79.71 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.321 -0.862 . . . . 0.0 110.176 -179.246 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 96.8 mt -112.79 128.35 69.55 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.069 0 O-C-N 121.478 -0.764 . . . . 0.0 109.878 -179.743 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.465 ' OG ' ' CA ' ' A' ' 54' ' ' LYS . 1.3 m -85.01 -67.98 0.76 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.751 -0.593 . . . . 0.0 109.528 -179.781 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 51.2 tt0 -139.68 151.48 45.95 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.477 -0.764 . . . . 0.0 109.595 -179.638 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 8.3 p -135.71 139.38 46.38 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 179.677 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -164.35 -163.13 16.68 Favored Glycine 0 N--CA 1.49 2.297 0 C-N-CA 119.341 -1.409 . . . . 0.0 110.434 -179.509 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.893 HD23 ' H ' ' A' ' 40' ' ' LEU . 1.4 pt? -136.98 146.23 45.12 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.553 -0.969 . . . . 0.0 109.852 179.904 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.438 ' CD2' HG22 ' A' ' 24' ' ' VAL . 52.9 mt -109.79 132.32 54.25 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.524 -0.735 . . . . 0.0 109.865 -179.274 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -79.06 163.82 49.52 Favored Glycine 0 N--CA 1.487 2.074 0 N-CA-C 110.512 -1.035 . . . . 0.0 110.512 -179.81 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.487 ' OD1' ' N ' ' A' ' 44' ' ' GLU . 49.7 t0 -171.8 138.52 1.09 Allowed 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.68 -0.894 . . . . 0.0 109.105 179.346 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.487 ' N ' ' OD1' ' A' ' 43' ' ' ASP . 18.1 pt-20 -55.7 -13.39 1.66 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.415 -0.803 . . . . 0.0 109.222 -179.773 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 13.9 p -98.29 -9.34 25.63 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.441 -0.787 . . . . 0.0 109.376 -179.794 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 144.92 -157.64 27.37 Favored Glycine 0 N--CA 1.497 2.749 0 C-N-CA 120.078 -1.058 . . . . 0.0 110.487 179.281 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 40.1 pt -126.35 154.57 35.94 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 O-C-N 121.738 -0.86 . . . . 0.0 109.584 -179.864 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.714 HD13 ' H ' ' A' ' 49' ' ' LYS . 0.3 OUTLIER -141.39 142.15 29.49 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 121.308 -0.87 . . . . 0.0 109.459 179.426 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.714 ' H ' HD13 ' A' ' 48' ' ' ILE . 99.1 mttt -91.24 143.97 26.1 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.658 -0.651 . . . . 0.0 109.348 179.455 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 33.4 p90 -137.61 152.51 49.45 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.168 -0.957 . . . . 0.0 109.674 -179.87 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 97.1 m -128.32 132.81 48.62 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 47.1 mm -99.99 121.33 50.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.405 -0.81 . . . . 0.0 109.875 -179.457 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . 0.482 ' CD1' ' OD1' ' A' ' 86' ' ' ASN . 89.2 m95 -82.16 124.19 29.66 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 108.72 -0.845 . . . . 0.0 108.72 179.368 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.465 ' CA ' ' OG ' ' A' ' 36' ' ' SER . 32.7 tttt -62.48 -15.17 48.53 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 -179.219 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 99.0 m-20 -63.33 -40.22 96.71 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.482 -0.761 . . . . 0.0 109.488 -179.706 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -64.59 -32.72 74.49 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.338 -0.851 . . . . 0.0 109.441 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 59.52 49.45 8.54 Favored 'General case' 0 N--CA 1.491 1.612 0 CA-C-O 121.282 0.563 . . . . 0.0 109.638 -179.458 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 37.3 mt -101.37 152.39 37.97 Favored Pre-proline 0 N--CA 1.493 1.676 0 O-C-N 121.624 -0.673 . . . . 0.0 109.5 179.868 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -50.57 148.6 15.06 Favored 'Trans proline' 0 N--CA 1.496 1.637 0 C-N-CA 122.177 1.918 . . . . 0.0 112.797 179.133 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 84.0 mt -69.28 154.37 42.15 Favored 'General case' 0 N--CA 1.492 1.632 0 CA-C-O 121.836 0.827 . . . . 0.0 110.543 -179.195 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.702 HD22 ' N ' ' A' ' 61' ' ' LEU . 3.4 mm? -78.72 149.61 32.69 Favored 'General case' 0 C--N 1.304 -1.382 0 CA-C-O 121.421 0.629 . . . . 0.0 110.304 -178.663 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -106.26 146.49 30.27 Favored 'General case' 0 N--CA 1.495 1.823 0 CA-C-O 121.738 0.78 . . . . 0.0 110.057 -179.111 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 49.2 tt0 -81.34 134.21 35.54 Favored 'General case' 0 N--CA 1.488 1.468 0 CA-C-O 121.284 0.564 . . . . 0.0 110.81 -178.905 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 90.38 -6.65 82.3 Favored Glycine 0 N--CA 1.495 2.611 0 N-CA-C 110.355 -1.098 . . . . 0.0 110.355 178.717 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -104.6 150.47 24.63 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.37 -1.076 . . . . 0.0 110.749 -179.438 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 8.4 m -95.37 136.59 35.54 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.698 -0.626 . . . . 0.0 109.358 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 72.5 m-85 -121.87 145.1 48.41 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-O 121.748 0.785 . . . . 0.0 110.142 -179.848 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 14.0 tp -110.34 112.14 23.89 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 179.344 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 71.4 mt -95.86 131.99 41.6 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 -179.827 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 80.4 mtp85 -123.52 141.87 51.57 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.561 -0.712 . . . . 0.0 110.537 -179.334 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 9.2 t 57.81 65.04 1.4 Allowed 'General case' 0 N--CA 1.493 1.692 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.547 179.397 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 2.9 m -121.76 160.82 22.97 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 179.258 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 14.8 p -118.7 133.22 66.24 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 CA-C-O 121.63 0.728 . . . . 0.0 109.45 -179.258 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 14.0 t -85.6 121.37 37.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.654 -0.654 . . . . 0.0 109.68 -179.193 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -98.87 -172.35 31.6 Favored Glycine 0 N--CA 1.494 2.531 0 N-CA-C 109.784 -1.327 . . . . 0.0 109.784 -179.773 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -111.31 120.75 43.29 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.644 -0.916 . . . . 0.0 109.65 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . 0.496 ' O ' ' N ' ' A' ' 79' ' ' ASP . 86.7 t80 -108.67 80.77 1.37 Allowed 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 179.44 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.455 ' C ' ' O ' ' A' ' 77' ' ' TYR . 94.3 m-20 31.07 -91.34 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.988 0 CA-C-O 121.482 0.658 . . . . 0.0 111.196 179.855 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.496 ' N ' ' O ' ' A' ' 77' ' ' TYR . 66.5 t0 -51.52 -68.69 0.15 Allowed 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.619 -0.676 . . . . 0.0 110.656 -179.453 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 85.2 mtp180 -120.96 -163.99 1.08 Allowed 'General case' 0 N--CA 1.501 2.123 0 O-C-N 121.528 -0.732 . . . . 0.0 110.336 -178.774 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 79.6 m-85 -99.08 162.93 12.79 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.56 -0.712 . . . . 0.0 109.793 -179.037 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 6.4 pt20 -141.95 162.01 36.55 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.377 -0.827 . . . . 0.0 109.834 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 2.7 m -107.96 131.18 59.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 179.81 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -106.7 131.72 53.51 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.676 -0.64 . . . . 0.0 110.041 -178.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 96.3 t -103.15 124.31 57.19 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.482 ' OD1' ' CD1' ' A' ' 53' ' ' TRP . 80.3 m-20 -125.01 -176.52 3.58 Favored 'General case' 0 N--CA 1.496 1.834 0 CA-C-O 121.524 0.678 . . . . 0.0 109.739 -179.528 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 62.9 pttt -59.86 -33.43 71.78 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.741 -0.6 . . . . 0.0 109.862 -179.888 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 52.3 t-20 -63.45 -38.23 90.33 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.393 -0.817 . . . . 0.0 109.523 -179.558 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 27.7 t -76.57 164.78 25.6 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.34 -0.85 . . . . 0.0 110.325 -179.064 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 95.1 p -133.06 158.3 43.11 Favored 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 179.825 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 96.8 mt -125.54 132.63 70.71 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 O-C-N 121.668 -0.645 . . . . 0.0 110.02 -179.383 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 31.7 mm-40 -136.15 135.42 39.2 Favored 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 179.633 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.451 ' C ' HD12 ' A' ' 94' ' ' LEU . 97.3 mttt -84.19 136.09 34.1 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.442 -0.786 . . . . 0.0 109.962 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.451 HD12 ' C ' ' A' ' 93' ' ' LYS . 8.9 mp -108.25 133.66 52.18 Favored 'General case' 0 N--CA 1.499 1.986 0 CA-C-O 121.623 0.725 . . . . 0.0 109.384 179.503 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 89.7 p -76.09 1.95 14.2 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 179.637 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.416 ' OE2' ' O ' ' A' ' 97' ' ' PRO . 8.7 tm-20 -109.52 95.72 20.29 Favored Pre-proline 0 N--CA 1.497 1.883 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 -179.948 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . 0.416 ' O ' ' OE2' ' A' ' 96' ' ' GLU . 64.7 Cg_endo -76.78 158.89 35.13 Favored 'Trans proline' 0 N--CA 1.491 1.363 0 C-N-CA 122.241 1.961 . . . . 0.0 112.351 -179.149 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 86.8 mt -104.48 128.12 58.3 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 O-C-N 121.499 -0.751 . . . . 0.0 109.79 -179.574 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -67.37 138.05 56.44 Favored 'General case' 0 N--CA 1.489 1.492 0 CA-C-O 121.503 0.668 . . . . 0.0 110.197 -179.299 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 5.4 m -101.11 31.66 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 N-CA-C 108.979 -0.748 . . . . 0.0 108.979 179.705 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 103.16 127.62 6.14 Favored Glycine 0 N--CA 1.497 2.747 0 N-CA-C 110.314 -1.114 . . . . 0.0 110.314 179.395 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.553 HD12 ' N ' ' A' ' 102' ' ' LEU . 10.7 mp -88.62 -2.97 58.87 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.476 -1.014 . . . . 0.0 108.538 179.376 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -78.91 -4.71 51.12 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.565 -0.71 . . . . 0.0 109.315 179.881 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 76.6 t60 -65.14 -41.25 94.95 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.419 -0.801 . . . . 0.0 109.463 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 58.1 t-80 -75.53 129.69 37.64 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.446 -0.783 . . . . 0.0 110.405 -179.181 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 52.3 p-80 -151.95 15.26 0.64 Allowed 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 179.287 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 81.1 t60 -80.24 126.98 31.81 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.569 -0.707 . . . . 0.0 110.087 -179.314 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 8.1 p80 -154.08 163.45 40.07 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.447 -0.783 . . . . 0.0 109.674 179.524 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . 0.542 ' OXT' ' CG ' ' A' ' 109' ' ' HIS . 85.5 t60 . . . . . 0 N--CA 1.488 1.471 0 CA-C-O 117.829 -1.081 . . . . 0.0 108.835 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.461 ' SD ' ' N ' ' A' ' 1' ' ' MET . 0.9 OUTLIER . . . . . 0 N--CA 1.488 1.473 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 . . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.439 ' N ' ' CD ' ' A' ' 3' ' ' PRO . 27.7 tt0 -162.73 54.5 0.46 Allowed Pre-proline 0 C--N 1.303 -1.454 0 O-C-N 121.384 -0.823 . . . . 0.0 109.285 179.706 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.439 ' CD ' ' N ' ' A' ' 2' ' ' GLU . 30.7 Cg_endo -63.96 143.97 86.67 Favored 'Trans proline' 0 N--CA 1.496 1.622 0 C-N-CA 122.675 2.25 . . . . 0.0 112.269 -179.868 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.556 ' H ' ' CD ' ' A' ' 4' ' ' GLN . 21.9 mp0 -72.72 92.61 1.57 Allowed 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.291 -0.88 . . . . 0.0 109.685 -179.719 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 86.6 mt -74.51 147.32 41.97 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.487 -0.758 . . . . 0.0 109.567 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 97.8 m -124.12 130.5 52.65 Favored 'General case' 0 N--CA 1.495 1.779 0 CA-C-O 121.736 0.779 . . . . 0.0 109.754 -179.897 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -98.87 159.12 15.18 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.597 -0.689 . . . . 0.0 110.048 -179.675 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 96.6 mt -63.84 -42.74 96.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.412 -0.805 . . . . 0.0 109.557 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 14.8 p -63.32 -23.58 33.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.24 -0.913 . . . . 0.0 109.441 -179.843 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 94.7 m-20 -78.9 -4.15 48.29 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.213 -0.929 . . . . 0.0 109.345 179.58 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 5.6 mm -69.12 98.95 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.079 -1.013 . . . . 0.0 109.639 -179.773 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 2.5 p -116.12 -40.11 2.7 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.36 0 O-C-N 121.625 -0.672 . . . . 0.0 109.3 179.871 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 79.4 tt0 -126.28 143.33 51.19 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.294 -0.879 . . . . 0.0 110.26 -178.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 55.8 p30 -87.14 163.16 17.12 Favored 'General case' 0 N--CA 1.492 1.627 0 CA-C-O 121.71 0.767 . . . . 0.0 110.447 -179.674 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 78.07 13.04 83.78 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 109.267 -1.533 . . . . 0.0 109.267 -179.494 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -83.58 129.94 34.98 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.187 -1.184 . . . . 0.0 110.082 -179.7 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 84.1 m95 -93.12 129.16 39.2 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.265 -0.897 . . . . 0.0 109.929 -179.734 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -174.35 -173.33 0.76 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.6 -0.687 . . . . 0.0 109.303 179.581 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 73.5 m-20 -105.64 145.25 31.27 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.515 -0.741 . . . . 0.0 109.822 -179.463 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 40.5 tp -128.07 132.14 49.06 Favored 'General case' 0 N--CA 1.498 1.968 0 CA-C-O 121.69 0.757 . . . . 0.0 109.9 179.766 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 38.2 ttmt -116.09 130.18 56.69 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 179.359 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -166.65 179.01 5.65 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.84 -1.162 . . . . 0.0 110.775 -179.589 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 64.5 tttp -114.55 139.93 49.18 Favored 'General case' 0 N--CA 1.497 1.919 0 CA-C-O 121.619 0.723 . . . . 0.0 109.968 -179.682 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 87.6 t -81.02 115.73 24.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.413 -0.804 . . . . 0.0 109.943 -179.766 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 19.1 mm -93.92 -48.93 12.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.297 -0.877 . . . . 0.0 109.645 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 82.4 mt-30 -144.62 144.97 31.53 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.04 -1.038 . . . . 0.0 110.199 -179.347 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.835 HD23 ' H ' ' A' ' 27' ' ' LEU . 1.1 pt? -141.95 133.32 26.54 Favored 'General case' 0 N--CA 1.492 1.675 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 179.836 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 3.4 m0 -118.86 146.51 44.83 Favored 'General case' 0 N--CA 1.499 2.014 0 CA-C-O 121.741 0.781 . . . . 0.0 109.999 -179.347 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 50.0 tp10 -91.1 133.39 35.37 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.405 -0.81 . . . . 0.0 109.576 -179.808 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.517 ' ND2' ' O ' ' A' ' 35' ' ' ILE . 14.1 p-10 -89.37 -168.88 2.3 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.342 -0.849 . . . . 0.0 110.143 -179.586 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 97.3 m -118.81 -14.5 9.48 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 179.508 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 99.3 m-70 -79.75 139.81 37.16 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.06 -1.025 . . . . 0.0 110.075 -179.871 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 71.8 mm-40 -69.29 -34.45 74.74 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.417 -0.802 . . . . 0.0 110.077 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 40.1 t -61.31 -42.4 98.6 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.146 -0.971 . . . . 0.0 110.555 -179.284 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.517 ' O ' ' ND2' ' A' ' 30' ' ' ASN . 96.9 mt -103.15 133.82 45.94 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 O-C-N 121.121 -0.987 . . . . 0.0 109.794 -179.523 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 28.7 t -86.33 -70.61 0.59 Allowed 'General case' 0 N--CA 1.49 1.544 0 CA-C-O 121.664 0.745 . . . . 0.0 109.804 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -141.19 153.93 45.57 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.088 -1.007 . . . . 0.0 110.375 -179.15 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 27.8 m -135.98 158.51 38.97 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 179.312 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -178.23 -150.91 8.99 Favored Glycine 0 N--CA 1.487 2.045 0 C-N-CA 119.467 -1.349 . . . . 0.0 110.033 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.41 HD23 ' N ' ' A' ' 40' ' ' LEU . 0.2 OUTLIER -135.25 148.11 49.48 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.655 -0.909 . . . . 0.0 109.374 -179.744 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 70.3 mt -111.54 128.4 56.01 Favored 'General case' 0 N--CA 1.495 1.787 0 CA-C-O 121.668 0.747 . . . . 0.0 109.31 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -80.44 158.03 41.1 Favored Glycine 0 N--CA 1.487 2.095 0 N-CA-C 110.012 -1.235 . . . . 0.0 110.012 -179.751 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.529 ' OD1' ' N ' ' A' ' 44' ' ' GLU . 67.2 t0 -172.58 143.14 1.3 Allowed 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.493 -1.004 . . . . 0.0 109.045 -179.923 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.529 ' N ' ' OD1' ' A' ' 43' ' ' ASP . 96.9 mt-10 -54.88 -14.45 1.45 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.427 -0.795 . . . . 0.0 109.793 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 37.4 p -93.33 -12.94 28.81 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.024 -1.047 . . . . 0.0 109.292 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 141.15 -157.32 25.99 Favored Glycine 0 N--CA 1.498 2.792 0 C-N-CA 119.876 -1.154 . . . . 0.0 110.245 179.378 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 41.5 pt -124.85 150.55 29.86 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 O-C-N 121.581 -0.953 . . . . 0.0 109.518 -179.451 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 20.8 tt -146.94 150.08 15.15 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 121.235 -0.916 . . . . 0.0 109.7 -179.741 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 72.5 mmtt -84.09 150.21 25.71 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.466 -0.771 . . . . 0.0 110.402 -179.23 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 17.3 p90 -143.65 151.76 40.51 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.321 -0.862 . . . . 0.0 109.19 179.52 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.545 ' OG1' ' NE2' ' A' ' 82' ' ' GLN . 35.0 m -132.99 137.18 46.44 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.629 -0.669 . . . . 0.0 109.469 179.807 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 29.7 mm -98.48 122.56 50.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.225 -0.922 . . . . 0.0 109.735 -179.676 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 97.3 m95 -98.17 140.97 31.68 Favored 'General case' 0 N--CA 1.49 1.543 0 CA-C-O 121.582 0.706 . . . . 0.0 109.639 179.841 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 29.0 mmtm -84.34 -10.41 57.62 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.144 -0.973 . . . . 0.0 109.781 179.547 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 89.7 m-20 -61.8 -41.01 97.2 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.174 -0.954 . . . . 0.0 109.477 -179.776 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -77.58 -8.59 58.08 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.226 -0.921 . . . . 0.0 108.937 179.654 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 58.18 58.11 3.66 Favored 'General case' 0 N--CA 1.495 1.797 0 CA-C-O 121.496 0.665 . . . . 0.0 109.604 -179.771 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.487 ' CD1' HG12 ' A' ' 85' ' ' VAL . 29.8 mt -105.65 147.52 34.82 Favored Pre-proline 0 N--CA 1.497 1.91 0 O-C-N 121.548 -0.72 . . . . 0.0 109.389 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -69.76 159.42 53.46 Favored 'Trans proline' 0 N--CA 1.497 1.72 0 C-N-CA 122.837 2.358 . . . . 0.0 113.195 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 97.2 mt -71.52 141.61 50.12 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.274 -0.891 . . . . 0.0 109.98 -179.814 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.596 ' N ' HD12 ' A' ' 61' ' ' LEU . 9.6 mp -80.04 149.04 30.84 Favored 'General case' 0 N--CA 1.493 1.724 0 CA-C-O 121.727 0.775 . . . . 0.0 110.705 -179.084 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -104.91 126.63 52.18 Favored 'General case' 0 N--CA 1.497 1.914 0 CA-C-O 121.802 0.81 . . . . 0.0 109.758 -179.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 58.2 tt0 -64.49 147.89 51.79 Favored 'General case' 0 N--CA 1.496 1.855 0 CA-C-O 121.965 0.888 . . . . 0.0 111.835 -178.933 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 81.05 22.94 60.15 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.937 -1.265 . . . . 0.0 109.937 178.825 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -139.26 145.46 39.21 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.248 -1.148 . . . . 0.0 110.094 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 11.1 p -84.42 149.73 25.79 Favored 'General case' 0 N--CA 1.486 1.333 0 CA-C-O 121.606 0.717 . . . . 0.0 109.856 179.915 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 66.6 m-85 -143.58 151.91 40.77 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.233 -0.917 . . . . 0.0 110.307 -179.867 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 21.9 tp -112.92 121.95 46.2 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 179.235 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 71.8 mt -100.84 130.74 46.9 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.393 -0.817 . . . . 0.0 109.849 -179.162 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 83.4 mtp180 -127.09 144.55 51.0 Favored 'General case' 0 N--CA 1.498 1.944 0 CA-C-O 121.878 0.847 . . . . 0.0 110.49 -179.876 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.8 m 58.34 57.43 3.91 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.798 -0.564 . . . . 0.0 110.49 179.385 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 17.9 m -118.81 164.67 14.85 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.98 0 O-C-N 121.598 -0.688 . . . . 0.0 109.656 179.33 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 11.8 p -120.47 136.11 58.56 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 CA-C-O 121.65 0.738 . . . . 0.0 109.379 -179.712 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 66.9 t -81.47 115.29 23.79 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 CA-C-O 121.831 0.824 . . . . 0.0 109.889 -178.863 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -84.92 167.32 41.89 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 110.024 -1.23 . . . . 0.0 110.024 -179.563 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -105.91 124.2 49.19 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.466 -1.02 . . . . 0.0 109.624 180.0 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 52.0 t80 -120.05 82.58 1.91 Allowed 'General case' 0 N--CA 1.492 1.637 0 CA-C-O 121.984 0.897 . . . . 0.0 108.807 179.719 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.451 ' CG ' ' N ' ' A' ' 79' ' ' ASP . 50.1 t30 42.95 -117.63 0.46 Allowed 'General case' 0 N--CA 1.501 2.087 0 CA-C-O 121.729 0.776 . . . . 0.0 112.179 179.774 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.451 ' N ' ' CG ' ' A' ' 78' ' ' ASN . 42.4 t0 -70.22 -35.16 73.7 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.184 -0.947 . . . . 0.0 109.991 -178.806 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 84.4 mtt85 -101.22 -170.88 1.9 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.267 -0.896 . . . . 0.0 110.011 -179.377 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -127.9 150.53 49.83 Favored 'General case' 0 N--CA 1.494 1.756 0 CA-C-O 121.694 0.759 . . . . 0.0 110.075 -179.297 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . 0.545 ' NE2' ' OG1' ' A' ' 51' ' ' THR . 40.5 tt0 -133.13 126.44 31.73 Favored 'General case' 0 N--CA 1.49 1.528 0 CA-C-O 121.493 0.663 . . . . 0.0 109.351 -179.803 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 34.1 m -81.13 141.21 15.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.477 -0.764 . . . . 0.0 109.553 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 87.7 mt-30 -111.54 120.82 43.4 Favored 'General case' 0 N--CA 1.495 1.812 0 CA-C-O 121.799 0.809 . . . . 0.0 109.738 -179.449 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.487 HG12 ' CD1' ' A' ' 58' ' ' LEU . 4.5 t -93.24 99.3 9.45 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 179.655 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.524 HD22 ' C ' ' A' ' 86' ' ' ASN . 0.1 OUTLIER -150.67 -176.7 5.61 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.495 -0.753 . . . . 0.0 109.313 -179.571 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.445 ' CG ' ' H ' ' A' ' 88' ' ' ASN . 14.4 tptm 66.27 -137.93 0.16 Allowed 'General case' 0 N--CA 1.491 1.621 0 CA-C-O 121.806 0.812 . . . . 0.0 110.826 179.588 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . 0.445 ' H ' ' CG ' ' A' ' 87' ' ' LYS . 15.0 m120 -86.14 22.62 1.71 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.474 -0.766 . . . . 0.0 109.227 -179.574 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 30.9 t -58.61 141.78 51.31 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.193 -0.942 . . . . 0.0 109.672 -179.759 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 64.0 m -127.16 152.32 47.5 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.546 -0.721 . . . . 0.0 109.318 -179.735 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 97.3 mt -128.07 131.73 69.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.692 -0.63 . . . . 0.0 109.351 -179.707 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -132.03 131.76 42.78 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.523 -0.736 . . . . 0.0 109.301 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 4.8 ttpm? -79.61 136.69 36.9 Favored 'General case' 0 N--CA 1.489 1.487 0 CA-C-O 121.789 0.804 . . . . 0.0 110.31 -179.588 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 70.9 mt -98.15 132.85 43.32 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.42 -0.8 . . . . 0.0 109.744 -179.797 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 31.3 t -75.51 3.84 8.62 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.481 -0.762 . . . . 0.0 109.342 179.642 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -118.36 90.28 38.22 Favored Pre-proline 0 N--CA 1.495 1.812 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 179.593 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_exo -56.09 147.38 64.93 Favored 'Trans proline' 0 N--CA 1.495 1.606 0 C-N-CA 122.829 2.353 . . . . 0.0 112.394 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 90.6 mt -97.43 125.82 50.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.299 -0.876 . . . . 0.0 109.869 -179.205 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 81.2 tt0 -90.49 124.05 34.67 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.557 -0.714 . . . . 0.0 109.989 -179.378 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 61.2 t -107.27 -14.3 9.55 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.918 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 179.496 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -75.1 55.46 2.71 Favored Glycine 0 N--CA 1.493 2.469 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 80.8 mt -88.32 -1.73 58.2 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.233 -1.157 . . . . 0.0 108.618 179.722 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -57.33 137.09 56.49 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.205 -0.934 . . . . 0.0 110.375 -179.524 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 61.0 t-80 -145.9 145.23 30.62 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.395 -0.816 . . . . 0.0 108.909 179.787 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 95.9 m-70 -114.04 -162.97 0.83 Allowed 'General case' 0 N--CA 1.498 1.947 0 CA-C-O 121.858 0.837 . . . . 0.0 110.71 -178.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 49.5 p-80 -69.72 139.71 53.41 Favored 'General case' 0 N--CA 1.49 1.533 0 CA-C-O 121.906 0.86 . . . . 0.0 110.957 -179.159 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 77.8 m80 -67.38 -41.99 84.12 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.476 -0.765 . . . . 0.0 109.367 179.637 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . 0.434 ' ND1' ' C ' ' A' ' 108' ' ' HIS . 2.1 p80 -155.23 165.18 37.47 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.187 -0.946 . . . . 0.0 109.921 -179.973 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 48.7 t-80 . . . . . 0 N--CA 1.492 1.663 0 CA-C-O 118.017 -0.992 . . . . 0.0 110.006 179.926 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 96.1 mtp . . . . . 0 N--CA 1.49 1.558 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.632 ' N ' ' CD ' ' A' ' 3' ' ' PRO . 4.1 tt0 -87.83 -41.28 0.5 Allowed Pre-proline 0 N--CA 1.496 1.831 0 O-C-N 121.705 -0.622 . . . . 0.0 109.734 179.467 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.632 ' CD ' ' N ' ' A' ' 2' ' ' GLU . 23.7 Cg_exo -61.6 146.24 97.04 Favored 'Trans proline' 0 N--CA 1.494 1.517 0 C-N-CA 122.532 2.155 . . . . 0.0 112.261 -179.225 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.419 ' H ' ' HG2' ' A' ' 4' ' ' GLN . 1.1 pt20 -74.88 72.35 2.07 Favored 'General case' 0 C--N 1.3 -1.55 0 CA-C-O 121.786 0.803 . . . . 0.0 109.905 -179.501 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.431 HD23 HD22 ' A' ' 19' ' ' ASN . 18.8 mt -65.74 137.3 57.18 Favored 'General case' 0 N--CA 1.489 1.479 0 CA-C-O 121.453 0.644 . . . . 0.0 109.734 179.882 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 91.8 m -128.54 135.5 49.48 Favored 'General case' 0 N--CA 1.494 1.728 0 CA-C-O 121.836 0.827 . . . . 0.0 109.811 -179.909 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 65.4 mttp -72.92 151.15 42.02 Favored 'General case' 0 N--CA 1.49 1.572 0 CA-C-O 121.704 0.764 . . . . 0.0 109.975 -179.458 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 92.4 mt -63.25 -43.13 98.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 CA-C-O 121.369 0.604 . . . . 0.0 109.379 -179.393 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 8.3 p -65.7 -24.07 33.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 -179.05 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -79.05 -6.47 56.48 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.639 -0.663 . . . . 0.0 109.327 -179.434 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 97.5 mt -85.89 113.79 24.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 CA-C-O 121.78 0.8 . . . . 0.0 109.543 179.907 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 31.7 m -150.12 12.21 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -124.97 137.51 54.25 Favored 'General case' 0 N--CA 1.501 2.123 0 CA-C-O 121.884 0.85 . . . . 0.0 110.268 -179.861 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 48.1 p-10 -84.08 140.8 31.58 Favored 'General case' 0 N--CA 1.489 1.518 0 CA-C-O 121.619 0.723 . . . . 0.0 109.881 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 75.99 19.0 79.16 Favored Glycine 0 N--CA 1.492 2.407 0 N-CA-C 109.647 -1.381 . . . . 0.0 109.647 179.626 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 57.0 tt0 -78.77 133.82 37.07 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.59 -0.947 . . . . 0.0 110.209 -179.623 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 84.3 m95 -106.78 130.64 54.45 Favored 'General case' 0 N--CA 1.494 1.748 0 CA-C-O 121.585 0.707 . . . . 0.0 110.148 -179.751 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -178.9 175.51 1.01 Allowed 'General case' 0 N--CA 1.493 1.689 0 CA-C-O 121.693 0.758 . . . . 0.0 110.391 179.248 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.522 HD21 HD11 ' A' ' 68' ' ' LEU . 1.4 t30 -102.05 150.01 23.67 Favored 'General case' 0 N--CA 1.498 1.944 0 CA-C-O 121.902 0.858 . . . . 0.0 110.137 -179.432 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 7.2 tt -147.56 138.2 23.32 Favored 'General case' 0 C--N 1.305 -1.36 0 CA-C-O 121.779 0.8 . . . . 0.0 110.449 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 37.8 ttmt -109.83 133.22 53.4 Favored 'General case' 0 N--CA 1.496 1.863 0 CA-C-O 121.594 0.711 . . . . 0.0 109.561 179.477 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -163.18 170.5 17.68 Favored 'General case' 0 N--CA 1.494 1.746 0 CA-C-O 121.762 0.791 . . . . 0.0 110.589 179.718 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.417 ' HZ3' ' N ' ' A' ' 65' ' ' GLU . 17.1 ttmm -113.83 142.31 46.24 Favored 'General case' 0 N--CA 1.498 1.957 0 CA-C-O 121.608 0.718 . . . . 0.0 109.934 -179.717 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.402 HG22 ' CD2' ' A' ' 41' ' ' LEU . 98.8 t -81.98 122.2 36.43 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 CA-C-O 121.528 0.68 . . . . 0.0 110.239 -179.515 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 26.0 mm -93.88 -44.98 13.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 CA-C-O 121.086 0.469 . . . . 0.0 110.031 -179.507 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.825 ' C ' HD13 ' A' ' 27' ' ' LEU . 59.3 tt0 -158.14 147.62 19.66 Favored 'General case' 0 N--CA 1.492 1.642 0 CA-C-O 122.182 0.992 . . . . 0.0 110.334 -179.072 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 1.041 HD22 ' H ' ' A' ' 27' ' ' LEU . 0.0 OUTLIER -116.87 151.46 36.52 Favored 'General case' 0 N--CA 1.502 2.13 0 CA-C-O 121.632 0.729 . . . . 0.0 109.272 -179.205 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 23.9 t90 -138.15 111.18 7.8 Favored 'General case' 0 N--CA 1.493 1.675 0 CA-C-O 121.879 0.847 . . . . 0.0 109.678 179.148 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -52.8 132.01 36.03 Favored 'General case' 0 N--CA 1.491 1.602 0 CA-C-O 121.675 0.75 . . . . 0.0 110.168 -179.618 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.41 HD22 ' HB ' ' A' ' 35' ' ' ILE . 59.9 t30 -88.74 172.05 9.52 Favored 'General case' 0 N--CA 1.491 1.614 0 CA-C-O 121.556 0.693 . . . . 0.0 110.112 -179.369 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 65.1 p -101.8 1.05 36.75 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.799 -0.563 . . . . 0.0 109.688 -179.126 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 65.3 m80 -105.04 139.11 40.21 Favored 'General case' 0 N--CA 1.501 2.079 0 CA-C-O 122.03 0.919 . . . . 0.0 110.531 -179.423 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -68.51 -37.23 79.86 Favored 'General case' 0 N--CA 1.491 1.607 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.853 -179.61 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 16.4 m -62.54 -36.31 82.21 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 -179.672 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.41 ' HB ' HD22 ' A' ' 30' ' ' ASN . 85.6 mt -103.07 128.61 55.86 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 CA-C-O 121.912 0.863 . . . . 0.0 109.39 -179.56 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 28.1 t -74.92 -75.14 0.17 Allowed 'General case' 0 N--CA 1.489 1.52 0 CA-C-O 121.508 0.67 . . . . 0.0 109.852 -179.273 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 13.1 pt20 -139.78 156.51 46.72 Favored 'General case' 0 N--CA 1.494 1.736 0 CA-C-O 122.045 0.926 . . . . 0.0 110.488 -179.064 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 56.6 t -130.92 136.15 58.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 CA-C-O 121.639 0.733 . . . . 0.0 109.367 179.856 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -153.63 -151.26 5.69 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 110.11 -1.196 . . . . 0.0 110.11 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.4 HD23 ' N ' ' A' ' 40' ' ' LEU . 0.2 OUTLIER -134.48 152.09 51.56 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.739 -0.859 . . . . 0.0 109.772 -179.414 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.402 ' CD2' HG22 ' A' ' 24' ' ' VAL . 53.0 mt -116.85 126.46 53.05 Favored 'General case' 0 N--CA 1.494 1.753 0 CA-C-O 121.84 0.829 . . . . 0.0 109.77 -179.867 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -85.08 150.59 25.07 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 110.959 -0.856 . . . . 0.0 110.959 -179.573 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 44.3 t0 -168.55 164.37 12.46 Favored 'General case' 0 N--CA 1.489 1.494 0 CA-C-O 121.723 0.773 . . . . 0.0 109.583 179.335 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -66.06 -22.38 66.42 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.864 -0.523 . . . . 0.0 109.923 -179.181 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 65.5 p -88.48 -6.02 57.88 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.289 -0.882 . . . . 0.0 109.723 -179.433 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 134.45 -157.65 23.03 Favored Glycine 0 N--CA 1.5 2.956 0 C-N-CA 120.347 -0.93 . . . . 0.0 110.987 178.709 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 4.9 mp -126.02 133.68 68.34 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 CA-C-O 121.491 0.662 . . . . 0.0 109.539 -179.465 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 20.0 tt -127.67 151.83 34.99 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 CA-C-O 122.023 0.916 . . . . 0.0 110.439 -179.457 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 28.2 mmtp -83.94 153.24 24.04 Favored 'General case' 0 N--CA 1.489 1.507 0 CA-C-O 121.543 0.687 . . . . 0.0 109.709 -179.346 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 17.2 p90 -147.2 154.99 41.71 Favored 'General case' 0 N--CA 1.491 1.623 0 CA-C-O 122.03 0.919 . . . . 0.0 110.289 179.8 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 13.8 t -142.22 139.05 31.88 Favored 'General case' 0 N--CA 1.492 1.648 0 CA-C-O 121.684 0.755 . . . . 0.0 109.629 179.493 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 85.8 mt -103.83 116.37 47.49 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 CA-C-O 121.84 0.828 . . . . 0.0 109.803 -179.793 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 73.3 m95 -86.04 138.42 31.97 Favored 'General case' 0 N--CA 1.491 1.591 0 CA-C-O 121.537 0.684 . . . . 0.0 109.402 179.8 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 18.8 mmmt -88.24 49.2 1.75 Allowed 'General case' 0 N--CA 1.491 1.587 0 CA-C-O 121.451 0.643 . . . . 0.0 109.453 -179.739 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 95.9 m-20 -69.69 -2.29 11.39 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -159.08 -88.61 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.541 -0.725 . . . . 0.0 109.564 179.538 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 179.15 71.56 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.87 0 CA-C-O 121.755 0.788 . . . . 0.0 109.485 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 14.8 mt -90.7 143.47 29.0 Favored Pre-proline 0 N--CA 1.488 1.473 0 O-C-N 121.519 -0.738 . . . . 0.0 109.333 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -71.54 156.37 58.05 Favored 'Trans proline' 0 C--N 1.31 -1.468 0 C-N-CA 122.561 2.174 . . . . 0.0 112.711 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 82.9 mt -72.41 144.98 47.96 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-O 121.894 0.855 . . . . 0.0 110.706 -179.439 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.568 ' N ' HD12 ' A' ' 61' ' ' LEU . 9.9 mp -86.86 137.62 32.25 Favored 'General case' 0 N--CA 1.488 1.427 0 CA-C-O 121.554 0.693 . . . . 0.0 109.625 -179.71 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.529 ' N ' ' OH ' ' A' ' 67' ' ' TYR . 97.8 mt-10 -80.74 144.9 31.83 Favored 'General case' 0 C--N 1.301 -1.516 0 CA-C-O 121.659 0.742 . . . . 0.0 110.27 -179.778 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.417 ' C ' ' OE1' ' A' ' 65' ' ' GLU . 57.9 tt0 -80.85 125.78 30.52 Favored 'General case' 0 N--CA 1.488 1.465 0 CA-C-O 121.541 0.686 . . . . 0.0 110.437 -179.231 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 96.62 31.46 7.08 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.382 -1.487 . . . . 0.0 109.382 179.304 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.45 ' OE1' ' N ' ' A' ' 65' ' ' GLU . 59.9 mp0 -139.53 145.48 38.74 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.54 -0.977 . . . . 0.0 110.142 179.472 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 30.0 t -75.79 145.14 40.94 Favored 'General case' 0 N--CA 1.489 1.478 0 CA-C-O 121.481 0.658 . . . . 0.0 110.087 -179.908 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.529 ' OH ' ' N ' ' A' ' 62' ' ' GLU . 94.0 m-85 -137.03 144.76 43.4 Favored 'General case' 0 N--CA 1.494 1.726 0 CA-C-O 121.9 0.857 . . . . 0.0 110.477 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.567 HD13 ' N ' ' A' ' 69' ' ' LEU . 0.2 OUTLIER -107.0 119.93 40.7 Favored 'General case' 0 N--CA 1.487 1.414 0 CA-C-O 121.551 0.691 . . . . 0.0 109.405 -179.541 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.567 ' N ' HD13 ' A' ' 68' ' ' LEU . 73.4 mt -93.83 110.44 22.09 Favored 'General case' 0 N--CA 1.491 1.591 0 CA-C-O 121.521 0.677 . . . . 0.0 109.335 179.909 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.532 ' NH2' ' OE1' ' A' ' 92' ' ' GLU . 94.6 mtt180 -102.36 135.39 44.05 Favored 'General case' 0 N--CA 1.492 1.656 0 CA-C-O 121.966 0.888 . . . . 0.0 110.438 -179.774 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 13.4 m 39.85 79.77 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.673 0 CA-C-N 115.03 -0.986 . . . . 0.0 110.806 179.86 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 22.3 m -120.98 163.34 18.76 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 CA-C-O 121.594 0.711 . . . . 0.0 109.921 179.082 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 8.4 p -120.96 135.98 59.41 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 CA-C-O 121.731 0.777 . . . . 0.0 109.953 -179.251 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 9.4 t -91.34 115.76 31.13 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 CA-C-O 121.809 0.814 . . . . 0.0 109.867 -179.534 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.504 ' O ' ' NE2' ' A' ' 82' ' ' GLN . . . -99.43 177.37 29.6 Favored Glycine 0 N--CA 1.492 2.427 0 N-CA-C 110.083 -1.207 . . . . 0.0 110.083 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -103.14 115.88 31.43 Favored 'General case' 0 N--CA 1.494 1.742 0 CA-C-O 121.767 0.794 . . . . 0.0 109.718 179.938 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . 0.404 ' HB3' HE21 ' A' ' 82' ' ' GLN . 82.0 t80 -124.88 120.55 31.97 Favored 'General case' 0 N--CA 1.494 1.771 0 CA-C-O 121.832 0.825 . . . . 0.0 109.893 179.833 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 11.6 t-20 55.67 41.39 30.52 Favored 'General case' 0 N--CA 1.491 1.58 0 CA-C-N 116.14 -0.482 . . . . 0.0 109.808 179.448 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 13.7 t0 69.52 -1.85 2.11 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 179.354 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 19.6 mmm180 -104.01 -170.16 1.73 Allowed 'General case' 0 N--CA 1.495 1.783 0 CA-C-O 121.406 0.622 . . . . 0.0 109.867 -179.886 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 78.9 m-85 -122.06 140.18 52.82 Favored 'General case' 0 N--CA 1.497 1.924 0 CA-C-O 121.949 0.88 . . . . 0.0 110.427 -179.128 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . 0.59 ' NE2' ' N ' ' A' ' 82' ' ' GLN . 0.0 OUTLIER -147.92 152.3 37.32 Favored 'General case' 0 N--CA 1.493 1.704 0 CA-C-O 121.623 0.725 . . . . 0.0 109.59 179.401 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 27.1 m -87.67 132.17 33.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 CA-C-O 121.808 0.813 . . . . 0.0 110.291 -179.658 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -109.18 122.64 47.75 Favored 'General case' 0 N--CA 1.496 1.831 0 CA-C-O 121.837 0.827 . . . . 0.0 110.106 -179.439 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 61.9 t -92.4 130.59 41.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 179.451 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 95.0 m-20 -128.92 -177.24 4.13 Favored 'General case' 0 N--CA 1.495 1.797 0 CA-C-O 121.874 0.845 . . . . 0.0 110.462 -179.449 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 63.7 tttp -56.1 -45.41 79.46 Favored 'General case' 0 N--CA 1.488 1.458 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.8 -179.318 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 98.8 m-20 -63.36 -35.54 80.72 Favored 'General case' 0 N--CA 1.488 1.475 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 -179.237 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 69.1 m -71.47 152.2 43.26 Favored 'General case' 0 N--CA 1.493 1.708 0 CA-C-O 121.717 0.77 . . . . 0.0 110.08 -179.752 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 43.7 t -131.93 146.15 51.93 Favored 'General case' 0 N--CA 1.497 1.875 0 CA-C-O 121.559 0.695 . . . . 0.0 109.615 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 96.5 mt -120.39 132.51 69.8 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 CA-C-O 121.697 0.76 . . . . 0.0 109.977 179.88 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.532 ' OE1' ' NH2' ' A' ' 70' ' ' ARG . 77.1 tt0 -123.07 119.33 29.99 Favored 'General case' 0 N--CA 1.495 1.806 0 CA-C-O 121.81 0.814 . . . . 0.0 109.488 179.669 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 37.9 ttmt -75.79 131.85 40.04 Favored 'General case' 0 N--CA 1.488 1.44 0 CA-C-O 121.42 0.629 . . . . 0.0 109.629 179.736 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.431 HD11 HD23 ' A' ' 68' ' ' LEU . 85.4 mt -109.1 140.54 42.53 Favored 'General case' 0 N--CA 1.494 1.775 0 CA-C-O 121.888 0.851 . . . . 0.0 110.04 -179.813 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 90.9 p -79.87 -4.89 54.21 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 109.341 -0.615 . . . . 0.0 109.341 -179.261 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 81.2 mt-10 -97.7 113.67 63.88 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.827 -0.546 . . . . 0.0 109.59 -179.896 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_endo -75.29 155.37 41.59 Favored 'Trans proline' 0 C--N 1.313 -1.301 0 C-N-CA 122.53 2.153 . . . . 0.0 112.256 -179.907 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 89.9 mt -107.44 129.68 60.92 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 CA-C-O 121.899 0.857 . . . . 0.0 110.273 -179.542 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . 0.512 ' OE1' ' N ' ' A' ' 99' ' ' GLU . 57.7 mp0 -81.39 122.03 26.97 Favored 'General case' 0 N--CA 1.489 1.477 0 CA-C-O 121.776 0.798 . . . . 0.0 110.004 -179.403 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 26.9 m -106.41 -3.86 9.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 179.708 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -162.77 118.04 0.8 Allowed Glycine 0 N--CA 1.493 2.492 0 N-CA-C 109.724 -1.351 . . . . 0.0 109.724 179.736 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.558 HD12 ' N ' ' A' ' 102' ' ' LEU . 9.7 mp -88.42 -2.45 58.61 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.744 -0.857 . . . . 0.0 109.202 -179.998 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 72.7 mm-40 -56.36 141.0 43.54 Favored 'General case' 0 N--CA 1.498 1.968 0 CA-C-O 121.647 0.736 . . . . 0.0 110.21 -179.666 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -73.12 -14.26 61.35 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 108.966 -0.754 . . . . 0.0 108.966 -179.442 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 28.8 t-80 -70.27 132.53 45.85 Favored 'General case' 0 N--CA 1.49 1.554 0 CA-C-O 121.498 0.666 . . . . 0.0 109.39 -179.515 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 80.6 m80 -112.32 148.48 34.12 Favored 'General case' 0 N--CA 1.496 1.852 0 CA-C-O 121.87 0.843 . . . . 0.0 109.909 -179.44 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 35.3 m170 -73.32 144.42 46.55 Favored 'General case' 0 N--CA 1.488 1.462 0 CA-C-O 121.797 0.808 . . . . 0.0 110.373 -179.096 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 47.9 p-80 -151.14 164.42 36.54 Favored 'General case' 0 N--CA 1.49 1.553 0 CA-C-O 121.667 0.746 . . . . 0.0 109.949 179.734 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . 0.491 ' OXT' ' CG ' ' A' ' 109' ' ' HIS . 53.9 t-80 . . . . . 0 N--CA 1.493 1.706 0 CA-C-O 118.108 -0.949 . . . . 0.0 109.512 -179.839 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.46 ' O ' ' O ' ' A' ' 2' ' ' GLU . 39.5 tpp . . . . . 0 N--CA 1.489 1.488 0 CA-C-O 121.361 0.601 . . . . 0.0 109.394 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.46 ' O ' ' O ' ' A' ' 1' ' ' MET . 19.0 mm-40 57.09 149.27 0.06 OUTLIER Pre-proline 0 N--CA 1.494 1.761 0 CA-C-O 121.092 0.472 . . . . 0.0 110.376 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -67.72 146.32 72.49 Favored 'Trans proline' 0 N--CA 1.496 1.654 0 C-N-CA 122.539 2.159 . . . . 0.0 112.568 -179.881 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 87.3 mt-30 -77.43 91.78 3.92 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.328 -0.857 . . . . 0.0 109.106 -179.935 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 79.5 mt -72.91 125.77 28.35 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.456 -0.777 . . . . 0.0 109.858 -179.229 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 98.8 m -127.12 132.49 50.58 Favored 'General case' 0 N--CA 1.498 1.927 0 CA-C-O 121.456 0.646 . . . . 0.0 109.327 179.878 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -74.76 153.31 38.85 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.555 -0.716 . . . . 0.0 110.415 -179.164 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 96.1 mt -62.52 -43.79 98.71 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.534 -0.729 . . . . 0.0 109.567 -179.691 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 11.7 p -64.05 -24.12 34.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.504 -0.747 . . . . 0.0 109.875 -179.341 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.434 ' OD1' ' O ' ' A' ' 10' ' ' ASP . 60.1 t0 -76.27 -5.88 48.97 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.202 -0.936 . . . . 0.0 109.644 -179.723 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 96.5 mt -84.01 120.39 34.83 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.078 -1.014 . . . . 0.0 109.886 -179.893 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 16.1 m -135.79 -0.04 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 179.352 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 49.9 tp10 -139.9 141.81 36.53 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.394 -0.816 . . . . 0.0 109.719 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 56.4 p30 -87.49 161.2 17.94 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.654 -0.654 . . . . 0.0 110.044 -179.859 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 81.93 14.72 76.79 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 108.816 -1.714 . . . . 0.0 108.816 -179.722 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 56.3 mt-30 -78.98 132.72 36.77 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.496 -1.002 . . . . 0.0 110.285 -179.752 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 92.2 m95 -105.32 106.57 17.13 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 179.407 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -156.82 -178.16 7.15 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.171 -0.955 . . . . 0.0 109.861 -179.727 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.504 HD21 ' CD1' ' A' ' 68' ' ' LEU . 0.6 OUTLIER -103.94 141.42 36.2 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.607 -0.683 . . . . 0.0 109.673 -179.743 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 92.2 mt -134.45 150.63 50.85 Favored 'General case' 0 N--CA 1.496 1.838 0 CA-C-O 121.652 0.739 . . . . 0.0 110.017 -179.816 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 35.7 ttpt -135.21 138.74 43.9 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 179.817 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -166.57 -171.44 1.88 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.157 -0.965 . . . . 0.0 110.396 -179.642 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 21.1 ptmt -121.85 144.73 48.66 Favored 'General case' 0 N--CA 1.496 1.858 0 CA-C-O 121.495 0.664 . . . . 0.0 109.584 -179.682 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 79.9 t -82.76 129.03 38.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.321 -0.862 . . . . 0.0 110.403 -179.284 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 96.7 mt -102.07 -51.52 9.14 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 179.501 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 52.5 tt0 -145.86 144.79 30.44 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.35 -0.844 . . . . 0.0 109.033 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -132.21 132.53 43.2 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.836 -0.54 . . . . 0.0 109.644 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 94.4 m95 -112.16 135.64 52.56 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.676 -0.64 . . . . 0.0 109.324 179.842 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 80.5 tt0 -91.17 136.91 32.76 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.439 -0.788 . . . . 0.0 110.146 -179.399 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.499 ' ND2' ' O ' ' A' ' 35' ' ' ILE . 20.6 p-10 -102.66 177.11 4.95 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.589 -0.694 . . . . 0.0 109.725 179.895 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.427 HG22 ' O ' ' A' ' 31' ' ' THR . 75.7 m -104.76 -10.99 17.05 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.614 -0.679 . . . . 0.0 109.394 179.873 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 99.5 m-70 -82.54 136.9 34.74 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.138 -0.977 . . . . 0.0 110.316 -179.31 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -70.65 -30.97 67.73 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.545 -0.722 . . . . 0.0 109.967 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 96.5 p -58.12 -34.46 70.25 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.265 -0.897 . . . . 0.0 109.852 -179.033 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.499 ' O ' ' ND2' ' A' ' 30' ' ' ASN . 96.8 mt -121.16 134.02 65.88 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.95 0 O-C-N 121.563 -0.71 . . . . 0.0 109.894 -179.907 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.407 ' O ' ' OD1' ' A' ' 30' ' ' ASN . 33.2 t -85.08 -71.76 0.51 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.653 -0.654 . . . . 0.0 109.802 -179.807 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 46.6 mt-30 -134.01 156.64 47.82 Favored 'General case' 0 N--CA 1.498 1.931 0 CA-C-O 121.794 0.807 . . . . 0.0 110.451 -179.035 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.8 p -139.65 139.85 37.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 179.727 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -167.38 -147.75 5.39 Favored Glycine 0 N--CA 1.49 2.256 0 C-N-CA 119.395 -1.383 . . . . 0.0 110.187 -179.827 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -133.7 152.19 51.82 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.662 -0.904 . . . . 0.0 109.951 -179.545 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 73.6 mt -115.5 131.39 56.95 Favored 'General case' 0 N--CA 1.494 1.745 0 CA-C-O 121.534 0.683 . . . . 0.0 109.291 179.712 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -80.79 160.91 43.62 Favored Glycine 0 N--CA 1.486 2.03 0 N-CA-C 110.613 -0.995 . . . . 0.0 110.613 -179.346 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -174.29 146.01 1.06 Allowed 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 179.508 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -57.36 -15.15 5.7 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.346 -0.846 . . . . 0.0 109.906 -179.603 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 42.1 p -94.69 -7.87 39.45 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.224 -0.923 . . . . 0.0 109.854 -179.709 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 138.77 -157.06 24.56 Favored Glycine 0 N--CA 1.5 2.936 0 N-CA-C 110.527 -1.029 . . . . 0.0 110.527 179.217 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 40.9 pt -124.87 153.83 32.23 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.005 0 O-C-N 121.856 -0.791 . . . . 0.0 109.517 -179.874 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 20.0 tt -147.31 149.5 15.53 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.253 -0.905 . . . . 0.0 109.937 179.667 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 18.9 mmmt -83.28 148.68 27.24 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.748 -0.595 . . . . 0.0 110.175 -179.605 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 16.1 p90 -143.88 153.63 42.53 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.441 -0.787 . . . . 0.0 109.435 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 87.9 m -134.14 135.57 43.24 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 179.711 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 91.9 mt -101.63 126.03 55.61 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.398 -0.814 . . . . 0.0 109.601 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 93.5 m95 -96.14 139.73 31.89 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.524 -0.735 . . . . 0.0 109.529 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 50.9 mtpt -79.33 -11.54 59.93 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.529 -0.732 . . . . 0.0 109.124 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 93.6 m-20 -61.46 -40.94 96.34 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.434 -0.791 . . . . 0.0 109.213 -179.732 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -75.66 -10.95 59.88 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 121.307 -0.871 . . . . 0.0 109.139 179.712 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 55.77 62.4 2.42 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.743 -0.598 . . . . 0.0 109.92 -179.858 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 36.6 mt -105.31 147.6 34.86 Favored Pre-proline 0 N--CA 1.496 1.844 0 O-C-N 121.649 -0.657 . . . . 0.0 109.617 179.797 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -69.98 162.03 43.73 Favored 'Trans proline' 0 N--CA 1.498 1.745 0 C-N-CA 122.911 2.408 . . . . 0.0 113.195 179.708 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 65.6 mt -69.0 143.55 54.34 Favored 'General case' 0 N--CA 1.493 1.69 0 CA-C-O 121.742 0.782 . . . . 0.0 110.388 -179.215 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.599 ' N ' HD12 ' A' ' 61' ' ' LEU . 9.7 mp -92.81 141.68 28.17 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.672 -0.643 . . . . 0.0 110.048 -179.186 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -85.1 152.03 23.7 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.424 -0.797 . . . . 0.0 110.342 -179.644 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 55.4 tt0 -81.98 138.46 34.92 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.616 -0.678 . . . . 0.0 110.822 -179.336 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 79.88 23.6 61.55 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 110.105 -1.198 . . . . 0.0 110.105 178.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -126.94 146.59 50.26 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.441 -1.034 . . . . 0.0 110.307 -179.796 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 12.8 p -83.01 146.44 28.75 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 179.745 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 65.4 m-85 -140.36 145.07 36.65 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.438 -0.789 . . . . 0.0 110.007 179.775 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.504 ' CD1' HD21 ' A' ' 19' ' ' ASN . 17.8 tp -105.59 123.1 47.36 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 179.106 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.408 ' O ' ' OD1' ' A' ' 19' ' ' ASN . 67.5 mt -103.81 125.25 50.12 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 179.899 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 82.5 mtp180 -114.53 134.81 54.74 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.69 -0.631 . . . . 0.0 110.054 -179.755 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 31.2 t 60.46 73.72 0.47 Allowed 'General case' 0 N--CA 1.493 1.687 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.791 179.65 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 3.7 m -124.6 159.32 30.93 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.129 0 O-C-N 121.605 -0.684 . . . . 0.0 109.294 178.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 13.6 p -121.74 135.09 62.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 -179.807 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 13.4 t -84.74 118.89 32.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.483 -0.761 . . . . 0.0 110.306 -178.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -97.22 171.34 26.77 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 179.723 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -111.37 121.3 44.86 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.724 -0.868 . . . . 0.0 109.789 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . 0.509 ' CZ ' ' OD1' ' A' ' 78' ' ' ASN . 54.8 t80 -134.16 124.96 26.93 Favored 'General case' 0 N--CA 1.495 1.819 0 CA-C-O 121.393 0.616 . . . . 0.0 109.499 179.578 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.509 ' OD1' ' CZ ' ' A' ' 77' ' ' TYR . 6.4 m120 51.56 51.49 16.61 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.648 -0.657 . . . . 0.0 110.574 179.789 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 55.6 2.6 0.07 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.736 -0.602 . . . . 0.0 110.184 179.351 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.487 ' H ' ' C ' ' A' ' 78' ' ' ASN . 18.7 mmm180 -103.88 163.0 12.65 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.378 -0.826 . . . . 0.0 109.704 -179.912 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 69.7 m-85 -95.71 143.51 26.9 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.449 -0.782 . . . . 0.0 109.748 -179.283 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -146.3 159.97 42.64 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.517 -0.739 . . . . 0.0 109.436 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.407 ' O ' HG23 ' A' ' 83' ' ' VAL . 33.2 m -111.44 128.31 68.03 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 179.431 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 76.8 mt-30 -109.42 124.67 51.4 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.563 -0.711 . . . . 0.0 109.474 -179.345 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 10.7 t -97.18 106.78 18.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.385 -0.822 . . . . 0.0 109.611 -179.773 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -152.04 -177.43 6.16 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.466 -0.771 . . . . 0.0 109.985 179.934 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 72.5 tttt 66.76 -133.19 0.15 Allowed 'General case' 0 N--CA 1.492 1.667 0 CA-C-O 121.444 0.64 . . . . 0.0 110.932 179.306 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 12.7 m120 -88.52 20.65 3.27 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.432 -0.792 . . . . 0.0 109.246 -179.093 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 15.5 m -60.13 147.65 38.82 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.459 -0.776 . . . . 0.0 109.511 -179.73 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 25.5 m -128.78 152.35 48.55 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.618 -0.676 . . . . 0.0 109.747 -179.81 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 93.9 mt -129.1 133.5 65.77 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 179.785 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -126.42 134.28 51.04 Favored 'General case' 0 N--CA 1.497 1.912 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 179.548 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.443 ' C ' HD22 ' A' ' 94' ' ' LEU . 63.7 tttp -79.79 129.26 34.33 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.41 -0.806 . . . . 0.0 109.837 -179.338 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.444 ' N ' HD22 ' A' ' 94' ' ' LEU . 4.1 mm? -100.54 133.18 45.37 Favored 'General case' 0 N--CA 1.493 1.702 0 CA-C-O 121.756 0.789 . . . . 0.0 109.802 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 23.1 t -85.29 10.43 12.56 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 -179.899 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 22.1 tt0 -118.47 90.24 38.58 Favored Pre-proline 0 N--CA 1.497 1.916 0 O-C-N 121.602 -0.686 . . . . 0.0 109.29 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_exo -56.14 146.84 68.51 Favored 'Trans proline' 0 N--CA 1.498 1.739 0 C-N-CA 122.785 2.323 . . . . 0.0 112.19 179.496 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 93.0 mt -100.43 127.97 52.93 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 O-C-N 121.474 -0.766 . . . . 0.0 109.997 -179.41 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -79.31 148.14 32.22 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.632 -0.667 . . . . 0.0 109.784 -179.865 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 2.5 t -98.66 3.2 10.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 179.803 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 88.9 54.67 2.28 Favored Glycine 0 N--CA 1.493 2.491 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 -179.883 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.518 HD12 ' N ' ' A' ' 102' ' ' LEU . 11.0 mp -63.36 -41.31 98.83 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.453 -1.028 . . . . 0.0 108.949 179.878 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 58.2 tt0 68.16 43.97 1.49 Allowed 'General case' 0 N--CA 1.494 1.747 0 CA-C-O 121.35 0.595 . . . . 0.0 109.697 179.859 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 33.0 p80 -83.42 -15.78 48.38 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.29 -0.881 . . . . 0.0 109.1 179.53 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 86.1 t60 -64.81 -40.67 95.6 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.381 -0.824 . . . . 0.0 109.436 179.746 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 59.2 t-80 -130.74 130.04 43.28 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.511 -0.743 . . . . 0.0 109.886 -179.779 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 86.3 t60 -156.36 72.03 0.73 Allowed 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 179.541 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 43.3 t-80 -151.96 139.54 19.67 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.369 -0.832 . . . . 0.0 109.494 -179.909 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 96.3 m-70 . . . . . 0 N--CA 1.491 1.624 0 CA-C-O 118.108 -0.948 . . . . 0.0 109.963 -179.608 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 97.7 mtp . . . . . 0 N--CA 1.49 1.541 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 24.4 mm-40 -57.41 150.82 41.87 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.855 -0.528 . . . . 0.0 110.208 -179.535 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -64.84 150.82 87.57 Favored 'Trans proline' 0 N--CA 1.49 1.304 0 C-N-CA 122.419 2.08 . . . . 0.0 112.714 -179.934 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.42 ' HG2' ' H ' ' A' ' 4' ' ' GLN . 7.8 pt20 -73.29 89.41 1.57 Allowed 'General case' 0 C--N 1.302 -1.487 0 CA-C-O 121.534 0.683 . . . . 0.0 110.223 -179.326 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 79.6 mt -79.33 139.78 37.71 Favored 'General case' 0 N--CA 1.488 1.474 0 CA-C-O 121.543 0.687 . . . . 0.0 109.734 179.7 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 69.5 m -127.16 130.91 50.66 Favored 'General case' 0 N--CA 1.496 1.854 0 CA-C-O 121.609 0.719 . . . . 0.0 109.666 179.667 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 63.7 mttp -84.23 156.95 21.77 Favored 'General case' 0 N--CA 1.49 1.568 0 CA-C-O 121.785 0.802 . . . . 0.0 109.688 179.914 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 95.6 mt -63.0 -42.58 97.23 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.557 0 CA-C-O 121.28 0.562 . . . . 0.0 109.518 -179.215 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 14.7 p -65.54 -24.04 33.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.605 -0.684 . . . . 0.0 109.559 -179.178 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 -77.03 -7.11 55.09 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.441 -0.787 . . . . 0.0 108.89 -179.455 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 98.6 mt -93.18 116.04 33.39 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 CA-C-O 121.662 0.744 . . . . 0.0 109.719 179.708 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 25.6 m -151.23 14.54 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 179.34 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -137.44 137.17 38.48 Favored 'General case' 0 N--CA 1.494 1.771 0 CA-C-O 121.762 0.792 . . . . 0.0 109.376 179.417 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 7.6 t-20 -74.32 147.59 42.13 Favored 'General case' 0 C--N 1.301 -1.529 0 CA-C-O 121.696 0.76 . . . . 0.0 109.99 -179.622 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 71.58 99.51 0.06 OUTLIER Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 179.92 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 27.5 tt0 -165.17 126.98 2.08 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.732 -0.863 . . . . 0.0 110.098 179.443 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 95.2 m95 -96.6 128.71 43.79 Favored 'General case' 0 N--CA 1.494 1.753 0 CA-C-O 121.477 0.656 . . . . 0.0 109.465 179.926 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.441 ' O ' HG22 ' A' ' 72' ' ' VAL . . . -174.88 177.08 2.07 Favored 'General case' 0 N--CA 1.493 1.717 0 CA-C-O 121.878 0.846 . . . . 0.0 110.419 179.818 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.481 ' ND2' ' H ' ' A' ' 71' ' ' SER . 5.7 m120 -99.24 148.91 23.64 Favored 'General case' 0 N--CA 1.495 1.776 0 CA-C-O 121.728 0.775 . . . . 0.0 109.445 -179.712 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 54.5 tp -139.57 135.94 33.9 Favored 'General case' 0 N--CA 1.487 1.418 0 CA-C-O 121.962 0.887 . . . . 0.0 110.244 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 37.3 ttmt -122.36 132.65 54.49 Favored 'General case' 0 N--CA 1.49 1.566 0 CA-C-O 121.773 0.797 . . . . 0.0 109.121 179.148 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -160.95 178.04 9.78 Favored 'General case' 0 C--N 1.3 -1.555 0 CA-C-O 121.658 0.742 . . . . 0.0 109.808 -179.866 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 63.7 tttp -114.55 145.55 41.81 Favored 'General case' 0 N--CA 1.496 1.839 0 CA-C-O 121.775 0.797 . . . . 0.0 110.332 -178.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 89.5 t -83.54 108.14 15.77 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 CA-C-O 121.684 0.754 . . . . 0.0 110.34 -179.501 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.412 HG12 ' H ' ' A' ' 42' ' ' GLY . 34.3 mm -94.24 -47.37 13.43 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 179.915 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 7.4 tt0 -148.41 140.55 24.06 Favored 'General case' 0 N--CA 1.494 1.774 0 CA-C-O 122.135 0.969 . . . . 0.0 109.968 -179.758 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.483 ' N ' HD23 ' A' ' 27' ' ' LEU . 0.3 OUTLIER -136.57 145.51 45.06 Favored 'General case' 0 N--CA 1.491 1.577 0 CA-C-O 121.956 0.884 . . . . 0.0 110.164 -179.335 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 5.7 m-90 -114.13 141.77 47.08 Favored 'General case' 0 N--CA 1.492 1.653 0 CA-C-O 121.648 0.737 . . . . 0.0 109.261 179.041 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.456 ' O ' ' O ' ' A' ' 30' ' ' ASN . 80.9 tt0 -80.44 119.42 23.11 Favored 'General case' 0 C--N 1.303 -1.42 0 CA-C-O 121.602 0.715 . . . . 0.0 109.795 -179.436 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.483 ' ND2' ' O ' ' A' ' 35' ' ' ILE . 16.9 t-20 47.06 -178.5 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.512 0 CA-C-O 121.683 0.754 . . . . 0.0 110.305 179.594 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.481 ' H ' ' CG ' ' A' ' 30' ' ' ASN . 17.9 m -171.2 -41.95 0.02 OUTLIER 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 179.859 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 85.2 t60 -115.94 -83.09 0.63 Allowed 'General case' 0 N--CA 1.499 2.012 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 179.707 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 11.4 tm-20 -165.86 -56.54 0.03 OUTLIER 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.491 -0.755 . . . . 0.0 109.379 179.52 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 12.8 m -79.78 -6.44 57.3 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 109.009 -0.738 . . . . 0.0 109.009 -179.42 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.483 ' O ' ' ND2' ' A' ' 30' ' ' ASN . 96.7 mt -93.17 119.07 40.29 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 CA-C-O 121.839 0.828 . . . . 0.0 109.507 179.794 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 3.6 t -71.3 -56.01 6.88 Favored 'General case' 0 C--N 1.3 -1.546 0 CA-C-O 121.428 0.633 . . . . 0.0 109.525 179.761 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 83.7 mt-30 -147.63 147.6 30.19 Favored 'General case' 0 N--CA 1.49 1.539 0 CA-C-O 121.925 0.869 . . . . 0.0 110.456 -179.286 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.9 p -142.77 142.47 26.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 CA-C-O 121.613 0.72 . . . . 0.0 109.349 179.589 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -171.99 -155.26 10.82 Favored Glycine 0 N--CA 1.491 2.308 0 C-N-CA 119.952 -1.118 . . . . 0.0 110.562 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -132.9 147.52 52.29 Favored 'General case' 0 N--CA 1.494 1.745 0 CA-C-O 121.895 0.855 . . . . 0.0 110.269 -179.463 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 41.1 mt -116.88 130.72 56.89 Favored 'General case' 0 N--CA 1.496 1.83 0 CA-C-O 121.743 0.782 . . . . 0.0 109.407 -179.258 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.412 ' H ' HG12 ' A' ' 25' ' ' ILE . . . -83.15 161.38 39.45 Favored Glycine 0 N--CA 1.495 2.609 0 N-CA-C 111.227 -0.749 . . . . 0.0 111.227 -179.146 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.557 ' OD1' ' N ' ' A' ' 44' ' ' GLU . 62.1 t0 -174.13 150.29 1.54 Allowed 'General case' 0 N--CA 1.493 1.722 0 CA-C-O 122.095 0.95 . . . . 0.0 110.031 179.643 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.557 ' N ' ' OD1' ' A' ' 43' ' ' ASP . 98.0 mt-10 -59.44 -17.67 32.93 Favored 'General case' 0 N--CA 1.491 1.601 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.139 179.979 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 41.6 p -92.25 -11.17 36.02 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 -179.688 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 139.95 -159.87 26.1 Favored Glycine 0 N--CA 1.498 2.77 0 C-N-CA 120.246 -0.978 . . . . 0.0 111.123 178.934 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 96.4 mt -125.21 132.86 70.64 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 CA-C-O 121.773 0.797 . . . . 0.0 109.993 -179.23 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 18.0 tt -131.17 148.43 32.91 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 CA-C-O 121.934 0.873 . . . . 0.0 110.421 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 54.7 mtpt -92.91 151.04 20.18 Favored 'General case' 0 N--CA 1.494 1.741 0 CA-C-O 121.713 0.768 . . . . 0.0 110.16 -179.841 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 5.8 p90 -142.84 152.99 42.75 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-O 122.003 0.906 . . . . 0.0 109.975 179.871 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 84.9 m -130.2 130.98 45.36 Favored 'General case' 0 N--CA 1.493 1.692 0 CA-C-O 121.864 0.84 . . . . 0.0 109.203 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 95.7 mt -100.26 121.93 51.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 CA-C-O 121.791 0.805 . . . . 0.0 110.049 -179.496 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 96.1 m95 -98.0 133.57 42.29 Favored 'General case' 0 N--CA 1.495 1.799 0 CA-C-O 121.551 0.691 . . . . 0.0 109.349 179.782 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 16.4 ptpt -89.25 53.35 2.62 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.759 -0.588 . . . . 0.0 109.83 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 99.3 m-20 -77.77 -1.89 33.62 Favored 'General case' 0 N--CA 1.496 1.856 0 CA-C-O 121.373 0.606 . . . . 0.0 109.401 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -154.63 -88.6 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.415 -0.803 . . . . 0.0 109.273 179.755 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 178.95 77.9 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.739 0 CA-C-O 121.582 0.706 . . . . 0.0 109.892 -179.798 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 11.4 mt -89.73 148.16 39.31 Favored Pre-proline 0 N--CA 1.491 1.593 0 N-CA-C 108.633 -0.876 . . . . 0.0 108.633 179.16 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -68.86 153.46 72.76 Favored 'Trans proline' 0 C--N 1.312 -1.358 0 C-N-CA 122.403 2.069 . . . . 0.0 112.646 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 71.4 mt -72.75 142.95 48.14 Favored 'General case' 0 C--N 1.301 -1.525 0 CA-C-O 121.678 0.752 . . . . 0.0 109.968 -179.754 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.542 ' N ' HD12 ' A' ' 61' ' ' LEU . 10.5 mp -87.84 135.49 33.37 Favored 'General case' 0 N--CA 1.49 1.554 0 CA-C-O 121.715 0.769 . . . . 0.0 109.707 -179.805 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 46.1 tp10 -93.78 144.85 25.05 Favored 'General case' 0 N--CA 1.49 1.558 0 CA-C-O 121.89 0.852 . . . . 0.0 109.685 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 57.5 tt0 -79.15 143.74 35.16 Favored 'General case' 0 C--N 1.299 -1.597 0 CA-C-O 121.677 0.751 . . . . 0.0 110.318 -179.614 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 82.08 23.8 56.4 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 110.036 -1.226 . . . . 0.0 110.036 179.054 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.513 ' OE1' ' NZ ' ' A' ' 93' ' ' LYS . 95.8 mt-10 -136.55 144.91 44.48 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.384 -1.068 . . . . 0.0 110.109 179.672 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 12.2 p -89.23 145.69 25.24 Favored 'General case' 0 N--CA 1.489 1.496 0 CA-C-O 121.702 0.763 . . . . 0.0 110.223 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -137.71 152.61 49.42 Favored 'General case' 0 N--CA 1.494 1.734 0 CA-C-O 122.122 0.963 . . . . 0.0 110.323 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 32.3 tp -111.1 121.55 45.62 Favored 'General case' 0 N--CA 1.494 1.733 0 CA-C-N 115.488 -0.778 . . . . 0.0 109.64 179.864 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 74.0 mt -102.15 133.1 47.55 Favored 'General case' 0 N--CA 1.494 1.728 0 CA-C-O 121.726 0.774 . . . . 0.0 109.373 179.538 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 86.8 mtm180 -129.61 147.35 51.4 Favored 'General case' 0 N--CA 1.495 1.819 0 CA-C-O 121.924 0.869 . . . . 0.0 110.51 -179.287 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.481 ' H ' ' ND2' ' A' ' 19' ' ' ASN . 1.7 m 56.46 55.34 6.61 Favored 'General case' 0 N--CA 1.494 1.729 0 CA-C-N 115.606 -0.725 . . . . 0.0 110.415 179.354 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.441 HG22 ' O ' ' A' ' 18' ' ' ALA . 12.5 m -111.12 158.19 11.71 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 CA-C-O 121.626 0.727 . . . . 0.0 109.972 179.369 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 13.5 p -116.7 134.88 58.82 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 CA-C-O 121.828 0.823 . . . . 0.0 109.677 -179.631 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 11.7 t -86.27 115.48 27.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 CA-C-O 121.862 0.839 . . . . 0.0 109.88 -179.433 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -100.96 175.25 26.1 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 110.074 -1.21 . . . . 0.0 110.074 -179.776 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 48.0 tp10 -111.51 121.39 45.05 Favored 'General case' 0 N--CA 1.493 1.699 0 CA-C-O 121.829 0.824 . . . . 0.0 109.673 -179.906 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 87.3 t80 -136.58 125.37 24.01 Favored 'General case' 0 N--CA 1.492 1.655 0 CA-C-O 121.865 0.84 . . . . 0.0 110.14 179.834 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.488 ' C ' ' H ' ' A' ' 80' ' ' ARG . 10.7 t-20 56.27 43.33 26.65 Favored 'General case' 0 N--CA 1.488 1.46 0 CA-C-N 116.081 -0.509 . . . . 0.0 109.781 179.193 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 48.2 t0 62.64 -1.36 0.45 Allowed 'General case' 0 N--CA 1.493 1.725 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 179.641 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.488 ' H ' ' C ' ' A' ' 78' ' ' ASN . 83.2 mtp180 -100.09 178.23 4.85 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.606 -0.684 . . . . 0.0 109.986 179.868 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 78.3 m-85 -112.94 138.15 50.24 Favored 'General case' 0 N--CA 1.498 1.953 0 CA-C-O 122.086 0.946 . . . . 0.0 110.062 -179.303 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -147.09 163.0 37.68 Favored 'General case' 0 N--CA 1.489 1.52 0 CA-C-O 121.829 0.823 . . . . 0.0 110.292 179.936 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 2.5 m -106.24 131.65 55.38 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 -179.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 86.7 mt-30 -104.91 122.6 46.15 Favored 'General case' 0 N--CA 1.495 1.807 0 CA-C-O 122.107 0.956 . . . . 0.0 110.364 -179.172 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 18.2 t -93.93 129.73 43.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 CA-C-O 121.947 0.879 . . . . 0.0 109.765 -179.875 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 81.7 m-20 -134.82 -174.74 3.68 Favored 'General case' 0 N--CA 1.493 1.702 0 CA-C-O 121.452 0.644 . . . . 0.0 109.309 179.79 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 24.8 pttm -58.88 -34.75 72.0 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.858 -0.526 . . . . 0.0 109.924 -179.296 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 38.7 t30 -64.11 -38.07 89.74 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 10.0 m -72.76 156.33 39.04 Favored 'General case' 0 N--CA 1.492 1.675 0 CA-C-O 121.709 0.766 . . . . 0.0 110.73 -179.153 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 88.2 p -129.52 151.36 50.22 Favored 'General case' 0 N--CA 1.493 1.717 0 CA-C-O 121.692 0.758 . . . . 0.0 109.759 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 94.8 mt -124.65 132.79 70.85 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 CA-C-O 121.572 0.701 . . . . 0.0 109.572 -179.508 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 81.6 tt0 -130.13 134.37 47.29 Favored 'General case' 0 N--CA 1.497 1.881 0 CA-C-O 121.996 0.903 . . . . 0.0 109.838 179.621 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.513 ' NZ ' ' OE1' ' A' ' 65' ' ' GLU . 64.1 tttp -79.95 134.45 36.26 Favored 'General case' 0 N--CA 1.489 1.478 0 CA-C-O 121.748 0.785 . . . . 0.0 110.117 179.933 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 73.6 mt -100.88 133.76 44.87 Favored 'General case' 0 N--CA 1.492 1.67 0 CA-C-O 121.689 0.757 . . . . 0.0 109.726 179.626 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 88.8 p -78.74 -5.52 53.43 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 -179.604 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 21.5 tp10 -111.82 121.03 40.81 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.794 -0.567 . . . . 0.0 109.894 -179.751 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -74.29 154.25 46.03 Favored 'Trans proline' 0 N--CA 1.488 1.202 0 C-N-CA 122.511 2.141 . . . . 0.0 112.065 179.63 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 96.7 mt -109.28 128.27 65.36 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 CA-C-O 121.915 0.864 . . . . 0.0 110.364 -179.603 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -86.26 136.12 33.29 Favored 'General case' 0 N--CA 1.495 1.82 0 CA-C-O 121.741 0.781 . . . . 0.0 110.388 -179.26 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 18.3 m -108.01 -4.66 10.44 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 N-CA-C 109.055 -0.721 . . . . 0.0 109.055 179.918 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 141.41 42.7 0.07 OUTLIER Glycine 0 N--CA 1.499 2.859 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 179.299 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.578 ' N ' HD12 ' A' ' 102' ' ' LEU . 10.2 mp -87.78 -6.7 58.04 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.647 -0.913 . . . . 0.0 108.657 179.684 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -66.62 176.94 1.73 Allowed 'General case' 0 N--CA 1.489 1.513 0 CA-C-O 121.709 0.766 . . . . 0.0 110.374 -179.892 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . 0.448 ' O ' ' CG ' ' A' ' 105' ' ' HIS . 33.8 p-80 -57.22 -42.9 82.21 Favored 'General case' 0 N--CA 1.49 1.574 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.736 -179.473 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . 0.448 ' CG ' ' O ' ' A' ' 104' ' ' HIS . 87.4 m-70 -156.8 117.62 3.67 Favored 'General case' 0 N--CA 1.493 1.699 0 CA-C-O 121.771 0.796 . . . . 0.0 110.001 179.605 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 86.6 t60 -92.08 -6.69 50.47 Favored 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 179.742 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 84.7 t60 -62.09 -42.38 99.16 Favored 'General case' 0 N--CA 1.492 1.652 0 CA-C-O 121.44 0.638 . . . . 0.0 109.573 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 58.0 t-80 -77.87 128.81 34.54 Favored 'General case' 0 C--N 1.303 -1.424 0 CA-C-O 121.7 0.762 . . . . 0.0 110.285 -179.177 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 56.0 p-80 . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 117.977 -1.011 . . . . 0.0 109.539 179.542 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 49.7 ttp . . . . . 0 N--CA 1.49 1.573 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.504 ' N ' ' CD ' ' A' ' 3' ' ' PRO . 28.3 tt0 -161.61 51.38 0.34 Allowed Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.355 -0.84 . . . . 0.0 109.169 179.446 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.504 ' CD ' ' N ' ' A' ' 2' ' ' GLU . 34.2 Cg_endo -62.83 143.52 91.86 Favored 'Trans proline' 0 N--CA 1.497 1.703 0 C-N-CA 122.891 2.394 . . . . 0.0 112.312 -179.938 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.401 ' N ' ' CD ' ' A' ' 4' ' ' GLN . 28.2 mp0 -84.49 89.41 7.42 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.057 -1.027 . . . . 0.0 109.664 -179.581 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -73.73 142.02 46.33 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.456 -0.777 . . . . 0.0 109.351 179.616 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 98.4 m -122.77 129.2 51.46 Favored 'General case' 0 N--CA 1.498 1.962 0 CA-C-O 121.666 0.746 . . . . 0.0 109.812 -179.7 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -85.42 159.36 19.99 Favored 'General case' 0 N--CA 1.491 1.618 0 CA-C-O 121.609 0.719 . . . . 0.0 110.051 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 33.0 mm -63.85 -43.38 97.82 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 O-C-N 121.275 -0.89 . . . . 0.0 109.198 179.893 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 12.6 p -65.02 -22.53 31.6 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 O-C-N 121.47 -0.769 . . . . 0.0 109.529 -179.692 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -74.79 -7.03 52.15 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.092 -1.005 . . . . 0.0 109.257 179.45 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 96.7 mt -83.11 120.83 35.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.232 -0.917 . . . . 0.0 109.4 179.886 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 15.8 m -134.93 -28.04 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 O-C-N 121.346 -0.846 . . . . 0.0 109.721 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -135.05 152.39 51.65 Favored 'General case' 0 N--CA 1.501 2.113 0 O-C-N 121.188 -0.945 . . . . 0.0 110.372 -179.424 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 57.4 p30 -79.12 166.0 22.73 Favored 'General case' 0 N--CA 1.491 1.618 0 CA-C-O 121.6 0.714 . . . . 0.0 110.652 -179.201 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 71.02 92.91 0.08 OUTLIER Glycine 0 N--CA 1.491 2.303 0 N-CA-C 110.294 -1.122 . . . . 0.0 110.294 179.476 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 20.5 tt0 -168.89 130.9 1.25 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.408 -1.054 . . . . 0.0 109.183 179.279 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 91.9 m95 -95.65 133.56 39.58 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.404 -0.81 . . . . 0.0 109.774 -179.686 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.461 ' O ' HG22 ' A' ' 72' ' ' VAL . . . -175.09 176.58 2.08 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.193 -0.942 . . . . 0.0 109.741 179.509 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 94.6 m-20 -103.91 145.01 30.75 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.438 -0.789 . . . . 0.0 109.072 179.888 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 5.6 tt -142.04 133.61 26.77 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.278 -0.889 . . . . 0.0 109.924 -179.818 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 3.5 ttmp? -117.01 141.85 47.72 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 179.558 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.464 ' CB ' ' OD1' ' A' ' 43' ' ' ASP . . . -164.2 -177.18 4.83 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.887 -1.133 . . . . 0.0 110.352 -179.648 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -112.05 137.63 49.82 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.633 -0.667 . . . . 0.0 109.487 -179.913 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 71.2 t -83.54 96.64 4.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.295 -0.878 . . . . 0.0 110.197 -179.572 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.49 ' O ' ' NE2' ' A' ' 63' ' ' GLN . 96.7 mt -65.53 -45.32 92.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.418 -0.801 . . . . 0.0 109.433 179.744 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.525 ' NE2' ' CZ2' ' A' ' 28' ' ' TRP . 14.6 pt20 -170.61 148.4 3.03 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.397 -0.814 . . . . 0.0 109.737 -179.875 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.546 ' O ' HD12 ' A' ' 27' ' ' LEU . 0.3 OUTLIER -143.65 137.15 28.05 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.566 -0.709 . . . . 0.0 109.274 179.589 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . 0.525 ' CZ2' ' NE2' ' A' ' 26' ' ' GLN . 5.6 m0 -117.69 146.06 43.99 Favored 'General case' 0 N--CA 1.498 1.936 0 CA-C-O 121.717 0.77 . . . . 0.0 109.672 -179.709 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.695 ' CD ' ' H ' ' A' ' 29' ' ' GLU . 1.5 pm0 -63.46 144.59 56.85 Favored 'General case' 0 N--CA 1.491 1.579 0 CA-C-O 121.617 0.722 . . . . 0.0 110.568 -179.25 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.528 ' ND2' ' O ' ' A' ' 36' ' ' SER . 0.0 OUTLIER -90.45 178.03 6.22 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.42 -0.8 . . . . 0.0 110.058 -179.698 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 81.4 p -114.61 7.81 16.14 Favored 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 179.413 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 59.9 m80 -106.25 137.54 44.02 Favored 'General case' 0 N--CA 1.502 2.13 0 O-C-N 121.436 -0.79 . . . . 0.0 109.809 -179.81 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 50.1 tp10 -66.93 -38.34 85.99 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.427 -0.796 . . . . 0.0 109.792 -179.599 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 11.0 t -61.88 -41.69 98.17 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.307 -0.871 . . . . 0.0 110.232 -179.536 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.513 ' O ' ' ND2' ' A' ' 30' ' ' ASN . 90.6 mt -98.6 133.69 40.09 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 O-C-N 121.299 -0.876 . . . . 0.0 110.173 -178.906 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.528 ' O ' ' ND2' ' A' ' 30' ' ' ASN . 25.0 m -81.47 -70.8 0.51 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.578 -0.701 . . . . 0.0 110.112 -179.664 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 34.4 mt-30 -132.55 155.5 48.52 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.393 -0.817 . . . . 0.0 109.62 -179.02 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 9.4 p -137.1 141.03 41.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 -179.805 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -165.79 -158.5 10.85 Favored Glycine 0 N--CA 1.491 2.328 0 C-N-CA 119.422 -1.371 . . . . 0.0 110.177 -179.085 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.732 ' O ' HD12 ' A' ' 40' ' ' LEU . 0.8 OUTLIER -135.65 151.94 50.72 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.573 -0.957 . . . . 0.0 109.761 179.826 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 52.5 mt -114.88 139.76 49.52 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.453 -0.779 . . . . 0.0 109.235 -179.0 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -94.37 127.65 9.17 Favored Glycine 0 N--CA 1.493 2.498 0 N-CA-C 110.359 -1.097 . . . . 0.0 110.359 -179.63 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.464 ' OD1' ' CB ' ' A' ' 22' ' ' ALA . 73.0 m-20 -128.6 142.32 51.08 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.795 -0.827 . . . . 0.0 108.872 179.005 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -56.76 -14.99 3.83 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.411 -0.805 . . . . 0.0 109.52 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 16.5 p -99.3 -8.47 24.89 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.316 -0.865 . . . . 0.0 109.775 -179.763 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 153.95 -167.14 32.16 Favored Glycine 0 N--CA 1.498 2.821 0 C-N-CA 119.733 -1.222 . . . . 0.0 110.257 179.292 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 96.6 mt -125.61 134.7 66.05 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.081 0 O-C-N 121.586 -0.949 . . . . 0.0 108.656 179.895 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 20.6 tt -131.42 144.71 36.78 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.231 0 O-C-N 121.168 -0.958 . . . . 0.0 110.463 -179.566 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 52.8 mtmt -84.34 157.19 21.56 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.727 -0.608 . . . . 0.0 110.42 -179.633 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 16.2 p90 -152.1 164.26 37.63 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.317 -0.864 . . . . 0.0 109.666 179.627 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.418 HG22 HE21 ' A' ' 82' ' ' GLN . 2.7 t -139.1 148.85 43.83 Favored 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 179.578 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 39.2 mm -106.41 126.36 62.12 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 O-C-N 121.472 -0.768 . . . . 0.0 109.562 -179.459 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 77.8 m95 -98.36 147.38 24.74 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.486 -0.759 . . . . 0.0 109.799 -179.72 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 64.7 mttp -78.83 -13.13 59.98 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.449 -0.782 . . . . 0.0 109.255 179.755 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 -61.51 -42.27 98.56 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.471 -0.768 . . . . 0.0 110.339 -179.22 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -76.01 -12.36 60.12 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.145 -0.972 . . . . 0.0 109.634 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 50.47 62.69 2.56 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.515 -0.741 . . . . 0.0 109.903 -179.882 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 14.2 mt -106.66 150.58 39.81 Favored Pre-proline 0 N--CA 1.499 1.975 0 O-C-N 121.59 -0.694 . . . . 0.0 109.749 -179.784 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -70.13 165.28 31.91 Favored 'Trans proline' 0 N--CA 1.502 1.99 0 C-N-CA 123.095 2.53 . . . . 0.0 113.918 -179.102 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 66.6 mt -65.56 141.08 58.57 Favored 'General case' 0 N--CA 1.494 1.761 0 CA-C-O 121.905 0.86 . . . . 0.0 110.88 -178.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.597 ' N ' HD12 ' A' ' 61' ' ' LEU . 9.1 mp -87.39 145.9 26.11 Favored 'General case' 0 N--CA 1.492 1.654 0 CA-C-O 121.344 0.593 . . . . 0.0 110.037 -179.523 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.443 ' N ' ' OH ' ' A' ' 67' ' ' TYR . 83.7 tt0 -98.63 126.69 44.3 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.399 -0.813 . . . . 0.0 109.126 179.461 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.49 ' NE2' ' O ' ' A' ' 25' ' ' ILE . 10.8 tm0? -69.19 140.34 54.61 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.508 -0.745 . . . . 0.0 111.231 -178.822 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.447 ' N ' ' CD ' ' A' ' 63' ' ' GLN . . . 91.78 20.06 38.33 Favored Glycine 0 N--CA 1.495 2.581 0 N-CA-C 110.541 -1.024 . . . . 0.0 110.541 178.812 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.488 ' OE1' ' N ' ' A' ' 65' ' ' GLU . 58.8 mp0 -139.0 155.58 47.88 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.158 -1.201 . . . . 0.0 110.47 179.911 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 13.5 p -80.72 156.44 26.26 Favored 'General case' 0 N--CA 1.49 1.527 0 CA-C-O 121.552 0.691 . . . . 0.0 110.534 -179.418 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.443 ' OH ' ' N ' ' A' ' 62' ' ' GLU . 88.4 m-85 -145.78 144.27 30.2 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.48 -0.763 . . . . 0.0 109.645 179.674 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 13.7 tp -111.86 117.93 34.13 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 179.219 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 4.6 mp -103.45 126.66 50.73 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.467 -0.771 . . . . 0.0 109.054 -179.553 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 90.3 mtm-85 -115.57 140.85 48.79 Favored 'General case' 0 N--CA 1.497 1.909 0 CA-C-O 121.645 0.736 . . . . 0.0 110.421 -178.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.4 ' OG ' ' O ' ' A' ' 71' ' ' SER . 22.2 p 59.77 66.69 0.96 Allowed 'General case' 0 N--CA 1.494 1.744 0 CA-C-O 121.121 0.486 . . . . 0.0 110.703 179.67 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.461 HG22 ' O ' ' A' ' 18' ' ' ALA . 16.5 m -116.26 160.79 15.45 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.134 0 O-C-N 121.537 -0.727 . . . . 0.0 109.252 178.841 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 7.4 p -117.72 133.16 65.37 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 CA-C-O 121.382 0.611 . . . . 0.0 109.423 -179.563 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 13.5 t -88.06 110.29 20.77 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.278 -0.889 . . . . 0.0 109.669 -179.427 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -88.29 172.15 41.14 Favored Glycine 0 N--CA 1.493 2.49 0 N-CA-C 109.887 -1.285 . . . . 0.0 109.887 -179.602 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -100.45 119.68 38.84 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.566 -0.961 . . . . 0.0 109.15 179.928 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 40.7 t80 -115.17 104.36 11.77 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.539 -0.726 . . . . 0.0 109.774 -179.68 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 41.45 -117.15 0.34 Allowed 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.582 -0.698 . . . . 0.0 111.204 179.471 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.418 ' N ' ' OD1' ' A' ' 79' ' ' ASP . 37.5 p-10 -94.53 -7.67 40.52 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.329 -0.857 . . . . 0.0 110.234 -178.794 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 95.4 mtt180 -112.18 177.46 4.63 Favored 'General case' 0 N--CA 1.501 2.091 0 O-C-N 121.417 -0.802 . . . . 0.0 110.015 -179.925 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 72.9 m-85 -109.54 148.64 30.9 Favored 'General case' 0 N--CA 1.497 1.905 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 -179.693 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . 0.418 HE21 HG22 ' A' ' 51' ' ' THR . 53.3 tt0 -137.88 154.01 49.5 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.306 -0.871 . . . . 0.0 109.751 -179.81 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 33.5 m -113.32 132.86 60.99 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 179.729 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 79.0 mt-30 -106.76 127.48 53.43 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.572 -0.705 . . . . 0.0 109.992 -178.883 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 16.8 t -94.8 98.14 7.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.474 -0.766 . . . . 0.0 109.093 179.753 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.529 HD22 ' C ' ' A' ' 86' ' ' ASN . 0.1 OUTLIER -151.18 177.7 9.95 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.412 -0.805 . . . . 0.0 109.767 -179.759 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.516 ' C ' ' H ' ' A' ' 89' ' ' SER . 71.2 mmtt 61.19 -141.27 0.5 Allowed 'General case' 0 N--CA 1.493 1.712 0 CA-C-O 121.639 0.733 . . . . 0.0 110.772 179.169 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 32.3 t30 -66.46 9.52 0.16 Allowed 'General case' 0 C--N 1.304 -1.405 0 CA-C-O 121.334 0.588 . . . . 0.0 109.658 -179.446 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.516 ' H ' ' C ' ' A' ' 87' ' ' LYS . 13.3 p -58.18 143.61 43.54 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.249 -0.907 . . . . 0.0 109.671 -179.882 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 19.2 p -141.26 156.4 45.89 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.482 -0.761 . . . . 0.0 109.655 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 96.5 mt -132.58 134.53 58.68 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 121.556 -0.715 . . . . 0.0 109.445 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -126.48 136.83 53.12 Favored 'General case' 0 N--CA 1.499 2.013 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 179.516 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.432 ' C ' HD12 ' A' ' 94' ' ' LEU . 88.4 tttt -80.13 128.91 34.07 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.397 -0.815 . . . . 0.0 109.678 -179.795 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.432 HD12 ' C ' ' A' ' 93' ' ' LYS . 10.1 mp -105.23 134.59 48.08 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.451 -0.781 . . . . 0.0 109.636 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 96.6 p -88.6 8.51 28.0 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 108.774 -0.825 . . . . 0.0 108.774 179.521 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 67.0 mt-10 -117.55 90.38 35.1 Favored Pre-proline 0 N--CA 1.498 1.951 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 -179.775 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_exo -55.7 147.52 59.89 Favored 'Trans proline' 0 N--CA 1.497 1.705 0 C-N-CA 122.741 2.294 . . . . 0.0 112.658 179.618 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.586 HG22 ' O ' ' A' ' 98' ' ' ILE . 97.1 mt -84.23 0.67 4.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 CA-C-O 121.709 0.766 . . . . 0.0 109.67 -179.675 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 45.06 87.47 0.02 OUTLIER 'General case' 0 C--N 1.293 -1.865 0 CA-C-O 121.401 0.619 . . . . 0.0 109.659 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 33.6 m -99.94 42.79 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 O-C-N 121.422 -0.799 . . . . 0.0 109.352 -179.84 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 155.87 -16.22 0.45 Allowed Glycine 0 N--CA 1.494 2.537 0 N-CA-C 109.055 -1.618 . . . . 0.0 109.055 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.531 HD12 ' N ' ' A' ' 102' ' ' LEU . 10.9 mp -83.28 1.84 38.97 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.395 -1.062 . . . . 0.0 108.755 179.779 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -72.91 -4.29 31.07 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.41 -0.806 . . . . 0.0 109.052 179.535 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 71.8 t60 -66.05 -41.29 91.01 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.472 -0.767 . . . . 0.0 109.984 -179.801 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 77.0 m80 -94.59 103.48 15.43 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.098 -1.001 . . . . 0.0 109.826 -179.585 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 45.4 p-80 -157.58 -2.52 0.1 Allowed 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 179.478 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 95.6 m-70 -67.19 -39.83 86.42 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.516 -0.74 . . . . 0.0 109.455 179.751 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 77.4 m80 -78.34 132.65 37.5 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.361 -0.837 . . . . 0.0 110.084 -179.336 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 39.3 p-80 . . . . . 0 N--CA 1.491 1.622 0 CA-C-O 118.082 -0.961 . . . . 0.0 109.205 179.748 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 67.0 mtt . . . . . 0 N--CA 1.491 1.595 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 52.5 mm-40 -138.27 60.41 21.74 Favored Pre-proline 0 N--CA 1.498 1.943 0 O-C-N 121.471 -0.768 . . . . 0.0 109.82 -179.578 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -68.88 136.59 35.8 Favored 'Trans proline' 0 C--N 1.308 -1.554 0 C-N-CA 122.056 1.838 . . . . 0.0 111.765 -179.742 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -87.89 87.95 7.51 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.806 -1.184 . . . . 0.0 109.201 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.459 HD22 ' N ' ' A' ' 5' ' ' LEU . 4.0 mm? -69.31 136.16 51.43 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.502 -0.748 . . . . 0.0 109.583 -179.913 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 96.7 m -124.58 128.59 49.14 Favored 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -84.28 156.94 21.71 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.513 -0.742 . . . . 0.0 110.135 -179.424 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 65.4 mt -62.53 -44.36 99.25 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 121.446 -0.784 . . . . 0.0 109.681 179.907 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 14.0 p -64.66 -23.53 33.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.28 -0.888 . . . . 0.0 109.527 -179.875 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -79.7 -4.04 50.05 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.127 -0.983 . . . . 0.0 109.513 179.693 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 97.1 mt -80.24 103.99 7.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.097 -1.002 . . . . 0.0 109.825 -179.609 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 28.0 m -122.15 -9.39 8.85 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 179.4 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 18.9 pt-20 -136.39 137.7 40.8 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.5 -0.75 . . . . 0.0 109.598 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 30.5 p30 -95.34 162.83 13.51 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.322 -0.861 . . . . 0.0 110.731 -179.238 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 79.5 2.8 88.34 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.738 -1.345 . . . . 0.0 109.738 179.764 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 21.1 pt20 -80.47 144.38 32.62 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.248 -1.148 . . . . 0.0 110.095 -179.671 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 87.9 m95 -97.94 137.27 37.02 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.515 -0.741 . . . . 0.0 109.526 179.796 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -177.0 -179.61 0.93 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.078 -1.014 . . . . 0.0 109.78 179.608 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -105.75 146.28 30.03 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 6.1 tt -143.64 134.3 25.04 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.141 -0.974 . . . . 0.0 109.719 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 34.3 ttpt -116.66 139.7 50.24 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.571 -0.706 . . . . 0.0 109.189 179.864 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -160.57 179.45 8.58 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.865 -1.147 . . . . 0.0 109.949 179.857 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 64.7 tttm -112.96 141.98 46.17 Favored 'General case' 0 N--CA 1.498 1.953 0 CA-C-O 121.37 0.605 . . . . 0.0 109.679 -179.656 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 97.2 t -82.4 125.01 39.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.283 -0.886 . . . . 0.0 110.438 -179.078 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 96.6 mt -102.05 -51.83 8.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 179.184 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 18.4 tt0 -148.02 145.05 28.35 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.446 -0.784 . . . . 0.0 109.193 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.919 ' H ' HD23 ' A' ' 27' ' ' LEU . 1.2 pt? -136.65 138.77 41.46 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 179.934 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 78.9 t90 -128.37 123.11 33.05 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.394 -0.816 . . . . 0.0 109.463 -179.543 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -64.27 138.83 58.64 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.227 -0.921 . . . . 0.0 110.401 -179.52 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.404 HD22 ' HB ' ' A' ' 35' ' ' ILE . 55.9 t30 -84.68 169.91 13.83 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.505 -0.747 . . . . 0.0 110.102 -179.538 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 81.8 p -101.95 3.23 38.81 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.454 -0.779 . . . . 0.0 109.068 179.629 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 96.1 m-70 -105.49 136.34 45.25 Favored 'General case' 0 N--CA 1.5 2.041 0 CA-C-O 121.615 0.721 . . . . 0.0 109.765 179.886 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 46.4 tp10 -67.35 -31.71 72.15 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.358 -0.839 . . . . 0.0 109.72 -179.834 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 38.4 t -60.52 -42.65 96.86 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.178 -0.951 . . . . 0.0 109.783 -179.671 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.404 ' HB ' HD22 ' A' ' 30' ' ' ASN . 86.4 mt -105.38 124.83 60.51 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.064 0 O-C-N 121.394 -0.816 . . . . 0.0 109.517 179.967 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 3.4 t -68.96 -57.21 5.79 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.466 -0.771 . . . . 0.0 110.256 -179.637 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . 0.417 HE22 HD12 ' A' ' 27' ' ' LEU . 2.4 pt20 -156.88 156.96 34.02 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.201 -0.937 . . . . 0.0 109.97 -179.543 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 30.6 m -132.49 135.8 57.14 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 179.521 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -160.07 -158.97 9.51 Favored Glycine 0 N--CA 1.492 2.423 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 -179.444 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 2.0 pp -135.7 147.39 48.48 Favored 'General case' 0 N--CA 1.503 2.182 0 O-C-N 121.291 -1.123 . . . . 0.0 110.498 -179.628 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 48.1 mt -111.98 139.26 47.64 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.608 -0.683 . . . . 0.0 109.29 -178.834 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -80.64 164.85 47.36 Favored Glycine 0 N--CA 1.491 2.333 0 C-N-CA 120.215 -0.993 . . . . 0.0 110.669 -179.522 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.53 ' OD1' ' N ' ' A' ' 44' ' ' GLU . 66.8 t0 -172.68 141.28 1.08 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.607 -0.937 . . . . 0.0 109.389 179.482 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.53 ' N ' ' OD1' ' A' ' 43' ' ' ASP . 97.2 mt-10 -54.81 -18.39 4.75 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.313 -0.867 . . . . 0.0 110.479 -179.593 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 33.3 p -94.76 -9.74 33.72 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.981 -1.074 . . . . 0.0 109.498 -179.903 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 146.04 -153.82 25.56 Favored Glycine 0 N--CA 1.497 2.729 0 N-CA-C 110.168 -1.173 . . . . 0.0 110.168 179.365 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 37.3 pt -125.93 154.78 35.27 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.969 0 O-C-N 121.714 -0.874 . . . . 0.0 109.14 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.405 HD12 ' HA ' ' A' ' 48' ' ' ILE . 10.9 tp -142.72 142.19 26.76 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 O-C-N 121.109 -0.994 . . . . 0.0 110.462 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 25.4 mtpp -83.3 153.02 24.85 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 179.661 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 30.9 p90 -147.55 160.82 42.2 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 120.972 -1.08 . . . . 0.0 110.103 -179.879 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.514 HG22 HE21 ' A' ' 82' ' ' GLN . 3.4 t -143.89 139.57 29.28 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 179.401 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 95.3 mt -104.5 119.86 54.01 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.983 0 O-C-N 121.301 -0.875 . . . . 0.0 109.695 -179.754 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 94.6 m95 -95.49 140.88 29.72 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.332 -0.855 . . . . 0.0 109.366 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -84.29 52.44 2.34 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.202 -0.936 . . . . 0.0 109.418 179.941 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.42 ' ND2' ' O ' ' A' ' 55' ' ' ASN . 0.5 OUTLIER -74.28 -9.06 58.23 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.37 -0.831 . . . . 0.0 109.022 179.837 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -163.41 -78.68 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.347 -0.846 . . . . 0.0 109.143 179.889 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -171.8 114.53 0.35 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.181 -0.949 . . . . 0.0 109.701 179.893 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 91.2 mt -139.57 95.55 8.92 Favored Pre-proline 0 N--CA 1.496 1.85 0 O-C-N 121.33 -0.856 . . . . 0.0 108.834 179.543 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -52.57 154.37 12.13 Favored 'Trans proline' 0 N--CA 1.494 1.525 0 C-N-CA 122.15 1.9 . . . . 0.0 111.956 -179.759 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 62.4 mt -62.63 139.88 58.66 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.251 -0.905 . . . . 0.0 110.258 -178.638 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.587 ' N ' HD12 ' A' ' 61' ' ' LEU . 8.8 mp -80.95 149.52 29.34 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.681 -0.637 . . . . 0.0 110.034 -179.308 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 80.4 mm-40 -83.49 139.42 32.93 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.35 -0.844 . . . . 0.0 109.955 -179.712 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 56.8 tt0 -77.53 133.15 38.6 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.398 -0.814 . . . . 0.0 111.07 -179.121 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 95.13 -0.33 64.02 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 110.048 -1.221 . . . . 0.0 110.048 179.475 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.514 ' OE1' ' N ' ' A' ' 65' ' ' GLU . 58.4 mp0 -111.73 150.82 29.69 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 121.451 -1.029 . . . . 0.0 110.292 -179.572 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 7.7 m -86.88 152.0 22.83 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.705 -0.622 . . . . 0.0 109.925 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 74.0 m-85 -142.52 145.77 34.01 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.544 -0.722 . . . . 0.0 109.557 179.677 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 18.0 tp -106.01 124.11 49.06 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 179.445 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 61.3 mt -100.97 131.52 46.8 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 -179.621 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.453 ' CZ ' ' OE2' ' A' ' 92' ' ' GLU . 84.8 mtm180 -126.93 141.32 51.83 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.376 -0.827 . . . . 0.0 110.168 -179.364 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 8.3 m 56.95 57.22 4.78 Favored 'General case' 0 N--CA 1.493 1.721 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.382 179.405 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 15.5 m -113.74 161.81 12.33 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.12 0 O-C-N 121.378 -0.826 . . . . 0.0 108.929 178.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 7.6 p -117.94 134.08 62.69 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.02 0 CA-C-O 121.435 0.636 . . . . 0.0 109.534 -179.239 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 20.1 t -78.67 122.11 33.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.38 -0.825 . . . . 0.0 109.922 -179.173 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -95.28 171.77 29.87 Favored Glycine 0 N--CA 1.495 2.605 0 N-CA-C 109.368 -1.493 . . . . 0.0 109.368 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.546 ' N ' ' OE1' ' A' ' 76' ' ' GLU . 57.5 mp0 -107.17 118.94 38.04 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.487 -1.008 . . . . 0.0 109.483 -179.691 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 55.5 t80 -118.75 107.41 13.62 Favored 'General case' 0 N--CA 1.496 1.836 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 179.508 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 97.7 m-20 44.57 -125.76 1.02 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.403 -0.811 . . . . 0.0 109.942 -179.369 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 66.1 m-20 -94.66 -5.42 45.65 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.363 -0.836 . . . . 0.0 108.994 179.867 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 88.3 mtm180 -100.2 166.18 11.12 Favored 'General case' 0 N--CA 1.493 1.69 0 CA-C-O 121.614 0.721 . . . . 0.0 109.704 -179.702 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 76.8 m-85 -101.84 151.01 22.58 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.425 -0.797 . . . . 0.0 109.579 -179.595 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . 0.514 HE21 HG22 ' A' ' 51' ' ' THR . 40.6 tt0 -138.54 157.1 46.8 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.389 -0.819 . . . . 0.0 109.643 -179.757 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 3.4 m -114.11 130.64 67.97 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 179.178 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 87.7 mt-30 -109.83 132.42 54.16 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.61 -0.682 . . . . 0.0 110.072 -178.316 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 3.9 t -104.55 126.93 59.29 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 179.505 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.499 HD22 ' C ' ' A' ' 86' ' ' ASN . 0.1 OUTLIER -145.97 -176.44 5.15 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.208 -0.932 . . . . 0.0 109.531 -179.776 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.529 ' C ' ' H ' ' A' ' 89' ' ' SER . 21.7 ptmt -37.93 161.12 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.804 0 CA-C-O 121.544 0.688 . . . . 0.0 111.589 -178.942 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 5.1 t30 69.51 -23.71 0.15 Allowed 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 -179.678 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.529 ' H ' ' C ' ' A' ' 87' ' ' LYS . 10.6 t -78.31 155.94 29.89 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.197 -0.939 . . . . 0.0 109.86 -179.755 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 27.1 p -141.2 154.59 45.9 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.46 -0.775 . . . . 0.0 108.956 179.571 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 97.3 mt -129.98 132.49 65.5 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.453 ' OE2' ' CZ ' ' A' ' 70' ' ' ARG . 80.3 mt-10 -120.95 140.95 51.16 Favored 'General case' 0 N--CA 1.502 2.126 0 O-C-N 121.436 -0.79 . . . . 0.0 109.264 -179.507 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 37.8 ttmt -84.18 122.95 29.56 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.185 -0.947 . . . . 0.0 109.266 -179.735 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.487 ' N ' HD22 ' A' ' 94' ' ' LEU . 3.9 mm? -96.79 136.85 36.75 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.367 -0.833 . . . . 0.0 109.804 -179.466 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 94.4 p -85.52 -1.23 56.87 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 179.349 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 37.6 mm-40 -108.48 98.81 29.81 Favored Pre-proline 0 N--CA 1.498 1.961 0 O-C-N 121.644 -0.66 . . . . 0.0 109.286 -179.81 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -74.3 155.28 46.41 Favored 'Trans proline' 0 N--CA 1.491 1.38 0 C-N-CA 121.982 1.788 . . . . 0.0 112.737 -178.796 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 90.6 mt -102.7 123.82 56.3 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -87.26 125.34 34.14 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.408 -0.807 . . . . 0.0 110.425 -178.577 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 29.4 m -109.71 1.43 9.36 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.019 0 O-C-N 121.626 -0.672 . . . . 0.0 109.448 179.775 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -127.54 65.64 0.57 Allowed Glycine 0 N--CA 1.502 3.046 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 4.3 tp -86.9 -4.01 59.13 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.262 -1.14 . . . . 0.0 108.99 179.851 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -54.02 135.15 43.38 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.213 -0.93 . . . . 0.0 110.608 -179.089 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . 0.46 ' CG ' ' O ' ' A' ' 104' ' ' HIS . 45.6 p-80 -99.23 106.82 19.01 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.439 -0.788 . . . . 0.0 109.585 -179.942 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 52.2 t-80 -75.68 -87.92 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.361 -0.837 . . . . 0.0 109.737 -179.831 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 60.7 t-80 -156.54 -12.74 0.1 Allowed 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 58.4 t-80 -62.09 -44.6 96.31 Favored 'General case' 0 N--CA 1.486 1.375 0 O-C-N 121.46 -0.775 . . . . 0.0 109.267 179.705 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 47.5 p-80 -152.91 164.42 37.93 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.144 -0.972 . . . . 0.0 109.787 179.908 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . 0.45 ' O ' ' CG ' ' A' ' 109' ' ' HIS . 86.4 t60 . . . . . 0 N--CA 1.49 1.551 0 CA-C-O 117.916 -1.04 . . . . 0.0 109.223 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.5 tpt . . . . . 0 N--CA 1.49 1.536 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.509 ' N ' ' CD ' ' A' ' 3' ' ' PRO . 1.5 tt0 -68.35 -47.66 36.94 Favored Pre-proline 0 C--N 1.303 -1.434 0 O-C-N 121.576 -0.702 . . . . 0.0 109.752 179.763 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.509 ' CD ' ' N ' ' A' ' 2' ' ' GLU . 72.5 Cg_endo -79.76 150.11 21.1 Favored 'Trans proline' 0 C--N 1.312 -1.343 0 C-N-CA 122.167 1.911 . . . . 0.0 112.144 -179.116 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 55.9 tt0 -78.61 89.07 4.52 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.367 -0.833 . . . . 0.0 109.321 -179.68 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 81.7 mt -76.63 144.91 39.22 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.65 -0.656 . . . . 0.0 109.582 -179.744 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 86.6 m -123.46 130.41 52.65 Favored 'General case' 0 N--CA 1.496 1.834 0 CA-C-O 121.551 0.691 . . . . 0.0 109.515 -179.887 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 65.7 mttp -82.59 149.35 27.5 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.555 -0.715 . . . . 0.0 110.074 -179.32 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 95.6 mt -63.12 -43.29 98.83 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 O-C-N 121.618 -0.676 . . . . 0.0 109.677 179.914 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 11.1 p -63.83 -24.1 34.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.333 -0.854 . . . . 0.0 109.824 -179.663 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -75.0 -3.89 35.08 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.096 -1.003 . . . . 0.0 109.385 179.712 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 5.7 mm -70.95 92.63 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.313 -0.867 . . . . 0.0 109.52 -179.789 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 15.0 m -114.82 -20.6 5.89 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -139.09 140.56 38.04 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.268 -0.895 . . . . 0.0 109.938 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.404 HD22 ' HB3' ' A' ' 76' ' ' GLU . 55.4 p30 -89.74 167.93 12.5 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.499 -0.751 . . . . 0.0 110.263 -179.507 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 80.26 15.74 77.87 Favored Glycine 0 N--CA 1.488 2.144 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 -179.807 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 27.8 tt0 -96.28 132.35 41.84 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.335 -1.097 . . . . 0.0 109.709 -179.82 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 76.6 m95 -94.72 134.33 37.43 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.587 -0.695 . . . . 0.0 109.954 -179.536 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -173.29 -169.46 0.53 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.526 -0.734 . . . . 0.0 109.667 179.566 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 70.9 m-20 -107.34 152.03 24.7 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.6 -0.687 . . . . 0.0 109.159 -179.889 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.616 HD13 ' N ' ' A' ' 21' ' ' LYS . 0.3 OUTLIER -133.85 120.25 20.2 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.408 -0.807 . . . . 0.0 109.318 179.835 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.616 ' N ' HD13 ' A' ' 20' ' ' LEU . 35.9 ttmt -112.51 126.56 55.46 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 179.131 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -168.57 -171.95 1.55 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.117 -0.989 . . . . 0.0 109.989 -179.706 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -119.28 138.8 52.77 Favored 'General case' 0 N--CA 1.497 1.887 0 CA-C-O 121.625 0.726 . . . . 0.0 109.976 -179.621 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 10.7 t -85.9 91.43 3.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.521 -0.737 . . . . 0.0 109.661 -179.476 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 62.6 mt -69.86 -42.65 79.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.481 -0.762 . . . . 0.0 109.612 179.915 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 98.8 mm-40 -127.64 125.94 41.07 Favored 'General case' 0 N--CA 1.498 1.932 0 CA-C-O 121.75 0.786 . . . . 0.0 110.117 -178.897 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 1.1 tt -121.92 130.55 53.43 Favored 'General case' 0 C--N 1.309 -1.193 0 N-CA-C 108.755 -0.832 . . . . 0.0 108.755 179.821 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 96.9 m95 -135.2 117.76 15.89 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.613 -0.68 . . . . 0.0 109.39 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -94.18 144.56 25.4 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.485 -0.76 . . . . 0.0 110.025 -179.537 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.45 HD21 ' CG2' ' A' ' 35' ' ' ILE . 54.0 p30 -117.19 164.8 14.23 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.601 -0.687 . . . . 0.0 109.708 179.908 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.529 HG22 ' O ' ' A' ' 31' ' ' THR . 85.5 m -93.27 3.64 55.31 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 179.722 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 59.9 m80 -63.47 132.15 50.46 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.423 -0.798 . . . . 0.0 110.105 -179.336 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 80.5 tt0 -76.99 -23.07 52.27 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.545 -0.722 . . . . 0.0 109.857 -179.806 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 87.7 p -87.08 -17.28 33.23 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.181 -0.949 . . . . 0.0 109.495 -179.583 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.45 ' CG2' HD21 ' A' ' 30' ' ' ASN . 84.0 mt -131.41 130.57 62.89 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 O-C-N 121.479 -0.763 . . . . 0.0 109.238 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.423 ' O ' ' OD1' ' A' ' 30' ' ' ASN . 37.2 t -75.28 -75.38 0.17 Allowed 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.568 -0.707 . . . . 0.0 109.46 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . 0.402 HE22 ' HA ' ' A' ' 60' ' ' LEU . 16.0 pt20 -141.42 162.36 35.67 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.394 -0.816 . . . . 0.0 110.013 -179.58 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 27.6 m -131.96 154.76 40.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 179.425 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.424 ' C ' ' CE1' ' A' ' 50' ' ' PHE . . . -178.88 -169.79 39.98 Favored Glycine 0 N--CA 1.486 1.987 0 C-N-CA 119.268 -1.444 . . . . 0.0 109.827 -179.751 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 2.2 pp -136.44 150.57 48.8 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.646 -0.914 . . . . 0.0 109.638 -179.621 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 54.5 mt -107.55 161.36 14.92 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 -179.006 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -140.09 131.99 5.33 Favored Glycine 0 N--CA 1.493 2.475 0 N-CA-C 109.967 -1.253 . . . . 0.0 109.967 -179.714 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.429 ' OD2' ' OG1' ' A' ' 45' ' ' THR . 52.3 p30 -151.59 -167.07 2.68 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.618 -0.93 . . . . 0.0 109.16 179.796 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -76.96 -12.4 59.94 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.514 -0.741 . . . . 0.0 109.473 179.633 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.429 ' OG1' ' OD2' ' A' ' 43' ' ' ASP . 34.7 p -91.98 -5.65 52.67 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.293 -0.88 . . . . 0.0 109.605 -179.518 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 122.76 -148.67 16.88 Favored Glycine 0 N--CA 1.5 2.953 0 N-CA-C 110.195 -1.162 . . . . 0.0 110.195 179.304 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 43.7 pt -128.71 154.89 40.22 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 O-C-N 121.758 -0.848 . . . . 0.0 109.712 -179.541 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 17.1 tt -152.6 144.46 15.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.212 -0.93 . . . . 0.0 109.96 179.621 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 63.7 mttp -83.36 150.7 25.94 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.557 -0.714 . . . . 0.0 109.909 -179.494 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.424 ' CE1' ' C ' ' A' ' 39' ' ' GLY . 35.5 p90 -142.36 152.12 42.56 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.291 -0.881 . . . . 0.0 109.622 -179.949 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 99.6 m -135.19 132.01 37.42 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 179.703 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 98.0 mt -106.05 129.06 59.85 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.601 -0.687 . . . . 0.0 109.844 -179.661 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 86.6 m95 -94.97 144.33 25.77 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.51 -0.744 . . . . 0.0 109.527 -179.924 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -66.92 -7.25 20.64 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.413 -0.804 . . . . 0.0 109.409 179.814 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 93.2 m-20 -61.95 -40.49 95.73 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.404 -0.81 . . . . 0.0 109.51 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -73.45 -11.77 60.57 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.357 -0.84 . . . . 0.0 109.089 179.776 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 46.07 46.7 12.85 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.72 -0.613 . . . . 0.0 109.67 179.908 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 23.3 mt -97.33 150.82 37.22 Favored Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 121.481 -0.762 . . . . 0.0 109.503 -179.926 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -68.85 159.55 53.35 Favored 'Trans proline' 0 N--CA 1.496 1.639 0 C-N-CA 122.832 2.355 . . . . 0.0 112.72 -179.817 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.402 ' HA ' HE22 ' A' ' 37' ' ' GLN . 69.2 mt -64.84 139.1 58.73 Favored 'General case' 0 N--CA 1.49 1.543 0 CA-C-O 121.624 0.726 . . . . 0.0 110.388 -179.163 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.591 ' N ' HD12 ' A' ' 61' ' ' LEU . 9.6 mp -76.94 149.85 35.98 Favored 'General case' 0 N--CA 1.49 1.545 0 CA-C-O 121.468 0.652 . . . . 0.0 110.175 -179.588 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 49.2 tp10 -81.2 118.86 22.93 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.45 -0.781 . . . . 0.0 109.297 -179.914 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 56.9 tt0 -64.21 134.63 55.16 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.55 -0.719 . . . . 0.0 110.902 -178.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 84.14 28.8 32.85 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 110.339 -1.105 . . . . 0.0 110.339 179.488 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -136.65 154.24 50.7 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.276 -1.132 . . . . 0.0 110.637 -179.634 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 6.7 m -81.16 142.07 33.6 Favored 'General case' 0 N--CA 1.488 1.444 0 CA-C-O 121.322 0.582 . . . . 0.0 109.707 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 29.3 m-85 -140.8 146.84 38.15 Favored 'General case' 0 N--CA 1.49 1.57 0 CA-C-O 121.782 0.801 . . . . 0.0 109.751 -179.942 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 23.3 tp -111.56 120.87 43.56 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 179.458 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 66.2 mt -102.87 133.17 48.39 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 -179.916 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.42 ' O ' ' OG ' ' A' ' 71' ' ' SER . 84.8 mtp180 -127.39 149.27 50.15 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.666 -0.646 . . . . 0.0 110.293 -179.517 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.496 ' HG ' ' HA ' ' A' ' 89' ' ' SER . 3.0 p 53.28 57.93 5.75 Favored 'General case' 0 N--CA 1.494 1.733 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.445 179.702 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 17.8 m -116.15 164.99 12.01 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.043 0 O-C-N 121.608 -0.682 . . . . 0.0 109.422 179.105 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 8.0 p -115.32 137.84 47.59 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 CA-C-O 121.485 0.659 . . . . 0.0 109.8 -179.065 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 89.0 t -85.28 108.43 17.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.559 -0.713 . . . . 0.0 109.65 -179.501 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -87.64 177.77 46.95 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 110.115 -1.194 . . . . 0.0 110.115 -179.43 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.404 ' HB3' HD22 ' A' ' 14' ' ' ASN . 17.2 pt-20 -107.68 134.57 50.47 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.602 -0.94 . . . . 0.0 109.216 -179.867 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 55.7 t80 -108.83 145.14 35.74 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.477 -0.764 . . . . 0.0 109.756 -179.468 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.442 ' O ' ' CB ' ' A' ' 79' ' ' ASP . 24.0 t-20 -69.43 62.99 0.16 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.588 -0.695 . . . . 0.0 109.96 -179.477 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.442 ' CB ' ' O ' ' A' ' 78' ' ' ASN . 0.7 OUTLIER 162.43 -25.57 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 179.701 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 25.1 ttm180 -166.88 -131.66 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.374 -0.829 . . . . 0.0 109.595 -179.778 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 89.6 m-85 -131.29 152.28 50.71 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.582 -0.699 . . . . 0.0 109.625 -179.573 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 6.0 pt20 -144.97 162.49 36.76 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.473 -0.767 . . . . 0.0 109.393 -179.836 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 3.3 m -109.36 132.66 56.89 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 179.804 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 87.0 mt-30 -107.14 132.48 52.98 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.632 -0.668 . . . . 0.0 110.18 -178.65 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 90.1 t -99.45 129.59 49.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 179.654 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 6.2 m-80 -144.38 176.36 9.42 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.475 -0.765 . . . . 0.0 109.524 -179.494 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.473 ' C ' ' H ' ' A' ' 89' ' ' SER . 61.3 tttp -40.94 159.75 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.723 0 CA-C-O 121.29 0.567 . . . . 0.0 110.459 -179.796 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . 0.447 ' CB ' ' O ' ' A' ' 87' ' ' LYS . 3.9 t30 77.26 -25.37 0.2 Allowed 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 -179.5 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.496 ' HA ' ' HG ' ' A' ' 71' ' ' SER . 94.0 p -73.27 154.41 40.19 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 121.62 -0.675 . . . . 0.0 109.825 -179.809 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 75.7 m -132.26 150.52 52.14 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.625 -0.672 . . . . 0.0 109.472 -179.945 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 96.9 mt -130.11 130.6 65.98 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 179.864 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 53.0 tp10 -126.57 130.93 51.51 Favored 'General case' 0 N--CA 1.497 1.881 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 179.784 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.4 ' C ' HD22 ' A' ' 94' ' ' LEU . 64.0 tttp -80.19 131.31 35.68 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.614 -0.679 . . . . 0.0 110.235 -179.274 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.48 ' N ' HD22 ' A' ' 94' ' ' LEU . 3.9 mm? -96.67 135.87 37.99 Favored 'General case' 0 N--CA 1.495 1.818 0 CA-C-O 121.777 0.799 . . . . 0.0 109.929 -179.809 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 68.1 m -84.65 -3.8 58.69 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.724 -0.61 . . . . 0.0 109.519 179.802 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 12.3 tp10 -117.47 91.17 37.07 Favored Pre-proline 0 N--CA 1.498 1.94 0 O-C-N 121.56 -0.712 . . . . 0.0 109.338 -179.854 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -55.77 147.66 59.86 Favored 'Trans proline' 0 N--CA 1.498 1.751 0 C-N-CA 122.727 2.284 . . . . 0.0 112.648 -179.869 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 95.9 mt -96.27 129.2 46.68 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.494 -0.754 . . . . 0.0 109.785 -179.434 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 74.8 mm-40 -90.15 125.36 35.43 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.582 -0.699 . . . . 0.0 109.643 -179.694 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 29.2 m -102.06 -2.48 9.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 N-CA-C 108.817 -0.808 . . . . 0.0 108.817 179.761 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 172.28 119.17 0.51 Allowed Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.811 -1.316 . . . . 0.0 109.811 179.74 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 83.1 mt -89.66 -5.17 57.34 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.458 -1.024 . . . . 0.0 109.118 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 76.1 mt-10 -81.87 107.63 14.74 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.406 -0.809 . . . . 0.0 109.994 -179.702 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 25.9 t-80 -170.25 71.51 0.06 Allowed 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 108.906 -0.775 . . . . 0.0 108.906 179.514 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 57.9 t-80 -157.96 134.85 9.91 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.327 -0.858 . . . . 0.0 109.78 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' HIS . . . . . 0.63 ' ND1' ' N ' ' A' ' 107' ' ' HIS . 55.3 t-80 42.44 -105.8 0.07 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.615 -0.678 . . . . 0.0 110.519 179.604 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . 0.63 ' N ' ' ND1' ' A' ' 106' ' ' HIS . 84.6 t60 46.03 80.34 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.579 -0.701 . . . . 0.0 109.718 -179.461 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . 0.444 ' CD2' ' O ' ' A' ' 109' ' ' HIS . 86.3 t60 -89.69 128.23 36.05 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.396 -0.815 . . . . 0.0 109.847 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . 0.444 ' O ' ' CD2' ' A' ' 108' ' ' HIS . 54.2 p-80 . . . . . 0 N--CA 1.49 1.552 0 CA-C-O 118.025 -0.988 . . . . 0.0 110.004 -179.869 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.6 ptt? . . . . . 0 N--CA 1.489 1.483 0 CA-C-O 121.792 0.806 . . . . 0.0 109.547 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 51.23 57.68 16.87 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.615 -0.678 . . . . 0.0 110.219 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -68.37 150.17 75.79 Favored 'Trans proline' 0 C--N 1.31 -1.463 0 C-N-CA 122.39 2.06 . . . . 0.0 112.067 179.685 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.513 ' OE1' ' N ' ' A' ' 4' ' ' GLN . 0.9 OUTLIER -76.24 90.12 3.14 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.352 -0.843 . . . . 0.0 109.878 -179.436 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 79.1 mt -76.61 145.74 38.7 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.706 -0.622 . . . . 0.0 109.435 179.897 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 92.0 m -125.26 132.24 52.96 Favored 'General case' 0 N--CA 1.493 1.723 0 CA-C-O 121.761 0.791 . . . . 0.0 109.704 -179.884 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -75.85 149.4 37.85 Favored 'General case' 0 C--N 1.3 -1.567 0 CA-C-O 121.785 0.802 . . . . 0.0 110.373 -179.578 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 97.2 mt -63.24 -43.22 98.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 CA-C-O 121.802 0.81 . . . . 0.0 109.563 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 7.6 p -65.06 -24.3 35.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.592 -0.693 . . . . 0.0 109.872 -179.67 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 50.3 t0 -79.4 -4.58 51.69 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.17 -0.956 . . . . 0.0 109.838 -179.639 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 97.1 mt -85.6 114.33 25.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 120.962 -1.086 . . . . 0.0 109.656 -179.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 34.6 m -149.84 15.04 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 179.741 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 79.3 mm-40 -127.87 133.54 49.34 Favored 'General case' 0 N--CA 1.497 1.907 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 -179.903 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 11.5 m120 -74.06 141.54 45.72 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-O 121.658 0.742 . . . . 0.0 110.079 -179.579 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 58.02 111.15 0.01 OUTLIER Glycine 0 N--CA 1.49 2.242 0 N-CA-C 110.465 -1.054 . . . . 0.0 110.465 179.504 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 29.1 tt0 -168.06 133.77 1.91 Allowed 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.424 -1.045 . . . . 0.0 109.174 179.501 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 60.4 m95 -88.63 136.82 32.8 Favored 'General case' 0 N--CA 1.49 1.558 0 CA-C-O 121.652 0.739 . . . . 0.0 109.938 -179.565 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -178.29 173.63 1.39 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.571 -0.705 . . . . 0.0 109.229 -179.717 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 73.0 m-20 -107.59 144.99 33.84 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.54 -0.725 . . . . 0.0 109.886 -179.434 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 60.4 tp -133.78 135.4 43.86 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.49 -0.756 . . . . 0.0 110.406 -179.59 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 38.5 ttmt -119.23 130.34 55.41 Favored 'General case' 0 N--CA 1.496 1.863 0 CA-C-O 121.321 0.581 . . . . 0.0 109.556 179.503 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -168.79 -172.91 1.72 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.345 -0.847 . . . . 0.0 109.93 179.414 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 21.3 ptmt -124.81 154.35 41.11 Favored 'General case' 0 N--CA 1.498 1.961 0 CA-C-O 121.46 0.648 . . . . 0.0 109.919 179.829 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 97.1 t -87.8 129.58 38.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 CA-C-O 121.613 0.721 . . . . 0.0 110.174 -179.539 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.402 HD11 ' HA3' ' A' ' 42' ' ' GLY . 96.4 mt -100.98 -55.81 5.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 N-CA-C 109.068 -0.715 . . . . 0.0 109.068 179.42 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.614 ' NE2' ' NE2' ' A' ' 63' ' ' GLN . 64.2 mm-40 -142.92 138.61 30.3 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.151 -0.968 . . . . 0.0 109.807 179.825 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.833 ' H ' HD23 ' A' ' 27' ' ' LEU . 1.2 pt? -143.22 139.41 30.25 Favored 'General case' 0 N--CA 1.492 1.631 0 CA-C-O 121.347 0.594 . . . . 0.0 109.988 -179.928 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 5.6 m-90 -111.86 140.31 46.61 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 179.595 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -78.59 119.75 22.3 Favored 'General case' 0 N--CA 1.493 1.687 0 CA-C-O 121.645 0.736 . . . . 0.0 110.265 -179.563 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.442 HD22 HG21 ' A' ' 35' ' ' ILE . 55.7 t-20 -107.04 -43.91 4.52 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.543 -0.723 . . . . 0.0 109.243 179.756 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.435 ' C ' ' O ' ' A' ' 30' ' ' ASN . 1.2 p 38.22 53.75 1.71 Allowed 'General case' 0 N--CA 1.504 2.265 0 CA-C-O 122.023 0.916 . . . . 0.0 109.783 -179.539 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . 0.729 ' CD2' ' H ' ' A' ' 33' ' ' GLU . 29.4 t60 -83.72 -151.6 0.12 Allowed 'General case' 0 N--CA 1.494 1.758 0 CA-C-O 122.072 0.939 . . . . 0.0 110.738 -179.137 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.729 ' H ' ' CD2' ' A' ' 32' ' ' HIS . 97.2 mt-10 -70.08 -38.81 75.8 Favored 'General case' 0 N--CA 1.491 1.618 0 CA-C-O 121.661 0.743 . . . . 0.0 109.799 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 14.7 m -137.79 2.76 2.43 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.303 -0.873 . . . . 0.0 109.138 -179.609 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.442 HG21 HD22 ' A' ' 30' ' ' ASN . 72.4 mt -107.34 126.39 63.54 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 O-C-N 121.131 -0.981 . . . . 0.0 109.576 -179.751 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.575 ' OG ' ' N ' ' A' ' 54' ' ' LYS . 1.0 OUTLIER -92.0 -69.47 0.74 Allowed 'General case' 0 N--CA 1.492 1.648 0 CA-C-O 121.837 0.827 . . . . 0.0 109.283 -179.905 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 99.3 mt-30 -138.71 154.01 48.54 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.303 -0.873 . . . . 0.0 109.792 -179.585 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.7 p -140.41 140.49 34.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.585 -0.697 . . . . 0.0 109.781 -179.806 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -170.56 -156.96 11.87 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 179.723 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.688 HD23 ' H ' ' A' ' 40' ' ' LEU . 1.7 pt? -132.12 150.6 52.11 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.709 -0.877 . . . . 0.0 110.117 179.836 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 66.2 mt -109.71 134.33 52.11 Favored 'General case' 0 N--CA 1.492 1.674 0 CA-C-O 121.763 0.792 . . . . 0.0 109.591 -179.438 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.402 ' HA3' HD11 ' A' ' 25' ' ' ILE . . . -86.87 144.04 19.3 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 110.06 -1.216 . . . . 0.0 110.06 179.897 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 43.8 t0 -152.7 165.55 34.94 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 121.497 -1.002 . . . . 0.0 110.105 179.84 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -63.99 -17.89 63.75 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.82 -0.55 . . . . 0.0 110.826 -179.583 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 17.3 p -98.63 -5.91 30.85 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 120.809 -1.182 . . . . 0.0 109.99 -179.314 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 140.21 -129.82 4.38 Favored Glycine 0 N--CA 1.496 2.678 0 N-CA-C 110.219 -1.153 . . . . 0.0 110.219 179.491 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.823 HD13 ' H ' ' A' ' 47' ' ' ILE . 0.1 OUTLIER -145.09 158.89 13.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.583 -0.951 . . . . 0.0 109.819 -179.54 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.547 HD11 ' O ' ' A' ' 81' ' ' PHE . 9.7 tp -148.73 147.72 16.54 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 179.172 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 69.1 mttm -85.07 153.52 22.66 Favored 'General case' 0 N--CA 1.49 1.533 0 CA-C-O 121.641 0.734 . . . . 0.0 110.403 -179.658 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 13.4 p90 -148.86 152.86 37.21 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.407 -0.808 . . . . 0.0 109.447 179.779 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 98.3 m -133.1 131.28 40.36 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 91.7 mt -100.55 125.43 54.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.4 -0.812 . . . . 0.0 110.098 -179.58 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 54.3 m95 -93.96 120.27 33.99 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 179.455 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.575 ' N ' ' OG ' ' A' ' 36' ' ' SER . 19.6 ptmt -69.76 -5.05 22.71 Favored 'General case' 0 C--N 1.3 -1.565 0 CA-C-O 121.764 0.792 . . . . 0.0 108.928 179.947 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 8.7 m120 -61.84 -40.77 96.49 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.542 -0.724 . . . . 0.0 109.262 179.57 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -78.82 -12.92 60.05 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.224 -0.923 . . . . 0.0 109.166 179.592 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 55.43 62.22 2.55 Favored 'General case' 0 N--CA 1.494 1.761 0 CA-C-O 121.59 0.71 . . . . 0.0 109.99 179.914 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 40.4 mt -101.54 154.21 37.39 Favored Pre-proline 0 N--CA 1.493 1.724 0 O-C-N 121.651 -0.656 . . . . 0.0 109.237 179.836 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -52.44 143.85 42.98 Favored 'Trans proline' 0 N--CA 1.497 1.694 0 C-N-CA 122.221 1.947 . . . . 0.0 112.752 179.929 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 79.2 mt -74.19 141.55 45.48 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.404 -0.81 . . . . 0.0 109.844 -179.852 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.623 ' N ' HD12 ' A' ' 61' ' ' LEU . 9.8 mp -86.26 149.07 25.33 Favored 'General case' 0 N--CA 1.489 1.508 0 CA-C-O 121.834 0.826 . . . . 0.0 110.078 -179.796 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -99.68 146.12 26.86 Favored 'General case' 0 N--CA 1.491 1.6 0 CA-C-O 121.761 0.791 . . . . 0.0 110.429 -179.275 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.614 ' NE2' ' NE2' ' A' ' 26' ' ' GLN . 57.4 tt0 -75.17 135.54 41.07 Favored 'General case' 0 N--CA 1.489 1.48 0 CA-C-O 121.727 0.775 . . . . 0.0 110.413 -179.894 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 81.32 18.09 69.87 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 110.011 -1.236 . . . . 0.0 110.011 179.535 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 -125.27 147.22 49.19 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.393 -1.063 . . . . 0.0 110.646 -179.8 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 12.7 p -80.19 150.89 29.97 Favored 'General case' 0 N--CA 1.485 1.299 0 CA-C-O 121.721 0.772 . . . . 0.0 110.011 179.772 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 40.0 m-85 -145.42 144.37 30.6 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.497 -0.752 . . . . 0.0 109.547 179.915 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 25.0 tp -111.13 119.83 40.29 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 179.034 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 71.4 mt -105.22 128.37 53.38 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 -179.675 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 83.1 mtp180 -130.13 137.74 50.3 Favored 'General case' 0 N--CA 1.493 1.691 0 CA-C-O 121.502 0.668 . . . . 0.0 110.021 179.835 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.3 m 72.73 52.52 0.15 Allowed 'General case' 0 N--CA 1.495 1.78 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.198 179.677 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 20.4 m -113.68 160.7 13.03 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 O-C-N 121.377 -0.827 . . . . 0.0 110.196 179.626 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 11.1 p -114.37 140.46 35.04 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 CA-C-O 121.549 0.69 . . . . 0.0 109.19 -179.841 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 85.7 t -86.21 113.43 24.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 CA-C-O 121.996 0.903 . . . . 0.0 110.529 -179.062 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -87.27 177.09 47.28 Favored Glycine 0 N--CA 1.488 2.148 0 N-CA-C 109.882 -1.287 . . . . 0.0 109.882 179.875 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.561 ' N ' ' OE1' ' A' ' 76' ' ' GLU . 52.8 mp0 -112.62 128.0 56.26 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.63 -0.923 . . . . 0.0 109.854 -179.341 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 80.7 t80 -130.7 86.11 2.35 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 179.662 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.494 ' CG ' ' H ' ' A' ' 79' ' ' ASP . 64.4 t30 58.87 -139.71 0.74 Allowed 'General case' 0 N--CA 1.491 1.594 0 CA-C-O 121.508 0.671 . . . . 0.0 110.527 179.944 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.494 ' H ' ' CG ' ' A' ' 78' ' ' ASN . 93.0 m-20 -78.22 -5.95 53.41 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.412 -0.805 . . . . 0.0 109.244 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 16.5 tpp180 -107.74 145.98 32.76 Favored 'General case' 0 N--CA 1.497 1.88 0 CA-C-O 121.866 0.841 . . . . 0.0 110.029 -179.442 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . 0.547 ' O ' HD11 ' A' ' 48' ' ' ILE . 94.5 m-85 -85.85 153.49 22.21 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.532 -0.73 . . . . 0.0 110.167 -179.066 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 48.7 tt0 -140.76 154.07 46.13 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.438 -0.789 . . . . 0.0 109.659 -179.715 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 27.2 m -113.55 131.19 66.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 CA-C-O 121.591 0.71 . . . . 0.0 109.085 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 87.1 mt-30 -105.94 119.81 40.13 Favored 'General case' 0 N--CA 1.493 1.689 0 CA-C-O 121.606 0.717 . . . . 0.0 110.091 -178.777 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 11.2 t -93.67 103.44 14.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 179.158 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.538 HD22 ' C ' ' A' ' 86' ' ' ASN . 0.4 OUTLIER -151.68 -178.77 6.91 Favored 'General case' 0 N--CA 1.489 1.49 0 CA-C-O 121.732 0.777 . . . . 0.0 110.474 -179.113 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 30.6 ttmt 68.6 -131.76 0.1 Allowed 'General case' 0 N--CA 1.492 1.673 0 CA-C-O 121.642 0.734 . . . . 0.0 110.895 179.466 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . 0.41 ' O ' ' C ' ' A' ' 89' ' ' SER . 12.6 m120 -93.23 10.62 31.1 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.393 -0.817 . . . . 0.0 108.813 -179.51 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.41 ' C ' ' O ' ' A' ' 88' ' ' ASN . 40.6 t -39.07 111.72 0.2 Allowed 'General case' 0 N--CA 1.495 1.801 0 CA-C-O 121.863 0.84 . . . . 0.0 110.516 -179.439 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 6.1 m -77.41 145.56 37.12 Favored 'General case' 0 N--CA 1.489 1.52 0 CA-C-O 121.531 0.682 . . . . 0.0 109.947 -179.542 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 97.9 mt -135.98 132.05 50.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.441 -0.787 . . . . 0.0 109.604 179.849 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 83.1 tt0 -129.15 131.34 47.17 Favored 'General case' 0 N--CA 1.497 1.913 0 CA-C-O 121.673 0.749 . . . . 0.0 109.376 179.375 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.425 ' C ' HD12 ' A' ' 94' ' ' LEU . 38.2 ttmt -80.77 125.74 30.44 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.622 -0.674 . . . . 0.0 109.613 -179.757 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.469 HD12 ' N ' ' A' ' 94' ' ' LEU . 10.9 mp -100.94 131.15 46.95 Favored 'General case' 0 N--CA 1.496 1.836 0 CA-C-O 121.907 0.86 . . . . 0.0 110.079 -179.733 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 38.1 t -79.8 -3.6 48.43 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 108.566 -0.902 . . . . 0.0 108.566 179.179 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 60.3 mt-10 -102.41 106.09 47.01 Favored Pre-proline 0 N--CA 1.496 1.841 0 O-C-N 121.299 -0.875 . . . . 0.0 109.325 -179.767 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -76.17 154.4 37.05 Favored 'Trans proline' 0 C--N 1.316 -1.184 0 C-N-CA 122.202 1.934 . . . . 0.0 111.879 -179.44 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 90.6 mt -101.73 127.04 55.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.311 -0.868 . . . . 0.0 109.3 -179.846 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -88.71 121.75 31.42 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.602 -0.687 . . . . 0.0 109.529 -179.71 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 47.6 t -109.53 -13.57 10.69 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 179.62 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 107.88 78.82 1.13 Allowed Glycine 0 N--CA 1.501 2.972 0 N-CA-C 109.83 -1.308 . . . . 0.0 109.83 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 87.1 mt -89.15 -4.46 58.27 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.289 -1.124 . . . . 0.0 108.644 179.544 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . 0.422 ' OE1' ' O ' ' A' ' 104' ' ' HIS . 10.3 tm-20 -156.04 -70.21 0.11 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.32 -0.863 . . . . 0.0 109.216 179.443 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . 0.543 ' CD2' ' H ' ' A' ' 105' ' ' HIS . 85.5 t60 44.76 -108.81 0.15 Allowed 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.505 -0.747 . . . . 0.0 110.16 179.849 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . 0.543 ' H ' ' CD2' ' A' ' 104' ' ' HIS . 97.9 m-70 -150.9 146.13 26.1 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.16 -0.963 . . . . 0.0 109.4 -179.778 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 18.5 p80 -155.74 149.72 25.44 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.457 -0.777 . . . . 0.0 109.727 -179.859 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 97.9 m-70 -114.65 124.74 52.58 Favored 'General case' 0 N--CA 1.498 1.943 0 CA-C-O 121.518 0.675 . . . . 0.0 109.457 -179.892 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 86.2 t60 -95.38 129.33 42.57 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.423 -0.798 . . . . 0.0 109.89 -179.827 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . 0.465 ' ND1' ' OXT' ' A' ' 109' ' ' HIS . 11.3 p80 . . . . . 0 N--CA 1.488 1.462 0 CA-C-O 118.096 -0.954 . . . . 0.0 109.034 179.984 . . . . . . . . 1 1 . 1 stop_ save_